Citrus Sinensis ID: 007608
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 596 | 2.2.26 [Sep-21-2011] | |||||||
| Q8W4S5 | 614 | Probable LRR receptor-lik | yes | no | 0.976 | 0.947 | 0.696 | 0.0 | |
| C0LGX1 | 607 | Probable LRR receptor-lik | no | no | 0.966 | 0.948 | 0.557 | 0.0 | |
| C0LGT1 | 613 | Probable LRR receptor-lik | no | no | 0.941 | 0.915 | 0.552 | 0.0 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.966 | 0.921 | 0.466 | 1e-143 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.902 | 0.874 | 0.490 | 1e-142 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.916 | 0.859 | 0.452 | 1e-137 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.956 | 0.901 | 0.442 | 1e-135 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.887 | 0.834 | 0.479 | 1e-134 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.934 | 0.873 | 0.439 | 1e-132 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.879 | 0.845 | 0.459 | 1e-132 |
| >sp|Q8W4S5|Y5371_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g63710 OS=Arabidopsis thaliana GN=At5g63710 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 827 bits (2137), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/587 (69%), Positives = 492/587 (83%), Gaps = 5/587 (0%)
Query: 13 LMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVT 72
L+ + + + F+ S+ +PD+EG AL+++ +LND+ + W FVSPC+SWS+VT
Sbjct: 30 LILQCFMALAFVGITSSTTQPDIEGGALLQLRDSLNDSSNRL-KWTRDFVSPCYSWSYVT 88
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
CR +V++L L S+GF+G +SP+ITKLKFL + ELQ+N LSG LPD LG+M +LQ+LNL
Sbjct: 89 CRGQSVVALNLASSGFTGTLSPAITKLKFLVTL-ELQNNSLSGALPDSLGNMVNLQTLNL 147
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPC 192
+ N FSGSIPA+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+GT LICG SL QPC
Sbjct: 148 SVNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPC 207
Query: 193 MSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDC 252
S PV++S+ KLR + +ASC A ++L LGA+ + ++R+ K+D+FFDVAGEDD
Sbjct: 208 SSSSRLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDR 267
Query: 253 KVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGG 312
K+S QL+RFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGG
Sbjct: 268 KISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGG 327
Query: 313 EAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW 372
EAAFQRE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDW
Sbjct: 328 EAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDW 387
Query: 373 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432
PTRKRVAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD LTH
Sbjct: 388 PTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTH 447
Query: 433 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 492
VTTQ+RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE++LLLD
Sbjct: 448 VTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLD 507
Query: 493 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE-D 551
HI+KLLRE RL DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP M++VVKMLQG
Sbjct: 508 HIKKLLREQRLRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGG 567
Query: 552 LAERWAEWEELEEVRQQEVSLLPHQFA-WG-EDSSIDQEAIQLSNAR 596
LAE+W EWE+LEEVR +E LLP A W E++++DQE+I+LS AR
Sbjct: 568 LAEKWTEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 649 bits (1675), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/608 (55%), Positives = 427/608 (70%), Gaps = 32/608 (5%)
Query: 18 LILVIFLNFGH--SSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRN 75
L+++ L F SS PD +G+AL + +L + Q +DWN + V PC +WS V C +
Sbjct: 3 LLIITALVFSSLWSSVSPDAQGDALFALRSSLRASPEQLSDWNQNQVDPC-TWSQVICDD 61
Query: 76 G-NVISLTLG-------------------------SNGFSGKISPSITKLKFLASFRELQ 109
+V S+TL NG G I SI L L S +L+
Sbjct: 62 KKHVTSVTLSYMNFSSGTLSSGIGILTTLKTLTLKGNGIMGGIPESIGNLSSLTSL-DLE 120
Query: 110 DNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 169
DN L+ +P LG++ +LQ L L+ N +GSIP + + LS L ++ L SNNL+G IP L
Sbjct: 121 DNHLTDRIPSTLGNLKNLQFLTLSRNNLNGSIPDSLTGLSKLINILLDSNNLSGEIPQSL 180
Query: 170 FSVATFNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFA 229
F + +NFT +L CG + QPC++ SP +S K I+ S A +LL F
Sbjct: 181 FKIPKYNFTANNLSCGGTFPQPCVTESSPSGDSSSRKTGIIAGVVSGIAVILLGFFFFFF 240
Query: 230 CRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVY 289
C+ K + K DVF DVAGE D +++ QLRRF+ RELQLATD FSE N++GQGGFGKVY
Sbjct: 241 CK-DKHKGYKRDVFVDVAGEVDRRIAFGQLRRFAWRELQLATDEFSEKNVLGQGGFGKVY 299
Query: 290 KGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349
KG+LSD TKVAVKRL D+ PGG+ AFQREV +ISVA+H+NLL+LIG+CTT +ER+LVYP
Sbjct: 300 KGLLSDGTKVAVKRLTDFERPGGDEAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYP 359
Query: 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 409
FMQNLSVAY LR++KPG+ LDW RK++A G A GLEYLHE CNPKIIHRD+KAAN+LL
Sbjct: 360 FMQNLSVAYCLREIKPGDPVLDWFRRKQIALGAARGLEYLHEHCNPKIIHRDVKAANVLL 419
Query: 410 DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLE 469
D++FEAV+ DFGLAKLVD + T+VTTQ+RGTMGHIAPE +STGKSSEKTDVFGYGI LLE
Sbjct: 420 DEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPECISTGKSSEKTDVFGYGIMLLE 479
Query: 470 LVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALL 528
LVTGQRAIDFSRLEEE+DVLLLDH++KL RE RL DIVD+ L+ Y +EVE M+QVALL
Sbjct: 480 LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLEDIVDKKLDEDYIKEEVEMMIQVALL 539
Query: 529 CTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQE 588
CTQ+ PE+RP M++VV+ML+GE LAERW EW+ LE RQ+E L +F WGEDS +Q+
Sbjct: 540 CTQAAPEERPAMSEVVRMLEGEGLAERWEEWQNLEVTRQEEFQRLQRRFDWGEDSINNQD 599
Query: 589 AIQLSNAR 596
AI+LS R
Sbjct: 600 AIELSGGR 607
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 643 bits (1659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 326/590 (55%), Positives = 417/590 (70%), Gaps = 29/590 (4%)
Query: 33 PDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGN-VISLTLGSNGFSGK 91
PD +G+AL + +L Q +DWN + V+PC +WS V C + N V SLTL FSG
Sbjct: 27 PDAQGDALFALRISLRALPNQLSDWNQNQVNPC-TWSQVICDDKNFVTSLTLSDMNFSGT 85
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
+S + L+ L + L+ N ++G +P+ G++T L SL+L +N+ +G IP+T L L
Sbjct: 86 LSSRVGILENLKTL-TLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPSTIGNLKKL 144
Query: 152 KHLDLSSNNLTG------------------------RIPMQLFSVATFNFTGTHLICGSS 187
+ L LS N L G +IP LF + +NFT +L CG
Sbjct: 145 QFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTSNNLNCGGR 204
Query: 188 LEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVA 247
PC+S + +S+ K I+ + VL + C+ + + + DVF DVA
Sbjct: 205 QPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCK-DRHKGYRRDVFVDVA 263
Query: 248 GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY 307
GE D +++ QL+RF+ RELQLATDNFSE N++GQGGFGKVYKGVL DNTKVAVKRL D+
Sbjct: 264 GEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDF 323
Query: 308 YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE 367
SPGG+AAFQREV +ISVA+H+NLL+LIG+CTT +ER+LVYPFMQNLS+A+RLR++K G+
Sbjct: 324 ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGD 383
Query: 368 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427
LDW TRKR+A G A G EYLHE CNPKIIHRD+KAAN+LLD++FEAV+ DFGLAKLVD
Sbjct: 384 PVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 443
Query: 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED 487
+ T+VTTQ+RGTMGHIAPEYLSTGKSSE+TDVFGYGI LLELVTGQRAIDFSRLEEE+D
Sbjct: 444 VRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 503
Query: 488 VLLLDHIRKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546
VLLLDH++KL RE RL IVD+NL+ Y +EVE M+QVALLCTQ +PEDRP M++VV+M
Sbjct: 504 VLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRM 563
Query: 547 LQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 596
L+GE LAERW EW+ +E R+ E L +F WGEDS +Q+AI+LS R
Sbjct: 564 LEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 510 bits (1314), Expect = e-143, Method: Compositional matrix adjust.
Identities = 288/618 (46%), Positives = 394/618 (63%), Gaps = 42/618 (6%)
Query: 18 LILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGN 77
L L++ N ++EG+AL + L D + W+ V+PC +W HVTC N N
Sbjct: 11 LSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPC-TWFHVTCNNEN 69
Query: 78 -VISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
VI + LG+ SG + P + LK L + EL N+++G +P LG++T+L SL+L N
Sbjct: 70 SVIRVDLGNAELSGHLVPELGVLKNL-QYLELYSNNITGPIPSNLGNLTNLVSLDLYLNS 128
Query: 137 FSGSIPATWSQLSNLKHL------------------------DLSSNNLTGRIPMQ-LFS 171
FSG IP + +LS L+ L DLS+N L+G +P FS
Sbjct: 129 FSGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFS 188
Query: 172 VAT-FNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFAC 230
+ T +F +CG PC P + V + G ++ G
Sbjct: 189 LFTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGA 248
Query: 231 RYQKL----------RKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNII 280
R+ D+FFDV E+D +V L QL+RFS RELQ+A+D FS NI+
Sbjct: 249 ALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNIL 308
Query: 281 GQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 340
G+GGFGKVYKG L+D T VAVKRL++ +PGGE FQ EV +IS+A+H+NLL+L G+C T
Sbjct: 309 GRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMT 368
Query: 341 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHR 400
+ER+LVYP+M N SVA LR+ P + LDWPTRKR+A G+A GL YLH+ C+PKIIHR
Sbjct: 369 PTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHR 428
Query: 401 DLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 460
D+KAANILLD+ FEAV+ DFGLAKL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDV
Sbjct: 429 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV 488
Query: 461 FGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEV 519
FGYGI LLEL+TGQRA D +RL ++DV+LLD ++ LL+E +L +VD +L T Y+ +E+
Sbjct: 489 FGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEEREL 548
Query: 520 ETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFA- 578
E ++QVALLCTQ +P +RP M++VV+ML+G+ LAE+W EW+++E +R +E+ L P+ +
Sbjct: 549 EQVIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILR-EEIDLSPNPNSD 607
Query: 579 WGEDSSIDQEAIQLSNAR 596
W DS+ + A++LS R
Sbjct: 608 WILDSTYNLHAVELSGPR 625
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 506 bits (1303), Expect = e-142, Method: Compositional matrix adjust.
Identities = 287/585 (49%), Positives = 382/585 (65%), Gaps = 47/585 (8%)
Query: 17 WLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNG 76
WLILV+ L S + EG+AL + +L D + W+ V+PC +W HVTC +
Sbjct: 12 WLILVLDLVLRVSG---NAEGDALSALKNSLADPNKVLQSWDATLVTPC-TWFHVTCNSD 67
Query: 77 N-VISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
N V + LG+ SG++ + +L L + EL N+++GT+P+ LG++T L SL+L N
Sbjct: 68 NSVTRVDLGNANLSGQLVMQLGQLPNL-QYLELYSNNITGTIPEQLGNLTELVSLDLYLN 126
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN--------FTGTHLICGS- 186
SG IP+T +L L+ L L++N+L+G IP L +V T TG + GS
Sbjct: 127 NLSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSF 186
Query: 187 SLEQPCMSRPSPPVSTSRTKL----------------------RIVVASASCGAFVLLSL 224
SL P+S + TKL RI A A A L
Sbjct: 187 SL--------FTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALL 238
Query: 225 GALFACRYQKLRKLK-HDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQG 283
A+ A R+ K D FFDV E+D +V L QL+RFS RELQ+A+DNFS NI+G+G
Sbjct: 239 FAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRG 298
Query: 284 GFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343
GFGKVYKG L+D T VAVKRL++ + GGE FQ EV +IS+A+H+NLL+L G+C T +E
Sbjct: 299 GFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 358
Query: 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLK 403
R+LVYP+M N SVA LR+ + LDWP R+R+A G+A GL YLH+ C+PKIIHRD+K
Sbjct: 359 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK 418
Query: 404 AANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGY 463
AANILLD+ FEAV+ DFGLAKL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGY
Sbjct: 419 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 478
Query: 464 GITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN-TYDSKEVETM 522
G+ LLEL+TGQRA D +RL ++DV+LLD ++ LL+E +L +VD +L Y +EVE +
Sbjct: 479 GVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQL 538
Query: 523 VQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQ 567
+QVALLCTQS+P +RP M++VV+ML+G+ LAERW EW++ E RQ
Sbjct: 539 IQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ 583
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1256), Expect = e-137, Method: Compositional matrix adjust.
Identities = 273/603 (45%), Positives = 376/603 (62%), Gaps = 57/603 (9%)
Query: 39 ALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITK 98
ALI + +L D HG +W+D V PC SW+ +TC +G VI L S SG +S SI
Sbjct: 45 ALIGIKSSLTDPHGVLMNWDDTAVDPC-SWNMITCSDGFVIRLEAPSQNLSGTLSSSIGN 103
Query: 99 LKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSS 158
L L + LQ+N ++G +P +G + L++L+L+ N F+G IP T S NL++L +++
Sbjct: 104 LTNLQTVL-LQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYSKNLQYLRVNN 162
Query: 159 NNLTGRIPMQLFSVA----------------------TFNFTGTHLICGSSLEQPCMSRP 196
N+LTG IP L ++ TFN G IC + E+ C
Sbjct: 163 NSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKTFNVMGNSQICPTGTEKDCNGTQ 222
Query: 197 SPPVS--------------TSRTKLRIVVA-SASCGAFVLLSLGALFACRYQKLRKLKHD 241
P+S T K+ +V S +C +++ G L + + R K
Sbjct: 223 PKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLL---WWRRRHNKQV 279
Query: 242 VFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAV 301
+FFD+ ++ ++ L LRRF+ +ELQ AT NFS N++G+GGFG VYKG L D + +AV
Sbjct: 280 LFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSIIAV 339
Query: 302 KRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 361
KRL+D + GGE FQ E+ +IS+A+H+NLL+L G+CTTSSER+LVYP+M N SVA RL+
Sbjct: 340 KRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVASRLK 399
Query: 362 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421
KP LDW TRKR+A G GL YLHEQC+PKIIHRD+KAANILLDD FEAV+ DFG
Sbjct: 400 -AKPV---LDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFG 455
Query: 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 481
LAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TG RA++F +
Sbjct: 456 LAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGK 515
Query: 482 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPM 540
+ +LD ++KL +E +L IVD++L + YD EVE MVQVALLCTQ P RP M
Sbjct: 516 AANQRGA-ILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRPKM 574
Query: 541 AQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGE-------DSSIDQEAIQLS 593
++VV+ML+G+ L E+W + E + P++F+ E DSS+ +A++LS
Sbjct: 575 SEVVRMLEGDGLVEKWEASSQRAETNRSYSK--PNEFSSSERYSDLTDDSSVLVQAMELS 632
Query: 594 NAR 596
R
Sbjct: 633 GPR 635
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1245), Expect = e-135, Method: Compositional matrix adjust.
Identities = 279/630 (44%), Positives = 389/630 (61%), Gaps = 60/630 (9%)
Query: 17 WLILVIFLNFGHSSREP---DVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTC 73
+L+ V F + ++ P + E AL+ V LND + +W+ + V PC SW V+C
Sbjct: 13 FLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPC-SWRMVSC 71
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLA 133
+G V SL L S SG +SP I L +L S LQ+N ++G +P+ +G + LQSL+L+
Sbjct: 72 TDGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVV-LQNNAITGPIPETIGRLEKLQSLDLS 130
Query: 134 NNKFSGSIPATW------------------------SQLSNLKHLDLSSNNLTGRIPMQL 169
NN F+G IPA+ S++ L +D+S NNL+G +P
Sbjct: 131 NNSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPK-- 188
Query: 170 FSVATFNFTGTHLICGSSLEQPCMSRPSPPV--------STSRTKLRIVVASASCGAFVL 221
S TF G LICG C + P P S +RT V + +
Sbjct: 189 VSARTFKVIGNALICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGHHVALAFAASFSAA 248
Query: 222 L----SLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSES 277
+ G RY++ ++ +FFDV + D +VSL L+R++ +EL+ AT++F+
Sbjct: 249 FFVFFTSGMFLWWRYRRNKQ----IFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSK 304
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
NI+G+GG+G VYKG L+D T VAVKRL+D GGE FQ EV IS+A+H+NLL+L G+
Sbjct: 305 NILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGF 364
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
C+++ ERILVYP+M N SVA RL+D GE LDW RK++A GTA GL YLHEQC+PKI
Sbjct: 365 CSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKI 424
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 457
IHRD+KAANILLD++FEAV+ DFGLAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEK
Sbjct: 425 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 484
Query: 458 TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN-TYDS 516
TDVFG+GI LLEL+TGQ+A+DF R ++ V +LD ++KL +E +L ++D++LN +D
Sbjct: 485 TDVFGFGILLLELITGQKALDFGRSAHQKGV-MLDWVKKLHQEGKLKQLIDKDLNDKFDR 543
Query: 517 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQ 576
E+E +VQVALLCTQ P RP M++V+KML+G+ LAERW E + Q L P
Sbjct: 544 VELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLAERW-EATQNGTGEHQPPPLPPGM 602
Query: 577 FA----------WGEDSSIDQEAIQLSNAR 596
+ + ++SS+ EAI+LS R
Sbjct: 603 VSSSPRVRYYSDYIQESSLVVEAIELSGPR 632
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 480 bits (1235), Expect = e-134, Method: Compositional matrix adjust.
Identities = 275/574 (47%), Positives = 370/574 (64%), Gaps = 45/574 (7%)
Query: 18 LILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGN 77
L+L F+ SS + E EALI + L+D HG F +W++ V PC SW+ ++C + N
Sbjct: 16 LLLCFFVTCSLSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPC-SWTMISCSSDN 74
Query: 78 -VISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
VI L S SG +S SI L L LQ+N++SG +P + S+ LQ+L+L+NN+
Sbjct: 75 LVIGLGAPSQSLSGTLSGSIGNLTNLRQV-SLQNNNISGKIPPEICSLPKLQTLDLSNNR 133
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL----------------------FSVAT 174
FSG IP + +QLSNL++L L++N+L+G P L F T
Sbjct: 134 FSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPKFPART 193
Query: 175 FNFTGTHLICGSSLEQPCM-SRPSPPVSTS-------RTKLRIVVASASCG--AFVLLSL 224
FN G LIC +SL + C S + P+S S RT + V S G V+LSL
Sbjct: 194 FNVAGNPLICKNSLPEICSGSISASPLSVSLRSSSGRRTNILAVALGVSLGFAVSVILSL 253
Query: 225 GALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGG 284
G F +K R+L D +++ + L LR F+ REL +ATD FS +I+G GG
Sbjct: 254 G--FIWYRKKQRRLTMLRISD--KQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGG 309
Query: 285 FGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 344
FG VY+G D T VAVKRL+D G + F+ E+ +IS+A+H+NLL+LIGYC +SSER
Sbjct: 310 FGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSER 369
Query: 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 404
+LVYP+M N SVA RL+ KP LDW TRK++A G A GL YLHEQC+PKIIHRD+KA
Sbjct: 370 LLVYPYMSNGSVASRLKA-KPA---LDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKA 425
Query: 405 ANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 464
ANILLD+ FEAV+ DFGLAKL++ + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+G
Sbjct: 426 ANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG 485
Query: 465 ITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN-TYDSKEVETMV 523
I LLEL+TG RA++F + ++ +L+ +RKL +E ++ ++VDR L TYD EV M+
Sbjct: 486 ILLLELITGMRALEFGKSVSQKGA-MLEWVRKLHKEMKVEELVDRELGTTYDRIEVGEML 544
Query: 524 QVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWA 557
QVALLCTQ P RP M++VV+ML+G+ LAERWA
Sbjct: 545 QVALLCTQFLPAHRPKMSEVVQMLEGDGLAERWA 578
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1216), Expect = e-132, Method: Compositional matrix adjust.
Identities = 271/616 (43%), Positives = 385/616 (62%), Gaps = 59/616 (9%)
Query: 29 SSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGN-VISLTLGSNG 87
S + + E +AL+++ +L+D HG +W+ V PC SW+ VTC + N VI L S
Sbjct: 34 SPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAVDPC-SWTMVTCSSENFVIGLGTPSQN 92
Query: 88 FSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQ 147
SG +SPSIT L L LQ+N++ G +P +G +T L++L+L++N F G IP +
Sbjct: 93 LSGTLSPSITNLTNL-RIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGY 151
Query: 148 LSNLKHLDLSSNNLTGRIPMQL----------------------FSVATFNFTGTHLICG 185
L +L++L L++N+L+G P+ L F+ TF+ G LIC
Sbjct: 152 LQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVPRFAAKTFSIVGNPLICP 211
Query: 186 SSLEQPCMSRPSPPVST-------------SRTKLRIVVASASCG--AFVLLSLGALFAC 230
+ E C P+S SR + +S G + + +++G
Sbjct: 212 TGTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWW 271
Query: 231 RYQKLRKLKHDVFFDVA-GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVY 289
R ++ + FFDV G +VSL LRRF RELQ+AT+NFS N++G+GG+G VY
Sbjct: 272 R----QRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVY 327
Query: 290 KGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349
KG+L D+T VAVKRL+D + GGE FQ EV +IS+A+H+NLL+L G+C T +E++LVYP
Sbjct: 328 KGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYP 387
Query: 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 409
+M N SVA R++ KP LDW RKR+A G A GL YLHEQC+PKIIHRD+KAANILL
Sbjct: 388 YMSNGSVASRMKA-KPV---LDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILL 443
Query: 410 DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLE 469
DD EAV+ DFGLAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLE
Sbjct: 444 DDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 503
Query: 470 LVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL---NTYDSKEVETMVQVA 526
LVTGQRA +F + ++ V +LD ++K+ +E +L +VD+ L +YD E++ MV+VA
Sbjct: 504 LVTGQRAFEFGKAANQKGV-MLDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVA 562
Query: 527 LLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEV-----RQQEVSLLPHQFA-WG 580
LLCTQ P RP M++VV+ML+G+ LAE+W + + V R E+ +++
Sbjct: 563 LLCTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLT 622
Query: 581 EDSSIDQEAIQLSNAR 596
+DSS+ +A++LS R
Sbjct: 623 DDSSLLVQAMELSGPR 638
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 471 bits (1213), Expect = e-132, Method: Compositional matrix adjust.
Identities = 258/561 (45%), Positives = 362/561 (64%), Gaps = 37/561 (6%)
Query: 34 DVEGEALIEVLKAL---NDTHGQFTDWNDHFVSPCFSWSHVTCRNGN-VISLTLGSNGFS 89
+ EG+AL ++ +L + + W+ V+PC +W HVTC N V + LG+ S
Sbjct: 30 NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPC-TWFHVTCNPENKVTRVDLGNAKLS 88
Query: 90 GKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLS 149
GK+ P + +L L + EL N+++G +P+ LG + L SL+L N SG IP++ +L
Sbjct: 89 GKLVPELGQLLNL-QYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLG 147
Query: 150 NLKHLDLSSNNLTGRIPM-------QLFSVATFNFTGTHLICGSSLEQPCMSRPSPPVST 202
L+ L L++N+L+G IPM Q+ ++ +G + GS + P +
Sbjct: 148 KLRFLRLNNNSLSGEIPMTLTSVQLQVLDISNNRLSGDIPVNGSF----SLFTPISFANN 203
Query: 203 SRTKL------------------RIVVASASCGAFVLLSLGALFACRYQK-LRKLKHDVF 243
S T L ++ A A A L A+ A + LR+ D F
Sbjct: 204 SLTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHF 263
Query: 244 FDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKR 303
FDV E+D +V L QL+RF+ REL +ATDNFS N++G+GGFGKVYKG L+D VAVKR
Sbjct: 264 FDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKR 323
Query: 304 LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL 363
L++ + GGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 324 LKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 383
Query: 364 KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423
G LDWP RK +A G+A GL YLH+ C+ KIIHRD+KAANILLD+ FEAV+ DFGLA
Sbjct: 384 PEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLA 443
Query: 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE 483
KL++ +HVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQ+A D +RL
Sbjct: 444 KLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLA 503
Query: 484 EEEDVLLLDHIRKLLREDRLNDIVDRNL-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 542
++D++LLD ++++L+E +L +VD L Y EVE ++Q+ALLCTQS+ +RP M++
Sbjct: 504 NDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSE 563
Query: 543 VVKMLQGEDLAERWAEWEELE 563
VV+ML+G+ LAERW EW++ E
Sbjct: 564 VVRMLEGDGLAERWEEWQKEE 584
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 596 | ||||||
| 359480667 | 621 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.954 | 0.760 | 0.0 | |
| 255568877 | 598 | ATP binding protein, putative [Ricinus c | 0.994 | 0.991 | 0.719 | 0.0 | |
| 356512884 | 596 | PREDICTED: probable LRR receptor-like se | 0.983 | 0.983 | 0.724 | 0.0 | |
| 356527105 | 595 | PREDICTED: probable LRR receptor-like se | 0.983 | 0.984 | 0.718 | 0.0 | |
| 224126743 | 595 | predicted protein [Populus trichocarpa] | 0.996 | 0.998 | 0.733 | 0.0 | |
| 224060473 | 594 | predicted protein [Populus trichocarpa] | 0.996 | 1.0 | 0.728 | 0.0 | |
| 357520193 | 597 | Plasma membrane receptor-like kinase [Me | 0.984 | 0.983 | 0.703 | 0.0 | |
| 297793957 | 614 | hypothetical protein ARALYDRAFT_496559 [ | 0.993 | 0.964 | 0.687 | 0.0 | |
| 10177052 | 579 | receptor-like protein kinase [Arabidopsi | 0.959 | 0.987 | 0.707 | 0.0 | |
| 18424740 | 614 | Leucine-rich repeat protein kinase famil | 0.976 | 0.947 | 0.696 | 0.0 |
| >gi|359480667|ref|XP_002272767.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g63710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2358), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/597 (76%), Positives = 511/597 (85%), Gaps = 4/597 (0%)
Query: 2 FGALHKCC--PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWND 59
FG L CC P L+ WLIL + L F +SS PDVEGEAL++ LK LND++ + TDWND
Sbjct: 27 FGLL-SCCLVPLKLILSWLILFVMLRFSYSSNGPDVEGEALVDFLKTLNDSNNRITDWND 85
Query: 60 HFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPD 119
HFVSPCFSWS+VTCRNGNVISL+L S GFSG +SPSITKLKFLAS +L+DN+LSG LPD
Sbjct: 86 HFVSPCFSWSNVTCRNGNVISLSLASKGFSGTLSPSITKLKFLASL-DLKDNNLSGALPD 144
Query: 120 FLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 179
+L SM +LQ+L+LA N FSGSIP++W QLSN+KHLDLSSN+LTGRIP QLFSV TFNFTG
Sbjct: 145 YLSSMINLQNLDLARNNFSGSIPSSWGQLSNIKHLDLSSNDLTGRIPEQLFSVPTFNFTG 204
Query: 180 THLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLK 239
L CGSSL+QPC S + PVST ++KLR+V A C AF+LLSLGA+FA RY K+K
Sbjct: 205 NRLTCGSSLQQPCASGSTIPVSTKKSKLRVVTPVAICAAFILLSLGAIFAYRYCYAHKIK 264
Query: 240 HDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV 299
DVF DV GED+CK+S Q+RRFS ELQLATD FSESNIIGQGGFGKVY+GVL + TKV
Sbjct: 265 RDVFHDVTGEDECKISFGQVRRFSWHELQLATDEFSESNIIGQGGFGKVYRGVLPNGTKV 324
Query: 300 AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYR 359
AVKRL DY++PGGEAAFQREV LISVA+HKNLL+LIG+CTT +ERILVYPFMQNLSVAYR
Sbjct: 325 AVKRLSDYHNPGGEAAFQREVQLISVAVHKNLLRLIGFCTTFNERILVYPFMQNLSVAYR 384
Query: 360 LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 419
LRDLKPGE+GLDWPTR++VAFG A+GLEYLHE CNPKIIHRDLKAANILLDD+FE VL D
Sbjct: 385 LRDLKPGERGLDWPTRRKVAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDDFEPVLGD 444
Query: 420 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 479
FGLAKL+D KLTHVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF
Sbjct: 445 FGLAKLLDTKLTHVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 504
Query: 480 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 539
SRLEEEEDVLLLDHIRKL RE RL+ IVDRNL T+D+KEVET+VQVALLCTQS+PEDRP
Sbjct: 505 SRLEEEEDVLLLDHIRKLQREKRLDAIVDRNLKTFDAKEVETIVQVALLCTQSSPEDRPK 564
Query: 540 MAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 596
MA+VV MLQGE LA RW EWE LEEVR Q SLL HQF W ++S+ DQEAIQLS AR
Sbjct: 565 MAEVVSMLQGEGLAARWVEWERLEEVRNQHFSLLSHQFPWADESTHDQEAIQLSKAR 621
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568877|ref|XP_002525409.1| ATP binding protein, putative [Ricinus communis] gi|223535300|gb|EEF36976.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 891 bits (2302), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/596 (71%), Positives = 505/596 (84%), Gaps = 3/596 (0%)
Query: 1 MFGALHKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDH 60
MFGA P L+ LIL+ FL G+ S++PD+EGEALI++L ALND++ + DWN +
Sbjct: 6 MFGAASIWHPLKLVISCLILLNFLCVGYPSKDPDLEGEALIQLLSALNDSNHRVEDWNYY 65
Query: 61 FVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDF 120
VSPCFSWSH+TCRNGNVISL+L +NGFSG +SP+ITKL+FL + ELQ+N+LSG LPD+
Sbjct: 66 LVSPCFSWSHITCRNGNVISLSLAANGFSGTLSPAITKLRFLVNL-ELQNNNLSGPLPDY 124
Query: 121 LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGT 180
LGS+THL++LNLA+NKF GSIP W +L NLKHLD+SSNNLTGR+P Q FSV FNFT T
Sbjct: 125 LGSLTHLENLNLASNKFHGSIPIAWGKLFNLKHLDISSNNLTGRVPKQFFSVPEFNFTET 184
Query: 181 HLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKH 240
L CGS LE+PC+S+ PVS ++++L I+V +ASCGAF+L LG FA R+ +LR+LK+
Sbjct: 185 SLTCGSRLEEPCVSKSPSPVSPNKSRLSIIVIAASCGAFILFLLG--FAYRHHRLRRLKN 242
Query: 241 DVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVA 300
DVF DVAGEDD K+SL Q++RFS RE+QLATDNFS+SNIIGQGGFGKVYKGVLSDNTKVA
Sbjct: 243 DVFVDVAGEDDRKISLGQIKRFSWREIQLATDNFSDSNIIGQGGFGKVYKGVLSDNTKVA 302
Query: 301 VKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRL 360
VKRL D Y PGGEAAF REV +ISVA+H+NLL+LIG+CTTSSERILVYP+MQNLSVA+ L
Sbjct: 303 VKRLSDCYIPGGEAAFHREVQIISVAVHRNLLRLIGFCTTSSERILVYPYMQNLSVAFHL 362
Query: 361 RDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420
R+LKPGE GLDW TR+RVAFG A+GLEYLHE CNPKIIHRDLKAANILLDDNFEAVL DF
Sbjct: 363 RELKPGETGLDWQTRRRVAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDNFEAVLGDF 422
Query: 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 480
GLA+LVD KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG+TLLELV G+RAID S
Sbjct: 423 GLARLVDTKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGVTLLELVNGKRAIDLS 482
Query: 481 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 540
RL EEEDVLLLDH +KLLRE+RL+DIVD NL TYD KEVET+V+VALLCTQS+PE RP M
Sbjct: 483 RLAEEEDVLLLDHAKKLLRENRLDDIVDGNLKTYDRKEVETLVKVALLCTQSSPECRPRM 542
Query: 541 AQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 596
++VVK+L G L ERW EWE LE+ R Q+ SL+ Q+ W EDS++DQEAI LS AR
Sbjct: 543 SEVVKLLHGVGLTERWIEWERLEDARNQDFSLMSCQYLWAEDSTVDQEAIHLSKAR 598
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356512884|ref|XP_003525144.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g63710-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2296), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/588 (72%), Positives = 497/588 (84%), Gaps = 2/588 (0%)
Query: 10 PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWS 69
P ++T+WLI + L G + ++PDVEGEAL++VL LND++ Q TDW+ VSPCFSWS
Sbjct: 10 PLKILTRWLIFLTILQVGCAIKDPDVEGEALLDVLHFLNDSNKQITDWDSFLVSPCFSWS 69
Query: 70 HVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQS 129
HVTCRNG+VISL L S GFSG +SPSITKLK+L+S ELQ+N+LSG LPD++ ++T LQ
Sbjct: 70 HVTCRNGHVISLALASVGFSGTLSPSITKLKYLSSL-ELQNNNLSGPLPDYISNLTELQY 128
Query: 130 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLE 189
LNLA+N F+GSIPA W +L NLKHLDLSSN LTG IPMQLFSV FNF+ THL CG E
Sbjct: 129 LNLADNSFNGSIPANWGELPNLKHLDLSSNGLTGSIPMQLFSVPLFNFSDTHLQCGPGFE 188
Query: 190 QPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHD-VFFDVAG 248
Q C S+ P S ++KL +V ASCGAF LL LGA+F R+ + K D VF DV+G
Sbjct: 189 QSCASKSENPASAHKSKLAKIVRYASCGAFALLCLGAIFTYRHHRKHWRKSDDVFVDVSG 248
Query: 249 EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY 308
ED+ K+ QLRRFS RELQLAT NFSE N+IGQGGFGKVYKGVLSDNTKVAVKRL DY+
Sbjct: 249 EDESKIFFGQLRRFSWRELQLATKNFSEGNVIGQGGFGKVYKGVLSDNTKVAVKRLIDYH 308
Query: 309 SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK 368
+PGGEAAF+REV LISVA+H+NLL+LIG+CTT++ERILVYPFM+NLSVAYRLRDLKPGEK
Sbjct: 309 NPGGEAAFEREVQLISVAVHRNLLRLIGFCTTTTERILVYPFMENLSVAYRLRDLKPGEK 368
Query: 369 GLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428
GLDWPTRKRVAFGTA+GLEYLHEQCNPKIIHRDLKAANILLDD FEAVL DFGLAKLVDA
Sbjct: 369 GLDWPTRKRVAFGTAHGLEYLHEQCNPKIIHRDLKAANILLDDEFEAVLGDFGLAKLVDA 428
Query: 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 488
++THVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG+RAID SRLEE+EDV
Sbjct: 429 RMTHVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGERAIDLSRLEEDEDV 488
Query: 489 LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
LL+D+++KLLRE RL DIVDRNL +YD KEVET++QVALLCTQ PEDRP M++VVKMLQ
Sbjct: 489 LLIDYVKKLLREKRLEDIVDRNLESYDPKEVETILQVALLCTQGYPEDRPTMSEVVKMLQ 548
Query: 549 GEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 596
G LA+RWA+W++LEE R QE SL+ HQF W ++S++DQEAIQLS AR
Sbjct: 549 GVGLADRWADWQQLEEARNQEFSLMTHQFVWNDESTLDQEAIQLSRAR 596
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356527105|ref|XP_003532154.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g63710-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 886 bits (2289), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/587 (71%), Positives = 495/587 (84%), Gaps = 1/587 (0%)
Query: 10 PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWS 69
P ++T+WLI + L + ++PDVEGEAL+++L LND++ Q TDW+ VSPCFSWS
Sbjct: 10 PLKILTRWLIFLTILQVSCAIKDPDVEGEALLDLLHFLNDSNKQITDWDSFLVSPCFSWS 69
Query: 70 HVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQS 129
HVTCRNG+VISL L S GFSG +SPSI KLK+L+S ELQ+N+LSG LPD++ ++T LQ
Sbjct: 70 HVTCRNGHVISLALASVGFSGTLSPSIIKLKYLSSL-ELQNNNLSGPLPDYISNLTELQY 128
Query: 130 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLE 189
LNLA+N F+GSIPA W ++ NLKHLDLSSN LTG IP QLFSV FNFT T L CG E
Sbjct: 129 LNLADNNFNGSIPAKWGEVPNLKHLDLSSNGLTGSIPKQLFSVPLFNFTDTQLQCGPGFE 188
Query: 190 QPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGE 249
QPC S+ P S ++KL +V ASCGAF LL LGA+F R + + K DVF DV+GE
Sbjct: 189 QPCASKSENPASAHKSKLAKIVRYASCGAFALLCLGAIFTYRQHQKHRRKIDVFVDVSGE 248
Query: 250 DDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS 309
D+ K+S QLRRFS RELQLAT NFSE N+IGQGGFGKVYKGVLSDNTKVAVKRL DY++
Sbjct: 249 DERKISFGQLRRFSWRELQLATKNFSEGNVIGQGGFGKVYKGVLSDNTKVAVKRLIDYHN 308
Query: 310 PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 369
PGGEAAF+REV LISVA+H+NLL+LIG+CTT++ERILVYPFM+NLSVAYRLRDLKPGEKG
Sbjct: 309 PGGEAAFEREVQLISVAVHRNLLRLIGFCTTTTERILVYPFMENLSVAYRLRDLKPGEKG 368
Query: 370 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429
LDWPTRKRVAFGTA+GLEYLHEQCNPKIIHRDLKAANILLDD FEAVL DFGLAKLVDA+
Sbjct: 369 LDWPTRKRVAFGTAHGLEYLHEQCNPKIIHRDLKAANILLDDEFEAVLGDFGLAKLVDAR 428
Query: 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 489
+THVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG+RA+D SRLEE+EDVL
Sbjct: 429 MTHVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGERALDLSRLEEDEDVL 488
Query: 490 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549
L+D+++KLLRE RL DIVDRNL +YD KEVET++QVALLCTQ PEDRP M++VVKMLQG
Sbjct: 489 LIDYVKKLLREKRLEDIVDRNLESYDPKEVETILQVALLCTQGYPEDRPTMSEVVKMLQG 548
Query: 550 EDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 596
LA+RWA+W++LEE R QE SL+ HQF W ++S++DQEAIQLS AR
Sbjct: 549 VGLADRWADWQQLEEARNQEFSLMTHQFVWNDESTLDQEAIQLSRAR 595
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126743|ref|XP_002329462.1| predicted protein [Populus trichocarpa] gi|222870142|gb|EEF07273.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 871 bits (2250), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/597 (73%), Positives = 504/597 (84%), Gaps = 3/597 (0%)
Query: 1 MFGALHKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDH 60
MFG P L+ LIL+ FL S++EPD EG AL ++L ALND++ Q +W+ +
Sbjct: 1 MFGVFSLWNPLKLVINCLILLNFLKITISTKEPDTEGNALRDLLLALNDSNRQI-NWDTN 59
Query: 61 FVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDF 120
VSPCFSW+HV CRNG+V SL+L S GFSG +SP+I KL+FL + ELQ+N LSG LPD+
Sbjct: 60 LVSPCFSWTHVICRNGHVESLSLNSLGFSGTLSPAIMKLEFLVTL-ELQNNSLSGPLPDY 118
Query: 121 LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGT 180
LG+M HLQ+LNLA+NKFSGSIP TW QLSNLK+LDLSSNNLTGRIP +LFSVA FNFT T
Sbjct: 119 LGNMVHLQNLNLASNKFSGSIPTTWGQLSNLKNLDLSSNNLTGRIPGKLFSVAMFNFTAT 178
Query: 181 HLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKH 240
HL CG SLE+PC+S VSTS+++L+++ SASCGAF+LL L A+ A RY + K K+
Sbjct: 179 HLACGLSLEEPCISGSPLRVSTSKSRLKVIATSASCGAFILLILVAVLAYRYHQFHKEKN 238
Query: 241 DVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVA 300
D+F DVAGEDD K++ QLRRFS RELQLATDNFSESNIIGQGG GKVYKG+LSDN KVA
Sbjct: 239 DIFVDVAGEDDRKITFGQLRRFSWRELQLATDNFSESNIIGQGGCGKVYKGILSDNMKVA 298
Query: 301 VKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRL 360
VKRL DYYSPGGEAAFQREV LISVA HKNLL+L+G+CTTSSERILVYP+MQNLSVAYRL
Sbjct: 299 VKRLADYYSPGGEAAFQREVQLISVAFHKNLLKLVGFCTTSSERILVYPYMQNLSVAYRL 358
Query: 361 RDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420
R+LKPGEKGLDWPTRK++AFG A+GLEYLHE CNPKIIHRDLKAANILLDDNFEAVL DF
Sbjct: 359 RELKPGEKGLDWPTRKKIAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDNFEAVLGDF 418
Query: 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 480
GLAKLVD K THVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID S
Sbjct: 419 GLAKLVDTKFTHVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDLS 478
Query: 481 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 540
RLEEEE+VLLLDHI+KLLRE+RL+DIVD NL TYD KEVET+VQVALLCT S+PE RP M
Sbjct: 479 RLEEEEEVLLLDHIKKLLRENRLDDIVDGNLKTYDRKEVETIVQVALLCTNSSPEGRPKM 538
Query: 541 AQVVKMLQGEDLAERWAEWEELEEVRQQEVS-LLPHQFAWGEDSSIDQEAIQLSNAR 596
+VVKML+G LAERWA+WE+LE+ Q+++ L+ Q+ W EDSSIDQEAIQLS AR
Sbjct: 539 EEVVKMLRGIGLAERWAKWEQLEDAMNQDLAVLMSQQYIWAEDSSIDQEAIQLSRAR 595
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224060473|ref|XP_002300217.1| predicted protein [Populus trichocarpa] gi|222847475|gb|EEE85022.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 865 bits (2235), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/596 (72%), Positives = 503/596 (84%), Gaps = 2/596 (0%)
Query: 1 MFGALHKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDH 60
MFG P L+ L+L+ FL +SS+EPD EG AL ++L ALND++GQ DW+ +
Sbjct: 1 MFGVFSIRNPLKLVINCLVLLNFLQIINSSKEPDTEGGALRDLLLALNDSNGQI-DWDPN 59
Query: 61 FVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDF 120
VSPC+SW++V C+NG+V+ L+L S G SG +SP+ITKLKFL S EL++N+LSG+LPD+
Sbjct: 60 LVSPCYSWTNVYCKNGHVVFLSLNSLGLSGTLSPAITKLKFLVSL-ELRNNNLSGSLPDY 118
Query: 121 LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGT 180
LG+M L++LNLA+NKFSGSIP TW QLSNLK LD+SSNNLTGRIP +LFSVATFNFT T
Sbjct: 119 LGNMVQLKNLNLASNKFSGSIPDTWDQLSNLKFLDVSSNNLTGRIPDKLFSVATFNFTAT 178
Query: 181 HLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKH 240
++ CG S E+PC+SR PVST + +L+++ ASASCGAF LL L + A RYQ+ K K+
Sbjct: 179 YIACGLSFEEPCLSRSPLPVSTRKLRLKVIAASASCGAFGLLILLVVLAYRYQQFHKEKN 238
Query: 241 DVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVA 300
D+F DV+GEDD K+S QLRRFS RELQLATDNFSESNIIGQGGFGKVYKG++SDN KVA
Sbjct: 239 DIFVDVSGEDDRKISFGQLRRFSWRELQLATDNFSESNIIGQGGFGKVYKGIISDNMKVA 298
Query: 301 VKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRL 360
VKRL+DYYSPGG+AAF REV LISVA HKNLL+LIG+CTTSSERILVYP+MQNLSVAY L
Sbjct: 299 VKRLEDYYSPGGKAAFLREVQLISVAAHKNLLRLIGFCTTSSERILVYPYMQNLSVAYHL 358
Query: 361 RDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420
RDLKPGEKGLDWPTRKR+AFG A+GLEYLHE CNPKIIHRDLKAANILLDDNFE VL DF
Sbjct: 359 RDLKPGEKGLDWPTRKRIAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDNFEPVLGDF 418
Query: 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 480
GLAKLVD K TH+TTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID S
Sbjct: 419 GLAKLVDTKFTHITTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDLS 478
Query: 481 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 540
RLEEEEDVLLLD+I+KLLRE+RL+D+VD NL TYD KEVET+VQVALLCTQS+PE RP M
Sbjct: 479 RLEEEEDVLLLDYIKKLLRENRLDDVVDGNLETYDRKEVETIVQVALLCTQSSPEGRPTM 538
Query: 541 AQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 596
A VVKMLQG LAERWA+ E+ + R QE SL+ Q+ W EDSSIDQEAIQLS AR
Sbjct: 539 AGVVKMLQGIGLAERWAKREQHGDARNQEFSLMSQQYIWSEDSSIDQEAIQLSKAR 594
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357520193|ref|XP_003630385.1| Plasma membrane receptor-like kinase [Medicago truncatula] gi|194441092|gb|ACF70844.1| plasma membrane receptor-like kinase [Medicago truncatula] gi|355524407|gb|AET04861.1| Plasma membrane receptor-like kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 864 bits (2232), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/590 (70%), Positives = 498/590 (84%), Gaps = 3/590 (0%)
Query: 9 CPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSW 68
P ++ +W I ++ L + ++PD+EGEAL+++L LND++ Q DW+ H VSPCFSW
Sbjct: 9 APFKILMRWFIFLVVLKLSSAIKDPDIEGEALLDLLNYLNDSNNQIQDWDSHLVSPCFSW 68
Query: 69 SHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQ 128
SHVTCRNG+VISLTL S GFSG +SPSIT+LK+L + ELQ+N+LSG +PD++ ++T LQ
Sbjct: 69 SHVTCRNGHVISLTLASIGFSGTLSPSITRLKYLVNL-ELQNNNLSGPIPDYISNLTDLQ 127
Query: 129 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSL 188
LNLANN F+GSIP +W QLS+LK++DLSSN LTG IP QLFSV FNF+ T L CGSS
Sbjct: 128 YLNLANNNFNGSIPVSWGQLSSLKNVDLSSNGLTGTIPTQLFSVPMFNFSDTPLDCGSSF 187
Query: 189 EQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAG 248
+QPC+S+ P ST+++KL + ASCGAFVLL LGA+F R+ + + K DVF DV G
Sbjct: 188 DQPCVSKSDHPASTNKSKLAKAMPYASCGAFVLLCLGAIFTYRHHQKIRHKSDVFVDVLG 247
Query: 249 EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY 308
ED+ K+S QLRRFS RELQLAT +FSESN+IGQGGFGKVYKGVLSDNTK+AVKRL DY+
Sbjct: 248 EDESKISFGQLRRFSLRELQLATKSFSESNVIGQGGFGKVYKGVLSDNTKIAVKRLTDYH 307
Query: 309 SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK 368
+PGGEAAF+REV LISVA+H+NLL+LIG+CTTS+ERILVYPFM+NLSVAY+LRDLK EK
Sbjct: 308 NPGGEAAFEREVDLISVAVHRNLLRLIGFCTTSTERILVYPFMENLSVAYQLRDLKSDEK 367
Query: 369 GLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428
GLDWPTRKRVAFGTA+GLEYLHEQCNPKIIHRDLKAANILLDD FE VL DFGLAKLVDA
Sbjct: 368 GLDWPTRKRVAFGTAHGLEYLHEQCNPKIIHRDLKAANILLDDEFEPVLGDFGLAKLVDA 427
Query: 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 488
++THVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL+TGQRAID SRLEEEEDV
Sbjct: 428 RMTHVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELITGQRAIDLSRLEEEEDV 487
Query: 489 LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
LL+DH++ L+RE+RL DIVD NL TYD KE ET++QVALLCTQ PEDRP M++VVKMLQ
Sbjct: 488 LLIDHVKNLIRENRLEDIVDNNLETYDPKEAETILQVALLCTQGYPEDRPTMSEVVKMLQ 547
Query: 549 GEDLAERWAEWEELEEVRQQEV--SLLPHQFAWGEDSSIDQEAIQLSNAR 596
G LA+RWA+W++LEE R QE+ SL+ HQF W ++S++DQEAIQLS AR
Sbjct: 548 GVGLADRWADWKQLEEARNQEIELSLMTHQFPWSDESTLDQEAIQLSRAR 597
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793957|ref|XP_002864863.1| hypothetical protein ARALYDRAFT_496559 [Arabidopsis lyrata subsp. lyrata] gi|297310698|gb|EFH41122.1| hypothetical protein ARALYDRAFT_496559 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 829 bits (2142), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/601 (68%), Positives = 497/601 (82%), Gaps = 9/601 (1%)
Query: 3 GALHKCC----PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWN 58
G +H+ C L+ + + + F+ S+ +PD+EG AL+++ +LND+ + W
Sbjct: 16 GFIHRNCFRWNNQKLILQCFMALAFVGVTSSTTQPDIEGGALLQLRDSLNDSSNRL-KWT 74
Query: 59 DHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLP 118
FVSPC+SWS+VTCR +V++L L SNGF+G +SP+ITKLKFL + ELQ+N LSG LP
Sbjct: 75 RDFVSPCYSWSYVTCRGQSVVALNLASNGFTGTLSPAITKLKFLVTL-ELQNNSLSGALP 133
Query: 119 DFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFT 178
+ LG+M +LQ+LNL+ N FSGSIPA+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+
Sbjct: 134 ESLGNMVNLQTLNLSMNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFS 193
Query: 179 GTHLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKL 238
GT LICG SL QPC S PV++S+ KLR + +ASC A ++L LGA+ + ++R+
Sbjct: 194 GTQLICGKSLNQPCSSSSRLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRQT 253
Query: 239 KHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTK 298
K+D+FFDVAGEDD K+S QLRRFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TK
Sbjct: 254 KYDIFFDVAGEDDRKISFGQLRRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTK 313
Query: 299 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY 358
VAVKRL DY+SPGGEAAFQRE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAY
Sbjct: 314 VAVKRLADYFSPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAY 373
Query: 359 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC 418
RLRDLK GE+GLDWPTRKRVAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL
Sbjct: 374 RLRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLG 433
Query: 419 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 478
DFGLAKLVD LTHVTTQ+RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAID
Sbjct: 434 DFGLAKLVDTSLTHVTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAID 493
Query: 479 FSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP 538
FSRLEEEE++LLLDHI+KLLRE RL DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP
Sbjct: 494 FSRLEEEENILLLDHIKKLLREQRLRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRP 553
Query: 539 PMAQVVKMLQGE-DLAERWAEWEELEEVRQQEVSLLPHQFA-WG-EDSSIDQEAIQLSNA 595
M++VVKMLQG LAE+W EWE+LEEVR +E LLP A W E++++DQE+I+LS A
Sbjct: 554 AMSEVVKMLQGTGGLAEKWTEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSAA 613
Query: 596 R 596
R
Sbjct: 614 R 614
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|10177052|dbj|BAB10464.1| receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 829 bits (2141), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/577 (70%), Positives = 487/577 (84%), Gaps = 5/577 (0%)
Query: 23 FLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLT 82
F+ S+ +PD+EG AL+++ +LND+ + W FVSPC+SWS+VTCR +V++L
Sbjct: 5 FVGITSSTTQPDIEGGALLQLRDSLNDSSNRL-KWTRDFVSPCYSWSYVTCRGQSVVALN 63
Query: 83 LGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP 142
L S+GF+G +SP+ITKLKFL + ELQ+N LSG LPD LG+M +LQ+LNL+ N FSGSIP
Sbjct: 64 LASSGFTGTLSPAITKLKFLVTL-ELQNNSLSGALPDSLGNMVNLQTLNLSVNSFSGSIP 122
Query: 143 ATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMSRPSPPVST 202
A+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+GT LICG SL QPC S PV++
Sbjct: 123 ASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPCSSSSRLPVTS 182
Query: 203 SRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRF 262
S+ KLR + +ASC A ++L LGA+ + ++R+ K+D+FFDVAGEDD K+S QL+RF
Sbjct: 183 SKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRKISFGQLKRF 242
Query: 263 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL 322
S RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGEAAFQRE+ L
Sbjct: 243 SLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGEAAFQREIQL 302
Query: 323 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 382
ISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWPTRKRVAFG+
Sbjct: 303 ISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWPTRKRVAFGS 362
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 442
A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD LTHVTTQ+RGTMG
Sbjct: 363 AHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHVTTQVRGTMG 422
Query: 443 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502
HIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE++LLLDHI+KLLRE R
Sbjct: 423 HIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDHIKKLLREQR 482
Query: 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE-DLAERWAEWEE 561
L DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP M++VVKMLQG LAE+W EWE+
Sbjct: 483 LRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGGLAEKWTEWEQ 542
Query: 562 LEEVRQQEVSLLPHQFA-WG-EDSSIDQEAIQLSNAR 596
LEEVR +E LLP A W E++++DQE+I+LS AR
Sbjct: 543 LEEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 579
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18424740|ref|NP_568977.1| Leucine-rich repeat protein kinase family protein [Arabidopsis thaliana] gi|75331406|sp|Q8W4S5.1|Y5371_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At5g63710; Flags: Precursor gi|16974577|gb|AAL31184.1| AT5g63710/MBK5_19 [Arabidopsis thaliana] gi|22655394|gb|AAM98289.1| At5g63710/MBK5_19 [Arabidopsis thaliana] gi|224589745|gb|ACN59404.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332010405|gb|AED97788.1| Leucine-rich repeat protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 827 bits (2137), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/587 (69%), Positives = 492/587 (83%), Gaps = 5/587 (0%)
Query: 13 LMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVT 72
L+ + + + F+ S+ +PD+EG AL+++ +LND+ + W FVSPC+SWS+VT
Sbjct: 30 LILQCFMALAFVGITSSTTQPDIEGGALLQLRDSLNDSSNRL-KWTRDFVSPCYSWSYVT 88
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
CR +V++L L S+GF+G +SP+ITKLKFL + ELQ+N LSG LPD LG+M +LQ+LNL
Sbjct: 89 CRGQSVVALNLASSGFTGTLSPAITKLKFLVTL-ELQNNSLSGALPDSLGNMVNLQTLNL 147
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPC 192
+ N FSGSIPA+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+GT LICG SL QPC
Sbjct: 148 SVNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPC 207
Query: 193 MSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDC 252
S PV++S+ KLR + +ASC A ++L LGA+ + ++R+ K+D+FFDVAGEDD
Sbjct: 208 SSSSRLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDR 267
Query: 253 KVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGG 312
K+S QL+RFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGG
Sbjct: 268 KISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGG 327
Query: 313 EAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW 372
EAAFQRE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDW
Sbjct: 328 EAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDW 387
Query: 373 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432
PTRKRVAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD LTH
Sbjct: 388 PTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTH 447
Query: 433 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 492
VTTQ+RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE++LLLD
Sbjct: 448 VTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLD 507
Query: 493 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE-D 551
HI+KLLRE RL DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP M++VVKMLQG
Sbjct: 508 HIKKLLREQRLRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGG 567
Query: 552 LAERWAEWEELEEVRQQEVSLLPHQFA-WG-EDSSIDQEAIQLSNAR 596
LAE+W EWE+LEEVR +E LLP A W E++++DQE+I+LS AR
Sbjct: 568 LAEKWTEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 614
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 596 | ||||||
| TAIR|locus:2160644 | 614 | AT5G63710 [Arabidopsis thalian | 0.976 | 0.947 | 0.652 | 1e-201 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.869 | 0.845 | 0.552 | 1.5e-147 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.865 | 0.825 | 0.466 | 7.1e-116 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.885 | 0.878 | 0.448 | 1.6e-111 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.865 | 0.821 | 0.458 | 8.7e-111 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.786 | 0.742 | 0.472 | 6.3e-108 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.775 | 0.728 | 0.486 | 1.7e-107 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.785 | 0.754 | 0.479 | 2.1e-107 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.780 | 0.717 | 0.482 | 6.5e-106 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.775 | 0.724 | 0.478 | 1.2e-104 |
| TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1952 (692.2 bits), Expect = 1.0e-201, P = 1.0e-201
Identities = 383/587 (65%), Positives = 459/587 (78%)
Query: 13 LMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVT 72
L+ + + + F+ S+ +PD+EG AL+++ +LND+ + W FVSPC+SWS+VT
Sbjct: 30 LILQCFMALAFVGITSSTTQPDIEGGALLQLRDSLNDSSNRLK-WTRDFVSPCYSWSYVT 88
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
CR +V++L L S+GF+G +SP+ITKLKFL + ELQ+N LSG LPD LG+M +LQ+LNL
Sbjct: 89 CRGQSVVALNLASSGFTGTLSPAITKLKFLVTL-ELQNNSLSGALPDSLGNMVNLQTLNL 147
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPC 192
+ N FSGSIPA+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+GT LICG SL QPC
Sbjct: 148 SVNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPC 207
Query: 193 MXXXXXXXXXXXXKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDC 252
KLR + +ASC A ++L LGA+ + ++R+ K+D+FFDVAGEDD
Sbjct: 208 SSSSRLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDR 267
Query: 253 KVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGG 312
K+S QL+RFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGG
Sbjct: 268 KISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGG 327
Query: 313 EAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW 372
EAAFQRE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDW
Sbjct: 328 EAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDW 387
Query: 373 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432
PTRKRVAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD LTH
Sbjct: 388 PTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTH 447
Query: 433 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXX 492
VTTQ+RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSR
Sbjct: 448 VTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLD 507
Query: 493 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDX 552
HI+KLLRE RL DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP M++VVKMLQG
Sbjct: 508 HIKKLLREQRLRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGG 567
Query: 553 XXXXXXXXXXXXXXXXXXSLL-PHQFA-WGED-SSIDQEAIQLSNAR 596
+LL P A W E+ +++DQE+I+LS AR
Sbjct: 568 LAEKWTEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 614
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1441 (512.3 bits), Expect = 1.5e-147, P = 1.5e-147
Identities = 288/521 (55%), Positives = 365/521 (70%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
N+ +LTL NG +G+I L L S +L+DN L+G +P +G++ LQ L L+ NK
Sbjct: 95 NLKTLTLKGNGITGEIPEDFGNLTSLTSL-DLEDNQLTGRIPSTIGNLKKLQFLTLSRNK 153
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMXXX 196
+G+IP + + L NL +L L SN+L+G+IP LF + +NFT +L CG PC+
Sbjct: 154 LNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTSNNLNCGGRQPHPCVSAV 213
Query: 197 XXXXXXXXXKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSL 256
K I+ + VL + C+ + + + DVF DVAGE D +++
Sbjct: 214 AHSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCK-DRHKGYRRDVFVDVAGEVDRRIAF 272
Query: 257 TQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAF 316
QL+RF+ RELQLATDNFSE N++GQGGFGKVYKGVL DNTKVAVKRL D+ SPGG+AAF
Sbjct: 273 GQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAF 332
Query: 317 QREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 376
QREV +ISVA+H+NLL+LIG+CTT +ER+LVYPFMQNLS+A+RLR++K G+ LDW TRK
Sbjct: 333 QREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRK 392
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 436
R+A G A G EYLHE CNPKIIHRD+KAAN+LLD++FEAV+ DFGLAKLVD + T+VTTQ
Sbjct: 393 RIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQ 452
Query: 437 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRK 496
+RGTMGHIAPEYLSTGKSSE+TDVFGYGI LLELVTGQRAIDFSR H++K
Sbjct: 453 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 512
Query: 497 LLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDXXXX 555
L RE RL IVD+NL+ Y +EVE M+QVALLCTQ +PEDRP M++VV+ML+GE
Sbjct: 513 LEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLAER 572
Query: 556 XXXXXXXXXXXXXXXSLLPHQFAWGEDSSIDQEAIQLSNAR 596
L +F WGEDS +Q+AI+LS R
Sbjct: 573 WEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1142 (407.1 bits), Expect = 7.1e-116, P = 7.1e-116
Identities = 250/536 (46%), Positives = 340/536 (63%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
N+ L L SN +G I ++ L L S +L N SG +P+ LG ++ L+ L L NN
Sbjct: 94 NLQYLELYSNNITGPIPSNLGNLTNLVSL-DLYLNSFSGPIPESLGKLSKLRFLRLNNNS 152
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ-LFSVAT-FNFTGTHLICGSSLEQPC-- 192
+GSIP + + ++ L+ LDLS+N L+G +P FS+ T +F +CG PC
Sbjct: 153 LTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSHPCPG 212
Query: 193 ----------MXXXXXXXXXXXXKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDV 242
+ + + GA +L + A+ +++ + L D+
Sbjct: 213 SPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAALLFAAPAIAFAWWRRRKPL--DI 270
Query: 243 FFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVK 302
FFDV E+D +V L QL+RFS RELQ+A+D FS NI+G+GGFGKVYKG L+D T VAVK
Sbjct: 271 FFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVK 330
Query: 303 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 362
RL++ +PGGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 331 RLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 390
Query: 363 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422
P + LDWPTRKR+A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEAV+ DFGL
Sbjct: 391 RPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 450
Query: 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRX 482
AKL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYGI LLEL+TGQRA D +R
Sbjct: 451 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARL 510
Query: 483 XXXXXXXXXXHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMA 541
++ LL+E +L +VD +L T Y+ +E+E ++QVALLCTQ +P +RP M+
Sbjct: 511 ANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMS 570
Query: 542 QVVKMLQGEDXXXXXXXXXXXXXXXXXXXSLLPHQFA-WGEDSSIDQEAIQLSNAR 596
+VV+ML+G D L P+ + W DS+ + A++LS R
Sbjct: 571 EVVRMLEG-DGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVELSGPR 625
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1101 (392.6 bits), Expect = 1.6e-111, P = 1.6e-111
Identities = 246/548 (44%), Positives = 343/548 (62%)
Query: 17 WLILVIFLNFGHSSREPDVEGEALIEVLKALND---THGQFTDWNDHFVSPCFSWSHVTC 73
WLIL FL+F S + +ALI + +L+ T+ WN V+PC SW HVTC
Sbjct: 11 WLIL--FLDFV-SRVTGKTQVDALIALRSSLSSGDHTNNILQSWNATHVTPC-SWFHVTC 66
Query: 74 RNGNVIS-LTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
N ++ L LGS SG++ P + +L L + EL +N+++G +P+ LG + L SL+L
Sbjct: 67 NTENSVTRLDLGSANLSGELVPQLAQLPNL-QYLELFNNNITGEIPEELGDLMELVSLDL 125
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL-------FSVATFNFTGTHLICG 185
N SG IP++ +L L+ L L +N+L+G IP L ++ +G + G
Sbjct: 126 FANNISGPIPSSLGKLGKLRFLRLYNNSLSGEIPRSLTALPLDVLDISNNRLSGDIPVNG 185
Query: 186 SSLEQPCMXXXXXXXXXXXXKLRIVVASASCGAFVLLSLGA--LFACRYQKLRKLKHDVF 243
S + M + S V ++ GA LFA + RKL+ F
Sbjct: 186 SFSQFTSMSFANNKLRPRPASPSPSPSGTSAAIVVGVAAGAALLFALAWWLRRKLQGH-F 244
Query: 244 FDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKR 303
DV E+D +V L Q +RFS REL +AT+ FS+ N++G+G FG +YKG L+D+T VAVKR
Sbjct: 245 LDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKR 304
Query: 304 LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL 363
L + + GGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 305 LNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 364
Query: 364 KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423
G LDWP RK +A G+A GL YLH+ C+ KIIH D+KAANILLD+ FEAV+ DFGLA
Sbjct: 365 PEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLA 424
Query: 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXX 483
KL++ +HVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQ+A D +R
Sbjct: 425 KLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLA 484
Query: 484 XXXXXXXXXHIRKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQ 542
++++L+E +L +VD L Y EVE ++Q+ALLCTQS+ +RP M++
Sbjct: 485 NDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSE 544
Query: 543 VVKMLQGE 550
VV+ML+G+
Sbjct: 545 VVRMLEGD 552
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1094 (390.2 bits), Expect = 8.7e-111, P = 8.7e-111
Identities = 246/536 (45%), Positives = 331/536 (61%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
N+ L L SN +G + + L L S +L N +G +PD LG + L+ L L NN
Sbjct: 97 NLQYLELYSNNITGPVPSDLGNLTNLVSL-DLYLNSFTGPIPDSLGKLFKLRFLRLNNNS 155
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ-LFSVAT-FNFTGTHLICGSSLEQPCMX 194
+G IP + + + L+ LDLS+N L+G +P FS+ T +F +CG +PC
Sbjct: 156 LTGPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSRPCPG 215
Query: 195 XXXXX------------XXXXXXKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDV 242
+ + GA +L + AL A + + RK +
Sbjct: 216 SPPFSPPPPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPAL-AFAWWRRRK-PQEF 273
Query: 243 FFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVK 302
FFDV E+D +V L QL+RFS RELQ+ATD+FS NI+G+GGFGKVYKG L+D T VAVK
Sbjct: 274 FFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVK 333
Query: 303 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 362
RL++ +PGGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 334 RLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 393
Query: 363 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422
P + L W R+++A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEAV+ DFGL
Sbjct: 394 RPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 453
Query: 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRX 482
A+L+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYGI LLEL+TGQRA D +R
Sbjct: 454 ARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARL 513
Query: 483 XXXXXXXXXXHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMA 541
++ LL+E +L +VD +L + Y EVE ++QVALLCTQS+P +RP M+
Sbjct: 514 ANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERPKMS 573
Query: 542 QVVKMLQGEDXXXXXXXXXXXXXXXXXXXSLLPHQFA-WGEDSSIDQEAIQLSNAR 596
+VV+ML+G D L H + W DS+ + A++LS R
Sbjct: 574 EVVRMLEG-DGLAEKWDEWQKVEVLRQEVELSSHPTSDWILDSTDNLHAMELSGPR 628
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1067 (380.7 bits), Expect = 6.3e-108, P = 6.3e-108
Identities = 233/493 (47%), Positives = 323/493 (65%)
Query: 74 RNGNVI---SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSL 130
R GN+ S+ L +N +G I +I +L+ L S +L +N +G +P LG + +L L
Sbjct: 93 RIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSL-DLSNNSFTGEIPASLGELKNLNYL 151
Query: 131 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICG----- 185
L NN G+ P + S++ L +D+S NNL+G +P S TF G LICG
Sbjct: 152 RLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPK--VSARTFKVIGNALICGPKAVS 209
Query: 186 --SSLEQPCMXXXX----XXXXXXXXKLRIV-VASASCGAFVLLSLGALFACRYQKLRKL 238
S++ +P + + AS S FV + G RY++ ++
Sbjct: 210 NCSAVPEPLTLPQDGPDESGTRTNGHHVALAFAASFSAAFFVFFTSGMFLWWRYRRNKQ- 268
Query: 239 KHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTK 298
+FFDV + D +VSL L+R++ +EL+ AT++F+ NI+G+GG+G VYKG L+D T
Sbjct: 269 ---IFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTL 325
Query: 299 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY 358
VAVKRL+D GGE FQ EV IS+A+H+NLL+L G+C+++ ERILVYP+M N SVA
Sbjct: 326 VAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVAS 385
Query: 359 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC 418
RL+D GE LDW RK++A GTA GL YLHEQC+PKIIHRD+KAANILLD++FEAV+
Sbjct: 386 RLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 445
Query: 419 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 478
DFGLAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TGQ+A+D
Sbjct: 446 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALD 505
Query: 479 FSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDR 537
F R ++KL +E +L ++D++LN +D E+E +VQVALLCTQ P R
Sbjct: 506 FGRSAHQKGVMLDW-VKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHR 564
Query: 538 PPMAQVVKMLQGE 550
P M++V+KML+G+
Sbjct: 565 PKMSEVMKMLEGD 577
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1063 (379.3 bits), Expect = 1.7e-107, P = 1.7e-107
Identities = 236/485 (48%), Positives = 311/485 (64%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
N+ ++L +N SGKI P I L L + +L +N SG +P + +++LQ L L NN
Sbjct: 99 NLRQVSLQNNNISGKIPPEICSLPKLQTL-DLSNNRFSGEIPGSVNQLSNLQYLRLNNNS 157
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPC---- 192
SG PA+ SQ+ +L LDLS NNL G +P F TFN G LIC +SL + C
Sbjct: 158 LSGPFPASLSQIPHLSFLDLSYNNLRGPVPK--FPARTFNVAGNPLICKNSLPEICSGSI 215
Query: 193 ----MXXXXXXXXXXXXKLRIVVASASCG--AFVLLSLGALFACRYQKLRKLKHDVFFDV 246
+ + V S G V+LSLG F +K R+L D
Sbjct: 216 SASPLSVSLRSSSGRRTNILAVALGVSLGFAVSVILSLG--FIWYRKKQRRLTMLRISDK 273
Query: 247 AGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQD 306
+++ + L LR F+ REL +ATD FS +I+G GGFG VY+G D T VAVKRL+D
Sbjct: 274 --QEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKD 331
Query: 307 YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG 366
G + F+ E+ +IS+A+H+NLL+LIGYC +SSER+LVYP+M N SVA RL+ KP
Sbjct: 332 VNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLK-AKPA 390
Query: 367 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426
LDW TRK++A G A GL YLHEQC+PKIIHRD+KAANILLD+ FEAV+ DFGLAKL+
Sbjct: 391 ---LDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLL 447
Query: 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXX 486
+ + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TG RA++F +
Sbjct: 448 NHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQK 507
Query: 487 XXXXXXHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
+RKL +E ++ ++VDR L T YD EV M+QVALLCTQ P RP M++VV+
Sbjct: 508 GAMLEW-VRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQ 566
Query: 546 MLQGE 550
ML+G+
Sbjct: 567 MLEGD 571
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1062 (378.9 bits), Expect = 2.1e-107, P = 2.1e-107
Identities = 229/478 (47%), Positives = 312/478 (65%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
N+ L L SN +G+I + L L S +L N +SG +P LG + L+ L L NN
Sbjct: 100 NLQYLELYSNNITGEIPEELGDLVELVSL-DLYANSISGPIPSSLGKLGKLRFLRLNNNS 158
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ-LFSVAT-FNFTGTHLICGSSLEQPCMX 194
SG IP T + + L+ LD+S+N L+G IP+ FS+ T +F L E P
Sbjct: 159 LSGEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFTPISFANNSLT--DLPEPPPTS 215
Query: 195 XXXXXXXXXXXKLRIVVASA-SCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCK 253
++ +A + GA +L ++ A+ + LR+ D FFDV E+D +
Sbjct: 216 TSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWW--LRRKPQDHFFDVPAEEDPE 273
Query: 254 VSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE 313
V L QL+RF+ REL +ATDNFS N++G+GGFGKVYKG L+D VAVKRL++ + GGE
Sbjct: 274 VHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGE 333
Query: 314 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP 373
FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+ G LDWP
Sbjct: 334 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWP 393
Query: 374 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433
RK +A G+A GL YLH+ C+ KIIHRD+KAANILLD+ FEAV+ DFGLAKL++ +HV
Sbjct: 394 KRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHV 453
Query: 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXH 493
TT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQ+A D +R
Sbjct: 454 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDW 513
Query: 494 IRKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550
++++L+E +L +VD L Y EVE ++Q+ALLCTQS+ +RP M++VV+ML+G+
Sbjct: 514 VKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGD 571
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 6.5e-106, P = 6.5e-106
Identities = 233/483 (48%), Positives = 307/483 (63%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
N+ ++L +N SGKI P + L L + +L +N SG +P + ++ LQ L L NN
Sbjct: 102 NLRQVSLQNNNISGKIPPELGFLPKLQTL-DLSNNRFSGDIPVSIDQLSSLQYLRLNNNS 160
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMXXX 196
SG PA+ SQ+ +L LDLS NNL+G +P F TFN G LIC S+ + C
Sbjct: 161 LSGPFPASLSQIPHLSFLDLSYNNLSGPVPK--FPARTFNVAGNPLICRSNPPEICSGSI 218
Query: 197 XXX-------XXXXXXKLRIVVA-SASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAG 248
R+ +A S S G+ V+L L C Y+K ++ + +
Sbjct: 219 NASPLSVSLSSSSGRRSNRLAIALSVSLGSVVILVLALGSFCWYRKKQRRLLILNLNDKQ 278
Query: 249 EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY 308
E+ + L LR F+ REL + TD FS NI+G GGFG VY+G L D T VAVKRL+D
Sbjct: 279 EEGLQ-GLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDIN 337
Query: 309 SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK 368
G++ F+ E+ +IS+A+HKNLL+LIGYC TS ER+LVYP+M N SVA +L+ KP
Sbjct: 338 GTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKS-KPA-- 394
Query: 369 GLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428
LDW RKR+A G A GL YLHEQC+PKIIHRD+KAANILLD+ FEAV+ DFGLAKL++
Sbjct: 395 -LDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNH 453
Query: 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXX 488
+HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TG RA++F +
Sbjct: 454 ADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGA 513
Query: 489 XXXXHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
+RKL E ++ +++DR L T YD EV M+QVALLCTQ P RP M++VV ML
Sbjct: 514 MLEW-VRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVVLML 572
Query: 548 QGE 550
+G+
Sbjct: 573 EGD 575
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1036 (369.7 bits), Expect = 1.2e-104, P = 1.2e-104
Identities = 236/493 (47%), Positives = 311/493 (63%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
N+ + L +N GKI I +L L + +L DN G +P +G + LQ L L NN
Sbjct: 106 NLRIVLLQNNNIKGKIPAEIGRLTRLETL-DLSDNFFHGEIPFSVGYLQSLQYLRLNNNS 164
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMXXX 196
SG P + S ++ L LDLS NNL+G +P F+ TF+ G LIC + E C
Sbjct: 165 LSGVFPLSLSNMTQLAFLDLSYNNLSGPVPR--FAAKTFSIVGNPLICPTGTEPDCNGTT 222
Query: 197 XX--------------XXXXXXXKLRIVVASASCGAFVLLSLGA-LFACRYQKLRKLKHD 241
K+ I V S S G L+ + LF Q+ + +
Sbjct: 223 LIPMSMNLNQTGVPLYAGGSRNHKMAIAVGS-SVGTVSLIFIAVGLFLWWRQRHNQ---N 278
Query: 242 VFFDVA-GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVA 300
FFDV G +VSL LRRF RELQ+AT+NFS N++G+GG+G VYKG+L D+T VA
Sbjct: 279 TFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVA 338
Query: 301 VKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRL 360
VKRL+D + GGE FQ EV +IS+A+H+NLL+L G+C T +E++LVYP+M N SVA R+
Sbjct: 339 VKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVASRM 398
Query: 361 RDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420
+ KP LDW RKR+A G A GL YLHEQC+PKIIHRD+KAANILLDD EAV+ DF
Sbjct: 399 K-AKPV---LDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDF 454
Query: 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 480
GLAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLELVTGQRA +F
Sbjct: 455 GLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFG 514
Query: 481 RXXXXXXXXXXXHIRKLLREDRLNDIVDRNL---NTYDSKEVETMVQVALLCTQSTPEDR 537
+ ++K+ +E +L +VD+ L +YD E++ MV+VALLCTQ P R
Sbjct: 515 KAANQKGVMLDW-VKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHR 573
Query: 538 PPMAQVVKMLQGE 550
P M++VV+ML+G+
Sbjct: 574 PKMSEVVRMLEGD 586
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8W4S5 | Y5371_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6967 | 0.9765 | 0.9478 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 596 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-21 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.002 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 5e-47
Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 34/278 (12%)
Query: 279 IIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+G FG+VYKG L +VAVK L++ S F RE ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
L+G CT ++V +M + LR +P K L A A G+EYL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK- 122
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYL 449
IHRDL A N L+ +N + DFGL++ + + IR APE L
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM----APESL 176
Query: 450 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509
GK + K+DV+ +G+ L E+ F+ EE + + + L++
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEI--------FTLGEEPYPGMSNAEVLEYLKKGYRLPKPP- 227
Query: 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
E + ++ L C PEDRP +++V++L
Sbjct: 228 ----NCPPE---LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 9e-47
Identities = 81/280 (28%), Positives = 127/280 (45%), Gaps = 40/280 (14%)
Query: 280 IGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 334
+G+G FG+VYKG L TKVAVK L++ S F E ++ H N+++L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 335 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 394
+G CT +V +M + LR L ++A A G+EYL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGHIAPEYL 449
+HRDL A N L+ +N + DFGL++ + + I+ APE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM----APESL 176
Query: 450 STGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508
GK + K+DV+ +G+ L E+ T G+ + + EE + LL+ +L R +
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGE--QPYPGMSNEEVLELLEDGYRLPRPE------- 227
Query: 509 RNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKML 547
E+ E M+Q C PEDRP +++V+ L
Sbjct: 228 -----NCPDELYELMLQ----CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 4e-46
Identities = 71/195 (36%), Positives = 98/195 (50%), Gaps = 12/195 (6%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
+G+GGFG VY KVA+K ++ S RE+ ++ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 339 TTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
+ LV + + S L+D LK E L R+ GLEYLH I
Sbjct: 61 EDENHLYLVMEYCEGGS----LKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 398 IHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGKSS 455
IHRDLK NILLD DN + L DFGL+KL+ + + I GT ++APE L G S
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 456 EKTDVFGYGITLLEL 470
EK+D++ G+ L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 8e-46
Identities = 76/279 (27%), Positives = 123/279 (44%), Gaps = 37/279 (13%)
Query: 279 IIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+G FG+VYKG L +VAVK L++ S F RE ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
L+G CT +V +M+ + LR +P L A A G+EYL +
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLESK- 121
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----APEY 448
IHRDL A N L+ +N + DFGL++ + + R G + APE
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDL-----YDDDYYRKRGGKLPIRWMAPES 174
Query: 449 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508
L GK + K+DV+ +G+ L E+ F+ E+ + + + + L+
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEI--------FTLGEQPYPGMSNEEVLEYLKNGYRLPQPP 226
Query: 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
E + + L C PEDRP +++V++L
Sbjct: 227 -----NCPPE---LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 6e-45
Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 41/287 (14%)
Query: 278 NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+G FG+VYKG L T+VAVK L++ S F +E ++ H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 334 LIGYCTTSSERILVYPFMQN---LSV--AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
L+G CT LV +M+ L R P + L A A G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---A 445
L + K +HRDL A N L+ ++ + DFGL++ V + G I A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK---LLRED 501
PE L G + K+DV+ +G+ L E+ T G A + L EE +L+++RK L + +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLG--ATPYPGLSNEE---VLEYLRKGYRLPKPE 230
Query: 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
D + Y+ + L C Q PEDRP +++V+ L+
Sbjct: 231 YCPDEL------YE---------LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 9e-43
Identities = 67/199 (33%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+G G FG VYK VAVK L+ + +RE+ ++ H N+++LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
LV + + + L L K++A GLEYLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SS 455
IIHRDLK NILLD+N + DFGLAK + + +TT GT ++APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177
Query: 456 EKTDVFGYGITLLELVTGQ 474
K DV+ G+ L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 8e-41
Identities = 140/514 (27%), Positives = 231/514 (44%), Gaps = 76/514 (14%)
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLA 133
+ + +L L N FSG + + L L + L +N LSG +PD L S L SL+L+
Sbjct: 473 GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLK-LSENKLSGEIPDELSSCKKLVSLDLS 531
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSV--------------ATFNFTG 179
+N+ SG IPA++S++ L LDLS N L+G IP L +V + TG
Sbjct: 532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTG 591
Query: 180 THLICGSSL----EQPCMSRPS---PPVS-TSRTKLRIVVASASCGAFVLLSLGALFACR 231
L +S C + PP +T + + GAF++L+L A F
Sbjct: 592 AFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVA-FGFV 650
Query: 232 YQKLRK---LKHDVFFDVAGED--------DCKVSLTQLRRFSCRELQLATDNFSESNII 280
+ + R LK V ED D KVS + + ++ + E N+I
Sbjct: 651 FIRGRNNLELKR-----VENEDGTWELQFFDSKVS----KSITINDILSSL---KEENVI 698
Query: 281 GQGGFGKVYKGVLSDN-TKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYC 338
+G G YKG N + VK + D S P E A ++ H N+++LIG C
Sbjct: 699 SRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ------HPNIVKLIGLC 752
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398
+ L++ +++ +++ LR L W R+++A G A L +LH +C+P ++
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 399 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 458
+L I++D E L L L+ + ++APE T +EK+
Sbjct: 806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKS 859
Query: 459 DVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD----RNLNTY 514
D++G+G+ L+EL+TG+ D E +++ R + L+ +D +++
Sbjct: 860 DIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916
Query: 515 DSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
++ VE M +AL CT + P RP V+K L+
Sbjct: 917 QNEIVEVM-NLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 1e-39
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 278 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+G+G FGKVY VA+K ++ RE+ ++ H N+++L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
+ LV + + + L+ L + LEYLH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALEYLHSK---G 117
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 456
I+HRDLK NILLD++ L DFGLA+ +D +TT + GT ++APE L +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 457 KTDVFGYGITLLELVTGQ 474
D++ G+ L EL+TG+
Sbjct: 176 AVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 16/224 (7%)
Query: 273 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEA-AFQREVHLISVAIHKN 330
++ ++G+G FG VY + D + +AVK ++ E A +RE+ ++S H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 331 LLQLIGYCTTSSERILVYPFMQNL---SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
+++ G E+ + F++ + S++ L+ L P ++ GL
Sbjct: 61 IVRYYG-SERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPVIRKYTRQILEGLA 115
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAP 446
YLH I+HRD+K ANIL+D + L DFG AK + D + T +RGT +AP
Sbjct: 116 YLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 490
E + + D++ G T++E+ TG+ +S L L
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP--WSELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (302), Expect = 7e-30
Identities = 72/278 (25%), Positives = 110/278 (39%), Gaps = 23/278 (8%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA--FQREVH-LISVAIHKNLLQLIG 336
+G+G FG+VY D VA+K L + F RE+ L S+ N+++L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
+ LV ++ S+ L + L + LEYLH +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 397 IIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIR-----GTMGHIAPEYL- 449
IIHRD+K NILLD D L DFGLAKL+ + + GT G++APE L
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 450 --STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507
S +S +D++ GITL EL+TG + + L I +L + +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-QTLKIILELPTPSLASPLS 240
Query: 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
N + P++R + +
Sbjct: 241 PSNPELISKA----ASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 67/198 (33%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 280 IGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
IG+GGFG+VYK +VA+K + S + E+ ++ H N+++ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 339 TTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
E +V F S L+D LK + L V GLEYLH I
Sbjct: 67 LKKDELWIVMEFCSGGS----LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GI 119
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 456
IHRD+KAANILL + E L DFGL+ L D K + GT +APE ++
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPYDY 176
Query: 457 KTDVFGYGITLLELVTGQ 474
K D++ GIT +EL G+
Sbjct: 177 KADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 78/270 (28%), Positives = 118/270 (43%), Gaps = 30/270 (11%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA-AFQREVHLISVAIHKNLLQLIGYC 338
IG+G FG V G KVAVK L+D A AF E +++ H NL+QL+G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDD---STAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398
+ +V +M S+ LR G + + A G+EYL E+ +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124
Query: 399 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 458
HRDL A N+L+ ++ A + DFGLAK ++ T APE L K S K+
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKS 180
Query: 459 DVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKE 518
DV+ +GI L E+ + R + R+ ++ ++ H+ K R + E
Sbjct: 181 DVWSFGILLWEIYSFGRV-PYPRIPLKD---VVPHVEKGYRMEAPEGCPP---------E 227
Query: 519 VETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
V +V C + P RP Q+ + L
Sbjct: 228 V---YKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 67/199 (33%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 337
+G G FG+V+ G + TKVAVK L+ PG AF +E ++ H L+QL
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK----PGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
C+ +V +M S+ L+ K L P +A A G+ YL +
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR---NY 124
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTGK 453
IHRDL A NIL+ +N + DFGLA+L+ D + I+ T APE + G+
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGR 180
Query: 454 SSEKTDVFGYGITLLELVT 472
+ K+DV+ +GI L E+VT
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 274 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLL 332
F+ +G G FG+V++G+ + +VA+K L D + FQ+EV + HK+L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLI 65
Query: 333 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
L C+ ++ M+ S+ LR P + L + +A A G+ YL EQ
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTT-QIRGTMGHIAPEYL 449
IHRDL A NIL+ ++ + DFGLA+L+ D L+ + T APE
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAA 176
Query: 450 STGKSSEKTDVFGYGITLLELVT 472
S G S K+DV+ +GI L E+ T
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 273 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHKN 330
N+ ++IG+G FG VYKG+ L VA+K++ + +E+ L+ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
+++ IG TS ++ + +N S LR + + GL YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGS----LRQIIKKFGPFPESLVAVYVYQVLQGLAYLH 116
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 450
EQ +IHRD+KAANIL + L DFG+A ++ ++ + GT +APE +
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIE 172
Query: 451 TGKSSEKTDVFGYGITLLELVTGQ 474
+S +D++ G T++EL+TG
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 262 FSCRELQLATDNFSESNIIGQGGFGKVYKG---VLSDNT--KVAVKRLQDYYSPGGEAAF 316
F R L+ +G+G FGKV L DNT +VAVK L + F
Sbjct: 1 FEKRHLKF-------IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF 53
Query: 317 QREVHLISVAIHKNLLQLIGYCTTSSERI--LVYPFMQNLSVAYRLRDLKPGEKGLDWPT 374
+RE+ ++ H+N+++ G C R L+ ++ + S+ L+ + ++
Sbjct: 54 EREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKR 110
Query: 375 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 434
+ G++YL Q + IHRDL A NIL++ + DFGLAK++ +
Sbjct: 111 LLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY 167
Query: 435 TQIRGT--MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472
+ G + APE L T K S +DV+ +G+TL EL T
Sbjct: 168 VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339
IG+G FG VYKGVL NT+VAVK + P + F +E ++ H N+++LIG C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 340 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG--TAYGLEYLHEQCNPKI 397
+V + S+ LR +K +K + A G+EYL +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR-----KKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----APEYLSTG 452
IHRDL A N L+ +N + DFG+++ + + V+ + I APE L+ G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS----DGLKQIPIKWTAPEALNYG 170
Query: 453 KSSEKTDVFGYGITLLELVTG 473
+ + ++DV+ YGI L E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 278 NIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+IG G FG+V +G L K VA+K L+ S F E ++ H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
L G T S +++ +M+N S+ LR+ + + G A G++YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGHIAPEY 448
+HRDL A NIL++ N + DFGL++ ++ TT+ IR T APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179
Query: 449 LSTGKSSEKTDVFGYGITLLELVT-GQR 475
++ K + +DV+ +GI + E+++ G+R
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (250), Expect = 1e-23
Identities = 77/279 (27%), Positives = 125/279 (44%), Gaps = 43/279 (15%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
IG+G FGKVY SD +K + S EV ++ H N+ I Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI---IKY 64
Query: 338 CTTSSERILVYPFMQ-----NLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEY 388
+ E+ + M+ +LS + + + P E+ LDW + L+Y
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKY 118
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
LH + KI+HRD+K NI L N L DFG++K++ + + T + GT +++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE- 173
Query: 449 LSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507
L K + K+D++ G L EL T + + L E L K+L+
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----L----ALKILKGQY----- 220
Query: 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546
+ + S E+ +V +LL Q PE+RP +AQ+++
Sbjct: 221 -PPIPSQYSSELRNLVS-SLL--QKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 337
+G G FG+V++G+ ++ T VAVK L+ PG F E ++ H L+QL
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK----PGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
CT +V M+ S+ L+ + L P +A A G+ YL Q
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEAQ---NY 124
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 457
IHRDL A N+L+ +N + DFGLA+++ + + + APE + S K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 458 TDVFGYGITLLELVT 472
+DV+ +GI L E+VT
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 81/282 (28%), Positives = 132/282 (46%), Gaps = 36/282 (12%)
Query: 278 NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+IG+G FG VY G L D+ AVK L F +E ++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 334 LIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAYGLEYL 389
L+G C + ++V P+M++ + +R PT K + FG A G+EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN------PTVKDLIGFGLQVAKGMEYL 114
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK---LTHVTTQIRGTMGHIAP 446
+ K +HRDL A N +LD++F + DFGLA+ + K H T + + +A
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506
E L T K + K+DV+ +G+ L EL+T + A + ++ + + L R+LL+ + D
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD- 229
Query: 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ +V L C PE RP +++V ++
Sbjct: 230 --------------PLYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 70/221 (31%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 277 SNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQ---REVHLISVAIHKN 330
N IG G FGKVY V L +AVK R+QD + E+ ++ + H N
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD----NDPKTIKEIADEMKVLELLKHPN 60
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
L + Y R VY FM+ S L +L + LD + GL YLH
Sbjct: 61 L---VKYYGVEVHREKVYIFMEYCSGG-TLEELLEHGRILDEHVIRVYTLQLLEGLAYLH 116
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG---HIAPE 447
I+HRD+K ANI LD N L DFG A + T + +++ G ++APE
Sbjct: 117 SH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 448 YLSTGKSSEK---TDVFGYGITLLELVTGQRAIDFSRLEEE 485
++ GK D++ G +LE+ TG+R +S L+ E
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP--WSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 73/200 (36%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 337
+G G FG+V+ G + NTKVAVK L+ PG +F E ++ H L+QL Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK----PGTMSPESFLEEAQIMKKLRHDKLVQL--Y 67
Query: 338 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGE-KGLDWPTRKRVAFGTAYGLEYLHEQCNP 395
S E I +V +M S+ L LK GE + L P +A A G+ Y+ E+ N
Sbjct: 68 AVVSEEPIYIVTEYMSKGSL---LDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMN- 122
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 455
IHRDL++ANIL+ D + DFGLA+L++ + + APE G+ +
Sbjct: 123 -YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 456 EKTDVFGYGITLLELVTGQR 475
K+DV+ +GI L ELVT R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 36/277 (12%)
Query: 280 IGQGGFGKVYKGV-LSDNTK---VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 335
+G G FG V KGV L + K VAVK L+ + G+ F RE +++ H +++LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 336 GYCTTSSERILVYPFM--QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
G C P M L+ L + + K +A A G+ YL +
Sbjct: 63 GVC-------KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK- 114
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT--MGHIAPEYLST 451
+HRDL A N+LL + +A + DFG+++ + A + G + APE ++
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 452 GKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510
GK S K+DV+ YG+TL E + G + + ++ E + +L+ +L R +
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKP--YGEMKGAEVIAMLESGERLPRPEECPQ----- 225
Query: 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
Y + L C + PEDRP +++
Sbjct: 226 -EIYS---------IMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 83/278 (29%), Positives = 127/278 (45%), Gaps = 43/278 (15%)
Query: 280 IGQGGFGKVYKGVLSDNTK-VAVKR--LQDYYSPGGEAAFQ--REVHLISVAIHKNLLQL 334
+G G FG VY+G+ D+ AVK L D G EA Q +E+ L+S H N++Q
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 335 IGYCTTSSERILVY-PFMQNLSVAYRLRDLKPGEKGLDWP-----TRKRVAFGTAYGLEY 388
+G + + ++ + S+A L+ P TR+ + GLEY
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGS----FPEPVIRLYTRQILL-----GLEY 117
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
LH++ +HRD+K ANIL+D N L DFG+AK V +G+ +APE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEV 172
Query: 449 L-STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507
+ G D++ G T+LE+ TG+ +S+LE V K+ R L I
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGK--PPWSQLEGVAAVF------KIGRSKELPPIP 224
Query: 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
D + S E + + L C Q P RP A++++
Sbjct: 225 D-----HLSDEAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 6e-22
Identities = 82/269 (30%), Positives = 131/269 (48%), Gaps = 44/269 (16%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
+G G FG+V+ G + +TKVA+K L Q SP AF E +L+ H L++L Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRL--YA 68
Query: 339 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV--AFGTAYGLEYLHEQCNP 395
+ E I ++ +M+N S L D +G+ K + A A G+ ++ E+ N
Sbjct: 69 VVTQEPIYIITEYMENGS----LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI-ERKN- 122
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAPEYL 449
IHRDL+AANIL+ + + DFGLA+L+ + T + I+ T APE +
Sbjct: 123 -YIHRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWT----APEAI 175
Query: 450 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509
+ G + K+DV+ +GI L E+VT R I + + E + L+ ++ R D
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGR-IPYPGMTNPEVIQNLERGYRMPRPDNCP----- 229
Query: 510 NLNTYDSKEVETMVQVALLCTQSTPEDRP 538
E + ++ LC + PE+RP
Sbjct: 230 ----------EELYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 280 IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+G FGKV+ G D VAVK L++ S F+RE L++ H+N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----------RVAFGTA 383
G CT I+V+ +M++ + LR P L P ++A A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 443
G+ YL Q +HRDL N L+ + + DFG+++ V TT GH
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRVGGH 183
Query: 444 -------IAPEYLSTGKSSEKTDVFGYGITLLELVT 472
+ PE + K + ++DV+ +G+ L E+ T
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 26/224 (11%)
Query: 279 IIGQGGFGKVYKGV---LSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
++G G FG VYKGV + K VA+K L++ SP E ++++ H ++++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG----LDWPTRKRVAFGTAYGLEYL 389
L+G C +S L+ M + +R+ K G L+W + A G+ YL
Sbjct: 74 LLGICLSSQ-VQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQ------IAKGMSYL 125
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---AP 446
E+ +++HRDL A N+L+ + DFGLAKL+D G I A
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMAL 180
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 489
E + + K+DV+ YG+T+ EL+T G + + E D+L
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-21
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 36 EGEALIEVLKALNDTHGQFT-----DWN-DHFVSPCFSWSHVTCRNGNVIS------LTL 83
E + L+E + AL WN D V WS C+ + L L
Sbjct: 366 ESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGL 425
Query: 84 GSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 143
+ G G I I+KL+ L S L N + G +P LGS+T L+ L+L+ N F+GSIP
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSI-NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 144 TWSQLSNLKHLDLSSNNLTGRIPM----QLFSVATFNFTGTHLICGSSLEQPCMSRPSPP 199
+ QL++L+ L+L+ N+L+GR+P +L A+FNFT +CG + C P
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC--GPHLS 542
Query: 200 VSTSRTKLRIVVASASCGAFVLLSLGALFACR 231
V +I +A AF+ L + A+ +
Sbjct: 543 VGA-----KIGIAFGVSVAFLFLVICAMCWWK 569
|
Length = 623 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 82/274 (29%), Positives = 119/274 (43%), Gaps = 23/274 (8%)
Query: 278 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+IG G VY + L +N KVA+KR+ ++EV +S H N+++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
E LV P++ S+ ++ P GLD V GLEYLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---G 122
Query: 397 IIHRDLKAANILLDDNFEAVLCDFG----LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 452
IHRD+KA NILL ++ + DFG LA D T GT +APE +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT-FVGTPCWMAPEVMEQV 181
Query: 453 KS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511
K D++ +GIT +EL TG A +S+ + VL+L L+ D + +
Sbjct: 182 HGYDFKADIWSFGITAIELATG--AAPYSKYPPMK-VLML-----TLQNDPPSLETGADY 233
Query: 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
Y SK M+ LC Q P RP +++K
Sbjct: 234 KKY-SKSFRKMIS---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 278 NIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPG----GEAAFQREVHLISVAIHKNLL 332
+ +G G +G+VY+GV + VAVK L++ EAA +E+ H NL+
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLV 65
Query: 333 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
QL+G CT ++ FM ++ LR+ + ++ +A + +EYL ++
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEY 448
IHRDL A N L+ +N + DFGL++L+ D H + I+ T APE
Sbjct: 124 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APES 176
Query: 449 LSTGKSSEKTDVFGYGITLLELVT 472
L+ K S K+DV+ +G+ L E+ T
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 61/210 (29%), Positives = 113/210 (53%), Gaps = 17/210 (8%)
Query: 275 SESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
++ +IG G FG+V++G+L VA+K L+ Y+ F E ++ H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEY 388
+++L G T +++ +M+N ++ LRD GE + + + V G A G++Y
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGE----FSSYQLVGMLRGIAAGMKY 122
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAP 446
L + +HRDL A NIL++ N E + DFGL++++ D + T+ T+ + + AP
Sbjct: 123 LSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 475
E ++ K + +DV+ +GI + E+++ G+R
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 1e-20
Identities = 81/264 (30%), Positives = 126/264 (47%), Gaps = 34/264 (12%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 337
+GQG FG+V+ G + T+VA+K L+ PG AF +E ++ H+ L+QL Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 67
Query: 338 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 394
S E I +V +M S L D GE G L P +A A G+ Y+ E+ N
Sbjct: 68 AVVSEEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 122
Query: 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 454
+HRDL+AANIL+ +N + DFGLA+L++ + + APE G+
Sbjct: 123 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 455 SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 514
+ K+DV+ +GI L EL T R + + + E +LD + + R
Sbjct: 181 TIKSDVWSFGILLTELTTKGR-VPYPGMVNRE---VLDQVERGYRM------------PC 224
Query: 515 DSKEVETMVQVALLCTQSTPEDRP 538
+ E++ + C + PE+RP
Sbjct: 225 PPECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 70/289 (24%), Positives = 124/289 (42%), Gaps = 46/289 (15%)
Query: 280 IGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-- 331
+GQG FG VY+G+ T+VA+K + + S F L ++ K
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF-----LNEASVMKEFNC 68
Query: 332 ---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK---GLDWPTRKRV---AFGT 382
++L+G +T ++V M + LR +P + GL PT ++ A
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 442
A G+ YL + K +HRDL A N ++ ++ + DFG+ + D T + +
Sbjct: 129 ADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKGLL 183
Query: 443 HI---APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 499
+ APE L G + K+DV+ +G+ L E+ T L E+ + L
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------LAEQP-------YQGLSN 227
Query: 500 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
E+ L ++D + ++++ +C Q P+ RP ++V L+
Sbjct: 228 EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 72/273 (26%), Positives = 127/273 (46%), Gaps = 32/273 (11%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQLIGY 337
+G G FG+V+ + +TKVAVK ++ PG + AF E +++ H L++L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK----PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLEYLHEQCNP 395
T I+ FM S L D ++G P K + F A G+ ++ ++
Sbjct: 70 VTKEPIYIIT-EFMAKGS----LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--- 121
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 455
IHRDL+AANIL+ + + DFGLA++++ + + APE ++ G +
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 456 EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD 515
K+DV+ +GI L+E+VT R I + + E + L+ ++ R +
Sbjct: 182 IKSDVWSFGILLMEIVTYGR-IPYPGMSNPEVIRALERGYRMPRPENCP----------- 229
Query: 516 SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
E + + + C ++ PE+RP + +L
Sbjct: 230 ----EELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 75/200 (37%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 337
+GQG FG+V+ G + TKVA+K L+ PG AF +E ++ H L+ L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK----PGTMMPEAFLQEAQIMKKLRHDKLVPL--Y 67
Query: 338 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGE-KGLDWPTRKRVAFGTAYGLEYLHEQCNP 395
S E I +V FM S+ L LK G+ K L P +A A G+ Y+ E+ N
Sbjct: 68 AVVSEEPIYIVTEFMGKGSL---LDFLKEGDGKYLKLPQLVDMAAQIADGMAYI-ERMN- 122
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 455
IHRDL+AANIL+ DN + DFGLA+L++ + + APE G+ +
Sbjct: 123 -YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 456 EKTDVFGYGITLLELVTGQR 475
K+DV+ +GI L ELVT R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 6/191 (3%)
Query: 279 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
++G+G FG+V+KG L D T VAVK ++ + F E ++ H N+++LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398
T +R +Y M+ + L L+ + L + A A G+ YL + I
Sbjct: 62 T---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 399 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 458
HRDL A N L+ +N + DFG+++ D + + + + APE L+ G+ S ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 459 DVFGYGITLLE 469
DV+ YGI L E
Sbjct: 176 DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 280 IGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
IG+G FG+V+ G L +DNT VAVK ++ P +A F +E ++ H N+++LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398
T +V +Q LR P L ++ A G+EYL + I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGP---RLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 399 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----APEYLSTGK 453
HRDL A N L+ + + DFG+++ + + T G M I APE L+ G+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST----GGMKQIPVKWTAPEALNYGR 172
Query: 454 SSEKTDVFGYGITLLE 469
S ++DV+ +GI L E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 67/202 (33%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIHKNLLQLIGY 337
IG+G FG+VYK + N VA+K + D E Q+E+ +S + + G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
S+ ++ + S DL KPG LD + GLEYLHE+
Sbjct: 68 FLKGSKLWIIMEYCGGGSC----LDLLKPG--KLDETYIAFILREVLLGLEYLHEE---G 118
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-----GTMGHIAPEYLST 451
IHRD+KAANILL + + L DFG V +LT T + GT +APE +
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFG----VSGQLTS--TMSKRNTFVGTPFWMAPEVIKQ 172
Query: 452 GKSSEKTDVFGYGITLLELVTG 473
EK D++ GIT +EL G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 38/275 (13%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339
IG G FG V+ G + KVA+K +++ E F E ++ H L+QL G CT
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 340 TSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGLEYLHEQCNPKII 398
S LV+ FM++ ++ LR ++G T + G+ YL +I
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLR----AQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 399 HRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 457
HRDL A N L+ +N + DFG+ + V D + T +T + + +PE S K S K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSK 181
Query: 458 TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT---- 513
+DV+ +G+ + E+ FS K E+R N V +N
Sbjct: 182 SDVWSFGVLMWEV--------FSE-------------GKTPYENRSNSEVVETINAGFRL 220
Query: 514 YDSKEVETMV-QVALLCTQSTPEDRPPMAQVVKML 547
Y + V ++ C + PEDRP + ++ L
Sbjct: 221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 279 IIGQGGFGKVYKGVLS--DNT--KVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQ 333
I+G+G FG V +G LS D + KVAVK ++ D ++ F E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 334 LIGYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYG 385
LIG C +S +++ PFM++ + L + G P + + F A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-RGTMGHI 444
+EYL N IHRDL A N +L ++ + DFGL+K + + + +I + + I
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRE-DR 502
A E L+ + K+DV+ +G+T+ E+ T GQ + +E E I LR +R
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP--YPGVENHE-------IYDYLRHGNR 233
Query: 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
L D YD M C ++ P+DRP ++ ++L+
Sbjct: 234 LKQPEDCLDELYDL-----MYS----CWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-19
Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 33/196 (16%)
Query: 6 HKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPC 65
+ CP + + + FLNF E E E L+ ++ND ++WN C
Sbjct: 6 PQHCPYLIFMLFFL---FLNFSMLHAE---ELELLLSFKSSINDPLKYLSNWNSS-ADVC 58
Query: 66 FSWSHVTCRNGN-VISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPD----- 119
W +TC N + V+S+ L SGKIS +I +L ++ + L +N LSG +PD
Sbjct: 59 -LWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTI-NLSNNQLSGPIPDDIFTT 116
Query: 120 -----FL-------------GSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNL 161
+L GS+ +L++L+L+NN SG IP S+LK LDL N L
Sbjct: 117 SSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL 176
Query: 162 TGRIPMQLFSVATFNF 177
G+IP L ++ + F
Sbjct: 177 VGKIPNSLTNLTSLEF 192
|
Length = 968 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 278 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLI 335
IG+G +G+VYK VA+K+++ + G RE+ L+ H N+++L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 336 GYCT--TSSERILVYPFMQNLSVAYRLRDL-----KPGEKGLDWPTRKRVAFGTAYGLEY 388
T +V+ +M + DL P K K GL+Y
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH--------DLTGLLDSPEVK-FTESQIKCYMKQLLEGLQY 115
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
LH I+HRD+K +NIL++++ L DFGLA+ + + T T+ + PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 449 L--STGKSSEKTDVFGYGITLLELVTG 473
L +T + + D++ G L EL G
Sbjct: 173 LLGAT-RYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 75/280 (26%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 274 FSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIH-- 328
+ +IG+G +G VY+G V + VA+K + + +P + + QREV L+S
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRV-VALKII-NLDTPDDDVSDIQREVALLSQLRQSQ 60
Query: 329 -KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
N+ + G ++ + + SV ++ EK + R+ L+
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIRE-----VLVALK 115
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 447
Y+H+ +IHRD+KAANIL+ + LCDFG+A L++ + +T + GT +APE
Sbjct: 116 YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPE 171
Query: 448 YLSTGKSSE-KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506
++ GK + K D++ GIT+ E+ TG +S ++ ++L+ + RL D
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPP--YSDVDAFRAMMLIPKSKP----PRLED- 224
Query: 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546
N Y SK + V C P++R +++K
Sbjct: 225 -----NGY-SKLLREFVA---ACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 274 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA-----AFQREVHLISVAIH 328
+++ ++G+G +G VY G+ + +AVK+++ S A Q EV L+ H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
N++Q +G C + + F+ S++ L P L P + G+ Y
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVAY 117
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK---LVDAKLTH--VTTQIRGTMGH 443
LH C ++HRD+K N++L N L DFG A+ V TH + + GT
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 444 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
+APE ++ K+D++ G T+ E+ TG+
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 45/213 (21%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLI-------------S 324
+G+G +G VYK + VA+K + +E+ ++ S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTA 383
+ +L ++ YC S + D+ K K L + + T
Sbjct: 67 YFKNTDLWIVMEYCGAGS-----------------VSDIMKITNKTLTEEEIAAILYQTL 109
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GT 440
GLEYLH K IHRD+KA NILL++ +A L DFG V +LT + GT
Sbjct: 110 KGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFG----VSGQLTDTMAKRNTVIGT 162
Query: 441 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
+APE + + K D++ GIT +E+ G
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 45/134 (33%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 363 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422
LK + + ++A GL YLHE+ KIIHRD+K +NIL++ + LCDFG+
Sbjct: 90 LKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGV 147
Query: 423 A-KLVDAK-LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 480
+ +LV++ T V GT ++APE + S K+D++ G++L+EL TG+
Sbjct: 148 SGQLVNSLAKTFV-----GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202
Query: 481 RLEEEEDVLLLDHI 494
+ LL +I
Sbjct: 203 NDPPDGIFELLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 266 ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 319
E+ L+ F E +G+G FGKVYKG L T VA+K L++ P + F++E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 320 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV-AYRLR-----------DLKPGE 367
L+S H N++ L+G CT +++ ++ + + + +R + +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 368 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV- 426
LD +A A G+EYL +HRDL A N L+ + + DFGL++ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 470
A V ++ + + PE + GK + ++D++ +G+ L E+
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 15/197 (7%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQLIGY 337
+G G FG+V+ G +++TKVAVK L+ PG + AF E +L+ H L++L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK----PGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLEYLHEQCNP 395
T ++ +M S L D ++G K + F A G+ Y+ +
Sbjct: 70 VTKEEPIYIITEYMAKGS----LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--- 122
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 455
IHRDL+AAN+L+ ++ + DFGLA++++ + + APE ++ G +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 456 EKTDVFGYGITLLELVT 472
K+DV+ +GI L E+VT
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
IG+G +G VYK VA+K++ + S G RE+ L+ H N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 338 CTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
+ LV+ FM +L Y+L +K ++GL K + GL + H
Sbjct: 67 FRHKGDLYLVFEFMDTDL---YKL--IKDRQRGLPESLIKSYLYQLLQGLAFCHSH---G 118
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-S 455
I+HRDLK N+L++ L DFGLA+ + + T + T + APE L K S
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYS 177
Query: 456 EKTDVFGYGITLLELVTGQ 474
D++ G EL++ +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 78/283 (27%), Positives = 132/283 (46%), Gaps = 34/283 (12%)
Query: 280 IGQGGFGKVYKGVLSDNT---KVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 335
+G+G FG V +G L+ + KVAVK ++ E F E + H N+++LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 336 GYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLE 387
G C + E +++ PFM++ + L + G+ PT+ V F T A G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-RGTMGHIAP 446
YL + IHRDL A N +L++N + DFGL+K + + +I + + IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505
E L+ + K+DV+ +G+T+ E+ T GQ + +E E + D++R+ R + D
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP--YPGVENSE---IYDYLRQGNRLKQPPD 238
Query: 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+D + + C P+DRP + L+
Sbjct: 239 CLD------------GLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 30/271 (11%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339
+G G FG V+ G VA+K +++ E F E ++ H NL+QL G CT
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE--GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 340 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 399
+V +M N + LR+ + G+ G +W + +EYL IH
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLD--MCSDVCEAMEYLESNG---FIH 123
Query: 400 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYLSTGKSSE 456
RDL A N L+ ++ + DFGLA+ V L T +GT + PE + S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 457 KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 516
K+DV+ +G+ + E+ + + + + R E +++ + R R
Sbjct: 181 KSDVWSFGVLMWEVFSEGK-MPYERFSNSE---VVESVSAGYRLYR---------PKLAP 227
Query: 517 KEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
EV T + C PEDRP +++ L
Sbjct: 228 TEVYT---IMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 79/298 (26%), Positives = 133/298 (44%), Gaps = 57/298 (19%)
Query: 279 IIGQGGFGKVYKG--VLSDNTK----VAVKRLQDYYSPGGEAAFQREV-HLIS------- 324
+G+G FG+V K V DN VAVK L+D A ++++ L+S
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-------DATEKDLSDLVSEMEMMKM 71
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE----KGLDWPTRKRV-- 378
+ HKN++ L+G CT +V + + ++ LR +P P + +
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 379 ------AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLT 431
A+ A G+E+L + K IHRDL A N+L+ ++ + DFGLA+ +
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL 490
TT R + +APE L + ++DV+ +G+ L E+ T G +EE
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------ 242
Query: 491 LDHIRKLLRE-DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
+ KLL+E R+ ++ N ++E+ ++ C P RP Q+V+ L
Sbjct: 243 ---LFKLLKEGYRM----EKPQNC--TQELYHLM---RDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEA-------AFQREVHLISVAIHK 329
+IG G FG VY G+ S +AVK+++ S + A RE+ L+ H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 330 NLLQLIGYCTTSSERILVY-PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
N++Q +G + ++ + ++ ++ SVA L + E+ L + GL Y
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFVRQILKGLNY 121
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGH 443
LH N IIHRD+K ANIL+D+ + DFG++K ++A T ++G++
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 444 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
+APE + + K D++ G ++E++TG
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 77/290 (26%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 279 IIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQ---REVHLISVAIHKNLLQL 334
++G+G +G V K + + VA+K+ S + + RE+ ++ H+NL+ L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 335 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 394
I LV+ F+ + L DL+ GLD ++ F G+E+ H +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTV----LDDLEKYPNGLDESRVRKYLFQILRGIEFCH---S 118
Query: 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGK 453
IIHRD+K NIL+ + LCDFG A+ + A V T T + APE L K
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYTDYVATRWYRAPELLVGDTK 177
Query: 454 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE--DRLNDIVDRN- 510
D++ G + E++TG+ + D+ L HI K L R +I +N
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGE-----PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 511 ----LNTYDSKEVETM-----------VQVALLCTQSTPEDRPPMAQVVK 545
+ + KE+E + + +A C + P+DRP +Q++
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 6e-18
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 280 IGQGGFGKVY--KGVLSDNT---KVAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+G FGKV + + KV K+ + E +++S H +++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVK 57
Query: 334 LIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLEYL 389
L Y + E++ LV + + L E +R F A LEYL
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSK----EGRFS---EERARFYAAEIVLALEYL 109
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H II+RDLK NILLD + L DFGLAK + ++ + T GT ++APE L
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVL 165
Query: 450 STGKSSEKTDVFGYGITLLELVTGQ 474
+ D + G+ L E++TG+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 75/276 (27%), Positives = 112/276 (40%), Gaps = 31/276 (11%)
Query: 280 IGQGGFGKVYKG----VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 335
+G G FG V +G VAVK L+ F +E ++ H+NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 336 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 395
G T ++V S+ RLR G + T A A G+ YL +
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLESK--- 116
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLSTGK 453
+ IHRDL A NILL + + + DFGL + + H + ++ APE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 454 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513
S +DV+ +G+TL E+ F+ EE L I K +D+
Sbjct: 177 FSHASDVWMFGVTLWEM--------FTYGEEPWAGLSGSQILKK---------IDKEGER 219
Query: 514 YDSKEV--ETMVQVALLCTQSTPEDRPPMAQVVKML 547
+ E + + V L C P DRP A + + L
Sbjct: 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 270 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIH 328
T F +IG+G +GKVYK ++ ++ D E + E + L + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNH 62
Query: 329 KNLLQLIGYCTTSSERI------LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 382
N+ G + LV SV ++ L+ K L + T
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 442
GL YLHE K+IHRD+K NILL N E L DFG++ +D+ L T I GT
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPY 178
Query: 443 HIAPEYLSTGKSSEKT-----DVFGYGITLLELVTGQ 474
+APE ++ + + + DV+ GIT +EL G+
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 77/275 (28%), Positives = 110/275 (40%), Gaps = 64/275 (23%)
Query: 273 NFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
+F +IG+G FGKV D K+ A+K Y + Q+ V SV N
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMK----YMNK------QKCVEKGSVRNVLNE 50
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVA-------YRLRDLKPGEKG-LDWPTRKRVAFGT- 382
+++ E L +PF+ NL + Y + DL G G L + ++V F
Sbjct: 51 RRIL------QE--LNHPFLVNLWYSFQDEENMYLVVDLLLG--GDLRYHLSQKVKFSEE 100
Query: 383 ---------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433
LEYLH + IIHRD+K NILLD+ + DF +A V +
Sbjct: 101 QVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TL 155
Query: 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL---- 489
TT GT G++APE L S D + G+T E + G+R + +
Sbjct: 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE 215
Query: 490 -------------LLDHIRKLLRED---RLNDIVD 508
+D I KLL D RL D +
Sbjct: 216 TADVLYPATWSTEAIDAINKLLERDPQKRLGDNLK 250
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 279 IIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
IIG+G FG V +G + KVAVK ++ D + AF E +++ HKNL++L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKNLVRLLGV 67
Query: 338 CTTSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 395
+ I V M NL R R G + + + A G+EYL +
Sbjct: 68 ILHNGLYI-VMELMSKGNLVNFLRTR----GRALVSVIQLLQFSLDVAEGMEYLESK--- 119
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 455
K++HRDL A NIL+ ++ A + DFGLA++ + + ++ T APE L K S
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFS 175
Query: 456 EKTDVFGYGITLLELVTGQRA 476
K+DV+ YG+ L E+ + RA
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 81/285 (28%), Positives = 129/285 (45%), Gaps = 46/285 (16%)
Query: 279 IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 334
+IG G FG+V +G L K VA+K L+ Y+ F E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 335 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 392
G T S +++ FM+N ++ LR G+ + + V G A G++YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLR-QNDGQ----FTVIQLVGMLRGIAAGMKYLSEM 125
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--------TQIRGTMGHI 444
+HRDL A NIL++ N + DFGL++ ++ + T IR T
Sbjct: 126 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT---- 178
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAI-DFSRLEEEEDVLLLDHIRKLLREDR 502
APE ++ K + +DV+ YGI + E+++ G+R D S +DV I + ++ R
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----NQDV-----INAIEQDYR 229
Query: 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
L +D + Q+ L C Q RP Q+V L
Sbjct: 230 LPPPMDCP---------TALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 54/299 (18%)
Query: 280 IGQGGFGKVYK----GVLS--DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
IGQG FG+V++ G+L T VAVK L++ S +A FQRE L++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------------GEKGLDWPTR 375
L+G C L++ +M + LR P L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 376 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 435
+A A G+ YL E+ K +HRDL N L+ +N + DFGL++ + + + +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 436 Q-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 490
+ IR + PE + + + ++DV+ YG+ L E+ + + EE +
Sbjct: 190 ENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE----V 241
Query: 491 LDHIRKLLREDRLNDIVDRN-LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ ++R D N L+ D+ +E + + LC P DRP A + ++LQ
Sbjct: 242 IYYVR------------DGNVLSCPDNCPLE-LYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 280 IGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+G+GGFG+V + K+ A K+L + GE E ++ + + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSLA 59
Query: 337 YC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLEYLHEQ 392
Y T + LV M + Y + ++ GE G R F A GLE+LH++
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEA---RAIFYAAQIICGLEHLHQR 114
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 452
+I++RDLK N+LLDD+ + D GLA V+ K GT G++APE L
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 453 KSSEKTDVFGYGITLLELVTGQ 474
D F G TL E++ G+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
+ E + +G+G G V K L + + A+K + +P + RE+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 331 LLQLIGYCT---TSSERILV-YPFMQNLSVAY---RLRDLKPGEKGLDWPTRKRVAFGTA 383
+++ G +SS I + Y +L Y + R + GEK L ++A
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVL 115
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMG 442
GL YLH + KIIHRD+K +NILL + LCDFG++ +LV++ T GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSF 168
Query: 443 HIAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
++APE + S +DV+ G+TLLE+
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 279 IIGQGGFGKVYKGVLSDNTKV-AVKRLQ---------DYYSPGGEAAFQREVHLISVAIH 328
+IG+G +G+VY + ++ AVK+++ D A + E+ + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
N++Q +G+ TT + ++ S+ LR G + + GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGR--FEEQLVRFFTEQVLEGLAY 123
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPE 447
LH + I+HRDLKA N+L+D + + DFG++K D + ++G++ +APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 448 YLSTGKS--SEKTDVFGYGITLLELVTGQRAIDFSRLE 483
+ + S K D++ G +LE+ G+R +S E
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--WSDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 280 IGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAA---FQREVHLISVAIHKNLLQLI 335
+G+G +G V K + VA+K+ ++ S E REV ++ H+N++ L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 336 GYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 394
LV+ ++ + L L L+ GL + + + Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTL-----LELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH-- 119
Query: 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL----S 450
IIHRD+K NIL+ ++ LCDFG A+ + A+ T T + APE L +
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 451 TGKSSEKTDVFGYGITLLELVTGQ 474
GK DV+ G + EL+ G+
Sbjct: 179 YGKP---VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 62/221 (28%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 266 ELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS 324
E + D E ++G+G +G VY LS ++A+K + + S + E+ L S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHS 60
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQNL---SVAYRLRD----LKPGEKGLDWPTRKR 377
H+N++Q +G SE FM+ + S++ LR LK E+ + + T++
Sbjct: 61 YLKHRNIVQYLGSD---SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 378 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKLVDAKLTHVTT 435
+ GL+YLH+ +I+HRD+K N+L+ + + V+ DFG +K + A + T
Sbjct: 118 LE-----GLKYLHDN---QIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRL-AGINPCTE 167
Query: 436 QIRGTMGHIAPEYLSTGKS--SEKTDVFGYGITLLELVTGQ 474
GT+ ++APE + G D++ G T++E+ TG+
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 61/200 (30%), Positives = 91/200 (45%), Gaps = 20/200 (10%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339
+G G FGKVYK + A ++ S F E+ ++S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 340 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 399
++ ++ F ++ + +L E+GL P + V L +LH K+IH
Sbjct: 73 YENKLWILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 400 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYLSTGKSS 455
RDLKA NILL + + L DFG V AK T Q R GT +APE ++
Sbjct: 127 RDLKAGNILLTLDGDVKLADFG----VSAKNKS-TLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 456 E-----KTDVFGYGITLLEL 470
+ K D++ GITL+EL
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 273 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGE---AAFQREVHLISVAI 327
N+ ++GQG FG+VY D + +AVK++ D SP + A + E+ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 328 HKNLLQLIGYCTTSSERILVY-PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 386
H+ ++Q G C E + ++ +M SV +L+ + + TRK G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TRK-YTRQILEGV 117
Query: 387 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHI 444
EYLH I+HRD+K ANIL D L DFG +K + + T + GT +
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVT 472
+PE +S K DV+ G T++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 40/221 (18%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIHK 329
+++ IG G +G VYK ++ VA+K ++ PG + Q+E+ ++ H
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60
Query: 330 NLLQLIG-------------YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 376
N++ G YC S L Y++ E + + R+
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGS-----------LQDIYQVTRGPLSELQIAYVCRE 109
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 436
T GL YLHE IHRD+K ANILL ++ + L DFG++ + A + +
Sbjct: 110 -----TLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161
Query: 437 IRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQ 474
I GT +APE G K D++ GIT +EL Q
Sbjct: 162 I-GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 58/213 (27%), Positives = 88/213 (41%), Gaps = 39/213 (18%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVAIHKNLLQ 333
+G+G +G VYK VA+K+++ G RE+ L+ H N+++
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKHPNIVK 62
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
L+ T + LV+ + L+ L L K + + GL Y H
Sbjct: 63 LLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGTMGHIAPE 447
+I+HRDLK NIL++ + L DFGLA+ TH VT R APE
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR------APE 168
Query: 448 YL------STGKSSEKTDVFGYGITLLELVTGQ 474
L ST D++ G E++TG+
Sbjct: 169 ILLGSKHYSTA-----VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 71/287 (24%), Positives = 122/287 (42%), Gaps = 31/287 (10%)
Query: 273 NFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA 326
N E +G+G FG+V+ T V VK LQ ++ F+RE+ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 327 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP---TRKRVAFGT- 382
HKN+++L+G C + ++ + + LR K ++ L P T+++VA T
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 383 -AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 441
A G+++L N + +HRDL A N L+ E + L+K V + +
Sbjct: 126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 442 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501
+APE + S K+DV+ +G+ + E+ T Q + F L +EE
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDEE--------------- 226
Query: 502 RLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
LN + L + ++ C P+DRP +++V L
Sbjct: 227 VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 71/297 (23%), Positives = 127/297 (42%), Gaps = 46/297 (15%)
Query: 279 IIGQGGFGKVYKGV------LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 332
+G+G FGKV K + T VAVK L++ S E +L+ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 333 QLIGYCTTSSERILVYPFMQNLSVAYRLR--------------------DLKPGEKGLDW 372
+L G C+ +L+ + + S+ LR P E+ L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 373 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432
A+ + G++YL E K++HRDL A N+L+ + + + DFGL++ V + ++
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 433 VT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL 491
V ++ R + +A E L + ++DV+ +G+ L E+VT + + E LL
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-LGGNPYPGIAPERLFNLL 242
Query: 492 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
++ R + + E M + L C + P+ RP A + K L+
Sbjct: 243 KTGYRMERPENCS---------------EEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 19/213 (8%)
Query: 269 LATDNFSESNIIGQGGFGKVYKGVL---SDNTK--VAVKRLQDYYSPGGEAAFQREVHLI 323
L F + ++G G FG VYKG+ + K VA+K L++ SP E +++
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 324 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 381
+ + ++ +L+G C TS+ +++ + PF L +D + L+W +
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 117
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 439
A G+ YL E+ +++HRDL A N+L+ + DFGLAKL+ D K H +
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KV 173
Query: 440 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472
+ +A E + + ++DV+ YG+T+ EL+T
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 274 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLL 332
F++ IG+G FG+V+KG+ + KV ++ D E Q+E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 333 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
+ G ++ ++ M+ L L L+PG LD + GL+YLH +
Sbjct: 66 KYYGSYLKDTK---LWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 120
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 451
K IHRD+KAAN+LL ++ E L DFG+A +L D ++ GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQ 175
Query: 452 GKSSEKTDVFGYGITLLELVTGQ 474
K D++ GIT +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 65/203 (32%), Positives = 95/203 (46%), Gaps = 23/203 (11%)
Query: 280 IGQGGFGKVY------KGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+GGFG+V G L K+ KRL+ G E A + L V H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKV--HSRFIV 56
Query: 334 LIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLEYL 389
+ Y T ++ LV M + Y + ++ G P R F TA GLE+L
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEP---RACFYTAQIISGLEHL 113
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEY 448
H++ +II+RDLK N+LLD++ + D GLA +L D + T GT G +APE
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPEL 168
Query: 449 LSTGKSSEKTDVFGYGITLLELV 471
L + D F G+TL E++
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 8e-16
Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 279 IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 334
+IG G FG+V G L K VA+K L+ Y+ F E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 335 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 392
G T S ++V +M+N S+ LR + + + V G A G++YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLR-----KHDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLS 450
+HRDL A NIL++ N + DFGL++++ D + + T + + APE ++
Sbjct: 126 ---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 451 TGKSSEKTDVFGYGITLLELVT-GQRAI-DFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508
K + +DV+ YGI + E+++ G+R + S +DV I+ + RL +D
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMS----NQDV-----IKAIEEGYRLPAPMD 233
Query: 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
+ Q+ L C Q +RP Q+V +L
Sbjct: 234 CPAALH---------QLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 280 IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 334
+G+G FG V L DNT VAVK+LQ + + F+RE+ ++ H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-HSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 335 IGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 391
G C ++ R LV ++ S LRD L+ + LD A G+EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGS----LRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYL 449
+ + +HRDL NIL++ + DFGL K++ D + V + APE L
Sbjct: 127 K---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 450 STGKSSEKTDVFGYGITLLELVT 472
+ K S +DV+ +G+ L EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 274 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLL 332
F++ IG+G FG+VYKG+ + +V ++ D E Q+E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 333 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
+ G ++ ++ M+ L L LKPG L+ + GL+YLH +
Sbjct: 66 RYYGSYLKGTK---LWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSE 120
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 451
+ IHRD+KAAN+LL + + L DFG+A +L D ++ T GT +APE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 175
Query: 452 GKSSEKTDVFGYGITLLELVTGQ 474
K D++ GIT +EL G+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 9e-16
Identities = 70/281 (24%), Positives = 110/281 (39%), Gaps = 65/281 (23%)
Query: 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRL----------QDYYSPGGEAAFQREV 320
D+F IIG+G F V N + A+K L Y ++EV
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY------VKIEKEV 54
Query: 321 HLISVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 378
L + H +++L Y T E L V + N + +R LD +
Sbjct: 55 -LTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFY 107
Query: 379 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 438
A LEYLH + IIHRDLK NILLD + + DFG AK++D + + +
Sbjct: 108 AAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 439 -------------------GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID- 478
GT +++PE L+ + + +D++ G + +++TG+
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
Query: 479 ------FSRLEEEE-------DVLLLDHIRKLLR---EDRL 503
F ++ + E D I KLL +DRL
Sbjct: 225 SNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 280 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG-Y 337
+GQG G VYK A+K++ RE+ + +++ G +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 338 CTTSSERI-LVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 395
I +V +M S+A L+ + E L +A GL+YLH +
Sbjct: 69 Y--KEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKGLDYLHTK--R 119
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 455
IIHRD+K +N+L++ E + DFG++K+++ L T + GT+ +++PE + S
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYS 178
Query: 456 EKTDVFGYGITLLELVTGQ 474
D++ G+TLLE G+
Sbjct: 179 YAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 63/224 (28%), Positives = 114/224 (50%), Gaps = 26/224 (11%)
Query: 279 IIGQGGFGKVYKGVL---SDNTK--VAVKRLQDYYSPGGEAAFQREV-HLISVAI--HKN 330
++G G FG V+KG+ D+ K VA+K +QD G FQ H++++ H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAY 70
Query: 331 LLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
+++L+G C +S +++ + P L + RD ++ L+W + A G+ Y
Sbjct: 71 IVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYY 124
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAP 446
L E ++HR+L A NILL + + DFG+A L+ D K + ++ + + +A
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK-KYFYSEHKTPIKWMAL 180
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 489
E + G+ + ++DV+ YG+T+ E+++ G R E D+L
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 32/273 (11%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339
+G G FG V G VA+K +++ E F E ++ H+ L+QL G CT
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 340 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 399
+V +M N + LR+ K + G+ YL + + IH
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 400 RDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTGKSS 455
RDL A N L+DD + DFGL++ V D + V ++ +R + PE L K S
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLLYSKFS 179
Query: 456 EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD 515
K+DV+ +G+ + E+ + + + + R E V + +L R +
Sbjct: 180 SKSDVWAFGVLMWEVYSLGK-MPYERFNNSETVEKVSQGLRLYRPHLAS----------- 227
Query: 516 SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
E + + C E+RP Q++ ++
Sbjct: 228 ----EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 336
+G G FG VY VA+K++ + +YS E REV L + H N+++L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 337 YCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 395
+ E V+ +M NL + R KP + + + GL ++H+
Sbjct: 66 VFRENDELYFVFEYMEGNLYQLMKDRKGKP----FSESVIRSIIYQILQGLAHIHKH--- 118
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL--STGK 453
HRDLK N+L+ + DFGLA+ + ++ + T + T + APE L ST
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILLRSTSY 176
Query: 454 SSEKTDVFGYGITLLELVTGQ 474
SS D++ G + EL T +
Sbjct: 177 SS-PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 58/226 (25%)
Query: 278 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REVHLISVAI 327
IG G +G V V KVA+K++ + F RE+ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISN--------VFDDLIDAKRILREIKLLRHLR 57
Query: 328 HKNLLQLI-----GYCTTSSERILVYPFMQ-NL-SVAYRLRDLKPGEKGLDWPTRKRVAF 380
H+N++ L+ ++ +V M+ +L V + L T + +
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQY 107
Query: 381 GTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK------L 430
Y GL+YLH N +IHRDLK +NIL++ N + +CDFGLA+ VD L
Sbjct: 108 FL-YQILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 431 T-HVTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTG 473
T +V T+ R APE LS+ + ++ D++ G EL+T
Sbjct: 164 TEYVVTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-15
Identities = 42/95 (44%), Positives = 55/95 (57%), Gaps = 1/95 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ISL L N SG+I + +L+ L L N+ +G +P L S+ LQ L L +NK
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNL-EILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
FSG IP + +NL LDLS+NNLTG IP L S
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
|
Length = 968 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 52/175 (29%), Positives = 87/175 (49%), Gaps = 20/175 (11%)
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 435
++A GL YL+ +I+HRD+K +NIL++ + LCDFG++ +L+++ +
Sbjct: 107 KIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IAD 160
Query: 436 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495
GT +++PE + GK + K+DV+ GI+++EL G+ FS D D
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS----NIDDDGQDDPM 216
Query: 496 KLLREDRLNDIVDR---NLNTYD-SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546
+L D L IV L + D +++ V LL P +RP Q+ M
Sbjct: 217 GIL--DLLQQIVQEPPPRLPSSDFPEDLRDFVDACLL---KDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 78/307 (25%), Positives = 125/307 (40%), Gaps = 58/307 (18%)
Query: 268 QLATDNFSESNIIGQGGFGKVYKGVLS----DNTK--VAVKRLQDYYSPGGEAAFQREVH 321
++ D+ + +G G FG+VY+G+ D + VAVK L + S E+ F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 322 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR---- 377
++S H+N+++LIG R ++ M + LR+ +P + P+
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRP---RPERPSSLTMKDL 118
Query: 378 --VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKLVDAKLTH 432
A A G +YL E IHRD+ A N LL A + DFG+A+ D
Sbjct: 119 LFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRAS 173
Query: 433 VTTQIRGTMGHIA---PEYLSTGKSSEKTDVFGYGITLLELV-------TGQRAIDFSRL 482
+ M I PE G + KTDV+ +G+ L E+ G+
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT------- 226
Query: 483 EEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMV-QVALLCTQSTPEDRPPMA 541
++V+ + RL+ K V ++ C Q TPEDRP A
Sbjct: 227 --NQEVMEF-----VTGGGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFA 269
Query: 542 QVVKMLQ 548
+++ +Q
Sbjct: 270 TILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 280 IGQGGFGKVYKGVLSDNT-------KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 332
+G+GGFG+V V NT K+ KRL+ GE E ++ ++
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLK---KKSGEKMALLEKEILEKVNSPFIV 56
Query: 333 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLEYL 389
L + + LV M + Y + ++ GE+GL+ +RV +A G+ +L
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEM---ERVIHYSAQITCGILHL 111
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H I++RD+K N+LLDD L D GLA V+ K TQ GT G++APE L
Sbjct: 112 HSM---DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEIL 166
Query: 450 STGKSSEKTDVFGYGITLLELVTGQRAI-DFSRLEEEEDVL 489
S D F G ++ E+V G+ D +E++
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 20/221 (9%)
Query: 279 IIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
++G G FG VYKG+ + VA+K L + P F E +++ H +L++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 334 LIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 391
L+G C + + +++ + P L + +D + L+W + A G+ YL E
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM--GHIAPEYL 449
+ +++HRDL A N+L+ + DFGLA+L++ G M +A E +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD-GGKMPIKWMALECI 183
Query: 450 STGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 489
K + ++DV+ YG+T+ EL+T G + D E D+L
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 52/301 (17%)
Query: 278 NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 333
++IG+G FG+V K + + A+KR+++Y S F E+ L + H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA------------FG 381
L+G C L + + ++ LR + E + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 441
A G++YL ++ + IHRDL A NIL+ +N+ A + DFGL++ + ++ TM
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 182
Query: 442 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEEEEDVLLLDHI 494
G + A E L+ + +DV+ YG+ L E+V+ G + E E
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-------- 234
Query: 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAE 554
KL + RL ++ LN D + + M Q C + P +RP AQ++ L L E
Sbjct: 235 -KLPQGYRL----EKPLNC-DDEVYDLMRQ----CWREKPYERPSFAQILVSL-NRMLEE 283
Query: 555 R 555
R
Sbjct: 284 R 284
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 72/296 (24%), Positives = 129/296 (43%), Gaps = 41/296 (13%)
Query: 280 IGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+GQG FG VY+G D T+VAVK + + S F E ++ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK---GLDWPTRK---RVAFGTAYGLE 387
L+G + ++V M + + LR L+P + G PT + ++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG----- 442
YL+ + K +HRDL A N ++ +F + DFG+ + + +G G
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 443 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502
+APE L G + +D++ +G+ L E+ + L E+ + L E
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQP-------YQGLSNEQV 230
Query: 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAE 558
L ++D E + + +C Q P+ RP ++V +L+ +DL + E
Sbjct: 231 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK-DDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 24/226 (10%)
Query: 266 ELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTK-VAVKRLQDYYSPGGEAAFQREV 320
EL L+ F E +G+ FGK+YKG L D+ + VA+K L+D +P FQ+E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 321 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP--------GEKG--- 369
L++ H N++ L+G T +++ ++ + L P E G
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 370 --LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LV 426
LD +A A G+EYL +H+DL A NIL+ + + D GL++ +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472
A V + + + PE + GK S +D++ +G+ L E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 22/232 (9%)
Query: 273 NFSESNIIGQGGFGKVYKGVLSDNTKV-AVKR--LQDYYSPGGEAAFQREVHLISVAIHK 329
+F N IG+G FG V+K V + +V A+K+ L E A E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLE 387
+I Y + ++ + M+ L L ++G P + R GL
Sbjct: 60 ---YIIRYYESFLDKGKLNIVMEYAENG-DLHKLLKMQRGRPLPEDQVWRFFIQILLGLA 115
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 447
+LH + KI+HRD+K+ N+ LD + D G+AKL+ T+ I GT +++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-TNFANTIVGTPYYLSPE 171
Query: 448 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 499
+EK+DV+ G+ L E TG+ D + L I K++R
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGAL----ILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 280 IGQGGFGKV----YKGVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+G FGKV Y +D T VAVK L+ + +++E++++ H+N+++
Sbjct: 12 LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
G C+ + L M+ + + LRD P K L+ A G+ YLH Q
Sbjct: 71 YKGCCSEQGGKGLQL-IMEYVPLG-SLRDYLPKHK-LNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYL 449
IHRDL A N+LLD++ + DFGLAK V H ++R + A E L
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEYYRVREDGDSPVFWYAVECL 182
Query: 450 STGKSSEKTDVFGYGITLLELVT 472
K S +DV+ +G+TL EL+T
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 26/224 (11%)
Query: 279 IIGQGGFGKVYKGVL---SDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
++G G FG VYKG+ +N K VA+K L++ SP E ++++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 334 LIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 391
L+G C TS+ +++ + P+ L +D + L+W + A G+ YL E
Sbjct: 74 LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----AP 446
+++HRDL A N+L+ + DFGLA+L+D T+ G + A
Sbjct: 128 V---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID----ETEYHADGGKVPIKWMAL 180
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 489
E + + + ++DV+ YG+T+ EL+T G + D E D+L
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 52/299 (17%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNT-----KVAVKRLQDYYSPGGEAAFQREVHLISVA 326
D + S+++ +G FG+++ G+L D +V VK ++D+ S +E L+
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 327 IHKNLLQLIGYCTTSSERILV-YPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGT- 382
H+N+L ++ C E V YP+M NL + + L T++ V
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 383 -AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 441
A G+ YLH +IH+D+ A N ++D+ + + D L++ + H +
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-------CL 175
Query: 442 GH--------IAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRA---IDFSRLEEEEDVL 489
G +A E L + S +DV+ +G+ L EL+T GQ ID E
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID----PFEMAAY 231
Query: 490 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
L D R + + +N D + V C PE+RP +Q+V+ L
Sbjct: 232 LKDGYR-----------LAQPINCPDE-----LFAVMACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 33/176 (18%)
Query: 270 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKR-LQDYYSPGGEAAFQREVHLISVAI 327
++ +G+G FG+VYK + VA+K+ L G RE+ ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 328 HKNLLQLIGYCTTSSERI--------LVYPFM--------QNLSVAYRLRDLKPGEKGLD 371
H N++ LI ++ +V P+M +N SV +K L
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL- 124
Query: 372 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427
G+ YLHE I+HRD+KAANIL+D+ + DFGLA+ D
Sbjct: 125 -----------LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 51/293 (17%)
Query: 278 NIIGQGGFGKVYKGVL-SDNTKV--AVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 333
++IG+G FG+V + ++ D K+ A+K L+++ S F E+ L + H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 334 LIGYCTTSSE---RILVYPFMQNLSVAYRLRDLKPG-----EKG----LDWPTRKRVAFG 381
L+G C I P+ L + R L+ E G L + A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 441
A G++YL E+ + IHRDL A N+L+ +N + + DFGL++ + ++ TM
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKKTM 177
Query: 442 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEEEEDVLLLDHI 494
G + A E L+ + K+DV+ +G+ L E+V+ G + E E
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE-------- 229
Query: 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
KL + R+ RN D + E M Q C + P +RPP AQ+ L
Sbjct: 230 -KLPQGYRMEK--PRNC---DDEVYELMRQ----CWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 18/216 (8%)
Query: 274 FSESNIIGQGGFGKVYKGVL--SDNT--KVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 328
F+ ++G+G FG V + L D + KVAVK L+ D +S F RE + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 329 KNLLQLIGYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF-- 380
N+++LIG S + +++ PFM++ + L + GE+ P + V F
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 381 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRG 439
A G+EYL + IHRDL A N +L++N + DFGL+ K+ +
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 440 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQ 474
+ +A E L+ + +DV+ +G+T+ E++T GQ
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 70/294 (23%), Positives = 125/294 (42%), Gaps = 52/294 (17%)
Query: 273 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA-----AFQREVHLISVA 326
+ + +G G F Y+ + T +AVK++ + E A ++E+ L++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 327 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 386
H ++++++G S L +M SV++ L ++ + +++ GL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGL 116
Query: 387 EYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLT---HVTTQIRGTMG 442
YLHE +IIHRD+K AN+L+D + + + DFG A + AK T Q+ GT+
Sbjct: 117 SYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 443 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR-----------AIDFSRLEEEEDVLLL 491
+APE L + DV+ G ++E+ T + A+ F +
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233
Query: 492 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
+H+ LR+ V L C + PEDRPP +++K
Sbjct: 234 EHLSPGLRD------------------------VTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-14
Identities = 50/127 (39%), Positives = 60/127 (47%), Gaps = 9/127 (7%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 140
L LG N GKI S+T L L F L N L G +P LG M L+ + L N SG
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSL-EFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227
Query: 141 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMSRPSPPV 200
IP L++L HLDL NNLTG IP L ++ + L Q +S P PP
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL--------FLYQNKLSGPIPPS 279
Query: 201 STSRTKL 207
S KL
Sbjct: 280 IFSLQKL 286
|
Length = 968 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 273 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 330
NF + IG+G +G VYK + VA+K+++ D + G + RE+ L+ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 331 LLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
+++L+ T ++ LV+ F+ Q+L + D P G+ P K F GL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASPLS-GIPLPLIKSYLFQLLQGLAFC 116
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H +++HRDLK N+L++ L DFGLA+ + T ++ T+ + APE L
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 172
Query: 450 STGK-SSEKTDVFGYGITLLELVTGQRAI 477
K S D++ G E+VT +RA+
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 43/102 (42%), Positives = 57/102 (55%), Gaps = 13/102 (12%)
Query: 378 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVD--AKLTHVT 434
+A T L YL E KIIHRD+K +NILLD N LCDFG++ +LVD AK
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----- 164
Query: 435 TQIRGTMGHIAPEYLSTGKSSE---KTDVFGYGITLLELVTG 473
T+ G ++APE + ++DV+ GITL E+ TG
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 12/206 (5%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
+ + IG+G G+VYK + +VA+K++ E E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIIN-EILIMKDCKHP 75
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N++ E +V +M S+ + ++ P V GLEYL
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVDAKLTHVTTQIRGTMGHIAPEY 448
H Q +IHRD+K+ NILL + L DFG A+L K + + GT +APE
Sbjct: 133 HSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEV 187
Query: 449 LSTGKSSEKTDVFGYGITLLELVTGQ 474
+ K D++ GI +E+ G+
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 51/293 (17%)
Query: 278 NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 333
++IG+G FG+V K + + A+KR+++Y S F E+ L + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 334 LIGYCTTSSE---RILVYPFMQNLSVAYRLRDLKPG-----EKG----LDWPTRKRVAFG 381
L+G C I P L + R L+ L A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 441
A G++YL ++ + IHRDL A NIL+ +N+ A + DFGL++ + ++ TM
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 170
Query: 442 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEEEEDVLLLDHI 494
G + A E L+ + +DV+ YG+ L E+V+ G + E E
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-------- 222
Query: 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
KL + RL N D + + M Q C + P +RP AQ++ L
Sbjct: 223 -KLPQGYRLEK--PLNC---DDEVYDLMRQ----CWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 39/94 (41%), Positives = 56/94 (59%), Gaps = 10/94 (10%)
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHI 444
L YL E+ +IHRD+K +NILLD + LCDFG++ +LVD+K T+ G ++
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---AKTRSAGCAAYM 181
Query: 445 APEYLSTGKSSEK----TDVFGYGITLLELVTGQ 474
APE + + K DV+ GI+L+EL TGQ
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339
+G G FGKVYK + +A ++ D S + E+ +++ H N+++L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 340 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 399
+ ++ F +V + +L E+ L P + V T L YLHE KIIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 400 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYLSTGKSS 455
RDLKA NIL + + L DFG V AK T T Q R GT +APE + S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFG----VSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 456 E-----KTDVFGYGITLLEL 470
+ K DV+ GITL+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 78/303 (25%), Positives = 135/303 (44%), Gaps = 43/303 (14%)
Query: 268 QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 319
+ + D + +G+G FG+V G+ D K VAVK L+D + + E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 320 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------G 366
+ ++ + HKN++ L+G CT ++ + ++ LR +P
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 367 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426
++ + + + A G+EYL Q K IHRDL A N+L+ +N + DFGLA+ V
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 427 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE 484
+ TT R + +APE L + ++DV+ +G+ + E+ T G +EE
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
Query: 485 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 544
+ KLL+E +D+ N + E+ M++ C + P RP Q+V
Sbjct: 248 ---------LFKLLKEGHR---MDKPANC--TNELYMMMRD---CWHAIPSHRPTFKQLV 290
Query: 545 KML 547
+ L
Sbjct: 291 EDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 271 TDNFSESNIIGQGGFGKV--YKGVLSDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAI 327
T+ + + +G G FG V + L+ VA+K++ +S P RE+ L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
H+N++ L + E I + + RL +P EK + + GL+
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLH-RLLTSRPLEKQF----IQYFLYQILRGLK 122
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAP 446
Y+H + ++HRDLK +NIL+++N + +CDFGLA++ D ++T +V+T+ + AP
Sbjct: 123 YVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAP 174
Query: 447 EYLST-GKSSEKTDVFGYGITLLELVTGQ 474
E + T K + D++ G E++ G+
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 69/298 (23%), Positives = 131/298 (43%), Gaps = 40/298 (13%)
Query: 268 QLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQREVH 321
++A + + S +GQG FG VY KGV+ D T+VA+K + + S F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 322 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRV 378
++ ++++L+G + +++ M + LR L+P P+ K++
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 379 ---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 435
A A G+ YL+ K +HRDL A N ++ ++F + DFG+ + +
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDY 174
Query: 436 QIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 490
+G G ++PE L G + +DV+ +G+ L E+ T E+ +
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--------LAEQPYQGMS 226
Query: 491 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + + + E L D D N D + ++ +C Q P+ RP +++ ++
Sbjct: 227 NEQVLRFVMEGGLLDKPD---NCPD-----MLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 280 IGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKN 330
+G+G FG+V + G+ VAVK L+D + A E+ L+ + HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRV 378
++ L+G CT ++ + ++ LR +P E+ L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 379 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQI 437
A+ A G+EYL + + IHRDL A N+L+ ++ + DFGLA+ V D T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 438 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472
R + +APE L + ++DV+ +GI + E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 71/270 (26%), Positives = 118/270 (43%), Gaps = 28/270 (10%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339
+G G FG V+ G KVA+K + + E F E ++ H L+QL G CT
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 340 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 399
+V FM+N + LR + G+ D + G+EYL E+ + IH
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKD--MLLSMCQDVCEGMEYL-ERNS--FIH 123
Query: 400 RDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 458
RDL A N L+ + DFG+ + V D + T ++ + + PE + K S K+
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 459 DVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSK- 517
DV+ +G+ + E+ T + E++ + + + + R RL Y K
Sbjct: 183 DVWSFGVLMWEVFTEGKM----PFEKKSN---YEVVEMISRGFRL----------YRPKL 225
Query: 518 EVETMVQVALLCTQSTPEDRPPMAQVVKML 547
T+ +V C PE RP A++++ +
Sbjct: 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 279 IIGQGGFGKV----YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 334
IG+G FG V Y+G KVAVK +++ AF E +++ H NL+QL
Sbjct: 13 TIGKGEFGDVMLGDYRG-----NKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQL 64
Query: 335 IGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
+G + +V +M S+ LR G L + + +EYL
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEAN- 121
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 453
+HRDL A N+L+ ++ A + DFGL K + ++ T APE L K
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKK 175
Query: 454 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 488
S K+DV+ +GI L E+ + R + + R+ ++ V
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR-VPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 59/282 (20%), Positives = 111/282 (39%), Gaps = 47/282 (16%)
Query: 279 IIGQGGFGK--VYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLI 335
++G+G FG+ +Y+ D++ V K + S E+ ++S+ H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 336 GYCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKGLDWPTRKRVA--FGTAYG 385
+ FM + ++ + G +KG + + F
Sbjct: 66 NH------------FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA 113
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445
+ Y+H+ I+HRD+K NI L L DFG++K++ ++ + T + GT +++
Sbjct: 114 VSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMS 169
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505
PE K + K+D++ G L EL+T +R D + +
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----------------LVVK 212
Query: 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
IV N S ++ + Q PE RP +V+
Sbjct: 213 IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 273 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGE---AAFQREVHLISVAI 327
N+ ++GQG FG+VY +D + +AVK++Q D SP A + E+ L+ +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
H+ ++Q G ER L FM+ ++D L ++ G+
Sbjct: 63 HERIVQYYGCLRDPMERTLSI-FME-HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIA 445
YLH I+HRD+K ANIL D L DFG +K + T + GT ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVT 472
PE +S K D++ G T++E++T
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 27/262 (10%)
Query: 299 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY 358
VAVK L+ S F +EV ++S N+ +L+G CT ++ +M+N +
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 359 RLRDLKPGEKGLDWPTRKRVAFGT--------AYGLEYLHEQCNPKIIHRDLKAANILLD 410
L+ GL K ++F T A G+ YL E N +HRDL N L+
Sbjct: 109 FLQKHVAETSGLAC-NSKSLSFSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVG 164
Query: 411 DNFEAVLCDFGLAKLVDAKLTHVTTQIRG-TMGHI---APEYLSTGKSSEKTDVFGYGIT 466
N+ + DFG+++ + + +++G I A E + GK + K+DV+ +G+T
Sbjct: 165 KNYTIKIADFGMSRNLYSS---DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221
Query: 467 LLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVA 526
L E++T R + L +++ ++++ R+D + R N + + ++
Sbjct: 222 LWEILTLCREQPYEHLTDQQ---VIENAGHFFRDDGRQIYLPRPPNC-----PKDIYELM 273
Query: 527 LLCTQSTPEDRPPMAQVVKMLQ 548
L C + EDRP ++ LQ
Sbjct: 274 LECWRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 30/192 (15%)
Query: 274 FSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA----AFQREVHL---ISV 325
+ E IG+G +G VYK L+ VA+K+++ P E + RE+ L +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 326 AIHKNLLQLIGYCTTS-SERI----LVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVA 379
H N+++L+ C ++R LV+ + Q+L+ K + GL T K +
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLS----KCPKPGLPPETIKDLM 113
Query: 380 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD--AKLTHVTTQI 437
G+++LH I+HRDLK NIL+ + + + DFGLA++ LT V
Sbjct: 114 RQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-- 168
Query: 438 RGTMGHIAPEYL 449
T+ + APE L
Sbjct: 169 --TLWYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 60/223 (26%), Positives = 89/223 (39%), Gaps = 47/223 (21%)
Query: 278 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQR---EVHLISVAIHKNLLQ 333
IG+G FG V K SD + K + Y E Q+ EV+++ H N+++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 334 LIGYCTTSSERIL------VYPFM---------QNLSVAYRLRDLKPGEKGLDWPTRKRV 378
+RI+ +Y M Q + + R E R+
Sbjct: 64 YY-------DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW------RI 110
Query: 379 AFGTAYGLEYLH--EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-----AKLT 431
L H ++HRDLK ANI LD N L DFGLAK++ AK T
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK-T 169
Query: 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
+V GT +++PE L+ EK+D++ G + EL
Sbjct: 170 YV-----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 274 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLL 332
F++ IG+G FG+V+KG+ + +V ++ D E Q+E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 333 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
+ G ++ ++ M+ L L L+ G D + GL+YLH +
Sbjct: 66 KYYGSYLKGTK---LWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLHSE 120
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 451
K IHRD+KAAN+LL + + L DFG+A +L D ++ T GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 175
Query: 452 GKSSEKTDVFGYGITLLELVTGQ 474
K D++ GIT +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 56/299 (18%)
Query: 272 DNFSESNIIGQGGFGKVYKGV---LSDN---TKVAVKRLQDYYSPGGEAAFQREVHLIS- 324
+N S +G G FGKV + LS + KVAVK L+ A E+ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT-- 382
+ H+N++ L+G CT +++ + DL L++ RKR +F T
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYC-------CYGDL------LNFLRRKRESFLTLE 141
Query: 383 ---------AYGLEYL-HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432
A G+ +L + C IHRDL A N+LL +CDFGLA+ + +
Sbjct: 142 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197
Query: 433 VTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR-LEEEEDVLL 490
V R + +APE + + ++DV+ YGI L E+ FS + +
Sbjct: 198 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI--------FSLGSNPYPGMPV 249
Query: 491 LDHIRKLLRED-RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
KL++E R+ + E+ +++ C + P RP Q+V+++
Sbjct: 250 DSKFYKLIKEGYRMAQPE------HAPAEIYDIMKT---CWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 263 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREV 320
CR + F + N IG+G +G VY+ + + + VA+K+++ D G + RE+
Sbjct: 2 RCRSVT----EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREI 57
Query: 321 HLISVAIHKNLLQLIGYCTTSS-ERI-LVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKR 377
L+ H N+++L + I LV + Q+L+ L D P K
Sbjct: 58 TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLA---SLLDNMP--TPFSESQVKC 112
Query: 378 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 437
+ GL+YLHE IIHRDLK +N+LL D + DFGLA+ +T ++
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 438 RGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 474
T+ + APE L + D++ G L EL+ +
Sbjct: 170 V-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 50/226 (22%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVH--------- 321
D + + +G G +G+V + KVA+K+L P FQ +H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL---SRP-----FQSAIHAKRTYRELR 66
Query: 322 LISVAIHKNLLQLIGYCTTSSER------ILVYPFM-QNLSVAYRLRDLKPGEKGLDWPT 374
L+ H+N++ L+ T +S LV M +L+ + + L +
Sbjct: 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKL----------S 116
Query: 375 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430
+ F Y GL+Y+H + IIHRDLK +NI ++++ E + DFGLA+ D ++
Sbjct: 117 DDHIQF-LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM 172
Query: 431 T-HVTTQIRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 474
T +V T + APE L+ ++ D++ G + EL+TG+
Sbjct: 173 TGYV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 280 IGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 330
+G+G FG+V G+ D VAVK L+D + + E+ ++ + HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW-------PTRK------- 376
++ L+G CT ++ + ++ LR +P G+D+ P +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRP--PGMDYSFDTCKLPEEQLTFKDLV 137
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTT 435
A+ A G+EYL Q K IHRDL A N+L+ ++ + DFGLA+ V + TT
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 436 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472
R + +APE L + ++DV+ +G+ L E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 17/206 (8%)
Query: 280 IGQGGFGKVYKG---VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
IG G FGKV G +V VK L+ +P + F +EV H N+LQ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP-TRKRVAFGTAYGLEYLHEQCNP 395
C S +LV F + LR + + +R+A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT--QIRGTMGHIAPEY----- 448
IH DL N L + + D+GLA L + T + +APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 449 --LSTGKSSEKTDVFGYGITLLELVT 472
L ++K++++ G+T+ EL T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 12/209 (5%)
Query: 280 IGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
+G+G + VYKG L+DN VA+K ++ + G REV L+ H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
T LV+ ++ Y L ++ K F GL Y H + K+
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQY----LDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTGKSSE 456
+HRDLK N+L+++ E L DFGLA+ + ++ T+ + P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 457 KTDVFGYGITLLELVTGQRAIDFSRLEEE 485
+ D++G G E+ TG+ S +EE+
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 47/141 (33%), Positives = 59/141 (41%), Gaps = 28/141 (19%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVD-----AKLTHVTTQI 437
LEYLH + IIHRDLK NIL+D N L DFGL+K LV +I
Sbjct: 105 ALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 438 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-----------------QRAIDFS 480
GT +IAPE + S+ D + G L E + G I++
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221
Query: 481 RLEEEEDVLLLDHIRKLLRED 501
E D +D I KLL D
Sbjct: 222 EDVEVSDE-AIDLISKLLVPD 241
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 280 IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+G FGKV+ D VAVK L++ S FQRE L++V H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLD-----------WPTRKRVAFGT 382
G CT ++V+ +M++ + LR P K L +A
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTM 441
A G+ YL + +HRDL N L+ + DFG+++ + V + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 442 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472
+ PE + K + ++D++ +G+ L E+ T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 82/334 (24%), Positives = 134/334 (40%), Gaps = 84/334 (25%)
Query: 280 IGQGGFGKVYKGVLSDNTK------VAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLL 332
+G+G FGKV + K VAVK L++ + A E+ LI + H N++
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 333 QLIGYCTTSSERILV---YPFMQNLS----------VAYRLRDL-------KPGEKG-LD 371
L+G CT ++V Y NLS YR + K G+K LD
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 372 ------------WPTRKRV-------------------------AFGTAYGLEYLHEQCN 394
+ K + +F A G+E+L +
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR-- 192
Query: 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGK 453
K IHRDL A NILL +N +CDFGLA+ + +V R + +APE +
Sbjct: 193 -KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251
Query: 454 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513
+ ++DV+ +G+ L E+ + A + ++ +E+ R+L R+
Sbjct: 252 YTTQSDVWSFGVLLWEIFS-LGASPYPGVQIDEEF-----CRRLKEGTRMRA-------- 297
Query: 514 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
+ + L C + PEDRP +++V++L
Sbjct: 298 -PEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 39/104 (37%), Positives = 61/104 (58%), Gaps = 14/104 (13%)
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVD--AKLTHV 433
++A LEYLH + +IHRD+K +N+L++ N + LCDFG++ LVD AK
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---- 160
Query: 434 TTQIRGTMGHIAPEYLSTGKSSE----KTDVFGYGITLLELVTG 473
T G ++APE ++ + + K+DV+ GIT++EL TG
Sbjct: 161 -TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 65/220 (29%), Positives = 90/220 (40%), Gaps = 52/220 (23%)
Query: 274 FSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQ---REVHLISVAIHK 329
F++ IG G FG VY + VA+K++ Y +Q +EV + H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 330 NLLQLIG-------------YCTTSSERIL-VY--PFMQNLSVAYRLRDLKPGEKGLDWP 373
N ++ G YC S+ IL V+ P +Q + +A
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP-LQEVEIA---------------- 118
Query: 374 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433
+ G GL YLH IHRD+KA NILL + L DFG A LV + V
Sbjct: 119 ---AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV 172
Query: 434 TTQIRGTMGHIAPEY---LSTGKSSEKTDVFGYGITLLEL 470
GT +APE + G+ K DV+ GIT +EL
Sbjct: 173 -----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 80/309 (25%), Positives = 139/309 (44%), Gaps = 55/309 (17%)
Query: 268 QLATDNFSESNIIGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQRE 319
++ D +G+G FG+V G+ + TKVAVK L+ + + E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 320 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW---PTR 375
+ ++ + HKN++ L+G CT ++ + ++ LR +P G+++ PT+
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP--PGMEYCYNPTQ 131
Query: 376 KRV-----------AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424
A+ A G+EYL + K IHRDL A N+L+ ++ + DFGLA+
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 188
Query: 425 LVDAKLTHV-----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 478
+ H+ TT R + +APE L + ++DV+ +G+ L E+ T G
Sbjct: 189 ----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244
Query: 479 FSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP 538
+EE + KLL+E +D+ N + E+ M++ C + P RP
Sbjct: 245 GVPVEE---------LFKLLKEGHR---MDKPSNC--TNELYMMMRD---CWHAVPSQRP 287
Query: 539 PMAQVVKML 547
Q+V+ L
Sbjct: 288 TFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 7e-13
Identities = 57/190 (30%), Positives = 79/190 (41%), Gaps = 43/190 (22%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQ--REVHLISVAIHKNLLQL 334
+G+G + VYK VA+K +L + F RE+ L+ H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 335 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---------- 384
+ S LV+ FM+ DL EK + K + A
Sbjct: 68 LDVFGHKSNINLVFEFMET--------DL---EKVIK---DKSIVLTPADIKSYMLMTLR 113
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRG 439
GLEYLH I+HRDLK N+L+ + L DFGLA+ + K+TH VT R
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR- 169
Query: 440 TMGHIAPEYL 449
APE L
Sbjct: 170 -----APELL 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 278 NIIGQGGFGKVYKGVLSD-------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
N +G G FG+VY+G +D +VAVK L+ + + F +E HL+S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK---PGEKGLDWPTRKRVAFGTAYGLE 387
+++L+G C + + ++ M+ + LRD + G L + A G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAV-----LCDFGLAK-LVDAKLTHVTTQIRGTM 441
YL + IHRDL A N L+ + + DFGLA+ + + + +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 442 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472
+APE L GK + ++DV+ +G+ + E++T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-13
Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 2/89 (2%)
Query: 83 LGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP 142
L N FSG++ TKL L F ++ +N+L G + M LQ L+LA NKF G +P
Sbjct: 411 LQDNSFSGELPSEFTKLP-LVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469
Query: 143 ATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ L++LDLS N +G +P +L S
Sbjct: 470 DS-FGSKRLENLDLSRNQFSGAVPRKLGS 497
|
Length = 968 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-13
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 280 IGQGGFGKVYKG-VLSD--NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
IG G FGKV G V S +V VK L+ S + F E H NLLQ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEK-GLDWPTRKRVAFGTAYGLEYLHEQCNP 395
CT + +LV F + LR + E D T +R+A A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKS 454
IH DL N LL + + D+GL+ + +VT Q+ + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 455 -------SEKTDVFGYGITLLEL 470
+++++V+ G+T+ EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
TD + IG+G +GKVYK D + AVK L E + + L S+ H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-LQSLPNHP 79
Query: 330 NLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 384
N+++ G + + + LV SV ++ L + LD + +G
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVDAKLTHVTTQIRGTMGH 443
GL++LH N +IIHRD+K NILL L DFG+ A+L +L T+ GT
Sbjct: 140 GLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFW 194
Query: 444 IAPEYLSTGKSSE-----KTDVFGYGITLLELVTG 473
+APE ++ + + + DV+ GIT +EL G
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-13
Identities = 37/89 (41%), Positives = 51/89 (57%), Gaps = 1/89 (1%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 140
L L N SG I PSI L+ L S +L DN LSG +P+ + + +L+ L+L +N F+G
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISL-DLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK 323
Query: 141 IPATWSQLSNLKHLDLSSNNLTGRIPMQL 169
IP + L L+ L L SN +G IP L
Sbjct: 324 IPVALTSLPRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 12/220 (5%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
D++ + +G+G + VYKG N K VA+K ++ G RE L+ H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
++ L T LV+ ++ Y D PG GL K F GL Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPG--GLHPENVKLFLFQLLRGLSYIH 120
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YL 449
++ I+HRDLK N+L+ D E L DFGLA+ + +H + T+ + P+ L
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 450 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 489
+ + S D++G G +E++ G A F +++ +D L
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAA--FPGMKDIQDQL 214
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 75/281 (26%), Positives = 111/281 (39%), Gaps = 41/281 (14%)
Query: 273 NFSESNIIGQGGFGKVYK-GVLSDNTKVAVKR--LQDYYSPGGEAAFQREVHLISVAIHK 329
+F +G+G +G VYK LSDN A+K L E A E+ +++ H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHP 59
Query: 330 NLLQLIGYCTTSSE-RILV----YPFMQNLSVAYRLRDL--KPGEKGLDWPTRKRVAFGT 382
N+ I Y + L Y +LS A R K + W R+
Sbjct: 60 NI---ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQL 112
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 442
GL+ LHEQ KI+HRDLK+ANILL N + D G++K+ K TQI GT
Sbjct: 113 LRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKTQI-GTPH 166
Query: 443 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502
++APE S K+D++ G L E+ T + +++ LR
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------------LRYKV 213
Query: 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQV 543
Y + + Q P+ RP ++
Sbjct: 214 QRGKYPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-12
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 279 IIGQGGFGKVYKG---VLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQ 333
+IG+GG G+VY V S +VA+K++++ S P + F RE + + IH ++
Sbjct: 9 LIGKGGMGEVYLAYDPVCS--RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 334 LIGYCTTSSERILVY---PFMQNLSVAYRLRDL-------KPGEKGLDWPTRKRVAFGTA 383
+ C S+ VY P+++ ++ L+ + K + +
Sbjct: 67 VYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK-------------- 429
+EY+H + ++HRDLK NILL E V+ D+G A +
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 430 LTHVTT---QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472
T +I GT ++APE L +SE TD++ G+ L +++T
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 280 IGQGGFGKVYKGVLSDNTKV--AVK--RLQDYYSPGGEAAFQ---REVHLISVAIHKNLL 332
+G+G +G VYK VL T V A+K RL+ E+ F E+ ++ A+ ++
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLEL-----DESKFNQIIMELDILHKAVSPYIV 62
Query: 333 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
G + +M S+ +L +G+ +R+ + GL++L E+
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 452
N IIHRD+K N+L++ N + LCDFG++ + A L T I G ++APE + +G
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--KTNI-GCQSYMAPERIKSG 176
Query: 453 KSSE------KTDVFGYGITLLELVTG 473
++ ++DV+ G+++LE+ G
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 7/103 (6%)
Query: 77 NVISLTLGSNGFSGKISPSI---TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLA 133
N+ +L L +N SG+I I + LK L +L N L G +P+ L ++T L+ L LA
Sbjct: 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVL----DLGGNVLVGKIPNSLTNLTSLEFLTLA 196
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN 176
+N+ G IP Q+ +LK + L NNL+G IP ++ + + N
Sbjct: 197 SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239
|
Length = 968 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 273 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
NF + +G+G + VYKG + VA+K + G + RE+ L+ H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-----GEKG-LDWPTRKRVAFGTAYG 385
++L T ++ +LV+ +M DLK G +G LD T K + G
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDK--------DLKKYMDTHGVRGALDPNTVKSFTYQLLKG 112
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445
+ + HE +++HRDLK N+L++ E L DFGLA+ + + ++ T+ + A
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRA 168
Query: 446 PEYLSTGKS-SEKTDVFGYGITLLELVTG 473
P+ L ++ S D++ G + E++TG
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339
+G G FGKVYK + +A ++ + S + E+ +++ H +++L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 340 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 399
+ ++ F +V + +L ++GL P + + L+YLH KIIH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIH 133
Query: 400 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYL--STGK 453
RDLKA N+LL + + L DFG V AK T Q R GT +APE + T K
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFG----VSAKNVK-TLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 454 SSE---KTDVFGYGITLLEL 470
+ K D++ GITL+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 273 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGE---AAFQREVHLISVAI 327
N+ ++GQG FG+VY D + +A K++Q D SP +A + E+ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
H+ ++Q G +E+ L FM+ + ++D L ++ G+
Sbjct: 63 HERIVQYYGCLRDRAEKTLTI-FMEYMP-GGSVKDQLKAYGALTESVTRKYTRQILEGMS 120
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIA 445
YLH I+HRD+K ANIL D L DFG +K + T + GT ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVT 472
PE +S K DV+ G T++E++T
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 273 NFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRLQDYYSPGGEA-AFQREVHLISVAIHK 329
+ IG+G FGK+Y K SD+ +K + P E A ++EV L++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD----LKPGEKGLDWPTRKRVAFGTAYG 385
N++ + +V + + R+ L ++ L W + + G
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLG 113
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
L+++H++ KI+HRD+K+ NI L N A L DFG+A+ ++ + T + GT ++
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYL 169
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVT 472
+PE + KTD++ G L EL T
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 62/236 (26%), Positives = 110/236 (46%), Gaps = 27/236 (11%)
Query: 274 FSESNIIGQGGFGKV------YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI 327
F + ++G+GGFG+V G + K+ KR++ GE+ E ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK---KRKGESMALNEKQILEKVN 58
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY--- 384
+ ++ L T LV M + + + + GE G + R F A
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFE---EGRAVFYAAEICC 113
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
GLE LH++ +I++RDLK NILLDD+ + D GLA V T + ++ GT+G++
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYM 168
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500
APE + + + D + G L E++ GQ S ++ + + + + +L++E
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQ-----SPFQQRKKKIKREEVERLVKE 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 280 IGQGGFGKVYKG------VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+G FGKV+ D VAVK L+D + FQRE L++ H+++++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 71
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP--------------GEKGLDWPTRKRVA 379
G C I+V+ +M++ + LR P GE GL +A
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS--QMLHIA 129
Query: 380 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 439
A G+ YL Q +HRDL N L+ N + DFG+++ V +T
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDV------YSTDYYR 180
Query: 440 TMGH-------IAPEYLSTGKSSEKTDVFGYGITLLELVT 472
GH + PE + K + ++DV+ +G+ L E+ T
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 5e-12
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 274 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
F ++G G +G+VYKG ++A ++ D E Q L + H+N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 334 LIGYCTTSS------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
G + + LV F SV +++ K +W + GL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLS 125
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 447
+LH+ K+IHRD+K N+LL +N E L DFG++ +D + T I GT +APE
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 181
Query: 448 YLSTGKSSE-----KTDVFGYGITLLELVTG 473
++ ++ + K+D++ GIT +E+ G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 280 IGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
+G+G + V+KG L++N VA+K ++ + G REV L+ H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
T LV+ ++ + Y L + K F GL Y H++ KI
Sbjct: 72 IHTERCLTLVFEYLDSDLKQY----LDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTGKSSE 456
+HRDLK N+L+++ E L DFGLA+ + ++ T+ + P+ L + + S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 457 KTDVFGYGITLLELVTGQRAIDFSRLEEE 485
D++G G L E+ TG+ S ++EE
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 280 IGQGGFGKVY------KGVLSDNT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
+G+G FGKV +G DNT +VAVK L+ A ++E+ ++ H+N+
Sbjct: 12 LGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 332 LQLIGYCTTSSER--ILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGLEY 388
++ G CT L+ F+ + S L++ P K ++ + + A G++Y
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGS----LKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAP 446
L + + +HRDL A N+L++ + + DFGL K + D + V + + AP
Sbjct: 125 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVT 472
E L K +DV+ +G+TL EL+T
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 274 FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKN 330
F + ++G+GGFG+V + K+ A KRL+ GE+ E ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLE 387
++ L T LV M + + + ++ G G + +R F A GLE
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFE---EERALFYAAEILCGLE 116
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIR---GTMGH 443
LH + ++RDLK NILLDD + D GLA K+ + + IR GT+G+
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES------IRGRVGTVGY 167
Query: 444 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
+APE L+ + + D +G G + E++ GQ
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 44/109 (40%), Positives = 56/109 (51%), Gaps = 15/109 (13%)
Query: 83 LGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP 142
LG N SG+I I L L +L N+L+G +P LG++ +LQ L L NK SG IP
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHL-DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP 277
Query: 143 ATWSQLSNLKHLDLSSNNLTGRIP-----------MQLFSVATFNFTGT 180
+ L L LDLS N+L+G IP + LFS NFTG
Sbjct: 278 PSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN---NFTGK 323
|
Length = 968 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 280 IGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
IG+G +G V+K + + VA+KR++ D G ++ RE+ L+ HKN+++L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 338 CTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
+ + LV+ + Q+L + D G+ +D K F GL + H
Sbjct: 68 LHSDKKLTLVFEYCDQDLK---KYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAK 424
++HRDLK N+L++ N E L DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 70/216 (32%), Positives = 96/216 (44%), Gaps = 45/216 (20%)
Query: 280 IGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREV-HLISVAIHKNLLQLIGY 337
IG+G FG+VY+ D ++ A+K L E ++EV H I +N+L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVAHTIG---ERNILV---- 48
Query: 338 CTTSSERILVYPFM-------QNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTA 383
T E PF+ Q S Y + D G + L W +K R F A
Sbjct: 49 RTLLDES----PFIVGLKFSFQTDSDLYLVTDYMSGGE-LFWHLQKEGRFSEDRAKFYIA 103
Query: 384 ---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIR 438
LE+LH+ I++RDLK NILLD LCDFGL+K L D K T+
Sbjct: 104 ELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--- 157
Query: 439 GTMGHIAPEYLSTGKSSEK-TDVFGYGITLLELVTG 473
GT ++APE L K K D + G+ + E+ G
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 280 IGQGGFGKVYK-GVLSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVAIHKNLLQL 334
IG+G G V+K VA+K++ E RE+ + H +++L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 335 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 394
+ S +LV +M + ++ LRD E+ L K G+ Y+H
Sbjct: 65 LDVFPHGSGFVLVMEYMPS-DLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN-- 118
Query: 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGK 453
I+HRDLK AN+L+ + + DFGLA+L + + + T + APE L K
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 454 SSEKTDVFGYGITLLELVTGQ 474
D++ G EL+ G
Sbjct: 178 YDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 65/280 (23%), Positives = 126/280 (45%), Gaps = 37/280 (13%)
Query: 273 NFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 329
+ + ++G+G FG V+ + +D V +K++ + + A Q E ++ + H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVA----YRLRDLKPGEKGLDWPTRKRVAFGTAYG 385
N+++ ++V + ++A R L + L + + +A
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------ 113
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
L ++H I+HRDLK NILLD + V + DFG++K++ +K T + GT +I
Sbjct: 114 LHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYI 168
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504
+PE ++K+D++ G L EL + +RA + + L L+L K++
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVL----KIMS-GTFA 219
Query: 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 544
I DR S ++ ++ L P RP ++Q++
Sbjct: 220 PISDRY-----SPDLRQLILSML---NLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 280 IGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
+G+G + V+KG L++N VA+K ++ + G REV L+ H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKG----LDWPTRKRVAFGTAYGLEYLHEQC 393
T LV+ ++ +DLK + K + GL Y H +
Sbjct: 73 VHTDKSLTLVFEYLD--------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR- 123
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTG 452
K++HRDLK N+L+++ E L DFGLA+ + ++ T+ + P+ L +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 453 KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 485
+ S + D++G G E+ +G+ S +E+E
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 280 IGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
IG+G +G V+K + + VA+K+ ++ P + RE+ ++ H NL+ LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
+ LV+ + + +V L +L+ +G+ K++ + T + + H+
Sbjct: 69 FRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NC 121
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGKSSE 456
IHRD+K NIL+ + LCDFG A+++ T + T + APE L +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYGP 180
Query: 457 KTDVFGYGITLLELVTGQ 474
DV+ G EL+TGQ
Sbjct: 181 PVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 274 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL 332
F ++G G +G+VYKG ++A ++ D + E + E++++ + H+N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIA 76
Query: 333 QLIGYCTTSS------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 386
G S + LV F SV +++ K DW + GL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 387 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 446
+LH K+IHRD+K N+LL +N E L DFG++ +D + T I GT +AP
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 190
Query: 447 EYLSTGKSSEKT-----DVFGYGITLLELVTG 473
E ++ ++ + T D++ GIT +E+ G
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 63/238 (26%), Positives = 109/238 (45%), Gaps = 27/238 (11%)
Query: 274 FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKN 330
F ++G+GGFG+V + K+ A K+L+ GEA E ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLE 387
++ L T LV M + + + ++ G G D +R F A GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFD---EQRAIFYAAELCCGLE 116
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMGHI 444
L + +I++RDLK NILLDD + D GLA + T +R GT+G++
Sbjct: 117 DLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYM 168
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502
APE ++ K + D +G G + E++ GQ S + ++ + + + + ++ED+
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQ-----SPFRKRKERVKREEVDRRVKEDQ 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 280 IGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+G FGKV+ D VAVK L+D S F RE L++ H+++++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVK 71
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL---DWPTR------KRVAFGTAY 384
G C I+V+ +M++ + LR P + + P +A A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH- 443
G+ YL Q +HRDL N L+ +N + DFG+++ V +T GH
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDV------YSTDYYRVGGHT 182
Query: 444 ------IAPEYLSTGKSSEKTDVFGYGITLLELVT 472
+ PE + K + ++DV+ G+ L E+ T
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 280 IGQGGFGKVYKGVLSDNTK--VAVKRLQDYYSPGG-------EAAFQREVHLISVAIHKN 330
IG+G +GKV+K N VA+KR++ G E A R + H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE---HPN 65
Query: 331 LLQLIGYCTTS-----SERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 384
+++L CT S ++ LV+ + Q+L+ K E G+ T K + F
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD----KVPEPGVPTETIKDMMFQLLR 121
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
GL++LH +++HRDLK NIL+ + + L DFGLA++ ++ T + T+ +
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYR 176
Query: 445 APEYLSTGKSSEKTDVFGYGITLLEL 470
APE L + D++ G E+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 35/102 (34%), Positives = 61/102 (59%), Gaps = 7/102 (6%)
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 435
+V+ GL YL E+ +I+HRD+K +NIL++ E LCDFG++ +L+D+ +
Sbjct: 107 KVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 436 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 477
GT +++PE L S ++D++ G++L+EL G+ I
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 61/277 (22%), Positives = 118/277 (42%), Gaps = 21/277 (7%)
Query: 273 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAIHK 329
NF IG+G F +VY+ L D VA+K++Q D A +E+ L+ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N+++ +E +V ++ ++ K ++ + T + LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H + +++HRD+K AN+ + L D GL + +K T + + GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 450 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509
+ K+D++ G L E+ Q ++ ++ L ++ D
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----------NLYSLCKKIEQCDYPPL 228
Query: 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546
+ Y S+E+ +V +C PE RP + V +
Sbjct: 229 PSDHY-SEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 53/172 (30%), Positives = 80/172 (46%), Gaps = 35/172 (20%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTK--VAVKR-LQDYYSPGGEAAFQREVHLISVAIH 328
+ + IGQG FG+V+K TK VA+K+ L + G RE+ ++ + H
Sbjct: 12 SKYEKLAKIGQGTFGEVFK-ARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKH 70
Query: 329 KNLLQLIGYCTTSSER--------ILVYPF--------MQNLSVAYRLRDLKPGEKGLDW 372
+N++ LI C T + LV+ F + N +V + L ++K K L
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML-- 128
Query: 373 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424
GL Y+H KI+HRD+KAANIL+ + L DFGLA+
Sbjct: 129 ----------LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 76/274 (27%), Positives = 111/274 (40%), Gaps = 38/274 (13%)
Query: 280 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHKNLLQLI 335
IG G FG VY S N VAVK++ Y +Q +EV + H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 336 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 395
G LV + L A L L+ +K L + G GL YLH
Sbjct: 88 GCYLKEHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY---LSTG 452
+IHRD+KA NILL + + L DFG A + V GT +APE + G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 453 KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 512
+ K DV+ GIT +EL E + + ++ + L I +
Sbjct: 196 QYDGKVDVWSLGITCIELA-----------ERKPPLFNMNAMSALYH------IAQNDSP 238
Query: 513 TYDSKE-VETMVQVALLCTQSTPEDRPPMAQVVK 545
T S E ++ C Q P++RP A++++
Sbjct: 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 33/102 (32%), Positives = 60/102 (58%), Gaps = 7/102 (6%)
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 435
+++ GL YL E KI+HRD+K +NIL++ E LCDFG++ +L+D+ +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156
Query: 436 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 477
GT +++PE L + ++D++ G++L+E+ G+ I
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 34/231 (14%)
Query: 280 IGQGGFGKVYKGV--LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
+G+G + VYKG L+ VA+K ++ + G RE L+ H N++ L
Sbjct: 13 LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHE 391
T LV+ ++ DLK G GL + F GL Y H+
Sbjct: 72 IHTKKTLTLVFEYLD--------TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL--THVTTQIRGTMGHIAPEYL 449
+ +++HRDLK N+L+ + E L DFGLA+ AK + + T+ + P+ L
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVVTLWYRPPDVL 175
Query: 450 --STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 498
ST S+ D++G G E+ TG+ S E++ L I ++L
Sbjct: 176 LGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVEDQ----LHKIFRVL 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-11
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 27/203 (13%)
Query: 298 KVAVKRLQDYYSPGGE---AAFQREVHLISVAIHKNLLQLIGYCTTSSERIL-VYPFMQN 353
+VA+K L+ +P E A F+RE L + H N++ L+ + V+ ++
Sbjct: 5 EVAIKLLRTD-APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63
Query: 354 LSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL- 409
++ L L GE G R+ L H Q I+HRDLK NI++
Sbjct: 64 RTLREVLAADGALPAGETG-------RLMLQVLDALACAHNQ---GIVHRDLKPQNIMVS 113
Query: 410 --DDNFEAVLCDFGLAKL------VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVF 461
A + DFG+ L D TT++ GT + APE L + +D++
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 462 GYGITLLELVTGQRAIDFSRLEE 484
+G+ LE +TGQR + + + E
Sbjct: 174 AWGLIFLECLTGQRVVQGASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 45/211 (21%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHKNLLQLIG- 336
+G G +G VYK L AVK ++ PG + + Q+E+ ++ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 337 ------------YCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 382
YC S + + V + L +AY R+ T
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRE-------------------T 115
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 442
GL YLH + +HRD+K ANILL DN + L DFG+A + A + + I GT
Sbjct: 116 LQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPY 171
Query: 443 HIAPEYLSTGKS---SEKTDVFGYGITLLEL 470
+APE + K+ ++ D++ GIT +EL
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 48/203 (23%), Positives = 93/203 (45%), Gaps = 7/203 (3%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAI 327
NF IG+G F VYK + L D VA+K++Q + +E+ L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
H N+++ + ++E +V ++ ++ K ++ + T + LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 447
++H + +I+HRD+K AN+ + L D GL + +K T + + GT +++PE
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 448 YLSTGKSSEKTDVFGYGITLLEL 470
+ + K+D++ G L E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 38/225 (16%)
Query: 268 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL-ISVA 326
+L D+F + + +G G G V+K + P G ++ +HL I A
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVS---------------HKPSGLIMARKLIHLEIKPA 45
Query: 327 IHKNL---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------- 376
I + LQ++ C + F + ++ + + G LD +K
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQ 103
Query: 377 ---RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTH 432
+V+ GL YL E+ KI+HRD+K +NIL++ E LCDFG++ +L+D+
Sbjct: 104 ILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157
Query: 433 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 477
+ GT +++PE L S ++D++ G++L+E+ G+ I
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 274 FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKN 330
F ++G+GGFG+V + K+ A K+L+ GEA E ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLE 387
++ L T LV M + + + ++ G D +R F A GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP--GFD---EERAVFYAAEITCGLE 116
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 447
LH + +I++RDLK NILLDD + D GLA V+ GT+G++APE
Sbjct: 117 DLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPE 171
Query: 448 YLSTGKSSEKTDVFGYGITLLELVTGQ 474
+ + + D +G G + E++ G+
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 273 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEA------AFQREVHLISV 325
N+ ++G+G FG+VY +D + +AVK++ + P + A + E+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVP--FDPDSQETSKEVNALECEIQLLKN 60
Query: 326 AIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 383
H ++Q G E+ L +M S+ +L+ L +R
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQIL 116
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTM 441
G+ YLH I+HRD+K ANIL D L DFG +K + T + GT
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 442 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472
++PE +S K DV+ T++E++T
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 53/161 (32%), Positives = 80/161 (49%), Gaps = 22/161 (13%)
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPE 447
+H + +IHRD+K+ANILL N L DFG +K+ A ++ V GT ++APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 448 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL--REDRLND 505
S+K D+F G+ L EL+T +R D +EE + K L R D L
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV--------MHKTLAGRYDPLPP 267
Query: 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546
+ S E++ +V ALL S P+ RP ++++ M
Sbjct: 268 SI--------SPEMQEIVT-ALLS--SDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 32/230 (13%)
Query: 266 ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 319
E+ L+T F E +G+ FGKVYKG L VA+K L+D F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 320 VHLISVAIHKNLLQLIGYCTTSS--ERILVYPFMQNLSVAYRLR----------DLKPGE 367
+ S H N++ L+G T I Y +L +R D K +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 368 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427
L+ + A G+E+L ++H+DL N+L+ D + D GL + V
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 428 AK-----LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472
A + + IR ++PE + GK S +D++ YG+ L E+ +
Sbjct: 176 AADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 280 IGQGGFGKVYKGVLSDNTK---VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+G G FG V KGV K VA+K L++ RE ++ + ++++IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA---FGTAYGLEYLHEQC 393
C +E +++ + ++ L G+K D T V + G++YL +
Sbjct: 63 VC--EAEALML---VMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK- 114
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT--MGHIAPEYLST 451
+HRDL A N+LL + A + DFGL+K + A ++ + G + APE ++
Sbjct: 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 452 GKSSEKTDVFGYGITLLELVT-GQR 475
K S ++DV+ YGIT+ E + GQ+
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445
L++LH+ II+RD+K NILLD VL DFGL+K A+ GT+ ++A
Sbjct: 118 LDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 446 PEYLSTGKS--SEKTDVFGYGITLLELVTG 473
PE + G + D + G+ EL+TG
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 280 IGQGGFGKVYKGVLSDN--TKVAVKRLQDYYSPGGEAAFQR---------EVHLISVAI- 327
+G G FG VYK +N +A+K + + G+ +R EV +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 328 HKNLLQLIGYCTTSSERILVYPFM---QNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGT 382
H N+++ Y T E +Y M + + LK EK + + +
Sbjct: 68 HPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLK--EKKQRFTEERIWNIFVQM 122
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA--KLVDAKLTHVTTQIRGT 440
L YLH++ +I+HRDL NI+L ++ + + DFGLA K ++KLT V GT
Sbjct: 123 VLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV----GT 176
Query: 441 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
+ + PE + EK DV+ +G L ++ T Q
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 9e-11
Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 17/210 (8%)
Query: 268 QLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLI 323
++ ++ + IG+G FG VY+GV ++ VAVK ++ SP F +E +++
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 324 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAF 380
H ++++LIG T + I+ + P + LR L+ + LD + ++
Sbjct: 62 RQFDHPHIVKLIGVITENPVWIVMELAPLGE-------LRSYLQVNKYSLDLASLILYSY 114
Query: 381 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 440
+ L YL + + +HRD+ A N+L+ L DFGL++ ++ + + ++ +
Sbjct: 115 QLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 441 MGHIAPEYLSTGKSSEKTDVFGYGITLLEL 470
+ +APE ++ + + +DV+ +G+ + E+
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
IG+G +G VYKG VA+K+++ + G + RE+ L+ H N++ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHE 391
S L++ F+ DLK P + +D K + G+ + H
Sbjct: 68 LMQESRLYLIFEFLS--------MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-S 450
+ +++HRDLK N+L+D+ L DFGLA+ + T ++ T+ + APE L
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLG 175
Query: 451 TGKSSEKTDVFGYGITLLELVT 472
+ + S D++ G E+ T
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 85/336 (25%), Positives = 141/336 (41%), Gaps = 75/336 (22%)
Query: 279 IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
++G+G FGKV+ L N A+K A +++V L+ +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIK------------ALKKDVVLMDDDVE--------- 40
Query: 338 CTTSSERILV----YPFMQNLSVAYRLRD--------LKPGE--------KGLDWPTRKR 377
CT +R+L +PF+ +L ++ ++ L G+ D P
Sbjct: 41 CTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF 100
Query: 378 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK---LVDAKLTHVT 434
A GL++LH + I++RDLK NILLD + + DFG+ K L DAK T
Sbjct: 101 YAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK----T 153
Query: 435 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 494
GT +IAPE L K + D + +G+ L E++ GQ F +EEE
Sbjct: 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP--FHGHDEEE-------- 203
Query: 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAE 554
L + R+++ T ++K++ + V PE R + ++ +
Sbjct: 204 --LFQSIRMDNPCYPRWLTREAKDILVKLFV------REPERRLGVKGDIR----QHPFF 251
Query: 555 RWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAI 590
R +W LEE R+ E P + + S+ D+E +
Sbjct: 252 REIDWSALEE-REIEPPFKPKVKSANDCSNFDKEFL 286
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIG 336
+G G +G V + KVA+K+L + + A+ RE+ L+ H+N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLLD 81
Query: 337 YCTTSS------ERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
T++ + LV P+MQ +L ++ E + + + + GL+Y+
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQY-----LVYQMLCGLKYI 133
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEY 448
H IIHRDLK N+ ++++ E + DFGLA+ DA++T +V T+ + APE
Sbjct: 134 HSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEV 185
Query: 449 -LSTGKSSEKTDVFGYGITLLELVTGQ 474
L+ ++ D++ G + E++TG+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 279 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVHLISVAIHKN--LLQ 333
IIG+GGFG+VY +D K+ + D GE E ++S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 334 LIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLEYL 389
+ Y + +++ + M + Y L + G+ + + F A GLE++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVF--SEAEMRFYAAEIILGLEHM 113
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H N +++RDLK ANILLD++ + D GLA K H + GT G++APE L
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 450 STGKSSEKT-DVFGYGITLLELVTGQ 474
G + + + D F G L +L+ G
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 8/99 (8%)
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 435
R+A GL YL + KI+HRD+K +N+L++ + LCDFG++ +LV++ +
Sbjct: 99 RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAK 151
Query: 436 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
GT ++APE +S + +DV+ GI+ +EL G+
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVA 326
D + + +G G +G V + KVA+K+L Y P F RE+ L+
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL---YRPFQSELFAKRAYRELRLLKHM 71
Query: 327 IHKNLLQLIGYCT--TSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 380
H+N++ L+ T S +R LV PFM + ++ K E + + + +
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQF-----LVY 125
Query: 381 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 440
GL+Y+H IIHRDLK N+ ++++ E + DFGLA+ D+++T T
Sbjct: 126 QMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----T 178
Query: 441 MGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 474
+ APE L+ ++ D++ G + E++TG+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 59/220 (26%), Positives = 89/220 (40%), Gaps = 58/220 (26%)
Query: 280 IGQGGFGKVYK-GVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
+G GGFG+V V S N A+K + ++ H++ +++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV-------------KKRHIVETGQQEHIFS----- 42
Query: 339 TTSSER----ILVYPFMQNLSVAYR-------LRDLKPG--------EKGL--DWPTRKR 377
E+ +PF+ L ++ L + G ++GL ++ R
Sbjct: 43 ----EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR-- 96
Query: 378 VAFGTAY---GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHV 433
F A EYLH + II+RDLK N+LLD N L DFG AK L + T
Sbjct: 97 --FYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151
Query: 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
GT ++APE + D + GI L EL+TG
Sbjct: 152 ---FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 57/269 (21%), Positives = 115/269 (42%), Gaps = 35/269 (13%)
Query: 299 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN----- 353
VAVK L+ + F +EV ++S N+++L+G C ++ +M+N
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 354 -LSVAYRLRDLKPGEKG---------LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLK 403
LS + + G + + + VA A G++YL + +HRDL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 404 AANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG--HIAPEYLSTGKSSEKTDVF 461
N L+ +N + DFG+++ + A + Q R + +A E + GK + +DV+
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAG-DYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 462 GYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV-- 519
+G+TL E++ + + L +E+ ++++ + R D+ Y +
Sbjct: 225 AFGVTLWEILMLCKEQPYGELTDEQ---VIENAGEFFR--------DQGRQVYLFRPPPC 273
Query: 520 -ETMVQVALLCTQSTPEDRPPMAQVVKML 547
+ + ++ L C +RP + + L
Sbjct: 274 PQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 279 IIGQGGFGKVYKGVLSDNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHK-NLLQ 333
IIG+GGFG+VY +D K+ + D G A + L V+ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 334 LIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLEYL 389
+ Y + +++ + M + Y L + G+ + K + F GLE++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL-----SQHGVF--SEKEMRFYATEIILGLEHM 113
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H N +++RDLK ANILLD++ + D GLA K H + GT G++APE L
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 450 STGKSSEKT-DVFGYGITLLELVTGQ 474
G + + + D F G L +L+ G
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 65/204 (31%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 274 FSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHK 329
FS+ IG G FG VY + ++ VA+K++ Y +Q +EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N +Q G LV + L A L L+ +K L V G GL YL
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY- 448
H + +IHRD+KA NILL + L DFG A ++ V GT +APE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 449 --LSTGKSSEKTDVFGYGITLLEL 470
+ G+ K DV+ GIT +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 47/236 (19%)
Query: 279 IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI-----SVAIHKNLL 332
++G+G FGKV L + A+K A +++V L + + +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIK------------ALKKDVVLEDDDVECTMVERRVL 49
Query: 333 QLIG--------YCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 382
L +CT ++ L V ++ + + ++ ++ R F
Sbjct: 50 ALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE-------ARARFYA 102
Query: 383 A---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 439
A GL++LH++ II+RDLK N+LLD + + DFG+ K + + G
Sbjct: 103 AEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCG 158
Query: 440 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495
T +IAPE L K +E D + +G+ L E++ GQ F +E+E L D I
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP--FHGEDEDE---LFDSIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHK 329
++F IG G +G VYK ++ A+K ++ PG + A Q+E+ ++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N++ G + + F S L+D+ L V+ T GL YL
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGS----LQDIYHVTGPLSESQIAYVSRETLQGLYYL 122
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H + +HRD+K ANILL DN L DFG++ + A + + I GT +APE
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVA 178
Query: 450 ST---GKSSEKTDVFGYGITLLEL 470
+ G ++ D++ GIT +EL
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 47/205 (22%), Positives = 95/205 (46%), Gaps = 7/205 (3%)
Query: 273 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ--REVHLISVAIHK 329
NF IG+G F +VY+ L D VA+K++Q + +A +E+ L+ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N+++ + +E +V ++ ++ K ++ + T + +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H + +++HRD+K AN+ + L D GL + +K T + + GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 450 STGKSSEKTDVFGYGITLLELVTGQ 474
+ K+D++ G L E+ Q
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 60/203 (29%), Positives = 84/203 (41%), Gaps = 18/203 (8%)
Query: 274 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHKN 330
F++ IG G FG VY +V + Y +Q +EV + H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
++ G LV + L A L L+ +K L + G GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY-- 448
+IHRD+KA NILL + + L DFG A + + V GT +APE
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVIL 194
Query: 449 -LSTGKSSEKTDVFGYGITLLEL 470
+ G+ K DV+ GIT +EL
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 280 IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
+G+G + VYKG+ N + VA+K + G RE L+ H N++ L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398
T V+ +M Y ++ PG GL + F GL Y+H Q I+
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQ--HPG--GLHPYNVRLFMFQLLRGLAYIHGQ---HIL 125
Query: 399 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL--STGKSSE 456
HRDLK N+L+ E L DFGLA+ ++++ T+ + P+ L +T SS
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184
Query: 457 KTDVFGYGITLLELVTGQ 474
D++G G +E++ GQ
Sbjct: 185 -LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 68/277 (24%), Positives = 116/277 (41%), Gaps = 44/277 (15%)
Query: 280 IGQGGFGKVYKGVLS---DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLI 335
+G G FG V KG+ VAVK L+ D P + RE +++ + ++++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 336 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP---TRKRV---AFGTAYGLEYL 389
G C ++ + L +L P K L T K + + G++YL
Sbjct: 63 GICEA-----------ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL 111
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT--MGHIAPE 447
E +HRDL A N+LL A + DFGL+K + A + + G + APE
Sbjct: 112 EET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
Query: 448 YLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506
++ K S K+DV+ +G+ + E + GQ+ + ++ E +++ +R+
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKP--YKGMKGNEVTQMIE------SGERMECP 220
Query: 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQV 543
YD + LC ++RP A V
Sbjct: 221 QRCPPEMYD---------LMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 271 TDNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 328
+D + IG+G +GKV+K VL+ + +K AVK L + E + + L +++ H
Sbjct: 17 SDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDH 74
Query: 329 KNLLQLIGY-----CTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGT 382
N+++ G + LV SV ++ LK GE+ ++ P +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-MEEPIIAYILHEA 133
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVDAKLTHVTTQIRGTM 441
GL++LH K IHRD+K NILL L DFG+ A+L +L T+ GT
Sbjct: 134 LMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTP 188
Query: 442 GHIAPEYLSTGKS-----SEKTDVFGYGITLLELVTG 473
+APE ++ + + DV+ GIT +EL G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 38/124 (30%), Positives = 60/124 (48%), Gaps = 11/124 (8%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMG 442
GL YLH Q +IIHRD+K NI ++D + + D G A+ +V + GT+
Sbjct: 169 GLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA----GTVE 221
Query: 443 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI--DFSRLEEEEDVLLLDHIRKLLRE 500
APE L+ K + K D++ GI L E++ I D EE H+ K++
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST 281
Query: 501 DRLN 504
+++
Sbjct: 282 LKVH 285
|
Length = 357 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 14/213 (6%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHL---ISVA 326
D + + IG+G +GKVYK + K VA+K+ + G RE+ L +S +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 327 IHKNLLQLIGYCTTSSERILVYPFMQNLSV---AYRLRDLKPGEKGLDWPTRKRVAFGTA 383
I+ L + + + + +Y + L + + + + L T K +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMG 442
G+ + H+ ++HRDLK N+L+D + + D GL + + T +I T+
Sbjct: 121 KGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLW 176
Query: 443 HIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 474
+ APE L S D++ G E+ Q
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
IG+G +G VYK VA+K+++ + G + RE+ L+ H N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKP-----GEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
+ ++ LV+ F+ DLK GLD P K + G+ Y H
Sbjct: 67 VHSENKLYLVFEFLD--------LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL---TH--VTTQIRGTMGHIAPE 447
+++HRDLK N+L+D L DFGLA+ + TH VT R APE
Sbjct: 119 ---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYR------APE 169
Query: 448 YLSTGKS-SEKTDVFGYGITLLELVTGQ 474
L + S D++ G E+V +
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGH 443
GL++LHE+ II+RDLK N+LLD + DFG+ K + L VTT GT +
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDY 162
Query: 444 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 488
IAPE LS D + G+ L E++ GQ + ++E+++
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 46/197 (23%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 299 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN--LSV 356
VAVK L+ + F +E+ ++S + N+++L+G C + ++ +M+N L+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 357 AYRLRDLKPG-EKGLDWPTRKR-----VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 410
R+++ + P+ +A A G++YL + +HRDL N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 411 DNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLE 469
+++ + DFG+++ L + + + +A E + GK + +DV+ +G+TL E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 470 LVTGQRAIDFSRLEEEE 486
+ T + +S L +E+
Sbjct: 224 MFTLCKEQPYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
LE+LH+ II+RD+K NILLD N VL DFGL+K GT+ ++
Sbjct: 117 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 445 APEYLSTGKS--SEKTDVFGYGITLLELVTG 473
AP+ + G + D + G+ + EL+TG
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 36/88 (40%), Positives = 48/88 (54%), Gaps = 4/88 (4%)
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445
LE LH+ +I+RDLK NILLD LCDFGL KL + K T GT ++A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLA 161
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVTG 473
PE L ++ D + G+ L E++TG
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQ-------DYYSPGGEAAFQREVHLISVAIHKNLL 332
+G+G FG VY ++ D VA +RL+ +P +E L+S H ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 333 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
+ ++ + + + +L +LK K L G+ Y+H++
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 452
+I+HRDLKA NI L +N + DFG+++L+ TT GT +++PE L
Sbjct: 126 ---RILHRDLKAKNIFLKNNLLKI-GDFGVSRLLMGSCDLATT-FTGTPYYMSPEALKHQ 180
Query: 453 KSSEKTDVFGYGITLLEL 470
K+D++ G L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 28/169 (16%)
Query: 280 IGQGGFGKVYKGVL---SDNTKVAVKRLQ---DYYSPGGEAAFQREVHLISVAIHKNLLQ 333
IG+G +G+VYK D + A+K+ + + Y+ G + RE+ L+ H+N++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-GISQSACREIALLRELKHENVVS 66
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDL--------KPGEKGLDWPTRKRVAFGTAYG 385
L+ +++ VY L Y DL + + K + + G
Sbjct: 67 LVEVFLEHADK-SVY-----LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 386 LEYLHEQCNPKIIHRDLKAANILL--DDNFEAV--LCDFGLAKLVDAKL 430
+ YLH ++HRDLK ANIL+ + V + D GLA+L +A L
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 379 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 437
+F A G+E+L + K IHRDL A NILL +N +CDFGLA+ + +V
Sbjct: 185 SFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 438 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK 496
R + +APE + + ++DV+ +G+ L E+ + G +++EE R+
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRR 294
Query: 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
L R+ Y + E M Q L C P RP +++V+ L
Sbjct: 295 LKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 279 IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 334
I+G G FG++ +G L +K VA+ L+ S F E + H N+++L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 335 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 394
G T + ++V +M N ++ LR E L + G A G++YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM-- 126
Query: 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI--APEYLSTG 452
+H+ L A +L++ + + F +L + K + T + G + APE +
Sbjct: 127 -GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 453 KSSEKTDVFGYGITLLELVT-GQR 475
S +DV+ +GI + E+++ G+R
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 62/244 (25%), Positives = 94/244 (38%), Gaps = 40/244 (16%)
Query: 245 DVAGEDDCKVSLTQLRRFSCRELQLATDNFS----ESNIIGQ---GGFGKVYKGVL---S 294
D +++ T + + C E ++D S + NI+ G G+V+
Sbjct: 59 DYDADEESLSPQTDVCQEPC-ETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDE 117
Query: 295 DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 354
KV VK + +PG E + + H+ ++ LI S +V P +
Sbjct: 118 QRKKVIVKAVTGGKTPGREIDILKTIS------HRAIINLIHAYRWKSTVCMVMPKYKCD 171
Query: 355 SVAY-------RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 407
Y L ++ L L YLH + IIHRD+K NI
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRL------------LEALAYLHGR---GIIHRDVKTENI 216
Query: 408 LLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGIT 466
LD+ AVL DFG A KL T GT+ +PE L+ KTD++ G+
Sbjct: 217 FLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLV 276
Query: 467 LLEL 470
L E+
Sbjct: 277 LFEM 280
|
Length = 392 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 8/91 (8%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
G+E LH++ IIHRD+K N+L+D L DFGL++ + GT ++
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYL 160
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 475
APE + + +D + G + E + G
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 57/261 (21%), Positives = 120/261 (45%), Gaps = 25/261 (9%)
Query: 299 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY 358
VAVK L++ + F +E+ ++S N+++L+ C TS ++ +M+N +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 359 RLRDLKPGEKGLD-------WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 411
L +P E + T +A A G++YL + +HRDL N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165
Query: 412 NFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 470
N+ + DFG+++ L + + + ++ E + GK + +DV+ +G+TL E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 471 VTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV---ETMVQVAL 527
+T + +S+L +E+ ++++ + R D+ Y K +++ ++ L
Sbjct: 226 LTLCKEQPYSQLSDEQ---VIENTGEFFR--------DQGRQVYLPKPALCPDSLYKLML 274
Query: 528 LCTQSTPEDRPPMAQVVKMLQ 548
C + ++RP ++ L
Sbjct: 275 SCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 20/178 (11%)
Query: 379 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 437
+F A G+E+L + K IHRDL A NILL +N +CDFGLA+ + +V
Sbjct: 180 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 438 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 497
R + +APE + + ++DV+ +G+ L E+ + A + ++ E+
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-LGASPYPGVQINEEFC-------- 287
Query: 498 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 555
RL D + E+ ++ L C Q P++RP + +V++L G+ L E
Sbjct: 288 ---QRLKDGTRMRAPENATPEIY---RIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 280 IGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLI-SVAIHKNLLQLIG- 336
IG+G F +V K A+K ++ ++ + RE+ + ++ H N+L+LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 337 -YCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 394
+ + LV+ M NL Y L +K ++ L K + L+++H +
Sbjct: 67 LFDRKTGRLALVFELMDMNL---YEL--IKGRKRPLPEKRVKSYMYQLLKSLDHMH-RNG 120
Query: 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTGK 453
I HRD+K NIL+ D+ L DFG + + +K + T+ T + APE L+ G
Sbjct: 121 --IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGY 175
Query: 454 SSEKTDVFGYGITLLELVT 472
K D++ G E+++
Sbjct: 176 YGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLIG 336
+IG+G +G V + KVA+K++ D + +A RE+ L+ + H +++++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 337 YCTTSSERILVYPFMQNLSVAYRL--RDLKPGEKGLDWPTRKRVAF---GTAYGLEYLHE 391
S R +++ V + L DL K D T + F L+Y+H
Sbjct: 67 IMLPPSRREF-----KDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH- 120
Query: 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGHIAPEYL 449
+ HRDLK NIL + + + +CDFGLA+ D T T + APE
Sbjct: 121 --TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 450 ST--GKSSEKTDVFGYGITLLELVTGQ 474
+ K + D++ G E++TG+
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 63/259 (24%), Positives = 108/259 (41%), Gaps = 60/259 (23%)
Query: 264 CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ----R 318
CR + D + + N I +G +G VY+ VA+K+L+ E F R
Sbjct: 1 CRSV----DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEG-FPITSLR 53
Query: 319 EVHLISVAIHKNLLQL--IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 376
E++++ H N++ + + + + +V ++++ DLK
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH--------DLK------SLMETM 99
Query: 377 RVAFGTA----------YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426
+ F + G+ +LH+ I+HRDLK +N+LL++ +CDFGLA+
Sbjct: 100 KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY 156
Query: 427 DAKLTHVTTQIRGTMGHIAPE-YLSTGKSSEKTDV------FGYGITLLELVTGQRAIDF 479
+ L TQ+ T+ + APE L + S D+ F +T L G+ ID
Sbjct: 157 GSPLKPY-TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID- 214
Query: 480 SRLEEEEDVLLLDHIRKLL 498
L+ I KLL
Sbjct: 215 ----------QLNKIFKLL 223
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 280 IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQ----REVHLI---SVAIHKNL 331
IG G +G VYK + VA+K ++ E REV L+ H N+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 332 LQLIGYCTTS--SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
++L+ C TS V +++ R K GL T K + GL++L
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H C I+HRDLK NIL+ + L DFGLA++ ++ T + T+ + APE L
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVL 179
Query: 450 STGKSSEKTDVFGYGITLLEL 470
+ D++ G E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 52/228 (22%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAF----QREVHLISVA 326
+ + IG+G +G V KVA+K++ SP F RE+ ++
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI----SPFEHQTFCQRTLREIKILRRF 60
Query: 327 IHKNLLQLIGYCTTSS-----ERILVYPFM----------QNLS---VAYRLRDLKPGEK 368
H+N++ ++ S + +V M Q+LS + Y L
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL-------- 112
Query: 369 GLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428
+ GL+Y+H N ++HRDLK +N+LL+ N + +CDFGLA++ D
Sbjct: 113 -----------YQILRGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158
Query: 429 KLTH--VTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 473
+ H T+ T + APE + K K D++ G L E+++
Sbjct: 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 48/200 (24%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 279 IIGQGGFGK--VYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
++G+G FG+ + + V SD K A+K ++ S ++E L++ H N++
Sbjct: 7 VVGEGSFGRALLVQHVNSDQ-KYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
+V + + +++ + P + L W + G++++HE+
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK 119
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 452
+++HRD+K+ NI L N + L DFG A+L+ + + T + GT ++ PE
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 453 KSSEKTDVFGYGITLLELVT 472
+ K+D++ G L EL T
Sbjct: 176 PYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
IGQG G VY + ++ +VA+K++ P E E+ ++ H N++ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398
E +V ++ S L D+ E +D V LE+LH ++I
Sbjct: 86 LVGDELWVVMEYLAGGS----LTDVVT-ETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 399 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 458
HRD+K+ NILL + L DFG + + + +T + GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 459 DVFGYGITLLELVTGQ 474
D++ GI +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 61/200 (30%), Positives = 85/200 (42%), Gaps = 14/200 (7%)
Query: 279 IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQ 333
+IG+G FGKV + K AVK LQ +R V L +V H L+
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVG 60
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
L T+ + V F+ + + L+ E+ P + A A L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLH--- 113
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 453
+ I++RDLK NILLD VL DFGL K + TT GT ++APE +
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 454 SSEKTDVFGYGITLLELVTG 473
D + G L E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 66/213 (30%), Positives = 91/213 (42%), Gaps = 40/213 (18%)
Query: 279 IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQR--EVHLI---SVAIHKNLL 332
+IG+G FGKV + K AVK LQ +A ++ + H++ +V + KN+
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQK------KAILKKKEQKHIMAERNVLL-KNVK 54
Query: 333 Q--LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG---------EKGLDWPTRKRVAFG 381
L+G L Y F Q Y + D G E+ P + A
Sbjct: 55 HPFLVG---------LHYSF-QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE 104
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGT 440
A L YLH II+RDLK NILLD VL DFGL K ++ T T+ GT
Sbjct: 105 IASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGT 159
Query: 441 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
++APE L D + G L E++ G
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 7e-09
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 42/219 (19%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREV-HLISVAIHK 329
D+F +G G FG+V + K A+K L + ++V H+++ K
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-----SKAKIVKLKQVEHVLN---EK 52
Query: 330 NLLQLIG--YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY--- 384
+LQ I + L F + ++ Y + + PG + RK F
Sbjct: 53 RILQSIRHPFLVN-----LYGSFQDDSNL-YLVMEYVPGGELFSH-LRKSGRFPEPVARF 105
Query: 385 -------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 437
LEYLH + I++RDLK N+LLD + + DFG AK V + T +
Sbjct: 106 YAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTL 158
Query: 438 RGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTG 473
GT ++APE + + GK+ D + GI + E++ G
Sbjct: 159 CGTPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 62/201 (30%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 279 IIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQ 333
+IG+G FGKV SD + AVK LQ +R V L ++ H L+
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVG 60
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
L T+ + V ++ + + L+ E+ P + A A + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL- 115
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPEYLSTG 452
II+RDLK NILLD VL DFGL K V+ + T T+ GT ++APE L
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 453 KSSEKTDVFGYGITLLELVTG 473
D + G L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 10/109 (9%)
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-GTM 441
+ GL +LH + II+RDLK N++LD + DFG+ K + + VTT+ GT
Sbjct: 111 SVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTP 165
Query: 442 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 490
+IAPE ++ + D + YG+ L E++ GQ D E+ED L
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD----GEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 279 IIGQGGFGKV----YKGVLSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHKNLLQ 333
++G+G +G+V ++ +D + +K+L + E A ++E L+S H N++
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 334 LI-GYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEY 388
+ +V F + + ++L++ K P + ++W + A L+Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQY 117
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
LHE+ I+HRDLK N+ L + D G+A++++ + +T I GT +++PE
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPEL 173
Query: 449 LSTGKSSEKTDVFGYGITLLELVTGQRAID 478
S + K+DV+ G + E+ T + A +
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 53/220 (24%)
Query: 279 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
++GQG FGKV+ V+++ G A Q ++ + V + K L++
Sbjct: 3 VLGQGSFGKVF----------LVRKIT------GPDAGQ--LYAMKV-LKKATLKVRDRV 43
Query: 339 TTSSER-ILV---YPFMQNLSVAYRLRDLKPGE--------KGLDWPTR--KRVAFGT-- 382
T ER IL +PF+ L A++ G+ +G D TR K V F
Sbjct: 44 RTKMERDILAEVNHPFIVKLHYAFQ----TEGKLYLILDFLRGGDLFTRLSKEVMFTEED 99
Query: 383 --------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHV 433
A L++LH + II+RDLK NILLD+ L DFGL+K +D +
Sbjct: 100 VKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK 154
Query: 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
GT+ ++APE ++ ++ D + +G+ + E++TG
Sbjct: 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGH 443
LE+LH+Q II+RDLK NILLD L DFGL K + + +TH GT+ +
Sbjct: 113 LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEY 166
Query: 444 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
+APE L + D + G + +++TG
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 43/127 (33%), Positives = 63/127 (49%), Gaps = 11/127 (8%)
Query: 374 TRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430
+ R F A GL+YLHE KI++RDLK N+LLD + DFGL K
Sbjct: 99 SEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGF 154
Query: 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE--DV 488
T+ GT +APE L+ + D +G G+ + E++ G+ F +EEE D
Sbjct: 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP--FPGDDEEEVFDS 212
Query: 489 LLLDHIR 495
++ D +R
Sbjct: 213 IVNDEVR 219
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 21/120 (17%)
Query: 74 RNGNVISLTLGSNGFSGKI------SPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHL 127
++ N+ L L +N +G+I S ++ KL + N L G +P LG+ L
Sbjct: 354 KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS-------NSLEGEIPKSLGACRSL 406
Query: 128 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRI--------PMQLFSVATFNFTG 179
+ + L +N FSG +P+ +++L + LD+S+NNL GRI +Q+ S+A F G
Sbjct: 407 RRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG 466
|
Length = 968 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 44/226 (19%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 329
D F IG+G +G+VYK D VA+K+++ D G RE+ ++ H+
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 330 NLLQLIGYCTTSSERI----------LVYPFMQNLSVAYRLRDLKPG--EKGLDWPTRKR 377
N++ L T + + LV+ +M + DL G E GL
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH--------DLM-GLLESGL------- 110
Query: 378 VAFGTAY----------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427
V F + GL Y H +HRD+K +NILL++ + L DFGLA+L +
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 428 AKLTHVTTQIRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVT 472
++ + T T+ + PE L + DV+ G L EL T
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
IGQG G VY + ++ +VA+K++ P E E+ ++ + N++ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398
E +V ++ S L D+ E +D V L++LH ++I
Sbjct: 86 LVGDELWVVMEYLAGGS----LTDVVT-ETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 399 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 458
HRD+K+ NILL + L DFG + + + +T + GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 459 DVFGYGITLLELVTGQ 474
D++ GI +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 67/261 (25%), Positives = 106/261 (40%), Gaps = 54/261 (20%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTK--VAVKRLQ--DYYSPGGEAAFQREVHLISVAI 327
D+ +G G FG+V+ V ++ A+K + + E E ++
Sbjct: 1 DDLERIKTVGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW-PTRKRVAFGTA--Y 384
H +++L + T +R L Y L + PG + + R + T Y
Sbjct: 60 HPFIIRL--FWTEHDQRFL-----------YMLMEYVPGGELFSYLRNSGRFSNSTGLFY 106
Query: 385 G------LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 438
LEYLH + +I++RDLK NILLD L DFG AK KL T +
Sbjct: 107 ASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLC 159
Query: 439 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-----------------QRAIDFSR 481
GT ++APE + + ++ D + GI + E++ G ++F R
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR 219
Query: 482 LEEEEDVLLLDHIRKLLREDR 502
D+ D I+KLL DR
Sbjct: 220 ---HLDLYAKDLIKKLLVVDR 237
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 36/89 (40%), Positives = 46/89 (51%), Gaps = 1/89 (1%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 140
L L SN F+GKI ++T L L +L N SG +P LG +L L+L+ N +G
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVL-QLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371
Query: 141 IPATWSQLSNLKHLDLSSNNLTGRIPMQL 169
IP NL L L SN+L G IP L
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 34/89 (38%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445
LE+LH+ I++RD+K NILLD VL DFGL+K ++ T GT+ ++A
Sbjct: 118 LEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 446 PEYL-STGKSSEKTDVFGYGITLLELVTG 473
PE + G + D + GI + EL+TG
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 42/119 (35%), Positives = 60/119 (50%), Gaps = 21/119 (17%)
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGT 440
A GL +LH + II+RDLK N++LD + DFG+ K + K T GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GT 164
Query: 441 MGHIAPE---YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL---LLDH 493
+IAPE Y GKS D + +G+ L E++ GQ D E+ED L +++H
Sbjct: 165 PDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFD----GEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 49/216 (22%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 268 QLATDNFSE---SNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI 323
A + SE N IG G G VYK + ++ A+K + + RE+ ++
Sbjct: 67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126
Query: 324 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 383
H N+++ + E ++ FM S+ G D VA
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--------GTHIADEQFLADVARQIL 178
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 443
G+ YLH + I+HRD+K +N+L++ + DFG+++++ + + + GT+ +
Sbjct: 179 SGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAY 234
Query: 444 IAPEYLSTGKSSEK-----TDVFGYGITLLELVTGQ 474
++PE ++T + D++ G+++LE G+
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 60/200 (30%), Positives = 86/200 (43%), Gaps = 14/200 (7%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQ 333
+IG+G FGKV ++ AVK LQ +R V L +V H L+
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVG 60
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
L T+ + V ++ + Y L+ E+ P + A A L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLH--- 113
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 453
+ I++RDLK NILLD VL DFGL K + + T+ GT ++APE L
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 454 SSEKTDVFGYGITLLELVTG 473
D + G L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 16/222 (7%)
Query: 279 IIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLI 335
++G+G FGKV L ++ ++ AVK L+ E ++S+A + L +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 336 GYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 394
C + +R+ V F+ + + ++ + D + A L +LH++
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-- 115
Query: 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGHIAPEYLSTG 452
II+RDLK N+LLD L DFG+ K + + K T+ GT +IAPE L
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT---TSTFCGTPDYIAPEILQEM 171
Query: 453 KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 494
D + G+ L E++ G + ++ + +L D +
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT---TQIRGTM 441
GL+Y+H +IHRDLK +N+L++++ E + DFG+A+ + + T T+ T
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 442 GHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQRAI 477
+ APE LS + + D++ G E++ G+R +
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDY--YSPGGEAAFQREVH 321
R+LQ+ +++ +IG+G FG+V + KV A+K L + A F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 322 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 381
+++ A ++QL +C ++ L Y M+ + DL D P K F
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYL-YMVMEYMPGG----DLVNLMSNYDVP-EKWAKFY 147
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGT 440
TA + L + +IHRD+K N+LLD + L DFG K+ + + T + GT
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GT 206
Query: 441 MGHIAPEYLST----GKSSEKTDVFGYGITLLELVTG 473
+I+PE L + G + D + G+ L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 280 IGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLIGY 337
IG+G +G V S+ N KVA+K++ + + +A RE+ L+ H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 338 CTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
+VY M L + + L + + GL+Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELMDT-----DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH-- 125
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 452
+ ++HRDLK +N+LL+ N + +CDFGLA+ K +T + T + APE L
Sbjct: 126 -SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLN- 182
Query: 453 KSSEKT---DVFGYGITLLELVTGQ 474
SE T DV+ G EL+ +
Sbjct: 183 -CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 7/87 (8%)
Query: 387 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 446
EYLH + II+RDLK N+LLD+ + DFG AK K+ T + GT ++AP
Sbjct: 132 EYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYLAP 184
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVTG 473
E + + + D + G+ L E + G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
IGQG G V+ + ++ +VA+K++ P E E+ ++ + N++ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLDSF 85
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398
E +V ++ S L D+ E +D V LE+LH ++I
Sbjct: 86 LVGDELFVVMEYLAGGS----LTDVVT-ETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 399 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 458
HRD+K+ N+LL + L DFG + + + +T + GT +APE ++ K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 459 DVFGYGITLLELVTGQ 474
D++ GI +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 9/115 (7%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
GL+YLH + I+HRD+K N+L++ N +CDFGLA++ + + TQ T +
Sbjct: 115 GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171
Query: 445 APEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 498
APE L + + D++ G EL+ R I F + + + LD I LL
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELL--GRRILF---QAQSPIQQLDLITDLL 221
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 50/219 (22%)
Query: 279 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY- 337
++G+G FGKV +A + D EV+ I V +LQ
Sbjct: 2 VLGKGSFGKVM---------LAELKGTD------------EVYAIKVLKKDVILQDDDVD 40
Query: 338 CTTSSERILV----YPFMQNLSVAYRLRD--------LKPGE--------KGLDWPTRKR 377
CT + +RIL +PF+ L ++ +D + G+ + D P +
Sbjct: 41 CTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF 100
Query: 378 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTT 435
A L +LH +I+RDLK NILLD L DFG+ K +++ TT
Sbjct: 101 YAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT---TT 154
Query: 436 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
GT +IAPE L + D + G+ + E++ GQ
Sbjct: 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 280 IGQGGFGKVYKGVL----SDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQL 334
IG+G FGK +L D + +K + SP ++EV ++S H N++Q
Sbjct: 8 IGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63
Query: 335 IGYCTTSSERILVYPFMQNLS-------VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
Y + E +Y M + + L P ++ LDW + L+
Sbjct: 64 --YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALK 115
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 447
++H++ KI+HRD+K+ NI L + L DFG+A+++++ + T I GT +++PE
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPE 171
Query: 448 YLSTGKSSEKTDVFGYGITLLELVTGQRAID 478
+ K+D++ G L E+ T + A +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 51/238 (21%)
Query: 279 IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
++G+G FGKV L AVK A +++V LI +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVK------------ALKKDVVLIDDDVE--------- 40
Query: 338 CTTSSERILVY----PFMQNLSVAYRLRD--------LKPGEKGLDWPTRKRVAF--GTA 383
CT +R+L PF+ +L ++ ++ L G+ + R T
Sbjct: 41 CTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF 100
Query: 384 Y------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 437
Y GL++LH + II+RDLK N++LD + + DFG+ K +T
Sbjct: 101 YAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-F 156
Query: 438 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495
GT +IAPE L K + D + +G+ L E++ GQ F +E+E L + IR
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP--FHGDDEDE---LFESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 45/252 (17%)
Query: 249 EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNT-KVAVKR-LQD 306
ED+ K+ + R + +L NIIG G FG VY+ + D + KVA+K+ LQD
Sbjct: 50 EDEEKMIDNDINRSPNKSYKLG-------NIIGNGSFGVVYEAICIDTSEKVAIKKVLQD 102
Query: 307 -YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER-----ILVYPFMQNL--SVAY 358
Y RE+ ++ H N++ L Y T + I + M+ + +V
Sbjct: 103 PQYK-------NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHK 155
Query: 359 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-L 417
++ L K ++ L Y+H + I HRDLK N+L+D N + L
Sbjct: 156 YMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKL 212
Query: 418 CDFGLAKLVDA---KLTHVTTQIRGTMGHIAPEYLSTGKSSEKT--DVFGYGITLLELV- 471
CDFG AK + A ++++ ++ + APE L G ++ T D++ G + E++
Sbjct: 213 CDFGSAKNLLAGQRSVSYICSRF-----YRAPE-LMLGATNYTTHIDLWSLGCIIAEMIL 266
Query: 472 -----TGQRAID 478
+GQ ++D
Sbjct: 267 GYPIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 38/165 (23%)
Query: 280 IGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAAFQ---------REV-HLISVA 326
+G+G +G V+K + D VA+K++ D AF+ RE+ L +
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFD--------AFRNATDAQRTFREIMFLQELG 64
Query: 327 IHKNLLQLIGYCTTSSER--ILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKR-VAFGT 382
H N+++L+ +++ LV+ +M+ +L R + KR + +
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR--------ANILEDVHKRYIMYQL 116
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427
L+Y+H +IHRDLK +NILL+ + L DFGLA+ +
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
IGQG G VY + ++ +VA++++ P E E+ ++ + N++ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398
E +V ++ S L D+ E +D V LE+LH ++I
Sbjct: 87 LVGDELWVVMEYLAGGS----LTDVVT-ETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 399 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 458
HRD+K+ NILL + L DFG + + + + + GT +APE ++ K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 459 DVFGYGITLLELVTGQ 474
D++ GI +E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQ--DYYSPGGEAAFQREVH 321
+L++ ++F +IG+G FG+V + +V A+K L + A F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 322 LISVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 379
+++ A + ++QL + ++ L V +M + + + EK W
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK---W-----AR 145
Query: 380 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK-LTHVTTQIR 438
F TA + L + IHRD+K N+LLD + L DFG +DA + T +
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV- 204
Query: 439 GTMGHIAPEYLST----GKSSEKTDVFGYGITLLELVTG 473
GT +I+PE L + G + D + G+ L E++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 10/109 (9%)
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-GTM 441
A GL +LH + II+RDLK N++LD + DFG+ K + VTT+ GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTP 165
Query: 442 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 490
+IAPE ++ + D + +G+ L E++ GQ + E+ED L
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
DNF + IG+G G V + + K VAVK++ E F EV ++ H+N
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 78
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
++++ E +V F++ ++ + + E+ + V L LH
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLH 133
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 450
Q +IHRD+K+ +ILL + L DFG V ++ + + GT +APE +S
Sbjct: 134 AQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELIS 189
Query: 451 TGKSSEKTDVFGYGITLLELVTGQ 474
+ D++ GI ++E+V G+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 265 RELQLATDNFSESNIIGQGGFGKV----YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 320
R+ ++ ++F+ +G G FG+V YK D VA+KR + + Q++V
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEK-----SKIIKQKQV 75
Query: 321 -------HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK--PGEKGLD 371
+++ H + L G S LV F+ LR K P + G
Sbjct: 76 DHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF 135
Query: 372 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431
+ + + F EYL + I++RDLK N+LLD + + DFG AK+VD +
Sbjct: 136 YAAQIVLIF------EYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184
Query: 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
T + GT +IAPE L + D + GI + E++ G
Sbjct: 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445
L YLH +++RDLK N++LD + + DFGL K GT ++A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
PE L D +G G+ + E++ G+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 56/239 (23%), Positives = 105/239 (43%), Gaps = 34/239 (14%)
Query: 280 IGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
+GQG F K++KG+ + T+V +K L + E+ F+ ++S HK+L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFE-AASMMSQLSHKHL 61
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK-GLDWPTRKRVAFGTAYGLEYLH 390
+ G C E I+V +++ S+ L+ K + W + VA A+ L +L
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLK--KNKNLINISW--KLEVAKQLAWALHFLE 117
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH----IAP 446
++ + H ++ A N+LL + + KL D ++ +T + + + P
Sbjct: 118 DK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLERIPWVPP 173
Query: 447 EYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL-REDRL 503
E + ++ S D + +G TL E+ +G ++ + LD +KL EDR
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGG----------DKPLSALDSQKKLQFYEDRH 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 3e-07
Identities = 18/54 (33%), Positives = 29/54 (53%)
Query: 108 LQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNL 161
L +N L+ + +L+ L+L+ N + P +S L +L+ LDLS NNL
Sbjct: 7 LSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 67/285 (23%), Positives = 105/285 (36%), Gaps = 35/285 (12%)
Query: 281 GQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339
+ K NT VAVK++ D S Q+E+ H N+L +
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 340 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 399
SE +V P M S L+ P +GL + L+Y+H + IH
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIH---SKGFIH 124
Query: 400 RDLKAANILLDDNFEAVLCDFGLAKLVD------AKLTHVTTQIRGTMGHIAPEYLSTGK 453
R +KA++ILL + + VL + + + + ++PE L
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184
Query: 454 S--SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL---------LLDHIRKLLREDR 502
+EK+D++ GIT EL G + F + + +L LLD L ED
Sbjct: 185 QGYNEKSDIYSVGITACELANGH--VPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242
Query: 503 LNDIVDRNLNTYDSKEVETMV---------QVALLCTQSTPEDRP 538
++ N + + V+ Q LC Q PE RP
Sbjct: 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 282 QGGFGKVY--------------KGVLSDNTKV--AVKRLQDYYSPGGEAAFQREVHLISV 325
G FGK++ +GV S N + + G AA Q E ++++
Sbjct: 158 AGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILAL 217
Query: 326 AI--HKNLLQLIGYCTTSSERILVYP---FMQNLSVAYRL------RDLKPGEKGLDWPT 374
H+N+L++ E IL +M + L ++ L T
Sbjct: 218 GRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQT 269
Query: 375 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 434
R + +EY+H++ K+IHRD+K NI L+ + + VL DFG A + +
Sbjct: 270 R-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325
Query: 435 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472
GT+ +PE L+ E TD++ G+ LL++++
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 36/173 (20%)
Query: 319 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 378
E H++ H +++QL G T + L+ P + Y L ++ +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCY-LAA------------KRNI 179
Query: 379 AF--------GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAK 429
A ++YLHE +IIHRD+KA NI ++ + L DFG A VD
Sbjct: 180 AICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD-- 234
Query: 430 LTHVTTQIR-----GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 477
+ GT+ APE L+ D++ GI L E+ T ++
Sbjct: 235 ----INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 35/121 (28%), Positives = 58/121 (47%), Gaps = 4/121 (3%)
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 442
+ L YLHE+ II+RDLK N+LLD L D+G+ K + T+ GT
Sbjct: 106 SLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPN 161
Query: 443 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502
+IAPE L D + G+ + E++ G+ D + D D++ +++ E +
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 221
Query: 503 L 503
+
Sbjct: 222 I 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 55/227 (24%), Positives = 86/227 (37%), Gaps = 40/227 (17%)
Query: 278 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY-YSPGGEAAFQ------------REVHLI 323
+G+G +GKV K VA+K+++ S Q RE+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 324 SVAIHKNLLQLIG-YCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 381
+ H+N++ L+ Y + I LV M A L+ + + L K +
Sbjct: 75 NEIKHENIMGLVDVYV--EGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQ 127
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-------------KLVDA 428
GL LH +HRDL ANI ++ + DFGLA K
Sbjct: 128 ILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 429 KLTHVTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 474
+ T T+ + APE L K D++ G EL+TG+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 8/113 (7%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMG 442
L+YLH + KI++RDLK N++LD + + DFGL K + DA GT
Sbjct: 107 ALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TMKTFCGTPE 160
Query: 443 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495
++APE L D +G G+ + E++ G+ E+ +++L++ I+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 11/141 (7%)
Query: 336 GYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----RVAFGTAYGLEYLH 390
G+ + S+ + + P + S + +D + E WP R + A G+++L
Sbjct: 172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTED--SWPLDLDDLLRFSSQVAQGMDFLA 229
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYL 449
+ IHRD+ A N+LL D A +CDFGLA+ + +V R + +APE +
Sbjct: 230 SK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 286
Query: 450 STGKSSEKTDVFGYGITLLEL 470
+ ++DV+ YGI L E+
Sbjct: 287 FDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAI 327
+ F ++G+G +G V K + VA+K+ +D S E + RE+ ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKD--SEENEEVKETTLRELKMLRTLK 58
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQN--LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 385
+N+++L + LV+ +++ L + + + P EK + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK------VRSYIYQLIKA 112
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445
+ + H+ I+HRD+K N+L+ N LCDFG A+ + T+ T + +
Sbjct: 113 IHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
PE L + D++ G L EL GQ
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 280 IGQGGFGKVYKGVLSDNTKVA---VKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
IG G FGKV + +T VA VK L+ S + F ++ + H N+LQ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR-------KRVAFGTAYGLEYL 389
C + +LV+ + + L DLK W R +R+A A G+ ++
Sbjct: 63 QCVEAIPYLLVFEYCE-------LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 443
H+ +H DL N L + + D+G+ K ++ T+ +R
Sbjct: 116 HKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 444 IAPEY---LSTGKSSEKTDVFGYGITLLEL 470
+ E+ L T + ++ ++V+ G+TL EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 12/204 (5%)
Query: 279 IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAA--FQREVHLISVAIHKNLLQLI 335
+IG+G + KV L N ++ A+K ++ E Q E H+ A L +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 336 GYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 394
C T+S LV ++ + + ++ ++ L + A L +LHE+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER-- 115
Query: 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 454
II+RDLK N+LLD + L D+G+ K T+ GT +IAPE L +
Sbjct: 116 -GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 455 SEKTDVFGYGITLLELVTGQRAID 478
D + G+ + E++ G+ D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 11/196 (5%)
Query: 280 IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
IG+G G V K VAVK++ E F EV ++ H+N++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSY 88
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398
E +V F++ ++ + + E+ + V L YLH Q +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQ---GVI 140
Query: 399 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 458
HRD+K+ +ILL + L DFG V ++ + + GT +APE +S +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 459 DVFGYGITLLELVTGQ 474
D++ GI ++E++ G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
+G G +G V KVAVK+L + + S RE+ L+ H+N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTAYGLEYLH 390
T ++ ++N + Y + +L + + L + + + GL+Y+H
Sbjct: 83 FTPATS-------IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YL 449
+ IIHRDLK +N+ ++++ E + DFGLA+ D ++T T + APE L
Sbjct: 136 ---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV----ATRWYRAPEIML 188
Query: 450 STGKSSEKTDVFGYGITLLELVTGQ 474
+ ++ D++ G + EL+ G+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMG 442
L +LH Q +IHRD+K+ +ILL + L DFG A+++ + + GT
Sbjct: 128 LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC----AQVSKEVPRRKSLVGTPY 180
Query: 443 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
+APE +S + D++ GI ++E+V G+
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHI 444
L+ +H + ++HRDLK+ANI L L DFG +K D+ V + GT ++
Sbjct: 182 LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 475
APE + S+K D++ G+ L EL+T R
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSD---NTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAI 327
D + + IG+G +G VYK D N +A+K+++ + G + RE+ L+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ 59
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG-EKGLDWPTRKRVAFGTAY-- 384
H N+++L SE+ L F Y DLK + D+ R+ Y
Sbjct: 60 HGNIVRL--QDVVHSEKRLYLVF------EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQI 111
Query: 385 --GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTM 441
G+ Y H +++HRDLK N+L+D A+ L DFGLA+ + T ++ T+
Sbjct: 112 LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TL 167
Query: 442 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVT 472
+ APE L + S D++ G E+V
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 280 IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLI 335
IG G G V Y VL N VA+K+L + A RE+ L+ HKN++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 336 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
T + E VY M+ NL ++ LD + + G+++
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 134
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
LH + IIHRDLK +NI++ + + DFGLA+ A + + T T + APE
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189
Query: 449 LSTGKSSEKTDVFGYGITLLELV 471
+ E D++ G + E+V
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 35/115 (30%), Positives = 58/115 (50%), Gaps = 14/115 (12%)
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGH 443
LEYLH + +++RD+K N++LD + + DFGL K ++ T GT +
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161
Query: 444 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI---DFSRLEEEEDVLLLDHIR 495
+APE L D +G G+ + E++ G+ D RL E ++L++ IR
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 3/111 (2%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
L+YLH + N +++RDLK N++LD + + DFGL K K GT ++
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 163
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495
APE L D +G G+ + E++ G+ E+ +++L++ IR
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 214
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 280 IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLI 335
IG G G V + VL N VAVK+L + A RE+ L+ HKN++ L+
Sbjct: 29 IGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 336 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGE---KGLDWPTRKRVAFGTAYGLEYLHEQ 392
T Q++ + L D + LD + + G+++LH
Sbjct: 87 NVFTPQKS----LEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH-- 140
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 452
+ IIHRDLK +NI++ + + DFGLA+ A + T T + APE +
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGM 197
Query: 453 KSSEKTDVFGYGITLLELVTG 473
E D++ G + ELV G
Sbjct: 198 GYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
GL+Y+H + IIHRDLK +N+ ++++ E + DFGLA+ D ++T T +
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 184
Query: 445 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 474
APE L+ ++ D++ G + EL+TG+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 33/178 (18%)
Query: 315 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 374
A Q EV L H N++ TT S ++ PFM S L+ P +G+
Sbjct: 45 ALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP--EGMSEAL 102
Query: 375 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 434
+ FG GL YLH+ IHR++KA++IL+ + GL L + L+H+
Sbjct: 103 IGNILFGALRGLNYLHQN---GYIHRNIKASHILISGD--------GLVSL--SGLSHLY 149
Query: 435 TQIRGTMGH----------------IAPEYLSTGKS--SEKTDVFGYGITLLELVTGQ 474
+ +R ++PE L + K+D++ GIT EL TG+
Sbjct: 150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 27/175 (15%)
Query: 379 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 437
++ A G+ +L + IHRDL A NILL +CDFGLA+ + +V
Sbjct: 220 SYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 438 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD-HIRK 496
R + +APE + + ++DV+ YGI L E+ FS + +D K
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEI--------FSLGSSPYPGMPVDSKFYK 328
Query: 497 LLRED-RLNDIVDRNLNTYDSKEVE--TMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+++E R+ S E M + C + P RP Q+V++++
Sbjct: 329 MIKEGYRM-----------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339
+G+G +G VYK D L+ G + RE+ L+ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 340 TSSER--ILVYPFMQN--LSVAYRLRDLKPGEKGLDWPTR--KRVAFGTAYGLEYLHEQC 393
+ S+R L++ + ++ + R K +K + P K + + G+ YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 394 NPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIAPE 447
++HRDLK ANIL+ + + D G A+L ++ L + + T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 448 YLSTGKSSEKT-DVFGYGITLLELVTGQ 474
L + K D++ G EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 35/122 (28%), Positives = 66/122 (54%), Gaps = 8/122 (6%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTH--VTTQIRGTM 441
GL+Y+H + ++HRDLK AN+ ++ ++ + DFGLA++VD +H ++ T
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 442 GHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500
+ +P LS ++ D++ G E++TG+ + E E+ L+L+ + + E
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH-ELEQMQLILESVPVVREE 241
Query: 501 DR 502
DR
Sbjct: 242 DR 243
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 4/115 (3%)
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445
L +LHE+ II+RDLK N+LLD L D+G+ K + T+ GT +IA
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIA 164
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500
PE L D + G+ + E++ G+ D + + D D++ +++ E
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 280 IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLI 335
IG G G V Y +L N VA+K+L + A RE+ L+ HKN++ L+
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 336 GYCTTSSERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
T Q++ + L D + + LD + + G+++LH
Sbjct: 90 NVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 143
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 452
+ IIHRDLK +NI++ + + DFGLA+ A + + T T + APE +
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 453 KSSEKTDVFGYGITLLELVTGQ 474
E D++ G + E++ G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 15/98 (15%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-------KLVDAKLTHVTTQI 437
GL+Y+H + ++HRDLK N+L++ + E +CDFGLA +T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-- 171
Query: 438 RGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 474
T + APE LS ++ DV+ G L EL+ +
Sbjct: 172 --TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 37/109 (33%), Positives = 49/109 (44%), Gaps = 23/109 (21%)
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT------ 435
T LEYLH N I+HRDLK N+L+ L DFGL+K+ L +TT
Sbjct: 110 TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGH 163
Query: 436 -----------QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
Q+ GT +IAPE + + D + GI L E + G
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 72/290 (24%), Positives = 111/290 (38%), Gaps = 56/290 (19%)
Query: 280 IGQGGFGKVYKGVLSDN-----------TKVAVKRLQDYYSPGGEA--AFQREVHLISVA 326
+GQG F +YKGVL V +K L AF L+S
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58
Query: 327 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 386
HK+L++L G C E I+V +++ + L + L W + VA A L
Sbjct: 59 SHKHLVKLYGVC-VRDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASAL 114
Query: 387 EYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDA--KLTHVTTQIR-GT 440
YL ++ K++H ++ NIL+ N V KL D +T ++ + R
Sbjct: 115 HYLEDK---KLVHGNVCGKNILVARYGLNEGYVPF----IKLSDPGIPITVLSREERVER 167
Query: 441 MGHIAPEYLSTGKSS--EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 498
+ IAPE + G++S D + +G TLLE+ S EE + L K
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEI--------CSN--GEEPLSTLSSSEKER 217
Query: 499 REDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKML 547
+ L D E+ + Q C P RP +++ L
Sbjct: 218 FYQDQH-----RLPMPDCAELANLINQ----CWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 32/86 (37%), Positives = 49/86 (56%), Gaps = 3/86 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
N+ SL L +N + I P I LK +L DN + +LP L ++ +L++L+L+ N
Sbjct: 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLT 162
S +P S LSNL +LDLS N ++
Sbjct: 175 LS-DLPKLLSNLSNLNNLDLSGNKIS 199
|
Length = 394 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
L YLH Q +IHRD+K+ +ILL + L DFG + + + + GT +
Sbjct: 129 ALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWM 184
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
APE +S + D++ GI ++E+V G+
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339
+G+G +G VYK D L+ G + RE+ L+ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 340 TSSER--ILVYPFMQN--LSVAYRLRDLKPGEKGLDWP--TRKRVAFGTAYGLEYLHEQC 393
+ ++R L++ + ++ + R K +K + P K + + G+ YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 394 NPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIAPE 447
++HRDLK ANIL+ + + D G A+L ++ L + + T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 448 YLSTGKSSEKT-DVFGYGITLLELVTGQ 474
L + K D++ G EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 36/211 (17%)
Query: 280 IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQL 334
IG G G V Y V VA+K+L + A A+ RE+ L+ + HKN++ L
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGL 80
Query: 335 IGYCT------TSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
+ T + LV M NL ++ LD + + G++
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--------LDHERMSYLLYQMLCGIK 132
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH----VTTQIRGTMGH 443
+LH + IIHRDLK +NI++ + + DFGLA+ VT R
Sbjct: 133 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR----- 184
Query: 444 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
APE + E D++ G + E++ G
Sbjct: 185 -APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 30/109 (27%), Positives = 48/109 (44%), Gaps = 9/109 (8%)
Query: 367 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKL 425
E L K++ L LH IIH D+K N+L D + + LCD+GL K+
Sbjct: 103 EGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159
Query: 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
+ + GT+ + +PE + D + G+ EL+TG+
Sbjct: 160 IGTPSCY-----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 40.9 bits (97), Expect = 3e-05
Identities = 17/38 (44%), Positives = 27/38 (71%), Gaps = 2/38 (5%)
Query: 125 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
T+L++L+L+NN+ + +P S L NL+ LDLS N +T
Sbjct: 1 TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 51/241 (21%), Positives = 96/241 (39%), Gaps = 50/241 (20%)
Query: 336 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW-------PTRKRVA--------- 379
GY S + Y MQ++ + D++ + P R R
Sbjct: 177 GYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPAL 236
Query: 380 ---------FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430
+ A G+E+L + +HRDL A N+L+ + +CDFGLA+ +
Sbjct: 237 SYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDS 293
Query: 431 THVTTQIRGT----MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 486
+++ +G+ + +APE + + +DV+ +GI L E+ T + L E
Sbjct: 294 NYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT-LGGTPYPELPMNE 349
Query: 487 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546
+ I++ R + + S E+ ++Q C + E RP +Q+V +
Sbjct: 350 --QFYNAIKRGYRMAK---------PAHASDEIYEIMQ---KCWEEKFEIRPDFSQLVHL 395
Query: 547 L 547
+
Sbjct: 396 V 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 8e-05
Identities = 25/62 (40%), Positives = 37/62 (59%), Gaps = 7/62 (11%)
Query: 126 HLQSLNLANNKFSGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLF----SVATFNFTGT 180
+L+SL+L+NN+ + IP L NLK LDLS NNLT I + F S+ + + +G
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGN 58
Query: 181 HL 182
+L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 17/217 (7%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDY--YSPGGEAAFQREVH 321
R+L++ +++ +IG+G FG+V KV A+K L + A F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 322 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 381
+++ A ++QL +V +M + + + EK + T + V
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV--- 152
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGT 440
L+ +H IHRD+K N+LLD + L DFG K+ + T + GT
Sbjct: 153 --LALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 206
Query: 441 MGHIAPEYLST----GKSSEKTDVFGYGITLLELVTG 473
+I+PE L + G + D + G+ L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 22/215 (10%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHK 329
++F +IG+G FG+V L + KV ++ + + E A RE + V
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 330 NLLQLIGYCTTSSERILV----YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 385
+ + Y + + Y L++ + D P + + +A + +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG-LAKLVDAKLTHVTTQIRGTMGHI 444
L Y +HRD+K NIL+D N L DFG KL++ + + GT +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170
Query: 445 APEYLST-----GKSSEKTDVFGYGITLLELVTGQ 474
+PE L GK + D + G+ + E++ G+
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 42/160 (26%), Positives = 66/160 (41%), Gaps = 8/160 (5%)
Query: 311 GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL 370
G A+ E L+ H +L L+ LV P ++ Y L+P L
Sbjct: 202 GWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRP----L 257
Query: 371 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-AK 429
VA ++Y+H + IIHRD+K N+L++ + L DFG A +
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314
Query: 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLE 469
T I GT+ APE L+ + D++ G+ + E
Sbjct: 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 380 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 439
+ A G+E+L + +HRDL A N+LL +CDFGLA+ + +V+ +G
Sbjct: 244 YQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KG 297
Query: 440 T----MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472
+ + +APE + + +DV+ YGI L E+ +
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 6/83 (7%)
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 457
+HRD+K N+L+D L DFG A + A + GT +IAPE L+T K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 458 T------DVFGYGITLLELVTGQ 474
D + G+ E++ G+
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 20/56 (35%), Positives = 29/56 (51%), Gaps = 4/56 (7%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 440
LEYLH I++RDLK NILL ++ +L DF L+K D + ++
Sbjct: 115 ALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE-PPPVSKALRK 166
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----G 452
+HRD+K N+LLD N L DFG ++ T ++ GT +I+PE L G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 453 KSSEKTDVFGYGITLLELVTGQ 474
K + D + G+ + E++ G+
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 31/109 (28%), Positives = 46/109 (42%), Gaps = 6/109 (5%)
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 456
IHRDLK N L+D + L DFGL+K + V G+ ++APE L
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDYMAPEVLRGKGYDF 177
Query: 457 KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505
D + G L E + G S E + L + ++ L+ +D
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK--YWKETLQRPVYDD 224
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-----STG 452
+HRD+K N+LLD N L DFG + A T + GT +I+PE L G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 453 KSSEKTDVFGYGITLLELVTGQ 474
+ + D + G+ + E++ G+
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 36.5 bits (85), Expect = 0.001
Identities = 15/39 (38%), Positives = 21/39 (53%), Gaps = 2/39 (5%)
Query: 36 EGEALIEVLKALN-DTHGQFTDWNDHFVSPCFSWSHVTC 73
+ +AL+ +LN D G + WN PC SW+ VTC
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSDPC-SWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 20/43 (46%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425
A L+YLH IIHRDLK N+L+ + L DFGL+K+
Sbjct: 114 ALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 4/87 (4%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N+ L L N + + L L + +L NDLS LP L ++++L +L+L+
Sbjct: 139 KSNLKELDLSDNKIE-SLPSPLRNLPNLKNL-DLSFNDLS-DLPKLLSNLSNLNNLDLSG 195
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNL 161
NK S +P LS L+ LDLS+N++
Sbjct: 196 NKIS-DLPPEIELLSALEELDLSNNSI 221
|
Length = 394 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 47/240 (19%), Positives = 105/240 (43%), Gaps = 20/240 (8%)
Query: 288 VYKGVLSDNTKVAVKRLQDYYSPGGEA---AFQREVHLISVAIHKNLLQLIGYCTTSSER 344
+YKG+ +N +V ++ + + G + + E+ + N+L++ G+ +
Sbjct: 36 IYKGIF-NNKEVIIRTFK-KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 404
+ + LR++ EK L + T+ +A GL L++ N +++L +
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 405 ANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFG 462
+ L+ +N++ + GL K+ L+ + M + + + L+ + + K D++
Sbjct: 152 VSFLVTENYKLKIICHGLEKI----LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYS 207
Query: 463 YGITLLELVTGQRAIDFSRLEEEE--DVLLLDHIRKLLRED---RLNDIVDRNLNTYDSK 517
G+ L E+ TG+ I F L +E D+++ + L D + IV+ + K
Sbjct: 208 LGVVLWEIFTGK--IPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIK 265
|
Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 596 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.22 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.99 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.97 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.96 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.93 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.89 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.76 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.65 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.64 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.61 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.6 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.58 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.57 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.55 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.54 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.52 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.45 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.45 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.43 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.42 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.34 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.32 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.29 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.27 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.25 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.24 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.21 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.19 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.17 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.1 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.04 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.02 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.99 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.97 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.96 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-57 Score=531.27 Aligned_cols=449 Identities=27% Similarity=0.451 Sum_probs=314.6
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|+|++|+++|.+|..+.++++|+.| +|++|+++|.+|..++++++|++|+|++|.++|.+|..++++++|+.||
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQL-KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEE-ECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 367888888888888888888888888888 8888888888888888888888888888888888888888888888888
Q ss_pred CCCCcccccCCccccc---cccccccccccccCCCCC---------------CCCCCCC----CCCCCC-Cccceeeeee
Q 007608 156 LSSNNLTGRIPMQLFS---VATFNFTGTHLICGSSLE---------------QPCMSRP----SPPVST-SRTKLRIVVA 212 (596)
Q Consensus 156 l~~N~l~g~iP~~l~~---l~~l~~~~n~~~~~~~~~---------------~~c~~~~----~~~~~~-s~~~~~iiv~ 212 (596)
|++|+++|.+|..+.+ |..|++++|++.+..|.. ..|...+ ++.... +.....++++
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~ 633 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYIT 633 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehh
Confidence 8888888888866543 455666666655432211 0122110 011111 1112222222
Q ss_pred ecccchhhhhhhhhhhhhhhhhccccccccccccCCCCCcc-ccccccccccHHHHHHHhcCCCcCceeeecCceEEEEE
Q 007608 213 SASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCK-VSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKG 291 (596)
Q Consensus 213 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~ 291 (596)
.+ ++++++++++++++++++++++.+........+..... ........++.+++ ...|...++||+|+||.||+|
T Consensus 634 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~ 709 (968)
T PLN00113 634 CT-LGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKG 709 (968)
T ss_pred HH-HHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEE
Confidence 22 22222222222222222221111111000000000000 00011122333333 345778899999999999999
Q ss_pred Ee-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCC
Q 007608 292 VL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL 370 (596)
Q Consensus 292 ~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l 370 (596)
.. .++..||||++..... ...+|++.+++++||||++++++|.+.+..++||||+++|+|.++++. +
T Consensus 710 ~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l 777 (968)
T PLN00113 710 KSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------L 777 (968)
T ss_pred EECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------C
Confidence 96 5789999999864221 123568889999999999999999999999999999999999999963 7
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceeccccccccccCccccc
Q 007608 371 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 450 (596)
Q Consensus 371 ~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 450 (596)
+|..+.+++.|+|+||+|||..+.++++||||||+||+++.++.+++. ||........ ....+++.|+|||++.
T Consensus 778 ~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~ 851 (968)
T PLN00113 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRE 851 (968)
T ss_pred CHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCccccc
Confidence 899999999999999999997777799999999999999999888875 6655433211 1235789999999999
Q ss_pred CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC---CCHHHHHHHHHHHH
Q 007608 451 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT---YDSKEVETMVQVAL 527 (596)
Q Consensus 451 ~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~---~~~~~~~~l~~l~~ 527 (596)
+..++.++|||||||++|||+||+.|++... .......+|++..........++|+.+.. ...++..++.+++.
T Consensus 852 ~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 928 (968)
T PLN00113 852 TKDITEKSDIYGFGLILIELLTGKSPADAEF---GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLAL 928 (968)
T ss_pred CCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHH
Confidence 9999999999999999999999999986432 22334666776555555556666766533 34567778999999
Q ss_pred HccccCCCCCCCHHHHHHHhccC
Q 007608 528 LCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 528 ~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
+||+.||++||+|+||+++|+++
T Consensus 929 ~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 929 HCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred hhCcCCchhCcCHHHHHHHHHHh
Confidence 99999999999999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=460.81 Aligned_cols=287 Identities=52% Similarity=0.851 Sum_probs=253.2
Q ss_pred ccccccHHHHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeE
Q 007608 258 QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337 (596)
Q Consensus 258 ~~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~ 337 (596)
..+.|+++|+..||++|...+.||+|+||.||+|.+++|+.||||++....... ..+|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567899999999999999999999999999999999999999999887543332 5669999999999999999999999
Q ss_pred EecCC-eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEE
Q 007608 338 CTTSS-ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 338 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 416 (596)
|.+.+ +.++|||||++|+|.++|+..... .++|..|++|+.++|+||+|||+.+.|+|+||||||+|||||+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99999 599999999999999999974432 899999999999999999999999999999999999999999999999
Q ss_pred EeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH
Q 007608 417 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 417 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
|+|||+++.......+......||.+|+|||++..+..++|+|||||||+|+|++||+++.+.... .....+.+|+..
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHHHHHH
Confidence 999999976543112221111699999999999999999999999999999999999999886542 233448999999
Q ss_pred HhccCcccccccCcCC--CCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 497 LLREDRLNDIVDRNLN--TYDS-KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~--~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+..+.+.+++|+.+. .+.. .++.++..++.+|++.+|.+||+|.||+++|+.
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 9988899999999986 3554 688899999999999999999999999999964
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=385.67 Aligned_cols=255 Identities=31% Similarity=0.461 Sum_probs=209.3
Q ss_pred CCcCceeeecCceEEEEEEeCCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC-eeEEEEEcc
Q 007608 274 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERILVYPFM 351 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~ 351 (596)
+...+.+|+|+||+||+|.+.....||||++.... +....+.|.+|+.++.+++|||||+++|+|.+.. ..++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 33456699999999999999655559999997432 2233679999999999999999999999999988 799999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-cEecCCCCCcEEEcCCC-cEEEeecccccccccc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK-IIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK 429 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~dlkp~NIll~~~~-~~kl~DfGl~~~~~~~ 429 (596)
++|+|..+++.. ....+++..+++++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999874 346799999999999999999999999 6 99999999999999997 9999999999876543
Q ss_pred CcceeccccccccccCccccc--CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLS--TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
. ...+...||+.|||||++. ...++.|+|||||||++|||+||+.||..... ......+ .....
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v---~~~~~----- 263 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAV---VVGGL----- 263 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHH---HhcCC-----
Confidence 2 2223367999999999999 56899999999999999999999999985432 1111111 11111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
....+..+...+..++.+||..||++||++.|++..|+..
T Consensus 264 ---Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 264 ---RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred ---CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 1112333667888999999999999999999999999853
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=367.49 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=213.3
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC-eeEEEEEcc
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERILVYPFM 351 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~ 351 (596)
++....||+|..|+|||+.++ +++.+|+|++.....+...+++.+|++++++.+||+||.++|.|.... +..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344789999999999999976 788899999976667777899999999999999999999999999988 599999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
++|+|...+... +.+++...-+|+.+|++||.|||+ . +||||||||+|||++..|++||+|||.++.+.+.
T Consensus 161 DgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred CCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999863 458999999999999999999996 5 8999999999999999999999999999977654
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
......||..|||||.+.+..|+.++||||||+.++|+.+|+.|+............+..+ |++..
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~------------Iv~~p 298 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA------------IVDEP 298 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH------------HhcCC
Confidence 3445679999999999999999999999999999999999999998642211222222222 23322
Q ss_pred CCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 511 LNTYDS-KEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 511 l~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+. ..+.++..++..|+++||.+||+++|++++
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 233344 377889999999999999999999999774
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=375.43 Aligned_cols=250 Identities=31% Similarity=0.440 Sum_probs=212.8
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCCh
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 356 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (596)
.+.||+|-||.||.|.++....||+|.++.. ....++|.+|+++|++++|+|||+++|+|..++..+||||||+.|+|
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 6789999999999999988889999999853 33567899999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceecc
Q 007608 357 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 436 (596)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 436 (596)
.++|++ .....+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+|+...++.......
T Consensus 289 l~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 289 LDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred HHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999997 3356788999999999999999999999 99999999999999999999999999999665554444444
Q ss_pred ccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCC
Q 007608 437 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD 515 (596)
Q Consensus 437 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 515 (596)
..-+..|.|||.+..+.++.|||||||||+||||+| |+.|+..... .+.+...-+..++ ..+
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------~ev~~~le~GyRl---------p~P 426 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------EEVLELLERGYRL---------PRP 426 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--------HHHHHHHhccCcC---------CCC
Confidence 445678999999999999999999999999999999 7777765332 1222222222222 235
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 516 SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 516 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
..++.++.++|..||..+|++|||++.+...|++.
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 66888999999999999999999999998888763
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=348.40 Aligned_cols=259 Identities=23% Similarity=0.333 Sum_probs=214.9
Q ss_pred CCCcCceeeecCceEEEEEE-eCCCcEEEEEEcc-ccCCcchHHHHHHHHHHHHhcCCCCccceEe-EEecCCe-eEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIG-YCTTSSE-RILVY 348 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~-~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~-~~~~~~~-~~lv~ 348 (596)
+|.+.++||+|.||+|||+. ..+|..+|.|.++ ...+....++..+|+.+|++++|||||++++ -+.++.+ .++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46667899999999999999 5699999999997 3345666788999999999999999999998 3444455 78999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP-KIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
||+..|+|...++.++...+.+++.+.++++.|+++||.++|+.... -|.||||||.||+++.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999999888889999999999999999999999994322 38999999999999999999999999999887
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
..... ....+|||.||+||.+.+.+|+.||||||+||++|||+.-.+||.+... .+.-. .+..+
T Consensus 180 s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------~~L~~-KI~qg------ 243 (375)
T KOG0591|consen 180 SKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------LSLCK-KIEQG------ 243 (375)
T ss_pred chhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--------HHHHH-HHHcC------
Confidence 65333 3456799999999999999999999999999999999999999986422 22111 11222
Q ss_pred cCcCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 508 DRNLNTYD-SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 508 d~~l~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.....+ ..++.++..++..|+..||+.||+...++..+..
T Consensus 244 --d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 244 --DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 222223 5678899999999999999999996555555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=352.86 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=182.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
..+|...+.||+|+||+||+|+++ ++..||||.+.... .....+....|+.+|+.++|||||.+++++..++..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888888999999999999965 68999999997543 5556777899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC------CcEEEeeccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN------FEAVLCDFGL 422 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~------~~~kl~DfGl 422 (596)
|||.+|+|.++++.. ..++..+.+.++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999973 4699999999999999999999999 99999999999999765 5689999999
Q ss_pred cccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCcc
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 481 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~ 481 (596)
|+.+... ......+|++-|||||+++..+|+.|+|+||.|+|+|||++|+.||+...
T Consensus 162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9988753 33455789999999999999999999999999999999999999998543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=386.25 Aligned_cols=262 Identities=25% Similarity=0.408 Sum_probs=220.9
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC
Q 007608 268 QLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 341 (596)
Q Consensus 268 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 341 (596)
++...+....+.||+|+||.||+|... +.+.||||.+++..+....++|++|++++..++|||||+++|.|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 334455556789999999999999842 45679999999877777899999999999999999999999999999
Q ss_pred CeeEEEEEcccCCChhhhhcccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPG----------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 411 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~ 411 (596)
+..++|+|||..|+|.++|+...+. ..+++..+.+.|+.|||.||.||-++ .+|||||..+|+|+.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 9999999999999999999853321 12388899999999999999999999 8999999999999999
Q ss_pred CCcEEEeeccccccccccCcce-eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhch
Q 007608 412 NFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 489 (596)
Q Consensus 412 ~~~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~ 489 (596)
+..|||+|||+++..-..+.+. .....-+.+|||||.+..+++|++||||||||+|||++| |+.|+.....+ .
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-----E 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-----E 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-----H
Confidence 9999999999999664443332 223345789999999999999999999999999999998 88998764332 2
Q ss_pred HHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 490 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 490 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.++.+ +. ..+...++.++.++.+||..||+..|.+||+++||-..|+.
T Consensus 714 VIe~i----~~--------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 714 VIECI----RA--------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred HHHHH----Hc--------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 22222 22 33344678889999999999999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=355.79 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=206.9
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcc------hHHHHHHHHHHHHhcCCCCccceEeEEecCCe
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPG------GEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 343 (596)
.+.|...+.||+|+||.|-+|.. ++|+.||||++.+..... ......+|+++|++++|||||++.+++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45677889999999999999995 589999999997543222 22335799999999999999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC---CcEEEeec
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDF 420 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Df 420 (596)
.|+|+||++||.|.+.+-. ++.+.....+.++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999876 34577777899999999999999999 99999999999999766 78999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCCC---CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHH
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 497 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~ 497 (596)
|+|+.... .......+|||.|.|||++.+..+ ..+.|+||+||+||-+++|.+||.... .+..+.+.+..
T Consensus 324 GlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~----~~~sl~eQI~~- 396 (475)
T KOG0615|consen 324 GLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY----TDPSLKEQILK- 396 (475)
T ss_pred chhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc----CCccHHHHHhc-
Confidence 99998763 345567889999999999976653 347899999999999999999998532 22223333321
Q ss_pred hccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 498 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 498 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+++.. -+.......++..+++.++|..||++||++.|++++
T Consensus 397 ---G~y~f-----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 ---GRYAF-----GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ---Ccccc-----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11111 011345567889999999999999999999999774
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=364.60 Aligned_cols=248 Identities=24% Similarity=0.390 Sum_probs=213.0
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.+|...+.||+|||+.||+++. .+|..||+|++.+. ..........+||++.++++|||||++++++.+.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999996 78999999999742 34566778899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
|+|++++|..+++. .+.++++++..++.||+.||.|||+. +|+|||||..|+++++++++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999885 46799999999999999999999999 999999999999999999999999999998865
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
+. ....+.+|||.|+|||++.....+..+||||+|||+|-|+.|++||+..... +........+
T Consensus 171 ~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk--------ety~~Ik~~~------- 234 (592)
T KOG0575|consen 171 DG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK--------ETYNKIKLNE------- 234 (592)
T ss_pred cc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH--------HHHHHHHhcC-------
Confidence 42 2334578999999999999999999999999999999999999999854321 1122111111
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...+.....+..+|+.++|+.+|.+|||+.+|+.
T Consensus 235 ---Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 ---YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0123345567788999999999999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=349.88 Aligned_cols=296 Identities=24% Similarity=0.288 Sum_probs=233.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
..++|+..++||+|+||.||.++.+ +++.+|+|++++.. .....+...+|..+|.+++||.||+++..+++.+..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3568999999999999999999954 68899999997532 33456788999999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
|+||+.||.|..+|.+ +..+++..+.-++..|+.||.|||+. +||||||||+|||||++|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999986 45688899999999999999999999 9999999999999999999999999999854
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
-.. ...+...+||+.|||||++.+..++..+|+||+||++|||++|.+||...+. .++........
T Consensus 176 ~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~--------~~~~~~I~~~k----- 241 (357)
T KOG0598|consen 176 LKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------KKMYDKILKGK----- 241 (357)
T ss_pred ccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH--------HHHHHHHhcCc-----
Confidence 332 2234457899999999999999999999999999999999999999986442 22233222222
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCcchhhHHHHHHHHhhhhcccccccccccccCCCCc
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSID 586 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (596)
+...+.-...+..+++...++.||++|-....=.+.++...+-... .|+.+...+ ..+.+.|.-....+++.++
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i-nW~~l~~k~-l~PpF~P~~~~~~~~~~Fd 315 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI-NWEKLLAKK-LSPPFKPNVTGLEDTSNFD 315 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC-CHHHHHhcC-CCCCeecCCCCcccccccc
Confidence 1111222345677888899999999997533333335544443322 377766654 4456677766667777776
Q ss_pred cchhhh
Q 007608 587 QEAIQL 592 (596)
Q Consensus 587 ~~~~~~ 592 (596)
.+....
T Consensus 316 ~eft~~ 321 (357)
T KOG0598|consen 316 NEFTSY 321 (357)
T ss_pred HHHHhc
Confidence 666554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=369.12 Aligned_cols=256 Identities=27% Similarity=0.390 Sum_probs=217.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeC----CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
.....+.++||.|.||.||+|+++ ....||||.++..++++...+|+.|..+|.++.||||+++.|+.......++
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 334566789999999999999975 3457999999999999999999999999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
|.|||+||+|..+|+... ..+++.+...++++||.||.||.++ ++|||||.++|||++.+..+|++|||+++.+
T Consensus 708 iTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999743 4589999999999999999999999 9999999999999999999999999999988
Q ss_pred cccCcceecccc--ccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 427 DAKLTHVTTQIR--GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 427 ~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
.++.....+..- -+.+|.|||.+..+++|.+||||||||+|||.++ |.+||-..... +.+..+. ++
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-----dVIkaIe----~g-- 850 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVIKAIE----QG-- 850 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-----HHHHHHH----hc--
Confidence 655422222222 2568999999999999999999999999999887 89998743321 1222221 11
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.....+.+++..+.+||+.||++|-.+||.+.||+.+|+.
T Consensus 851 ------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 851 ------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred ------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 1112366788999999999999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=351.86 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=206.5
Q ss_pred HHhcCCCcCceeeecCceEEEEEEe------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecC
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 341 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 341 (596)
+..++|+..+.||+|+||.||+|.. .+++.||+|+++..........+.+|+.++.++ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4567899999999999999999974 235689999997544444567799999999999 899999999988765
Q ss_pred C-eeEEEEEcccCCChhhhhcccCCC------------------------------------------------------
Q 007608 342 S-ERILVYPFMQNLSVAYRLRDLKPG------------------------------------------------------ 366 (596)
Q Consensus 342 ~-~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 366 (596)
+ ..++||||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 578999999999999988742210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc-eeccccccc
Q 007608 367 ----EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTM 441 (596)
Q Consensus 367 ----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~ 441 (596)
...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........ ......+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 13478889999999999999999998 9999999999999999999999999999865432221 122334567
Q ss_pred cccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHH
Q 007608 442 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVE 520 (596)
Q Consensus 442 ~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 520 (596)
.|+|||++.+..++.++|||||||++|||++ |..||......+ ...... ..+.. ...+.....
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~----~~~~~--------~~~~~~~~~ 304 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQRL----KDGTR--------MRAPENATP 304 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHHH----hcCCC--------CCCCCCCCH
Confidence 8999999999999999999999999999997 999987533211 111111 11110 111223446
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 521 TMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 521 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+.+++.+||+.||++||++.|+++.|++
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 78899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=341.42 Aligned_cols=262 Identities=25% Similarity=0.333 Sum_probs=208.0
Q ss_pred hcCCCcCceeeecCceEEEEEE-eCCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecC--CeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 346 (596)
.+.|+..+.||+|.||.||+|+ ..+|+.||+|+++-. ..++......+||.+|+++.||||+++.+...+. ...|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3557778899999999999999 568999999999843 3556667788999999999999999999998776 68999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
|+|||+. +|..++.. ....++..+++.++.|++.||+|+|++ +|.|||||.+|||||.+|.+||+|||+|+++
T Consensus 196 VFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999986 77777764 235689999999999999999999999 9999999999999999999999999999988
Q ss_pred cccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc---cCc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---EDR 502 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~ 502 (596)
........+..+-|..|+|||++.+. .|+.+.|+||.||||.||++|++.+++....+ -.+.+..... +..
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-----Ql~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-----QLHKIFKLCGSPTEDY 343 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-----HHHHHHHHhCCCChhc
Confidence 77665555556679999999999875 59999999999999999999999988643221 2222222211 111
Q ss_pred cc--cc-----ccCcCCCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 503 LN--DI-----VDRNLNTYDS-------KEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 503 ~~--~~-----~d~~l~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+. ++ +.+. ..+.. ......++|+..+|..||.+|.|+.++++
T Consensus 344 W~~~kLP~~~~~kp~-~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQ-QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCcccccCCC-CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11 11 1110 01111 12345778888999999999999999976
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.32 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=205.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC-cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
+.|+...++|+|+||.|||++.+ +|+.||||++.+..+ +.-.+-.++|+++|++++|+|+|.++++|......++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999976 699999999986544 3445667899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|++. ++.+.|... ..+++.....+++.|++.|+.|+|++ +++||||||+|||++.++.+||+|||+|+.+...
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9986 555555543 34688899999999999999999999 9999999999999999999999999999988753
Q ss_pred CcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc--Cccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE--DRLNDI 506 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~ 506 (596)
....+.++.|..|+|||.+.+ .+|....||||.||++.||+||.+.|...+.- +..-.++..+.. .+..++
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi-----DQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI-----DQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH-----HHHHHHHHHHcccCHHHHHH
Confidence 334456678999999999987 78999999999999999999999988764321 111112111110 011111
Q ss_pred cc----------CcCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 507 VD----------RNLN------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 507 ~d----------~~l~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+. |... ..-+....-+++++..|++.||.+|++-+|++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 1110 011223446789999999999999999999865
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=373.23 Aligned_cols=262 Identities=29% Similarity=0.431 Sum_probs=217.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeC--CCc----EEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS--DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 344 (596)
.++.+..+.||+|+||.||.|... +|. .||||.+++..+.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 445566789999999999999964 343 49999999888888899999999999999999999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPG---EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
++++|||++|+|..+|++.+.. ...++....+.++.|||+|+.||+++ ++|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999975332 35688999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeccc-cccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhc
Q 007608 422 LAKLVDAKLTHVTTQI-RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLR 499 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~ 499 (596)
+|+.+........... .-+..|||||.+..+.+|.|+|||||||++||++| |..||...+.. .+.. ...+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-----~v~~---~~~~ 919 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-----EVLL---DVLE 919 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-----HHHH---HHHh
Confidence 9995544333322222 23568999999999999999999999999999999 78888753321 1211 1222
Q ss_pred cCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCc
Q 007608 500 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL 552 (596)
Q Consensus 500 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 552 (596)
.+++ ..+..++..+.+++.+||+.+|++||++..+++.+..+.-
T Consensus 920 ggRL---------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 920 GGRL---------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CCcc---------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 3322 2356678889999999999999999999999997776443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=333.35 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=204.3
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC--eeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~ 348 (596)
.++...+.||+|+||+||++... +|...|||.+....... .+.+.+|+.+|.+++|||||+.+|...... ..++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 35667899999999999999965 48999999986542222 667899999999999999999999855555 588999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-CCcEEEeecccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVD 427 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfGl~~~~~ 427 (596)
||+++|+|.+++.... . .++...+.+++.||++||+|||++ +|+|+||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999998743 2 599999999999999999999999 9999999999999999 7999999999998776
Q ss_pred c--cCcceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 428 A--KLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 428 ~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
. ..........||+.|||||++..+. ...++|||||||++.||+||++||... ....+++.......
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~--- 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGRED--- 239 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccC---
Confidence 3 2222334577999999999998643 345999999999999999999999742 01111122111111
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
..+..+...+.+..+++..|+..+|++|||+.|++++..
T Consensus 240 -----~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 -----SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred -----CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111234445667888999999999999999999988654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=345.94 Aligned_cols=267 Identities=27% Similarity=0.430 Sum_probs=215.1
Q ss_pred ccHHHHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEec
Q 007608 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 340 (596)
Q Consensus 262 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 340 (596)
.+.+++++..+.+...+.||+|.||+||+|.+.. .||||+++.. -++...+.|.+|+.++++-+|.||+-+.|||.+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3446777777788889999999999999999843 5999999843 345567899999999999999999999999998
Q ss_pred CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
+.. .+|+.+|++-+|..+++... ..++..+.+.|++|||+||.|||.+ +|||||||+.||++.+++.|||+||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence 887 99999999999999999743 4688899999999999999999999 9999999999999999999999999
Q ss_pred ccccccccc-CcceeccccccccccCcccccC---CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH
Q 007608 421 GLAKLVDAK-LTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 421 Gl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
|++..-..- ......+..|...|||||+++. .+|+..+||||||+|+|||+||..||... ..+. .+.
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dq---Iif----- 603 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQ---IIF----- 603 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chhh---eEE-----
Confidence 998643221 1122233457889999999863 46899999999999999999999999832 2111 010
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.+..+. +-+++......+..++.+|+..||..++++||.+.+|+.+|++.
T Consensus 604 mVGrG~----l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 604 MVGRGY----LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred Eecccc----cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 011110 11222233456677889999999999999999999999988763
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=306.60 Aligned_cols=262 Identities=24% Similarity=0.296 Sum_probs=208.5
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
++|...+++|+|.||.||+|+. ++|+.||||+++.. ..++-.....+|++.|+.++|+||+.+++.+...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999994 58999999999843 344445678999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
||+. +|...+++. ...++...++.++.++++|++|+|++ .|+||||||.|+|++.+|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9985 888888863 46789999999999999999999999 8999999999999999999999999999988765
Q ss_pred CcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc--
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI-- 506 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-- 506 (596)
......+ +-|..|+|||.+.|. +|+...||||.|||+.||+-|.+-|.+... .+-...+...+......++
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-----idQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-----IDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-----HHHHHHHHHHcCCCCcccCcc
Confidence 4443333 468999999999875 589999999999999999998877665332 1112222222221111111
Q ss_pred -------------ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 -------------VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 -------------~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..+.+...-.....+.++++..++..||.+|+++.|++++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111111233455677999999999999999999999764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=325.78 Aligned_cols=263 Identities=27% Similarity=0.362 Sum_probs=208.6
Q ss_pred HhcCCCcCceeeecCceEEEEEE-eCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
..+.|+..++||.|..++||+|+ .+.+..||||++.-.......+.+.+|+..++.++||||++++..|..+...++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 45678999999999999999999 56789999999974434444788999999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
.||.+|++.+.+....+ .++++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.+||+|||.+..+..
T Consensus 104 pfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999987554 3599999999999999999999999 999999999999999999999999999876654
Q ss_pred cCcce---eccccccccccCcccccC--CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 429 KLTHV---TTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 429 ~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
..... .....||+.|||||++.. ..|+.|+||||||+...||.+|..||..... ... +......... ...
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP---mkv-Ll~tLqn~pp-~~~ 253 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP---MKV-LLLTLQNDPP-TLL 253 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh---HHH-HHHHhcCCCC-Ccc
Confidence 33221 144679999999999543 4589999999999999999999999974321 111 1111111000 000
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...+|.. ........+.+++..|+++||.+|||++++++
T Consensus 254 t~~~~~d---~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKD---EDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChH---HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0011110 11123347788899999999999999999987
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=333.86 Aligned_cols=266 Identities=20% Similarity=0.316 Sum_probs=206.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeCC-----------------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccc
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSD-----------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 333 (596)
.++|...+.||+|+||.||+|.+.+ +..||+|.+...........|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999998532 33699999875444455678999999999999999999
Q ss_pred eEeEEecCCeeEEEEEcccCCChhhhhcccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 007608 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398 (596)
Q Consensus 334 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 398 (596)
+++++.+.+..++||||+++|+|.+++..... ....++|....+++.|++.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999998864221 113478899999999999999999999 999
Q ss_pred ecCCCCCcEEEcCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhC--CC
Q 007608 399 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG--QR 475 (596)
Q Consensus 399 H~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg--~~ 475 (596)
||||||+||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433221 22233457889999999888999999999999999999974 45
Q ss_pred CCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 476 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 476 p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
||..... ......+....+....... ...+...+..+.+++.+||+.||++||++.||.+.|++
T Consensus 241 p~~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTD-----EQVIENAGEFFRDQGRQVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCH-----HHHHHHHHHHhhhcccccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6653221 1122222222211110000 01122345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=336.13 Aligned_cols=263 Identities=22% Similarity=0.299 Sum_probs=211.0
Q ss_pred HhcCCCcCceeeecCceEEEEEE-eCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCC-eeEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS-ERIL 346 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~-~~~l 346 (596)
..++|...+.||.|.||.||+|+ ..+|..||||+++.....-.+..=.+|++.|++++ ||||+++.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34678888999999999999999 45789999999986554444555679999999998 999999999998888 8999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
|||||+. +|.+.+++. +..++...++.|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+..
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999974 999999874 57899999999999999999999999 9999999999999998889999999999977
Q ss_pred cccCcceeccccccccccCccccc-CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC----
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---- 501 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~---- 501 (596)
... ...+.++.|..|+|||++. .+-|+.+.|||++|||++|+.+-++.|.+.+.-+. +-.+...+...
T Consensus 161 ~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-----i~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 161 RSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-----IYKICEVLGTPDKDS 233 (538)
T ss_pred ccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-----HHHHHHHhCCCcccc
Confidence 543 3345667899999999975 56789999999999999999999998886543211 11112222111
Q ss_pred c-------------ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 R-------------LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ~-------------~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+ +..+..-.+....+....+.++++.+|+..||.+|||++|.+++
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1 11111111122223367889999999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.70 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=209.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 345 (596)
...+|..++.||+|+|++|++|+. .+++.||||++.+.. .+...+....|-+.|.++ .||.|++++..+++....|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 456889999999999999999995 478999999986432 233456677888899999 8999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+|+||.++|+|.++++.. ..++....+.++.+|+.||+|||+. |||||||||+|||||+|++++|+|||.|+.
T Consensus 151 FvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999974 4588889999999999999999999 999999999999999999999999999998
Q ss_pred ccccCcc----------ee--ccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHH
Q 007608 426 VDAKLTH----------VT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 493 (596)
Q Consensus 426 ~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~ 493 (596)
+...... .. ..++||..|.+||++.....+..+|+|+||||+|+|+.|.+||...+.. ...+.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-----liFqk 298 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-----LIFQK 298 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-----HHHHH
Confidence 7542211 11 3477999999999999999999999999999999999999999864321 12222
Q ss_pred HHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 494 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 494 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
+... |- .+++..++.+.+|+.+.|..||.+|++.+||-++.
T Consensus 299 I~~l----------~y---~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 299 IQAL----------DY---EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHh----------cc---cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 2211 11 12333346778888899999999999998887653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=337.53 Aligned_cols=240 Identities=28% Similarity=0.423 Sum_probs=202.7
Q ss_pred CcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCC
Q 007608 275 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 275 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 354 (596)
...+-||+|+.|.||.|++ .++.||||+++.. -..+|+-|++++||||+.+.|+|....-++||||||..|
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 3467899999999999998 5678999998642 135788999999999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCccee
Q 007608 355 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 434 (596)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 434 (596)
.|...|+. +..+.......+..+||.||.|||.+ .|||||||+-||||+.+..+||+|||-++..... ...
T Consensus 198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STk 268 (904)
T KOG4721|consen 198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STK 268 (904)
T ss_pred cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhh
Confidence 99999986 45688888899999999999999999 9999999999999999999999999999877554 223
Q ss_pred ccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCC-C
Q 007608 435 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN-T 513 (596)
Q Consensus 435 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~ 513 (596)
..+.||..|||||++...+.++|.||||||||||||+||..||..-+... .+.. +=...+. .
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--------IIwG---------VGsNsL~Lp 331 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--------IIWG---------VGSNSLHLP 331 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--------eEEe---------ccCCccccc
Confidence 34679999999999999999999999999999999999999987321100 0000 0011111 2
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+..++.-+.-|+++||+.-|..||++.+++.+|+-
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 466778888999999999999999999999999973
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=333.76 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=212.8
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
++|...+.||+|.||.||||+.+ +.+.||+|.+.+. ..+...+.+.+|+++++.++||||+.+++++.+..+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999976 6788999998643 344566779999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+.+ +|..+|.+ +..+++.....++.++..||.|||+. +|.|||+||.|||++.++.+|++|||+|+.+...
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9987 99999987 56799999999999999999999999 9999999999999999999999999999988664
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
+...+.+.|||-|||||+..+.+|+..+|+||+|||+||+++|++||.... +.+.+.....+.
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d~-------- 216 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKDP-------- 216 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcCC--------
Confidence 445566789999999999999999999999999999999999999997422 222233222211
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+......+..+....+.+||.+|.+..+++.+
T Consensus 217 --v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 --VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 12345667788899999999999999999998763
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=326.36 Aligned_cols=256 Identities=22% Similarity=0.298 Sum_probs=206.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeC----CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
.++|+..+.||+|+||.||+|.+. .+..||+|.++...+......|.+|+..+.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999853 4678999999865555556789999999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998753 23689999999999999999999999 9999999999999999999999999987654
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
............++..|+|||++.+..++.++|||||||++||+++ |+.||...... ...+.+. ....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----~~~~~~~----~~~~-- 226 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----DVIKAVE----DGFR-- 226 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHH----CCCC--
Confidence 3221111122335678999999999999999999999999999875 99998743221 1112111 1100
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+...+..+.+++.+||+.+|++||++.|+.+.|+.
T Consensus 227 ------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 ------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 01123345678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=334.89 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=207.9
Q ss_pred cCCCcCceeeecCceEEEEEE-eCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
..|..-..||+|+.|.||.|. ..+++.||||++... .....+-+.+|+.+|+..+|+|||+++..+...++.++||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~-~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR-KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEec-cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 457777899999999999999 457899999999642 233456688999999999999999999998888999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
|++|+|.+.+.. ..+++.++..|..++++||+|||.+ +|+|||||.+|||++.++.+||+|||++..+....
T Consensus 352 m~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999998875 3488999999999999999999999 99999999999999999999999999998876654
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.. .....|||.|||||+.....|.+|.||||||++++||+-|.+||-.... +..... +......+
T Consensus 424 ~K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAlyL--Ia~ng~P~----- 488 (550)
T KOG0578|consen 424 SK-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYL--IATNGTPK----- 488 (550)
T ss_pred Cc-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHHHH--HhhcCCCC-----
Confidence 33 3445699999999999999999999999999999999999999974221 100000 01110011
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...++..+..+.++..+||+.||++||+++|++++
T Consensus 489 -lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 -LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11345567788999999999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=308.73 Aligned_cols=282 Identities=23% Similarity=0.317 Sum_probs=218.9
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||.|+||.|..++.+ +|..+|+|++... ......+...+|..+|+.+.||+++++.+.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56778899999999999999965 6889999999742 23345667889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||++||.|.++++.. ..++.+.++-++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999973 4588899999999999999999999 999999999999999999999999999998754
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
. +...+|||.|+|||.++...+..++|+|||||++|||+.|.+||..... ..+ ....+ .
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~i---Y~KI~---------~ 255 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQI---YEKIL---------E 255 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHH---HHHHH---------h
Confidence 3 5567899999999999999999999999999999999999999986433 111 11111 1
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHhccCCcchhh---HHHHHHHHhhhhcccccccccccccCCC
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDR-PPMAQVVKMLQGEDLAERW---AEWEELEEVRQQEVSLLPHQFAWGEDSS 584 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (596)
.. ..+++-...++.+|+...++.|-.+| =+++.=.+.+. .+.| -.|+++...+-..+-..|+...-++.|.
T Consensus 256 ~~-v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk----~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsn 330 (355)
T KOG0616|consen 256 GK-VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIK----NHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSN 330 (355)
T ss_pred Cc-ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccc----cCcccccccHHHHhhccccCCCCCccccCCccccc
Confidence 11 12344445577788889999999999 22221222222 1222 2477776665443333344444344444
Q ss_pred Cc
Q 007608 585 ID 586 (596)
Q Consensus 585 ~~ 586 (596)
..
T Consensus 331 fd 332 (355)
T KOG0616|consen 331 FD 332 (355)
T ss_pred cc
Confidence 33
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.43 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=206.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEe------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCC
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS 342 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 342 (596)
..++|+..+.||+|+||.||+|+. .++..||||+++........+.+.+|+.++..+ +||||++++++|...+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 445788899999999999999973 245689999997544444566789999999999 8999999999999999
Q ss_pred eeEEEEEcccCCChhhhhcccCC---------------------------------------------------------
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKP--------------------------------------------------------- 365 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 365 (596)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999998864221
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 366 --------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 366 --------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
....++|..+.+++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 112578999999999999999999998 999999999999999999999999999986643322
Q ss_pred c-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 432 H-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 432 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ....+.+.. +....
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----~~~~~~~~~----~~~~~---- 337 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----SKFYKMIKE----GYRML---- 337 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----HHHHHHHHh----CccCC----
Confidence 1 1122335678999999999999999999999999999998 88888643221 112222211 11000
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+.....++.+++.+|++.||++||++.||+++|++
T Consensus 338 ----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 ----SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 111224578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=333.59 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=206.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCC----cchHHHHHHHHHHHHhcC-CCCccceEeEEecCCe
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS----PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSE 343 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~ 343 (596)
...+|...+.||+|+||.|+.|.. .++..||+|++..... ....+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456889999999999999999985 4789999997764211 133556678999999999 9999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC-CcEEEeeccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGL 422 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfGl 422 (596)
.++||||+.+|+|.+++.+ ...+....+.+++.|++.|++|+|+. +|+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999987 34578899999999999999999999 99999999999999999 9999999999
Q ss_pred cccccccCcceeccccccccccCcccccCCC-CC-cccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SS-EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
+.... ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... ....+.. ..
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--------~~l~~ki-~~ 237 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--------PNLYRKI-RK 237 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--------HHHHHHH-hc
Confidence 99774 2223345567999999999999877 75 789999999999999999999985322 1111111 11
Q ss_pred CcccccccCcCCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 501 DRLNDIVDRNLNTYDSKE-VETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+. ..++... ..++..++.+|+..+|.+|+++.||++
T Consensus 238 ~~---------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 GE---------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CC---------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 10 1112222 678899999999999999999999984
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=323.99 Aligned_cols=259 Identities=17% Similarity=0.254 Sum_probs=203.7
Q ss_pred cccccHHHHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCc--chHHHHHHHHHHHHhcCCCCccceEe
Q 007608 259 LRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP--GGEAAFQREVHLISVAIHKNLLQLIG 336 (596)
Q Consensus 259 ~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~ 336 (596)
++.++.++++ ......||+|++|.||+|.. +|+.||||+++..... ...+.|.+|+.++.+++||||++++|
T Consensus 12 ~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 3445555552 22346899999999999998 7899999999753221 12467889999999999999999999
Q ss_pred EEec----CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC
Q 007608 337 YCTT----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 412 (596)
Q Consensus 337 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 412 (596)
++.+ ....++||||+++|+|.+++.. ...+++....+++.+++.||.|||+.. +++||||||+||+++++
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTEN 159 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCC
Confidence 9876 3467899999999999999975 346899999999999999999999742 68899999999999999
Q ss_pred CcEEEeeccccccccccCcceeccccccccccCcccccC--CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchH
Q 007608 413 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 490 (596)
Q Consensus 413 ~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l 490 (596)
+.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||+||+.||...... .+
T Consensus 160 ~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-----~~ 230 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-----EI 230 (283)
T ss_pred CcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----HH
Confidence 999999999998654321 12347889999999976 67899999999999999999999999753221 11
Q ss_pred HHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 491 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 491 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+. ..+. .. ..+......+.+++.+||+.||++||+++|+++.|+.
T Consensus 231 ~~~i~---~~~~-----~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 231 YDLII---NKNN-----SL---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHH---hcCC-----CC---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11111 1110 00 1122345678899999999999999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=339.97 Aligned_cols=263 Identities=27% Similarity=0.386 Sum_probs=211.0
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEeCC--C--cE-EEEEEccc--cCCcchHHHHHHHHHHHHhcCCCCccceEeE
Q 007608 265 RELQLATDNFSESNIIGQGGFGKVYKGVLSD--N--TK-VAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337 (596)
Q Consensus 265 ~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~l~~--~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~ 337 (596)
..+++.-++....++||+|+||.||+|.++. + .. ||||..+. ........+|.+|.+++++++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3344555566667999999999999999653 2 23 89999874 3456677899999999999999999999999
Q ss_pred EecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEE
Q 007608 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL 417 (596)
Q Consensus 338 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 417 (596)
+......++|||+|.||+|.++|.... ..++..++.+++.++|.||+|||++ +++||||.++|+|++.+..+||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEe
Confidence 999999999999999999999999743 2599999999999999999999999 9999999999999999999999
Q ss_pred eeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHH
Q 007608 418 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 418 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
+|||+++.-..... ......-+.+|+|||.+..+.++.++|||||||++||+++ |..||...... ....++.
T Consensus 304 SDFGLs~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----~v~~kI~- 376 (474)
T KOG0194|consen 304 SDFGLSRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----EVKAKIV- 376 (474)
T ss_pred CccccccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----HHHHHHH-
Confidence 99999875431111 1111124679999999999999999999999999999999 78888754332 1222221
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
..+. ....+...+.++..++.+|+..+|++||+|.++.+.|+..
T Consensus 377 --~~~~--------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 377 --KNGY--------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred --hcCc--------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 1111 1112334566777888899999999999999999999863
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.91 Aligned_cols=263 Identities=22% Similarity=0.317 Sum_probs=206.7
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||.||++... ++..+|+|.+...........+.+|++++.+++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999965 6888999998754444456779999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999875 245889999999999999999999852 5999999999999999999999999998765332
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC---cc---
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RL--- 503 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~---~~--- 503 (596)
......|++.|+|||++.+..++.++|||||||++|||+||+.||......+ +...+....... ..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-----LEAIFGRPVVDGEEGEPHSI 229 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHhcccccccccCCcccc
Confidence 1233458999999999999899999999999999999999999997543211 111110000000 00
Q ss_pred ----------------------------cccccCcCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 504 ----------------------------NDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 504 ----------------------------~~~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
..+....... .......++.+++.+||+.||++||+++|++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000 0112356788999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.03 Aligned_cols=265 Identities=19% Similarity=0.290 Sum_probs=202.9
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
++|+..+.||+|+||.||+|+.+ +++.||+|+++... .......+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999975 68899999987432 23345678899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|++++.+...... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998776654432 24588999999999999999999999 9999999999999999999999999999876443
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHH---------HHHHhcc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH---------IRKLLRE 500 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~---------~~~~~~~ 500 (596)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||......+. ...... .......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ--LFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhCCCCHHHHHhhhcc
Confidence 33233345689999999999988899999999999999999999999975432111 000000 0000000
Q ss_pred CcccccccCcCCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 501 DRLNDIVDRNLNT-------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 501 ~~~~~~~d~~l~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
........+.... +....+..+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 11123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=318.30 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=204.2
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
++|+..+.||+|+||.||++..+++..+|+|.+... ......|.+|++++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 457778999999999999999988889999987632 233567899999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++|+|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 9999999887532 3588999999999999999999999 999999999999999999999999999886543322
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+. ..... ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~~~~~i~---~~~~~---~~-- 222 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVVEMIS---RGFRL---YR-- 222 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHH---CCCCC---CC--
Confidence 22222335678999999998889999999999999999999 8889874322 11122221 11110 01
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
+......+.+++.+||+.+|++||++.|+++.|.
T Consensus 223 ----~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 ----PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1122357899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=337.96 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=205.9
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecC
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 341 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 341 (596)
...++|+..+.||+|+||.||+|... ++..||+|+++..........+.+|+++++.+ +|+||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34567888999999999999998842 34579999997544444566788999999999 899999999999999
Q ss_pred CeeEEEEEcccCCChhhhhcccCC--------------------------------------------------------
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKP-------------------------------------------------------- 365 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 365 (596)
...++||||+++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999998864210
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc-ee
Q 007608 366 ----------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VT 434 (596)
Q Consensus 366 ----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~ 434 (596)
....+++....+++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........ ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 113478899999999999999999998 9999999999999999999999999999865433221 11
Q ss_pred ccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 435 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 435 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
....++..|+|||++.+..++.++|||||||++|||++ |+.||....... ....... ... ...
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~~~~~~~----~~~-----~~~--- 335 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----KFYKMVK----RGY-----QMS--- 335 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----HHHHHHH----ccc-----Ccc---
Confidence 22335678999999998899999999999999999997 999987432211 1111111 110 000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+...+.++.+++.+||+.||++||++.||+++|++
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011124578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=324.49 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=201.3
Q ss_pred CCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++.+++|+|++++.+++.+.+..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999996 478999999986322 22334567899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999988876432 24589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ .+.+.......
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~-------- 220 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-----REEVDRRVKED-------- 220 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-----HHHHHHHhhcc--------
Confidence 2 12334689999999999999999999999999999999999999975432111 11111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK 545 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 545 (596)
...++.....++.+++.+||+.||++||+ ++|+++
T Consensus 221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01122334567889999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=323.20 Aligned_cols=258 Identities=25% Similarity=0.432 Sum_probs=209.0
Q ss_pred cCCCcCceeeecCceEEEEEEeCC------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
++|+..+.||+|+||.||+|.... ...||+|.++..........|.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467788999999999999998642 25799999875544555677999999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC
Q 007608 346 LVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 413 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~ 413 (596)
++|||+++++|.+++...... ...+++...+.++.|++.||+|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999998753221 14588999999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHH
Q 007608 414 EAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL 491 (596)
Q Consensus 414 ~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~ 491 (596)
.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-----~~~ 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-----EVI 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHH
Confidence 999999999986543221 12233346788999999998899999999999999999998 99998753321 122
Q ss_pred HHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 492 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 492 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+. .+. ....+...+.++.+++.+||+.||.+||+++||++.|++
T Consensus 237 ~~i~----~~~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 EMIR----SRQ--------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH----cCC--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2211 111 111234456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=326.29 Aligned_cols=250 Identities=20% Similarity=0.220 Sum_probs=204.3
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCee
Q 007608 268 QLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 268 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 344 (596)
....++|+...+||+|+||.||.|+- .+|..+|+|++++. ......+....|-.+|....+|+||+++..+++.+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 44678899999999999999999995 47999999999853 2344567888999999999999999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
||||||++||++..+|.. ...++...+..++.+++-|+.-+|+. |+|||||||+|+|||..|++||+|||++.
T Consensus 217 YLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999986 45799999999999999999999999 99999999999999999999999999985
Q ss_pred cccc----------------------cCcc-----ee-------------------ccccccccccCcccccCCCCCccc
Q 007608 425 LVDA----------------------KLTH-----VT-------------------TQIRGTMGHIAPEYLSTGKSSEKT 458 (596)
Q Consensus 425 ~~~~----------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~s 458 (596)
-+.. .... .. ...+|||.|+|||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3311 0000 00 114599999999999999999999
Q ss_pred ccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 007608 459 DVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP 538 (596)
Q Consensus 459 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP 538 (596)
|+||+|||+|||+.|.+||......+ .-..+..|-..+..+. ......+..+++.+|+. ||++|.
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~-T~rkI~nwr~~l~fP~-------------~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQE-TYRKIVNWRETLKFPE-------------EVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhhhccCCC-------------cCcccHHHHHHHHHHhc-CHHHhc
Confidence 99999999999999999998755432 2223334433222111 11223677889999998 999997
Q ss_pred C
Q 007608 539 P 539 (596)
Q Consensus 539 s 539 (596)
-
T Consensus 435 G 435 (550)
T KOG0605|consen 435 G 435 (550)
T ss_pred C
Confidence 6
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=323.22 Aligned_cols=249 Identities=29% Similarity=0.473 Sum_probs=195.8
Q ss_pred CceeeecCceEEEEEEeC-----CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 277 SNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
.+.||.|.||.||+|.+. .+..|+||.++........+.|.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 578999999999999975 367899999976555556789999999999999999999999999888899999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++|+|.+++... ....+++..+..++.|++.||+|||+. +++|+||+++||++++++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999974 235689999999999999999999999 999999999999999999999999999987632222
Q ss_pred -ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 432 -HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 432 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
...........|+|||.+.+..++.++||||||+++|||+| |+.|+..... ..+...+.. ...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~~~~~~~---~~~------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEIIEKLKQ---GQR------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHHHHHHHT---TEE-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccc---ccc-------
Confidence 22233446789999999999889999999999999999999 6788764321 112222211 111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
...+......+.+++.+||+.+|++||++.++++.|
T Consensus 224 --~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 --LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111223456788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=325.85 Aligned_cols=249 Identities=26% Similarity=0.357 Sum_probs=209.7
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
..|+..+.||+|.||.||+|.. ..++.||+|++.-........++++|+.++.+++++||.+++|.+..+....++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4577789999999999999995 478999999998666666778899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
|.+|++.+.+.. ...++......+++++..|+.|||.+ +.+|||||+.||++..+|.+|++|||.+..+....
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999885 23346666777899999999999999 99999999999999999999999999998776554
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
... ....||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+ .+..-++...
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------------mrvlflIpk~ 226 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------------MRVLFLIPKS 226 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------------------ceEEEeccCC
Confidence 433 567899999999999988999999999999999999999999874321 1111122221
Q ss_pred C-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 511 L-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 511 l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
- +.........+.+++..|++++|+.||++.+++++
T Consensus 227 ~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 227 APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1 11233556678899999999999999999999873
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=329.40 Aligned_cols=268 Identities=22% Similarity=0.356 Sum_probs=218.7
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 268 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 268 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
+.+.....+.+.||+|.||.|..+....+..||||+++.........+|.+|+++|.+++||||++++|+|..++..++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34455667789999999999999999888999999999877777789999999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
+|||++|+|.+++...... .+.-....+|+.|||.||+||.+- ++|||||.++|+|+|.++++||+|||+++.+-
T Consensus 614 ~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999864221 133445567999999999999998 99999999999999999999999999999665
Q ss_pred ccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh--CCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 428 AKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 428 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt--g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
....+ ......-+.+|||+|.+.-+++|++||||+||+.+||+++ ..+||... .+....+-.....+.....
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l-----t~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL-----TDEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh-----hHHHHHHhhhhhcCCCCcc
Confidence 44433 3334445789999999999999999999999999999976 56777632 2222333333333333222
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
..+ ..+.-++..+++++.+||..|-++||+++++...|++.
T Consensus 764 ~~l-----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVL-----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eec-----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 211 23556778899999999999999999999999999863
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=316.61 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=208.1
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
..++|+..+.||+|++|.||+|...+++.||+|.++.. ......+.+|+.++++++|||++++++++...+..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG--TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC--cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 45678889999999999999999878889999998643 2245678999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++.... ...+++.....++.|++.|+.|||+. +++|+||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999987633 34689999999999999999999998 9999999999999999999999999999876533
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
..........+..|+|||+..+..++.++||||||+++|||+| |+.||..... ......+. .....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~---~~~~~----- 223 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----AEVLQQVD---QGYRM----- 223 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHH---cCCCC-----
Confidence 2221222223468999999998899999999999999999999 9988864321 11111111 11000
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+......+.+++.+|++.+|++||++.++++.|++
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 ----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1122345678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=297.41 Aligned_cols=262 Identities=25% Similarity=0.326 Sum_probs=211.7
Q ss_pred HhcCCCcCceeeecCceEEEEEE-eCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC-----Ce
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE 343 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 343 (596)
..++|++.+.||+|||+-||.++ ..+++.+|+|++.-. +.++.+..++|++..++++|||++++++++..+ .+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~-~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH-SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeecc-chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 45689999999999999999999 668899999999743 345677789999999999999999999887544 34
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.+++++|...|+|.+.+...+..+..++..+.++|+.++++||.+||+. .|+++||||||.||++.+++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999998777777899999999999999999999997 346999999999999999999999999999
Q ss_pred ccccccCccee--------ccccccccccCccccc---CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHH
Q 007608 424 KLVDAKLTHVT--------TQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 492 (596)
Q Consensus 424 ~~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~ 492 (596)
+...-...... ..-..|..|+|||.+. +...++++|||||||++|+|+.|..||+....
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------- 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------- 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence 86543221111 1134688999999985 45679999999999999999999999984221
Q ss_pred HHHHHhccCccc-ccccCcCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 493 HIRKLLREDRLN-DIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 493 ~~~~~~~~~~~~-~~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+.+.+. .+..+.+.. .....++.+.+++.+|++.||.+||++.|++..++.
T Consensus 247 ------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 ------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 111111 111211111 122367889999999999999999999999998875
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=321.32 Aligned_cols=261 Identities=23% Similarity=0.381 Sum_probs=206.5
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 342 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 342 (596)
..+++|+..+.||+|+||.||+|... ++..||+|++...........|.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999998753 356799999865433345567899999999999999999999999999
Q ss_pred eeEEEEEcccCCChhhhhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEE
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPG------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 416 (596)
..++||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998753321 23468889999999999999999998 999999999999999999999
Q ss_pred EeeccccccccccCcce-eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHH
Q 007608 417 LCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI 494 (596)
Q Consensus 417 l~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~ 494 (596)
|+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||...... ...+.+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-----~~~~~~ 234 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-----QVLRFV 234 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHH
Confidence 99999987654322211 112335778999999998889999999999999999999 68888643221 111111
Q ss_pred HHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 495 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
. .... ...+......+.+++.+|++.+|++||++.|++++|++
T Consensus 235 ~----~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 M----EGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred H----cCCc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1 1111 11122334578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=316.82 Aligned_cols=256 Identities=24% Similarity=0.379 Sum_probs=208.1
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
..++|+..+.||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 34678889999999999999999888889999987642 2245788999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999987532 34588899999999999999999998 9999999999999999999999999999876543
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
.........++..|+|||++.+..++.++|||||||++|||+| |+.||...... .....+... ...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~~~~---~~~----- 223 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-----DVMSALQRG---YRM----- 223 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-----HHHHHHHcC---CCC-----
Confidence 2222223345678999999998889999999999999999998 99998643211 111221111 000
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+ .....+.++.+++.+|+..+|++||+++++.+.|++
T Consensus 224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 P----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 111234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.95 Aligned_cols=254 Identities=19% Similarity=0.217 Sum_probs=204.5
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999975 58899999987432 2234567889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999975 34588999999999999999999999 999999999999999999999999999976543
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+.... ... ..
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~~~--~~~---~~ 219 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-----TWENLKYWK--ETL---QR 219 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-----HHHHHHhcc--ccc---cC
Confidence 2233468999999999999999999999999999999999999997543211 111111100 000 00
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+...........++.+++.+|+..+|++||+++|++++
T Consensus 220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11000012345678889999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=318.16 Aligned_cols=262 Identities=23% Similarity=0.317 Sum_probs=200.8
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|...+.||+|+||.||+|..+ +++.||+|.++..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999965 68999999987544444456778999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 985 888888643 23578899999999999999999999 99999999999999999999999999997654322
Q ss_pred cceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc---cC-----
Q 007608 431 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---ED----- 501 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~----- 501 (596)
.. .....+++.|+|||++.+ ..++.++||||+||++|||+||+.||......+.. ..+..... .+
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL-----HLIFRLLGTPTEETWPGI 231 (288)
T ss_pred cc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHHHhCCCChHHhhcc
Confidence 11 223457899999999865 56899999999999999999999999754332111 11111100 00
Q ss_pred ----cccccccCcCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 ----RLNDIVDRNLNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ----~~~~~~d~~l~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.......+.... .......+..+++.+|++.||.+|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000111111000 011124567899999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=314.72 Aligned_cols=256 Identities=26% Similarity=0.372 Sum_probs=207.8
Q ss_pred hcCCCcCceeeecCceEEEEEEeC----CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
.++|+..+.||+|+||.||+|.+. +...||+|.++..........|.+|+.++.+++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357888999999999999999974 2457999998765555566789999999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++++|.+++.... ..+++..+.+++.|++.|++|||+. +++|+||||+||++++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999987532 3689999999999999999999998 9999999999999999999999999999877
Q ss_pred cccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 427 DAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 427 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ....+.+.. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~~----~~~~ 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----QDVIKAVED----GYRL 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHc----CCCC
Confidence 522221 1222335678999999998899999999999999999998 9988863221 112222211 1000
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+...+..+.+++.+|++.+|++||++.||+++|++
T Consensus 228 --------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 --------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0112335678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=328.77 Aligned_cols=243 Identities=21% Similarity=0.245 Sum_probs=197.1
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 354 (596)
+.||+|+||.||++... +|+.||+|+++... .......+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 78999999987422 2334456788999999999999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCccee
Q 007608 355 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 434 (596)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 434 (596)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 99998875 34689999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred ccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCC
Q 007608 435 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 514 (596)
Q Consensus 435 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 514 (596)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+. .+. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~~~~~~----~~~---------~~~ 214 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELIL----MEE---------IRF 214 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----HHHHHHH----cCC---------CCC
Confidence 3356899999999999999999999999999999999999999743221 1111111 110 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 515 DSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 515 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
+.....++.+++.+|++.||++|| ++.|++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 223456788999999999999999 78888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=319.80 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=207.8
Q ss_pred cCCCcCceeeecCceEEEEEEeCC------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
++|...+.||+|+||.||+|...+ +..||+|.++..........|.+|++++.+++|+|++++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778999999999999998633 47899999876544445678999999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcE
Q 007608 346 LVYPFMQNLSVAYRLRDLK----------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 415 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 415 (596)
+||||+++++|.+++.... .....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997532 1234588999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHH
Q 007608 416 VLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH 493 (596)
Q Consensus 416 kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~ 493 (596)
+|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ...+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-----~~~~~ 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-----EVIEC 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHH
Confidence 9999999976533221 11223345788999999999999999999999999999999 99998643221 12222
Q ss_pred HHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 494 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 494 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
+. .+.. ...+......+.+++.+||+.+|++||++.||++.|+
T Consensus 237 ~~----~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 IT----QGRL--------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH----cCCc--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 21 1111 1112234567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=324.92 Aligned_cols=246 Identities=21% Similarity=0.220 Sum_probs=200.8
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999975 68999999986321 2234566889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++.. ...+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999875 34588999999999999999999999 999999999999999999999999999986543
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
. .....|++.|+|||++.+..++.++|||||||++|||+||+.||...... ...+.+. . ...
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~i~---~-~~~----- 215 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEKIL---A-GKL----- 215 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH---h-CCc-----
Confidence 2 12345899999999999888999999999999999999999999753221 1111111 1 100
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM 546 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 546 (596)
..+......+.+++.+|++.||.+||+ +.|++++
T Consensus 216 ----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 112223456789999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=324.83 Aligned_cols=202 Identities=25% Similarity=0.374 Sum_probs=176.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
..++|+..+.||+|+||.||++... ++..+|+|.+...........+.+|++++.+++||||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3478999999999999999999975 688899998875444445677999999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++.. ...+++.....++.|++.||.|||+.. +++|+||||+||+++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999875 345788999999999999999999742 699999999999999999999999999875533
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 480 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~ 480 (596)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2 122345889999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.32 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=216.3
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcc-ccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe-eEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE-RILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~-~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-~~lv~ 348 (596)
++|...+.+|+|+||.++.++.+ +++.+++|.+. ...+........+|+.++++++|||||.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999965 67899999987 33445556678999999999999999999999999888 89999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
+|++||++.+.+...+ ...++...+.+++.|++.|+.|||+. .|+|||||+.||+++.+..|||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998754 45688999999999999999999988 999999999999999999999999999999877
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
... ....+.||+.|+.||.+.+.+|..|+||||+||++|||++-+++|...+... .+.. +..
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~--------Li~k---------i~~ 220 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE--------LILK---------INR 220 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH--------HHHH---------Hhh
Confidence 642 3445679999999999999999999999999999999999999998755422 1111 111
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
......+..+..++..++..|+..+|+.||++.+++.+
T Consensus 221 ~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12233466778889999999999999999999999887
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.84 Aligned_cols=246 Identities=22% Similarity=0.266 Sum_probs=200.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||+|+.. +++.||+|.+... ........+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 6889999998642 12234567889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999875 34578889999999999999999999 999999999999999999999999999986643
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
.. ....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .. ..... .+..
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~---~~~i~-~~~~----- 232 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-----RI---YEKIL-AGRL----- 232 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-----HH---HHHHh-cCCc-----
Confidence 22 2346899999999999999999999999999999999999999743211 11 11111 1110
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM 546 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 546 (596)
..+.....++.+++.+||+.||.+||+ ++|++++
T Consensus 233 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011123346788999999999999997 5666544
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=332.09 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=207.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCC
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS 342 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~ 342 (596)
..++|.+.+.||+|+||.||+|+.. .+..||||+++........+.|.+|++++.++. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4567888999999999999999852 234699999975544455678999999999996 999999999999999
Q ss_pred eeEEEEEcccCCChhhhhcccCC---------------------------------------------------------
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKP--------------------------------------------------------- 365 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 365 (596)
..++||||+++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998864210
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc
Q 007608 366 -----------------------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 410 (596)
Q Consensus 366 -----------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~ 410 (596)
....+++..+..++.|++.||+|||+. +++|+||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 013478889999999999999999998 999999999999999
Q ss_pred CCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhc
Q 007608 411 DNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDV 488 (596)
Q Consensus 411 ~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~ 488 (596)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~----~ 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD----S 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh----H
Confidence 9999999999999865432221 1223346788999999999899999999999999999997 88898643211 1
Q ss_pred hHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 489 LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 489 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.....+. .+.. ...+.....++.+++.+||+.+|++||++.+|+++|+.
T Consensus 348 ~~~~~~~----~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 348 TFYNKIK----SGYR--------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HHHHHHh----cCCC--------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 1111111 1100 01123345678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.06 Aligned_cols=261 Identities=26% Similarity=0.413 Sum_probs=204.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecC-
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS- 341 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~- 341 (596)
..++|++.+.||+|+||.||+|... +++.||+|+++........+.+.+|++++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4467889999999999999999742 35789999987544444456788999999999 899999999988654
Q ss_pred CeeEEEEEcccCCChhhhhcccCCC-------------------------------------------------------
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPG------------------------------------------------------- 366 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 366 (596)
...++++||+++++|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5678999999999999988642210
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc-eeccccccccc
Q 007608 367 --EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGH 443 (596)
Q Consensus 367 --~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y 443 (596)
...++|..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++.+...... ......++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 13689999999999999999999999 9999999999999999999999999999876433221 12233457789
Q ss_pred cCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHH
Q 007608 444 IAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETM 522 (596)
Q Consensus 444 ~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 522 (596)
+|||++.+..++.++|||||||++|||++ |..||......+ .+..... .... ...+.....++
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----~~~~~~~----~~~~--------~~~~~~~~~~~ 305 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----EFCRRLK----EGTR--------MRAPEYATPEI 305 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----HHHHHHh----ccCC--------CCCCccCCHHH
Confidence 99999999999999999999999999998 999986432211 1111111 1100 00122334678
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 523 VQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 523 ~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+++.+|++.+|++||++.|++++|++
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=315.25 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=205.7
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
.+|...+.||+|+||.||+|... +++.||+|.+... ......+.+|++++.+++|+|++++++++...+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 45777889999999999999965 5889999998642 33456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 84 MTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999987532 34589999999999999999999998 99999999999999999999999999998765433
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
........++..|+|||++.+..++.++|||||||++|||+| |..|+...... ...+... ... ..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~~----~~~-----~~ 224 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLE----KGY-----RM 224 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHH----CCC-----CC
Confidence 222222334678999999999999999999999999999998 88888643221 1111111 110 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+...+.++.+++.+|++.+|++||++.|++++|+.
T Consensus 225 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 225 ---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 1122234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=312.27 Aligned_cols=261 Identities=21% Similarity=0.336 Sum_probs=210.5
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||+|+.. +++.||+|.+... ........+.+|+++++.++|||++++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999964 7899999987532 23344567899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++.........++......++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998876544445688999999999999999999998 999999999999999999999999999886643
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ............ .
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~------~ 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKIEQCD------Y 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHHHHhcCC------C
Confidence 221 112345788999999998888999999999999999999999998643211 111111111101 1
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
+.. ........+.+++.+||+.+|++||++.||++.+++.
T Consensus 226 ~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 PPL--PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCC--ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111 1233456788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.91 Aligned_cols=262 Identities=24% Similarity=0.274 Sum_probs=203.0
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC--CeeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv 347 (596)
+.|+..+.|++|.||.||+|+.+ +++.||+|+++... ..+-...-.+||.+|.+.+|||||.+..+.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45777899999999999999965 78899999998432 334445678999999999999999999887544 578999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||++. +|.+.++..+ +++...+.+.++.|+++|++|||+. .|+|||||++|+|++..|.+||+|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999986 8998888743 5688899999999999999999999 89999999999999999999999999999887
Q ss_pred ccCcceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC---cc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RL 503 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~---~~ 503 (596)
......+ ..+-|..|+|||.+.+.+ |++..|+||+|||+.||+++++.|.+...-+ -.+.+...+... .+
T Consensus 229 sp~k~~T-~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-----Ql~~If~llGtPte~iw 302 (419)
T KOG0663|consen 229 SPLKPYT-PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-----QLDKIFKLLGTPSEAIW 302 (419)
T ss_pred CCcccCc-ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-----HHHHHHHHhCCCccccC
Confidence 7644433 345699999999998764 8999999999999999999999887643221 122222221110 00
Q ss_pred ccccc------CcCCCCCH---------H-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 504 NDIVD------RNLNTYDS---------K-EVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 504 ~~~~d------~~l~~~~~---------~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..+.. -.....+. . ..+.-.++....+..||.+|.|+.|.+++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00000 00111111 1 23566788889999999999999998663
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=313.78 Aligned_cols=264 Identities=29% Similarity=0.404 Sum_probs=196.5
Q ss_pred CCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHH--hcCCCCccceEeEEecCC----eeEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS--VAIHKNLLQLIGYCTTSS----ERIL 346 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~--~l~H~niv~l~~~~~~~~----~~~l 346 (596)
.....++||+|.||.||||.+ +++.||||++. ....+.|.+|-+++. .++|+||++++++-.... +..+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 344467899999999999999 55999999985 346778888877766 468999999998865554 7899
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ------CNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
|++|.+.|+|.++|.. ..++|....+++..+++||+|||+. .+|+|+|||||++|||+..|+++.|+||
T Consensus 286 Vt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999986 4689999999999999999999964 4578999999999999999999999999
Q ss_pred cccccccccCcc-eeccccccccccCcccccCCCC------CcccccHHHHHHHHHHHhCCCCCC--------Cccchhh
Q 007608 421 GLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKS------SEKTDVFGYGITLLELVTGQRAID--------FSRLEEE 485 (596)
Q Consensus 421 Gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~------~~~sDv~S~Gvil~elltg~~p~~--------~~~~~~~ 485 (596)
|+|..+...... .....+||.+|||||++.+.-. -.+.||||+|.|||||++.-..++ .++..+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999987654322 2223569999999999976422 236899999999999998654332 1111111
Q ss_pred hhchHHHHHHHHh-ccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 486 EDVLLLDHIRKLL-REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 486 ~~~~l~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...-..+.++..+ +......+.|.-. ....+..+.+.+..||+.||+.|.|+.=|-+.+.+
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~ 502 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWR---KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE 502 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhh---cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence 1111122222221 1111111111111 11456678899999999999999999888777654
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.97 Aligned_cols=259 Identities=24% Similarity=0.294 Sum_probs=207.5
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC---
Q 007608 268 QLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--- 342 (596)
Q Consensus 268 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--- 342 (596)
+...++|.+.+.||+|+||+||+|.. .+++.||||++... .+......+.+|+..+..++|+|++++...+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 33457899999999999999999985 47899999998642 33445567889999999999999999887664332
Q ss_pred -----eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEE
Q 007608 343 -----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL 417 (596)
Q Consensus 343 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 417 (596)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 35799999999999999986544456789999999999999999999999 9999999999999999999999
Q ss_pred eeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH
Q 007608 418 CDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 418 ~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--------~~~~~ 256 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--------EVMHK 256 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHH
Confidence 99999986643322 2223456899999999999999999999999999999999999999753321 11111
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.... . ....+.....++.+++.+||+.||++||++.+++++
T Consensus 257 ~~~~-~--------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAG-R--------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcC-C--------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 1 111122345678899999999999999999999864
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=321.74 Aligned_cols=256 Identities=23% Similarity=0.373 Sum_probs=203.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCc----EEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
..+|+..+.||+|+||.||+|.+. ++. .||+|.++..........|.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356888999999999999999853 333 48999987544445567899999999999999999999999765 567
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+|++|+++|+|.+++... ...+++...++++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999998753 23588999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCccee-ccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 426 VDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 426 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
......... ....++..|+|||++.+..++.++|||||||++|||+| |+.||......+ +..... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----~~~~~~----~~~~ 229 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILE----KGER 229 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHh----CCCC
Confidence 654332221 12234678999999999999999999999999999998 999987432211 111111 1100
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...+.....++.+++.+||+.+|++||++.+++..+...
T Consensus 230 --------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 230 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001122345688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=316.71 Aligned_cols=261 Identities=25% Similarity=0.349 Sum_probs=195.8
Q ss_pred cCCCcCceeeecCceEEEEEEeC--CCcEEEEEEccccC-CcchHHHHHHHHHHHHhc---CCCCccceEeEEec-----
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA---IHKNLLQLIGYCTT----- 340 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~----- 340 (596)
.+|+..+.||+|+||.||+|... +++.||+|+++... .......+.+|+.++..+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46889999986432 222344566787777665 69999999998853
Q ss_pred CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
....++||||+. ++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 345789999997 58988887533 24589999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc-
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR- 499 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~- 499 (596)
|+++..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+.....
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-----~~~~i~~~~~~ 227 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLGKILDVIGL 227 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-----HHHHHHHHhCC
Confidence 999865433 22233458999999999988899999999999999999999999997543211 1111111110
Q ss_pred ---cCccc------ccccCcCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 500 ---EDRLN------DIVDRNLN----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 500 ---~~~~~------~~~d~~l~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..+.. ..+.+... .........+.+++.+|++.||++||++.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 00100000 011123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=312.53 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=203.7
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
++|...+.||+|+||+||+|...++..+|+|.+... ......|.+|+.++.+++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC--cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 457778899999999999999877778999988642 223567899999999999999999999999888899999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999999987532 2589999999999999999999999 999999999999999999999999999886544322
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.......++..|+|||+..+..++.++||||||+++|||+| |+.||...... .....+.. ..+.
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~---~~~~------- 220 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVEKVSQ---GLRL------- 220 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHhc---CCCC-------
Confidence 22222335678999999988889999999999999999999 99998643221 11111111 1110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
..+......+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011123467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=328.79 Aligned_cols=248 Identities=22% Similarity=0.273 Sum_probs=209.2
Q ss_pred CCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.|+.++.||.|+.|.|..|++ .+|+.+|||++.+. .+......+.+|+-+|+.+.|||++++++++.+..+.|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 466688999999999999995 58999999999743 233445678899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++|-|++++.. ..+++..++.+++.||..|+.|+|.. +|+|||+||+|+|||..+++||+|||+|..--++
T Consensus 93 yv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999986 45789999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
......+|+|.|.|||++.+.+| ..++||||.|||||.|+||+.||+.++. ..+...++ .+.
T Consensus 166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-----r~LLlKV~----~G~------ 228 (786)
T KOG0588|consen 166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-----RVLLLKVQ----RGV------ 228 (786)
T ss_pred --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-----HHHHHHHH----cCc------
Confidence 23445679999999999999998 5789999999999999999999985332 12222222 111
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
-..+...+.+..+|+.+|+..||++|.|++||.++-
T Consensus 229 ---f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 ---FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ---ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 112445566788899999999999999999998853
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=318.52 Aligned_cols=257 Identities=23% Similarity=0.323 Sum_probs=203.8
Q ss_pred CCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
+|...+.||+|+||.||+|... ++..||+|+++..........|.+|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4566788999999999999853 2578999999754444445678899999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc
Q 007608 347 VYPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 414 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 414 (596)
++||+++++|.+++.... .....+++..+..++.|++.||.|||+. +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985321 1123588899999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHH
Q 007608 415 AVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 492 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~ 492 (596)
+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||+| |..||..... ....+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~ 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDVIE 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Confidence 99999999886543221 11223345789999999988889999999999999999998 7788764321 11111
Q ss_pred HHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 493 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 493 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+. . ......+......+.+++.+|++.+|++||+++||++.|+.
T Consensus 238 ~i~---~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIR---N---------RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH---c---------CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 1 11111233455678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=311.07 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=200.1
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe-----eEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE-----RIL 346 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----~~l 346 (596)
.|+..+++|+|+||.||+|... +++.||||++..... .-.+|+++|+++.|||||+++.++....+ ..+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4556789999999999999964 579999999853211 22479999999999999999988854432 358
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC-CcEEEeecccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKL 425 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfGl~~~ 425 (596)
|||||+. +|...+++....+..++...++-+..|+.+||+|||+. +|+||||||.|+|+|.+ +.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999996 99999997666677888888999999999999999998 99999999999999977 8999999999998
Q ss_pred ccccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc-
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL- 503 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~- 503 (596)
+..+....+ ...|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+..+. +. .+...+.....
T Consensus 176 L~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ----L~-eIik~lG~Pt~e 248 (364)
T KOG0658|consen 176 LVKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ----LV-EIIKVLGTPTRE 248 (364)
T ss_pred eccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH----HH-HHHHHhCCCCHH
Confidence 876554433 3468899999999875 599999999999999999999999986443211 11 12122111111
Q ss_pred ---------cccccCcCCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 504 ---------NDIVDRNLNT------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 504 ---------~~~~d~~l~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+...+.+.. .......+.++++.++++.+|.+|.++.|++.+
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111122211 233456788999999999999999999999764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=318.75 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=198.7
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||.||+|... +++.||+|+++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 7899999998754333344567899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+. ++|.+++... ...++...+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 5777777642 24588899999999999999999999 9999999999999999999999999998754322
Q ss_pred CcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc---Ccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLND 505 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~ 505 (596)
.. ......+++.|+|||++.+ ..++.++|||||||++|||+||+.||........ ....+...... .....
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD----QLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhCCCChhhccc
Confidence 21 1223457899999999865 4578899999999999999999999975322111 11111111000 00000
Q ss_pred -----cccC-cCCCC-C---H------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 506 -----IVDR-NLNTY-D---S------KEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 506 -----~~d~-~l~~~-~---~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..++ ..... + . .....+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 00000 0 0 11245778999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.81 Aligned_cols=261 Identities=20% Similarity=0.237 Sum_probs=197.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
...+|+..+.||+|+||.||++... +++.||+|... ...+.+|++++++++||||+++++++......++|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 3467999999999999999999964 78899999753 234678999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
|++. ++|..++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 163 e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 163 PRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 9986 688887765 34588999999999999999999999 999999999999999999999999999975433
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhh--hhchHHHHHHHHhcc---C--
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE--EDVLLLDHIRKLLRE---D-- 501 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~--~~~~l~~~~~~~~~~---~-- 501 (596)
..........||+.|+|||++.+..++.++|||||||++|||+||+.|+........ ........+...... +
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 222223345689999999999998999999999999999999999987643211000 000001111000000 0
Q ss_pred -----cccccc---------cCcCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 502 -----RLNDIV---------DRNLNT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 502 -----~~~~~~---------d~~l~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...+.. .+.... .......++.+++.+||+.||++|||++|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 000000 01123457889999999999999999999975
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=326.87 Aligned_cols=247 Identities=24% Similarity=0.263 Sum_probs=200.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeCC--CcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSD--NTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
.++|...+.||+|+||.||+|..++ +..||+|++... ........+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4578889999999999999998543 368999998632 123345678899999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999875 34688999999999999999999999 9999999999999999999999999999866
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+ .. +..
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~i---~~-~~~--- 245 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----LIYQKI---LE-GII--- 245 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----HHHHHH---hc-CCC---
Confidence 432 22346899999999999888999999999999999999999999753221 111111 11 100
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
.++......+.+++.+|++.||++|+ +++|+.++
T Consensus 246 ------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01122234577899999999999995 78888654
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=328.11 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=194.4
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
+|+..+.||+|+||.||+|+.. +++.||+|++...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4555789999999999999965 689999999865444445677899999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++++|.... ..++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999885432 345677889999999999999999 999999999999999999999999999986643221
Q ss_pred ceeccccccccccCcccccC-----CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 432 HVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
......||..|+|||++.. ...+.++|||||||++|||++|+.||......+ ............
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~----- 292 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASLMCAICMSQ----- 292 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHhccC-----
Confidence 1233468999999998743 234568999999999999999999997432211 111111110000
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..........++.+++.+||+.||++||++.|++++
T Consensus 293 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001122345678899999999999999999999874
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=306.99 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=201.1
Q ss_pred ceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCChh
Q 007608 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVA 357 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 357 (596)
++||+|+||.||+|...+++.+|+|.+...........|.+|++++.+++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999876544445567899999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceeccc
Q 007608 358 YRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 437 (596)
Q Consensus 358 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 437 (596)
+++... ...+++..+..++.|++.+|.|+|+. +++|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 988652 23578999999999999999999998 999999999999999999999999999875543322222223
Q ss_pred cccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCH
Q 007608 438 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 516 (596)
Q Consensus 438 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 516 (596)
.++..|+|||+..+..++.++||||||+++||+++ |..||....... ....+. ..... ..+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----~~~~~~----~~~~~--------~~~~ 217 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----AREQVE----KGYRM--------SCPQ 217 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHH----cCCCC--------CCCC
Confidence 34678999999998899999999999999999998 999986432211 111111 11000 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 517 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 517 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
..+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=314.14 Aligned_cols=256 Identities=29% Similarity=0.441 Sum_probs=209.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
+..+|+..+.||+|+||.||+|...++..+++|.+.... ......+.+|+.+++.++|+|++++++++...+..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 345688889999999999999998889999999986432 2245678899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++.+.. ...+++..+.+++.|++.|++|||+. +++|+||||+||++++++.+||+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999999998643 34689999999999999999999998 9999999999999999999999999999866433
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .....+.. ...
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~---~~~------ 222 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-----EVYDQITA---GYR------ 222 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHHHh---CCc------
Confidence 221 223345778999999988889999999999999999998 88998643311 11111111 000
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 ---MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=315.28 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=205.0
Q ss_pred cCCCcCceeeecCceEEEEEEe-----CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
++|+..+.||+|+||.||+|.. .++..|++|.+...........|.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577789999999999999984 25678999999754444455788999999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC
Q 007608 347 VYPFMQNLSVAYRLRDLKP-------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 413 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~ 413 (596)
||||+++++|.+++..... ....+++.....++.|++.||+|||+. +++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853211 123578999999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccccC-cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHH
Q 007608 414 EAVLCDFGLAKLVDAKL-THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL 491 (596)
Q Consensus 414 ~~kl~DfGl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~ 491 (596)
.+||+|||+++...... ........++..|+|||++.+..++.++||||||+++|||++ |..||..... ....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-----~~~~ 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-----QEVI 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence 99999999998653322 112223345678999999988889999999999999999999 8888864321 1122
Q ss_pred HHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 492 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 492 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+.+.. ... ...+......+.+++.+|++.||++||++.+|.++|..
T Consensus 237 ~~~~~----~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVRK----RQL--------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHc----CCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 22211 110 01122334578889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=321.76 Aligned_cols=271 Identities=22% Similarity=0.365 Sum_probs=225.1
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC---CC--cEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCee
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS---DN--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~---~~--~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 344 (596)
..+.....+.||.|-||.||+|... .| -.||||..+.+.++...+.|..|..+|++++||||++++|+|.+. ..
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 3344445678999999999999953 23 358999999877788889999999999999999999999999865 46
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++|||.++-|.|..+|...+ ..++......++.||+.||+|||+. .+|||||..+|||+...-.+|++|||+++
T Consensus 466 WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence 89999999999999998743 4588889999999999999999999 99999999999999999999999999999
Q ss_pred cccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
.+............-+..|||||.+.-.++|.+||||-|||.+||++. |..||..-...+ .+
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------------VI 602 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------------VI 602 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------------eE
Confidence 988765554444445778999999999999999999999999999986 999998533211 11
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCcchhhHHHHHHHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEE 564 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 564 (596)
..+-.......++.++..+..++.+||..+|.+||.+.|+...|.++...|+...-++...
T Consensus 603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq~r~ 663 (974)
T KOG4257|consen 603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQLRR 663 (974)
T ss_pred EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHHHHh
Confidence 1122222234577888999999999999999999999999999998777666665555444
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=307.58 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=211.7
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccc--cCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||+|... +|+.||+|.++. .......+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 899999998863 223334678899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++.........+++..++.++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876554456689999999999999999999999 999999999999999999999999999876543
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
.... .....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+...... .+.
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~~~------ 224 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIE-KCD------ 224 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhh-cCC------
Confidence 3221 2223578899999999988899999999999999999999999864321 1111111111 110
Q ss_pred CcCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 509 RNLNTYD-SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 509 ~~l~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
....+ ......+.+++.+|+..+|++||++.+|+++|++.
T Consensus 225 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 --YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11111 24456788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=323.16 Aligned_cols=243 Identities=22% Similarity=0.276 Sum_probs=196.9
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 354 (596)
+.||+|+||.||++... +++.||+|++.... .......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999964 78999999987432 2334567889999999999999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCccee
Q 007608 355 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 434 (596)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 434 (596)
+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 99988865 34689999999999999999999999 99999999999999999999999999987543221 122
Q ss_pred ccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCC
Q 007608 435 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 514 (596)
Q Consensus 435 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 514 (596)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ........ . ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-----~---~~~~~~~~-------~---~~ 214 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----L---FELILMED-------I---KF 214 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-----H---HHHhccCC-------c---cC
Confidence 33568999999999999899999999999999999999999997432211 1 11111100 0 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 515 DSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 515 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
+.....++.+++.+|++.||++|| ++.|++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 223345778899999999999997 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=323.08 Aligned_cols=243 Identities=22% Similarity=0.271 Sum_probs=195.8
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 354 (596)
+.||+|+||.||++... +|+.||+|+++... .......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 78999999987422 2334556788999999999999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCccee
Q 007608 355 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 434 (596)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 434 (596)
+|..++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 99988865 34689999999999999999999999 99999999999999999999999999987532221 112
Q ss_pred ccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCC
Q 007608 435 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 514 (596)
Q Consensus 435 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 514 (596)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+ .... . ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~~~~~---~~~~-------~---~~ 214 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELI---LMEE-------I---RF 214 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHH---hcCC-------C---CC
Confidence 23568999999999999999999999999999999999999997432211 11111 1110 0 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 515 DSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 515 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
+.....++.+++.+|++.||++|| ++.+++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 223345778899999999999998 78887653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=320.41 Aligned_cols=244 Identities=24% Similarity=0.271 Sum_probs=196.1
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCCh
Q 007608 280 IGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 356 (596)
Q Consensus 280 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (596)
||+|+||.||+|... +++.||+|+++.. ........+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 6889999998642 2333456788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceecc
Q 007608 357 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 436 (596)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 436 (596)
.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 999875 34589999999999999999999999 99999999999999999999999999987543221 22234
Q ss_pred ccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCH
Q 007608 437 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 516 (596)
Q Consensus 437 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 516 (596)
..||+.|+|||++.+..++.++|||||||++|||+||+.||...... +......... ...+.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--------~~~~~~~~~~----------~~~~~ 214 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--------EMYRKILQEP----------LRFPD 214 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCC----------CCCCC
Confidence 56899999999999999999999999999999999999999753221 1111111110 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 517 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 517 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
....++.+++.+||+.||++||++..+.+.|+.
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 334577889999999999999875555444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=310.79 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=202.8
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
.+|+..+.||+|+||.||+|..+++..+|+|.+... ......|.+|++++++++||||+++++++...+..++|+||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG--AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC--CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 357778999999999999999877788999988642 223457889999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 9999999987532 3589999999999999999999999 999999999999999999999999999886543322
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.......++..|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+.. . ...
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~----~-----~~~- 220 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----EVVESVSA----G-----YRL- 220 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----HHHHHHHc----C-----CcC-
Confidence 22222234568999999998899999999999999999999 78888643221 11111111 0 000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
..+...+.++.+++.+|+..+|++||++.|+++.|.
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 --YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 011224567899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=328.17 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=205.1
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCe
Q 007608 268 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 268 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 343 (596)
....++|....+||+|.||.|+++..+ +++.+|||.+++.. ..+..+..+.|-.++... +||.+++++..+++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 445678999999999999999999976 67899999998543 445567778888887766 59999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||..||++..+.+ ...++...+.-++..|+.||.|||++ +||+||||-+|||||.+|++||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 999999999999443333 24689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
+..-.. ...+.+.+|||.|+|||++.+..|+...|+|||||+||||+.|..||.+++.++ +.+-+. .
T Consensus 516 Ke~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-----~FdsI~---~---- 582 (694)
T KOG0694|consen 516 KEGMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-----VFDSIV---N---- 582 (694)
T ss_pred cccCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHh---c----
Confidence 854322 234667889999999999999999999999999999999999999998654322 111111 0
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 540 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 540 (596)
|. ..|+...+.+.+.++.+.+.++|++|--+
T Consensus 583 ----d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 ----DE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 00 12566778889999999999999999877
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.33 Aligned_cols=246 Identities=23% Similarity=0.294 Sum_probs=192.8
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||.||+|... +++.||+|+++... .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 68899999987432 223445677888888776 799999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 999888765 34689999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...............++......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------~ 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------R 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------C
Confidence 2345689999999999999999999999999999999999999964222111111112222222111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPM 540 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 540 (596)
.+.....++.+++.+|++.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 223345577899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=322.64 Aligned_cols=253 Identities=22% Similarity=0.265 Sum_probs=198.6
Q ss_pred CCCcCceeeecCceEEEEEEe----CCCcEEEEEEccccC---CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCee
Q 007608 273 NFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 344 (596)
+|+..+.||+|+||.||+++. .+++.||+|++.... .......+.+|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999885 368899999986421 222345678899999999 499999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999875 34588999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
..............||+.|+|||++.+. .++.++|||||||++|||+||+.||......... ..........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~~--- 226 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILKC--- 226 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhcC---
Confidence 6544333333345689999999999865 4788999999999999999999999743221111 1111111110
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
++. .+......+.+++.+|++.||++|| +++|++++
T Consensus 227 ----~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 ----DPP---FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----CCC---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111 1222345678899999999999999 66677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=310.70 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=204.4
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
.++|+..+.||+|+||.||+|...++..+|+|.+.... .....|.+|+.++++++|+|++++++++. ....+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 45688889999999999999998888899999986432 23567999999999999999999999875 4567999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999987532 24589999999999999999999999 99999999999999999999999999998764432
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
........++..|+|||+..+..++.++||||||+++|||++ |..||..... ....+... ....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~---~~~~------- 221 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----REVLEQVE---RGYR------- 221 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHH---cCCC-------
Confidence 222222335678999999988889999999999999999999 8888864321 11112111 1100
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+......+.+++.+|++.+|++|||+.++.+.|++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 --MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01122345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=314.70 Aligned_cols=266 Identities=24% Similarity=0.351 Sum_probs=202.4
Q ss_pred CCcCceeeecCceEEEEEEe-----CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC--CeeEE
Q 007608 274 FSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERIL 346 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 346 (596)
|...+.||+|+||+||++.. .++..||+|.++..........|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 367889999987544444567889999999999999999999988654 35789
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999875 3489999999999999999999999 9999999999999999999999999999866
Q ss_pred cccCcc--eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 427 DAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 427 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
...... ......++..|+|||.+.+..++.++||||||+++|||+||..|+........ ................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE---EMIGPKQGQMTVVRLI 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh---hhhcccccccchhhhh
Confidence 443221 11222356679999999888899999999999999999999999864321100 0000000000000111
Q ss_pred ccccCcCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 505 DIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 505 ~~~d~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
+..+.... ..+...+.++.+++.+|++.+|++||++++++++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111 12233456889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=337.76 Aligned_cols=252 Identities=19% Similarity=0.264 Sum_probs=203.6
Q ss_pred CCCcCceeeecCceEEEEEEeC-C-CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-D-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
.|...+.||+|+||.||+|... + +..||+|.+.. ........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3788899999999999999854 3 67788887643 2333456778899999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++|+|.+++.+.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998875443445689999999999999999999999 99999999999999999999999999998764432
Q ss_pred c-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 431 T-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 431 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +......... .
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~~~~-~------ 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVLYGK-Y------ 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-C------
Confidence 2 1233456899999999999999999999999999999999999999743221 1111111111 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...+.....++.+++.+|++.||++||++.+++.
T Consensus 289 --~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 --DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112233457889999999999999999999975
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=324.25 Aligned_cols=261 Identities=21% Similarity=0.367 Sum_probs=195.7
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC-----eeE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERI 345 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 345 (596)
+|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999964 78999999987422 2234457889999999999999999999885432 479
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 688888764 34589999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCc--ceeccccccccccCcccccC--CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHh---
Q 007608 426 VDAKLT--HVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL--- 498 (596)
Q Consensus 426 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~--- 498 (596)
...... .......|++.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...+....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~-----~~~~~~~~~~~ 227 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-----LDLITDLLGTP 227 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-----HHHHHHHhCCC
Confidence 432211 11233568999999999865 6789999999999999999999999975432110 00110000
Q ss_pred --------ccCccccccc---CcCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 499 --------REDRLNDIVD---RNLNT----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 499 --------~~~~~~~~~d---~~l~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
......+.++ +.... ........+.+++.+|++.||++||+++|++++
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 00000 001123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=317.09 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=209.1
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEec
Q 007608 268 QLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 340 (596)
Q Consensus 268 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 340 (596)
....++|+..+.||+|+||.||++... ....+|+|.+...........+.+|++++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 345567888999999999999999864 23679999987544444556788999999999 79999999999999
Q ss_pred CCeeEEEEEcccCCChhhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEE
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 408 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl 408 (596)
.+..+++|||+++|+|..++.... .....+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence 999999999999999999986532 2235689999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhh
Q 007608 409 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE 486 (596)
Q Consensus 409 l~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~ 486 (596)
+++++.+||+|||+++.+...... ......++..|+|||+..+..++.++|||||||++|||++ |..||......+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 242 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--
Confidence 999999999999999876543221 1122235678999999988899999999999999999998 888886432211
Q ss_pred hchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 487 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 487 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
..+.. .... ....+......+.+++.+|+..+|++|||+.|+++.|+++
T Consensus 243 ---~~~~~----~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 ---LFKLL----KEGY--------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHH----HcCC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11111 1110 0011223356788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=314.70 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=208.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCC------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 343 (596)
..++|...+.||+|+||.||+|...+ +..||+|.+...........+.+|+.++..++|||++++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34678889999999999999998642 468999998754444556788999999999999999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEE
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPG------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL 417 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 417 (596)
.++||||+++++|.+++...... ...++|..+..++.|++.||.|||+. +++|+||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 99999999999999999754322 23478999999999999999999998 9999999999999999999999
Q ss_pred eeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHH
Q 007608 418 CDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR 495 (596)
Q Consensus 418 ~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~ 495 (596)
+|||+++....... .......++..|+|||.+.+..++.++|||||||++||++| |..||...... .......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----~~~~~~~ 235 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-----EVLKFVI 235 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-----HHHHHHh
Confidence 99999886543321 12223346789999999988889999999999999999998 88888643221 1111111
Q ss_pred HHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 496 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+.. ...+......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 236 ----~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 ----DGGH--------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ----cCCC--------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111 11122235678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=307.13 Aligned_cols=248 Identities=28% Similarity=0.393 Sum_probs=198.8
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCCh
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 356 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (596)
+.||+|+||.||+|... +++.||+|.+...........|.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999964 78999999887544455567899999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCccee-c
Q 007608 357 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT-T 435 (596)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~-~ 435 (596)
.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998642 23588999999999999999999999 999999999999999999999999999876543211111 1
Q ss_pred cccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCC
Q 007608 436 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 514 (596)
Q Consensus 436 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 514 (596)
....+..|+|||.+.+..++.++||||||+++|||++ |..|+...... .....+. .... ...
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----~~~~~~~----~~~~--------~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----QTREAIE----QGVR--------LPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----HHHHHHH----cCCC--------CCC
Confidence 1123457999999999899999999999999999998 88888642211 1111111 0000 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 515 DSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 515 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
+...+..+.+++.+|++.+|++||++.|+.++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2233567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=313.95 Aligned_cols=266 Identities=24% Similarity=0.369 Sum_probs=208.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeCC-----------------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccc
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSD-----------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 333 (596)
..+|+..+.||+|+||.||+|...+ +..||+|.+.........+.+.+|++++.+++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999988542 24589999876555556778999999999999999999
Q ss_pred eEeEEecCCeeEEEEEcccCCChhhhhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCc
Q 007608 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 406 (596)
Q Consensus 334 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N 406 (596)
+++++...+..++|+||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999876431 123689999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh--CCCCCCCccch
Q 007608 407 ILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLE 483 (596)
Q Consensus 407 Ill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt--g~~p~~~~~~~ 483 (596)
|+++.++.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ +..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876543321 12233446778999999988889999999999999999998 5667653221
Q ss_pred hhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 484 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 484 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.................... ..+...+.++.+++.+|++.||++||++.||++.|++
T Consensus 240 ----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 ----QQVIENAGHFFRDDGRQIYL-----PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ----HHHHHHHHhccccccccccC-----CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11222222211111111101 1122334678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=309.46 Aligned_cols=254 Identities=28% Similarity=0.396 Sum_probs=204.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
.++|+..+.||+|+||.||+|...++..||+|++... ......|.+|++++.+++||||+++++++. ....++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC--ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 3568889999999999999999877778999998742 223467899999999999999999998874 4557899999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999997532 24578999999999999999999998 99999999999999999999999999998665433
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
........++..|+|||+..+..++.++||||||+++|||+| |..||...... ...... ....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~~~~~---~~~~-------- 220 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQV---ERGY-------- 220 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HHHHHH---hcCC--------
Confidence 222223346778999999988899999999999999999999 78888643211 111111 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
........+..+.+++.+|++.+|++||++.++++.|++
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 221 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 001123455678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.76 Aligned_cols=251 Identities=23% Similarity=0.296 Sum_probs=196.5
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
++||+|+||.||+|... +++.||+|+++... .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999965 68899999997432 223345678899999888 699999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|..++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 999988865 34689999999999999999999999 99999999999999999999999999987432211 12
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||+.............++.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 223 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------R 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------C
Confidence 2345689999999999999999999999999999999999999974322211111122222222211111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPP------MAQVVK 545 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~ 545 (596)
.+.....++.+++.+|++.||.+||+ +.|+++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12223456888999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=314.19 Aligned_cols=260 Identities=27% Similarity=0.383 Sum_probs=205.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCC------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 343 (596)
..++|...+.||+|+||.||+|...+ +..|++|.+...........|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678889999999999999999753 567999988754445556779999999999999999999999999889
Q ss_pred eEEEEEcccCCChhhhhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC---cEEE
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPG---EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVL 417 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl 417 (596)
.++||||+++++|.+++...... ...+++..+.+++.||+.||+|||+. +++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 99999999999999998764321 23589999999999999999999999 999999999999998654 5999
Q ss_pred eeccccccccccCcce-eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHH
Q 007608 418 CDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR 495 (596)
Q Consensus 418 ~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~ 495 (596)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...... ...+.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----~~~~~~~ 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----EVMEFVT 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHH
Confidence 9999998663322111 112223568999999998999999999999999999997 99998753321 1111111
Q ss_pred HHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 496 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..... ..+...+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 236 ---~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 236 ---GGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred ---cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11110 1122334678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=314.23 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=210.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCC-----CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec-CCe
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSE 343 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~ 343 (596)
..++|...+.||+|+||.||+|...+ +..|++|++...........+.+|+.++++++|+|++++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45788889999999999999999765 788999998765555567788999999999999999999998876 467
Q ss_pred eEEEEEcccCCChhhhhcccCCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEee
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGE----KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 419 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 419 (596)
.+++++|+++++|.+++....... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999987643321 5689999999999999999999998 999999999999999999999999
Q ss_pred ccccccccccCcce-eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHH
Q 007608 420 FGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKL 497 (596)
Q Consensus 420 fGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~ 497 (596)
||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+..++..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~- 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----FEMAAYLKD- 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----HHHHHHHHc-
Confidence 99998664332221 122345778999999988889999999999999999999 9999874322 112222211
Q ss_pred hccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 498 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 498 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.... ......+..+.+++.+|+..||++||++.|+++.|++.
T Consensus 235 --~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 --GYRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred --CCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1100 01112345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.22 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=196.2
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCCh
Q 007608 280 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 356 (596)
Q Consensus 280 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (596)
||+|+||+||++... +++.||+|.+.... .......+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 78899999986422 122335678899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceecc
Q 007608 357 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 436 (596)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 436 (596)
...+.........+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865444456789999999999999999999999 999999999999999999999999999976543322 1233
Q ss_pred ccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCH
Q 007608 437 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 516 (596)
Q Consensus 437 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 516 (596)
..|++.|+|||++.+..++.++|||||||++|||++|+.||........ ......... ... ...+.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~---------~~~-~~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRIL---------NDS-VTYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh----HHHHHHhhc---------ccC-CCCcc
Confidence 4689999999999999999999999999999999999999974322110 011111110 000 11233
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 007608 517 KEVETMVQVALLCTQSTPEDRP-----PMAQVVK 545 (596)
Q Consensus 517 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 545 (596)
.....+.+++.+|++.||++|| +++|+++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 4556788999999999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=315.70 Aligned_cols=262 Identities=23% Similarity=0.385 Sum_probs=206.6
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 342 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 342 (596)
+..++|++.+.||+|+||.||+|..+ .+..||+|.+...........+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999753 245799999875444444567889999999999999999999999999
Q ss_pred eeEEEEEcccCCChhhhhcccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEE
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKP------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 416 (596)
..++||||+++|+|.+++..... .....++..+..++.|++.||.|||+. +++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975332 123467788899999999999999999 999999999999999999999
Q ss_pred EeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHH
Q 007608 417 LCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI 494 (596)
Q Consensus 417 l~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~ 494 (596)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....+ ...+.+
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~ 234 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVLKFV 234 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH
Confidence 9999998865432211 1122235678999999998899999999999999999999 78888643221 111111
Q ss_pred HHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 495 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...+ ....+......+.+++.+|++.+|++||++.|+++.|++.
T Consensus 235 ---~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 ---MDGG---------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ---HcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111 1111222346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=314.93 Aligned_cols=266 Identities=20% Similarity=0.326 Sum_probs=204.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeCC---------------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSD---------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 335 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~ 335 (596)
.++|+..+.||+|+||.||++...+ ...||+|.++..........|.+|++++.+++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578889999999999999987532 2358999987554555567799999999999999999999
Q ss_pred eEEecCCeeEEEEEcccCCChhhhhcccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcE
Q 007608 336 GYCTTSSERILVYPFMQNLSVAYRLRDLKP--------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 407 (596)
Q Consensus 336 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 407 (596)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999864211 112478999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh--CCCCCCCccchh
Q 007608 408 LLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEE 484 (596)
Q Consensus 408 ll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt--g~~p~~~~~~~~ 484 (596)
++++++.+||+|||++......... ......++..|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 9999999999999999765332211 1222345678999999998889999999999999999998 55666542221
Q ss_pred hhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 485 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 485 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
................. . ...+...+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 240 ----~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 ----QVIENTGEFFRNQGRQI-Y----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ----HHHHHHHHhhhhccccc-c----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111111110000 0 00111234689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.47 Aligned_cols=265 Identities=23% Similarity=0.303 Sum_probs=199.1
Q ss_pred CCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC-----eeE
Q 007608 273 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERI 345 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 345 (596)
+|+..+.||+|+||.||++.. .+++.||+|++.... .......+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 478999999986432 2234567889999999999999999999998776 789
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+|+||+. ++|.+.+.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 577777654 34689999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHH------------
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD------------ 492 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~------------ 492 (596)
.............+++.|+|||++.+. .++.++|||||||++|||++|+.||.......... .+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD-LITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHHcCCCCHHHHHH
Confidence 544332223334578999999998774 47899999999999999999999997543221100 0000
Q ss_pred ---HHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 493 ---HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 493 ---~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.............-....+.........++.+++.+|++.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000000000000112235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.41 Aligned_cols=258 Identities=26% Similarity=0.392 Sum_probs=205.3
Q ss_pred cCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
++|...+.||+|+||.||++... ++..+|+|.+... .......+.+|++++.+++|||++++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 56788899999999999999842 3456899988643 3344667999999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEE
Q 007608 346 LVYPFMQNLSVAYRLRDLKP---------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 416 (596)
+||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999999875321 123589999999999999999999998 999999999999999999999
Q ss_pred EeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHH
Q 007608 417 LCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI 494 (596)
Q Consensus 417 l~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~ 494 (596)
|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||+| |..||....... ....+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-----~~~~i 235 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----VIECI 235 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH
Confidence 9999999865432211 1222345778999999998889999999999999999999 888886433211 11111
Q ss_pred HHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 495 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
. .+.... .+.....++.+++.+|++.+|.+||++.||.+.|+..
T Consensus 236 ~----~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 236 T----QGRVLQ--------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred H----cCCcCC--------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1 111100 1112345689999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.37 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=206.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 343 (596)
..++|+..+.||+|+||.||+|... ++..||+|.+...........|.+|+.+++++.|||++++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888999999999999999853 4678999998754444556779999999999999999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 007608 344 RILVYPFMQNLSVAYRLRDLKP------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA 405 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~ 405 (596)
.++|+||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999874321 123578899999999999999999998 9999999999
Q ss_pred cEEEcCCCcEEEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccch
Q 007608 406 NILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE 483 (596)
Q Consensus 406 NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~ 483 (596)
||++++++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876533221 11122234678999999998899999999999999999998 87887532221
Q ss_pred hhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 484 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 484 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+.... ...+.. ...+.....++.+++.+|++.+|++||++.|+++.|++
T Consensus 240 --------~~~~~-~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --------EVIYY-VRDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --------HHHHH-HhcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 111111 11122345678899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=308.74 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=205.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
..++|+..++||+|+||.||+|..++++.||+|.+... ......|.+|++++++++|+|++++++++. .+..++++|
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG--SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCC--CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 45678889999999999999999889999999998643 234567899999999999999999998864 456899999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++.... ...+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999987532 34689999999999999999999998 9999999999999999999999999999866533
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||...... ....... .....
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~---~~~~~----- 222 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-----EVIQNLE---RGYRM----- 222 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-----HHHHHHH---cCCCC-----
Confidence 2222223345678999999998889999999999999999999 99998743321 1111111 10000
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+.....++.+++.+|++.+|++||+++++++.|+.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0112234578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=321.14 Aligned_cols=262 Identities=25% Similarity=0.376 Sum_probs=217.6
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEeCC-CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe
Q 007608 265 RELQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 265 ~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 343 (596)
++++....+....++||-|.||.||.|.|+. .-.||||.++.+ .....+|++|..+|+.++|||+|+++|+|..+..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 4555555566678899999999999999874 567999999863 4467899999999999999999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.|||+|||.+|+|.++|++.. +..++.-..+.++.||+.||.||..+ ++|||||.++|+|+.++..+||+|||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999999754 34577778889999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
+++..+.........-+..|.|||-+....++.|+|||+|||+|||+.| |..||..-+. .+ +..+++.+.
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------Sq-VY~LLEkgy 483 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQ-VYGLLEKGY 483 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH--------HH-HHHHHhccc
Confidence 9986654332222223678999999999999999999999999999998 7888875332 11 112222211
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
....++.++..+++|++.||+.+|.+||++.|+-+.++..
T Consensus 484 --------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 484 --------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred --------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 1123567888999999999999999999999999988763
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=312.28 Aligned_cols=266 Identities=21% Similarity=0.334 Sum_probs=204.6
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-----------------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccc
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-----------------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 333 (596)
.++|+..+.||+|+||.||++... +...||+|++...........|.+|+.++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998532 234689999875444555678999999999999999999
Q ss_pred eEeEEecCCeeEEEEEcccCCChhhhhcccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCc
Q 007608 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG-------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 406 (596)
Q Consensus 334 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N 406 (596)
+++++...+..++||||+++++|.+++...... ...+++.++..++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998764321 13478899999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeeccccccccccCcce-eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh--CCCCCCCccch
Q 007608 407 ILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLE 483 (596)
Q Consensus 407 Ill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt--g~~p~~~~~~~ 483 (596)
|+++.++.++|+|||+++.+....... .....++..|+|||...++.++.++|||||||++|||+| |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999998654332211 122334678999999888889999999999999999998 66777532221
Q ss_pred hhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 484 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 484 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+ ................ ..+ .+..+...+.+++.+|++.||++||++.||++.|++
T Consensus 241 ~-----~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q-----VIENTGEFFRDQGRQV-YLP----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H-----HHHHHHHHHhhccccc-cCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111111111110000 001 112234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=325.35 Aligned_cols=253 Identities=23% Similarity=0.255 Sum_probs=203.9
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|...+.||+|+||+||+|... +++.||+|+++... .......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999965 78999999987421 2244567889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999763 4688999999999999999999998 999999999999999999999999999986644
Q ss_pred cC----------------------------cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCc
Q 007608 429 KL----------------------------THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 480 (596)
Q Consensus 429 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~ 480 (596)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11122345899999999999999999999999999999999999999754
Q ss_pred cchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 007608 481 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-MAQVVKM 546 (596)
Q Consensus 481 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 546 (596)
.... ......... ....-+ . ......++.+++.+|+. ||.+||+ ++|++++
T Consensus 234 ~~~~--------~~~~i~~~~--~~~~~p---~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQE--------TYNKIINWK--ESLRFP---P-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHH--------HHHHHhccC--CcccCC---C-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 3211 111111100 000000 0 01135677888899997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=309.26 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=201.9
Q ss_pred CCcCceeeecCceEEEEEEeCC----CcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe-----
Q 007608 274 FSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE----- 343 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 343 (596)
|...+.||+|+||.||+|.... +..||+|+++.. ........+.+|++.++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 367999998743 233345678999999999999999999998866554
Q ss_pred -eEEEEEcccCCChhhhhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 344 -RILVYPFMQNLSVAYRLRDLKP--GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 344 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
.++++||+++|+|..++..... ....+++.....++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 6899999999999998864322 234689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccCcce-eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHh
Q 007608 421 GLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL 498 (596)
Q Consensus 421 Gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~ 498 (596)
|+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... ....+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-----~~~~~~~~~-- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-----HEIYDYLRH-- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHc--
Confidence 9998664432221 112234678999999988889999999999999999999 8888864321 112222211
Q ss_pred ccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 499 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+. ....+.....++.+++.+|++.||++||++.|+++.|++
T Consensus 231 --~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 --GN--------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred --CC--------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11 111223445688999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=307.18 Aligned_cols=253 Identities=29% Similarity=0.419 Sum_probs=203.1
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
++|...+.||+|+||.||+|...++..+|+|.+... ......+.+|++++++++|+|++++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG--TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC--CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 567888999999999999999877778999987642 223567889999999999999999998875 45678999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999997532 34589999999999999999999998 999999999999999999999999999986643322
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.......++..|+|||+..+..++.++||||||+++|||+| |+.||...... ....++.. ...
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~---~~~-------- 221 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-----EVLEQVER---GYR-------- 221 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHc---CCC--------
Confidence 22222345678999999998899999999999999999999 88888743211 11111111 100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+...+..+.+++.+|+..+|++||++++|++.|++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 -MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=312.22 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=204.3
Q ss_pred CCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
+|...+.||+|+||.||+|... ....+++|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999852 2357899988754444455778999999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCc
Q 007608 347 VYPFMQNLSVAYRLRDLKP--------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 406 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N 406 (596)
++||+.+++|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999998864321 123588999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEeeccccccccccCcce-eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchh
Q 007608 407 ILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE 484 (596)
Q Consensus 407 Ill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~ 484 (596)
|++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||+| |..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 999999999999999998653322211 122335678999999988889999999999999999999 9988864321
Q ss_pred hhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 485 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 485 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
..+.+... ... .. ..+.....++.+++.+|++.+|++||++.|+++.|++.
T Consensus 236 ---~~~~~~~~----~~~-----~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 236 ---ERLFNLLK----TGY-----RM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred ---HHHHHHHh----CCC-----CC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11222211 110 00 01223345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.27 Aligned_cols=256 Identities=20% Similarity=0.228 Sum_probs=202.5
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
...++|+..+.||+|+||.||+++.. +++.||+|++... ........+.+|+.+++.++||||+++++++.+....+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 35678999999999999999999965 6889999998632 12233456788999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+||||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999998865 2477888889999999999999999 999999999999999999999999999986
Q ss_pred ccccCcceeccccccccccCcccccCC----CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTG----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..........
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~ 263 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMDHK 263 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCC
Confidence 644322223345689999999998653 4789999999999999999999999753321 1111111111
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM 546 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 546 (596)
.... .+ .....+.++.+++.+|++.+|.+ ||++.|++++
T Consensus 264 ~~~~--~~----~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 NSLT--FP----DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CcCC--CC----CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000 00 01123567788999999999988 9999999775
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=307.54 Aligned_cols=260 Identities=22% Similarity=0.339 Sum_probs=209.0
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||+|.. .++..++||.+... ........+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677889999999999999995 48899999987632 22234567889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++.........+++...+.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875444456789999999999999999999999 999999999999999999999999999876643
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
.... .....++..|+|||++.+..++.++||||||+++|||++|..||...... ......... ....
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~------~~~~ 225 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIE------QCDY 225 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhh------cCCC
Confidence 3221 22345788999999999888999999999999999999999998643211 111111111 0011
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+.. .......++.+++.+|++.+|++||||.+|++.+++
T Consensus 226 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 226 PPL--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCC--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 111 112345678899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.64 Aligned_cols=264 Identities=23% Similarity=0.368 Sum_probs=207.2
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEe
Q 007608 267 LQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCT 339 (596)
Q Consensus 267 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~ 339 (596)
.++..++|...+.||+|+||.||+|++. .+..||+|+++..........+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3445566778899999999999999853 346799999975444444567899999999997 999999999999
Q ss_pred cCCeeEEEEEcccCCChhhhhcccCC------------------------------------------------------
Q 007608 340 TSSERILVYPFMQNLSVAYRLRDLKP------------------------------------------------------ 365 (596)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 365 (596)
..+..++|+||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999864321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 007608 366 ----------------------------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA 405 (596)
Q Consensus 366 ----------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~ 405 (596)
....+++.....++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112478888999999999999999998 9999999999
Q ss_pred cEEEcCCCcEEEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccch
Q 007608 406 NILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE 483 (596)
Q Consensus 406 NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~ 483 (596)
||++++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986533211 11222346788999999998889999999999999999998 88888643211
Q ss_pred hhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 484 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 484 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+ .....+. .+... ..+.....++.+++.+||..+|++||+++||++.|+.
T Consensus 349 ~----~~~~~~~----~~~~~--------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 349 E----QFYNAIK----RGYRM--------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred H----HHHHHHH----cCCCC--------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 0111111 11000 0122235678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=314.06 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=201.4
Q ss_pred cCCCcCceeeecCceEEEEEEeCC-Cc--EEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSD-NT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 347 (596)
++|+..+.||+|+||.||+|..++ +. .+++|.++........+.|.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998753 33 47888887544444556789999999999 799999999999999999999
Q ss_pred EEcccCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcE
Q 007608 348 YPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 415 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 415 (596)
+||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999865321 113588999999999999999999998 99999999999999999999
Q ss_pred EEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHH
Q 007608 416 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI 494 (596)
Q Consensus 416 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~ 494 (596)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|||+| |..||......+ . .
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~---~ 228 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----L---Y 228 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----H---H
Confidence 9999999864322111 111123557999999998889999999999999999998 999987433211 1 1
Q ss_pred HHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 495 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
....... . ...+......+.+++.+|++.+|.+||++.++++.|+.
T Consensus 229 ~~~~~~~------~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 229 EKLPQGY------R---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred HHHhcCC------C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111100 0 01112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=308.35 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=198.0
Q ss_pred CcCceeeecCceEEEEEEeCC-Cc--EEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecC------Cee
Q 007608 275 SESNIIGQGGFGKVYKGVLSD-NT--KVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SER 344 (596)
Q Consensus 275 ~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~ 344 (596)
.+.+.||+|+||.||+|...+ +. .+|+|.++.. .+......+.+|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 457889999999999999754 33 5899988643 2334457789999999999999999999987532 246
Q ss_pred EEEEEcccCCChhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
++++||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874321 2234589999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCcce-eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 423 AKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 423 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
++......... .....+++.|+|||+..+..++.++||||||+++|||++ |+.||..... ....+.+. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~~~----~ 229 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----SEIYDYLR----Q 229 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHH----c
Confidence 98764432211 122235678999999999899999999999999999999 7888864221 11111111 1
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+... .........+.+++.+||+.+|++||++.|+++.|++
T Consensus 230 ~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 230 GNRL--------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1110 1112234568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=312.66 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=201.8
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
+|+..+.||+|+||+||++... +++.||+|.+.... .......+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999964 68999999986422 12234567889999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886532 34689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
.. .....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+.......
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~-------- 220 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----VKREEVERRVKED-------- 220 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----hHHHHHHHHhhhc--------
Confidence 21 12335889999999999888999999999999999999999999753221 1111111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
...++......+.+++.+|++.||++|| ++++++++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 -QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1112334456788999999999999999 77787554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.84 Aligned_cols=243 Identities=26% Similarity=0.311 Sum_probs=194.8
Q ss_pred ceeeecCceEEEEEEe----CCCcEEEEEEccccC---CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 278 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+.||+|+||.||+++. .+++.||+|+++... .......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357899999986421 223345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999998875 34578888899999999999999999 99999999999999999999999999987543221
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
. ......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ......... ..
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~~~~~~-~~------- 217 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTIDKILKG-KL------- 217 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcC-CC-------
Confidence 1 223356899999999999888999999999999999999999999753321 111111111 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
..+.....++.+++.+|++.+|++|| ++.+++++
T Consensus 218 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 --NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11222345678999999999999999 78887663
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=321.74 Aligned_cols=243 Identities=21% Similarity=0.266 Sum_probs=195.3
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 354 (596)
+.||+|+||.||++... +++.||+|.+.... .......+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 78999999987421 2234456788999999999999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 355 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
+|..++.. ...+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 99988865 3468999999999999999999997 6 899999999999999999999999999875432211 1
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+. .... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-----~~~~i~----~~~~---------~ 214 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELIL----MEEI---------R 214 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-----HHHHHh----cCCC---------C
Confidence 223458999999999999999999999999999999999999997532211 111111 0000 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
++.....++.+++.+|++.||++|+ ++.+++++
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1222345678899999999999996 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=304.20 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=205.6
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|+..+.||+|++|.||+|... +++.|++|.+... ........+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999965 6899999998632 3345567889999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998632 34689999999999999999999998 99999999999999999999999999988665432
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.. .....|++.|+|||+..+..++.++||||||+++|||+||+.||...... .....+ .. + .
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~---~~-~--------~ 217 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----ALILKI---IR-G--------V 217 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH---Hc-C--------C
Confidence 21 22345788999999999988999999999999999999999999754311 111111 11 1 1
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...........+.+++.+|++.+|++||++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111222445678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=314.46 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=207.1
Q ss_pred HHhcCCCcCceeeecCceEEEEEEe--------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEe
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 339 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 339 (596)
...++|.+.+.||+|+||.||+|.. .++..||+|.+...........+.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3456788899999999999999974 134579999987544444567789999999999 8999999999999
Q ss_pred cCCeeEEEEEcccCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcE
Q 007608 340 TSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 407 (596)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 407 (596)
.....++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999976322 123588999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeccccccccccCcce-eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhh
Q 007608 408 LLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 485 (596)
Q Consensus 408 ll~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~ 485 (596)
++++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..|+......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-- 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence 99999999999999998764432221 222335678999999998889999999999999999998 77887643211
Q ss_pred hhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 486 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 486 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+........... ..+...+..+.+++.+||..+|++||++.|+++.|++
T Consensus 247 ------~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 247 ------ELFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred ------HHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 111111111100 1122345678889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=309.02 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=205.8
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CC---cEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
.++|+..+.||+|+||.||+|..+ ++ ..+|+|.++........+.+.+|++++.+++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999975 33 37999998755445556789999999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++++|.+++... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999998752 24589999999999999999999999 9999999999999999999999999999866
Q ss_pred cccCccee--ccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 427 DAKLTHVT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 427 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
........ .....+..|+|||++.+..++.++|||||||++|||+| |+.||...... .....+. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~i~---~~~~~ 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKAIN---DGFRL 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHHHh---cCCCC
Confidence 43322111 11223457999999988889999999999999999998 99998643211 1111111 11100
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 230 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ---------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01123346788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=312.48 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=205.3
Q ss_pred cCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
.+|...+.||+|+||.||+|... ++..+++|.+... .....+.+.+|++.+++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 35677889999999999999842 3556899988642 2334467899999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC
Q 007608 346 LVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 413 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~ 413 (596)
+||||+++++|.+++..... ....+++..++.++.|++.|++|||+. +++||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999875321 123589999999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHH
Q 007608 414 EAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL 491 (596)
Q Consensus 414 ~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~ 491 (596)
.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||+| |+.||......+ ..
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----~~ 235 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-----VI 235 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HH
Confidence 999999999976543221 11223446788999999999899999999999999999999 999986433211 11
Q ss_pred HHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 492 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 492 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
+.. ..+... ......+..+.+++.+|++.+|++||++.+|+++|+++
T Consensus 236 ~~~----~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 236 ECI----TQGRVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHH----hCCCCC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111 111111 11222356788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=307.97 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=199.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCc----EEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
++|+..+.||+|+||+||+|.+. +++ .+++|.+...........+..|+..+.++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46777899999999999999964 444 4788887543333344677888889999999999999998754 45788
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
++||+++|+|.+++... ...+++.....++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999753 24589999999999999999999998 9999999999999999999999999999866
Q ss_pred cccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 427 DAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 427 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
...... ......++..|+|||++.+..++.++|||||||++|||+| |+.||...... ...+.+. .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~~----~~~~- 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-----EVPDLLE----KGER- 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHH----CCCc-
Confidence 433221 2233456778999999998899999999999999999998 99998753221 1112221 1110
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
... +......+.+++.+|+..+|++||++.|+++.|+.
T Consensus 230 -~~~------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 230 -LAQ------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred -CCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 001 11123467788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=301.84 Aligned_cols=265 Identities=24% Similarity=0.300 Sum_probs=205.2
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCC-cchHHHHHHHHHHHHhcCCCC-ccceEeEEecCC------
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKN-LLQLIGYCTTSS------ 342 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~------ 342 (596)
..|...++||+|+||+||+|+. .+|+.||+|+++-... ++......+|+.++++++|+| |+++.+++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3466677899999999999995 4789999999984433 445566789999999999999 999999998877
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++||||++. +|..++.........++...++.++.|+++||+|||++ +|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78899999975 99999987654335677789999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc-
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE- 500 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~- 500 (596)
|+...-.... .+...+|..|+|||++.+. .|++..||||+|||+.||++++.-|..... ......+...+..
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-----~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-----IDQLFRIFRLLGTP 240 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-----HHHHHHHHHHcCCC
Confidence 9966533222 3334579999999999887 689999999999999999999988876543 1122222222211
Q ss_pred --Ccccccc---cCc--CCC------CCH---HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 --DRLNDIV---DRN--LNT------YDS---KEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 --~~~~~~~---d~~--l~~------~~~---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..+..+. +-. ... ... .......+++.+|++.+|.+|.|++.++++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111111 111 000 011 112467899999999999999999999876
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=305.38 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=196.5
Q ss_pred eeeecCceEEEEEEe---CCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCC
Q 007608 279 IIGQGGFGKVYKGVL---SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 279 ~lG~G~~g~Vy~~~~---~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 354 (596)
.||+|+||.||+|.+ +++..+|+|+++... .....+.+.+|+.+++.+.||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 357889999986432 2334577899999999999999999999885 45678999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCccee
Q 007608 355 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 434 (596)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 434 (596)
+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999865 24588999999999999999999998 999999999999999999999999999987654332211
Q ss_pred --ccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcC
Q 007608 435 --TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511 (596)
Q Consensus 435 --~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 511 (596)
....++..|+|||.+....++.++|||||||++|||+| |+.||...... .....+. .+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~i~----~~~~~------- 217 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----EVTQMIE----SGERM------- 217 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH----CCCCC-------
Confidence 12234578999999988889999999999999999998 99998753221 1222221 11110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 512 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+.....++.+++.+|++.||++||++.+|++.|++
T Consensus 218 -~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 -ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1122344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.09 Aligned_cols=238 Identities=26% Similarity=0.331 Sum_probs=191.5
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||+||+|+.+ +++.||+|++... ........+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 6889999998642 1233456677888888876 699999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999988875 34588999999999999999999999 99999999999999999999999999987543221 12
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+. . +.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~---~-~~~---------~ 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAIL---N-DEV---------V 214 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHh---c-CCC---------C
Confidence 23356899999999999989999999999999999999999999753321 1111111 1 100 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMA 541 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 541 (596)
.+.....++.+++.+|++.||++||++.
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 1222345778899999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=306.68 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=208.0
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
+..++|.+.+.||+|+||.||+|..+++..||+|.+... .....++.+|+.++++++|+|++++++++......++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG--TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC--ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 345788899999999999999999888889999998642 234567899999999999999999999999888999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++|+||||+||++++++.++++|||.+.....
T Consensus 81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999997632 24689999999999999999999999 999999999999999999999999999886653
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
..........++..|+|||.+.+..++.++||||||+++|||+| |+.||..... ....+.+.. ....
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~~~---~~~~---- 223 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----REVLEQVER---GYRM---- 223 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHc---CCCC----
Confidence 22222222234678999999998889999999999999999999 9999864321 111111111 0000
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 -----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0111224578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=316.29 Aligned_cols=239 Identities=24% Similarity=0.321 Sum_probs=189.3
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHh-cCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||.||+|... +++.||+|+++... .......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 67899999987422 22334455667666665 4899999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|..++.. ...++......++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999998875 23588899999999999999999999 99999999999999999999999999997543322 22
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+. ... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~---~~~----------~~ 214 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELFDSIL---NDR----------PH 214 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH---cCC----------CC
Confidence 23456899999999999989999999999999999999999999753321 1111111 100 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMAQ 542 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 542 (596)
++.....++.+++.+||+.+|++||++.+
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 12223456778999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=322.49 Aligned_cols=253 Identities=19% Similarity=0.229 Sum_probs=198.6
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||+||+|+.. +++.||||++.... .......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47888999999999999999965 68999999986421 2234456788999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999875 34589999999999999999999999 999999999999999999999999999875432
Q ss_pred cCcc-------------------------------------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHH
Q 007608 429 KLTH-------------------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 471 (596)
Q Consensus 429 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ell 471 (596)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 001235899999999999999999999999999999999
Q ss_pred hCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 007608 472 TGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP---MAQVVKM 546 (596)
Q Consensus 472 tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 546 (596)
+|+.||......+ . ......... ...-+. ......++.+++.+|+. +|.+|++ +.|++++
T Consensus 234 ~G~~Pf~~~~~~~-----~---~~~i~~~~~--~~~~~~----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQE-----T---YRKIINWKE--TLQFPD----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHH-----H---HHHHHcCCC--ccCCCC----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999997543211 1 111111000 000000 01123466778888886 9999998 8887664
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=319.25 Aligned_cols=202 Identities=21% Similarity=0.266 Sum_probs=174.8
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||+||+|... +++.||+|++.... .......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999865 68999999986421 2233456888999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999875 34689999999999999999999999 999999999999999999999999999875432
Q ss_pred cCc----------------------------------ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCC
Q 007608 429 KLT----------------------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474 (596)
Q Consensus 429 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~ 474 (596)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346899999999999999999999999999999999999
Q ss_pred CCCCCc
Q 007608 475 RAIDFS 480 (596)
Q Consensus 475 ~p~~~~ 480 (596)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=307.03 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=205.0
Q ss_pred cCCCcCceeeecCceEEEEEEeC----CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.+|++.+.||+|+||.||+|... ++..+|+|.++..........|.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999863 23479999987544444567899999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|.+++... ...+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++++|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999998753 23589999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceec--cccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 428 AKLTHVTT--QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 428 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
........ ...++..|+|||++.+..++.++||||||+++||+++ |..||...... .....+.. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----~~~~~~~~---~~~~- 228 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----DVIKAIEE---GYRL- 228 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----HHHHHHhC---CCcC-
Confidence 43322211 1223568999999998889999999999999999887 99998643221 11122211 0000
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
......+..+.+++.+|++.+|++||++.++++.|++
T Consensus 229 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 --------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0112234577899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=322.92 Aligned_cols=253 Identities=20% Similarity=0.211 Sum_probs=195.8
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.|+..+.||+|+||+||+|+.. +++.||+|++... ........+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999864 6889999998642 123345678899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999875 24588889999999999999999998 9999999999999999999999999997643110
Q ss_pred Cc----------------------------------------------ceeccccccccccCcccccCCCCCcccccHHH
Q 007608 430 LT----------------------------------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGY 463 (596)
Q Consensus 430 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~ 463 (596)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123468999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHH--ccccCCCCCCCHH
Q 007608 464 GITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALL--CTQSTPEDRPPMA 541 (596)
Q Consensus 464 Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~ 541 (596)
||++|||+||+.||......+. ...+. .......+ +. ......++.+++.+ |+..+|..||++.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~-----~~~i~---~~~~~~~~--~~----~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTET-----QLKVI---NWENTLHI--PP----QVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHH-----HHHHH---ccccccCC--CC----CCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 9999999999999975432111 00111 00000000 00 01123455666665 6667777899999
Q ss_pred HHHHH
Q 007608 542 QVVKM 546 (596)
Q Consensus 542 evl~~ 546 (596)
|++++
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=303.70 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=202.6
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC----cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
++|...+.||+|++|.||++... +++.||+|.+..... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999964 689999998863321 1223568899999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998875 24578899999999999999999999 9999999999999999999999999998765
Q ss_pred cccCccee--ccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 427 DAKLTHVT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 427 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
........ ....++..|+|||++.+..++.++||||||+++|||++|+.||....... . .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~---~~~~~~~~~-- 224 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----A---IFKIATQPT-- 224 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----H---HHHHhccCC--
Confidence 43221111 23457889999999999889999999999999999999999986432110 0 111111110
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+......+.+++.+|+..+|++||++.|++++
T Consensus 225 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 ------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011223345578889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=314.79 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=205.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeC--------CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecC
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 341 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 341 (596)
.++|.+.+.||+|+||.||+|... ++..+|+|.++..........+.+|++++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467888999999999999999752 23579999987544444556788999999999 799999999999999
Q ss_pred CeeEEEEEcccCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 409 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll 409 (596)
+..++||||+++|+|.+++..... ....+++.++++++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999976432 123589999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhh
Q 007608 410 DDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEED 487 (596)
Q Consensus 410 ~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~ 487 (596)
+.++.+||+|||.++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 99999999999998765432111 1111224568999999998889999999999999999998 88888643211
Q ss_pred chHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 488 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 488 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.....+ ..... ...+.....++.+++.+|+..+|++||++.||++.|++
T Consensus 250 -~~~~~~----~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 250 -ELFKLL----KEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred -HHHHHH----HcCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 111111 11110 01122345678889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.35 Aligned_cols=242 Identities=24% Similarity=0.293 Sum_probs=193.6
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCC-CccceEeEEecCCeeEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHK-NLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~ 348 (596)
+|+..+.||+|+||.||+|... +++.||+|++.... .......+..|.+++..+.|+ +|+++.+++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999965 57889999987422 233456788899999999765 5788888999899999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998875 24588999999999999999999999 999999999999999999999999999874322
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+. . ..
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i~---~-~~------ 217 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQSIM---E-HN------ 217 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHH---c-CC------
Confidence 111 223346899999999999999999999999999999999999999753321 1111111 1 00
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 540 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 540 (596)
..++.....++.+++.+|++.||.+|++.
T Consensus 218 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 ---VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01122234577889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=313.70 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=201.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCc--EEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 346 (596)
.++|+..+.||+|+||.||+|..+ ++. .+++|.++...+......|.+|++++.++ +|+||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999964 454 46888776544445567889999999999 89999999999999999999
Q ss_pred EEEcccCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc
Q 007608 347 VYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 414 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 414 (596)
|+||+++++|.+++..... ....+++.+++.++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999875321 123588999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHH
Q 007608 415 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH 493 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~ 493 (596)
+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||......+ ..+.
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~ 235 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEK 235 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----HHHH
Confidence 9999999986432111 1111224568999999988889999999999999999998 999986432211 1111
Q ss_pred HHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 494 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 494 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+. ..... ..+......+.+++.+|++.+|++||++.+++++|+.
T Consensus 236 ~~---~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 236 LP---QGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred Hh---cCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11 00000 0111234567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=308.07 Aligned_cols=255 Identities=25% Similarity=0.298 Sum_probs=200.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCC-------------cchHHHHHHHHHHHHhcCCCCccceE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-------------PGGEAAFQREVHLISVAIHKNLLQLI 335 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-------------~~~~~~~~~e~~~l~~l~H~niv~l~ 335 (596)
..+.|+..+.||+|.||.|-+|.. .+++.||||++.+... -...+...+||.+|+++.|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 346789999999999999999995 4799999999853210 11235788999999999999999999
Q ss_pred eEEecC--CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC
Q 007608 336 GYCTTS--SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 413 (596)
Q Consensus 336 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~ 413 (596)
++..+. +..|+|+|||..|.+...-.+ ...++..++++++.++..||.|||.+ +|+||||||+|+|++++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 999775 568999999998876433222 22389999999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccccCc----ceeccccccccccCcccccCCC----CCcccccHHHHHHHHHHHhCCCCCCCccchhh
Q 007608 414 EAVLCDFGLAKLVDAKLT----HVTTQIRGTMGHIAPEYLSTGK----SSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 485 (596)
Q Consensus 414 ~~kl~DfGl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~ 485 (596)
++||+|||.+........ .......|||.|+|||...++. .+.+.||||+||+||-|+.|+.||-....
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--- 324 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--- 324 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence 999999999986633211 1122367999999999987743 35678999999999999999999974322
Q ss_pred hhchHHHHHHHHhccCcccccccCcCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 486 EDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 486 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
.+... +|+...+.. ..++..+++.+|++++|++||++|.+..+|..+..
T Consensus 325 -----~~l~~---------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 325 -----LELFD---------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred -----HHHHH---------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 11111 222222221 23356778889999999999999999999987654
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.06 Aligned_cols=254 Identities=19% Similarity=0.227 Sum_probs=202.1
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|...+.||+|+||+||++... +++.||+|+++... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999965 78999999987432 2334567889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999998763 24689999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeccccccccccCccccc------CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLS------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~~ 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--------KTYNNIMNFQR 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--------HHHHHHHcCCC
Confidence 4333333446899999999986 456789999999999999999999999753221 11111111111
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..... .......++.+++..|++ +|.+||++.+++++
T Consensus 227 ~~~~~------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 FLKFP------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ccCCC------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11100 011234567788889997 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=315.37 Aligned_cols=245 Identities=25% Similarity=0.335 Sum_probs=193.3
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHH---HhcCCCCccceEeEEecCCeeEEE
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLI---SVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l---~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
|++.+.||+|+||.||+|... +++.||+|+++... .....+.+.+|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999965 68999999987421 222345566666654 567899999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|...+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999888763 3589999999999999999999999 99999999999999999999999999987532
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+ .... .
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-----~~~~i---~~~~-~---- 218 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-----VFDSI---VNDE-V---- 218 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-----HHHHH---HhCC-C----
Confidence 221 12234568999999999999899999999999999999999999997543211 11111 1110 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 545 (596)
.++......+.+++.+|++.||.+||+ +.++++
T Consensus 219 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 -----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 112233456788999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=311.17 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=206.9
Q ss_pred HHhcCCCcCceeeecCceEEEEEEe------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecC
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 341 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 341 (596)
...++|...+.||+|+||.||++.. .++..||+|.++........+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3456788899999999999999974 134579999987544444556789999999999 799999999999999
Q ss_pred CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
+..++||||+++|+|.+++.... ...+++.+...++.|++.||+|||+. +++|+||||+||+++.++.++++|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999987532 23489999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhc
Q 007608 422 LAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLR 499 (596)
Q Consensus 422 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~ 499 (596)
+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |..||......+ .......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----~~~~~~~---- 258 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----KFYKLIK---- 258 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----HHHHHHH----
Confidence 99865433221 1222345778999999998899999999999999999998 999986432211 1111111
Q ss_pred cCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 500 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 500 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+.. . ..+.....++.+++.+|++.+|++||++.|+++.|++
T Consensus 259 ~~~~-----~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 259 EGYR-----M---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred cCCc-----C---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1100 0 0111234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=307.31 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=203.6
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCc----EEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
.++|+..+.||+|+||+||+|.+ .++. .||+|.++..........+.+|+.++..+.|||++++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 45788889999999999999985 3444 48999987555555567889999999999999999999999754 568
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
++++|+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999998752 23589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcce-eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 426 VDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 426 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
........ .....+++.|+|||...+..++.++|||||||++|||+| |..||..... .....++.. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~----~~~ 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REIPDLLEK----GER 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHC----CCc
Confidence 65332221 112234678999999998899999999999999999998 8888864321 112222221 100
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
. ..+.....++.+++.+|++.||++||++.|+++.|++.
T Consensus 230 ~--------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 230 L--------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred C--------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0 01123345788999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.02 Aligned_cols=239 Identities=23% Similarity=0.266 Sum_probs=193.4
Q ss_pred ceeeecCceEEEEEEe----CCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEccc
Q 007608 278 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 352 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 352 (596)
+.||+|+||.||++.. .+|+.||+|++.... .......+..|++++.+++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 368899999987422 22234567789999999999999999999999999999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc
Q 007608 353 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432 (596)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 432 (596)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999998865 34689999999999999999999999 999999999999999999999999999876543321
Q ss_pred eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCC
Q 007608 433 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 512 (596)
Q Consensus 433 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 512 (596)
......|++.|+|||.+.+..++.++|||||||++|||+||+.||...... .....+ ... . .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~i---~~~-~---------~ 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETMTMI---LKA-K---------L 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHHHHH---HcC-C---------C
Confidence 223356899999999999888999999999999999999999999753221 111111 111 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 007608 513 TYDSKEVETMVQVALLCTQSTPEDRPPMAQ 542 (596)
Q Consensus 513 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 542 (596)
..+......+.+++.+||+.||++||++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 112223456788999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.39 Aligned_cols=259 Identities=20% Similarity=0.254 Sum_probs=201.0
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC
Q 007608 266 ELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 342 (596)
Q Consensus 266 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 342 (596)
++....++|+..+.||+|+||.||++... +++.+|+|.+... ........+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999975 6889999998632 22233456889999999999999999999999999
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++||||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999999998864 2478889999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeccccccccccCcccccCC----CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHh
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTG----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 498 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 498 (596)
+...............||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--------~~~~~i~ 260 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--------GTYSKIM 260 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------HHHHHHH
Confidence 987654332223345699999999998654 3788999999999999999999999754321 1111111
Q ss_pred ccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 007608 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM 546 (596)
Q Consensus 499 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 546 (596)
.......+ . ........+.+++..|+..++.+ ||++.|++++
T Consensus 261 ~~~~~~~~-----p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKNSLNF-----P-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCcccCC-----C-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11100000 0 01123455677788888755543 8899998775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=304.39 Aligned_cols=248 Identities=20% Similarity=0.320 Sum_probs=208.7
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.+|++.+.||+|.||.|-+|.. ..|+.||||.+++.. ++...-.+.+|+++|..++||||+.++.+|.+.+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677788999999999999994 689999999998543 3344456889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||..+|.|.+++.. ...++..++..++.||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+..
T Consensus 133 EYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999987 45699999999999999999999999 999999999999999999999999999987754
Q ss_pred cCcceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
. ...+.++|++-|.+||.+.+.+| .+..|.||+||+||-|+.|.-||++.+. ...+++..+ +.+.+
T Consensus 206 ~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvrQIs~-GaYrE-- 272 (668)
T KOG0611|consen 206 K--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVRQISR-GAYRE-- 272 (668)
T ss_pred c--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHHHhhc-ccccC--
Confidence 3 23456789999999999999987 5789999999999999999999986432 222232221 11111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
++.+.+..-++.+|+..+|++|.|..+|..+.
T Consensus 273 --------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 --------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 22233566788899999999999999998764
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=306.48 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=195.9
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCCh
Q 007608 280 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 356 (596)
Q Consensus 280 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (596)
||+|+||.||++..+ +|+.||+|++.... .......+..|++++.+++||||+++.+++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 68999999986321 122344566799999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceecc
Q 007608 357 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 436 (596)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 436 (596)
.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 98886432 34588999999999999999999998 99999999999999999999999999987664322 2223
Q ss_pred ccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCH
Q 007608 437 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 516 (596)
Q Consensus 437 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 516 (596)
..|+..|+|||++.+..++.++|||||||++|||++|+.||....... . ..+......... ......
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~---~~~~~~~~~~~~---------~~~~~~ 220 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-A---KEELKRRTLEDE---------VKFEHQ 220 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-h---HHHHHHHhhccc---------cccccc
Confidence 458999999999998889999999999999999999999987432111 1 111111111110 000111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 517 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 517 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
....++.+++.+||+.||++||+++|+++.+.
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 23456889999999999999999988875554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=316.82 Aligned_cols=243 Identities=25% Similarity=0.341 Sum_probs=194.2
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
++||+|+||.||+|+.. +++.||+|++.... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999965 57899999987421 233445677888888866 799999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|...+.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 999988875 34588999999999999999999999 999999999999999999999999999875432211 2
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ...+.+ ..... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~~i---~~~~~----------~ 214 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFESI---LHDDV----------L 214 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHHHH---HcCCC----------C
Confidence 23346899999999999989999999999999999999999999754321 111111 11110 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRP-------PMAQVVKM 546 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~evl~~ 546 (596)
.+.....++.+++.+|++.||++|| ++.+++++
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1112345778899999999999999 67777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=313.83 Aligned_cols=260 Identities=28% Similarity=0.410 Sum_probs=205.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC--------CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEec
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 340 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 340 (596)
..++|.+.+.||+|+||.||+|... ....+|+|.++..........+.+|++++.++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4467888999999999999999742 24579999987544445567788999999999 69999999999999
Q ss_pred CCeeEEEEEcccCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEE
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 408 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl 408 (596)
.+..++|+||+++|+|.+++..... ....+++.+..+++.|++.||.|||+. +++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 8899999999999999999975321 124589999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEeeccccccccccCcce-eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhh
Q 007608 409 LDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE 486 (596)
Q Consensus 409 l~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~ 486 (596)
+++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--- 243 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--- 243 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 9999999999999998654322111 111224567999999998889999999999999999999 88888643221
Q ss_pred hchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 487 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 487 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
....... .... ...+.....++.+++.+|++.+|++||++.|+++.|++
T Consensus 244 --~~~~~~~----~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 244 --ELFKLLR----EGHR--------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred --HHHHHHH----cCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 1111111 1110 01122334578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=302.80 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=203.6
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
+|+..+.||+|+||.||++... ++..+|+|.++........+.+.+|+.+++.++|+|++++.+.+...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4777899999999999999965 688999999864444445677889999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++++|.+++.... ...++....+.++.|++.||.|||+. +++|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999886532 24578899999999999999999999 999999999999999999999999999876643221
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcC
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 511 (596)
......|++.|+|||+..+..++.++||||||+++|+|++|+.||...... ....... .+...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~-~~~~~------- 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--------NLILKVC-QGSYK------- 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--------HHHHHHh-cCCCC-------
Confidence 122345788999999999888999999999999999999999999743211 1111111 11111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 512 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..+......+.+++.+||+.||++||++.|++..
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122234567899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=301.30 Aligned_cols=255 Identities=28% Similarity=0.363 Sum_probs=193.8
Q ss_pred ceeeecCceEEEEEEeCC---CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCC
Q 007608 278 NIIGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 354 (596)
+.||+|+||.||+|...+ +..+|+|.++..........|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 45799999875444445567899999999999999999999999999999999999999
Q ss_pred ChhhhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 355 SVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 355 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
+|.+++..... .....++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 223567888889999999999999999 99999999999999999999999999987543322211
Q ss_pred -eccccccccccCcccccCC-------CCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 434 -TTQIRGTMGHIAPEYLSTG-------KSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 434 -~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ ...... . +...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-----~~~~~~---~-~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-----VLTYTV---R-EQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-----HHHHHh---h-cccC
Confidence 1224467889999998642 35789999999999999996 999997533211 111110 0 1111
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
...++.+.. .....+.+++..|+ .+|++||+++||++.|+
T Consensus 229 ~~~~~~~~~---~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKL---PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCC---CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 112222211 12345677888998 68999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=303.05 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=200.5
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||+|+||.||+|.. .+++.||+|++...........+.+|++++.+++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577789999999999999985 478899999986544444567799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|..+. .+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999986542 367888899999999999999999 99999999999999999999999999997654321
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||......... .............. .+.
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~------~~~ 219 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-LMPLQLLQCIVDED------PPV 219 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-cchHHHHHHHhccC------CCC
Confidence 22345889999999999889999999999999999999999999743221110 00111111111000 011
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
+. ......++.+++.+|++.+|++||+++|++++-.
T Consensus 220 ~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 220 LP--VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 10 1123456889999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.44 Aligned_cols=254 Identities=24% Similarity=0.299 Sum_probs=200.3
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++.+++||||+++++++...+..++|+||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC-ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 5788899999999999999996 47889999998643 223445688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998875 24588999999999999999999998 99999999999999999999999999998664322
Q ss_pred cceeccccccccccCccccc---CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 431 THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
. ......+++.|+|||.+. ...++.++|||||||++|||++|+.|+......... .. .... ...
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--------~~-~~~~---~~~ 227 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--------FL-MSKS---NFQ 227 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--------ee-eecC---CCC
Confidence 1 112345788999999874 345788999999999999999999998532211000 00 0000 000
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
.+.. .........+.+++.+|++.+|++||+++++++.|
T Consensus 228 ~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0111 11123456788999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.84 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=196.6
Q ss_pred eeeecCceEEEEEEeC---CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCC
Q 007608 279 IIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 355 (596)
Q Consensus 279 ~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (596)
.||+|+||.||+|.+. ++..||+|++.........+.|.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 355799999875444445567999999999999999999999885 456789999999999
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCccee-
Q 007608 356 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT- 434 (596)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~- 434 (596)
|.+++... ...+++..+++++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99988742 24689999999999999999999998 999999999999999999999999999986543322211
Q ss_pred -ccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCC
Q 007608 435 -TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 512 (596)
Q Consensus 435 -~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 512 (596)
....++..|+|||.+.+..++.++|||||||++||+++ |..||...... .....+. .+.. .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~----~~~~--------~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EVMSFIE----QGKR--------L 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHH----CCCC--------C
Confidence 11223578999999988889999999999999999996 99998743221 1111111 1110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 513 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 513 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
..+.....++.+++.+||..+|++||++.+|.+.|+..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11223456788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=328.49 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=194.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC-------
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------- 341 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------- 341 (596)
...+|...+.||+|+||.||+|... +++.||||++... .....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 4467999999999999999999964 6889999988532 12345799999999999999998876432
Q ss_pred -CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC-cEEEee
Q 007608 342 -SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCD 419 (596)
Q Consensus 342 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~D 419 (596)
...++||||+++ ++.+++.........+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 135689999985 77777765444456789999999999999999999999 999999999999998664 799999
Q ss_pred ccccccccccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHh
Q 007608 420 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 498 (596)
Q Consensus 420 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 498 (596)
||+++....... .....||+.|+|||++.+. .++.++|||||||++|||+||.+||......+. +...+. ..
T Consensus 215 FGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~----~~~i~~-~~ 287 (440)
T PTZ00036 215 FGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ----LVRIIQ-VL 287 (440)
T ss_pred cccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHH-Hh
Confidence 999986643222 2234579999999998764 689999999999999999999999975432211 111111 10
Q ss_pred ccC----------cccccccCcCC-----C-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 499 RED----------RLNDIVDRNLN-----T-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 499 ~~~----------~~~~~~d~~l~-----~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
... ...++.-+... . ++...+.++.+++.+||+.||.+||++.|++++
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000 00000000000 0 122234678899999999999999999999764
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=314.05 Aligned_cols=241 Identities=26% Similarity=0.344 Sum_probs=191.6
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHh-cCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||.||+|... +++.||+|+++... .......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999987432 12334556677778776 4899999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999999875 24588999999999999999999999 999999999999999999999999999875322111 2
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+.. .. + .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~i~~---~~-------~---~ 214 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-----ELFQSIRM---DN-------P---C 214 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh---CC-------C---C
Confidence 23346899999999999989999999999999999999999999753321 11111110 00 0 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMA-QVV 544 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 544 (596)
++.....++.+++.+|++.||++||++. ++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1122345678899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=307.90 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=202.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
.+|...+.||+|+||.||++... ++..+|+|.+.. ........|.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 45677889999999999999732 456799998864 33445678999999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPG-----------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 414 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 414 (596)
+++||+++++|.+++...... ...+++..++.++.|++.|++|||+. +++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 999999999999998754321 13588999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHH
Q 007608 415 AVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 492 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~ 492 (596)
++|+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~ 235 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-----EAIE 235 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-----HHHH
Confidence 999999998765432211 1122335678999999999999999999999999999998 88888642211 1111
Q ss_pred HHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 493 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 493 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
... ..... ..+...+..+.+++.+||+.||++||++.||.+.|+
T Consensus 236 ~~~---~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CIT---QGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHH---cCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111 11100 011223456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.54 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=199.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|...+.||+|+||.||+|+.+ +++.||+|.++..........+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 67889999987544444455678999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 985 787777643 23578899999999999999999999 99999999999999999999999999987653322
Q ss_pred cceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc---Cccc--
Q 007608 431 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLN-- 504 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~~-- 504 (596)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||......+.. ..+...... ....
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL-----HLIFRLLGTPTEETWPGI 232 (309)
T ss_pred cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHHHHhCCCCHHHHhhh
Confidence 11 122347889999999865 45889999999999999999999999754332111 111100000 0000
Q ss_pred ----ccccCcCCC--------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 505 ----DIVDRNLNT--------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 505 ----~~~d~~l~~--------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+..+..... .......++.+++.+|++.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 01123456789999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=322.67 Aligned_cols=253 Identities=19% Similarity=0.209 Sum_probs=196.3
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|...+.||+|+||.||++... +++.||+|++... ........+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999864 7899999998632 12334567889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999875 24588899999999999999999999 999999999999999999999999999863321
Q ss_pred cCcc----------------------------------------------eeccccccccccCcccccCCCCCcccccHH
Q 007608 429 KLTH----------------------------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFG 462 (596)
Q Consensus 429 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S 462 (596)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001245899999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCC---CC
Q 007608 463 YGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR---PP 539 (596)
Q Consensus 463 ~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps 539 (596)
|||++|||+||+.||......+ . ............+ +. ......++.+++.+|+. +|.+| ++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~-----~---~~~i~~~~~~~~~--p~----~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHE-----T---YRKIINWRETLYF--PD----DIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHH-----H---HHHHHccCCccCC--CC----CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 9999999999999997533211 1 1111110000000 00 11224567788889997 66665 59
Q ss_pred HHHHHHH
Q 007608 540 MAQVVKM 546 (596)
Q Consensus 540 ~~evl~~ 546 (596)
+.|++++
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9888775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=309.75 Aligned_cols=263 Identities=23% Similarity=0.341 Sum_probs=203.5
Q ss_pred CCCcCceeeecCceEEEEEEe-----CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC--CeeE
Q 007608 273 NFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERI 345 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~ 345 (596)
.|...+.||+|+||.||.+.. .++..||+|.++..........+.+|++++++++|||++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467789999999999999974 357889999987544444567899999999999999999999998775 5678
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999998642 23589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcc--eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchh-------hhhchHHHHHHH
Q 007608 426 VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE-------EEDVLLLDHIRK 496 (596)
Q Consensus 426 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~-------~~~~~l~~~~~~ 496 (596)
....... ......++..|+|||++.+..++.++||||||+++|||+|++.|........ .........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR- 237 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-
Confidence 6443221 1223446778999999988889999999999999999999876643211000 00000111111
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...... ....+...+..+.+++.+|++.+|++||+++++++.|+++
T Consensus 238 ~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGK--------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCc--------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111110 0011223456899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=305.28 Aligned_cols=250 Identities=27% Similarity=0.420 Sum_probs=196.2
Q ss_pred ceeeecCceEEEEEEeCC-Cc--EEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLSD-NT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
++||+|+||.||+|..++ +. .+++|.++..........+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999753 43 46888887544445567889999999999 799999999999999999999999999
Q ss_pred CChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 354 LSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 354 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
|+|.+++..... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999875321 123588999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||...... .. .......
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~---~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----EL---YEKLPQG 227 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HH---HHHHhCC
Confidence 9863321111 111223567999999988889999999999999999997 99998643211 11 1111111
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
... ..+.....++.+++.+|+..+|.+||++.|+++.|++
T Consensus 228 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 228 YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 100 0112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=317.18 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=201.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEe------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecC-
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS- 341 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~- 341 (596)
..++|+..+.||+|+||.||+|.. .+++.||||+++..........+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346789999999999999999973 357889999997544444556788999999999 689999999988655
Q ss_pred CeeEEEEEcccCCChhhhhcccCC--------------------------------------------------------
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKP-------------------------------------------------------- 365 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 365 (596)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 456899999999999998864211
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc-ceeccc
Q 007608 366 -------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQI 437 (596)
Q Consensus 366 -------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~ 437 (596)
....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........ ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 012478889999999999999999999 999999999999999999999999999986532211 111223
Q ss_pred cccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCH
Q 007608 438 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 516 (596)
Q Consensus 438 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 516 (596)
.++..|+|||.+.+..++.++||||||+++|||++ |..|+....... .....+ ..+.... .+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~----~~~~~~~--------~~~ 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRL----KEGTRMR--------APD 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HHHHHH----hccCCCC--------CCC
Confidence 35678999999988899999999999999999997 888886432211 111111 1111000 011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 517 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 517 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
....++.+++..||+.+|++||++.||+++|+.
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=314.71 Aligned_cols=241 Identities=24% Similarity=0.312 Sum_probs=191.3
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHh-cCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||.||+|..+ +|+.||+|.++... .......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 68899999987432 12334556777777765 4899999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999988875 34588999999999999999999999 99999999999999999999999999987432211 12
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+.. . .+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-----~~~~~~~~----~------~~---~ 214 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-----ELFESIRV----D------TP---H 214 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh----C------CC---C
Confidence 23456899999999999999999999999999999999999999753321 11111110 0 01 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMA-QVV 544 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 544 (596)
.+.....++.+++.+|++.||++||++. ++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1122345678899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=319.57 Aligned_cols=262 Identities=19% Similarity=0.248 Sum_probs=203.6
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEec
Q 007608 264 CRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 340 (596)
Q Consensus 264 ~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 340 (596)
..++....++|+..+.||+|+||.||++... +++.+|+|++... ........+.+|+.++..++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455667789999999999999999999975 6889999998632 122334567889999999999999999999999
Q ss_pred CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
....++||||+++|+|.+++.. ..++...+..++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999998864 2478888899999999999999999 9999999999999999999999999
Q ss_pred cccccccccCcceeccccccccccCcccccCC----CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
|+++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~ 258 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSK 258 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 99987654332233345699999999998653 3789999999999999999999999753321 11111
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHh
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKML 547 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L 547 (596)
.........+. ........+.+++..|+..++.+ ||++.|+.++.
T Consensus 259 i~~~~~~~~~~------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 259 IMNHKNSLTFP------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHcCCCcccCC------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11111100111 01233456778888999844433 67888887764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=284.70 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=208.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
+.++|++++.||+|.||.||.|+.+ ++..||+|++.+.. ..+...++.+|+++-+.++||||+++++|+.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3467899999999999999999964 67889999987432 33456789999999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
++||..+|++...|.... ...++......++.|+|.|+.|+|.. +++||||||+|+|++..+..|++|||-+-..
T Consensus 100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999998533 34577778889999999999999999 9999999999999999999999999987543
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
. .......+||..|.+||...+...+.+.|+|++|++.||++.|.+||.... .......++.. ++
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-----~~etYkrI~k~-------~~ 239 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-----HSETYKRIRKV-------DL 239 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-----hHHHHHHHHHc-------cc
Confidence 2 222345679999999999999999999999999999999999999998432 11222222211 11
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. ++........+++.+|+..+|.+|.+..|++++
T Consensus 240 ~------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 K------FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred c------CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1 234455678899999999999999999999765
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=315.72 Aligned_cols=242 Identities=23% Similarity=0.296 Sum_probs=193.7
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 348 (596)
+|+..+.||+|+||.||+|... +++.||+|.+.... .......+..|..++..+ .|++|+++.+++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999965 57899999987432 222344567788887776 5899999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999988875 24588999999999999999999999 999999999999999999999999999875432
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .+...+. ...
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-----~~~~~i~---~~~------- 217 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQSIM---EHN------- 217 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-----HHHHHHH---hCC-------
Confidence 21 1223456899999999999999999999999999999999999999753321 1111111 110
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 540 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 540 (596)
..++.....++.+++.+|++.||++|++.
T Consensus 218 ---~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01122345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=300.26 Aligned_cols=250 Identities=28% Similarity=0.391 Sum_probs=205.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
.++|+..+.||+|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.++++++|+|++++++++.+....++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 45788899999999999999987 478999999875332 467889999999999999999999999998999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.... ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999987532 23689999999999999999999999 99999999999999999999999999998663322
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
. ....+..|+|||++.+..++.++||||||+++|||++ |+.||...... .+...+. .....
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~----~~~~~----- 218 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPHVE----KGYRM----- 218 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHh----cCCCC-----
Confidence 1 2234668999999998889999999999999999997 99998643221 1111111 11000
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+...+..+.+++.+|+..+|++||++.|++++|+.
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 ---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1122335678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.18 Aligned_cols=262 Identities=22% Similarity=0.331 Sum_probs=203.1
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||+|+||.||++... ++..+|+|.+...........+.+|++++.+++||||+++++++.+++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999965 67889999886543444456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++... ..+++.....++.|++.||.|||+.+ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999752 45889999999999999999999732 79999999999999999999999999987553321
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc-------
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL------- 503 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~------- 503 (596)
.....++..|+|||.+.+..++.++||||||+++|||+||+.||....... ..............
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-----LEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-----HHHhhcCccccccccCCcccc
Confidence 223457899999999988889999999999999999999999986433211 11111100000000
Q ss_pred -----------------cccccCcCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 504 -----------------NDIVDRNLNTY-DSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 504 -----------------~~~~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
..+........ ......++.+++.+|+..+|++||+++||++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000000 011345688999999999999999999997753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=313.72 Aligned_cols=243 Identities=26% Similarity=0.332 Sum_probs=194.9
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||+||+|... +++.||+|+++... .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 57899999987431 233455677888888877 699999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 999988875 23689999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+. ... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~~~~i~---~~~----------~~ 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----ELFQSIL---EDE----------VR 214 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HHHHHHH---cCC----------CC
Confidence 23345899999999999999999999999999999999999999753321 1111111 110 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPM-----AQVVKM 546 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 546 (596)
++......+.+++.+||+.||++||++ .++++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 122334578899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.79 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=202.6
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
.+|+..+.||+|+||.||+|...++..+|+|.+... ......|.+|+++++++.|||++++++++......++|+||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG--AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC--CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 467778999999999999999877889999988642 223567899999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++++|.+++.... ..+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.++.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 9999999887522 3578999999999999999999998 999999999999999999999999999876543222
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.......++.+|+|||++.+..++.++||||||+++|||++ |+.||...... ...+... .+. ....+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~----~~~--~~~~~- 223 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETIN----AGF--RLYKP- 223 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHHh----CCC--CCCCC-
Confidence 21222234678999999998899999999999999999998 89998643211 1111111 110 00111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
......+.+++.+|++.+|++||++.|++++|.
T Consensus 224 -----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 -----RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.74 Aligned_cols=264 Identities=23% Similarity=0.338 Sum_probs=200.7
Q ss_pred cCCCcCceeeecCceEEEEEEe-----CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC--Cee
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 344 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 344 (596)
.+|+..+.||+|+||.||++.. .++..||+|++... .....+.|.+|++++.+++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 4678889999999999999974 25789999998643 334456789999999999999999999987543 457
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++|+||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 8999999999999998753 23589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcce--eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhh-------hhchHHHHHH
Q 007608 425 LVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE-------EDVLLLDHIR 495 (596)
Q Consensus 425 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~-------~~~~l~~~~~ 495 (596)
......... .....++..|+|||+..+..++.++|||||||++|||++|..++........ ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 764432211 1112234569999999988899999999999999999998776543211000 0000000000
Q ss_pred HHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 496 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...... ...........++.+++.+||+.+|++|||++||++.|+.+
T Consensus 237 ~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNN--------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcC--------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111000 00011223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=300.70 Aligned_cols=251 Identities=31% Similarity=0.455 Sum_probs=204.9
Q ss_pred ceeeecCceEEEEEEeCC----CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||.||+|.... +..|++|.+...........+.+|++.+..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999753 8889999997544443567899999999999999999999999999999999999999
Q ss_pred CChhhhhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 354 LSVAYRLRDLKPG-----EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 354 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999874322 35689999999999999999999998 999999999999999999999999999987654
Q ss_pred cCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 429 KLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 429 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||..... ....+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~---~~----- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLEYLRK---GY----- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHc---CC-----
Confidence 321 12233457889999999988889999999999999999999 6999875421 111121111 10
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
....+...+.++.+++.+|++.+|++||++.|++++|+
T Consensus 225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01122333568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=301.18 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=205.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
..++|...+.||+|+||.||+|...++..+++|.+... ......|.+|++++++++|+|++++.+++.. ...+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 45678889999999999999999878888999988642 2345678999999999999999999999887 77899999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999987532 34578999999999999999999998 9999999999999999999999999999765433
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
.........++..|+|||++....++.++|||||||++||++| |+.||...... ....... .....
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~~----~~~~~---- 222 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIRALE----RGYRM---- 222 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHh----CCCCC----
Confidence 2222222345678999999998889999999999999999999 89898743221 1111111 11000
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
........++.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112344578899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.59 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=203.4
Q ss_pred CCCcCceeeecCceEEEEEEeC-CC---cEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
+|+..+.||+|+||.||+|... ++ ..||+|.+...........|..|+.++++++||||+++.+++.++...++|+
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677899999999999999964 33 3699999876545556678999999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998753 23589999999999999999999998 999999999999999999999999999876543
Q ss_pred cCcce--ecccc--ccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 429 KLTHV--TTQIR--GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 429 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
..... ..... .+..|+|||++.+..++.++|||||||++||+++ |..||..... ....+++.. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~~~~~~i~~---~~~~ 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVINAIEQ---DYRL 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----HHHHHHHHc---CCcC
Confidence 22211 11111 2457999999999999999999999999999987 9999864322 112222211 0000
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+.+.+..+.+++.+|++.+|++||++.+|+.+|+.
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 231 ---------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0112334567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=300.04 Aligned_cols=248 Identities=28% Similarity=0.460 Sum_probs=198.0
Q ss_pred ceeeecCceEEEEEEeC--C--CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS--D--NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~--~--~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||.||+|... + +..+|+|.+.........+.+.+|+++++++.|+|++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46899999999999853 2 26899999875444345678999999999999999999999876 4567999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999762 3689999999999999999999998 99999999999999999999999999998664433222
Q ss_pred ec--cccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 434 TT--QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 434 ~~--~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.. ...++..|+|||...+..++.++||||||+++|||++ |+.||..... ......+.. ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~~~~~~~~---~~~~------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AEVIAMLES---GERL------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHHc---CCcC-------
Confidence 11 1223567999999998899999999999999999998 9999874322 112222221 1100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
..+...+..+.+++.+|++.+|++||++.++++.|++.
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11223346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.89 Aligned_cols=259 Identities=23% Similarity=0.365 Sum_probs=206.6
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||+|+||+||++... +++.||+|++...........+.+|++++..++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56777899999999999999964 68899999887544455567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.. ...+++.....++.+++.+|.|||+.. +++|+||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999988865 245899999999999999999999732 79999999999999999999999999987543221
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhh---hhchHHHHHHHHhccCcccccc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE---EDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~---~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.....|+..|+|||++.+..++.++|||||||++|||+||+.||........ ......+.........
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence 2234588999999999888899999999999999999999999985433211 1111222222221111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
.+.+. ......++.+++.+|++.||++||++.|++++.
T Consensus 230 ~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 01111 122456788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=299.78 Aligned_cols=252 Identities=20% Similarity=0.297 Sum_probs=206.0
Q ss_pred CCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|+..+.||+|+||.||.++. .+++.+++|.+... .+......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999985 46899999998632 3445567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999987643 24589999999999999999999998 99999999999999999999999999998664433
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
. ......+++.|+|||+..+..++.++||||||+++|||++|+.||...... +.........
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~~--------- 217 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--------NLVVKIVQGN--------- 217 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCC---------
Confidence 2 223345889999999998888999999999999999999999998743221 1111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
..........++.+++.+|+..+|++||+++|+++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 218 YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1111233456788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=327.49 Aligned_cols=258 Identities=22% Similarity=0.280 Sum_probs=208.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCCC-cEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEe-EEec------
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIG-YCTT------ 340 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~-~~~~------ 340 (596)
...++++.++|.+|||+.||.|....+ ..||+|++... ++.......+|+++|++|. |+|||.+++ ....
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 334566789999999999999997655 99999998754 6667788999999999997 999999998 3321
Q ss_pred CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
.-+.++.||||.+|+|-+++..... ..++..++++|+.++++|+++||.. +|+|||||||.+||||+.++..|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1357899999999999999986544 3499999999999999999999985 678999999999999999999999999
Q ss_pred cccccccccCc-ce-------eccccccccccCcccc---cCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhch
Q 007608 421 GLAKLVDAKLT-HV-------TTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 489 (596)
Q Consensus 421 Gl~~~~~~~~~-~~-------~~~~~gt~~y~aPE~~---~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~ 489 (596)
|.+.-...... .. .-...-|+.|+|||.+ .+..+++|+|||++||+||-|+....||+...
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------- 262 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------- 262 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------
Confidence 99874322211 10 0012368999999987 46789999999999999999999999998431
Q ss_pred HHHHHHHHhccCcccccccCcCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCc
Q 007608 490 LLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL 552 (596)
Q Consensus 490 l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 552 (596)
...|++....- ..+.+...+.+||..||+.+|++||++.||+..+-++.-
T Consensus 263 -------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 263 -------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 11233332221 235788999999999999999999999999998776443
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=315.22 Aligned_cols=262 Identities=27% Similarity=0.382 Sum_probs=206.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC--------CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEec
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 340 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 340 (596)
...+|.+.+.||+|+||.||+|... .+..||+|.++..........+.+|++++.++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3456888999999999999999742 12368999887544445567899999999999 79999999999999
Q ss_pred CCeeEEEEEcccCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEE
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 408 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl 408 (596)
.+..++++||+++|+|.+++..... ....++|.++..++.|++.||+|||+. +++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 9999999999999999999875321 134588999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhh
Q 007608 409 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE 486 (596)
Q Consensus 409 l~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~ 486 (596)
++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 243 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--- 243 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 999999999999999865432211 1122234567999999999899999999999999999998 88888643221
Q ss_pred hchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 007608 487 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 551 (596)
Q Consensus 487 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 551 (596)
+.......... ...+.....++.+++.+|++.+|++||++.|+++.|+.+.
T Consensus 244 -----~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 -----ELFKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -----HHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 11111111110 0112233457889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.19 Aligned_cols=245 Identities=23% Similarity=0.282 Sum_probs=191.9
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||.||+|... +++.||+|+++... .......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 67899999997432 223445688899998888 699999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 999988864 34689999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||........ ....+........... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~---------~ 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD--MNTEDYLFQVILEKPI---------R 221 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc--cccHHHHHHHHHhCCC---------C
Confidence 2345689999999999999999999999999999999999999964321111 0111111111111110 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMA 541 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 541 (596)
.+......+.+++.+|++.||++||++.
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 1222345678899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.10 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=199.7
Q ss_pred ceeeecCceEEEEEEeCC-------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 278 NIIGQGGFGKVYKGVLSD-------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+.||+|+||.||+|+..+ +..+|+|.+...........+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2579999886544444567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC-----cEEEeeccc
Q 007608 351 MQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-----EAVLCDFGL 422 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-----~~kl~DfGl 422 (596)
+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.+. .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 124578999999999999999999998 999999999999999877 899999999
Q ss_pred cccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 423 AKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 423 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
++........ ......++..|+|||++.+..++.++|||||||++|||+| |+.||...... .....+. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~---~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-----EVLQHVT---AG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-----HHHHHHh---cC
Confidence 8765432211 1122335678999999999999999999999999999998 99998643221 1111111 11
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.. ...+...+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 230 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 GR---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred Cc---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 01122345678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.20 Aligned_cols=201 Identities=22% Similarity=0.245 Sum_probs=172.0
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
+|+..+.||+|+||+||+|... +++.||+|++.... .......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999964 68899999986421 22345678899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++|+|.+++... ..++......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999998752 3578888999999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------cceeccccccccccCcccccCCCCCcccccHHH
Q 007608 430 L----------------------------------------------THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGY 463 (596)
Q Consensus 430 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~ 463 (596)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000112458999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCc
Q 007608 464 GITLLELVTGQRAIDFS 480 (596)
Q Consensus 464 Gvil~elltg~~p~~~~ 480 (596)
||++|||++|+.||...
T Consensus 235 Gvil~elltG~~Pf~~~ 251 (382)
T cd05625 235 GVILYEMLVGQPPFLAQ 251 (382)
T ss_pred hHHHHHHHhCCCCCCCC
Confidence 99999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=297.81 Aligned_cols=249 Identities=29% Similarity=0.380 Sum_probs=199.7
Q ss_pred ceeeecCceEEEEEEeCC--C--cEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLSD--N--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|++|.||+|.+.+ + ..||+|.+.........+.|.+|+..+++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 36899998754433556789999999999999999999999988 888999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc-
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH- 432 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~- 432 (596)
++|.+++.+... ..+++.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999986432 4689999999999999999999999 9999999999999999999999999999876543222
Q ss_pred -eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 433 -VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 433 -~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
......++..|+|||++.+..++.++|||||||++|||+| |+.||...... ........ ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~---~~~-------- 218 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKKIDK---EGE-------- 218 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHh---cCC--------
Confidence 1122446789999999998899999999999999999999 99998643221 11111111 000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
....+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00112233467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=302.95 Aligned_cols=256 Identities=22% Similarity=0.363 Sum_probs=203.4
Q ss_pred hcCCCcCceeeecCceEEEEEEeCC----CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
.++|...+.||+|+||.||+|...+ ...|++|...........+.+.+|+.+++++.|||++++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3567788999999999999998643 346899988754444556789999999999999999999998875 45789
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999999753 23589999999999999999999998 9999999999999999999999999999866
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
............++..|+|||.+....++.++||||||+++||+++ |..||...... .....+. .....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~~---~~~~~-- 227 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----DVIGRIE---NGERL-- 227 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHH---cCCcC--
Confidence 5432222222334568999999988889999999999999999996 99998754321 1111111 11111
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
..+...+..+.+++.+|+..+|++||++.++++.|++.
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11223345788899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=322.00 Aligned_cols=252 Identities=21% Similarity=0.204 Sum_probs=194.8
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
+|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++.+++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999964 68999999986321 22234668899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++|+|.+++.. ...++......++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999875 24578888899999999999999999 9999999999999999999999999997532100
Q ss_pred C------------------------------------------cceeccccccccccCcccccCCCCCcccccHHHHHHH
Q 007608 430 L------------------------------------------THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITL 467 (596)
Q Consensus 430 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil 467 (596)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001124689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHH
Q 007608 468 LELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP---PMAQVV 544 (596)
Q Consensus 468 ~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl 544 (596)
|||++|+.||......+. ...+.. .. .....+. ......++.+++.+|+ .+|.+|+ ++.|++
T Consensus 235 yell~G~~Pf~~~~~~~~-----~~~i~~---~~--~~~~~~~----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 235 YEMLVGQPPFLADTPAET-----QLKVIN---WE--TTLHIPS----QAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eehhhCCCCCCCCCHHHH-----HHHHhc---cC--ccccCCC----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 999999999975432111 111110 00 0000010 1122345566666665 5999999 888887
Q ss_pred HH
Q 007608 545 KM 546 (596)
Q Consensus 545 ~~ 546 (596)
++
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 65
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=300.77 Aligned_cols=254 Identities=27% Similarity=0.402 Sum_probs=199.0
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchH-HHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~-~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
|+..+.||+|+||+||++... +++.+|+|.+......... ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999976 5678999999754322222 23456999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred ccccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 99999999983 35689999999999999999999999 999999999999999999999999999976422 12
Q ss_pred ceeccccccccccCccccc-CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 432 HVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.......++..|+|||++. +..++.++||||+|+++|+|++|..|+......... ...............
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~-------- 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL-EIIEKILKRPLPSSS-------- 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH-HHHHHHHHTHHHHHT--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhh-hhhhhcccccccccc--------
Confidence 2334456899999999998 788999999999999999999999999854211111 111111110000000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. .......++.+++.+||+.||++||++.|++++
T Consensus 224 -~-~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 -Q-QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -T-SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -c-ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000112688999999999999999999999753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=335.70 Aligned_cols=260 Identities=22% Similarity=0.322 Sum_probs=202.2
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC--cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||+|... +++.||+|++..... +...+.|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999965 689999999874322 234567899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 349 PFMQNLSVAYRLRDLKP-------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
||+++|+|.+++..... ....+++..+++++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 123467788899999999999999999 99999999999999999999999999
Q ss_pred ccccccccCc-----------------ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchh
Q 007608 422 LAKLVDAKLT-----------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 484 (596)
Q Consensus 422 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~ 484 (596)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521100 01122468999999999999999999999999999999999999997422110
Q ss_pred hhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhcc
Q 007608 485 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-PMAQVVKMLQG 549 (596)
Q Consensus 485 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~ 549 (596)
... .. . +.++.-.......+..+.+++.+|++.||++|| +++++.+.|+.
T Consensus 239 -----i~~--~~-----~---i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 -----ISY--RD-----V---ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred -----hhh--hh-----h---ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 00 0 000100000123345678899999999999995 56666666654
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=299.38 Aligned_cols=254 Identities=20% Similarity=0.336 Sum_probs=190.6
Q ss_pred eeeecCceEEEEEEeCCC---cEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCC
Q 007608 279 IIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 355 (596)
Q Consensus 279 ~lG~G~~g~Vy~~~~~~~---~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (596)
.||+|+||.||+|...++ ..+++|.+...........|.+|+..++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985433 34667766544444456789999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC-ccee
Q 007608 356 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL-THVT 434 (596)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~-~~~~ 434 (596)
|.+++..........++...+.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999986443334567778889999999999999998 99999999999999999999999999986432211 1112
Q ss_pred ccccccccccCcccccC-------CCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 435 TQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 435 ~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
....++..|+|||++.. ..++.++|||||||++|||++ |..||...... +.+...... .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~-~~~~~ 229 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--------EVLNHVIKD-QQVKL 229 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhh-ccccc
Confidence 23457889999999753 245789999999999999997 46677532211 111111111 11222
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
.++.+.. .....+.+++..|+ .+|++||+++||++.|.
T Consensus 230 ~~~~~~~---~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLEL---PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCC---CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333222 13345677888899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.83 Aligned_cols=239 Identities=26% Similarity=0.293 Sum_probs=188.9
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHH-HHHhcCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||+||+|... +|+.||+|++.... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 78999999986321 1222344555554 56789999999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999998875 34688999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........ .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~-~~---------~ 214 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--------EMYDNILNK-PL---------R 214 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcC-CC---------C
Confidence 23456899999999999999999999999999999999999999753321 111111111 00 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMAQ 542 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 542 (596)
........+.+++.+|++.||.+||++.+
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 215 LKPNISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 11223557888999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=301.88 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=203.0
Q ss_pred CCCcCceeeecCceEEEEEEeCC--CcEEEEEEcccc---------CCcchHHHHHHHHHHHHh-cCCCCccceEeEEec
Q 007608 273 NFSESNIIGQGGFGKVYKGVLSD--NTKVAVKRLQDY---------YSPGGEAAFQREVHLISV-AIHKNLLQLIGYCTT 340 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~l~~~---------~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~ 340 (596)
+|+..+.||+|+||.||+|.... ++.+|+|.+... ........+.+|+.++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999764 688999987522 112234557788888765 799999999999999
Q ss_pred CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
.+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+.. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988654444556899999999999999999999631 7999999999999999999999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
|.+....... ......++..|+|||...+..++.++||||||+++|||++|+.||...... .....+. .
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-----~~~~~~~----~ 227 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-----SLATKIV----E 227 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-----HHHHHHh----h
Confidence 9998665432 223445788999999999888999999999999999999999998643221 1111111 1
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...... ........+.+++.+|++.||++||++.|+.+++++
T Consensus 228 ~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVYEPL-------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccCCcC-------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111100 011234578899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=303.80 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=199.1
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|+..+.||+|++|.||+|+.. +++.||+|+++... .......+.+|+.++.+++|||++++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777899999999999999965 68999999986432 233346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
++ ++|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 688888875433 35689999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc--cC------
Q 007608 431 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR--ED------ 501 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~--~~------ 501 (596)
. ......+++.|+|||++.+. .++.++|||||||++|||+||+.||........ .......... ..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ----LFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHHhCCCChhhhhcch
Confidence 1 11223468899999988654 478999999999999999999999975432111 1111100000 00
Q ss_pred ---cccccc----cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 ---RLNDIV----DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ---~~~~~~----d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.....+ .............++.+++.+|++.||++||++.||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 000000111234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=313.10 Aligned_cols=265 Identities=21% Similarity=0.290 Sum_probs=197.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC-----
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----- 342 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----- 342 (596)
..++|+..+.||+|+||.||++... +|..||+|++.... .......+.+|+.++..++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999964 68999999986432 3334567889999999999999999999886543
Q ss_pred -eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 343 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 343 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
..++||||+++ ++...+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999975 56555532 378888999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhc----------hH-
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV----------LL- 490 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~----------~l- 490 (596)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...+....-.. ..
T Consensus 169 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 997543321 22334589999999999999999999999999999999999999975432110000 00
Q ss_pred ---HHHHHHHhccC-c-----ccccccC----cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 491 ---LDHIRKLLRED-R-----LNDIVDR----NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 491 ---~~~~~~~~~~~-~-----~~~~~d~----~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+....... . ..+.... ...........++.+++.+|++.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00011110000 0 0000000 0000111224567899999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=298.77 Aligned_cols=248 Identities=26% Similarity=0.348 Sum_probs=199.7
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEe-cCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT-TSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~ 350 (596)
++|...+.||+|+||.||++.. .|..||+|.++.. ...+.|.+|+.++++++|+|++++++++. ..+..++|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 4688889999999999999987 4788999988642 23567899999999999999999999764 45668999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999987532 23588999999999999999999998 99999999999999999999999999987543321
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
....++..|+|||+..+..++.++|||||||++|||++ |+.||...... .....+. .+...
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~-----~~~~~~~----~~~~~----- 218 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVE----KGYKM----- 218 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHh----cCCCC-----
Confidence 12234668999999998889999999999999999998 89888643221 1111111 11100
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
......+..+.+++.+|++.+|++||++.++++.|++
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 ---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=304.13 Aligned_cols=260 Identities=25% Similarity=0.319 Sum_probs=193.8
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC-cchHHHHHHHHHHHHhc---CCCCccceEeEEecC-----C
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVA---IHKNLLQLIGYCTTS-----S 342 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~-----~ 342 (596)
+|+..+.||+|+||+||+|... +++.||+|.++.... ......+.+|+.++..+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999965 688999999874322 22234566777777655 699999999988643 3
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 47899999984 8888886532 24589999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc--
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE-- 500 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~-- 500 (596)
++...... ......|+..|+|||++.+..++.++|||||||++|||++|++||......+. +.. +......
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~----~~~-~~~~~~~~~ 227 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ----LGK-IFDLIGLPP 227 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH----HHH-HHHHhCCCC
Confidence 98664322 12234578999999999988999999999999999999999999875332111 111 1111000
Q ss_pred -Cccc-------ccccCcC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 501 -DRLN-------DIVDRNL----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 501 -~~~~-------~~~d~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.... ..+.+.. .........++.+++.+|++.||++||++.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0000000 0011233456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=300.28 Aligned_cols=254 Identities=27% Similarity=0.351 Sum_probs=190.9
Q ss_pred eeeecCceEEEEEEeCC---CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCC
Q 007608 279 IIGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 355 (596)
Q Consensus 279 ~lG~G~~g~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (596)
.||+|+||.||+|...+ ...+++|.+...........|.+|++.++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 456888887654444456678999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc-e
Q 007608 356 VAYRLRDLKPG-EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-V 433 (596)
Q Consensus 356 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~ 433 (596)
|.+++...... ....++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764322 23356788899999999999999999 9999999999999999999999999998754322111 1
Q ss_pred eccccccccccCcccccC-------CCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 434 TTQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
.....++..|+|||+... ..++.++|||||||++|||++ |..||...... ..+. ...... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~~----~~~~~~-~~~ 229 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE----QVLK----QVVREQ-DIK 229 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHHH----HHhhcc-Ccc
Confidence 122345678999998742 356889999999999999999 77787643211 1111 111111 111
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
+.++. ........+.+++..|+ .||++||+++||++.|.
T Consensus 230 ~~~~~---~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQ---LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCc---ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11121 12233455667778888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=302.48 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=204.2
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||.|+||.||+|... +++.||+|.+...........+.+|+++++.++|+|++++.+++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999965 68899999987544445567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++... .+++.....++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998752 689999999999999999999998 99999999999999999999999999998775432
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
. ......+++.|+|||++.+..++.++||||||+++|||+||+.||...... .....+. .... +.
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~----~~~~-----~~ 217 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVLFLIP----KNNP-----PS 217 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHHHHhh----hcCC-----CC
Confidence 2 222345788999999999888999999999999999999999999743211 0111111 1111 11
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+.. ......+.+++.+|+..+|++||++++++++
T Consensus 218 ~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred Ccc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 110 0144568889999999999999999999773
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=296.78 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=200.6
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEec-----CCe
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-----SSE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~ 343 (596)
...|...+.||+|+||.|+.+..+ +|+.||+|++.+. ......+.-.+|+.+++.++|+||+.+...+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345555789999999999999964 7899999999743 334445667899999999999999999998865 356
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.|+|+|+|+ -+|...++. ++.++.....-++.|+++||.|+|+. +++||||||+|++++.+...||+|||+|
T Consensus 101 vYiV~elMe-tDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELME-TDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHHh-hHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 899999995 588888875 45589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccC-cceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc--
Q 007608 424 KLVDAKL-THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR-- 499 (596)
Q Consensus 424 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~-- 499 (596)
+..+... ....+....|..|+|||++.. ..||...||||.|||+.||++|++-|.+.+.... .+.+...+.
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q-----l~lI~~~lGtP 247 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ-----LQLILELLGTP 247 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH-----HHHHHHhcCCC
Confidence 9876431 122345668999999999854 5799999999999999999999999986543211 111111110
Q ss_pred -c--------Cccccccc--CcCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 500 -E--------DRLNDIVD--RNLNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 500 -~--------~~~~~~~d--~~l~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+ +.....+. +.... .-+......+++..+||..||.+|+|++|.+++
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 00000000 00000 111334567888999999999999999999764
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=295.93 Aligned_cols=248 Identities=29% Similarity=0.443 Sum_probs=200.0
Q ss_pred ceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCChh
Q 007608 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVA 357 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 357 (596)
++||+|+||.||++...+++.|++|.+...........|.+|+++++++.|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999987799999999875444345678999999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCccee-cc
Q 007608 358 YRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT-TQ 436 (596)
Q Consensus 358 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~-~~ 436 (596)
+++... ...+++.....++.+++.|++|||++ +++||||||+||+++.++.++|+|||++........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998753 23578999999999999999999999 999999999999999999999999999986543221111 11
Q ss_pred ccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCC
Q 007608 437 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD 515 (596)
Q Consensus 437 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 515 (596)
..++..|+|||.+.+..++.++|||||||++|||+| |..||...... .....+. ... . ...+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-----~~~~~~~----~~~--~------~~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-----QTRERIE----SGY--R------MPAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-----HHHHHHh----cCC--C------CCCC
Confidence 223567999999988899999999999999999999 78888643221 1111111 000 0 0112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 516 SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 516 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
...+.++.+++.+|+..+|++||++.|+++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 234567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=299.63 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=204.0
Q ss_pred cCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
++|+..+.||+|+||.||+|+.+ +.+.|++|.+...........+.+|++++++++|+|++++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999964 346799998864333324567999999999999999999999999989999
Q ss_pred EEEEcccCCChhhhhcccCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGE-----KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
+||||+++|+|.+++....... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997643221 2689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhc
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLR 499 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~ 499 (596)
|++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----~~~~~~~~---- 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----EEVLNRLQ---- 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----HHHHHHHH----
Confidence 9987543322222233346778999999988888999999999999999999 7778753211 11111111
Q ss_pred cCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 500 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 500 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
...... ......+..+.+++.+|++.+|++||++.|+++.|+
T Consensus 233 ~~~~~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 AGKLEL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCcCC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111100 011233457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=301.60 Aligned_cols=263 Identities=24% Similarity=0.298 Sum_probs=205.8
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC--CeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 348 (596)
++|+..+.||.|++|.||++... +++.+|+|.+...........+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999974 68899999987544444567789999999999999999999988654 3679999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++.........++......++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988765444445688999999999999999999998 999999999999999999999999999875533
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...............+.... ....+.+
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 230 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELKD 230 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhhcc
Confidence 221 223468899999999988999999999999999999999999985432111122222322211 0001100
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. . .........+.+++.+|++.+|++||++.|+++.
T Consensus 231 ~-~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 231 E-P-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred C-C-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 0 0011245678899999999999999999999883
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=299.85 Aligned_cols=250 Identities=28% Similarity=0.414 Sum_probs=192.6
Q ss_pred ceeeecCceEEEEEEeC----CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec-CCeeEEEEEccc
Q 007608 278 NIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILVYPFMQ 352 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~~ 352 (596)
+.||+|+||.||+|... +...||+|++...........+.+|+.+++.++|||++++++++.. ++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998643334456788899999999999999999998764 456789999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc
Q 007608 353 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432 (596)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 432 (596)
+++|.+++.... ...++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999987532 3467788899999999999999998 9999999999999999999999999999765332111
Q ss_pred e---eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhC-CCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 433 V---TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 433 ~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg-~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
. .....++..|+|||++.+..++.++|||||||++|||++| ..|+..... ......+ ......
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~~~~---~~~~~~----- 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----FDITVYL---LQGRRL----- 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHH---hcCCCC-----
Confidence 1 1123456789999999888999999999999999999995 455543211 1111111 111100
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
..+...+..+.+++.+||+.+|++||++.||++.|++.
T Consensus 222 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 ----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 01112245788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=303.46 Aligned_cols=255 Identities=23% Similarity=0.391 Sum_probs=203.0
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||+|+||.||++... ++..||+|.+...........+.+|++++.+++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46788899999999999999975 78999999887544444557889999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|..++.... ....+++..+..++.|++.||.|||+.+ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999998887532 1246899999999999999999999642 89999999999999999999999999987653321
Q ss_pred cceeccccccccccCcccccCCC------CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGK------SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
.....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||...... ........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-------- 221 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLSA-------- 221 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHHH--------
Confidence 22334788999999985543 488999999999999999999999643211 11111111
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+.+......+.....++.+++.+|++.+|++||++.+++..
T Consensus 222 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 222 -IVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -HhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111112233456778899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=308.44 Aligned_cols=256 Identities=21% Similarity=0.250 Sum_probs=196.1
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||+||+++.. +++.||+|++... ........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47888999999999999999965 6899999998631 22334566889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998752 23588899999999999999999999 999999999999999999999999999876544
Q ss_pred cCcceeccccccccccCcccccC-----CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~ 226 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHKEH 226 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCc
Confidence 33222233458999999999863 45788999999999999999999999753321 111111111110
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQS--TPEDRPPMAQVVKM 546 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~ 546 (596)
.. +..........+.+++.+|+.. ++..||++++++++
T Consensus 227 ~~-----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 FQ-----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cc-----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 0111112344566677776644 44447899888775
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=306.68 Aligned_cols=264 Identities=25% Similarity=0.338 Sum_probs=201.3
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|...+.||+|+||.||+|..+ +++.||+|.+...........+.+|+.++++++||||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999965 68899999987444444455678999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
++ ++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5888887653 23578999999999999999999999 99999999999999999999999999987653322
Q ss_pred cceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc---cCccccc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---EDRLNDI 506 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~~ 506 (596)
.. .....+++.|+|||.+.+. .++.++|||||||++|||+||+.||......+ ....+..... ......+
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-----QLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCCCChhhchhh
Confidence 11 1223468899999998654 47889999999999999999999997543321 1111111110 0111111
Q ss_pred ccC------cCCC--------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 507 VDR------NLNT--------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 507 ~d~------~l~~--------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
.+. .... ........+.+++.+|++.||.+|||++|++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 000 0000 01123456789999999999999999999987543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=304.52 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=198.3
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC--cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
|+..+.||+|+||+||++... +++.||+|.+..... ......+.+|+.++++++|+|++++.+.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667889999999999999965 688999999864221 22345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999886432 24588999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ......... ..
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~-~~----------- 221 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKE-VQ----------- 221 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhh-hh-----------
Confidence 1 12335899999999999999999999999999999999999999753211000 001000000 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK 545 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 545 (596)
..+......++.+++.+|++.||++||+ ++|+++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 -EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0112223456789999999999999999 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=303.28 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=195.8
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
|+..+.||+|+||+||+|... +++.||+|.+.... .......+.+|++++.+++|+|++++.+++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666789999999999999964 78899999986422 122345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998886532 34689999999999999999999998 99999999999999999999999999987654321
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
......|+..|+|||++.+..++.++|+|||||++|||+||..||........ .+.+........
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-----~~~~~~~~~~~~-------- 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-----REEVDRRVLETE-------- 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhhhccc--------
Confidence 12234689999999999988999999999999999999999999975322111 111111111110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMA 541 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 541 (596)
..+.......+.+++..|++.||++||++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred -cccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 011223345678899999999999999944
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.99 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=193.6
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 348 (596)
+|+..+.||+|+||+||+|... +++.||+|++.... .......+..|..++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999965 68899999987421 2334456778888888876 567888999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998875 24589999999999999999999999 999999999999999999999999999875432
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ...+.+. ... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i~---~~~-~----- 218 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-----ELFQSIM---EHN-V----- 218 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHH---hCC-C-----
Confidence 21 1223355899999999999989999999999999999999999999753321 1111111 110 0
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 541 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 541 (596)
.++.....++.+++.+|++.+|.+|++..
T Consensus 219 ----~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 ----SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ----CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11223345778899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=297.90 Aligned_cols=256 Identities=22% Similarity=0.301 Sum_probs=204.9
Q ss_pred CCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEec--CCeeEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERILVY 348 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~ 348 (596)
+|+..+.||.|+||.||++.. .+++.+|+|.+... ......+.+.+|++++++++|+|++++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477789999999999999985 47889999998642 334455678899999999999999999998764 34578999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC--NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||+++++|.+++.........+++..++.++.|++.||+|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999865444567999999999999999999999221 229999999999999999999999999999876
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
...... .....+++.|+|||++.+..++.++||||||+++++|++|+.||...... .+.+.+. ..
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~----~~----- 225 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-----QLASKIK----EG----- 225 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-----HHHHHHh----cC-----
Confidence 543321 22345789999999999888999999999999999999999999754311 1111111 11
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.....+......+.+++.+|++.+|++||+++||+++
T Consensus 226 ---~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 ---KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112233455688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=317.84 Aligned_cols=262 Identities=21% Similarity=0.235 Sum_probs=195.7
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
..+|.+.+.||+|+||.||++... .++.||||... ...+.+|++++++++|+||+++++++...+..++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 447888999999999999999975 57889999642 2345789999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
++. ++|..++... ...++|..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 995 6888887642 23689999999999999999999999 9999999999999999999999999999866432
Q ss_pred Ccc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhh---hhchHHHHHHHHhc-cCccc
Q 007608 430 LTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE---EDVLLLDHIRKLLR-EDRLN 504 (596)
Q Consensus 430 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~---~~~~l~~~~~~~~~-~~~~~ 504 (596)
... ......||+.|+|||++.+..++.++|||||||++|||++|..|+-....... ....+...+..... .....
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 221 22235689999999999999999999999999999999998765432111100 01111122211100 00000
Q ss_pred ccc----------------cCcCCC-CC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 505 DIV----------------DRNLNT-YD---SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 505 ~~~----------------d~~l~~-~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
... .+.... .. ......+.+++.+||+.||.+|||+.|++++
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 000000 00 0122367889999999999999999999875
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=297.11 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=201.3
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEec-CCeeEEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILVYP 349 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e 349 (596)
+|+..+.||+|++|.||++..+ +++.||+|++... ......+.+.+|++++++++|+|++++.+.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999965 5788999998643 233345678899999999999999999988764 445789999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++.... ...+++.+++.++.+++.|++|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999987532 24589999999999999999999999 9999999999999999999999999999866432
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
.. ......+++.|+|||+..+..++.++||||||++++||++|+.||...... ....... .+.
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--------~~~~~~~-~~~------- 218 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--------SLVYRII-EGK------- 218 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHH-hcC-------
Confidence 22 222345788999999999999999999999999999999999998743221 1111111 111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+...+......+.+++.+|++.+|++||++.|++++
T Consensus 219 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 -LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111223455678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.96 Aligned_cols=238 Identities=26% Similarity=0.295 Sum_probs=187.9
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHH-HHHhcCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
++||+|+||.||+|+.. +++.||+|++.... .......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68899999986321 1223344555554 57889999999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
++|...+.. ...++......++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 999888865 34578888999999999999999998 99999999999999999999999999987532221 12
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+ .. .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i---~~-~~---------~~ 214 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-----QMYDNI---LH-KP---------LQ 214 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-----HHHHHH---hc-CC---------CC
Confidence 23356899999999999889999999999999999999999999753221 111111 11 10 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMA 541 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 541 (596)
.+......+.+++.+|++.||.+||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1223345788999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.87 Aligned_cols=246 Identities=26% Similarity=0.301 Sum_probs=192.8
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHH-HHHhcCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||+||+|... +|+.||+|++.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999964 78999999986421 2233445556655 46778999999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 999988865 34689999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... +......... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~~~~~~-~---------~ 214 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--------EMYDNILHKP-L---------V 214 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--------HHHHHHHcCC-c---------c
Confidence 23456899999999999999999999999999999999999999753321 1111111111 0 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
........+.+++.+|++.+|.+||++++.++.+.+
T Consensus 215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 111234567789999999999999999765554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=298.64 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=200.9
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 267 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 267 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
++.+++++.....||+|+||.||+|... ++..|++|.+.... ......+.+|+.++++++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 4556777777889999999999999954 67889999886432 334567899999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-CCcEEEeeccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGL--DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGL 422 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfGl 422 (596)
+|+||+++++|.+++.... ..+ ++..+..++.|++.||+|||+. +++||||||+||+++. ++.++|+|||.
T Consensus 82 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 9999999999999987532 234 7888899999999999999998 9999999999999976 67899999999
Q ss_pred cccccccCcceeccccccccccCcccccCCC--CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
+........ ......+++.|+|||++.+.. ++.++||||||+++|||++|+.||....... ...+.....
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-----~~~~~~~~~-- 227 (268)
T cd06624 156 SKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-----AAMFKVGMF-- 227 (268)
T ss_pred heecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-----hhHhhhhhh--
Confidence 876543221 122234789999999986643 7889999999999999999999986422110 000000000
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
......+.....++.+++.+|++.+|++||++.|++++
T Consensus 228 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 --------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00011223345678899999999999999999999764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=303.58 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=201.0
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
.|+..+.||+|+||.||+|... ++..||+|.+...........+.+|++++++++||||+++++++......++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3555678999999999999864 678899998874444445667899999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++|||++........
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999988863 3588999999999999999999998 999999999999999999999999999976543221
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcC
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 511 (596)
......++..|+|||++.+..++.++|||||||++|||+||+.|+...... .....+ ... ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~----~~~--------~~ 218 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RVLFLI----PKN--------SP 218 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hHHhhh----hcC--------CC
Confidence 122235788999999999888999999999999999999999998632211 011111 011 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 512 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..........+.+++.+|++.+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11122345678899999999999999999999885
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=303.40 Aligned_cols=250 Identities=20% Similarity=0.291 Sum_probs=201.9
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
.+|+..+.||+|+||.||+|.. .+++.|++|.+..... .....+.+|+.+++.+.|+|++++++++......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4788889999999999999995 4789999998864332 3456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.. ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998864 3478899999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.. .....+++.|+|||.+.+..++.++|||||||++|||++|+.||....... ...... ... . +.
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~~~----~~~-~-----~~ 235 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLIA----TNG-T-----PE 235 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHHHh----cCC-C-----CC
Confidence 11 122357889999999998889999999999999999999999997432210 011110 000 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+ ..+......+.+++.+|+..+|++||++.|+++.
T Consensus 236 ~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 L-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred C-CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0 1123344678899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=301.29 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=197.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecC------
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS------ 341 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~------ 341 (596)
+++.|+..+.||+|+||.||+|... +++.||+|++... ......+.+|+.++.++ +|+|++++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4567888899999999999999964 6889999998642 33456788999999998 699999999998653
Q ss_pred CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
...++||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 35789999999999999987632 34688999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeccccccccccCccccc-----CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||....... ....
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~~~- 227 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFL- 227 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHH-
Confidence 9886543222 223345889999999986 3457889999999999999999999986422110 0000
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. ..... +.. .......++.+++.+||..+|.+||++.|+++
T Consensus 228 ~-~~~~~-----~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 I-PRNPA-----PRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred H-hcCCC-----CCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 00100 111 11123456889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=304.30 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=204.5
Q ss_pred ccHHHHHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEe
Q 007608 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 339 (596)
Q Consensus 262 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 339 (596)
+.++.+..+.++|+..+.||+|+||.||+|... +++.+|+|.+... ......+.+|+.++.++ +|||++++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 334555667889999999999999999999864 6889999987532 22346688899999999 6999999999874
Q ss_pred -----cCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc
Q 007608 340 -----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 414 (596)
Q Consensus 340 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 414 (596)
.++..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||++++++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence 34568999999999999998875433345688999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccccccCcceeccccccccccCcccccC-----CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhch
Q 007608 415 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 489 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~ 489 (596)
++|+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+.......
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----- 236 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----- 236 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----
Confidence 99999999886543221 1223458899999999753 447889999999999999999999987432110
Q ss_pred HHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 490 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 490 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
...... ........+ +.....++.+++.+|++.||++||++.|+++..
T Consensus 237 ---~~~~~~-~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 ---ALFKIP-RNPPPTLHQ------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ---HHhhcc-ccCCCcccC------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000000 000001111 112245688999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.66 Aligned_cols=246 Identities=26% Similarity=0.288 Sum_probs=191.3
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHH-HHHhcCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||+||+|+.. +++.||+|++.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 67889999986421 1222334444444 56788999999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|.+++.. ...++......++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 999998875 34577888889999999999999999 99999999999999999999999999987543221 12
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..+.+. .. .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~---~~-~~---------~ 214 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MYDNIL---NK-PL---------Q 214 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HHHHHH---hC-Cc---------C
Confidence 234568999999999999999999999999999999999999997533211 111111 11 00 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
........+.+++.+|++.||.+||++.+.+..+.+
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 112234567888999999999999998865554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=297.52 Aligned_cols=251 Identities=20% Similarity=0.324 Sum_probs=203.7
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|+..+.||+|+||.||++... +++.||+|++... .......++.+|+.++++++||||+++.+++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999964 6899999998632 2334456889999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.... ...+++...+.++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999887522 23578999999999999999999998 99999999999999999999999999998654322
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
. ......|++.|+|||+..+...+.++|||||||+++||+||+.|+...... +.+.......
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~~--------- 217 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--------NLVLKIIRGS--------- 217 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--------HHHHHHhcCC---------
Confidence 1 122345788999999999888999999999999999999999998743221 1111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+.....++.+++.+|++.+|++||++.||+++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111223345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=299.37 Aligned_cols=254 Identities=23% Similarity=0.357 Sum_probs=205.9
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||+|+||.||++... +++.+++|++...........+.+|++.+++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999976 68999999987654455667889999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
+++++|.+++.... ..++......++.|++.|++|||+ . +++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999987632 468889999999999999999999 7 9999999999999999999999999998765432
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
... ...++..|+|||+..+..++.++||||||+++|+|++|+.||....... ....+.+.......
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~-------- 220 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP---DGIFELLQYIVNEP-------- 220 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHHHHhcCC--------
Confidence 211 1557889999999999899999999999999999999999987432111 11122222211111
Q ss_pred cCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 510 NLNTYDSK-EVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 510 ~l~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+.. ...++.+++.+|+..+|++||++.|++.+
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 221 -PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111112 55678899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=296.19 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=203.6
Q ss_pred hcCCCcCceeeecCceEEEEEEeCC-CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||.||+|...+ ++.+++|.+.... ..+.+.+|++++++++|+|++++++++......++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 3678889999999999999999764 7899999986421 26789999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999998642 24689999999999999999999999 9999999999999999999999999999876443
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
.. ......++..|+|||++.+..++.++||||||+++|||+||+.|+........ ... ..... .+
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~~~-~~~~~-----~~ 217 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------IFM-IPNKP-----PP 217 (256)
T ss_pred cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------hhh-hccCC-----CC
Confidence 21 22234478899999999988999999999999999999999999874322110 000 00000 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. ...+......+.+++.+|++.+|++||++.||++
T Consensus 218 ~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 T-LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred C-CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0 0112234467889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=297.77 Aligned_cols=251 Identities=22% Similarity=0.353 Sum_probs=200.5
Q ss_pred CCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCC-----cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS-----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
+|...+.||+|+||+||+|...+++.+|+|.+..... ......+.+|++.+++++|+||+++.+++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677899999999999999988899999998863221 12335688999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999998752 3578899999999999999999998 99999999999999999999999999987653
Q ss_pred ccC-----cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 428 AKL-----THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 428 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
... ........++..|+|||++.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~ 226 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-------AMFYIGAHRGL 226 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-------HHHHhhhccCC
Confidence 211 111223458899999999998889999999999999999999999997432111 00000000000
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. + ..+.....++.+++.+|++.+|++||++.|+++
T Consensus 227 ~-----~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 M-----P---RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-----C---CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 1 112234567789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=300.73 Aligned_cols=265 Identities=25% Similarity=0.378 Sum_probs=204.9
Q ss_pred cCCCcCceeeecCceEEEEEEeC-----CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec--CCee
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSER 344 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~ 344 (596)
+.|...+.||+|+||.||+|.+. ++..+|+|.+...........|.+|+++++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999853 3688999998754333356789999999999999999999999877 5578
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999997532 2589999999999999999999998 99999999999999999999999999998
Q ss_pred cccccCcc--eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhh------hchHHHHHHH
Q 007608 425 LVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE------DVLLLDHIRK 496 (596)
Q Consensus 425 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~------~~~l~~~~~~ 496 (596)
........ ......++..|+|||...+..++.++||||||+++|||+||+.|+......... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532221 111223456799999998889999999999999999999999988643221100 0000111111
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...... . ...+.....++.+++.+|++.+|++||++.||+++|+.+
T Consensus 238 ~~~~~~-------~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGE-------R-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCC-------c-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111110 0 011223346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=300.23 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=203.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCc----EEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
.+|+..+.||+|+||.||+|..+ +|. .+|+|.+...........+.+|+..+.+++|||++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46777899999999999999864 333 5899988755444456788999999999999999999999987 78899
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
|+||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999998753 23589999999999999999999998 9999999999999999999999999999876
Q ss_pred cccCccee-ccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 427 DAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 427 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
........ ....++..|+|||.+....++.++||||||+++||++| |+.||...... .+.+.+. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~----~~~-- 228 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-----EIPDLLE----KGE-- 228 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHh----CCC--
Confidence 53322211 11223568999999988889999999999999999999 99998753321 1112121 110
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
....+......+.+++.+||..+|.+||++.++++.|++.
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0011122345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.49 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=203.9
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
.|+..+.||.|+||.||+|... ++..||+|.+...........+.+|+.+++++.|||++++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999965 688999999875444455678899999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++++|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998864 3578889999999999999999998 999999999999999999999999999976543221
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcC
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 511 (596)
......++..|+|||++.+..++.++|||||||++|||+||..|+....... ... ..... ..
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~----~~~~~--------~~ 218 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VLF----LIPKN--------NP 218 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----Hhh----hhhcC--------CC
Confidence 1223457889999999988889999999999999999999999987432110 000 00000 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 512 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12344566788999999999999999999999775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=306.09 Aligned_cols=197 Identities=24% Similarity=0.370 Sum_probs=160.4
Q ss_pred CceeeecCceEEEEEEeC---CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec--CCeeEEEEEcc
Q 007608 277 SNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERILVYPFM 351 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~ 351 (596)
.+.||+|+||+||+|+.. +++.||+|.+... .....+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC---CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999864 4678999998642 223457889999999999999999998854 35578999998
Q ss_pred cCCChhhhhcccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE----cCCCcEEEeeccc
Q 007608 352 QNLSVAYRLRDLKP-----GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGL 422 (596)
Q Consensus 352 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~DfGl 422 (596)
.+ +|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 64 77777653211 123588999999999999999999999 99999999999999 4567899999999
Q ss_pred cccccccCcc--eeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCc
Q 007608 423 AKLVDAKLTH--VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 480 (596)
Q Consensus 423 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~ 480 (596)
++........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9876543221 22345689999999998764 5899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.94 Aligned_cols=265 Identities=19% Similarity=0.275 Sum_probs=197.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC------
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------ 341 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 341 (596)
..++|...+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999964 68899999987432 333456788999999999999999999987543
Q ss_pred CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
...++||||+++ ++...+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 346999999975 66666642 478889999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchH----------H
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL----------L 491 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l----------~ 491 (596)
+++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+.....+ .
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 998654322 1223458999999999999999999999999999999999999997543221110000 0
Q ss_pred H----HHHHHhccC-cc-----cccccCcCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 492 D----HIRKLLRED-RL-----NDIVDRNLN----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 492 ~----~~~~~~~~~-~~-----~~~~d~~l~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. .+....... .. .+....... ........++.+++.+|++.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 000000000 00 000000000 0111123567899999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=313.17 Aligned_cols=265 Identities=20% Similarity=0.271 Sum_probs=197.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC------
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------ 341 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 341 (596)
..++|...+.||+|+||.||++... .++.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 68899999987432 233456778899999999999999999988643
Q ss_pred CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
...++||||+++ ++...+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 346899999975 56665542 478889999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchH-----------
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL----------- 490 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l----------- 490 (596)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+......
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998654321 2233458999999999999899999999999999999999999997543211100000
Q ss_pred ---HHHHHHHhcc-CcccccccC-----cCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 491 ---LDHIRKLLRE-DRLNDIVDR-----NLN----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 491 ---~~~~~~~~~~-~~~~~~~d~-----~l~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+...... .....+..+ ... ........++.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0001111000 000000000 000 0111234577899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=308.95 Aligned_cols=256 Identities=20% Similarity=0.242 Sum_probs=196.5
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||++..+ +++.+|+|++... ........+.+|+.++..++|+||+++.+++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999975 5788999998532 12223455888999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999753 23588999999999999999999999 999999999999999999999999999876543
Q ss_pred cCcceeccccccccccCccccc-----CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...... +...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHKER 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--------HHHHHHhCCCcc
Confidence 3222333356899999999986 345789999999999999999999999753321 111111111100
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCC--CCCCCHHHHHHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTP--EDRPPMAQVVKM 546 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP--~~RPs~~evl~~ 546 (596)
. ...........++.+++.+|+..++ ..|+++.|++++
T Consensus 227 ~-----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 F-----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c-----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0111112234566777778775544 346889888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=287.98 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=205.2
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEcc-ccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~-~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++.|+.-++||+|+|+.||+... ++|+.+|+|++. +..+....+.+.+|+.+-+.++||||+++...+......++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677788999999999999884 579999999886 3344556788899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc---CCCcEEEeecccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAKL 425 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~DfGl~~~ 425 (596)
|+|+|++|..-+-.. ...++..+-..++||+++|.|+|.+ +|||||+||+|+++. ..--+|++|||++..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998777642 3467778889999999999999999 999999999999994 445699999999998
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
+.. ........|||+|||||++...+|+..+|||+.|||||-|+.|+.||...+. ..+.+.+.. +.+
T Consensus 163 l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----~rlye~I~~----g~y-- 229 (355)
T KOG0033|consen 163 VND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYEQIKA----GAY-- 229 (355)
T ss_pred eCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----HHHHHHHhc----ccc--
Confidence 873 3334456799999999999999999999999999999999999999985322 122222221 100
Q ss_pred cccCcCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 506 IVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 506 ~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+ +.+...++..+++.+|+..||.+|.|+.|.+++
T Consensus 230 ----d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 230 ----DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ----CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1111 233445677889999999999999999999764
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.17 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=199.2
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCc--------chHHHHHHHHHHHHhcCCCCccceEeEEecCCe
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP--------GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 343 (596)
+|.....||+|+||.||+|... +++.+|+|.+...... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667889999999999999864 6889999988643221 122568899999999999999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++|+||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999999752 4578899999999999999999998 9999999999999999999999999999
Q ss_pred ccccccCcc-----eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHh
Q 007608 424 KLVDAKLTH-----VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 498 (596)
Q Consensus 424 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 498 (596)
+........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~ 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------QAIFKIG 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------HHHHHHh
Confidence 866432111 111234788999999999888999999999999999999999999743211 0111110
Q ss_pred ccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 499 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. . ..+ ..+......+.+++.+||+.||.+||++.|+++
T Consensus 226 ~-~-----~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 E-N-----ASP---EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c-c-----CCC---cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 0 011 122334567888999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=298.33 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=201.1
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
++|+..+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999976 68999999986432 22334668899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|++++++..++.. ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888877654 23589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc--------c
Q 007608 430 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR--------E 500 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~--------~ 500 (596)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ............ .
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL-YLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChHHhhhcccc
Confidence 21 1223346789999999876 45789999999999999999999999754321110 000000000000 0
Q ss_pred CcccccccCcCCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 DRLNDIVDRNLNT------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 ~~~~~~~d~~l~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
........+.... ........+.+++.+|++.+|++||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000000000 011234678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=308.02 Aligned_cols=262 Identities=19% Similarity=0.235 Sum_probs=194.2
Q ss_pred cCceeeec--CceEEEEEEe-CCCcEEEEEEccccCC-cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 276 ESNIIGQG--GFGKVYKGVL-SDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 276 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
..++||+| +|++||++.. .+|+.||+|++..... ......+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 6899999986 4789999999874332 334456778999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999986532 23589999999999999999999998 999999999999999999999999986543321111
Q ss_pred c------eeccccccccccCcccccC--CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc----
Q 007608 432 H------VTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---- 499 (596)
Q Consensus 432 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---- 499 (596)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~ 232 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM----LLEKLNGTVPCLLD 232 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH----HHHHhcCCcccccc
Confidence 0 0112246778999999876 4589999999999999999999999974322110 0000000000
Q ss_pred -----cCcc-----cccccC------------------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 500 -----EDRL-----NDIVDR------------------NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 500 -----~~~~-----~~~~d~------------------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+.. ....+. ............+.+++.+|++.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 000000 0000122335678899999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=310.57 Aligned_cols=256 Identities=20% Similarity=0.249 Sum_probs=197.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|...+.||+|+||+||+++.. +++.||+|.+... ........+.+|+.++..+.|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999965 6788999998642 12233456888999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999753 23588899999999999999999999 999999999999999999999999999986654
Q ss_pred cCcceeccccccccccCcccccC-----CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
..........|++.|+|||++.+ ..++.++|||||||++|||++|+.||...... +...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~ 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHEER 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--------HHHHHHHcCCCc
Confidence 33322333568999999999875 46788999999999999999999999753321 111111111100
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM 546 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 546 (596)
. .+.........++.+++.+|+..++.+ |++++++.++
T Consensus 227 ~-----~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 F-----QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred c-----cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 011111223456778888888765543 4677777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=294.59 Aligned_cols=252 Identities=29% Similarity=0.476 Sum_probs=202.4
Q ss_pred CCcCceeeecCceEEEEEEeCC-----CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 274 FSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
|+..+.||+|+||.||++...+ +..||+|++.........+.+..|+..+..++|+|++++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3457899999999999999753 38899999975544436778999999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999875321 1289999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
..........+++.|+|||.+.+..++.++||||+|++++||++ |+.||..... ....+.+. ....
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~~~---~~~~----- 222 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----EEVLEYLK---KGYR----- 222 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHh---cCCC-----
Confidence 42222212336789999999988889999999999999999998 7788764221 11111111 1110
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
...+.....++.+++.+|+..+|++|||+.|+++.|
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011222456788899999999999999999998865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=320.50 Aligned_cols=250 Identities=27% Similarity=0.436 Sum_probs=209.7
Q ss_pred cCceeeecCceEEEEEEe-CCC----cEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 276 ESNIIGQGGFGKVYKGVL-SDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 276 ~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
...+||+|+||+||+|.+ ++| .+||+|++..........++.+|+..|.+++|||+++++|+|..+. ..+|++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 367999999999999985 444 4689999988777778899999999999999999999999998777 8899999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
|+.|+|.++++..+ ..+.-...+.+..|||+||.|||++ ++|||||.++|||+..-..+||.|||+++.+....
T Consensus 779 mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999998743 4577788899999999999999999 99999999999999999999999999999887654
Q ss_pred cceec-cccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 431 THVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 431 ~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
..... ...-.+.|||-|.+....++.++|||||||.+||++| |..|++....++ +...++.+
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------I~dlle~g------- 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------IPDLLEKG------- 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------hhHHHhcc-------
Confidence 44332 2233668999999999999999999999999999999 889988644322 22222211
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.....++.+..++..++.+||..|+..||+++++...+.+
T Consensus 917 -eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 917 -ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 1123467788899999999999999999999999887654
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.22 Aligned_cols=264 Identities=25% Similarity=0.343 Sum_probs=205.1
Q ss_pred ccHHHHHHHhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEe
Q 007608 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 339 (596)
Q Consensus 262 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 339 (596)
+..+++..++++|...+.||+|+||.||+|.. .+++.+|+|.+... ......+.+|+.++.++ +|||++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 34455566788999999999999999999996 47889999998642 22356678899999998 7999999999986
Q ss_pred cC-----CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc
Q 007608 340 TS-----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 414 (596)
Q Consensus 340 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 414 (596)
.. +..++|+||+++++|.++++........+++..++.++.|++.||.|||+. +++|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 54 357999999999999998875443345689999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccccccCcceeccccccccccCcccccCC-----CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhch
Q 007608 415 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 489 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~ 489 (596)
+||+|||++......... .....|+..|+|||++... .++.++|||||||++|||++|+.||...... ..
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~----~~ 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV----KT 241 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH----HH
Confidence 999999998865432211 1234578899999997643 3688999999999999999999998743211 11
Q ss_pred HHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 490 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 490 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+.+ ..+ .....+. .+......+.+++.+|++.+|++||++.|++++
T Consensus 242 ~~~----~~~-~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 LFK----IPR-NPPPTLL------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHH----Hhc-CCCCCCC------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111 111 1011111 122334578899999999999999999999764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=295.82 Aligned_cols=240 Identities=23% Similarity=0.338 Sum_probs=187.1
Q ss_pred ceeeecCceEEEEEEeCC-------------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCee
Q 007608 278 NIIGQGGFGKVYKGVLSD-------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 344 (596)
+.||+|+||.||+|+..+ ...|++|.+... .......|.+|+.++..++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 368999999999998532 235888887542 223445788899999999999999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc-------EEE
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-------AVL 417 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-------~kl 417 (596)
++||||+++++|..++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999998887642 24589999999999999999999999 9999999999999987654 899
Q ss_pred eeccccccccccCcceeccccccccccCccccc-CCCCCcccccHHHHHHHHHHH-hCCCCCCCccchhhhhchHHHHHH
Q 007608 418 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELV-TGQRAIDFSRLEEEEDVLLLDHIR 495 (596)
Q Consensus 418 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvil~ell-tg~~p~~~~~~~~~~~~~l~~~~~ 495 (596)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......+ .. ...
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~-~~~ 222 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----KE-RFY 222 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----HH-HHH
Confidence 999998754321 1234678899999986 466899999999999999998 5888876432111 00 000
Q ss_pred HHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 496 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
. ... . .......++.+++.+||+.||++||++.+|++.++
T Consensus 223 ---~-~~~-~--------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 ---E-GQC-M--------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ---h-cCc-c--------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 000 0 01112356789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=336.16 Aligned_cols=258 Identities=19% Similarity=0.254 Sum_probs=200.3
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecC--Cee
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 344 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 344 (596)
...++|.+.+.||+|+||+||+|... ++..||+|.+... ........|..|+.++.+++||||+++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999965 5778999988632 2334567789999999999999999999987543 567
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCcEecCCCCCcEEEcC---------
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN----PKIIHRDLKAANILLDD--------- 411 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~dlkp~NIll~~--------- 411 (596)
++||||+++|+|.++|.........+++..++.|+.||+.||+|||+... .+|+||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 89999999999999998644434579999999999999999999998521 25999999999999964
Q ss_pred --------CCcEEEeeccccccccccCcceeccccccccccCcccccC--CCCCcccccHHHHHHHHHHHhCCCCCCCcc
Q 007608 412 --------NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSR 481 (596)
Q Consensus 412 --------~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvil~elltg~~p~~~~~ 481 (596)
...+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2348999999998664322 2233468999999999854 458899999999999999999999997432
Q ss_pred chhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 482 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 482 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. ....+... .... +..+ .....++.+|+..||+.+|.+||++.|++.
T Consensus 248 ~-------~~qli~~l-k~~p-----~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N-------FSQLISEL-KRGP-----DLPI----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c-------HHHHHHHH-hcCC-----CCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1 11111111 1110 0001 122457889999999999999999999984
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=314.39 Aligned_cols=202 Identities=22% Similarity=0.281 Sum_probs=174.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||+||++... +++.||+|++... ........+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 6899999998632 12334567888999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999875 34588999999999999999999999 999999999999999999999999999875432
Q ss_pred cCc----------------------------------ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCC
Q 007608 429 KLT----------------------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474 (596)
Q Consensus 429 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~ 474 (596)
... .......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 0011346899999999999999999999999999999999999
Q ss_pred CCCCCc
Q 007608 475 RAIDFS 480 (596)
Q Consensus 475 ~p~~~~ 480 (596)
.||...
T Consensus 234 ~Pf~~~ 239 (360)
T cd05627 234 PPFCSE 239 (360)
T ss_pred CCCCCC
Confidence 999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=314.59 Aligned_cols=260 Identities=22% Similarity=0.259 Sum_probs=198.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeC---CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
..+|...+.||+|+||.||++... .+..||+|.+... ..+.+|++++++++||||+++++++......++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 457999999999999999999753 3578999987532 2356899999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
||++. ++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++...
T Consensus 165 ~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99986 588888743 35689999999999999999999999 99999999999999999999999999997664
Q ss_pred ccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc--
Q 007608 428 AKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN-- 504 (596)
Q Consensus 428 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~-- 504 (596)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...+. ........
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~-~~~~~~~~~~ 314 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIR-CMQVHPLEFP 314 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHH-HhccCccccC
Confidence 43221 2234568999999999999999999999999999999999999997543221 1111111111 11000000
Q ss_pred ---------------ccccCcC--CC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 505 ---------------DIVDRNL--NT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 505 ---------------~~~d~~l--~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+.. .. .......++.+++.+|+..||++||++.|++.+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00 001123567788999999999999999999775
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=303.24 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=201.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCc----EEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
.++|+..+.||+|+||.||+|... ++. .||+|.+...........+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356777899999999999999853 444 57889886544444455789999999999999999999998754 467
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 999999999999988753 23588999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 426 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 426 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ...+++. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-----~~~~~~~----~~~~ 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-----EIPDLLE----KGER 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH----CCCC
Confidence 6433221 1122335678999999998899999999999999999998 88888643211 1122221 1100
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
. ..+......+.+++..|+..+|++||+++|+++.|+..
T Consensus 230 ---~-----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 ---L-----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---C-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 01122345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.06 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=196.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHH-HHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHL-ISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
++|++.+.||+|+||.||+|... +|+.||+|+++..........+..|+.. ++...|||++++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999975 6999999998754333344556666665 566789999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|++ |+|.+++.........+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 6888887764444467899999999999999999999853 7999999999999999999999999998865432
Q ss_pred CcceeccccccccccCcccccC----CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLST----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... . +.........
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~---- 224 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------F-QQLKQVVEEP---- 224 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------H-HHHHHHHhcC----
Confidence 1 1122357889999998864 45688999999999999999999998632110 0 0111111100
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.+.+. ....+.++.+++.+|+..+|++||++.++++
T Consensus 225 --~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 --SPQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01110 1123467889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=301.10 Aligned_cols=263 Identities=22% Similarity=0.332 Sum_probs=203.1
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
++|+..+.||+|+||.||+|... +++.||+|+++... .......+.+|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999975 68899999987432 33345778999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|++++.+...... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998777665543 34589999999999999999999999 9999999999999999999999999999876554
Q ss_pred CcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc---------
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR--------- 499 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~--------- 499 (596)
.........++..|+|||++.+. .++.++||||||+++|||++|+.||......+ ..........
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-----QLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCCHHHhhh
Confidence 33233345578899999999888 78999999999999999999999987533211 0000110000
Q ss_pred ---cCccc--ccccCcCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 500 ---EDRLN--DIVDRNLN-----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 500 ---~~~~~--~~~d~~l~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..... +..+.... .++.....++.+++.+||..+|++||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 00000000 0122236789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=306.30 Aligned_cols=193 Identities=24% Similarity=0.324 Sum_probs=164.9
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
....+|+..+.||+|+||.||+|... +++.||+|..... ....|+.++.+++||||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34567999999999999999999975 5778999975431 235689999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
+||+. ++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 136 ~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99995 5888877642 34689999999999999999999999 99999999999999999999999999987543
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCC
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 477 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~ 477 (596)
... ......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 221 122345899999999999999999999999999999999966554
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=282.75 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=203.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC----cc---hHHHHHHHHHHHHhc-CCCCccceEeEEecC
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS----PG---GEAAFQREVHLISVA-IHKNLLQLIGYCTTS 341 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 341 (596)
...|+..+++|+|..++|-+...+ +|+.+|+|++..... +. -.+.-.+|+.+|+++ .||+|+++.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456777889999999999988864 788999999863221 11 123456789999998 599999999999999
Q ss_pred CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
...++|+|.|+.|.|.++|.+ ...++.....+|+.|+..|+.|||.. .||||||||+|||+|++.++||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 999999999999999999987 46789999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeccccccccccCcccccC------CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHH
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~ 495 (596)
+++.+..+. .....+|||+|+|||.+.. ..|+...|+|+.|||+|-|+.|.+||-.. .......
T Consensus 169 Fa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-----kQmlMLR--- 238 (411)
T KOG0599|consen 169 FACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-----KQMLMLR--- 238 (411)
T ss_pred eeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-----HHHHHHH---
Confidence 999886643 3456789999999999852 35788999999999999999999998631 1111111
Q ss_pred HHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 496 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+.++.+.- -. ....+...+..+++.+|++.||.+|.|++|++++
T Consensus 239 -~ImeGkyqF-~s----peWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 -MIMEGKYQF-RS----PEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -HHHhccccc-CC----cchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 122222111 00 1234556788999999999999999999999763
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=292.65 Aligned_cols=254 Identities=24% Similarity=0.292 Sum_probs=204.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||.|+||.||+|... +++.+++|.+.... ....+.+.+|++++++++|||++++++++.+....+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 367888999999999999999964 67889999987432 2256788999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++... ...++...+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999988752 24688999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcceeccccccccccCcccccCC---CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
.. ......++..|+|||.+.+. .++.++||||||+++|||+||+.|+........ ... ... ..
T Consensus 155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~----~~~----~~~-~~---- 220 (262)
T cd06613 155 IA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA----LFL----ISK-SN---- 220 (262)
T ss_pred hh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHH----HHh-cc----
Confidence 21 12234578899999999776 789999999999999999999999874332111 000 000 00
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+.+...........++.+++.+|+..+|.+||++.+|+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 221 FPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011111123345677899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.63 Aligned_cols=249 Identities=20% Similarity=0.309 Sum_probs=201.5
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
.+|+..+.||.|+||.||+|.. .+++.|++|.+... .......+.+|+..++.++|||++++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc-cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4588889999999999999985 57899999998643 233456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|..++.. ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999998864 3589999999999999999999999 99999999999999999999999999987654332
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ .. .+. ... ...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~----~~-~~~---~~~-~~~----- 234 (296)
T cd06655 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LY-LIA---TNG-TPE----- 234 (296)
T ss_pred cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HH-HHH---hcC-Ccc-----
Confidence 21 2234578899999999988899999999999999999999999975432110 10 110 000 000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...+......+.+++.+||..||++||++.+++.
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0112233456788999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=295.45 Aligned_cols=238 Identities=26% Similarity=0.385 Sum_probs=188.6
Q ss_pred ceeeecCceEEEEEEeCCCc-----------EEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 278 NIIGQGGFGKVYKGVLSDNT-----------KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
+.||+|+||.||+|...+.. .+++|.+..... ....|.+|+.++++++|||++++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999976433 578887654322 26788999999999999999999999988 77899
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC-------cEEEee
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-------EAVLCD 419 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-------~~kl~D 419 (596)
|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++ .+||+|
T Consensus 78 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999988632 2689999999999999999999998 999999999999999887 799999
Q ss_pred ccccccccccCcceeccccccccccCcccccCC--CCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHH
Q 007608 420 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 420 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+......+ ...+..
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-----~~~~~~- 220 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-----KERFYQ- 220 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-----HHHHHh-
Confidence 999986543 1123467789999999876 78999999999999999999 466665432110 111111
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
.... . +......+.+++.+|+..+|++||++.||++.|+
T Consensus 221 --~~~~--------~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --DQHR--------L---PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --cCCC--------C---CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 0 0011167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=293.95 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=194.1
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC----CcchHHHHHHHHHHHHhcCCCCccceEeEEecC--Cee
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 344 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 344 (596)
.+|+..+.||+|+||.||+|... ++..|++|++.... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999964 68999999886321 122345688999999999999999999988653 567
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999875 23578999999999999999999998 99999999999999999999999999987
Q ss_pred cccccCc--ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 425 LVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 425 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
....... .......++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~~~~~~~~~- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AAIFKIATQP- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HHHHHHhcCC-
Confidence 6543211 1112345788999999999888999999999999999999999998743211 1111111110
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..+ ..+......+..++ +|+..+|++||+++||++
T Consensus 226 ----~~~---~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 ----TNP---QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCC---CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011 11222334455555 688899999999999965
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=300.30 Aligned_cols=249 Identities=19% Similarity=0.297 Sum_probs=201.6
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
.+|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+|++++++++...+..++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 5788899999999999999995 479999999986432 23456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999998864 3578899999999999999999998 99999999999999999999999999987654332
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.. .....+++.|+|||...+..++.++|||||||++|+|++|+.||........ .. .....+ .+.
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~----~~----~~~~~~------~~~ 234 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LY----LIATNG------TPE 234 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh----ee----eeccCC------CCC
Confidence 21 2234578899999999988899999999999999999999999964322100 00 000000 000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...+......+.+++.+|++.+|++||+++++++
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 -LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112334456788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.64 Aligned_cols=262 Identities=25% Similarity=0.363 Sum_probs=197.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999975 68999999987443333345677899999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+.+ +|.+++.... ..+++...+.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 8988887532 3688999999999999999999999 99999999999999999999999999987543221
Q ss_pred cceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc---cCccccc
Q 007608 431 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---EDRLNDI 506 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~~ 506 (596)
.. .....++..|+|||+..+ ..++.++||||||+++|||++|+.||........ ....+..... ......+
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED----QLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH----HHHHHHHhcCCCChhhhhhh
Confidence 11 112236789999999875 4578999999999999999999999964331111 0111111000 0000000
Q ss_pred ------c--------cCcCCCCCHH--HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 507 ------V--------DRNLNTYDSK--EVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 507 ------~--------d~~l~~~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. ...+...... ...++.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0000000001 1256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.73 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=198.3
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|+..+.||.|++|.||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999965 68999999986432 233346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+. ++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 68888886532 34689999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC--------
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED-------- 501 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~-------- 501 (596)
.. .....++..|+|||++.+.. ++.++||||||+++|||+||+.||....... ...+.........
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----QLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHhCCCChhhhhhhh
Confidence 21 12234678999999887654 5889999999999999999999997543211 1111111100000
Q ss_pred -------cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 -------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 -------~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...................++.+++.+|++.||++||+++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000011223567789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.95 Aligned_cols=253 Identities=24% Similarity=0.293 Sum_probs=210.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCc--chHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP--GGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~ 345 (596)
..+.|+..+.||+|.||.||+++.+ +|+.+|+|.+.+.... .....+.+|+.+|+++. |||||.+.+.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456888899999999999999976 5999999999754332 24578899999999998 999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC----CcEEEeecc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLCDFG 421 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~DfG 421 (596)
+|||++.+|.|.+.+... .++...+..++.|++.++.|||+. +++||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999874 389999999999999999999998 99999999999999543 579999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
++..... ........||+.|+|||++....|+..+||||.||++|.|+.|..||........ .. .....+
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~----~~----~i~~~~ 254 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI----FL----AILRGD 254 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH----HH----HHHcCC
Confidence 9998766 3345567899999999999999999999999999999999999999986432111 11 111111
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+ ++. ....+.......+++..|+..||.+|+++.+++++
T Consensus 255 -~-~f~----~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 -F-DFT----SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -C-CCC----CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1 111 11344557788899999999999999999999995
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.99 Aligned_cols=247 Identities=27% Similarity=0.401 Sum_probs=198.6
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
++|+..+.||+|+||.||++.. +++.||+|.++.. .....+.+|+.++.+++|||++++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4578889999999999999975 7788999988642 2346789999999999999999999998654 579999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 9999999997532 34588999999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+. ..... +
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~----~~~~~---~-- 217 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----VKECVE----KGYRM---E-- 217 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHHh----CCCCC---C--
Confidence 11224568999999988899999999999999999998 899987433211 111111 11000 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.....+..+.+++.+|++.+|++||+++++++.|++
T Consensus 218 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 ---PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112335678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.51 Aligned_cols=197 Identities=24% Similarity=0.371 Sum_probs=159.7
Q ss_pred CceeeecCceEEEEEEeC---CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec--CCeeEEEEEcc
Q 007608 277 SNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERILVYPFM 351 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~ 351 (596)
...||+|+||+||+|+.. ++..||+|.+... .....+.+|++++++++||||+++++++.. ....++|+||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC---CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 468999999999999964 4578999988642 223467899999999999999999998854 45678999998
Q ss_pred cCCChhhhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE----cCCCcEEEeeccc
Q 007608 352 QNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGL 422 (596)
Q Consensus 352 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~DfGl 422 (596)
.+ +|.+++.... .....+++..+..++.|++.||.|||+. +++||||||+||++ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 7776664211 1123588999999999999999999999 99999999999999 5667899999999
Q ss_pred cccccccCcc--eeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCc
Q 007608 423 AKLVDAKLTH--VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 480 (596)
Q Consensus 423 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~ 480 (596)
++........ ......+|+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9876543221 12334578999999998764 5799999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=299.14 Aligned_cols=266 Identities=24% Similarity=0.366 Sum_probs=200.3
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC-cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
++|+..+.||+|+||.||+|..+ +++.||+|++..... ....+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999975 589999999864322 2345678899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|++++++.++... ...+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999888877654 23589999999999999999999998 9999999999999999999999999998866443
Q ss_pred CcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc-------cC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR-------ED 501 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~-------~~ 501 (596)
.. ......++..|+|||+..+ ..++.++||||||+++|||++|+.||......+. ............. ..
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-LYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHHHhCCCchhhHHHhccc
Confidence 22 2223457889999999875 3478899999999999999999998864332110 0000000000000 00
Q ss_pred cc-cccccCcCCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 RL-NDIVDRNLNT------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ~~-~~~~d~~l~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. .....+.... ........+.+++.+|++.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 0000000000 011235678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=293.46 Aligned_cols=257 Identities=28% Similarity=0.403 Sum_probs=206.3
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||.|+||+||+|... ++..+++|++.........+.+.+|++.++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47888999999999999999954 68899999987544344667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++..... ...+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975332 24689999999999999999999998 99999999999999999999999999988665432
Q ss_pred cc---eeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 431 TH---VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 431 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
.. ......|+..|+|||++... .++.++|||||||++|||++|+.||...... ....+.. ...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~~~~----~~~----- 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----KVLMLTL----QND----- 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----hhHHHHh----cCC-----
Confidence 22 22334578899999998776 7899999999999999999999999743221 1111111 110
Q ss_pred ccCcCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLNTY--DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+..... .......+.+++.+|++.||++||+++|++++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 224 -PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0111110 12345678899999999999999999999763
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=308.96 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=194.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC------
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------ 341 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 341 (596)
..++|...+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999999995 478899999986432 222345677899999999999999999877543
Q ss_pred CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
...+++++++ +++|..++.. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3468899987 6788877753 3589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.. +......
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~-~~~~~~~ 234 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ----LKR-IMEVVGT 234 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH----HHH-HHHHhCC
Confidence 99865432 223458999999999876 5689999999999999999999999975332110 111 1000000
Q ss_pred -----------CcccccccCcCCCCC--------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 -----------DRLNDIVDRNLNTYD--------SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 -----------~~~~~~~d~~l~~~~--------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....... ..+...+ ......+.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000000 1122357799999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=296.84 Aligned_cols=253 Identities=24% Similarity=0.301 Sum_probs=198.0
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 46777889999999999999964 68899999986432 23345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.. ...+++.+.+.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999998875 34588999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeccccccccccCccccc---CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 431 THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
. ......|+..|+|||++. ...++.++|||||||++|||++|+.|+....... ..... .... . .
T Consensus 161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~----~~~~~----~~~~-~---~ 227 (267)
T cd06645 161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----ALFLM----TKSN-F---Q 227 (267)
T ss_pred c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh----hHHhh----hccC-C---C
Confidence 1 123345889999999974 4568899999999999999999999986432110 00000 0000 0 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+... ........+.+++.+|++.+|++||++++++++
T Consensus 228 ~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 228 PPKLK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCccc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00000 011223467889999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=296.63 Aligned_cols=257 Identities=27% Similarity=0.384 Sum_probs=199.3
Q ss_pred CCcCceeeecCceEEEEEEeC----CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC------
Q 007608 274 FSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 342 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 342 (596)
|...+.||+|+||.||+|.+. ++..||+|++... ......+.+.+|++++++++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999853 3688999998743 23445667899999999999999999999886542
Q ss_pred eeEEEEEcccCCChhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 343 ERILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
..+++++|+.+|+|.+++.... .....+++...+.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999988875322 1223578999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHh
Q 007608 421 GLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL 498 (596)
Q Consensus 421 Gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~ 498 (596)
|+++........ ......+++.|++||.+.+..++.++||||||+++|||++ |+.||...... ....++..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~~-- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYNYLIK-- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----HHHHHHHc--
Confidence 999865432211 1122335678999999988889999999999999999999 88888643221 12222111
Q ss_pred ccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 499 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.... .........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 231 -~~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 -GNRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -CCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 01123346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=292.42 Aligned_cols=250 Identities=23% Similarity=0.353 Sum_probs=201.6
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|+..+.||+|+||.||++... +++.+|+|++... ........+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999964 7889999998643 2344567889999999999999999999999989999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC-CcEEEeecccccccccc
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfGl~~~~~~~ 429 (596)
+++++|.+++.... ...+++..+..++.+++.+++|||++ +++|+||||+||+++++ ..+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997632 34589999999999999999999999 99999999999999855 46899999999866443
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
. ......++..|+|||.+.+...+.++||||||+++|+|++|+.||...... .. +....... .
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~---~~~~~~~~-~------ 218 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----AL---VLKIMSGT-F------ 218 (256)
T ss_pred c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HH---HHHHHhcC-C------
Confidence 2 122345788999999999888999999999999999999999998753221 11 11111110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+.....++.+++.+|++.+|++||++.|++++
T Consensus 219 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 --APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11122245578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.43 Aligned_cols=239 Identities=25% Similarity=0.328 Sum_probs=185.6
Q ss_pred eeeecCceEEEEEEeCC-------------------------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccc
Q 007608 279 IIGQGGFGKVYKGVLSD-------------------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333 (596)
Q Consensus 279 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 333 (596)
.||+|+||.||+|.+.. ...|++|++.... ......|.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 58999999999998421 1358899886422 223456888999999999999999
Q ss_pred eEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC
Q 007608 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 413 (596)
Q Consensus 334 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~ 413 (596)
++++|.+....++||||+++|+|..++... ...+++..+..++.|+++||+|||+. +++||||||+||+++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 999999999999999999999999888642 24588999999999999999999998 999999999999997643
Q ss_pred -------cEEEeeccccccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHH-hCCCCCCCccchh
Q 007608 414 -------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELV-TGQRAIDFSRLEE 484 (596)
Q Consensus 414 -------~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~ell-tg~~p~~~~~~~~ 484 (596)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999987643221 12246788999998865 56899999999999999995 6888886432211
Q ss_pred hhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 485 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 485 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
....... ... .+.....++.+++.+||+.+|++||++.+|++.|.
T Consensus 230 -----~~~~~~~---~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 -----KERFYEK---KHR-----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -----HHHHHHh---ccC-----------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111110 000 01112246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=294.11 Aligned_cols=266 Identities=25% Similarity=0.347 Sum_probs=200.1
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHH--hcCCCCccceEeEEecCC----e
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS--VAIHKNLLQLIGYCTTSS----E 343 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~--~l~H~niv~l~~~~~~~~----~ 343 (596)
........+.||+|.||.||+|.+ .|..||||++.. .+++.+.+|.+++. .++|+||+.+++.-..++ +
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 445666788999999999999999 788999999853 34667777777766 469999999998765543 5
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCcEecCCCCCcEEEcCCCcEEEe
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLC 418 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivH~dlkp~NIll~~~~~~kl~ 418 (596)
.++|.+|.+.|||.++|.. ..++-...++++..+|.||+|||. +.+|.|.|||||+.|||+..++.+.|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 7899999999999999986 468899999999999999999994 457899999999999999999999999
Q ss_pred eccccccccccCcc---eeccccccccccCcccccCCC------CCcccccHHHHHHHHHHHhC----------CCCCCC
Q 007608 419 DFGLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTGK------SSEKTDVFGYGITLLELVTG----------QRAIDF 479 (596)
Q Consensus 419 DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~S~Gvil~elltg----------~~p~~~ 479 (596)
|+|+|-........ .....+||.+|||||++...- .-..+||||||.|+||+.-. +.||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999766544222 234467999999999986431 12358999999999999752 345543
Q ss_pred ccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 007608 480 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 551 (596)
Q Consensus 480 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 551 (596)
-...+... +.++..+-..++...++.+. ...+....+.++++.||..+|..|-|+--+-+.|.+..
T Consensus 439 ~Vp~DPs~----eeMrkVVCv~~~RP~ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 439 VVPSDPSF----EEMRKVVCVQKLRPNIPNRW--KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCCCCH----HHHhcceeecccCCCCCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 22111111 11121111111111111111 34577889999999999999999999999888886543
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=291.19 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=200.7
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC----CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
+|+..+.||+|+||.||+|... +++.|++|.+.... .....+.+.+|+++++.++|+|++++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999976 78999999886322 123456789999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
+||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999998752 3588999999999999999999999 99999999999999999999999999987654
Q ss_pred ccCcceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||...... +..........
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~~---- 219 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--------AAVFKIGRSKE---- 219 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--------HHHHHHHhccc----
Confidence 332 223345788999999987766 899999999999999999999998743210 11111111010
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+......+.+++.+|++.+|++||++.++++.
T Consensus 220 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 ----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111122334677889999999999999999999753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=293.10 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=207.3
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||+|++|.||+|+.. +++.|++|++...........+.+|+..+.+++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888899999999999999976 58999999987543334567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
+++++|.+++... ..+++...+.++.|+++|++|||+ . +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999763 568999999999999999999999 8 9999999999999999999999999999876543
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
.... ....++..|+|||.+.+..++.++||||||+++|||+||+.|+...... . ..+....... .
T Consensus 154 ~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~---~~~~~~~~~~---------~ 218 (264)
T cd06623 154 LDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--S---FFELMQAICD---------G 218 (264)
T ss_pred CCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--C---HHHHHHHHhc---------C
Confidence 2221 2345788999999999888999999999999999999999998754310 1 1111111111 1
Q ss_pred cCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 510 NLNTYDSK-EVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 510 ~l~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
........ .+..+.+++.+|+..+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111222 55788999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=294.82 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=201.5
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
-|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+..+.+++|||++++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667889999999999999864 688999998764433445577899999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++++|.+++.. ..+++.....++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999998864 3588999999999999999999998 999999999999999999999999999876543221
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcC
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 511 (596)
......++..|+|||...+...+.++|||||||++|||++|..|+..... ......+ .... .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~----~~~~--------~ 218 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFLI----PKNN--------P 218 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHHH----hcCC--------C
Confidence 12224578899999999888889999999999999999999999864221 1111111 1110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 512 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.........++.+++.+|++.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11222345678889999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=297.57 Aligned_cols=262 Identities=23% Similarity=0.255 Sum_probs=202.2
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|+..+.||+|+||.||+|... +|+.|++|++.... .......+.+|+.++++++|||++++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777899999999999999964 78999999987433 234457789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+ +++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999887532 4689999999999999999999999 99999999999999999999999999998765433
Q ss_pred cceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC--------
Q 007608 431 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED-------- 501 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~-------- 501 (596)
........++..|+|||.+.+. .++.++||||+|++++||+||.++|...... .....+.......
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-----EQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-----HHHHHHHHHcCCCChHHHhhc
Confidence 2222334578999999998654 4689999999999999999998777643221 1111111111000
Q ss_pred ----cccccccCcCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 ----RLNDIVDRNLN-----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ----~~~~~~d~~l~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+..+... ....+....+.+++.+|++.+|++||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0111234788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=294.50 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=200.1
Q ss_pred CCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC---CCCccceEeEEecCCeeEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~ 348 (596)
.|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999996 5789999999875444555677889999999986 999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++.. ..+++...+.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998864 2688999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.... .....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||...... .... ..... .
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~-~~~~~-----~ 218 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------RAMM-LIPKS-----K 218 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------hhhh-ccccC-----C
Confidence 3322 2234588899999998654 4689999999999999999999999743211 1110 00000 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.+.+.. .....++.+++.+|++.||++||++.|+++
T Consensus 219 ~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLED--NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111111 114567889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=297.30 Aligned_cols=265 Identities=23% Similarity=0.247 Sum_probs=197.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++++|...+.||+|+||.||+|... +++.||+|++...........+.+|+++++.++|+||+++.+++......++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578889999999999999999864 789999999875444444556789999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+. +++.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 6777666532 23578888999999999999999999 999999999999999999999999999875433
Q ss_pred cCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH-----------
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK----------- 496 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~----------- 496 (596)
.... .....+++.|+|||++.+. .++.++|||||||++|||+||+.||+...... ..+.+....
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF---EQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH---HHHHHHHHHcCCCChhhhhh
Confidence 2111 1223468899999998754 47889999999999999999999997533211 111111000
Q ss_pred Hhc-cCcccccccCcCCC----C--CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 497 LLR-EDRLNDIVDRNLNT----Y--DSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 497 ~~~-~~~~~~~~d~~l~~----~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
... .....+........ . .......+.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 00000000000000 0 0012456778999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.02 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=199.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.+.|++.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++|||++++++.+..+...++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 356888999999999999999975 5889999998642 34456778899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|...+.+. ...+++..+..++.|++.+++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999998877642 23589999999999999999999998 9999999999999999999999999998754322
Q ss_pred CcceeccccccccccCccccc-----CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
.. ......+++.|+|||++. ...++.++|||||||++|||++|+.|+...... ...........
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~-- 232 (292)
T cd06644 164 LQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEP-- 232 (292)
T ss_pred cc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcCCC--
Confidence 11 122345788999999984 345688999999999999999999998643211 11111111110
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+.. ..+.....++.+++.+|++.+|++||++.|+++.
T Consensus 233 ----~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 ----PTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ----ccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 1122344578889999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=290.27 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=201.1
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC-cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|...+.||+|+||.||+|... +++.|++|.++.... ....+.+.+|+++++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999964 789999999874322 23567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999875 23578899999999999999999999 99999999999999999999999999998765433
Q ss_pred cceec---cccccccccCcccccCCC---CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 431 THVTT---QIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 431 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
..... ...++..|+|||++.+.. .+.++||||||+++||+++|+.||...... ........ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~----~~~~~~~~----~~--- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----FQIMFHVG----AG--- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----HHHHHHHh----cC---
Confidence 22211 345788999999998766 889999999999999999999999743211 00110011 00
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..+.+.. .......+.+++.+|++.+|++||++.|++.
T Consensus 223 --~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 --HKPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --CCCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0111111 1122556778999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=293.89 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=197.4
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEccc
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 352 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 352 (596)
|+..+.||+|+||.||+|... ++..+++|.+... .......+.+|+++++.++|||++++++++...+..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 556788999999999999975 5778899887532 33445678899999999999999999999999999999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc
Q 007608 353 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432 (596)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 432 (596)
+++|...+... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....... .
T Consensus 86 ~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 99998887642 24689999999999999999999999 99999999999999999999999999987553321 1
Q ss_pred eeccccccccccCccccc-----CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 433 VTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 433 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
......++..|+|||++. +..++.++|||||||++|||++|+.||...... ..... ...... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~----~~~~~~-~~~- 228 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----RVLLK----IAKSEP-PTL- 228 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----HHHHH----HhhcCC-CCC-
Confidence 222345789999999974 345788999999999999999999998743211 01111 111100 000
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
..+.....++.+++.+||+.+|++||++.+++++-
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 229 -----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 01222346788999999999999999999997643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=292.78 Aligned_cols=255 Identities=23% Similarity=0.350 Sum_probs=198.5
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCc---------chHHHHHHHHHHHHhcCCCCccceEeEEecCC
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP---------GGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 342 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 342 (596)
+|...+.||+|+||.||+|... +++.||+|.++..... ...+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999854 6899999987532110 11346788999999999999999999999999
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999998763 4688999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCcc-eeccccccccccCcccccCCC--CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc
Q 007608 423 AKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 499 (596)
Q Consensus 423 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 499 (596)
++........ ......++..|+|||.+.... ++.++||||||+++||+++|..|+...... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~ 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--------AAMFKLGN 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--------HHHHHhhc
Confidence 9765432211 122345788999999987654 789999999999999999999998632211 01111111
Q ss_pred cCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 500 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 500 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. ....++.. ........+.+++.+|+..+|++||++.||+++
T Consensus 227 ~~-~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 KR-SAPPIPPD---VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cc-cCCcCCcc---ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11 01111111 112345678889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.31 Aligned_cols=255 Identities=28% Similarity=0.377 Sum_probs=201.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCC-----
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS----- 342 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~----- 342 (596)
++++|+..+.||+|++|.||+|... +++.+++|++... ....+.+.+|+++++++ .|+|++++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII--EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4688999999999999999999975 6788999988643 23456789999999999 6999999999997644
Q ss_pred -eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 343 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 343 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 47999999999999998876443345789999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeccccccccccCcccccC-----CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
++........ ......++..|+|||++.. ..++.++|||||||+++||+||+.||...... .... .
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~----~ 229 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM----RALF----K 229 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH----HHHH----H
Confidence 9876543221 1223457889999998753 34678999999999999999999999642211 0111 1
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
... ... +.+ .........+.+++.+|+..||++||++.|+++
T Consensus 230 ~~~-~~~-----~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPR-NPP-----PTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhc-cCC-----CCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 000 011 112335567889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=297.35 Aligned_cols=262 Identities=24% Similarity=0.266 Sum_probs=198.9
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC----cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
+|+..+.||+|+||.||+|... +++.||+|++..... ......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999965 689999999874322 22345677899999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+ +++|.+++.... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999987522 3689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc-------
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR------- 499 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~------- 499 (596)
..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||......+. +.........
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ----LGKIFEALGTPTEENWP 228 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH----HHHHHHHcCCCchhhhh
Confidence 43221 122345788999998865 4578999999999999999999877764332111 1111110000
Q ss_pred -cCccccccc------CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 500 -EDRLNDIVD------RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 500 -~~~~~~~~d------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
......... ............++.+++.+|++.+|++||+++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 00000112235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=308.77 Aligned_cols=237 Identities=24% Similarity=0.268 Sum_probs=183.3
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc---CCCCccceEeEEecCCeeEEEEEcccC
Q 007608 280 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA---IHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 280 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
||+|+||+||+|+.. +++.||+|++.... .......+..|..++... .||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 68999999986321 122233455666666655 699999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.++|+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 999988875 34588999999999999999999999 999999999999999999999999999875432211 2
Q ss_pred eccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCC
Q 007608 434 TTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 512 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 512 (596)
.....||+.|+|||++.+. .++.++|||||||++|||+||+.||...... +...... .+.. .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--------~~~~~i~-~~~~------~~~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--------QMYRNIA-FGKV------RFP 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--------HHHHHHH-cCCC------CCC
Confidence 2345689999999998764 4799999999999999999999999753221 1111111 1100 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007608 513 TYDSKEVETMVQVALLCTQSTPEDRPPMA 541 (596)
Q Consensus 513 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 541 (596)
......++.+++.+|++.||.+||++.
T Consensus 218 --~~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 218 --KNVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 112345677899999999999999544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=294.51 Aligned_cols=240 Identities=23% Similarity=0.369 Sum_probs=187.4
Q ss_pred ceeeecCceEEEEEEeCC--------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 278 NIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
+.||+|+||.||+|.... ...+++|.+... .....+.+.+|+.+++.+.|||++++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 468999999999998642 234888877532 22345678899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc--------EEEeecc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--------AVLCDFG 421 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~--------~kl~DfG 421 (596)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999987532 3589999999999999999999999 9999999999999987765 6999999
Q ss_pred ccccccccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCC-CCCCCccchhhhhchHHHHHHHHhc
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQ-RAIDFSRLEEEEDVLLLDHIRKLLR 499 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~-~p~~~~~~~~~~~~~l~~~~~~~~~ 499 (596)
++...... ....++..|+|||++.+. .++.++|||||||++|||++|. .|+...... .......
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-----~~~~~~~---- 219 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-----KKLQFYE---- 219 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-----HHHHHHH----
Confidence 88654321 223478899999999874 5799999999999999999995 554422111 0011110
Q ss_pred cCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 500 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 500 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
. . ...+.....++.+++.+|++.+|++||+++++++.|+
T Consensus 220 ~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 D-R---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c-c---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 0111223357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=294.80 Aligned_cols=265 Identities=23% Similarity=0.314 Sum_probs=200.8
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
+|+..+.||.|++|.||+|+.. +|+.||+|.++..........+.+|++++++++|+|++++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 688999999875444445567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++ +|.+++..... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 88888765332 34689999999999999999999998 999999999999999999999999999976543222
Q ss_pred ceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc----
Q 007608 432 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI---- 506 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~---- 506 (596)
. .....++..|++||++.+. .++.++|||||||++|||++|+.||......+.... ..+.... ........+
T Consensus 156 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~ 232 (284)
T cd07836 156 T-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK-IFRIMGT-PTESTWPGISQLP 232 (284)
T ss_pred c-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-HHHHhCC-CChhhHHHHhcCc
Confidence 1 1223468899999988664 468899999999999999999999975443211110 0000000 000000000
Q ss_pred -ccCcCC--------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 507 -VDRNLN--------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 507 -~d~~l~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...... ...+.....+.+++.+|++.||.+||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 011223456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=317.27 Aligned_cols=267 Identities=19% Similarity=0.267 Sum_probs=192.5
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCC------CCccceEeE
Q 007608 265 RELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH------KNLLQLIGY 337 (596)
Q Consensus 265 ~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H------~niv~l~~~ 337 (596)
+++...+++|++.+.||+|+||+||+|... +++.||||+++.. ......+..|++++..++| .++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 344556788999999999999999999964 6788999998642 1223445667777776654 458888888
Q ss_pred EecC-CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC---
Q 007608 338 CTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF--- 413 (596)
Q Consensus 338 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~--- 413 (596)
+... ...++||+++ +++|.+++.. ...+++..+..++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccc
Confidence 8765 4678889887 6788888865 246899999999999999999999732 899999999999998765
Q ss_pred -------------cEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCc
Q 007608 414 -------------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 480 (596)
Q Consensus 414 -------------~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~ 480 (596)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||+..
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998764322 223456899999999999999999999999999999999999999754
Q ss_pred cchhhhhchHHH---------HHHH--------Hhc-cCcccccccCc-----CCC---CCHHHHHHHHHHHHHccccCC
Q 007608 481 RLEEEEDVLLLD---------HIRK--------LLR-EDRLNDIVDRN-----LNT---YDSKEVETMVQVALLCTQSTP 534 (596)
Q Consensus 481 ~~~~~~~~~l~~---------~~~~--------~~~-~~~~~~~~d~~-----l~~---~~~~~~~~l~~l~~~Cl~~dP 534 (596)
...+. ..... |... ... ...+....++. ... ........+.+|+.+||+.||
T Consensus 349 ~~~~~--~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 349 DNLEH--LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred ChHHH--HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 32111 00000 0000 000 00000000000 000 000123457799999999999
Q ss_pred CCCCCHHHHHHH
Q 007608 535 EDRPPMAQVVKM 546 (596)
Q Consensus 535 ~~RPs~~evl~~ 546 (596)
++|||++|++++
T Consensus 427 ~~R~ta~e~L~H 438 (467)
T PTZ00284 427 QKRLNARQMTTH 438 (467)
T ss_pred hhCCCHHHHhcC
Confidence 999999999763
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=308.54 Aligned_cols=244 Identities=23% Similarity=0.374 Sum_probs=199.4
Q ss_pred CceeeecCceEEEEEEeC-CCcEEEEEEcc---ccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe--eEEEEEc
Q 007608 277 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ---DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE--RILVYPF 350 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~---~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~--~~lv~e~ 350 (596)
..+||+|+|-+||+|... +|..||---++ ...++...+.|..|+++|+.|+||||++++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 568999999999999964 57777643332 23345556889999999999999999999999877765 6789999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-CCcEEEeecccccccccc
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfGl~~~~~~~ 429 (596)
|..|+|..|.+.++ .++....+.+++||++||.|||++ .|+|+|||||..||+++. .|.|||+|.|+|..+...
T Consensus 125 ~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999998754 477889999999999999999997 678999999999999975 489999999999987653
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
.. ..+.|||.|||||.+. ..|++..||||||+.++||+|+..||..... ...+.+.+.+...+..+..+-||
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n----~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN----PAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC----HHHHHHHHHcCCCHHHhhccCCH
Confidence 22 2367999999999987 7899999999999999999999999975432 23344444444444444444444
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
++.+++.+|+.. .++|||+.|++.
T Consensus 272 -----------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 -----------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 677888999999 999999999976
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=307.08 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=204.8
Q ss_pred CceeeecCceEEEEEEeC--CCc--EEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEccc
Q 007608 277 SNIIGQGGFGKVYKGVLS--DNT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 352 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~--~~~--~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 352 (596)
.+.||+|.||.|++|.|+ +|+ .||||.++.........+|.+|+.+|.+++|||+++++|+..+ ....+|+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 578999999999999975 344 5899999865555577899999999999999999999999887 67789999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc
Q 007608 353 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432 (596)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 432 (596)
.|+|.+.|+.. ....+-......++.|||.||.||.++ ++|||||..+|+++-....+||+|||+.+.+......
T Consensus 194 lGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 194 LGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999972 235677788889999999999999999 9999999999999999999999999999988665444
Q ss_pred ee--ccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 433 VT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 433 ~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
.. ....-...|.|||.+...+++.++|||+|||.+|||+| |..||..... ..+.+.+ -+.
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----~qIL~~i------------D~~ 331 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----IQILKNI------------DAG 331 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----HHHHHhc------------ccc
Confidence 32 22334678999999999999999999999999999999 6778875332 1111111 112
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
.....+..++++++++++.||...|++||++..|.+.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 22234677899999999999999999999999997543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=291.89 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=201.4
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|+..+.||+|+||.||+|... +|..+|+|.+... ......+.+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777899999999999999965 6889999998642 2233456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC-cEEEeecccccccccc
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK 429 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfGl~~~~~~~ 429 (596)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999987532 23579999999999999999999998 999999999999998885 4699999998866433
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
.. ......|++.|+|||+..+..++.++||||||+++|||++|..||..... .+.+...... ..
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~------ 219 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVLKICQG-YF------ 219 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHhcc-cC------
Confidence 21 22234578899999999888899999999999999999999999874321 1122211111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.........++.+++.+|++.+|++||++.|++++
T Consensus 220 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 --APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11112234578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.51 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=201.5
Q ss_pred CCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCC-----cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
+|+..+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|++.+++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999995 5789999999863221 1134678899999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC-cEEEeecccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKL 425 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfGl~~~ 425 (596)
|+||+++++|.+++.+ ...+++.....++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999875 24688999999999999999999999 999999999999998775 599999999876
Q ss_pred ccccCcc---eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 426 VDAKLTH---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 426 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
....... ......++..|+|||.+.+..++.++||||+|+++++|++|+.||....... ............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~- 227 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-----HLALIFKIASAT- 227 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-----hHHHHHHHhccC-
Confidence 6443211 1223457889999999988889999999999999999999999986432211 111111110000
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.....+.....++.+++.+|+..+|++||++.|+++
T Consensus 228 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 -------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011123445677889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.84 Aligned_cols=198 Identities=25% Similarity=0.333 Sum_probs=171.1
Q ss_pred CCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-C-----CCccceEeEEecCCeeE
Q 007608 273 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-H-----KNLLQLIGYCTTSSERI 345 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H-----~niv~l~~~~~~~~~~~ 345 (596)
+|++.++||+|+||.|-+|.. ++++.||||++++. .....+-..|+.+|..++ | -|+|++++|+...++.+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 789999999999999999995 57999999999863 233455677899999887 3 47999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC--CcEEEeecccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN--FEAVLCDFGLA 423 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~DfGl~ 423 (596)
+|+|.+. -+|.++++... ..+++....+.|+.||+.||.+||+. +|||+||||+||||.+. ..+||+|||.+
T Consensus 265 iVfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999986 49999999744 35699999999999999999999999 99999999999999644 36999999999
Q ss_pred ccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccc
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 482 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~ 482 (596)
+....... ...-+..|+|||++.+.+|+.+.||||||||+.||+||.+.|.+.+.
T Consensus 339 c~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 339 CFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 97765433 23357789999999999999999999999999999999888876543
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.35 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=196.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC----CcchHHHHHHHHHHHHhcCCCCccceEeEEecC--Cee
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 344 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 344 (596)
++|+..+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999964 68999999875221 112345788899999999999999999988664 456
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||+++++|.+++... ..+++...+.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 7999999999999988752 3478888999999999999999999 99999999999999999999999999987
Q ss_pred cccccCc--ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 425 LVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 425 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
....... .......++..|+|||++.+..++.++|||||||++|||++|+.||....... . +......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~-~~~~~~~-- 224 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------A-IFKIATQ-- 224 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------H-HHHHhcC--
Confidence 6533211 11223457889999999988889999999999999999999999986422110 0 1111111
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+.....+......+.+++.+|+. +|++||+++|+++.
T Consensus 225 ------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 225 ------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 01111234455677788888884 99999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=298.27 Aligned_cols=262 Identities=23% Similarity=0.297 Sum_probs=196.3
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|+..+.||+|+||.||+|... +|+.||+|+++... .......+.+|++++++++|||++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777899999999999999965 78999999986422 223345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
++ ++|.+++... ...+++..++.++.||++||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 4777776542 24589999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc------c
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR------L 503 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~------~ 503 (596)
.. .....++..|+|||++.+.. ++.++|||||||++|||+||+.|+........ ..+.+........ .
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD----QLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH----HHHHHHHHhCCCChHHhHHh
Confidence 21 12234688999999987654 68999999999999999999988643222111 1111111000000 0
Q ss_pred cccccC----cCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 504 NDIVDR----NLN------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 504 ~~~~d~----~l~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+. ... ........++.+++.+|++.||.+|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000 000 0111234677899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=294.33 Aligned_cols=253 Identities=28% Similarity=0.368 Sum_probs=201.3
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|++.+.||+|+||.||+|... ++..+|+|.+... .......|.+|++++++++|||++++++++......++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 456888899999999999999964 6889999998642 33445678999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999988753 24589999999999999999999999 9999999999999999999999999998755332
Q ss_pred CcceeccccccccccCccccc-----CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
.. ......+++.|+|||++. +..++.++||||||+++|||++|+.||...... +......... .
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~-~- 225 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKILKSE-P- 225 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHHhcCC-C-
Confidence 21 122345789999999974 345678999999999999999999998743211 1111111110 0
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+.+ ..+.....++.+++.+|++.+|++||++.++++.
T Consensus 226 ----~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ----PTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 1122344578889999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=296.96 Aligned_cols=256 Identities=23% Similarity=0.272 Sum_probs=201.7
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||++... +++.|++|.+.... .......+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999965 57899999886432 1233457889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999975 24589999999999999999999998 999999999999999999999999999864211
Q ss_pred cCc--------------ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHH
Q 007608 429 KLT--------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 494 (596)
Q Consensus 429 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~ 494 (596)
... .......++..|+|||++.+..++.++|+||||+++|||++|..||...... .+ .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~---~ 225 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----EL---F 225 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH---H
Confidence 000 0111234788999999998888999999999999999999999998643211 11 1
Q ss_pred HHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 495 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
....... ...+. .......++.+++.+|++.+|++||++.++.+.|+.
T Consensus 226 ~~~~~~~----~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 226 GQVISDD----IEWPE---GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHhcc----cCCCC---ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111100 00010 111234567899999999999999998878777776
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=298.45 Aligned_cols=255 Identities=23% Similarity=0.257 Sum_probs=201.0
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCc--chHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP--GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|++++..++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999975 5899999998743222 24567889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987532 34689999999999999999999998 999999999999999999999999999875532
Q ss_pred cCcc----------------------------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCc
Q 007608 429 KLTH----------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 480 (596)
Q Consensus 429 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~ 480 (596)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 011235788999999999888999999999999999999999999754
Q ss_pred cchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 481 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 481 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
.... . ........ . ... ........+.+++.+|++.+|++||+++..++.+
T Consensus 236 ~~~~----~----~~~~~~~~-~------~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l 286 (316)
T cd05574 236 NRDE----T----FSNILKKE-V------TFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286 (316)
T ss_pred chHH----H----HHHHhcCC-c------cCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence 3211 0 11111100 0 000 1112467889999999999999999944444443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=294.34 Aligned_cols=259 Identities=24% Similarity=0.341 Sum_probs=201.0
Q ss_pred cHHHHHHHhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEec
Q 007608 263 SCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 340 (596)
Q Consensus 263 ~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 340 (596)
++.++..+.+.|+..+.||+|+||.||+|.. .+++.+|+|.+... ......+..|+.++.++ +|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 4455555778899999999999999999996 46889999987532 23446788899999998 69999999999853
Q ss_pred ------CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc
Q 007608 341 ------SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 414 (596)
Q Consensus 341 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 414 (596)
....+++|||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 356799999999999999887533 23578888999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccccCcceeccccccccccCccccc-----CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhch
Q 007608 415 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 489 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~ 489 (596)
++|+|||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|+.||........
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---- 234 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA---- 234 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh----
Confidence 99999999876533211 122345789999999975 34578899999999999999999999864321100
Q ss_pred HHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 490 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 490 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
........ .+.. .......++.+++.+||+.||.+||++.|+++
T Consensus 235 ----~~~~~~~~------~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 ----LFLIPRNP------PPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----hhhHhhCC------CCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000000 0000 11234567899999999999999999999965
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=293.04 Aligned_cols=262 Identities=24% Similarity=0.329 Sum_probs=198.1
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
|+..+.||.|++|.||+|... +|..||+|++.... .......+.+|++.+++++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999964 79999999986432 2333467889999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
+ ++|.+++..... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689988875331 3689999999999999999999998 999999999999999999999999999976543222
Q ss_pred ceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC---------
Q 007608 432 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED--------- 501 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~--------- 501 (596)
.. ....++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+.+.........
T Consensus 155 ~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 TY-THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID----QLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred cc-CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHHhhhhhh
Confidence 11 222467899999988664 46889999999999999999999987543211 1111111100000
Q ss_pred ------cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 ------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ------~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....................+.+++.+|++.+|++||+++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000001111112234678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=295.88 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=197.4
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEccc
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 352 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 352 (596)
|.....||+|+||.||++... ++..||+|.+... .......+.+|+..+..++|+|++++++.+...+..++||||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 333467999999999999964 6889999998642 23345678899999999999999999999999999999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc
Q 007608 353 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432 (596)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 432 (596)
+++|.+++.. ..+++.....++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 103 ~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 103 GGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 9999998754 3478999999999999999999999 999999999999999999999999999875543222
Q ss_pred eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCC
Q 007608 433 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 512 (596)
Q Consensus 433 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 512 (596)
......|+..|+|||+..+..++.++||||||+++|||++|+.||....... ....+... ..+...
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~---------~~~~~~ 239 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AMRRIRDN---------LPPRVK 239 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhc---------CCCccc
Confidence 1223457899999999988889999999999999999999999987432210 11111110 111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 513 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 513 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
........+.+++.+|+..||++||+++|+++.
T Consensus 240 -~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 -DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111234567788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=294.20 Aligned_cols=245 Identities=24% Similarity=0.283 Sum_probs=199.7
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||++... +++.+|+|.+.... .......+.+|+++++++.||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999965 68999999986421 2234567889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++... ..++...+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999998762 4688999999999999999999998 999999999999999999999999999986644
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...... .....+ . .+.
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~---~-~~~------ 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-----QIYEKI---L-EGK------ 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH---h-cCC------
Confidence 3 22345789999999998888899999999999999999999998743311 111111 1 110
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVK 545 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 545 (596)
. ..+......+.+++.+||+.+|.+|| +++|+++
T Consensus 215 ~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 V---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred c---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0 11122346778899999999999998 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.41 Aligned_cols=247 Identities=23% Similarity=0.351 Sum_probs=199.9
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCCh
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 356 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (596)
-+||+|.||+||.|+.. +...+|||-+....+ ...+-...|+.+-++++|.|||+++|.+.+++..-+.||-++||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 47999999999999965 566799999875333 3455678999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc-CCCcEEEeeccccccccccCcceec
Q 007608 357 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTT 435 (596)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DfGl~~~~~~~~~~~~~ 435 (596)
.+.|+..-. .-.-+..+.-.+.+||++||.|||++ .|||||||-.|||++ -.|.+||+|||-++.+.. ....+.
T Consensus 660 SsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE 734 (1226)
T KOG4279|consen 660 SSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE 734 (1226)
T ss_pred HHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence 999986321 11226777888999999999999999 999999999999995 678999999999987743 345566
Q ss_pred cccccccccCcccccCCC--CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 436 QIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 436 ~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.+-||..|||||++..++ |..++|||||||.+.||.||++||....... +. +.+-+ +-+.-+.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---------AA-MFkVG-----myKvHP~ 799 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---------AA-MFKVG-----MYKVHPP 799 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---------Hh-hhhhc-----ceecCCC
Confidence 677999999999998654 8889999999999999999999997422110 00 00001 0111123
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.+.+...+...++++|+.+||.+||+++++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 56788889999999999999999999999965
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=295.60 Aligned_cols=266 Identities=20% Similarity=0.239 Sum_probs=196.7
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC-cchHHHHHHHHHHHHhcC-CCCccceEeEEecCCe-----
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSE----- 343 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~----- 343 (596)
++|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.++..+. |||++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 689999998864322 223467888999999995 6999999999877665
Q ss_pred eEEEEEcccCCChhhhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-CCcEEEeecc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPG-EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFG 421 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfG 421 (596)
.++||||+++ ++.+++...... ...+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 788887653322 35689999999999999999999999 9999999999999998 8899999999
Q ss_pred ccccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||....... .+..........
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ----QLLHIFKLLGTP 231 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHHhCCC
Confidence 98765332211 122246788999998865 457899999999999999999999987532211 111111100000
Q ss_pred C--ccccccc-------C-----cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 D--RLNDIVD-------R-----NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 ~--~~~~~~d-------~-----~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. ......+ + .+....+....++.+++.+|++.+|.+||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0000000 0 0000012245678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=294.32 Aligned_cols=266 Identities=22% Similarity=0.290 Sum_probs=198.6
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC--CeeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv 347 (596)
++|+..+.||+|+||.||+|... +++.+++|.++... .......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999975 68899999987432 223344677899999999999999999998777 789999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
+||++ ++|.+.+.... ..+++...+.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 48888887532 3589999999999999999999999 99999999999999999999999999998665
Q ss_pred ccCcceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHH-----------
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR----------- 495 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~----------- 495 (596)
..... .....+++.|+|||.+.+.. ++.++||||||+++|||++|+.||......+.... +.....
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK-IFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCchHHHHHhh
Confidence 43221 12234688999999987654 68999999999999999999999975432111100 000000
Q ss_pred HH--hccCcccccccCcCCC-CCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 496 KL--LREDRLNDIVDRNLNT-YDSK-EVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 496 ~~--~~~~~~~~~~d~~l~~-~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. .............+.. ++.. ....+.+++.+|++.+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 0000000000001111 1111 35668899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=287.08 Aligned_cols=260 Identities=23% Similarity=0.238 Sum_probs=204.5
Q ss_pred cCCCcCceeeecCceEEEEEEeCC-CcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||.|.-|+||++.+.+ +..+|+|++.+.. +.......+.|-++|+.++||.+..+++.+..+...++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345557899999999999999764 5889999997432 2233455677899999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
|||+||+|....+... .+.++...++-++..|+-||+|||-. |||.|||||+|||+.++|++-|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999887643 46789999999999999999999999 999999999999999999999999998643210
Q ss_pred ---------------------------------cCc----------------------ceeccccccccccCcccccCCC
Q 007608 429 ---------------------------------KLT----------------------HVTTQIRGTMGHIAPEYLSTGK 453 (596)
Q Consensus 429 ---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~ 453 (596)
... ..+...+||..|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 0112246999999999999999
Q ss_pred CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC-CCHHHHHHHHHHHHHcccc
Q 007608 454 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQS 532 (596)
Q Consensus 454 ~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~Cl~~ 532 (596)
.+.+.|+|+|||++|||+.|..||.+....+. + . .++...+.- .....+....+|+.+.|.+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----l----~---------NIv~~~l~Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----L----R---------NIVGQPLKFPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhh----H----H---------HHhcCCCcCCCCCcchhHHHHHHHHHhcc
Confidence 99999999999999999999999987544221 1 1 122221111 1124566788999999999
Q ss_pred CCCCCCCHHHHHHHhccCCcc
Q 007608 533 TPEDRPPMAQVVKMLQGEDLA 553 (596)
Q Consensus 533 dP~~RPs~~evl~~L~~~~~~ 553 (596)
||++|...+-=++.+++..+-
T Consensus 375 dP~kRlg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKRHPFF 395 (459)
T ss_pred ChhhhhccccchHHhhcCccc
Confidence 999999944444444554443
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=290.65 Aligned_cols=258 Identities=21% Similarity=0.259 Sum_probs=195.0
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecC--CeeEEEEE
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTS--SERILVYP 349 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~e 349 (596)
|+..+.||+|+||.||+|... +++.||+|+++............+|+..+.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556789999999999999964 689999999875433333445567888898885 99999999999887 78899999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|++ +++.+.+... ...+++..+..++.|++.||.|||+. +++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 5887777642 24689999999999999999999999 9999999999999999 99999999999866433
Q ss_pred CcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc---------
Q 007608 430 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR--------- 499 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~--------- 499 (596)
... ....++..|+|||++.+ ..++.++|||||||++|||++|..||......+ ..........
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-----QIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-----HHHHHHHHcCCCCHHHHHh
Confidence 221 22347889999997654 557889999999999999999999997543211 1111111110
Q ss_pred --cCcccccccCc-----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 500 --EDRLNDIVDRN-----LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 500 --~~~~~~~~d~~-----l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.........+. +.......+.++.+++.+|++.+|++||++.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 000112346789999999999999999999999763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.19 Aligned_cols=251 Identities=23% Similarity=0.284 Sum_probs=206.2
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|+..+.||+|+||.||++... +++.+++|++.... .......+.+|++++++++|+||+++.+++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777899999999999999854 78899999986432 334456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.........+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876444446789999999999999999999999 9999999999999999999999999999876544
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
......+++.|+|||...+..++.++|+||||+++|||++|+.||......+ +...+ ... .
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~----~~~--------~ 217 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----LRYKV----QRG--------K 217 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH----hcC--------C
Confidence 1222347889999999999889999999999999999999999997543211 11111 111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..........++.+++.+|++.+|++||++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111233456778999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.53 Aligned_cols=246 Identities=27% Similarity=0.352 Sum_probs=201.4
Q ss_pred CCCcCceeeecCceEEEEEEe-CCCcEEEEEEccc--cCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.|...+.||+|+||.||-|+. .+...||||++.- ..+.....++.+|+..|.+++|||.+.+.|++......++|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 366678999999999999995 4788999999862 2334455789999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
||- |+-.+.+.-. .+++...++..|..|.+.||+|||+. +.||||||+.|||+++.|.|||+|||.+....+.
T Consensus 107 YCl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 996 5777777643 35788889999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeccccccccccCccccc---CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
..+.|||.|||||++. .++|+-|+||||+||...||...++|.-..+. . ..+...+. .
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--M--SALYHIAQ----N------ 240 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--M--SALYHIAQ----N------ 240 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--H--HHHHHHHh----c------
Confidence 3457999999999984 57899999999999999999999988753221 1 11111111 1
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
-.|.+. ..+....+..++..|+++-|.+|||..+++++
T Consensus 241 esPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 241 ESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 112222 45677888999999999999999999999874
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=302.15 Aligned_cols=262 Identities=21% Similarity=0.342 Sum_probs=197.3
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC-----Cee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~ 344 (596)
+++|+..+.||+|+||.||+|.. .+|+.||+|.+...........+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 478999999986433334456788999999999999999999887544 357
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++|+||+.+ ++...+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 899999975 77776653 4589999999999999999999999 99999999999999999999999999988
Q ss_pred cccccCcc--eeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc-
Q 007608 425 LVDAKLTH--VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE- 500 (596)
Q Consensus 425 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~- 500 (596)
........ ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-----~~~~~~~~~~~~ 229 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-----QLNLILGVLGTP 229 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCCC
Confidence 65432221 1123457899999998754 468999999999999999999999997533211 11111111110
Q ss_pred --CcccccccCc-------CC---C-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 --DRLNDIVDRN-------LN---T-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 --~~~~~~~d~~-------l~---~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+....+.+.. .. . .......++.+++.+|++.+|++||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 00 0 011234578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=295.47 Aligned_cols=245 Identities=21% Similarity=0.266 Sum_probs=196.5
Q ss_pred CceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCC
Q 007608 277 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 355 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (596)
...||+|+||.||+|... +++.||+|.+... .......+.+|+..+..+.|||++++++++..++..++|+||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEec-ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 457999999999999964 7899999998643 22345678899999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceec
Q 007608 356 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 435 (596)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~ 435 (596)
|...+.. ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........ ...
T Consensus 105 L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 105 LTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred HHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 9987754 3588999999999999999999999 999999999999999999999999999875543221 122
Q ss_pred cccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCC
Q 007608 436 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD 515 (596)
Q Consensus 436 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 515 (596)
...|+..|+|||++.+..++.++|||||||++|||++|+.||...... .....+. ...... ....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~----~~~~~~------~~~~ 240 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-----QAMKRLR----DSPPPK------LKNA 240 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHh----ccCCCC------cccc
Confidence 345789999999999888999999999999999999999998743221 1111111 110000 0011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 516 SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 516 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
......+.+++.+|++.+|++||++.|+++.
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1234567889999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=285.65 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=206.8
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|...+.||+|+||.||++... ++..+++|++.... .......+.+|+++++.++|+|++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777899999999999999965 68999999987432 234567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.........+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987543346799999999999999999999999 99999999999999999999999999998665432
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.......|++.|+|||...+..++.++||||+|+++++|++|+.|+...... +.........
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~--------- 219 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKGQ--------- 219 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcCC---------
Confidence 1223345788999999998888999999999999999999999998753311 1111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+......+.+++.+|+..+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111122344678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=292.71 Aligned_cols=247 Identities=28% Similarity=0.363 Sum_probs=196.6
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
..|...+.||+|+||+||+|... +++.||+|.+... ........+.+|+++++.++|||++++.+++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999965 6899999988632 22233467889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+. |++.+.+... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 5776666532 23589999999999999999999998 999999999999999999999999999875533
Q ss_pred cCcceeccccccccccCccccc---CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
. ....+++.|+|||++. ...++.++||||||+++|||+||+.||....... ........+.
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~--- 231 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNDS--- 231 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--------HHHHHhcCCC---
Confidence 2 2235788999999874 4568899999999999999999999986432111 0111111000
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+. .........+.+++.+||+.+|++||++.+++.+
T Consensus 232 ---~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 ---PT--LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CC--CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 1123355678999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.34 Aligned_cols=256 Identities=24% Similarity=0.365 Sum_probs=195.9
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|...+.||+|+||.||++... +++.||+|.+...........+.+|+..+.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556788999999999999964 689999999875443445677899999999996 99999999999999999999999
Q ss_pred ccCCChhhhhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 351 MQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 351 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
+.. ++.++.... ......+++.....++.|++.||+|||+.. +++||||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 554433211 112356899999999999999999999743 7999999999999999999999999998765432
Q ss_pred CcceeccccccccccCcccccCC---CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
... ....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.+.......
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~----- 227 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGD----- 227 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCC-----
Confidence 211 223478899999998766 68999999999999999999999987422 1111111111111
Q ss_pred ccCcCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+.+. ........++.+++.+|++.+|++||+++||++.
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111 1122355678999999999999999999999774
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=289.99 Aligned_cols=261 Identities=24% Similarity=0.301 Sum_probs=198.9
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC--CeeEEEEE
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILVYP 349 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 349 (596)
|+..+.||+|+||.||+|... +++.+|+|++.... .......+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999965 58899999997543 233456788999999999999999999999888 78999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++ +|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 888877652 24689999999999999999999998 9999999999999999999999999999876544
Q ss_pred CcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc---Ccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLND 505 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~ 505 (596)
.........++..|+|||.+.+ ..++.++||||||+++|||+||+.||....... ....+...... .....
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-----QLEKIFELCGSPTDENWPG 228 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCchhhccc
Confidence 3222233446788999998765 457899999999999999999999997543211 11111111100 00000
Q ss_pred ccc--------C------cCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 506 IVD--------R------NLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 506 ~~d--------~------~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..+ + .+.. ....+...+.+++.+|++.+|++||+++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 0 0000 011125678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=291.61 Aligned_cols=250 Identities=20% Similarity=0.299 Sum_probs=201.3
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|...+.||+|+||.||++... +++.|++|.+... .....+.+.+|+.++++++|||++++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 57888999999999999999854 6889999998532 233456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999998874 3478899999999999999999999 99999999999999999999999999887654332
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.. .....+++.|+|||.+....++.++||||||+++||+++|+.||........ +......+. +.
T Consensus 170 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--------~~~~~~~~~------~~ 234 (293)
T cd06647 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIATNGT------PE 234 (293)
T ss_pred cc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--------eeehhcCCC------CC
Confidence 21 2223578899999999888899999999999999999999999974322100 000000000 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..........+.+++.+||+.+|++||++.+++.+
T Consensus 235 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 -LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122344578889999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=295.03 Aligned_cols=270 Identities=21% Similarity=0.282 Sum_probs=197.7
Q ss_pred CCCcCceeeecCceEEEEEEeC---CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecC--CeeE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERI 345 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~ 345 (596)
+|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4677889999999999999964 47899999987522 123345678899999999999999999999888 7889
Q ss_pred EEEEcccCCChhhhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC----CCcEEEeec
Q 007608 346 LVYPFMQNLSVAYRLRDLKPG-EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD----NFEAVLCDF 420 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~Df 420 (596)
+||||+++ ++.+.+...... ...++....+.++.|++.||+|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 676666543322 23688999999999999999999999 9999999999999999 999999999
Q ss_pred cccccccccCc--ceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhh-----hchHHH
Q 007608 421 GLAKLVDAKLT--HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE-----DVLLLD 492 (596)
Q Consensus 421 Gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~-----~~~l~~ 492 (596)
|++........ .......++..|+|||++.+. .++.++|||||||+++||++|+.||......... ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987644322 112234578899999988764 5789999999999999999999999754332100 001111
Q ss_pred HHHHHhcc-----------CcccccccC-cCCCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 493 HIRKLLRE-----------DRLNDIVDR-NLNTYD---------S--KEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 493 ~~~~~~~~-----------~~~~~~~d~-~l~~~~---------~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+...... .......+. ....+. . ....++.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11100000 000000000 000011 0 234568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=286.39 Aligned_cols=246 Identities=24% Similarity=0.329 Sum_probs=207.3
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEccc
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 352 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 352 (596)
|.++.+||+|+||.||+|.++ .|+.+|+|.+.. +...+++.+|+.++.+++.|++|+++|.+......++|||||-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 566789999999999999965 799999999864 3356789999999999999999999999999999999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc
Q 007608 353 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432 (596)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 432 (596)
-|+..+.++-. +++++..++..++...+.||+|||.. .-+|||||+.|||++.+|.+||+|||.+..+.....
T Consensus 112 AGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 112 AGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred CCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 99999988753 46799999999999999999999998 889999999999999999999999999986644322
Q ss_pred eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCC
Q 007608 433 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 512 (596)
Q Consensus 433 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 512 (596)
....+.|||.|||||+++.-.|..++||||+|+...||..|++||..-.. .+ .+--+.-..-.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP-----------MR------AIFMIPT~PPP 247 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP-----------MR------AIFMIPTKPPP 247 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc-----------cc------eeEeccCCCCC
Confidence 23456799999999999999999999999999999999999999874211 00 00001111111
Q ss_pred --CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 513 --TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 513 --~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..++..+.++.+++++|+.+.|++|-++.+++++
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2366778899999999999999999999999875
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=288.52 Aligned_cols=248 Identities=25% Similarity=0.292 Sum_probs=202.0
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
+|+..+.||.|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999975 68999999986422 22456789999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+.+++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998752 4688999999999999999999998 9999999999999999999999999998865443
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ....+......
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~--------- 216 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET--------- 216 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc---------
Confidence 2 122345788999999998888999999999999999999999999854321 11111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPM--AQVV 544 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl 544 (596)
.....+......+.+++.+|++.||.+||++ +|+.
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0011222344788899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=290.37 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=204.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.++.|+..+.||+|++|.||+|..+ ++..+++|++..... ....+.+|++.++.++|+|++++++++......++|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4567888899999999999999976 689999999864322 4677889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999998632 3689999999999999999999998 999999999999999999999999999875543
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
... ......++..|+|||++.+..++.++|||||||++|+|++|+.|+....... ...... . ......
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-----~~~~~~---~-~~~~~~-- 236 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-----ALFLIT---T-KGIPPL-- 236 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHH---h-cCCCCC--
Confidence 221 1122347889999999988889999999999999999999999987432211 011110 0 000000
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.........+.+++.+|++.+|.+||++.++++
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 ----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 011224567889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=282.53 Aligned_cols=250 Identities=29% Similarity=0.380 Sum_probs=203.1
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
+|+..+.||+|++|.||++... ++..+++|++..... .....+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4677899999999999999975 788999999875332 35678999999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999887632 4689999999999999999999998 999999999999999999999999999887654322
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcC
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 511 (596)
.....++..|+|||++.+...+.++||||||+++++|++|+.|+....... ...... . .......
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~---~-~~~~~~~---- 218 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-----ALFKIA---T-NGPPGLR---- 218 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-----HHHHHH---h-cCCCCcC----
Confidence 233457889999999988889999999999999999999999987432110 001111 0 1111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 512 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
........+.+++.+|++.||++||++.|++++
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111124678899999999999999999999763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.99 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=199.6
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEcc-ccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~-~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 348 (596)
...|++.+.||+||.+.||++...+.+.||+|++. ...+......|.+|+..|.+++ |.+|+++++|-..++..|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 44588899999999999999998888889988876 3445666788999999999996 999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||-+ .+|..+|..... ....| .++.+..|++.++.++|.+ ||||.||||.|.|+-.+ .+||+|||+|..+..
T Consensus 440 E~Gd-~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANAIQP 511 (677)
T ss_pred eccc-ccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhcccCc
Confidence 9864 599999987432 22334 7788999999999999999 99999999999999764 899999999998876
Q ss_pred cCcce-eccccccccccCcccccCC-----------CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH
Q 007608 429 KLTHV-TTQIRGTMGHIAPEYLSTG-----------KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 429 ~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
+.... .....||+.||+||.+... ++++++||||+|||||+|+.|+.||... ...+.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~----------~n~~a- 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI----------INQIA- 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----------HHHHH-
Confidence 65443 2345699999999998432 3578999999999999999999999731 11111
Q ss_pred HhccCcccccccCcCC-CCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 497 LLREDRLNDIVDRNLN-TYDS-KEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~-~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
++..+.||... .|+. ....+++++++.||..||.+||+..|+++.
T Consensus 581 -----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12233344221 0111 111239999999999999999999999874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.75 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=215.4
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEeC----C----CcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEe
Q 007608 266 ELQLATDNFSESNIIGQGGFGKVYKGVLS----D----NTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIG 336 (596)
Q Consensus 266 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~ 336 (596)
.+++..++..+.+.||+|+||.|++|... . ...||||.++........+.+..|+++++.+ +|+|++.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45556666667779999999999999842 1 4579999999777777889999999999998 5999999999
Q ss_pred EEecCCeeEEEEEcccCCChhhhhcccC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCC
Q 007608 337 YCTTSSERILVYPFMQNLSVAYRLRDLK---PG-------E--KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 404 (596)
Q Consensus 337 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp 404 (596)
+|...+..++|.||+..|+|.++|+..+ .- . ..++....+.++.|||.|++||++. +++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999999755 00 0 2388899999999999999999999 999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccccCcceecccc--ccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCcc
Q 007608 405 ANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR--GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 481 (596)
Q Consensus 405 ~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~ 481 (596)
+|||++++..+||+|||+++.............. -+..|||||.+....++.|+|||||||+|||++| |..|+....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999966554433322222 2457999999999999999999999999999999 777876411
Q ss_pred chhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 482 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 482 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
. ...+.++++. +. ....+..+..++.++++.||+.+|++||++.|+++.++.
T Consensus 527 ~----~~~l~~~l~~----G~--------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 527 P----TEELLEFLKE----GN--------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred c----HHHHHHHHhc----CC--------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 0 1122333332 21 112345567889999999999999999999999999987
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=288.81 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=198.7
Q ss_pred CCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 273 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
.|...+.||+|++|.||++.. .+++.+++|++... .....+.+.+|+.+++.+.|||++++++++...+..++|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 345567999999999999996 47889999988632 2334566889999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++++|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 99 EGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999998875 3478999999999999999999999 999999999999999999999999998875543221
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcC
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 511 (596)
......|++.|+|||...+..++.++|||||||++|||++|+.||..... ......... ... +..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~~~-~~~-----~~~ 235 (285)
T cd06648 171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRIRD-NLP-----PKL 235 (285)
T ss_pred -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHh-cCC-----CCC
Confidence 12234588999999999888899999999999999999999999864321 111111111 100 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 512 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.........+.+++.+|++.+|++||++.|+++
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 -KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 011224467899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=291.12 Aligned_cols=261 Identities=22% Similarity=0.312 Sum_probs=195.6
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
++|+..+.||+|++|+||+|... +++.||+|.+.... .......+.+|++++++++|||++++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999965 78899999986432 22344678899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-CCcEEEeeccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfGl~~~~~~ 428 (596)
|++ +++.+++.... ...+++.....++.|++.||+|||+. +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 57777775422 23467888889999999999999999 9999999999999985 56799999999976543
Q ss_pred cCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.... .....+++.|+|||++.+. .++.++|||||||++|+|+||+.||......+ ....... ..... .....
T Consensus 156 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~----~~~~~~~-~~~~~-~~~~~ 228 (294)
T PLN00009 156 PVRT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID----ELFKIFR-ILGTP-NEETW 228 (294)
T ss_pred Cccc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHH-HhCCC-Chhhc
Confidence 2211 1223468899999998664 57899999999999999999999997533211 1111110 00000 00000
Q ss_pred -----------------cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 508 -----------------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 508 -----------------d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.............++.+++.+|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000011223456889999999999999999999986
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=290.41 Aligned_cols=266 Identities=24% Similarity=0.277 Sum_probs=199.2
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC----
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS---- 342 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~---- 342 (596)
...++|+..+.||+|+||.||+|..+ +++.||+|+++... .......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 68899999987432 2334456788999999999999999999887654
Q ss_pred ------eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEE
Q 007608 343 ------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 343 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 416 (596)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 68999999986 666666542 24689999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHH
Q 007608 417 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495 (596)
Q Consensus 417 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~ 495 (596)
|+|||++...............++..|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-----~~~~~~~ 231 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-----AQLELIS 231 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHH
Confidence 999999987654332222223457789999988653 5788999999999999999999999743221 1111111
Q ss_pred HHhcc---Ccccccc--------cC------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 496 KLLRE---DRLNDIV--------DR------NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 496 ~~~~~---~~~~~~~--------d~------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..... .....+. +. .........+..+.+++.+|++.+|.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11100 0000000 00 0000011124678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=290.69 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=196.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCC-CcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 347 (596)
..++|+..+.||+|+||.||+|...+ ++.||||.++..........+..|+.++.+.. ||||+++++++.+....++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678889999999999999999764 89999999975444444566777887777665 99999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+. +++.+..... ...+++..+..++.|++.||+|||+.. +++||||+|+||++++++.++|+|||++....
T Consensus 93 ~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99986 4666665542 236899999999999999999999732 89999999999999999999999999987654
Q ss_pred ccCcceeccccccccccCcccccCCC----CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGK----SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
..... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+......... .
T Consensus 167 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~-~ 236 (296)
T cd06618 167 DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEE-P 236 (296)
T ss_pred CCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCC-C
Confidence 32221 2234778999999987554 788999999999999999999998642111 01111111111 0
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
. ... .......++.+++.+|++.||++||++.+++++-
T Consensus 237 ~-----~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 237 P-----SLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred C-----CCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0 000 0112345788999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.10 Aligned_cols=271 Identities=19% Similarity=0.244 Sum_probs=188.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCC--CcEEEEEE--------------ccc--cCCcchHHHHHHHHHHHHhcCCCCc
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSD--NTKVAVKR--------------LQD--YYSPGGEAAFQREVHLISVAIHKNL 331 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~--------------l~~--~~~~~~~~~~~~e~~~l~~l~H~ni 331 (596)
..++|+..+.||+|+||+||++..+. +...+.|. +.+ .........+.+|+.++.+++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35789999999999999999987532 22222221 110 0112234568899999999999999
Q ss_pred cceEeEEecCCeeEEEEEcccCCChhhhhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc
Q 007608 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 410 (596)
Q Consensus 332 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~ 410 (596)
+++++++...+..++|++++. +++.+++.... .............++.|++.||.|||+. +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999986 46666664321 1112234566778999999999999999 999999999999999
Q ss_pred CCCcEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCC-CCCccchhhhhch
Q 007608 411 DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA-IDFSRLEEEEDVL 489 (596)
Q Consensus 411 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p-~~~~~~~~~~~~~ 489 (596)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +...... ....
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~--~~~~ 379 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK--PGKQ 379 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC--HHHH
Confidence 999999999999987654433333345689999999999999999999999999999999998754 3321111 1111
Q ss_pred HHHHHHHHhc-cCcc-------cccccC-cC----CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 490 LLDHIRKLLR-EDRL-------NDIVDR-NL----NTYD-----SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 490 l~~~~~~~~~-~~~~-------~~~~d~-~l----~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+.+.+..... .+.. .+.++. .. .... .....++.+++.+|++.||.+||++.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111111000 0000 000000 00 0000 0112356777889999999999999999874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=282.63 Aligned_cols=266 Identities=23% Similarity=0.297 Sum_probs=221.1
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeE
Q 007608 264 CRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337 (596)
Q Consensus 264 ~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~ 337 (596)
..++.+..++++....+.+|.||.||.|.+. +.+.|.+|.++...++-+...+..|.-++..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4567777888888899999999999999653 3566899999988888888899999999999999999999999
Q ss_pred EecC-CeeEEEEEcccCCChhhhhcccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC
Q 007608 338 CTTS-SERILVYPFMQNLSVAYRLRDLKP----GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 412 (596)
Q Consensus 338 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 412 (596)
+.+. ...+.+|.++.-|+|..+|...+. ..+.++-.+...++.|++.|++|||.. ++||.||.++|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 9765 457899999999999999984332 234577778889999999999999999 99999999999999999
Q ss_pred CcEEEeeccccccccccCcceecc-ccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchH
Q 007608 413 FEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL 490 (596)
Q Consensus 413 ~~~kl~DfGl~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l 490 (596)
..+||+|-.+++.+.+.+.+.... ...+..||+||.+....++..+|||||||+||||+| |+.|+..-++.+ .
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-----m 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-----M 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-----H
Confidence 999999999999887766665433 345779999999999999999999999999999998 888886433321 1
Q ss_pred HHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 491 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 491 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..... |......+-+++.++..++..||..+|++||+++|++..|.+
T Consensus 508 ~~ylk------------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 508 EHYLK------------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHHh------------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11111 111122355678899999999999999999999999999975
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=290.64 Aligned_cols=247 Identities=26% Similarity=0.331 Sum_probs=203.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
..+.|+.-++||+|+||.||-++.. +|+-+|.|++.+. .....+....+|-.++.++..+.||.+-..+.+.+..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 4456888899999999999999854 7899999988532 223455667899999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
|+..|.||+|..+|.+.. +..++...+.-++.+|+.||.+||.. +||.||+||+|||+|+.|+++|+|.|+|..+
T Consensus 263 VLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999998754 36799999999999999999999999 9999999999999999999999999999977
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
...... ...+||.+|||||++.+..|+...|+||+||++|||+.|+.||....... -. +-
T Consensus 338 ~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-----k~-------------eE 397 (591)
T KOG0986|consen 338 PEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-----KR-------------EE 397 (591)
T ss_pred CCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-----hH-------------HH
Confidence 654433 33479999999999999999999999999999999999999997422100 00 01
Q ss_pred ccCcC----CCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007608 507 VDRNL----NTYDSKEVETMVQVALLCTQSTPEDRPPMA 541 (596)
Q Consensus 507 ~d~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 541 (596)
+|.+. ..+++..+++..++....|++||++|.--.
T Consensus 398 vdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 398 VDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11111 124555667778888889999999996544
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=278.45 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=205.0
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC--CeeEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILVY 348 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 348 (596)
+|...+.||+|++|.||+|... +++.|++|++.... .....+.+.+|++.+++++|+|++++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999976 78999999986432 234567889999999999999999999999888 8899999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998763 2789999999999999999999998 999999999999999999999999999987655
Q ss_pred cCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.... ......++..|+|||...+...+.++||||||+++++|++|+.||..... ............
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~------ 220 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIGSSG------ 220 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhccccC------
Confidence 4321 12334578899999999888899999999999999999999999975431 111111111101
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.....+......+.+++.+|++.+|++||++.|+++.
T Consensus 221 --~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 221 --EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1111233346788999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=287.58 Aligned_cols=244 Identities=24% Similarity=0.287 Sum_probs=187.4
Q ss_pred eeeecCceEEEEEEeC-CCcEEEEEEccccCC--cchHHHHHHHHHHHH---hcCCCCccceEeEEecCCeeEEEEEccc
Q 007608 279 IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLIS---VAIHKNLLQLIGYCTTSSERILVYPFMQ 352 (596)
Q Consensus 279 ~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~---~l~H~niv~l~~~~~~~~~~~lv~e~~~ 352 (596)
.||+|+||.||++... +++.+|+|.+..... ......+.+|..++. ...|||++.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 689999998864322 122333445544433 3479999999999999999999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc
Q 007608 353 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432 (596)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 432 (596)
+++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999988875 34689999999999999999999999 99999999999999999999999999987554322
Q ss_pred eeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcC
Q 007608 433 VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511 (596)
Q Consensus 433 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 511 (596)
.....|+..|+|||...+ ..++.++|||||||++|||++|+.||......... ........ .+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~------~~~-- 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------EIDRMTLT------VNV-- 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH------HHHHHhhc------CCc--
Confidence 122358999999999864 55899999999999999999999999743221110 11111000 001
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHh
Q 007608 512 NTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKML 547 (596)
Q Consensus 512 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 547 (596)
..+.....++.+++.+|+..||++|| +++|++++-
T Consensus 217 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 217 -ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred -CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 12233456788999999999999999 599887753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=290.70 Aligned_cols=263 Identities=25% Similarity=0.293 Sum_probs=196.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC--CeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 346 (596)
.++|+..+.||+|+||.||+|... +|+.||+|+++... .......+.+|+.++.+++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999964 68999999986332 222234567899999999999999999998755 46799
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999974 7888776532 4689999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc---Cc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DR 502 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~ 502 (596)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ....+...... ..
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-----~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-----QLDLIIQLLGTPNESI 232 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcCCCChhh
Confidence 543221 122235778999999865 457899999999999999999999997533211 11111111100 00
Q ss_pred cc---------cc-cc-CcCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 503 LN---------DI-VD-RNLNT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 503 ~~---------~~-~d-~~l~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. .. .. ..... .......++.+++.+|++.||++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00 00 00000 001135567889999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=285.84 Aligned_cols=260 Identities=18% Similarity=0.193 Sum_probs=182.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCC----CcEEEEEEccccCCcc-hH---------HHHHHHHHHHHhcCCCCccceE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPG-GE---------AAFQREVHLISVAIHKNLLQLI 335 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~-~~---------~~~~~e~~~l~~l~H~niv~l~ 335 (596)
..++|.+.+.||+|+||+||+|...+ +..+|+|......... .. .....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34678899999999999999999654 3456666533211110 00 1122333445667899999999
Q ss_pred eEEecCC----eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC
Q 007608 336 GYCTTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 411 (596)
Q Consensus 336 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~ 411 (596)
+++.... ..+++++++.. ++.+.+... ...++..+..++.|++.||+|||+. +++||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 8765543 23567776643 555555432 2356788899999999999999999 9999999999999999
Q ss_pred CCcEEEeeccccccccccCcc------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhh
Q 007608 412 NFEAVLCDFGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 485 (596)
Q Consensus 412 ~~~~kl~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~ 485 (596)
++.++|+|||+++........ ......||+.|+|||+..+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999866432111 11224589999999999999999999999999999999999999975422111
Q ss_pred -hhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 486 -EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 486 -~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
......++...... + ... .......+.+++..|++.+|++||++.++.+.++
T Consensus 242 ~~~~~~~~~~~~~~~-~--------~~~--~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLHE-G--------KIK--IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhhh-h--------hhc--cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111111111111 1 000 1122467889999999999999999999998763
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=281.62 Aligned_cols=243 Identities=24% Similarity=0.292 Sum_probs=195.8
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCCh
Q 007608 280 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 356 (596)
Q Consensus 280 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (596)
||.|+||.||+++.. +++.+++|++.... .....+.+.+|+.+++.++||||+++++++.+....++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 58999999986432 224457799999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceecc
Q 007608 357 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 436 (596)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 436 (596)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999762 3588999999999999999999998 99999999999999999999999999998765432 1223
Q ss_pred ccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCH
Q 007608 437 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 516 (596)
Q Consensus 437 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 516 (596)
..+++.|+|||.+.+..++.++|+||||+++|||++|..||...... ..+......... ....++.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~--------~~~~~~~ 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED------PMEIYNDILKGN--------GKLEFPN 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC------HHHHHHHHhccC--------CCCCCCc
Confidence 45788999999998888999999999999999999999999754310 111111111100 0111222
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 007608 517 KEVETMVQVALLCTQSTPEDRPP-----MAQVVK 545 (596)
Q Consensus 517 ~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 545 (596)
....++.+++.+|++.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 33568899999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=290.27 Aligned_cols=267 Identities=23% Similarity=0.307 Sum_probs=194.7
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe-----
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE----- 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 343 (596)
.++|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357888999999999999999965 68999999886432 22234456789999999999999999999876543
Q ss_pred ---eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 344 ---RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 344 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
.++||||+.+ ++.+.+... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 4999999974 777777542 23589999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccCcc---eeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH
Q 007608 421 GLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 421 Gl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
|++......... ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||....... .......+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~~~~ 241 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQLCG 241 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence 999866432211 112334678899999886644 6889999999999999999999987543211 1111111110
Q ss_pred HhccCccccc-----ccC-cCCC-C---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 497 LLREDRLNDI-----VDR-NLNT-Y---------DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 497 ~~~~~~~~~~-----~d~-~l~~-~---------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+..... .+. .... . .......+.+++.+|+..||++||+++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000000 000 0000 0 00113456789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=283.53 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=195.3
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC-cchHHHHHHHHHHHHhc---CCCCccceEeEEecCCe-----
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVA---IHKNLLQLIGYCTTSSE----- 343 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~----- 343 (596)
|+..+.||+|+||.||+|+.+ +++.||+|+++.... ......+.+|+.++.++ .|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999976 589999999974322 22344566788777665 59999999999987776
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.+++|||+.+ +|.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999974 78888875332 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc-
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR- 502 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~- 502 (596)
........ .....++..|+|||++.+..++.++|||||||++|||++|+.||......+ ..............
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 228 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD----QLDKIFDVIGLPSEE 228 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH----HHHHHHHHcCCCChH
Confidence 87643321 122346889999999999899999999999999999999999887533211 11111111100000
Q ss_pred --c------cccccC----cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 503 --L------NDIVDR----NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 503 --~------~~~~d~----~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. ...+.. ............+.+++.+||+.||++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000 001112234567789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=286.59 Aligned_cols=242 Identities=26% Similarity=0.327 Sum_probs=190.7
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCCh
Q 007608 280 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 356 (596)
Q Consensus 280 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (596)
||+|+||+||++... +|+.||+|.+.... .......+..|++++++++|||++++++++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68999999886321 222345678899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceecc
Q 007608 357 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 436 (596)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 436 (596)
.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 99987533 24689999999999999999999999 99999999999999999999999999987654321 1223
Q ss_pred ccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCH
Q 007608 437 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 516 (596)
Q Consensus 437 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 516 (596)
..++..|+|||+..+..++.++|||||||++++|++|+.||........ ...+...... .....+.
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~---------~~~~~~~ 219 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-----KEELKRRTLE---------MAVEYPD 219 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-----HHHHHhcccc---------ccccCCc
Confidence 3578899999999888899999999999999999999999975332110 0011110000 0011222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHH
Q 007608 517 KEVETMVQVALLCTQSTPEDRPPMAQ 542 (596)
Q Consensus 517 ~~~~~l~~l~~~Cl~~dP~~RPs~~e 542 (596)
.....+.+++.+||+.+|++||+..|
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCc
Confidence 33567889999999999999995554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=294.10 Aligned_cols=267 Identities=21% Similarity=0.331 Sum_probs=197.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhc-CCCCccceEeEEecC--Cee
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS--SER 344 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~--~~~ 344 (596)
..++|+..+.||+|+||.||+|... +++.+|+|++... ........+.+|+.++.++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999965 6889999988532 2233445677899999999 999999999988654 357
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||++ ++|..++.. ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 588888764 2678999999999999999999998 99999999999999999999999999998
Q ss_pred cccccCc----ceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHH------
Q 007608 425 LVDAKLT----HVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH------ 493 (596)
Q Consensus 425 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~------ 493 (596)
....... .......|+..|+|||++.+ ..++.++||||||+++|||+||+.||......+... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~ 234 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE-KIIEVIGPPSA 234 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCH
Confidence 6643322 12233457889999998765 457889999999999999999999997543221100 00000
Q ss_pred -----HHHHhccCcccccccCc---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 494 -----IRKLLREDRLNDIVDRN---LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 494 -----~~~~~~~~~~~~~~d~~---l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.........+..+.+.. ..........++.+++.+|++.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000000 001111245678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=285.98 Aligned_cols=265 Identities=22% Similarity=0.268 Sum_probs=197.8
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEEEEcc
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
|...+.||+|++|+||+|+.. +++.|++|++.............+|+..+.+++ |+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999975 578899999875433333445567999999999 999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
+|+|.+.+.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789988887532 24689999999999999999999998 999999999999999999999999999986644222
Q ss_pred ceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhch--------HHHHHHHHhccCc
Q 007608 432 HVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL--------LLDHIRKLLREDR 502 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~--------l~~~~~~~~~~~~ 502 (596)
.....++..|+|||++.+ ..++.++|+||||++++||++|+.||......+..... ...|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122347889999998754 45789999999999999999999998654321110000 0001000000000
Q ss_pred cccccc----CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 503 LNDIVD----RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 503 ~~~~~d----~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+. ..+..........+.+++.+|++.+|++||+++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 00000111124678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.28 Aligned_cols=265 Identities=20% Similarity=0.277 Sum_probs=198.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecC------
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------ 341 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 341 (596)
..++|+..+.||+|+||.||+|... +++.||+|.+... ........+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999964 7899999998642 2333445678899999999999999999988544
Q ss_pred CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
...++||||+. ++|.+.+.. .++...+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 34689999996 478777753 278888999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhc----------hHH
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV----------LLL 491 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~----------~l~ 491 (596)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+....... .+.
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9986644321 2233578899999999999999999999999999999999999975432111000 000
Q ss_pred HH----HHHHhcc------CcccccccCcCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 492 DH----IRKLLRE------DRLNDIVDRNLNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 492 ~~----~~~~~~~------~~~~~~~d~~l~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+. ....... ....+.+...... ........+.+++.+|++.||++||++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000000 0000111111000 012345678899999999999999999999763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=294.36 Aligned_cols=263 Identities=21% Similarity=0.328 Sum_probs=198.6
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEec----CCee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~ 344 (596)
.++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|+.++++++||||+++.+++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368888999999999999999964 68999999987432 22345667889999999999999999987753 3467
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++|+||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 588888764 34589999999999999999999998 99999999999999999999999999997
Q ss_pred cccccCcc---eeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHh--
Q 007608 425 LVDAKLTH---VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL-- 498 (596)
Q Consensus 425 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~-- 498 (596)
........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-----~~~~~~~~g~ 230 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-----LKLILSVLGS 230 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-----HHHHHHHhCC
Confidence 65432211 1123457889999999865 4589999999999999999999999975432111 01111000
Q ss_pred ---------ccCcccccccC--cCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 499 ---------REDRLNDIVDR--NLNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 499 ---------~~~~~~~~~d~--~l~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..+...+..+. .... .......++.+++.+|++.+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00011110000 0000 112345778999999999999999999998774
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=286.10 Aligned_cols=259 Identities=20% Similarity=0.253 Sum_probs=202.1
Q ss_pred CCCcCceeeecCceEEEEEEe----CCCcEEEEEEccccC---CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCee
Q 007608 273 NFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 344 (596)
+|+..+.||+|+||.||+++. .+++.||||.++... .......+.+|++++.++ +|||++++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999984 357889999986321 122345688999999999 599999999999988999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||+++++|.+++.. ...+++.....++.|++++|.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999998864 24588999999999999999999998 99999999999999999999999999988
Q ss_pred cccccCcceeccccccccccCcccccCCC--CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
..............|+..|+|||...+.. .+.++||||||+++|||+||..||...... . ...+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~---~~~~~~~~~~~~~- 228 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-N---SQSEISRRILKSK- 228 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-c---hHHHHHHHHHccC-
Confidence 65443322223345788999999987665 788999999999999999999998632211 0 0111111111110
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCc
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL 552 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 552 (596)
...+......+.+++.+|++.+|++|||+.++.+.|+..-+
T Consensus 229 ---------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 229 ---------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred ---------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 01122234567889999999999999999999988876433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=287.44 Aligned_cols=247 Identities=27% Similarity=0.357 Sum_probs=195.4
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
|...+.||+|+||.||+|+.. ++..||+|.+.... .......+.+|++++++++|||++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666789999999999999964 68899999986322 223345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+. |++.+.+... ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 97 4777766532 34589999999999999999999999 9999999999999999999999999998754322
Q ss_pred cceeccccccccccCccccc---CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 431 THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
....+++.|+|||++. .+.++.++|||||||++|||++|+.||...... ....... ....
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~----~~~~----- 241 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIA----QNES----- 241 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHH----hccC-----
Confidence 2235788999999974 456899999999999999999999998642211 0111111 1110
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
...........+.+++.+|++.+|.+||++.++++.+.
T Consensus 242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00112234456889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=280.52 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=197.7
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc----CCcchHHHHHHHHHHHHhcCCCCccceEeEEecC--Cee
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 344 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 344 (596)
.+|+..+.||+|+||.||+|... ++..||+|.+... ........+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999964 6899999987522 1223446788999999999999999999998764 457
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++++||+++++|.+++.. ...+++...+.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999998875 23478899999999999999999999 99999999999999999999999999998
Q ss_pred cccccCc--ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 425 LVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 425 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
....... .......++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------AAIFKIATQP- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------HHHHHHHcCC-
Confidence 6533211 1112345788999999999888999999999999999999999998743211 1111111111
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.....+......+.+++.+|++ +|..||++.+++.+
T Consensus 226 -------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 -------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0011234455678899999999 57999999988653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.06 Aligned_cols=260 Identities=24% Similarity=0.297 Sum_probs=192.8
Q ss_pred ceeeec--CceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQG--GFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
..||+| +||+||++... +|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 345666 89999999964 79999999986432 333457788999999999999999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
+++.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999988643 23588999999999999999999998 99999999999999999999999998654332111100
Q ss_pred ------eccccccccccCcccccCC--CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHH--------
Q 007608 434 ------TTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL-------- 497 (596)
Q Consensus 434 ------~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~-------- 497 (596)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||........ ........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM----LLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH----HHHHhcCCCCCCcccc
Confidence 0112245679999998764 478999999999999999999999975332111 11100000
Q ss_pred ------------------------hccCcccccccCcCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 498 ------------------------LREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 498 ------------------------~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..........+..+.. ........+.+++.+|++.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000000011111111 123456788999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=283.58 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=198.6
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc----CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
+|.+.+.||+|+||.||++... .+..+++|.++.. ........+..|+.++++++|||++++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4777899999999999999864 3455666665421 1233445677899999999999999999999988999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||++++ +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999876544456799999999999999999999998 9999999999999986 469999999987664
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.... ......|++.|+|||...+..++.++|+||||+++|+|++|..||..... .........
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~~~~-------- 219 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------LSVVLRIVE-------- 219 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHc--------
Confidence 3221 22234578899999999888889999999999999999999999864221 111111111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
......+.....++.+++.+|+..+|++||++.|+++.
T Consensus 220 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 -GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11112234556688899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=286.08 Aligned_cols=248 Identities=21% Similarity=0.282 Sum_probs=209.1
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.-|...+.||+|.|..|-.|++ -+|..||||++.+. .+......+.+|+..|+.++|||||+++++.......|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3466678899999999999984 48999999999743 344456778899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE-cCCCcEEEeeccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL-DDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~DfGl~~~~~~ 428 (596)
.-++|+|.+++... +.++.+....+++.||..|+.|+|+. .+|||||||+||.+ ..-|-+||.|||++..+.+
T Consensus 98 LGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999864 45699999999999999999999999 89999999999877 5668899999999987655
Q ss_pred cCcceeccccccccccCcccccCCCCC-cccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSS-EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
+. .....+|+..|-|||.+.+..|+ ++.||||+|||||.|+.|+.||+..+.. +.+..|+
T Consensus 172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------------ETLTmIm 232 (864)
T KOG4717|consen 172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------------ETLTMIM 232 (864)
T ss_pred cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------------hhhhhhh
Confidence 43 23446799999999999998886 5789999999999999999999854332 1233344
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
|-.. ..+.....+..+++.+|+..||.+|.+.+||+.
T Consensus 233 DCKY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cccc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 4322 246677888999999999999999999999976
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=286.67 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=195.7
Q ss_pred CCCcCceeeecCceEEEEEEe----CCCcEEEEEEccccC---CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCee
Q 007608 273 NFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 344 (596)
+|+..+.||+|+||.||+|.. .+|..||+|++.... .....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999985 378999999986421 122346678899999999 599999999999988899
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999875 24578899999999999999999998 99999999999999999999999999998
Q ss_pred cccccCcceeccccccccccCcccccCC--CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
..............|+..|+|||.+.+. .++.++||||||+++|+|+||+.|+...... ....+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~- 228 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSE- 228 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----ccHHHHHHHhhccC-
Confidence 6544322222334588999999998753 4678999999999999999999998642211 11111111111110
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVK 545 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 545 (596)
..++......+.+++.+|++.+|++|| ++.+++.
T Consensus 229 ---------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ---------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 112223445778999999999999997 5566644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=288.81 Aligned_cols=260 Identities=24% Similarity=0.278 Sum_probs=192.5
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCC
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 355 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (596)
.+.+|.|+++.||++.. +++.||+|++... ........+.+|+++++.++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33445555555555554 7899999998743 344556789999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc----
Q 007608 356 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT---- 431 (596)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~---- 431 (596)
+.+++.... ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+........
T Consensus 86 l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999988543 23588899999999999999999999 999999999999999999999999998875532211
Q ss_pred --ceeccccccccccCcccccC--CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc----cC--
Q 007608 432 --HVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR----ED-- 501 (596)
Q Consensus 432 --~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~----~~-- 501 (596)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...+....... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ----MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccCccccccCch
Confidence 11122346788999999876 357899999999999999999999997532211 11111110000 00
Q ss_pred -----cccc----cccCcC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 -----RLND----IVDRNL-----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 -----~~~~----~~d~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.... ..++.. .........++.+++.+||+.||++||+++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 001100 01223345678899999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=284.90 Aligned_cols=260 Identities=23% Similarity=0.314 Sum_probs=200.3
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
|+..+.||+|++|.||+|... +++.+++|++.... .......+.+|++++++++|+|++++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556789999999999999964 78999999987433 2234567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++ ++.+.+... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 888777652 24689999999999999999999999 999999999999999999999999999987654331
Q ss_pred ceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc---Ccccccc
Q 007608 432 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLNDIV 507 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~ 507 (596)
......++..|+|||.+.+. ..+.++||||||+++|+|+||+.||......+. .......... .......
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-----LFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHcCCCchHhcccch
Confidence 12223477889999998776 789999999999999999999999875432111 0011110000 0000000
Q ss_pred --------------cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 --------------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 --------------d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+.......+....++.+++.+|++.||.+||++.|++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000001122346788999999999999999999999763
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=275.48 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=201.7
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC-cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|+..+.||+|++|.||++... +++.|++|.+..... ......+.+|++++.+++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999865 678999999875322 23557789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++... ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999988753 4689999999999999999999999 99999999999999999999999999998765433
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.|+...... .. ...... ..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------~~-~~~~~~-~~-------- 215 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-------AA-LFRIVQ-DD-------- 215 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------HH-HHHHhc-cC--------
Confidence 22 22345788999999998888899999999999999999999998643210 00 011110 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
....+......+.+++.+|+..+|++||++.|++.
T Consensus 216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 01112233467889999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.28 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=192.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC------
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 342 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 342 (596)
.++|...+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478989999999999999999964 78999999986432 2333456889999999999999999999886543
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++|+||+.. ++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999964 6655442 2578999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHh---
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL--- 498 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~--- 498 (596)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ + ..+....
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~----~-~~~~~~~~~~ 234 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ----L-TQILKVTGVP 234 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----H-HHHHHhcCCC
Confidence 8765332 122346889999999876 4688999999999999999999999975432110 0 0000000
Q ss_pred --------ccCccccccc-------CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 499 --------REDRLNDIVD-------RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 499 --------~~~~~~~~~d-------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.........+ ..+....+....++.+++.+|++.||++||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 00000001234567899999999999999999999764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.38 Aligned_cols=254 Identities=26% Similarity=0.333 Sum_probs=187.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC-------
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------- 341 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------- 341 (596)
-..+|++.+.||+||||.|||++.+ ||+.||||++.-..+......+.+|+.++++++|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3457888999999999999999976 99999999998544555667788999999999999999976422110
Q ss_pred --------------------------------------------------------------------------------
Q 007608 342 -------------------------------------------------------------------------------- 341 (596)
Q Consensus 342 -------------------------------------------------------------------------------- 341 (596)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 007608 342 --------------------------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389 (596)
Q Consensus 342 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L 389 (596)
...|+-||||+.-++.+.+++.... -.....++++.+|+.||+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHHH
Confidence 0124556777776666666542211 03567789999999999999
Q ss_pred HhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc--------------c---cCcceeccccccccccCcccccCC
Q 007608 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD--------------A---KLTHVTTQIRGTMGHIAPEYLSTG 452 (596)
Q Consensus 390 H~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~--------------~---~~~~~~~~~~gt~~y~aPE~~~~~ 452 (596)
|++ +||||||||.||++|++..|||+|||+++... . ......+...||.-|+|||++.+.
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 999 99999999999999999999999999998721 0 001112335699999999999765
Q ss_pred ---CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHc
Q 007608 453 ---KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLC 529 (596)
Q Consensus 453 ---~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~C 529 (596)
+|+.|+|+||+|||++||+. ||... .+....+. .++.+.+..- ..+..+....=.+++.++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL~----~LR~g~iP~~-----~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS----MERASILT----NLRKGSIPEP-----ADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCch----HHHHHHHH----hcccCCCCCC-----cccccccchHHHHHHHHH
Confidence 49999999999999999985 45521 11111111 1222222221 223445555667888999
Q ss_pred cccCCCCCCCHHHHHH
Q 007608 530 TQSTPEDRPPMAQVVK 545 (596)
Q Consensus 530 l~~dP~~RPs~~evl~ 545 (596)
++.||.+|||+.|++.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999965
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=297.97 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=201.0
Q ss_pred CCCcCceeeecCceEEEEEEeCCCcE-EEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~~~~~-vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
.+++.-.||.|+||.||+|..++... .|.|++ ...+.....+|.-||++|..+.||+||++++.|...+..+++.|||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI-etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI-ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhh-cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34456679999999999999775444 455555 3455667788999999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
.||.....+-.. +..++..++.-+..|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+...... .
T Consensus 112 ~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-R 184 (1187)
T ss_pred CCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-H
Confidence 999988877654 35799999999999999999999999 9999999999999999999999999997643221 1
Q ss_pred ceeccccccccccCccccc-----CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 432 HVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
.....+.|||.|||||+.. ..+|+.++||||||+.|.||..+.+|-..-.. ...+......
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--------MRVllKiaKS------ 250 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKS------ 250 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------HHHHHHHhhc------
Confidence 1233467999999999874 56899999999999999999999998753211 1111111111
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+|.....+......+-++..+||.++|..||++.+++++
T Consensus 251 -ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 251 -EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 121122356677888999999999999999999999874
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=292.15 Aligned_cols=261 Identities=23% Similarity=0.350 Sum_probs=200.9
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC-cchHHHHHHHHHHHHhcCCCCccceEeEEecCC-----eeE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERI 345 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 345 (596)
+|...+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|+.+++.++|+||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999965 589999999875332 345567899999999999999999999987775 789
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+||||++ ++|.+++.. ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999998 478888765 23789999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCc--ceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc--
Q 007608 426 VDAKLT--HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE-- 500 (596)
Q Consensus 426 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~-- 500 (596)
...... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+. ...+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-----~~~i~~~~~~~~ 227 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-----LNLIVEVLGTPS 227 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-----HHHHHHhcCCCC
Confidence 654321 112234578899999999887 789999999999999999999999975432211 1111111000
Q ss_pred ---------Cccccccc---C----cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 ---------DRLNDIVD---R----NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 ---------~~~~~~~d---~----~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+.+. . .+..........+.+++.+||+.+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 0 0000112235678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.66 Aligned_cols=266 Identities=21% Similarity=0.332 Sum_probs=197.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC-----Ce
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 343 (596)
.++|...+.||+|+||+||+|... +++.||+|.+.... .......+.+|+.++..++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888999999999999999954 78999999986432 233445677899999999999999999987644 34
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++|+||+. ++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 688887764 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHH-------
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR------- 495 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~------- 495 (596)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ........
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL-KLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH-HHHHHHhCCCChHHh
Confidence 8664332 11223457889999998865 46889999999999999999999999754321100 00000000
Q ss_pred HHhccCcccccc-------cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 496 KLLREDRLNDIV-------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 496 ~~~~~~~~~~~~-------d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.........+.+ +............++.+++.+|++.+|++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000000 000000112345678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=277.74 Aligned_cols=246 Identities=20% Similarity=0.230 Sum_probs=189.6
Q ss_pred HHHhcCCCcCcee--eecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCe
Q 007608 268 QLATDNFSESNII--GQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 268 ~~~~~~f~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 343 (596)
....++|+..+.+ |+|+||.||++..+ ++..+|+|.+...... . .|+.....+ +|||++++++++...+.
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~--~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN----A--IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc----h--hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 3334566666666 99999999999964 6888999987642111 1 122222222 69999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC-cEEEeeccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGL 422 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfGl 422 (596)
.++||||+++++|.+++... ..+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999998752 3789999999999999999999999 999999999999999998 999999999
Q ss_pred cccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
++...... ...++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+.... ..
T Consensus 157 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~--~~- 225 (267)
T PHA03390 157 CKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLKRQ--QK- 225 (267)
T ss_pred ceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHHHhh--cc-
Confidence 87654321 2347899999999999899999999999999999999999997432211 1111221111 00
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-MAQVVK 545 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~ 545 (596)
. ..........+.+++.+|++.+|.+||+ ++|+++
T Consensus 226 -------~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 -------K-LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -------c-CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 0112245567889999999999999996 588864
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=283.71 Aligned_cols=244 Identities=23% Similarity=0.285 Sum_probs=195.3
Q ss_pred CceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCC
Q 007608 277 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 355 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (596)
...||+|+||.||++... +++.||+|++... .......+.+|+.+++.++|+|++++++++...+..++||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 357999999999999864 7899999988532 33456678999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceec
Q 007608 356 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 435 (596)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~ 435 (596)
|.+++.. ..+++.....++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++........ ...
T Consensus 104 L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~ 174 (292)
T cd06657 104 LTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 174 (292)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccc
Confidence 9987754 3478999999999999999999999 999999999999999999999999999876543221 122
Q ss_pred cccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCC
Q 007608 436 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD 515 (596)
Q Consensus 436 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 515 (596)
...+++.|+|||+..+..++.++|+||||+++|||++|..||...... .....+.... .+.+.. .
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-----~~~~~~~~~~---------~~~~~~-~ 239 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----KAMKMIRDNL---------PPKLKN-L 239 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhhC---------CcccCC-c
Confidence 345788999999998888899999999999999999999998743221 1111111110 011100 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 516 SKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 516 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
......+.+++.+|++.+|.+||++.|+++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 123446778899999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=280.14 Aligned_cols=245 Identities=23% Similarity=0.303 Sum_probs=196.8
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEccccCC--cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCCh
Q 007608 280 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 356 (596)
Q Consensus 280 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (596)
||+|+||.||++... +|+.+++|.+..... ......+.+|++++.+++|||++++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999976 589999999864321 23456788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc-----
Q 007608 357 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT----- 431 (596)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~----- 431 (596)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998763 3689999999999999999999998 999999999999999999999999999875433211
Q ss_pred --ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 432 --HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 432 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
.......++..|+|||...+...+.++||||||+++||+++|+.||...... ....... . +...
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~---~-~~~~----- 219 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNIL---N-GKIE----- 219 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHh---c-CCcC-----
Confidence 1222345788999999998888999999999999999999999999753321 1111111 1 1000
Q ss_pred cCCCCCHH--HHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 510 NLNTYDSK--EVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 510 ~l~~~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+.. ....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 220 ----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred ----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0111 25678899999999999999999777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=277.76 Aligned_cols=246 Identities=21% Similarity=0.239 Sum_probs=189.8
Q ss_pred ceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHH-HhcCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLI-SVAIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||.||+|... +++.||+|++.... .......+..|..++ ....|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999964 68999999986421 111223344554443 455899999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999875 24588999999999999999999998 999999999999999999999999999875432
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....++..|+|||...+..++.++||||||+++|||+||..||...... ....... ..... ... .
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~----~~~~~--~~~---~ 215 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-----AVFDNIL----SRRIN--WPE---E 215 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHH----hcccC--CCC---c
Confidence 12335788999999998888899999999999999999999999743221 1111111 00000 000 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
........+.+++.+|++.+|++||++.++.+.|..
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 112345678899999999999999988777666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=287.13 Aligned_cols=266 Identities=23% Similarity=0.282 Sum_probs=193.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC-cchHHHHHHHHHHHHhcCCCCccceEeEEecCC------
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 342 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 342 (596)
.++|+..+.||+|+||.||+|... +++.+|+|++..... ......+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999965 689999999864322 223356788999999999999999998875443
Q ss_pred --eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 343 --ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 343 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
..++|+||+.. ++...+... ...+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 35899999975 666666542 34689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccCcc----------eeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhch
Q 007608 421 GLAKLVDAKLTH----------VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 489 (596)
Q Consensus 421 Gl~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~ 489 (596)
|+++........ ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.......... .
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~-~ 238 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH-L 238 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH-H
Confidence 999865432211 11223467889999987654 57899999999999999999999987533211110 0
Q ss_pred HHHHHHHHhcc------Ccccccc----cCcCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 490 LLDHIRKLLRE------DRLNDIV----DRNLNT----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 490 l~~~~~~~~~~------~~~~~~~----d~~l~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
....... ... ....... ...... ........+.+++.+|++.+|++||++.|++.
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGT-PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCC-CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1000000 000 0000000 000000 00112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=320.20 Aligned_cols=252 Identities=25% Similarity=0.294 Sum_probs=202.3
Q ss_pred hcCCCcCceeeecCceEEEEEE-eCCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
+-++.....||.|.||.||.|. ..+|...|+|-++-. ......+...+|+.++..++|||+|+++|+-...+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3356667899999999999999 567899999988632 22344567889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
|||++|+|.+.+.. ....++.....+..|++.|++|||++ |||||||||.||+|+.+|.+|++|||.|..+.+
T Consensus 1314 EyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999986 33466777788999999999999999 999999999999999999999999999987765
Q ss_pred cCcc---eeccccccccccCcccccCCC---CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHH-hccC
Q 007608 429 KLTH---VTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL-LRED 501 (596)
Q Consensus 429 ~~~~---~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~-~~~~ 501 (596)
.... ......||+.|||||++.+.. ...+.||||+|||++||+||++|+...+. +|...+ +..+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWAIMYHVAAG 1457 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhHHHhHHhcc
Confidence 4322 223467999999999997643 46789999999999999999999974322 222221 1111
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. .+..+.....+=.+++.+|++.||++|-++.|+++.
T Consensus 1458 h--------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 H--------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred C--------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1 122344456667788899999999999888877654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=281.49 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=201.9
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 347 (596)
++|...+.||+|+||.||+|... +++.||+|++... ........+.+|++++.++. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999965 7899999998642 22334567889999999998 99999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999762 3689999999999999999999998 99999999999999999999999999988654
Q ss_pred ccCc-------------------ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhc
Q 007608 428 AKLT-------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 488 (596)
Q Consensus 428 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~ 488 (596)
.... .......++..|+|||...+..++.++||||||++++++++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----- 228 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----- 228 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence 3321 1122345788999999998888999999999999999999999999753210
Q ss_pred hHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 007608 489 LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM----AQVVK 545 (596)
Q Consensus 489 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~ 545 (596)
.. ........ ...+......+.+++.+|++.+|++||++ +|+++
T Consensus 229 ~~---~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LT---FQKILKLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH---HHHHHhcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 01 11111000 01122335678899999999999999999 67654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=310.19 Aligned_cols=260 Identities=22% Similarity=0.292 Sum_probs=210.3
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEec
Q 007608 264 CRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 340 (596)
Q Consensus 264 ~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 340 (596)
..+++...++|++.++||+|+||.|..++++ +++.||+|++.+. ........|..|-++|..-+.+.|+.+...|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4667778899999999999999999999975 6888999999752 223456778999999999999999999999999
Q ss_pred CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
....|+|||||+||+|...+..+. .++...++.++..|.-||.-+|+. |+|||||||+|||+|..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999998742 588899999999999999999999 9999999999999999999999999
Q ss_pred cccccccccCcceeccccccccccCccccc----C-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHH
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLS----T-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~ 495 (596)
|.+-.++.+..-.+...+|||.|++||++. + +.|+..+|+||+||++|||+.|..||..+. +.+.+.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--------lveTY~ 291 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--------LVETYG 291 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--------HHHHHH
Confidence 999888876665666678999999999985 3 578999999999999999999999998543 333333
Q ss_pred HHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 007608 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP---MAQVVK 545 (596)
Q Consensus 496 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~ 545 (596)
........-.+.| ..+.+++..+|+.+.+ -+|+.|-. ..++-.
T Consensus 292 KIm~hk~~l~FP~------~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 292 KIMNHKESLSFPD------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHhchhhhcCCCc------ccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 3322211111110 1224455666666554 37888877 766644
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=288.50 Aligned_cols=268 Identities=22% Similarity=0.284 Sum_probs=199.4
Q ss_pred ccHHHHHHHhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEe
Q 007608 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339 (596)
Q Consensus 262 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 339 (596)
....++...+++|...+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.++.+++||||+++.+++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34566777889999999999999999999985 478999999986432 2233466788999999999999999999875
Q ss_pred cC------CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC
Q 007608 340 TS------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 413 (596)
Q Consensus 340 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~ 413 (596)
.. ...+++++++ +++|.+++.. ..+++..++.++.|++.||+|||+. +++||||||+||++++++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 43 2356777776 7788877753 3589999999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHH
Q 007608 414 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 492 (596)
Q Consensus 414 ~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~ 492 (596)
.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +..
T Consensus 158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----~~~ 229 (345)
T cd07877 158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ----LKL 229 (345)
T ss_pred CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHH
Confidence 9999999998754322 223457889999999866 4678899999999999999999999864332110 111
Q ss_pred HHHHH----------hccCcc-------cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 493 HIRKL----------LREDRL-------NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 493 ~~~~~----------~~~~~~-------~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..... ...... .................++.+++.+|++.||.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 000000 0000000000001134567899999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=279.69 Aligned_cols=243 Identities=24% Similarity=0.295 Sum_probs=186.4
Q ss_pred eeeecCceEEEEEEeC-CCcEEEEEEccccCC--cchHHHHHHHHH---HHHhcCCCCccceEeEEecCCeeEEEEEccc
Q 007608 279 IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVH---LISVAIHKNLLQLIGYCTTSSERILVYPFMQ 352 (596)
Q Consensus 279 ~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~---~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 352 (596)
+||+|+||.||+|... +++.||+|.+..... ......+..|.. .+....||+++++.+++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4799999999999864 688999998864221 122223444443 3444579999999999999999999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc
Q 007608 353 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432 (596)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 432 (596)
+++|.+++.. ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999988864 34689999999999999999999998 99999999999999999999999999987553321
Q ss_pred eeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcC
Q 007608 433 VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511 (596)
Q Consensus 433 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 511 (596)
.....|+..|+|||++.++ .++.++||||+||++|||++|+.||......... . ....... .+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----~-~~~~~~~------~~~~- 217 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----E-IDRMTLT------MAVE- 217 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----H-HHHHhhc------cCCC-
Confidence 1234589999999998754 5899999999999999999999999753221110 0 0000000 0111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 512 NTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 512 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
.+.....++.+++.+|+..+|.+|| ++.|++++
T Consensus 218 --~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 218 --LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1222356788999999999999999 99999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=287.38 Aligned_cols=262 Identities=22% Similarity=0.251 Sum_probs=195.2
Q ss_pred cCCCc-CceeeecCceEEEEEEeC-CCcEEEEEEccccCCcc-------------hHHHHHHHHHHHHhcCCCCccceEe
Q 007608 272 DNFSE-SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPG-------------GEAAFQREVHLISVAIHKNLLQLIG 336 (596)
Q Consensus 272 ~~f~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-------------~~~~~~~e~~~l~~l~H~niv~l~~ 336 (596)
++|.. .+.||+|+||+||+|... +++.||+|.+....... ....+.+|++++..++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 477999999999999965 68999999986432111 1125778999999999999999999
Q ss_pred EEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEE
Q 007608 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 337 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 416 (596)
++...+..++||||+. ++|.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999997 688888864 34588999999999999999999998 999999999999999999999
Q ss_pred EeeccccccccccC-------------cceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccc
Q 007608 417 LCDFGLAKLVDAKL-------------THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRL 482 (596)
Q Consensus 417 l~DfGl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~ 482 (596)
|+|||.+....... ........++..|+|||.+.+. .++.++|||||||++|||+||+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997654111 0111122367889999998764 468999999999999999999999975432
Q ss_pred hhhhhchHHHHHHHHhccCc---ccccc------------cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 483 EEEEDVLLLDHIRKLLREDR---LNDIV------------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 483 ~~~~~~~l~~~~~~~~~~~~---~~~~~------------d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+ ....+........ +.... .+...........++.+++.+|++.+|++||++.|++.+
T Consensus 240 ~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 ID-----QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HH-----HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11 1111111111000 00000 000000111235678899999999999999999999763
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=284.94 Aligned_cols=264 Identities=22% Similarity=0.324 Sum_probs=197.8
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEec-CCee
Q 007608 268 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSER 344 (596)
Q Consensus 268 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~ 344 (596)
..++++|+..+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++.+++|||++++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999955 78999999886432 23345678899999999999999999998865 4578
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++++||+ +++|...+.. ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 8999998 4688877763 3478888889999999999999999 99999999999999999999999999987
Q ss_pred cccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHH--------HHH
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD--------HIR 495 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~--------~~~ 495 (596)
..... .....++..|+|||++.+ ..++.++||||||+++|||+||+.||....... ....+.+ +..
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence 54332 122346889999999866 568999999999999999999999997533211 0000111 111
Q ss_pred HHhccCcccccccC-cC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 496 KLLREDRLNDIVDR-NL-NTYD-----SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 496 ~~~~~~~~~~~~d~-~l-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....... .+++.. .. ...+ ......+.+++.+|++.+|++||++.|++..
T Consensus 232 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhh-HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000000 00 0011 1234678899999999999999999999664
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=280.26 Aligned_cols=249 Identities=28% Similarity=0.333 Sum_probs=195.3
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.|+..+.||+|+||.||+|+.. ++..+|+|.+... ........+.+|+++++.++|+|++++.+++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999964 6788999988632 223344578899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+. |++.+.+... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 997 5777776532 24588999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcceeccccccccccCccccc---CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
....+++.|+|||++. ...++.++|||||||++|||++|+.|+...... .......... .
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~-~--- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNE-S--- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--------HHHHHHhhcC-C---
Confidence 2234788999999974 356788999999999999999999998642211 0011111110 0
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+. .........+.+++.+||+.+|++||++.++++.-..
T Consensus 232 --~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 232 --PA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred --CC--cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 00 0122345668899999999999999999999987553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=279.22 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=198.6
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... .......+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999965 58999999987533 2334567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 58999987632 4689999999999999999999999 999999999999999999999999999986644322
Q ss_pred ceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc---Ccc---c
Q 007608 432 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRL---N 504 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~---~ 504 (596)
. .....++..|+|||.+.+. .++.++|||||||++|||++|+.||......+ ....+...... ... .
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-----QLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHHHHhCCCcHHHHHhhc
Confidence 1 1223356789999998776 78999999999999999999999987533211 11111111000 000 0
Q ss_pred cc--ccCcCCC--------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 505 DI--VDRNLNT--------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 505 ~~--~d~~l~~--------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+ .+..... ........+.+++.+|++.+|++||++.+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00 0000000 011125678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=295.16 Aligned_cols=201 Identities=27% Similarity=0.359 Sum_probs=175.6
Q ss_pred CcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC------CeeEEE
Q 007608 275 SESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SERILV 347 (596)
Q Consensus 275 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv 347 (596)
...+.||+|+||.||+|+. .+|+.||||.++........+...+|++++++++|+|||++++.-.+. ....+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 3457899999999999994 589999999998766677788899999999999999999998875443 356899
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc--CCC--cEEEeecccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNF--EAVLCDFGLA 423 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~--~~kl~DfGl~ 423 (596)
||||.+|+|...|.+. .+..+++..+.+.+..+++.||.|||++ +|+||||||.||++- ++| .-||+|||.|
T Consensus 96 mEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999874 3457899999999999999999999998 999999999999993 223 4699999999
Q ss_pred ccccccCcceeccccccccccCccccc-CCCCCcccccHHHHHHHHHHHhCCCCCCCcc
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSR 481 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvil~elltg~~p~~~~~ 481 (596)
+.++.+. ....+.||..|++||++. .+.|+..+|.|||||++||+.||..||....
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9887654 455678999999999998 5889999999999999999999999998644
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=278.46 Aligned_cols=245 Identities=27% Similarity=0.377 Sum_probs=191.9
Q ss_pred CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
|...+.||+|+||+||+|+.. +++.|++|++.... .......+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999964 68899999986322 223345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+. +++.+.+... ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 5777776542 24589999999999999999999999 999999999999999999999999999864322
Q ss_pred cceeccccccccccCccccc---CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 431 THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.....|+..|+|||++. ...++.++|||||||++|||++|..|+...... ........... ...
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~-~~~- 240 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNDS-PTL- 240 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHhcCC-CCC-
Confidence 12345788999999984 456888999999999999999999998643211 11111111110 000
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
........+.+++.+|++.+|.+||++.++++.
T Consensus 241 ------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223467889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=288.32 Aligned_cols=263 Identities=23% Similarity=0.342 Sum_probs=195.6
Q ss_pred HHhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC----
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS---- 342 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~---- 342 (596)
...++|...+.||+|+||.||+|.. .++..||||++.... .......+.+|++++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999985 478999999986432 2233456889999999999999999999886553
Q ss_pred --eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 343 --ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 343 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
..++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 358999998 6788877753 3589999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchH-------HH
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL-------LD 492 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l-------~~ 492 (596)
|++....... ....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||............. ..
T Consensus 163 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 163 GLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9998654321 22346889999999876 458899999999999999999999997543211000000 00
Q ss_pred HHHHHhccCcccc-------cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 493 HIRKLLREDRLND-------IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 493 ~~~~~~~~~~~~~-------~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+... ........ .....+.........++.+++.+|++.||++||++.++++
T Consensus 239 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQK-LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHh-hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00000000 0000000011123446889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=270.88 Aligned_cols=243 Identities=22% Similarity=0.265 Sum_probs=199.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
..++|+..++||+|.||.|-.++-+ +++.+|+|++++.. .....+.-..|-++|...+||.+..+...++..+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888999999999999999965 78999999998543 23345566788999999999999999888999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||..||.|..+|.+ ...++.....-+-..|..||.|||++ +||.||||.+|.|+|.+|++||+|||+++.-
T Consensus 246 VMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999998876 45678888888899999999999999 9999999999999999999999999999843
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
-. ....+...+|||.|+|||++....|....|+|.+||++|||+.|+.||...+. ..+.+.+.. + +
T Consensus 319 I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-----~kLFeLIl~----e---d- 384 (516)
T KOG0690|consen 319 IK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-----EKLFELILM----E---D- 384 (516)
T ss_pred cc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-----hHHHHHHHh----h---h-
Confidence 22 22345568899999999999999999999999999999999999999985322 222222221 0 0
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRP 538 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP 538 (596)
..++.....+...+....+.+||.+|.
T Consensus 385 -----~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 385 -----LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -----ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 113444455667777788999999993
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=289.29 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=196.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe----
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE---- 343 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~---- 343 (596)
..++|+..+.||+|++|.||+|... +++.||+|++.... .......+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999975 68899999986432 23344567789999999999999999987765554
Q ss_pred --eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 344 --RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 344 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 79999998 5689888764 3589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||....... ....+......
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-----~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-----QLKRIMNLVGT 234 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHhcCC
Confidence 99865432 223357889999999865 367899999999999999999999997533211 11111111000
Q ss_pred -----------Cccccccc-------CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 -----------DRLNDIVD-------RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 -----------~~~~~~~d-------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
......+. +...........++.+++.+|++.+|++||++.||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000 00000011235678899999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=284.45 Aligned_cols=265 Identities=21% Similarity=0.296 Sum_probs=190.9
Q ss_pred CCCcCceeeecCceEEEEEEeC-C--CcEEEEEEccccCC-cchHHHHHHHHHHHHhc-CCCCccceEeEEecC----Ce
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-D--NTKVAVKRLQDYYS-PGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS----SE 343 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~----~~ 343 (596)
+|+..+.||+|+||.||++... + +..||+|++..... ....+.+.+|++++.++ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999964 4 78899999864322 22356788899999999 599999999875432 34
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.+++++|+. ++|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 678888886 688888764 34689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcc---eeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchH-------HH
Q 007608 424 KLVDAKLTH---VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL-------LD 492 (596)
Q Consensus 424 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l-------~~ 492 (596)
+........ ......|+..|+|||+..+ ..++.++|||||||++|+|++|+.||............. .+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 1223458899999998765 468999999999999999999999987543211000000 00
Q ss_pred HHHHHhccC------cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 493 HIRKLLRED------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 493 ~~~~~~~~~------~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
......... .........+..........+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 00000000000011112457889999999999999999999853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=263.36 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=195.5
Q ss_pred CceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEEEEcccCC
Q 007608 277 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 354 (596)
...||+|..|.|++++.. +|..+|||.+.+.......+.+...++++.+-. .|.||+-+||+..+....+.||.|.-
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 567999999999999965 689999999987666666777888888877664 89999999999999999999999863
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCccee
Q 007608 355 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 434 (596)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 434 (596)
-...++... ..++++...-++...+..||.||-+++ +|+|||+||+|||+|+.|++|++|||++..+-+...+
T Consensus 176 C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 176 CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 344555543 245788888889999999999999876 8999999999999999999999999999877554333
Q ss_pred ccccccccccCcccccC---CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcC
Q 007608 435 TQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511 (596)
Q Consensus 435 ~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 511 (596)
+...|-+.|||||.+.- .+|+.++|||||||.++||.||..||...+.+ ......+.+ ++ .|.+
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td----Fe~ltkvln---~e------PP~L 315 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD----FEVLTKVLN---EE------PPLL 315 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc----HHHHHHHHh---cC------CCCC
Confidence 23458889999999853 46899999999999999999999999864432 112222221 11 1222
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 512 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. ....+..+.+++..||.+|+.+||...+++++
T Consensus 316 ~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred Cc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 22256788899999999999999999999774
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=288.07 Aligned_cols=250 Identities=25% Similarity=0.321 Sum_probs=205.1
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC-cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
....|.+...||+|.|+.|..|++. ++..||+|.+.+... ......+.+|+++|..++|||||+++.+...+...|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4567888999999999999999954 799999999975432 33345589999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||..+|.+.+++... ..+....+..++.|+.+|++|+|++ .|+|||||++||||+.++++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999863 2345588889999999999999999 89999999999999999999999999999886
Q ss_pred ccCcceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
. .......+|++.|.|||++.+.++ ++++|+||+|+++|-|+.|..||+.....+..... ++..
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv--------l~gk----- 271 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV--------LRGK----- 271 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh--------eeee-----
Confidence 4 334556789999999999999876 67999999999999999999999864332111100 0000
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+.-...+.-+++.+++..+|.+|++++++.+.
T Consensus 272 -----~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 -----YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -----ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 00122234456678889999999999999999653
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=285.76 Aligned_cols=261 Identities=22% Similarity=0.306 Sum_probs=191.6
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC---------
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--------- 341 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------- 341 (596)
.+|...+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57888999999999999999964 68999999986432 24456788999999999999999998766543
Q ss_pred -----CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc-CCCcE
Q 007608 342 -----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEA 415 (596)
Q Consensus 342 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~~ 415 (596)
...++|+||++ ++|.+++.. ..+++...+.++.|++.||.|||+. +++||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35689999997 588877753 3588999999999999999999999 999999999999997 45678
Q ss_pred EEeeccccccccccCcce--eccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHH
Q 007608 416 VLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 492 (596)
Q Consensus 416 kl~DfGl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~ 492 (596)
+++|||.++......... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... .
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~----~ 230 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ----L 230 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----H
Confidence 999999998654322111 122347889999998654 557889999999999999999999997543211110 0
Q ss_pred HHHHH--hccCccccc--------c-cCcCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 493 HIRKL--LREDRLNDI--------V-DRNLNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 493 ~~~~~--~~~~~~~~~--------~-d~~l~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..... ......... . +..... .......++.+++.+|++.||++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 000000000 0 000000 011234568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=269.90 Aligned_cols=237 Identities=25% Similarity=0.250 Sum_probs=192.4
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEccccCC--cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCCh
Q 007608 280 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 356 (596)
Q Consensus 280 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (596)
||+|+||.||++... +++.+++|.+..... ......+..|++++++++|+|++++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 589999999864322 22456789999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceecc
Q 007608 357 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 436 (596)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 436 (596)
.+++... ..+++.....++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 9998752 3589999999999999999999998 99999999999999999999999999998664432 12233
Q ss_pred ccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCH
Q 007608 437 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 516 (596)
Q Consensus 437 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 516 (596)
..++..|+|||...+...+.++|+||||+++||+++|+.||..... ......+ .. .. ...+.
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~---~~-~~---------~~~~~ 214 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKI---LK-DP---------LRFPE 214 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH---hc-CC---------CCCCC
Confidence 4578899999999888889999999999999999999999964322 1111111 11 10 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHH
Q 007608 517 KEVETMVQVALLCTQSTPEDRPPMAQ 542 (596)
Q Consensus 517 ~~~~~l~~l~~~Cl~~dP~~RPs~~e 542 (596)
.....+.+++.+|+..||++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 22567789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=259.92 Aligned_cols=269 Identities=23% Similarity=0.310 Sum_probs=198.8
Q ss_pred cCCCcCceeeecCceEEEEEEeCC-----CcEEEEEEccccCC-cchHHHHHHHHHHHHhcCCCCccceEeEEec-CCee
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSER 344 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~ 344 (596)
..|+....||+|.||.||+|..++ ...+|+|+++...+ .+-.....+|+.+++.++|||++.+..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468888999999999999997432 23689999974322 2334567899999999999999999998877 6778
Q ss_pred EEEEEcccCCChhhhhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC----CcEEEee
Q 007608 345 ILVYPFMQNLSVAYRLRDLK-PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLCD 419 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~D 419 (596)
+++|||.+. +|...++..+ .....++....+.|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999986 8888776432 2235789999999999999999999999 69999999999999877 8999999
Q ss_pred ccccccccccCcce--eccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhh-c---hHHH
Q 007608 420 FGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED-V---LLLD 492 (596)
Q Consensus 420 fGl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~-~---~l~~ 492 (596)
+|+++.+.+..... ...++-|..|+|||++.+.+ ||.+.|||+.|||+.||+|-.+-|.......... . .-.+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999887654432 33466799999999998865 8999999999999999999988876532211111 1 1111
Q ss_pred HHHHHhccCcccccccCcCCCCCH-------------------H-------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 493 HIRKLLREDRLNDIVDRNLNTYDS-------------------K-------EVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 493 ~~~~~~~~~~~~~~~d~~l~~~~~-------------------~-------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+...+....-.... .+..+++ . .....+++..++++.||-+|.|++|.++.
T Consensus 260 rIf~vLG~Pt~~~Wp--~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWP--DLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccch--hhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 222221111101100 0000000 0 01236788889999999999999999764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=301.01 Aligned_cols=146 Identities=27% Similarity=0.346 Sum_probs=130.7
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|.+.+.||+|+||.||+|... +++.||+|+++... .......+.+|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999975 68999999986422 2233467889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
||+.+++|.+++... ..+++..++.++.||+.||.|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998752 3578899999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=257.00 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=195.4
Q ss_pred CceeeecCceEEEEEE-eCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEEEEcccCC
Q 007608 277 SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 354 (596)
.+.||+|+|+.|..++ +.+|..+|||++.+. .........+|++++.+.+ |+||+++++++.++...|+|||-|.||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 4789999999999988 679999999999754 4456778889999999985 999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC---cEEEeecccccccc--cc
Q 007608 355 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAKLVD--AK 429 (596)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~DfGl~~~~~--~~ 429 (596)
+|..++.. ...++..++.+++++|+.||.|||.+ +|.|||+||+|||..+.. -+||+||.+..-.. .+
T Consensus 162 plLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 162 PLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred hHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999987 45689999999999999999999999 999999999999996554 38999998875432 11
Q ss_pred Cc----ceeccccccccccCccccc-----CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhh---h---chHHHHH
Q 007608 430 LT----HVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE---D---VLLLDHI 494 (596)
Q Consensus 430 ~~----~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~---~---~~l~~~~ 494 (596)
.+ .......|+..|||||+.. ...|+.++|.||+|||+|-|+.|.+||.+.-..+.. + ....+..
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 11 1122356888999999863 345889999999999999999999999864322110 0 0111111
Q ss_pred HHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 495 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..-++++.+ ++.|.. ....+.+..+++...+..|+.+|-++.+++.
T Consensus 315 FesIQEGkY-eFPdkd----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 315 FESIQEGKY-EFPDKD----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHhccCC-cCChhh----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 112222221 111111 1223455667777888899999999999987
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=264.06 Aligned_cols=220 Identities=21% Similarity=0.190 Sum_probs=176.0
Q ss_pred cCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCChhhhhc
Q 007608 283 GGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 361 (596)
Q Consensus 283 G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 361 (596)
|.+|.||++... +++.||+|++... ..+.+|...+....|||++++++++...+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~------~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKS------SEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecch------hhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 889999999964 7899999998642 123455555666679999999999999999999999999999999987
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceeccccccc
Q 007608 362 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 441 (596)
Q Consensus 362 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~ 441 (596)
.. ..+++.....++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 78 KF----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred Hh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 52 3589999999999999999999998 9999999999999999999999999987655432 12233567
Q ss_pred cccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHH
Q 007608 442 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVET 521 (596)
Q Consensus 442 ~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 521 (596)
.|+|||...+..++.++||||+|+++|||++|+.|+....... ... ... ..+......
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~~~-----~~~---~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------NTH-----TTL---NIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------ccc-----ccc---CCcccCCHH
Confidence 8999999988889999999999999999999998765321100 000 000 012223457
Q ss_pred HHHHHHHccccCCCCCCCHH
Q 007608 522 MVQVALLCTQSTPEDRPPMA 541 (596)
Q Consensus 522 l~~l~~~Cl~~dP~~RPs~~ 541 (596)
+.+++.+|++.||++||++.
T Consensus 205 ~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHccCCHHHhcCCC
Confidence 78899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-34 Score=263.36 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=200.8
Q ss_pred cccccHHHHHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHh-cCCCCccceEe
Q 007608 259 LRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKNLLQLIG 336 (596)
Q Consensus 259 ~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~~ 336 (596)
+..|+.+.++ ....||.|+||+|+|-.++ .|+..|||+++........+++..|.+...+ -+.||||+++|
T Consensus 58 ~~~F~~~~Lq-------dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQ-------DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHH-------HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 4455544444 3567999999999999865 7999999999876666778889999887554 47999999999
Q ss_pred EEecCCeeEEEEEcccCCChhhhhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcE
Q 007608 337 YCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 415 (596)
Q Consensus 337 ~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 415 (596)
.+..++..++.||.|. .|+..+-... .-.+..+++...-.|+.-...||.||-+.. .|+|||+||+|||++..|.+
T Consensus 131 a~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence 9999999999999996 4655443321 112346787777888888999999998775 79999999999999999999
Q ss_pred EEeeccccccccccCcceeccccccccccCcccccC--CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHH
Q 007608 416 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 493 (596)
Q Consensus 416 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~ 493 (596)
||+|||++..+..... .+.-.|-..|||||.+.. ..|+.+|||||+|+.|+|+.||+.|+.... ...+.
T Consensus 208 KLCDFGIcGqLv~SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeq 278 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQ 278 (361)
T ss_pred eeecccchHhHHHHHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHH
Confidence 9999999986654322 222347778999999863 348999999999999999999999997432 13344
Q ss_pred HHHHhccCcccccccCcCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 494 IRKLLREDRLNDIVDRNLNTY---DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 494 ~~~~~~~~~~~~~~d~~l~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+...+..+ +..... ..+....+.+++..|+.+|-+.||+..++.++
T Consensus 279 l~~Vv~gd-------pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 279 LCQVVIGD-------PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHcCC-------CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 44443332 211111 23356788999999999999999999998653
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=259.00 Aligned_cols=254 Identities=23% Similarity=0.278 Sum_probs=196.5
Q ss_pred HhcCCCc-CceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecC----C
Q 007608 270 ATDNFSE-SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS----S 342 (596)
Q Consensus 270 ~~~~f~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~----~ 342 (596)
.+++|.+ .++||-|-.|.|-.+..+ +|+.+|+|++.+. ...++|+++--.. .|||||.+++++.+. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 3556655 368999999999999865 7899999999752 2345777764444 699999999988654 3
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC---CCcEEEee
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCD 419 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~D 419 (596)
..++|||.|+||.|...+.+.. ...+++.++-.|+.||+.|+.|||+. +|.||||||+|+|.+. |...||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 4679999999999999998743 46789999999999999999999999 9999999999999964 55699999
Q ss_pred ccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc
Q 007608 420 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 499 (596)
Q Consensus 420 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 499 (596)
||+|+.-... ......+-||.|.|||++-..+|+..+|+||+||++|-|+.|.+||..... ..+....+..++
T Consensus 208 fGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-----~aispgMk~rI~ 280 (400)
T KOG0604|consen 208 FGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKRRIR 280 (400)
T ss_pred cccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-----ccCChhHHhHhh
Confidence 9999865432 222334569999999999999999999999999999999999999975322 222222333222
Q ss_pred cCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 500 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 500 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+.+.- .++ -....++...++++..|..+|.+|.++.|+..+
T Consensus 281 ~gqy~F-P~p----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 281 TGQYEF-PEP----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccCccC-CCh----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 222111 011 123446677899999999999999999999873
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=236.51 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=195.8
Q ss_pred CCCcCceeeecCceEEEEEEe-CCCcEEEEEEccc-cCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+|...++||+|.||+|++|+. .+++.||+|+++- ..+++......+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455678899999999999995 4688999999983 34455567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
|.. +|..+.... +..++......++.|+++||.|+|++ ++.|||+||.|.+++.+|+.|++|||+++.++-..
T Consensus 83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 975 777776653 35689999999999999999999999 99999999999999999999999999999876554
Q ss_pred cceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHH--hccCccc--
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKL--LREDRLN-- 504 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~--~~~~~~~-- 504 (596)
...+ ...-|..|++|.++.+.+ |++..|+||-|||+.|+.. |++.|...+..+ .+...++.. ..++.+.
T Consensus 156 rcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd----qlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 156 RCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD----QLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred Eeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH----HHHHHHHHhCCCccccCCcc
Confidence 3333 334689999999998876 7899999999999999987 555555433211 122222211 1122211
Q ss_pred -ccccCcC-CCCCH-----HHHHH----HHHHHHHccccCCCCCCCHHHHHHH
Q 007608 505 -DIVDRNL-NTYDS-----KEVET----MVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 505 -~~~d~~l-~~~~~-----~~~~~----l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+.|-.. +.++. ..... =.++....+.-+|.+|.++++.++.
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1122111 11211 11111 2355556677799999999988654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=264.63 Aligned_cols=262 Identities=21% Similarity=0.269 Sum_probs=199.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCC--C----CccceEeEEecCCe
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--K----NLLQLIGYCTTSSE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H--~----niv~l~~~~~~~~~ 343 (596)
+++|.+...+|+|.||.|-++... .+..||||+++.- ..-.+..+-|++++.++.+ | -+|.+.+++...++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 678999999999999999999854 5789999999742 2234455679999999842 2 26788888999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc-------------
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD------------- 410 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~------------- 410 (596)
.++|+|.+ |.|+.+++... +..+.+...+..++.|++++++|||+. +++|.||||+|||+.
T Consensus 166 iCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 99999988 45899999863 345788899999999999999999999 999999999999994
Q ss_pred -------CCCcEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccch
Q 007608 411 -------DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE 483 (596)
Q Consensus 411 -------~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~ 483 (596)
.+..+||+|||.|+...... ..+..|..|+|||++.+-.++..+||||+||||.|+.||...|+..+..
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 24568999999998765433 3455789999999999999999999999999999999999998865422
Q ss_pred hhhhchHHHHHHH--------------HhccCcc-----------cccccCcC-----CCCCHHHHHHHHHHHHHccccC
Q 007608 484 EEEDVLLLDHIRK--------------LLREDRL-----------NDIVDRNL-----NTYDSKEVETMVQVALLCTQST 533 (596)
Q Consensus 484 ~~~~~~l~~~~~~--------------~~~~~~~-----------~~~~d~~l-----~~~~~~~~~~l~~l~~~Cl~~d 533 (596)
+ ...+.+.+.. ....+++ ....++.. ....+.+..++++|+..++..|
T Consensus 316 E--HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 316 E--HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred H--HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 1 1112222111 0001100 01111110 0123456778999999999999
Q ss_pred CCCCCCHHHHHHH
Q 007608 534 PEDRPPMAQVVKM 546 (596)
Q Consensus 534 P~~RPs~~evl~~ 546 (596)
|.+|+|+.|++.+
T Consensus 394 P~~RiTl~EAL~H 406 (415)
T KOG0671|consen 394 PARRITLREALSH 406 (415)
T ss_pred ccccccHHHHhcC
Confidence 9999999999763
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=276.89 Aligned_cols=240 Identities=21% Similarity=0.267 Sum_probs=191.6
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++.|+....+|.|+|+.|-.+.. .+++..+||++.+. ..+-.+|+.++... .|||++++.+.+.+..+.++||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc-----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 56778888899999999999885 47889999998653 12234566665555 6999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE-cCCCcEEEeecccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL-DDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~DfGl~~~~~ 427 (596)
|++.++-+.+.+...+ ... ..+..|+.+++.|+.|||++ ++|||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~----~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcc----hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999998888877522 222 66778999999999999999 99999999999999 588999999999999776
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.. ....+-|..|.|||+.....+++++||||||++||+|++|+.||...... .. +...+..+.
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~e----i~~~i~~~~----- 530 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IE----IHTRIQMPK----- 530 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HH----HHHhhcCCc-----
Confidence 54 11223478999999999999999999999999999999999999854321 11 111111111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+....+....+|+.+||+.||.+||+|.|+...
T Consensus 531 ------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 531 ------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ------cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 123445677889999999999999999999653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=262.98 Aligned_cols=244 Identities=23% Similarity=0.308 Sum_probs=195.6
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC--cchHHHHHHHHHHHHhc-CCCCccceEeEEecCCee
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 344 (596)
+...+|....+||+|+||.|.+|..+ +.+.+|||++++..- ....+--+.|-++|... +-|.++++..++++-+..
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34457888999999999999999865 456799999986432 12223334566666655 578899999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
|+||||+.+|+|-..+.+.. .+..+.+.-++..||-||-|||++ +|+.||||..||++|.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence 99999999999999998743 356677889999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
.--.. ...+....|||.|+|||.+...+|+..+|+|||||+||||+.|.+||+..+.+ .+.+.+.
T Consensus 499 Eni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-----elF~aI~--------- 563 (683)
T KOG0696|consen 499 ENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQAIM--------- 563 (683)
T ss_pred ccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHH---------
Confidence 43221 22345678999999999999999999999999999999999999999965432 1222221
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP 538 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP 538 (596)
+. -..|+...+.+.+.+....+.+.|.+|.
T Consensus 564 ---eh-nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 ---EH-NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---Hc-cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11 1235666677888888899999999993
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=280.30 Aligned_cols=258 Identities=26% Similarity=0.357 Sum_probs=209.4
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEE-eCCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEe--
Q 007608 264 CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT-- 339 (596)
Q Consensus 264 ~~el~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~-- 339 (596)
++.+-..++-|++.++||.|.+|.||+++ .++++.+|+|++... .....++..|.+++... .|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~--~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT--EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC--ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34444467789999999999999999999 457899999988643 34456677888888877 5999999999884
Q ss_pred ---cCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEE
Q 007608 340 ---TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 340 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 416 (596)
.+++.++|||||.+||..+.++... ...+.|..+.-|+..++.|+.+||.. .++|||||-.|||++.++.+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 3468899999999999999999876 56799999999999999999999999 899999999999999999999
Q ss_pred EeeccccccccccCcceeccccccccccCcccccC-----CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHH
Q 007608 417 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL 491 (596)
Q Consensus 417 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~ 491 (596)
+.|||.+..+...... .....||+.|||||++.. ..|+..+|+||+|++..||--|.+|+.....
T Consensus 164 LvDFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------- 233 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------- 233 (953)
T ss_pred Eeeeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---------
Confidence 9999999877654322 334569999999999853 3467889999999999999999999864322
Q ss_pred HHHHHHhccCcccccc-cCcCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 492 DHIRKLLREDRLNDIV-DRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 492 ~~~~~~~~~~~~~~~~-d~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
++.+. .+. .|... ..+....+++.+++..|+.+|-++||++.+++++
T Consensus 234 --mraLF------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 234 --MRALF------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --hhhhc------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11110 011 11111 1467788999999999999999999999999764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=277.38 Aligned_cols=264 Identities=20% Similarity=0.230 Sum_probs=181.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEe-----------------CCCcEEEEEEccccCCcchHHH--------------HHH
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL-----------------SDNTKVAVKRLQDYYSPGGEAA--------------FQR 318 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~~--------------~~~ 318 (596)
..++|++.++||+|+||+||+|.. .+++.||||++.... ....++ +..
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~-~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR-QGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc-hhhHHHHHhhhhhhhcccchhHH
Confidence 467899999999999999999964 245679999986421 112222 344
Q ss_pred HHHHHHhcCCCCc-----cceEeEEec--------CCeeEEEEEcccCCChhhhhcccCC--------------------
Q 007608 319 EVHLISVAIHKNL-----LQLIGYCTT--------SSERILVYPFMQNLSVAYRLRDLKP-------------------- 365 (596)
Q Consensus 319 e~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------- 365 (596)
|+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777776654 677787753 3567999999999999999874211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceeccccccccccC
Q 007608 366 GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445 (596)
Q Consensus 366 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~a 445 (596)
....++|..++.++.|++.+|.|||+. +|+||||||+||+++.++.+||+|||++...............+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 012357888999999999999999999 99999999999999999999999999997654332222222234789999
Q ss_pred cccccCCCC----------------------CcccccHHHHHHHHHHHhCCC-CCCCccchhh----hhchHHHHHHHHh
Q 007608 446 PEYLSTGKS----------------------SEKTDVFGYGITLLELVTGQR-AIDFSRLEEE----EDVLLLDHIRKLL 498 (596)
Q Consensus 446 PE~~~~~~~----------------------~~~sDv~S~Gvil~elltg~~-p~~~~~~~~~----~~~~l~~~~~~~~ 498 (596)
||.+..... ..+.||||+||+++||++|.. |+.....-.. ....+..|.. .
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~- 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-Y- 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-h-
Confidence 998754321 234799999999999999875 6542111000 0111111111 0
Q ss_pred ccCcccccccCcCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 007608 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTP---EDRPPMAQVVKM 546 (596)
Q Consensus 499 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~ 546 (596)
.... .+-. ..+.......+++.+++..+| .+|+|++|++++
T Consensus 457 ~~~~----~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQK----YDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccC----CCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0000 0100 112234567788888888765 689999999764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=286.05 Aligned_cols=263 Identities=16% Similarity=0.201 Sum_probs=170.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-C----CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeE------E
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-D----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY------C 338 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~------~ 338 (596)
..++|+..+.||+|+||.||+|++. + +..||+|++.... ....+..+ .+....+.++..+... +
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 5678999999999999999999975 4 6899999876421 11111111 1122222222222211 2
Q ss_pred ecCCeeEEEEEcccCCChhhhhcccCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC
Q 007608 339 TTSSERILVYPFMQNLSVAYRLRDLKPG----------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 402 (596)
Q Consensus 339 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl 402 (596)
......++||||+.+++|.+++...... ........+..++.|++.||+|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4556789999999999999988742110 00112334567999999999999999 9999999
Q ss_pred CCCcEEEcC-CCcEEEeeccccccccccCcceeccccccccccCcccccCC----------------------CCCcccc
Q 007608 403 KAANILLDD-NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG----------------------KSSEKTD 459 (596)
Q Consensus 403 kp~NIll~~-~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 459 (596)
||+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 57899999999987654433444456789999999965322 2345679
Q ss_pred cHHHHHHHHHHHhCCCCCCCccchh-----hhhchHHHHHHHHhccCcccccccCcCCC---CCHHHHHHHHHHHHHccc
Q 007608 460 VFGYGITLLELVTGQRAIDFSRLEE-----EEDVLLLDHIRKLLREDRLNDIVDRNLNT---YDSKEVETMVQVALLCTQ 531 (596)
Q Consensus 460 v~S~Gvil~elltg~~p~~~~~~~~-----~~~~~l~~~~~~~~~~~~~~~~~d~~l~~---~~~~~~~~l~~l~~~Cl~ 531 (596)
||||||++|||+++..+++...... ..+.....|..... .. ..+.+.. ..........+++.+|++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE-PR-----ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc-cc-----cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 9999999999999776654211000 00011111111100 00 0000000 001112234589999999
Q ss_pred cCCCCCCCHHHHHHH
Q 007608 532 STPEDRPPMAQVVKM 546 (596)
Q Consensus 532 ~dP~~RPs~~evl~~ 546 (596)
.||++|||++|++++
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999885
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=269.15 Aligned_cols=246 Identities=22% Similarity=0.307 Sum_probs=196.9
Q ss_pred CceeeecCceEEEEEEe-CCCcEEEEEEccc-cCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCC
Q 007608 277 SNIIGQGGFGKVYKGVL-SDNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 354 (596)
.++||+|.||+||-|++ ++|+.||||++.+ ......+.++.+|+.+|.++.||.||.+.-.|.+.+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 57899999999999995 5899999999974 345566788999999999999999999999999999999999999764
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC---CcEEEeeccccccccccCc
Q 007608 355 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~DfGl~~~~~~~~~ 431 (596)
-|.-.|... ...++....+.++.||+.||.|||.+ +|+|+||||+|||+... -.+||+|||+|+...+..
T Consensus 649 MLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 649 MLEMILSSE---KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred HHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 444444432 34588888889999999999999999 99999999999999643 469999999999887643
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcC
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 511 (596)
....+.|||.|+|||+++.+.|...-|+||.|||+|.-++|..||..+ .++.+.++... +.-|.
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-------EdIndQIQNAa-------FMyPp- 785 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-------EDINDQIQNAA-------FMYPP- 785 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-------cchhHHhhccc-------cccCC-
Confidence 345578999999999999999999999999999999999999999632 22333343211 11110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 512 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+...+.++++...++..=++|-+...-+.+
T Consensus 786 -~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 786 -NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred -CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1133445667788888888888888887766543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=254.33 Aligned_cols=239 Identities=26% Similarity=0.305 Sum_probs=192.4
Q ss_pred CceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCChhhhhcc
Q 007608 284 GFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 362 (596)
Q Consensus 284 ~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 362 (596)
+||.||+|... +++.+++|++.........+.+.+|++.+++++|+|++++.+++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 58999999987543332267899999999999999999999999999999999999999999999875
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceecccccccc
Q 007608 363 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 442 (596)
Q Consensus 363 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~ 442 (596)
.. .+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++..
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 32 388999999999999999999999 99999999999999999999999999998765432 2233457889
Q ss_pred ccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHH
Q 007608 443 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETM 522 (596)
Q Consensus 443 y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 522 (596)
|++||...+..++.++||||||++++++++|..|+..... .....+... ...... .........++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----~~~~~~~~~----~~~~~~------~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----LLELFKKIG----KPKPPF------PPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHh----ccCCCC------ccccccCCHHH
Confidence 9999999888899999999999999999999999874211 111111111 110000 00000144678
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 007608 523 VQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 523 ~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=263.71 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=194.6
Q ss_pred CCCcCceeeecCceEEEEEE-eCCCcEEEEEEccccCCcc------hHHHHHHHHHHHHhcCCCCccceEeEEecC-Cee
Q 007608 273 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPG------GEAAFQREVHLISVAIHKNLLQLIGYCTTS-SER 344 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~ 344 (596)
+|-..+.||+|+|+.||+|. +...+.||||+-.-..+.. -.+...+|..+-+.+.||.||++++|+.-+ +..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 45557789999999999999 4577889999864222111 124567899999999999999999998654 567
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc---CCCcEEEeecc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFG 421 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~DfG 421 (596)
+-|.||++|-+|.-+|+. .+.++..++..|+.||+.||.||.+. +|+|+|-||||.|||+. .-|.+||+|||
T Consensus 544 CTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred eeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 899999999999999987 45689999999999999999999986 67899999999999995 45789999999
Q ss_pred ccccccccCcc------eeccccccccccCcccccC----CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHH
Q 007608 422 LAKLVDAKLTH------VTTQIRGTMGHIAPEYLST----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL 491 (596)
Q Consensus 422 l~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~ 491 (596)
+++.++..... .+.+..||..|++||.+.- .+++.|.||||.|||+|.++.|+.||...... ..+.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ----QdIL 694 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ----QDIL 694 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH----HHHH
Confidence 99998765432 3456789999999998743 35788999999999999999999999853221 1111
Q ss_pred HHHHHHhccCcccccccCcCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 492 DHIRKLLREDRLNDIVDRNLNTY--DSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 492 ~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
....+ +...-..+ .+....+...++.+|++.--++|....++..
T Consensus 695 -------qeNTI---lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 -------QENTI---LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -------hhhch---hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11111 11000011 1223456678899999999999998877743
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=251.38 Aligned_cols=265 Identities=24% Similarity=0.349 Sum_probs=195.4
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEcc-ccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC--------C
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--------S 342 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~-~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~ 342 (596)
.|+....||+|.||.||+|+.+ +|+.||+|++. ....++-.....+|++++..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4556778999999999999965 67888998764 333444556678999999999999999999888432 3
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++||++|+. +|...|.+. ...++..++.+++.++..||.|+|.. .|+|||+||.|||++.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 47899999985 788877753 25688999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCc---ceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHh
Q 007608 423 AKLVDAKLT---HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 498 (596)
Q Consensus 423 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 498 (596)
++.+..... ...+..+-|..|++||.+.+. .++++.|||.-|||+.||+|+.+-++.... .....++.......
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte--qqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--QQQLHLISQLCGSI 248 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH--HHHHHHHHHHhccC
Confidence 986644322 122334458999999998875 589999999999999999999888775332 11111222211111
Q ss_pred ccCccccccc---------CcCCC----CCHHH------HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 499 REDRLNDIVD---------RNLNT----YDSKE------VETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 499 ~~~~~~~~~d---------~~l~~----~~~~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..+.+.++.. +.+.. ...+. ..+.++++..++..||.+||.+.+++.+
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1111111110 00111 00111 1356788889999999999999999764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=235.88 Aligned_cols=209 Identities=22% Similarity=0.329 Sum_probs=175.3
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHh-cCCCCccceEeEEecCCee
Q 007608 267 LQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 267 l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~ 344 (596)
+++..++......||+|++|.|-+-++ .+|+..|+|+++.....+..+....|+++..+ ...|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 445556666678899999999988885 58999999999877666777888889887655 4799999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++.||.|.- ||..+-++....+..+++...-+|+..+..||.|||++. .++|||+||+|||++.+|.+|++|||++.
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999974 777776655555677899999999999999999999986 79999999999999999999999999998
Q ss_pred cccccCcceeccccccccccCccccc----CCCCCcccccHHHHHHHHHHHhCCCCCCCc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLS----TGKSSEKTDVFGYGITLLELVTGQRAIDFS 480 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDv~S~Gvil~elltg~~p~~~~ 480 (596)
.+.+..... .-.|-..|||||.+. ...|+.|+||||+|+.+.||.+++.||+..
T Consensus 198 ~L~dSiAkt--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVDSIAKT--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eehhhhHHH--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 765432221 123667899999985 346899999999999999999999999854
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=243.49 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=194.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 345 (596)
...+|...++||+|+|..|-.++++ +.+.+|+|++++.. .....+=.+.|-.+..+. +||.+|-+..+++++...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 4467888999999999999999965 67889999997432 222333455666666665 6999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+|.||.++|+|--++.+ ...++...+..+...|.-||.|||++ ||+.||||..|||+|..|++|++|+|+++.
T Consensus 328 fvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999877765 45689999999999999999999999 999999999999999999999999999984
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
--.. ...+...+|||.|+|||.+.+..|....|+|++||+++||+.|+.||+.-... ..+....+...+.+-+..+
T Consensus 401 ~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~-n~d~ntedylfqvilekqi-- 476 (593)
T KOG0695|consen 401 GLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD-NPDMNTEDYLFQVILEKQI-- 476 (593)
T ss_pred CCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC-CcccchhHHHHHHHhhhcc--
Confidence 3222 23455678999999999999999999999999999999999999999852211 1111122222222111111
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP 538 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP 538 (596)
..+...+.+...+.+.-+.+||.+|.
T Consensus 477 -------riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 -------RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -------cccceeehhhHHHHHHhhcCCcHHhc
Confidence 11233344556777788999999983
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=260.88 Aligned_cols=243 Identities=23% Similarity=0.264 Sum_probs=198.8
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCc-EEEEEEccc--cCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNT-KVAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~l~~--~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.+++....||-|+||.|-.+...... .+|+|.+++ .........+..|-.+|...+.|.||+++--+.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 44555678999999999999975443 489998874 345566778889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
|-|-||.+...|++ +..++..+...++..+.+|++|||++ +||.|||||+|.++|.+|-+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999987 34577788889999999999999999 999999999999999999999999999998876
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
... +-.++|||.|.|||.+.....+.++|.||+|+++|||+||.+||...+.- . ....+...+ |
T Consensus 573 g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-k----tYn~ILkGi---------d 636 (732)
T KOG0614|consen 573 GRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-K----TYNLILKGI---------D 636 (732)
T ss_pred CCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-H----HHHHHHhhh---------h
Confidence 543 44578999999999999999999999999999999999999999865431 1 111111110 0
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPP 539 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 539 (596)
...++........+++++....+|.+|.-
T Consensus 637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 --KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 00123344456678888888899999965
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=258.74 Aligned_cols=206 Identities=22% Similarity=0.258 Sum_probs=172.8
Q ss_pred HhcCCCcCceeeecCceEEEEEE-eCCCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
....|...+.||-|+||.|.++. .++...+|+|.+++. ...........|-++|.....+.||+++..|.+.+.+|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 34557778899999999999998 445667999998742 122345667889999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||++||++-++|-+ ..-+.+..+..++..+..|+++.|.. |+|||||||+|||||.+|++||+|||++.-+
T Consensus 707 VMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999998876 24577888888999999999999999 9999999999999999999999999998643
Q ss_pred cc--------cCcc-----------------e----------------eccccccccccCcccccCCCCCcccccHHHHH
Q 007608 427 DA--------KLTH-----------------V----------------TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGI 465 (596)
Q Consensus 427 ~~--------~~~~-----------------~----------------~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gv 465 (596)
.. ...+ + ....+||+.|+|||++....++..+|+||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 10 0000 0 01134999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCccc
Q 007608 466 TLLELVTGQRAIDFSRL 482 (596)
Q Consensus 466 il~elltg~~p~~~~~~ 482 (596)
|||||+.|+.||-....
T Consensus 860 il~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTP 876 (1034)
T ss_pred HHHHHhhCCCCccCCCC
Confidence 99999999999986543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=242.10 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=194.1
Q ss_pred CcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC-----eeEEE
Q 007608 275 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERILV 347 (596)
Q Consensus 275 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv 347 (596)
+..+.||.|+||.||.++.+ +|+.||.|++... ..-...+.+.+|++++..++|.|++..++...-.. +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34678999999999999965 8999999998642 22234567889999999999999999888765443 56777
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
+|.|.. +|...+-. .+.++-...+-+..||++||.|||+. +|.||||||.|.|++.+...||+|||+++..+
T Consensus 136 TELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 887753 55555543 56788889999999999999999999 99999999999999999999999999999876
Q ss_pred ccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHH--------HHHHHHh
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL--------DHIRKLL 498 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~--------~~~~~~~ 498 (596)
.+.....++..-|..|+|||.+++. .|+.+.||||.|||+.|++..+-.|+....-+.-+ .+. +.++...
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~-lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ-MIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH-HHHHHhCCCcHHHHHHHh
Confidence 6555445555568899999999886 48999999999999999999888887544321111 011 1111110
Q ss_pred ccCccccccc-----Cc---CCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 499 REDRLNDIVD-----RN---LNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 499 ~~~~~~~~~d-----~~---l~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+ +....++. +. +.+ .+.....+.+.+...++..||++|.+..+.+..+-.
T Consensus 287 E-GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 287 E-GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred h-hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 0 00011111 11 111 112233455666777899999999999999876543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=270.56 Aligned_cols=247 Identities=26% Similarity=0.315 Sum_probs=186.0
Q ss_pred CCcCceeeecCce-EEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEEEcc
Q 007608 274 FSESNIIGQGGFG-KVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 274 f~~~~~lG~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
|...+++|.|+.| .||+|.. +|+.||||++-. ...+-..+|+..++.- .|||||++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 4456789999987 5799998 788999999853 2344567899999877 5999999988878888899999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC---C--CcEEEeeccccccc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---N--FEAVLCDFGLAKLV 426 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~--~~~kl~DfGl~~~~ 426 (596)
. .+|.+++...........-...+.+..|++.||++||+- +||||||||.||||+. + ..++|+|||+++.+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 6 599999986311111111134567889999999999997 9999999999999975 2 57999999999988
Q ss_pred cccCcce--eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhC-CCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 427 DAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 427 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg-~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
..+.... .....||.||+|||.+.....+.++||||+|||+|+.++| ..||......+ ...+.....
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----------~NIl~~~~~ 731 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----------ANILTGNYT 731 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh----------hhhhcCccc
Confidence 7654432 3346799999999999998888999999999999999996 89997432110 011111100
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. .+.. ..++ +..+|+.+|+..+|..||++.+|+.+
T Consensus 732 L~----~L~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 LV----HLEP-LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ee----eecc-CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 00 0011 1112 77889999999999999999999763
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=247.48 Aligned_cols=265 Identities=23% Similarity=0.302 Sum_probs=195.7
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-----C---CCccceEeEEec-
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----H---KNLLQLIGYCTT- 340 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~l~~~~~~- 340 (596)
..+|-..++||+|.|++||++.. .+.+.||+|+.+.. +.-.+....||++|++++ | ..||+++++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 36788899999999999999995 46788999998742 223455678999999884 3 358999998853
Q ss_pred ---CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC------
Q 007608 341 ---SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD------ 411 (596)
Q Consensus 341 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~------ 411 (596)
+.+.++|+|++ |-+|..++... .-++++....+.|+.||+.||.|||.+| +|||.||||+|||+..
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~ 229 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPA 229 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchh
Confidence 45789999998 55888888753 3467999999999999999999999999 9999999999999940
Q ss_pred --------------------------------------------------------------------------------
Q 007608 412 -------------------------------------------------------------------------------- 411 (596)
Q Consensus 412 -------------------------------------------------------------------------------- 411 (596)
T Consensus 230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~ 309 (590)
T KOG1290|consen 230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI 309 (590)
T ss_pred hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 007608 412 -------------------------------------------------------------------------------- 411 (596)
Q Consensus 412 -------------------------------------------------------------------------------- 411 (596)
T Consensus 310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~ 389 (590)
T KOG1290|consen 310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC 389 (590)
T ss_pred CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence
Q ss_pred CCcEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhh-hchH
Q 007608 412 NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE-DVLL 490 (596)
Q Consensus 412 ~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~-~~~l 490 (596)
+..+||+|||-|+......+.. .-|..|+|||++.+..|++.+|||||+|+++||.||...|+....+... +...
T Consensus 390 di~vKIaDlGNACW~~khFT~D----IQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 390 DIRVKIADLGNACWVHKHFTED----IQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred ceeEEEeeccchhhhhhhhchh----hhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 0124566666665544322211 1477899999999999999999999999999999999888764433221 1112
Q ss_pred HHHHHH--------HhccCc-ccccccCc--------C------------CCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007608 491 LDHIRK--------LLREDR-LNDIVDRN--------L------------NTYDSKEVETMVQVALLCTQSTPEDRPPMA 541 (596)
Q Consensus 491 ~~~~~~--------~~~~~~-~~~~~d~~--------l------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 541 (596)
+..+.. ....++ ..+++++. + ..++.++..++.++..-||+.+|++|||+.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 111111 111121 22333321 0 113567788999999999999999999999
Q ss_pred HHHHH
Q 007608 542 QVVKM 546 (596)
Q Consensus 542 evl~~ 546 (596)
+.+++
T Consensus 546 ~cl~h 550 (590)
T KOG1290|consen 546 QCLKH 550 (590)
T ss_pred HHhcC
Confidence 99864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=227.98 Aligned_cols=212 Identities=33% Similarity=0.487 Sum_probs=182.7
Q ss_pred eeecCceEEEEEEeCC-CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCChhh
Q 007608 280 IGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY 358 (596)
Q Consensus 280 lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 358 (596)
||+|.+|.||++...+ ++.+++|++...........+.+|++.+..++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998753322235789999999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-CCcEEEeeccccccccccCcceeccc
Q 007608 359 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDAKLTHVTTQI 437 (596)
Q Consensus 359 ~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfGl~~~~~~~~~~~~~~~ 437 (596)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987532 3588999999999999999999999 9999999999999999 89999999999986654321 12224
Q ss_pred cccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCH
Q 007608 438 RGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 516 (596)
Q Consensus 438 ~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 516 (596)
.+...|++||..... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 467899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 517 KEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 517 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3567888899999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=220.40 Aligned_cols=259 Identities=17% Similarity=0.281 Sum_probs=190.7
Q ss_pred hcCCCcCceeeecCceEEEEEE-eCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCC--eeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS--ERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~~l 346 (596)
.++|++.+.+|+|.++.|+.|. ..+.+.++||+++. ...+.+.+|+.+|..+. ||||+++++...++. ...+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 4678889999999999999999 56788999999863 34677899999999997 999999999987764 4579
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC-CcEEEeecccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKL 425 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfGl~~~ 425 (596)
|+||+.+.+....-. .++...+..++.+++.||.|+|++ ||.|||+||.||++|.. -..+|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 999999877665543 366677889999999999999999 99999999999999864 4699999999998
Q ss_pred ccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhc---------hHHHHHH
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV---------LLLDHIR 495 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~---------~l~~~~~ 495 (596)
........ ....+..|.-||.+-. ..++..-|+|||||++..|+..+.||-........-. .+...+.
T Consensus 183 YHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 183 YHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred cCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 86643322 2235667888999865 4578899999999999999999999864322111100 0111111
Q ss_pred HH--hccCcccccccCcCCC----C----C-HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 496 KL--LREDRLNDIVDRNLNT----Y----D-SKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 496 ~~--~~~~~~~~~~d~~l~~----~----~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.. .-......++...... + . .-...+.++++...+..|-.+|||++|...
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 10 0001111111110000 0 0 012367888888999999999999999854
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=224.63 Aligned_cols=200 Identities=30% Similarity=0.402 Sum_probs=171.3
Q ss_pred CCcCceeeecCceEEEEEEeCC-CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEccc
Q 007608 274 FSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 352 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 352 (596)
|...+.||+|++|.||++...+ ++.+++|.+.........+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999764 899999998753322256788999999999999999999999999999999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc
Q 007608 353 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432 (596)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 432 (596)
+++|.+++..... .+++.....++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999876321 178999999999999999999999 9999999999999999999999999999876543211
Q ss_pred eeccccccccccCcccc-cCCCCCcccccHHHHHHHHHHHhCCCCCCC
Q 007608 433 VTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQRAIDF 479 (596)
Q Consensus 433 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~S~Gvil~elltg~~p~~~ 479 (596)
......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12234467889999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-28 Score=243.74 Aligned_cols=197 Identities=23% Similarity=0.357 Sum_probs=166.6
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-------CcchHHHHHHHHHHHHhcC---CCCccceEeEEec
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAI---HKNLLQLIGYCTT 340 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~ 340 (596)
.+|...+.+|.|+||.|+.+.++ +...|+||.+.+.. .....-..-.|+++|..++ |+||++++.++.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35788899999999999999986 46678999886421 1111123456999999997 9999999999999
Q ss_pred CCeeEEEEEcc-cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEee
Q 007608 341 SSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 419 (596)
Q Consensus 341 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 419 (596)
++..|+++|-. ++.+|.+++.. ...+++.+++-|++||+.|+++||++ +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999976 45688888875 45689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccCcceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCC
Q 007608 420 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAID 478 (596)
Q Consensus 420 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~ 478 (596)
||.+.....+. .....||.+|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99998665432 334579999999999999887 455799999999999999888875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=222.41 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=189.8
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeE-EecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGY-CTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~-~~~~~~~~lv 347 (596)
.+.|.+.+.+|+|.||.+-++.++ +.+.+++|-+.... ...++|.+|...--.+ .|.||+.-++. ++..+..+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 357888999999999999999975 67889999886543 3578899998765555 59999987764 5666778899
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE--cCCCcEEEeecccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL--DDNFEAVLCDFGLAKL 425 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll--~~~~~~kl~DfGl~~~ 425 (596)
+||++.|+|.+.+.. .++.+...++++.|+++|+.|+|++ ++||||||.+|||+ .+...+||+|||..+.
T Consensus 101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999999988875 4577888899999999999999999 99999999999999 2445899999999876
Q ss_pred ccccCcceeccccccccccCcccccCC-----CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
.+... .....+..|.+||+.... ...+.+|||.||++++.++||+.|++.....+.......+|.....
T Consensus 173 ~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~-- 246 (378)
T KOG1345|consen 173 VGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN-- 246 (378)
T ss_pred cCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC--
Confidence 54321 122345679999987432 3577899999999999999999999965443333333444433211
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
+.++..-....+.+.++.++-+..+|++|=...++.++-
T Consensus 247 --------~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 --------PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred --------ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 122221223345677778888999999996555555544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=223.05 Aligned_cols=262 Identities=22% Similarity=0.269 Sum_probs=191.1
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC------e
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------E 343 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~ 343 (596)
.+|.....+|.|+- .|..+... .+++||+|++... ......+...+|..++..+.|+|+++++.++.-.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888888 56666543 6889999988633 22233456678999999999999999999886543 5
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.|+|||||. ++|...+.- .++-.+...|..|++.|+.|||+. +|+||||||+||++..+...||.|||++
T Consensus 96 ~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 689999996 588877762 356678889999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhh--------------hhch
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE--------------EDVL 489 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~--------------~~~~ 489 (596)
+..+.. ...+....|..|.|||++.+..+.+.+||||.||++.||++|.--|.+...-+. --..
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 865543 344556678999999999998899999999999999999999987764321000 0001
Q ss_pred HHHHHHHHhccC------cccccc-cCcCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 490 LLDHIRKLLRED------RLNDIV-DRNLNT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 490 l~~~~~~~~~~~------~~~~~~-d~~l~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+...++...+.. ...+.+ |..... ..........+++.+||..+|++|.++++++++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 112222222110 000111 111111 112234456788889999999999999999764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-27 Score=243.94 Aligned_cols=254 Identities=24% Similarity=0.273 Sum_probs=200.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
..++|+....+|.|.||.|||++.. .++..|+|+++-. .....+-.++|+-+++..+||||+.++|-+...+..+++|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe-p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE-PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeecc-CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3467888999999999999999964 7899999999742 2334566788999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+.+|+|.+.-+- ..+++..++..+.+...+|++|||++ +=+|||||-.||++++.+.+|++|||.+..+..
T Consensus 92 EycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999886654 45788888889999999999999999 889999999999999999999999999876644
Q ss_pred cCcceeccccccccccCcccc---cCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
... ......||+.|||||+. ..+.|..++|||+.|+...|+---.+|.-.-. ...+..... ..
T Consensus 165 ti~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh---------pmr~l~LmT----kS 230 (829)
T KOG0576|consen 165 TIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH---------PMRALFLMT----KS 230 (829)
T ss_pred hhh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc---------hHHHHHHhh----cc
Confidence 322 22345699999999986 45678999999999999999977665532100 001111111 11
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.+++.-........+.+-++++.|+.++|.+||+++.+++
T Consensus 231 ~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2333222234455677889999999999999999998876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=224.60 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=194.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC----CCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCee
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSER 344 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~ 344 (596)
..+.|...++||.|.|++||++++. ..+.||+|.+....+ ...+.+|+++|..+. +.||+++.+++...+..
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 4567888999999999999999953 467899999875433 345789999999985 99999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-CCcEEEeecccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLA 423 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfGl~ 423 (596)
.+|+||++.....++... ++...+..++..+..||.++|.+ |||||||||+|+|.+. .+.-.|.|||++
T Consensus 111 ~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred EEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 999999999888888775 66888999999999999999999 9999999999999974 456789999998
Q ss_pred ccccccC------c---------------------------c----------eeccccccccccCcccccCC-CCCcccc
Q 007608 424 KLVDAKL------T---------------------------H----------VTTQIRGTMGHIAPEYLSTG-KSSEKTD 459 (596)
Q Consensus 424 ~~~~~~~------~---------------------------~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sD 459 (596)
...+... . . ......||+||+|||++... ..++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7321000 0 0 00124599999999998764 4789999
Q ss_pred cHHHHHHHHHHHhCCCCCCCccchhhhhchHHHH-----HHH-HhccCc--ccc------c---------cc-CcCCC--
Q 007608 460 VFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH-----IRK-LLREDR--LND------I---------VD-RNLNT-- 513 (596)
Q Consensus 460 v~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~-----~~~-~~~~~~--~~~------~---------~d-~~l~~-- 513 (596)
|||-|||++-+++++.||-....+-..-..+... ++. ..-.++ +.+ + ++ ..+..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 9999999999999999986543221111111100 111 011111 100 0 00 00000
Q ss_pred --------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 514 --------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 514 --------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
..+..+..++++..+|++.||.+|.+++|.+++-
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 0111234678999999999999999999997653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=228.38 Aligned_cols=205 Identities=21% Similarity=0.236 Sum_probs=171.3
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcC------CCCccceEeEEe
Q 007608 267 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI------HKNLLQLIGYCT 339 (596)
Q Consensus 267 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~------H~niv~l~~~~~ 339 (596)
-+..-.+|...-..|+|-|++|..|... .|+.||||++.... .-.+.=+.|+++|++++ -.++++++-.|.
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 3445678888889999999999999954 68899999997532 23344468999999986 357889999999
Q ss_pred cCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC-cEEEe
Q 007608 340 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLC 418 (596)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~ 418 (596)
..++.++|||-+. .+|.+.|..+.. +.++.......++.|+.-||..|-.. +|+|.||||.|||+++.. ..|||
T Consensus 505 hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 505 HKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeec
Confidence 9999999999875 699999987654 56789999999999999999999887 999999999999998764 58999
Q ss_pred eccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCcc
Q 007608 419 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 481 (596)
Q Consensus 419 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~ 481 (596)
|||.|....... .+.+.-+..|.|||++.+.+|+...|+||.||.||||.||+-.|.+..
T Consensus 580 DfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 580 DFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 999998765432 222334668999999999999999999999999999999999887643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-26 Score=258.30 Aligned_cols=195 Identities=13% Similarity=0.117 Sum_probs=136.9
Q ss_pred cCC-CCccceEeEE-------ecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 007608 326 AIH-KNLLQLIGYC-------TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397 (596)
Q Consensus 326 l~H-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 397 (596)
+.| +||.++++++ ......+.++||+ +++|.+++... ...+++.+++.++.||++||+|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 345 5777777776 2223456778887 56999999742 34589999999999999999999999 99
Q ss_pred EecCCCCCcEEEcC-------------------CCcEEEeeccccccccccCc---------------ceeccccccccc
Q 007608 398 IHRDLKAANILLDD-------------------NFEAVLCDFGLAKLVDAKLT---------------HVTTQIRGTMGH 443 (596)
Q Consensus 398 vH~dlkp~NIll~~-------------------~~~~kl~DfGl~~~~~~~~~---------------~~~~~~~gt~~y 443 (596)
+||||||+|||++. ++.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965 34556666666653211000 000113478889
Q ss_pred cCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHH
Q 007608 444 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMV 523 (596)
Q Consensus 444 ~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~ 523 (596)
+|||++.+..++.++|||||||++|||++|..|+.... ......... ..++. ......+..
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~---------~~~~~----~~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHR---------VLPPQ----ILLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHh---------hcChh----hhhcCHHHH
Confidence 99999999999999999999999999999888764211 011111110 01110 011223456
Q ss_pred HHHHHccccCCCCCCCHHHHHHH
Q 007608 524 QVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 524 ~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.++.+||+++|.+||+|.|++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 78889999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=203.51 Aligned_cols=166 Identities=21% Similarity=0.195 Sum_probs=125.2
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|.+++... +..+++..++.++.|++.||+|||++ + ||+||+++.++.+++ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6888888753 34699999999999999999999998 5 999999999999999 99988664321
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
..|++.|+|||++.+..++.++|||||||++|||+||+.||...... ...+....... ... ++....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~---~~~~~~~~~~~-~~~------~~~~~~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL---SAILEILLNGM-PAD------DPRDRS 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh---cHHHHHHHHHh-ccC------Cccccc
Confidence 24789999999999999999999999999999999999998643211 11111111111 110 000001
Q ss_pred CCHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 514 YDSKEVE--TMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 514 ~~~~~~~--~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
....... ++.+++.+|++.+|++||++.|+++++..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 1122222 68999999999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=205.53 Aligned_cols=247 Identities=18% Similarity=0.277 Sum_probs=187.0
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEcc-ccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCC
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 355 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~-~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (596)
..+|.+...|..|+|+++ |..+++|+++ ...+....++|..|.-.++-+.||||+.++|.|..+.+..++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 346788889999999995 4456667776 33455556789999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceec
Q 007608 356 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 435 (596)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~ 435 (596)
|...|+... ...++-.++.+++.++|+|++|||+. .|-|.---|.+..|++|++.+++|+= +-+++. ....
T Consensus 274 lynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs-----fqe~ 344 (448)
T KOG0195|consen 274 LYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS-----FQEV 344 (448)
T ss_pred HHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee-----eecc
Confidence 999999733 34567788999999999999999986 34455556899999999999988741 111111 0111
Q ss_pred cccccccccCcccccCCCC---CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCC
Q 007608 436 QIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 512 (596)
Q Consensus 436 ~~~gt~~y~aPE~~~~~~~---~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 512 (596)
...-.|.|++||.++..+. -.++|+|||++++||+.|...||..-..-+..- +.+ -+.+. .
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm----kia-----leglr-------v 408 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM----KIA-----LEGLR-------V 408 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh----hhh-----hcccc-------c
Confidence 1223689999999987654 357899999999999999999997543321110 000 01111 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 513 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 513 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..++.....+.+++.-|+..||.+||.+..|+-.||.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 2345556788899999999999999999999998875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=209.16 Aligned_cols=167 Identities=20% Similarity=0.231 Sum_probs=129.6
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC--CCcEEEEEEccccC----CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 342 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 342 (596)
...++|...+.||+|+||+||+|..+ +++.||||++.... .......|.+|++++.+++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34578999999999999999999864 57778999865321 22235679999999999999999863322 24
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC-CCCcEEEcCCCcEEEeecc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL-KAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~DfG 421 (596)
..++||||+++++|... .. .. ...++.+++++|.|||+. +|+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 57999999999998632 11 01 146788999999999999 9999999 9999999999999999999
Q ss_pred ccccccccCcce-------eccccccccccCcccccCC
Q 007608 422 LAKLVDAKLTHV-------TTQIRGTMGHIAPEYLSTG 452 (596)
Q Consensus 422 l~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 452 (596)
+++......... .....+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999765432111 1345678899999998643
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=228.25 Aligned_cols=158 Identities=37% Similarity=0.606 Sum_probs=139.3
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCCCCCCCCCC----CcceeEeeC------CCEEEEEcCCCCCCcccCcchhhh
Q 007608 30 SREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCF----SWSHVTCRN------GNVISLTLGSNGFSGKISPSITKL 99 (596)
Q Consensus 30 ~~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~----~w~gv~c~~------~~l~~L~l~~n~l~g~~p~~~~~l 99 (596)
......|..||+.+|+++.++.. .+|+++ ||+ .|.||.|.. ..|+.|+|++|.|+|.+|+.+++|
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g~---~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNGD---PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCCC---CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence 34456689999999999976542 489764 553 799999953 148999999999999999999999
Q ss_pred cccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCCCCcccccCCccccc----cccc
Q 007608 100 KFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS----VATF 175 (596)
Q Consensus 100 ~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l~~----l~~l 175 (596)
++|+.| +|++|+|+|.+|..+++|++|+.|||++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..+.. +..+
T Consensus 442 ~~L~~L-~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l 520 (623)
T PLN03150 442 RHLQSI-NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520 (623)
T ss_pred CCCCEE-ECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence 999999 99999999999999999999999999999999999999999999999999999999999988754 3578
Q ss_pred cccccccccCCCCCCCCC
Q 007608 176 NFTGTHLICGSSLEQPCM 193 (596)
Q Consensus 176 ~~~~n~~~~~~~~~~~c~ 193 (596)
++.+|+.+|+.+....|.
T Consensus 521 ~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 521 NFTDNAGLCGIPGLRACG 538 (623)
T ss_pred EecCCccccCCCCCCCCc
Confidence 899999999987666774
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-21 Score=195.43 Aligned_cols=257 Identities=20% Similarity=0.249 Sum_probs=187.2
Q ss_pred CCCcCceeeecCceEEEEEEeCCC--cEEEEEEccccCCcchHHHHHHHHHHHHhcCC----CCccceEeEE-ecCCeeE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLSDN--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH----KNLLQLIGYC-TTSSERI 345 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~~~~-~~~~~~~ 345 (596)
+|...+.||+|+||.||.|...+. ..+|+|........... .+..|..++..+.. +++..++... ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 788999999999999999996553 47888887643222222 67788888888863 5788888887 4667789
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC-----CcEEEeec
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-----FEAVLCDF 420 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-----~~~kl~Df 420 (596)
+||+.+ +.+|.+...... ...++..+..+|+.|++.+|.++|+. |++||||||.|+.+... ..+.+.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999976 678988776543 46789999999999999999999999 99999999999999754 46999999
Q ss_pred cccc--cccccCc----ce---eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHH
Q 007608 421 GLAK--LVDAKLT----HV---TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL 491 (596)
Q Consensus 421 Gl~~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~ 491 (596)
|+++ ....... .. .....||.+|.++....+...+.+.|+||++.++.|++.|..|+........ .
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~ 246 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----K 246 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----H
Confidence 9998 3211111 11 1234599999999999999999999999999999999999999865332111 1
Q ss_pred HHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 492 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 492 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+......... .. ..... ..++.++...+-..+...+|....+...+++
T Consensus 247 ~~~~~~~~~~~~----~~-~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 247 SKFEKDPRKLLT----DR-FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred HHHHHHhhhhcc----cc-ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 111111111100 00 11112 2344445555556889999999999888664
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-20 Score=190.45 Aligned_cols=262 Identities=26% Similarity=0.337 Sum_probs=197.5
Q ss_pred CCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcc--hHHHHHHHHHHHHhcCCC-CccceEeEEecCCeeEEEEEc
Q 007608 274 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHK-NLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~ 350 (596)
|...+.||.|+||.||++... ..+++|.+....... ....|.+|+.++..+.|+ +++++..++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999976 789999987544433 477899999999999988 799999999777778999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC-cEEEeecccccccccc
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK 429 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfGl~~~~~~~ 429 (596)
+.++++.+.+...... ..+.......++.|++.++.|+|+. +++|||+||+||+++... .+++.|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999666642211 3688889999999999999999999 899999999999999988 7999999999865443
Q ss_pred Ccc-----eeccccccccccCcccccC---CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 430 LTH-----VTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 430 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..|+...... .......+.+......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTP- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCc-
Confidence 322 2345678999999999987 57889999999999999999999997643321 0011111111111100
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
......... ........+.+++..|+..+|..|.++.+....
T Consensus 234 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPS---NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCcc---ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000 002223567788889999999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=213.87 Aligned_cols=254 Identities=19% Similarity=0.223 Sum_probs=185.0
Q ss_pred CcCceeeecCceEEEEEEeC-CCcEEEEEEcc----ccCCcch-HHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 275 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ----DYYSPGG-EAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 275 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~----~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
...+++|.|++|.|+..... .....+.|..+ ...+... ...+..|+.+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988777643 34444444332 1111111 122556777778899999988777776666666669
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++ +|...+... ..+....+-.++.|+..|+.|+|+. ++.|||+|++|++++.++.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999988862 3577788899999999999999999 999999999999999999999999999986654
Q ss_pred cCc---ceeccccccccccCcccccCCCCCc-ccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 429 KLT---HVTTQIRGTMGHIAPEYLSTGKSSE-KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 429 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
... .......|+..|+|||++.+..|.+ ..||||.||++..|.+|+.||......+... .......+.
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~~- 544 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQR- 544 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhcccccc-
Confidence 332 3455677999999999999999876 4799999999999999999998755432210 000000000
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.+.. .........+.+...++.++++.||.+|.++++|++
T Consensus 545 ~~~~-~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFE-GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccc-ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000 000112334556778888999999999999999965
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=174.08 Aligned_cols=141 Identities=16% Similarity=0.163 Sum_probs=108.2
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEccccCCc-ch-------H-----------------HHHHHHHHHHHhcCCCCc
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-GG-------E-----------------AAFQREVHLISVAIHKNL 331 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~-------~-----------------~~~~~e~~~l~~l~H~ni 331 (596)
...||+|+||.||+|...+|+.||||+++..... .. . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999889999999999743211 11 1 122349999999988876
Q ss_pred cceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEecCCCCCcEEEc
Q 007608 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL-HEQCNPKIIHRDLKAANILLD 410 (596)
Q Consensus 332 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~dlkp~NIll~ 410 (596)
.....+.. ...++||||++++++...... ...++......++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333222 234899999998776544221 24688899999999999999999 687 999999999999998
Q ss_pred CCCcEEEeecccccccc
Q 007608 411 DNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 411 ~~~~~kl~DfGl~~~~~ 427 (596)
+ +.++|+|||++...+
T Consensus 153 ~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 D-GKLYIIDVSQSVEHD 168 (190)
T ss_pred C-CcEEEEEccccccCC
Confidence 4 689999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-20 Score=191.30 Aligned_cols=215 Identities=24% Similarity=0.374 Sum_probs=163.5
Q ss_pred HHhcCCCCccceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc-EecC
Q 007608 323 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI-IHRD 401 (596)
Q Consensus 323 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-vH~d 401 (596)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.....++++++.||+|+|.. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 3567899999999999999999999999999999999986 346799999999999999999999987 45 9999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccccccC-cceeccccccccccCcccccCCC-------CCcccccHHHHHHHHHHHhC
Q 007608 402 LKAANILLDDNFEAVLCDFGLAKLVDAKL-THVTTQIRGTMGHIAPEYLSTGK-------SSEKTDVFGYGITLLELVTG 473 (596)
Q Consensus 402 lkp~NIll~~~~~~kl~DfGl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDv~S~Gvil~elltg 473 (596)
++++|+++|....+|++|||+........ ........-..-|.|||.+.... .+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987664210 01111111345699999987631 46789999999999999999
Q ss_pred CCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 474 QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 474 ~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
+.||+........ ..++..+.. .....+.|.+.... +...++..++..||..+|++||++++|-..++..
T Consensus 155 ~~~~~~~~~~~~~-~eii~~~~~-----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP-DEIILRVKK-----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cCccccccccCCh-HHHHHHHHh-----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9999864433322 223222322 11112222222111 3344789999999999999999999998887754
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.8e-20 Score=174.53 Aligned_cols=173 Identities=12% Similarity=0.080 Sum_probs=132.9
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcc--hHHH------HHHHHHHHHhcCCCCccceEeEEec
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAA------FQREVHLISVAIHKNLLQLIGYCTT 340 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~------~~~e~~~l~~l~H~niv~l~~~~~~ 340 (596)
...++|...+++|.|+||.||.+.. ++..+|+|.++...... .... +.+|++.+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3567899999999999999999766 67789999997433222 1122 6899999999999999999887553
Q ss_pred C--------CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC
Q 007608 341 S--------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 412 (596)
Q Consensus 341 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 412 (596)
. ...++||||++|.+|.++.. ++. ....+++.++..+|+. +++|||+||+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 3 35789999999999977632 121 3456999999999999 99999999999999998
Q ss_pred CcEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHH
Q 007608 413 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 471 (596)
Q Consensus 413 ~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ell 471 (596)
+ ++|+|||........... ..+.....+..++|+||||+.+....
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999987654221111 11334445667999999999877654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.5e-20 Score=168.59 Aligned_cols=258 Identities=19% Similarity=0.243 Sum_probs=189.9
Q ss_pred HhcCCCcCceeeecCceEEEEEE-eCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCC-CCccceEeEEecCCeeEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv 347 (596)
....|...+.||+|+||.+|.|. ..+|..||+|.-.. .....+...|..+.+.++| ..|..+..|..+.....+|
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~---~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS---KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc---cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 34678999999999999999999 67899999998543 2334567789999998875 5566677777888888999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC---CcEEEeeccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLAK 424 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~DfGl~~ 424 (596)
|+.. +.+|.+...-+ ...++..+.+-++.|++.-++|+|.+ +++||||||+|.|..-+ ..+.++|||+++
T Consensus 90 MdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9987 66888877653 24578889999999999999999999 89999999999999643 458899999999
Q ss_pred cccccCcc------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHh
Q 007608 425 LVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 498 (596)
Q Consensus 425 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 498 (596)
.+.+..+. ......||.+|.+-....+...+..-|+=|+|.+|.+..-|..||+........ +......
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~-----QKyEkI~ 237 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK-----QKYEKIS 237 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-----HHHHHHH
Confidence 76543221 123456999999988887778888999999999999999999999864432111 1111111
Q ss_pred ccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 499 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
+.... -.+.......+.++.-.+..|-..--++-|...-+-+..
T Consensus 238 -EkK~s----~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 238 -EKKMS----TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred -HhhcC----CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 11000 000011222345666667778888888888876665544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-19 Score=167.68 Aligned_cols=141 Identities=18% Similarity=0.164 Sum_probs=110.9
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEccccCCc-ch------------------------HHHHHHHHHHHHhcCCCCc
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-GG------------------------EAAFQREVHLISVAIHKNL 331 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~------------------------~~~~~~e~~~l~~l~H~ni 331 (596)
...||+|+||.||+|...+|+.||||+++..... .. ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998753211 00 1224578899999999987
Q ss_pred cceEeEEecCCeeEEEEEcccCCChhhh-hcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCcEEE
Q 007608 332 LQLIGYCTTSSERILVYPFMQNLSVAYR-LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILL 409 (596)
Q Consensus 332 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll 409 (596)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 554443332 34899999998855433 322 346778889999999999999999 8 99999999999999
Q ss_pred cCCCcEEEeeccccccccc
Q 007608 410 DDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 410 ~~~~~~kl~DfGl~~~~~~ 428 (596)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-20 Score=203.80 Aligned_cols=258 Identities=21% Similarity=0.211 Sum_probs=185.4
Q ss_pred CCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHH--HHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL--ISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++...+.||++.|=.|.+|++++|. |+||++-+....-..+.|.++++- ...++|||.+++.-........|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4556789999999999999998887 889998654433344455544433 4556899999987776667777888888
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc--cc
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DA 428 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~--~~ 428 (596)
... +|.+.+.. +.-+...+.+.|+.|++.|+..+|.. +|+|||||.+|||++.-.=+.|+||..-+.. ..
T Consensus 103 vkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 865 88888775 44577888899999999999999999 9999999999999998888999999876532 11
Q ss_pred cCcc----eeccccccccccCcccccCC----------C-CCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHH
Q 007608 429 KLTH----VTTQIRGTMGHIAPEYLSTG----------K-SSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 492 (596)
Q Consensus 429 ~~~~----~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~ 492 (596)
+... .......-.+|+|||.+... . .+++-||||.||++.||++ |+++|..... ..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL--------~a 246 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL--------LA 246 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH--------Hh
Confidence 1111 11112233479999987431 2 4678899999999999988 6788763221 00
Q ss_pred HHHH--HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCcchhhHH
Q 007608 493 HIRK--LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAE 558 (596)
Q Consensus 493 ~~~~--~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 558 (596)
.-.. ...+..++++-|. .+.+++..|++.||++|.++++.++.-.+..+.+-+..
T Consensus 247 Yr~~~~~~~e~~Le~Ied~-----------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~ 303 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDV-----------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYS 303 (1431)
T ss_pred HhccCccCHHHHHHhCcCc-----------cHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHH
Confidence 0000 0000111122222 46788999999999999999999999988877765543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-19 Score=172.60 Aligned_cols=233 Identities=23% Similarity=0.242 Sum_probs=150.0
Q ss_pred CcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCC-----------CCccceEeE---
Q 007608 275 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIH-----------KNLLQLIGY--- 337 (596)
Q Consensus 275 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H-----------~niv~l~~~--- 337 (596)
...+.||.|+++.||.+++. +++.+|+|.+... ......+++.+|.-....+.+ .-++++--.
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34678999999999999975 5899999988632 233345677777655554332 222222111
Q ss_pred -----EecC---C-----eeEEEEEcccCCChhhhhcc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecC
Q 007608 338 -----CTTS---S-----ERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 401 (596)
Q Consensus 338 -----~~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~d 401 (596)
.... . ..+++|+-+. ++|.+.+.- .......+....++.+..|+.+.+++||+. |++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 1111 1 2356777774 577776542 222223455667778889999999999999 999999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccccccCcceeccccccccccCcccccC--------CCCCcccccHHHHHHHHHHHhC
Q 007608 402 LKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--------GKSSEKTDVFGYGITLLELVTG 473 (596)
Q Consensus 402 lkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~S~Gvil~elltg 473 (596)
|||+|++++.+|.+.|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|+.|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999987755442221 224578999998643 2478899999999999999999
Q ss_pred CCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCC
Q 007608 474 QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR 537 (596)
Q Consensus 474 ~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R 537 (596)
+.||+........+. .+.... +.++.+..++..+|+.+|++|
T Consensus 247 ~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999985433211110 223334 778888999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-18 Score=161.99 Aligned_cols=186 Identities=16% Similarity=0.080 Sum_probs=138.0
Q ss_pred CcCceeeecCceEEEEEEeCCCcEEEEEEccccCC---cchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEEEEc
Q 007608 275 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 275 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
.....|++|+||+||.+.. .+.+++.+.+..... .-....|.+|+++++++. |+++.+++++ +..+++|+|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997766 778888887753211 111235889999999995 5778888886 456999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC-CCCcEEEcCCCcEEEeecccccccccc
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL-KAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
+.+.+|...+.. ....++.|++++|.++|+. +|+|||| ||+||+++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999888654321 1135778999999999999 9999999 799999999999999999999865433
Q ss_pred Ccc----e--------eccccccccccCcccccCC-CCC-cccccHHHHHHHHHHHhCCCCCCC
Q 007608 430 LTH----V--------TTQIRGTMGHIAPEYLSTG-KSS-EKTDVFGYGITLLELVTGQRAIDF 479 (596)
Q Consensus 430 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDv~S~Gvil~elltg~~p~~~ 479 (596)
..- . ..-...++.|++|+...-- ..+ ...++++-|.-+|.++|++.+.-.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 210 0 0112256777777754322 222 567999999999999999887653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.1e-18 Score=163.06 Aligned_cols=200 Identities=21% Similarity=0.260 Sum_probs=166.4
Q ss_pred cCCCcCceeeecCceEEEEEE-eCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 349 (596)
-+|.++++||+|.||..+.|+ +-+++.||||.-... ....++..|....+.+. .++|..++.+...+-...+|+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 478889999999999999999 568999999975321 22456778888888875 6888888877777788899999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-----CCcEEEeeccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-----NFEAVLCDFGLAK 424 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~DfGl~~ 424 (596)
.+ |-||.++..-+ ...++..+...+|.|+..-++|+|++ .+|.|||||+|.||.. ...+.++|||+|+
T Consensus 105 LL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 87 56888877653 34688999999999999999999999 9999999999999953 3458999999999
Q ss_pred cccccCcc------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCcc
Q 007608 425 LVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 481 (596)
Q Consensus 425 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~ 481 (596)
.+.+..+. ......||.+||+-....+...+.+-|+=|+|-++.+.+-|..||+.-.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 87654332 1234569999999999999999999999999999999999999998644
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=205.72 Aligned_cols=148 Identities=35% Similarity=0.620 Sum_probs=113.6
Q ss_pred ChhHHHHHHHHHHhccCCCCCCCCCCCCCCCCCCCcceeEeeC-CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCc
Q 007608 33 PDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRN-GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDN 111 (596)
Q Consensus 33 ~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~~w~gv~c~~-~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n 111 (596)
.+.|..||++||+++.+|.+.+.+|+.. ++||.|.||+|++ ++|+.|+|++|+++|.+|+.+..+++|+.| +|++|
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L-~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS--ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTI-NLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC--CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEE-ECCCC
Confidence 4568999999999998888888999754 5677999999974 689999999999999999999999999999 89999
Q ss_pred cccccCCcccC-CCCcccEEEccCccCcC----------------------CCccccccCCCCcEEeCCCCcccccCCcc
Q 007608 112 DLSGTLPDFLG-SMTHLQSLNLANNKFSG----------------------SIPATWSQLSNLKHLDLSSNNLTGRIPMQ 168 (596)
Q Consensus 112 ~l~g~~p~~~~-~l~~L~~L~l~~N~l~g----------------------~~p~~~~~l~~L~~L~l~~N~l~g~iP~~ 168 (596)
+++|.+|..+. ++++|++|||++|+++| .+|..++++++|++|+|++|.+++.+|..
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 99988887765 66666666666666554 55555666666666666666666666654
Q ss_pred cc---ccccccccccccc
Q 007608 169 LF---SVATFNFTGTHLI 183 (596)
Q Consensus 169 l~---~l~~l~~~~n~~~ 183 (596)
+. +|+.|++++|.+.
T Consensus 184 ~~~l~~L~~L~L~~n~l~ 201 (968)
T PLN00113 184 LTNLTSLEFLTLASNQLV 201 (968)
T ss_pred hhhCcCCCeeeccCCCCc
Confidence 43 3455566666543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-19 Score=188.13 Aligned_cols=226 Identities=23% Similarity=0.243 Sum_probs=177.1
Q ss_pred eeeecCceEEEEEE----eCCCcEEEEEEccccCC-cchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEEEEccc
Q 007608 279 IIGQGGFGKVYKGV----LSDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQ 352 (596)
Q Consensus 279 ~lG~G~~g~Vy~~~----~~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 352 (596)
++|+|.||.|+.+. .+.|+.+|+|.+++... .+.......|..++...+ ||.++++...+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999998765 24577899998874321 111224556777888887 9999999999999999999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc
Q 007608 353 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432 (596)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 432 (596)
+|.+...+.. ....+......+...++-+++++|+. +++|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999888875 34566667777888899999999999 9999999999999999999999999999865432221
Q ss_pred eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCC
Q 007608 433 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 512 (596)
Q Consensus 433 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 512 (596)
+||..|||||++. .....+|+||||++++||+||-.||.. +..+..... -.
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~----------~~ 204 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKA----------EL 204 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhh----------cc
Confidence 6899999999998 567889999999999999999999974 111111111 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 007608 513 TYDSKEVETMVQVALLCTQSTPEDRPPM 540 (596)
Q Consensus 513 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 540 (596)
..+.+......++...++..+|..|--.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2456666677788888889999999655
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.5e-18 Score=167.61 Aligned_cols=197 Identities=23% Similarity=0.278 Sum_probs=136.5
Q ss_pred CCCCccceEeEEecC---------------------------CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHH
Q 007608 327 IHKNLLQLIGYCTTS---------------------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 379 (596)
Q Consensus 327 ~H~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 379 (596)
+|||||++.+++.++ ...|+||.-++ -+|..++.. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 599999998876442 24577777665 388888875 345666777889
Q ss_pred HHHHHHHHHHHhCCCCCcEecCCCCCcEEE--cCCC--cEEEeeccccccccccC---c--ceeccccccccccCccccc
Q 007608 380 FGTAYGLEYLHEQCNPKIIHRDLKAANILL--DDNF--EAVLCDFGLAKLVDAKL---T--HVTTQIRGTMGHIAPEYLS 450 (596)
Q Consensus 380 ~~ia~~L~~LH~~~~~~ivH~dlkp~NIll--~~~~--~~kl~DfGl~~~~~~~~---~--~~~~~~~gt~~y~aPE~~~ 450 (596)
.|+++|+.|||.+ +|.|||+|++|||+ |+|. ...|+|||.+-.-+... . ......-|.-..||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 4444 36799999875322211 1 1112234677899999985
Q ss_pred CCC------CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHH
Q 007608 451 TGK------SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQ 524 (596)
Q Consensus 451 ~~~------~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~ 524 (596)
..+ .-.|+|.|+.|-+.||+++...||..- .+..+ +. +. .++ ..+...++..+..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-----Gem~L-~~-r~-Yqe--------~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-----GEMLL-DT-RT-YQE--------SQLPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc-----chhee-ch-hh-hhh--------hhCCCCcccCChHHHH
Confidence 432 146899999999999999999999741 11111 00 00 111 1222334445566778
Q ss_pred HHHHccccCCCCCCCHHHHHHHhc
Q 007608 525 VALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 525 l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
++...++.||++|++..=....|+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 888899999999999876666554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.3e-17 Score=154.34 Aligned_cols=137 Identities=19% Similarity=0.250 Sum_probs=104.9
Q ss_pred CCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-----CCCCccceEeEEecCC---eeE
Q 007608 274 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-----IHKNLLQLIGYCTTSS---ERI 345 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~~~~~~~~---~~~ 345 (596)
+...+.||+|+||.||. +++....+||++.... ....+.+.+|+..++.+ .||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34568999999999996 4433334799886422 23456799999999999 5799999999998874 323
Q ss_pred -EEEEc--ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCcEecCCCCCcEEEcC----CCcEEE
Q 007608 346 -LVYPF--MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL-EYLHEQCNPKIIHRDLKAANILLDD----NFEAVL 417 (596)
Q Consensus 346 -lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl 417 (596)
+|+|| +.+++|.+++.+. .++.. ..++.+++.++ +|||++ +|+||||||+||+++. +..++|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 5579999999752 24444 35677888777 999999 9999999999999974 347999
Q ss_pred eecccc
Q 007608 418 CDFGLA 423 (596)
Q Consensus 418 ~DfGl~ 423 (596)
+||+-+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.8e-18 Score=187.16 Aligned_cols=199 Identities=21% Similarity=0.188 Sum_probs=158.3
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC---CCCccceEeEEecCC
Q 007608 266 ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTSS 342 (596)
Q Consensus 266 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~ 342 (596)
+.+...+.|.+...||+|+||+||+|...+|+.||+|+=+..... +|.--.+++.+++ -+-|..+...+...+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 445556778888999999999999999888999999986543222 2222334444444 234555555566778
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc-------CCCcE
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-------DNFEA 415 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-------~~~~~ 415 (596)
.-++|++|.+.|+|.+++.. .+.++|.....++.|+++-+.+||.. +||||||||+|.+|. +...+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 88999999999999999983 56799999999999999999999999 999999999999994 34458
Q ss_pred EEeeccccccccccC-cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCC
Q 007608 416 VLCDFGLAKLVDAKL-THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 475 (596)
Q Consensus 416 kl~DfGl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~ 475 (596)
+|+|||.+-.+.--. .......++|-.+-.+|...++++++..|.|.++-+++-|+.|+.
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999987553211 123345668889999999999999999999999999999999863
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.5e-17 Score=157.53 Aligned_cols=143 Identities=15% Similarity=0.112 Sum_probs=110.4
Q ss_pred CCCcCceeeecCceEEEEEE--eCCCcEEEEEEccccCCcc-----------------------hHHHHHHHHHHHHhcC
Q 007608 273 NFSESNIIGQGGFGKVYKGV--LSDNTKVAVKRLQDYYSPG-----------------------GEAAFQREVHLISVAI 327 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~l~~~~~~~-----------------------~~~~~~~e~~~l~~l~ 327 (596)
.|.+.+.||+|+||.||+|. ..+|+.||+|+++...... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47778999999999999998 5689999999987432100 1123568999999997
Q ss_pred CCC--ccceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-cEecCCCC
Q 007608 328 HKN--LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK-IIHRDLKA 404 (596)
Q Consensus 328 H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~dlkp 404 (596)
+.. +.+++++ ...++||||+++.++...... ...........++.|++.++.+||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 633 3344433 235899999999887665422 22355566788999999999999999 8 99999999
Q ss_pred CcEEEcCCCcEEEeecccccccc
Q 007608 405 ANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 405 ~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 7899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.1e-16 Score=152.10 Aligned_cols=135 Identities=21% Similarity=0.246 Sum_probs=113.4
Q ss_pred ceeeecCceEEEEEEeCCCcEEEEEEccccCCc-------chHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-------GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+.||+|++|.||+|.. +|..+++|+....... .....+.+|+.++..+.|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 7778999976532211 1124578899999999999998877777777888999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+++++|.+.+... .+ .+..++.+++.+|.++|+. +++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988642 12 7889999999999999999 999999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-16 Score=150.52 Aligned_cols=146 Identities=21% Similarity=0.137 Sum_probs=112.0
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCc---------------------chHHHHHHHHHHHH
Q 007608 266 ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP---------------------GGEAAFQREVHLIS 324 (596)
Q Consensus 266 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---------------------~~~~~~~~e~~~l~ 324 (596)
++......|...+.||+|+||.||++..++|+.||||++...... .....+..|+..+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 444444447778999999999999999888999999987532100 01123677888899
Q ss_pred hcCCCC--ccceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC
Q 007608 325 VAIHKN--LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 402 (596)
Q Consensus 325 ~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl 402 (596)
.+.|++ +.+.++ ....++||||+++++|...... .....++.+++.++.++|+. +++||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 988874 444443 2455899999999988764321 23457889999999999998 9999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccc
Q 007608 403 KAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 403 kp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+||++++++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.2e-16 Score=148.50 Aligned_cols=131 Identities=20% Similarity=0.274 Sum_probs=107.0
Q ss_pred eeeecCceEEEEEEeCCCcEEEEEEccccC-Cc-c-----hHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 279 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SP-G-----GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 279 ~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~-~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
.||+|+||.||+|.. ++..+++|...... .. . ....+.+|++++..+.|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 67889999865321 11 1 1255778999999999988766666666677789999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
++++|.+.+.... . .++.+++.+|.++|+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875411 0 7899999999999999 999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.1e-16 Score=170.79 Aligned_cols=139 Identities=20% Similarity=0.270 Sum_probs=112.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEE-ccccCCc------chHHHHHHHHHHHHhcCCCCccceEeEEecCCe
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKR-LQDYYSP------GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~-l~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 343 (596)
...|...+.||+|+||+||+|.+.+.. +++|+ +...... .....+.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566889999999999999875444 33333 2221111 123568899999999999999988888887778
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||+++++|.+++. ....++.+++.+|.|||+. +++||||||+||++ +++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999988875 2467899999999999999 99999999999999 5779999999998
Q ss_pred ccc
Q 007608 424 KLV 426 (596)
Q Consensus 424 ~~~ 426 (596)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.1e-17 Score=167.74 Aligned_cols=123 Identities=27% Similarity=0.359 Sum_probs=106.9
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++.|+++...+|.+|+..... ....+|...+.++.|++.|+.| + +.+|+|+||.||+...+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 36789999999999999985443 3457888999999999999999 5 899999999999999999999999999
Q ss_pred cccccccC-----cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh
Q 007608 423 AKLVDAKL-----THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472 (596)
Q Consensus 423 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt 472 (596)
........ ....+...||..||+||.+.+.+|+.|+||||+|+|++|+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 98776544 223344569999999999999999999999999999999997
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.2e-16 Score=171.11 Aligned_cols=216 Identities=25% Similarity=0.302 Sum_probs=144.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
..++|+.++.|-.|+||.||.++++ ..+++|+| +++. ..+.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq------~lilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQ------NLILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-cccc------chhhhc--cccccCCccee----------------
Confidence 3568888999999999999999976 45678884 3321 001110 22222233332
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
|+=...++.. ..++. +.+.+++|||+. +|+|||+||+|.+++.-|++|++|||+++....
T Consensus 136 -----gDc~tllk~~----g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 -----GDCATLLKNI----GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred -----chhhhhcccC----CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 3333334331 12222 227789999999 999999999999999999999999999875321
Q ss_pred cC------------c--ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHH
Q 007608 429 KL------------T--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 494 (596)
Q Consensus 429 ~~------------~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~ 494 (596)
.. . ....+++||+.|+|||++....|....|+|++|+|+||.+-|..||..+..++.-+..+.+.+
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 275 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence 10 0 112357899999999999999999999999999999999999999987544332222111111
Q ss_pred HHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 495 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.+ .+ ..+....+..+++.+.++.+|..|--.....+
T Consensus 276 ------~w-pE--------~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 276 ------EW-PE--------EDEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred ------cc-cc--------cCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 00 11 11223346777788889999999954444433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-14 Score=131.47 Aligned_cols=135 Identities=19% Similarity=0.159 Sum_probs=113.8
Q ss_pred cCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCC--CCccceEeEEecCCeeEEEEEcccC
Q 007608 276 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 276 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++.+++++....+..++++||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35789999999999999854 7899998864322 5678899999999987 5888999888888889999999998
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+.+... +......++.+++++++++|.....+++|+|++|+||++++++.+++.|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 766433 5566778899999999999986545799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-14 Score=136.43 Aligned_cols=137 Identities=22% Similarity=0.250 Sum_probs=97.6
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEccccCCc-chHHH----------------------HHHHHHHHHhcCCCC--c
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-GGEAA----------------------FQREVHLISVAIHKN--L 331 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~----------------------~~~e~~~l~~l~H~n--i 331 (596)
.+.||+|+||+||+|...+++.||||+++..... ..... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999988642211 11111 134555555554432 3
Q ss_pred cceEeEEecCCeeEEEEEcccCCChhh-hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCcEEE
Q 007608 332 LQLIGYCTTSSERILVYPFMQNLSVAY-RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILL 409 (596)
Q Consensus 332 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll 409 (596)
.+.++. ...++||||++++++.. .+.... .. .....++.+++.++.++|. . +++|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 344332 24589999999865432 122111 11 5577899999999999999 7 99999999999999
Q ss_pred cCCCcEEEeecccccccc
Q 007608 410 DDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 410 ~~~~~~kl~DfGl~~~~~ 427 (596)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=8.2e-14 Score=136.02 Aligned_cols=137 Identities=17% Similarity=0.151 Sum_probs=105.5
Q ss_pred Cceee-ecCceEEEEEEeCCCcEEEEEEccccC------------CcchHHHHHHHHHHHHhcCCCCc--cceEeEEecC
Q 007608 277 SNIIG-QGGFGKVYKGVLSDNTKVAVKRLQDYY------------SPGGEAAFQREVHLISVAIHKNL--LQLIGYCTTS 341 (596)
Q Consensus 277 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~l~~~~------------~~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~~ 341 (596)
...|| .|+.|+||.+.. ++..++||++.... +......+.+|++++.++.|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 899999999988 47789998874310 11234567889999999998875 6677665433
Q ss_pred C----eeEEEEEcccC-CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEE
Q 007608 342 S----ERILVYPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 342 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 416 (596)
. ..++|+||+++ .+|.+++.. ..++.. .+.+++.++.+||+. +|+|+||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 22599999997 688888754 234432 367899999999999 999999999999999988999
Q ss_pred Eeeccccccc
Q 007608 417 LCDFGLAKLV 426 (596)
Q Consensus 417 l~DfGl~~~~ 426 (596)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.3e-15 Score=161.67 Aligned_cols=255 Identities=21% Similarity=0.251 Sum_probs=185.7
Q ss_pred cCCCcCceeeecCceEEEEEEeCC--CcEEEEEEccccC-CcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSD--NTKVAVKRLQDYY-SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 347 (596)
..|...+.||+|+|+.|-...... ...+|+|.+.... +.........|..+-..+. |+|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456667789999999998887543 4456666654321 2233344455777777776 99999999999999999999
Q ss_pred EEcccCCChhhhh-cccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCcEecCCCCCcEEEcCCC-cEEEeeccccc
Q 007608 348 YPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTAYGLEYLH-EQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAK 424 (596)
Q Consensus 348 ~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfGl~~ 424 (596)
.+|..++++.+-+ +. .....+-.....++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccC---CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999988877 32 1124556677889999999999999 76 999999999999999999 99999999998
Q ss_pred cccc--cCcceeccccc-cccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 425 LVDA--KLTHVTTQIRG-TMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 425 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
.+.. +.........| ++.|+|||...+. -.....|+||.|+++.-+++|..|++....... ....|....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---~~~~~~~~~--- 247 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---RYSSWKSNK--- 247 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---cceeecccc---
Confidence 7765 22233344567 9999999999885 446778999999999999999999986543221 111111110
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+..-............++...++..+|+.|.+.+++..
T Consensus 248 -------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 -------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00000112223345566777888899999999888744
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.6e-14 Score=136.70 Aligned_cols=205 Identities=20% Similarity=0.292 Sum_probs=144.3
Q ss_pred HHHHHhcCCCCccceEeEEecC-----CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 007608 320 VHLISVAIHKNLLQLIGYCTTS-----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 394 (596)
Q Consensus 320 ~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 394 (596)
+.-+-++.|.|||++..|+.+. ....++.|||..|++..+|++.+.....+......++..||..||.|||+ |.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 4456667799999999888654 34688999999999999999877777778888889999999999999998 68
Q ss_pred CCcEecCCCCCcEEEcCCCcEEEeeccccccccccC----cceeccccccccccCcccccCCCCCcccccHHHHHHHHHH
Q 007608 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL----THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 470 (596)
Q Consensus 395 ~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~el 470 (596)
|+|+|+++..+-|++..++-+|++--- ........ ........+.++|.+||+-...+.+..+|||+||...+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 899999999999999999988875321 11111100 0111122367899999998888889999999999999999
Q ss_pred HhCCCC-CCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 471 VTGQRA-IDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 471 ltg~~p-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
..+.-- ........ ...-+..... .+..-++ ..++..|++..|..||+|.+++.+.
T Consensus 276 ailEiq~tnseS~~~-----~ee~ia~~i~--~len~lq--------------r~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNSESKVE-----VEENIANVII--GLENGLQ--------------RGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCCCcceee-----hhhhhhhhee--eccCccc--------------cCcCcccccCCCCCCcchhhhhcCc
Confidence 877643 21111000 0000110000 0000011 1345579999999999999987753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.8e-13 Score=139.93 Aligned_cols=143 Identities=22% Similarity=0.227 Sum_probs=99.8
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEccccCCcch---------------------------------------HHHHH
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGG---------------------------------------EAAFQ 317 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~---------------------------------------~~~~~ 317 (596)
.+.||.|++|.||+|++++|+.||||+.+......- +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 468999999999999999999999999864211100 01244
Q ss_pred HHHHHHHhcC----CCCccceEeEE-ecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 007608 318 REVHLISVAI----HKNLLQLIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-GLEYLHE 391 (596)
Q Consensus 318 ~e~~~l~~l~----H~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~ 391 (596)
+|...+.++. |.+-+.+-..+ ......++||||++|+++.+....... .. .+..++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh
Confidence 4555444442 33323322222 234567999999999999887653111 12 23456666666 4678888
Q ss_pred CCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 392 ~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
. +++|+|+||.||++++++.+++.|||++..+..
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.1e-13 Score=121.53 Aligned_cols=104 Identities=28% Similarity=0.514 Sum_probs=95.0
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|.|++|+|+ .+|+.++.|.+|+.| +++||+++ .+|.++++|++|+.|+++-|++. .+|..||.++.|+.||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevl-n~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVL-NLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhh-hcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 47899999999999 999999999999999 99999999 99999999999999999999999 9999999999999999
Q ss_pred CCCCcccc-cCCcccccc---ccccccccccc
Q 007608 156 LSSNNLTG-RIPMQLFSV---ATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g-~iP~~l~~l---~~l~~~~n~~~ 183 (596)
|++|+++. .+|..|+-+ ..|+++.|.+.
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe 140 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE 140 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc
Confidence 99999974 578887755 45678887663
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.2e-12 Score=134.98 Aligned_cols=146 Identities=21% Similarity=0.205 Sum_probs=93.0
Q ss_pred cCCCcCceeeecCceEEEEEEeCC-CcEEEEEEccccCCc---------------------------------chHH---
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSP---------------------------------GGEA--- 314 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~---------------------------------~~~~--- 314 (596)
..|+. +.||+|++|+||+|++++ |+.||||+.+....+ ...+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 789999999999999887 999999998643110 0011
Q ss_pred ---HHHHHHHHHHhcC----CCCccceEeEEec-CCeeEEEEEcccCCChhhhh--cccCCCCCCCCHHHHHHHHHHHHH
Q 007608 315 ---AFQREVHLISVAI----HKNLLQLIGYCTT-SSERILVYPFMQNLSVAYRL--RDLKPGEKGLDWPTRKRVAFGTAY 384 (596)
Q Consensus 315 ---~~~~e~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia~ 384 (596)
+|.+|...+.+++ +.+.+.+-.++.+ ....++||||++|+.+.+.- .........+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 2334444444332 3333333333332 45678999999999997642 211000001222222222333
Q ss_pred HHHHHHhCCCCCcEecCCCCCcEEEcCCC----cEEEeeccccccccc
Q 007608 385 GLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDFGLAKLVDA 428 (596)
Q Consensus 385 ~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~DfGl~~~~~~ 428 (596)
+... |++|+|+||.||+++.++ .+++.|||++..++.
T Consensus 276 ----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3345 999999999999999888 999999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.1e-11 Score=110.80 Aligned_cols=130 Identities=20% Similarity=0.131 Sum_probs=95.7
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccc-eEeEEecCCeeEEEEEcccCCC
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ-LIGYCTTSSERILVYPFMQNLS 355 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~~~~~~~lv~e~~~~gs 355 (596)
.+.++.|.++.||++... +..+++|....... ....+.+|+..+..+.+.++++ ++.+. ....++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 456889999999999874 77899998754321 2345678999999887666554 44332 334589999999987
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 356 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC--NPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
+... . .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 78 l~~~--~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE--D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6543 0 011345678999999999872 12369999999999999 5689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3e-10 Score=120.22 Aligned_cols=233 Identities=16% Similarity=0.158 Sum_probs=152.6
Q ss_pred eCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCH
Q 007608 293 LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW 372 (596)
Q Consensus 293 ~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 372 (596)
..++.+|.|...+.... .......+.++.++.++||||++++.....++..|+|+|-+. .|..++.... -
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-------~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-------K 103 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-------H
Confidence 34788888888764333 334556788999999999999999999999999999999875 5666666522 3
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceeccccccccccCcccccCC
Q 007608 373 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 452 (596)
Q Consensus 373 ~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 452 (596)
......+.||+.||.|||+.| +++|++|.-.-|+++..|+.||++|-++........ ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 444556889999999999877 899999999999999999999999998764432211 00111112245666655332
Q ss_pred CCCcccccHHHHHHHHHHHhCCCCCCCc-cchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccc
Q 007608 453 KSSEKTDVFGYGITLLELVTGQRAIDFS-RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQ 531 (596)
Q Consensus 453 ~~~~~sDv~S~Gvil~elltg~~p~~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~ 531 (596)
. -..|.|-||++++|++.|..+.... ...............+..... ...... .++++..|..
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~-------------~~~r~n-~~~~~~~~~~ 244 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGAT-------------ELKRPN-KLRFILECRL 244 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhccc-------------cccccc-hhhHHHHHHh
Confidence 2 3469999999999999993322211 000011111111111111000 000111 4566667777
Q ss_pred cCCCCCCCHHHHHHHhccCCcch
Q 007608 532 STPEDRPPMAQVVKMLQGEDLAE 554 (596)
Q Consensus 532 ~dP~~RPs~~evl~~L~~~~~~~ 554 (596)
..+--|=.+-+++..|++..+.+
T Consensus 245 ~~gff~n~fvd~~~fLeel~lks 267 (690)
T KOG1243|consen 245 LGGFFRNDFVDTLLFLEELRLKS 267 (690)
T ss_pred ccccccchHHHHHHHHHhcccCc
Confidence 77777777888888887766654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.7e-11 Score=133.37 Aligned_cols=90 Identities=30% Similarity=0.522 Sum_probs=83.2
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccC-CCCcEE
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQL-SNLKHL 154 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~~L~~L 154 (596)
.+|+.|+|++|+|+|.+|+.++.|++|+.| +|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..++++ .++..+
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L-dLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l 520 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVL-DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEE-ECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence 589999999999999999999999999999 999999999999999999999999999999999999998874 578899
Q ss_pred eCCCCcccccCC
Q 007608 155 DLSSNNLTGRIP 166 (596)
Q Consensus 155 ~l~~N~l~g~iP 166 (596)
++++|......|
T Consensus 521 ~~~~N~~lc~~p 532 (623)
T PLN03150 521 NFTDNAGLCGIP 532 (623)
T ss_pred EecCCccccCCC
Confidence 999998664454
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.7e-11 Score=123.52 Aligned_cols=248 Identities=21% Similarity=0.166 Sum_probs=173.6
Q ss_pred CCCcCceeee--cCceEEEEEEe---CCCcEEEEEEccccCC-cchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeE
Q 007608 273 NFSESNIIGQ--GGFGKVYKGVL---SDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 273 ~f~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~ 345 (596)
.|.....+|. |.+|.||.+.. .++..+|+|+-+...+ +.....=.+|+....+++ |+|.++........+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3555678899 99999999987 3688899998543222 222223345666666664 999999877888888888
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCcEecCCCCCcEEEcCC-CcEEEeec
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDF 420 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Df 420 (596)
+-.|++. .++..+.+... ..++....+.+..+..+ |+.++|+. .++|-|+||.||+...+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 8889886 57777766422 23555667777777777 99999999 99999999999999999 88999999
Q ss_pred cccccccccCcce----eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH
Q 007608 421 GLAKLVDAKLTHV----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 421 Gl~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
|+...+....... .....|...|++||...+ -++.++|+|++|.+..+..++......... ..|..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~~- 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWSQ- 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC--------CCccc-
Confidence 9998776543221 222357788999998854 568889999999999999998766543211 01111
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.+... +-+. +...-...+.....++++.+|..|++.+.+..
T Consensus 338 -~r~~~---ip~e----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -LRQGY---IPLE----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccccc---Cchh----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00100 0010 11112233444778899999999999887754
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.3e-12 Score=112.22 Aligned_cols=96 Identities=26% Similarity=0.432 Sum_probs=79.6
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCc-CCCccccccCCCCcEEe
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS-GSIPATWSQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~-g~~p~~~~~l~~L~~L~ 155 (596)
+++.|++.+|++. .+|.+++.|++|+.| +++-|++. .+|..||.++.|+.|||.+|+++ ..+|..|..|+.|+.|+
T Consensus 57 nlevln~~nnqie-~lp~~issl~klr~l-nvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly 133 (264)
T KOG0617|consen 57 NLEVLNLSNNQIE-ELPTSISSLPKLRIL-NVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY 133 (264)
T ss_pred hhhhhhcccchhh-hcChhhhhchhhhhe-ecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence 7888999999998 899999999999999 99999999 89999999999999999999886 34677777777777777
Q ss_pred CCCCcccccCCcccccccccc
Q 007608 156 LSSNNLTGRIPMQLFSVATFN 176 (596)
Q Consensus 156 l~~N~l~g~iP~~l~~l~~l~ 176 (596)
|+.|.|. -+|+.+++|+.|+
T Consensus 134 l~dndfe-~lp~dvg~lt~lq 153 (264)
T KOG0617|consen 134 LGDNDFE-ILPPDVGKLTNLQ 153 (264)
T ss_pred hcCCCcc-cCChhhhhhccee
Confidence 7777777 7777666555444
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.9e-10 Score=106.89 Aligned_cols=144 Identities=18% Similarity=0.208 Sum_probs=109.4
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCC--CCccceEeEEecCC---eeEEEEEcc
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSS---ERILVYPFM 351 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~---~~~lv~e~~ 351 (596)
.+.|+.|.++.||++...+|..+++|.............+.+|.+++..+.+ .++.+++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 3578999999999999877789999987643322235578899999999876 34567777766542 568999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-------------------------------------- 393 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 393 (596)
++.++.+.+.. ..++......++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99887765431 23666777788888888888888421
Q ss_pred ---------------CCCcEecCCCCCcEEEcC--CCcEEEeecccccc
Q 007608 394 ---------------NPKIIHRDLKAANILLDD--NFEAVLCDFGLAKL 425 (596)
Q Consensus 394 ---------------~~~ivH~dlkp~NIll~~--~~~~kl~DfGl~~~ 425 (596)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.4e-09 Score=101.77 Aligned_cols=137 Identities=18% Similarity=0.205 Sum_probs=98.1
Q ss_pred ceeeecCceEEEEEEeCC-------CcEEEEEEccccC------------C---------cchHHHHH----HHHHHHHh
Q 007608 278 NIIGQGGFGKVYKGVLSD-------NTKVAVKRLQDYY------------S---------PGGEAAFQ----REVHLISV 325 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~------------~---------~~~~~~~~----~e~~~l~~ 325 (596)
-.||.|.-+.||.|...+ +..+|||+.+... . ......+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 4789999874210 0 11123344 79999988
Q ss_pred cCC--CCccceEeEEecCCeeEEEEEcccCCChh-hhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEecC
Q 007608 326 AIH--KNLLQLIGYCTTSSERILVYPFMQNLSVA-YRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL-HEQCNPKIIHRD 401 (596)
Q Consensus 326 l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~d 401 (596)
+.. -++.+.+++ ...++||||+.+..+. ..+.+ ..++......+..+++.+|..+ |.. +++|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 863 455566653 5678999999765332 12322 1234455667889999999999 777 999999
Q ss_pred CCCCcEEEcCCCcEEEeecccccccc
Q 007608 402 LKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 402 lkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|++.||++++ +.+.|+|||.+-..+
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 579999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.6e-11 Score=123.56 Aligned_cols=247 Identities=18% Similarity=0.187 Sum_probs=171.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEe--CCCcEEEEEEccccCCcchHH-HHHHHHHHHHhc-CCCCccceEeEEecCCeeE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL--SDNTKVAVKRLQDYYSPGGEA-AFQREVHLISVA-IHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~-~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 345 (596)
-..+|..+..||.|.|+.|++... .++..|++|.+.+.......+ .-..|+.+...+ .|.+++.....+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 455788899999999999999874 368889999887543322222 224455555554 4888888766666666777
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC-CcEEEeeccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAK 424 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfGl~~ 424 (596)
+=-||++++++.....- ...++...++++..|++.++.++|+. .++|+|+||+||++..+ +.-+++|||.+.
T Consensus 343 ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 88899999988766632 34567778899999999999999998 99999999999999886 788999999987
Q ss_pred cccccCcceecccccccccc--CcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 425 LVDAKLTHVTTQIRGTMGHI--APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
.+.-. .......-++. +++......+..+.|+||||.-+.|.+++..--.... .|.. ++.+.
T Consensus 416 ~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------~~~~--i~~~~ 479 (524)
T KOG0601|consen 416 RLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------QSLT--IRSGD 479 (524)
T ss_pred cccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc----------ccee--eeccc
Confidence 42211 11111233334 5555666778899999999999999999875332110 0110 11111
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
....+ ....++..+...+...++..||.+.+...+.+
T Consensus 480 --------~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 480 --------TPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred --------ccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11111 11255666677788999999999988876654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.3e-09 Score=93.60 Aligned_cols=132 Identities=21% Similarity=0.309 Sum_probs=98.0
Q ss_pred ceeeecCceEEEEEEeCCCcEEEEEE-ccccCCcch------HHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 278 NIIGQGGFGKVYKGVLSDNTKVAVKR-LQDYYSPGG------EAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~~~~vavK~-l~~~~~~~~------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
..+++|+-+.+|.+.+.+. .+.+|. +.+.+.... ...-.+|..++.+++--.|.--+=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999977443 355553 333222111 23356788888888755555545567788888999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+++-.|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888752 245667777778889999 999999999999998874 99999999874
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.1e-11 Score=117.94 Aligned_cols=100 Identities=24% Similarity=0.390 Sum_probs=62.3
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccC-CCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLG-SMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
++..|+|.+|+|. .+| +|..+..|..| .++.|+|. .+|.+.+ +|.+|.+|||..|++. ++|+++.-|.+|..||
T Consensus 207 ~L~~LyL~~Nki~-~lP-ef~gcs~L~El-h~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLD 281 (565)
T KOG0472|consen 207 SLELLYLRRNKIR-FLP-EFPGCSLLKEL-HVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLD 281 (565)
T ss_pred hhHHHHhhhcccc-cCC-CCCccHHHHHH-HhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhc
Confidence 3444455555555 444 55555555555 55555555 5555555 5677777777777777 7777777777777777
Q ss_pred CCCCcccccCCcccccc--cccccccccc
Q 007608 156 LSSNNLTGRIPMQLFSV--ATFNFTGTHL 182 (596)
Q Consensus 156 l~~N~l~g~iP~~l~~l--~~l~~~~n~~ 182 (596)
||+|.++ .+|.+++++ ..|.+.|||+
T Consensus 282 lSNN~is-~Lp~sLgnlhL~~L~leGNPl 309 (565)
T KOG0472|consen 282 LSNNDIS-SLPYSLGNLHLKFLALEGNPL 309 (565)
T ss_pred ccCCccc-cCCcccccceeeehhhcCCch
Confidence 7777777 677766654 4455566664
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.3e-10 Score=103.78 Aligned_cols=100 Identities=28% Similarity=0.440 Sum_probs=39.6
Q ss_pred CEEEEEcCCCCCCcccCcchh-hhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCcccc-ccCCCCcEE
Q 007608 77 NVISLTLGSNGFSGKISPSIT-KLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATW-SQLSNLKHL 154 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~-~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~L 154 (596)
++++|+|.+|.|+ .|. .++ .|.+|+.| +|++|+|+ .++ .+..|++|++|+|++|+|+ .++..+ ..+++|+.|
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L-~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVL-DLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp ------------------S--TT-TT--EE-E-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEE-ECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 6889999999998 664 566 68899999 99999999 676 5888999999999999999 787655 479999999
Q ss_pred eCCCCcccccCCc-----cccccccccccccccc
Q 007608 155 DLSSNNLTGRIPM-----QLFSVATFNFTGTHLI 183 (596)
Q Consensus 155 ~l~~N~l~g~iP~-----~l~~l~~l~~~~n~~~ 183 (596)
+|++|+|. .+-. .+.+|..|++.|||..
T Consensus 94 ~L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 94 YLSNNKIS-DLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp E-TTS----SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ECcCCcCC-ChHHhHHHHcCCCcceeeccCCccc
Confidence 99999998 4432 3456778889999873
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.96 E-value=7.7e-11 Score=116.67 Aligned_cols=106 Identities=25% Similarity=0.379 Sum_probs=78.2
Q ss_pred eeCCCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccc-cccCCCC
Q 007608 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNL 151 (596)
Q Consensus 73 c~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L 151 (596)
|...+++.|+|++|-|. .+|.+++.+..|+.| ++++|+|. .+|..+..+..|+.+-.++|++. .+|++ +.+|.+|
T Consensus 432 ~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~L-nlS~NrFr-~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL 507 (565)
T KOG0472|consen 432 SQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTL-NLSFNRFR-MLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNL 507 (565)
T ss_pred Hhhhcceeeecccchhh-hcchhhhhhhhhhee-cccccccc-cchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhc
Confidence 44456666777776666 677777777667777 67777776 66666666666666666666776 66655 8999999
Q ss_pred cEEeCCCCcccccCCcccccc---ccccccccccc
Q 007608 152 KHLDLSSNNLTGRIPMQLFSV---ATFNFTGTHLI 183 (596)
Q Consensus 152 ~~L~l~~N~l~g~iP~~l~~l---~~l~~~~n~~~ 183 (596)
++|||.+|.+. .||+.++++ .+|.+.||++-
T Consensus 508 ~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 508 TTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 99999999999 999988765 56789999774
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1e-10 Score=121.45 Aligned_cols=101 Identities=30% Similarity=0.446 Sum_probs=51.6
Q ss_pred EEEEEcCCCCCCc-ccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccc-cccCCCCcEEe
Q 007608 78 VISLTLGSNGFSG-KISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKHLD 155 (596)
Q Consensus 78 l~~L~l~~n~l~g-~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~ 155 (596)
++.+++.+|+|.. -||+.|.+|..|+.| |||+|+|. +.|..+-.-+++-+|+||+|+|. +||.. +.+|+-|-+||
T Consensus 80 LRsv~~R~N~LKnsGiP~diF~l~dLt~l-DLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLD 156 (1255)
T KOG0444|consen 80 LRSVIVRDNNLKNSGIPTDIFRLKDLTIL-DLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLD 156 (1255)
T ss_pred hHHHhhhccccccCCCCchhcccccceee-ecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhc
Confidence 4444444554432 245555555555555 55555555 55555555555555555555555 55543 34555555555
Q ss_pred CCCCcccccCCccc---ccccccccccccc
Q 007608 156 LSSNNLTGRIPMQL---FSVATFNFTGTHL 182 (596)
Q Consensus 156 l~~N~l~g~iP~~l---~~l~~l~~~~n~~ 182 (596)
||+|++. .+|+.+ ..|++|.+++||+
T Consensus 157 LS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL 185 (1255)
T KOG0444|consen 157 LSNNRLE-MLPPQIRRLSMLQTLKLSNNPL 185 (1255)
T ss_pred cccchhh-hcCHHHHHHhhhhhhhcCCChh
Confidence 5555555 555443 2344555555554
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.1e-10 Score=119.15 Aligned_cols=102 Identities=34% Similarity=0.564 Sum_probs=73.5
Q ss_pred CEEEEEcCCCCCCcccCcc-hhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCc-----------------
Q 007608 77 NVISLTLGSNGFSGKISPS-ITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS----------------- 138 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~-~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~----------------- 138 (596)
+...|+|++|+|. +||.. +.+|+.|-.| |||+|+|. .+|+.+..|..|++|+||+|.|.
T Consensus 127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfL-DLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLh 203 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFL-DLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLH 203 (1255)
T ss_pred CcEEEEcccCccc-cCCchHHHhhHhHhhh-ccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhh
Confidence 6677888888887 67754 5678888888 88888888 78888888888888888887543
Q ss_pred --------CCCccccccCCCCcEEeCCCCcccccCCccccc---ccccccccccc
Q 007608 139 --------GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS---VATFNFTGTHL 182 (596)
Q Consensus 139 --------g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l~~---l~~l~~~~n~~ 182 (596)
..+|.++..|.+|..+|||.|++. .+|..+.+ |..|++++|.+
T Consensus 204 ms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~i 257 (1255)
T KOG0444|consen 204 MSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKI 257 (1255)
T ss_pred cccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCce
Confidence 346777777777777777777777 77766543 34455666553
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.1e-08 Score=101.92 Aligned_cols=219 Identities=15% Similarity=0.135 Sum_probs=148.3
Q ss_pred ceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec----CCeeEEEEEcccCC-Chhh
Q 007608 285 FGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERILVYPFMQNL-SVAY 358 (596)
Q Consensus 285 ~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~~g-sL~~ 358 (596)
..+.||++. .||..|++|+++....... ..-..-++..+++.|+|+|++..++.. +...++||+|.++. +|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 467899984 4899999999953322211 112355788999999999999987753 34678999999864 4544
Q ss_pred hhcccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 359 RLRDLK-----------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 359 ~l~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
.-.... ..+...++...|.++.|+..||.++|+. |+..+-|.+++|+++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 332211 1224577889999999999999999999 99999999999999999999999999887665
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.+.. |-+.+ -.+-|.=.||.+++.|.||..---..+. ......+.
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~---~~~s~~~~-------------- 489 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDS---TQSSHLTR-------------- 489 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccc---hHHHHHHH--------------
Confidence 4431 11111 2356888999999999998533111000 00000111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.......++.+++.......+++ -+..+++.++-+
T Consensus 490 ------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~ 524 (655)
T KOG3741|consen 490 ------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGS 524 (655)
T ss_pred ------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence 12234445556666666667766 577777766543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.1e-10 Score=125.05 Aligned_cols=249 Identities=16% Similarity=0.168 Sum_probs=165.6
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
...+.+.+.+-+-+|.++.+..+.-. .|...+.|..... ......+....+-.++...+||.++....-+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 35567777788889999999887632 3444444443211 01111222233333333344566665443334456678
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+|++|..+++|...|+... ..+..........+..+++|||.. .+.|+|++|.|.+...++..+++|||....
T Consensus 881 L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 9999999999999988643 344444456667788899999998 799999999999999999999999984322
Q ss_pred cc---------------------ccCc---------ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCC
Q 007608 426 VD---------------------AKLT---------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 475 (596)
Q Consensus 426 ~~---------------------~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~ 475 (596)
.. .... .......||+.|.+||...+......+|+|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 11 0000 01123558999999999999999999999999999999999999
Q ss_pred CCCCccchhhhhchHHHHHHHHhccCcccccccC--cCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007608 476 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR--NLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 541 (596)
Q Consensus 476 p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~--~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 541 (596)
||.....+.. ++ .+... .....+.....+..+++...+..+|.+|-.|.
T Consensus 1034 p~na~tpq~~--------f~---------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQI--------FE---------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhh--------hh---------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9985433211 11 11111 11223444555666777778889999997776
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.4e-10 Score=122.98 Aligned_cols=112 Identities=29% Similarity=0.474 Sum_probs=97.8
Q ss_pred CCCCCcceeEeeCCCEEEEEcCCCCCCcccCc-chhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCC
Q 007608 63 SPCFSWSHVTCRNGNVISLTLGSNGFSGKISP-SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 141 (596)
Q Consensus 63 ~~c~~w~gv~c~~~~l~~L~l~~n~l~g~~p~-~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~ 141 (596)
+.| |+-..|- .+|+.|+|++|+|. .+|+ .+.+|..|+.| +||+|+|+ .||.++.++..|++|...+|+|. .+
T Consensus 373 d~c--~p~l~~~-~hLKVLhLsyNrL~-~fpas~~~kle~LeeL-~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~f 445 (1081)
T KOG0618|consen 373 DSC--FPVLVNF-KHLKVLHLSYNRLN-SFPASKLRKLEELEEL-NLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SF 445 (1081)
T ss_pred ccc--hhhhccc-cceeeeeecccccc-cCCHHHHhchHHhHHH-hcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ec
Confidence 456 6655543 38999999999998 6775 68999999999 99999999 99999999999999999999999 99
Q ss_pred ccccccCCCCcEEeCCCCccc-ccCCccc--ccccccccccccc
Q 007608 142 PATWSQLSNLKHLDLSSNNLT-GRIPMQL--FSVATFNFTGTHL 182 (596)
Q Consensus 142 p~~~~~l~~L~~L~l~~N~l~-g~iP~~l--~~l~~l~~~~n~~ 182 (596)
| ++.+++.|+.+|||.|+|+ +.+|..+ .+|+.|+++||.+
T Consensus 446 P-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 446 P-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred h-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9 9999999999999999998 3345444 4789999999985
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=3e-08 Score=89.19 Aligned_cols=143 Identities=20% Similarity=0.252 Sum_probs=102.5
Q ss_pred cCceeeecCceEEEEEEeCCCcEEEEEE-ccccC-Ccc-----hHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 276 ESNIIGQGGFGKVYKGVLSDNTKVAVKR-LQDYY-SPG-----GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 276 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~-l~~~~-~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
....+-+|+-+.|+++.+ .|+...||. +.+.+ .+. ......+|+..+.++.--.|.--.-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467889999999999998 566666664 32222 111 2345678999999887555554444666777778999
Q ss_pred EcccC-CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC---cEEEeeccccc
Q 007608 349 PFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAK 424 (596)
Q Consensus 349 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~DfGl~~ 424 (596)
||+++ .++.+++...... ...-.....++..|-+.+.-||.. +|+||||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99986 3677777653321 222223367888899999999999 999999999999996554 35899999975
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=9.2e-08 Score=94.56 Aligned_cols=142 Identities=13% Similarity=0.042 Sum_probs=100.4
Q ss_pred ceeeecCceEEEEEEeCCCcEEEEEEccccCCc----------chHHHHHHHHHHHHhcCCCC--ccceEeEEec-----
Q 007608 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP----------GGEAAFQREVHLISVAIHKN--LLQLIGYCTT----- 340 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~----- 340 (596)
+.+-......|+++.+ +|+.+.||+....... .....+.+|...+.++...+ ..+.+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455777666 6788999976432100 11124778999888885333 3455556543
Q ss_pred CCeeEEEEEcccCC-ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-------C
Q 007608 341 SSERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-------N 412 (596)
Q Consensus 341 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-------~ 412 (596)
....++|+|++++. +|.+++.+... ...+......++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999986 78888754221 2345567778999999999999999 9999999999999975 5
Q ss_pred CcEEEeecccccc
Q 007608 413 FEAVLCDFGLAKL 425 (596)
Q Consensus 413 ~~~kl~DfGl~~~ 425 (596)
..+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998863
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=8e-10 Score=114.33 Aligned_cols=104 Identities=23% Similarity=0.340 Sum_probs=81.8
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCcc---ccccCCCCcE
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA---TWSQLSNLKH 153 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~---~~~~l~~L~~ 153 (596)
+|.+|+|++|+|+..-+.+|..|..|+.| +|++|+++-.--..|..+++|+.|||++|.|++.|-+ .|..|++|+.
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~L-nLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEEL-NLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhh-cccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 78999999999996556688889999999 8999988844446677888888888888888877754 3677888888
Q ss_pred EeCCCCcccccCCc----ccccccccccccccc
Q 007608 154 LDLSSNNLTGRIPM----QLFSVATFNFTGTHL 182 (596)
Q Consensus 154 L~l~~N~l~g~iP~----~l~~l~~l~~~~n~~ 182 (596)
|+|.+|+|. .||. .+.+|..|++.+|+.
T Consensus 397 L~l~gNqlk-~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 397 LRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred eeecCceee-ecchhhhccCcccceecCCCCcc
Confidence 888888888 7774 345667777777764
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.2e-09 Score=80.81 Aligned_cols=61 Identities=39% Similarity=0.642 Sum_probs=44.4
Q ss_pred cccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCCCCcc
Q 007608 100 KFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNL 161 (596)
Q Consensus 100 ~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 161 (596)
++|+.| ++++|+|+..-+..|.++++|++|+|++|.++..-|..|.++++|++|++++|+|
T Consensus 1 p~L~~L-~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESL-DLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEE-EETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEE-ECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 356777 7888888833335677788888888888888744445678888888888888875
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=7.9e-08 Score=89.60 Aligned_cols=126 Identities=22% Similarity=0.280 Sum_probs=81.4
Q ss_pred EEEEEEeCCCcEEEEEEccccC------------Cc-------------chHHHHHHHHHHHHhcCCC--CccceEeEEe
Q 007608 287 KVYKGVLSDNTKVAVKRLQDYY------------SP-------------GGEAAFQREVHLISVAIHK--NLLQLIGYCT 339 (596)
Q Consensus 287 ~Vy~~~~~~~~~vavK~l~~~~------------~~-------------~~~~~~~~e~~~l~~l~H~--niv~l~~~~~ 339 (596)
.||.|...+|..+|+|..+... .. .......+|.+.|.++..- ++.+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899999899999999874210 00 0123467899999999765 45555544
Q ss_pred cCCeeEEEEEccc--CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEecCCCCCcEEEcCCCcEE
Q 007608 340 TSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL-HEQCNPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 340 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~dlkp~NIll~~~~~~k 416 (596)
....+||||++ +..+.. +.+.. ++......++.+++..+..+ |.. +++|||+.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~-l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPR-LKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGC-HHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhh-HHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 24589999998 544433 33211 11233456777888866664 676 99999999999999988 999
Q ss_pred Eeeccccccc
Q 007608 417 LCDFGLAKLV 426 (596)
Q Consensus 417 l~DfGl~~~~ 426 (596)
++|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.5e-07 Score=90.14 Aligned_cols=259 Identities=17% Similarity=0.168 Sum_probs=152.8
Q ss_pred cCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeE------EecCCe-eEEE
Q 007608 276 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGY------CTTSSE-RILV 347 (596)
Q Consensus 276 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~------~~~~~~-~~lv 347 (596)
..+.||+|+-+.+|..--- +.. +-|+.... .+... .+.+..|.+. .||-+..-+.+ ..+... .-+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~P-ppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAP-PPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh-hch-hheeecCC-CchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3678999999999964321 122 33544332 11111 2233334443 46554331221 112222 4566
Q ss_pred EEcccCCC-hhhhhc--ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 348 YPFMQNLS-VAYRLR--DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 348 ~e~~~~gs-L~~~l~--~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
|+.+.+.. ...++. ..+..-...+|...++.+..+|.+.+.||.. |.+-+|+.++|+|+++++.+.+.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 77665542 111111 1122234578999999999999999999999 99999999999999999999999865544
Q ss_pred cccccCcceeccccccccccCccccc-----CCCCCcccccHHHHHHHHHHHhC-CCCCCCccchhhhhchHHHHHHHHh
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLEEEEDVLLLDHIRKLL 498 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltg-~~p~~~~~~~~~~~~~l~~~~~~~~ 498 (596)
...++.. .....|...|.+||.-. +-..+...|-|.+||++++++.| +.||..-........-....+.
T Consensus 166 i~~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia--- 240 (637)
T COG4248 166 INANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA--- 240 (637)
T ss_pred eccCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh---
Confidence 3333222 22245888999999864 33457789999999999999886 9999753221111111110111
Q ss_pred ccCcccccccCc--CC----CC-CHHHHHHHHHHHHHccccC--CCCCCCHHHHHHHhcc
Q 007608 499 REDRLNDIVDRN--LN----TY-DSKEVETMVQVALLCTQST--PEDRPPMAQVVKMLQG 549 (596)
Q Consensus 499 ~~~~~~~~~d~~--l~----~~-~~~~~~~l~~l~~~Cl~~d--P~~RPs~~evl~~L~~ 549 (596)
.+....--|.. .. .. .......+..+..+|+... +.-||+++-.+..|.+
T Consensus 241 -~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 241 -HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred -cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 01111111110 00 01 1222345667777888653 5689999999888764
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.7e-08 Score=75.91 Aligned_cols=59 Identities=32% Similarity=0.563 Sum_probs=53.7
Q ss_pred CEEEEEcCCCCCCcccC-cchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccC
Q 007608 77 NVISLTLGSNGFSGKIS-PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 137 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p-~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l 137 (596)
+|+.|+|++|+|+ .+| ..|..+++|++| ++++|.++..-|..|.++++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L-~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLT-EIPPDSFSNLPNLETL-DLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTES-EECTTTTTTGTTESEE-EETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCC-ccCHHHHcCCCCCCEe-EccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 6889999999999 555 588999999999 9999999976678999999999999999986
|
... |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.3e-08 Score=105.62 Aligned_cols=104 Identities=27% Similarity=0.389 Sum_probs=89.8
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
.+..|||++|+|+..-+..|.+|++|+.+ +|.+|.|+ .||...+...+|+.|+|.+|.|+..-..++.-++.|+.|||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v-~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL 156 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEV-NLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL 156 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceee-eeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence 46679999999997777789999999999 99999999 99998888888999999999999444557999999999999
Q ss_pred CCCcccccCCcc-c---cccccccccccccc
Q 007608 157 SSNNLTGRIPMQ-L---FSVATFNFTGTHLI 183 (596)
Q Consensus 157 ~~N~l~g~iP~~-l---~~l~~l~~~~n~~~ 183 (596)
|.|.|+ .||.. + -+++.|++++|...
T Consensus 157 SrN~is-~i~~~sfp~~~ni~~L~La~N~It 186 (873)
T KOG4194|consen 157 SRNLIS-EIPKPSFPAKVNIKKLNLASNRIT 186 (873)
T ss_pred hhchhh-cccCCCCCCCCCceEEeecccccc
Confidence 999999 88853 2 25788899988764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.6e-07 Score=88.64 Aligned_cols=136 Identities=21% Similarity=0.187 Sum_probs=95.0
Q ss_pred CcCceeeecCceEEEEEEeCCCcEEEEEEccccC-------------------C--cchHHHHHHHHHHHHhcCCC--Cc
Q 007608 275 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-------------------S--PGGEAAFQREVHLISVAIHK--NL 331 (596)
Q Consensus 275 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-------------------~--~~~~~~~~~e~~~l~~l~H~--ni 331 (596)
.++..||-|.-+.||.|..++|.++|||.=+... + ........+|.+.|.++... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3468899999999999999999999999542110 0 11234567899999988644 55
Q ss_pred cceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC
Q 007608 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 411 (596)
Q Consensus 332 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~ 411 (596)
.+.++ .+...+||||+++-.|...- ++-.....++..|+.-+.-+-.. |+||+|+.+-||++++
T Consensus 174 P~P~~----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIA----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCccc----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 55543 45678999999985543321 11122233444455544444455 9999999999999999
Q ss_pred CCcEEEeeccccccc
Q 007608 412 NFEAVLCDFGLAKLV 426 (596)
Q Consensus 412 ~~~~kl~DfGl~~~~ 426 (596)
+|.+.++||-.+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999877543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.6e-08 Score=67.60 Aligned_cols=40 Identities=43% Similarity=0.869 Sum_probs=29.5
Q ss_pred hhHHHHHHHHHHhcc-CCCCCCCCCCCCC-CCCCCCcceeEee
Q 007608 34 DVEGEALIEVLKALN-DTHGQFTDWNDHF-VSPCFSWSHVTCR 74 (596)
Q Consensus 34 ~~~~~al~~~~~~~~-~~~~~l~~w~~~~-~~~c~~w~gv~c~ 74 (596)
+.|++||++||+++. ++.+.+.+|+... .+|| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-eeccEEeC
Confidence 568999999999998 5678999999764 4455 99999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.60 E-value=6.5e-09 Score=99.48 Aligned_cols=100 Identities=23% Similarity=0.400 Sum_probs=65.2
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
.++.|||++|.|+ .+..++.-++.++.| ++|+|+|. .+-. +..|.+|+.||||+|.|+ .+-..-..|-+.++|.|
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L-~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRL-ILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEE-ecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 4667777777777 677777777777777 77777776 4443 666777777777777777 55555555666666677
Q ss_pred CCCcccccCC--cccccccccccccccc
Q 007608 157 SSNNLTGRIP--MQLFSVATFNFTGTHL 182 (596)
Q Consensus 157 ~~N~l~g~iP--~~l~~l~~l~~~~n~~ 182 (596)
++|.+. .+. ..+.+|.+|++.+|+.
T Consensus 360 a~N~iE-~LSGL~KLYSLvnLDl~~N~I 386 (490)
T KOG1259|consen 360 AQNKIE-TLSGLRKLYSLVNLDLSSNQI 386 (490)
T ss_pred hhhhHh-hhhhhHhhhhheeccccccch
Confidence 776665 332 2344556666666654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.2e-08 Score=90.77 Aligned_cols=85 Identities=28% Similarity=0.435 Sum_probs=44.0
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCccc-CCCCcccEEEccCccCcCCCc--cccccCCCCc
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFL-GSMTHLQSLNLANNKFSGSIP--ATWSQLSNLK 152 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~-~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~ 152 (596)
.+++.|+|++|+|+ .++ .+..|++|+.| ++++|+|+ .+++.+ ..+++|+.|+|++|+|. .+- ..++.+++|+
T Consensus 42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L-~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~ 116 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTL-DLSNNRIS-SISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLR 116 (175)
T ss_dssp TT--EEE-TTS--S---T-T----TT--EE-E--SS----S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--
T ss_pred cCCCEEECCCCCCc-ccc-CccChhhhhhc-ccCCCCCC-ccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCcc
Confidence 47999999999999 675 58889999999 99999999 676655 46999999999999998 443 3578899999
Q ss_pred EEeCCCCcccccCC
Q 007608 153 HLDLSSNNLTGRIP 166 (596)
Q Consensus 153 ~L~l~~N~l~g~iP 166 (596)
.|+|.+|.++ .-+
T Consensus 117 ~L~L~~NPv~-~~~ 129 (175)
T PF14580_consen 117 VLSLEGNPVC-EKK 129 (175)
T ss_dssp EEE-TT-GGG-GST
T ss_pred eeeccCCccc-chh
Confidence 9999999998 444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.9e-08 Score=102.86 Aligned_cols=101 Identities=25% Similarity=0.466 Sum_probs=89.5
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
-|..|-+++|+++ .+|+.++.+..|..| |.+.|.+. .+|+.++.|.+|+.|++..|++. .+|.++..| .|..||+
T Consensus 144 pLkvli~sNNkl~-~lp~~ig~~~tl~~l-d~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDf 218 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHL-DVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDF 218 (722)
T ss_pred cceeEEEecCccc-cCCcccccchhHHHh-hhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeec
Confidence 4888999999998 999999999999999 99999999 89999999999999999999999 999999955 4999999
Q ss_pred CCCcccccCCcccccc---ccccccccccc
Q 007608 157 SSNNLTGRIPMQLFSV---ATFNFTGTHLI 183 (596)
Q Consensus 157 ~~N~l~g~iP~~l~~l---~~l~~~~n~~~ 183 (596)
|.|+++ .||..|.+| ..|.+..||+.
T Consensus 219 ScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 219 SCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred ccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 999999 999887655 55668888875
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.1e-08 Score=109.40 Aligned_cols=99 Identities=34% Similarity=0.483 Sum_probs=89.3
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+|..|+|++|.++ ..|..+..+.+|+.| +++.|.|. ..|.+.+++.+|++|+|.+|.+. .+|.++..+++|+.||+
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~l-n~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~Ldl 121 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQL-NLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDL 121 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhc-ccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhccccccc
Confidence 4999999999998 999999999999999 99999999 89999999999999999999999 99999999999999999
Q ss_pred CCCcccccCCcccccc---cccccccc
Q 007608 157 SSNNLTGRIPMQLFSV---ATFNFTGT 180 (596)
Q Consensus 157 ~~N~l~g~iP~~l~~l---~~l~~~~n 180 (596)
|+|+|. .+|..+..+ ..+.++||
T Consensus 122 S~N~f~-~~Pl~i~~lt~~~~~~~s~N 147 (1081)
T KOG0618|consen 122 SFNHFG-PIPLVIEVLTAEEELAASNN 147 (1081)
T ss_pred chhccC-CCchhHHhhhHHHHHhhhcc
Confidence 999999 999765433 33445555
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=8.6e-08 Score=107.54 Aligned_cols=94 Identities=27% Similarity=0.488 Sum_probs=47.9
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+.+.|+|++++|+ .+|..+. ++|+.| +|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L-~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTL-ILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEE-EecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 4566666666666 5555443 355555 56666666 4555443 35555555555555 4554332 23444444
Q ss_pred CCCcccccCCcccc-ccccccccccc
Q 007608 157 SSNNLTGRIPMQLF-SVATFNFTGTH 181 (596)
Q Consensus 157 ~~N~l~g~iP~~l~-~l~~l~~~~n~ 181 (596)
++|+++ .+|..+. +|..|++++|.
T Consensus 249 s~N~L~-~LP~~l~s~L~~L~Ls~N~ 273 (754)
T PRK15370 249 SINRIT-ELPERLPSALQSLDLFHNK 273 (754)
T ss_pred cCCccC-cCChhHhCCCCEEECcCCc
Confidence 444444 4443332 23444444443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.4e-09 Score=108.81 Aligned_cols=102 Identities=25% Similarity=0.499 Sum_probs=82.7
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
..++.|||+.|+++ .+|..++.|+ |+.| -++||+++ .+|.+++.+..|..||.+.|++. ++|+.+++|.+|+.|+
T Consensus 121 ~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl-i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~ 195 (722)
T KOG0532|consen 121 EALTFLDLSSNQLS-HLPDGLCDLP-LKVL-IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLN 195 (722)
T ss_pred hHHHHhhhccchhh-cCChhhhcCc-ceeE-EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHH
Confidence 46777888888888 7888887776 6667 68888888 78888888888888888888888 8888888888888888
Q ss_pred CCCCcccccCCcccccc--ccccccccccc
Q 007608 156 LSSNNLTGRIPMQLFSV--ATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP~~l~~l--~~l~~~~n~~~ 183 (596)
+..|++. .+|.++..| ..|+|+.|...
T Consensus 196 vrRn~l~-~lp~El~~LpLi~lDfScNkis 224 (722)
T KOG0532|consen 196 VRRNHLE-DLPEELCSLPLIRLDFSCNKIS 224 (722)
T ss_pred Hhhhhhh-hCCHHHhCCceeeeecccCcee
Confidence 8888888 888887754 57888888764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.2e-08 Score=101.19 Aligned_cols=86 Identities=30% Similarity=0.484 Sum_probs=72.5
Q ss_pred CEEEEEcCCCCCCcccCc-chhhhcccchhhcccCccccccCCcccCCCCcccEEEccC-ccCcCCCcc-ccccCCCCcE
Q 007608 77 NVISLTLGSNGFSGKISP-SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN-NKFSGSIPA-TWSQLSNLKH 153 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~-~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~-~~~~l~~L~~ 153 (596)
..++|+|..|+|+ .||+ .|..+++|+.| |||+|+|+-.-|..|..|++|..|-+.+ |+|+ .+|. .|++|.+|+.
T Consensus 68 ~tveirLdqN~I~-~iP~~aF~~l~~LRrL-dLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 68 ETVEIRLDQNQIS-SIPPGAFKTLHRLRRL-DLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQR 144 (498)
T ss_pred cceEEEeccCCcc-cCChhhccchhhhcee-cccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHH
Confidence 6788999999999 6655 89999999999 9999999977799999999998877666 9999 7875 5888888888
Q ss_pred EeCCCCcccccCC
Q 007608 154 LDLSSNNLTGRIP 166 (596)
Q Consensus 154 L~l~~N~l~g~iP 166 (596)
|.+.-|++. .++
T Consensus 145 LllNan~i~-Cir 156 (498)
T KOG4237|consen 145 LLLNANHIN-CIR 156 (498)
T ss_pred HhcChhhhc-chh
Confidence 888877777 444
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.3e-08 Score=106.54 Aligned_cols=150 Identities=18% Similarity=0.311 Sum_probs=102.8
Q ss_pred HHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce--------eccccccccccCcccccC
Q 007608 380 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--------TTQIRGTMGHIAPEYLST 451 (596)
Q Consensus 380 ~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 451 (596)
.+++.|+.|+|.. +++||++|.|++|.++.++..||+.|+++.......... ..-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999987 489999999999999999999999999876543311110 001123457999999999
Q ss_pred CCCCcccccHHHHHHHHHHHhCCCC-CCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHcc
Q 007608 452 GKSSEKTDVFGYGITLLELVTGQRA-IDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCT 530 (596)
Q Consensus 452 ~~~~~~sDv~S~Gvil~elltg~~p-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl 530 (596)
...+.++|+||+||++|-+..|..+ +...... ......+ ...+-....+....+.++.+-+.+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~~~---------~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSFSR---------NLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc-----chhhhhh---------cccccccccccccCcHHHHHHHHHHh
Confidence 8889999999999999999854444 3321110 0000000 01112222234455667788888899
Q ss_pred ccCCCCCCCHHHHHH
Q 007608 531 QSTPEDRPPMAQVVK 545 (596)
Q Consensus 531 ~~dP~~RPs~~evl~ 545 (596)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998887744
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.3e-06 Score=83.52 Aligned_cols=108 Identities=19% Similarity=0.208 Sum_probs=83.4
Q ss_pred hHHHHHHHHHHHHhcCC--CCccceEeEEecCC----eeEEEEEcccCC-ChhhhhcccCCCCCCCCHHHHHHHHHHHHH
Q 007608 312 GEAAFQREVHLISVAIH--KNLLQLIGYCTTSS----ERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 384 (596)
Q Consensus 312 ~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~ 384 (596)
......+|...+..+.. -...+.+++..... ..++|+|++++. +|.+++..... .+......++.+++.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALAR 129 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHH
Confidence 34457788888777753 33456666665432 347999999874 78888875221 455667889999999
Q ss_pred HHHHHHhCCCCCcEecCCCCCcEEEcCCC---cEEEeeccccccc
Q 007608 385 GLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAKLV 426 (596)
Q Consensus 385 ~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~DfGl~~~~ 426 (596)
.++-||.. +|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 130 ~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999 999999999999999887 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.2e-08 Score=98.32 Aligned_cols=96 Identities=27% Similarity=0.395 Sum_probs=83.6
Q ss_pred ccCc-chhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCc-cccccCCCCcEEeCCCCcccccCCcc
Q 007608 91 KISP-SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP-ATWSQLSNLKHLDLSSNNLTGRIPMQ 168 (596)
Q Consensus 91 ~~p~-~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~iP~~ 168 (596)
.-|. .|..|++|+.| +|++|+|++.-+..|..+..|+.|.|..|+|. .+- ..|.++..|++|+|.+|+|+-.-|..
T Consensus 264 ~cP~~cf~~L~~L~~l-nlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~a 341 (498)
T KOG4237|consen 264 ICPAKCFKKLPNLRKL-NLSNNKITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGA 341 (498)
T ss_pred cChHHHHhhcccceEe-ccCCCccchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEeccc
Confidence 4443 58999999999 99999999888999999999999999999999 444 46889999999999999999666654
Q ss_pred c---cccccccccccccccCCCC
Q 007608 169 L---FSVATFNFTGTHLICGSSL 188 (596)
Q Consensus 169 l---~~l~~l~~~~n~~~~~~~~ 188 (596)
| .++..|++.+||+.|++.+
T Consensus 342 F~~~~~l~~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 342 FQTLFSLSTLNLLSNPFNCNCRL 364 (498)
T ss_pred ccccceeeeeehccCcccCccch
Confidence 4 5788999999999999864
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=4e-06 Score=78.77 Aligned_cols=138 Identities=17% Similarity=0.153 Sum_probs=101.4
Q ss_pred eecCceEEEEEEeCCCcEEEEEEcccc----CC-cchHHHHHHHHHHHHhcCCC--CccceEeEEe-cC----CeeEEEE
Q 007608 281 GQGGFGKVYKGVLSDNTKVAVKRLQDY----YS-PGGEAAFQREVHLISVAIHK--NLLQLIGYCT-TS----SERILVY 348 (596)
Q Consensus 281 G~G~~g~Vy~~~~~~~~~vavK~l~~~----~~-~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~-~~----~~~~lv~ 348 (596)
|+||.+-|+.... +|..+-+|+-... .. +-....|.+|+..+.++..- .+.+.. ++. .. -.-++|+
T Consensus 27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 6788888998777 4447888876421 11 45778999999999988632 344444 332 11 2357899
Q ss_pred EcccC-CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc--EEEeecccccc
Q 007608 349 PFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--AVLCDFGLAKL 425 (596)
Q Consensus 349 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~DfGl~~~ 425 (596)
|-+.+ -+|.+++.+.. -...+...+..+..+++..+.-||+. ++.|+|+.+.||+++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 47888876422 12456677789999999999999999 9999999999999986666 99999987653
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.2e-07 Score=65.65 Aligned_cols=37 Identities=38% Similarity=0.694 Sum_probs=27.5
Q ss_pred CcccEEEccCccCcCCCccccccCCCCcEEeCCCCccc
Q 007608 125 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162 (596)
Q Consensus 125 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 162 (596)
++|++|+|++|+|+ .+|+.+++|++|+.|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 46778888888887 77777788888888888888777
|
... |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=8.4e-08 Score=107.14 Aligned_cols=98 Identities=28% Similarity=0.409 Sum_probs=71.2
Q ss_pred CCEEEEEcCCCCCCcccCcchhhh-----------------cccchhhcccCccccccCCcccCCCCcccEEEccCccCc
Q 007608 76 GNVISLTLGSNGFSGKISPSITKL-----------------KFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 138 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l-----------------~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~ 138 (596)
.+|+.|+|++|+|+ .+|+...+| .+|+.| +|++|+|+ .+|... ++|+.|+|++|+|+
T Consensus 342 ~~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~L-dLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls 415 (788)
T PRK15387 342 SGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKEL-IVSGNRLT-SLPVLP---SELKELMVSGNRLT 415 (788)
T ss_pred cccceEecCCCccC-CCCCCCcccceehhhccccccCcccccccceE-EecCCccc-CCCCcc---cCCCEEEccCCcCC
Confidence 37888888888887 455433222 356677 78888887 466543 57888899999998
Q ss_pred CCCccccccCCCCcEEeCCCCcccccCCcccc---cccccccccccccc
Q 007608 139 GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHLIC 184 (596)
Q Consensus 139 g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l~---~l~~l~~~~n~~~~ 184 (596)
.+|... .+|+.|+|++|+|+ .||..+. ++..+++++|++.+
T Consensus 416 -sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 416 -SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred -CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCc
Confidence 688643 46788999999999 8998765 45678889998754
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.6e-07 Score=103.71 Aligned_cols=98 Identities=19% Similarity=0.373 Sum_probs=85.2
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|+|++|+|+ .+|..+. ++|+.| ++++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|+
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L-~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~ 268 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTL-YANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLD 268 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEE-ECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEE
Confidence 37899999999999 7888765 589999 99999999 7898765 48999999999999 8998775 5899999
Q ss_pred CCCCcccccCCcccc-cccccccccccccc
Q 007608 156 LSSNNLTGRIPMQLF-SVATFNFTGTHLIC 184 (596)
Q Consensus 156 l~~N~l~g~iP~~l~-~l~~l~~~~n~~~~ 184 (596)
|++|+|+ .+|..+. +|..|++++|.+..
T Consensus 269 Ls~N~L~-~LP~~l~~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 269 LFHNKIS-CLPENLPEELRYLSVYDNSIRT 297 (754)
T ss_pred CcCCccC-ccccccCCCCcEEECCCCcccc
Confidence 9999999 7887764 78999999997653
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.9e-07 Score=102.92 Aligned_cols=93 Identities=23% Similarity=0.348 Sum_probs=52.7
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|+|+ .+|.. +++|++| +|++|+|+ .+|..+ ++|+.|+|++|.|+ .+|..+ ++|+.|+|
T Consensus 223 ~L~~L~L~~N~Lt-~LP~l---p~~Lk~L-dLs~N~Lt-sLP~lp---~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~L 289 (788)
T PRK15387 223 HITTLVIPDNNLT-SLPAL---PPELRTL-EVSGNQLT-SLPVLP---PGLLELSIFSNPLT-HLPALP---SGLCKLWI 289 (788)
T ss_pred CCCEEEccCCcCC-CCCCC---CCCCcEE-EecCCccC-cccCcc---cccceeeccCCchh-hhhhch---hhcCEEEC
Confidence 5667777777776 46642 3566666 67777777 556432 45555666666555 444322 34455555
Q ss_pred CCCcccccCCccccccccccccccccc
Q 007608 157 SSNNLTGRIPMQLFSVATFNFTGTHLI 183 (596)
Q Consensus 157 ~~N~l~g~iP~~l~~l~~l~~~~n~~~ 183 (596)
++|+|+ .+|..+.+|..|++++|.+.
T Consensus 290 s~N~Lt-~LP~~p~~L~~LdLS~N~L~ 315 (788)
T PRK15387 290 FGNQLT-SLPVLPPGLQELSVSDNQLA 315 (788)
T ss_pred cCCccc-cccccccccceeECCCCccc
Confidence 555555 45554445555555555443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.6e-08 Score=83.39 Aligned_cols=89 Identities=29% Similarity=0.436 Sum_probs=77.6
Q ss_pred CCEEEEEcCCCCCCcccCcchhhh-cccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEE
Q 007608 76 GNVISLTLGSNGFSGKISPSITKL-KFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 154 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l-~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 154 (596)
..++.++|++|.+. .+|+.|... +.++.| +|++|.|+ .+|.++..++.|+.|++++|.|. ..|..+..|.+|-.|
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~l-Nl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTL-NLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhh-hcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence 36888999999998 777777654 578888 99999999 89999999999999999999999 889888889999999
Q ss_pred eCCCCcccccCCccc
Q 007608 155 DLSSNNLTGRIPMQL 169 (596)
Q Consensus 155 ~l~~N~l~g~iP~~l 169 (596)
|..+|.+. +||-.+
T Consensus 129 ds~~na~~-eid~dl 142 (177)
T KOG4579|consen 129 DSPENARA-EIDVDL 142 (177)
T ss_pred cCCCCccc-cCcHHH
Confidence 99999988 888554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=8.6e-07 Score=94.99 Aligned_cols=146 Identities=22% Similarity=0.269 Sum_probs=92.4
Q ss_pred CCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcc---------------------------------------hH
Q 007608 273 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG---------------------------------------GE 313 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~---------------------------------------~~ 313 (596)
.|+ .+.|+.++-|.||+|++++|+.||||+.+....+. .+
T Consensus 127 eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 444 36899999999999999999999999875321110 01
Q ss_pred HHHHHHHHHHHhcC----CCCccceEeEE-ecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHH-HH
Q 007608 314 AAFQREVHLISVAI----HKNLLQLIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG-LE 387 (596)
Q Consensus 314 ~~~~~e~~~l~~l~----H~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-L~ 387 (596)
-++.+|..-+.+++ ...-+++=..+ .-.....++|||++|-.+.+...-.. .+.+ +..++..++++ +.
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f~~ 279 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRAFLR 279 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHHHHH
Confidence 11333333333332 11112222233 33567899999999988887743211 2344 23333333332 22
Q ss_pred HHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 388 ~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
.+-.. ++.|.|..|.||+++.++.+.+.|||+...++.
T Consensus 280 q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 280 QLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22234 899999999999999999999999999887654
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.3e-07 Score=98.26 Aligned_cols=100 Identities=35% Similarity=0.607 Sum_probs=90.4
Q ss_pred CEEEEEcCCCCCCcccCcchhhhc-ccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 77 NVISLTLGSNGFSGKISPSITKLK-FLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~-~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.++.|++.+|.++ .+|+..+.++ +|+.| ++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus 117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L-~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKEL-DLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred ceeEEecCCcccc-cCccccccchhhcccc-cccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 6899999999999 8999999885 99999 99999999 89889999999999999999999 9998888999999999
Q ss_pred CCCCcccccCCcc--cc-ccccccccccc
Q 007608 156 LSSNNLTGRIPMQ--LF-SVATFNFTGTH 181 (596)
Q Consensus 156 l~~N~l~g~iP~~--l~-~l~~l~~~~n~ 181 (596)
+++|+++ .+|.. .. .+..+.+++|+
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 9999999 99985 33 48888888885
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=4e-08 Score=83.75 Aligned_cols=95 Identities=25% Similarity=0.358 Sum_probs=78.4
Q ss_pred CEEEEEcCCCCCCcccCcchhhh---cccchhhcccCccccccCCcccCCC-CcccEEEccCccCcCCCccccccCCCCc
Q 007608 77 NVISLTLGSNGFSGKISPSITKL---KFLASFRELQDNDLSGTLPDFLGSM-THLQSLNLANNKFSGSIPATWSQLSNLK 152 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l---~~L~~l~~l~~n~l~g~~p~~~~~l-~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 152 (596)
.+..|+|+++.|. .++..+..+ ..|+.. +|++|.|. .+|+.|... +.+++|+|++|.|+ .+|.++..++.|+
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i-~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr 103 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKI-SLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALR 103 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEE-ecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhh
Confidence 4557889999887 787766655 455556 89999999 788777664 59999999999999 9999999999999
Q ss_pred EEeCCCCcccccCCcccccccccc
Q 007608 153 HLDLSSNNLTGRIPMQLFSVATFN 176 (596)
Q Consensus 153 ~L~l~~N~l~g~iP~~l~~l~~l~ 176 (596)
.|+++.|.|. ..|.-+..|..|+
T Consensus 104 ~lNl~~N~l~-~~p~vi~~L~~l~ 126 (177)
T KOG4579|consen 104 SLNLRFNPLN-AEPRVIAPLIKLD 126 (177)
T ss_pred hcccccCccc-cchHHHHHHHhHH
Confidence 9999999999 8887766555444
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.1e-07 Score=89.30 Aligned_cols=90 Identities=21% Similarity=0.320 Sum_probs=76.5
Q ss_pred cccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCCCCcccccCC---
Q 007608 90 GKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP--- 166 (596)
Q Consensus 90 g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP--- 166 (596)
|.+-..+.....|+.| |||+|.|+ .|..+..-++.++.|+||+|.|. .+-. +..|++|+.||||+|.++ ++-
T Consensus 274 G~~~~~~dTWq~Ltel-DLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh 348 (490)
T KOG1259|consen 274 GSALVSADTWQELTEL-DLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWH 348 (490)
T ss_pred CceEEecchHhhhhhc-cccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhH
Confidence 4444455667788899 99999999 89999999999999999999998 6654 889999999999999998 554
Q ss_pred cccccccccccccccccc
Q 007608 167 MQLFSVATFNFTGTHLIC 184 (596)
Q Consensus 167 ~~l~~l~~l~~~~n~~~~ 184 (596)
..+++.+.|.+++|.+..
T Consensus 349 ~KLGNIKtL~La~N~iE~ 366 (490)
T KOG1259|consen 349 LKLGNIKTLKLAQNKIET 366 (490)
T ss_pred hhhcCEeeeehhhhhHhh
Confidence 468899999999997643
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.27 E-value=9e-07 Score=105.75 Aligned_cols=105 Identities=23% Similarity=0.359 Sum_probs=82.5
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+|. .++..+..+++|+.| +|++|...+.+|. ++.+++|++|+|++|.....+|..+++|++|+.|+
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L-~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNI-DLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEE-ECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 47888999999888 788888888889888 8888765557774 88888999999988776668888888888899999
Q ss_pred CCCCcccccCCcc--ccccccccccccccc
Q 007608 156 LSSNNLTGRIPMQ--LFSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP~~--l~~l~~l~~~~n~~~ 183 (596)
+++|..-+.+|.. +.+|..|+++||..+
T Consensus 688 L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L 717 (1153)
T PLN03210 688 MSRCENLEILPTGINLKSLYRLNLSGCSRL 717 (1153)
T ss_pred CCCCCCcCccCCcCCCCCCCEEeCCCCCCc
Confidence 9886544478864 456777777776543
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.2e-06 Score=104.84 Aligned_cols=99 Identities=20% Similarity=0.272 Sum_probs=55.1
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|++.+|.+. .+|..+ .+.+|+.| +|++|++. .+|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L-~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L 664 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKL-QMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKL 664 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEE-ECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEe
Confidence 4556666666555 555554 34566666 66666665 5565566666666666665543335553 555666666666
Q ss_pred CCCcccccCCcccc---cccccccccc
Q 007608 157 SSNNLTGRIPMQLF---SVATFNFTGT 180 (596)
Q Consensus 157 ~~N~l~g~iP~~l~---~l~~l~~~~n 180 (596)
++|.....+|..+. +|..|++.++
T Consensus 665 ~~c~~L~~lp~si~~L~~L~~L~L~~c 691 (1153)
T PLN03210 665 SDCSSLVELPSSIQYLNKLEDLDMSRC 691 (1153)
T ss_pred cCCCCccccchhhhccCCCCEEeCCCC
Confidence 66554445665443 3344455544
|
syringae 6; Provisional |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=7.4e-08 Score=102.38 Aligned_cols=104 Identities=32% Similarity=0.453 Sum_probs=81.5
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcc-cCCCCcccEEEccCccCcCCCccccccCCCCcEE
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDF-LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 154 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 154 (596)
..++.|||++|+++ ... .+..|++|+.| ||+.|.|. .+|.- ...++ |+.|+|+||.++ ++- .+.+|.+|..|
T Consensus 187 ~ale~LnLshNk~~-~v~-~Lr~l~~LkhL-DlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~-tL~-gie~LksL~~L 259 (1096)
T KOG1859|consen 187 PALESLNLSHNKFT-KVD-NLRRLPKLKHL-DLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALT-TLR-GIENLKSLYGL 259 (1096)
T ss_pred HHhhhhccchhhhh-hhH-HHHhccccccc-ccccchhc-cccccchhhhh-heeeeecccHHH-hhh-hHHhhhhhhcc
Confidence 36788999999998 454 78888999999 89999998 77742 23344 999999999988 543 47899999999
Q ss_pred eCCCCcccccC---C-ccccccccccccccccccCC
Q 007608 155 DLSSNNLTGRI---P-MQLFSVATFNFTGTHLICGS 186 (596)
Q Consensus 155 ~l~~N~l~g~i---P-~~l~~l~~l~~~~n~~~~~~ 186 (596)
||++|-|++-- | -.+..|..|.+.|||+.|..
T Consensus 260 DlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 260 DLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred chhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 99999888531 2 23557788999999999964
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.21 E-value=6e-07 Score=62.16 Aligned_cols=40 Identities=38% Similarity=0.634 Sum_probs=32.3
Q ss_pred cccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCc
Q 007608 100 KFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP 142 (596)
Q Consensus 100 ~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 142 (596)
++|++| ++++|+|+ .+|+.|++|++|++|+|++|+|+ .+|
T Consensus 1 ~~L~~L-~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEEL-DLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEE-EETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEE-EccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 467888 89999999 78888999999999999999998 554
|
... |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.7e-07 Score=93.49 Aligned_cols=106 Identities=21% Similarity=0.324 Sum_probs=83.8
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcc---cchhhcccCccccc----cCCcccCCC-CcccEEEccCccCcCC----Ccc
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKF---LASFRELQDNDLSG----TLPDFLGSM-THLQSLNLANNKFSGS----IPA 143 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~---L~~l~~l~~n~l~g----~~p~~~~~l-~~L~~L~l~~N~l~g~----~p~ 143 (596)
.+++.|+|++|.+.+..+..+..+.+ |+.| ++++|++++ .+...+..+ ++|+.|+|++|.+++. ++.
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L-~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQEL-KLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEE-EeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 48999999999998777888888877 9999 999999883 444566777 8999999999999853 344
Q ss_pred ccccCCCCcEEeCCCCccccc----CCcccc---cccccccccccc
Q 007608 144 TWSQLSNLKHLDLSSNNLTGR----IPMQLF---SVATFNFTGTHL 182 (596)
Q Consensus 144 ~~~~l~~L~~L~l~~N~l~g~----iP~~l~---~l~~l~~~~n~~ 182 (596)
.+..+.+|++|+|++|.+++. ++..+. +|+.|++++|.+
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i 205 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGL 205 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCcc
Confidence 567778999999999999853 333344 778888888754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.5e-05 Score=74.65 Aligned_cols=138 Identities=14% Similarity=0.191 Sum_probs=84.7
Q ss_pred ceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCC--ccceEeEEecCCeeEEEEEcccCCC
Q 007608 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGYCTTSSERILVYPFMQNLS 355 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gs 355 (596)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 35567788765322 3345688999998886443 4567777777777889999999863
Q ss_pred -hhhh---------------------hcccCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCcEec
Q 007608 356 -VAYR---------------------LRDLKPGEKGLDWPTRKR-VAF----------GTAY-GLEYLHEQ-CNPKIIHR 400 (596)
Q Consensus 356 -L~~~---------------------l~~~~~~~~~l~~~~~~~-i~~----------~ia~-~L~~LH~~-~~~~ivH~ 400 (596)
+... ++....... ....... +.. .+.. ...+|... ..+.++|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~--~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTS--TFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCC--cHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 1111 121111111 1111100 000 0111 12222211 12357899
Q ss_pred CCCCCcEEEcCCCcEEEeeccccc
Q 007608 401 DLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 401 dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
|+.|.||++++++ +.|+||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.10 E-value=9.6e-07 Score=90.42 Aligned_cols=106 Identities=29% Similarity=0.403 Sum_probs=77.1
Q ss_pred CEEEEEcCCCCCCc----ccCcchhhh-cccchhhcccCcccccc----CCcccCCCCcccEEEccCccCcCC----Ccc
Q 007608 77 NVISLTLGSNGFSG----KISPSITKL-KFLASFRELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----IPA 143 (596)
Q Consensus 77 ~l~~L~l~~n~l~g----~~p~~~~~l-~~L~~l~~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~ 143 (596)
+++.|++++|++++ .+...+..+ ++|+.| +|++|.+++. ++..+..+++|++|+|++|.+++. ++.
T Consensus 109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L-~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 187 (319)
T cd00116 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL-VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE 187 (319)
T ss_pred cccEEEeeCCccchHHHHHHHHHHHhCCCCceEE-EcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence 48999999998873 344456666 888998 8999998843 445667778899999999998843 444
Q ss_pred ccccCCCCcEEeCCCCcccccCC-------ccccccccccccccccc
Q 007608 144 TWSQLSNLKHLDLSSNNLTGRIP-------MQLFSVATFNFTGTHLI 183 (596)
Q Consensus 144 ~~~~l~~L~~L~l~~N~l~g~iP-------~~l~~l~~l~~~~n~~~ 183 (596)
.+..+++|+.|+|++|.+++.-+ ..+.+|..|++++|+..
T Consensus 188 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~ 234 (319)
T cd00116 188 GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234 (319)
T ss_pred HHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCc
Confidence 56667789999999998874322 12345778888887653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.8e-05 Score=72.61 Aligned_cols=155 Identities=21% Similarity=0.215 Sum_probs=98.9
Q ss_pred cccHHHHHHHhcCCCcCce---eeecCceEEEEEEeCCCcEEEEEEccccCCcc------------------hHHH----
Q 007608 261 RFSCRELQLATDNFSESNI---IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG------------------GEAA---- 315 (596)
Q Consensus 261 ~~~~~el~~~~~~f~~~~~---lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~------------------~~~~---- 315 (596)
..+.+.+....++..+.+. |..|.-+.||+|...++..+|||+.+...... ...+
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 3455555555566655555 44566678999998889999999986321110 0000
Q ss_pred -HHHHHHHHHhcC--CCCccceEeEEecCCeeEEEEEcccCC-ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 007608 316 -FQREVHLISVAI--HKNLLQLIGYCTTSSERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 391 (596)
Q Consensus 316 -~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 391 (596)
..+|+.-|.++. +-.+.+-+++ .+..+||||+... .-.-.|.+ .++.......+..++.+.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHH
Confidence 234555555553 2223333322 2457999999654 22222322 223333567778888888888877
Q ss_pred CCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 392 ~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
.+ ++||+||..-|||+. ++.+.|+|||.+-...
T Consensus 185 ~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 43 899999999999999 7799999999886554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.04 E-value=6e-05 Score=73.15 Aligned_cols=144 Identities=17% Similarity=0.190 Sum_probs=84.5
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCC--CccceEeEEecC---CeeEEEEEcc
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK--NLLQLIGYCTTS---SERILVYPFM 351 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~~~---~~~~lv~e~~ 351 (596)
++.++.|..+.||++...+ ..+++|..... .....+.+|..++..+... .+.+++.+.... ...+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 4678999999999999877 69999986532 3456778888888887533 345666654333 3468999999
Q ss_pred cCCChhh----------------hh---cccCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHH
Q 007608 352 QNLSVAY----------------RL---RDLKPGEKGLDWPTR---------KRV------------AFGTAY-GLEYLH 390 (596)
Q Consensus 352 ~~gsL~~----------------~l---~~~~~~~~~l~~~~~---------~~i------------~~~ia~-~L~~LH 390 (596)
++..+.. .+ +..........+... ... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9887766 11 111111111111110 000 112222 233333
Q ss_pred h----CCCCCcEecCCCCCcEEEc-CCCcEEEeeccccc
Q 007608 391 E----QCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAK 424 (596)
Q Consensus 391 ~----~~~~~ivH~dlkp~NIll~-~~~~~kl~DfGl~~ 424 (596)
. .....++|+|+.|.||+++ +++.+.|.||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 1234799999999999999 66666899999765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.02 E-value=7.1e-05 Score=70.71 Aligned_cols=137 Identities=15% Similarity=0.130 Sum_probs=89.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHH---------HHHHHHHHhcCC---CCccceEeE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAF---------QREVHLISVAIH---KNLLQLIGY 337 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~---------~~e~~~l~~l~H---~niv~l~~~ 337 (596)
...+|...+++-......|.+... +|+.+++|..+... ...++.| .+++..+.+++. .....++..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~-~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREEN-RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhh-hhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 456777778887777777777666 77899999876422 1122222 233333333332 222222222
Q ss_pred E-----ecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC
Q 007608 338 C-----TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 412 (596)
Q Consensus 338 ~-----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 412 (596)
. .-....+++|||++|..|.+... ++. .++..+.+++.-+|.. |++|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 2 12234568999999987765432 121 2456677889999999 99999999999999966
Q ss_pred CcEEEeeccccc
Q 007608 413 FEAVLCDFGLAK 424 (596)
Q Consensus 413 ~~~kl~DfGl~~ 424 (596)
.+++.||+..+
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 49999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.8e-06 Score=91.37 Aligned_cols=103 Identities=30% Similarity=0.493 Sum_probs=89.1
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|++++|.+. .+|..+..+++|+.| ++++|+++ .+|...+.+++|+.|++++|+++ .+|..++.+..|+.|++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L-~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~ 216 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNL-DLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216 (394)
T ss_pred hcccccccccchh-hhhhhhhcccccccc-ccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhh
Confidence 7999999999999 898899999999999 99999999 99999989999999999999999 99998888888999999
Q ss_pred CCCcccccCCcccccc---cccccccccccc
Q 007608 157 SSNNLTGRIPMQLFSV---ATFNFTGTHLIC 184 (596)
Q Consensus 157 ~~N~l~g~iP~~l~~l---~~l~~~~n~~~~ 184 (596)
++|++. .+|..+.++ ..+.+.+|...+
T Consensus 217 ~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 217 SNNSII-ELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred cCCcce-ecchhhhhcccccccccCCceeee
Confidence 999765 566655544 444555665544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00011 Score=84.82 Aligned_cols=150 Identities=13% Similarity=0.207 Sum_probs=92.9
Q ss_pred CceeeecCceEEEEEEeCCC---cEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCc--cceEeEEecC---CeeEEE
Q 007608 277 SNIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNL--LQLIGYCTTS---SERILV 347 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lv 347 (596)
.+.++.|.++.+|+....++ ..+++|+............+.+|+++++.+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56788999999999887554 4677787643222223457889999999985 6654 7788888765 457899
Q ss_pred EEcccCCChhh-----------------------hhcccCCCC-------CCCCHH--HHHHHH---------------H
Q 007608 348 YPFMQNLSVAY-----------------------RLRDLKPGE-------KGLDWP--TRKRVA---------------F 380 (596)
Q Consensus 348 ~e~~~~gsL~~-----------------------~l~~~~~~~-------~~l~~~--~~~~i~---------------~ 380 (596)
|||+++..+.+ .|+...... .+..+. +..++. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998754321 112111100 011111 111111 1
Q ss_pred HHHHHHHHHHhCCC--------CCcEecCCCCCcEEEcCC-Cc-EEEeeccccccc
Q 007608 381 GTAYGLEYLHEQCN--------PKIIHRDLKAANILLDDN-FE-AVLCDFGLAKLV 426 (596)
Q Consensus 381 ~ia~~L~~LH~~~~--------~~ivH~dlkp~NIll~~~-~~-~kl~DfGl~~~~ 426 (596)
.+...+.+|..+.. +.++|+|+++.||+++.+ .. +-|.||.++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23344566754322 359999999999999753 33 579999987653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.96 E-value=4.7e-05 Score=81.48 Aligned_cols=144 Identities=20% Similarity=0.216 Sum_probs=89.1
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEccccCCcc------------------------------------hHHHHHHHH
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG------------------------------------GEAAFQREV 320 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~------------------------------------~~~~~~~e~ 320 (596)
.+.||.-+.|.||+|++++|+.||||+-+...... .+-+|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46799999999999999999999999865322111 011244444
Q ss_pred HHHHh----cCCCCccc---eEeEE-ecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 007608 321 HLISV----AIHKNLLQ---LIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392 (596)
Q Consensus 321 ~~l~~----l~H~niv~---l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 392 (596)
+-..+ +.|-+... +=.++ .-...+.++||||+|..+.+.-.-. +..++.... +..+.++ |++.-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i---~~~l~~~--~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID---KRGISPHDI---LNKLVEA--YLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH---HcCCCHHHH---HHHHHHH--HHHHH
Confidence 33332 33444111 11122 2345789999999998776653211 123554433 3333332 22222
Q ss_pred CCCCcEecCCCCCcEEEc----CCCcEEEeeccccccccc
Q 007608 393 CNPKIIHRDLKAANILLD----DNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 393 ~~~~ivH~dlkp~NIll~----~~~~~kl~DfGl~~~~~~ 428 (596)
...|++|+|=.|.||+++ .++.+.+-|||+......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 222899999999999998 367899999999876644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 596 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-107 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-105 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-38 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-10 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-07 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 533 bits (1375), Expect = 0.0
Identities = 204/326 (62%), Positives = 261/326 (80%), Gaps = 1/326 (0%)
Query: 243 FFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVK 302
FFDV E+D +V L QL+RFS RELQ+A+DNFS NI+G+GGFGKVYKG L+D T VAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 303 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 362
RL++ + GGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 363 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422
+ LDWP R+R+A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEAV+ DFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 482
AKL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQRA D +RL
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 483 EEEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMA 541
++DV+LLD ++ LL+E +L +VD +L Y +EVE ++QVALLCTQS+P +RP M+
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 542 QVVKMLQGEDLAERWAEWEELEEVRQ 567
+VV+ML+G+ LAERW EW++ E RQ
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 405 bits (1043), Expect = e-139
Identities = 116/312 (37%), Positives = 178/312 (57%), Gaps = 21/312 (6%)
Query: 249 EDDCKVSLTQLRRFSCRELQLATDNFSE------SNIIGQGGFGKVYKGVLSDNTKVAVK 302
+VS T+ FS EL+ T+NF E N +G+GGFG VYKG + +NT VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 303 RL---QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYR 359
+L D + + F +E+ +++ H+NL++L+G+ + + LVY +M N S+ R
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 360 LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 419
L G L W R ++A G A G+ +LHE IHRD+K+ANILLD+ F A + D
Sbjct: 121 LSC-LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 420 FGLAKLVDA-KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 478
FGLA+ + T +T++I GT ++APE L G+ + K+D++ +G+ LLE++TG A+D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 479 FSRLEEEEDVLLLDHIRKLLREDR-LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR 537
R E LLLD ++ E++ + D +D+ +N DS VE M VA C R
Sbjct: 236 EHR----EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 538 PPMAQVVKMLQG 549
P + +V ++LQ
Sbjct: 292 PDIKKVQQLLQE 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 370 bits (953), Expect = e-125
Identities = 106/295 (35%), Positives = 160/295 (54%), Gaps = 8/295 (2%)
Query: 257 TQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAF 316
+ R +L+ AT+NF +IG G FGKVYKGVL D KVA+KR S G F
Sbjct: 24 FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEF 82
Query: 317 QREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 376
+ E+ +S H +L+ LIG+C +E IL+Y +M+N ++ L + W R
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTT 435
+ G A GL YLH + IIHRD+K+ NILLD+NF + DFG++K + TH++T
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199
Query: 436 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495
++GT+G+I PEY G+ +EK+DV+ +G+ L E++ + AI S E + L +
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN--LAEWAV 257
Query: 496 KLLREDRLNDIVDRNL-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549
+ +L IVD NL + + + A+ C + EDRP M V+ L+
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 4e-74
Identities = 72/313 (23%), Positives = 121/313 (38%), Gaps = 38/313 (12%)
Query: 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE-- 319
L + + +G FG V+K L N VAVK + ++Q E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF----PIQDKQSWQNEYE 68
Query: 320 VHLISVAIHKNLLQLIGYCTTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR 375
V+ + H+N+LQ IG + + L+ F + S++ L+ + W
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNEL 123
Query: 376 KRVAFGTAYGLEYLHE-------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428
+A A GL YLHE P I HRD+K+ N+LL +N A + DFGLA +A
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 429 KLTHV-TTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFSRL 482
+ T GT ++APE L + + D++ G+ L EL + A D
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV- 242
Query: 483 EEEEDVLLLDHIRKLLREDRLNDIVDRNL------NTYDSKEV-ETMVQVALLCTQSTPE 535
+E + + I + + + ++V + + + + C E
Sbjct: 243 -DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 536 DRPPMAQVVKMLQ 548
R V + +
Sbjct: 302 ARLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 5e-62
Identities = 69/322 (21%), Positives = 117/322 (36%), Gaps = 45/322 (13%)
Query: 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE-- 319
+ E L DN +IG+G +G VYKG L D VAVK S F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKN 57
Query: 320 VHLISVAIHKNLLQLIGYCTTSS-----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 374
++ + + H N+ + I + E +LV + N S+ L DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVS 112
Query: 375 RKRVAFGTAYGLEYLHE------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD- 427
R+A GL YLH P I HRDL + N+L+ ++ V+ DFGL+ +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 428 ------AKLTHVTTQIRGTMGHIAPEYL-------STGKSSEKTDVFGYGITLLELVTGQ 474
+ + GT+ ++APE L + ++ D++ G+ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 475 RAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR--------NLNTYDSKEVETMVQVA 526
+ E + + + + +V R +S V ++ +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 527 LLCTQSTPEDRPPMAQVVKMLQ 548
C E R + +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 5e-56
Identities = 76/272 (27%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
IG G FG V++ + VAVK L + + F REV ++ H N++ +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
T +V ++ S+ L E+ LD R +A+ A G+ YLH NP
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 456
I+HR+LK+ N+L+D + +CDFGL++L A + GT +APE L S+E
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 457 KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 516
K+DV+ +G+ L EL T Q + L + V + K R + ++ +
Sbjct: 219 KSDVYSFGVILWELATLQ--QPWGNLNPAQVVAAV--GFKCKRLEIPRNL--------NP 266
Query: 517 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + C + P RP A ++ +L+
Sbjct: 267 QVAAIIEG----CWTNEPWKRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 3e-54
Identities = 68/283 (24%), Positives = 109/283 (38%), Gaps = 37/283 (13%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
++G+G FG V K VA+K+++ S AF E+ +S H N+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE---SESERKAFIVELRQLSRVNHPNI 63
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 391
++L G C + LV + + S+ L +P + G+ YLH
Sbjct: 64 VKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHS 120
Query: 392 QCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 450
+IHRDLK N+LL + +CDFG A + +T+ G+ +APE
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK----GSAAWMAPEVFE 176
Query: 451 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510
SEK DVF +GI L E++T ++ F + ++ V
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIM--------------WAVHNG 220
Query: 511 L-----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
M + C P RP M ++VK++
Sbjct: 221 TRPPLIKNLPKPIESLMTR----CWSKDPSQRPSMEEIVKIMT 259
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 8e-53
Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 28/275 (10%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
IG G FG VYKG + VAVK L +P AF+ EV ++ H N+L +GY
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 339 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
T + ++ +V + + S+ Y L E + +A TA G++YLH + I
Sbjct: 90 T--APQLAIVTQWCEGSSL-YHH--LHASETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE---YLSTGK 453
IHRDLK+ NI L ++ + DFGLA +H Q+ G++ +APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 454 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513
S ++DV+ +GI L EL+TGQ + +S + + + I + R D+ N
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQI-----IEMVGRGSLSPDLSKVRSNC 254
Query: 514 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
M ++ C + ++RP +++ ++
Sbjct: 255 PKR-----MKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-52
Identities = 62/285 (21%), Positives = 109/285 (38%), Gaps = 36/285 (12%)
Query: 278 NIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
++G+G FG+ K + + + +K L + + F +EV ++ H N+L+ IG
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
+ +++ ++ ++ + W R A A G+ YLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLVD-------------AKLTHVTTQIRGTMGH 443
IIHRDL + N L+ +N V+ DFGLA+L+ + G
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 444 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503
+APE ++ EK DVF +GI L E++ A L+ +R L
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--DPDYLPRTMDFGLN-VRGFLDRYCP 245
Query: 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + + + C PE RP ++ L+
Sbjct: 246 PNC------------PPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 6e-51
Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 38/291 (13%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL------QDYYSPGGEAAFQREVHLIS 324
+ IG+GGFG V+KG + D + VA+K L + FQREV ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 384
H N+++L G +V F+ + +RL D + W + R+ A
Sbjct: 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIAL 133
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-----LCDFGLAKLVDAKLTHVTTQIRG 439
G+EY+ NP I+HRDL++ NI L E + DFGL++ H + + G
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLG 188
Query: 440 TMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 497
+APE + +EK D + + + L ++TG+ F + + +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKIKFINMIREEG 246
Query: 498 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
LR D + V LC P+ RP + +VK L
Sbjct: 247 LRPTIPEDC------------PPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-50
Identities = 73/287 (25%), Positives = 109/287 (37%), Gaps = 46/287 (16%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRL---QDYYSPGGEAAFQREVHLISVAIHKNLLQL 334
IIG GGFGKVY+ +VAVK D ++E L ++ H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 335 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 394
G C LV F + + L K + A A G+ YLH++
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 395 PKIIHRDLKAANILLDDNFEAV--------LCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 446
IIHRDLK++NIL+ E + DFGLA+ T + G +AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA-GAYAWMAP 183
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506
E + S+ +DV+ YG+ L EL+TG+ + F ++ +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE--VPFRGIDGLAVAY---------------GV 226
Query: 507 VDRNL-----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
L +T + M C P RP ++ L
Sbjct: 227 AMNKLALPIPSTCPEPFAKLMED----CWNPDPHSRPSFTNILDQLT 269
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-50
Identities = 72/323 (22%), Positives = 121/323 (37%), Gaps = 63/323 (19%)
Query: 261 RFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 320
R R++ L +G+G +G+V++G VAVK S E ++ RE
Sbjct: 4 RTVARDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIF----SSRDEKSWFRET 51
Query: 321 HLISVAI--HKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPT 374
L + + H+N+L I TS L+ + + S+ L+ LD +
Sbjct: 52 ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVS 106
Query: 375 RKRVAFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429
R+ A GL +LH Q P I HRDLK+ NIL+ N + + D GLA +
Sbjct: 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166
Query: 430 LTHV---TTQIRGTMGHIAPE------YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 480
+ GT ++APE + S ++ D++ +G+ L E+ +
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
Query: 481 R---------------LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQV 525
E+ V+ +D R + +D +L + M +
Sbjct: 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL-------AKLMKE- 278
Query: 526 ALLCTQSTPEDRPPMAQVVKMLQ 548
C P R ++ K L
Sbjct: 279 ---CWYQNPSARLTALRIKKTLT 298
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 9e-50
Identities = 63/285 (22%), Positives = 116/285 (40%), Gaps = 39/285 (13%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+IG+G FG+VY G + +VA++ + + + AF+REV H+N++ +G
Sbjct: 39 ELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
C + ++ + ++ +RD K LD +++A G+ YLH
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLVD----AKLTHVTTQIRGTMGHIAPEYLSTG 452
I+H+DLK+ N+ D+ + V+ DFGL + + G + H+APE +
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 453 KS---------SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503
S+ +DVF G EL + F E I +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE--WPFKTQPAEA-------IIWQMGTGMK 260
Query: 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
++ + + + + L C E+RP +++ ML+
Sbjct: 261 PNLSQIGMG-------KEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-49
Identities = 54/306 (17%), Positives = 104/306 (33%), Gaps = 65/306 (21%)
Query: 273 NFSE---SNIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIH 328
+F + + + G+++KG + VK L +S F E + + H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 329 KNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDL--KPGEKGLDWPTRKRVAFGTAY 384
N+L ++G C + + +M S L ++ + +D + A A
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGS----LYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
G+ +LH P I L + ++++D++ A + + + + +
Sbjct: 123 GMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAPAWV 175
Query: 445 APEYLSTGKS---SEKTDVFGYGITLLELVTGQRA-IDFSRLEEEEDVLLLD-------- 492
APE L D++ + + L ELVT + D S +E V L
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG 235
Query: 493 ---HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549
H+ KL++ C P RP +V +L
Sbjct: 236 ISPHVSKLMKI----------------------------CMNEDPAKRPKFDMIVPIL-- 265
Query: 550 EDLAER 555
E + ++
Sbjct: 266 EKMQDK 271
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-49
Identities = 68/319 (21%), Positives = 119/319 (37%), Gaps = 63/319 (19%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS 324
+++Q+ IG+G +G+V+ G KVAVK EA++ RE +
Sbjct: 37 KQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVF----FTTEEASWFRETEIYQ 84
Query: 325 VAI--HKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 378
+ H+N+L I + L+ + +N S+ L+ LD + ++
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKL 139
Query: 379 AFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433
A+ + GL +LH Q P I HRDLK+ NIL+ N + D GLA + V
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 434 ---TTQIRGTMGHIAPE------YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR--- 481
GT ++ PE + +S D++ +G+ L E+ +
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
Query: 482 ------------LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLC 529
E+ +++ + +R +D R + + M + C
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM-------GKLMTE----C 308
Query: 530 TQSTPEDRPPMAQVVKMLQ 548
P R +V K L
Sbjct: 309 WAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-46
Identities = 69/319 (21%), Positives = 116/319 (36%), Gaps = 63/319 (19%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE--VHL 322
R + L IG+G FG+V++G +VAVK S E ++ RE ++
Sbjct: 42 RTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIF----SSREERSWFREAEIYQ 89
Query: 323 ISVAIHKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 378
+ H+N+L I + LV + ++ S+ L + ++
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKL 144
Query: 379 AFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433
A TA GL +LH Q P I HRDLK+ NIL+ N + D GLA D+ +
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 434 T---TQIRGTMGHIAPEYL------STGKSSEKTDVFGYGITLLELVTGQRAIDFSR--- 481
GT ++APE L +S ++ D++ G+ E+
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
Query: 482 ------------LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLC 529
+EE V+ +R + + R + + M + C
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM-------AKIMRE----C 313
Query: 530 TQSTPEDRPPMAQVVKMLQ 548
+ R ++ K L
Sbjct: 314 WYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 36/283 (12%)
Query: 280 IGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
IG+G FG+V+ G L +DNT VAVK ++ P +A F +E ++ H N+++LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398
T +V +Q LR L T ++ A G+EYL + I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 399 HRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ---IRGTMGHIAPEYLSTGK 453
HRDL A N L+ + + DFG+++ + ++ T APE L+ G+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYGR 291
Query: 454 SSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 512
S ++DV+ +GI L E + G + L ++ + + RL
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP--YPNLSNQQ-T-----REFVEKGGRL----PCPEL 339
Query: 513 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 555
D+ + ++ C P RP + + + L + + +R
Sbjct: 340 CPDA-----VFRLMEQCWAYEPGQRPSFSTIYQEL--QSIRKR 375
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 64/293 (21%), Positives = 120/293 (40%), Gaps = 43/293 (14%)
Query: 278 NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 332
+G+G FGKV + +VAVK L+ A ++E+ ++ H+N++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 333 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 389
+ G CT L+ F+ + S L++ L + ++ + + A G++YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGS----LKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 443
+ + +HRDL A N+L++ + + DFGL K ++ + T + +
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY--- 196
Query: 444 IAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE------DVLLLDHIRK 496
APE L K +DV+ +G+TL EL+T L + + + +
Sbjct: 197 -APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255
Query: 497 LLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
L RL N EV + M + C + P +R +++ +
Sbjct: 256 LKEGKRL----PCPPNC--PDEVYQLMRK----CWEFQPSNRTSFQNLIEGFE 298
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 59/240 (24%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 248 GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVK 302
GE + L L+ E + ++G G FG VYKG+ VA+K
Sbjct: 1 GEAPNQALLRILKE---TEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 50
Query: 303 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 362
L++ SP E ++++ + ++ +L+G C TS+ ++ + M L D
Sbjct: 51 ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGC----LLD 105
Query: 363 -LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421
++ + + A G+ YL ++ +++HRDL A N+L+ + DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 422 LAKLVDAKLTHVTTQ-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 475
LAKL+ A+ + I+ A E + + ++DV+ YG+T+ EL+T G +
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 276 ESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
+IG+G FG VY G D + A+K L AF RE L+ H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 332 LQLIGYCTTSSERIL-VYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 389
L LIG + P+M + L ++ ++ A G+EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGD----LLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---AP 446
EQ K +HRDL A N +LD++F + DFGLA+ + + + Q R + A
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVT 472
E L T + + K+DV+ +G+ L EL+T
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 77/284 (27%), Positives = 119/284 (41%), Gaps = 40/284 (14%)
Query: 278 NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+IG+G FG VY G L DN AVK L G + F E ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 334 LIGYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
L+G C S L V P+M++ + +R+ A G++YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASK 147
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYL 449
K +HRDL A N +LD+ F + DFGLA+ + K + G + A E L
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 450 STGKSSEKTDVFGYGITLLELVT-GQR---AIDFSRLEEEEDVLLLDHIRKLLREDRLND 505
T K + K+DV+ +G+ L EL+T G ++ D+ LL+ RL
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDI-----TVYLLQGRRL-- 251
Query: 506 IVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + E M++ C E RP +++V +
Sbjct: 252 --LQPEYC--PDPLYEVMLK----CWHPKAEMRPSFSELVSRIS 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 16/203 (7%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
IG+G F VYKG+ +VA LQD + F+ E ++ H N+++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 337 YCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
++ + +LV M + ++ L+ K + + GL++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT- 147
Query: 393 CNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 451
P IIHRDLK NI + +V + D GLA L A + GT +APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 452 GKSSEKTDVFGYGITLLELVTGQ 474
E DV+ +G+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 278 NIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 332
++G G FG V+KGV V +K ++D A + I H +++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 333 QLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 391
+L+G C SS ++ V ++ S L D ++ L A G+ YL E
Sbjct: 79 RLLGLCPGSSLQL-VTQYLPLGS----LLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGHIAP 446
++HR+L A N+LL + + DFG+A L+ + I+ A
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----AL 186
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 475
E + GK + ++DV+ YG+T+ EL+T G
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 38/143 (26%), Positives = 61/143 (42%), Gaps = 9/143 (6%)
Query: 36 EGEALIEVLKALNDTHGQFTDWNDHFVSPCF-SWSHVTC----RNGNVISLTLGSNGFSG 90
+ +AL+++ K L + + W C +W V C + V +L L
Sbjct: 7 DKQALLQIKKDLGN-PTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 91 --KISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQL 148
I S+ L +L N+L G +P + +T L L + + SG+IP SQ+
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 149 SNLKHLDLSSNNLTGRIPMQLFS 171
L LD S N L+G +P + S
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISS 147
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 36/120 (30%), Positives = 50/120 (41%), Gaps = 5/120 (4%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N N+ + L N G S K L N L+ L +G +L L+L N
Sbjct: 196 NLNLAFVDLSRNMLEGDASVLFGSDKNTQKI-HLAKNSLAFDLGK-VGLSKNLNGLDLRN 253
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM--QLFSVATFNFTGTHLICGSSLEQPC 192
N+ G++P +QL L L++S NNL G IP L + +CGS L C
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL-PAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 2/96 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ L + SG I ++++K L + + N LSGTLP + S+ +L + N+
Sbjct: 102 QLHYLYITHTNVSGAIPDFLSQIKTLVTL-DFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 137 FSGSIPATWSQLSNL-KHLDLSSNNLTGRIPMQLFS 171
SG+IP ++ S L + +S N LTG+IP +
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 1/90 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
N++ +T N SG I S L + + N L+G +P ++ L ++L+ N
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
G + N + + L+ N+L +
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
IG G FG V+ G + KVA+K +++ E F E ++ H L+QL G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 338 CTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
C + LV FM++ L D L+ T + G+ YL E
Sbjct: 72 CLEQAPICLVTEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---C 124
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTG 452
+IHRDL A N L+ +N + DFG+ + V D + T+ ++ +PE S
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFS 180
Query: 453 KSSEKTDVFGYGITLLELVT 472
+ S K+DV+ +G+ + E+ +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 78/292 (26%), Positives = 119/292 (40%), Gaps = 42/292 (14%)
Query: 278 NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 332
+ +G+G FG V + VAVK+LQ P + FQRE+ ++ ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIV 87
Query: 333 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 389
+ G + LV ++ + LRD L+ LD + G+EYL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGC----LRDFLQRHRARLDASRLLLYSSQICKGMEYL 143
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI----- 444
+ + +HRDL A NIL++ + DFGLAKL+ + + G
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR---EPGQSPIFWY 197
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVT-GQR-----AIDFSRLEEEEDVLLLDHIRKLL 498
APE LS S ++DV+ +G+ L EL T + A + E DV L + +LL
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 499 RED-RLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
E RL EV E M C +P+DRP + + L
Sbjct: 258 EEGQRL----PAPPAC--PAEVHELMKL----CWAPSPQDRPSFSALGPQLD 299
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 59/240 (24%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 248 GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVK 302
GE + L L+ E + ++G G FG VYKG+ VA+K
Sbjct: 1 GEAPNQALLRILKE---TEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 50
Query: 303 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 362
L++ SP E ++++ + ++ +L+G C TS+ ++ + M L D
Sbjct: 51 ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGC----LLD 105
Query: 363 -LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421
++ + + A G+ YL ++ +++HRDL A N+L+ + DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 422 LAKLVDAKLTHVTTQ-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 475
LAKL+ A+ + I+ A E + + ++DV+ YG+T+ EL+T G +
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 278 NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+IG+G FG VY G L DN AVK L G + F E ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 334 LIGYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
L+G C S L V P+M++ + +R+ A G+++L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK 211
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYL 449
K +HRDL A N +LD+ F + DFGLA+ + K G + A E L
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 450 STGKSSEKTDVFGYGITLLELVT 472
T K + K+DV+ +G+ L EL+T
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMT 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 76/312 (24%), Positives = 121/312 (38%), Gaps = 48/312 (15%)
Query: 264 CRELQLATDN--FSESNI-----IGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPG 311
Q D F + + +G+G FGKV VAVK L+ P
Sbjct: 16 EVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ 75
Query: 312 GEAAFQREVHLISVAIHKNLLQLIGYCTTSSER--ILVYPFMQNLSVAYRLRDLKPGEKG 369
+ +++E+ ++ H+++++ G C + LV ++ S LRD P
Sbjct: 76 HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS----LRDYLPRHS- 130
Query: 370 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429
+ A G+ YLH Q IHRDL A N+LLD++ + DFGLAK V
Sbjct: 131 IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187
Query: 430 LTHVTTQIRGT-----MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE 483
+ + G APE L K +DV+ +G+TL EL+T +
Sbjct: 188 HEYYRVREDGDSPVFWY---APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF 244
Query: 484 EEEDV-----LLLDHIRKLLRE-DRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPED 536
E + + + +LL +RL R EV M C ++
Sbjct: 245 LELIGIAQGQMTVLRLTELLERGERL----PRPDKC--PAEVYHLMKN----CWETEASF 294
Query: 537 RPPMAQVVKMLQ 548
RP ++ +L+
Sbjct: 295 RPTFENLIPILK 306
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 73/322 (22%), Positives = 131/322 (40%), Gaps = 53/322 (16%)
Query: 278 NIIGQGGFGKVYKGVLSDN----TKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLL 332
++G+G FG V + L KVAVK L D + F RE + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 333 QLIGYCTTSSERI------LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AY 384
+L+G S + ++ PFM++ + L + GE + P + V F A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
G+EYL + IHRDL A N +L ++ + DFGL++ + + + +G +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCASKL 201
Query: 445 -----APEYLSTGKSSEKTDVFGYGITLLELVT-GQR---AIDFSRLEEEEDVLLLDHIR 495
A E L+ + +DV+ +G+T+ E++T GQ I+ ++
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE------NAEI-----YN 250
Query: 496 KLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAE 554
L+ +RL + +EV + M Q C + P+ RP + L E++
Sbjct: 251 YLIGGNRL----KQPPEC--MEEVYDLMYQ----CWSADPKQRPSFTCLRMEL--ENILG 298
Query: 555 RWAEWEELEEVRQQEVSLLPHQ 576
+ ++ + H
Sbjct: 299 HLSVLSTSQDPLYINIERAHHH 320
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-34
Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 26/272 (9%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
+GQG FG+V+ G + T+VA+K L+ AF +E ++ H+ L+QL
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
+ I V +M S+ L+ K L P +A A G+ Y+
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 457
+HRDL+AANIL+ +N + DFGLA+L++ + + APE G+ + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 458 TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSK 517
+DV+ +GI L EL T R + + + E +LD + + R + +
Sbjct: 362 SDVWSFGILLTELTTKGR-VPYPGMVNRE---VLDQVERGYRMPCPPEC---------PE 408
Query: 518 EV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + M Q C + PE+RP + L+
Sbjct: 409 SLHDLMCQ----CWRKEPEERPTFEYLQAFLE 436
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 278 NIIGQGGFGKVYKGVLSD----NTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLL 332
I+G+G FG V +G L + KVAVK + D S F E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 333 QLIGYCT-----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYG 385
+L+G C + +++ PFM+ + L + P + + F A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI- 444
+EYL + +HRDL A N +L D+ + DFGL+K + + + +G + +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QGRIAKMP 212
Query: 445 ----APEYLSTGKSSEKTDVFGYGITLLELVT 472
A E L+ + K+DV+ +G+T+ E+ T
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
+G G FG V G VA+K +++ E F E ++ H+ L+QL G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 338 CTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
CT ++ +M N L + L+ + +EYL + +
Sbjct: 88 CTKQRPIFIITEYMANGC----LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 140
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTG 452
+HRDL A N L++D + DFGL++ V D + V ++ +R + PE L
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYS 196
Query: 453 KSSEKTDVFGYGITLLELVT 472
K S K+D++ +G+ + E+ +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 16/198 (8%)
Query: 279 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
+G G FG V G VAVK +++ E F +E + H L++ G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 339 TTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
+ +V ++ N L + L+ KGL+ + + G+ +L +
Sbjct: 73 SKEYPIYIVTEYISNGC----LLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYLSTGKS 454
IHRDL A N L+D + + DFG+ + V GT + APE K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVL---DDQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 455 SEKTDVFGYGITLLELVT 472
S K+DV+ +GI + E+ +
Sbjct: 183 SSKSDVWAFGILMWEVFS 200
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 278 NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 332
+G+G FG V + VAVK+LQ + F+RE+ ++ H N++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 74
Query: 333 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 389
+ G C ++ R L+ ++ S LRD L+ ++ +D + G+EYL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGS----LRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 443
+ + IHRDL NIL+++ + DFGL K++ + I
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY--- 184
Query: 444 IAPEYLSTGKSSEKTDVFGYGITLLELVT 472
APE L+ K S +DV+ +G+ L EL T
Sbjct: 185 -APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 280 IGQGGFGKVYKGVL---SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+G G FG V +GV VA+K L+ RE ++ + +++LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 395
C + + V L L + + + + G++YL E+
Sbjct: 78 VCQAEALML-VMEMAGGGP----LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 129
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG------TMGHIAPEYL 449
+HRDL A N+LL + A + DFGL+K + A ++ T + G APE +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 185
Query: 450 STGKSSEKTDVFGYGITLLELVT-GQR 475
+ K S ++DV+ YG+T+ E ++ GQ+
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-33
Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 26/272 (9%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
+GQG FG+V+ G + T+VA+K L+ AF +E ++ H+ L+QL
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
+ I V +M S+ L+ K L P +A A G+ Y+
Sbjct: 331 VSEEPIYI-VTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 457
+HRDL+AANIL+ +N + DFGLA+L++ + + APE G+ + K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 458 TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSK 517
+DV+ +GI L EL T R + + + E +LD + + R + +
Sbjct: 445 SDVWSFGILLTELTTKGR-VPYPGMVNRE---VLDQVERGYRMPCPPEC---------PE 491
Query: 518 EV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + M Q C + PE+RP + L+
Sbjct: 492 SLHDLMCQ----CWRKEPEERPTFEYLQAFLE 519
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 74/295 (25%), Positives = 131/295 (44%), Gaps = 53/295 (17%)
Query: 278 NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQ 333
++IG+G FG+V K + + A+KR+++Y S F E+ ++ + H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------------RVAFG 381
L+G C L + + ++ LR + E + A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 441
A G++YL ++ + IHRDL A NIL+ +N+ A + DFGL++ + ++ TM
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 200
Query: 442 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR 495
G + A E L+ + +DV+ YG+ L E+V+ G + + E +
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAE-------LY 251
Query: 496 KLLRED-RLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ L + RL ++ LN EV + M Q C + P +RP AQ++ L
Sbjct: 252 EKLPQGYRL----EKPLNC--DDEVYDLMRQ----CWREKPYERPSFAQILVSLN 296
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 44/207 (21%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 279 IIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 334
I+G+G FG+VY+GV + VAVK + + + F E ++ H ++++L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 335 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
IG I + L L+ + L T + + YL
Sbjct: 79 IGIIEEEPTWI-IMELYPYGE----LGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI- 132
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYL 449
+HRD+ NIL+ L DFGL++ ++ + + + I+ +PE +
Sbjct: 133 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186
Query: 450 STGKSSEKTDVFGYGITLLELVT-GQR 475
+ + + +DV+ + + + E+++ G++
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 69/294 (23%), Positives = 120/294 (40%), Gaps = 45/294 (15%)
Query: 278 NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 332
+G+G FG V + VAVK+LQ + F+RE+ ++ H N++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 105
Query: 333 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 389
+ G C ++ R L+ ++ S LRD L+ ++ +D + G+EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGS----LRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 443
+ + IHRDL NIL+++ + DFGL K++ + + I
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY--- 215
Query: 444 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV-------LLLDHIRK 496
APE L+ K S +DV+ +G+ L EL T E + +++ H+ +
Sbjct: 216 -APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 497 LLRED-RLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
LL+ + RL R E+ M + C + RP + +
Sbjct: 275 LLKNNGRL----PRPDGC--PDEIYMIMTE----CWNNNVNQRPSFRDLALRVD 318
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 278 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
IIG G G+V G L + VA+K L+ Y+ F E ++ H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
L G T ++V +M+N S L L+ + + G G+ YL +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGS----LDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAP 446
+HRDL A N+L+D N + DFGL+++++ T IR T AP
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----AP 223
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 475
E ++ S +DV+ +G+ + E++ G+R
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 7e-33
Identities = 69/288 (23%), Positives = 131/288 (45%), Gaps = 26/288 (9%)
Query: 278 NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+ +G G +G+VY+GV + VAVK L++ F +E ++ H NL+QL+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
CT ++ FM ++ LR + + + +A + +EYL ++
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 456
IHR+L A N L+ +N + DFGL++L+ + + APE L+ K S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 457 KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 516
K+DV+ +G+ L E+ T + ++ + + + + K R +R ++
Sbjct: 399 KSDVWAFGVLLWEIATYGM-SPYPGIDLSQ---VYELLEKDYRMERPEGCPEK------- 447
Query: 517 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEE 564
+ ++ C Q P DRP A++ + E + + + +E+E+
Sbjct: 448 -----VYELMRACWQWNPSDRPSFAEIHQAF--ETMFQESSISDEVEK 488
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 74/293 (25%), Positives = 133/293 (45%), Gaps = 36/293 (12%)
Query: 278 NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+ +G G +G+VY+GV + VAVK L++ F +E ++ H NL+QL+G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
CT ++ FM ++ LR+ E + +A + +EYL ++
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---N 131
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYLSTG 452
IHRDL A N L+ +N + DFGL++L+ I+ T APE L+
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 453 KSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511
K S K+DV+ +G+ L E+ T G + ++ + + + + K R +R ++
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQ---VYELLEKDYRMERPEGCPEK-- 240
Query: 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEE 564
+ ++ C Q P DRP A++ + E + + + +E+E+
Sbjct: 241 ----------VYELMRACWQWNPSDRPSFAEIHQAF--ETMFQESSISDEVEK 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 75/290 (25%), Positives = 117/290 (40%), Gaps = 44/290 (15%)
Query: 278 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
+G G FG+VY+G +S +VAVK L + S E F E +IS H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR---VAFGTAYGLEY 388
++ IG S R ++ M + LR+ +P VA A G +Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLC---DFGLAKLVDAKLTHVTTQIR-GTMGHI 444
L E IHRD+ A N LL + DFG+A+ + + + R G +
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAML 207
Query: 445 -----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL 498
PE G + KTD + +G+ L E+ + G + +E +L+ +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQE---VLEFVTSGG 262
Query: 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
R D + Y M Q C Q PEDRP A +++ ++
Sbjct: 263 RMDPPKNCPGP---VY-----RIMTQ----CWQHQPEDRPNFAIILERIE 300
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 64/290 (22%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 278 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
+GQG FG VY+GV T+VA+K + + S F E ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKR---VAFGTAYG 385
++L+G + +++ M + LR L+P L P+ + +A A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI- 444
+ YL+ K +HRDL A N ++ ++F + DFG+ + + + +G G +
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLP 203
Query: 445 ----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLR 499
+PE L G + +DV+ +G+ L E+ T ++ + L E+ +L + +
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQ---VLRFVMEGGL 258
Query: 500 EDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
D+ ++ + E M C Q P+ RP +++ ++
Sbjct: 259 LDKPDNC---------PDMLFELMRM----CWQYNPKMRPSFLEIISSIK 295
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 279 IIGQGGFGKVYKGVL---SDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQL 334
+G G FG V KG VAVK L + P + E +++ + ++++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 335 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
IG C S + V + L L+ + + + G++YL E
Sbjct: 84 IGICEAESWML-VMEMAELGP----LNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEES- 136
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAPE 447
+HRDL A N+LL A + DFGL+K + A + Q ++ APE
Sbjct: 137 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APE 190
Query: 448 YLSTGKSSEKTDVFGYGITLLELVT-GQR 475
++ K S K+DV+ +G+ + E + GQ+
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 279 IIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 334
IG+G FG V++G+ VA+K ++ S F +E + H ++++L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 335 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
IG T + I + LR L+ + LD + A+ + L YL +
Sbjct: 82 IGVITENPVWI-IMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 135
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYL 449
+ +HRD+ A N+L+ N L DFGL++ ++ + ++ I+ APE +
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 189
Query: 450 STGKSSEKTDVFGYGITLLELVT-GQR 475
+ + + +DV+ +G+ + E++ G +
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 279 IIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+IG G FG+VYKG+L VA+K L+ Y+ F E ++ H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
L G + +++ +M+N + L L+ + + G A G++YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGA----LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQ-----IRGTMGHIAP 446
+HRDL A NIL++ N + DFGL++++ D TT IR T AP
Sbjct: 167 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----AP 219
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 475
E +S K + +DV+ +GI + E++T G+R
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-32
Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
IG+G FG V G KVAVK +++ + AF E +++ H NL+QL+G
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 338 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
+ +V +M S+ LR G L + + +EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLSTGKS 454
+HRDL A N+L+ ++ A + DFGL K +A T T + ++ T APE L K
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT----APEALREKKF 363
Query: 455 SEKTDVFGYGITLLELVT 472
S K+DV+ +GI L E+ +
Sbjct: 364 STKSDVWSFGILLWEIYS 381
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 72/290 (24%), Positives = 116/290 (40%), Gaps = 44/290 (15%)
Query: 278 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
+G G FG+VY+G +S +VAVK L + S E F E +IS H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR---VAFGTAYGLEY 388
++ IG S R ++ M + LR+ +P VA A G +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLC---DFGLAKLVDAKLTHVTTQIR-GTMGHI 444
L E IHRD+ A N LL + DFG+A+ + + R G +
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRAGYYRKGGCAML 248
Query: 445 -----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL 498
PE G + KTD + +G+ L E+ + G + +E +L+ +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQE---VLEFVTSGG 303
Query: 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
R D + + ++ C Q PEDRP A +++ ++
Sbjct: 304 RMDPPKNCPGP------------VYRIMTQCWQHQPEDRPNFAIILERIE 341
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-32
Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
IG+G FG V G KVAVK +++ + AF E +++ H NL+QL+G
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 338 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 396
+ +V +M S+ LR G L + + +EYL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLSTGKS 454
+HRDL A N+L+ ++ A + DFGL K +A T T + ++ T APE L K
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT----APEALREKKF 191
Query: 455 SEKTDVFGYGITLLELVT 472
S K+DV+ +GI L E+ +
Sbjct: 192 STKSDVWSFGILLWEIYS 209
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 67/299 (22%), Positives = 120/299 (40%), Gaps = 53/299 (17%)
Query: 278 NIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIH 328
+G+G FG+V VAVK L+D + + E+ ++ + H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 329 KNLLQLIGYCTTSSERILVYPFMQN------------LSVAYRLRDLKPGEKGLDWPTRK 376
KN++ L+G CT ++ + + Y + E+ + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 436
+ A G+EYL Q K IHRDL A N+L+ +N + DFGLA+ ++ + T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 437 -----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL 490
++ APE L + ++DV+ +G+ + E+ T G + + EE L
Sbjct: 218 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEE---L 268
Query: 491 LDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+++ R D+ + + E+ M C + P RP Q+V+ L
Sbjct: 269 FKLLKEGHRMDKPANC---------TNELYMMMRD----CWHAVPSQRPTFKQLVEDLD 314
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-32
Identities = 63/211 (29%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 279 IIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLL 332
+G G FG V +G VAVK L+ P F REV+ + H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 333 QLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 391
+L G T ++ V S L D L+ + T R A A G+ YL
Sbjct: 85 RLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIA 445
+ + IHRDL A N+LL + DFGL + + H Q A
Sbjct: 140 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----A 192
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVT-GQR 475
PE L T S +D + +G+TL E+ T GQ
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 26/204 (12%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
+G G FG+V+ G + +TKVAVK L+ AF E +L+ H+ L++L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
T I + +M+N S+ L+ P L +A A G+ ++ E+
Sbjct: 77 VTQEPIYI-ITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVD---------AKLTHVTTQIRGTMGHIAPEY 448
IHRDL+AANIL+ D + DFGLA+L++ AK I+ T APE
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-----IKWT----APEA 181
Query: 449 LSTGKSSEKTDVFGYGITLLELVT 472
++ G + K+DV+ +GI L E+VT
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 67/304 (22%), Positives = 120/304 (39%), Gaps = 63/304 (20%)
Query: 278 NIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIH 328
+G+G FG+V VAVK L+D + + E+ ++ + H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 329 KNLLQLIGYCTTSSERILVYPFMQN------------LSVAYRLRDLKPGEKGLDWPTRK 376
KN++ L+G CT ++ + + Y + E+ + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---------- 426
+ A G+EYL Q K IHRDL A N+L+ +N + DFGLA+ +
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 485
+ +L ++ APE L + ++DV+ +G+ + E+ T G + + E
Sbjct: 264 NGRLP-----VKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVE 312
Query: 486 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVV 544
E L +++ R D+ + + E+ M C + P RP Q+V
Sbjct: 313 E---LFKLLKEGHRMDKPANC---------TNELYMMMRD----CWHAVPSQRPTFKQLV 356
Query: 545 KMLQ 548
+ L
Sbjct: 357 EDLD 360
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 278 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
++G G FG+V G L VA+K L+ Y+ F E ++ H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
L G T S ++V +M+N S L L+ + + G A G++YL +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGS----LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAP 446
+HRDL A NIL++ N + DFGL ++++ T IR T +P
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SP 219
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 475
E ++ K + +DV+ YGI L E+++ G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 51/298 (17%)
Query: 278 NIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 330
+G+G FG+V + + VAVK L++ + A E+ ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 331 LLQLIGYCTTSSERILV-YPFMQN------------LSVAYRLRDLKPGEKGLDWPTRKR 377
++ L+G CT ++V F + V Y++ + L
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 378 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ- 436
+F A G+E+L + K IHRDL A NILL + +CDFGLA+ + +V
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 437 ----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL 491
++ APE + + ++DV+ +G+ L E+ + G + ++ +E+
Sbjct: 210 ARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFC-- 261
Query: 492 DHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
R+L R+ T + E+ +TM+ C P RP +++V+ L
Sbjct: 262 ---RRLKEGTRM----RAPDYT--TPEMYQTMLD----CWHGEPSQRPTFSELVEHLG 306
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
+G G FG+V+ + +TKVAVK ++ AF E +++ H L++L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
T I + FM S+ L+ P + A G+ ++ ++
Sbjct: 252 VTKEPIYI-ITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYLSTGKS 454
IHRDL+AANIL+ + + DFGLA++++ + T G I APE ++ G
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 455 SEKTDVFGYGITLLELVT 472
+ K+DV+ +GI L+E+VT
Sbjct: 363 TIKSDVWSFGILLMEIVT 380
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 280 IGQGGFGKVYKGVL---SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+G G FG V +GV VA+K L+ RE ++ + +++LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 395
C + + V L L + + + + G++YL E+
Sbjct: 404 VCQAEALML-VMEMAGGGP----LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 455
Query: 396 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAPEYL 449
+HR+L A N+LL + A + DFGL+K + A ++ T + ++ APE +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 511
Query: 450 STGKSSEKTDVFGYGITLLELVT-GQR 475
+ K S ++DV+ YG+T+ E ++ GQ+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 64/296 (21%), Positives = 109/296 (36%), Gaps = 50/296 (16%)
Query: 278 NIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
+G+ FGKVYKG L VA+K L+D F+ E L + H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------------RVA 379
+ L+G T +++ + + + L P + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 380 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--- 436
A G+EYL ++H+DL N+L+ D + D GL + V A +
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 437 --IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH 493
IR APE + GK S +D++ YG+ L E+ + G + + ++ +++
Sbjct: 192 LPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQD---VVEM 242
Query: 494 IRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
IR +D V M++ C P RP + L+
Sbjct: 243 IRNRQVLPCPDDC---------PAWVYALMIE----CWNEFPSRRPRFKDIHSRLR 285
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 73/337 (21%), Positives = 128/337 (37%), Gaps = 64/337 (18%)
Query: 280 IGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 330
+G+G FG+V + TKVAVK L+ + + E+ ++ + HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 331 LLQLIGYCTTSSERILVYPFMQN------------LSVAYRLRDLKPGEKGLDWPTRKRV 378
++ L+G CT ++ + + Y E+ L
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 379 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-- 436
A+ A G+EYL + K IHRDL A N+L+ ++ + DFGLA+ + + T
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 437 ---IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 492
++ APE L + ++DV+ +G+ L E+ T G + + EE L
Sbjct: 254 RLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEE---LFK 304
Query: 493 HIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 551
+++ R D+ ++ + E+ M C + P RP Q+V+ L
Sbjct: 305 LLKEGHRMDKPSNC---------TNELYMMMRD----CWHAVPSQRPTFKQLVEDLD--- 348
Query: 552 LAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQE 588
+ QE+ H D +
Sbjct: 349 --------RIVALTSNQEMGYYHHHHHHDYDIPTTEN 377
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 58/300 (19%)
Query: 278 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 330
+G G FGKV + KVAVK L+ + A E+ ++S + H+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----------RVAF 380
++ L+G CT +++ + + LR + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 381 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV----------DAKL 430
A G+ +L + IHRD+ A N+LL + A + DFGLA+ + +A+L
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 489
++ APE + + ++DV+ YGI L E+ + G + +
Sbjct: 229 P-----VKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLG--LNPYPGILVNSKFY 277
Query: 490 LLDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + ++ + K + M C P RP Q+ LQ
Sbjct: 278 -----KLVKDGYQM----AQPAFA--PKNIYSIMQA----CWALEPTHRPTFQQICSFLQ 322
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 10/151 (6%)
Query: 26 FGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGS 85
S+ E LI L D DW+ + +PC ++ VTCR+ V S+ L S
Sbjct: 3 QASPSQSLYREIHQLISFKDVLPD-KNLLPDWSSN-KNPC-TFDGVTCRDDKVTSIDLSS 59
Query: 86 NGFS---GKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP 142
+ +S S+ L L S L ++ ++G++ F L SL+L+ N SG +
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLF-LSNSHINGSVSGF-KCSASLTSLDLSRNSLSGPVT 117
Query: 143 ATWS--QLSNLKHLDLSSNNLTGRIPMQLFS 171
S S LK L++SSN L +
Sbjct: 118 TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGL 148
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-27
Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 1/99 (1%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
+ +L L N +G+I ++ L L +N L+G +P ++G + +L L L
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWIS-LSNNRLTGEIPKWIGRLENLAILKL 521
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+NN FSG+IPA +L LDL++N G IP +F
Sbjct: 522 SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 38/94 (40%), Positives = 51/94 (54%), Gaps = 1/94 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ L L +NGF+GKI P+++ L S L N LSGT+P LGS++ L+ L L N
Sbjct: 395 TLQELYLQNNGFTGKIPPTLSNCSELVSL-HLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 170
G IP + L+ L L N+LTG IP L
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-25
Identities = 45/135 (33%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
G+++ L + N SG I I + +L L ND+SG++PD +G + L L+L++N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFIL-NLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIP-MQLFSVATFN---FTGTHLICGSSLEQP 191
K G IP S L+ L +DLS+NNL+G IP M F TF F +CG L
Sbjct: 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE--TFPPAKFLNNPGLCGYPL-PR 747
Query: 192 CMSRPSPPVSTSRTK 206
C + + +
Sbjct: 748 CDPSNADGYAHHQRS 762
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 34/94 (36%), Positives = 47/94 (50%), Gaps = 1/94 (1%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
++SL L N SG I S+ L L + L N L G +P L + L++L L
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK-LWLNMLEGEIPQELMYVKTLETLIL 473
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
N +G IP+ S +NL + LS+N LTG IP
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 3/98 (3%)
Query: 76 GNVISLTLGSNGFSGKISPSI--TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLA 133
++++L L SN FSG I P++ L LQ+N +G +P L + + L SL+L+
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY-LQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
N SG+IP++ LS L+ L L N L G IP +L
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-23
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 80 SLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
L+L N F+G+I + L L +L N G +P F GS + L+SL L++N
Sbjct: 273 YLSLAENKFTGEIPDFLSGACDTLTGL----DLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 136 KFSGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 171
FSG +P ++ LK LDLS N +G +P L +
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTN 365
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-23
Identities = 37/95 (38%), Positives = 46/95 (48%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLG--SMTHLQSLNLAN 134
+ L L N FSG++ S+T L +L N+ SG + L LQ L L N
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 169
N F+G IP T S S L L LS N L+G IP L
Sbjct: 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-23
Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 77 NVISLTLGSNGFSGKISPS-ITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
+ L + N SG + S L+FL ++ N+ S +P FLG + LQ L+++ N
Sbjct: 179 ELKHLAISGNKISGDVDVSRCVNLEFL----DVSSNNFSTGIP-FLGDCSALQHLDISGN 233
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
K SG S + LK L++SSN G IP
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK 269
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 38/97 (39%), Positives = 50/97 (51%), Gaps = 3/97 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLP-DFLGSMTHLQSLNLANN 135
+ L L N F G + P L S L N+ SG LP D L M L+ L+L+ N
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESL-ALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
Query: 136 KFSGSIPATWSQLS-NLKHLDLSSNNLTGRIPMQLFS 171
+FSG +P + + LS +L LDLSSNN +G I L
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ 390
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-22
Identities = 35/101 (34%), Positives = 50/101 (49%), Gaps = 9/101 (8%)
Query: 76 GNVISLT---LGSNGFSGKISPSI-TKLKFLASFRELQDNDLSGTLPDFL-GSMTHLQSL 130
L + SN F G I P L++L L +N +G +PDFL G+ L L
Sbjct: 244 STCTELKLLNISSNQFVGPIPPLPLKSLQYL----SLAENKFTGEIPDFLSGACDTLTGL 299
Query: 131 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+L+ N F G++P + S L+ L LSSNN +G +PM
Sbjct: 300 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-19
Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
N+ ++L +N +G+I I +L+ LA + L +N SG +P LG L L+L
Sbjct: 487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK-LSNNSFSGNIPAELGDCRSLIWLDL 545
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
N F+G+IPA + S +++N + G+ + + +
Sbjct: 546 NTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKN 580
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-18
Identities = 18/91 (19%), Positives = 35/91 (38%), Gaps = 1/91 (1%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFR-ELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 138
S + +N +GK I + G + L ++ N+ + +
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621
Query: 139 GSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 169
G T+ ++ LD+S N L+G IP ++
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-14
Identities = 25/101 (24%), Positives = 35/101 (34%), Gaps = 7/101 (6%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
R N+ L L +N FSG I + + L L N +GT+P + QS +
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLD-LNTNLFNGTIPAAMFK----QSGKI 565
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSN--NLTGRIPMQLFS 171
A N +G K + N G QL
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 73/304 (24%), Positives = 131/304 (43%), Gaps = 58/304 (19%)
Query: 278 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
+G+G FGKV K T VAVK L++ SP E +++ H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--------- 382
++L G C+ +L+ + + S+ LR+ + G R +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 383 -----------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431
+ G++YL E K++HRDL A NIL+ + + + DFGL++ V + +
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 432 HVTTQIRGTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 485
+V + + G I A E L + ++DV+ +G+ L E+VT G + + E
Sbjct: 206 YV----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG--NPYPGIPPE 259
Query: 486 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVV 544
L + ++ R +R ++ S+E+ M+Q C + P+ RP A +
Sbjct: 260 R---LFNLLKTGHRMERPDNC---------SEEMYRLMLQ----CWKQEPDKRPVFADIS 303
Query: 545 KMLQ 548
K L+
Sbjct: 304 KDLE 307
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 69/309 (22%), Positives = 114/309 (36%), Gaps = 47/309 (15%)
Query: 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREV 320
F + + ++ +G+GGF V L D A+KR+ + QRE
Sbjct: 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQQDREEAQREA 77
Query: 321 HLISVAIHKNLLQLIGYCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 376
+ + H N+L+L+ YC L+ PF + ++ + LK L
Sbjct: 78 DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--------DA 428
+ G GLE +H HRDLK NILL D + VL D G A
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 429 KLTHVTTQIRGTMGHIAPEYLSTGKS----SEKTDVFGYGITLLELVTGQRAIDFSRLEE 484
R T+ + APE L + +S E+TDV+ G L ++ G+ + + +
Sbjct: 195 LTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--YDMVFQ 251
Query: 485 EEDVLLLDHIRKLLREDRLNDIVDRNL-----NTYDSKEVETMVQVALLCTQSTPEDRPP 539
+ D + L V L + S + ++ + P RP
Sbjct: 252 KGDSVAL--------------AVQNQLSIPQSPRH-SSALWQLLNSMM---TVDPHQRPH 293
Query: 540 MAQVVKMLQ 548
+ ++ L+
Sbjct: 294 IPLLLSQLE 302
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-30
Identities = 49/217 (22%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREV 320
R+ ++ + IG+G FG V++G+ + VA+K ++ S F +E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 321 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVA 379
+ H ++++LIG T + I + LR L+ + LD + A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGE----LRSFLQVRKFSLDLASLILYA 497
Query: 380 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--- 436
+ + L YL + + +HRD+ A N+L+ N L DFGL++ ++ + ++
Sbjct: 498 YQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 437 -IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 472
I+ APE ++ + + +DV+ +G+ + E++
Sbjct: 555 PIKWM----APESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 67/305 (21%), Positives = 122/305 (40%), Gaps = 59/305 (19%)
Query: 278 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 330
++G G FGKV + +VAVK L++ A E+ +++ + H+N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 331 LLQLIGYCTTSSERILVYPFMQN----------------LSVAYRLRDLKPGEKGLDWPT 374
++ L+G CT S L++ + + Y + E+ L+ T
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 375 RKR---VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431
+ A+ A G+E+L + +HRDL A N+L+ +CDFGLA+ + +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 432 HVTTQ-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 485
+V ++ APE L G + K+DV+ YGI L E+ + G + + +
Sbjct: 228 YVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLG--VNPYPGIPVD 281
Query: 486 EDVLLLDHIRKLLRE-DRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQV 543
+ KL++ ++ D+ ++E+ M C RP +
Sbjct: 282 ANFY------KLIQNGFKM----DQPFYA--TEEIYIIMQS----CWAFDSRKRPSFPNL 325
Query: 544 VKMLQ 548
L
Sbjct: 326 TSFLG 330
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 64/299 (21%), Positives = 113/299 (37%), Gaps = 52/299 (17%)
Query: 278 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 330
+G G FGKV + VAVK L+ A E+ ++S + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 331 LLQLIGYCTTSSERILVYPFMQN--------------LSVAYRLRDLKPGEKGLDWPTRK 376
++ L+G CT +++ + + ++ E LD
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 436
++ A G+ +L + IHRDL A NILL +CDFGLA+ + +V
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 437 -----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL 490
++ APE + + ++DV+ YGI L EL + G + + +
Sbjct: 206 NARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGS--SPYPGMPVDSKFY- 258
Query: 491 LDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + R+ + E+ + M C + P RP Q+V++++
Sbjct: 259 ----KMIKEGFRM----LSPEHA--PAEMYDIMKT----CWDADPLKRPTFKQIVQLIE 303
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 51/294 (17%)
Query: 280 IGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+G FGKV+ D VAVK L+D + FQRE L++ H+++++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 81
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR------------VAFG 381
G C I+V+ +M++ + LR P L ++ +A
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQ---- 436
A G+ YL Q +HRDL N L+ N + DFG+++ V V
Sbjct: 142 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 437 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR 495
IR PE + K + ++DV+ +G+ L E+ T G++ + +L E +++ I
Sbjct: 199 IRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--WFQLSNTE---VIECIT 249
Query: 496 KLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ +R KEV + M+ C Q P+ R + ++ K+L
Sbjct: 250 QGRVLERPRVC---------PKEVYDVMLG----CWQREPQQRLNIKEIYKILH 290
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 70/304 (23%), Positives = 123/304 (40%), Gaps = 58/304 (19%)
Query: 278 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
IG+G FG+V++ T VAVK L++ S +A FQRE L++ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 332 LQLIGYCTTSSERILVYPFMQN--------------------LSVAYRLRDLKPGEKGLD 371
++L+G C L++ +M ++ R R PG L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 372 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431
+ +A A G+ YL E+ K +HRDL N L+ +N + DFGL++ + +
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 432 HVTTQIRGTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 485
+ I PE + + + ++DV+ YG+ L E+ + G + + + E
Sbjct: 230 YK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--YYGMAHE 283
Query: 486 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVV 544
E ++ ++R + E+ M C P DRP +
Sbjct: 284 E---VIYYVRDGNILACPENC---------PLELYNLMRL----CWSKLPADRPSFCSIH 327
Query: 545 KMLQ 548
++LQ
Sbjct: 328 RILQ 331
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 72/295 (24%), Positives = 118/295 (40%), Gaps = 50/295 (16%)
Query: 278 NIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
+G+G FGKV+ D VAVK L++ S FQRE L+++ H+++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHI 105
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-----------VAF 380
++ G CT ++V+ +M++ + LR P K L VA
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 381 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQ--- 436
A G+ YL +HRDL N L+ + DFG+++ + V +
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 437 -IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI 494
IR PE + K + ++DV+ +G+ L E+ T G++ + +L E +D I
Sbjct: 223 PIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSNTE---AIDCI 273
Query: 495 RKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ +R EV M C Q P+ R + V LQ
Sbjct: 274 TQGRELERPRAC---------PPEVYAIMRG----CWQREPQQRHSIKDVHARLQ 315
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 31/212 (14%)
Query: 279 IIGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
+GQG F K++KGV T+V +K L +F ++S HK+
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKH 73
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 389
L+ G C E ILV F++ S L LK + ++ + VA A + +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGS----LDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAV--------LCDFGLAKLVDAKLTHVTTQIRGTM 441
E +IH ++ A NILL + L D G++ V K + +I
Sbjct: 130 EEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-DILQERIPWV- 184
Query: 442 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVT 472
PE + K+ + TD + +G TL E+ +
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 61/298 (20%), Positives = 109/298 (36%), Gaps = 47/298 (15%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
+F +G+GGFG V++ D+ A+KR++ REV ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 331 LLQLIGY---------CTTSSERILVYPFMQ---NLSVAYRLRDLKPGEKGLDWPTRKRV 378
+++ SS ++ +Y MQ ++ + E+ + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123
Query: 379 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 438
A +E+LH + ++HRDLK +NI + + DFGL +D T
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 439 -----------GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED 487
GT +++PE + S K D+F G+ L EL+ FS E
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-----FSTQMERVR 235
Query: 488 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
L +R + + + MVQ +P +RP +++
Sbjct: 236 TL------TDVRNLKFPPLFTQK-----YPCEYVMVQ---DMLSPSPMERPEAINIIE 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 59/278 (21%), Positives = 114/278 (41%), Gaps = 21/278 (7%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISVAIH 328
NF IG+G F +VY+ L D VA+K ++ D A +E+ L+ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
N+++ +E +V ++ ++ K ++ + T + LE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
+H + +++HRD+K AN+ + L D GL + +K T + + GT +++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 449 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508
+ + K+D++ G L E+ Q ++ L I + +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---LCKKIEQ----CDYPPLPS 260
Query: 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546
+ S+E+ +V +C PE RP + V +
Sbjct: 261 DHY----SEELRQLVN---MCINPDPEKRPDVTYVYDV 291
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 30/215 (13%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL--LQL 334
IG GG KV++ + A+K + + +++ E+ ++ + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 335 IGYCTTSSERILVYPFM--QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
Y T +Y M N+ + L+ +K +D RK + +H+
Sbjct: 94 YDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYL- 449
I+H DLK AN L+ D L DFG+A + T V +Q+ GT+ ++ PE +
Sbjct: 147 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 201
Query: 450 ----------STGKSSEKTDVFGYGITLLELVTGQ 474
S K S K+DV+ G L + G+
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 4e-28
Identities = 54/279 (19%), Positives = 96/279 (34%), Gaps = 40/279 (14%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNT------KVAVK-----RLQDYYSPGGE 313
E QL + +++G+G F +VY+ D K +K ++Y
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY----- 112
Query: 314 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-PGEKGLDW 372
+ + + ++ ++ + +LV ++ + K EK +
Sbjct: 113 -IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 373 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA-----------VLCDFG 421
A Y +E +H+ +IIH D+K N +L + F L D G
Sbjct: 172 GLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 422 LAKLVDAKL---THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 478
+ +D KL + T T G E LS + + D FG T+ ++ G +
Sbjct: 229 QS--IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-TYMK 285
Query: 479 FSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSK 517
E + R+L D N+ LN D
Sbjct: 286 VK--NEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCH 322
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL--LQL 334
IG GG KV++ + A+K + + +++ E+ ++ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 335 IGYCTTSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
Y T +Y M+ N+ + L+ +K +D RK + +H+
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYL- 449
I+H DLK AN L+ D L DFG+A + T V +Q+ GT+ ++ PE +
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 182
Query: 450 ----------STGKSSEKTDVFGYGITLLELVTGQ 474
S K S K+DV+ G L + G+
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 50/235 (21%), Positives = 89/235 (37%), Gaps = 23/235 (9%)
Query: 249 EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQ 305
ED+ V LT+ + E + + +G+G FG+V++ + AVK RL+
Sbjct: 35 EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE 94
Query: 306 DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP 365
E+ + ++ L G + ++ S+ ++ +
Sbjct: 95 V--------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC 146
Query: 366 GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAK 424
L GLEYLH + +I+H D+KA N+LL + LCDFG A
Sbjct: 147 ----LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHAL 199
Query: 425 LVDAKLTHVTTQIRGTM-G---HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 475
+ + + G H+APE + K D++ +L ++ G
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 25/300 (8%), Positives = 71/300 (23%), Gaps = 49/300 (16%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 335
+ G V+ + A+K + S + + ++ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 336 GYC--------------------------TTSSERILVYPFMQ--NLSVAYRLRDLKPGE 367
+ +L+ P + L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 368 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427
+ L + ++H N+ + + +L D V
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 428 AKLTHVTTQIRGTMGHIAPEYLSTGKS--SEKTDVFGYGITLLELVTGQRAIDFSRLEEE 485
+ + + + E+L+ + + + + G+++ + F +
Sbjct: 246 TRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPG 299
Query: 486 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
++ D L L V+T++ L R + ++
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPL----PDFVKTLIG-RFLNFD--RRRRLLPLEAME 352
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 65/292 (22%), Positives = 117/292 (40%), Gaps = 49/292 (16%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
+F E +IG GGFG+V+K D +KR+ +REV ++ H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLDHVN 65
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRL---------RDL-----KPGEKGLDWPTRK 376
++ G + S L L K + LD
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 436
+ G++Y+H + K+I+RDLK +NI L D + + DFGL + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS- 181
Query: 437 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR-AIDFSRLEEEEDVLLLDHIR 495
+GT+ +++PE +S+ ++ D++ G+ L EL+ A + S+
Sbjct: 182 -KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF------------- 227
Query: 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547
D+ D ++ K+ +T++Q PEDRP +++++ L
Sbjct: 228 -------FTDLRDGIISDIFDKKEKTLLQ---KLLSKKPEDRPNTSEILRTL 269
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL--LQL 334
IG GG KV++ + A+K + + +++ E+ ++ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 335 IGYCTTSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
Y T +Y M+ N+ + L+ +K +D RK + +H+
Sbjct: 122 YDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLS 450
I+H DLK AN L+ D L DFG+A + T V +Q+ G + ++ PE +
Sbjct: 175 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIK 229
Query: 451 -----------TGKSSEKTDVFGYGITLLELVTGQ 474
K S K+DV+ G L + G+
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 63/313 (20%), Positives = 128/313 (40%), Gaps = 36/313 (11%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 329
+ + IG+G FGK D + +K + S +REV +++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG----EKGLDWPTRKRVAFGTAYG 385
N++Q + +V + + + R+ K ++ LDW
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLA 137
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445
L+++H++ KI+HRD+K+ NI L + L DFG+A+++++ + I GT +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505
PE + K+D++ G L EL T + A + ++ L+ I
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----LVLKIIS--------G 240
Query: 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEV 565
Y S ++ ++V + P DRP + + L+ +A+R ++ + +
Sbjct: 241 SFPPVSLHY-SYDLRSLVS---QLFKRNPRDRPSVNSI---LEKGFIAKRIEKFLSPQLI 293
Query: 566 RQQEVSLLPHQFA 578
++ +F
Sbjct: 294 AEEFCLKTFSKFG 306
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 55/222 (24%), Positives = 78/222 (35%), Gaps = 45/222 (20%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVH-LISVAIH 328
+F + +G G +G+V+K D AVKR + P A EV V H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 329 KNLLQLIG-------------YCTTSSERILVYPFMQNLS---VAYRLRDLKPGEKGLDW 372
++L C S ++ + +L V LRD
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHC-EAWGASLPEAQVWGYLRDT--------- 166
Query: 373 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432
L +LH Q ++H D+K ANI L L DFGL +
Sbjct: 167 ----------LLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGA 212
Query: 433 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
Q G ++APE L G DVF G+T+LE+
Sbjct: 213 GEVQE-GDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNM 252
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
+ F++ IG+G FG+V+KG+ VA+K + + Q+E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEY 388
+ + G ++ ++ ++ S DL +PG LD + GL+Y
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPG--PLDETQIATILREILKGLDY 134
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM-GH---I 444
LH + K IHRD+KAAN+LL ++ E L DFG V +LT T R T G +
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFG----VAGQLTD-TQIKRNTFVGTPFWM 186
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
APE + K D++ GIT +EL G+
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 60/220 (27%), Positives = 86/220 (39%), Gaps = 27/220 (12%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
D++ +IG G V KVA+KR+ +E+ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVA----YRLRDLKPGEKGLDWPTRKRVAFGTAYGL 386
++ E LV + SV + + + LD T + GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 387 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-------- 438
EYLH+ IHRD+KA NILL ++ + DFG V A L R
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG----VSAFLATGGDITRNKVRKTFV 187
Query: 439 GT---MGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 474
GT M APE + + K D++ +GIT +EL TG
Sbjct: 188 GTPCWM---APEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 67/280 (23%), Positives = 115/280 (41%), Gaps = 20/280 (7%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLI 323
+ +L D+F + + +G G G V+K +A K + P RE+ ++
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 324 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGT 382
++ G + E + M S+ L+ E+ L +V+
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAV 140
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVD--AKLTHVTTQIRG 439
GL YL E+ KI+HRD+K +NIL++ E LCDFG++ +L+D A + V G
Sbjct: 141 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFV-----G 192
Query: 440 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 499
T +++PE L S ++D++ G++L+E+ G+ I +E E +
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 500 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 539
R LN + M LL + PP
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELL--DYIVNEPPP 290
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 40/313 (12%), Positives = 74/313 (23%), Gaps = 62/313 (19%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAA------------FQREVHLISV 325
++GQ + V P A + +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 326 AIHKNLLQLIGYCTTSS-----------------ERILVYPFMQ--NLSVAYRLRDLKPG 366
+H + R +YP MQ + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 367 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426
K L R ++ L LH ++H L+ +I+LD L F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 427 DAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSR 481
A + A L + D + G+ + + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTD 319
Query: 482 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 541
+ R + +I + V +++ L + EDR
Sbjct: 320 DAALGG------SEWIFRSCK--NI---------PQPVRALLEGFL---RYPKEDRLLPL 359
Query: 542 QVVKMLQGEDLAE 554
Q ++ + E L
Sbjct: 360 QAMETPEYEQLRT 372
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 60/281 (21%), Positives = 110/281 (39%), Gaps = 24/281 (8%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 329
+++ IG G +G+ K SD + K L + + EV+L+ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 330 NLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
N+++ + L V + + +A + + LD RV L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 388 YLHEQCNP--KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445
H + + ++HRDLK AN+ LD L DFGLA++++ + T + GT +++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505
PE ++ +EK+D++ G L EL +E L IR+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGKIRE--------G 231
Query: 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546
R Y S E+ ++ RP + ++++
Sbjct: 232 KFRRIPYRY-SDELNEIIT---RMLNLKDYHRPSVEEILEN 268
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 64/252 (25%), Positives = 103/252 (40%), Gaps = 39/252 (15%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
+F E ++GQG FG+V K D+ A+K+++ ++ + EV L++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAY---------RLRDL-KPGEKGLDWPTRKRVA 379
+++ + ++ S + L DL R+
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 380 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV------ 433
L Y+H Q IIHRDLK NI +D++ + DFGLAK V L +
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 434 --------TTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 484
T+ I GT ++A E L TG +EK D++ GI E++ FS
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FS--TG 231
Query: 485 EEDVLLLDHIRK 496
E V +L +R
Sbjct: 232 MERVNILKKLRS 243
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 64/259 (24%), Positives = 104/259 (40%), Gaps = 42/259 (16%)
Query: 273 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNL 331
+F +++G G G + + DN VAVKR+ P + REV L H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI----LPECFSFADREVQLLRESDEHPNV 80
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLH 390
++ +CT + Y ++ A L++ + + + T GL +LH
Sbjct: 81 IRY--FCTEKDRQ-FQYIAIEL--CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 391 EQCNPKIIHRDLKAANILLDDNFE-----AVLCDFGLAKLVDA--KLTHVTTQIRGTMGH 443
I+HRDLK NIL+ A++ DFGL K + + + GT G
Sbjct: 136 SL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 444 IAPEYLS---TGKSSEKTDVFGYGITLLELVT------------------GQRAIDFSRL 482
IAPE LS + D+F G +++ G ++D
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252
Query: 483 EEEEDVLLLDHIRKLLRED 501
E+ EDV+ + I K++ D
Sbjct: 253 EKHEDVIARELIEKMIAMD 271
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 49/218 (22%), Positives = 80/218 (36%), Gaps = 32/218 (14%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVK----------------RLQDYYSPGGEAAFQREVHLI 323
+ QG F K+ DN A+K F+ E+ +I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 324 SVAIHKNLLQLIGYCTTSSERILVYPFMQN------LSVAYRLRDLKPGEKGLDWPTRKR 377
+ ++ L G T E ++Y +M+N + L + K
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF--IPIQVIKC 155
Query: 378 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 437
+ Y+H + N I HRD+K +NIL+D N L DFG ++ + K +
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS-- 210
Query: 438 RGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 473
RGT + PE+ S + K D++ GI L +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 279 IIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
++G+G +G VY G N ++A+K + + S + E+ L HKN++Q +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQYLGS 87
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397
+ + + + S++ LR K G + T GL+YLH+ +I
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 398 IHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGT---MGHIAPEYLSTGK 453
+HRD+K N+L++ + + DFG +K + T GT M APE + G
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYM---APEIIDKGP 199
Query: 454 S--SEKTDVFGYGITLLELVTGQR 475
+ D++ G T++E+ TG+
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 50/238 (21%), Positives = 90/238 (37%), Gaps = 36/238 (15%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-L 322
+ ++L ++ +GGF VY+ + + A+KRL A +EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNRAIIQEVCFM 79
Query: 323 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR----- 377
++ H N++Q + E + L +L G+ +++ +
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEES-----DTGQAEFLLLTELCKGQ-LVEFLKKMESRGPL 133
Query: 378 -------VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430
+ + T ++++H Q P IIHRDLK N+LL + LCDFG A +
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 431 THVTT-----------QIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQ 474
+ + T + PE + + EK D++ G L L Q
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
+ + +G G FGKVYK A K + + S + E+ +++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDHP 76
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEY 388
+++L+G + ++ F +V + ++GL P + V L +
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---- 444
LH + +IIHRDLKA N+L+ + L DFG V AK T Q R + I
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLK-TLQKRDSF--IGTPY 182
Query: 445 --APEYLSTGKSSE-----KTDVFGYGITLLELVTGQ 474
APE + + K D++ GITL+E+ +
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 60/213 (28%), Positives = 85/213 (39%), Gaps = 24/213 (11%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAI 327
FS+ IG G FG VY + ++ VA+K++ E +EV +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
H N +Q G LV + S L+ +K L V G GL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLG-SA---SDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT---MGHI 444
YLH +IHRD+KA NILL + L DFG + + + + GT M
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANSFV-GTPYWM--- 217
Query: 445 APEYLSTGKSSE---KTDVFGYGITLLELVTGQ 474
APE + + K DV+ GIT +EL +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 45/230 (19%), Positives = 78/230 (33%), Gaps = 37/230 (16%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAI- 327
T F E IG G FG V+K V D A+KR + E REV+ +V
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 328 HKNLLQLIGYCTTSSERILVYPFM---QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 384
H ++ + Y + +E + S+A + + K +
Sbjct: 70 HSHV---VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-------------------LCDFGLAKL 425
GL Y+H ++H D+K +NI + + D G
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182
Query: 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 474
+++ + G +A E L + K D+F +T++ +
Sbjct: 183 ---RISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 46/217 (21%), Positives = 94/217 (43%), Gaps = 17/217 (7%)
Query: 267 LQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LIS 324
+++ D+ +G+G +G V K + +AVKR++ + + ++ +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 384
+ G + + M + S+ + + + + ++A
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVD--AKLTHVTTQIRGTM 441
LE+LH +IHRD+K +N+L++ + +CDFG+ LVD AK G
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GCK 173
Query: 442 GHIAPEYLSTGKS----SEKTDVFGYGITLLELVTGQ 474
++APE ++ + S K+D++ GIT++EL +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 42/221 (19%), Positives = 76/221 (34%), Gaps = 27/221 (12%)
Query: 271 TDNFSESNIIGQG--GFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 326
+ +IG+G V V V+R+ + S Q E+H+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 327 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 386
H N++ +E +V FM S + G++ + G L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKAL 141
Query: 387 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-- 444
+Y+H +HR +KA++IL+ + + L + + Q + +
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLR----SNLSMIS-HGQRQRVVHDFPK 193
Query: 445 ---------APEYLSTGKS--SEKTDVFGYGITLLELVTGQ 474
+PE L K+D++ GIT EL G
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 42/232 (18%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-L 322
+ ++ + IG+G +G V K V +AVKR++ + ++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 323 ISVAIHKNLLQLIG-------------YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 369
+ + ++Q G +TS ++ Y + D E+
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFY--------KYVYSVLDDVIPEEI 126
Query: 370 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVD- 427
L ++ T L +L E N KIIHRD+K +NILLD + LCDFG+ +LVD
Sbjct: 127 L-----GKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179
Query: 428 -AKLTHVTTQIRGTMGHIAPEYLSTGKS----SEKTDVFGYGITLLELVTGQ 474
AK G ++APE + S ++DV+ GITL EL TG+
Sbjct: 180 IAKTRDA-----GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIH 328
F ++G G +G+VYKG + A+K + + E ++E++++ + H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHH 80
Query: 329 KNLLQLIG-YCTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF-- 380
+N+ G + + + LV F SV +++ K +W +A+
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYIC 135
Query: 381 -GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 439
GL +LH+ K+IHRD+K N+LL +N E L DFG++ +D + T I G
Sbjct: 136 REILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-G 191
Query: 440 T---MGHIAPEYLSTGKSSE-----KTDVFGYGITLLELVTGQ 474
T M APE ++ ++ + K+D++ GIT +E+ G
Sbjct: 192 TPYWM---APEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKR--LQDYYSPGGEAAFQREVHLISVAI 327
+ F +G+G +G VYK + VA+K+ ++ +E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCD 82
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGL 386
++++ G +++ +V + SV+ D+ + K L + T GL
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVS----DIIRLRNKTLTEDEIATILQSTLKGL 138
Query: 387 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-- 444
EYLH + IHRD+KA NILL+ A L DFG+A +LT T R T+ I
Sbjct: 139 EYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTD-TMAKRNTV--IGT 188
Query: 445 ----APEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
APE + + D++ GIT +E+ G+
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 48/272 (17%), Positives = 87/272 (31%), Gaps = 51/272 (18%)
Query: 280 IGQGGFGKVYKG---VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
I GG G +Y ++ V +K L +A E ++ +H +++Q+
Sbjct: 88 IAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 337 YCTTSSERILVYPF--MQNLSVAY----RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
+ + + M+ Y L+ K + L L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVME-----YVGGQSLKRSKGQK--LPVAEAIAYLLEILPALSYLH 199
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 450
+++ DLK NI+L + + L D G +++ + GT G APE +
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPE-IV 249
Query: 451 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510
+ TD++ G TL L + +D + + + D R
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPT---------RNGRYVDGLPEDDPVLKTYDSYGR- 299
Query: 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 542
+ P R A+
Sbjct: 300 --------------LLRRAIDPDPRQRFTTAE 317
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 41/310 (13%), Positives = 79/310 (25%), Gaps = 73/310 (23%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAA---------------------- 315
++GQ + V P A
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 316 -----FQREVHLISVAIHKNLLQLIGYCTTSS--ERILVYPFMQ--NLSVAYRLRDLKPG 366
F L+ K ++++ R +YP MQ + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 367 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426
K L R ++ L LH ++H L+ +I+LD L F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 427 DAKLTHVTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQR 475
A++ + G PE + + D + G+ + +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 476 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPE 535
++ + R + +I + V +++ L + E
Sbjct: 312 P--ITKDAALGG------SEWIFRSCK--NI---------PQPVRALLE-GFL--RYPKE 349
Query: 536 DRPPMAQVVK 545
DR Q ++
Sbjct: 350 DRLLPLQAME 359
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 21/220 (9%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-L 322
+ Q ++ +G G G+V+K +AVK+++ + ++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 323 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 382
+ ++Q G T+++ + M + + K + + ++
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA----EKLKKRMQGPIPERILGKMTVAI 133
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVD--AKLTHVTTQIRG 439
L YL E+ +IHRD+K +NILLD+ + LCDFG+ +LVD AK G
Sbjct: 134 VKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA-----G 186
Query: 440 TMGHIAPEYLSTGKSSE-----KTDVFGYGITLLELVTGQ 474
++APE + ++ + DV+ GI+L+EL TGQ
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 19/209 (9%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
++ IGQG G VY + ++ +VA++++ + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N++ + E +V ++ S+ + E +D V LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFL 132
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM-GH---IA 445
H ++IHRD+K+ NILL + L DFG A++T R TM G +A
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITP-EQSKRSTMVGTPYWMA 184
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
PE ++ K D++ GI +E++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 59/284 (20%), Positives = 104/284 (36%), Gaps = 59/284 (20%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIG 336
+G GG VY N KVA+K + F+REVH S H+N++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS--- 75
Query: 337 YCTTSSERILVYPFMQNLSVAY---------RLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
+ + Y L + L T G++
Sbjct: 76 ----------MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAP 446
+ H+ +I+HRD+K NIL+D N + DFG+AK + + LT T + GT+ + +P
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSP 181
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVTGQR--------AIDFSRLEEEEDVLLLDHIRKLL 498
E + E TD++ GI L E++ G+ +I +++ +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT-------- 233
Query: 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 542
++ + + ++ L T+ +R Q
Sbjct: 234 ----------TDVRKDIPQSLSNVI---LRATEKDKANRYKTIQ 264
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 17/200 (8%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+GGF K ++ A K L P E+ + H++++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLL---KPHQREKMSMEISIHRSLAHQHVVG 79
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
G+ + +V + S+ + K L P + G +YLH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN- 134
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 453
++IHRDLK N+ L+++ E + DFGLA V+ + GT +IAPE LS
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 191
Query: 454 SSEKTDVFGYGITLLELVTG 473
S + DV+ G + L+ G
Sbjct: 192 HSFEVDVWSIGCIMYTLLVG 211
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 7e-23
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 13/209 (6%)
Query: 268 QLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLIS 324
Q A ++F +G+G FG VY +A+K L G E +REV + S
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 384
H N+L+L GY ++ L+ + +V L+ L D A
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 120
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
L Y H + ++IHRD+K N+LL E + DFG + + GT+ ++
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYL 174
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTG 473
PE + EK D++ G+ E + G
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 19/209 (9%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
IG+G G V +VAVK + D EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N++++ E ++ F+Q ++ + ++ E+ + V L YL
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI-----ATVCEAVLQALAYL 157
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM-GH---IA 445
H Q +IHRD+K+ +ILL + L DFG A+++ R ++ G +A
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC----AQISK-DVPKRKSLVGTPYWMA 209
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
PE +S + + D++ GI ++E+V G+
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 17/200 (8%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+GGF K ++ A K L P E+ + H++++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLL---KPHQREKMSMEISIHRSLAHQHVVG 105
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
G+ + +V + S+ + K L P + G +YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN- 160
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 453
++IHRDLK N+ L+++ E + DFGLA V+ + GT +IAPE LS
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 217
Query: 454 SSEKTDVFGYGITLLELVTG 473
S + DV+ G + L+ G
Sbjct: 218 HSFEVDVWSIGCIMYTLLVG 237
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 13/209 (6%)
Query: 268 QLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLIS 324
+ D+F +G+G FG VY + +A+K L G E +RE+ + S
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 384
H N+L++ Y L+ F + L+ D A
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELAD 125
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
L Y HE+ K+IHRD+K N+L+ E + DFG + + GT+ ++
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYL 179
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTG 473
PE + EK D++ G+ E + G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 3e-22
Identities = 65/304 (21%), Positives = 108/304 (35%), Gaps = 57/304 (18%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVH-LISVAIHK 329
+ I+G G G V VAVKR+ D+ E+ L H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHP 69
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-------KPGEKGLDWPTRKRVAFGT 382
N+++ TT + ++ L+DL K +
Sbjct: 70 NVIRYYCSETTDRFLYIA---LEL--CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLD-------------DNFEAVLCDFGLAKLVDAK 429
A G+ +LH KIIHRDLK NIL+ +N ++ DFGL K +D+
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 430 LTHVTTQIR---GTMGHIAPEYLS-------TGKSSEKTDVFGYGITLLELVTGQRAIDF 479
+ T + GT G APE L + + D+F G +++ +
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 480 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 539
+ E +++ R + D + + DR+L E ++ ++ P RP
Sbjct: 242 DKYSRESNII-----RGIFSLDEMKCLHDRSL----IAEATDLIS-QMIDHD--PLKRPT 289
Query: 540 MAQV 543
+V
Sbjct: 290 AMKV 293
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 21/218 (9%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
+ S+I+GQG V++G A+K + RE ++ HKN
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 331 LLQLIGY--CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
+++L TT+ ++L+ F S+ L + GL V G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNH 127
Query: 389 LHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
L E I+HR++K NI+ D L DFG A+ ++ + GT ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLYGTEEYL 182
Query: 445 APEYLSTGKS--------SEKTDVFGYGITLLELVTGQ 474
P+ D++ G+T TG
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 50/211 (23%), Positives = 80/211 (37%), Gaps = 34/211 (16%)
Query: 280 IGQGGFGKVYKGVLSDNTK---VAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQL 334
+G+GG G VY+ D + VA+K + + S P QRE +++
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP- 98
Query: 335 IGYCTTSSERILVYPFMQNLSVAY---------RLRDLKPGEKGLDWPTRKRVAFGTAYG 385
++ F + Y L + + L P +
Sbjct: 99 ------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHI 444
L+ H HRD+K NIL+ + A L DFG+A D KLT GT+ ++
Sbjct: 147 LDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYM 202
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 475
APE S ++ + D++ L E +TG
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 7e-22
Identities = 53/200 (26%), Positives = 81/200 (40%), Gaps = 16/200 (8%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+G F VY+ + +VA+K + G Q EV + H ++L+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY---KAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 334 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 393
L Y S+ LV N + R LK K + G+ YLH
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEM---NRYLKNRVKPFSENEARHFMHQIITGMLYLHSH- 131
Query: 394 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 453
I+HRDL +N+LL N + DFGLA + T + GT +I+PE +
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSA 188
Query: 454 SSEKTDVFGYGITLLELVTG 473
++DV+ G L+ G
Sbjct: 189 HGLESDVWSLGCMFYTLLIG 208
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 9e-22
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 16/215 (7%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
+ +G GGFG V + + +VA+K+ + SP + E+ ++ H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 330 NLLQLI------GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 383
N++ + +L + + + L GL + + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDIS 131
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGT 440
L YLHE +IIHRDLK NI+L + + + D G AK +D + T+ GT
Sbjct: 132 SALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGT 186
Query: 441 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 475
+ ++APE L K + D + +G E +TG R
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 63/235 (26%), Positives = 89/235 (37%), Gaps = 43/235 (18%)
Query: 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ--- 317
AT + IG G +G VYK VA+K ++ GG
Sbjct: 3 LGSM----ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST 58
Query: 318 -REVHL---ISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLK---- 364
REV L + H N+++L+ C TS LV+ + +DL+
Sbjct: 59 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDLRTYLD 110
Query: 365 -PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423
GL T K + GL++LH I+HRDLK NIL+ L DFGLA
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 167
Query: 424 KL--VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
++ LT VT R APE L + D++ G E+ +
Sbjct: 168 RIYSYQMALTPVVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAI--HKNLLQL 334
+G GG +V+ L D+ VAVK L+ + P F+RE + A H ++ +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ--NAAALNHPAIVAV 77
Query: 335 --IGYCTTSSERILVYPFMQNLSVAY----RLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
G + L Y M+ Y LRD+ E + V L +
Sbjct: 78 YDTG-EAETPAGPLPYIVME-----YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT--QIRGTMGHIAP 446
H+ IIHRD+K ANI++ + DFG+A+ + VT + GT +++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVTGQR 475
E ++DV+ G L E++TG+
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 8e-21
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 21/218 (9%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
+ S+I+GQG V++G A+K + RE ++ HKN
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 331 LLQLIGY--CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
+++L TT+ ++L+ F S+ L + GL V G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 389 LHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
L E I+HR++K NI+ D L DFG A+ ++ + GT ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYL 182
Query: 445 APEYLSTGKS--------SEKTDVFGYGITLLELVTGQ 474
P+ D++ G+T TG
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-20
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 268 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQ--DYYSPGGEAAFQREVHLIS 324
+ + F + ++G+GGFG+V + K+ A K+L+ GEA E ++
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 325 VAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 383
+ ++ L Y + + + LV M + + + G+ G R F A
Sbjct: 240 KVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFP---EARAVFYAA 293
Query: 384 ---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 440
GLE LH + +I++RDLK NILLDD+ + D GLA V T GT
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGT 348
Query: 441 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
+G++APE + + + D + G L E++ GQ
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 8e-20
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 17/215 (7%)
Query: 268 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 324
+ D F + ++G+GGFG+V+ + K+ A K+L + G E +++
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 325 VAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 383
+ ++ L Y + + LV M + Y + ++ G P R F TA
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP---RAIFYTA 296
Query: 384 ---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-G 439
GLE+LH++ II+RDLK N+LLDD+ + D GLA + K T+ G
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAG 351
Query: 440 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
T G +APE L + D F G+TL E++ +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 53/213 (24%), Positives = 82/213 (38%), Gaps = 40/213 (18%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--------RLQDYYSPGGEAAFQREVH 321
+N+ I+G+G V + + + AVK A +EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 322 -LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK---- 376
L V+ H N++QL T++ LV+ M+ GE D+ T K
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK------------GEL-FDYLTEKVTLS 122
Query: 377 -RVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431
+ + LH+ I+HRDLK NILLDD+ L DFG + +D
Sbjct: 123 EKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--G 177
Query: 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 464
++ GT ++APE + + GYG
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHP---GYG 207
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 41/232 (17%)
Query: 263 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTK--VAVKRLQ-DYYSPGGEAAFQRE 319
CR A + IG+G +GKV+K N VA+KR++ G + RE
Sbjct: 6 LCR----ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 320 VHL---ISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLK-----PG 366
V + + H N+++L CT S LV+ + +DL
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--------QDLTTYLDKVP 113
Query: 367 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL- 425
E G+ T K + F GL++LH +++HRDLK NIL+ + + L DFGLA++
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 426 -VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
LT VT R APE L + D++ G E+ +
Sbjct: 171 SFQMALTSVVVTLWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 92.2 bits (228), Expect = 2e-19
Identities = 58/403 (14%), Positives = 125/403 (31%), Gaps = 133/403 (33%)
Query: 227 LFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNII--GQGG 284
R Q KL+ +L +LR N++ G G
Sbjct: 129 YNVSRLQPYLKLRQ--------------ALLELR--------------PAKNVLIDGVLG 160
Query: 285 FGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 344
GK T VA+ Y + ++ +++ C +
Sbjct: 161 SGK---------TWVALDVCLSY---KVQCKMDFKIFWLNL----------KNCNSPETV 198
Query: 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 404
+ + +Q L L + P +W +R + + + + + + +
Sbjct: 199 LEM---LQKL-----LYQIDP-----NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
Query: 405 ANILLDDNFEAVLCDFGLAKLVDA-----KLTHVTTQIRG--------TMGHIAPEYLST 451
++L + + + AK +A K +TT+ + T HI+ ++ S
Sbjct: 246 CLLVLLN-----VQN---AKAWNAFNLSCK-ILLTTRFKQVTDFLSAATTTHISLDHHSM 296
Query: 452 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE----------- 500
+ ++ +LL R D R + L I + +R+
Sbjct: 297 TLTPDEVK------SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV 350
Query: 501 --DRLNDIVDRNLNTYDSKEVETM-VQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWA 557
D+L I++ +LN + E M ++++ P ++ ++
Sbjct: 351 NCDKLTTIIESSLNVLEPAEYRKMFDRLSVF-----PPSAHIPTILLSLI---------- 395
Query: 558 EWEELEEVRQQEV-------SLLPHQFAWGEDSSIDQEAIQLS 593
W ++ + V SL+ ++S+I +I L
Sbjct: 396 -WFDVIKSDVMVVVNKLHKYSLV---EKQPKESTISIPSIYLE 434
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 2e-08
Identities = 79/529 (14%), Positives = 155/529 (29%), Gaps = 126/529 (23%)
Query: 28 HSSREPDVEGEALIEVLKALNDT-----HGQF----TDW------NDHFVSPCFS----W 68
+ SR L + L L G T W + V W
Sbjct: 130 NVSRLQPYL--KLRQALLELRPAKNVLIDGVLGSGKT-WVALDVCLSYKVQCKMDFKIFW 186
Query: 69 SHV-TCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHL 127
++ C + + L +I P+ T +S +L+ + + L L S +
Sbjct: 187 LNLKNCNSPETVLEML--QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 128 QSL----NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLI 183
L N+ N K W +LS L + T T +
Sbjct: 245 NCLLVLLNVQNAK-------AW------NAFNLSCKIL----------LTTRFKQVTDFL 281
Query: 184 CGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVL-----------LSL-GAL---F 228
++ + S ++ +++ C L LS+
Sbjct: 282 SAATTTHISLDHHSMTLTPDEV-KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340
Query: 229 ACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCREL--QLATDNFSESNIIGQGGFG 286
+ + + D + + SL L R++ +L+ F S I
Sbjct: 341 LATWDNWKHVNCDKLTTII-----ESSLNVLEPAEYRKMFDRLSV--FPPSAHIPTILLS 393
Query: 287 KVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE--R 344
++ V+ + V V +L Y + +++ +++I L+L R
Sbjct: 394 LIWFDVIKSDVMVVVNKLHKY------SLVEKQPKESTISIPSIYLELKVKLENEYALHR 447
Query: 345 ILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL--H-EQCNPKIIH 399
+V Y N+ + DL P LD Y ++ H +
Sbjct: 448 SIVDHY----NIPKTFDSDDLIP--PYLD-----------QYFYSHIGHHLKNIEH--PE 488
Query: 400 RDLKAANILLDDNF-EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA---PEYLSTGKSS 455
R + LD F E + A + + Q++ +I P+Y +
Sbjct: 489 RMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI 548
Query: 456 EKTDVFGYGITLLE-----LVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 499
+ L+ L+ + A L E++ + + +++ R
Sbjct: 549 LDF-LPKIEENLICSKYTDLL--RIA-----LMAEDEAIFEEAHKQVQR 589
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-19
Identities = 70/272 (25%), Positives = 110/272 (40%), Gaps = 59/272 (21%)
Query: 230 CRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVY 289
+ + L+ DVF D + + L ++FS IIG+GGFG+VY
Sbjct: 149 YIEEICQNLRGDVFQKFIESDKFTRFCQW--KNVELNIHLTMNDFSVHRIIGRGGFGEVY 206
Query: 290 KGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER-ILV 347
+D K+ A+K L K + G +ER +L
Sbjct: 207 GCRKADTGKMYAMKCLDK----------------------KRIKMKQGETLALNERIMLS 244
Query: 348 ------YPFMQNLSVAYRLRD--------LKPGEKGLDWPTRK-------RVAFGTA--- 383
PF+ +S A+ D + G+ L + + + F A
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD--LHYHLSQHGVFSEADMRFYAAEII 302
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 443
GLE++H + +++RDLK ANILLD++ + D GLA K H + GT G+
Sbjct: 303 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGY 356
Query: 444 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 474
+APE L G + + + D F G L +L+ G
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 7e-19
Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 33/217 (15%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 329
+ + + IG+G +G V+K VA+K+ + P + RE+ ++ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 330 NLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
NL+ L+ LV+ + + L +L ++G+ K + + T + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTV-----LHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-----RGTMGH 443
H+ IHRD+K NIL+ + LCDFG A+L+ + ++ R
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR----- 169
Query: 444 IAPEYL------STGKSSEKTDVFGYGITLLELVTGQ 474
+PE L DV+ G EL++G
Sbjct: 170 -SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 27/224 (12%)
Query: 260 RRFSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQ 317
+ + + + ++G+G +G V K VA+K+ + +
Sbjct: 17 ENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM 72
Query: 318 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRK 376
RE+ L+ H+NL+ L+ C LV+ F+ + L DL+ GLD+ +
Sbjct: 73 REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI-----LDDLELFPNGLDYQVVQ 127
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 436
+ F G+ + H IIHRD+K NIL+ + LCDFG A+ + A +
Sbjct: 128 KYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184
Query: 437 I-----RGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 474
+ R APE L + DV+ G + E+ G+
Sbjct: 185 VATRWYR------APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 9e-19
Identities = 51/251 (20%), Positives = 77/251 (30%), Gaps = 51/251 (20%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK----RLQDYYSPGGEAAFQREVHLISV 325
+ IGQG +G V + A+K +P + EV L+
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 326 AIHKNLLQLIGYCTTSS---------------ERILVYPFMQNLSVAYRLRDLKPGEKGL 370
H N+ +L +++ V+ A + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 371 DWPTRKRVAFGTAY---------------------GLEYLHEQCNPKIIHRDLKAANILL 409
+ L YLH Q I HRD+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201
Query: 410 --DDNFEAVLCDFGLAKLVDAKLT---HVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFG 462
+ +FE L DFGL+K + T GT +APE L+T K D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 463 YGITLLELVTG 473
G+ L L+ G
Sbjct: 262 AGVLLHLLLMG 272
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKR-LQDYYSPGGEAAFQ-REVHLISVAIH 328
++ +IG G FG V++ L ++ +VA+K+ LQD F+ RE+ ++ + H
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-------KRFKNRELQIMRIVKH 91
Query: 329 KNLLQLIGYCTTSSERI------LVYPFM-QNLSVAYR-LRDLKPGEKGLDWPTRKRVAF 380
N++ L + ++ ++ LV ++ + + YR R ++ + K +
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV---YRASRHYAKLKQTMPMLLIKLYMY 148
Query: 381 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDA--KLTH--VTT 435
L Y+H I HRD+K N+LLD + L DFG AK++ A +
Sbjct: 149 QLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205
Query: 436 QIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 474
R APE + + + D++ G + EL+ GQ
Sbjct: 206 YYR------APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 62/212 (29%), Positives = 89/212 (41%), Gaps = 39/212 (18%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-------RLQDYYSPGGEAAFQREVH- 321
+ ++IG+G V + V + + AVK RL A +RE H
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 322 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----- 376
L VA H +++ LI +SS LV+ M+ GE D+ T K
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRK------------GEL-FDYLTEKVALSE 199
Query: 377 ---RVAFGT-AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432
R + + +LH I+HRDLK NILLDDN + L DFG + ++
Sbjct: 200 KETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GE 254
Query: 433 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 464
++ GT G++APE L K S GYG
Sbjct: 255 KLRELCGTPGYLAPEIL---KCSMDETHPGYG 283
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 39/215 (18%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVH----LISVAIHK 329
+G+GGFG V+ G L+D +VA+K R+ + EV + + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFG 381
+++L+ + T +LV P + D+ T K R FG
Sbjct: 99 GVIRLLDWFETQEGFMLVLERP------------LPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 382 -TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRG 439
+++ H + ++HRD+K NIL+D L DFG L+ + G
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---G 200
Query: 440 TMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTG 473
T + PE++S + + V+ GI L ++V G
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 45/235 (19%)
Query: 264 CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVH 321
C E+ + + IGQG FG+V+K KVA+K++ + G RE+
Sbjct: 13 CDEV----SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 68
Query: 322 LISVAIHKNLLQLIGYCTTSSERI--------LVYPFMQNLSVAYRLRDLK----PGEKG 369
++ + H+N++ LI C T + LV+ F ++ DL
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH--------DLAGLLSNVLVK 120
Query: 370 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA------ 423
KRV GL Y+H KI+HRD+KAAN+L+ + L DFGLA
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177
Query: 424 -KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 474
+ T+ VT R PE L + D++G G + E+ T
Sbjct: 178 KNSQPNRYTNRVVTLWYR------PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 37/213 (17%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHK--NL 331
+G GGFG VY G+ +SDN VA+K R+ D+ EV L+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFG-T 382
++L+ + +L+ ++DL D+ T + R F
Sbjct: 111 IRLLDWFERPDSFVLILER------PEPVQDL------FDFITERGALQEELARSFFWQV 158
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTM 441
+ + H ++HRD+K NIL+D N + L DFG L+ + GT
Sbjct: 159 LEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTR 212
Query: 442 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTG 473
+ PE++ + V+ GI L ++V G
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 5e-18
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 330
+ + + +G+G +G VYK S VA+KR++ D G + RE+ L+ H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGL 386
++ LI + LV+ FM+ DLK + GL K + G+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK--------DLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 387 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGTM 441
+ H+ +I+HRDLK N+L++ + L DFGLA+ TH VT R
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--- 186
Query: 442 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 474
AP+ L K S D++ G E++TG+
Sbjct: 187 ---APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 38/173 (21%), Positives = 66/173 (38%), Gaps = 33/173 (19%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR------ 438
+E+LH + ++HRDLK +NI + + DFGL +D T
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 439 -----GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 493
GT +++PE + S K D+F G+ L EL+ FS E ++
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-----FSTQMERVRII---- 283
Query: 494 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546
+R + + + + MVQ +P +RP +++
Sbjct: 284 --TDVRNLKFPLLFTQ-----KYPQEHMMVQ---DMLSPSPTERPEATDIIEN 326
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 43/217 (19%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 333
+G+G +GKV + + + AVK +L+ P GEA ++E+ L+ HKN++Q
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR--IPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 334 L--IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTA------- 383
L + Y + +V + G + + D KR A
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVC------------GMQEMLDSVPEKRFPVCQAHGYFCQL 118
Query: 384 -YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK----LTHVTTQIR 438
GLEYLH Q I+H+D+K N+LL + G+A+ + T+Q
Sbjct: 119 IDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR-TSQ-- 172
Query: 439 GTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 473
G+ PE + S K D++ G+TL + TG
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 271 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKR-LQDYYSPGGEAAFQ-REVHLISVAI 327
+++++ +IG G FG VY+ L D VA+K+ LQD F+ RE+ ++
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLD 105
Query: 328 HKNLLQLIGYCTTSSERI------LVYPFM-QNLSVAYR-LRDLKPGEKGLDWPTRKRVA 379
H N+++L + +S E+ LV ++ + + YR R ++ L K
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYM 162
Query: 380 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDA--KLTH--VT 434
+ L Y+H I HRD+K N+LLD + + LCDFG AK + +
Sbjct: 163 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 435 TQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 474
R APE + + DV+ G L EL+ GQ
Sbjct: 220 RYYR------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 29/218 (13%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 329
+ + IG+G +G V+K + VA+KR++ D G ++ RE+ L+ HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYG 385
N+++L + + LV+ F DLK LD K F G
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ--------DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGT 440
L + H + ++HRDLK N+L++ N E L +FGLA+ + VT R
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR-- 168
Query: 441 MGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAI 477
P+ L K S D++ G EL R +
Sbjct: 169 ----PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 28/214 (13%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 330
+ + IG+G +G VYK + A+K+++ + G + RE+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGL 386
+++L T +LV+ + DLK E GL+ T K G+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ--------DLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 387 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA---KLTH--VTTQIRGTM 441
Y H++ +++HRDLK N+L++ E + DFGLA+ K TH VT R
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--- 167
Query: 442 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 474
AP+ L K S D++ G E+V G
Sbjct: 168 ---APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 272 DNFSESNIIGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
+ + + + +G+G + VYKG + VA+K ++ + G REV L+ H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGL 386
++ L T LV+ ++ +DLK ++ K F GL
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD--------KDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 387 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGTM 441
Y H Q K++HRDLK N+L+++ E L DFGLA+ + VT R
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--- 167
Query: 442 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 474
P+ L S + D++G G E+ TG+
Sbjct: 168 ---PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 270 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQ----REVHL 322
++ F + +G G + VYKG+ + VA+K +L E RE+ L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS------EEGTPSTAIREISL 56
Query: 323 ISVAIHKNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 381
+ H+N+++L T ++ LV+ FM +L R + +GL+ K +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA---KLTH--VTTQ 436
GL + HE KI+HRDLK N+L++ + L DFGLA+ + VT
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW 173
Query: 437 IRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 474
R AP+ L ++ S D++ G L E++TG+
Sbjct: 174 YR------APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 28/112 (25%), Positives = 43/112 (38%), Gaps = 12/112 (10%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
L + N F P I L FL +L L P S++ LQ LN+++N
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFL----DLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVAT----FNFTGTHLIC 184
F + L++L+ LD S N++ +L + N T C
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 20/90 (22%), Positives = 30/90 (33%), Gaps = 1/90 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ +L L N S S L L ++ S++HL +L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLD-LSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
+S LS+L+ L NL
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLEN 117
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-16
Identities = 18/96 (18%), Positives = 41/96 (42%), Gaps = 3/96 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLP-DFLGSMTHLQSLNLANN 135
++ L L NG +S + L+ L Q ++L S+ +L L++++
Sbjct: 374 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLD-FQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ ++ LS+L+ L ++ N+ +F+
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 16/92 (17%), Positives = 28/92 (30%), Gaps = 1/92 (1%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 139
L L + L L++ L N + ++ LQ L +
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLI-LTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 140 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
L LK L+++ N + + FS
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 22/95 (23%), Positives = 39/95 (41%), Gaps = 6/95 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDL-SGTLPDFLGSMTHLQSLNLANN 135
++ L + + I LK L + N + S LP++ ++T+L+ L+L++N
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELN-VAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 136 KFSGSIPATWSQLSNLK----HLDLSSNNLTGRIP 166
K L + LDLS N + P
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 24/112 (21%), Positives = 40/112 (35%), Gaps = 10/112 (8%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N L L + F L S + L G + L+ L+L+
Sbjct: 303 NFGWQHLELVNCKFGQ-FPTL-----KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSR 356
Query: 135 NK--FSGSIPATWSQLSNLKHLDLSSNNLTGRIP--MQLFSVATFNFTGTHL 182
N F G + ++LK+LDLS N + + L + +F ++L
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 18/107 (16%), Positives = 33/107 (30%), Gaps = 6/107 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSM-THLQSLNLANN 135
++ L + N F + L L N + + L + L LNL N
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLD-YSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 136 KFSGSIPATW--SQLSNLKHLDLSSNNLTGRIPMQL--FSVATFNFT 178
F+ + + + + L + + P V + N T
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 18/100 (18%), Positives = 34/100 (34%), Gaps = 7/100 (7%)
Query: 77 NVISLTLGSNGF-SGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQ----SLN 131
+ L + N S K+ + L L L N + L + + SL+
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLD-LSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 132 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
L+ N + P + ++ L L L +N + +
Sbjct: 184 LSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQ 222
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 21/118 (17%), Positives = 42/118 (35%), Gaps = 10/118 (8%)
Query: 78 VISLTLGSNGFSGKIS-PSITKLKFLASFRELQDNDLS------GTLPDFLGSMTHLQSL 130
V L LG G + + L+ L + +++ L+ + D +T++ S
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNL-TIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 131 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSL 188
+L + +S +HL+L + ++L S+ FT S
Sbjct: 288 SLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE 343
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 11/59 (18%), Positives = 22/59 (37%), Gaps = 3/59 (5%)
Query: 108 LQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
+ + +PD L ++L+L+ N ++ L+ LDLS +
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 14/104 (13%), Positives = 31/104 (29%), Gaps = 9/104 (8%)
Query: 77 NVISLTLGSNGFSGKISPSI------TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSL 130
+ LTL +N S + + ++ L + +L L + +L
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 131 NLA---NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ + I ++ L+N+ L S +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 20/98 (20%), Positives = 33/98 (33%), Gaps = 14/98 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQ--DNDLSGTLPDFLGSMTHLQSLNLAN 134
NV S +L S + + ++ L+ + L S+ L +
Sbjct: 283 NVSSFSLVSVTIER-----VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN-- 335
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLT--GRIPMQLF 170
G + L +L+ LDLS N L+ G F
Sbjct: 336 ---KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 55/177 (31%), Positives = 78/177 (44%), Gaps = 25/177 (14%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL----QDYYSPGGEAAFQREVHLISVA 326
+ + + +G+G F VYK + N VA+K++ + G RE+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 327 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGT 382
H N++ L+ S LV+ FM+ DL+ L K T
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME--------TDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VT 434
GLEYLH+ I+HRDLK N+LLD+N L DFGLAK + TH VT
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT 175
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 53/225 (23%), Positives = 87/225 (38%), Gaps = 38/225 (16%)
Query: 271 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKR-LQDYYSPGGEAAFQ----REVHLIS 324
D F + GQG FG V G VA+K+ +QD F+ + + ++
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-------PRFRNRELQIMQDLA 74
Query: 325 VAIHKNLLQLIGYCTTSSER-------ILVYPFM-QNLSVAYR-LRDLKPGEKGLDWPTR 375
V H N++QL Y T ER +V ++ L +R R+ +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTL---HRCCRNYYRRQVAPPPILI 131
Query: 376 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLV--DAKLTH 432
K F + LH + HRD+K N+L++ + LCDFG AK +
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 433 --VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 474
+ R APE + + + D++ G E++ G+
Sbjct: 191 YICSRYYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 73/330 (22%), Positives = 124/330 (37%), Gaps = 54/330 (16%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRL-------QDYYSPGGEAAFQREVHLISVAIHKNL 331
+G G FG V+ V N +V VK + + E+ ++S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 391
++++ LV M+ L LD P + + YL
Sbjct: 92 IKVLDIFENQGFFQLV---MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLS 450
+ IIHRD+K NI++ ++F L DFG A + KL + GT+ + APE L
Sbjct: 149 K---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLM 202
Query: 451 TGKSSE--KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508
G + +++ G+TL LV + + + V+
Sbjct: 203 -GNPYRGPELEMWSLGVTLYTLVFEE--------------NPFCELEE---------TVE 238
Query: 509 RNLN--TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK---MLQGEDLAERWAEWEELE 563
++ SKE+ ++V L Q PE R + ++V + Q +LA+ WEE+
Sbjct: 239 AAIHPPYLVSKELMSLVSGLL---QPVPERRTTLEKLVTDPWVTQPVNLADY--TWEEVF 293
Query: 564 EVRQQEVSLLPHQFAWGEDSSIDQEAIQLS 593
V + E +L + S+ A
Sbjct: 294 RVNKPESGVLSAASLEMGNRSLSDVAQAQE 323
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 17/211 (8%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 328
++ + +G G +G+V + + A+K ++ S + EV ++ + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLE 387
N+++L + LV + + + E + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA-----AVIIKQVLSGVT 150
Query: 388 YLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
YLH+ I+HRDLK N+LL + + + DFGL+ + + + GT +I
Sbjct: 151 YLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERLGTAYYI 205
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 475
APE L K EK DV+ G+ L L+ G
Sbjct: 206 APEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 46/226 (20%), Positives = 85/226 (37%), Gaps = 42/226 (18%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-------RLQDYYSPGGEAAFQREVHL 322
D + S +G G G+V KVA++ + + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 323 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKG-LDWP 373
+ H ++++ + Y + +L G L
Sbjct: 194 LKKLNHPCIIKIKNFFDAED----YYIVL----------ELMEGGELFDKVVGNKRLKEA 239
Query: 374 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKL 430
T K + ++YLHE IIHRDLK N+LL +++ + DFG +K++
Sbjct: 240 TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-- 294
Query: 431 THVTTQIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTG 473
T + + GT ++APE L + + + D + G+ L ++G
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
L+YL Q +IIHRD+K NILLD++ + DF +A ++ + T + GT ++
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYM 181
Query: 445 APEYLSTGKSSEKT---DVFGYGITLLELVTGQR 475
APE S+ K + + D + G+T EL+ G+R
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 43/229 (18%)
Query: 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA-AFQ---------REV 320
++ I G +G V GV S+ VA+KR+ + S G RE+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 321 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPT 374
L++ H N+L L E LV M+ +L+ + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA-----QVIHDQRIVI---S 132
Query: 375 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DA 428
+ + + Y GL LH ++HRDL NILL DN + +CDF LA+ DA
Sbjct: 133 PQHIQY-FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 429 KLT-HVTTQ-IRGTMGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 474
T +VT + R APE + ++ D++ G + E+ +
Sbjct: 189 NKTHYVTHRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 51/228 (22%), Positives = 91/228 (39%), Gaps = 37/228 (16%)
Query: 263 SCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREV 320
S + D + +G+G +G+VYK + N VA+KR+ ++ G REV
Sbjct: 29 SATSI----DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV 84
Query: 321 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKR 377
L+ H+N+++L + L++ + + DLK + K
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKS 136
Query: 378 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-----LCDFGLAKLV---DAK 429
+ G+ + H + + +HRDLK N+LL + + + DFGLA+ +
Sbjct: 137 FLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ 193
Query: 430 LTH--VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 474
TH +T R PE L + S D++ E++
Sbjct: 194 FTHEIITLWYR------PPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 267 LQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ--DYYSPGGEAAFQRE 319
+Q +T FS+ ++G+G FG+V + AVK + + + RE
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 320 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRV 378
V L+ H N+++L + LV + + K E R+
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA-----ARI 131
Query: 379 AFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTT 435
G+ Y+H+ KI+HRDLK N+LL + + DFGL+ +A +
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMK 186
Query: 436 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
GT +IAPE L G EK DV+ G+ L L++G
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 44/191 (23%), Positives = 78/191 (40%), Gaps = 33/191 (17%)
Query: 280 IGQGGFGKVYKGVLSDNT---KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+G+G +G VYK D A+K+++ G + RE+ L+ H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 85
Query: 337 YCTTSSERI--LVYPFMQN----LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
+ ++R L++ + ++ + +R L K + + G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAV----LCDFGLAKLVDA---KLTHVTTQI-----R 438
++HRDLK ANIL+ + D G A+L ++ L + + R
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 439 GTMGHIAPEYL 449
APE L
Sbjct: 203 ------APELL 207
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-16
Identities = 28/149 (18%), Positives = 48/149 (32%), Gaps = 21/149 (14%)
Query: 36 EGEALIEVLKALNDTHGQF--------TDWNDHFVSPCFSWSH---VTC-RNGNVISLTL 83
+ AL E+ ALN + +WN F W V+ NG V L+L
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWN--FNKELDMWGAQPGVSLNSNGRVTGLSL 88
Query: 84 GSNGFSGKISPSITKLKFLASFRELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSG 139
G SG++ +I +L L L + P + + + +
Sbjct: 89 EGFGASGRVPDAIGQLTELEVLA-LGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQK 147
Query: 140 SIPA--TWSQLSNLKHLDLSSNNLTGRIP 166
+ S+L ++S+ I
Sbjct: 148 TFVDYDPREDFSDLIKDCINSDPQQKSIK 176
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-15
Identities = 17/100 (17%), Positives = 29/100 (29%), Gaps = 9/100 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASF-----RELQDNDLSGTLPDFLGSMTHLQSLN 131
++ + L N FS L F R+ Q N P+ + L L
Sbjct: 514 YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572
Query: 132 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ +N + N+ LD+ N +
Sbjct: 573 IGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 24/108 (22%), Positives = 41/108 (37%), Gaps = 12/108 (11%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG-------TLPDFLGSMT 125
+ NV S+ L +N S + L+S L N L+ + +
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSIN-LMGNMLTEIPKNSLKDENENFKNTY 488
Query: 126 HLQSLNLANNKFSGSIPA--TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
L S++L NK + + + L L +DLS N+ + P Q +
Sbjct: 489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN 534
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 27/88 (30%), Positives = 39/88 (44%), Gaps = 4/88 (4%)
Query: 80 SLTLGSNGF-SGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 138
+ +G N + + S+ K+K L E N L G LP F GS L SLNLA N+ +
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGML-ECLYNQLEGKLPAF-GSEIKLASLNLAYNQIT 366
Query: 139 GSIPATWSQLSNLKHLDLSSNNLTGRIP 166
+++L + N L IP
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKY-IP 393
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-15
Identities = 8/84 (9%), Positives = 26/84 (30%), Gaps = 6/84 (7%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 139
+G++ F + + + + T ++ L + + N
Sbjct: 210 QFYMGNSPFVAENICEAWENE------NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263
Query: 140 SIPATWSQLSNLKHLDLSSNNLTG 163
+P L ++ ++++ N
Sbjct: 264 KLPTFLKALPEMQLINVACNRGIS 287
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 18/100 (18%), Positives = 32/100 (32%), Gaps = 10/100 (10%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKF-- 137
+ LK L E+ + LP FL ++ +Q +N+A N+
Sbjct: 229 NENSEYAQQYKTEDLKWDNLKDLTDV-EVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287
Query: 138 ------SGSIPATWSQLSNLKHLDLSSNNL-TGRIPMQLF 170
A ++ + + NNL T + L
Sbjct: 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 16/106 (15%), Positives = 35/106 (33%), Gaps = 18/106 (16%)
Query: 77 NVISLTLGSNGFSGKISPSI-----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSL- 130
+ S+ L N + +S L + +L N S P + + L+
Sbjct: 489 LLTSIDLRFNKLTK-LSDDFRATTLPYLVGI----DLSYNSFSK-FPTQPLNSSTLKGFG 542
Query: 131 -----NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ N+ P + +L L + SN++ + ++
Sbjct: 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP 587
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 18/101 (17%), Positives = 34/101 (33%), Gaps = 16/101 (15%)
Query: 80 SLTLGSNGFSG-------KISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
++ N + P+ K ++S L +N +S + + + L S+NL
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSIN-LSNNQISKFPKELFSTGSPLSSINL 464
Query: 133 ANNKFSG-------SIPATWSQLSNLKHLDLSSNNLTGRIP 166
N + + L +DL N LT +
Sbjct: 465 MGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LS 504
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 23/112 (20%), Positives = 39/112 (34%), Gaps = 12/112 (10%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSG-------TLPDFLGSMTHL 127
V +L+ N I + +++ N++ L ++
Sbjct: 378 QVENLSFAHNKLKY-IPNIFDAKSVSVMSAID-FSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 128 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 179
S+NL+NN+ S +S S L ++L N LT IP NF
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFKN 486
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 4/99 (4%), Positives = 23/99 (23%), Gaps = 2/99 (2%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLA-SFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 138
+ + F + + ++ + +N +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 139 GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNF 177
+ +L+ L+ + ++ + + +
Sbjct: 197 -FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY 234
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 14/114 (12%), Positives = 36/114 (31%), Gaps = 21/114 (18%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
++I + S+ I S N+++ + + +T L+ + N+
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQI-GQLSNNITF-VSKAVMRLTKLRQFYMGNSP 217
Query: 137 FSG-------------------SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
F + W L +L +++ + ++P L +
Sbjct: 218 FVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 18/85 (21%), Positives = 27/85 (31%), Gaps = 7/85 (8%)
Query: 88 FSGKISPSITKLKFLASFRELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPATWS 146
G + F D+ G P L S + L+L SG +P
Sbjct: 49 QQGFGTQPGANWNFNKEL------DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIG 102
Query: 147 QLSNLKHLDLSSNNLTGRIPMQLFS 171
QL+ L+ L L S+ +
Sbjct: 103 QLTELEVLALGSHGEKVNERLFGPK 127
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 9/82 (10%), Positives = 22/82 (26%), Gaps = 4/82 (4%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 140
N + IT L + + ND+ + + ++ L++ +N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQ-IGSNDIR-KVNE--KITPNISVLDIKDNPNISI 602
Query: 141 IPATWSQLSNLKHLDLSSNNLT 162
+ L +
Sbjct: 603 DLSYVCPYIEAGMYMLFYDKTQ 624
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 42/218 (19%), Positives = 75/218 (34%), Gaps = 44/218 (20%)
Query: 265 RELQLATDNFSE-----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQR 318
+ + ++ ++G G GKV + K A+K L D ++
Sbjct: 17 QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD------SPKARQ 70
Query: 319 EV-HLISVAIHKNLLQLIG-YCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EK 368
EV H + +++ ++ Y + + M + G E+
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM----------ECMEGGELFSRIQER 120
Query: 369 GLDWPTRKRVAFGT---AYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGL 422
G T + A +++LH I HRD+K N+L + + L DFG
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 460
AK + T ++APE L K + D+
Sbjct: 178 AKETT---QNALQTPCYTPYYVAPEVLGPEKYDKSCDM 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 33/203 (16%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
F ++G G F +V+ A+K + +++ + E+ ++ H+
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI-KKSPAFRDSSLENEIAVLKKIKHE 66
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTAY 384
N++ L +++ LV MQ L G + D + + A
Sbjct: 67 NIVTLEDIYESTTHYYLV---MQ----------LVSGGELFDRILERGVYTEKDASLVIQ 113
Query: 385 ----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQI 437
++YLHE I+HRDLK N+L ++N + ++ DFGL+K+ + +
Sbjct: 114 QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTA 167
Query: 438 RGTMGHIAPEYLSTGKSSEKTDV 460
GT G++APE L+ S+ D
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDC 190
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 53/228 (23%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 320
+ +G G +G V + KVA+K+L FQ RE+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74
Query: 321 HLISVAIHKNLLQLIGYCTTSSERI------LVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 373
L+ H+N++ L+ T +S LV PFMQ +L L+
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK-----------F 123
Query: 374 TRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429
+ +++ + Y GL+Y+H + ++HRDLK N+ ++++ E + DFGLA+ DA+
Sbjct: 124 SEEKIQY-LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
Query: 430 LTH-VTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 474
+T V T+ R APE LS ++ D++ G + E++TG+
Sbjct: 180 MTGYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 23/90 (25%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
N+ L L N + + T+ L S + N +S P+ + L+ LNL +N+
Sbjct: 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLD-VGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
S T++ +NL L L SN++
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 17/114 (14%), Positives = 35/114 (30%), Gaps = 6/114 (5%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N ++ L + G + L L L+ N + + L+ ++L
Sbjct: 512 QHNNLA-RLWKHANPGGPIYFLKGLSHLHILN-LESNGFDEIPVEVFKDLFELKIIDLGL 569
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVAT----FNFTGTHLIC 184
N + + ++ +LK L+L N +T + C
Sbjct: 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 26/95 (27%), Positives = 36/95 (37%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ SL +G N S KL L LQ N+LS T+L L+L +N
Sbjct: 50 QLTSLDVGFNTISKLEPELCQKLPMLKVLN-LQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ + NL LDLS N L+ +
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSS-TKLGTQV 142
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 21/92 (22%), Positives = 35/92 (38%), Gaps = 2/92 (2%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 139
L L N S + L L N + + +L +L+L++N S
Sbjct: 77 VLNLQHNELSQLSDKTFAFCTNLTELH-LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 140 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ T QL NL+ L LS+N + + +
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQA-LKSEELD 166
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 17/85 (20%), Positives = 33/85 (38%), Gaps = 2/85 (2%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLP-DFLGSMTHLQSLNLANNKFS 138
L L N S S + + L L L N++ L + ++ + L+ NK+
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLD-LGLNEIGQELTGQEWRGLENIFEIYLSYNKYL 443
Query: 139 GSIPATWSQLSNLKHLDLSSNNLTG 163
+++ + +L+ L L L
Sbjct: 444 QLTRNSFALVPSLQRLMLRRVALKN 468
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 25/99 (25%), Positives = 38/99 (38%), Gaps = 5/99 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPD---FLG-SMTHLQSLNL 132
+ L + N G S T L L L ++ S F+ + + L LNL
Sbjct: 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLS-LSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
NK S +S L +L+ LDL N + + Q +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 18/94 (19%), Positives = 36/94 (38%), Gaps = 4/94 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFREL--QDNDLSGTLPDFLGSM--THLQSLNL 132
+ L L + ++ + S R L ++ LS T + T+L L+L
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
+ N + +++ L L++ L NN+
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS 289
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 20/97 (20%), Positives = 32/97 (32%), Gaps = 9/97 (9%)
Query: 75 NGNVISLT-LGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLA 133
+ + SL L + F + L L N +S D + HL+ L+L
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILN-------LTKNKISKIESDAFSWLGHLEVLDLG 413
Query: 134 NNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQL 169
N+ + W L N+ + LS N
Sbjct: 414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSF 450
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 22/105 (20%), Positives = 35/105 (33%), Gaps = 3/105 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG--TLPDFLGSMTHLQSLNLAN 134
N+ + L N + S + L L+ L + P + +L L+L+N
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLM-LRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 179
N + L L+ LDL NNL + G
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 23/111 (20%), Positives = 42/111 (37%), Gaps = 13/111 (11%)
Query: 77 NVISLTLGSNGFSGKISPSI---TKLKFLASFRELQDNDLSGTLPDFLGSM--THLQSLN 131
N+I+L L NG S + L+ L L +N + + L + L+ L
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQEL----LLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 132 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 182
L++N+ P + + L L L++ L + +L T +
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC----LELANTSI 224
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 22/115 (19%), Positives = 44/115 (38%), Gaps = 10/115 (8%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSI-----TKLKFLASFRELQDNDLSGTLPDFLGSMTHL 127
N ++ +L+L ++ S + + T L L +L N+L+ D + L
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML----DLSYNNLNVVGNDSFAWLPQL 274
Query: 128 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM-QLFSVATFNFTGTH 181
+ L N + L N+++L+L + I + L + F+F
Sbjct: 275 EYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 24/118 (20%), Positives = 37/118 (31%), Gaps = 9/118 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
++ L L SNGF L L L N+L+ + L+SLNL N
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIID-LGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 137 FSGSIPAT-WSQLSNLKHLDLSSNNLTGRIPMQLF-------SVATFNFTGTHLICGS 186
+ NL LD+ N + + +H +C +
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNT 653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 20/104 (19%), Positives = 36/104 (34%), Gaps = 9/104 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFR--------ELQDNDLSGTLPDFLGSMTHLQ 128
+ L N S S+ L + + L + L+
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 129 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR-IPMQLFS 171
LN+ +N G ++ L NLK+L LS++ + R + + F
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV 376
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 16/59 (27%), Positives = 28/59 (47%), Gaps = 3/59 (5%)
Query: 108 LQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
L+ +PD L T++ LNL +N+ A +++ S L LD+ N ++ P
Sbjct: 11 CSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP 66
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 48/231 (20%), Positives = 84/231 (36%), Gaps = 36/231 (15%)
Query: 260 RRFSCRELQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA 314
+++ + +++ D+ + +G G FG V++ + A K + +
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDKE 199
Query: 315 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 374
++E+ +SV H L+ L +E +++Y FM GE +
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG------------GEL-FEKVA 246
Query: 375 RKRVAF----GTAY------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGL 422
+ Y GL ++HE +H DLK NI+ L DFGL
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 303
Query: 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
+D K GT APE TD++ G+ L++G
Sbjct: 304 TAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 41/219 (18%), Positives = 81/219 (36%), Gaps = 38/219 (17%)
Query: 260 RRFSCRELQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA 314
+++ + +++ + + +G G FG V++ V + K + + P +
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKY 93
Query: 315 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWP 373
+ E+ +++ H L+ L E +L+ F+ GE L D
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG------------GE--LFDRI 139
Query: 374 TRKRVAFGTAY----------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFG 421
+ A GL+++HE I+H D+K NI+ + + + DFG
Sbjct: 140 AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196
Query: 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 460
LA ++ + T APE + TD+
Sbjct: 197 LATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFYTDM 233
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 46/234 (19%), Positives = 84/234 (35%), Gaps = 56/234 (23%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL------------QDYYSPGGEAAFQ 317
+++ + +G G +G+V + +++ A+K + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 318 REVHLISVAIHKNLLQLIGYCTTSS---------------ERILVYPFMQNLSVAYRLRD 362
E+ L+ H N+++L E+I+ A ++
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 363 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCD 419
+ G+ YLH+ I+HRD+K NILL + + D
Sbjct: 155 I-------------------LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVD 192
Query: 420 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
FGL+ + GT +IAPE L K +EK DV+ G+ + L+ G
Sbjct: 193 FGLSSFFSK--DYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 52/232 (22%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVK-------------------------RLQDYYSPGGE 313
IG+G +G V +DNT A+K G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 314 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP 373
+E+ ++ H N+++L+ +E L Y + + G ++ P
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFE-----L----VNQGPV-MEVP 129
Query: 374 TRKRVAFGTA--------YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425
T K ++ A G+EYLH Q KIIHRD+K +N+L+ ++ + DFG++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQ 474
++ + GT +APE LS + S + DV+ G+TL V GQ
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 47/211 (22%), Positives = 79/211 (37%), Gaps = 38/211 (18%)
Query: 271 TDNFSE-----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVH-L 322
+NF+ S +G+G F V + + S + A K L+ A E+ L
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 323 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTR 375
++ L +SE IL+ + GE + + +
Sbjct: 83 ELAKSCPRVINLHEVYENTSEIILILEYAAG------------GEIFSLCLPELAEMVSE 130
Query: 376 KRVAFGT---AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAK 429
V G+ YLH+ I+H DLK NILL + + DFG+++ +
Sbjct: 131 NDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 460
+I GT ++APE L+ + TD+
Sbjct: 188 --CELREIMGTPEYLAPEILNYDPITTATDM 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 47/215 (21%), Positives = 79/215 (36%), Gaps = 49/215 (22%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 324
D++ +G G F V K + A K RL +REV+++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQ------------NLS---VAYRLRDLKPGEKG 369
H N++ L ++ +L+ + +L+ L+ +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI------ 117
Query: 370 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 425
LD G+ YLH + +I H DLK NI+L N L DFG+A
Sbjct: 118 LD-------------GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 460
++A + I GT +APE ++ + D+
Sbjct: 162 IEAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADM 194
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 51/226 (22%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 328
+ ++ ++G+G FG+V K + AVK + + REV L+ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 329 KNLLQLIGYCTTSS---------------ERILVYPFMQNLS---VAYRLRDLKPGEKGL 370
N+++L SS + I+ + S A ++ +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQV------- 130
Query: 371 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVD 427
G+ Y+H+ I+HRDLK NILL + + + + DFGL+
Sbjct: 131 ------------FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
GT +IAPE L G EK DV+ G+ L L++G
Sbjct: 176 Q--NTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 47/215 (21%), Positives = 75/215 (34%), Gaps = 49/215 (22%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 324
D + +G G F V K S + A K + + +REV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTA 383
+H N++ L ++ +L+ + GE L D +A +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSG------------GE--LFD-----FLAQKES 111
Query: 384 Y--------------GLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 425
G+ YLH + KI H DLK NI+L L DFGLA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 460
++ I GT +APE ++ + D+
Sbjct: 169 IEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 52/228 (22%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 320
+ + +G G +G V V KVA+K+L FQ RE+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75
Query: 321 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 373
L+ H+N++ L+ ++ LV PFM +L + L
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL---------- 125
Query: 374 TRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429
R+ F Y GL Y+H IIHRDLK N+ ++++ E + DFGLA+ D++
Sbjct: 126 GEDRIQF-LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 430 LT-HVTTQ-IRGTMGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 474
+T +V T+ R APE L+ + ++ D++ G + E++TG+
Sbjct: 182 MTGYVVTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-15
Identities = 43/202 (21%), Positives = 76/202 (37%), Gaps = 26/202 (12%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
D F +G G FG V+ S + +K + S + E+ ++ H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLS--------VAYRLRDLKPGEKGLDWPTRKRVAFG 381
N++++ +V M+ V+ + R E + ++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIV---METCEGGELLERIVSAQARGKALSEGYVAELMKQMMN-- 135
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIR 438
L Y H Q ++H+DLK NIL + + DFGLA+L + +T
Sbjct: 136 ---ALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAA 187
Query: 439 GTMGHIAPEYLSTGKSSEKTDV 460
GT ++APE + K D+
Sbjct: 188 GTALYMAPEVFK-RDVTFKCDI 208
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 52/204 (25%), Positives = 81/204 (39%), Gaps = 33/204 (16%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 328
+ ++ ++G+G FG+V K + AVK + + REV L+ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 383
N+++L SS +V +L G + D ++ A
Sbjct: 81 PNIMKLFEILEDSSSFYIV---G----------ELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 384 Y----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQ 436
G+ Y+H+ I+HRDLK NILL + + + + DFGL+
Sbjct: 128 KQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKD 182
Query: 437 IRGTMGHIAPEYLSTGKSSEKTDV 460
GT +IAPE L G EK DV
Sbjct: 183 RIGTAYYIAPEVLR-GTYDEKCDV 205
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 51/221 (23%), Positives = 84/221 (38%), Gaps = 38/221 (17%)
Query: 271 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---------REV 320
+ IG G G V + VA+K+L FQ RE+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75
Query: 321 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 373
L+ HKN++ L+ + +V M NL + LD
Sbjct: 76 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------MELDHE 127
Query: 374 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433
+ + G+++LH + IIHRDLK +NI++ + + DFGLA+ + +
Sbjct: 128 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFM 182
Query: 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
T T + APE + E D++ G + E++ G
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 44/199 (22%), Positives = 73/199 (36%), Gaps = 38/199 (19%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 336
++G G GKV + K A+K LQD +REV + ++++++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVD 122
Query: 337 -YCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKGLDWPTRKRVAFGT---AY 384
Y + R + M + G ++G T + +
Sbjct: 123 VYENLYAGRKCLLIVM----------ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGTM 441
++YLH I HRD+K N+L L DFG AK + + T T
Sbjct: 173 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTP 227
Query: 442 GHIAPEYLSTGKSSEKTDV 460
++APE L K + D+
Sbjct: 228 YYVAPEVLGPEKYDKSCDM 246
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 48/224 (21%), Positives = 85/224 (37%), Gaps = 50/224 (22%)
Query: 262 FSCRELQLATDNFSE------SNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYS 309
F R + + + I+G G FG+V+K + K+A K ++D
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--- 129
Query: 310 PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 369
+ + E+ +++ H NL+QL + ++ +LV ++ GE
Sbjct: 130 ---KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG------------GE-- 172
Query: 370 L-DWPTRKRVAFGTAY----------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL- 417
L D + G+ ++H+ I+H DLK NIL + +
Sbjct: 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIK 229
Query: 418 -CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 460
DFGLA+ + GT +APE ++ S TD+
Sbjct: 230 IIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 53/236 (22%), Positives = 91/236 (38%), Gaps = 50/236 (21%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI 323
++++L ++F +IG+G FG+V L + KV A+K L + E + E
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW-----EMLKRAETA-- 119
Query: 324 SVAIHKNLLQLIGYCTTSSERILVY---PFMQNLSVA-------YRLRDLKPG------- 366
C +LV ++ L A Y + D G
Sbjct: 120 --------------CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL 165
Query: 367 EKGLDWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423
K D + F A ++ +H+ +HRD+K NIL+D N L DFG
Sbjct: 166 SKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 222
Query: 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-----DVFGYGITLLELVTGQ 474
+ T ++ GT +I+PE L + + D + G+ + E++ G+
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 38/221 (17%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 320
+ IG G G V + VA+K+L FQ RE+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112
Query: 321 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 373
L+ HKN++ L+ + LV M NL + LD
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--------MELDHE 164
Query: 374 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433
+ + G+++LH + IIHRDLK +NI++ + + DFGLA+ + +
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFM 219
Query: 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
T T + APE + E D++ G + E+V +
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 379 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 438
+F A G+E+L + K IHRDL A NILL + +CDFGLA+ + +V R
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV----R 251
Query: 439 GTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT 472
+ APE + + ++DV+ +G+ L E+ +
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 23/90 (25%), Positives = 39/90 (43%), Gaps = 8/90 (8%)
Query: 272 DNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREV-HLIS 324
D +G+G FG+V + + VAVK L++ + A E+ LI
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 325 VAIHKNLLQLIGYCTTSSERILV-YPFMQN 353
+ H N++ L+G CT ++V F +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKF 111
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 47/215 (21%), Positives = 75/215 (34%), Gaps = 49/215 (22%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 324
D + +G G F V K S + A K + + +REV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTA 383
+H N++ L ++ +L+ + GE L D +A +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSG------------GE--LFD-----FLAQKES 111
Query: 384 Y--------------GLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 425
G+ YLH + KI H DLK NI+L L DFGLA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 460
++ I GT +APE ++ + D+
Sbjct: 169 IED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGHI 444
LEYLH + IIHRDLK NILL+++ + DFG AK++ + GT ++
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 445 APEYLST---GKSSEKTDVFGYGITLLELVTGQ 474
+PE L+ KSS D++ G + +LV G
Sbjct: 200 SPELLTEKSACKSS---DLWALGCIIYQLVAGL 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 28/281 (9%), Positives = 73/281 (25%), Gaps = 55/281 (19%)
Query: 280 IGQGGFGKVYKGVLSDNT---KVAVK--RLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 334
G + ++ + D +VA+ Q +S + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 335 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 394
+ T + ++V + L+++ + R A + H
Sbjct: 97 LDVVHTRAGGLVV---AE-WIRGGSLQEV--ADTSPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 454
+ + + + + + VL + +
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQ------------------------- 182
Query: 455 SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 514
D+ G G +L L+ + + + + D + + ++ + ++
Sbjct: 183 ---DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA- 238
Query: 515 DSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 555
VA Q R + M Q +A+R
Sbjct: 239 ----------VAARSVQGDGGIRSASTLLNLMQQATAVADR 269
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 34/203 (16%), Positives = 75/203 (36%), Gaps = 33/203 (16%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
+ + + +G+G FG V++ V S K ++ + ++E+ ++++A H+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG----TAY- 384
N+L L + E ++++ F+ + + +Y
Sbjct: 62 NILHLHESFESMEELVMIFEFISG------------LDI-FERINTSAFELNEREIVSYV 108
Query: 385 -----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKLVDAKLTHVTTQI 437
L++LH I H D++ NI+ + + +FG A+ + +
Sbjct: 109 HQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLL 163
Query: 438 RGTMGHIAPEYLSTGKSSEKTDV 460
+ APE S TD+
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDM 186
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 45/214 (21%), Positives = 79/214 (36%), Gaps = 45/214 (21%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-------RLQDYYSPGGEAAFQREVHL 322
D + S +G G G+V KVA+K + + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 323 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKG-LDWP 373
+ H ++++ + Y + +L G L
Sbjct: 69 LKKLNHPCIIKIKNFFDAED----YYIVL----------ELMEGGELFDKVVGNKRLKEA 114
Query: 374 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKL 430
T K + ++YLHE IIHRDLK N+LL +++ + DFG +K++
Sbjct: 115 TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-- 169
Query: 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 464
T + + GT ++APE L + ++ GY
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTA------GYN 197
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 26/117 (22%), Positives = 42/117 (35%), Gaps = 13/117 (11%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
L + N F ++ T L FL +L L ++ LQ LN+++N
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFL----DLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVAT----FNFTGTHLICGSSLE 189
+ ++QL +L LD S N + L FN T + C +
Sbjct: 509 LLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICEHQ 564
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 19/92 (20%), Positives = 31/92 (33%), Gaps = 1/92 (1%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 139
L L + L L++ L N + P +T L++L K +
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLI-LTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 140 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
QL LK L+++ N + FS
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 17/96 (17%), Positives = 35/96 (36%), Gaps = 3/96 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLP-DFLGSMTHLQSLNLANN 135
++ L L NG +S + L+ L Q + L S+ L L+++
Sbjct: 377 SLRHLDLSFNGAII-MSANFMGLEELQHLD-FQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ L++L L ++ N+ +F+
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 17/80 (21%), Positives = 28/80 (35%), Gaps = 8/80 (10%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
I S + +L N L + + LQ L+L+ + W L +L
Sbjct: 30 IPSSTKNI-------DLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82
Query: 152 KHLDLSSNNLTGRIPMQLFS 171
+L L+ N + FS
Sbjct: 83 SNLILTGNPIQS-FSPGSFS 101
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 20/100 (20%), Positives = 36/100 (36%), Gaps = 7/100 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG-TLPDFLGSMTHLQSLNLANN 135
++ +L + S I +L L + N + LP + ++T+L ++L+ N
Sbjct: 105 SLENLVAVETKLASLESFPIGQLITLKKLN-VAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 136 KFSGSIPATWSQLSNLK----HLDLSSNNLTGRIPMQLFS 171
L LD+S N + I Q F
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQ 202
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 23/85 (27%), Positives = 37/85 (43%), Gaps = 8/85 (9%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 139
SL++ + + LK L L N S + ++ L L+L+ N S
Sbjct: 311 SLSIIRCQLKQFPTLDLPFLKSL----TLTMNKGSISFK--KVALPSLSYLDLSRNALSF 364
Query: 140 SIPATWSQL--SNLKHLDLSSNNLT 162
S ++S L ++L+HLDLS N
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAI 389
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 26/99 (26%), Positives = 39/99 (39%), Gaps = 17/99 (17%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG----TLPDFLGSMTHLQSLNL 132
NV +++L SI L+ + + Q + P + L+SL L
Sbjct: 286 NVSAMSLAGV--------SIKYLEDVPKHFKWQSLSIIRCQLKQFPTL--DLPFLKSLTL 335
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
NK GSI L +L +LDLS N L+ +S
Sbjct: 336 TMNK--GSISFKKVALPSLSYLDLSRNALSF-SGCCSYS 371
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 13/91 (14%), Positives = 27/91 (29%), Gaps = 8/91 (8%)
Query: 80 SLTLGSNGFSGKISPSI------TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQ--SLN 131
LTL N S I + + L + +L P + + +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 132 LANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
L + L+N+ + L+ ++
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 18/103 (17%), Positives = 30/103 (29%), Gaps = 13/103 (12%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHL----Q 128
+ L + N P+ T L + +L N + + L +
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHV----DLSYNYIQTITVNDLQFLRENPQVNL 184
Query: 129 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
SL+++ N I Q L L L N + I
Sbjct: 185 SLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQ 226
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 15/86 (17%), Positives = 25/86 (29%), Gaps = 6/86 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ L L +++ L + L D QSL++ +
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMS-LAGVSIK-YLEDVPK-HFKWQSLSIIRCQ 318
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLT 162
P L LK L L+ N +
Sbjct: 319 LK-QFPT--LDLPFLKSLTLTMNKGS 341
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 10/110 (9%), Positives = 31/110 (28%), Gaps = 9/110 (8%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGT-------LPDFLGSMTHLQSLNL 132
L F + + I + + ++ ++ T + ++ +++L
Sbjct: 233 VHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSL 292
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 182
A + + + L + L + L + + T
Sbjct: 293 AGVSIK-YLED-VPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKG 340
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 40/204 (19%), Positives = 73/204 (35%), Gaps = 31/204 (15%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 328
T+ + +G+G F V + V + + A + S +RE + + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 383
N+++L + L+ DL G + + + A
Sbjct: 70 PNIVRLHDSISEEGHHYLI---F----------DLVTGGELFEDIVAREYYSEADASHCI 116
Query: 384 Y----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQ 436
+ + H+ ++HR+LK N+LL L DFGLA V+ +
Sbjct: 117 QQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFG 172
Query: 437 IRGTMGHIAPEYLSTGKSSEKTDV 460
GT G+++PE L + D+
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDL 196
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 5e-14
Identities = 22/96 (22%), Positives = 31/96 (32%), Gaps = 11/96 (11%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 139
S + LK L EL + LPDFL + LQSLN+A N+
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDV-ELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
Query: 140 ---------SIPATWSQLSNLKHLDLSSNNLTGRIP 166
+ ++ + NNL P
Sbjct: 530 AAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FP 564
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 19/120 (15%), Positives = 35/120 (29%), Gaps = 14/120 (11%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASF-----RELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
++ + N FS L +F R+ + N + P + + L L + +
Sbjct: 757 NMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGS 815
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLT-----GRIPMQLFSVATFNFTGTHLICGSSLE 189
N + L LD++ N P + + T I G
Sbjct: 816 NDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDAL 872
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 15/103 (14%), Positives = 36/103 (34%), Gaps = 18/103 (17%)
Query: 80 SLTLGSNGFSGKISPSI-----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL-- 132
++ L N + +S L + ++ N S + P + + L++ +
Sbjct: 732 TIDLRFNKLTS-LSDDFRATTLPYLSNM----DVSYNCFS-SFPTQPLNSSQLKAFGIRH 785
Query: 133 ----ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
N+ P + +L L + SN++ + +L
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTP 827
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 9/84 (10%), Positives = 24/84 (28%), Gaps = 6/84 (7%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 139
+ ++ F+ + ++ ++ L + L N
Sbjct: 452 IIYFANSPFTY-DNIAVDWEDAN-----SDYAKQYENEELSWSNLKDLTDVELYNCPNMT 505
Query: 140 SIPATWSQLSNLKHLDLSSNNLTG 163
+P L L+ L+++ N
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGIS 529
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 5e-12
Identities = 15/97 (15%), Positives = 30/97 (30%), Gaps = 13/97 (13%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---------TLPDFLGSMTHL 127
++ + L + ++ + L L S + N L D + +
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLN-IACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 128 QSLNLANNKFSGSIPATW--SQLSNLKHLDLSSNNLT 162
Q + N PA+ ++ L LD N +
Sbjct: 551 QIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR 586
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 26/176 (14%), Positives = 58/176 (32%), Gaps = 17/176 (9%)
Query: 36 EGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVT--CRNGNVISLTLGSNGFSGKIS 93
+ +AL + +AL+ + ++ + +W+ G+ + L +NG
Sbjct: 270 DYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNG------ 323
Query: 94 PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKH 153
+T L L G +PD +G +T L+ L+ + + S +
Sbjct: 324 -RVTGL-------SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375
Query: 154 LDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRI 209
+ + + ++F + L+ + P M S +I
Sbjct: 376 SEERKHRIRMHYK-KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQI 430
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 19/116 (16%), Positives = 41/116 (35%), Gaps = 28/116 (24%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG------TLPDFLGSMTHLQSLNLAN 134
L + + +P + +K S L+D + + + +T LQ + AN
Sbjct: 401 SDLLQDAINR--NPEMKPIKKD-SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFAN 457
Query: 135 NKFSG-------------------SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ F+ + +WS L +L ++L + ++P L+
Sbjct: 458 SPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 17/109 (15%), Positives = 34/109 (31%), Gaps = 8/109 (7%)
Query: 77 NVISLTLGSNGFSG-KISPSITKLKFLASFRELQDNDLSGTLPDFLGSM-----THLQSL 130
V L N + + + S N + + SM + ++
Sbjct: 620 QVEGLGFSHNKLKYIPNIFNAKSVYVMGSVD-FSYNKIGSEGRNISCSMDDYKGINASTV 678
Query: 131 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 179
L+ N+ ++ S + + LS+N +T IP N+
Sbjct: 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKN 726
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 20/92 (21%), Positives = 30/92 (32%), Gaps = 5/92 (5%)
Query: 80 SLTLGSNGFSG-KISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 138
+G N S S+ K+ L + N + L F G+ L L L N+
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLL-DCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIE 608
Query: 139 GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 170
+ ++ L S N L IP
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFN 639
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 15/103 (14%), Positives = 31/103 (30%), Gaps = 13/103 (12%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ N I + G N + L N++ + + + + ++ L+N
Sbjct: 652 SYNKIG-SEGRNISCSMDDYKGINASTV----TLSYNEIQKFPTELFATGSPISTIILSN 706
Query: 135 NKFS-------GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 170
N + + L +DL N LT +
Sbjct: 707 NLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFR 748
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 46/215 (21%), Positives = 75/215 (34%), Gaps = 49/215 (22%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 324
D + +G G F V K S + A K R + +REV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQ------------NLS---VAYRLRDLKPGEKG 369
H N++ L ++ IL+ + +L+ L+ +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------ 123
Query: 370 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 425
L+ G+ YLH +I H DLK NI+L + DFGLA
Sbjct: 124 LN-------------GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 460
+D + I GT +APE ++ + D+
Sbjct: 168 IDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 24/224 (10%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVH 321
+E++L D+F +IG+G F +V + +V A+K + D G + F+ E
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 322 LISVAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 380
++ + + QL + + LV + + L K GE+ + F
Sbjct: 114 VLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS--KFGERI----PAEMARF 166
Query: 381 GTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 437
A ++ +H +HRD+K NILLD L DFG + A T +
Sbjct: 167 YLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 438 RGTMGHIAPEYLSTGKSSEKTDVFG-------YGITLLELVTGQ 474
GT +++PE L T +G G+ E+ GQ
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 52/228 (22%)
Query: 271 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---------REV 320
+ + + +G G +G V + +VAVK+L FQ RE+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79
Query: 321 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 373
L+ H+N++ L+ ++ LV M +L+ + + L
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL---------- 129
Query: 374 TRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429
T V F Y GL+Y+H + IIHRDLK +N+ ++++ E + DFGLA+ +
Sbjct: 130 TDDHVQF-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 430 LT-HVTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 474
+T +V T+ R APE L+ ++ D++ G + EL+TG+
Sbjct: 186 MTGYVATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 48/227 (21%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 320
++ + IG+G +G V + +VA+K++ F+ RE+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---------PFEHQTYCQRTLREI 76
Query: 321 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPT 374
++ H+N++ + + +V M+ +L + + L +
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL----------S 126
Query: 375 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430
+ + Y GL+Y+H + ++HRDLK +N+LL+ + +CDFGLA++ D
Sbjct: 127 NDHICYFL-YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 431 THVT--TQIRGTMGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 474
H T+ T + APE L++ ++ D++ G L E+++ +
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 38/210 (18%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337
IG+G F KV + +VA+K + +P REV ++ + H N+++L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFG-TAYGLEY 388
T L+ + GE D+ R F ++Y
Sbjct: 83 IETEKTLYLIMEYASG------------GE-VFDYLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKL-THVTTQIRGTMGHIA 445
H++ I+HRDLKA N+LLD + + DFG + KL G + A
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPPYAA 181
Query: 446 PEYLSTGKSSE--KTDVFGYGITLLELVTG 473
PE GK + + DV+ G+ L LV+G
Sbjct: 182 PELFQ-GKKYDGPEVDVWSLGVILYTLVSG 210
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 8e-14
Identities = 47/204 (23%), Positives = 75/204 (36%), Gaps = 32/204 (15%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 328
+DN+ +G+G F V + V + + A K + S +RE + H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 383
N+++L S LV DL G + + + A
Sbjct: 65 PNIVRLHDSIQEESFHYLV---F----------DLVTGGELFEDIVAREFYSEADASHCI 111
Query: 384 Y----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQ 436
+ Y H I+HR+LK N+LL + L DFGLA V+ +
Sbjct: 112 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHG 166
Query: 437 IRGTMGHIAPEYLSTGKSSEKTDV 460
GT G+++PE L S+ D+
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDI 190
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 50/215 (23%), Positives = 81/215 (37%), Gaps = 41/215 (19%)
Query: 265 RELQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQRE 319
++L + F++ IG G + + + + N + AVK + E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-----TEE 65
Query: 320 VH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-- 376
+ L+ H N++ L +V +L G + LD R+
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVV---T----------ELMKGGELLDKILRQKF 112
Query: 377 -------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAV-LCDFGLAKL 425
V F +EYLH Q ++HRDLK +NIL N E++ +CDFG AK
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 460
+ A+ + T +APE L D+
Sbjct: 170 LRAE-NGLLMTPCYTANFVAPEVLERQGYDAACDI 203
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 43/249 (17%), Positives = 83/249 (33%), Gaps = 60/249 (24%)
Query: 271 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIH 328
+ +S +G G FG V + + + A+K++ + + RE+ ++ V H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR------------- 375
N+++L+ Y T+ + P + ++
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 376 -----KRVAFGTA---------------Y----GLEYLHEQCNPKIIHRDLKAANILLD- 410
+V Y + ++H I HRD+K N+L++
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176
Query: 411 DNFEAVLCDFGLAKLV--DAKLTH--VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGI 465
+ LCDFG AK + + R APE + + D++ G
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSIDLWSIGC 230
Query: 466 TLLELVTGQ 474
EL+ G+
Sbjct: 231 VFGELILGK 239
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 48/216 (22%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
+G+G +G+V V VAVK + + ++E+ + + H+N+++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTA-------- 383
+ + L + GE + A
Sbjct: 75 REGNIQYLFLEYCSG------------GELFDRIEPDI-------GMPEPDAQRFFHQLM 115
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD----AKLTHVTTQIRG 439
G+ YLH I HRD+K N+LLD+ + DFGLA + +L + G
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---G 169
Query: 440 TMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 473
T+ ++APE L + +E DV+ GI L ++ G
Sbjct: 170 TLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAG 204
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 37/223 (16%)
Query: 272 DNFSESNIIGQGGFGKVY---KGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAI 327
+NF ++G G +GKV+ K D K+ A+K L+ Q+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK------ATIVQKAKTTEHTRT 107
Query: 328 HKNLLQLIG---------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 376
+ +L+ I Y + ++ L+ ++ + L + + E
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH-------- 159
Query: 377 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433
V LE+LH+ II+RD+K NILLD N VL DFGL+K A T
Sbjct: 160 EVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216
Query: 434 TTQIRGTMGHIAPEYLSTGKSSEKTDV--FGYGITLLELVTGQ 474
GT+ ++AP+ + G S V + G+ + EL+TG
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 47/202 (23%), Positives = 72/202 (35%), Gaps = 47/202 (23%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 336
+G+G F K V N AVK + EA Q+E+ L H N+++L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHE 73
Query: 337 YCTTSS---------------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 381
ERI +Y +R L
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL------------------ 115
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIR 438
+ ++H+ ++HRDLK N+L +DN E + DFG A+L + T
Sbjct: 116 -VSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC- 170
Query: 439 GTMGHIAPEYLSTGKSSEKTDV 460
T+ + APE L+ E D+
Sbjct: 171 FTLHYAAPELLNQNGYDESCDL 192
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 23/99 (23%), Positives = 35/99 (35%), Gaps = 2/99 (2%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
+V S+ L + F S + L L LS LP L ++ L+ L L
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELD-LTATHLS-ELPSGLVGLSTLKKLVL 308
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ NKF + S +L HL + N +
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 25/99 (25%), Positives = 41/99 (41%), Gaps = 11/99 (11%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDL--SGTLPDFLGSMTHLQSLNL 132
GN L LG+ + L+ L +L +D+ S L +++HLQSLNL
Sbjct: 333 KGNTKRLELGTGCLEN-----LENLREL----DLSHDDIETSDCCNLQLRNLSHLQSLNL 383
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ N+ + + L+ LDL+ L + F
Sbjct: 384 SYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 17/95 (17%), Positives = 26/95 (27%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ L N + + ++L L L + D S L +L L N
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLD-LTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
S LKHL ++ I
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISS-IDFIPLH 126
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 19/95 (20%), Positives = 33/95 (34%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ +L L +N +++ K L +S L + L+SL L +N
Sbjct: 82 RLDTLVLTANPLIFMAETALSGPKALKHLF-FIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
S LK LD +N + + + S
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNNAIHY-LSKEDMS 174
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 18/88 (20%), Positives = 31/88 (35%), Gaps = 2/88 (2%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFS 138
SL L N + + + L L L ++ L+ LNL+++
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLD-LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD 438
Query: 139 GSIPATWSQLSNLKHLDLSSNNLTGRIP 166
S + L L+HL+L N+
Sbjct: 439 ISSEQLFDGLPALQHLNLQGNHFPKGNI 466
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 27/118 (22%), Positives = 45/118 (38%), Gaps = 6/118 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFREL--QDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ L L N F L+ L L DLS S+ + ++L++
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP---MQLFSVATFNFTGTHLICGSSLE 189
N+ + S S L + +L+L+SN+++ +P L T N L C S
Sbjct: 510 NRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI 566
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 22/102 (21%), Positives = 37/102 (36%), Gaps = 13/102 (12%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGT---LPDFLGSMTHLQS 129
+ L L + S + L+ L LQ N + L ++ L+
Sbjct: 426 LLKVLNLSHSLLDI-SSEQLFDGLPALQHL----NLQGNHFPKGNIQKTNSLQTLGRLEI 480
Query: 130 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
L L+ S ++ L + H+DLS N LT ++ S
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALS 521
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 23/101 (22%), Positives = 33/101 (32%), Gaps = 4/101 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ L G S + K L S L N +S L+ L+ NN
Sbjct: 106 ALKHLFFIQTGISSIDFIPLHNQKTLESLY-LGSNHISSIKLPKGFPTEKLKVLDFQNNA 164
Query: 137 FSGSIPATWSQLSNLKH--LDLSSNNLTGRIPMQLFSVATF 175
S L + L+L+ N++ G I F A F
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVF 204
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 23/94 (24%), Positives = 37/94 (39%), Gaps = 2/94 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ L L S + T LK + L N L+ + + L + + LNLA+N
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVD-LSHNRLTSSSIEALSHLKGIY-LNLASNH 534
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 170
S +P+ LS + ++L N L F
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDCTCSNIYF 568
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 20/94 (21%), Positives = 32/94 (34%), Gaps = 8/94 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFREL--QDNDLSGTLPDFLGSMTHLQ--SLNL 132
+ SL LGSN S P + + L Q+N + + + S+ SLNL
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTE---KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL 186
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
N + I + + L+ I
Sbjct: 187 NGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIF 219
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 15/64 (23%), Positives = 26/64 (40%), Gaps = 4/64 (6%)
Query: 108 LQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM 167
++ L+ +P L + + L + N T+S+L NL LDL+ + I
Sbjct: 19 CENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-IHE 74
Query: 168 QLFS 171
F
Sbjct: 75 DTFQ 78
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 17/106 (16%), Positives = 36/106 (33%), Gaps = 22/106 (20%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ + L N + +++ LK + + L N +S LP L ++ +++NL N
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGI--YLNLASNHISIILPSLLPILSQQRTINLRQNP 558
Query: 137 FSGSIPATW--------------------SQLSNLKHLDLSSNNLT 162
+ + L+ + LS L+
Sbjct: 559 LDCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 15/102 (14%), Positives = 28/102 (27%), Gaps = 7/102 (6%)
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLG--SMTHLQSLN 131
+ +SL L N I P S + L ++ L
Sbjct: 177 QQATNLSLNLNGN-DIAGIEPGAFDSAVFQSLN-FGGTQNLLVIFKGLKNSTIQSLWLGT 234
Query: 132 LANNKFSGSIPATWSQLS--NLKHLDLSSNNLTGRIPMQLFS 171
+ PA + L +++ ++L + I F
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFH 275
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 13/89 (14%), Positives = 26/89 (29%), Gaps = 4/89 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFR-ELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
+ L +N ++ L+ + L ND++ + QSLN
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGT 212
Query: 136 KFSGSIPA--TWSQLSNLKHLDLSSNNLT 162
+ I S + +L +
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 47/204 (23%), Positives = 74/204 (36%), Gaps = 32/204 (15%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 328
+DN+ +G+G F V + V + + A K + S +RE + H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 383
N+++L S LV DL G + + + A
Sbjct: 88 PNIVRLHDSIQEESFHYLV---F----------DLVTGGELFEDIVAREFYSEADASHCI 134
Query: 384 Y----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQ 436
+ Y H I+HR+LK N+LL L DFGLA V+ +
Sbjct: 135 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHG 189
Query: 437 IRGTMGHIAPEYLSTGKSSEKTDV 460
GT G+++PE L S+ D+
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDI 213
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 39/221 (17%)
Query: 272 DNFSESNIIGQGGFGKVY---KGVLSDNTKV-AVKRLQDYYSPGGEAAFQR-EVHLISVA 326
F ++GQG FGKV+ K SD ++ A+K L+ R V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK------ATLKVRDRVRTKM-- 75
Query: 327 IHKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 376
+++L + Y + ++ L+ F++ + RL +++ E+
Sbjct: 76 -ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-------- 126
Query: 377 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433
V F A L++LH II+RDLK NILLD+ L DFGL+K
Sbjct: 127 DVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK 182
Query: 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
GT+ ++APE ++ ++ D + +G+ + E++TG
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 42/200 (21%), Positives = 72/200 (36%), Gaps = 43/200 (21%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLL 332
IG+G +G+V V + A K ++D F++E+ ++ H N++
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNII 69
Query: 333 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTAY--- 384
+L +++ LV M +L G + + K A
Sbjct: 70 RLYETFEDNTDIYLV---M----------ELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 385 -GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 440
+ Y H+ + HRDLK N L + L DFGLA + GT
Sbjct: 117 SAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGT 171
Query: 441 MGHIAPEYLSTGKSSEKTDV 460
+++P+ L G + D
Sbjct: 172 PYYVSPQVLE-GLYGPECDE 190
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+G G FGKV G KVAVK L Q S +RE+ + + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFG-TAYGLEY 388
+T ++ +V ++ GE G R F ++Y
Sbjct: 79 VISTPTDFFMVMEYVSG------------GELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE 447
H ++HRDLK N+LLD + A + DFGL+ + D + + G+ + APE
Sbjct: 127 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 180
Query: 448 YLSTGK--SSEKTDVFGYGITLLELVTG 473
+S G+ + + D++ G+ L L+ G
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCG 207
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 50/221 (22%), Positives = 87/221 (39%), Gaps = 32/221 (14%)
Query: 268 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 326
++ + F ++G+G FGKV + A+K L+ + + +
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTL 196
Query: 327 IHKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 376
+LQ Y + +R+ V + + + L R+ E
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-------- 248
Query: 377 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433
R F A L+YLH + N +++RDLK N++LD + + DFGL K K
Sbjct: 249 RARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGAT 305
Query: 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
GT ++APE L D +G G+ + E++ G+
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 50/225 (22%), Positives = 80/225 (35%), Gaps = 52/225 (23%)
Query: 270 ATDNFSES---------NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQRE 319
+TD+FS +++G+G +V + L + + AVK ++ F RE
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-RE 60
Query: 320 VH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 378
V L H+N+L+LI + LV+ M+ S+ + KR
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH--------------KRR 106
Query: 379 AFG----------TAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL 425
F A L++LH + I HRDLK NIL + +CDF L
Sbjct: 107 HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163
Query: 426 VDAKLTHVTTQIR------GTMGHIAPEYLSTGKSSEKTDVFGYG 464
+ G+ ++APE + Y
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEAS----IYD 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 50/206 (24%), Positives = 81/206 (39%), Gaps = 40/206 (19%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL---QDYYSPGGEAAFQREVHLISVA 326
+D F + +G+G VY+ A+K L D + + E+ ++
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD------KKIVRTEIGVLLRL 105
Query: 327 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFG 381
H N+++L T +E LV + +L G + D K R A
Sbjct: 106 SHPNIIKLKEIFETPTEISLV---L----------ELVTGGELFDRIVEKGYYSERDAAD 152
Query: 382 TAY----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVT 434
+ YLHE I+HRDLK N+L + + DFGL+K+V+ +
Sbjct: 153 AVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLM 207
Query: 435 TQIRGTMGHIAPEYLSTGKSSEKTDV 460
+ GT G+ APE L + D+
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDM 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 35/220 (15%)
Query: 272 DNFSESNIIGQGGFGKVY---KGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAI 327
+ F ++G+GG+GKV+ K ++ K+ A+K L+ +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK------AMIVRNAKDTAHTKA 70
Query: 328 HKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKR 377
+N+L+ + Y + ++ L+ ++ + +L R+ E
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED--------T 122
Query: 378 VAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 434
F A L +LH++ II+RDLK NI+L+ L DFGL K VT
Sbjct: 123 ACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVT 178
Query: 435 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
GT+ ++APE L + D + G + +++TG
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 52/228 (22%), Positives = 84/228 (36%), Gaps = 58/228 (25%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
D F +G G FG+V ++ A+K L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----------------KQKVVKLK 83
Query: 331 LLQLIGYCTTSSERILV---YPFMQNLSVA-------YRLRDLKPGEKG-LDWPTRKRVA 379
++ T + +RIL +PF+ L + Y + + G G + R+
Sbjct: 84 QIE----HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG--GEMFSHLRRIGR 137
Query: 380 FGTA----Y------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429
F Y EYLH +I+RDLK N+L+D + DFG AK V +
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
Query: 430 LTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQ 474
T + GT +APE + + K+ D + G+ + E+ G
Sbjct: 195 ----TWTLCGTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAGY 235
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 48/216 (22%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
+G+G +G+V V VAVK + + ++E+ + + H+N+++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTA-------- 383
+ + L + GE + A
Sbjct: 75 REGNIQYLFLEYCSG------------GELFDRIEPDI-------GMPEPDAQRFFHQLM 115
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD----AKLTHVTTQIRG 439
G+ YLH I HRD+K N+LLD+ + DFGLA + +L + G
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---G 169
Query: 440 TMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 473
T+ ++APE L + +E DV+ GI L ++ G
Sbjct: 170 TLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 51/236 (21%), Positives = 85/236 (36%), Gaps = 53/236 (22%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI 323
R+L++ +++ +IG+G FG+V KV A+K L
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-----------------K 104
Query: 324 SVAIHKNLLQLIGYCTTSSERILVY---PFMQNLSVA-------YRLRDLKPG------- 366
I ++ I+ + P++ L A Y + + PG
Sbjct: 105 FEMIKRSDSA----FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 367 -EKGLDWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422
+ K F TA L+ +H IHRD+K N+LLD + L DFG
Sbjct: 161 SNYDVP---EKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214
Query: 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK----TDVFGYGITLLELVTGQ 474
++ + GT +I+PE L + D + G+ L E++ G
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.4 bits (166), Expect = 1e-12
Identities = 39/211 (18%), Positives = 59/211 (27%), Gaps = 44/211 (20%)
Query: 269 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISVA 326
L T+ IG+G FG+V++ + D+T VA+K ++ G E L +
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 327 IHKNLLQLIGYCTTSSERILVY--------PFMQNLSVAYRLRDLKPG------------ 366
I K L L G +E + + L A+ + G
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 367 -------------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 407
K T K + L + HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNV 193
Query: 408 LLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 438
LL L K + I
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 39/93 (41%), Positives = 50/93 (53%), Gaps = 13/93 (13%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
LEYLH + II+RDLK NILLD N + DFG AK V T + GT +I
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYI 170
Query: 445 APEYLST---GKSSEKTDVFGYGITLLELVTGQ 474
APE +ST KS D + +GI + E++ G
Sbjct: 171 APEVVSTKPYNKS---IDWWSFGILIYEMLAGY 200
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 46/221 (20%), Positives = 79/221 (35%), Gaps = 44/221 (19%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK----RLQDYYSPGGEAAFQREVHLISV 325
D + +IG+G F V + + + AVK +RE + +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 326 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR--KRVAFGTA 383
H ++++L+ ++ +V+ FM + KR G
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDG------------ADL-CF---EIVKRADAGFV 126
Query: 384 Y--------------GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLV 426
Y L Y H+ IIHRD+K +LL +++ L FG+A +
Sbjct: 127 YSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITL 467
+ V GT +APE + + DV+G G+ L
Sbjct: 184 G-ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 54/210 (25%), Positives = 78/210 (37%), Gaps = 39/210 (18%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
IG G FG VAVK ++ + QRE+ H N+++
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRK-RVAFGTA--------YGLEY 388
T + ++ + GE L + R + A G+ Y
Sbjct: 86 LTPTHLAIIMEYASG------------GE--LYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKL-VDAKLTHVTTQIRGTMGHIA 445
H +I HRDLK N LLD + L CDFG +K V T GT +IA
Sbjct: 132 CHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIA 185
Query: 446 PEYLSTGK--SSEKTDVFGYGITLLELVTG 473
PE L + + DV+ G+TL ++ G
Sbjct: 186 PEVLL-RQEYDGKIADVWSCGVTLYVMLVG 214
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 36/168 (21%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 336
++G G GKV + K A+K LQD +REV + ++++++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVD 78
Query: 337 -YCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKGLDWPTRKRVAFGT---AY 384
Y + R + M + G ++G T + +
Sbjct: 79 VYENLYAGRKCLLIVM----------ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 385 GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAK 429
++YLH I HRD+K N+L N L DFG AK +
Sbjct: 129 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+G G FGKV G KVAVK L Q S +RE+ + + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFG-TAYGLEY 388
+T S+ +V ++ GE G R F G++Y
Sbjct: 84 VISTPSDIFMVMEYVSG------------GELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE 447
H ++HRDLK N+LLD + A + DFGL+ + D + + G+ + APE
Sbjct: 132 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 185
Query: 448 YLSTGKSSE--KTDVFGYGITLLELVTG 473
+S G+ + D++ G+ L L+ G
Sbjct: 186 VIS-GRLYAGPEVDIWSSGVILYALLCG 212
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 39/205 (19%), Positives = 73/205 (35%), Gaps = 37/205 (18%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 320
D + ++IG G +G V + + VA+K++ F+ RE+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--------VFEDLIDCKRILREI 103
Query: 321 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLK---PGEKGLDW 372
+++ H ++++++ +V D K L
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--------SDFKKLFRTPVYLTE 155
Query: 373 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432
K + + G++Y+H I+HRDLK AN L++ + +CDFGLA+ VD
Sbjct: 156 LHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 433 VTTQIRGTMGHIAPEYLSTGKSSEK 457
+ + K
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLK 237
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 34/208 (16%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 336
+G+G FGKV KVA+K + Q +RE+ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFG-TAYGLEY 388
TT ++ ++V + GE K R F +EY
Sbjct: 77 VITTPTDIVMVIEYAG-------------GELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE 447
H KI+HRDLK N+LLDDN + DFGL+ + D + G+ + APE
Sbjct: 124 CHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE 177
Query: 448 YLSTGKSSE--KTDVFGYGITLLELVTG 473
++ GK + DV+ GI L ++ G
Sbjct: 178 VIN-GKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
GL++LH + I++RDLK NILLD + + DFG+ K + T GT +I
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYI 185
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
APE L K + D + +G+ L E++ GQ
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 57/224 (25%), Positives = 85/224 (37%), Gaps = 46/224 (20%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
DNF ++G+G FGKV + + + AVK L+ + Q + + K
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK------DVILQDD-DVECTMTEKR 75
Query: 331 LLQLIG---------YCTTSSERI-LVYPF------MQNLSVAYRLRDLKPGEKGLDWPT 374
+L L C + +R+ V F M ++ + R
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-------------D 122
Query: 375 RKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431
R F A L +LH++ II+RDLK N+LLD L DFG+ K
Sbjct: 123 EARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNG 178
Query: 432 HVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 474
T GT +IAPE L D + G+ L E++ G
Sbjct: 179 VTTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 49/221 (22%), Positives = 88/221 (39%), Gaps = 33/221 (14%)
Query: 268 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 326
++ ++F ++G+G FGKV + A+K L+ E ++ +
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK------EVIIAKD-EVAHTV 53
Query: 327 IHKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 376
+LQ Y + +R+ V + + + L R+ E+
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-------- 105
Query: 377 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433
R F A LEYLH + +++RD+K N++LD + + DFGL K
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGAT 161
Query: 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
GT ++APE L D +G G+ + E++ G+
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 43/196 (21%), Positives = 74/196 (37%), Gaps = 39/196 (19%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 320
DN+ ++IG+G +G VY + VA+K++ F+ RE+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--------MFEDLIDCKRILREI 76
Query: 321 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTR 375
+++ +++L +V DLK K + T
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD--------SDLKKLFKTPIFLTE 128
Query: 376 KRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431
+ + Y G ++HE IIHRDLK AN LL+ + +CDFGLA+ ++++
Sbjct: 129 EHIKT-ILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 432 HVTTQIRGTMGHIAPE 447
P
Sbjct: 185 TNIVNDLEENEEPGPH 200
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 33/90 (36%), Positives = 43/90 (47%), Gaps = 4/90 (4%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
L YLH I++RDLK NILLD VL DFGL K + + T+ GT ++
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYL 206
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
APE L D + G L E++ G
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 50/243 (20%), Positives = 98/243 (40%), Gaps = 69/243 (28%)
Query: 271 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---------REV 320
+ + +G GG G V+ V +D + +VA+K++ RE+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI----------VLTDPQSVKHALREI 59
Query: 321 HLISVAIHKNLLQLI--------------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKP 365
+I H N++++ G T + +V +M+ +L+ L
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL-- 117
Query: 366 GEKGLDWPTRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDF 420
+ Y GL+Y+H + ++HRDLK AN+ ++ ++ + DF
Sbjct: 118 --------LEEHARL-FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDF 165
Query: 421 GLAKLVDAKLTH-------VTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELV 471
GLA+++D +H + T+ R +P LS ++ D++ G E++
Sbjct: 166 GLARIMDPHYSHKGHLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEML 219
Query: 472 TGQ 474
TG+
Sbjct: 220 TGK 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 9e-12
Identities = 52/227 (22%), Positives = 87/227 (38%), Gaps = 44/227 (19%)
Query: 268 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 326
L +F +IG+G + KV L ++ A+K ++ E E + V
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK------ELVNDDE-DIDWVQ 57
Query: 327 IHKNLLQLIG---------YCTTSSERI-LVYPF------MQNLSVAYRLRDLKPGEKGL 370
K++ + C + R+ V + M ++ +L
Sbjct: 58 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---------- 107
Query: 371 DWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427
+ F +A L YLHE+ II+RDLK N+LLD L D+G+ K
Sbjct: 108 ---PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-G 160
Query: 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
+ T+ GT +IAPE L D + G+ + E++ G+
Sbjct: 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 444
GL +L + II+RDLK N++LD + DFG+ K + T GT +I
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYI 188
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
APE ++ + D + +G+ L E++ GQ
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 53/227 (23%), Positives = 88/227 (38%), Gaps = 44/227 (19%)
Query: 268 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 326
++ +F+ ++G+G FGKV ++ AVK L+ + Q + +
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK------DVVIQDD-DVECTM 389
Query: 327 IHKNLLQLIGYCTTSSERILVYPFMQNLSVA-------YRLRDLKPG---------EKGL 370
+ K +L L G PF+ L Y + + G
Sbjct: 390 VEKRVLALPGKP----------PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 439
Query: 371 DWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427
P F A GL +L + II+RDLK N++LD + DFG+ K +
Sbjct: 440 KEP---HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-N 492
Query: 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
T GT +IAPE ++ + D + +G+ L E++ GQ
Sbjct: 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 50/235 (21%), Positives = 94/235 (40%), Gaps = 55/235 (23%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 320
+ +F +++G+G +G V VA+K+++ F RE+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---------PFDKPLFALRTLREI 60
Query: 321 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPT 374
++ H+N++ + S ++ MQ +L + L +
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML----------S 110
Query: 375 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430
+ + Y ++ LH +IHRDLK +N+L++ N + +CDFGLA+++D
Sbjct: 111 DDHIQY-FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES- 165
Query: 431 THVTTQIRGTMGHI----------APEY-LSTGKSSEKTDVFGYGITLLELVTGQ 474
++ G + APE L++ K S DV+ G L EL +
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 24/97 (24%), Positives = 34/97 (35%), Gaps = 9/97 (9%)
Query: 77 NVISLTLGSNGFSGKISPSI--TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ L L N + + KLK L +L N L+ + S + ++L N
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVVFAKLKTL----DLSSNKLA-FMGPEFQSAAGVTWISLRN 223
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
NK I NL+H DL N FS
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 4/71 (5%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
I + + K ++ D+ L L S +++ L+L+ N S A + + L
Sbjct: 5 IKQNGNRYKIE----KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 152 KHLDLSSNNLT 162
+ L+LSSN L
Sbjct: 61 ELLNLSSNVLY 71
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 19/96 (19%), Positives = 40/96 (41%), Gaps = 8/96 (8%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
++ +L +N S ++S S K + L +N ++ G + +Q L+L N
Sbjct: 100 SIETLHAANNNIS-RVSCSRGQGKKNI----YLANNKITMLRDLDEGCRSRVQYLDLKLN 154
Query: 136 KFSG-SIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 170
+ + + L+HL+L N + + Q+
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 21/86 (24%), Positives = 34/86 (39%), Gaps = 11/86 (12%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ + + S+ +K L +L N LS L T L+ LNL++N
Sbjct: 15 EKVTDSSLK-QALASLRQSAWNVKEL----DLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLT 162
LS L+ LDL++N +
Sbjct: 70 LY-ETLDL-ESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 16/88 (18%), Positives = 34/88 (38%), Gaps = 13/88 (14%)
Query: 77 NVISLTLGSNGFSGKIS--PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ +L L +N + ++ L +N++S + +++ LAN
Sbjct: 81 TLRTLDLNNN----YVQELLVGPSIETL----HAANNNIS-RVS--CSRGQGKKNIYLAN 129
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLT 162
NK + S +++LDL N +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 9/55 (16%), Positives = 23/55 (41%), Gaps = 1/55 (1%)
Query: 117 LPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ + + + + ++ ++ + N+K LDLS N L+ +I +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLA 55
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 22/120 (18%), Positives = 43/120 (35%), Gaps = 6/120 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ +L L SN + + P + L++N L + L +L+ +L N
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWIS-LRNNKLV-LIEKALRFSQNLEHFDLRGNG 248
Query: 137 FS-GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMSR 195
F G++ +S+ ++ + + + +V T G C L P R
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA--YCCEDLPAPFADR 306
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
++L L S + +L L + L LPD + L++L L
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMT-IDAAGLM-ELPDTMQQFAGLETLTL 134
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
A N ++PA+ + L+ L+ L + + +P
Sbjct: 135 ARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 21/84 (25%), Positives = 37/84 (44%), Gaps = 3/84 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
N+ SL L G + SI L+ L S +++++ LS L + + L+ L+L
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSL-KIRNSPLS-ALGPAIHHLPKLEELDLRGCT 240
Query: 137 FSGSIPATWSQLSNLKHLDLSSNN 160
+ P + + LK L L +
Sbjct: 241 ALRNYPPIFGGRAPLKRLILKDCS 264
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 15/94 (15%), Positives = 34/94 (36%), Gaps = 10/94 (10%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASFRELQ--------DNDLSGTLPDFLGSMTHLQSLNL 132
L++ + ++ + + L + +LP + ++ +L+SL +
Sbjct: 155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
N+ S ++ L L+ LDL P
Sbjct: 214 RNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYP 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 15/92 (16%), Positives = 29/92 (31%), Gaps = 1/92 (1%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 140
L L P L ++L TLP + +T L+ L+L
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 141 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFSV 172
+P+ +QL + + + + +
Sbjct: 293 LPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 17/95 (17%), Positives = 36/95 (37%), Gaps = 12/95 (12%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
++ +T+ + G ++ ++ + L + L N L LP + S+ L+ L++
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETL-TLARNPLR-ALPASIASLNRLRELSIRACP 161
Query: 137 FSGSIPA---------TWSQLSNLKHLDLSSNNLT 162
+P L NL+ L L +
Sbjct: 162 ELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR 196
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 51/227 (22%), Positives = 87/227 (38%), Gaps = 44/227 (19%)
Query: 268 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 326
L +F +IG+G + KV L ++ A++ ++ E E + V
Sbjct: 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK------ELVNDDE-DIDWVQ 100
Query: 327 IHKNLLQLIG---------YCTTSSERI-LVYPF------MQNLSVAYRLRDLKPGEKGL 370
K++ + C + R+ V + M ++ +L
Sbjct: 101 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---------- 150
Query: 371 DWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427
+ F +A L YLHE+ II+RDLK N+LLD L D+G+ K
Sbjct: 151 ---PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-G 203
Query: 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
+ T+ GT +IAPE L D + G+ + E++ G+
Sbjct: 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 41/200 (20%), Positives = 77/200 (38%), Gaps = 40/200 (20%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 320
+ +G+G +G V+K + VAVK++ D AFQ RE+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--------AFQNSTDAQRTFREI 59
Query: 321 HLIS-VAIHKNLLQLIGYCTTSSER--ILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRK 376
+++ ++ H+N++ L+ ++R LV+ +M+ +L R L
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL----------EPV 109
Query: 377 RVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432
+ Y ++YLH ++HRD+K +NILL+ + DFGL++
Sbjct: 110 HKQY-VVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 433 VTTQIRGTMGHIAPEYLSTG 452
+
Sbjct: 166 TNNIPLSINENTENFDDDQP 185
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 24/97 (24%), Positives = 34/97 (35%), Gaps = 9/97 (9%)
Query: 77 NVISLTLGSNGFSGKISPSI--TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ L L N + + KLK L +L N L+ + S + ++L N
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVVFAKLKTL----DLSSNKLA-FMGPEFQSAAGVTWISLRN 223
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
NK I NL+H DL N FS
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 18/72 (25%), Positives = 32/72 (44%), Gaps = 4/72 (5%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
I + + K ++ D+ L L S +++ L+L+ N S A + + L
Sbjct: 5 IKQNGNRYKIE----KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 152 KHLDLSSNNLTG 163
+ L+LSSN L
Sbjct: 61 ELLNLSSNVLYE 72
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 19/96 (19%), Positives = 40/96 (41%), Gaps = 8/96 (8%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
++ +L +N S ++S S K + L +N ++ G + +Q L+L N
Sbjct: 100 SIETLHAANNNIS-RVSCSRGQGKKNI----YLANNKITMLRDLDEGCRSRVQYLDLKLN 154
Query: 136 KFSG-SIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 170
+ + + L+HL+L N + + Q+
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 3/82 (3%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 140
+ + ++ + L N LS L T L+ LNL++N
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELD-LSGNPLSQISAADLAPFTKLELLNLSSNVLY-E 72
Query: 141 IPATWSQLSNLKHLDLSSNNLT 162
LS L+ LDL++N +
Sbjct: 73 TLD-LESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 13/88 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFREL--QDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ +L L +N + +L S L +N++S + +++ LAN
Sbjct: 81 TLRTLDLNNN--------YVQELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLAN 129
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLT 162
NK + S +++LDL N +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 9/55 (16%), Positives = 23/55 (41%), Gaps = 1/55 (1%)
Query: 117 LPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ + + + + ++ ++ + N+K LDLS N L+ +I +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLA 55
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 15/82 (18%), Positives = 33/82 (40%), Gaps = 4/82 (4%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS- 138
+L L SN + + P + L++N L + L +L+ +L N F
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWIS-LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251
Query: 139 GSIPATWSQLSNLKHLDLSSNN 160
G++ +S+ ++ + +
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 12/116 (10%), Positives = 31/116 (26%), Gaps = 5/116 (4%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASFR----ELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
G+ +P +L L Q ++ L + + ++ +
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQARQREIDALKEQ 347
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPC 192
+ I + L+ L ++ + A + T + L+
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHAT 403
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-11
Identities = 18/87 (20%), Positives = 38/87 (43%), Gaps = 7/87 (8%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N+ LT+ + + +P ++ L+ L + D++ L +T L L++++
Sbjct: 67 NIKDLTINNIHAT-NYNPISGLSNLERL----RIMGKDVTSDKIPNLSGLTSLTLLDISH 121
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNL 161
+ SI + L + +DLS N
Sbjct: 122 SAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 8e-10
Identities = 15/96 (15%), Positives = 39/96 (40%), Gaps = 11/96 (11%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLA 133
++ +TL + +T L + ++D ++ T + + +++L+ L +
Sbjct: 45 SLTYITLANIN--------VTDLTGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIM 96
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 169
+ S L++L LD+S + I ++
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 13/86 (15%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
N+ L + + P+++ L L ++ + ++ + ++ + S++L+ N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLL-DISHSAHDDSILTKINTLPKVNSIDLSYNG 147
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLT 162
I L LK L++ + +
Sbjct: 148 AITDIMPL-KTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 17/91 (18%), Positives = 29/91 (31%), Gaps = 12/91 (13%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG----TLPDFLGSMTHLQSLNL 132
++ L + + I I L + + DLS T L ++ L+SLN+
Sbjct: 113 SLTLLDISHSAHDDSILTKINTLPKV---NSI---DLSYNGAITDIMPLKTLPELKSLNI 166
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTG 163
+ L L S + G
Sbjct: 167 QFDGVHDYRGI--EDFPKLNQLYAFSQTIGG 195
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 43/214 (20%), Positives = 87/214 (40%), Gaps = 24/214 (11%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIH 328
D++ +G+G + +V++ + +++N KV VK L+ P + +RE+ L ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGG 90
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
N++ L R F + D K + L + + L+Y
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNT-----DFKQLYQTLTDYDIRFYMYEILKALDY 145
Query: 389 LHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDA--KLTH-VTTQIRGTMGHI 444
H I+HRD+K N+++D ++ + L D+GLA+ + V ++
Sbjct: 146 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FK 197
Query: 445 APEYLSTGKS-SEKTDVFGYGITLLELVTGQRAI 477
PE L + D++ G L ++ +
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 30/109 (27%), Positives = 49/109 (44%), Gaps = 10/109 (9%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ L +G+N S I+ +TKLK L + N +S L +++ L SL L N
Sbjct: 244 QLTWLEIGTNQIS-DINAVKDLTKLKML----NVGSNQISD--ISVLNNLSQLNSLFLNN 296
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM-QLFSVATFNFTGTHL 182
N+ L+NL L LS N++T P+ L + + +F +
Sbjct: 297 NQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 5e-10
Identities = 22/90 (24%), Positives = 39/90 (43%), Gaps = 9/90 (10%)
Query: 75 NGNVISLTLGSNGFSGKIS--PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
+ L +GSN +IS + L L S L +N L + +G +T+L +L L
Sbjct: 264 LTKLKMLNVGSN----QISDISVLNNLSQLNSLF-LNNNQLGNEDMEVIGGLTNLTTLFL 318
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
+ N + P + LS + D ++ +
Sbjct: 319 SQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 16/72 (22%), Positives = 31/72 (43%), Gaps = 6/72 (8%)
Query: 96 ITKLKFLASFRELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
I+ + LA+ ++ +L + L +MT L L + +K P + L++L
Sbjct: 122 ISDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDL 179
Query: 152 KHLDLSSNNLTG 163
L L+ N +
Sbjct: 180 YSLSLNYNQIED 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 20/93 (21%), Positives = 39/93 (41%), Gaps = 13/93 (13%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLA 133
N+ L L N IT + L++ +L + + T L ++T+L+ L L
Sbjct: 67 NLEYLNLNGN--------QITDISPLSNLVKLTNLYIGTNKITDISALQNLTNLRELYLN 118
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
+ S P + L+ + L+L +N+ +
Sbjct: 119 EDNISDISPL--ANLTKMYSLNLGANHNLSDLS 149
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 10/92 (10%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ SL LG+N +SP ++T L +L + ++ + P + ++T L SL+L
Sbjct: 133 KMYSLNLGANHNLSDLSPLSNMTGLNYL----TVTESKVKDVTP--IANLTDLYSLSLNY 186
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
N+ P + L++L + N +T P
Sbjct: 187 NQIEDISP--LASLTSLHYFTAYVNQITDITP 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 6e-09
Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 11/89 (12%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
++ SL+L N ISP S+T L + N ++ P + +MT L SL + N
Sbjct: 178 DLYSLSLNYNQIED-ISPLASLTSLHYF----TAYVNQITDITP--VANMTRLNSLKIGN 230
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTG 163
NK + P + LS L L++ +N ++
Sbjct: 231 NKITDLSP--LANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 8e-09
Identities = 19/104 (18%), Positives = 40/104 (38%), Gaps = 19/104 (18%)
Query: 77 NVISLTLGSNGFSGKISPS--------------ITKLKFLASFRELQDNDLSG---TLPD 119
I L + ++ + ++ + L+ +L+G T
Sbjct: 23 EGIRAVLQKASVTDVVTQEELESITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDIS 82
Query: 120 FLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTG 163
L ++ L +L + NK + I A L+NL+ L L+ +N++
Sbjct: 83 PLSNLVKLTNLYIGTNKIT-DISA-LQNLTNLRELYLNEDNISD 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 19/90 (21%), Positives = 32/90 (35%), Gaps = 13/90 (14%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLANNK 136
+L I ++ A E L T + + L +A K
Sbjct: 4 TLATLPA--------PINQIFPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEK 55
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
+ SI L+NL++L+L+ N +T P
Sbjct: 56 VA-SIQG-IEYLTNLEYLNLNGNQITDISP 83
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 9e-08
Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 11/92 (11%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ LT+ + ++P ++T L L L N + L S+T L
Sbjct: 156 GLNYLTVTESKVK-DVTPIANLTDLYSL----SLNYNQIED--ISPLASLTSLHYFTAYV 208
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
N+ + P + ++ L L + +N +T P
Sbjct: 209 NQITDITP--VANMTRLNSLKIGNNKITDLSP 238
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 19/105 (18%), Positives = 45/105 (42%), Gaps = 5/105 (4%)
Query: 69 SHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPD--FLGSMTH 126
S ++ L L NG +S + L+ L + Q ++L + + S+ +
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL-DFQHSNLK-QMSEFSVFLSLRN 422
Query: 127 LQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
L L++++ + ++ LS+L+ L ++ N+ +F+
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 22/100 (22%), Positives = 42/100 (42%), Gaps = 11/100 (11%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTL-PDFLGSMTHLQSLN 131
N+I L + I + L+ L ++ N PD + +L L+
Sbjct: 422 NLIYLDISHTHTRV-AFNGIFNGLSSLEVL----KMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 132 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
L+ + P ++ LS+L+ L+++SN L +P +F
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFD 515
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 23/94 (24%), Positives = 38/94 (40%), Gaps = 8/94 (8%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
L + N F P I L FL +L L P S++ LQ LN+A+N+
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFL----DLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 170
+ +L++L+ + L +N P +
Sbjct: 506 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 15/86 (17%), Positives = 24/86 (27%), Gaps = 9/86 (10%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
L L I + L L L N + ++ LQ L
Sbjct: 57 LDLSRCEIQ-TIEDGAYQSLSHLSTL----ILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLT 162
+ L LK L+++ N +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 18/80 (22%), Positives = 29/80 (36%), Gaps = 8/80 (10%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
+ S L +L N L S LQ L+L+ + + LS+L
Sbjct: 26 LPFSTKNL-------DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 152 KHLDLSSNNLTGRIPMQLFS 171
L L+ N + + + FS
Sbjct: 79 STLILTGNPIQ-SLALGAFS 97
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 23/97 (23%), Positives = 38/97 (39%), Gaps = 7/97 (7%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDL-SGTLPDFLGSMTHLQSLNLANNKFS 138
L + + I LK L + N + S LP++ ++T+L+ L+L++NK
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELN-VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 139 GSIPATWSQLSNLK----HLDLSSNNLTGRIPMQLFS 171
L + LDLS N + I F
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 20/85 (23%), Positives = 33/85 (38%), Gaps = 8/85 (9%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK--F 137
L L + F + + LK L N + + L+ L+L+ N F
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRL----TFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSF 361
Query: 138 SGSIPATWSQLSNLKHLDLSSNNLT 162
G + ++LK+LDLS N +
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI 386
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 26/90 (28%), Positives = 40/90 (44%), Gaps = 13/90 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLA 133
N+ SL +N I+ + L L + L+G L S+T+L L+LA
Sbjct: 200 NLESLIATNN--------QISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLA 251
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLTG 163
NN+ S P S L+ L L L +N ++
Sbjct: 252 NNQISNLAP--LSGLTKLTELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 14/91 (15%), Positives = 36/91 (39%), Gaps = 9/91 (9%)
Query: 77 NVISLTLGSNGFSGKISPS-ITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
+ LG + +S + + ++ L + + D + + +L +N +NN
Sbjct: 25 EKMKTVLGKTNVTDTVSQTDLDQVTTL----QADRLGIKS--IDGVEYLNNLTQINFSNN 78
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
+ + P L+ L + +++N + P
Sbjct: 79 QLTDITPL--KNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 25/89 (28%), Positives = 46/89 (51%), Gaps = 11/89 (12%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N+ + +N + I+P ++TKL + + +N ++ P L ++T+L L L N
Sbjct: 69 NLTQINFSNNQLTD-ITPLKNLTKLVDI----LMNNNQIADITP--LANLTNLTGLTLFN 121
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTG 163
N+ + P L+NL L+LSSN ++
Sbjct: 122 NQITDIDPL--KNLTNLNRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 11/92 (11%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N+ L L +N S ++P +TKL L +L N +S P L +T L +L L
Sbjct: 244 NLTDLDLANNQISN-LAPLSGLTKLTEL----KLGANQISNISP--LAGLTALTNLELNE 296
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
N+ P S L NL +L L NN++ P
Sbjct: 297 NQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 26/94 (27%), Positives = 41/94 (43%), Gaps = 11/94 (11%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ +L L N ISP ++ L +L L N++S P + S+T LQ L N
Sbjct: 288 ALTNLELNENQLED-ISPISNLKNLTYL----TLYFNNISDISP--VSSLTKLQRLFFYN 340
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 168
NK S + L+N+ L N ++ P+
Sbjct: 341 NKVSDVSS--LANLTNINWLSAGHNQISDLTPLA 372
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 11/94 (11%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ L + SN S IS +T L+ L +N +S P LG +T+L L+L
Sbjct: 178 TLERLDISSNKVSD-ISVLAKLTNLESL----IATNNQISDITP--LGILTNLDELSLNG 230
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 168
N+ T + L+NL LDL++N ++ P+
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQISNLAPLS 262
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 23/97 (23%), Positives = 48/97 (49%), Gaps = 12/97 (12%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDF--LGSMTHLQSLNLAN 134
N+ L L SN +I+ + L+ LQ + D L ++T L+ L++++
Sbjct: 135 NLNRLELSSN--------TISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS 186
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
NK S + ++L+NL+ L ++N ++ P+ + +
Sbjct: 187 NKVSD--ISVLAKLTNLESLIATNNQISDITPLGILT 221
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 21/67 (31%), Positives = 31/67 (46%), Gaps = 8/67 (11%)
Query: 97 TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156
T L+ L ++ N +S L +T+L+SL NN+ S P L+NL L L
Sbjct: 177 TTLERL----DISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSL 228
Query: 157 SSNNLTG 163
+ N L
Sbjct: 229 NGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 15/75 (20%), Positives = 25/75 (33%), Gaps = 5/75 (6%)
Query: 95 SITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
I ++ + E L T + + +L SI L+NL
Sbjct: 13 PINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SIDG-VEYLNNL 70
Query: 152 KHLDLSSNNLTGRIP 166
++ S+N LT P
Sbjct: 71 TQINFSNNQLTDITP 85
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 25/90 (27%), Positives = 41/90 (45%), Gaps = 14/90 (15%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLA 133
N+ LTL +N IT + L + L +LS + L +T LQ L+
Sbjct: 113 NLTGLTLFNN--------QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSF- 163
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLTG 163
N+ + P + L+ L+ LD+SSN ++
Sbjct: 164 GNQVTDLKPL--ANLTTLERLDISSNKVSD 191
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 15/86 (17%), Positives = 33/86 (38%), Gaps = 5/86 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
N+ L+ G N S ++P + L + L D + ++ +++ ++
Sbjct: 354 NINWLSAGHNQISD-LTP-LANLTRITQL-GLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLT 162
PAT S + D++ N +
Sbjct: 411 LI--APATISDGGSYTEPDITWNLPS 434
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 18/99 (18%), Positives = 38/99 (38%), Gaps = 12/99 (12%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
++ + L N KI +L+ L + +N L L + + L+ L+L
Sbjct: 249 GLVEVDLSYNELE-KIMYHPFVKMQRLERL----YISNNRLV-ALNLYGQPIPTLKVLDL 302
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
++N + Q L++L L N++ + +
Sbjct: 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHH 339
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 22/100 (22%), Positives = 39/100 (39%), Gaps = 15/100 (15%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG----TLP-DFLGSMTHLQSLN 131
+ L L N ++T +L ++ L + DLS + M L+ L
Sbjct: 227 ELTILKLQHN--------NLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 278
Query: 132 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
++NN+ ++ + LK LDLS N+L +
Sbjct: 279 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 14/100 (14%), Positives = 36/100 (36%), Gaps = 7/100 (7%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
C +V + + G ++ K + +++ + L S ++ LNL
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIV----TFKNSTMRKLPAALLDSFRQVELLNL 76
Query: 133 ANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ + I ++ ++ L + N + +P +F
Sbjct: 77 NDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ 114
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 17/100 (17%), Positives = 36/100 (36%), Gaps = 12/100 (12%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
N +T ++ K+ ++ +++ L L D + +Q L +
Sbjct: 46 NQKIVTFKNSTMR-KLPAALLDSFRQVELL----NLNDLQIEEIDTYAFAYAHTIQKLYM 100
Query: 133 ANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
N +P + + L L L N+L+ +P +F
Sbjct: 101 GFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 138
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 26/96 (27%), Positives = 42/96 (43%), Gaps = 12/96 (12%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
L +G N + P + L L L+ NDLS + L +L+++NN
Sbjct: 98 LYMGFNAIR-YLPPHVFQNVPLLTVL----VLERNDLSSLPRGIFHNTPKLTTLSMSNNN 152
Query: 137 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
I T+ ++L++L LSSN LT + + L
Sbjct: 153 LE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP 186
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 19/92 (20%), Positives = 32/92 (34%), Gaps = 6/92 (6%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 139
L + +N ++ + L L N L + L++L L +N
Sbjct: 276 RLYISNNRLV-ALNLYGQPIPTLKVLD-LSHNHLL-HVERNQPQFDRLENLYLDHNSIV- 331
Query: 140 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
++ S LK+L LS N+ LF
Sbjct: 332 TLKL--STHHTLKNLTLSHNDWDCNSLRALFR 361
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 10/88 (11%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
V L N + + + +L L +LQ N+L+ L L ++L+ N
Sbjct: 206 AVEELDASHNSIN-VVRGPVNVELTIL----KLQHNNLT-DTAWLLN-YPGLVEVDLSYN 258
Query: 136 KFSGSIPA-TWSQLSNLKHLDLSSNNLT 162
+ I + ++ L+ L +S+N L
Sbjct: 259 ELE-KIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 18/83 (21%), Positives = 31/83 (37%), Gaps = 12/83 (14%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 139
+L L SN +T + + L ++S L L ++ L+ ++N +
Sbjct: 169 NLQLSSN--------RLTHVDL-SLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN- 218
Query: 140 SIPATWSQLSNLKHLDLSSNNLT 162
+ L L L NNLT
Sbjct: 219 VVRG--PVNVELTILKLQHNNLT 239
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 28/117 (23%), Positives = 47/117 (40%), Gaps = 6/117 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKF--LASFREL--QDNDLSGTLPDFLGSMTHLQSLNL 132
++ L LG N + F L+ + L N L+ P +T L+ L+L
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSL 511
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLE 189
+N+ + + +NL+ LD+S N L P S++ + T IC L
Sbjct: 512 NSNRLT-VLSH-NDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELS 566
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 21/96 (21%), Positives = 38/96 (39%), Gaps = 4/96 (4%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
+V L L ++ + LK L L N ++ + + +LQ LNL+ N
Sbjct: 267 SVRHLDLSHGFVF-SLNSRVFETLKDLKVLN-LAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ + L + ++DL N++ I Q F
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFK 359
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 18/92 (19%), Positives = 34/92 (36%), Gaps = 12/92 (13%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTL-PDFLGSMTHLQSLN 131
L L N ++ S +L+ L EL T+ + ++ +L+ L+
Sbjct: 25 TTERLLLSFNYIR-TVTASSFPFLEQLQLL----ELGSQYTPLTIDKEAFRNLPNLRILD 79
Query: 132 LANNKFSGSIPATW-SQLSNLKHLDLSSNNLT 162
L ++K + L +L L L L+
Sbjct: 80 LGSSKIY-FLHPDAFQGLFHLFELRLYFCGLS 110
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 21/90 (23%), Positives = 33/90 (36%), Gaps = 9/90 (10%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
++ L L N + KI+ L+ L L N L + + ++L
Sbjct: 291 DLKVLNLAYNKIN-KIADEAFYGLDNLQVL----NLSYNLLGELYSSNFYGLPKVAYIDL 345
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
N + T+ L L+ LDL N LT
Sbjct: 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 27/97 (27%), Positives = 40/97 (41%), Gaps = 5/97 (5%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N N S G S +PS+ +L LQ + D ++HLQ L L +
Sbjct: 434 NQNRFSSCSGDQTPSE--NPSLEQLFL--GENMLQLAWETELCWDVFEGLSHLQVLYLNH 489
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
N + P +S L+ L+ L L+SN LT +
Sbjct: 490 NYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLP 525
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 19/108 (17%), Positives = 38/108 (35%), Gaps = 12/108 (11%)
Query: 73 CRNGNVISLTLGSNGFSGKISP-----SITKLKFLASFRELQDNDLSG-TLPDFLGSMTH 126
++ L L G S + ++ L L +L N + L G +
Sbjct: 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRL----DLSKNQIRSLYLHPSFGKLNS 149
Query: 127 LQSLNLANNKFSGSIPATWSQLS--NLKHLDLSSNNLTGRIPMQLFSV 172
L+S++ ++N+ L L L++N+L R+ +
Sbjct: 150 LKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 14/101 (13%), Positives = 37/101 (36%), Gaps = 5/101 (4%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRE--LQDNDLSGTLPDFLGSM--THLQSL 130
+GN ++ + N + L +++ + + + ++ L
Sbjct: 212 SGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHL 271
Query: 131 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+L++ + L +LK L+L+ N + +I + F
Sbjct: 272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFY 311
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 13/64 (20%), Positives = 25/64 (39%), Gaps = 4/64 (6%)
Query: 108 LQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM 167
+ +L+ +P L + L L+ N +++ L L+ L+L S I
Sbjct: 11 YRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 168 QLFS 171
+ F
Sbjct: 67 EAFR 70
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 22/117 (18%), Positives = 44/117 (37%), Gaps = 19/117 (16%)
Query: 58 NDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRE--LQDNDLSG 115
N + ++ + + +L L N ++T + F+ S + L N L
Sbjct: 348 NHIAIIQDQTFKFLE----KLQTLDLRDN--------ALTTIHFIPSIPDIFLSGNKLV- 394
Query: 116 TLPDFLGSMTHLQSLNLANNKFSG-SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
TLP + ++L+ N+ I ++ +L+ L L+ N + Q S
Sbjct: 395 TLPKINLT---ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 18/99 (18%), Positives = 38/99 (38%), Gaps = 12/99 (12%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
++ + L N KI +L+ L + +N L L + + L+ L+L
Sbjct: 255 GLVEVDLSYNELE-KIMYHPFVKMQRLERL----YISNNRLV-ALNLYGQPIPTLKVLDL 308
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
++N + Q L++L L N++ + +
Sbjct: 309 SHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHH 345
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 22/100 (22%), Positives = 39/100 (39%), Gaps = 15/100 (15%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG----TLP-DFLGSMTHLQSLN 131
+ L L N ++T +L ++ L + DLS + M L+ L
Sbjct: 233 ELTILKLQHN--------NLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 284
Query: 132 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
++NN+ ++ + LK LDLS N+L +
Sbjct: 285 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 322
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 12/90 (13%), Positives = 33/90 (36%), Gaps = 7/90 (7%)
Query: 83 LGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP 142
+ + G ++ K + +++ + L S ++ LNL + + I
Sbjct: 37 QTQDVYFGFEDITLNNQKIV----TFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EID 91
Query: 143 A-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
++ ++ L + N + +P +F
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ 120
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 26/100 (26%), Positives = 43/100 (43%), Gaps = 12/100 (12%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
+ L +G N + P + L L L+ NDLS + L +L++
Sbjct: 100 TIQKLYMGFNAIR-YLPPHVFQNVPLLTVL----VLERNDLSSLPRGIFHNTPKLTTLSM 154
Query: 133 ANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+NN I T+ ++L++L LSSN LT + + L
Sbjct: 155 SNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP 192
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
V L N + P +L L +LQ N+L+ L L ++L+ N+
Sbjct: 212 AVEELDASHNSINVVRGPVNVELTIL----KLQHNNLT-DTAWLLN-YPGLVEVDLSYNE 265
Query: 137 FSGSIPA-TWSQLSNLKHLDLSSNNLT 162
I + ++ L+ L +S+N L
Sbjct: 266 LE-KIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 17/100 (17%), Positives = 36/100 (36%), Gaps = 12/100 (12%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
N +T ++ K+ ++ +++ L L D + +Q L +
Sbjct: 52 NQKIVTFKNSTMR-KLPAALLDSFRQVELL----NLNDLQIEEIDTYAFAYAHTIQKLYM 106
Query: 133 ANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
N +P + + L L L N+L+ +P +F
Sbjct: 107 GFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 144
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 17/82 (20%), Positives = 31/82 (37%), Gaps = 6/82 (7%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 140
L + +N ++ + L +L N L + L++L L +N +
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVL-DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 338
Query: 141 IPATWSQLSNLKHLDLSSNNLT 162
+ S LK+L LS N+
Sbjct: 339 LKL--STHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 23/90 (25%), Positives = 40/90 (44%), Gaps = 12/90 (13%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
+ L L N S + I KL L + +N+L D + T LQ+L L
Sbjct: 124 LLTVLVLERNDLS-SLPRGIFHNTPKLTTL----SMSNNNLERIEDDTFQATTSLQNLQL 178
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
++N+ + + S + +L H ++S N L+
Sbjct: 179 SSNRLT-HVDL--SLIPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 18/83 (21%), Positives = 31/83 (37%), Gaps = 12/83 (14%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 139
+L L SN +T + + L ++S L L ++ L+ ++N +
Sbjct: 175 NLQLSSN--------RLTHVDL-SLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN- 224
Query: 140 SIPATWSQLSNLKHLDLSSNNLT 162
+ L L L NNLT
Sbjct: 225 VVRG--PVNVELTILKLQHNNLT 245
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 57/247 (23%), Positives = 98/247 (39%), Gaps = 49/247 (19%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLI-----------S 324
+G G F V+ + +NT VA+K R Y EAA + E+ L+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAA-EDEIKLLQRVNDADNTKED 81
Query: 325 VAIHKNLLQLIG---YCTTSSERI-LVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKR 377
++L+L+ + + + +V+ + +NL L K +G+ K+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENL------LALIKKYEHRGIPLIYVKQ 135
Query: 378 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD------NFEAVLCDFGLAKLVDAKLT 431
++ GL+Y+H +C IIH D+K N+L++ + + D G A D T
Sbjct: 136 ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 432 H--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 489
+ T + R +PE L D++ + EL+TG F E
Sbjct: 194 NSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTK 245
Query: 490 LLDHIRK 496
DHI +
Sbjct: 246 DDDHIAQ 252
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 23/130 (17%), Positives = 37/130 (28%), Gaps = 14/130 (10%)
Query: 44 LKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLA 103
LK L + S + LTL + +G P + +
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQ-------ELTLENLEVTGTAPPPLLEATGP- 121
Query: 104 SFRELQDNDLS-GTLPDFLGSM-----THLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 157
L ++S T +L + L+ L++A L LDLS
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181
Query: 158 SNNLTGRIPM 167
N G +
Sbjct: 182 DNPELGERGL 191
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 21/110 (19%), Positives = 35/110 (31%), Gaps = 13/110 (11%)
Query: 58 NDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDL 113
N +P S + + L L N ++L L L L
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL----NLSFTGL 265
Query: 114 SGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTG 163
+P L + L L+L+ N+ P+ +L + +L L N
Sbjct: 266 K-QVPKGLPA--KLSVLDLSYNRLD-RNPSPD-ELPQVGNLSLKGNPFLD 310
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 33/174 (18%), Positives = 57/174 (32%), Gaps = 43/174 (24%)
Query: 280 IGQGGFGKVYKGV---------LSDNTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIHK 329
+ G +Y+ K ++K E F QR + V K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 330 NLL--------QLIGYCTTSSE-RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 380
L +G+ + R LV + +L R L + LD + ++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLG-----RSL---QSALDVSPKHVLSE 158
Query: 381 GTAY--------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAK 424
+ LE+LHE +H ++ A NI +D ++ L +G A
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 27/107 (25%), Positives = 41/107 (38%), Gaps = 11/107 (10%)
Query: 80 SLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
L L N I +KL L L N + L + L+ L+L NN
Sbjct: 197 ELHLDHNKIQ-AIELEDLLRYSKLYRL----GLGHNQIRMIENGSLSFLPTLRELHLDNN 251
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 182
K S +PA L L+ + L +NN+T ++ + F F +
Sbjct: 252 KLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 22/99 (22%), Positives = 39/99 (39%), Gaps = 13/99 (13%)
Query: 77 NVISLTLGSNGFSGKISPS----ITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
+ L L +N S ++ + L L L +N +S + LQ L +
Sbjct: 55 DTTLLDLQNNDIS-ELRKDDFKGLQHLYAL----VLVNNKISKIHEKAFSPLRKLQKLYI 109
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ N IP + S+L L + N + ++P +FS
Sbjct: 110 SKNHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFS 144
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 18/105 (17%), Positives = 34/105 (32%), Gaps = 20/105 (19%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N I + + S + L+ L L +N LS +P L + LQ + L
Sbjct: 225 GHNQIR-MIENGSLSF-----LPTLREL----HLDNNKLS-RVPAGLPDLKLLQVVYLHT 273
Query: 135 NKFSGSIPAT-------WSQLSNLKHLDLSSNNLT-GRIPMQLFS 171
N + + + + + L +N + + F
Sbjct: 274 NNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 11/65 (16%), Positives = 21/65 (32%), Gaps = 2/65 (3%)
Query: 108 LQDNDLSGTLPDFLGSMTHLQSLNLANNKF-SGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
+ DN + + ++ + + N + L +L +S LT IP
Sbjct: 130 IHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIP 188
Query: 167 MQLFS 171
L
Sbjct: 189 KDLPE 193
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 21/99 (21%), Positives = 36/99 (36%), Gaps = 16/99 (16%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N IS + FS + KL+ L + N L +P + L L + +
Sbjct: 86 VNNKIS-KIHEKAFSP-----LRKLQKL----YISKNHLV-EIPP--NLPSSLVELRIHD 132
Query: 135 NKFSGSIPA-TWSQLSNLKHLDLSSNNLT-GRIPMQLFS 171
N+ +P +S L N+ +++ N L F
Sbjct: 133 NRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 18/98 (18%), Positives = 31/98 (31%), Gaps = 15/98 (15%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDL-SGTLPDFLGSMTHLQSLNLA 133
+ N I + FSG + + + E+ N L + L L ++
Sbjct: 131 HDNRIR-KVPKGVFSG-----LRNMNCI----EMGGNPLENSGFEPGAFDGLKLNYLRIS 180
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
K + IP L L L N + I ++
Sbjct: 181 EAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLL 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 23/98 (23%), Positives = 35/98 (35%), Gaps = 12/98 (12%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+GN IS + + F L L L N L+ + L+ L+L++
Sbjct: 40 HGNRIS-HVPAASFRA-----CRNLTIL----WLHSNVLARIDAAAFTGLALLEQLDLSD 89
Query: 135 NKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
N S+ T+ L L L L L + LF
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 24/102 (23%), Positives = 41/102 (40%), Gaps = 15/102 (14%)
Query: 77 NVISLTLGSNGFSGKISP----SITKLKFLASFRELQDNDLSGTLPD--FLGSMTHLQSL 130
N+ L L SN + +I + L+ L +L DN ++ F G + L +L
Sbjct: 57 NLTILWLHSNVLA-RIDAAAFTGLALLEQL----DLSDNAQLRSVDPATFHG-LGRLHTL 110
Query: 131 NLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+L + + L+ L++L L N L +P F
Sbjct: 111 HLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 21/104 (20%), Positives = 37/104 (35%), Gaps = 12/104 (11%)
Query: 72 TCRNGNVISLTLGSNGFS---GKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQ 128
C N ++ + G I + ++ L N +S + +L
Sbjct: 7 VCYNEPKVTTSCPQQGLQAVPVGIPAASQRIF-------LHGNRISHVPAASFRACRNLT 59
Query: 129 SLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
L L +N + I A ++ L+ L+ LDLS N + F
Sbjct: 60 ILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 20/96 (20%), Positives = 32/96 (33%), Gaps = 12/96 (12%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
L L N + L L L N +S + L L L N+
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHL----FLHGNRISSVPERAFRGLHSLDRLLLHQNR 188
Query: 137 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ + + L L L L +NNL+ +P + +
Sbjct: 189 VA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALA 222
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 22/88 (25%), Positives = 36/88 (40%), Gaps = 12/88 (13%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+GN IS ++ F G + L L L N ++ P + L +L L
Sbjct: 161 HGNRIS-SVPERAFRG-----LHSLDRL----LLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 135 NKFSGSIPA-TWSQLSNLKHLDLSSNNL 161
N S ++P + L L++L L+ N
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 9e-09
Identities = 31/199 (15%), Positives = 57/199 (28%), Gaps = 30/199 (15%)
Query: 65 CFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFREL--QDNDLSGTLPDF-L 121
S + C + S+ L + EL ++ L L
Sbjct: 7 PHGSSGLRCTRDGALD--------------SLHHLPGAENLTELYIENQQHLQHLELRDL 52
Query: 122 GSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGT 180
+ L++L + + + + L L+LS N L + + +
Sbjct: 53 RGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ----GLSLQ 106
Query: 181 HL-ICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLK 239
L + G+ L C R + C L+ +C L+
Sbjct: 107 ELVLSGNPLHCSCALRWLQRWEEEGL-GGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQV 165
Query: 240 HDVFFDVAGED---DCKVS 255
+ DV G+D C+V
Sbjct: 166 PNASVDV-GDDVLLRCQVE 183
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 20/99 (20%), Positives = 36/99 (36%), Gaps = 9/99 (9%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
N+ SL +G N IS L+ L L+ +L+ + L + L L L
Sbjct: 129 NLKSLEVGDNDLV-YISHRAFSGLNSLEQL----TLEKCNLTSIPTEALSHLHGLIVLRL 183
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ + ++ +L LK L++S +
Sbjct: 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 27/109 (24%), Positives = 42/109 (38%), Gaps = 18/109 (16%)
Query: 65 CFSWS-HVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGS 123
C + V C +++ G I L +L N + D S
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEG-------IPTETRLL-------DLGKNRIKTLNQDEFAS 54
Query: 124 MTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
HL+ L L N S ++ ++ L NL+ L L SN L IP+ +F+
Sbjct: 55 FPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT 101
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 17/93 (18%), Positives = 36/93 (38%), Gaps = 4/93 (4%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 138
LTL + I +++ L L R L+ +++ + L+ L +++ +
Sbjct: 156 QLTLEKCNLT-SIPTEALSHLHGLIVLR-LRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213
Query: 139 GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
++ NL L ++ NLT +P
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVR 245
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 24/125 (19%), Positives = 46/125 (36%), Gaps = 16/125 (12%)
Query: 69 SHVTCRNGNVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSM 124
+ N+ SL++ + + L+FL L N +S L +
Sbjct: 217 TPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFL----NLSYNPISTIEGSMLHEL 271
Query: 125 THLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF----SVATFNFTG 179
LQ + L + + + + L+ L+ L++S N LT + +F ++ T
Sbjct: 272 LRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDS 329
Query: 180 THLIC 184
L C
Sbjct: 330 NPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 23/97 (23%), Positives = 42/97 (43%), Gaps = 11/97 (11%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N N++S + F+ + L+ L L+ N L +++L L+++
Sbjct: 64 NENIVS-AVEPGAFNN-----LFNLRTL----GLRSNRLKLIPLGVFTGLSNLTKLDISE 113
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
NK + + L NLK L++ N+L I + FS
Sbjct: 114 NKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS 149
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 17/93 (18%), Positives = 36/93 (38%), Gaps = 4/93 (4%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 139
L + + ++P+ L S + +L+ + + +L+ LNL+ N S
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLS-ITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS- 261
Query: 140 SIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 171
+I + +L L+ + L L + F
Sbjct: 262 TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFR 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 26/98 (26%), Positives = 41/98 (41%), Gaps = 12/98 (12%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ N I T+ F+G + L L EL DN L+ ++ L+ L L N
Sbjct: 96 SRNHIR-TIEIGAFNG-----LANLNTL----ELFDNRLTTIPNGAFVYLSKLKELWLRN 145
Query: 135 NKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
N SIP+ ++++ +L+ LDL I F
Sbjct: 146 NPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 23/104 (22%), Positives = 37/104 (35%), Gaps = 14/104 (13%)
Query: 73 CR-NGNVISLTLGSNGFS---GKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQ 128
C + + IS + L L +N + + + HL+
Sbjct: 39 CSCSNQFSKVICVRKNLREVPDGISTNTRLL-------NLHENQIQIIKVNSFKHLRHLE 91
Query: 129 SLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
L L+ N +I ++ L+NL L+L N LT IP F
Sbjct: 92 ILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFV 133
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 26/97 (26%), Positives = 38/97 (39%), Gaps = 8/97 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFREL--QDNDLSGTLPDFLGSMTHLQSLNLAN 134
N+ L L I L L EL N LS P + HLQ L +
Sbjct: 186 NLRYLNLAMCNLR-----EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
++ + L +L ++L+ NNLT +P LF+
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFT 276
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 24/98 (24%), Positives = 40/98 (40%), Gaps = 13/98 (13%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ N I + N F + L+ L +L N + + +L +L L +
Sbjct: 72 HENQIQ-IIKVNSFKH-----LRHLEIL----QLSRNHIRTIEIGAFNGLANLNTLELFD 121
Query: 135 NKFSGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 171
N+ + +IP LS LK L L +N + IP F+
Sbjct: 122 NRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 17/88 (19%), Positives = 37/88 (42%), Gaps = 12/88 (13%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+GN +S + F G + L+ L + + + + ++ L +NLA+
Sbjct: 215 SGNHLS-AIRPGSFQG-----LMHLQKL----WMIQSQIQVIERNAFDNLQSLVEINLAH 264
Query: 135 NKFSGSIPA-TWSQLSNLKHLDLSSNNL 161
N + +P ++ L +L+ + L N
Sbjct: 265 NNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 24/82 (29%), Positives = 40/82 (48%), Gaps = 11/82 (13%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPA-TWSQLS 149
+ L +L N+LS + +T+L SL L++N + I + + +
Sbjct: 37 LPSYTALL-------DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 150 NLKHLDLSSNNLTGRIPMQLFS 171
NL++LDLSSN+L + LFS
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFS 109
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 25/100 (25%), Positives = 42/100 (42%), Gaps = 12/100 (12%)
Query: 77 NVISLTLGSNGFSGKISP----SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
N+ SL L N + IS + L++L +L N L + L+ L L
Sbjct: 65 NLHSLLLSHNHLN-FISSEAFVPVPNLRYL----DLSSNHLHTLDEFLFSDLQALEVLLL 119
Query: 133 ANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
NN + + ++ L+ L LS N ++ R P++L
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 28/103 (27%), Positives = 42/103 (40%), Gaps = 20/103 (19%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPD--FLGSMTHLQSLNL 132
+ N + TL FS + L+ L L +N + + F M LQ L L
Sbjct: 96 SSNHLH-TLDEFLFSD-----LQALEVL----LLYNNHIV-VVDRNAFED-MAQLQKLYL 143
Query: 133 ANNKFSGSIPA----TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ N+ S P ++L L LDLSSN L ++P+
Sbjct: 144 SQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQ 184
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 24/114 (21%), Positives = 37/114 (32%), Gaps = 22/114 (19%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
C + L L + G S + L+ L N L+ LP+ S+ L N
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELPPHLESL----VASCNSLT-ELPELPQSLKSLLVDNN 121
Query: 133 ANNKFSGSIPATWS---------------QLSNLKHLDLSSNNLTGRIPMQLFS 171
S P S LK +D+ +N+L ++P S
Sbjct: 122 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS 174
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 25/109 (22%), Positives = 42/109 (38%), Gaps = 14/109 (12%)
Query: 76 GNVISLTLGSNGFSGKIS--PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLA 133
++ + G+N ++ P + L FL + +N L LPD S L+S+
Sbjct: 173 PSLEFIAAGNN----QLEELPELQNLPFLTAI-YADNNSLK-KLPDLPLS---LESIVAG 223
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 182
NN +P L L + +N L +P S+ N +L
Sbjct: 224 NNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYL 269
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 17/87 (19%), Positives = 38/87 (43%), Gaps = 11/87 (12%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
++ SL + +N +S L++L + +N L LP+ + + L+ +++ NN
Sbjct: 111 QSLKSLLVDNNNLK-ALSDLPPLLEYL----GVSNNQLE-KLPEL-QNSSFLKIIDVDNN 163
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLT 162
+P +L+ + +N L
Sbjct: 164 SLK-KLP---DLPPSLEFIAAGNNQLE 186
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 20/87 (22%), Positives = 30/87 (34%), Gaps = 13/87 (14%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
N+ L SN + L+ L + +N L LP L+ L + N
Sbjct: 297 PNLYYLNASSNEIR-SLCDLPPSLEEL----NVSNNKLI-ELPALPPR---LERLIASFN 347
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLT 162
+ +P NLK L + N L
Sbjct: 348 HLA-EVP---ELPQNLKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 18/87 (20%), Positives = 38/87 (43%), Gaps = 13/87 (14%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
++ +L + N + + L FL ++ +N S L + + L LN ++N
Sbjct: 257 PSLEALNVRDNYLT-DLPELPQSLTFL----DVSENIFS-GLSELPPN---LYYLNASSN 307
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLT 162
+ S+ +L+ L++S+N L
Sbjct: 308 EIR-SLC---DLPPSLEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 17/86 (19%), Positives = 36/86 (41%), Gaps = 11/86 (12%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ ++ +N K+ L+ + +N L LP+ L ++ L ++ NN
Sbjct: 196 FLTAIYADNNSLK-KLPDLPLSLESI----VAGNNILE-ELPE-LQNLPFLTTIYADNNL 248
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLT 162
++P +L+ L++ N LT
Sbjct: 249 LK-TLP---DLPPSLEALNVRDNYLT 270
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 13/98 (13%), Positives = 32/98 (32%), Gaps = 16/98 (16%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFL-----------ASFRELQDNDLSGTLPDFLGSM 124
+ L N + ++ LK L ++D ++ L +
Sbjct: 337 PRLERLIASFNHLA-EVPELPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELP 395
Query: 125 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
+L+ L++ N P +++ L ++S +
Sbjct: 396 QNLKQLHVETNPLR-EFPDI---PESVEDLRMNSERVV 429
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 13/104 (12%), Positives = 33/104 (31%), Gaps = 16/104 (15%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLS-- 149
I+P FL ++L+ +P ++ A +++ + P +
Sbjct: 3 INPRNVSNTFLQEPL-RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 150 -----------NLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 182
L+L++ L+ +P + + + L
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLVASCNSL 103
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 12/80 (15%), Positives = 24/80 (30%), Gaps = 8/80 (10%)
Query: 83 LGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP 142
L N ++ LK L ++ N L PD S ++ L + + +
Sbjct: 382 LRMNSHLAEVPELPQNLKQL----HVETNPLR-EFPDIPES---VEDLRMNSERVVDPYE 433
Query: 143 ATWSQLSNLKHLDLSSNNLT 162
L+ ++
Sbjct: 434 FAHETTDKLEDDVFEHHHHH 453
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 27/131 (20%), Positives = 44/131 (33%), Gaps = 16/131 (12%)
Query: 36 EGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPS 95
E LKA++ + D S + +V L L
Sbjct: 403 ETLQYFSTLKAVDPMRAAYLDDLRSKF--LLENSVLKMEYADVRVLHLAHK--------D 452
Query: 96 ITKLKFLASFRELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
+T L L + DLS LP L ++ L+ L ++N ++ + L L
Sbjct: 453 LTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDGV-ANLPRL 510
Query: 152 KHLDLSSNNLT 162
+ L L +N L
Sbjct: 511 QELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 22/88 (25%), Positives = 34/88 (38%), Gaps = 7/88 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
V L L N + P++ L+ L + DN L + + ++ LQ L L NN+
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQ-ASDNALE-NVDG-VANLPRLQELLLCNNR 519
Query: 137 FSGSIPATW--SQLSNLKHLDLSSNNLT 162
A L L+L N+L
Sbjct: 520 LQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 21/148 (14%), Positives = 48/148 (32%), Gaps = 6/148 (4%)
Query: 20 LVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVI 79
L + + + + + +K L TD + + + +
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFR----ELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
G F+ S +++L + + + L L + ++ + + N+
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 136 KFSGSIPA-TWSQLSNLKHLDLSSNNLT 162
K +P L +L+ LDLS N +
Sbjct: 321 KVF-LVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 19/99 (19%), Positives = 40/99 (40%), Gaps = 13/99 (13%)
Query: 76 GNVIS-LTLGSNGFSGKISPSITKLKFLASFRELQDNDLS--GTLPDFLGSMTHLQSLNL 132
N++ L ++ G + L+ L L N L + L ++ +L SL++
Sbjct: 343 ENLMVEEYLKNSACKG----AWPSLQTL----VLSQNHLRSMQKTGEILLTLKNLTSLDI 394
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ N F +P + ++ L+LSS + + +
Sbjct: 395 SRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ 431
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 24/97 (24%), Positives = 42/97 (43%), Gaps = 12/97 (12%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
N I+ +G L+ L L+ + ++ D S+ L+ L+L++N
Sbjct: 35 FNKIT-YIGHGDLRA-----CANLQVL----ILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 136 KFSGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 171
S S+ ++W LS+LK+L+L N LF
Sbjct: 85 HLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 22/104 (21%), Positives = 44/104 (42%), Gaps = 13/104 (12%)
Query: 71 VTCRNGNVISLTLGSNGFS---GKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHL 127
++C V S F+ ++ ++ L +L N ++ L + +L
Sbjct: 2 LSCDASGVCDGR--SRSFTSIPSGLTAAMKSL-------DLSFNKITYIGHGDLRACANL 52
Query: 128 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
Q L L +++ + + L +L+HLDLS N+L+ + F
Sbjct: 53 QVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFG 95
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 7/94 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ L + +N S + +L+ L + N L TLPD L + ++ N+
Sbjct: 432 TLEVLDVSNNNLD-SFSLFLPRLQEL----YISRNKLK-TLPDA-SLFPVLLVMKISRNQ 484
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 170
+ +L++L+ + L +N P +
Sbjct: 485 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 518
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 16/75 (21%), Positives = 28/75 (37%), Gaps = 9/75 (12%)
Query: 97 TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156
L L ++ N +PD ++ LNL++ + L+ LD+
Sbjct: 387 KNLTSL----DISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVK--TCIPQTLEVLDV 438
Query: 157 SSNNLTGRIPMQLFS 171
S+NNL + L
Sbjct: 439 SNNNLD-SFSLFLPR 452
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 14/85 (16%), Positives = 32/85 (37%), Gaps = 4/85 (4%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 140
L + +S + L+ + ++++ + F + L+ L+L+ N
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRIT-VENSKVFLVPCSFSQHLKSLEFLDLSENLMVEE 349
Query: 141 IPATWS---QLSNLKHLDLSSNNLT 162
+ +L+ L LS N+L
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 21/104 (20%), Positives = 41/104 (39%), Gaps = 9/104 (8%)
Query: 77 NVISLTLGSNGFSGKISPS----ITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
N+ +L +G+ +I +T L L E++ L L S+ + L L
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNEL----EIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN 176
++ + + LS++++L+L NL R V +
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVS 222
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 13/96 (13%), Positives = 27/96 (28%), Gaps = 2/96 (2%)
Query: 77 NVISLTLGSNGFSG-KISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
++ L L N + ++ L L + R S +T L L +
Sbjct: 99 SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ + ++ HL L + +
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFAD 193
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 25/95 (26%), Positives = 38/95 (40%), Gaps = 9/95 (9%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
L + N F P I L FL +L L P S++ LQ LN+++N
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFL----DLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 210
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
F + L++L+ LD S N++ Q
Sbjct: 211 FFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQ 244
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 27/103 (26%), Positives = 44/103 (42%), Gaps = 17/103 (16%)
Query: 63 SPCF-SWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFL 121
S C S + + C + + S+ G I S T+L EL+ N L
Sbjct: 3 SRCSCSGTEIRCNSKGLTSVPTG-------IPSSATRL-------ELESNKLQSLPHGVF 48
Query: 122 GSMTHLQSLNLANNKFS-GSIPA-TWSQLSNLKHLDLSSNNLT 162
+T L L+L++N S + + ++LK+LDLS N +
Sbjct: 49 DKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 91
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 18/98 (18%), Positives = 41/98 (41%), Gaps = 7/98 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPD--FLGSMTHLQSLNLAN 134
++ L L NG +S + L+ L Q ++L + + S+ +L L++++
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLD-FQHSNLK-QMSEFSVFLSLRNLIYLDISH 135
Query: 135 NKFSGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ LS+L+ L ++ N+ +F+
Sbjct: 136 THTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 172
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 17/87 (19%), Positives = 32/87 (36%), Gaps = 12/87 (13%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
L L ++SP+ + L+ L + N+ + LQ L+ + N
Sbjct: 180 LDLSQCQLE-QLSPTAFNSLSSLQVL----NMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 234
Query: 137 FSGSIPATWSQ--LSNLKHLDLSSNNL 161
+ Q S+L L+L+ N+
Sbjct: 235 IM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 13/48 (27%), Positives = 20/48 (41%), Gaps = 1/48 (2%)
Query: 125 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR-IPMQLFS 171
+ L L +NK + +L+ L L LSSN L+ + Q
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDF 75
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 24/104 (23%), Positives = 37/104 (35%), Gaps = 14/104 (13%)
Query: 73 CR-NGNVISLTLGSNGFS---GKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQ 128
C + + G S I + L L +N++ D + HL+
Sbjct: 50 CSCSNQFSKVVCTRRGLSEVPQGIPSNTRYL-------NLMENNIQMIQADTFRHLHHLE 102
Query: 129 SLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
L L N I ++ L++L L+L N LT IP F
Sbjct: 103 VLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFE 144
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 11/100 (11%)
Query: 77 NVISLTLGSNGFSGKISP----SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
++ L LG N +I + L L EL DN L+ ++ L+ L L
Sbjct: 100 HLEVLQLGRNSIR-QIEVGAFNGLASLNTL----ELFDNWLTVIPSGAFEYLSKLRELWL 154
Query: 133 ANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
NN SIP+ ++++ +L LDL I F
Sbjct: 155 RNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 24/98 (24%), Positives = 40/98 (40%), Gaps = 8/98 (8%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASFREL--QDNDLSGTLPDFLGSMTHLQSLNLA 133
N+ L LG + L L EL N P ++ L+ L +
Sbjct: 196 FNLKYLNLGMCNIK-----DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
N++ S + L++L L+L+ NNL+ +P LF+
Sbjct: 251 NSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 22/88 (25%), Positives = 36/88 (40%), Gaps = 12/88 (13%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+GN + F G ++ LK L + ++ +S + + L LNLA+
Sbjct: 226 SGNHFP-EIRPGSFHG-----LSSLKKL----WVMNSQVSLIERNAFDGLASLVELNLAH 275
Query: 135 NKFSGSIPA-TWSQLSNLKHLDLSSNNL 161
N S S+P ++ L L L L N
Sbjct: 276 NNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 21/81 (25%), Positives = 36/81 (44%), Gaps = 10/81 (12%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSN 150
+ P L +LQ+N ++ ++ +L +L L NNK S I ++ L
Sbjct: 50 LPPDTALL-------DLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVK 101
Query: 151 LKHLDLSSNNLTGRIPMQLFS 171
L+ L LS N L +P ++
Sbjct: 102 LERLYLSKNQLK-ELPEKMPK 121
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 18/96 (18%), Positives = 36/96 (37%), Gaps = 7/96 (7%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
+ + + + I + L L L N ++ L + +L L L+ N
Sbjct: 172 KLSYIRIADTNIT-TIPQGLPPSLTEL----HLDGNKITKVDAASLKGLNNLAKLGLSFN 226
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
S + + +L+ L L++N L ++P L
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 23/96 (23%), Positives = 40/96 (41%), Gaps = 12/96 (12%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+GN I+ + + G + L L L N +S L + HL+ L+L N
Sbjct: 200 DGNKIT-KVDAASLKG-----LNNLAKL----GLSFNSISAVDNGSLANTPHLRELHLNN 249
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 170
NK +P + ++ + L +NN++ I F
Sbjct: 250 NKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDF 283
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 10/66 (15%), Positives = 25/66 (37%), Gaps = 3/66 (4%)
Query: 108 LQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI--PATWSQLSNLKHLDLSSNNLTGRI 165
+ +N+++ + + + L N S + + L ++ ++ N+T I
Sbjct: 128 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI 186
Query: 166 PMQLFS 171
P L
Sbjct: 187 PQGLPP 192
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 21/105 (20%), Positives = 39/105 (37%), Gaps = 20/105 (19%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ N IS + + + L+ L L +N L +P L ++Q + L N
Sbjct: 224 SFNSIS-AVDNGSLAN-----TPHLREL----HLNNNKLV-KVPGGLADHKYIQVVYLHN 272
Query: 135 NKFSGSIPATW-------SQLSNLKHLDLSSNNLT-GRIPMQLFS 171
N S +I + ++ ++ + L SN + I F
Sbjct: 273 NNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 22/99 (22%), Positives = 38/99 (38%), Gaps = 16/99 (16%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N IS + F+ + KL+ L L N L LP+ LQ L +
Sbjct: 84 INNKIS-KISPGAFAP-----LVKLERL----YLSKNQLK-ELPE--KMPKTLQELRVHE 130
Query: 135 NKFSGSIPA-TWSQLSNLKHLDLSSNNLT-GRIPMQLFS 171
N+ + + ++ L+ + ++L +N L I F
Sbjct: 131 NEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 23/107 (21%), Positives = 48/107 (44%), Gaps = 15/107 (14%)
Query: 69 SHVTCRNGNVISLTLGSNGFS---GKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMT 125
+ ++C + + S + ++ ++ L +L +N ++ L
Sbjct: 26 ASLSCDRNGICKGS--SGSLNSIPSGLTEAVKSL-------DLSNNRITYISNSDLQRCV 76
Query: 126 HLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+LQ+L L +N + +I ++S L +L+HLDLS N L+ + F
Sbjct: 77 NLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFK 121
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 29/100 (29%), Positives = 44/100 (44%), Gaps = 11/100 (11%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
V SL L +N + IS S L+ L L N ++ D S+ L+ L+L
Sbjct: 53 AVKSLDLSNNRIT-YISNSDLQRCVNLQAL----VLTSNGINTIEEDSFSSLGSLEHLDL 107
Query: 133 ANNKFSGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ N S ++ ++W LS+L L+L N LFS
Sbjct: 108 SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFS 146
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 21/108 (19%), Positives = 41/108 (37%), Gaps = 10/108 (9%)
Query: 77 NVISLTLGSNGFSGKISP----SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
+ L +G+ KI +T L+ L E+ +DL P L S+ ++ L L
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEEL----EIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 133 ANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 179
+ + S+++ L+L +L +L + T +
Sbjct: 206 HMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 14/93 (15%), Positives = 35/93 (37%), Gaps = 8/93 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKF--LASFRELQDNDLSG----TLPDFLGSMTHLQSL 130
+V L L ++ + L ++ ++ + L ++ L L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLEL 282
Query: 131 NLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLT 162
+ N+ S+P + +L++L+ + L +N
Sbjct: 283 EFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 14/95 (14%), Positives = 27/95 (28%), Gaps = 6/95 (6%)
Query: 80 SLTLGSNGFSGKISPSIT--KLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 137
L L N + + + L L R + + +T L+ L + +
Sbjct: 128 FLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186
Query: 138 SGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
S + + N+ HL L +
Sbjct: 187 Q-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 15/99 (15%), Positives = 33/99 (33%), Gaps = 11/99 (11%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLA----SFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
L L + + ++ L ++LS + L +++ +
Sbjct: 203 LILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ + +Q+S L L+ S N L +P +F
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFD 298
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 22/99 (22%), Positives = 44/99 (44%), Gaps = 13/99 (13%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N I+ T+ + FS + L+ L +L N LS + ++ L LNL
Sbjct: 84 TSNGIN-TIEEDSFSS-----LGSLEHL----DLSYNYLSNLSSSWFKPLSSLTFLNLLG 133
Query: 135 NKFSGSIP--ATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
N + ++ + +S L+ L+ L + + + +I + F+
Sbjct: 134 NPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 42/170 (24%), Positives = 67/170 (39%), Gaps = 35/170 (20%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRL----QDYYSPGG---EAAFQREV---HLISVAIHK 329
IGQGGFG +Y ++ + V + G E F + I I
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 330 NLLQLIG-----YCTTSSERILVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK------- 376
L+ +G + Y FM + R DL +K + ++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFGSDL---QKIYEANAKRFSRKTVL 155
Query: 377 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAV-LCDFGLAK 424
+++ LEY+HE +H D+KA+N+LL+ N + V L D+GLA
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 11/94 (11%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQS----LNLANN 135
L++ +N + + L+ L ++ N L +LP H + N
Sbjct: 164 VLSVRNNQLT-FLPELPESLEAL----DVSTNLLE-SLPAVPVRNHHSEETEIFFRCREN 217
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 169
+ + IP L + L N L+ RI L
Sbjct: 218 RIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 25/112 (22%), Positives = 44/112 (39%), Gaps = 28/112 (25%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHL--------- 127
+ L + N + L++L + DN LS TLP+ S+ HL
Sbjct: 81 QITVLEITQNALI-SLPELPASLEYL----DACDNRLS-TLPELPASLKHLDVDNNQLTM 134
Query: 128 --------QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ +N NN+ + +P ++L+ L + +N LT +P S
Sbjct: 135 LPELPALLEYINADNNQLT-MLPE---LPTSLEVLSVRNNQLT-FLPELPES 181
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 9e-07
Identities = 24/91 (26%), Positives = 42/91 (46%), Gaps = 14/91 (15%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSI-TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLN 131
C L L S + ++ ++ L E+ N L +LP+ S L+ L+
Sbjct: 56 CLINQFSELQLNRLNLS-SLPDNLPPQITVL----EITQNALI-SLPELPAS---LEYLD 106
Query: 132 LANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
+N+ S ++P ++LKHLD+ +N LT
Sbjct: 107 ACDNRLS-TLPE---LPASLKHLDVDNNQLT 133
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 12/91 (13%), Positives = 30/91 (32%), Gaps = 5/91 (5%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASFRE---LQDNDLSGTLPDFLGSMTHLQSLNLANNKF 137
L + +N + + ++N ++ +P+ + S+ ++ L +N
Sbjct: 185 LDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL 242
Query: 138 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 168
S I + SQ + + Q
Sbjct: 243 SSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 26/95 (27%), Positives = 41/95 (43%), Gaps = 13/95 (13%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
L L N S + T+L L L +L+ L G++ L +L+L++N+
Sbjct: 36 LHLSENLLY-TFSLATLMPYTRLTQL----NLDRAELT-KLQVD-GTLPVLGTLDLSHNQ 88
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
S+P L L LD+S N LT +P+
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 27/95 (28%), Positives = 40/95 (42%), Gaps = 12/95 (12%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
L + N + + +L+ L L+ N+L P L L+ L+LANN
Sbjct: 105 LDVSFNRLT-SLPLGALRGLGELQEL----YLKGNELKTLPPGLLTPTPKLEKLSLANNN 159
Query: 137 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 170
+ +PA + L NL L L N+L IP F
Sbjct: 160 LT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 20/78 (25%), Positives = 34/78 (43%), Gaps = 7/78 (8%)
Query: 94 PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLK 152
++ L L ++ N L+ L + LQ L L N+ ++P + L+
Sbjct: 97 QTLPALTVL----DVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLE 151
Query: 153 HLDLSSNNLTGRIPMQLF 170
L L++NNLT +P L
Sbjct: 152 KLSLANNNLT-ELPAGLL 168
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 21/99 (21%), Positives = 44/99 (44%), Gaps = 9/99 (9%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
N+ + T+ + PS + L + +N L+ T+ + G +T L++L L N
Sbjct: 303 NIKNFTVSGTRMVHMLCPSKISPFLHL----DFSNNLLTDTVFENCGHLTELETLILQMN 358
Query: 136 KFSGSIPAT---WSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ + +Q+ +L+ LD+S N+++ S
Sbjct: 359 QLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS 396
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 16/71 (22%), Positives = 31/71 (43%), Gaps = 7/71 (9%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
+S T L + N +S + S++ L+ L +++N+ + + L
Sbjct: 19 LSQKTTIL-------NISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 152 KHLDLSSNNLT 162
++LDLS N L
Sbjct: 72 EYLDLSHNKLV 82
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 22/87 (25%), Positives = 47/87 (54%), Gaps = 8/87 (9%)
Query: 77 NVISLTLGSNGFSGKISPSIT-KLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
+++SL + SN + I + ++K L +L N + ++P + + LQ LN+A+N
Sbjct: 400 SLLSLNMSSNILTDTIFRCLPPRIKVL----DLHSNKIK-SIPKQVVKLEALQELNVASN 454
Query: 136 KFSGSIP-ATWSQLSNLKHLDLSSNNL 161
+ S+P + +L++L+ + L +N
Sbjct: 455 QLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 16/132 (12%), Positives = 45/132 (34%), Gaps = 4/132 (3%)
Query: 34 DVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLT---LGSNGFSG 90
+ + I +L+ + T + ++ + + ++ +L+ + S+ F
Sbjct: 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 91 KISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSN 150
S + + + + ++ L+ +NN + ++ L+
Sbjct: 291 PQSYIYEIFSNM-NIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349
Query: 151 LKHLDLSSNNLT 162
L+ L L N L
Sbjct: 350 LETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 24/95 (25%), Positives = 39/95 (41%), Gaps = 12/95 (12%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
L + N S L L + N L+ T+ L ++ L+L +NK
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSL----NMSSNILTDTIFRCL--PPRIKVLDLHSNK 432
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
SIP +L L+ L+++SN L +P +F
Sbjct: 433 IK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFD 465
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 33/207 (15%), Positives = 60/207 (28%), Gaps = 9/207 (4%)
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPD--FLGSMTHLQSLN 131
N + L L N LK L +L N LP G+M+ L+ L
Sbjct: 67 FNQELEYLDLSHNKLVKISCHPTVNLKHL----DLSFNAFD-ALPICKEFGNMSQLKFLG 121
Query: 132 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRI-PMQLFSVATFNFTGTHLICGSSLEQ 190
L+ S + L+ K L + + P L T +
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFI 181
Query: 191 PCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGED 250
+S + + + ++ V+ C F+ + + L + ++
Sbjct: 182 LDVSVKT-VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI 240
Query: 251 DCKVSLTQLRRFSCRELQLATDNFSES 277
V T + FS ++L
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQLDFRD 267
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 13/96 (13%)
Query: 67 SWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTH 126
+H+ + L + N + + L+ L + DN L+ +LP
Sbjct: 112 PLTHLPALPSGLCKLWIFGNQLT-SLPVLPPGLQEL----SVSDNQLA-SLPALPS---E 162
Query: 127 LQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
L L NN+ + S+P S L+ L +S N L
Sbjct: 163 LCKLWAYNNQLT-SLPM---LPSGLQELSVSDNQLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 21/87 (24%), Positives = 38/87 (43%), Gaps = 13/87 (14%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
+ L++ N + + ++L L +N L+ +LP L+ L ++ N
Sbjct: 181 SGLQELSVSDNQLA-SLPTLPSELYKL----WAYNNRLT-SLPALPSG---LKELIVSGN 231
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLT 162
+ + S+P S LK L +S N LT
Sbjct: 232 RLT-SLPVL---PSELKELMVSGNRLT 254
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 16/87 (18%), Positives = 30/87 (34%), Gaps = 9/87 (10%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
+ L + N + + + L L + N L+ LP+ L ++ ++NL N
Sbjct: 241 SELKELMVSGNRLT-SLPMLPSGLLSL----SVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLT 162
S T L + S +
Sbjct: 295 PLS---ERTLQALREITSAPGYSGPII 318
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 21/98 (21%), Positives = 40/98 (40%), Gaps = 12/98 (12%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSI-TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLN 131
C N L +G +G + + + + L + DN+L+ +LP L++L
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCLPAHITTL----VIPDNNLT-SLPALPP---ELRTLE 87
Query: 132 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 169
++ N+ + S+P L L +L +P L
Sbjct: 88 VSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGL 123
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 44/168 (26%), Positives = 62/168 (36%), Gaps = 34/168 (20%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGG----EAAFQREV---HLISVAIHKNL 331
IG GGFG +Y + K A ++ Y G E F + V I I +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 332 LQLIG-----YCTTSSERILVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK-------RV 378
L +G + + Y FM V RL DL +K ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFM----VMERLGIDL---QKISGQ-NGTFKKSTVLQL 156
Query: 379 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAK 424
LEY+HE +H D+KAAN+LL L D+GL+
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 24/89 (26%), Positives = 42/89 (47%), Gaps = 13/89 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLA 133
+ SL+L NG I+ + L +L+ L T L +T L +L+L
Sbjct: 110 KLKSLSLEHNG--------ISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLE 161
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
+N+ S I + L+ L++L LS N+++
Sbjct: 162 DNQIS-DIVP-LAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 7e-07
Identities = 15/89 (16%), Positives = 25/89 (28%), Gaps = 13/89 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLA 133
I L S+T + + + + ++ L L
Sbjct: 22 ETIKDNLKKK--------SVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLN 73
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
NK + I + L NL L L N +
Sbjct: 74 GNKLT-DIKP-LTNLKNLGWLFLDENKIK 100
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 9e-07
Identities = 17/89 (19%), Positives = 34/89 (38%), Gaps = 13/89 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGT-LPDF--LGSMTHLQSLNLA 133
++ + ++ I ++ + + L+G L D L ++ +L L L
Sbjct: 44 SIDQIIANNSD--------IKSVQGIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLD 95
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
NK + + L LK L L N ++
Sbjct: 96 ENKIK-DLSSL-KDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 14/70 (20%), Positives = 26/70 (37%), Gaps = 5/70 (7%)
Query: 96 ITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 152
I ++ +F E ++L T + + + N+ S+ L N+
Sbjct: 11 IKQIFPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQGI-QYLPNVT 68
Query: 153 HLDLSSNNLT 162
L L+ N LT
Sbjct: 69 KLFLNGNKLT 78
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 24/89 (26%), Positives = 37/89 (41%), Gaps = 13/89 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLA 133
N+ L L N I L L ++L+ L + + L + L+SL L
Sbjct: 88 NLGWLFLDEN--------KIKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLG 139
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
NNK + I S+L+ L L L N ++
Sbjct: 140 NNKIT-DITVL-SRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 31/102 (30%), Positives = 45/102 (44%), Gaps = 11/102 (10%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFREL--QDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ SL LG+N KI+ IT L L L +DN +S L +T LQ+L L+
Sbjct: 132 QLESLYLGNN----KIT-DITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSK 184
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN 176
N S + A + L NL L+L S + ++ N
Sbjct: 185 NHIS-DLRAL-AGLKNLDVLELFSQECLNKPINHQSNLVVPN 224
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 53/221 (23%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISV------AIHK 329
+IG+G FG+V K + VA+K R + + A E+ ++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH---RQA-AEEIRILEHLRKQDKDNTM 159
Query: 330 NLLQLIGY-------CTTSSERILVYPFM-QNLSVAYRLRDLKPGE-KGLDWPTRKRVAF 380
N++ ++ C + + + NL Y L +K + +G P ++ A
Sbjct: 160 NVIHMLENFTFRNHIC-------MTFELLSMNL---YEL--IKKNKFQGFSLPLVRKFAH 207
Query: 381 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAKLVDAKLTHVTTQI- 437
L+ LH+ +IIH DLK NILL + + DFG + V T I
Sbjct: 208 SILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH---QRVYTYIQ 261
Query: 438 ----RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
R APE + + D++ G L EL+TG
Sbjct: 262 SRFYR------APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 13/89 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLP---DFLGSMTHLQSLNLA 133
N I + G + ++T A + GT + + + +L L L
Sbjct: 20 NAIKIAAGKS--------NVTDTVTQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELK 71
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
+N+ + + L+ + L+LS N L
Sbjct: 72 DNQIT-DLAPL-KNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 18/89 (20%), Positives = 40/89 (44%), Gaps = 13/89 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLA 133
+ L L N + + +A + ++ DL+ T L +++LQ L L
Sbjct: 86 KITELELSGNP--------LKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
N+ + +I + L+NL++L + + ++
Sbjct: 138 LNQIT-NISPL-AGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 11/71 (15%), Positives = 23/71 (32%), Gaps = 5/71 (7%)
Query: 95 SITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
+I + + T + + +L+ + +I L+NL
Sbjct: 8 AINVIFPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNL 65
Query: 152 KHLDLSSNNLT 162
L+L N +T
Sbjct: 66 IGLELKDNQIT 76
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 13/89 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLA 133
N+I L L N IT L L + ++ + +LSG + + +++L+L
Sbjct: 64 NLIGLELKDN--------QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLT 115
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
+ + + + + LSNL+ L L N +T
Sbjct: 116 STQIT-DVTPL-AGLSNLQVLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 21/88 (23%), Positives = 41/88 (46%), Gaps = 11/88 (12%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
++ +L L S + ++P ++ L+ L L N ++ P L +T+LQ L++ N
Sbjct: 108 SIKTLDLTSTQIT-DVTPLAGLSNLQVL----YLDLNQITNISP--LAGLTNLQYLSIGN 160
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLT 162
+ S + + LS L L N ++
Sbjct: 161 AQVS-DLTPL-ANLSKLTTLKADDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 23/88 (26%), Positives = 41/88 (46%), Gaps = 11/88 (12%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N+ L L N + ISP +T L++L + + +S L +++ L +L +
Sbjct: 130 NLQVLYLDLNQIT-NISPLAGLTNLQYL----SIGNAQVSDL--TPLANLSKLTTLKADD 182
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLT 162
NK S I + L NL + L +N ++
Sbjct: 183 NKIS-DISP-LASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 19/89 (21%), Positives = 39/89 (43%), Gaps = 13/89 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLA 133
N+ L++G+ ++ L LA+ +L + L S+ +L ++L
Sbjct: 152 NLQYLSIGNAQ--------VSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLK 203
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
NN+ S + + SNL + L++ +T
Sbjct: 204 NNQIS-DVSP-LANTSNLFIVTLTNQTIT 230
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 20/95 (21%), Positives = 35/95 (36%), Gaps = 11/95 (11%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ +L N + L L N+++ L L L L+ ++NK
Sbjct: 171 QLTTLDCSFNKITELDVSQNKLLNRL----NCDTNNIT-KLD--LNQNIQLTFLDCSSNK 223
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ I + L+ L + D S N LT + + S
Sbjct: 224 LT-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLS 254
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 19/90 (21%), Positives = 35/90 (38%), Gaps = 17/90 (18%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG----TLPDFLGSMTHLQSLNL 132
+ SL ++ IT + + L + TL L T+L L
Sbjct: 43 TLTSLDCHNSS--------ITDMTGIEKLTGLTKLICTSNNITTLD--LSQNTNLTYLAC 92
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
+NK + ++ + L+ L +L+ +N LT
Sbjct: 93 DSNKLT-NLDV--TPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 24/119 (20%), Positives = 43/119 (36%), Gaps = 23/119 (19%)
Query: 44 LKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLA 103
L L+ + + T+ + VS + + C N+ L L N +L FL
Sbjct: 172 LTTLDCSFNKITELD---VSQNKLLNRLNCDTNNITKLDLNQN----------IQLTFL- 217
Query: 104 SFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
+ N L+ + + +T L + + N + + S LS L L +L
Sbjct: 218 ---DCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDV--STLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 15/86 (17%), Positives = 32/86 (37%), Gaps = 9/86 (10%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
+ ++ + L L + ++ ++ + +T L L +N
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSL----DCHNSSIT-DMTGI-EKLTGLTKLICTSNN 75
Query: 137 FSGSIPATWSQLSNLKHLDLSSNNLT 162
+ ++ SQ +NL +L SN LT
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLT 98
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 15/87 (17%), Positives = 27/87 (31%), Gaps = 7/87 (8%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
N + + G +T L Q ++ L L L L L N
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHNTQLYLLD-CQAAGIT-ELD--LSQNPKLVYLYLNNT 328
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLT 162
+ + + S + LK L + ++
Sbjct: 329 ELT-ELDV--SHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 12/90 (13%), Positives = 24/90 (26%), Gaps = 13/90 (14%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKF--LASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
+ +L + ++ Q + T L L+
Sbjct: 253 LSKLTTLHCIQT--------DLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDC 304
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
+ + SQ L +L L++ LT
Sbjct: 305 QAAGIT-ELDL--SQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 24/90 (26%), Positives = 36/90 (40%), Gaps = 20/90 (22%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
C + N+ +L L N T L +L N L+ L + +T L LN
Sbjct: 71 CTSNNITTLDLSQN----------TNLTYL----ACDSNKLT-NLD--VTPLTKLTYLNC 113
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
NK + + SQ L +L+ + N LT
Sbjct: 114 DTNKLT-KLDV--SQNPLLTYLNCARNTLT 140
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 20/101 (19%), Positives = 43/101 (42%), Gaps = 13/101 (12%)
Query: 77 NVISLTLGSNGFSGKISP----SITKLKFLASFRELQDNDLSGTLP-DFLGSMTHLQSLN 131
+V + L N + +++ + L+FL +++ + + ++ L L
Sbjct: 31 HVNYVDLSLNSIA-ELNETSFSRLQDLQFL----KVEQQTPGLVIRNNTFRGLSSLIILK 85
Query: 132 LANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG-RIPMQLF 170
L N+F + ++ L+NL+ L L+ NL G + F
Sbjct: 86 LDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFF 125
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 30/132 (22%), Positives = 56/132 (42%), Gaps = 16/132 (12%)
Query: 47 LNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSI----TKLKFL 102
L++++ + + +++ V + L + + S+ T L+ L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304
Query: 103 ASFRELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSN 159
L N+++ + D F G +THL LNL+ N SI + + L L+ LDLS N
Sbjct: 305 ----TLAQNEIN-KIDDNAFWG-LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYN 357
Query: 160 NLTGRIPMQLFS 171
++ + Q F
Sbjct: 358 HIR-ALGDQSFL 368
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 14/81 (17%), Positives = 27/81 (33%), Gaps = 9/81 (11%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSN 150
+ + + +L N ++ + LQ L + I T+ LS+
Sbjct: 28 LPAHVNYV-------DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 151 LKHLDLSSNNLTGRIPMQLFS 171
L L L N ++ F+
Sbjct: 81 LIILKLDYNQFL-QLETGAFN 100
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 14/98 (14%)
Query: 80 SLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFL-GSMTHLQSLNLAN 134
LTL N + KI + T L L L N L ++ + ++ L+ L+L+
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTHLLKL----NLSQNFLG-SIDSRMFENLDKLEVLDLSY 356
Query: 135 NKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
N ++ ++ L NLK L L +N L +P +F
Sbjct: 357 NHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 24/109 (22%), Positives = 33/109 (30%), Gaps = 12/109 (11%)
Query: 81 LTLGSNGFSGKISPS-----ITKLKFLASFRELQDNDLSGTLPD-FLGSMTHLQSLNLAN 134
LTL G + +T L+ L L+DN++ P F +M L+L
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEML----VLRDNNIKKIQPASFFLNMRRFHVLDLTF 163
Query: 135 NKFSGSIPATWSQL--SNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTH 181
NK + L LSS L L N
Sbjct: 164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 19/90 (21%), Positives = 38/90 (42%), Gaps = 11/90 (12%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
+++ L L N I + KL+ L +L N + + +L+ L L
Sbjct: 324 HLLKLNLSQNFLG-SIDSRMFENLDKLEVL----DLSYNHIRALGDQSFLGLPNLKELAL 378
Query: 133 ANNKFSGSIPA-TWSQLSNLKHLDLSSNNL 161
N+ S+P + +L++L+ + L +N
Sbjct: 379 DTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 18/89 (20%), Positives = 36/89 (40%), Gaps = 13/89 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTL---PDFLGSMTHLQSLNLA 133
N + LG S+T L +Q+ + + + T+L+ L+L+
Sbjct: 20 NAVKQNLGKQ--------SVTDLVSQKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLS 71
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
+N+ S + L+ L+ L ++ N L
Sbjct: 72 HNQIS-DLSPL-KDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 14/71 (19%), Positives = 26/71 (36%), Gaps = 5/71 (7%)
Query: 95 SITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
I ++ +L T ++ +Q+ N N+ S+ +NL
Sbjct: 8 PINQVFPDPGLANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNL 65
Query: 152 KHLDLSSNNLT 162
K L LS N ++
Sbjct: 66 KELHLSHNQIS 76
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 24/87 (27%), Positives = 38/87 (43%), Gaps = 10/87 (11%)
Query: 77 NVISLTLGSNGFSGKISP-SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
+ L++ N ++ L L L +N+L T L + +L+ L++ NN
Sbjct: 86 KLEELSVNRNRLK-NLNGIPSACLSRL----FLDNNELRDTDS--LIHLKNLEILSIRNN 138
Query: 136 KFSGSIPATWSQLSNLKHLDLSSNNLT 162
K SI LS L+ LDL N +T
Sbjct: 139 KLK-SIVML-GFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 16/88 (18%), Positives = 37/88 (42%), Gaps = 11/88 (12%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ L L +N + L+ L +++N L ++ LG ++ L+ L+L
Sbjct: 107 CLSRLFLDNNELR-DTDSLIHLKNLEIL----SIRNNKLK-SI-VMLGFLSKLEVLDLHG 159
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLT 162
N+ + + ++L + +DL+
Sbjct: 160 NEIT-NTGG-LTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 20/89 (22%), Positives = 34/89 (38%), Gaps = 14/89 (15%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLA 133
N+ L L N I+ L L +L++ ++ + + S L L L
Sbjct: 64 NLKELHLSHN--------QISDLSPLKDLTKLEELSVNRNRLKNLNGIPSAC-LSRLFLD 114
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
NN+ + L NL+ L + +N L
Sbjct: 115 NNELR-DTDS-LIHLKNLEILSIRNNKLK 141
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 14/119 (11%), Positives = 29/119 (24%), Gaps = 24/119 (20%)
Query: 65 CFSWSHVTCRN----------GNVISLTLGSNGFSGKISPSI----TKLKFLASFRELQD 110
C + +L L I + + +
Sbjct: 10 CHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRI----YVSI 64
Query: 111 NDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIP 166
+ L F ++ + + + N + I +L LK L + + L P
Sbjct: 65 DVTLQQLESHSFYN-LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFP 121
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 16/102 (15%), Positives = 37/102 (36%), Gaps = 12/102 (11%)
Query: 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDN-DLSGTLPDFLGSMTHLQSLN 131
N+ + + + ++ +K+ + E+++ +L+ PD L + L+ L
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHI----EIRNTRNLTYIDPDALKELPLLKFLG 111
Query: 132 LANNKFSGSIPAT--WSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ N P L+++ N IP+ F
Sbjct: 112 IFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 18/95 (18%), Positives = 38/95 (40%), Gaps = 5/95 (5%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 138
L + N + I + L +L +N + ++ + + T L ++ L NK+
Sbjct: 134 ILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYL 192
Query: 139 GSIPA-TWSQL-SNLKHLDLSSNNLTGRIPMQLFS 171
I + + S LD+S ++T +P +
Sbjct: 193 TVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLE 226
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 25/102 (24%), Positives = 43/102 (42%), Gaps = 16/102 (15%)
Query: 77 NVISLTLGSNGFSGKISP----SITKLKFLASFRELQDNDLSGTLPD--FLGSMTHLQSL 130
+ + L N I P KL+ + +L +N +S L F G + L SL
Sbjct: 33 TITEIRLEQNTIK-VIPPGAFSPYKKLRRI----DLSNNQIS-ELAPDAFQG-LRSLNSL 85
Query: 131 NLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
L NK + +P + L +L+ L L++N + + + F
Sbjct: 86 VLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQ 125
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 7e-07
Identities = 19/80 (23%), Positives = 35/80 (43%), Gaps = 10/80 (12%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSN 150
+ +IT++ L+ N + P L+ ++L+NN+ S + + L +
Sbjct: 30 LPETITEI-------RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 151 LKHLDLSSNNLTGRIPMQLF 170
L L L N +T +P LF
Sbjct: 82 LNSLVLYGNKIT-ELPKSLF 100
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 20/76 (26%), Positives = 26/76 (34%), Gaps = 7/76 (9%)
Query: 97 TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLD 155
L L L N ++ + LQ L L NK + + + L NL L
Sbjct: 80 RSLNSLV----LYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLS 134
Query: 156 LSSNNLTGRIPMQLFS 171
L N L I FS
Sbjct: 135 LYDNKLQ-TIAKGTFS 149
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 10/78 (12%)
Query: 97 TKLKFLASFRELQDNDLSGTLPDFL-GSMTHLQSLNLANNKFSGSIPA--TWSQLSNLKH 153
+ L+ L + +L+ +L +F G + L+ LN+A+N S +S L+NL+H
Sbjct: 100 SSLQKL----VAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEH 153
Query: 154 LDLSSNNLTGRIPMQLFS 171
LDLSSN + I
Sbjct: 154 LDLSSNKIQ-SIYCTDLR 170
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 22/99 (22%), Positives = 39/99 (39%), Gaps = 16/99 (16%)
Query: 80 SLTLGSNGFSGKISP----SITKLKFLASFRELQDNDLSGTLPD--FLGSMTHLQSLNLA 133
+L L N + S +L+ L +L ++ T+ D + ++HL +L L
Sbjct: 32 NLDLSFNPLR-HLGSYSFFSFPELQVL----DLSRCEIQ-TIEDGAYQS-LSHLSTLILT 84
Query: 134 NNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
N S+ +S LS+L+ L NL +
Sbjct: 85 GNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIG 121
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 37/158 (23%), Positives = 59/158 (37%), Gaps = 31/158 (19%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL----- 332
IG G FG +Y G ++ +VA+K E + L I+K +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL---------ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 333 -QLIGYCTTSSERILVYPFMQNL--SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
+ ++V M+ L S+ L + + T +A +EY+
Sbjct: 68 PTIRWCGAEGDYNVMV---MELLGPSLED-LFNFCS--RKFSLKTVLLLADQMISRIEYI 121
Query: 390 HEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK 424
H + IHRD+K N L+ + DFGLAK
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 24/119 (20%), Positives = 46/119 (38%), Gaps = 31/119 (26%)
Query: 63 SPCFSWSHVTCRN-----------GNVISLTLGSNGFSGKISP----SITKLKFLASFRE 107
S V N +L+L N S ++ +++L+ L
Sbjct: 28 FSNELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSIS-ELRMPDISFLSELRVL----R 82
Query: 108 LQDNDLSGTLP----DFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
L N + +L F L+ L++++N+ +I +++L+HLDLS N+
Sbjct: 83 LSHNRIR-SLDFHVFLFN---QDLEYLDVSHNRLQ-NISCCP--MASLRHLDLSFNDFD 134
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 23/87 (26%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 76 GNVISLTLGSNGFSGKISPSIT-KLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+++ L L SN +G + + K+K L +L +N + ++P + + LQ LN+A+
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLPPKVKVL----DLHNNRIM-SIPKDVTHLQALQELNVAS 482
Query: 135 NKFSGSIP-ATWSQLSNLKHLDLSSNN 160
N+ S+P + +L++L+++ L N
Sbjct: 483 NQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 21/74 (28%), Positives = 36/74 (48%), Gaps = 8/74 (10%)
Query: 97 TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156
+ L L N L+G++ L ++ L+L NN+ SIP + L L+ L++
Sbjct: 428 ESILVL----NLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNV 480
Query: 157 SSNNLTGRIPMQLF 170
+SN L +P +F
Sbjct: 481 ASNQLK-SVPDGVF 493
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 15/71 (21%), Positives = 23/71 (32%), Gaps = 4/71 (5%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
+ ++ L +D S + LN N F+ S+ S L L
Sbjct: 324 LYSVFAEMNIKM----LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379
Query: 152 KHLDLSSNNLT 162
+ L L N L
Sbjct: 380 QTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 16/77 (20%), Positives = 32/77 (41%), Gaps = 11/77 (14%)
Query: 97 TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP--ATWSQLSNLKHL 154
L++L ++ N L + M L+ L+L+ N F +P + L+ L L
Sbjct: 100 QDLEYL----DVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFL 151
Query: 155 DLSSNNLTGRIPMQLFS 171
LS+ ++ + +
Sbjct: 152 GLSAAKFR-QLDLLPVA 167
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 24/117 (20%), Positives = 40/117 (34%), Gaps = 16/117 (13%)
Query: 61 FVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDF 120
C + L N F+ + + LK L + LQ N L
Sbjct: 344 IHMVCPPSP------SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI-LQRNGLK-NFFKV 395
Query: 121 LGSMTHLQSLNLANNKF----SGSIPATWSQLSNLKHLDLSSNNLTG----RIPMQL 169
++ SL + S + T + ++ L+LSSN LTG +P ++
Sbjct: 396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKV 452
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 23/89 (25%), Positives = 37/89 (41%), Gaps = 13/89 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLA 133
N+ L L N + L L ++L+ L + + L + L+SL L
Sbjct: 91 NLGWLFLDEN--------KVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLG 142
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
NNK + I S+L+ L L L N ++
Sbjct: 143 NNKIT-DITVL-SRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 14/71 (19%), Positives = 26/71 (36%), Gaps = 5/71 (7%)
Query: 95 SITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
I ++ +F E ++L T + + + N+ S+ L N+
Sbjct: 13 PIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNV 70
Query: 152 KHLDLSSNNLT 162
L L+ N LT
Sbjct: 71 TKLFLNGNKLT 81
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 15/89 (16%), Positives = 25/89 (28%), Gaps = 13/89 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG---TLPDFLGSMTHLQSLNLA 133
I L S+T + + + + ++ L L
Sbjct: 25 ETIKDNLKKK--------SVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLN 76
Query: 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 162
NK + I + L NL L L N +
Sbjct: 77 GNKLT-DIKP-LANLKNLGWLFLDENKVK 103
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 30/90 (33%), Positives = 41/90 (45%), Gaps = 15/90 (16%)
Query: 80 SLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPD--FLGSMTHLQSLNLA 133
L L SN S + TKL+ L L DN L TLP F + +L++L +
Sbjct: 41 KLDLQSNKLS-SLPSKAFHRLTKLRLL----YLNDNKLQ-TLPAGIFKE-LKNLETLWVT 93
Query: 134 NNKFSGSIPA-TWSQLSNLKHLDLSSNNLT 162
+NK ++P + QL NL L L N L
Sbjct: 94 DNKLQ-ALPIGVFDQLVNLAELRLDRNQLK 122
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 30/105 (28%), Positives = 46/105 (43%), Gaps = 16/105 (15%)
Query: 72 TCRNGNVISLTLGSNGF----SGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHL 127
+C N N S+ S S I KL +LQ N LS +T L
Sbjct: 13 SC-NNNKNSVDCSSKKLTAIPSN-IPADTKKL-------DLQSNKLSSLPSKAFHRLTKL 63
Query: 128 QSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ L L +NK ++PA + +L NL+ L ++ N L +P+ +F
Sbjct: 64 RLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFD 106
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 16/97 (16%)
Query: 81 LTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSGTLPD--FLGSMTHLQSLNLAN 134
L L N + P + TKL +L L N+L +LP F +T L+ L L N
Sbjct: 114 LRLDRNQLK-SLPPRVFDSLTKLTYL----SLGYNELQ-SLPKGVF-DKLTSLKELRLYN 166
Query: 135 NKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 170
N+ +P + +L+ LK L L +N L R+P F
Sbjct: 167 NQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAF 201
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 42/201 (20%), Positives = 60/201 (29%), Gaps = 66/201 (32%)
Query: 346 LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 404
+V+ + +L + +GL P K++ GL+YLH +C IIH D+K
Sbjct: 122 MVFEVLGHHL---LKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKP 175
Query: 405 ANILL-------------------------------------------------DDNFEA 415
NILL + +
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 416 VLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
+ D G A V T T Q R + E L + D++ EL TG
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQYR------SLEVLIGSGYNTPADIWSTACMAFELATG 289
Query: 474 QRAIDFSRLEEEEDVLLLDHI 494
F EE DHI
Sbjct: 290 DYL--FEPHSGEEYTRDEDHI 308
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 29/169 (17%), Positives = 53/169 (31%), Gaps = 27/169 (15%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
++ + + N I + + L L R + N+L P+ ++ +LQ L ++N
Sbjct: 55 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 114
Query: 136 KFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMS 194
+P LD+ N I F +F L
Sbjct: 115 GIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL------------ 161
Query: 195 RPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVF 243
++ ++ + AF L L L +L +DVF
Sbjct: 162 --------NKNGIQEI----HNSAFNGTQLDELNLSDNNNLEELPNDVF 198
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 14/82 (17%), Positives = 26/82 (31%), Gaps = 10/82 (12%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSN 150
+ + +L L L+ + ++ N I A +S L
Sbjct: 28 LPRNAIEL-------RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 151 LKHLDLS-SNNLTGRIPMQLFS 171
L + + +NNL I + F
Sbjct: 81 LHEIRIEKANNLL-YINPEAFQ 101
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 9e-04
Identities = 20/101 (19%), Positives = 32/101 (31%), Gaps = 4/101 (3%)
Query: 73 CRNGNVISLTLGSNGFSGKISP-SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLN 131
+ + L + N I S L F + L N + + + + T L LN
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELN 183
Query: 132 L-ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
L NN + S LD+S + +P
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLE 223
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 38/165 (23%), Positives = 62/165 (37%), Gaps = 43/165 (26%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL----- 332
IG+G FG +++G L +N +VA+K E L +K L
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF---------EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 333 -QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTAY 384
+ + +LV + L L DL LD RK A
Sbjct: 69 PNVYYFGQEGLHNVLV---IDLLG--PSLEDL------LDLCGRKFSVKTVAMAAKQMLA 117
Query: 385 GLEYLHEQCNPKIIHRDLKAANILL----DDNFEAV-LCDFGLAK 424
++ +HE+ +++RD+K N L+ N + + DFG+ K
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 33/213 (15%)
Query: 278 NIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISV------AIH 328
++IG+G FG+V K + VA+K + + + A Q EV L+ + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---NQA-QIEVRLLELMNKHDTEMK 115
Query: 329 KNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKRVAFGTAYG 385
++ L + + LV+ + NL DL +G+ ++ A
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNL------YDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAKLVDAKLTH--VTTQIRGTM 441
L +L IIH DLK NILL + + + DFG + + ++ + R
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--- 225
Query: 442 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 474
+PE L D++ G L+E+ TG+
Sbjct: 226 ---SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 36/161 (22%), Positives = 57/161 (35%), Gaps = 35/161 (21%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVK---RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 335
IG G FG++ G L N VA+K E F +++ + Q+
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSG-----DGIPQVY 71
Query: 336 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTAYGLEY 388
+ +V ++ L L DL D R +A +EY
Sbjct: 72 YFGPCGKYNAMV---LELLG--PSLEDL------FDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 389 LHEQCNPKIIHRDLKAANILL-----DDNFEAVLCDFGLAK 424
+H + +I+RD+K N L+ + DF LAK
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 40/163 (24%), Positives = 64/163 (39%), Gaps = 41/163 (25%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL----- 332
IG G FG++Y G + N +VA+K E + L+ I++ L
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---------ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 333 -QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTAY 384
+ + +LV M L L DL ++ +RK +A
Sbjct: 66 PNVRWFGVEGDYNVLV---MDLLG--PSLEDL------FNFCSRKLSLKTVLMLADQMIN 114
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEA---VLCDFGLAK 424
+E++H + +HRD+K N L+ A + DFGLAK
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 20/65 (30%), Positives = 34/65 (52%), Gaps = 4/65 (6%)
Query: 107 ELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRI 165
L N + +P L + HL ++L+NN+ S ++ ++S ++ L L LS N L I
Sbjct: 37 YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 166 PMQLF 170
P + F
Sbjct: 94 PPRTF 98
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 11/98 (11%)
Query: 77 NVISLTLGSNGFSG--KISPSITKLKFLASFRELQDNDLSGTLPDFL-GSMTHLQSLNLA 133
+V L L N F+ K + L + +L +N +S TL + +MT L +L L+
Sbjct: 32 DVTELYLDGNQFTLVPKELSNYKHLTLI----DLSNNRIS-TLSNQSFSNMTQLLTLILS 86
Query: 134 NNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 170
N+ IP T+ L +L+ L L N+++ +P F
Sbjct: 87 YNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAF 122
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 6/88 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFREL--QDNDLSGTLPDFLGSMTHLQSLNLAN 134
+V L L ++ L + L+ ++ + L + L+ L L++
Sbjct: 18 DVKELVLDNSRS--NEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLT 162
N+ SG + + NL HL+LS N +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-05
Identities = 30/89 (33%), Positives = 42/89 (47%), Gaps = 8/89 (8%)
Query: 77 NVISLTLGSNGFSGKIS--PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
+ L+ + G + I+ P + KLK L EL DN +SG L +L LNL+
Sbjct: 43 ELEFLSTINVGLT-SIANLPKLNKLKKL----ELSDNRVSGGLEVLAEKCPNLTHLNLSG 97
Query: 135 NKFSG-SIPATWSQLSNLKHLDLSSNNLT 162
NK S +L NLK LDL + +T
Sbjct: 98 NKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 19/103 (18%), Positives = 43/103 (41%), Gaps = 17/103 (16%)
Query: 77 NVISLTLGSNGFSGKISPS-----ITKLKFLASFRELQDNDLSGTLPD--FLGSMTHLQS 129
L L +N F+ + + + +L+ + +N ++ + + F G + +
Sbjct: 33 YTAELRLNNNEFT-VLEATGIFKKLPQLRKI----NFSNNKIT-DIEEGAFEG-ASGVNE 85
Query: 130 LNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+ L +N+ ++ + L +LK L L SN +T + F
Sbjct: 86 ILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFI 126
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 16/81 (19%), Positives = 32/81 (39%), Gaps = 11/81 (13%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPA-TWSQLS 149
I +L L +N+ + + L+ +N +NNK + I + S
Sbjct: 30 IPQYTAEL-------RLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 150 NLKHLDLSSNNLTGRIPMQLF 170
+ + L+SN L + ++F
Sbjct: 82 GVNEILLTSNRLE-NVQHKMF 101
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 16/100 (16%), Positives = 37/100 (37%), Gaps = 12/100 (12%)
Query: 77 NVISLTLGSNGFSGKISP----SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
+ + +N + I + + + L N L + L++L L
Sbjct: 58 QLRKINFSNNKIT-DIEEGAFEGASGVNEIL----LTSNRLENVQHKMFKGLESLKTLML 112
Query: 133 ANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+N+ + + ++ LS+++ L L N +T + F
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 29/89 (32%), Positives = 42/89 (47%), Gaps = 8/89 (8%)
Query: 77 NVISLTLGSNGFSGKIS--PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
N+ L+L + G +S P + KLK L EL +N + G L + +L LNL+
Sbjct: 50 NLEFLSLINVGLI-SVSNLPKLPKLKKL----ELSENRIFGGLDMLAEKLPNLTHLNLSG 104
Query: 135 NKFSG-SIPATWSQLSNLKHLDLSSNNLT 162
NK S +L LK LDL + +T
Sbjct: 105 NKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 20/66 (30%), Positives = 29/66 (43%), Gaps = 6/66 (9%)
Query: 97 TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156
L+FL L + L L + L+ L L+ N+ G + +L NL HL+L
Sbjct: 49 VNLEFL----SLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102
Query: 157 SSNNLT 162
S N L
Sbjct: 103 SGNKLK 108
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 14/66 (21%), Positives = 27/66 (40%), Gaps = 6/66 (9%)
Query: 97 TKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156
+ + DN++ L D + L++L + NN+ L +L L L
Sbjct: 42 DQFDAID----FSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95
Query: 157 SSNNLT 162
++N+L
Sbjct: 96 TNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 7e-04
Identities = 16/79 (20%), Positives = 25/79 (31%), Gaps = 16/79 (20%)
Query: 95 SITKLKFLASFRELQ-----DNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWS--- 146
I KL R L+ +N + ++ L L L NN
Sbjct: 53 EIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLD 107
Query: 147 ---QLSNLKHLDLSSNNLT 162
L +L +L + N +T
Sbjct: 108 PLASLKSLTYLCILRNPVT 126
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 21/88 (23%), Positives = 38/88 (43%), Gaps = 10/88 (11%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134
L L +N KIS + L+ L L N + + + L+ L ++
Sbjct: 49 ACKHLALSTNNIE-KISSLSGMENLRIL----SLGRNLIK-KIENLDAVADTLEELWISY 102
Query: 135 NKFSGSIPATWSQLSNLKHLDLSSNNLT 162
N+ + S+ +L NL+ L +S+N +T
Sbjct: 103 NQIA-SLSG-IEKLVNLRVLYMSNNKIT 128
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 25/95 (26%), Positives = 37/95 (38%), Gaps = 17/95 (17%)
Query: 80 SLTLGSNGFSGKISP-----SITKLKFLASFRELQDNDLSGTLPD--FLGSMTHLQSLNL 132
L L N +IS + L L EL+ N L+ + F +H+Q L L
Sbjct: 33 ELLLNDNELG-RISSDGLFGRLPHLVKL----ELKRNQLT-GIEPNAF-EGASHIQELQL 85
Query: 133 ANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIP 166
NK I + L LK L+L N ++ +
Sbjct: 86 GENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 18/66 (27%), Positives = 29/66 (43%), Gaps = 4/66 (6%)
Query: 107 ELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGR 164
L DN+L D G + HL L L N+ + I + S+++ L L N +
Sbjct: 35 LLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-E 92
Query: 165 IPMQLF 170
I ++F
Sbjct: 93 ISNKMF 98
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 45/241 (18%), Positives = 83/241 (34%), Gaps = 75/241 (31%)
Query: 279 IIGQGGFGKVYKGV--LSDNTKVAVK---RLQDYYSPGGEAAFQREVHLISV------AI 327
+G+G FGKV + + ++VA+K + Y EAA + E++++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR----EAA-RLEINVLKKIKEKDKEN 80
Query: 328 HKNLLQLIGY-------CTTSSERILVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKR 377
+ + + C + + + +N + + + P +
Sbjct: 81 KFLCVLMSDWFNFHGHMC-------IAFELLGKNT------FEFLKENNFQPYPLPHVRH 127
Query: 378 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-------------------LC 418
+A+ + L +LHE ++ H DLK NIL ++ +
Sbjct: 128 MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 419 DFGLAKLVDAKLTHVTTQI-----RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 473
DFG A H TT + R PE + ++ DV+ G L E G
Sbjct: 185 DFGSATFDH---EHHTTIVATRHYR------PPEVILELGWAQPCDVWSIGCILFEYYRG 235
Query: 474 Q 474
Sbjct: 236 F 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 50/247 (20%), Positives = 79/247 (31%), Gaps = 83/247 (33%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISV-----AIHKN 330
+G G FG+V + + AVK R Y+ +A + E ++ + N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT---RSA-KIEADILKKIQNDDINNNN 97
Query: 331 LLQLIGY-------CTTSSERILVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKRVAF 380
+++ G C L++ + +L ++ + G K
Sbjct: 98 IVKYHGKFMYYDHMC-------LIFEPLGPSL------YEIITRNNYNGFHIEDIKLYCI 144
Query: 381 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV------------------------ 416
L YL + + H DLK NILLDD +
Sbjct: 145 EILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 417 -LCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPE------YLSTGKSSEKTDVFGYGITL 467
L DFG A + T Q R APE + +D++ +G L
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYR------APEVILNLGW------DVSSDMWSFGCVL 249
Query: 468 LELVTGQ 474
EL TG
Sbjct: 250 AELYTGS 256
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 19/70 (27%), Positives = 31/70 (44%), Gaps = 8/70 (11%)
Query: 94 PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLK 152
+ +++L L N L + +T+L L L N+ S+P + +L+NLK
Sbjct: 60 QYLPNVRYL----ALGGNKLH-DISAL-KELTNLTYLILTGNQLQ-SLPNGVFDKLTNLK 112
Query: 153 HLDLSSNNLT 162
L L N L
Sbjct: 113 ELVLVENQLQ 122
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 28/79 (35%), Positives = 40/79 (50%), Gaps = 11/79 (13%)
Query: 95 SITKLKFLASFRELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNL 151
+T+L L L N L +LP F +T L+ L L N+ SIPA + +L+NL
Sbjct: 105 HLTQLDKL----YLGGNQLK-SLPSGVF-DRLTKLKELRLNTNQLQ-SIPAGAFDKLTNL 157
Query: 152 KHLDLSSNNLTGRIPMQLF 170
+ L LS+N L +P F
Sbjct: 158 QTLSLSTNQLQ-SVPHGAF 175
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 26/78 (33%), Positives = 38/78 (48%), Gaps = 10/78 (12%)
Query: 95 SITKLKFLASFRELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 152
S+T+L L +L N L+ LP F + HL+ L + NK + +P +L++L
Sbjct: 86 SLTQLTVL----DLGTNQLT-VLPSAVF-DRLVHLKELFMCCNKLT-ELPRGIERLTHLT 138
Query: 153 HLDLSSNNLTGRIPMQLF 170
HL L N L IP F
Sbjct: 139 HLALDQNQLK-SIPHGAF 155
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 596 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.87 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.81 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.8 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.71 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.62 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.61 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.55 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.54 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.54 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.53 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.53 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.48 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.46 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.4 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.4 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.4 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.4 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.39 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.39 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.37 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.37 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.37 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.35 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.35 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.35 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.34 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.34 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.33 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.33 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.33 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.33 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.33 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.32 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.31 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.31 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.3 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.29 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.29 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.28 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.28 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.28 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.27 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.26 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.26 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.26 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.26 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.26 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.25 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.25 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.24 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.24 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.23 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.23 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.23 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.23 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.22 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.21 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.2 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.2 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.2 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.2 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.19 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.19 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.19 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.18 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.18 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.18 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.18 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.18 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.18 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.18 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.18 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.17 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.17 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.17 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.17 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.17 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.16 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.16 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.15 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.14 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.14 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.14 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.1 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.07 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.07 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.06 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.02 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.0 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.99 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.99 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.98 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.98 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.96 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.95 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.95 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.95 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.93 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.93 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.92 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.86 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.85 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.84 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.84 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.84 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.81 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.8 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.79 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.78 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.76 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.76 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.76 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.76 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.69 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.51 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.5 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.46 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.46 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.33 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.19 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.09 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.06 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.94 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.82 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.76 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.74 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.69 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.64 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.61 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.6 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.6 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.49 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.42 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.39 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.27 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.13 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.1 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.05 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.91 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.9 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.89 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.87 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.69 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.3 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.27 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.94 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 95.68 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.67 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 95.37 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.11 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.85 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 94.76 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.62 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.36 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 91.15 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 90.54 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 89.58 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.94 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 87.99 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 87.78 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.01 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.86 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 80.44 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=436.26 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=212.9
Q ss_pred CCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
+++..+.||+|+||+||+|.+. +++.||||+++........++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4555789999999999999862 4678999999865555667889999999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc
Q 007608 347 VYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 414 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 414 (596)
|||||++|+|.++|..... ....++|..+.+|+.|||+||+|||++ +||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999975321 124699999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHH
Q 007608 415 AVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 492 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~ 492 (596)
+||+|||+++....... .......||++|||||++.++.++.++|||||||++|||+| |+.||..... ..+..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-----~~~~~ 258 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDVVE 258 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-----HHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence 99999999987654322 23345679999999999999999999999999999999999 8999975432 12222
Q ss_pred HHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 493 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 493 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+. .+. ....+..++.++.+++.+||+.||++||||+||+++|+.
T Consensus 259 ~i~----~~~--------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 259 MIR----NRQ--------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHH----TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHH----cCC--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 222 111 111234456778999999999999999999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=433.23 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=211.8
Q ss_pred cCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
++|...+.||+|+||+||+|++. ++..||||+++. .+....++|.+|++++++++|||||+++|+|.+++..+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 56777899999999999999863 478899999975 34556778999999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEE
Q 007608 346 LVYPFMQNLSVAYRLRDLK---------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 416 (596)
+|||||++|+|.++|+... .....++|.+++.++.|||.||+|||++ +|+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999997532 2235799999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHH
Q 007608 417 LCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI 494 (596)
Q Consensus 417 l~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~ 494 (596)
|+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||..... ..+...+
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~~~~i 243 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVIECI 243 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHH
Confidence 9999999876544332 2334568999999999999999999999999999999999 8999975432 1222222
Q ss_pred HHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 495 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.. +.. ...+..++.++.+++.+||+.||++||||+||++.|++
T Consensus 244 ~~----~~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 244 TQ----GRV--------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HH----TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Hc----CCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 21 111 11233455678999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=426.75 Aligned_cols=260 Identities=28% Similarity=0.430 Sum_probs=206.3
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
+..+++...+.||+|+||+||+|++++ .||||+++.. .+....+.|.+|++++++++|||||+++|+|.+ +..++|
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 345678888999999999999999754 5999998743 344556789999999999999999999999865 568999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
||||++|+|.++|+.. ...++|..+..|+.|||.||+|||++ +||||||||+|||+++++.+||+|||+|+...
T Consensus 110 mEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp EECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 9999999999999753 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred ccC-cceeccccccccccCcccccC---CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 428 AKL-THVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 428 ~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
... ........||+.|||||++.+ ++++.++|||||||++|||+||+.||....... .+...+. .+
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~----~~~~~~~----~~-- 253 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD----QIIFMVG----RG-- 253 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHH----TT--
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH----HHHHHHh----cC--
Confidence 432 223345679999999999864 468999999999999999999999997533211 1111111 11
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+.+...+..++.++.+++.+||+.||++||||.||+++|+.
T Consensus 254 --~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 254 --YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp --CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred --CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11222233344556788999999999999999999999998864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=433.23 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=205.5
Q ss_pred cCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
++|...+.||+|+||+||+|++. +++.||||+++. .+....+.|.+|++++++++|||||+++|+|.+.+..+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45666789999999999999864 478899999974 34556678999999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc
Q 007608 346 LVYPFMQNLSVAYRLRDLKP-----------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 414 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 414 (596)
+|||||++|+|.++++.... ....++|.+++.|+.|||.||+|||+. +|+||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 99999999999999986432 124699999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHH
Q 007608 415 AVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 492 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~ 492 (596)
+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||...... .+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-----~~~~ 271 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-----EAID 271 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-----HHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-----HHHH
Confidence 99999999987654322 23345679999999999999999999999999999999999 89999754321 1222
Q ss_pred HHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 493 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 493 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+... .+ ...+..++.++.+++.+||+.||++||||+||+++|+.
T Consensus 272 ~i~~g---~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 272 CITQG---RE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp HHHHT---CC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred HHHcC---CC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 22211 11 11223345678899999999999999999999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=423.51 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=204.5
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
++|+..+.||+|+||+||+|+.. +|+.||||++... ......+.|.+|++++++++|||||++++++.+.+..++|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999964 7999999999743 344456789999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999997532 34578999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
. .......||+.|||||++.+..|+.++|||||||++|||+||+.||...... .+ +.......
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-----~~---~~~i~~~~-------- 241 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-----NL---VLKIISGS-------- 241 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HH---HHHHHHTC--------
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HH---HHHHHcCC--------
Confidence 2 1223456999999999999999999999999999999999999999854321 11 11111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+...+.++.+++.+||+.||++|||++|++++
T Consensus 242 -~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 242 -FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122345678899999999999999999999763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=426.42 Aligned_cols=269 Identities=24% Similarity=0.370 Sum_probs=220.6
Q ss_pred ccHHHHHHHhcCCCcCceeeecCceEEEEEEeCC------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCC-CCccce
Q 007608 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQL 334 (596)
Q Consensus 262 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l 334 (596)
+...++++..++|+..+.||+|+||+||+|.+.. ++.||||+++........+.|.+|++++.++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4556778888999999999999999999998532 367999999876666667889999999999975 899999
Q ss_pred EeEEecC-CeeEEEEEcccCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecC
Q 007608 335 IGYCTTS-SERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 401 (596)
Q Consensus 335 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~d 401 (596)
+|+|.+. +..++|||||++|+|.++|+.... ....++|..+..++.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 568999999999999999975321 134589999999999999999999999 999999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCC
Q 007608 402 LKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDF 479 (596)
Q Consensus 402 lkp~NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~ 479 (596)
|||+|||+++++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999997654433 23445678999999999999999999999999999999998 8999975
Q ss_pred ccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 480 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 480 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.... ..+...+.. +.. ...+...+.++.+++.+||+.||++|||+.||+++|++
T Consensus 291 ~~~~----~~~~~~i~~----g~~--------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VKID----EEFCRRLKE----GTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CCCS----HHHHHHHHH----TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHH----HHHHHHHHc----CCC--------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 4321 112222221 111 11223345678899999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=417.30 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=201.3
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC----eeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv 347 (596)
++|...+.||+|+||+||+|++ +|+.||||++... ......+..|+..+.+++|||||+++++|.+++ ..++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~--~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc--chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 3466678999999999999998 6899999998642 122223345666677899999999999997654 57999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-----NPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
||||++|+|.++++. ..++|..+.+++.|++.||+|||+++ .++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999985 35899999999999999999999862 45899999999999999999999999999
Q ss_pred cccccccCcc---eeccccccccccCcccccCC------CCCcccccHHHHHHHHHHHhCCCCCCCccchhhh------h
Q 007608 423 AKLVDAKLTH---VTTQIRGTMGHIAPEYLSTG------KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE------D 487 (596)
Q Consensus 423 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~------~ 487 (596)
++........ ......||+.|||||++.+. +++.++|||||||++|||+||+.|+......... .
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 9876544322 12345699999999999764 4678999999999999999998876532211100 0
Q ss_pred chHHHHHHHHhccCcccccccCcCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 488 VLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 488 ~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
....+.+....... ..++.+.. ...+....+.+++.+||+.||++||||.||++.|++
T Consensus 235 ~~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp SCCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cchHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 00111122221111 12233322 234567789999999999999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=415.57 Aligned_cols=317 Identities=62% Similarity=1.043 Sum_probs=266.1
Q ss_pred CCccccccccccccHHHHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCC
Q 007608 250 DDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329 (596)
Q Consensus 250 ~~~~~~~~~~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ 329 (596)
.+......+...|+.++++...++|+..+.||+|+||.||+|...+++.||||++...........+.+|++++.+++||
T Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ 87 (326)
T 3uim_A 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 87 (326)
T ss_dssp -------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCT
T ss_pred cCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCC
Confidence 33344455677899999999999999999999999999999998889999999997544444445789999999999999
Q ss_pred CccceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE
Q 007608 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 409 (596)
Q Consensus 330 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll 409 (596)
||+++++++.+.+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+.++|+||||||+||++
T Consensus 88 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~ 167 (326)
T 3uim_A 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 167 (326)
T ss_dssp TBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred CccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence 99999999999999999999999999999998766666679999999999999999999999888899999999999999
Q ss_pred cCCCcEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhch
Q 007608 410 DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 489 (596)
Q Consensus 410 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~ 489 (596)
+.++.+||+|||+++..............||+.|+|||++.+..++.++||||||+++|||+||+.||+...........
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 99999999999999877655555555566999999999999889999999999999999999999999755444455566
Q ss_pred HHHHHHHHhccCcccccccCcCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCcchhhHHHHHHHHhh
Q 007608 490 LLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVR 566 (596)
Q Consensus 490 l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~ 566 (596)
..+|+...........+.+..+.. ........+.+++.+||+.||++|||+.||+++|++..+.+++++|...+..+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~ 325 (326)
T 3uim_A 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFR 325 (326)
T ss_dssp HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC---------
T ss_pred HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHHHhhc
Confidence 777887777777777777776654 67888999999999999999999999999999999999999998888766554
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=402.94 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=196.6
Q ss_pred CcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEec----CCeeEEEE
Q 007608 275 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERILVY 348 (596)
Q Consensus 275 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 348 (596)
+..+.||+|+||+||+|... ++..||+|++... ......+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44568999999999999965 6899999999743 344456789999999999999999999999865 34578999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-CCcEEEeecccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVD 427 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfGl~~~~~ 427 (596)
|||++|+|.+++.. ...+++..+..++.||+.||+|||++ +++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999986 34689999999999999999999998 123999999999999984 7899999999998654
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.. ......||+.|||||++.+ +++.++|||||||++|||+||+.||...... ..+...+. .+.....+
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~----~~~~~~i~----~~~~~~~~ 251 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVT----SGVKPASF 251 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHT----TTCCCGGG
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH----HHHHHHHH----cCCCCCCC
Confidence 32 2344679999999999865 6999999999999999999999999743221 11111111 11111111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+ ...+.++.+++.+||+.||++|||++|+++
T Consensus 252 ~-------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 D-------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G-------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 112346788999999999999999999976
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=412.62 Aligned_cols=249 Identities=22% Similarity=0.280 Sum_probs=207.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+.|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 46888899999999999999975 79999999996432 23455688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999875 3589999999999999999999999 99999999999999999999999999998775433
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
. ......||+.|||||++.+..|+.++|||||||++|||+||+.||..... ......+.. .. .+.
T Consensus 225 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~----~~-----~~~ 289 (346)
T 4fih_A 225 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRD----NL-----PPR 289 (346)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHH----SS-----CCC
T ss_pred C-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHc----CC-----CCC
Confidence 2 23456799999999999999999999999999999999999999975322 112222221 10 011
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+ ......+.++.+++.+||+.||++|||++|+++
T Consensus 290 ~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 L-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp C-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 112234567889999999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=410.90 Aligned_cols=250 Identities=20% Similarity=0.226 Sum_probs=203.5
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+.|+..+.||+|+||+||+|+.. +|+.||||+++... .+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45777889999999999999965 68999999997422 124799999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC-cEEEeecccccccccc
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK 429 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfGl~~~~~~~ 429 (596)
+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.+...
T Consensus 132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999999863 4699999999999999999999999 999999999999999987 6999999999977543
Q ss_pred Ccc----eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 430 LTH----VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 430 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
... ......||+.|||||++.+..++.++|||||||++|||+||+.||......+ +...+.. ..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~i~~---~~---- 272 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----LCLKIAS---EP---- 272 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-----CHHHHHH---SC----
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----HHHHHHc---CC----
Confidence 211 1233579999999999999999999999999999999999999997543211 1111111 11
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+.....+...+.++.+++.+||+.||++|||+.|+++.|..
T Consensus 273 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 273 ---PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp ---CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 00111233445678899999999999999999999998753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=405.50 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=208.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||+||+|+.. +|+.||||++... ......+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999964 7999999999632 12334677999999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999986 34689999999999999999999999 999999999999999999999999999998754
Q ss_pred cC-cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KL-THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.. ........||+.|||||++.+..++.++||||+||++|||+||+.||...... .+...+.. . ..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-----~~~~~i~~---~-~~---- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-----LIFAKIIK---L-EY---- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH---T-CC----
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHc---C-CC----
Confidence 32 22344567999999999999999999999999999999999999999754321 12222211 1 10
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 544 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 544 (596)
.++...+.++.+++.+||+.||++|||++|+.
T Consensus 252 -----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11223345788999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=392.83 Aligned_cols=246 Identities=21% Similarity=0.335 Sum_probs=191.8
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||+||+|... +|+.||+|++.... .......+.+|++++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 79999999996432 2334567999999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6799999876 34699999999999999999999999 999999999999999999999999999987644
Q ss_pred cCcceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.. ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||...... .+.+.+.. +..
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-----~~~~~i~~----~~~---- 229 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-----VLFKNISN----GVY---- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH----TCC----
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHc----CCC----
Confidence 32 2334579999999999998876 57999999999999999999999753321 12222211 110
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..+...+.++.+++.+||+.||++|||++|+++
T Consensus 230 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112223457788999999999999999999976
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=412.80 Aligned_cols=249 Identities=22% Similarity=0.283 Sum_probs=207.6
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+.|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST-TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 56889999999999999999965 7999999999643 233456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
|++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 230 ~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999875 3589999999999999999999999 99999999999999999999999999998775432
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
. ......||+.|||||++.+..|+.++|||||||++|||++|+.||..... ......+.. .. .+.
T Consensus 302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~----~~-----~~~ 366 (423)
T 4fie_A 302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRD----NL-----PPR 366 (423)
T ss_dssp C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHH----SC-----CCC
T ss_pred c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHc----CC-----CCC
Confidence 2 23456799999999999999999999999999999999999999975322 112222221 10 011
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+ ........++.+++.+||+.||++|||+.|+++
T Consensus 367 ~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 L-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp C-SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 112233467889999999999999999999865
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=401.11 Aligned_cols=243 Identities=23% Similarity=0.266 Sum_probs=194.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC----CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
++|+..+.||+|+||+||+|+.. +++.||||+++... .......+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57899999999999999999852 47889999996432 22334568899999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999986 34689999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
..... ......||+.|||||++.+..++.++||||+||++|||+||+.||...... .+...+. . ...
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-----~~~~~i~---~-~~~--- 243 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-----ETMTMIL---K-AKL--- 243 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHH---H-CCC---
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-----HHHHHHH---c-CCC---
Confidence 43322 233467999999999999999999999999999999999999999854321 1222121 1 110
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 540 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 540 (596)
..+...+.++.+++.+||+.||++|||+
T Consensus 244 ------~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ------GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ------CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1122345678899999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=395.23 Aligned_cols=251 Identities=20% Similarity=0.299 Sum_probs=190.9
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC--------
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-------- 342 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-------- 342 (596)
++|+..+.||+|+||+||+|+.. +|+.||||+++........+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999964 789999999975555556678999999999999999999999886544
Q ss_pred ----eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEe
Q 007608 343 ----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC 418 (596)
Q Consensus 343 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 418 (596)
..++||||+++|+|.+++..... ....++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 36899999999999999986332 23457788899999999999999999 99999999999999999999999
Q ss_pred eccccccccccCcc-----------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhh
Q 007608 419 DFGLAKLVDAKLTH-----------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED 487 (596)
Q Consensus 419 DfGl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~ 487 (596)
|||+|+........ ......||+.|||||++.+..++.++|||||||++|||++ ||.... +.
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~ 233 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ER 233 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HH
Confidence 99999877543211 1123569999999999999999999999999999999996 665311 11
Q ss_pred chHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 488 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 488 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...+... .... .............+++.+||+.||++|||+.|+++
T Consensus 234 ---~~~~~~~-~~~~--------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 ---VRTLTDV-RNLK--------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---HHHHHHH-HTTC--------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHH-hcCC--------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111 1111 11111233445678999999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=386.41 Aligned_cols=262 Identities=18% Similarity=0.261 Sum_probs=201.9
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEec------CCe
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT------SSE 343 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~ 343 (596)
++|+..+.||+|+||+||+|+.. +|+.||||+++... .....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999964 79999999997433 33345678899999999999999999998754 356
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||++ |+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 799999996 689998875 35799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccC---cceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc
Q 007608 424 KLVDAKL---THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 499 (596)
Q Consensus 424 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 499 (596)
+.+.... ........||+.|+|||++.+. .++.++||||+||++|||+||+.||...... .....+.....
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-----~~l~~I~~~~g 280 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-----HQLQLIMMVLG 280 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-----HHHHHHHHHHC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHhcC
Confidence 8764322 1223456799999999998875 4699999999999999999999999864321 11222221111
Q ss_pred cCccc---c--------ccc--CcCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 500 EDRLN---D--------IVD--RNLNTYD-----SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 500 ~~~~~---~--------~~d--~~l~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..... . .+. +.....+ .....++.+|+.+||+.||++|||+.|++++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 10000 0 000 0000001 1124577899999999999999999999763
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=374.20 Aligned_cols=282 Identities=38% Similarity=0.615 Sum_probs=237.8
Q ss_pred ccHHHHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC
Q 007608 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 341 (596)
Q Consensus 262 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 341 (596)
++..++...+++|+..+.||+|+||.||+|...+++.||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3334445578899999999999999999999888999999998643 334567899999999999999999999999999
Q ss_pred CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
+..++||||+++|+|.+++.........++|..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999986544445799999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccC-cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 422 LAKLVDAKL-THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 422 l~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
+++...... ........||+.|+|||++.+..++.++||||||+++|||+||+.||...... .......|.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNN 262 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS--SCCCHHHHTHHHHTT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH--HHHHHHHHhhhcccc
Confidence 998654322 22233345899999999999899999999999999999999999999754432 223345555555555
Q ss_pred CcccccccCcCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 501 DRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 501 ~~~~~~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+.+..++++.+.. ........+.+++.+||+.||++||++.|++++|+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 6666777766544 677889999999999999999999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=375.89 Aligned_cols=198 Identities=23% Similarity=0.366 Sum_probs=170.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC----CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCee
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 344 (596)
..++|++.+.||+|+||+||+|+.+ +++.||+|++... .....+.+|++++..+ .||||+++++++.+.+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4578999999999999999999853 4678999998643 2345688999999988 699999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC-CcEEEeecccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLA 423 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfGl~ 423 (596)
++||||+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999884 378999999999999999999999 99999999999999877 79999999999
Q ss_pred ccccccCc---------------------------ceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCC
Q 007608 424 KLVDAKLT---------------------------HVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQR 475 (596)
Q Consensus 424 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~ 475 (596)
+....... .......||+.|+|||++.+.+ ++.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86543211 0122346999999999998764 8999999999999999999999
Q ss_pred CCCCc
Q 007608 476 AIDFS 480 (596)
Q Consensus 476 p~~~~ 480 (596)
||...
T Consensus 246 Pf~~~ 250 (361)
T 4f9c_A 246 PFYKA 250 (361)
T ss_dssp SSSCC
T ss_pred CCCCC
Confidence 99643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=387.38 Aligned_cols=250 Identities=24% Similarity=0.277 Sum_probs=199.3
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHH---HHHHHhcCCCCccceEeEEecCCee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQRE---VHLISVAIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e---~~~l~~l~H~niv~l~~~~~~~~~~ 344 (596)
.++|+..++||+|+||+||+|+.. +|+.||||++.+.. .......+.+| +.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999965 79999999986321 11223333444 5667778999999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||++||+|.++|.. ...+++..+..++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999986 34689999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
...... .....||+.|||||++.+ ..|+.++||||+||++|||++|+.||....... ............
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-----~~~i~~~i~~~~-- 410 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTMA-- 410 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-----HHHHHHHHHHCC--
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhhcCCC--
Confidence 765432 234579999999999975 579999999999999999999999997533211 111111111110
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK 545 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 545 (596)
..++...+.++.+++.+||+.||.+|++ ++||.+
T Consensus 411 --------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 --------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0122234567889999999999999998 566643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=388.53 Aligned_cols=253 Identities=22% Similarity=0.268 Sum_probs=207.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|++.+.||+|+||.||+|..+ +|+.||+|++... .....+.+.+|+++|+.++|||||++++++.+....++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 368999999999999999999965 7999999998643 23345678999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC--CcEEEeecccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN--FEAVLCDFGLAKLVD 427 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~DfGl~~~~~ 427 (596)
||++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 235 ~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 235 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred ecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999998642 24689999999999999999999999 99999999999999854 899999999999875
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+. .... ...
T Consensus 309 ~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-----~~~~~i~---~~~~--~~~ 376 (573)
T 3uto_A 309 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-----ETLRNVK---SCDW--NMD 376 (573)
T ss_dssp TTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHH---TTCC--CCC
T ss_pred CCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HHHHHHH---hCCC--CCC
Confidence 432 233456999999999999999999999999999999999999999854321 1112221 1110 000
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
++ .......++.+|+.+||+.||++||++.|++++
T Consensus 377 ~~----~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 377 DS----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp SG----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01 011234567889999999999999999999884
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=349.50 Aligned_cols=283 Identities=39% Similarity=0.646 Sum_probs=234.0
Q ss_pred ccccccHHHHHHHhcCCCcC------ceeeecCceEEEEEEeCCCcEEEEEEccccC---CcchHHHHHHHHHHHHhcCC
Q 007608 258 QLRRFSCRELQLATDNFSES------NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIH 328 (596)
Q Consensus 258 ~~~~~~~~el~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~~~e~~~l~~l~H 328 (596)
....|++.++..++++|... +.||+|+||.||+|.. +++.||+|++.... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34679999999999999887 8999999999999987 68899999986432 23446789999999999999
Q ss_pred CCccceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEE
Q 007608 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 408 (596)
Q Consensus 329 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl 408 (596)
|||+++++++.+.+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+. +++||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999999875332 35689999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhh
Q 007608 409 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED 487 (596)
Q Consensus 409 l~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~ 487 (596)
++.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||+||+.||.......
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--- 241 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--- 241 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS---
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH---
Confidence 999999999999999876543222 2334568999999998865 58899999999999999999999998543221
Q ss_pred chHHHHHHHHh-ccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 488 VLLLDHIRKLL-REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 488 ~~l~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
....+..... ....+.+.+++.+..........+.+++.+||+.||++||++.||++.|+++
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 242 -LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp -BTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1112222111 1223445566666667788899999999999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=350.21 Aligned_cols=257 Identities=23% Similarity=0.407 Sum_probs=209.8
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|...+.||+|+||+||+|... +++.||+|++.. ......+.|.+|++++.+++||||+++++++.+.+..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 457888999999999999999975 689999998854 345567789999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999999863 34689999999999999999999999 9999999999999999999999999999876443
Q ss_pred Ccce-------------eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhh-hchHHHHHH
Q 007608 430 LTHV-------------TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE-DVLLLDHIR 495 (596)
Q Consensus 430 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~-~~~l~~~~~ 495 (596)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..|+......... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 11456899999999999999999999999999999999999998753322111 111111111
Q ss_pred HHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 496 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.. .+...+..+.+++.+||+.||++||++.|+++.|+..
T Consensus 242 ~~----------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 242 RY----------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp HT----------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 10 0112234678899999999999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=363.13 Aligned_cols=259 Identities=26% Similarity=0.399 Sum_probs=212.6
Q ss_pred hcCCCcCceeeecCceEEEEEEe--------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecC
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 341 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 341 (596)
.++|...+.||+|+||.||+|.. .++..||||+++..........+.+|+.++.++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46788899999999999999985 245679999997655555667899999999999 899999999999999
Q ss_pred CeeEEEEEcccCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 409 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll 409 (596)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999986432 124589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhh
Q 007608 410 DDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEED 487 (596)
Q Consensus 410 ~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~ 487 (596)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---- 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 99999999999999866543221 2233457889999999999999999999999999999999 99999754321
Q ss_pred chHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 488 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 488 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+...+.. +.. ...+.....++.+++.+||+.||++||++.|+++.|+.
T Consensus 313 -~~~~~~~~----~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 313 -ELFKLLKE----GHR--------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp -GHHHHHHT----TCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHHhc----CCC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 12222211 110 11123345678899999999999999999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=351.98 Aligned_cols=264 Identities=26% Similarity=0.413 Sum_probs=204.4
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC
Q 007608 264 CRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 342 (596)
Q Consensus 264 ~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 342 (596)
..++.+..++|+..+.||+|+||+||+|.. +++.||||++.... .......|.+|++++++++||||+++++++.+.+
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 344445667899999999999999999987 68899999987432 3344567999999999999999999999999999
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCcEEEcCCCcEEEeec
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999985221 12389999999999999999999998 7 999999999999999999999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
|+++....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ ....+.. .
T Consensus 184 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-----~~~~~~~---~ 254 (309)
T 3p86_A 184 GLSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-----VVAAVGF---K 254 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHH---S
T ss_pred CCCcccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh---c
Confidence 99986543321 2234568999999999999999999999999999999999999997543211 1111110 0
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.. ....+.....++.+++.+||+.||++||++.|+++.|+.
T Consensus 255 ~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 255 CK--------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp CC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC--------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00 011223344578899999999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=346.13 Aligned_cols=251 Identities=20% Similarity=0.292 Sum_probs=207.1
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 46799999999999999999995 578999999986432 2345678999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999975 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....... .... +. ..... .
T Consensus 170 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~-~~---~~~~~-~---- 235 (297)
T 3fxz_A 170 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYL-IA---TNGTP-E---- 235 (297)
T ss_dssp TCC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHH-HH---HHCSC-C----
T ss_pred ccc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH-HH---hCCCC-C----
Confidence 322 234568999999999999999999999999999999999999997533211 1111 11 11100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+......+.+++.+||+.||++|||+.|++++
T Consensus 236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01122344678899999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=354.62 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=209.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeC----CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
.++|+..+.||+|+||.||+|... .+..||||+++........+.|.+|+.++.+++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 456788899999999999999974 3456999999866566667889999999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999753 24689999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcc--eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 427 DAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 427 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.. ...
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~~~~~---~~~- 272 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----DVISSVEE---GYR- 272 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHHHHHT---TCC-
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHHHc---CCC-
Confidence 543222 2223346778999999998999999999999999999999 99999753321 11111111 100
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+......+.+++.+||+.||++||++.||++.|+.
T Consensus 273 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~ 310 (325)
T 3kul_A 273 --------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310 (325)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 01122345678899999999999999999999999985
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=344.67 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=211.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
.++|+..+.||+|+||.||+|...+++.||+|++... ....+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc--ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 4578889999999999999999988999999999743 23456799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999753 24589999999999999999999999 99999999999999999999999999998765443
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
........+++.|+|||++.+..++.++||||||+++|||+| |+.||...... .....+. ....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~~~~---~~~~------- 225 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDIS---TGFR------- 225 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHH---TTCC-------
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHh---cCcc-------
Confidence 333334457788999999998999999999999999999999 99999753321 1111111 1100
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+......+.+++.+|++.||++||++.|++++|++
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 226 --LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 01122234578899999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=343.22 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=212.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
..++|+..+.||+|+||.||+|...++..||+|+++.. ....+.+.+|++++.+++||||+++++++.+....++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG--SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT--TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC--CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 35678889999999999999999988889999999743 2345679999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999763 23589999999999999999999999 9999999999999999999999999999876554
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
.........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....... . ......... .
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~---~~~~~~~~~---~-- 224 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----V---VLKVSQGHR---L-- 224 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----H---HHHHHTTCC---C--
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----H---HHHHHcCCC---C--
Confidence 4333344456788999999998899999999999999999999 999997543211 1 111111110 0
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 551 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 551 (596)
..+......+.+++.+|++.||++|||+.|+++.|+...
T Consensus 225 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 225 ----YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp ----CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred ----CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 011122457889999999999999999999999998743
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=357.98 Aligned_cols=266 Identities=26% Similarity=0.404 Sum_probs=216.5
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEE
Q 007608 265 RELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338 (596)
Q Consensus 265 ~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~ 338 (596)
.++....++|+..+.||+|+||.||+|... +++.||+|+++..........|.+|+.++.+++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344556788999999999999999999974 34889999998655555667899999999999999999999999
Q ss_pred ecCCeeEEEEEcccCCChhhhhcccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 007608 339 TTSSERILVYPFMQNLSVAYRLRDLKPG--------------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398 (596)
Q Consensus 339 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 398 (596)
.+.+..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 9999999999999999999999864321 25689999999999999999999999 999
Q ss_pred ecCCCCCcEEEcCCCcEEEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCC
Q 007608 399 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRA 476 (596)
Q Consensus 399 H~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p 476 (596)
||||||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||+| |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999986643322 22233457899999999998899999999999999999999 9999
Q ss_pred CCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 477 IDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 477 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
|...... .....+. .+.. ...+.....++.+++.+||+.||++||++.|+++.|++.
T Consensus 277 ~~~~~~~-----~~~~~~~----~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 277 YYGMAHE-----EVIYYVR----DGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp TTTSCHH-----HHHHHHH----TTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCChH-----HHHHHHh----CCCc--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 9753321 1111111 1111 112233446788999999999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=352.59 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=207.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
..++|+..+.||+|+||.||+|.. .+|+.||||++... ........+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346789999999999999999996 58999999998643 2344566788999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999999999999763 4589999999999999999999999 99999999999999999999999999998664
Q ss_pred ccCcceeccccccccccCcccccCCCCC-cccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSS-EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
... ......||+.|+|||++.+..++ .++|||||||++|||+||+.||......+ +...+. . +..
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i~---~-~~~--- 231 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-----LRERVL---R-GKY--- 231 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---H-CCC---
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHH---h-CCC---
Confidence 432 23445699999999999888765 79999999999999999999998543211 111111 1 110
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..+.....++.+++.+||+.||.+|||++|++++
T Consensus 232 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122234567889999999999999999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=360.78 Aligned_cols=270 Identities=24% Similarity=0.385 Sum_probs=217.8
Q ss_pred cccHHHHHHHhcCCCcCceeeecCceEEEEEEe------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccc
Q 007608 261 RFSCRELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQ 333 (596)
Q Consensus 261 ~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~ 333 (596)
.+...+++...++|+..+.||+|+||.||+|.+ .+++.||||+++........+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 355677778889999999999999999999973 256889999998655555667899999999999 7999999
Q ss_pred eEeEEecCCe-eEEEEEcccCCChhhhhcccCCC----------------------------------------------
Q 007608 334 LIGYCTTSSE-RILVYPFMQNLSVAYRLRDLKPG---------------------------------------------- 366 (596)
Q Consensus 334 l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------- 366 (596)
+++++.+.+. .++||||+++|+|.+++......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 89999999999999999864321
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 367 ----------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 367 ----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12289999999999999999999999 99999999999999999999999999998664432
Q ss_pred c-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 431 T-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 431 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... .....+.. ...
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~~----~~~----- 314 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLKE----GTR----- 314 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----HHHHHHHH----TCC-----
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH----HHHHHHHc----CCC-----
Confidence 2 22334568899999999999999999999999999999999 999997543221 11111111 100
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+.....++.+++.+||+.||++||++.|++++|++
T Consensus 315 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 315 ---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 01122234578899999999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=346.82 Aligned_cols=261 Identities=23% Similarity=0.317 Sum_probs=206.7
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||.||+|... +++.||+|++.... .....+.|.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467889999999999999999964 78999999986432 233456789999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999863 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
...........||+.|+|||.+.+..++.++||||||+++|||+||+.||....... ......... .....
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--------~~~~~~~~~-~~~~~ 233 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS--------IAIKHIQDS-VPNVT 233 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH--------HHHHHHSSC-CCCHH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHhhcc-CCCcc
Confidence 543333445568999999999999999999999999999999999999998543211 111111111 00000
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhccCC
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRP-PMAQVVKMLQGED 551 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~ 551 (596)
.......+..+.+++.+|++.||++|| +++++.+.|+...
T Consensus 234 ----~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 234 ----TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp ----HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred ----hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 001223346788999999999999998 8999999998643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=360.21 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=200.4
Q ss_pred hcCCCcCceeeecCceEEEEEEeC----CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
.++|+..+.||+|+||.||+|+.. ++..||||+++........+.|.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467899999999999999999864 5778999999765555667789999999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999753 34689999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcce--eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 427 DAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 427 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.... .
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-----~~~~~i~~~~---~- 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----DVIKAVDEGY---R- 268 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-----HHHHHHHTTE---E-
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCC---C-
Confidence 5432221 122235778999999999999999999999999999998 99999753321 1112121110 0
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...+...+..+.+++.+||+.||++||++.||++.|+..
T Consensus 269 --------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 --------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 011223456788999999999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=344.31 Aligned_cols=262 Identities=20% Similarity=0.259 Sum_probs=213.1
Q ss_pred ccccHHHHHHHhcC----------CCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCC
Q 007608 260 RRFSCRELQLATDN----------FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 328 (596)
Q Consensus 260 ~~~~~~el~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H 328 (596)
..++.+++..+++. |+..+.||+|+||.||+|+.. +|+.||||++... .......+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-TCCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc-chhHHHHHHHHHHHHHhCCC
Confidence 34677777777654 666779999999999999976 7999999998643 23456778999999999999
Q ss_pred CCccceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEE
Q 007608 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 408 (596)
Q Consensus 329 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl 408 (596)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999998864 3589999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhc
Q 007608 409 LDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 488 (596)
Q Consensus 409 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~ 488 (596)
++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----- 247 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----- 247 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence 99999999999999987654322 223456899999999999999999999999999999999999999753321
Q ss_pred hHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 489 LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 489 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.....+.. .. .+.+. ........+.+++.+||+.||++||++.|+++.
T Consensus 248 ~~~~~~~~----~~-----~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 QAMKRLRD----SP-----PPKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHH----SS-----CCCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhc----CC-----CCCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111 10 00000 112234568899999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=362.48 Aligned_cols=259 Identities=26% Similarity=0.376 Sum_probs=211.5
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
+..++|...+.||+|+||.||+|... +++.||||+++..........|.+|++++++++||||+++++++...+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34567888999999999999999976 78999999997654445556789999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++...
T Consensus 191 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999752 23589999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCccee-ccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 428 AKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 428 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
....... ....+++.|+|||.+.+..++.++|||||||++|||+| |..||...... ...+.+. .+..
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-----~~~~~~~----~~~~-- 333 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-----QTREFVE----KGGR-- 333 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-----HHHHHHH----TTCC--
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH----cCCC--
Confidence 3221111 12235778999999998899999999999999999999 99999754321 1112221 1110
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...+...+.++.+++.+||+.||++|||+.|+++.|+++
T Consensus 334 ------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 ------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 011223446788999999999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=343.27 Aligned_cols=273 Identities=18% Similarity=0.207 Sum_probs=216.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC--eeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~ 348 (596)
++|...+.||+|+||+||+|... +++.||||++.........+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888999999999999999975 589999999975444455678899999999999999999999987765 679999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE----cCCCcEEEeeccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAK 424 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~DfGl~~ 424 (596)
||+++++|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999986432 23489999999999999999999999 99999999999999 888889999999998
Q ss_pred cccccCcceeccccccccccCccccc--------CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLS--------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
....... .....||+.|+|||++. +..++.++|||||||++|||+||+.||..................
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~- 241 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT- 241 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH-
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc-
Confidence 7654322 22346899999999986 577899999999999999999999999754332222222222222
Q ss_pred HhccCcccccc---------cCcC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 007608 497 LLREDRLNDIV---------DRNL---NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 551 (596)
Q Consensus 497 ~~~~~~~~~~~---------d~~l---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 551 (596)
.........+. ++.+ ..........+.+++.+||+.||++||+++|+++...+..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11111111110 0111 1245778888999999999999999999999999988643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=344.21 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=202.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHh--cCCCCccceEeEEecC----Cee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTTS----SER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~----~~~ 344 (596)
.++|+..+.||+|+||+||+|+. +++.||||++.. .....+..|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46789999999999999999998 789999999864 235566677777766 7899999999987543 457
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCcEecCCCCCcEEEcCCCcEE
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--------EQCNPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~dlkp~NIll~~~~~~k 416 (596)
++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 899999999999999964 46899999999999999999999 66 999999999999999999999
Q ss_pred EeeccccccccccCcce---eccccccccccCcccccCC------CCCcccccHHHHHHHHHHHhC----------CCCC
Q 007608 417 LCDFGLAKLVDAKLTHV---TTQIRGTMGHIAPEYLSTG------KSSEKTDVFGYGITLLELVTG----------QRAI 477 (596)
Q Consensus 417 l~DfGl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvil~elltg----------~~p~ 477 (596)
|+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998665433222 2234689999999999876 456799999999999999999 7777
Q ss_pred CCccchhhhhchHHHHHHHHhccCcccccccCcCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 478 DFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 478 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
......... . ........... ..+.+.. .......++.+++.+||+.||++|||+.||++.|+++
T Consensus 234 ~~~~~~~~~---~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPS---F-EDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCC---H-HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcc---h-hhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 543221111 1 11111111111 0111111 2345778899999999999999999999999999863
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=354.97 Aligned_cols=265 Identities=25% Similarity=0.379 Sum_probs=211.3
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEe------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEe
Q 007608 267 LQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 339 (596)
Q Consensus 267 l~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 339 (596)
.+...++|...+.||+|+||.||+|.. .++..||+|++...........+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 345667899999999999999999995 245689999997554455567899999999999 8999999999999
Q ss_pred cCCeeEEEEEcccCCChhhhhcccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEec
Q 007608 340 TSSERILVYPFMQNLSVAYRLRDLKPG-------------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHR 400 (596)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 400 (596)
..+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999864321 13489999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCC
Q 007608 401 DLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 478 (596)
Q Consensus 401 dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~ 478 (596)
||||+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999876543322 2334457889999999999999999999999999999998 999997
Q ss_pred CccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 479 FSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 479 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...... .....+. .... . ..+.....++.+++.+||+.||.+||++.|++++|+..
T Consensus 277 ~~~~~~----~~~~~~~----~~~~-----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 277 GIPVDA----NFYKLIQ----NGFK-----M---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp TCCCSH----HHHHHHH----TTCC-----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCcHH----HHHHHHh----cCCC-----C---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 543211 1111111 1100 0 11222356788999999999999999999999999863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=350.54 Aligned_cols=267 Identities=27% Similarity=0.306 Sum_probs=207.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC----eeE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERI 345 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~ 345 (596)
..++|+..+.||+|+||+||+|+.. ++.||||++... ......+..|+.++.+++||||+++++++.... ..+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 3467888999999999999999874 789999998642 233455677899999999999999999997754 369
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCcEecCCCCCcEEEcCCCcEEEe
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-------NPKIIHRDLKAANILLDDNFEAVLC 418 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------~~~ivH~dlkp~NIll~~~~~~kl~ 418 (596)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 99999999999999975 34899999999999999999999862 3479999999999999999999999
Q ss_pred eccccccccccCcc-eeccccccccccCcccccCC-----CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhh-----
Q 007608 419 DFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED----- 487 (596)
Q Consensus 419 DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~----- 487 (596)
|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||..........
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999876543322 23335689999999999763 45678999999999999999999997543211100
Q ss_pred ---chHHHHHHHHhccCcccccccCcCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 488 ---VLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 488 ---~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.....+..... ... ..+.+.. .......++.+++.+||+.||++|||+.||++.|+.
T Consensus 254 ~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 254 GQHPSLEDMQEVVV-HKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp CSSCCHHHHHHHHT-TSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCchhhhhhhhh-ccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 01111111111 111 1111111 123456779999999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=356.34 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=214.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC--------CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEec
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 340 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 340 (596)
..++|...+.||+|+||.||+|... ++..||||+++..........+.+|++++.++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4567888999999999999999852 34679999998665566668899999999999 89999999999999
Q ss_pred CCeeEEEEEcccCCChhhhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEE
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 408 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl 408 (596)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 99999999999999999999864321 24599999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhh
Q 007608 409 LDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE 486 (596)
Q Consensus 409 l~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~ 486 (596)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--- 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999987654322 22333457889999999999999999999999999999999 99999754321
Q ss_pred hchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 487 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 487 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.+.+.+.. .... ..+.....++.+++.+||+.||++||+++||++.|+.+
T Consensus 301 --~~~~~~~~----~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 301 --ELFKLLKE----GHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp --HHHHHHHT----TCCC--------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHc----CCCC--------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 12222211 1100 11223345788999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=358.36 Aligned_cols=259 Identities=27% Similarity=0.368 Sum_probs=210.8
Q ss_pred hcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 344 (596)
.++|+..+.||+|+||.||+|.+. ++..||||+++..........+.+|+.++.+++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 457888999999999999999943 46789999997655666677899999999999999999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC---cEEEe
Q 007608 345 ILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLC 418 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~ 418 (596)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999986432 224589999999999999999999999 999999999999999554 59999
Q ss_pred eccccccccccC-cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHH
Q 007608 419 DFGLAKLVDAKL-THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 419 DfGl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-----~~~~~i~~ 301 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----EVLEFVTS 301 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHHHT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHc
Confidence 999998653322 122233457899999999999999999999999999999998 99999754321 12222211
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
... ...+......+.+++.+||+.||++||++.||++.|+.
T Consensus 302 ---~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 302 ---GGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp ---TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 110 01122334568899999999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=343.34 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=198.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCC----CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
..++|+..+.||+|+||.||+|.... +..||+|++...........+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 44678889999999999999999643 45799999876555556678999999999999999999999984 56789
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999999753 24589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
.............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+.. ...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-----~~~~~i~~---~~~-- 235 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIEN---GER-- 235 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHT---TCC--
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-----HHHHHHHc---CCC--
Confidence 65443333333456789999999998899999999999999999997 99999754321 12222211 110
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...+...+..+.+++.+|++.||++||++.|+++.|+++
T Consensus 236 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 112233456788999999999999999999999999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.71 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=203.4
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||+||+|... +++.||+|++.........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367889999999999999999965 7899999998654444445678999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999875 34689999999999999999999999 9999999999999999999999999999866432
Q ss_pred Cc-ceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 430 LT-HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 430 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.. .......||+.|+|||++.+..+ +.++|||||||++|||+||+.||........ ....+.. .... .
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~~~----~~~~---~ 228 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWKE----KKTY---L 228 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH---HHHHHHT----TCTT---S
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHHhc----cccc---C
Confidence 22 22334568999999999987775 7789999999999999999999975432111 1111111 0000 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. ........+.+++.+||+.||++|||+.|+++.
T Consensus 229 ~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 012234567889999999999999999999764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=341.18 Aligned_cols=256 Identities=22% Similarity=0.341 Sum_probs=208.9
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
+..++|+..+.||+|+||.||+|...++..||+|+++.. ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC--CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 345678889999999999999999988889999999743 234577999999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 99 EYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999999753 23589999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
..........+|+.|+|||++.+..++.++||||||+++|||+| |+.||...... .....+.. ...
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~~~---~~~----- 239 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHIAQ---GLR----- 239 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHHHT---TCC-----
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHHHHHhc---ccC-----
Confidence 33333333456788999999998899999999999999999998 99999753321 11111111 100
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
. ..+......+.+++.+||+.||++||+++|+++.|++
T Consensus 240 -~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 240 -L---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp -C---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -C---CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0 0112224578899999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=345.95 Aligned_cols=261 Identities=27% Similarity=0.396 Sum_probs=213.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEe------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 343 (596)
..++|...+.||+|+||.||+|.. .+++.||+|+++........+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 456788899999999999999985 24588999999865555566789999999999999999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCC
Q 007608 344 RILVYPFMQNLSVAYRLRDLKP--------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLK 403 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk 403 (596)
.++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999986432 123489999999999999999999999 99999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCcc
Q 007608 404 AANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 481 (596)
Q Consensus 404 p~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~ 481 (596)
|+||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876543322 2223456889999999999899999999999999999999 999997543
Q ss_pred chhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 482 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 482 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.. .+...+.. ... ...+.....++.+++.+||+.||++||++.|+++.|++.
T Consensus 258 ~~-----~~~~~~~~----~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 PE-----RLFNLLKT----GHR--------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GG-----GHHHHHHT----TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH-----HHHHHhhc----CCc--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 21 12222221 110 111223456788999999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=367.03 Aligned_cols=260 Identities=24% Similarity=0.381 Sum_probs=212.8
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 267 LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 267 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
+++..++|...+.||+|+||.||+|.+.++..||||+++.. ....+.|.+|+.++++++||||+++++++. .+..++
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC--CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 34556788889999999999999999988999999999753 235678999999999999999999999986 567899
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 260 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999997532 23578999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
............++..|+|||++....++.++|||||||++|||+| |+.||...... .....+... .+.
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~~~---~~~-- 404 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIRALERG---YRM-- 404 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHHHHT---CCC--
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcC---CCC--
Confidence 5432222223346789999999998999999999999999999999 99999753321 122222111 110
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 551 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 551 (596)
..+...+.++.+++.+||+.||++||++.+|++.|++..
T Consensus 405 -------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 -------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 112234567889999999999999999999999998753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=347.76 Aligned_cols=250 Identities=21% Similarity=0.267 Sum_probs=206.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||+||+|+.. +|+.||+|+++... .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367888999999999999999975 68999999986421 233456788999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|..++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999875 24689999999999999999999999 99999999999999999999999999998643
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+. ... .
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~i~---~~~-~---- 222 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELIL---MEE-I---- 222 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHH---HCC-C----
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-----HHHHHHH---cCC-C----
Confidence 222 1233456899999999999999999999999999999999999999753321 1111111 110 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
.++.....++.+++.+||+.||++|| +++|++++
T Consensus 223 -----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11223346788999999999999999 88888764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=347.65 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=206.3
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCc-----chHHHHHHHHHHHHhcCCCCccceEeEEecCCee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 344 (596)
.+.|+..+.||+|+||.||+|... +|+.||+|+++..... .....+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467889999999999999999975 6899999999753321 1357899999999999999999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC----cEEEeec
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF 420 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Df 420 (596)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999975 34689999999999999999999999 999999999999998877 7999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+.. .
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-----~~~~~i~~---~ 233 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANITA---V 233 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHT---T
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh---c
Confidence 9998765432 223456999999999999999999999999999999999999999754321 11111111 0
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. .. +++. ........+.+++.+||..||++|||+.|++++
T Consensus 234 ~-~~--~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 234 S-YD--FDEE---FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp C-CC--CCHH---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred C-CC--CCch---hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00 0000 001224568899999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.85 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=201.7
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCc----EEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
.++|+..+.||+|+||+||+|+.. +++ +||+|.+.........+.|.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 356888999999999999999954 444 368888875555566788999999999999999999999998754 78
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+|++|+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 999999999999999863 24689999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 426 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 426 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
....... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+... ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~~~---~~- 237 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEKG---ER- 237 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHTT---CC-
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----HHHHHHHcC---CC-
Confidence 6543322 2223456889999999999999999999999999999999 99999754322 122222111 00
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...+.....++.+++.+||+.||++||++.|++++|+..
T Consensus 238 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 238 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011233455788999999999999999999999999763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=341.16 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=203.4
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||+||+|...+|+.||+|++.... .......+.+|++++++++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788999999999999999999889999999987432 23345778999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++ +|.+.+... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9985 787777652 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc---ccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR---LND 505 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~---~~~ 505 (596)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+........ ...
T Consensus 173 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 173 VRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-----QLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-----HHHHHHHHHCCCCTTTSGG
T ss_pred ccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHHCCCChHHhhh
Confidence 222 233458999999999876 568999999999999999999999997543221 1122222111110 000
Q ss_pred c------ccCc---CCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 506 I------VDRN---LNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 506 ~------~d~~---l~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. .+.. ... ..+....++.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 0000 000 011234578899999999999999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=352.89 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=200.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 345 (596)
..++|+..++||+|+||.||+|+.+ +++.||+|+++... .......+.+|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3467889999999999999999975 67899999997432 222345678899999887 8999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+||||+++|+|..++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 999999999999998862 4689999999999999999999999 999999999999999999999999999985
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......+...........
T Consensus 203 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 279 (396)
T 4dc2_A 203 GLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 279 (396)
T ss_dssp CCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred cccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence 3322 1223446799999999999999999999999999999999999999974322111111111111111111110
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 540 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 540 (596)
.++.....++.+++.+||+.||++||++
T Consensus 280 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1223345678899999999999999996
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=337.92 Aligned_cols=263 Identities=23% Similarity=0.300 Sum_probs=202.6
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
++|+..+.||+|+||+||+|... +++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47888999999999999999975 68999999997432 33445778999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++ ++.+.+... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 555555432 34689999999999999999999999 9999999999999999999999999999876533
Q ss_pred CcceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc---Ccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLND 505 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~ 505 (596)
.. ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+....... .....+...... .....
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~----~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD----DQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH----HHHHHHHHHHCCCCTTTCTT
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHHHhCCCChhhhhh
Confidence 22 223346899999999998766 7999999999999999999988864322211 111222211111 00000
Q ss_pred cc-------------cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 506 IV-------------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 506 ~~-------------d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. ...+.........++.+++.+|++.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 000111122345678899999999999999999999763
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=366.90 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=215.3
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
+..++|+..+.||+|+||.||+|.+. ++..||||+++.. ....+.|.+|+.++++++||||++++++|......++|
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc--ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 34567888899999999999999976 4889999999753 23467899999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 295 ~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999998633 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
...........++..|+|||++.+..++.++|||||||++|||+| |+.||...... ...+.+....+
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~------- 437 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEKDYR------- 437 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHHHHHTTCC-------
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCC-------
Confidence 433333333446789999999999999999999999999999999 99999754322 12222211100
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCcc
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLA 553 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 553 (596)
...+...+.++.+++.+||+.||++||++.||++.|+.....
T Consensus 438 -----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 438 -----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred -----CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 011233456788999999999999999999999999976433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=360.36 Aligned_cols=265 Identities=21% Similarity=0.245 Sum_probs=212.0
Q ss_pred cHHHHHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEe
Q 007608 263 SCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339 (596)
Q Consensus 263 ~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 339 (596)
.+.++....++|+..++||+|+||+||+|+.+ +++.||+|++.... .......+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45566777899999999999999999999976 57899999986421 1122344889999999999999999999999
Q ss_pred cCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEee
Q 007608 340 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 419 (596)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 419 (596)
+.+..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999763 24689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccCcceeccccccccccCccccc-----CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHH
Q 007608 420 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 494 (596)
Q Consensus 420 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~ 494 (596)
||+++..............||+.|+|||++. ...++.++|||||||++|||+||+.||......+ ....+
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-----~~~~i 293 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKI 293 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-----HHHhh
Confidence 9999876554444444567999999999987 5678999999999999999999999998543221 11111
Q ss_pred HHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 007608 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM 546 (596)
Q Consensus 495 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 546 (596)
......- ...........++.+++.+|+..+|++ ||+++|++++
T Consensus 294 ~~~~~~~--------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 294 MNHKERF--------QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HTHHHHC--------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhccccc--------cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1100000 001111123456788899999888888 9999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=347.68 Aligned_cols=256 Identities=20% Similarity=0.271 Sum_probs=205.4
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc----CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
.+.|+..+.||+|+||+||+|... +++.||||++... ......+.+.+|+.++..++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356888999999999999999964 7899999998531 11224677999999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc---EEEeeccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGL 422 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~DfGl 422 (596)
+||||+++++|.+.+.........+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988875433345689999999999999999999999 9999999999999986654 99999999
Q ss_pred cccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....+.. ..
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~i~~----~~ 248 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------RLFEGIIK----GK 248 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH------HHHHHHHH----TC
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH------HHHHHHHc----CC
Confidence 987654322 22345689999999999999999999999999999999999999975321 11111111 10
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.. .++. .......++.+++.+||+.||++||++.|+++
T Consensus 249 ~~--~~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YK--MNPR---QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CCHH---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--CCcc---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0000 00112457889999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=346.56 Aligned_cols=252 Identities=19% Similarity=0.286 Sum_probs=200.9
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC--------
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-------- 342 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-------- 342 (596)
++|+..+.||+|+||.||+|+.. +|+.||||+++........+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 56888999999999999999976 799999999975555556788999999999999999999999986543
Q ss_pred -------------------------------------------------eeEEEEEcccCCChhhhhcccCCCCCCCCHH
Q 007608 343 -------------------------------------------------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWP 373 (596)
Q Consensus 343 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~ 373 (596)
..++||||+++++|.+++..... ....++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhhH
Confidence 27899999999999999986432 2446778
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc-----------ceecccccccc
Q 007608 374 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-----------HVTTQIRGTMG 442 (596)
Q Consensus 374 ~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~-----------~~~~~~~gt~~ 442 (596)
.++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999999 999999999999999999999999999987654321 11233468999
Q ss_pred ccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHH
Q 007608 443 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETM 522 (596)
Q Consensus 443 y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 522 (596)
|+|||++.+..++.++|||||||++|||++|..|+.. ......... .. ...........++
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~~~~~~----~~--------~~~~~~~~~~~~~ 302 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRIITDVR----NL--------KFPLLFTQKYPQE 302 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHHHHHHH----TT--------CCCHHHHHHCHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHHHHHhh----cc--------CCCcccccCChhH
Confidence 9999999999999999999999999999998766421 111111111 11 1111123344667
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 007608 523 VQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 523 ~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+++.+||+.||++||++.|++++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 899999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=336.05 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=201.6
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||+|+||+||+|...+|+.||+|++.... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688899999999999999999889999999986432 223346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 985 888888753 24689999999999999999999999 99999999999999999999999999998664322
Q ss_pred cceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC---cccc-
Q 007608 431 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RLND- 505 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~- 505 (596)
.. .....||+.|+|||++.+. .++.++|||||||++|||+||+.||......+ .+.. +....... ....
T Consensus 155 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~-~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 155 RK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMR-IFRILGTPNSKNWPNV 228 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH-HHHHHCCCCTTTSTTG
T ss_pred cc-cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH-HHHHHCCCChhhchhh
Confidence 21 2234589999999999764 58999999999999999999999997543211 1111 11111110 0000
Q ss_pred ----cccCcCC--------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 506 ----IVDRNLN--------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 506 ----~~d~~l~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..++... ........++.+++.+||+.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0111111 0112245678899999999999999999999763
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=340.62 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=204.3
Q ss_pred hcCCCcCceeeecCceEEEEEEe-----CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC--Ce
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~ 343 (596)
.++|+..+.||+|+||+||+|++ .+++.||||++... .....+.|.+|++++.+++||||+++++++... ..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 46788899999999999999984 36889999998742 344557899999999999999999999998654 45
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred eEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 899999999999999997632 3489999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcc--eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhh-------hhchHHHHH
Q 007608 424 KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE-------EDVLLLDHI 494 (596)
Q Consensus 424 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~-------~~~~l~~~~ 494 (596)
+........ ......++..|+|||.+.+..++.++||||||+++|||+||..|+........ .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 876543221 22234467789999999999999999999999999999999999875321100 000001111
Q ss_pred HHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 495 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
....... .....+...+.++.+++.+||+.||++|||++|+++.|++
T Consensus 242 ~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 242 IELLKNN--------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHHTT--------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcc--------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 1111111 1111233445678899999999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=345.57 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=202.5
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|...+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999996 578999999986321 1223457899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+ +|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 68998888752 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ... +
T Consensus 161 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------------~~~-i 220 (336)
T 3h4j_B 161 GNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------------FKK-V 220 (336)
T ss_dssp SBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------------BCC-C
T ss_pred Ccc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------------HHH-H
Confidence 322 233468999999999988776 7899999999999999999999975332110 001 1
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.......+......+.+++.+|++.||.+|||++|+++
T Consensus 221 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11111123334567889999999999999999999976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=347.40 Aligned_cols=263 Identities=23% Similarity=0.356 Sum_probs=196.6
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEeCCC----cEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC
Q 007608 268 QLATDNFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 342 (596)
Q Consensus 268 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 342 (596)
.+..++|+..+.||+|+||.||+|..... ..||||+++... .....+.+.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34567899999999999999999996543 279999997432 3445678999999999999999999999998776
Q ss_pred ee------EEEEEcccCCChhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc
Q 007608 343 ER------ILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 414 (596)
Q Consensus 343 ~~------~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 414 (596)
.. ++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 65 89999999999999986432 2223689999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHH
Q 007608 415 AVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 492 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~ 492 (596)
+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||+| |+.||...... ....
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~ 250 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-----EIYN 250 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-----HHHH
Confidence 999999999876443221 2223446789999999999999999999999999999999 89999754321 1211
Q ss_pred HHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 493 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 493 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.+. ... ....+.....++.+++.+||+.||++||++.|+++.|+++
T Consensus 251 ~~~---~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 251 YLI---GGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HHH---TTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHh---cCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111 111 1112233446788999999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=365.25 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=206.8
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 267 LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 267 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
+++..++|+..+.||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 344567788899999999999999999888899999997532 245789999999999999999999999876 67899
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 256 v~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 999999999999997521 24589999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
............++..|+|||.+.+..++.++|||||||++|||+| |+.||...... .....+. ...+
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~---~~~~--- 399 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVE---RGYR--- 399 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHH---TTCC---
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH---cCCC---
Confidence 5433222233446789999999999999999999999999999999 99999753321 1112111 1110
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 551 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 551 (596)
...+...+..+.+++.+||+.||++|||++++++.|++..
T Consensus 400 ------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 400 ------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0112334567889999999999999999999999998743
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=334.78 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=209.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
.++|+..+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 45788899999999999999999888999999997532 2356799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999763 24589999999999999999999999 99999999999999999999999999998764432
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
........+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.. ... .
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~i~~---~~~------~ 224 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDIST---GFR------L 224 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHT---TCC------C
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-----HHHHHHhc---CCc------C
Confidence 222233457789999999998899999999999999999999 89998753321 11111111 100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+......+.+++.+|++.||++||++.|++++|++
T Consensus 225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 225 ---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0112234578899999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=342.24 Aligned_cols=262 Identities=26% Similarity=0.398 Sum_probs=213.5
Q ss_pred HHhcCCCcCceeeecCceEEEEEEe------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecC
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 341 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 341 (596)
...++|+..+.||+|+||.||+|+. .+++.||+|+++........+.+.+|+.++.++ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3456788899999999999999984 356889999997655555667899999999999 999999999999999
Q ss_pred CeeEEEEEcccCCChhhhhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcE
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKP--------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 407 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 407 (596)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence 999999999999999999986432 123589999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhh
Q 007608 408 LLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 485 (596)
Q Consensus 408 ll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~ 485 (596)
+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-
Confidence 9999999999999999876554322 2233457889999999999999999999999999999999 999997543211
Q ss_pred hhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 486 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 486 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.....+..... . ..+......+.+++.+|++.||.+||++.|++++|++
T Consensus 256 ---~~~~~~~~~~~---------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 256 ---KFYKMIKEGFR---------M---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp ---HHHHHHHHTCC---------C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHhccCCC---------C---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 11111111100 0 0112334678899999999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=333.44 Aligned_cols=254 Identities=27% Similarity=0.374 Sum_probs=196.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCC---cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||.||+|.. .++.||||+++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46788899999999999999997 488999999874322 22346789999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC--------CCcEEEee
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--------NFEAVLCD 419 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--------~~~~kl~D 419 (596)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+....+++||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999998863 46899999999999999999999982222999999999999986 67899999
Q ss_pred ccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc
Q 007608 420 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 499 (596)
Q Consensus 420 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 499 (596)
||+++....... ....||+.|+|||.+.+..++.++||||||+++|||+||+.||....... . ......
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~---~~~~~~ 228 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----V---AYGVAM 228 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-----H---HHHHHT
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----H---HHhhhc
Confidence 999986544322 23458999999999999999999999999999999999999997533211 1 111111
Q ss_pred cCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 500 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 500 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
... ....+......+.+++.+|++.||++||++.|++++|++
T Consensus 229 ~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 NKL--------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SCC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCC--------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 110 011223345678899999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.16 Aligned_cols=254 Identities=21% Similarity=0.252 Sum_probs=206.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
..++|+..+.||+|+||.||+|... +++.||+|++... ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999965 6899999999743 2334456789999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC---CcEEEeeccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLAK 424 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~DfGl~~ 424 (596)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999998875 34689999999999999999999999 99999999999999865 459999999998
Q ss_pred cccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+.. +...
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----~~~~~i~~----~~~~ 248 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYAQIKA----GAYD 248 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH----TCCC
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHh----CCCC
Confidence 765432 223456899999999999999999999999999999999999999753321 12222211 1100
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+ .......++.+++.+||+.||++||++.|++++
T Consensus 249 -~~~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 -YPSP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CCTT----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCcc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 011234578899999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.62 Aligned_cols=252 Identities=16% Similarity=0.238 Sum_probs=205.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||.||+|... +++.||+|.+.. .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC--CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec--CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 467888999999999999999975 688999999863 23345678999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC--CCcEEEeecccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVD 427 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~DfGl~~~~~ 427 (596)
|+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 82 ~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999998752 24689999999999999999999999 9999999999999987 7899999999998765
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.. ... . +
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~---~~~-~--~ 222 (321)
T 1tki_A 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENIMN---AEY-T--F 222 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHH---TCC-C--C
T ss_pred CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHHHc---CCC-C--C
Confidence 432 223356899999999999988999999999999999999999999754321 11111111 110 0 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+.. .....+.++.+++.+|++.||++|||+.|++++
T Consensus 223 ~~~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 223 DEE---AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CHH---HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Chh---hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 001224578899999999999999999999883
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.43 Aligned_cols=265 Identities=23% Similarity=0.342 Sum_probs=213.4
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEeCC-C-----cEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEe
Q 007608 267 LQLATDNFSESNIIGQGGFGKVYKGVLSD-N-----TKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 339 (596)
Q Consensus 267 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 339 (596)
.+...++|...+.||+|+||.||+|.... + ..||+|.+...........+.+|+.++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 44567889999999999999999999642 2 479999997655555677899999999999 8999999999999
Q ss_pred cCCeeEEEEEcccCCChhhhhcccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE
Q 007608 340 TSSERILVYPFMQNLSVAYRLRDLKP----------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 409 (596)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll 409 (596)
+.+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 99999999999999999999875321 124589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhh
Q 007608 410 DDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEED 487 (596)
Q Consensus 410 ~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~ 487 (596)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--- 274 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--- 274 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---
Confidence 99999999999999866443322 2233456889999999999899999999999999999999 999987533211
Q ss_pred chHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 488 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 488 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.....+..... . ..+......+.+++.+||+.||.+||++.|+++.|++.
T Consensus 275 -~~~~~~~~~~~---------~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 275 -KFYKLVKDGYQ---------M---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -HHHHHHHHTCC---------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHhcCCC---------C---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11111111100 0 01122245788999999999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.74 Aligned_cols=254 Identities=19% Similarity=0.238 Sum_probs=205.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.++|+..+.||+|+||.||+|... +|+.||+|++.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 467889999999999999999864 78999999987432 2334567899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc---CCCcEEEeecccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAKL 425 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~DfGl~~~ 425 (596)
||+++|+|.+.+.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||++..
T Consensus 90 E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999886 34689999999999999999999999 999999999999998 567899999999987
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .....+.. +.. .
T Consensus 163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-----~~~~~i~~----~~~-~ 231 (444)
T 3soa_A 163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-----RLYQQIKA----GAY-D 231 (444)
T ss_dssp CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH----TCC-C
T ss_pred ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHh----CCC-C
Confidence 654322 223456999999999999999999999999999999999999999753321 12222211 110 0
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+. ......++.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 FPSPE----WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCTTT----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCccc----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00111 12234578899999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=346.01 Aligned_cols=290 Identities=22% Similarity=0.319 Sum_probs=219.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++..++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367888999999999999999965 68899999986321 223456788999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+.+|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999986 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeccccccccccCcccccC---CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......+..
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~~-------- 234 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHTFET-------- 234 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHHHHH--------
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHHHhh--------
Confidence 432 2344569999999999864 4589999999999999999999999975332111 111111111
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHhccCCcchhhHHHHHHHHhhhhcccccccccccccCC
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-MAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDS 583 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (596)
....++.....++.+++.+||+.||++||+ ++++.++-- -. .-.|..+... ...+.+.|.......+.
T Consensus 235 -----~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~----f~-~~~w~~~~~~-~~~p~~~p~~~~~~~~~ 303 (384)
T 4fr4_A 235 -----TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY----MN-DINWDAVFQK-RLIPGFIPNKGRLNCDP 303 (384)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGG----GT-TCCHHHHHTT-CSCCCCCCSCCSSCCCC
T ss_pred -----cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChh----hh-cCCHHHHHhC-CCCCCCCCCCCCCCCCC
Confidence 011123334567889999999999999999 666543211 10 1124444333 23445555544444444
Q ss_pred CCccchh
Q 007608 584 SIDQEAI 590 (596)
Q Consensus 584 ~~~~~~~ 590 (596)
....+++
T Consensus 304 ~~~~~~~ 310 (384)
T 4fr4_A 304 TFELEEM 310 (384)
T ss_dssp CCCSTTS
T ss_pred ccChhhh
Confidence 4444443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.89 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=200.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 347 (596)
++|+..+.||+|+||.||+|+.+ +++.||+|+++... .......+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999975 68899999997432 233456688999999987 899999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999752 4589999999999999999999999 99999999999999999999999999998543
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........................
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 221 223445799999999999999999999999999999999999999974322111110111111111111110
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 540 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 540 (596)
..+.....++.+++.+||+.||++||++
T Consensus 237 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 -----RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -----CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1222345678899999999999999996
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=346.03 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=211.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEe--------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEec
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 340 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 340 (596)
..++|+..+.||+|+||.||+|.. .++..||+|+++..........+.+|++++.++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 457888999999999999999986 356789999998655555667899999999999 89999999999999
Q ss_pred CCeeEEEEEcccCCChhhhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEE
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 408 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl 408 (596)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 99999999999999999999864321 23489999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhh
Q 007608 409 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE 486 (596)
Q Consensus 409 l~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~ 486 (596)
++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||+| |+.||......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence 999999999999999876543322 2233456889999999998889999999999999999999 99999754321
Q ss_pred hchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 487 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 487 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.+...+.. ... ...+.....++.+++.+||+.||++||++.|+++.|+.+
T Consensus 267 --~~~~~~~~----~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 267 --ELFKLLKE----GHR--------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp --HHHHHHHH----TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHhc----CCC--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 12222211 110 011223345788999999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=345.62 Aligned_cols=270 Identities=23% Similarity=0.368 Sum_probs=217.9
Q ss_pred ccHHHHHHHhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceE
Q 007608 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 335 (596)
Q Consensus 262 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~ 335 (596)
+..+++++..++|+..+.||+|+||.||+|... +++.||+|++...........+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334455667788999999999999999999854 36789999997655555667899999999999999999999
Q ss_pred eEEecCCeeEEEEEcccCCChhhhhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE
Q 007608 336 GYCTTSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 409 (596)
Q Consensus 336 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll 409 (596)
+++.+.+..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 99999999999999999999999987532 1124578999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhh
Q 007608 410 DDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEED 487 (596)
Q Consensus 410 ~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~ 487 (596)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||......
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---- 247 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---- 247 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH----
Confidence 99999999999999866443222 1223346889999999999999999999999999999999 88898753321
Q ss_pred chHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 007608 488 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 551 (596)
Q Consensus 488 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 551 (596)
.....+. ... ....+......+.+++.+|++.||++||++.|+++.|++..
T Consensus 248 -~~~~~~~----~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 248 -QVLRFVM----EGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp -HHHHHHH----TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -HHHHHHH----cCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1111111 111 11112234567889999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.46 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=205.7
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCc-----chHHHHHHHHHHHHhcCCCCccceEeEEecCCee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 344 (596)
.++|...+.||+|+||.||+|... +|+.||+|++...... .....+.+|+.++.+++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999975 6899999998743221 2467899999999999999999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC----cEEEeec
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF 420 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Df 420 (596)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999975 34689999999999999999999999 999999999999999887 7999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+... .
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~--~ 233 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVSAV--N 233 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHHHT--C
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----HHHHHHhc--C
Confidence 9998765332 2234568999999999999999999999999999999999999997533211 11111110 0
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.... +. ........+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~---~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 YEFE---DE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCCC---HH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCcC---cc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 00 001224567899999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=356.07 Aligned_cols=262 Identities=19% Similarity=0.243 Sum_probs=210.3
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEec
Q 007608 264 CRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 340 (596)
Q Consensus 264 ~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 340 (596)
..++....++|+..+.||+|+||+||+|+.. +++.||+|+++... .......+.+|+.++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4456667889999999999999999999975 68899999986311 12223457899999999999999999999999
Q ss_pred CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeec
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 420 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 420 (596)
....++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999875 3488999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCC----CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK----SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
|+++..............||+.|+|||++.+.. ++.++|||||||++|||+||+.||......+ ....+..
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~~ 287 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----TYSKIMN 287 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHT
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-----HHHHHHh
Confidence 999877554433344567999999999997655 7899999999999999999999998543211 1111111
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHh
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKML 547 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L 547 (596)
....-.. +. ......++.+++.+|++.+|.+ ||+++||+++-
T Consensus 288 ~~~~~~~-----p~----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 288 HKNSLTF-----PD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp HHHHCCC-----CT----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred ccccccC-----CC----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 0000000 00 0123457888999999999988 99999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=338.49 Aligned_cols=265 Identities=24% Similarity=0.340 Sum_probs=192.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||.||+|... +++.||+|+++..........+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999965 6899999999754444456778999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 350 FMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|++ ++|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59998887532 2234689999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc---Ccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRL 503 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~ 503 (596)
.... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||......+ ....+...... ...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-----QLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCSCCTTTC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCChhHh
Confidence 3322 12334589999999999764 68999999999999999999999998543221 11222211110 000
Q ss_pred ccc-----ccCcCCC-------------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 504 NDI-----VDRNLNT-------------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 504 ~~~-----~d~~l~~-------------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
... ..+.+.. .......++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 0000000 01123457889999999999999999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=347.55 Aligned_cols=251 Identities=25% Similarity=0.321 Sum_probs=200.5
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCee
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 344 (596)
...++|+..+.||+|+||.||+|+.. +++.||||+++... .......+.+|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999965 68999999987421 223456688999999988 699999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||+++|+|..++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 9999999999999999762 4589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+. ...
T Consensus 173 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~---~~~--- 240 (353)
T 3txo_A 173 EGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAIL---NDE--- 240 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHH---HCC---
T ss_pred ecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-----HHHHHHH---cCC---
Confidence 543221 2233456999999999999888999999999999999999999999854321 1111111 111
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM------AQVVK 545 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 545 (596)
..++......+.+++.+|++.||++||++ +|+++
T Consensus 241 -------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 -------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01122234568889999999999999998 66654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.82 Aligned_cols=251 Identities=26% Similarity=0.344 Sum_probs=206.2
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC-eeEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERILV 347 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv 347 (596)
+..++|+..+.||+|+||.||+|.. .++.||||+++... ..+.|.+|+.++++++||||+++++++.... ..++|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 4456788899999999999999998 47899999997532 4578999999999999999999999987765 68999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999998642 23479999999999999999999999 99999999999999999999999999998543
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+.. +..
T Consensus 341 ~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~~----~~~--- 404 (450)
T 1k9a_A 341 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVEK----GYK--- 404 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-----THHHHHHT----TCC---
T ss_pred ccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHc----CCC---
Confidence 221 12246889999999999999999999999999999999 99999754321 12222211 100
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+...+.++.+++.+||+.||++||++.|+++.|+.
T Consensus 405 -----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 405 -----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11223345678899999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.45 Aligned_cols=261 Identities=29% Similarity=0.464 Sum_probs=198.4
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
+..++|+..+.||+|+||+||+|+..+ .||+|+++... .....+.|.+|+.++++++||||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 345789999999999999999998643 59999987433 344557899999999999999999999965 45668999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999998642 34689999999999999999999999 99999999999999999999999999998654
Q ss_pred ccC-cceeccccccccccCccccc---CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 428 AKL-THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 428 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+ .....+.. ...
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~----~~~ 243 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIEMVGR----GSL 243 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH----HHHHHHHH----TSC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH----HHHHHhcc----ccc
Confidence 322 22223456899999999986 5678899999999999999999999997533211 12222221 111
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.+.+.......+.++.+++.+||+.||++||++.|+++.|++.
T Consensus 244 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 244 ----SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp ----CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ----CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1112222334457889999999999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=333.05 Aligned_cols=250 Identities=25% Similarity=0.328 Sum_probs=195.8
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC-------------------------cchHHHHHHHHHHHH
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-------------------------PGGEAAFQREVHLIS 324 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------------------------~~~~~~~~~e~~~l~ 324 (596)
.++|+..+.||+|+||.||+|... +++.||||++..... ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467888999999999999999964 688999999864321 112356889999999
Q ss_pred hcCCCCccceEeEEec--CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC
Q 007608 325 VAIHKNLLQLIGYCTT--SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 402 (596)
Q Consensus 325 ~l~H~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl 402 (596)
+++||||+++++++.+ ....++||||+++++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 5678999999999998876542 4689999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccccCcceeccccccccccCcccccCCC---CCcccccHHHHHHHHHHHhCCCCCCC
Q 007608 403 KAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDF 479 (596)
Q Consensus 403 kp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvil~elltg~~p~~~ 479 (596)
||+||+++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654322 233456899999999997765 37889999999999999999999975
Q ss_pred ccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 480 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 480 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.... .....+. ...... +. ......++.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~-----~~~~~~~----~~~~~~---~~----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIM-----CLHSKIK----SQALEF---PD----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHH-----HHHHHHH----HCCCCC---CS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHH-----HHHHHHh----cccCCC---CC----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 3221 1111111 111100 00 1123456889999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=337.19 Aligned_cols=256 Identities=29% Similarity=0.424 Sum_probs=209.1
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
+..++|+..+.||+|+||.||+|...++..||+|++... ....+.+.+|++++++++||||+++++++. .+..++||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 86 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC--cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence 345678889999999999999999988889999998643 234678999999999999999999999986 45689999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 87 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp ECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999987521 12589999999999999999999999 999999999999999999999999999987755
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
..........++..|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+. ....
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~---~~~~----- 228 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLE---RGYR----- 228 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHH---TTCC-----
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-----HHHHHHh---cccC-----
Confidence 43333334456789999999998889999999999999999999 89998753321 1111111 1100
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+.....++.+++.+|++.||++||++.++++.|++
T Consensus 229 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 01122334678899999999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.54 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=195.7
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCee---
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER--- 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~--- 344 (596)
.++|+..+.||+|+||.||+|.. .+++.||||+++... .......+.+|+.++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788999999999999999996 578999999997532 223346789999999999999999999998765543
Q ss_pred -EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 345 -ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 345 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 9999999999999999762 4689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcc--eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 424 KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 424 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
+........ ......||+.|+|||++.+..++.++||||||+++|||+||+.||....... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--------~~~~~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--------VAYQHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHhcCC
Confidence 876543221 2233568999999999999999999999999999999999999997543211 111111111
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..... ......+.++.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 236 PIPPS------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCCHH------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCcc------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 10000 001123457889999999999999998887765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=354.17 Aligned_cols=265 Identities=21% Similarity=0.223 Sum_probs=210.6
Q ss_pred ccHHHHHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEE
Q 007608 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYC 338 (596)
Q Consensus 262 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~ 338 (596)
+.+++.....++|+..+.||+|+||+||+|+.+ +|+.||+|+++... .......+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445666677889999999999999999999975 79999999986421 122334588999999999999999999999
Q ss_pred ecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEe
Q 007608 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC 418 (596)
Q Consensus 339 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 418 (596)
.+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence 99999999999999999999997532 3689999999999999999999999 99999999999999999999999
Q ss_pred eccccccccccCcceeccccccccccCccccc-------CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHH
Q 007608 419 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL 491 (596)
Q Consensus 419 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~ 491 (596)
|||+++..............||+.|+|||++. +..++.++|||||||++|||++|+.||......+ ..
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----~~ 279 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-----TY 279 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HH
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-----HH
Confidence 99999877554433344467999999999987 4568999999999999999999999997543211 11
Q ss_pred HHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 007608 492 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR---PPMAQVVKM 546 (596)
Q Consensus 492 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~ 546 (596)
..+......- .........+.++.+++.+||. +|++| |+++|+.++
T Consensus 280 ~~i~~~~~~~--------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 GKIVHYKEHL--------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHTHHHHC--------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHhcccCc--------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1111100000 0011112234678899999999 99998 688888653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=342.35 Aligned_cols=264 Identities=22% Similarity=0.333 Sum_probs=206.6
Q ss_pred cCCCcCceeeecCceEEEEEEe-----CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC--Cee
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 344 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 344 (596)
+.|+..+.||+|+||.||+|++ .+++.||+|++...........+.+|++++.+++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4577889999999999999983 468999999998555555668899999999999999999999999877 567
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 9999999999999999653 24589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcc--eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchh------hhhchHHHHHHH
Q 007608 425 LVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE------EEDVLLLDHIRK 496 (596)
Q Consensus 425 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~------~~~~~l~~~~~~ 496 (596)
........ ......||..|+|||++.+..++.++||||||+++|||+||..|+....... ............
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 77554322 2234557888999999999999999999999999999999998865321100 000001111111
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...... ....+...+.++.+++.+||+.||++|||+.|+++.|+.
T Consensus 255 ~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 255 TLKEGK--------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhccC--------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 111111 111233445678899999999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=334.64 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=205.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCC----CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
..++|...+.||+|+||.||+|...+ +..||+|.+.........+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45678889999999999999998532 346999999765555567889999999999999999999999765 4568
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 999999999999999753 24589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
.............+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~~~~~~~~---~~-- 232 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVLEKG---DR-- 232 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GHHHHHHHT---CC--
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HHHHHHhcC---CC--
Confidence 65543333334457889999999998899999999999999999998 99999753321 122222211 00
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...+......+.+++.+|++.||++||++.|+++.|++.
T Consensus 233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 -------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 001122345688999999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=340.08 Aligned_cols=257 Identities=27% Similarity=0.408 Sum_probs=214.6
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
...++|+..+.||+|+||.||+|... ++..||+|++.. .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS--CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 45677888999999999999999976 588999999864 334567899999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999997632 35689999999999999999999999 99999999999999999999999999998776
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
...........+++.|+|||++.+..++.++||||||+++|||++ |..||...... ...+.+.....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----~~~~~~~~~~~------- 230 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEKDYR------- 230 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHHHHHTTCC-------
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHhccCC-------
Confidence 554444444557889999999998999999999999999999999 99998754322 12222211100
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+...+..+.+++.+|++.||++||++.|+++.|+.
T Consensus 231 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 231 -----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 01122334678899999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=341.62 Aligned_cols=269 Identities=24% Similarity=0.388 Sum_probs=216.6
Q ss_pred ccHHHHHHHhcCCCcCceeeecCceEEEEEEe------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccce
Q 007608 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQL 334 (596)
Q Consensus 262 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l 334 (596)
+...++....++|+..+.||+|+||.||+|.. .+++.||||+++..........+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45566667788999999999999999999984 356889999998655555667899999999999 79999999
Q ss_pred EeEEecCC-eeEEEEEcccCCChhhhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecC
Q 007608 335 IGYCTTSS-ERILVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 401 (596)
Q Consensus 335 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~d 401 (596)
++++...+ ..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987765 489999999999999999864321 12388999999999999999999999 999999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCC
Q 007608 402 LKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDF 479 (596)
Q Consensus 402 lkp~NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~ 479 (596)
|||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654322 22334557889999999999999999999999999999998 9999975
Q ss_pred ccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 480 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 480 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..... .....+.. ... ...+.....++.+++.+||+.||++||++.|++++|+.
T Consensus 254 ~~~~~----~~~~~~~~----~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 254 VKIDE----EFCRRLKE----GTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp CCCSH----HHHHHHHH----TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cchhH----HHHHHhcc----Ccc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 43211 11111111 110 01112234578899999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=342.50 Aligned_cols=260 Identities=25% Similarity=0.337 Sum_probs=207.2
Q ss_pred CCcCceeeecCceEEEEEEeC-----CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC--CeeEE
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERIL 346 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 346 (596)
|+..+.||+|+||+||++.+. +++.||||+++..........+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999988642 68899999998655556677899999999999999999999999874 56789
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999975 2489999999999999999999999 9999999999999999999999999999877
Q ss_pred cccCcc--eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhh------hchHHHHHHHHh
Q 007608 427 DAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE------DVLLLDHIRKLL 498 (596)
Q Consensus 427 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~------~~~l~~~~~~~~ 498 (596)
...... ......+|..|+|||++.+..++.++||||||+++|||+||+.||......... ............
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 544322 223345788899999999989999999999999999999999998753211000 000000111111
Q ss_pred ccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 499 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
... .....+...+.++.+++.+||+.||++||++.|+++.|+.
T Consensus 265 ~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 265 ERG--------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp HTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcc--------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 111 0111233445688999999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=330.29 Aligned_cols=253 Identities=31% Similarity=0.488 Sum_probs=202.6
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcch------HHHHHHHHHHHHhcCCCCccceEeEEecCCe
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGG------EAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 343 (596)
.++|+..+.||+|+||+||+|.. .+++.||+|++........ .+.+.+|++++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46788899999999999999996 4789999999864332221 167899999999999999999999986655
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCcEEEcCCCc-----EE
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFE-----AV 416 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~~~~~-----~k 416 (596)
++||||+++|+|.+.+... ...+++..++.++.|++.||+|||+. + ++||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 6999999999999888752 34689999999999999999999998 7 999999999999988776 99
Q ss_pred EeeccccccccccCcceeccccccccccCccccc--CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHH
Q 007608 417 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS--TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 494 (596)
Q Consensus 417 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~ 494 (596)
|+|||+++.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ ......
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~ 242 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI---KFINMI 242 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH---HHHHHH
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH---HHHHHH
Confidence 999999975433 233456899999999984 45678999999999999999999999975432211 111111
Q ss_pred HHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 495 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
. ... .. + ..+.....++.+++.+||+.||++||++.|+++.|++
T Consensus 243 ~---~~~-~~----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 243 R---EEG-LR----P---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp H---HSC-CC----C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred h---ccC-CC----C---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1 111 10 1 1223345678899999999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=345.98 Aligned_cols=271 Identities=20% Similarity=0.227 Sum_probs=204.8
Q ss_pred hcCCCcCceeeec--CceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 271 TDNFSESNIIGQG--GFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
.++|+..+.||+| +||+||+|+.. +++.||||++.... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578889999999 99999999975 79999999997432 33445778899999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999998632 24589999999999999999999999 9999999999999999999999999998654
Q ss_pred cccCc------ceeccccccccccCcccccC--CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHh
Q 007608 427 DAKLT------HVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 498 (596)
Q Consensus 427 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 498 (596)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....................
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 32111 11222468899999999987 57899999999999999999999999754332111111100000000
Q ss_pred cc-----Cc-------------ccccc----------cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 499 RE-----DR-------------LNDIV----------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 499 ~~-----~~-------------~~~~~----------d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. .. ..+.. +............++.+++.+||+.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 00 00000 000001122345678999999999999999999999764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=330.37 Aligned_cols=251 Identities=19% Similarity=0.269 Sum_probs=204.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC--CeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv 347 (596)
.++|...+.||+|+||.||+|+. +++.||+|+++... .....+.|.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 45788899999999999999998 48899999997432 344567799999999999999999999999887 678999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. + ++||||||+||+++.++.++|+|||+...
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999998632 23689999999999999999999998 7 99999999999999999999999998764
Q ss_pred ccccCcceeccccccccccCcccccCCCCCc---ccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE---KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
... ....||+.|+|||.+.+...+. ++||||||+++|||+||+.||....... ..........
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~ 228 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME--------IGMKVALEGL 228 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH--------HHHHHHHSCC
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH--------HHHHHHhcCC
Confidence 322 2235799999999998765544 7999999999999999999997543211 1111111110
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.+ ..+.....++.+++.+||+.||++|||+.|+++.|++
T Consensus 229 -----~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~ 267 (271)
T 3kmu_A 229 -----RP---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267 (271)
T ss_dssp -----CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 01 1122345578899999999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=337.61 Aligned_cols=247 Identities=25% Similarity=0.319 Sum_probs=204.7
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||.||+|+.. +|+.||+|+++... .......+.+|+.++..++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357888999999999999999975 78999999986421 123456788999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999986 34689999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +......... .
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~-~---- 220 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNAE-L---- 220 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHCC-C----
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-C----
Confidence 32 23456899999999999999999999999999999999999999753321 1111111111 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
.++.....++.+++.+|++.||++|| +++|++++
T Consensus 221 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11223345788999999999999999 88888653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.75 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=201.0
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|...+.||+|+||.||+|... ++..||+|++.........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 57888999999999999999964 68999999998655555678899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE---cCCCcEEEeecccccccc
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DfGl~~~~~ 427 (596)
+++|+|.+.+.........+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999875433345799999999999999999999999 99999999999999 456789999999998664
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||......+ ...... ....
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~-----~~~~~~---~~~~----- 242 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-----VQQKAT---YKEP----- 242 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---HCCC-----
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH-----HHhhhc---cCCc-----
Confidence 432 223456899999999985 568999999999999999999999997543211 111111 0000
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...........++.+++.+|++.||++||++.|+++
T Consensus 243 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 --NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000112456788999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=332.69 Aligned_cols=259 Identities=15% Similarity=0.194 Sum_probs=208.0
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.++|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+|+..+..+ +|+|++++++++.+....++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 46788999999999999999995 578999999986432 234578899999999 7999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc-----EEEeecccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-----AVLCDFGLA 423 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~DfGl~ 423 (596)
||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 99999999863 23589999999999999999999999 9999999999999987776 999999999
Q ss_pred ccccccCcc------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHH
Q 007608 424 KLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 497 (596)
Q Consensus 424 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~ 497 (596)
+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~ 236 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQKYERIGEK 236 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--HHHHHHHHhh
Confidence 876543221 12345689999999999999999999999999999999999999986432111 1111111111
Q ss_pred hccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 498 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 498 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.......+. ....+.++.+++.+||+.||++||++++|++.|++
T Consensus 237 ~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 237 KQSTPLREL--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp HHHSCHHHH--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ccCccHHHH--------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 111111110 11234678899999999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=339.67 Aligned_cols=258 Identities=17% Similarity=0.165 Sum_probs=206.5
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+|+++++++ +||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 46788899999999999999996 578999999986432 234588999999999 9999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc-----EEEeecccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-----AVLCDFGLA 423 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~DfGl~ 423 (596)
||+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 89999999863 34699999999999999999999999 9999999999999999887 999999999
Q ss_pred ccccccCcc------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHH
Q 007608 424 KLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 497 (596)
Q Consensus 424 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~ 497 (596)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~~~i~~~ 235 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERYQKIGDT 235 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHHHHHHhh
Confidence 876443221 12345699999999999999999999999999999999999999986432111 1111111111
Q ss_pred hccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 498 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 498 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
........ + ....+ ++.+++..|++.||.+||++.+|++.|++
T Consensus 236 ~~~~~~~~-----~---~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 236 KRATPIEV-----L---CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHHSCHHH-----H---TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred hccCCHHH-----H---hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 11100000 0 00122 78899999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=342.21 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=191.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
..++|+..+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 3567889999999999999999976 58899999987532 3456889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC---CCcEEEeecccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFGLAKL 425 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DfGl~~~ 425 (596)
||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999875 34589999999999999999999999 9999999999999975 88999999999986
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+. ... . .
T Consensus 201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~i~---~~~-~-~ 269 (349)
T 2w4o_A 201 VEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ----FMFRRIL---NCE-Y-Y 269 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH----HHHHHHH---TTC-C-C
T ss_pred cCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH----HHHHHHH---hCC-C-c
Confidence 64322 2234568999999999999999999999999999999999999997533211 1111111 111 0 0
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
... ........++.+++.+||+.||++||++.|+++.
T Consensus 270 ~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 FIS----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CCT----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCC----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001 1122345678899999999999999999999884
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=332.57 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=207.4
Q ss_pred cCCCcCc-eeeecCceEEEEEEeC---CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 272 DNFSESN-IIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 272 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
++|...+ .||+|+||.||+|... ++..||+|+++........+.+.+|++++.+++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 8999999999999853 67889999998655555677899999999999999999999999 45668999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999998742 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcce--eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 428 AKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 428 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
...... .....+|+.|+|||++.+..++.++||||||+++|||+| |+.||...... .....+.. ...
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~i~~----~~~- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVMAFIEQ----GKR- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----HHHHHHHT----TCC-
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHHhc----CCc-
Confidence 433221 222346889999999988889999999999999999999 99999754321 12222211 110
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+...+.++.+++.+||+.||++||++.|+++.|+.
T Consensus 232 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 232 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11223345678899999999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=338.06 Aligned_cols=247 Identities=22% Similarity=0.235 Sum_probs=194.4
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||+||+|... +++.||||++.... .......+..|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357889999999999999999976 79999999986432 233344556666666655 899999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+ +++|.+++... ...++|..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 67898888764 24699999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ... .........+
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~-~~~~~~~~~~ 273 (311)
T 3p1a_A 209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQ-LRQGYLPPEF 273 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHH-HTTTCCCHHH
T ss_pred cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHH-HhccCCCccc
Confidence 432 2233458999999999876 789999999999999999999776653111 001 1111111000
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
......++.+++.+||+.||++||++.|++++
T Consensus 274 -------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 274 -------TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11234678899999999999999999999763
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.30 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=203.9
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCe
Q 007608 268 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 268 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 343 (596)
....++|...+.||+|+||.||+|+.+ +++.||+|+++... .......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445688999999999999999999975 68999999997421 123456678899999877 89999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 99999999999999999762 4589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+.. ..
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~i~~---~~-- 234 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-----ELFHSIRM---DN-- 234 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH---CC--
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHh---CC--
Confidence 8543222 1234457999999999999999999999999999999999999999754321 11111111 10
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA-QVV 544 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 544 (596)
+ .++.....++.+++.+||+.||++||++. |+.
T Consensus 235 -----~---~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -----P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----C---CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 11222346788999999999999999997 554
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=343.89 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=202.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcE----EEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
.++|+..+.||+|+||+||+|... +++. ||+|.+...........+.+|+.++.+++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357888999999999999999964 4443 88888764443444566789999999999999999999986 45688
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999999753 23588899999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 426 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 426 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
....... ......++..|+|||++.+..++.++||||||+++|||+| |+.||...... .....+... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~---~~~ 236 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-----EVPDLLEKG---ERL 236 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-----HHHHHHHTT---CBC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-----HHHHHHHcC---CCC
Confidence 7544322 2334557889999999999999999999999999999999 99999854321 122222211 000
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
..+.....++.+++.+||+.||++||++.|+++.|+..
T Consensus 237 ---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 237 ---------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp ---------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred ---------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01112233577899999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.78 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=202.4
Q ss_pred hcCCCcCceeeecCceEEEEEEeCC-----CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
.++|...+.||+|+||.||+|.... +..||+|+++..........+.+|+.++.+++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3466778999999999999998642 24599999986555556678999999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999753 24689999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcc--eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 426 VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 426 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
....... ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||...... .....+. ....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~~~~~---~~~~ 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVMKAIN---DGFR 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHH---TTCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHHH---CCCc
Confidence 6543221 1222346788999999999999999999999999999999 99999743221 1111111 1111
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
. ..+......+.+++.+||+.||++||++.|+++.|+.
T Consensus 269 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 269 L---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp C---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred C---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 1122345678899999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=342.39 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=197.4
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCC--CCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||.||++...+++.||||++... ......+.+.+|+.++.+++| |||+++++++.+....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568889999999999999999988999999998743 233445788999999999987 9999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|| +.+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 567899999986 34689999999999999999999999 999999999999997 5689999999998765
Q ss_pred ccCcc-eeccccccccccCcccccC-----------CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHH
Q 007608 428 AKLTH-VTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495 (596)
Q Consensus 428 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~ 495 (596)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~ 231 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLH 231 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------HHHHH
Confidence 43322 2234569999999999864 67899999999999999999999999743211 11111
Q ss_pred HHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 496 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
......... ..+.....++.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~--------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 AIIDPNHEI--------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHCTTSCC--------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhcCCccc--------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111111100 1122223567899999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.31 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=202.2
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHh--cCCCCccceEeEEecC--
Q 007608 266 ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTTS-- 341 (596)
Q Consensus 266 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~-- 341 (596)
......++|+..+.||+|+||.||+|+.. ++.||||++... ....+..|.+++.. ++||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 33445678999999999999999999984 899999998532 33445556666555 4899999999999877
Q ss_pred --CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCcEecCCCCCcEEEcCCCc
Q 007608 342 --SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-----NPKIIHRDLKAANILLDDNFE 414 (596)
Q Consensus 342 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~dlkp~NIll~~~~~ 414 (596)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 678999999999999999975 35899999999999999999999762 348999999999999999999
Q ss_pred EEEeeccccccccccCcce---eccccccccccCcccccCCCCCcc------cccHHHHHHHHHHHhC----------CC
Q 007608 415 AVLCDFGLAKLVDAKLTHV---TTQIRGTMGHIAPEYLSTGKSSEK------TDVFGYGITLLELVTG----------QR 475 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDv~S~Gvil~elltg----------~~ 475 (596)
+||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||+|| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999997664432221 123468999999999987766655 9999999999999999 55
Q ss_pred CCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 476 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 476 p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
||......... ............. .+.... .......++.+++.+||+.||++||++.||+++|+.
T Consensus 261 p~~~~~~~~~~----~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 261 PYHDLVPSDPS----YEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp TTTTTSCSSCC----HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cHhhhcCCCCc----hhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 55432211111 1111111111111 111111 123677889999999999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.31 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=205.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.++|+..+.||+|+||.||+|... +++.||+|++... ........+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468899999999999999999965 6899999998743 23445577889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc---EEEeecccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKL 425 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~DfGl~~~ 425 (596)
||+++++|.+.+... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999888752 4589999999999999999999999 9999999999999986655 99999999986
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+.. +...
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~----~~~~- 225 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYAQIKA----GAYD- 225 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH----TCCC-
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-----HHHHHHHh----cccc-
Confidence 654322 23356899999999999999999999999999999999999999753321 11111111 1000
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...+ .......++.+++.+|++.||++||++.|+++
T Consensus 226 ~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 YPSP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCch----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0001 11223456889999999999999999999976
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=334.77 Aligned_cols=258 Identities=21% Similarity=0.274 Sum_probs=207.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEec--CCeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~l 346 (596)
.++|+..+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999975 78999999997432 34456779999999999999999999998753 567899
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----cEecCCCCCcEEEcCCCcEEEeecc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK-----IIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
||||+++++|.+++.........+++..++.++.|++.||+|||+. + ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999986444445699999999999999999999998 7 9999999999999999999999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
+++....... ......|++.|+|||.+.+..++.++||||||+++|||+||+.||...... .....+. .+
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~i~----~~ 231 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-----ELAGKIR----EG 231 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHH----HT
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-----HHHHHHh----hc
Confidence 9987644321 122345899999999999989999999999999999999999999754321 1112221 11
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
... ..+.....++.+++.+||+.||++||++.|+++.+..
T Consensus 232 ~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 KFR--------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ccc--------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 111 1122344678899999999999999999999988764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=341.13 Aligned_cols=246 Identities=21% Similarity=0.260 Sum_probs=204.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999975 78999999986421 2234567889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999863 3589999999999999999999999 999999999999999999999999999987643
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+. . +..
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~i~---~-~~~----- 255 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-----QIYEKIV---S-GKV----- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHH---H-CCC-----
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-----HHHHHHH---c-CCC-----
Confidence 2 23356899999999999999999999999999999999999999754321 1111111 1 110
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM 546 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 546 (596)
.++.....++.+++.+||+.||++||+ ++|+.++
T Consensus 256 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 ----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 112233467889999999999999998 7777553
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=337.62 Aligned_cols=250 Identities=22% Similarity=0.262 Sum_probs=194.7
Q ss_pred hcCCCcCceeeecCceEEEEEEe----CCCcEEEEEEccccC---CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 343 (596)
.++|+..+.||+|+||.||+|+. .+++.||+|+++... .......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788899999999999999996 478999999997532 12334567899999999999999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999999752 4588999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.. . ..
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~---~-~~ 238 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-----TIDKILK---C-KL 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHH---T-CC
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHh---C-CC
Confidence 7543322 12334568999999999999999999999999999999999999997543211 1111111 1 00
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
..+.....++.+++.+||+.||++|| ++.|++++
T Consensus 239 ---------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 ---------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11223346788999999999999999 66777653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.63 Aligned_cols=254 Identities=27% Similarity=0.390 Sum_probs=194.5
Q ss_pred CCCcCceeeecCceEEEEEEeC--CC--cEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec-CCeeEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS--DN--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILV 347 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv 347 (596)
.|...+.||+|+||.||+|... ++ ..||+|.++........+.|.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556789999999999999863 22 46899998765555667889999999999999999999999765 4577999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999753 34588999999999999999999999 99999999999999999999999999998664
Q ss_pred ccCcc---eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 428 AKLTH---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 428 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
..... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||...... .....+.. ...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-----~~~~~~~~---~~~- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQ---GRR- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-----CHHHHHHT---TCC-
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-----HHHHHHHc---CCC-
Confidence 33211 1223457789999999999999999999999999999999 66777643221 12222211 110
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+...+..+.+++.+||+.||++||++.|+++.|+.
T Consensus 315 --------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 315 --------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 01122334578899999999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=344.34 Aligned_cols=266 Identities=17% Similarity=0.199 Sum_probs=201.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCC------CcEEEEEEccccCCcc----------hHHHHHHHHHHHHhcCCCCccc
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPG----------GEAAFQREVHLISVAIHKNLLQ 333 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~----------~~~~~~~e~~~l~~l~H~niv~ 333 (596)
..++|...+.||+|+||.||+|.+.+ ++.||||++....... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999754 4789999986432100 0122344555667778999999
Q ss_pred eEeEEecC----CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE
Q 007608 334 LIGYCTTS----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 409 (596)
Q Consensus 334 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll 409 (596)
+++++... ...++||||+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998765 4479999999 99999999762 34699999999999999999999999 99999999999999
Q ss_pred c--CCCcEEEeeccccccccccCcce------eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCcc
Q 007608 410 D--DNFEAVLCDFGLAKLVDAKLTHV------TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 481 (596)
Q Consensus 410 ~--~~~~~kl~DfGl~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~ 481 (596)
+ .++.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 88999999999998765432211 123459999999999999999999999999999999999999997432
Q ss_pred chhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 482 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 482 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.. ........... .....+++++.+.. ...+.++.+++..|++.+|++||++.++++.|++
T Consensus 266 ~~----~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 266 KD----PKYVRDSKIRY-RENIASLMDKCFPA--ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp TC----HHHHHHHHHHH-HHCHHHHHHHHSCT--TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cC----HHHHHHHHHHh-hhhHHHHHHHhccc--ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 21 11111111111 11122223322211 1224578899999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=329.51 Aligned_cols=259 Identities=20% Similarity=0.258 Sum_probs=200.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999965 78899999987432 223347789999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
+||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999863 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
...........|++.|+|||++.+..++.++||||||+++|||+||+.||...... .....+. .......
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~---~~~~~~~-- 255 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-----VMGAHIN---QAIPRPS-- 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-----HHHHHHH---SCCCCGG--
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-----HHHHHhc---cCCCCcc--
Confidence 44333333456899999999999999999999999999999999999999753221 1111111 1000000
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhccCC
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRP-PMAQVVKMLQGED 551 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~ 551 (596)
......+.++.+++.+||+.||++|| +++++++.|+...
T Consensus 256 -----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 256 -----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp -----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred -----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 11223345788899999999999999 9999999998643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=346.00 Aligned_cols=272 Identities=18% Similarity=0.210 Sum_probs=213.7
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC--eeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv 347 (596)
.++|...+.||+|+||+||+|... +++.||||++.........+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 356888999999999999999975 589999999975444455678889999999999999999999998765 67999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE----cCCCcEEEeecccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLA 423 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~DfGl~ 423 (596)
|||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999986432 23489999999999999999999999 99999999999999 78888999999999
Q ss_pred ccccccCcceeccccccccccCcccccC--------CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHH
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLST--------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~ 495 (596)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||............+.....
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp EECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred eEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 87654322 233568999999999865 56788999999999999999999999753332222222222211
Q ss_pred HHhccCcccccc---------cCc---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 496 KLLREDRLNDIV---------DRN---LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 496 ~~~~~~~~~~~~---------d~~---l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.........+. ... ...........+.+++.+||+.||++||++.|+++.+++
T Consensus 242 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 242 -GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp -SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred -CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 11111111100 001 112457788889999999999999999999999998875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=366.00 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=200.3
Q ss_pred eeeecCceEEEEEEeC---CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCC
Q 007608 279 IIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 355 (596)
Q Consensus 279 ~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (596)
.||+|+||.||+|.+. ++..||||+++........+.|.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999863 5667999999865555567889999999999999999999999976 56899999999999
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCccee-
Q 007608 356 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT- 434 (596)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~- 434 (596)
|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999752 34689999999999999999999999 999999999999999999999999999987654322211
Q ss_pred -ccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCC
Q 007608 435 -TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 512 (596)
Q Consensus 435 -~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 512 (596)
....+++.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+.. +.. .
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~~~~~i~~----~~~--------~ 558 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVMAFIEQ----GKR--------M 558 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-----HHHHHHHT----TCC--------C
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHc----CCC--------C
Confidence 22235689999999999999999999999999999998 99999754321 12222221 110 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 513 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 513 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+...+.++.+++.+||+.||++||++.+|++.|+.
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1223445688899999999999999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.96 Aligned_cols=253 Identities=19% Similarity=0.227 Sum_probs=206.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||.||+|... +++.||+|++... .......+.+|++++.+++||||+++++++.+....++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 467899999999999999999975 6899999998643 23345678999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC--CCcEEEeecccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVD 427 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~DfGl~~~~~ 427 (596)
|+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 129 ~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999988752 24689999999999999999999999 9999999999999974 5779999999998765
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+.. ... .+
T Consensus 203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~~~~i~~---~~~---~~ 269 (387)
T 1kob_A 203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-----ETLQNVKR---CDW---EF 269 (387)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHH---CCC---CC
T ss_pred CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-----HHHHHHHh---CCC---CC
Confidence 4322 22346899999999999999999999999999999999999999753321 11111111 110 01
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
++. .......++.+++.+||+.||++||++.|++++
T Consensus 270 ~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DED---AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSS---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred Ccc---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111 112334578899999999999999999999885
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.29 Aligned_cols=262 Identities=22% Similarity=0.296 Sum_probs=200.5
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC-cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
++|+..+.||+|+||+||+|... +|+.||+|++..... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999975 589999999864332 2335678899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999888775 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHh----------
Q 007608 430 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL---------- 498 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~---------- 498 (596)
... .....||+.|+|||++.+ ..++.++||||||+++|||+||+.||......+.. ..+....
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 156 SDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL-----YLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----HHHHHHHCSCCHHHHHH
T ss_pred ccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHHHhcccccccccc
Confidence 222 233458999999999876 56899999999999999999999999764432111 1111110
Q ss_pred --ccCcccc--cccCcCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 499 --REDRLND--IVDRNLNT----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 499 --~~~~~~~--~~d~~l~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....... +.++.-.. ........+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 00110000 011234568899999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=365.12 Aligned_cols=261 Identities=27% Similarity=0.390 Sum_probs=212.4
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 266 ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 266 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
.+++..++|+..+.||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 3445567788899999999999999999888899999997532 245789999999999999999999999876 6789
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 9999999999999997521 23589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
.............++..|+|||++.+..++.++|||||||++|||+| |+.||...... .....+.. ..+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-----~~~~~i~~---~~~-- 482 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVER---GYR-- 482 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----HHHHHHHT---TCC--
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHc---CCC--
Confidence 65432222223446789999999999999999999999999999999 89999753321 12222211 111
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 551 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 551 (596)
...+......+.+++.+||+.||++||++.+|+++|++..
T Consensus 483 -------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 483 -------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0112234567889999999999999999999999998753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=332.49 Aligned_cols=261 Identities=22% Similarity=0.344 Sum_probs=200.0
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||.||+|.. .+|+.||+|++... ........+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35688899999999999999996 47999999998742 2344567789999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999976444456789999999999999999999999 99999999999999999999999999998664
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ........ ........
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~- 258 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKI-EQCDYPPL- 258 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHHHHH-HTTCSCCC-
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHHHHh-hcccCCCC-
Confidence 4322 122345899999999999999999999999999999999999999743221 11111111 11111110
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.......++.+++.+||+.||++||++.||++.|++
T Consensus 259 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~ 294 (310)
T 2wqm_A 259 ------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294 (310)
T ss_dssp ------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 012234578899999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=333.85 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=196.0
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
++|+..+.||+|+||+||+|.. .++.||+|++.. ....+.|.+|++++++++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 5678889999999999999998 478899999863 3356789999999999999999999998764 479999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc-EEEeeccccccccccC
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-AVLCDFGLAKLVDAKL 430 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-~kl~DfGl~~~~~~~~ 430 (596)
++|+|.+++..... ...+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999986321 234788999999999999999999933238999999999999988876 799999999765432
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||....... ......... ....
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~~------ 223 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA------FRIMWAVHN-GTRP------ 223 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH------HHHHHHHHT-TCCC------
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH------HHHHHHHhc-CCCC------
Confidence 123358999999999999999999999999999999999999997432211 011111111 1100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
......+..+.+++.+||+.||++||++.|+++.|+.
T Consensus 224 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 260 (307)
T 2eva_A 224 --PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260 (307)
T ss_dssp --CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 1112234568889999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=338.96 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=202.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCc----EEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
.++|+..+.||+|+||.||+|... +++ +||+|.+...........+.+|+.++.+++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467888999999999999999964 444 358888765555667788999999999999999999999998765 78
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+|++|+.+|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999999863 24589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 426 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 426 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ ....+.. ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~~~~~----~~- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILEK----GE- 236 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHHHHT----TC-
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHc----CC-
Confidence 6443222 2223446789999999999999999999999999999999 999997543321 2222211 10
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
....+.....++.+++.+||+.||++||++.|+++.|+..
T Consensus 237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0011223445788999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=345.46 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=197.7
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcC--CCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||+|...+++.||||++... ........+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999998643 23445678999999999997 599999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
| +.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 567899999986 24688999999999999999999999 999999999999996 57899999999987654
Q ss_pred cCcc-eeccccccccccCcccccC-----------CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH
Q 007608 429 KLTH-VTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 429 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~~ 279 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLHA 279 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------HHHHHH
Confidence 3222 2334569999999999865 46899999999999999999999999743211 111111
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
........ ..+.....++.+++.+||+.||++||++.|++++
T Consensus 280 ~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 IIDPNHEI--------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHCTTSCC--------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCccccC--------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111100 0111124578899999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=339.80 Aligned_cols=267 Identities=18% Similarity=0.208 Sum_probs=199.8
Q ss_pred hcCCCcCceeeecCceEEEEEEeC----CCcEEEEEEccccCCcc----------hHHHHHHHHHHHHhcCCCCccceEe
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPG----------GEAAFQREVHLISVAIHKNLLQLIG 336 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~----------~~~~~~~e~~~l~~l~H~niv~l~~ 336 (596)
.++|...+.||+|+||.||+|... ++..+|+|++....... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 457888999999999999999975 57889999986432211 1234667888899999999999999
Q ss_pred EEec----CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC
Q 007608 337 YCTT----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 412 (596)
Q Consensus 337 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~ 412 (596)
++.. ....++||||+ +++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9987 67889999999 99999999863 2689999999999999999999999 99999999999999888
Q ss_pred C--cEEEeeccccccccccCcc------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchh
Q 007608 413 F--EAVLCDFGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 484 (596)
Q Consensus 413 ~--~~kl~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~ 484 (596)
+ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999876433211 1134568999999999999999999999999999999999999996422111
Q ss_pred hhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCc
Q 007608 485 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL 552 (596)
Q Consensus 485 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 552 (596)
.. . .......... ....+..... ....+.++.+++.+||+.||++||++.||++.|++..+
T Consensus 268 ~~---~-~~~~~~~~~~-~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VA---V-QTAKTNLLDE-LPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HH---H-HHHHHHHHHT-TTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HH---H-HHHHHhhccc-ccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11 1 1111111111 0000000000 01234578899999999999999999999999997554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=332.14 Aligned_cols=255 Identities=27% Similarity=0.384 Sum_probs=202.0
Q ss_pred cCCCcCceeeecCceEEEEEEeCC----CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec-CCeeEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERIL 346 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~l 346 (596)
.+|+..+.||+|+||+||+|...+ ...+|+|.+.........+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999999642 235899998765555567789999999999999999999998654 557799
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999752 34589999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcc---eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 427 DAKLTH---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 427 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...... ........ ...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-----~~~~~~~~---~~~ 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQ---GRR 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-----THHHHHHT---TCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-----HHHHHHhc---CCC
Confidence 443221 2233457889999999999999999999999999999999 45555432211 11111111 100
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+......+.+++.+|++.||++||++.|+++.|++
T Consensus 251 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 251 ---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00112234578899999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=337.84 Aligned_cols=264 Identities=25% Similarity=0.389 Sum_probs=200.2
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEeC----CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEec
Q 007608 266 ELQLATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 340 (596)
Q Consensus 266 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 340 (596)
++....++|...+.||+|+||.||+|... ++..||+|+++.. ......+.+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33445678888999999999999999853 3458999998743 234445779999999999999999999999977
Q ss_pred CCe-----eEEEEEcccCCChhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC
Q 007608 341 SSE-----RILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 413 (596)
Q Consensus 341 ~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~ 413 (596)
... .++||||+++++|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 653 499999999999999985322 2345799999999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHH
Q 007608 414 EAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL 491 (596)
Q Consensus 414 ~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~ 491 (596)
.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ...
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~ 259 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-----EMY 259 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHH
Confidence 9999999999866443221 2223457889999999999999999999999999999999 88898754321 122
Q ss_pred HHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 492 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 492 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+.. ... ...+.....++.+++.+||+.||++||++.|++++|+.
T Consensus 260 ~~~~~---~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 260 DYLLH---GHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp HHHHT---TCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHc---CCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 22211 100 11122334678899999999999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=326.32 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=206.3
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||.||+|... +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357888999999999999999975 7899999998754444556789999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999998875 34689999999999999999999999 9999999999999999999999999999865432
Q ss_pred Cc-ceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 430 LT-HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 430 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.. .......|++.|+|||.+.+..+ +.++||||||+++|||+||+.||........ ....+.. .... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~----~~~~---~ 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWKE----KKTY---L 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH---HHHHHHT----TCTT---S
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHhhh----cccc---c
Confidence 21 12234568999999999987765 7789999999999999999999975432111 1111111 0000 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.........+.+++.+|++.||++|||+.|+++.
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0012234567889999999999999999999763
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.70 Aligned_cols=254 Identities=27% Similarity=0.346 Sum_probs=202.9
Q ss_pred CCcCceeeecCceEEEEEEeC-C---CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCee-EEEE
Q 007608 274 FSESNIIGQGGFGKVYKGVLS-D---NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER-ILVY 348 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~-~lv~ 348 (596)
|...+.||+|+||+||+|... + +..||+|++.........+.+.+|+.++++++||||+++++++.+.+.. ++|+
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 455689999999999999853 2 2379999997655555667899999999999999999999999877665 9999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+.+|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 103 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred ecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999752 34689999999999999999999999 999999999999999999999999999986543
Q ss_pred cCc---ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 429 KLT---HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 429 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
... .......+++.|+|||.+.+..++.++||||||+++|||+||..|+..... .......+.....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~~~~~------ 246 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----PFDLTHFLAQGRR------ 246 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----GGGHHHHHHTTCC------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC----HHHHHHHhhcCCC------
Confidence 321 122334578899999999999999999999999999999996655432211 1122222221110
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+......+.+++.+|++.||++|||++|+++.|++
T Consensus 247 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 247 ------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 01122234578899999999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=356.15 Aligned_cols=251 Identities=21% Similarity=0.262 Sum_probs=196.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
..++|+..+.||+|+||.||+|... +|+.||||++... ........+.+|+.++..++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467889999999999999999964 7899999998742 233345677899999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++.
T Consensus 226 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999876 3468999999999999999999998 7 899999999999999999999999999986
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+. ... .
T Consensus 299 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~i~---~~~-~-- 366 (446)
T 4ejn_A 299 GIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELIL---MEE-I-- 366 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHH---HCC-C--
T ss_pred ccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHH---hCC-C--
Confidence 433222 233467999999999999999999999999999999999999999754321 1111111 110 0
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
.++.....++.+++.+||+.||++|| +++|++++
T Consensus 367 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 -------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11223346788999999999999999 99998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=339.52 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=203.5
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCee
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 344 (596)
...++|+..+.||+|+||.||+|+.. +++.||+|+++... .......+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34578999999999999999999976 57899999987421 223456788999999887 799999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 9999999999999999863 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+. ... .
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~---~~~-~- 238 (353)
T 2i0e_A 170 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQSIM---EHN-V- 238 (353)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHH---HCC-C-
T ss_pred ccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-----HHHHHHH---hCC-C-
Confidence 543221 2233456999999999999999999999999999999999999999754321 1111111 111 0
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM-----AQVVK 545 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 545 (596)
.++.....++.+++.+||+.||++||++ +|+.+
T Consensus 239 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1222345678899999999999999964 55544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=333.32 Aligned_cols=257 Identities=24% Similarity=0.332 Sum_probs=205.2
Q ss_pred HHHhcCCCcCc-eeeecCceEEEEEEe---CCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC
Q 007608 268 QLATDNFSESN-IIGQGGFGKVYKGVL---SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 342 (596)
Q Consensus 268 ~~~~~~f~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 342 (596)
....++|...+ .||+|+||.||+|.. .+++.||||+++... .....+.+.+|++++..++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 33455677777 999999999999964 347889999997432 233467899999999999999999999999 566
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 78999999999999999986 34589999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcce--eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhc
Q 007608 423 AKLVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLR 499 (596)
Q Consensus 423 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~ 499 (596)
+.......... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~---- 234 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVTAMLE---- 234 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHH----
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHH----
Confidence 98765443322 122346788999999998889999999999999999999 99999754321 1122221
Q ss_pred cCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 500 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 500 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.... ...+......+.+++.+||+.||++||++.|+++.|++
T Consensus 235 ~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 235 KGER--------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp TTCC--------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cCCC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1110 11223345678899999999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=338.41 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=204.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcE--EEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTK--VAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 346 (596)
.++|+..+.||+|+||.||+|... ++.. +|+|+++..........+.+|++++.++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367888999999999999999964 5654 4999987655555567799999999999 89999999999999999999
Q ss_pred EEEcccCCChhhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc
Q 007608 347 VYPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 414 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 414 (596)
||||+++++|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999998643 2234689999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHH
Q 007608 415 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH 493 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~ 493 (596)
+||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|||+| |+.||...... +.
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~~ 250 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------EL 250 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HH
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--------HH
Confidence 9999999997543221 1122346889999999998889999999999999999998 99999754321 11
Q ss_pred HHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 494 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 494 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
... ...+.. ...+.....++.+++.+||+.||++||++.|+++.|+.
T Consensus 251 ~~~-~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 251 YEK-LPQGYR--------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp HHH-GGGTCC--------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH-hhcCCC--------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111 111100 01122334678899999999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=340.31 Aligned_cols=262 Identities=21% Similarity=0.204 Sum_probs=201.6
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc----CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC
Q 007608 268 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 342 (596)
Q Consensus 268 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 342 (596)
....++|+..+.||+|+||.||+|... ++..||+|++... ......+.+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 445678999999999999999999964 6889999998632 23455678999999999999999999999999999
Q ss_pred eeEEEEEcccCCChhhhhcccCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPG------------------------------------EKGLDWPTRKRVAFGTAYGL 386 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~~L 386 (596)
..++||||+++|+|.+++...... ...+++..++.++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998632111 11235677889999999999
Q ss_pred HHHHhCCCCCcEecCCCCCcEEEcCCC--cEEEeeccccccccccCc---ceeccccccccccCcccccC--CCCCcccc
Q 007608 387 EYLHEQCNPKIIHRDLKAANILLDDNF--EAVLCDFGLAKLVDAKLT---HVTTQIRGTMGHIAPEYLST--GKSSEKTD 459 (596)
Q Consensus 387 ~~LH~~~~~~ivH~dlkp~NIll~~~~--~~kl~DfGl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~sD 459 (596)
+|||+. +|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||++.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 899999999986543221 12334568999999999875 67899999
Q ss_pred cHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 007608 460 VFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 539 (596)
Q Consensus 460 v~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 539 (596)
||||||++|||++|+.||......+ . .......... ...+ ........+.+++.+|++.||++||+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~-----~---~~~~~~~~~~--~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDAD-----T---ISQVLNKKLC--FENP----NYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHH-----H---HHHHHHCCCC--TTSG----GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHH-----H---HHHHHhcccc--cCCc----ccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999997543211 1 1111111100 0000 01123457889999999999999999
Q ss_pred HHHHHHH
Q 007608 540 MAQVVKM 546 (596)
Q Consensus 540 ~~evl~~ 546 (596)
+.|+++.
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999773
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=334.54 Aligned_cols=267 Identities=23% Similarity=0.309 Sum_probs=209.9
Q ss_pred cHHHHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHh--cCCCCccceEeEEec
Q 007608 263 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTT 340 (596)
Q Consensus 263 ~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~ 340 (596)
+........++|...+.||+|+||.||+|+. +++.||||++.. .....+.+|.+++.. ++||||+++++++..
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3334455667899999999999999999998 689999999853 245677889998887 789999999999988
Q ss_pred CC----eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCcEecCCCCCcEE
Q 007608 341 SS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--------EQCNPKIIHRDLKAANIL 408 (596)
Q Consensus 341 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~dlkp~NIl 408 (596)
.. ..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 76 78999999999999999975 35899999999999999999999 66 9999999999999
Q ss_pred EcCCCcEEEeeccccccccccCcc---eeccccccccccCcccccCC------CCCcccccHHHHHHHHHHHhC------
Q 007608 409 LDDNFEAVLCDFGLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTG------KSSEKTDVFGYGITLLELVTG------ 473 (596)
Q Consensus 409 l~~~~~~kl~DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvil~elltg------ 473 (596)
++.++.+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999876543322 12345689999999999765 234789999999999999999
Q ss_pred ----CCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 474 ----QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 474 ----~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
..||......... ...+.... .... ..+.+.. ........+.+++.+||+.||++||++.||+++|
T Consensus 260 ~~~~~~p~~~~~~~~~~---~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPS---VEEMRKVV-CEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp CCCCCCTTTTTSCSSCC---HHHHHHHH-TTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccccccCccccCcCccc---HHHHHHHH-HHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 6677543221111 11111111 1111 1111111 1346677899999999999999999999999999
Q ss_pred ccC
Q 007608 548 QGE 550 (596)
Q Consensus 548 ~~~ 550 (596)
+.+
T Consensus 332 ~~i 334 (342)
T 1b6c_B 332 SQL 334 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=340.70 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=194.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||+||+++.. +++.||+|++.... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 467899999999999999999975 78999999997432 234668899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc--EEEeecccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--AVLCDFGLAKLVD 427 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~DfGl~~~~~ 427 (596)
|+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999999875 23589999999999999999999999 9999999999999987765 9999999997443
Q ss_pred ccCcceeccccccccccCcccccCCCCCcc-cccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEK-TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...... ......+........ .
T Consensus 170 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~~~~~~~~-~-- 240 (361)
T 3uc3_A 170 LHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----RDYRKTIQRILSVKY-S-- 240 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C----CCHHHHHHHHHTTCC-C--
T ss_pred ccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH----HHHHHHHHHHhcCCC-C--
Confidence 221 2233468999999999988887665 89999999999999999999753321 112222222211110 0
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. .......++.+++.+||+.||++|||+.|++++
T Consensus 241 ----~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 ----IP-DDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----CC-TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----CC-CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 011124577899999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=342.96 Aligned_cols=257 Identities=22% Similarity=0.273 Sum_probs=204.9
Q ss_pred hcCCCcCceeeecCceEEEEEEe----CCCcEEEEEEccccC---CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCC
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS 342 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 342 (596)
.++|+..+.||+|+||.||+|+. .+++.||||+++... .......+.+|++++.++ .||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36788899999999999999997 478999999986422 122345677899999999 6999999999999999
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999999863 4589999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeccccccccccCcccccC--CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
++..............||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...........
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~ 281 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILKS 281 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHHC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHHHHHHHhcc
Confidence 98765443333445579999999999986 3478999999999999999999999975332111 11111111111
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhc
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKMLQ 548 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~ 548 (596)
. ..++......+.+++.+||+.||++|| +++|++++.-
T Consensus 282 ~----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 282 E----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp C----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred C----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 0 112233445788999999999999999 8999977653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=335.73 Aligned_cols=264 Identities=24% Similarity=0.313 Sum_probs=206.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEe----cCCee
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT----TSSER 344 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~----~~~~~ 344 (596)
..++|+..+.||+|+||.||++.. .+++.||+|++.. ........+.+|++++++++||||+++++++. .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE-SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec-CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 456788999999999999999996 5789999999864 23445678899999999999999999999986 33467
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++|+||+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 899999999999999987544456799999999999999999999999 99999999999999999999999999987
Q ss_pred cccccCcc--------eeccccccccccCcccccCCC---CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHH
Q 007608 425 LVDAKLTH--------VTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 493 (596)
Q Consensus 425 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~ 493 (596)
........ ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... .......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~ 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVALA 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHHHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhhHH
Confidence 65321111 011234799999999987654 689999999999999999999998632111 1111111
Q ss_pred HHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCc
Q 007608 494 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL 552 (596)
Q Consensus 494 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 552 (596)
... . .. ..........+.+++.+||+.||.+||++.|+++.|+....
T Consensus 260 ~~~----~-~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 VQN----Q-LS-------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHC----C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhc----c-CC-------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 111 0 00 00112234578899999999999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=328.30 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=201.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
+.++|+..+.||+|+||+||+|... ++..||+|++.... .......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567888999999999999999965 67899999986321 12235678999999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999999998763 3589999999999999999999998 9999999999999999999999999998654
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
.... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+.. ..
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~---~~----- 223 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYKRISR---VE----- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHH---TC-----
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-----HHHHHHh---CC-----
Confidence 3321 233468999999999999999999999999999999999999997543211 1111111 00
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. ..+......+.+++.+||+.||++||++.|++++
T Consensus 224 --~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 --F---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --C---CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --C---CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 1122234567889999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=331.02 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=201.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||+||+|... +++.||+|++... ........+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457888999999999999999975 7999999998743 2344567788999999999 899999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC----------------
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---------------- 411 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---------------- 411 (596)
|||+++++|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999986433335689999999999999999999999 9999999999999984
Q ss_pred ---CCcEEEeeccccccccccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhh
Q 007608 412 ---NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED 487 (596)
Q Consensus 412 ---~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~ 487 (596)
...+||+|||.+....... ...||+.|+|||.+.+. .++.++||||||+++|||++|.+++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence 4479999999998765432 23489999999999876 567899999999999999999877643211
Q ss_pred chHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 488 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 488 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+. .+.. ...+......+.+++.+||+.||++||++.|++++
T Consensus 237 ---~~~~~----~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 ---WHEIR----QGRL--------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---HHHHH----TTCC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---HHHHH----cCCC--------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11111 1111 11122334678899999999999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=337.64 Aligned_cols=270 Identities=22% Similarity=0.256 Sum_probs=210.4
Q ss_pred cccccHHHHHHHhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-----CCCcc
Q 007608 259 LRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----HKNLL 332 (596)
Q Consensus 259 ~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-----H~niv 332 (596)
...+++++.....++|...+.||+|+||+||+|+. .+++.||||+++. .......+..|+.++..+. ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 34456666666788999999999999999999997 4789999999863 2344567788999999986 99999
Q ss_pred ceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-
Q 007608 333 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD- 411 (596)
Q Consensus 333 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~- 411 (596)
++++++...+..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP 173 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence 9999999999999999999 899999998633 23589999999999999999999999 9999999999999975
Q ss_pred ------------------------CCcEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHH
Q 007608 412 ------------------------NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITL 467 (596)
Q Consensus 412 ------------------------~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil 467 (596)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 789999999999865432 2345689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCccchhhhhchHHHHHHHHhccC-----------cccccccCc-----CCC--CC--------------
Q 007608 468 LELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED-----------RLNDIVDRN-----LNT--YD-------------- 515 (596)
Q Consensus 468 ~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~-----------~~~~~~d~~-----l~~--~~-------------- 515 (596)
|||+||+.||......+ ....+....... .....++.. ... ..
T Consensus 250 ~ell~g~~pf~~~~~~~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 324 (360)
T 3llt_A 250 AELYTGSLLFRTHEHME-----HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324 (360)
T ss_dssp HHHHHSSCSCCCSSHHH-----HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred HHHHHCCCCCCCCcHHH-----HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence 99999999997543211 111111111000 000000000 000 00
Q ss_pred -HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 516 -SKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 516 -~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
......+.+++.+||+.||++|||++|+++
T Consensus 325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 001256789999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.24 Aligned_cols=253 Identities=22% Similarity=0.285 Sum_probs=206.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCc-----chHHHHHHHHHHHHhcCCCCccceEeEEecCCee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 344 (596)
.++|+..+.||+|+||.||+|... +|+.||+|++...... .....+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888999999999999999975 6899999998743322 1367899999999999999999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC----cEEEeec
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF 420 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Df 420 (596)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999975 34689999999999999999999999 999999999999999888 7999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
|++....... ......||+.|+|||++.+..++.++||||||+++|||+||+.||......+ ....+.. .
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~i~~---~ 233 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANITS---V 233 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHHT---T
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHh---c
Confidence 9998765432 2234468999999999999999999999999999999999999997533211 1111111 0
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. . . .++. ........+.+++.+|++.||++|||+.|++++
T Consensus 234 ~-~-~-~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 S-Y-D-FDEE---FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C-C-C-CCHH---HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c-c-c-cChh---hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 0 0000 001123568899999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=332.47 Aligned_cols=250 Identities=20% Similarity=0.262 Sum_probs=181.3
Q ss_pred CceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEEEEcccCC
Q 007608 277 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 354 (596)
.+.||+|+||.||+|... +++.||||++.. .....+.+|+.++..+. ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999975 689999999864 24567889999999997 999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC---cEEEeeccccccccccCc
Q 007608 355 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~DfGl~~~~~~~~~ 431 (596)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 92 ~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 92 ELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp BHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999986 34689999999999999999999999 999999999999997665 899999999986644322
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcC
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 511 (596)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+...... .+... .
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i~-~~~~~------~ 235 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKIK-KGDFS------F 235 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHT-TTCCC------C
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHHH-cCCCC------C
Confidence 22334589999999999999999999999999999999999999975332111 011111121111 11100 0
Q ss_pred CC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 512 NT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 512 ~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. .......++.+++.+||+.||++||++.|++++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 00 011235678899999999999999999999753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=331.03 Aligned_cols=265 Identities=25% Similarity=0.296 Sum_probs=200.7
Q ss_pred HHhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC----CcchHHHHHHHHHHHHhcC---CCCccceEeEEec
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAI---HKNLLQLIGYCTT 340 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~ 340 (596)
...++|+..+.||+|+||+||+|+. .+++.||+|++.... .......+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467899999999999999999996 478999999986322 1222356778888777665 9999999999977
Q ss_pred CC-----eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcE
Q 007608 341 SS-----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 415 (596)
Q Consensus 341 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 415 (596)
.. ..++||||+. ++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 65 4789999997 59999988633 23489999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHH
Q 007608 416 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495 (596)
Q Consensus 416 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~ 495 (596)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+.
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~i~ 232 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-----QLGKIF 232 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-----HHHHHH
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHH
Confidence 999999998664332 2234568999999999999999999999999999999999999997543221 111222
Q ss_pred HHhcc---Cccccc-------ccCcCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 496 KLLRE---DRLNDI-------VDRNLNT----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 496 ~~~~~---~~~~~~-------~d~~l~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..... ...... +.+.... ........+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 11111 000000 0000000 011234678899999999999999999999763
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.26 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=200.4
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.++|+..+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357888999999999999999975 58999999986433 2334566889999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999998887664 34589999999999999999999999 999999999999999999999999999986644
Q ss_pred cCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH----------H
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK----------L 497 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~----------~ 497 (596)
... ......|++.|+|||++.+. .++.++|||||||++|||++|+.||......+. +...... .
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ----LYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCHHHHHH
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhCCCChhhhhH
Confidence 322 22334589999999999875 689999999999999999999999986433211 1111100 0
Q ss_pred -hccCcccccccCcCCC-C-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 498 -LREDRLNDIVDRNLNT-Y-----DSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 498 -~~~~~~~~~~d~~l~~-~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...........+.+.. . .......+.+++.+||+.||++||++.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000011111111111 1 1123567899999999999999999999976
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=341.59 Aligned_cols=267 Identities=22% Similarity=0.292 Sum_probs=206.4
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||.||+|... ++..||+|++...........+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467888999999999999999975 7899999999765555566789999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999863 35899999999999999999999832 7999999999999999999999999999765332
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHH------------
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL------------ 497 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~------------ 497 (596)
......||+.|+|||++.+..++.++|||||||++|||+||+.||......+.............
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 12334689999999999999999999999999999999999999986443221100000000000
Q ss_pred ---------hccCcc----cccccCcCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 498 ---------LREDRL----NDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 498 ---------~~~~~~----~~~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...... ..+....... .......++.+++.+||+.||++|||++|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000 0000000000 111234578899999999999999999999763
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=329.76 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=207.7
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.+.|+..+.||+|+||.||+|... +++.||+|++...........+.+|+.++.+++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999964 7899999999755555567889999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999864 4689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
.. ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .....+.. ... +
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~----~~~-----~ 237 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-----KVLFLIPK----NNP-----P 237 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHH----SCC-----C
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-----HHHHHhhc----CCC-----C
Confidence 22 223356899999999999999999999999999999999999999753221 11111111 110 1
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.........+.+++.+||+.||++||++.|+++.
T Consensus 238 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 ---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ---CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ---CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1112234568899999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=353.17 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=206.3
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|...++||+|+||.||+|+.. +|+.||+|++.... .......+.+|+.++.+++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999975 69999999986421 123456788999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++.........+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999987554456799999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ..+.........
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~i~~~~------ 409 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRVLEQA------ 409 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHHHHHCC------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHHHhhcc------
Confidence 4322 22335799999999999999999999999999999999999999975422111 111111111110
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 541 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 541 (596)
..++......+.+++.+||+.||++||++.
T Consensus 410 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 410 ----VTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred ----cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 112233456788999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=325.72 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=183.6
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|...+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688899999999999999996 478999999986321 1223467899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999998753 24689999999999999999999999 999999999999999999999999999987643
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ... +..
T Consensus 165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~---------~~~ 226 (278)
T 3cok_A 165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------LNK---------VVL 226 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CCS
T ss_pred CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------HHH---------Hhh
Confidence 3221 2234589999999999998899999999999999999999999975432110 000 000
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
... ..+.....++.+++.+|++.||++||++.|+++
T Consensus 227 ~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 ADY-EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCC-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccc-CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000 112233457889999999999999999999976
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=328.53 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=201.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CC-------cEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DN-------TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 342 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 342 (596)
.++|...+.||+|+||+||+|... ++ ..||+|++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 457888999999999999999864 33 47999998642 3345678999999999999999999999999999
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc--------
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-------- 414 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-------- 414 (596)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999863 23489999999999999999999999 9999999999999998887
Q ss_pred EEEeeccccccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHH
Q 007608 415 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 493 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~ 493 (596)
+||+|||++...... ....|++.|+|||++.+ ..++.++||||||+++|||+||..|+...... ......
T Consensus 160 ~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~----~~~~~~ 230 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS----QRKLQF 230 (289)
T ss_dssp EEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHH
T ss_pred eeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch----HHHHHH
Confidence 999999998755332 22347889999999987 67899999999999999999965544322111 011111
Q ss_pred HHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCcc
Q 007608 494 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLA 553 (596)
Q Consensus 494 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 553 (596)
.. ..... +.....++.+++.+||+.||++|||+.|+++.|++....
T Consensus 231 ~~---~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 231 YE---DRHQL-----------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HH---TTCCC-----------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred hh---ccCCC-----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11 11111 111133578899999999999999999999999976543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=350.59 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=205.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|...+.||+|+||.||+|+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357888999999999999999975 79999999986421 122356789999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999875 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .+...+. . +..
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----~~~~~i~---~-~~~--- 233 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-----TLFKKIC---D-GIF--- 233 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-----HHHHHHH---T-TCC---
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHh---c-CCc---
Confidence 432 2234568999999999988765 68999999999999999999999854321 1111111 1 100
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..+.....++.+++.+||+.||++|||+.|+++
T Consensus 234 ------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 ------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 111223456889999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=336.53 Aligned_cols=260 Identities=27% Similarity=0.372 Sum_probs=206.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEe------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 343 (596)
..++|+..+.||+|+||.||+|.. .++..||||++...........+.+|+.++.+++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 356788999999999999999984 25778999999765555667789999999999999999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC---CCcEEE
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPG---EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVL 417 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl 417 (596)
.++||||+++++|.+++...... ...+++..++.++.|++.||.|||+. +|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999864321 24589999999999999999999999 9999999999999984 456999
Q ss_pred eeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHH
Q 007608 418 CDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR 495 (596)
Q Consensus 418 ~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~ 495 (596)
+|||+++....... .......|++.|+|||++.+..++.++||||||+++|||+| |+.||...... .....+.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~ 259 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----EVLEFVT 259 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-----HHHHHHh
Confidence 99999986543222 12233457889999999998899999999999999999998 99998753221 1222221
Q ss_pred HHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 496 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
. ... ...+......+.+++.+||+.||++||++.|+++.|+.
T Consensus 260 ~---~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 260 S---GGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp T---TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c---CCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 1 110 01122334578899999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=338.17 Aligned_cols=265 Identities=26% Similarity=0.321 Sum_probs=209.6
Q ss_pred hcCCCcCceeeecCceEEEEEEe-----CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEe--cCCe
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT--TSSE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~ 343 (596)
.++|+..+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++. +...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 35788899999999999999984 36889999998743 3445567999999999999999999999886 4456
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 889999999999999997532 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcc--eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhh------chHHHHHH
Q 007608 424 KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED------VLLLDHIR 495 (596)
Q Consensus 424 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~------~~l~~~~~ 495 (596)
+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 876543322 2233457888999999999889999999999999999999999987432211000 00001111
Q ss_pred HHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 496 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...... .....+......+.+++.+||+.||++||++.|++++|+..
T Consensus 255 ~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 255 ELLEEG--------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred HHhhcc--------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 11112334456788999999999999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.12 Aligned_cols=247 Identities=23% Similarity=0.243 Sum_probs=195.4
Q ss_pred CceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccCCC
Q 007608 277 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 355 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (596)
.+.||+|+||.||+|... +|+.||+|+++.. .....+.+.+|++++.+++||||+++++++.+.+..++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 568999999999999964 7899999998743 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE--cCCCcEEEeeccccccccccCcce
Q 007608 356 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL--DDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll--~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 99988752 23589999999999999999999999 99999999999999 6778999999999987654322
Q ss_pred eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCC
Q 007608 434 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 513 (596)
Q Consensus 434 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 513 (596)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||......+ ....+. .... ...+..
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~~i~---~~~~--~~~~~~--- 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-----TLNNIL---ACRW--DLEDEE--- 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHH---HTCC--CSCSGG---
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHH---hccC--CCChhh---
Confidence 223458999999999999999999999999999999999999997543211 111111 1110 000000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 514 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 514 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
......++.+++.+||+.||++||++.|++++
T Consensus 312 -~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 -FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11234578899999999999999999999873
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=338.66 Aligned_cols=243 Identities=21% Similarity=0.273 Sum_probs=201.9
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCC-------cchHHHHHHHHHHHHhcCCCCccceEeEEecCC
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-------PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 342 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 342 (596)
.++|+..+.||+|+||.||+|.. .+++.||||++..... ......+.+|+.++.+++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46799999999999999999995 4789999999874321 113345778999999999999999999999999
Q ss_pred eeEEEEEcccCC-ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 343 ERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 343 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
..++||||+.+| +|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 99999876 34689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------- 236 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------- 236 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence 9987654322 223468999999999988876 88999999999999999999999742110
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...... .+.....++.+++.+||+.||++||++.|+++.
T Consensus 237 --~~~~~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 --VEAAIH-----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --TTTCCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --HhhccC-----CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 111134568899999999999999999999886
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=340.56 Aligned_cols=253 Identities=26% Similarity=0.284 Sum_probs=196.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHH-HHhcCCCCccceEeEEecCCeeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHL-ISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
.++|+..+.||+|+||.||+|+.+ +++.||+|+++... .......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357888999999999999999975 68899999997432 22334556677776 577899999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999976 24588999999999999999999999 9999999999999999999999999999864
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..+.+. .. ..
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~~~~i~---~~-~~--- 256 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MYDNIL---NK-PL--- 256 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-----HHHHHH---HS-CC---
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHH---hc-cc---
Confidence 3221 22344579999999999999999999999999999999999999997543211 111111 11 00
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.++.....++.+++.+||+.||.+||++.+.++.+..
T Consensus 257 ------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~ 293 (373)
T 2r5t_A 257 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293 (373)
T ss_dssp ------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence 0112234568889999999999999999765555544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=323.88 Aligned_cols=260 Identities=18% Similarity=0.232 Sum_probs=201.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEE-ecCCeeEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC-TTSSERILV 347 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv 347 (596)
..++|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+|++++..++|++++..++++ ......++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 357899999999999999999996 578999999875422 223578899999999998888777766 566778999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE---cCCCcEEEeeccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK 424 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DfGl~~ 424 (596)
|||+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 89999998753 24589999999999999999999999 99999999999999 788999999999998
Q ss_pred cccccCcc------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHh
Q 007608 425 LVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 498 (596)
Q Consensus 425 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 498 (596)
........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~ 234 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERISEKK 234 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh--hhhhhhhccc
Confidence 76543221 123456899999999999999999999999999999999999999854322111 1111111110
Q ss_pred ccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 499 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
....... .....+.++.+++.+|++.||++||++.|+++.|++
T Consensus 235 ~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 235 MSTPIEV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHSCHHH--------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred ccchhhh--------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 0000000 001123578899999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=336.44 Aligned_cols=253 Identities=17% Similarity=0.178 Sum_probs=203.6
Q ss_pred HHHhcCCCcCceeeecCceEEEEEE------eCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC---CCCccceEeEE
Q 007608 268 QLATDNFSESNIIGQGGFGKVYKGV------LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYC 338 (596)
Q Consensus 268 ~~~~~~f~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~ 338 (596)
+...++|...+.||+|+||+||+|. ..+++.||+|++.. .....+..|++++..++ |+|++++++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC----CChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 3456789999999999999999994 44688999999864 23557788888888876 99999999999
Q ss_pred ecCCeeEEEEEcccCCChhhhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC------
Q 007608 339 TTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD------ 411 (596)
Q Consensus 339 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~------ 411 (596)
...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999975322 245699999999999999999999998 9999999999999998
Q ss_pred -----CCcEEEeecccccccccc-CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhh
Q 007608 412 -----NFEAVLCDFGLAKLVDAK-LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 485 (596)
Q Consensus 412 -----~~~~kl~DfGl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~ 485 (596)
++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 899999999999765422 2223445679999999999999999999999999999999999999986322100
Q ss_pred hhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHhcc
Q 007608 486 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR-PPMAQVVKMLQG 549 (596)
Q Consensus 486 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~ 549 (596)
..+...+...+ ....+.+++..|++.+|.+| |+++++.+.|++
T Consensus 293 -------------------~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 -------------------CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -------------------EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -------------------eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 00111111111 23456677889999999999 678888887775
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.04 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=191.7
Q ss_pred cCCCcC-ceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHH-hcCCCCccceEeEEec----CCee
Q 007608 272 DNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTT----SSER 344 (596)
Q Consensus 272 ~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~----~~~~ 344 (596)
++|... ++||+|+||+||+|... +++.||||+++. ...+.+|++++. ..+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 456555 68999999999999965 689999999863 245678888874 4589999999998865 5568
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC---CCcEEEeecc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFG 421 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DfG 421 (596)
++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 99999999999999998632 34689999999999999999999999 9999999999999997 7899999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .....+.. +
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~i~~----~ 282 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKTRIRM----G 282 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-SHHHHHHH----T
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-HHHHHHHc----C
Confidence 998654322 2234568999999999999999999999999999999999999997543221111 11111111 1
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
... ...+ .......++.+++.+||+.||++|||+.|++++
T Consensus 283 ~~~-~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYE-FPNP----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCC-CCTT----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc-CCCc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 100 0000 112234678899999999999999999999984
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.58 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=193.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCC--ee
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS--ER 344 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~ 344 (596)
..++|+..+.||+|+||.||+|... +|+.||||++... ........+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999964 7899999998643 23344567889999999997 999999999997554 67
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||++ ++|...+.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999998 589888875 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccC--------------------cceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccch
Q 007608 425 LVDAKL--------------------THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLE 483 (596)
Q Consensus 425 ~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~ 483 (596)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 653211 111233569999999999976 67899999999999999999999999864332
Q ss_pred hhhhchHHHHHHHHhccCcccc---cc------------------cCcCCCCC-------------HHHHHHHHHHHHHc
Q 007608 484 EEEDVLLLDHIRKLLREDRLND---IV------------------DRNLNTYD-------------SKEVETMVQVALLC 529 (596)
Q Consensus 484 ~~~~~~l~~~~~~~~~~~~~~~---~~------------------d~~l~~~~-------------~~~~~~l~~l~~~C 529 (596)
.. ...+........... +. ........ .....++.+++.+|
T Consensus 238 ~~-----~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 238 NQ-----LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp HH-----HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred HH-----HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 11 111111111000000 00 00000000 02245788999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 007608 530 TQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 530 l~~dP~~RPs~~evl~~ 546 (596)
|+.||++|||++|++++
T Consensus 313 L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 313 LQFNPNKRISANDALKH 329 (388)
T ss_dssp CCSSGGGSCCHHHHTTS
T ss_pred hccCcccCCCHHHHhCC
Confidence 99999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.22 Aligned_cols=247 Identities=28% Similarity=0.353 Sum_probs=199.8
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCC--cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
+.|+..+.||+|+||+||+|+. .+++.||||++..... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4578889999999999999996 5789999999864322 223467899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+. |++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 6888877642 24689999999999999999999999 999999999999999999999999999986543
Q ss_pred cCcceeccccccccccCccccc---CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
. ....||+.|+|||++. +..++.++|||||||++|||+||+.||...... ...........
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------~~~~~~~~~~~--- 270 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNES--- 270 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCC---
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHhcCC---
Confidence 2 2346899999999984 567899999999999999999999998753321 11111111110
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+.. ........+.+++.+||+.||++|||+.|+++.
T Consensus 271 ---~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 ---PAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---CCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 112234567889999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=337.24 Aligned_cols=261 Identities=25% Similarity=0.336 Sum_probs=196.2
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|...+.||+|+||+||+|... +++.||+|++...........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999975 78999999987433333333456799999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
++ |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 98 5888888763 34689999999999999999999999 99999999999999999999999999998654332
Q ss_pred cceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc---Cccccc
Q 007608 431 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLNDI 506 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~~ 506 (596)
. ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+ ....+...... ......
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-----QLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCChHhchhh
Confidence 2 2223457999999999876 568999999999999999999999998643321 12222221111 111111
Q ss_pred ccC---------cCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 507 VDR---------NLNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 507 ~d~---------~l~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
... .... .......++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 100 0000 01123457789999999999999999999976
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=361.33 Aligned_cols=247 Identities=25% Similarity=0.346 Sum_probs=198.6
Q ss_pred ceeeecCceEEEEEEeC---CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS---DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||.||+|.+. .++.||||+++.. ......+.|.+|++++.+++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999652 4678999999753 233446789999999999999999999999964 457899999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc-
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH- 432 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~- 432 (596)
|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999975 34689999999999999999999999 9999999999999999999999999999876543221
Q ss_pred -eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 433 -VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 433 -~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+. .+.
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~~~~~i~----~~~-------- 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVTAMLE----KGE-------- 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHH----TTC--------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH----cCC--------
Confidence 2223346789999999999999999999999999999998 99999754321 1222221 111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
....+...+.++.+++..||+.||++||++.+|++.|++
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 011223345678899999999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=322.45 Aligned_cols=259 Identities=18% Similarity=0.233 Sum_probs=204.0
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEE-ecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC-TTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv~ 348 (596)
.++|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+|+.++..++|++++..+.++ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46789999999999999999996 579999999986432 234688999999999998877777666 5566779999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE---cCCCcEEEeecccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL 425 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DfGl~~~ 425 (596)
||+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 89999999743 24689999999999999999999999 99999999999999 4888999999999987
Q ss_pred ccccCcc------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc
Q 007608 426 VDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 499 (596)
Q Consensus 426 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 499 (596)
....... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||......... .....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~ 235 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh--hhhhhhccccc
Confidence 6543321 123456899999999999999999999999999999999999999854321111 11111111100
Q ss_pred cCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 500 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 500 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...... .....+.++.+++.+||+.||++||++.||++.|++
T Consensus 236 ~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 236 STPIEV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HSCHHH--------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred CCchHH--------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 000000 011223578899999999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=352.84 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=207.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
..++|+..+.||+|+||.||+|... +|+.||+|++... ........+.+|++++.+++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567888999999999999999975 7999999998642 122345678899999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999997632 34589999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...+.. ..
T Consensus 337 ~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~i~~----~~---- 405 (576)
T 2acx_A 337 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKE----VP---- 405 (576)
T ss_dssp CTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHHHHH----CC----
T ss_pred ccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHHhhc----cc----
Confidence 54322 2334699999999999998999999999999999999999999985432111 1111111111 00
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
..++.....++.+++.+||+.||++|| +++||+++
T Consensus 406 -----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 -----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 011223346788999999999999999 67777653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=346.55 Aligned_cols=263 Identities=20% Similarity=0.271 Sum_probs=196.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecC------C
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------S 342 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~ 342 (596)
.++|+..+.||+|+||+||+|... +++.||||++... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999964 6899999999743 2334567788999999999999999999999655 3
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++||||++++ +.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 569999999864 5555542 388999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHH---------
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH--------- 493 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~--------- 493 (596)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+.+.
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~-~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN-KVIEQLGTPCPEFM 287 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCSCCHHHH
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcCCCCHHHH
Confidence 98765422 2334568999999999999999999999999999999999999998644221100 00000
Q ss_pred ------HHHHhccC------cccccccCcCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 494 ------IRKLLRED------RLNDIVDRNLNT----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 494 ------~~~~~~~~------~~~~~~d~~l~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
........ .....+...+.. .......++.+++.+||+.||++|||++|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000000000000 011235678999999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.76 Aligned_cols=264 Identities=19% Similarity=0.274 Sum_probs=194.3
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
...++|+..+.||+|+||+||+|... +++.||||+++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999954 78999999997432 23334567899999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE-----cCCCcEEEeecc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL-----DDNFEAVLCDFG 421 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll-----~~~~~~kl~DfG 421 (596)
||||+++ +|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 111 v~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999984 99999876 34589999999999999999999999 99999999999999 455569999999
Q ss_pred ccccccccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
+++........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+..........
T Consensus 183 ~a~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~ 257 (329)
T 3gbz_A 183 LARAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID----QLFKIFEVLGLP 257 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCC
T ss_pred CccccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH----HHHHHHHHhCCC
Confidence 99876533222 2334579999999999875 48999999999999999999999997543211 111111111000
Q ss_pred --Ccccccc-----c---CcCCCCC------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 501 --DRLNDIV-----D---RNLNTYD------SKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 501 --~~~~~~~-----d---~~l~~~~------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
....... . +...... .....++.+++.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 0 0000000 113467889999999999999999999976
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=323.38 Aligned_cols=246 Identities=20% Similarity=0.304 Sum_probs=202.3
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 457888999999999999999975 577999999875332 346789999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE---cCCCcEEEeeccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DfGl~~~~ 426 (596)
|+++++|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999998876 24589999999999999999999999 99999999999999 78899999999999876
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
.... ......||+.|+|||.+.+. ++.++||||||+++|||+||+.||......+ ....+.. ...
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~----~~~--- 224 (277)
T 3f3z_A 160 KPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-----VMLKIRE----GTF--- 224 (277)
T ss_dssp CTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----CCC---
T ss_pred cCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHh----CCC---
Confidence 5432 22334689999999998654 8999999999999999999999997543211 1111111 100
Q ss_pred ccCcCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 507 VDRNLNTYDS----KEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 507 ~d~~l~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..+. .....+.+++.+|++.||++||++.|+++
T Consensus 225 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 ------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111 12467889999999999999999999965
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=323.32 Aligned_cols=251 Identities=23% Similarity=0.297 Sum_probs=201.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC-----cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
++|+..+.||+|+||.||+|... +++.||+|.++.... ....+.+.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999976 689999999874321 123678999999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC----cEEEeecc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDFG 421 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~DfG 421 (596)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999975 24689999999999999999999999 999999999999998877 89999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
++........ .....|++.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.. .
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~----~ 226 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-----TLTNISA----V 226 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHT----T
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-----HHHHhHh----c
Confidence 9987644321 233458999999999999999999999999999999999999997543211 1111110 0
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
... .+.. ........+.+++.+|++.||++||++.|+++
T Consensus 227 ~~~--~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 NYD--FDEE---YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCC--CCHH---HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccC--Ccch---hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000 0000 00112456889999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.55 Aligned_cols=260 Identities=18% Similarity=0.217 Sum_probs=203.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeCC---------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccc--------
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSD---------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ-------- 333 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~-------- 333 (596)
.++|...+.||+|+||.||+|.... ++.||+|++... ..+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 3678889999999999999999763 789999998642 35789999999999999987
Q ss_pred -------eEeEEec-CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 007608 334 -------LIGYCTT-SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA 405 (596)
Q Consensus 334 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~ 405 (596)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 5677765 67889999999 999999998632 24699999999999999999999999 9999999999
Q ss_pred cEEEcCCC--cEEEeeccccccccccCcc------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCC
Q 007608 406 NILLDDNF--EAVLCDFGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 477 (596)
Q Consensus 406 NIll~~~~--~~kl~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~ 477 (596)
||+++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 8999999999876543221 112346899999999999999999999999999999999999999
Q ss_pred CCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 478 DFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 478 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
....... ............ ....+.+.... ......++.+++.+||+.||++||++.|+++.|++
T Consensus 269 ~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 269 TNCLPNT---EDIMKQKQKFVD--KPGPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GGGTTCH---HHHHHHHHHHHH--SCCCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ccCCcCH---HHHHHHHHhccC--Chhhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 7543111 112222221111 11111111100 01224678899999999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=341.57 Aligned_cols=254 Identities=21% Similarity=0.323 Sum_probs=192.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-------CcchHHHHHHHHHHHHhcCCCCccceEeEEecC
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 341 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 341 (596)
..++|...+.||+|+||+||+|... +++.||||++.... .......+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4678999999999999999999965 68999999986421 1112235889999999999999999999975 4
Q ss_pred CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC---CcEEEe
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLC 418 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~ 418 (596)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 557999999999999988875 35689999999999999999999999 99999999999999654 459999
Q ss_pred eccccccccccCcceeccccccccccCcccccC---CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHH
Q 007608 419 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495 (596)
Q Consensus 419 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~ 495 (596)
|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ..+.+.+.
T Consensus 285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~~~~~i~ 358 (419)
T 3i6u_A 285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKDQIT 358 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS----CCHHHHHH
T ss_pred ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch----HHHHHHHh
Confidence 99999876542 22334568999999999863 56788999999999999999999999753221 11222221
Q ss_pred HHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 496 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. ..... ... ........+.+++.+||+.||++||++.|++++
T Consensus 359 ~----~~~~~-~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 S----GKYNF-IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp T----TCCCC-CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred c----CCCCC-Cch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1 10000 000 001134578899999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=325.48 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=205.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|...+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356888999999999999999975 58899999986432 234567789999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998875 24689999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.... ......|++.|+|||.+.+..++.++||||||+++|||+||+.||......+ ......... .
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~-~---- 232 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNE-Y---- 232 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTC-C----
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhhcc-C----
Confidence 3322 2233568999999999999889999999999999999999999997543211 111111110 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..+......+.+++.+|++.||++||++.|+++
T Consensus 233 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 -----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111223456888999999999999999999976
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=322.03 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=197.5
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEec----CCeeEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERIL 346 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~l 346 (596)
.|...+.||+|+||.||+|... ++..||+|++... ......+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3666789999999999999964 6889999998743 344456789999999999999999999998865 345789
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCcEEEc-CCCcEEEeecccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLD-DNFEAVLCDFGLA 423 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~DfGl~ 423 (596)
||||+++++|.+++... ..+++..++.++.|++.||.|||+. + ++||||||+||+++ .++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999999763 4589999999999999999999998 7 99999999999997 7899999999999
Q ss_pred ccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
....... .....||+.|+|||++. +.++.++||||||+++|||+||+.||....... ...... .....
T Consensus 180 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~-~~~~~ 247 (290)
T 1t4h_A 180 TLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRV-TSGVK 247 (290)
T ss_dssp GGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHH-TTTCC
T ss_pred ccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-------HHHHHH-hccCC
Confidence 7554332 23345899999999886 458999999999999999999999997532211 111111 11111
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+ .....++.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 248 PASFD-------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CGGGG-------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccC-------CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11111 1123468899999999999999999999763
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=334.31 Aligned_cols=269 Identities=24% Similarity=0.363 Sum_probs=197.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHH--HHhcCCCCccceEeEEec-----CC
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL--ISVAIHKNLLQLIGYCTT-----SS 342 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~~-----~~ 342 (596)
..++|+..+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++.+.. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 346888899999999999999987 7899999998632 23444445444 456899999999985532 23
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCcEecCCCCCcEEEcCCCcEE
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------NPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~dlkp~NIll~~~~~~k 416 (596)
..++||||+++|+|.+++.. ...++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 56899999999999999975 23589999999999999999999873 33899999999999999999999
Q ss_pred EeeccccccccccCc-------ceeccccccccccCcccccC-------CCCCcccccHHHHHHHHHHHhCCCCCCCccc
Q 007608 417 LCDFGLAKLVDAKLT-------HVTTQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVTGQRAIDFSRL 482 (596)
Q Consensus 417 l~DfGl~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvil~elltg~~p~~~~~~ 482 (596)
|+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643221 11223468999999999976 4567889999999999999999777643221
Q ss_pred hhhhhchH---------HHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 483 EEEEDVLL---------LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 483 ~~~~~~~l---------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
........ ................+... .........++.+++.+||+.||++|||++|+++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 11100000 01111111111111111111 11234567789999999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=335.38 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=196.8
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC------
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 342 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 342 (596)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788899999999999999996 479999999986432 3334567899999999999999999999997663
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899999875 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ...+.......
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----l~~i~~~~g~~ 245 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-----LKEIMKVTGTP 245 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHHHCCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhcCCC
Confidence 9875432 233568999999999877 6799999999999999999999999986432211 11111110000
Q ss_pred ------------------cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 ------------------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ------------------~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+.......+..........+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000111111222345678899999999999999999999884
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=336.22 Aligned_cols=271 Identities=23% Similarity=0.304 Sum_probs=202.2
Q ss_pred ccHHHHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcc----------hHHHHHHHHHHHHhcCCCCc
Q 007608 262 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG----------GEAAFQREVHLISVAIHKNL 331 (596)
Q Consensus 262 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~----------~~~~~~~e~~~l~~l~H~ni 331 (596)
....++....++|...+.||+|+||.||+|...+|+.||||++....... ..+.+.+|++++.+++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 44678888899999999999999999999998889999999986432211 23778999999999999999
Q ss_pred cceEeEEec-----CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCc
Q 007608 332 LQLIGYCTT-----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 406 (596)
Q Consensus 332 v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N 406 (596)
+++++++.. ....++||||++ |+|.+.+... ...+++..+..++.|++.||.|||+. +|+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence 999999844 335799999998 5888887742 34689999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeeccccccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhh
Q 007608 407 ILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 485 (596)
Q Consensus 407 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~ 485 (596)
|+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999997544322 2233468999999999877 6789999999999999999999999986432211
Q ss_pred hhchHHHHHHHHhccCcc-----------cccccCcCCC--------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 486 EDVLLLDHIRKLLREDRL-----------NDIVDRNLNT--------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 486 ~~~~l~~~~~~~~~~~~~-----------~~~~d~~l~~--------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+......... .+.+...... ........+.+++.+||+.||++|||+.|++++
T Consensus 243 -----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 -----LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -----HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111111110000 0000000000 112234668899999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=345.33 Aligned_cols=195 Identities=25% Similarity=0.368 Sum_probs=154.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC-----Ce
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 343 (596)
.++|+..+.||+|+||+||+|... +++.||||++.... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999965 78999999986432 333457789999999999999999999998443 56
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||+. ++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 689888875 35699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCc--------------------------ceeccccccccccCcccc-cCCCCCcccccHHHHHHHHHHHhC
Q 007608 424 KLVDAKLT--------------------------HVTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTG 473 (596)
Q Consensus 424 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~S~Gvil~elltg 473 (596)
+....... .......||+.|+|||++ .+..++.++|||||||++|||+||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87643211 112335689999999986 456799999999999999999993
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=336.82 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=199.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.++|+..+.||+|+||.||+|..+ +++.||+|++..... .+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999975 688999999975322 235688888887 7999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC----CcEEEeeccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLCDFGLAK 424 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~DfGl~~ 424 (596)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++.++ +.+||+|||+++
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999875 34689999999999999999999999 99999999999998443 359999999998
Q ss_pred cccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+...+. .+...
T Consensus 169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~----~~~~~ 241 (342)
T 2qr7_A 169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIG----SGKFS 241 (342)
T ss_dssp ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHH----HCCCC
T ss_pred cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHc----cCCcc
Confidence 7654322 223456899999999998888999999999999999999999999753211 1111222221 11110
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+. .........++.+++.+||+.||++||++.|+++
T Consensus 242 --~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 --LS---GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --CC---STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --cC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0112234567889999999999999999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=330.45 Aligned_cols=266 Identities=27% Similarity=0.306 Sum_probs=198.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCc----chHHHHHHHHHHHHhcCCCCccceEeEEecCCee
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 344 (596)
..++|+..+.||+|+||.||+|... +|+.||+|++...... .....+.+|++++.+++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999975 6899999998742211 1234688999999999999999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||+++ +|..++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 888887652 34588889999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc--cC
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR--ED 501 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~--~~ 501 (596)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||......+ .+......... ..
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~----~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCTT
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHcCCCChh
Confidence 7644322 22335689999999999764 48999999999999999999999987543211 11111111110 00
Q ss_pred ccccc---cc----CcCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 007608 502 RLNDI---VD----RNLNTYD-----SKEVETMVQVALLCTQSTPEDRPPMAQVVKML 547 (596)
Q Consensus 502 ~~~~~---~d----~~l~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 547 (596)
..... .+ ......+ .....++.+++.+|++.||++|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 01000 00 0000111 22346789999999999999999999998753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=324.23 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=200.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec---------
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--------- 340 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------- 340 (596)
..+|+..+.||+|+||.||+|... +++.||+|++... ...+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC-----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 356888999999999999999975 7999999998642 1356789999999999999999998854
Q ss_pred -------CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC
Q 007608 341 -------SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 413 (596)
Q Consensus 341 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~ 413 (596)
....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 345789999999999999997532 24689999999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHH
Q 007608 414 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 493 (596)
Q Consensus 414 ~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~ 493 (596)
.+||+|||++........ .....|++.|+|||++.+..++.++||||||+++|||++|..|+... . ..
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~---~~ 227 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------S---KF 227 (284)
T ss_dssp EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------H---HH
T ss_pred CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------H---HH
Confidence 999999999987654322 22345899999999999999999999999999999999999886411 0 11
Q ss_pred HHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 494 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 494 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
... ....... ......+.+++.+||+.||++||++.|+++.|+.
T Consensus 228 ~~~-~~~~~~~-----------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 228 FTD-LRDGIIS-----------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp HHH-HHTTCCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH-hhccccc-----------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111 1111111 1123457789999999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=322.55 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=203.6
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++.+++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357888999999999999999975 67889999986321 122356789999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999999763 3589999999999999999999999 99999999999999999999999999987654
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
... .....|++.|+|||++.+..++.++||||||+++|||++|+.||......+ . ........
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~---~~~~~~~~------ 228 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-----T---HRRIVNVD------ 228 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H---HHHHHTTC------
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-----H---HHHHhccc------
Confidence 321 233468999999999999999999999999999999999999997543211 1 11111110
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. ..+......+.+++.+|++.||++||++.|+++
T Consensus 229 -~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 -L---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -C---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -c---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0 112223457889999999999999999999965
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=328.98 Aligned_cols=256 Identities=19% Similarity=0.268 Sum_probs=189.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHH-HHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~-~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
..++|+..+.||+|+||+||+|.. .+++.||+|+++.......... +.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 456788999999999999999996 4789999999975433333333 44455557888999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||++ |+|.+++.........+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99998 5888877654334567999999999999999999999853 79999999999999999999999999998765
Q ss_pred ccCcceeccccccccccCcccc----cCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYL----STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
.... .....||+.|+|||++ .+..++.++||||||+++|||+||+.||....... ..+ .........
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~----~~~~~~~~~ 232 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF---QQL----KQVVEEPSP 232 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH---HHH----HHHHHSCCC
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH---HHH----HHHhccCCC
Confidence 4322 2223589999999996 55678999999999999999999999997432211 111 111111110
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. ........++.+++.+|++.||++|||+.|+++
T Consensus 233 -~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 -Q-------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -C-------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -C-------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 011223457889999999999999999999966
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=336.77 Aligned_cols=263 Identities=17% Similarity=0.257 Sum_probs=197.9
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC----
Q 007608 267 LQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS---- 341 (596)
Q Consensus 267 l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~---- 341 (596)
++...++|+..+.||+|+||+||+|.. .+|+.||+|++..... ...+|+++++.++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345678899999999999999999996 5799999999864322 224799999999999999999998443
Q ss_pred ----------------------------------CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHH
Q 007608 342 ----------------------------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387 (596)
Q Consensus 342 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~ 387 (596)
...++||||++ |+|.+.+.........+++..++.++.|++.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 23789999998 5888887754444567999999999999999999
Q ss_pred HHHhCCCCCcEecCCCCCcEEEc-CCCcEEEeeccccccccccCcceeccccccccccCcccccCC-CCCcccccHHHHH
Q 007608 388 YLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGI 465 (596)
Q Consensus 388 ~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gv 465 (596)
|||+. +|+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99999 999999999999997 688999999999987644322 2334579999999998775 4899999999999
Q ss_pred HHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC----------cccccccCcCCC------CCHHHHHHHHHHHHHc
Q 007608 466 TLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED----------RLNDIVDRNLNT------YDSKEVETMVQVALLC 529 (596)
Q Consensus 466 il~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~----------~~~~~~d~~l~~------~~~~~~~~l~~l~~~C 529 (596)
++|||++|+.||......+ .+...+. ..... ...+..-+.... .+.....++.+++.+|
T Consensus 231 il~ell~g~~pf~~~~~~~----~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSID----QLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHH----HHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCChHH----HHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence 9999999999998643221 1111111 11100 001100011110 1223456789999999
Q ss_pred cccCCCCCCCHHHHHH
Q 007608 530 TQSTPEDRPPMAQVVK 545 (596)
Q Consensus 530 l~~dP~~RPs~~evl~ 545 (596)
|+.||++|||+.|+++
T Consensus 306 L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCSSGGGSCCHHHHHT
T ss_pred ccCChhhCCCHHHHhc
Confidence 9999999999999976
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=331.39 Aligned_cols=249 Identities=22% Similarity=0.364 Sum_probs=205.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|...+.||+|+||.||++... +++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 356888999999999999999975 57899999986432 334567789999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999998875 24689999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+ . ........ .
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~---~~~~~~~~-~---- 258 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----T---YLRIKKNE-Y---- 258 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H---HHHHHHTC-C----
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-----H---HHHHhcCC-C----
Confidence 3322 2233568999999999999899999999999999999999999997543211 1 11111110 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..+......+.+++.+||+.||++||++.|+++
T Consensus 259 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011223356788999999999999999999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=322.52 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=196.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|...+.||+|+||.||+|... +++.||+|++.... .......+.+|+..++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467888999999999999999976 79999999986321 223456789999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999999763 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
... ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ...+.+.. ..
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~----~~---- 227 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-----TLFKKIRG----GV---- 227 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH----CC----
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----HHHHHhhc----Cc----
Confidence 432 1223458999999999987765 68999999999999999999999753221 11111111 10
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+......+.+++.+|++.||++||++.|++++
T Consensus 228 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 -----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00112234568889999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=328.35 Aligned_cols=259 Identities=20% Similarity=0.276 Sum_probs=199.2
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEec--CCeeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTT--SSERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~lv 347 (596)
++|+..+.||+|+||+||+|.. .+++.||+|+++. ...+.+.+|+.++.+++ ||||+++++++.+ ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 5788899999999999999985 5789999999863 23577899999999997 9999999999987 5678999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC-cEEEeeccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLV 426 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfGl~~~~ 426 (596)
|||+++++|.+++.. +++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999998864 78899999999999999999999 999999999999999776 8999999999876
Q ss_pred cccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchH---------HHHHHH
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL---------LDHIRK 496 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l---------~~~~~~ 496 (596)
..... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||.........-... .+++..
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 54322 233458999999999877 668999999999999999999999996433211110000 011100
Q ss_pred Hhcc--Ccccccc--------cCcCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 497 LLRE--DRLNDIV--------DRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 497 ~~~~--~~~~~~~--------d~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.... ....+.. ..... ........++.+++.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 0000000 00000 0112245678999999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=325.18 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=197.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC-CeeEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-SERILVY 348 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~ 348 (596)
..++|+..+.||+|+||.||+|.. +|+.||+|+++.. ...+.+.+|++++.+++||||+++++++.+. +..++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 346788899999999999999987 5889999998642 2457789999999999999999999997655 4689999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999997531 12378899999999999999999999 999999999999999999999999999875543
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.. ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+. .+..
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~~~~----~~~~---- 232 (278)
T 1byg_A 170 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVE----KGYK---- 232 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHHHHT----TTCC----
T ss_pred cc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHh----cCCC----
Confidence 21 22346889999999998899999999999999999998 99999754321 1111111 1100
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...+...+..+.+++.+||+.||++||++.|+++.|+++
T Consensus 233 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 233 ----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 111223456788999999999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=329.95 Aligned_cols=264 Identities=22% Similarity=0.330 Sum_probs=206.9
Q ss_pred hcCCCcCceeeecCceEEEEEEe-----CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC--e
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--E 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~ 343 (596)
.++|+..+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 45688899999999999999983 36889999998753 3445678999999999999999999999987654 6
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 79999999999999999863 23589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcce--eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhh-------hhchHHHHH
Q 007608 424 KLVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE-------EDVLLLDHI 494 (596)
Q Consensus 424 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~-------~~~~l~~~~ 494 (596)
+......... .....++..|+|||.+.+..++.++||||||+++|||+||..|+........ ........+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 8765443221 2233467789999999988899999999999999999999998764211000 000011111
Q ss_pred HHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 495 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
........ ....+...+.++.+++.+||+.||++||++.|+++.|++
T Consensus 273 ~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 273 IELLKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHHHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhhcCC--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111110 011123345678899999999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=327.42 Aligned_cols=258 Identities=20% Similarity=0.262 Sum_probs=196.6
Q ss_pred cCCCcC-ceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 348 (596)
+.|.+. +.||+|+||+||+|... +++.||||++... .......+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC-SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC-cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 567664 78999999999999954 7899999999753 334567889999999985 7999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc---EEEeecccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKL 425 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~DfGl~~~ 425 (596)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999763 4589999999999999999999999 9999999999999998776 99999999876
Q ss_pred ccccCc------ceeccccccccccCcccccC-----CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhh---c---
Q 007608 426 VDAKLT------HVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED---V--- 488 (596)
Q Consensus 426 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~---~--- 488 (596)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 542211 11123458999999999875 557899999999999999999999997543211000 0
Q ss_pred hHHHHHHHHhccCcccccccCcCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 489 LLLDHIRKLLREDRLNDIVDRNLNTYDS----KEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 489 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
............... ..+. ....++.+++.+||+.||++||++.|++++
T Consensus 244 ~~~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 244 ACQNMLFESIQEGKY---------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHCCC---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHHhccCc---------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000001111111110 1111 124578899999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=330.91 Aligned_cols=268 Identities=25% Similarity=0.343 Sum_probs=188.0
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 268 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 268 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
.+..++|+..+.||+|+||.||+|... +++.||+|++...........+.+|+.++.+++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 445678999999999999999999954 7899999998754434456778899999999999999999999999999999
Q ss_pred EEEcccCCChhhhhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 347 VYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
||||+++++|.+++.... .....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999987421 1234589999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCc----ceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHH
Q 007608 423 AKLVDAKLT----HVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 497 (596)
Q Consensus 423 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~ 497 (596)
+........ .......||+.|+|||++.+ ..++.++||||||+++|||+||+.||....... .... ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~-~~~~ 242 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK----VLML-TLQN 242 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHHH-HHTS
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh----HHHH-Hhcc
Confidence 986643211 11233468999999999875 568999999999999999999999997543211 1111 1100
Q ss_pred hccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 498 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 498 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..........++.. ......++.+++.+||+.||++||++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPSLETGVQDKEM---LKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCCTTC-----CC---CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccccccccchh---hhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000000111111 12234568889999999999999999999763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=328.00 Aligned_cols=258 Identities=21% Similarity=0.223 Sum_probs=203.1
Q ss_pred HHHhcCCCcC-ceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCe
Q 007608 268 QLATDNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSE 343 (596)
Q Consensus 268 ~~~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~ 343 (596)
+...+.|... +.||+|+||.||+|... +++.||+|++... ........+.+|+.++.++. ||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3345566666 88999999999999965 6899999998743 23345678999999999995 6999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC---CCcEEEeec
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDF 420 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Df 420 (596)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999986422 35689999999999999999999999 9999999999999988 789999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
|+++...... ......||+.|+|||++.+..++.++||||||+++|||+||+.||......+ ....+.... .
T Consensus 179 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~~-~ 250 (327)
T 3lm5_A 179 GMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-----TYLNISQVN-V 250 (327)
T ss_dssp GGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHTC-C
T ss_pred ccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHHHhcc-c
Confidence 9998765432 1233568999999999999999999999999999999999999997543211 111111110 0
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. .. ..........+.+++.+||+.||++||+++|+++.
T Consensus 251 ~----~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 D----YS----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C----CC----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c----cC----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 00 01112334568899999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=344.32 Aligned_cols=244 Identities=15% Similarity=0.098 Sum_probs=190.9
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc--CCcchHHHHHHHH---HHHHhcCCCCccceE-------eE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREV---HLISVAIHKNLLQLI-------GY 337 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~~e~---~~l~~l~H~niv~l~-------~~ 337 (596)
.++|...+.||+|+||+||+|+. .+|+.||||++... ......+.|.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999996 57999999998742 2334567899999 555666899999998 66
Q ss_pred EecCC-----------------eeEEEEEcccCCChhhhhcccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 007608 338 CTTSS-----------------ERILVYPFMQNLSVAYRLRDLK---PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397 (596)
Q Consensus 338 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 397 (596)
+.+.+ ..++||||+ +|+|.+++.... .....+++..++.++.|++.||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 65543 278999999 689999998531 1123355788899999999999999999 99
Q ss_pred EecCCCCCcEEEcCCCcEEEeeccccccccccCcceeccccccccccCcccccCC-----------CCCcccccHHHHHH
Q 007608 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-----------KSSEKTDVFGYGIT 466 (596)
Q Consensus 398 vH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~S~Gvi 466 (596)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985432 2334457 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 467 LLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 467 l~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+|||+||+.||....... ....+.. . ......++.+++.+||+.||++||++.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~-----------------~~~~~~~-~----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG-----------------GSEWIFR-S----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------C-----------------CSGGGGS-S----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCccccccc-----------------chhhhhh-h----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999997432111 0111111 0 0122457888999999999999999999976
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.81 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=205.4
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCc-------chHHHHHHHHHHHHhc-CCCCccceEe
Q 007608 266 ELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-------GGEAAFQREVHLISVA-IHKNLLQLIG 336 (596)
Q Consensus 266 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~~~e~~~l~~l-~H~niv~l~~ 336 (596)
......++|+..+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33445678999999999999999999975 7999999998643211 1245678999999999 7999999999
Q ss_pred EEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEE
Q 007608 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 337 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 416 (596)
++......++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999975 24689999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccccCcceeccccccccccCcccccC------CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchH
Q 007608 417 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 490 (596)
Q Consensus 417 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l 490 (596)
|+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ..
T Consensus 241 l~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-----~~ 313 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-----LM 313 (365)
T ss_dssp ECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH
T ss_pred EEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-----HH
Confidence 999999987654322 234568999999999863 35889999999999999999999999753221 11
Q ss_pred HHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 491 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 491 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+.. ..... ..+.. ......+.+++.+|++.||++||++.|++++
T Consensus 314 ~~~i~~----~~~~~-~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 314 LRMIME----GQYQF-SSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHH----TCCCC-CHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHh----CCCCC-CCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111 10000 00000 0123568899999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=324.82 Aligned_cols=250 Identities=20% Similarity=0.313 Sum_probs=201.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|...+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 357888999999999999999975 78999999997432 2234678899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE---cCCCcEEEeeccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DfGl~~~~ 426 (596)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999998752 3589999999999999999999999 99999999999999 78899999999998765
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
.... .....|++.|+|||++.+..++.++||||||+++|||++|+.||...... .....+.. +.. ..
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~----~~~-~~ 226 (304)
T 2jam_A 160 QNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-----KLFEKIKE----GYY-EF 226 (304)
T ss_dssp CCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHH----CCC-CC
T ss_pred CCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHc----CCC-CC
Confidence 4321 22345899999999999999999999999999999999999999753221 11111111 110 00
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.. ........++.+++.+|++.||++||++.|+++
T Consensus 227 -~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 -ES---PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -CT---TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -Cc---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 112233467889999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=319.21 Aligned_cols=253 Identities=22% Similarity=0.353 Sum_probs=198.6
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|....+||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 4455667999999999999996 47889999998753 334467789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-CCcEEEeecccccccccc
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfGl~~~~~~~ 429 (596)
+++++|.+++.... ....+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 101 VPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99999999998632 234577899999999999999999999 9999999999999987 899999999999876432
Q ss_pred CcceeccccccccccCcccccCCC--CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.. ......|++.|+|||++.+.. ++.++||||||+++|||+||+.||........ .... .. .. . .
T Consensus 177 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~-~~-~~--~-----~ 243 (295)
T 2clq_A 177 NP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFK-VG-MF--K-----V 243 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHH-HH-HH--C-----C
T ss_pred CC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHh-hc-cc--c-----c
Confidence 21 223456899999999987643 78999999999999999999999964221110 0100 00 00 0 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.+ ..+.....++.+++.+||+.||++||++.|+++
T Consensus 244 ~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CC---CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cc---cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01 112234467889999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.37 Aligned_cols=252 Identities=23% Similarity=0.270 Sum_probs=202.8
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.++|+..+.||+|+||+||+|... +++.||||++... ........+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457889999999999999999975 7899999998632 22334678899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc---CCCcEEEeecccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAKL 425 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~DfGl~~~ 425 (596)
||+++|+|.+.+... ..+++..+..++.|++.||.|||+. +|+||||||+||+++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999988752 4589999999999999999999999 999999999999995 556799999999986
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .....+.. .....
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~----~~~~~ 241 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-----DILKRVET----GKYAF 241 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH----TCCCS
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh----CCCCC
Confidence 64432 2234568999999999875 5899999999999999999999999754321 12222211 11000
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. .+ .....+.++.+++.+||+.||++|||+.|++++
T Consensus 242 ~-~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 D-LP----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp C-SG----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C-Cc----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00 012234578899999999999999999999884
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=329.95 Aligned_cols=264 Identities=19% Similarity=0.271 Sum_probs=193.3
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC------
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 342 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 342 (596)
.++|+..+.||+|+||.||+|... +++.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367889999999999999999964 68999999987432 3344567889999999999999999999997665
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999985 78777753 488999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchH------------
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL------------ 490 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l------------ 490 (596)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+......
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98664321 2233568999999999999999999999999999999999999998643211100000
Q ss_pred --HHHHHHHhccC------cccccccCcC-CC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 491 --LDHIRKLLRED------RLNDIVDRNL-NT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 491 --~~~~~~~~~~~------~~~~~~d~~l-~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
...+....... .....+.... .. .......++.+++.+||+.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000000 0000000000 00 112336788999999999999999999999774
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=346.76 Aligned_cols=251 Identities=24% Similarity=0.301 Sum_probs=204.8
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457888999999999999999975 78999999986432 234567899999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE---cCCCcEEEeeccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK 424 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DfGl~~ 424 (596)
|||+.+|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999998875 34689999999999999999999999 99999999999999 567899999999998
Q ss_pred cccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .....+.. +...
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~----~~~~ 245 (484)
T 3nyv_A 178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-----DILKKVEK----GKYT 245 (484)
T ss_dssp HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH----CCCC
T ss_pred Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHc----CCCC
Confidence 7654322 233468999999999876 6899999999999999999999999854321 12222211 1110
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. ..+ .....+.++.+++.+||+.||++|||+.|+++
T Consensus 246 ~-~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 F-ELP----QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp C-CSG----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-CCc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 000 01223457889999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.37 Aligned_cols=262 Identities=21% Similarity=0.326 Sum_probs=203.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC-----Cee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~ 344 (596)
.++|+..+.||+|+||.||+|... +++.||+|++...........+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457999999999999999999965 78899999997544455567899999999999999999999999665 367
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++|+||+. ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999998 589988875 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcce--eccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 425 LVDAKLTHV--TTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 425 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
......... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+ ....+.......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~~~~~~ 251 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-----QLNHILGILGSP 251 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-----HHHHHHHHHCSC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-----HHHHHHHHhCCC
Confidence 765432221 234568999999998754 458999999999999999999999997644321 111111111100
Q ss_pred cc---c------------ccccCcCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 RL---N------------DIVDRNLNT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ~~---~------------~~~d~~l~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. . ....+.... .......++.+++.+||+.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0 000000000 011234578899999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=360.31 Aligned_cols=260 Identities=20% Similarity=0.321 Sum_probs=207.6
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEeC----CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC
Q 007608 267 LQLATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 342 (596)
Q Consensus 267 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 342 (596)
.++..++|+..+.||+|+||.||+|... .+..||+|+++..........|.+|+.++++++||||+++++++. .+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 3344567888899999999999999864 246799999876555555678999999999999999999999985 45
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence 689999999999999999753 24589999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
++..............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .....+.. ..
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~~~~~i~~---~~ 609 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIEN---GE 609 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHH---TC
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHc---CC
Confidence 98765443333333456789999999998899999999999999999997 99999754321 12222211 11
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
. ...+...+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus 610 ~---------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 R---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 011223456788999999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.02 Aligned_cols=270 Identities=20% Similarity=0.231 Sum_probs=192.4
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe
Q 007608 265 RELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 265 ~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 343 (596)
.+.....++|+..+.||+|+||.||+|... +++.||||++.... .....+.++++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 345567789999999999999999999974 68999999986432 223456788888999999999999999865433
Q ss_pred -------eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCcEecCCCCCcEEEcC-CC
Q 007608 344 -------RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--EQCNPKIIHRDLKAANILLDD-NF 413 (596)
Q Consensus 344 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~dlkp~NIll~~-~~ 413 (596)
.++||||+++ ++...+.........+++..+..++.|++.||.||| +. +|+||||||+||+++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 7899999986 555554433333567899999999999999999999 77 9999999999999996 89
Q ss_pred cEEEeeccccccccccCcceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHH
Q 007608 414 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 492 (596)
Q Consensus 414 ~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~ 492 (596)
.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||+||+.||....... .+..
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~~ 243 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG----QLHE 243 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH----HHHH
Confidence 999999999987654322 23345899999999987654 8999999999999999999999998643321 1111
Q ss_pred HHHHH-----------hccCcccccccC-------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 493 HIRKL-----------LREDRLNDIVDR-------NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 493 ~~~~~-----------~~~~~~~~~~d~-------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..... ..........+. ...........++.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11110 000000000000 0011122246789999999999999999999999763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.39 Aligned_cols=263 Identities=25% Similarity=0.309 Sum_probs=200.7
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC--------
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-------- 341 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-------- 341 (596)
++|+..+.||+|+||.||+|+. .+|+.||+|++.... .......+.+|+.++.+++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788899999999999999997 478999999986432 333456788999999999999999999998763
Q ss_pred CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
+..++||||+++ ++.+.+... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 467999999985 777777643 24589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCc---ceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHH
Q 007608 422 LAKLVDAKLT---HVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 497 (596)
Q Consensus 422 l~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~ 497 (596)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... .....+...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~ 244 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALISQL 244 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHH
Confidence 9987643221 12234568999999999876 45799999999999999999999999864321 111222221
Q ss_pred hc---cCcccccccC----cC-----CCC-CHH------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 498 LR---EDRLNDIVDR----NL-----NTY-DSK------EVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 498 ~~---~~~~~~~~d~----~l-----~~~-~~~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. .......-+. .+ ... ... ....+.+++.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11 1111110000 00 000 011 13457899999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.91 Aligned_cols=265 Identities=22% Similarity=0.276 Sum_probs=202.8
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcC--------CCCccceEeEEe--
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--------HKNLLQLIGYCT-- 339 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~~~~~-- 339 (596)
.++|+..+.||+|+||+||+|+.. +++.||||+++. .......+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS--AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec--CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 467999999999999999999964 688999999863 2344577889999999886 788999999987
Q ss_pred --cCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC----
Q 007608 340 --TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---- 413 (596)
Q Consensus 340 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---- 413 (596)
+....++||||+ ++++.+.+.... ...+++..++.++.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 556789999999 556666665422 246899999999999999999999864 799999999999999775
Q ss_pred ---------------------------------------------cEEEeeccccccccccCcceeccccccccccCccc
Q 007608 414 ---------------------------------------------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448 (596)
Q Consensus 414 ---------------------------------------------~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~ 448 (596)
.+||+|||+++..... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999876543 223458999999999
Q ss_pred ccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhh-hchHHHHHHHHhcc---------CcccccccC---------
Q 007608 449 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE-DVLLLDHIRKLLRE---------DRLNDIVDR--------- 509 (596)
Q Consensus 449 ~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~-~~~l~~~~~~~~~~---------~~~~~~~d~--------- 509 (596)
+.+..++.++|||||||++|||+||+.||......... .......+...... ....+.+..
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999754432111 11111111111110 000000000
Q ss_pred -----------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 510 -----------NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 510 -----------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
............+.+++.+||+.||++|||++|++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0011356677889999999999999999999999763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=330.49 Aligned_cols=259 Identities=22% Similarity=0.286 Sum_probs=204.6
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCc--c--------------hHHHHHHHHHHHHhcCCCCccce
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP--G--------------GEAAFQREVHLISVAIHKNLLQL 334 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~--------------~~~~~~~e~~~l~~l~H~niv~l 334 (596)
.++|...+.||+|+||.||+|.. +++.||+|++...... . ....+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999999999 9999999998632111 1 11789999999999999999999
Q ss_pred EeEEecCCeeEEEEEcccCCChhhh------hcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCcE
Q 007608 335 IGYCTTSSERILVYPFMQNLSVAYR------LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANI 407 (596)
Q Consensus 335 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NI 407 (596)
++++.+.+..++||||+++++|.++ +... ....+++..++.++.|++.||.|||+ . +++||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 4431 14579999999999999999999999 8 999999999999
Q ss_pred EEcCCCcEEEeeccccccccccCcceeccccccccccCcccccCC-CCCc-ccccHHHHHHHHHHHhCCCCCCCccchhh
Q 007608 408 LLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSE-KTDVFGYGITLLELVTGQRAIDFSRLEEE 485 (596)
Q Consensus 408 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~S~Gvil~elltg~~p~~~~~~~~~ 485 (596)
+++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|||++|+.||......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 9999999999999999876433 23345689999999999887 5666 999999999999999999999854321
Q ss_pred hhchHHHHHHHHhccCccccc------ccCcC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 486 EDVLLLDHIRKLLREDRLNDI------VDRNL----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 486 ~~~~l~~~~~~~~~~~~~~~~------~d~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
......+. ....... ..+.. .........++.+++.+||+.||++||++.|++++
T Consensus 259 --~~~~~~i~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 --VELFNNIR----TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp --HHHHHHHT----SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHh----ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111111 1111000 00000 00113345678899999999999999999999873
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.52 Aligned_cols=251 Identities=21% Similarity=0.303 Sum_probs=198.4
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.++|+..+.||+|+||+||+|+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346888999999999999999975 78899999987432 3344677899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC---CCcEEEeecccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFGLAKL 425 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DfGl~~~ 425 (596)
||+++|+|.+.+... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999988752 4589999999999999999999999 9999999999999976 45599999999987
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
..... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... .+...+.. ....
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~----~~~~- 255 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-----EILRKVEK----GKYT- 255 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH----TCCC-
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh----CCCC-
Confidence 65432 223456899999999986 56999999999999999999999999854321 12222211 1100
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...+.. ...+..+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 FDSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000111 123456889999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=333.05 Aligned_cols=255 Identities=24% Similarity=0.288 Sum_probs=186.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEe--------
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCT-------- 339 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~-------- 339 (596)
...+|+..+.||+|+||.||+|... +++.||+|++... .......+.+|+.++.++. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 4457888999999999999999964 7899999998543 3445677899999999996 999999999984
Q ss_pred cCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCcEEEcCCCcEEE
Q 007608 340 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFEAVL 417 (596)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl 417 (596)
.....++|+||+. |+|.+++..... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 3345789999996 799888875332 34699999999999999999999998 7 999999999999999999999
Q ss_pred eeccccccccccCcce-----------eccccccccccCcccc---cCCCCCcccccHHHHHHHHHHHhCCCCCCCccch
Q 007608 418 CDFGLAKLVDAKLTHV-----------TTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE 483 (596)
Q Consensus 418 ~DfGl~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~ 483 (596)
+|||+++......... .....||+.|+|||++ .+..++.++|||||||++|||+||+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998765432211 1134589999999998 5667899999999999999999999999642210
Q ss_pred hhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 484 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 484 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...... .. . .........+.+++.+||+.||++||++.|+++.|+..
T Consensus 260 --------~~~~~~-----~~----~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 260 --------RIVNGK-----YS----I---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp -------------------CC----C---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred --------HhhcCc-----cc----C---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000000 00 0 00111123477899999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.42 Aligned_cols=253 Identities=21% Similarity=0.268 Sum_probs=201.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCc------------chHHHHHHHHHHHHhcCCCCccceEe
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP------------GGEAAFQREVHLISVAIHKNLLQLIG 336 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------------~~~~~~~~e~~~l~~l~H~niv~l~~ 336 (596)
..++|...+.||+|+||+||+|... +++.||+|++...... .....+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3568999999999999999999975 6889999998743211 34567899999999999999999999
Q ss_pred EEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC---
Q 007608 337 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF--- 413 (596)
Q Consensus 337 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~--- 413 (596)
++.+....++||||+++|+|.+.+... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999988762 4589999999999999999999999 999999999999998775
Q ss_pred cEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHH
Q 007608 414 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 493 (596)
Q Consensus 414 ~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~ 493 (596)
.+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... .....
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~ 258 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-----DIIKK 258 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence 69999999998765432 223456899999999986 46899999999999999999999999854321 12222
Q ss_pred HHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 494 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 494 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+.. +.... +.. .....+.++.+++.+||+.||.+|||+.|++++
T Consensus 259 i~~----~~~~~--~~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 VEK----GKYYF--DFN---DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHH----CCCCC--CHH---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHc----CCCCC--Ccc---ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 211 11000 000 001124578899999999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.56 Aligned_cols=200 Identities=24% Similarity=0.358 Sum_probs=167.8
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC-----Ce
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 343 (596)
.++|+..+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999965 68899999997432 334457889999999999999999999999766 56
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999987 599999875 35689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcc---------------------eeccccccccccCcccc-cCCCCCcccccHHHHHHHHHHHhCCCCCC
Q 007608 424 KLVDAKLTH---------------------VTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQRAID 478 (596)
Q Consensus 424 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~S~Gvil~elltg~~p~~ 478 (596)
+........ ......||+.|+|||++ .+..++.++|||||||++|||++|..|+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543211 12446689999999986 55669999999999999999998655544
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=324.29 Aligned_cols=258 Identities=28% Similarity=0.365 Sum_probs=197.8
Q ss_pred hcCCCcCceeeecCceEEEEEEeC--CCc--EEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS--DNT--KVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 344 (596)
.++|+..+.||+|+||+||+|.+. +++ .||+|+++... .....+.+.+|++++.+++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457888999999999999999853 333 68999987432 3345678999999999999999999999998765 8
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++|+||+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999998753 23588999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcce--eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 425 LVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 425 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .. ........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~---~~~~~~~~ 241 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QI---LHKIDKEG 241 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HH---HHHHHTSC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HH---HHHHHccC
Confidence 765433221 223457889999999998889999999999999999999 99999754321 11 11111111
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 551 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 551 (596)
.. ...+...+.++.+++.+|++.||++||++.|+++.|++..
T Consensus 242 ~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 ER--------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC--------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 00 0112234567889999999999999999999999998643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=323.01 Aligned_cols=264 Identities=24% Similarity=0.352 Sum_probs=202.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEe--CCCcEEEEEEccccC-CcchHHHHHHHHHHHHhc---CCCCccceEeEEe----
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVL--SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA---IHKNLLQLIGYCT---- 339 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~---- 339 (596)
+.++|+..+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 468899999987432 222234566788777766 8999999999987
Q ss_pred -cCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEe
Q 007608 340 -TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC 418 (596)
Q Consensus 340 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 418 (596)
.....++||||+. |+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 69999987643 23589999999999999999999999 99999999999999999999999
Q ss_pred eccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHh
Q 007608 419 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 498 (596)
Q Consensus 419 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~ 498 (596)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||+||+.||....... ....+....
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~ 235 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLGKILDVI 235 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHH
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHHHc
Confidence 999998664322 2233568999999999999999999999999999999999999998543211 111121111
Q ss_pred cc---Ccccc-------cc----cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 499 RE---DRLND-------IV----DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 499 ~~---~~~~~-------~~----d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. ..... .+ ...+..........+.+++.+||+.||++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 10 00000 00 000111223345678899999999999999999999853
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=321.14 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=199.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
..++|+..+.||+|+||.||+|... +|+.||+|.+... .....+.+|+.++.+++||||+++++++...+..++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 4567999999999999999999975 5899999998642 23567899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999998742 34689999999999999999999999 999999999999999999999999999986644
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ...... . ......
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~---~-~~~~~~-- 245 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----AIFMIP---T-NPPPTF-- 245 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHH---H-SCCCCC--
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHh---c-CCCccc--
Confidence 322 2233468999999999999999999999999999999999999997532211 111111 0 100000
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..+......+.+++.+||+.||++||++.|+++
T Consensus 246 ----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 012223457889999999999999999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.15 Aligned_cols=262 Identities=21% Similarity=0.316 Sum_probs=201.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC-----Cee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~ 344 (596)
.++|...+.||+|+||.||+|... +|+.||||++...........+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999975 68999999997544455567788999999999999999999988654 568
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||+. ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 589988875 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcc---------eeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHH
Q 007608 425 LVDAKLTH---------VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 494 (596)
Q Consensus 425 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~ 494 (596)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~ 235 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-----QLLLI 235 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HHHHH
Confidence 76532211 1123468999999998764 678999999999999999999999998643211 11111
Q ss_pred HHHhccCc----cc--------cccc-------CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 495 RKLLREDR----LN--------DIVD-------RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 495 ~~~~~~~~----~~--------~~~d-------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
........ .. +.+. ..+.........++.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11111000 00 0000 00000011234678899999999999999999999873
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=333.82 Aligned_cols=260 Identities=23% Similarity=0.292 Sum_probs=195.2
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC----C--ee
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS----S--ER 344 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~----~--~~ 344 (596)
.+|+..+.||+|+||.||+|+.. +|+.||||++.... ..+.+|++++++++||||+++++++... + ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 35778899999999999999975 68999999986432 1234799999999999999999988532 2 25
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC-CcEEEeecccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLA 423 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfGl~ 423 (596)
++||||+++ ++...+.........+++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999986 66666654333356799999999999999999999999 99999999999999955 67899999999
Q ss_pred ccccccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc---
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR--- 499 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~--- 499 (596)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+.+.+...-.
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~----~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVEIIKVLGTPTR 278 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCSCCH
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCH
Confidence 87644322 2335689999999999765 78999999999999999999999998643211 11121111000
Q ss_pred ------cCcccccccCcCCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 500 ------EDRLNDIVDRNLNT------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 500 ------~~~~~~~~d~~l~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.....+...+.+.. +......++.+++.+||+.||++||++.|++++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00111111111111 112234678999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=338.08 Aligned_cols=262 Identities=18% Similarity=0.238 Sum_probs=204.6
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCC-CccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK-NLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~ 348 (596)
.++|+..+.||+|+||.||+|.. .+++.||||++..... ...+.+|++++..++|+ ++..+..++...+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 46789999999999999999996 5799999998764322 23578999999999874 5555666667778889999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE---cCCCcEEEeecccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL 425 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DfGl~~~ 425 (596)
||+ +++|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 89999999753 24699999999999999999999999 99999999999999 6889999999999987
Q ss_pred ccccCcc------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc
Q 007608 426 VDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 499 (596)
Q Consensus 426 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 499 (596)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~i~~~~~ 233 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK--QKYEKISEKKV 233 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH--HHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH--HHHHHHhhccc
Confidence 6543321 122456999999999999999999999999999999999999999864332111 11111111111
Q ss_pred cCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCc
Q 007608 500 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL 552 (596)
Q Consensus 500 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 552 (596)
......+. .....++.+++..||+.+|++||++.+|++.|++...
T Consensus 234 ~~~~~~l~--------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 234 ATSIEALC--------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HSCHHHHH--------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cccHHHHh--------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111100 1124578899999999999999999999999987533
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=320.78 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=196.6
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-------CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 342 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 342 (596)
.++|...+.||+|+||.||+|... +++.||||++.... .......+.+|++++.+++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467889999999999999999965 68899999986421 1122345889999999999999999999987655
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc---EEEee
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCD 419 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~D 419 (596)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 8999999999999998875 35689999999999999999999999 9999999999999987654 99999
Q ss_pred ccccccccccCcceeccccccccccCccccc---CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHH
Q 007608 420 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 496 (596)
Q Consensus 420 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~ 496 (596)
||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..+...+..
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~ 234 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKDQITS 234 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS----SCHHHHHHH
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH----HHHHHHHHh
Confidence 99998764321 122345899999999974 567899999999999999999999999753321 112222211
Q ss_pred HhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 497 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+.... . +. ........+.+++.+||+.||++||++.|++++
T Consensus 235 ----~~~~~-~-~~---~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 235 ----GKYNF-I-PE---VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp ----TCCCC-C-HH---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----Ccccc-C-ch---hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 10000 0 00 001224578899999999999999999999764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.82 Aligned_cols=259 Identities=25% Similarity=0.346 Sum_probs=199.0
Q ss_pred cHHHHHHHhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEec
Q 007608 263 SCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 340 (596)
Q Consensus 263 ~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 340 (596)
...++....++|+..+.||+|+||.||+|.. .+++.||+|++... ......+.+|+.++.++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC--cccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 3334444678899999999999999999996 47899999998642 23457789999999999 79999999999976
Q ss_pred ------CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc
Q 007608 341 ------SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 414 (596)
Q Consensus 341 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 414 (596)
....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence 457899999999999999998632 24689999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccccCcceeccccccccccCccccc-----CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhch
Q 007608 415 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 489 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~ 489 (596)
+||+|||++........ ......|++.|+|||++. +..++.++|||||||++|||+||+.||.......
T Consensus 168 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----- 241 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----- 241 (326)
T ss_dssp EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----
T ss_pred EEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-----
Confidence 99999999986643221 123345899999999987 5678999999999999999999999997433211
Q ss_pred HHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 490 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 490 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
....+. . ....... .......+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~---~-~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 242 ALFLIP---R-NPAPRLK-------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHH---H-SCCCCCS-------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhh---c-CccccCC-------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111 1 1111111 1122457888999999999999999999988
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.53 Aligned_cols=259 Identities=20% Similarity=0.307 Sum_probs=194.5
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe------eE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE------RI 345 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~ 345 (596)
.+|+..+.||+|+||.||+|+..++..||+|++..... ...+|+++++.++||||+++++++..... .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 46888999999999999999988777799998864322 12379999999999999999999855432 78
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc-CCCcEEEeeccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAK 424 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DfGl~~ 424 (596)
+||||++++.+ ..+.........+++..++.++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+++
T Consensus 115 lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999987543 33332222245789999999999999999999999 999999999999999 79999999999998
Q ss_pred cccccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHH------
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL------ 497 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~------ 497 (596)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +...+...
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ----LVEIIKVLGTPSRE 264 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCCHH
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCCHH
Confidence 7644322 2334689999999998765 589999999999999999999999986432211 11111110
Q ss_pred ----hccCcccccccCcCCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 498 ----LREDRLNDIVDRNLNT------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 498 ----~~~~~~~~~~d~~l~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.........+ +.... +......++.+++.+||+.||++|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 265 QIKTMNPNYMEHKF-PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHCGGGSSSCC-CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhcc-ccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000 01110 122245688999999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=356.06 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=202.4
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCee
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 344 (596)
...++|+..++||+|+||.||+|... +++.||||+++... .......+..|..++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34578999999999999999999965 68899999987421 223456778899999887 799999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 9999999999999999863 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. .......
T Consensus 491 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-----~~~---~~i~~~~--- 558 (674)
T 3pfq_A 491 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELF---QSIMEHN--- 558 (674)
T ss_dssp ECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH---HHHHSSC---
T ss_pred ccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-----HHH---HHHHhCC---
Confidence 643322 2234567999999999999999999999999999999999999999854321 111 1111111
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 540 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 540 (596)
..++.....++.+++.+||+.||++||++
T Consensus 559 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred -------CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 11233445678899999999999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=333.08 Aligned_cols=199 Identities=22% Similarity=0.306 Sum_probs=172.6
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhc------CCCCccceEeEEecCCe
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA------IHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l------~H~niv~l~~~~~~~~~ 343 (596)
..+|+..+.||+|+||+||+|... +++.||||+++. .......+.+|+.++..+ .|+||+++++++.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC--ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 457899999999999999999865 689999999864 233456778888888877 57799999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc--EEEeecc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--AVLCDFG 421 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~DfG 421 (596)
.++||||+. ++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 68999887633 24589999999999999999999999 9999999999999999887 9999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCcc
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 481 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~ 481 (596)
+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99765432 223468999999999999999999999999999999999999998643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=333.13 Aligned_cols=258 Identities=22% Similarity=0.303 Sum_probs=184.3
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecC------C
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------S 342 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~ 342 (596)
.++|+..+.||+|+||.||+|.. .+|+.||||++... ........+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46889999999999999999995 47899999998643 2334556788999999999999999999998654 5
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 579999999 6788888764 4589999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~l~~i~~~~g~p 249 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-----QLKLILRLVGTP 249 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCSC
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCC
Confidence 9865432 233568999999999877 678999999999999999999999997643211 111111111100
Q ss_pred ---cccc--------ccc--CcCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 ---RLND--------IVD--RNLNTYD-----SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ---~~~~--------~~d--~~l~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+.. .+. +...... ......+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 000 0000000 1124568899999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=318.94 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=199.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC---CcchHHHHHHHHHHHHhcCCCCccceEeEEe--cCCee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIHKNLLQLIGYCT--TSSER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~ 344 (596)
.++|...+.||+|+||.||+|... +++.||+|+++... .......+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999964 68999999986421 2334678999999999999999999999984 44578
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||++++ +.+.+.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999976 767766533 34689999999999999999999999 99999999999999999999999999998
Q ss_pred cccccC-cceeccccccccccCcccccCCC--CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 425 LVDAKL-THVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 425 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
...... ........|++.|+|||++.+.. .+.++||||||+++|||++|+.||...... .....+. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~i~----~~ 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-----KLFENIG----KG 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHH----HC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-----HHHHHHh----cC
Confidence 764322 22233456899999999997654 378999999999999999999999853321 1111111 11
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. ..+......+.+++.+|++.||++||++.|++++
T Consensus 229 ~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 SY---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10 1112234577889999999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=327.25 Aligned_cols=263 Identities=24% Similarity=0.392 Sum_probs=202.4
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe
Q 007608 265 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 343 (596)
Q Consensus 265 ~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 343 (596)
++..+..++|+..+.||+|+||.||+|...+ .+|+|+++.. ......+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3444566789999999999999999999754 4999998743 223344567889999999999999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++ ++.+||+|||++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred eEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999753 24689999999999999999999999 999999999999998 679999999998
Q ss_pred ccccccC----cceeccccccccccCcccccC---------CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchH
Q 007608 424 KLVDAKL----THVTTQIRGTMGHIAPEYLST---------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 490 (596)
Q Consensus 424 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l 490 (596)
+...... ........|++.|+|||++.+ ..++.++||||||+++|||+||+.||....... .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~ 251 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----I 251 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----H
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----H
Confidence 7653211 111223458999999999864 357889999999999999999999997543211 1
Q ss_pred HHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCc
Q 007608 491 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL 552 (596)
Q Consensus 491 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 552 (596)
...+. ......... .....++.+++.+||+.||++||++.|++++|+...-
T Consensus 252 ~~~~~----~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 252 IWQMG----TGMKPNLSQ-------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHHHH----TTCCCCCCC-------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred HHHhc----cCCCCCCCc-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111 111111111 1123468899999999999999999999999997543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=317.27 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=199.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
..++|+..+.||+|+||.||+|... +++.||+|++... .......+.+|++++.+++||||+++++++...+..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3467888999999999999999975 5899999998643 3345678999999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp ECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999988753 24589999999999999999999999 999999999999999999999999998764322
Q ss_pred cCcceeccccccccccCcccc-----cCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYL-----STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
.. .......|++.|+|||++ .+..++.++||||||+++|||++|+.||....... ..........
T Consensus 170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~- 239 (302)
T 2j7t_A 170 TL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSDP- 239 (302)
T ss_dssp HH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCC-
T ss_pred cc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------HHHHHhccCC-
Confidence 11 112234589999999998 46678999999999999999999999997543211 1111111110
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. ...+......+.+++.+||+.||++||++.|++++
T Consensus 240 ~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 240 PT------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp CC------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cc------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 01122334578899999999999999999999774
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=316.61 Aligned_cols=253 Identities=22% Similarity=0.277 Sum_probs=203.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC--------cchHHHHHHHHHHHHhcC-CCCccceEeEEe
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--------PGGEAAFQREVHLISVAI-HKNLLQLIGYCT 339 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~ 339 (596)
..++|+..+.||+|+||.||+|... +++.||||++..... ......+.+|++++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3468899999999999999999975 689999999864321 122456889999999996 999999999999
Q ss_pred cCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEee
Q 007608 340 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 419 (596)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 419 (596)
.....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999986 24689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccCcceeccccccccccCccccc------CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHH
Q 007608 420 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 493 (596)
Q Consensus 420 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~ 493 (596)
||++....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||...... .....
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~ 240 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-----LMLRM 240 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-----HHHHH
Confidence 99998765432 223346899999999985 456889999999999999999999999753321 11111
Q ss_pred HHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 494 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 494 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+.. .... ...+ ........+.+++.+||+.||++||++.|+++
T Consensus 241 ~~~----~~~~-~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMS----GNYQ-FGSP----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH----TCCC-CCTT----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Hhc----CCcc-cCcc----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111 1100 0000 11234567889999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=334.96 Aligned_cols=253 Identities=8% Similarity=-0.005 Sum_probs=180.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC--cchHHHHHHHHHHHHhc--CCCCccceE-------eEEe
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVA--IHKNLLQLI-------GYCT 339 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l--~H~niv~l~-------~~~~ 339 (596)
.+|...+.||+|+||.||+|... +++.||||++..... ......+.+|+.++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45788999999999999999965 789999999975432 23455677885544444 699988754 3443
Q ss_pred cC-----------------CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 007608 340 TS-----------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR------KRVAFGTAYGLEYLHEQCNPK 396 (596)
Q Consensus 340 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~ 396 (596)
.. ...++||||++ |+|.+++.... ..+++..+ ..++.|++.||+|||++ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 22 33799999999 89999998632 22344555 77889999999999999 9
Q ss_pred cEecCCCCCcEEEcCCCcEEEeeccccccccccCcceeccccccccccCcccccC--CCCCcccccHHHHHHHHHHHhCC
Q 007608 397 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQ 474 (596)
Q Consensus 397 ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvil~elltg~ 474 (596)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||+||+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999866432 213446799999999987 67999999999999999999999
Q ss_pred CCCCCccchhhhhchHHHHHHHHhccCcccccccCcCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 475 RAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 475 ~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.||.......... ............... .........+.+++.+||+.||++||++.|+++
T Consensus 291 ~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS----------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC----------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc----------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9998543211100 000000000000000 011234567889999999999999999999964
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=321.27 Aligned_cols=259 Identities=20% Similarity=0.299 Sum_probs=203.6
Q ss_pred hcCCCcCceeeecCceEEEEEEe--CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCC------ccceEeEEecCC
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL--SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN------LLQLIGYCTTSS 342 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~ 342 (596)
.++|+..+.||+|+||+||+|.. .+++.||+|+++. .......+.+|++++..++|++ ++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec--CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 46789999999999999999986 3688999999864 2334567889999999887665 999999999999
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-----------
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD----------- 411 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~----------- 411 (596)
..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 889999987632 24689999999999999999999999 9999999999999987
Q ss_pred --------CCcEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccch
Q 007608 412 --------NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE 483 (596)
Q Consensus 412 --------~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~ 483 (596)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999865432 23346899999999999999999999999999999999999999864332
Q ss_pred hhhhchHHHHHHHHhcc--------Ccccccc---------------------cC--cCCCCCHHHHHHHHHHHHHcccc
Q 007608 484 EEEDVLLLDHIRKLLRE--------DRLNDIV---------------------DR--NLNTYDSKEVETMVQVALLCTQS 532 (596)
Q Consensus 484 ~~~~~~l~~~~~~~~~~--------~~~~~~~---------------------d~--~l~~~~~~~~~~l~~l~~~Cl~~ 532 (596)
+. ...+...... ....... .+ ...........++.+++.+||+.
T Consensus 241 ~~-----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 241 EH-----LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp HH-----HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred HH-----HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 11 1111111100 0000000 00 00112345678899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 007608 533 TPEDRPPMAQVVKM 546 (596)
Q Consensus 533 dP~~RPs~~evl~~ 546 (596)
||++|||+.|++++
T Consensus 316 dP~~Rpt~~ell~h 329 (339)
T 1z57_A 316 DPAKRITLREALKH 329 (339)
T ss_dssp STTTSCCHHHHTTS
T ss_pred CcccccCHHHHhcC
Confidence 99999999999753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=321.11 Aligned_cols=256 Identities=21% Similarity=0.302 Sum_probs=198.4
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcC--CCCccceEeEEecCCe
Q 007608 267 LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTSSE 343 (596)
Q Consensus 267 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~ 343 (596)
+....++|+..+.||+|+||.||++...+++.||+|++... ........+.+|++++.+++ ||||+++++++.+.+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 34456779999999999999999999888999999998643 23345678899999999997 5999999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||| +.+++|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||++++ +.+||+|||++
T Consensus 103 ~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccc
Confidence 999999 567899999986 34689999999999999999999999 9999999999999975 79999999999
Q ss_pred ccccccCcc-eeccccccccccCcccccC-----------CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHH
Q 007608 424 KLVDAKLTH-VTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL 491 (596)
Q Consensus 424 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~ 491 (596)
+........ ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~ 246 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------I 246 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------H
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-------H
Confidence 876543222 2233468999999999875 46888999999999999999999999743211 1
Q ss_pred HHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 492 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 492 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
............. ..+.....++.+++.+||+.||++||++.|+++.
T Consensus 247 ~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 SKLHAIIDPNHEI--------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHCTTSCC--------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhccccc--------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111111111100 0111224578889999999999999999999763
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=327.53 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=196.6
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCee----
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER---- 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~---- 344 (596)
.++|...+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999965 68999999997432 333457788999999999999999999999877655
Q ss_pred --EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 345 --ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 345 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 588777642 489999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+. + ..+.......
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~-~~i~~~~~~~ 261 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ----L-TQILKVTGVP 261 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH----H-HHHHHHHCCC
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH----H-HHHHHHhCCC
Confidence 9865432 233468999999999987 6789999999999999999999999986432211 1 1111100000
Q ss_pred ---ccc------------ccccCcCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 ---RLN------------DIVDRNLNT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ---~~~------------~~~d~~l~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
... .+....... ........+.+++.+||+.||++|||+.|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 000000000 111235678899999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.67 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=197.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe-----
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE----- 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 343 (596)
.++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888999999999999999965 68999999987433 33345678999999999999999999999987654
Q ss_pred -eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 344 -RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 344 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
.++||||+. ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 588776642 489999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+.......
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~~~~ 243 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-----QLTQILKVTGVP 243 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-----HHHHHHHHHCBC
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCC
Confidence 9865432 223458999999999877 678999999999999999999999997643211 111111110000
Q ss_pred ------------------cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 ------------------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ------------------~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.......+.+.........++.+++.+|++.||++||++.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000111112223446788999999999999999999999764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=332.02 Aligned_cols=267 Identities=21% Similarity=0.289 Sum_probs=182.8
Q ss_pred CCCc-CceeeecCceEEEEEEeC---CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEe--cCCeeEE
Q 007608 273 NFSE-SNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT--TSSERIL 346 (596)
Q Consensus 273 ~f~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~~l 346 (596)
.|+. .++||+|+||+||+|... +++.||+|++... .....+.+|+.++++++||||+++++++. .....++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS---SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC---CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 3544 568999999999999965 5788999998643 23456889999999999999999999995 4677899
Q ss_pred EEEcccCCChhhhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE----cCCCcEEE
Q 007608 347 VYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVL 417 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl 417 (596)
||||+.+ +|.+.+.... .....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999974 7777765321 1123589999999999999999999999 99999999999999 77889999
Q ss_pred eeccccccccccCc--ceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhh----hchH
Q 007608 418 CDFGLAKLVDAKLT--HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE----DVLL 490 (596)
Q Consensus 418 ~DfGl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~----~~~l 490 (596)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||......... ....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987654322 122345689999999999874 5899999999999999999999999754321000 0011
Q ss_pred HHHHHHHhccC---ccccccc-------------CcCCCCCH---------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 491 LDHIRKLLRED---RLNDIVD-------------RNLNTYDS---------KEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 491 ~~~~~~~~~~~---~~~~~~d-------------~~l~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...+....... .+..+.. ........ .....+.+|+.+||+.||++|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111100 0000000 00000000 01346789999999999999999999988
Q ss_pred H
Q 007608 546 M 546 (596)
Q Consensus 546 ~ 546 (596)
+
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=314.07 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=202.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
..++|+..+.||+|+||.||+|... +++.||+|++... ........+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3468999999999999999999975 7899999998643 2344567899999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC---CcEEEeeccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLAK 424 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~DfGl~~ 424 (596)
+||+++++|.+.+... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999988752 3589999999999999999999999 99999999999999754 469999999998
Q ss_pred cccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
....... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... .....+.. +...
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~----~~~~ 240 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-----DILKRVET----GKYA 240 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH----CCCC
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHc----CCCC
Confidence 6644322 223347899999999875 4899999999999999999999999754321 11111111 1110
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
... +. ......++.+++.+|++.||++||++.|+++
T Consensus 241 ~~~-~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDL-PQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCS-GG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCc-hh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 00 0123457889999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=320.07 Aligned_cols=202 Identities=24% Similarity=0.291 Sum_probs=171.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CC-----CccceEeEEecCC
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HK-----NLLQLIGYCTTSS 342 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~~ 342 (596)
..++|+..+.||+|+||+||+|... +++.||||+++. .......+..|+.++..++ |+ +++++++++...+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN--KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec--cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4578999999999999999999965 688999999864 2334566788888888875 44 4999999999999
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc--CCCcEEEeec
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCDF 420 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Df 420 (596)
..++||||+. ++|.+++.... ...+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999996 59999988633 24589999999999999999999952 12899999999999994 5778999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCcc
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 481 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~ 481 (596)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999876432 233568999999999999999999999999999999999999998643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=318.92 Aligned_cols=260 Identities=20% Similarity=0.305 Sum_probs=192.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEe----------
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT---------- 339 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~---------- 339 (596)
.++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 357888999999999999999976 5899999998642 3445678899999999999999999999874
Q ss_pred ----cCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc-CCCc
Q 007608 340 ----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFE 414 (596)
Q Consensus 340 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~ 414 (596)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3467799999998 699998864 4589999999999999999999999 999999999999997 5679
Q ss_pred EEEeeccccccccccCcc--eeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHH
Q 007608 415 AVLCDFGLAKLVDAKLTH--VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL 491 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~ 491 (596)
+||+|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||......+. .
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~ 234 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-----M 234 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----H
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-----H
Confidence 999999999876432211 1233457899999998865 6789999999999999999999999986432111 1
Q ss_pred HHHHHHhcc----------CcccccccCcCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 492 DHIRKLLRE----------DRLNDIVDRNLN-------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 492 ~~~~~~~~~----------~~~~~~~d~~l~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..+...... ......+..... ........++.+++.+||+.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111110000 000000000000 011123567889999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.58 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=193.0
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec---------
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--------- 340 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------- 340 (596)
.++|+..+.||+|+||.||+|+.. +++.||+|++.. .......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 457888999999999999999964 789999999864 23345778999999999999999999998865
Q ss_pred ----CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEE
Q 007608 341 ----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 416 (596)
Q Consensus 341 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 416 (596)
....++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 34678999999999999999852 24578899999999999999999999 999999999999999999999
Q ss_pred EeeccccccccccC-------------cceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccc
Q 007608 417 LCDFGLAKLVDAKL-------------THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRL 482 (596)
Q Consensus 417 l~DfGl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~ 482 (596)
|+|||++....... ........|++.|+|||++.+. .++.++||||||+++|||++ |+...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-- 231 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-- 231 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--
Confidence 99999998664321 1112334589999999999764 68999999999999999998 44321
Q ss_pred hhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 483 EEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 483 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.........+.. .. ..+.+ .........+.+++.+||+.||++||++.|++++
T Consensus 232 --~~~~~~~~~~~~----~~--~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 --MERVNILKKLRS----VS--IEFPP---DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --HHHHHHHHHHHS----TT--CCCCT---TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --hhHHHHHHhccc----cc--cccCc---cccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111111111 00 00111 1233445678899999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=320.08 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=181.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHH-HHHhcCCCCccceEeEEecCCeeEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
..++|...+.||+|+||.||+|... +|+.||||++...........+..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3467888999999999999999975 789999999976544445556666766 67778999999999999999999999
Q ss_pred EEcccCCChhhhhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 348 YPFMQNLSVAYRLRDLK-PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
|||+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +++||||||+||+++.++.+||+|||+++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999985 7777765311 12356899999999999999999999852 7999999999999999999999999999866
Q ss_pred cccCcceeccccccccccCcccc----cCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYL----STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||...... .+...... .+.
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~-~~~ 246 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLTQVV-KGD 246 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCC-CSC
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHHHHh-cCC
Confidence 44322 2233589999999998 4567899999999999999999999999743210 00000000 000
Q ss_pred ccccccCcCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 503 LNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 503 ~~~~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.+.+.. ........+.+++.+||+.||++||++.|+++
T Consensus 247 -----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 -----PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -----CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 011111 11234567889999999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=319.99 Aligned_cols=247 Identities=21% Similarity=0.320 Sum_probs=191.5
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCc-----chHHHHHHHHHHHHhc----CCCCccceE
Q 007608 266 ELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVA----IHKNLLQLI 335 (596)
Q Consensus 266 el~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~~e~~~l~~l----~H~niv~l~ 335 (596)
+.+...++|+..+.||+|+||.||+|.. .+++.||+|++...... .....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3344567899999999999999999986 47899999999643221 1233456799999988 899999999
Q ss_pred eEEecCCeeEEEEEc-ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc-CCC
Q 007608 336 GYCTTSSERILVYPF-MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNF 413 (596)
Q Consensus 336 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~ 413 (596)
+++...+..++|+|| +.+++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999999 789999999986 23589999999999999999999999 999999999999999 889
Q ss_pred cEEEeeccccccccccCcceeccccccccccCcccccCCCCC-cccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHH
Q 007608 414 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS-EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 492 (596)
Q Consensus 414 ~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~ 492 (596)
.+||+|||++....... .....|++.|+|||++.+..+. .++||||||+++|||++|+.||.....
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------- 244 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------- 244 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------
Confidence 99999999998765432 2334589999999998876664 589999999999999999999974210
Q ss_pred HHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 493 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 493 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
... .. ...+.....++.+++.+||+.||++||++.|++++
T Consensus 245 ~~~-----~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ILE-----AE---------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHH-----TC---------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred Hhh-----hc---------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00 01122234578899999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.47 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=188.2
Q ss_pred CCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEEEcc
Q 007608 273 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 34456889999999998777778999999998642 345678999999876 8999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCC-------------CcE
Q 007608 352 QNLSVAYRLRDLKPGEKG---LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-------------FEA 415 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-------------~~~ 415 (596)
. |+|.+++......... .++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 6999999864322211 13334578999999999999999 99999999999999754 489
Q ss_pred EEeeccccccccccCcc---eeccccccccccCcccccC-------CCCCcccccHHHHHHHHHHHh-CCCCCCCccchh
Q 007608 416 VLCDFGLAKLVDAKLTH---VTTQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE 484 (596)
Q Consensus 416 kl~DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~ 484 (596)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999877543222 1233569999999999975 568999999999999999999 999997432211
Q ss_pred hhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 485 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 485 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
......... . +............++.+++.+||+.||++||++.||+++
T Consensus 248 ------~~i~~~~~~---~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 ------SNIIRGIFS---L----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp ------HHHHHTCCC---C----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------HHHhcCCCC---c----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 111111000 0 000011245667889999999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=321.83 Aligned_cols=265 Identities=21% Similarity=0.302 Sum_probs=200.4
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-----------CCCccceEeEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----------HKNLLQLIGYC 338 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~ 338 (596)
.++|...+.||+|+||+||+|.. .+++.||||++.. .......+.+|+.++.++. ||||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 35788899999999999999996 4789999999863 2334567889999998886 89999999998
Q ss_pred ecCC----eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc----
Q 007608 339 TTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---- 410 (596)
Q Consensus 339 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---- 410 (596)
...+ ..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+++ +|+||||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 7654 678999999 889999998643 245899999999999999999999953 799999999999994
Q ss_pred --CCCcEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhh-h
Q 007608 411 --DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE-D 487 (596)
Q Consensus 411 --~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~-~ 487 (596)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......... .
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999876542 22346899999999999999999999999999999999999999854321110 0
Q ss_pred chHHHHHHHHhcc-------------------Cccccccc----------CcCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 007608 488 VLLLDHIRKLLRE-------------------DRLNDIVD----------RNLNTYDSKEVETMVQVALLCTQSTPEDRP 538 (596)
Q Consensus 488 ~~l~~~~~~~~~~-------------------~~~~~~~d----------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP 538 (596)
......+...... +....+.. ......+.....++.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 0111111111100 00000000 001124567788999999999999999999
Q ss_pred CHHHHHHH
Q 007608 539 PMAQVVKM 546 (596)
Q Consensus 539 s~~evl~~ 546 (596)
|++|++++
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=323.93 Aligned_cols=248 Identities=22% Similarity=0.378 Sum_probs=199.7
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCc-----chHHHHHHHHHHHHhcC--CCCccceEe
Q 007608 265 RELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAI--HKNLLQLIG 336 (596)
Q Consensus 265 ~el~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~~e~~~l~~l~--H~niv~l~~ 336 (596)
.+.+...++|+..+.||+|+||.||+|.. .+++.||||++...... .....+.+|+.++.+++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 33444567899999999999999999995 47899999998743221 12345678999999996 599999999
Q ss_pred EEecCCeeEEEEEcccC-CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc-CCCc
Q 007608 337 YCTTSSERILVYPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFE 414 (596)
Q Consensus 337 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~ 414 (596)
++...+..++|+||+.+ ++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++ +++.
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence 99999999999999986 899999876 24689999999999999999999999 999999999999999 7889
Q ss_pred EEEeeccccccccccCcceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHH
Q 007608 415 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 493 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~ 493 (596)
+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||+||+.||..... .
T Consensus 189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------~ 255 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------I 255 (320)
T ss_dssp EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------H
T ss_pred EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------h
Confidence 9999999998765432 223458999999999987665 6889999999999999999999974210 0
Q ss_pred HHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 494 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 494 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. .. . . .......++.+++.+||+.||++||++.|+++.
T Consensus 256 ~~----~~-~--~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 256 IR----GQ-V--F-------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HH----CC-C--C-------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hc----cc-c--c-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 0 0 111234578899999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.55 Aligned_cols=252 Identities=20% Similarity=0.259 Sum_probs=172.6
Q ss_pred hcCCCcC-ceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec----CCee
Q 007608 271 TDNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSER 344 (596)
Q Consensus 271 ~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~ 344 (596)
.++|... ++||+|+||+||+|... +++.||+|++... .....+....+..+.||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4678874 46999999999999976 7899999998641 2222233334567799999999999876 3457
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC---CCcEEEeecc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFG 421 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DfG 421 (596)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 89999999999999998632 34699999999999999999999999 9999999999999976 4559999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..........
T Consensus 177 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~ 248 (336)
T 3fhr_A 177 FAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-----PGMKRRIRLG 248 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-----hhHHHhhhcc
Confidence 998654322 22345799999999998888999999999999999999999999753321110 0000000000
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.. ....+ .......++.+++.+|++.||++|||+.|+++
T Consensus 249 ~~-~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 QY-GFPNP----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---CCCTT----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cc-ccCch----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00000 11234567889999999999999999999998
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=316.92 Aligned_cols=258 Identities=21% Similarity=0.281 Sum_probs=200.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CC-cEEEEEEccccCCcchHHHHHHHHHHHHhcCCCC------ccceEeEEecCC
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN------LLQLIGYCTTSS 342 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~ 342 (596)
.++|+..+.||+|+||+||+|... ++ +.||+|+++. .......+.+|+.++++++|++ ++.+.+++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc--cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 468999999999999999999964 44 6899999864 2344567889999999998766 899999999999
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEE-------------
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL------------- 409 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll------------- 409 (596)
..++||||+ ++++.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 567777776522 24689999999999999999999999 99999999999999
Q ss_pred ------cCCCcEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccch
Q 007608 410 ------DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE 483 (596)
Q Consensus 410 ------~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~ 483 (596)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999865432 23346899999999999999999999999999999999999999854322
Q ss_pred hhhhchHHHHHHHHhcc--------Ccccccc-c----------------------CcCCCCCHHHHHHHHHHHHHcccc
Q 007608 484 EEEDVLLLDHIRKLLRE--------DRLNDIV-D----------------------RNLNTYDSKEVETMVQVALLCTQS 532 (596)
Q Consensus 484 ~~~~~~l~~~~~~~~~~--------~~~~~~~-d----------------------~~l~~~~~~~~~~l~~l~~~Cl~~ 532 (596)
+ ....+...... ....... . ............++.+++.+||+.
T Consensus 246 ~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 246 E-----HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp H-----HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred H-----HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 1 11111111100 0000000 0 000012334566889999999999
Q ss_pred CCCCCCCHHHHHH
Q 007608 533 TPEDRPPMAQVVK 545 (596)
Q Consensus 533 dP~~RPs~~evl~ 545 (596)
||++|||+.|+++
T Consensus 321 dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 321 DPAQRITLAEALL 333 (355)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999965
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.03 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=179.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHH-HHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEA-AFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~-~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.++|+..+.||+|+||.||+|... +|+.||||++.......... .+.++..++..++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 457888899999999999999975 78999999997544333333 3444555678889999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
||+ ++.+....... ...+++..+..++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 44554444332 2468999999999999999999998 5 89999999999999999999999999997654
Q ss_pred ccCcceeccccccccccCccccc-----CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
... ......|++.|+|||++. ...++.++||||||+++|||++|+.||...... ... .........
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~---~~~~~~~~~ 247 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD----FEV---LTKVLQEEP 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH----HHH---HHHHHHSCC
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----HHH---HHHHhccCC
Confidence 432 122345899999999984 456889999999999999999999999753221 111 111111110
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. .+. .......++.+++.+||+.||.+||++.|+++
T Consensus 248 -~-----~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 -P-----LLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -C-----CCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -C-----CCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 000 01123456888999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=321.81 Aligned_cols=250 Identities=24% Similarity=0.306 Sum_probs=186.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 349 (596)
..+|...++||+|+||+||.....+++.||||++.... ...+.+|+++++++ +||||+++++++.+....++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 34678889999999999765556689999999986422 12356899999999 79999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-----CCcEEEeeccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-----NFEAVLCDFGLAK 424 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~DfGl~~ 424 (596)
|+. |+|.+++.... ....+..+..++.|++.||.|||+. +|+||||||+||+++. ...+||+|||+++
T Consensus 99 ~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 997 59999987533 2234445678999999999999999 9999999999999943 3468899999998
Q ss_pred cccccCc--ceeccccccccccCccccc---CCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHh
Q 007608 425 LVDAKLT--HVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL 498 (596)
Q Consensus 425 ~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~ 498 (596)
....... .......||+.|+|||++. ...++.++|||||||++|||+| |..||....... .....
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---------~~~~~ 242 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---------ANILL 242 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---------HHHHT
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---------HHHHh
Confidence 7654321 1233456999999999997 4567889999999999999999 899986432110 01111
Q ss_pred ccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 499 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
..... . ...........+.+++.+||+.||++||++.||+++
T Consensus 243 ~~~~~-~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 243 GACSL-D-----CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TCCCC-T-----TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCc-c-----ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 11100 0 011123445667899999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=338.97 Aligned_cols=260 Identities=22% Similarity=0.271 Sum_probs=201.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec------CCe
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT------SSE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~ 343 (596)
.++|+..+.||+|+||.||+|... +|+.||||++...........+.+|++++.+++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999964 6899999999765566667789999999999999999999998765 667
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc---EEEeec
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDF 420 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Df 420 (596)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 7999999999999999986432 34588899999999999999999999 9999999999999997664 999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
|++....... ......||+.|+|||++.+..++.++||||||+++|||+||+.||...... ..|.......
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-------~~~~~~i~~~ 239 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-------VQWHGKVREK 239 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-------HHSSTTCC--
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-------hhhhhhhhcc
Confidence 9998765432 223456899999999999999999999999999999999999999753221 1111000000
Q ss_pred ----Cccccc------ccCc---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 007608 501 ----DRLNDI------VDRN---LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQV 543 (596)
Q Consensus 501 ----~~~~~~------~d~~---l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 543 (596)
....+. +... ...........+.+++.+|++.||++||++.|+
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000000 0011 111344567889999999999999999999774
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=339.38 Aligned_cols=238 Identities=19% Similarity=0.283 Sum_probs=192.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeC--CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCe-----
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE----- 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 343 (596)
.++|++.+.||+|+||.||+|... +++.||||++...........+.+|++++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 6899999998754445556788999999999999999999999987655
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||+++++|.+++.. .+++..++.++.||+.||.|||+. +|+||||||+||+++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999877653 589999999999999999999999 99999999999999986 8999999999
Q ss_pred ccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
+..... ....||+.|+|||++.+.. +.++|||||||++|||++|..|+........
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------------ 284 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------------ 284 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------------
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc------------------
Confidence 876443 3356899999999987654 8999999999999999999888763211000
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHhc
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-MAQVVKMLQ 548 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~ 548 (596)
. . ..........+.+++.+||+.||++||+ ++++.+.|.
T Consensus 285 ---~-~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 ---P-E--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ---C-T--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---c-c--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 0 0001123357889999999999999996 555555554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.50 Aligned_cols=229 Identities=10% Similarity=0.025 Sum_probs=182.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC--cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||.||+|... +++.||+|++..... ......|.+|+..+.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367889999999999999999975 589999999975433 33447899999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++++|.+++.. .....+..+++.|++.||+|||+. +|+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999854 135557889999999999999999 99999999999999999999997443
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
|++ +++.++|||||||++|||+||+.||.......... ......
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------------~~~~~~ 218 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------------PAERDT 218 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------------ECCBCT
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------------HHHHHh
Confidence 333 36889999999999999999999998543211000 000000
Q ss_pred cCcCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 007608 508 DRNLN---TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 551 (596)
Q Consensus 508 d~~l~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 551 (596)
..... ........++.+++.+||+.||++| |+.|+++.|+...
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 00000 0112234678899999999999999 9999999998643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=294.17 Aligned_cols=227 Identities=20% Similarity=0.278 Sum_probs=178.3
Q ss_pred cCCCcC-ceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHH-HhcCCCCccceEeEEec----CCee
Q 007608 272 DNFSES-NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLI-SVAIHKNLLQLIGYCTT----SSER 344 (596)
Q Consensus 272 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~~ 344 (596)
++|... +.||+|+||.||+|.. .+++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456665 7899999999999996 4789999999863 34567888887 55689999999999876 5678
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC---CCcEEEeecc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFG 421 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DfG 421 (596)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999998632 34689999999999999999999999 9999999999999998 7899999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
++.... +..++.++|||||||++|||+||+.||........ ...
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------------~~~ 209 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------------SPG 209 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-------------hHH
Confidence 986432 23467899999999999999999999974322110 000
Q ss_pred cccccccCcCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 502 RLNDIVDRNLNTYD----SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 502 ~~~~~~d~~l~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.... +.......+ .....++.+++.+||+.||++||++.|++++
T Consensus 210 ~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 210 MKTR-IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCCS-SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHH-HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 100011112 1235678899999999999999999999873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.70 Aligned_cols=243 Identities=16% Similarity=0.089 Sum_probs=180.4
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCC--cchHHHHHHHHHHHHhcCC-CCcc----------ce---
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIH-KNLL----------QL--- 334 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H-~niv----------~l--- 334 (596)
..|...+.||+|+||+||+|.. .+|+.||||++..... ....+.|.+|+.++..++| +|.. .+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4466778999999999999995 4799999999873222 2235779999999999987 2211 11
Q ss_pred --------EeEEec-----CCeeEEEEEcccCCChhhhhccc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 007608 335 --------IGYCTT-----SSERILVYPFMQNLSVAYRLRDL---KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398 (596)
Q Consensus 335 --------~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 398 (596)
..+... ....+++|+++ +++|.+++... ......+++..++.++.|++.||+|||+. +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111111 12345666654 57999888522 22344588899999999999999999999 999
Q ss_pred ecCCCCCcEEEcCCCcEEEeeccccccccccCcceeccccccccccCcccc----------cCCCCCcccccHHHHHHHH
Q 007608 399 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL----------STGKSSEKTDVFGYGITLL 468 (596)
Q Consensus 399 H~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~S~Gvil~ 468 (596)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998865433 334457 999999999 5556889999999999999
Q ss_pred HHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 469 ELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 469 elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
||+||+.||........ ...++... ...+.++.+++.+||+.||++||++.|+++
T Consensus 309 elltg~~Pf~~~~~~~~-----------------~~~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG-----------------SEWIFRSC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC-----------------SGGGGSSC-----CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh-----------------HHHHHhhc-----ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999975332111 11111110 112367889999999999999999999865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.61 Aligned_cols=243 Identities=15% Similarity=0.129 Sum_probs=184.7
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccC-------CcchHHHHHHHHHHHHhcC---------CCCccce
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAI---------HKNLLQL 334 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~e~~~l~~l~---------H~niv~l 334 (596)
.++|+..+.||+|+||+||+|+. +|+.||||++.... .....+.+.+|+.+++.++ |||++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45688899999999999999998 78999999997432 2333478899999998886 7777777
Q ss_pred EeEEe------------------------------cCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHH
Q 007608 335 IGYCT------------------------------TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 384 (596)
Q Consensus 335 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~ 384 (596)
.+.+. ..+..++||||+++|++.+.+.. ..+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 76542 26788999999999987776643 45899999999999999
Q ss_pred HHHHHH-hCCCCCcEecCCCCCcEEEcCCC--------------------cEEEeeccccccccccCcceeccccccccc
Q 007608 385 GLEYLH-EQCNPKIIHRDLKAANILLDDNF--------------------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 443 (596)
Q Consensus 385 ~L~~LH-~~~~~~ivH~dlkp~NIll~~~~--------------------~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y 443 (596)
||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 88 999999999999999887 8999999999876432 23589999
Q ss_pred cCcccccCCCCCcccccHHHHHH-HHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHH
Q 007608 444 IAPEYLSTGKSSEKTDVFGYGIT-LLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETM 522 (596)
Q Consensus 444 ~aPE~~~~~~~~~~sDv~S~Gvi-l~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 522 (596)
+|||++.+.. +.++||||+|++ .+++++|..||.... ......+ ......... .............++
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~----~~~~~~~---~~~~~~~~~---~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL----WLHYLTD---KMLKQMTFK---TKCNTPAMKQIKRKI 312 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH----HHHHHHH---HHHHTCCCS---SCCCSHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh----hhhHHHH---hhhhhhccC---cccchhhhhhcCHHH
Confidence 9999998766 899999998777 778888998874210 0000111 111010000 000111234567889
Q ss_pred HHHHHHccccCCCCCCCHHHHH
Q 007608 523 VQVALLCTQSTPEDRPPMAQVV 544 (596)
Q Consensus 523 ~~l~~~Cl~~dP~~RPs~~evl 544 (596)
.+++.+||+.| |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999976 898887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=269.59 Aligned_cols=185 Identities=13% Similarity=0.046 Sum_probs=129.4
Q ss_pred eeecCceEEEEEE-eCCCcEEEEEEccccC---------CcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEEE
Q 007608 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYY---------SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 280 lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~---------~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 348 (596)
.+.|++|.+..++ .--|+.+++|++.... .+...++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666666554 2357889999986431 122346799999999999 6999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||++|++|.+.|... .+++. .+|+.||+.||+|+|++ +||||||||+|||+++++.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~~----~~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG----EEIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTT----CCCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhC----CCCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999862 34554 35899999999999999 999999999999999999999999999987654
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCC
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA 476 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p 476 (596)
... ......||++|+|||++.+ ++..++|+||+|++++++.++..+
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 2334569999999999875 467789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-26 Score=246.99 Aligned_cols=185 Identities=15% Similarity=0.196 Sum_probs=146.7
Q ss_pred cCceeeecCceEEEEEEeCCCcEEEEEEccccCC-cc------hHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 276 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS-PG------GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 276 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
..+.||+|+||+||+|.. .++.+++|+...... .. ..+.|.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999954 678889988643211 11 1345899999999999999997777777888889999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++++|.+++.. +..++.|+++||.|||++ +|+||||||+|||++. .+||+|||+++....
T Consensus 419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 99999999999875 458999999999999999 9999999999999999 999999999998755
Q ss_pred cCcce------eccccccccccCcccccC--CCCCcccccHHHHHHHHHHHhCCCCCC
Q 007608 429 KLTHV------TTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAID 478 (596)
Q Consensus 429 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvil~elltg~~p~~ 478 (596)
..... .....||+.|+|||++.. ..|+..+|+||..+-.++-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32211 234569999999999976 567888999999998888888776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8.1e-23 Score=204.22 Aligned_cols=154 Identities=13% Similarity=0.045 Sum_probs=122.6
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCc-----------------chHHHHHHHHHHHHhc
Q 007608 264 CRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-----------------GGEAAFQREVHLISVA 326 (596)
Q Consensus 264 ~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------------~~~~~~~~e~~~l~~l 326 (596)
...+......|...+.||+|+||.||+|...+|+.||+|.++..... .....+.+|+.++.++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 44455556667778999999999999999977999999998632211 1346789999999999
Q ss_pred CCCCccceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCc
Q 007608 327 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 406 (596)
Q Consensus 327 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N 406 (596)
+ | +++.+++. .+..++||||+++++|.+ +.. .....++.|++.||.|||+. +|+||||||+|
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence 8 4 66666543 356699999999999988 431 12447999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeeccccccccccCcceeccccccccccCccccc
Q 007608 407 ILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 450 (596)
Q Consensus 407 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 450 (596)
||++ ++.+||+|||+++. +..|.|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9999 99999999999863 34568888874
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=205.49 Aligned_cols=149 Identities=26% Similarity=0.495 Sum_probs=134.9
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCCCCCCCCCCC--cceeEeeC----CCEEEEEcCCCCCCc--ccCcchhhhccc
Q 007608 31 REPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFS--WSHVTCRN----GNVISLTLGSNGFSG--KISPSITKLKFL 102 (596)
Q Consensus 31 ~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~~--w~gv~c~~----~~l~~L~l~~n~l~g--~~p~~~~~l~~L 102 (596)
.|.+.|++||++||+++.+|. .+.+|+.+ ++||. |.||.|+. ++|+.|+|++|+++| .+|+.|+++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~--~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT--SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCC--CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 467889999999999998876 78899764 34556 99999985 699999999999999 999999999999
Q ss_pred chhhcccC-ccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCCCCcccccCCcccc---cccccccc
Q 007608 103 ASFRELQD-NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFT 178 (596)
Q Consensus 103 ~~l~~l~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l~---~l~~l~~~ 178 (596)
++| +|++ |.++|.+|..|+++++|++|+|++|+++|.+|..++++++|++|+|++|+++|.+|..+. +|+.|+++
T Consensus 79 ~~L-~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 157 (313)
T 1ogq_A 79 NFL-YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp SEE-EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred Cee-eCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECc
Confidence 999 9994 999999999999999999999999999999999999999999999999999999998765 56778888
Q ss_pred ccccc
Q 007608 179 GTHLI 183 (596)
Q Consensus 179 ~n~~~ 183 (596)
+|.+.
T Consensus 158 ~N~l~ 162 (313)
T 1ogq_A 158 GNRIS 162 (313)
T ss_dssp SSCCE
T ss_pred CCccc
Confidence 88764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-20 Score=214.44 Aligned_cols=148 Identities=26% Similarity=0.354 Sum_probs=100.2
Q ss_pred CCCCChhHHHHHHHHHHhccCCCCCCCCCCCCCCCCCCCcceeEeeCCCEEEEEcCCCCCCcc---cCcchhhhcccchh
Q 007608 29 SSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGK---ISPSITKLKFLASF 105 (596)
Q Consensus 29 ~~~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~~w~gv~c~~~~l~~L~l~~n~l~g~---~p~~~~~l~~L~~l 105 (596)
++.+.+.|++||++||+++.||. .+++|+.+ ++||.|.||+|+.++|+.|+|+++.+.|. +|+.+++|++|+.+
T Consensus 6 ~~~~~~~~~~all~~k~~~~~~~-~l~~W~~~--~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLPDKN-LLPDWSSN--KNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCSCTT-SSTTCCTT--SCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred cccCCHHHHHHHHHHHhhCCCcc-cccCCCCC--CCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 34446779999999999999888 89999854 56779999999989999999999999998 77766666555555
Q ss_pred hcccCccccccCCcccCCCCcccEEEccCccCcCCCcc--ccccCCCCcEEeCCCCcccccCCcc----ccccccccccc
Q 007608 106 RELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA--TWSQLSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTG 179 (596)
Q Consensus 106 ~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~iP~~----l~~l~~l~~~~ 179 (596)
+++.|.+. .+|..|+++++|++|||++|.++|.+|. .++++++|++|+|++|+++|.+|.. +.+|+.|++++
T Consensus 83 -~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~ 160 (768)
T 3rgz_A 83 -FLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160 (768)
T ss_dssp -ECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred -CCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence 45555444 3445555555566666665555555555 5555555555555555555555532 23344444444
Q ss_pred cc
Q 007608 180 TH 181 (596)
Q Consensus 180 n~ 181 (596)
|.
T Consensus 161 n~ 162 (768)
T 3rgz_A 161 NS 162 (768)
T ss_dssp SC
T ss_pred Cc
Confidence 43
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.7e-20 Score=210.91 Aligned_cols=146 Identities=21% Similarity=0.336 Sum_probs=127.5
Q ss_pred CCCChhHHHHHHHHHHhccCCCCCCCCCCCCC----CCCC-CCc------------ceeEee-CCCEEEEEcCCCCCCcc
Q 007608 30 SREPDVEGEALIEVLKALNDTHGQFTDWNDHF----VSPC-FSW------------SHVTCR-NGNVISLTLGSNGFSGK 91 (596)
Q Consensus 30 ~~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~----~~~c-~~w------------~gv~c~-~~~l~~L~l~~n~l~g~ 91 (596)
+.....|+.||++||+++.+| +|+.+. .+|| |.| .||+|+ .++|+.|+|++|+|+|.
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ 338 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEE
T ss_pred cccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCc
Confidence 344556899999999999876 786553 3452 599 999998 48999999999999999
Q ss_pred cCcchhhhcccchhhcc-cCcccccc------------------------------------------------------
Q 007608 92 ISPSITKLKFLASFREL-QDNDLSGT------------------------------------------------------ 116 (596)
Q Consensus 92 ~p~~~~~l~~L~~l~~l-~~n~l~g~------------------------------------------------------ 116 (596)
+|++|++|++|+.| +| ++|.++|.
T Consensus 339 ip~~l~~L~~L~~L-dLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i 417 (876)
T 4ecn_A 339 VPDAIGQLTELKVL-SFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417 (876)
T ss_dssp ECGGGGGCTTCCEE-ESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred CchHHhccccceEe-eecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence 99999999999999 99 88876655
Q ss_pred ----------------------CCcccCCCCcccEEEccCccCcC-----------------CCccccc--cCCCCcEEe
Q 007608 117 ----------------------LPDFLGSMTHLQSLNLANNKFSG-----------------SIPATWS--QLSNLKHLD 155 (596)
Q Consensus 117 ----------------------~p~~~~~l~~L~~L~l~~N~l~g-----------------~~p~~~~--~l~~L~~L~ 155 (596)
||..|++|++|++|+|++|+|+| .+|..++ +|++|++|+
T Consensus 418 ~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~ 497 (876)
T 4ecn_A 418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497 (876)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred ccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEE
Confidence 89999999999999999999998 4999988 999999999
Q ss_pred CCCCcccccCCcccc---ccccccccccc
Q 007608 156 LSSNNLTGRIPMQLF---SVATFNFTGTH 181 (596)
Q Consensus 156 l~~N~l~g~iP~~l~---~l~~l~~~~n~ 181 (596)
|++|+++|.+|..+. +|+.|++++|.
T Consensus 498 Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 498 LYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp EESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 999999999998776 55678889987
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-19 Score=202.22 Aligned_cols=145 Identities=21% Similarity=0.291 Sum_probs=126.6
Q ss_pred ChhHHHHHHHHHHhccCCCCC--------CCCCCCCCCCCCCCc---ceeEeeC-CCEEEEEcCCCCCCcccCcchhhhc
Q 007608 33 PDVEGEALIEVLKALNDTHGQ--------FTDWNDHFVSPCFSW---SHVTCRN-GNVISLTLGSNGFSGKISPSITKLK 100 (596)
Q Consensus 33 ~~~~~~al~~~~~~~~~~~~~--------l~~w~~~~~~~c~~w---~gv~c~~-~~l~~L~l~~n~l~g~~p~~~~~l~ 100 (596)
...|++||.++++++.++... ..+|+.+ .+||.| .||+|+. ++|+.|+|++|+++|.+|++|++|+
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~--~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~ 105 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN--KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS--SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC--CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCc
Confidence 345889999999999766433 2369865 566699 9999975 6999999999999999999999999
Q ss_pred ccchhhcccCc---------------------------------------------------------------------
Q 007608 101 FLASFRELQDN--------------------------------------------------------------------- 111 (596)
Q Consensus 101 ~L~~l~~l~~n--------------------------------------------------------------------- 111 (596)
+|+.| +|++|
T Consensus 106 ~L~~L-~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~ 184 (636)
T 4eco_A 106 ELEVL-ALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184 (636)
T ss_dssp TCCEE-ESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCC
T ss_pred cceEE-ECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchh
Confidence 99999 99988
Q ss_pred ---------cccccCCcccCCCCcccEEEccCccCcCC-----------------Cccccc--cCCCCcEEeCCCCcccc
Q 007608 112 ---------DLSGTLPDFLGSMTHLQSLNLANNKFSGS-----------------IPATWS--QLSNLKHLDLSSNNLTG 163 (596)
Q Consensus 112 ---------~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-----------------~p~~~~--~l~~L~~L~l~~N~l~g 163 (596)
+|+| ||..|+++++|++|+|++|.|+|. +|..++ ++++|++|+|++|+++|
T Consensus 185 ~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~ 263 (636)
T 4eco_A 185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263 (636)
T ss_dssp TTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS
T ss_pred hhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc
Confidence 4556 999999999999999999999986 999999 99999999999999999
Q ss_pred cCCcccc---ccccccccccc
Q 007608 164 RIPMQLF---SVATFNFTGTH 181 (596)
Q Consensus 164 ~iP~~l~---~l~~l~~~~n~ 181 (596)
.+|..+. +|+.|++++|.
T Consensus 264 ~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 264 KLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp SCCTTTTTCSSCCEEECTTCT
T ss_pred cChHHHhcCCCCCEEECcCCC
Confidence 9998776 55678888887
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-18 Score=171.15 Aligned_cols=137 Identities=20% Similarity=0.171 Sum_probs=105.8
Q ss_pred CCcCceeeecCceEEEEEEe-CCCcE--EEEEEccccCCc-----------------------chHHHHHHHHHHHHhcC
Q 007608 274 FSESNIIGQGGFGKVYKGVL-SDNTK--VAVKRLQDYYSP-----------------------GGEAAFQREVHLISVAI 327 (596)
Q Consensus 274 f~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~l~~~~~~-----------------------~~~~~~~~e~~~l~~l~ 327 (596)
|+..+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|+..+.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 68989 999987532111 01236789999999999
Q ss_pred CCCc--cceEeEEecCCeeEEEEEcccC-C----ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCcEe
Q 007608 328 HKNL--LQLIGYCTTSSERILVYPFMQN-L----SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH-EQCNPKIIH 399 (596)
Q Consensus 328 H~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH 399 (596)
|+++ ..++.+ ...++||||+.+ | +|.+.... .++..+..++.|++.+|.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8864 334432 356899999942 4 55554432 123456789999999999999 87 9999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 400 RDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 400 ~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=7.9e-18 Score=191.83 Aligned_cols=119 Identities=34% Similarity=0.588 Sum_probs=111.8
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|+|++|+++|.+|.+|++|++|+.| +|++|+|+|.+|..|++|++|++|||++|+|+|.+|..++++++|++||
T Consensus 632 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L-~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFIL-NLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp BCCCEEECCSSCCBSCCCGGGGGCTTCCEE-ECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred ccccEEECcCCcccccCCHHHhccccCCEE-eCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 478999999999999999999999999999 9999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccccCCcc--ccccccccccccccccCCCCCCCCCCCC
Q 007608 156 LSSNNLTGRIPMQ--LFSVATFNFTGTHLICGSSLEQPCMSRP 196 (596)
Q Consensus 156 l~~N~l~g~iP~~--l~~l~~l~~~~n~~~~~~~~~~~c~~~~ 196 (596)
|++|+|+|.||.. +.++..+.|.||+.+||.++. +|....
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~~ 752 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPSN 752 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSCC
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCCc
Confidence 9999999999964 667888899999999999876 886543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.8e-18 Score=176.85 Aligned_cols=149 Identities=17% Similarity=0.271 Sum_probs=129.5
Q ss_pred CCCChhHHHHHHHHHHhc-cCCCCCCCCCC---CCCCCCCCCcceeEeeC----------CCEEEEEcCCCCCCcccCcc
Q 007608 30 SREPDVEGEALIEVLKAL-NDTHGQFTDWN---DHFVSPCFSWSHVTCRN----------GNVISLTLGSNGFSGKISPS 95 (596)
Q Consensus 30 ~~~~~~~~~al~~~~~~~-~~~~~~l~~w~---~~~~~~c~~w~gv~c~~----------~~l~~L~l~~n~l~g~~p~~ 95 (596)
..+...++.||++||.++ .++.+.+.+|. ... ..||.|.|+.|.. .+|+.|+|++|+|+ .+|+.
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~-~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~ 99 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNN-PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ 99 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTC-TTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhccccccc-ccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence 345567899999999998 47766777894 222 3455999999952 68999999999999 99999
Q ss_pred hhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCCCCcccccCCccc------
Q 007608 96 ITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL------ 169 (596)
Q Consensus 96 ~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l------ 169 (596)
++++++|++| +|++|+++ .+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|++.|.+|..+
T Consensus 100 l~~l~~L~~L-~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~ 176 (328)
T 4fcg_A 100 AFRLSHLQHM-TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176 (328)
T ss_dssp GGGGTTCSEE-EEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-C
T ss_pred hhhCCCCCEE-ECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccch
Confidence 9999999999 99999999 99999999999999999999999 999999999999999999999999999864
Q ss_pred ------cccccccccccccc
Q 007608 170 ------FSVATFNFTGTHLI 183 (596)
Q Consensus 170 ------~~l~~l~~~~n~~~ 183 (596)
.+|+.|++++|.+.
T Consensus 177 ~~~~~l~~L~~L~L~~n~l~ 196 (328)
T 4fcg_A 177 GEHQGLVNLQSLRLEWTGIR 196 (328)
T ss_dssp CCEEESTTCCEEEEEEECCC
T ss_pred hhhccCCCCCEEECcCCCcC
Confidence 45778888888664
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=3.1e-17 Score=154.09 Aligned_cols=124 Identities=25% Similarity=0.402 Sum_probs=108.8
Q ss_pred CCC-CCcceeEeeC-----------CCEEEEEcCCCCCCcccCc-chhhhcccchhhcccCccccccCCcccCCCCcccE
Q 007608 63 SPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISP-SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQS 129 (596)
Q Consensus 63 ~~c-~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~-~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~ 129 (596)
..| |.|..+.|+. .+++.|+|++|+|++..+. .++.+++|+.| +|++|+|++..|..|+++++|++
T Consensus 4 ~~C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~ 82 (192)
T 1w8a_A 4 AMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKL-ELKRNQLTGIEPNAFEGASHIQE 82 (192)
T ss_dssp TTSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEE-ECCSSCCCCBCTTTTTTCTTCCE
T ss_pred CCCEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEE-ECCCCCCCCcCHhHcCCcccCCE
Confidence 455 5899999974 2789999999999955544 49999999999 99999999888999999999999
Q ss_pred EEccCccCcCCCccccccCCCCcEEeCCCCcccccCCcccc---ccccccccccccccCCC
Q 007608 130 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHLICGSS 187 (596)
Q Consensus 130 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l~---~l~~l~~~~n~~~~~~~ 187 (596)
|+|++|+|++..|..|.++++|++|+|++|+|++.+|..+. +|..|++++|++.|.++
T Consensus 83 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 83 LQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp EECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred EECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99999999987777899999999999999999988887665 56788999999998754
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=8.5e-17 Score=151.13 Aligned_cols=122 Identities=25% Similarity=0.435 Sum_probs=107.6
Q ss_pred CCC-CCcceeEeeC-----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEE
Q 007608 63 SPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSL 130 (596)
Q Consensus 63 ~~c-~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L 130 (596)
..| |.|..+.|++ .+++.|+|++|+|+ .+|..|.++++|+.| +|++|+|++..|..|.++++|++|
T Consensus 6 ~~C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L-~Ls~N~i~~i~~~~f~~l~~L~~L 83 (193)
T 2wfh_A 6 TECTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLI-DLSNNRISTLSNQSFSNMTQLLTL 83 (193)
T ss_dssp TTCEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEE-ECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEE-ECCCCcCCEeCHhHccCCCCCCEE
Confidence 445 5788888864 27899999999999 899999999999999 999999997777889999999999
Q ss_pred EccCccCcCCCccccccCCCCcEEeCCCCcccccCCcc----ccccccccccccccccCCC
Q 007608 131 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHLICGSS 187 (596)
Q Consensus 131 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~----l~~l~~l~~~~n~~~~~~~ 187 (596)
+|++|+|++..|..|.++++|+.|+|++|+|+ .+|.. +.+|..|++.+|++.|.+.
T Consensus 84 ~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 84 ILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ECCCCccCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeecCCc
Confidence 99999999777778999999999999999999 66653 3467889999999999865
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.6e-16 Score=163.09 Aligned_cols=146 Identities=13% Similarity=0.099 Sum_probs=102.3
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCC-------------cchHHH--------HHHHHHHHH
Q 007608 266 ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS-------------PGGEAA--------FQREVHLIS 324 (596)
Q Consensus 266 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------------~~~~~~--------~~~e~~~l~ 324 (596)
.+.....-|++...||+|+||.||+|...+|+.||||+++.... ...... ..+|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33333334888999999999999999998999999998752110 001111 234566666
Q ss_pred hcCCCCccceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCC
Q 007608 325 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 404 (596)
Q Consensus 325 ~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp 404 (596)
++.+.++.-..-+.. ...++||||+++++|...... .....++.|++.+|.|||+. +||||||||
T Consensus 169 rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp 233 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNE 233 (397)
T ss_dssp HHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred HHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCH
Confidence 665444322111111 234799999998887654321 12356889999999999998 999999999
Q ss_pred CcEEEcCCC----------cEEEeeccccccc
Q 007608 405 ANILLDDNF----------EAVLCDFGLAKLV 426 (596)
Q Consensus 405 ~NIll~~~~----------~~kl~DfGl~~~~ 426 (596)
.|||+++++ .+.|+||+.+-..
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999998776 3899999987543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=3.1e-16 Score=145.05 Aligned_cols=122 Identities=25% Similarity=0.366 Sum_probs=103.6
Q ss_pred CCC-CCcceeEeeC-----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEE
Q 007608 63 SPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSL 130 (596)
Q Consensus 63 ~~c-~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L 130 (596)
+.| |+|.++.|+. .+++.|+|++|++++..+..+..+++|++| +|++|+|++..|..++++++|++|
T Consensus 3 ~~C~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L-~l~~n~l~~~~~~~~~~l~~L~~L 81 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKL-SLSQNQIQSLPDGVFDKLTKLTIL 81 (177)
T ss_dssp TTCEEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEE-ECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCEeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEE-ECCCCcceEeChhHccCCCccCEE
Confidence 345 5899999975 378999999999996556678999999999 999999996555668999999999
Q ss_pred EccCccCcCCCccccccCCCCcEEeCCCCcccccCCcc----ccccccccccccccccCC
Q 007608 131 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHLICGS 186 (596)
Q Consensus 131 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~----l~~l~~l~~~~n~~~~~~ 186 (596)
+|++|+|++..|..+.++++|++|+|++|+|+ .+|.. +.+|+.|++++|++.|.+
T Consensus 82 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 82 YLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ECCCCCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccC
Confidence 99999999666666899999999999999999 56654 346788999999998764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.62 E-value=7e-16 Score=149.03 Aligned_cols=118 Identities=25% Similarity=0.293 Sum_probs=100.4
Q ss_pred CCCCcceeEeeC-----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEc
Q 007608 64 PCFSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132 (596)
Q Consensus 64 ~c~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l 132 (596)
..|+|.+|.|+. .+++.|+|++|+|++..|..|.++++|+.| +|++|+|++..+..|.++++|++|+|
T Consensus 17 ~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L-~L~~N~l~~i~~~~~~~l~~L~~L~L 95 (229)
T 3e6j_A 17 CSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKEL-YLGSNQLGALPVGVFDSLTQLTVLDL 95 (229)
T ss_dssp CEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE-ECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEE-ECCCCCCCCcChhhcccCCCcCEEEC
Confidence 334999999975 368999999999998888899999999999 99999998444466799999999999
Q ss_pred cCccCcCCCccccccCCCCcEEeCCCCcccccCCcccc---ccccccccccccc
Q 007608 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHLI 183 (596)
Q Consensus 133 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l~---~l~~l~~~~n~~~ 183 (596)
++|+|++..|..|..+++|+.|+|++|+|+ .+|..+. +|+.|++++|.+.
T Consensus 96 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 148 (229)
T 3e6j_A 96 GTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCC
T ss_pred CCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCC
Confidence 999999555556899999999999999999 8997664 5677888888765
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.61 E-value=8.9e-16 Score=147.33 Aligned_cols=120 Identities=23% Similarity=0.325 Sum_probs=92.3
Q ss_pred CCCC-CCcceeEeeC-----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccE
Q 007608 62 VSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQS 129 (596)
Q Consensus 62 ~~~c-~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~ 129 (596)
+..| |.|..|.|+. .+++.|+|++|+|++..+..|..+++|+.| +|++|+|++..|..|.++++|++
T Consensus 6 P~~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L-~Ls~N~i~~~~~~~~~~l~~L~~ 84 (220)
T 2v9t_B 6 PAACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRI-DLSNNQISELAPDAFQGLRSLNS 84 (220)
T ss_dssp CTTSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEE-ECCSSCCCEECTTTTTTCSSCCE
T ss_pred CCCCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEE-ECCCCcCCCcCHHHhhCCcCCCE
Confidence 4456 5888999964 268889999999885555578888888888 88888888777888888888888
Q ss_pred EEccCccCcCCCcc-ccccCCCCcEEeCCCCcccccCCccc---cccccccccccccc
Q 007608 130 LNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHLI 183 (596)
Q Consensus 130 L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~iP~~l---~~l~~l~~~~n~~~ 183 (596)
|+|++|+|+ .+|. .|.++++|+.|+|++|+|++..|..+ .+|+.|++++|.+.
T Consensus 85 L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (220)
T 2v9t_B 85 LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141 (220)
T ss_dssp EECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred EECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence 888888888 5554 46788888888888888886555544 35566777777654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=3.6e-15 Score=143.08 Aligned_cols=120 Identities=20% Similarity=0.275 Sum_probs=77.2
Q ss_pred CCC-CCcceeEeeCC-----------CEEEEEcCCCCCCcccCc-chhhhcccchhhcccCccccccCCcccCCCCcccE
Q 007608 63 SPC-FSWSHVTCRNG-----------NVISLTLGSNGFSGKISP-SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQS 129 (596)
Q Consensus 63 ~~c-~~w~gv~c~~~-----------~l~~L~l~~n~l~g~~p~-~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~ 129 (596)
..| |.|..+.|++. .++.|+|++|+|++..|. .|.++++|+.| +|++|+|++..|..|.++++|++
T Consensus 7 ~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L-~L~~N~i~~i~~~~~~~l~~L~~ 85 (220)
T 2v70_A 7 EKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKI-NFSNNKITDIEEGAFEGASGVNE 85 (220)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEE-ECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEE-ECCCCcCCEECHHHhCCCCCCCE
Confidence 344 46777777541 456777777777754343 36777777777 77777777555556777777777
Q ss_pred EEccCccCcCCCccccccCCCCcEEeCCCCcccccCCcccc---ccccccccccccc
Q 007608 130 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHLI 183 (596)
Q Consensus 130 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l~---~l~~l~~~~n~~~ 183 (596)
|+|++|+|++..|..|.++++|++|+|++|+|++..|..+. +|..|++++|.+.
T Consensus 86 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 142 (220)
T 2v70_A 86 ILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142 (220)
T ss_dssp EECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCC
T ss_pred EECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCC
Confidence 77777777755555577777777777777777755554443 4455666666553
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.54 E-value=8.1e-15 Score=139.21 Aligned_cols=120 Identities=23% Similarity=0.308 Sum_probs=98.5
Q ss_pred CCC-CCcceeEeeC-----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEE
Q 007608 63 SPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSL 130 (596)
Q Consensus 63 ~~c-~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L 130 (596)
+.| |+|.+|.|+. .+++.|+|++|++++..+..+.++++|+.| +|++|++++..+..|.++++|++|
T Consensus 3 ~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L-~l~~n~l~~~~~~~~~~l~~L~~L 81 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQL-YLGGNKLQSLPNGVFNKLTSLTYL 81 (208)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEE-ECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEE-ECCCCccCccChhhcCCCCCcCEE
Confidence 345 5999999975 268999999999996555668999999999 999999996555667999999999
Q ss_pred EccCccCcCCCccccccCCCCcEEeCCCCcccccCCcc---ccccccccccccccc
Q 007608 131 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ---LFSVATFNFTGTHLI 183 (596)
Q Consensus 131 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~---l~~l~~l~~~~n~~~ 183 (596)
+|++|+|++..+..+.++++|++|+|++|+|++..|.. +.+|+.|++++|.+.
T Consensus 82 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 137 (208)
T 2o6s_A 82 NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137 (208)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc
Confidence 99999999555556899999999999999999544433 346788889998764
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.9e-16 Score=169.16 Aligned_cols=113 Identities=22% Similarity=0.201 Sum_probs=91.6
Q ss_pred CcceeEeeC-CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccC-CCCcccEEEccCccCcCCCccc
Q 007608 67 SWSHVTCRN-GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLG-SMTHLQSLNLANNKFSGSIPAT 144 (596)
Q Consensus 67 ~w~gv~c~~-~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~ 144 (596)
.+.++.|.. .+|+.|+|++|.|++..|..++.+++|+.| +|++|.|++.+|..+. ++++|++|+|++|.|++. |.
T Consensus 110 ~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~- 186 (487)
T 3oja_A 110 NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL-DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG- 186 (487)
T ss_dssp CCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEE-ECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-
T ss_pred cCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEE-ECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-
Confidence 455666543 578999999999998888899999999999 9999999988888886 789999999999999844 43
Q ss_pred cccCCCCcEEeCCCCcccccCCcccc---ccccccccccccc
Q 007608 145 WSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHLI 183 (596)
Q Consensus 145 ~~~l~~L~~L~l~~N~l~g~iP~~l~---~l~~l~~~~n~~~ 183 (596)
+..+++|+.|+|++|+|++ +|+.+. +|..|++++|.+.
T Consensus 187 ~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 187 QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC
T ss_pred cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc
Confidence 4468899999999999994 555554 5677888888765
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.53 E-value=4e-15 Score=150.88 Aligned_cols=112 Identities=30% Similarity=0.455 Sum_probs=92.9
Q ss_pred EEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCC
Q 007608 78 VISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 157 (596)
Q Consensus 78 l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 157 (596)
++.|+|++|.+++.+|..+..+++|+.| +|++|++++.+|. +..+++|++|+|++|+|+|.+|..+.++++|+.|+|+
T Consensus 199 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 276 (313)
T 1ogq_A 199 LAFVDLSRNMLEGDASVLFGSDKNTQKI-HLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276 (313)
T ss_dssp CSEEECCSSEEEECCGGGCCTTSCCSEE-ECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECC
T ss_pred ccEEECcCCcccCcCCHHHhcCCCCCEE-ECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECc
Confidence 6677777777777777777778888888 7888888865555 7888899999999999999999999999999999999
Q ss_pred CCcccccCCcc--ccccccccccccccccCCCCCCCC
Q 007608 158 SNNLTGRIPMQ--LFSVATFNFTGTHLICGSSLEQPC 192 (596)
Q Consensus 158 ~N~l~g~iP~~--l~~l~~l~~~~n~~~~~~~~~~~c 192 (596)
+|+|+|.+|.. +.+|..+++.+|+.+|+.++. .|
T Consensus 277 ~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 277 FNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp SSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 99999999964 557788899999999997765 45
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.4e-14 Score=138.94 Aligned_cols=111 Identities=17% Similarity=0.235 Sum_probs=100.5
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+|++..+..|.++++|+.| +|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 57 PQLRKINFSNNKITDIEEGAFEGASGVNEI-LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEE-ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCEEECCCCcCCEECHHHhCCCCCCCEE-ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 589999999999997666799999999999 9999999977777899999999999999999988889999999999999
Q ss_pred CCCCcccccCCcccc---ccccccccccccccCCC
Q 007608 156 LSSNNLTGRIPMQLF---SVATFNFTGTHLICGSS 187 (596)
Q Consensus 156 l~~N~l~g~iP~~l~---~l~~l~~~~n~~~~~~~ 187 (596)
|++|+|++..|..+. +|..|++++|++.|.++
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999999976676655 56788999999999765
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.50 E-value=1.7e-14 Score=148.34 Aligned_cols=108 Identities=17% Similarity=0.292 Sum_probs=93.7
Q ss_pred CCcceeEeeCCCEEEEEcCCC-CCCcccCcchhhhcccchhhcccC-ccccccCCcccCCCCcccEEEccCccCcCCCcc
Q 007608 66 FSWSHVTCRNGNVISLTLGSN-GFSGKISPSITKLKFLASFRELQD-NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 143 (596)
Q Consensus 66 ~~w~gv~c~~~~l~~L~l~~n-~l~g~~p~~~~~l~~L~~l~~l~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~ 143 (596)
|.|..|.|+ ++ +|+ .+|. |..+++|+.| +|++ |+|++..|..|++|++|++|+|++|+|+|..|.
T Consensus 8 C~~~~v~~~----------~~n~l~-~ip~-l~~~~~L~~L-~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCT----------RDGALD-SLHH-LPGAENLTEL-YIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECC----------SSCCCT-TTTT-SCSCSCCSEE-ECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcC----------CCCCCC-ccCC-CCCCCCeeEE-EccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 588877775 44 788 6898 9999999999 9996 999976678899999999999999999988888
Q ss_pred ccccCCCCcEEeCCCCcccccCCcccc---ccccccccccccccCCC
Q 007608 144 TWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHLICGSS 187 (596)
Q Consensus 144 ~~~~l~~L~~L~l~~N~l~g~iP~~l~---~l~~l~~~~n~~~~~~~ 187 (596)
.|++|++|+.|+|++|+|+ .+|..++ .|..|++.+|++.|.+.
T Consensus 75 ~~~~l~~L~~L~l~~N~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp GGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred HhcCCcCCCEEeCCCCccc-eeCHHHcccCCceEEEeeCCCccCCCc
Confidence 9999999999999999999 6775543 37889999999999875
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=3.4e-14 Score=130.36 Aligned_cols=103 Identities=21% Similarity=0.363 Sum_probs=84.5
Q ss_pred EEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCCCC
Q 007608 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 159 (596)
Q Consensus 80 ~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 159 (596)
.|++++|+|+ .+|..+. ++|+.| +|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L-~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVL-YLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEE-ECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEE-EcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 5777888888 6887764 788889 99999999777888999999999999999999555556789999999999999
Q ss_pred cccccCCc-cc---cccccccccccccccCCC
Q 007608 160 NLTGRIPM-QL---FSVATFNFTGTHLICGSS 187 (596)
Q Consensus 160 ~l~g~iP~-~l---~~l~~l~~~~n~~~~~~~ 187 (596)
+|+ .+|. .+ .+|+.|++++|++.|.++
T Consensus 89 ~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLK-SIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccC-EeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999 4554 33 466788899999988764
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=5.7e-14 Score=128.87 Aligned_cols=102 Identities=23% Similarity=0.311 Sum_probs=88.4
Q ss_pred CCC-CCcceeEeeC-----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEE
Q 007608 63 SPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSL 130 (596)
Q Consensus 63 ~~c-~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L 130 (596)
..| |+|..+.|++ .+++.|+|++|+|++..|..|.++++|+.| +|++|+|++..|..|.++++|++|
T Consensus 5 ~~C~C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L-~Ls~N~l~~l~~~~f~~l~~L~~L 83 (170)
T 3g39_A 5 SQCSCSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRL-DLDNNQLTVLPAGVFDKLTQLTQL 83 (170)
T ss_dssp -CCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEE-ECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CcCCcCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEE-ECCCCCcCccChhhccCCCCCCEE
Confidence 455 5899999974 368899999999998778899999999999 999999996555667999999999
Q ss_pred EccCccCcCCCccccccCCCCcEEeCCCCcccccC
Q 007608 131 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRI 165 (596)
Q Consensus 131 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~i 165 (596)
+|++|+|++..|..|.++++|++|+|++|.+++.-
T Consensus 84 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 84 SLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 99999999555557999999999999999999543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.48 E-value=5.9e-14 Score=129.27 Aligned_cols=103 Identities=19% Similarity=0.319 Sum_probs=89.2
Q ss_pred EEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCCC
Q 007608 79 ISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSS 158 (596)
Q Consensus 79 ~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 158 (596)
+.+++++|+|+ .+|..+. ++|+.| +|++|+|++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRL-WLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEE-ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEE-EeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 57899999997 8998775 899999 9999999988889999999999999999999954444578999999999999
Q ss_pred CcccccCCcc-c---cccccccccccccccCC
Q 007608 159 NNLTGRIPMQ-L---FSVATFNFTGTHLICGS 186 (596)
Q Consensus 159 N~l~g~iP~~-l---~~l~~l~~~~n~~~~~~ 186 (596)
|+|+ .+|.. + .+|..|++++|++.|.+
T Consensus 91 N~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 91 NHLK-SIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp SCCC-CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred Cccc-eeCHHHhccccCCCEEEeCCCCccccc
Confidence 9999 56654 3 46788899999998865
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.46 E-value=4.7e-14 Score=138.12 Aligned_cols=105 Identities=24% Similarity=0.342 Sum_probs=83.9
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|++++..+..|.++++|++| +|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWL-NLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEE-ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEE-ECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 57788888888887777788888888888 88888888777777888888888888888888555567788888888888
Q ss_pred CCCcccccCCcc----ccccccccccccccc
Q 007608 157 SSNNLTGRIPMQ----LFSVATFNFTGTHLI 183 (596)
Q Consensus 157 ~~N~l~g~iP~~----l~~l~~l~~~~n~~~ 183 (596)
++|+|+ .+|.. +.+|+.|++++|.+.
T Consensus 115 ~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~ 144 (251)
T 3m19_A 115 GGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144 (251)
T ss_dssp CSSCCC-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCcCC-CcChhHhccCCcccEEECcCCcCC
Confidence 888888 45543 346677788888664
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.44 E-value=1.7e-13 Score=128.36 Aligned_cols=112 Identities=21% Similarity=0.382 Sum_probs=97.3
Q ss_pred CCCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEE
Q 007608 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 154 (596)
Q Consensus 75 ~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 154 (596)
..+|+.|+|++|+|++..|..|.++++|+.| +|++|+|++..|..|.++++|++|+|++|+|++.+|..+..+++|++|
T Consensus 53 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 131 (192)
T 1w8a_A 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQEL-QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEE-ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred CCCCCEEECCCCCCCCcCHhHcCCcccCCEE-ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEE
Confidence 3589999999999998889999999999999 999999998888889999999999999999999889999999999999
Q ss_pred eCCCCcccccCCcccc--ccccccccccccccCCC
Q 007608 155 DLSSNNLTGRIPMQLF--SVATFNFTGTHLICGSS 187 (596)
Q Consensus 155 ~l~~N~l~g~iP~~l~--~l~~l~~~~n~~~~~~~ 187 (596)
+|++|.+++..|.... .+....+.++...|..+
T Consensus 132 ~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 132 NLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp ECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred EeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 9999999988774321 23444566777777654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.6e-13 Score=123.97 Aligned_cols=105 Identities=19% Similarity=0.258 Sum_probs=86.9
Q ss_pred CCcceeEeeC-----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccC
Q 007608 66 FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLAN 134 (596)
Q Consensus 66 ~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~ 134 (596)
|....+.|++ .+++.|+|++|+|++..|..|.++++|+.| +|++|+|++..+..|.++++|++|+|++
T Consensus 12 C~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 12 CDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQL-YFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp ECSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE-ECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ECCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEE-ECCCCCCCccChhHhCCcchhhEEECCC
Confidence 3556666754 368899999999998878899999999999 9999999964445578999999999999
Q ss_pred ccCcCCCccccccCCCCcEEeCCCCcccccCCcccccc
Q 007608 135 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSV 172 (596)
Q Consensus 135 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l~~l 172 (596)
|+|++..|..|.++++|++|+|++|.++ ..|..+..+
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~-c~~~~~~~l 127 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD-CECRDIMYL 127 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC-TTBGGGHHH
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc-cccccHHHH
Confidence 9999444445999999999999999999 566544433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.40 E-value=3.2e-13 Score=135.14 Aligned_cols=104 Identities=24% Similarity=0.285 Sum_probs=62.4
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|+|+ .+|..+..+++|+.| +|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L-~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 155 (290)
T 1p9a_G 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVL-DVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (290)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEE-ECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCEEECCCCcCC-cCchhhccCCCCCEE-ECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence 5666666666666 566666666666666 66666666444455666666666666666666433344566666666666
Q ss_pred CCCcccccCCcc----ccccccccccccccc
Q 007608 157 SSNNLTGRIPMQ----LFSVATFNFTGTHLI 183 (596)
Q Consensus 157 ~~N~l~g~iP~~----l~~l~~l~~~~n~~~ 183 (596)
++|+|+ .+|.. +.+|+.|++++|.+.
T Consensus 156 ~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 156 ANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp TTSCCS-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCcCC-ccCHHHhcCcCCCCEEECCCCcCC
Confidence 666666 45532 234455555555543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.40 E-value=4e-13 Score=127.40 Aligned_cols=110 Identities=24% Similarity=0.332 Sum_probs=93.5
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+|++..+..|..+++|++| +|++|+|++..+..++++++|++|+|++|+|++..|..+.++++|+.|+
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYL-NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEE-ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCccCccChhhcCCCCCcCEE-ECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 479999999999995555567999999999 9999999965556689999999999999999965556689999999999
Q ss_pred CCCCcccccCCcc----ccccccccccccccccCCC
Q 007608 156 LSSNNLTGRIPMQ----LFSVATFNFTGTHLICGSS 187 (596)
Q Consensus 156 l~~N~l~g~iP~~----l~~l~~l~~~~n~~~~~~~ 187 (596)
|++|++++ +|.. +.+|+.|++++|++.|..+
T Consensus 131 l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 131 LYQNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CCSSCCSC-CCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CCCCccce-eCHHHhccCCCccEEEecCCCeecCCC
Confidence 99999994 5543 3467889999999987653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.40 E-value=4.3e-13 Score=132.96 Aligned_cols=107 Identities=26% Similarity=0.300 Sum_probs=73.8
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|++++..+..+.++++|+.| +|++|++++..|..++++++|++|+|++|++++..|..++++++|+.|+
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKEL-VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEE-ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEE-ECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 367777888887775555567777777777 7777777755555677777777777777777755555567777777777
Q ss_pred CCCCcccccCCcc---ccccccccccccccc
Q 007608 156 LSSNNLTGRIPMQ---LFSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP~~---l~~l~~l~~~~n~~~ 183 (596)
|++|++++..|.. +.+|+.|++++|.+.
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 7777777433322 335566677777654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.40 E-value=4e-13 Score=131.44 Aligned_cols=105 Identities=23% Similarity=0.353 Sum_probs=64.3
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+|+.|+|++|.|++..|..|.++++|+.| +|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 60 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 138 (251)
T 3m19_A 60 KLTWLNLDYNQLQTLSAGVFDDLTELGTL-GLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRL 138 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEE-ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCEEECCCCcCCccCHhHhccCCcCCEE-ECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEEC
Confidence 56667777777765555556666666666 66666666544455666666666666666666333334566666666666
Q ss_pred CCCcccccCCc-cc---cccccccccccccc
Q 007608 157 SSNNLTGRIPM-QL---FSVATFNFTGTHLI 183 (596)
Q Consensus 157 ~~N~l~g~iP~-~l---~~l~~l~~~~n~~~ 183 (596)
++|+|+ .+|. .+ .+|+.|++++|.+.
T Consensus 139 s~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 139 NTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp CSSCCC-CCCTTTTTTCTTCCEEECCSSCCS
T ss_pred cCCcCC-ccCHHHcCcCcCCCEEECCCCcCC
Confidence 666666 3333 23 34555666666543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.39 E-value=2.4e-13 Score=153.28 Aligned_cols=102 Identities=26% Similarity=0.383 Sum_probs=92.4
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+|+.|+|++|.|. .+|+.+++|++|++| +|++|.|+ .+|..|++|++|++|||++|.|+ .||..|++|++|++|+|
T Consensus 225 ~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L-~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 300 (727)
T 4b8c_D 225 LWHALDLSNLQIF-NISANIFKYDFLTRL-YLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYF 300 (727)
T ss_dssp CCCEEECTTSCCS-CCCGGGGGCCSCSCC-BCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEEC
T ss_pred CCcEEECCCCCCC-CCChhhcCCCCCCEE-EeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEEC
Confidence 4667899999998 899999999999999 99999999 89999999999999999999999 99999999999999999
Q ss_pred CCCcccccCCcccc---ccccccccccccc
Q 007608 157 SSNNLTGRIPMQLF---SVATFNFTGTHLI 183 (596)
Q Consensus 157 ~~N~l~g~iP~~l~---~l~~l~~~~n~~~ 183 (596)
++|.|+ .||..|. +|..|++++|++.
T Consensus 301 ~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 301 FDNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp CSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 999998 8998765 5667888888875
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=2.3e-13 Score=151.06 Aligned_cols=111 Identities=25% Similarity=0.363 Sum_probs=99.3
Q ss_pred CCEEEEEcCCCCCC-cccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEE
Q 007608 76 GNVISLTLGSNGFS-GKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 154 (596)
Q Consensus 76 ~~l~~L~l~~n~l~-g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 154 (596)
..++.|+|++|++. +.+|..|..+++|+.| +|++|+|++..|..|++|++|++|+|++|+|++..|..|.++++|++|
T Consensus 469 ~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L-~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L 547 (635)
T 4g8a_A 469 SSLEVLKMAGNSFQENFLPDIFTELRNLTFL-DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 547 (635)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEE-ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEE
T ss_pred hhhhhhhhhhcccccccCchhhhhccccCEE-ECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEE
Confidence 47889999999754 4577889999999999 999999998889999999999999999999997778889999999999
Q ss_pred eCCCCcccccCCcccc----ccccccccccccccCCC
Q 007608 155 DLSSNNLTGRIPMQLF----SVATFNFTGTHLICGSS 187 (596)
Q Consensus 155 ~l~~N~l~g~iP~~l~----~l~~l~~~~n~~~~~~~ 187 (596)
||++|+|++..|..+. +|+.|++++|++.|.|.
T Consensus 548 ~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 548 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp ECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred ECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999999987777664 57789999999999875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.37 E-value=5.9e-13 Score=135.70 Aligned_cols=107 Identities=21% Similarity=0.314 Sum_probs=95.7
Q ss_pred CCCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEE
Q 007608 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 154 (596)
Q Consensus 75 ~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 154 (596)
..+|+.|+|++|+|+ .+|..++++++|+.| +|++|+++ .+|+.++++++|++|+|++|.+.+.+|..++++++|+.|
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L-~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L 258 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSL-KIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEE-EEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEE
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEE-EccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEE
Confidence 357999999999999 899999999999999 99999999 588889999999999999999999999999999999999
Q ss_pred eCCCCcccccCCcccc---cccccccccccccc
Q 007608 155 DLSSNNLTGRIPMQLF---SVATFNFTGTHLIC 184 (596)
Q Consensus 155 ~l~~N~l~g~iP~~l~---~l~~l~~~~n~~~~ 184 (596)
+|++|++.+.+|..+. +|+.|++++|+.+.
T Consensus 259 ~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp ECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred ECCCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 9999999999997765 45678888887654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.37 E-value=3.6e-13 Score=120.50 Aligned_cols=104 Identities=21% Similarity=0.310 Sum_probs=86.9
Q ss_pred CEEEEEcCCCCCC-cccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 77 NVISLTLGSNGFS-GKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~-g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
+++.|++++|+++ |.+|..+..+++|+.| ++++|.+++. ..++++++|++|+|++|.+++.+|..++++++|++|+
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L-~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFL-STINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEE-ECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEE-ECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 6889999999998 8889888999999999 8999999854 7888999999999999999977888888899999999
Q ss_pred CCCCccccc-CCccc---cccccccccccccc
Q 007608 156 LSSNNLTGR-IPMQL---FSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~-iP~~l---~~l~~l~~~~n~~~ 183 (596)
|++|++++. .|..+ .+|+.|++++|++.
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~ 126 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence 999999852 23444 45677888888654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.37 E-value=5.3e-13 Score=122.02 Aligned_cols=103 Identities=25% Similarity=0.332 Sum_probs=85.4
Q ss_pred CEEEEEcCCCCCC-cccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 77 NVISLTLGSNGFS-GKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~-g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
+++.|+|++|+++ |.+|..+..+++|+.| +|++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L-~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFL-SLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEE-EEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEE-eCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 6888999999998 7888888899999999 8999998854 7888899999999999999977888888899999999
Q ss_pred CCCCcccccCC--ccc---cccccccccccccc
Q 007608 156 LSSNNLTGRIP--MQL---FSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP--~~l---~~l~~l~~~~n~~~ 183 (596)
|++|+++ .+| ..+ .+|..|++++|++.
T Consensus 102 Ls~N~l~-~~~~~~~l~~l~~L~~L~l~~N~l~ 133 (168)
T 2ell_A 102 LSGNKLK-DISTLEPLKKLECLKSLDLFNCEVT 133 (168)
T ss_dssp CBSSSCC-SSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred ccCCccC-cchhHHHHhcCCCCCEEEeeCCcCc
Confidence 9999998 444 343 45677788888664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.2e-12 Score=129.43 Aligned_cols=85 Identities=27% Similarity=0.349 Sum_probs=41.7
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+|+.|+|++|++++..+..+..+++|+.| +|++|++++..|..|+++++|++|+|++|.|++..+..|+++++|+.|+|
T Consensus 86 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 164 (270)
T 2o6q_A 86 NLETLWVTDNKLQALPIGVFDQLVNLAEL-RLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRL 164 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCSSCCEE-ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCcCCHhHcccccCCCEE-ECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEe
Confidence 45555555555553333344555555555 55555555443444455555555555555555222223445555555555
Q ss_pred CCCccc
Q 007608 157 SSNNLT 162 (596)
Q Consensus 157 ~~N~l~ 162 (596)
++|+++
T Consensus 165 ~~n~l~ 170 (270)
T 2o6q_A 165 YNNQLK 170 (270)
T ss_dssp CSSCCS
T ss_pred cCCcCc
Confidence 555555
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=7.7e-13 Score=146.89 Aligned_cols=106 Identities=20% Similarity=0.202 Sum_probs=90.4
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|||++|+|++..|..|.+|++|++| +|++|+|++..|..|.+|++|++|+|++|+|++..|..|.+|++|++|+|
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L-~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVL-DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEE-ECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEE-ECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 78999999999995555689999999999 99999999666678999999999999999999545567999999999999
Q ss_pred CCCcccccCCc-cc---ccccccccccccccc
Q 007608 157 SSNNLTGRIPM-QL---FSVATFNFTGTHLIC 184 (596)
Q Consensus 157 ~~N~l~g~iP~-~l---~~l~~l~~~~n~~~~ 184 (596)
++|+|+ .+|. .+ .+|+.|++++|.+..
T Consensus 132 s~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~ 162 (635)
T 4g8a_A 132 VETNLA-SLENFPIGHLKTLKELNVAHNLIQS 162 (635)
T ss_dssp TTSCCC-CSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred CCCcCC-CCChhhhhcCcccCeeccccCcccc
Confidence 999999 4553 34 467788888887643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.35 E-value=6.4e-13 Score=137.36 Aligned_cols=122 Identities=18% Similarity=0.194 Sum_probs=100.3
Q ss_pred CCCC-CCcceeEeeC-----------CCEEEEEcCCCCCCcccCcchh-hhcccchhhcccCccccccCCcccCCCCccc
Q 007608 62 VSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSIT-KLKFLASFRELQDNDLSGTLPDFLGSMTHLQ 128 (596)
Q Consensus 62 ~~~c-~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~-~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~ 128 (596)
+..| |.|..+.|.+ ..++.|+|++|+|++..+..+. ++++|+.| +|++|+|++..|..|.++++|+
T Consensus 13 p~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L-~L~~N~i~~i~~~~~~~l~~L~ 91 (361)
T 2xot_A 13 PANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSL-LLSHNHLNFISSEAFVPVPNLR 91 (361)
T ss_dssp CTTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEE-ECCSSCCCEECTTTTTTCTTCC
T ss_pred CCCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEE-ECCCCcCCccChhhccCCCCCC
Confidence 3456 5788889975 2578999999999965566676 89999999 9999999976677899999999
Q ss_pred EEEccCccCcCCCccccccCCCCcEEeCCCCcccccCCccc---ccccccccccccccc
Q 007608 129 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHLIC 184 (596)
Q Consensus 129 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l---~~l~~l~~~~n~~~~ 184 (596)
+|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+ .+|..|++++|.+..
T Consensus 92 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 150 (361)
T 2xot_A 92 YLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR 150 (361)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS
T ss_pred EEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe
Confidence 99999999996556679999999999999999996556554 466778889887653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.34 E-value=1e-12 Score=130.02 Aligned_cols=104 Identities=26% Similarity=0.301 Sum_probs=51.7
Q ss_pred EEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCC
Q 007608 78 VISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 157 (596)
Q Consensus 78 l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 157 (596)
++.|+|++|++++..+..|.++++|++| +|++|+++...+..|.++++|++|+|++|.+++..+..+.++++|++|+|+
T Consensus 39 l~~L~l~~n~l~~~~~~~~~~l~~L~~L-~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLL-YLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp CSEEECCSSCCSCCCTTSSSSCTTCCEE-ECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCEEECcCCCCCeeCHHHhcCCCCCCEE-ECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 4555555555553333355555555555 555555552222233555555555555555553333344555555555555
Q ss_pred CCcccccCCcc---cccccccccccccc
Q 007608 158 SNNLTGRIPMQ---LFSVATFNFTGTHL 182 (596)
Q Consensus 158 ~N~l~g~iP~~---l~~l~~l~~~~n~~ 182 (596)
+|++++..|.. +.+|+.|++++|.+
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 145 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNEL 145 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcC
Confidence 55555322222 23444555555543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.34 E-value=7.3e-13 Score=133.52 Aligned_cols=106 Identities=21% Similarity=0.347 Sum_probs=67.3
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccc-cCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG-TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
+++.|+|++|.+.+..|..+..+++|+.| +|++|.+++ .+|..+.++++|++|+|++|++++..|..+.++++|+.|+
T Consensus 127 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 205 (306)
T 2z66_A 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVL-KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205 (306)
T ss_dssp TCCEEECTTSCCEECSTTTTTTCTTCCEE-ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCEEECCCCcCCccchhhcccCcCCCEE-ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEE
Confidence 56667777777666666666666667666 677776665 4666666666777777777766655566666666666666
Q ss_pred CCCCcccccCCccc---cccccccccccccc
Q 007608 156 LSSNNLTGRIPMQL---FSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP~~l---~~l~~l~~~~n~~~ 183 (596)
|++|++++..+..+ .+|+.|++++|.+.
T Consensus 206 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 236 (306)
T 2z66_A 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236 (306)
T ss_dssp CTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred CCCCccCccChhhccCcccCCEeECCCCCCc
Confidence 66666663333232 34556666666554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=9.2e-13 Score=140.46 Aligned_cols=108 Identities=23% Similarity=0.296 Sum_probs=57.7
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+|+.|+|++|++++..|..|.++++|+.| +|++|++++..|..++++++|++|+|++|++++..|..+.++++|++|+|
T Consensus 300 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 378 (455)
T 3v47_A 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKL-NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELAL 378 (455)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEE-ECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcccccChhHhcCcccCCEE-ECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEEC
Confidence 45555555555554444455555555555 55555555444555555555555555555555444555555555555555
Q ss_pred CCCcccccCCcc----ccccccccccccccccCC
Q 007608 157 SSNNLTGRIPMQ----LFSVATFNFTGTHLICGS 186 (596)
Q Consensus 157 ~~N~l~g~iP~~----l~~l~~l~~~~n~~~~~~ 186 (596)
++|+|+ .+|.. +.+|+.|++++|++.|.+
T Consensus 379 ~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 379 DTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp CSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCccc-cCCHhHhccCCcccEEEccCCCcccCC
Confidence 555555 23321 224455555555555544
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=4.9e-13 Score=142.57 Aligned_cols=116 Identities=21% Similarity=0.263 Sum_probs=99.2
Q ss_pred Ccce--eEeeC----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCC-cccCCCCcccEEEcc
Q 007608 67 SWSH--VTCRN----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLP-DFLGSMTHLQSLNLA 133 (596)
Q Consensus 67 ~w~g--v~c~~----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p-~~~~~l~~L~~L~l~ 133 (596)
.|.+ |.|+. .+++.|+|++|.+++..|..|+++++|++| +|++|.+.+.+| ..|.++++|++|+|+
T Consensus 9 ~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L-~L~~n~~~~~i~~~~~~~l~~L~~L~Ls 87 (455)
T 3v47_A 9 SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFL-KVEQQTPGLVIRNNTFRGLSSLIILKLD 87 (455)
T ss_dssp EEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEE-ECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred EEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEE-ECcCCcccceECcccccccccCCEEeCC
Confidence 5554 78875 368999999999998778899999999999 999999987774 679999999999999
Q ss_pred CccCcCCCccccccCCCCcEEeCCCCcccccCCcc-----ccccccccccccccc
Q 007608 134 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ-----LFSVATFNFTGTHLI 183 (596)
Q Consensus 134 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~-----l~~l~~l~~~~n~~~ 183 (596)
+|++++..|..|+++++|++|+|++|++++.+|.. +.+|+.|++++|.+.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~ 142 (455)
T 3v47_A 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142 (455)
T ss_dssp TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCC
T ss_pred CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccC
Confidence 99999888999999999999999999999766543 456778888888764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.3e-13 Score=155.23 Aligned_cols=110 Identities=25% Similarity=0.345 Sum_probs=93.2
Q ss_pred CCEEEEEcCCCCCC-----cccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCC
Q 007608 76 GNVISLTLGSNGFS-----GKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSN 150 (596)
Q Consensus 76 ~~l~~L~l~~n~l~-----g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 150 (596)
.+++.|+|++|.++ +..+..|..+++|+.| +|++|+|++..|..|.++++|+.|+|++|+|++..|..+. ++
T Consensus 451 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~ 527 (844)
T 3j0a_A 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVL-YLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--AN 527 (844)
T ss_dssp TTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECC-CCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SC
T ss_pred CccccccCCCCccccccccccchhhhcCcccccEE-ECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cc
Confidence 35667777777765 3444568889999999 9999999988888899999999999999999955555554 89
Q ss_pred CcEEeCCCCcccccCCccccccccccccccccccCCCC
Q 007608 151 LKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSL 188 (596)
Q Consensus 151 L~~L~l~~N~l~g~iP~~l~~l~~l~~~~n~~~~~~~~ 188 (596)
|+.|+|++|+|+|.+|..+.++..+++++|++.|.+++
T Consensus 528 L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 528 LEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp CCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred ccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 99999999999999999999999999999999997764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.4e-12 Score=139.06 Aligned_cols=114 Identities=21% Similarity=0.284 Sum_probs=97.5
Q ss_pred CcceeEeeC-----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCc
Q 007608 67 SWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135 (596)
Q Consensus 67 ~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N 135 (596)
.|..|.|.+ .+++.|+|++|+|++..|..|.++++|+.| +|++|+|++..|..|.++++|++|+|++|
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L-~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVL-QLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEE-ECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEE-ECCCCccCCcChhhccCcccCCEEECCCC
Confidence 467889975 268999999999998888899999999999 99999999888899999999999999999
Q ss_pred cCcCCCccccccCCCCcEEeCCCCcccccCCc-c---cccccccccccccc
Q 007608 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM-Q---LFSVATFNFTGTHL 182 (596)
Q Consensus 136 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~-~---l~~l~~l~~~~n~~ 182 (596)
+|++..+..|.++++|++|+|++|+|+ .+|. . +.+|..|++++|..
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~~ 183 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTT
T ss_pred cCCccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCCC
Confidence 999555556999999999999999999 5664 3 34567777777543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=8.1e-13 Score=144.42 Aligned_cols=116 Identities=21% Similarity=0.220 Sum_probs=100.8
Q ss_pred CCcceeEeeC-------------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEc
Q 007608 66 FSWSHVTCRN-------------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132 (596)
Q Consensus 66 ~~w~gv~c~~-------------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l 132 (596)
|.|.|+ |+. .+++.|+|++|++++..|..|.++++|++| +|++|++++..|..|+++++|++|||
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L-~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVL-ILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEE-ECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEE-ECCCCCcCccChhhccccccCCEEEC
Confidence 389998 863 279999999999998788899999999999 99999999888899999999999999
Q ss_pred cCccCcCCCccccccCCCCcEEeCCCCcccc-cCCccc---cccccccccccccc
Q 007608 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTG-RIPMQL---FSVATFNFTGTHLI 183 (596)
Q Consensus 133 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~iP~~l---~~l~~l~~~~n~~~ 183 (596)
++|++++..|..|+++++|++|+|++|++++ .+|..+ .+|+.|++++|...
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~ 136 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccc
Confidence 9999997777779999999999999999995 355544 46677888888643
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.3e-12 Score=130.34 Aligned_cols=105 Identities=23% Similarity=0.243 Sum_probs=54.9
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+|+.|+|++|++++..|..+.++++|++| +|++|++++..+..++++++|++|+|++|++++..+..+.++++|+.|+|
T Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 184 (285)
T 1ozn_A 106 RLHTLHLDRCGLQELGPGLFRGLAALQYL-YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (285)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEE-ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCEECHhHhhCCcCCCEE-ECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEEC
Confidence 45556666666554445555555555555 55555555433344555555555555555555322233555555555555
Q ss_pred CCCcccccCCcccc---cccccccccccc
Q 007608 157 SSNNLTGRIPMQLF---SVATFNFTGTHL 182 (596)
Q Consensus 157 ~~N~l~g~iP~~l~---~l~~l~~~~n~~ 182 (596)
++|++++..|..+. +|+.|++++|.+
T Consensus 185 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 213 (285)
T 1ozn_A 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNL 213 (285)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCcccccCHhHccCcccccEeeCCCCcC
Confidence 55555544444332 334444555443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.5e-12 Score=134.03 Aligned_cols=112 Identities=21% Similarity=0.303 Sum_probs=95.6
Q ss_pred CCcceeEeeC-------------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEc
Q 007608 66 FSWSHVTCRN-------------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132 (596)
Q Consensus 66 ~~w~gv~c~~-------------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l 132 (596)
|.|.|+ |+. .+++.|+|++|++++..+..|.++++|+.| +|++|++++..|..|+++++|++|+|
T Consensus 30 C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 30 CDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQAL-VLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp ECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEE-ECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEE-ECCCCccCccCHhhcCCCCCCCEEEC
Confidence 488887 642 279999999999996555589999999999 99999999877888999999999999
Q ss_pred cCccCcCCCccc-cccCCCCcEEeCCCCcccccCCc--c---ccccccccccccc
Q 007608 133 ANNKFSGSIPAT-WSQLSNLKHLDLSSNNLTGRIPM--Q---LFSVATFNFTGTH 181 (596)
Q Consensus 133 ~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~iP~--~---l~~l~~l~~~~n~ 181 (596)
++|+++ .+|.. ++++++|++|+|++|+++ .+|. . +.+|+.|++++|.
T Consensus 108 s~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 108 SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160 (353)
T ss_dssp CSSCCS-SCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCCcCC-cCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCc
Confidence 999999 56654 899999999999999999 6776 3 4467788888884
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=1e-12 Score=145.49 Aligned_cols=109 Identities=24% Similarity=0.299 Sum_probs=75.3
Q ss_pred CEEEEEcCCCCCCcc-cCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 77 NVISLTLGSNGFSGK-ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~-~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
+++.|+|++|.+++. +|..+..+++|+.| +|++|++++..|..++++++|++|+|++|++++.+|..++++++|+.|+
T Consensus 449 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L-~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 527 (606)
T 3vq2_A 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFL-DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD 527 (606)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEE-ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEE
T ss_pred CCCEEECCCCcCCCcchHHhhccCCCCCEE-ECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEE
Confidence 566677777776653 56666777777777 7777777766666777777777777777777766677777777777777
Q ss_pred CCCCcccccCCcccc----ccccccccccccccCCC
Q 007608 156 LSSNNLTGRIPMQLF----SVATFNFTGTHLICGSS 187 (596)
Q Consensus 156 l~~N~l~g~iP~~l~----~l~~l~~~~n~~~~~~~ 187 (596)
|++|+|+ .+|..+. +|+.+++++|++.|.++
T Consensus 528 l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 528 CSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 7777777 6666543 25566777777777654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.4e-12 Score=136.76 Aligned_cols=114 Identities=23% Similarity=0.297 Sum_probs=95.8
Q ss_pred CcceeEeeC-----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCc
Q 007608 67 SWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135 (596)
Q Consensus 67 ~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N 135 (596)
.|..|.|.+ .+++.|+|++|+|++..+..|.++++|+.| +|++|+|++..|..|.++++|++|+|++|
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L-~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEIL-QLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEE-ECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEE-ECCCCcCCccChhhccCCccCCEEECCCC
Confidence 477899975 368899999999997777899999999999 99999999777789999999999999999
Q ss_pred cCcCCCccccccCCCCcEEeCCCCcccccCCc-c---cccccccccccccc
Q 007608 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM-Q---LFSVATFNFTGTHL 182 (596)
Q Consensus 136 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~-~---l~~l~~l~~~~n~~ 182 (596)
+|++..+..|.++++|++|+|++|+|+ .+|. . +.+|+.|++++|..
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~~ 172 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTT
T ss_pred cCCeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCCC
Confidence 999444457999999999999999999 5554 3 34567777877544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=3.2e-12 Score=139.67 Aligned_cols=103 Identities=22% Similarity=0.360 Sum_probs=91.1
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
.++.|+|++|+|++ +|. |+.|++|+.| +|++|+|+ .+|..|++|++|++|+|++|+|++ +| .+++|++|+.|+|
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L-~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~L 515 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHL-DLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLL 515 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEE-ECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEEC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEe-ecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEEC
Confidence 57889999999995 776 9999999999 99999999 899999999999999999999995 88 8999999999999
Q ss_pred CCCcccccC-Ccccc---ccccccccccccccC
Q 007608 157 SSNNLTGRI-PMQLF---SVATFNFTGTHLICG 185 (596)
Q Consensus 157 ~~N~l~g~i-P~~l~---~l~~l~~~~n~~~~~ 185 (596)
++|+|++.+ |..+. +|..|++++|++...
T Consensus 516 s~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp CSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 999999765 87665 556788999987543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.6e-12 Score=136.55 Aligned_cols=107 Identities=24% Similarity=0.376 Sum_probs=80.4
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+|+.|+|++|+|+ .+| .+..+++|+.| +|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|
T Consensus 186 ~L~~L~L~~n~l~-~~~-~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 262 (440)
T 3zyj_A 186 NLRYLNLAMCNLR-EIP-NLTPLIKLDEL-DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINL 262 (440)
T ss_dssp SCCEEECTTSCCS-SCC-CCTTCSSCCEE-ECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEEC
T ss_pred ccCeecCCCCcCc-ccc-ccCCCcccCEE-ECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEEC
Confidence 4566666666666 454 46677777777 78888888766778888888888888888888767777888888888888
Q ss_pred CCCcccccCCcc----ccccccccccccccccCCC
Q 007608 157 SSNNLTGRIPMQ----LFSVATFNFTGTHLICGSS 187 (596)
Q Consensus 157 ~~N~l~g~iP~~----l~~l~~l~~~~n~~~~~~~ 187 (596)
++|+|+ .+|.. +.+|+.|++++|++.|.+.
T Consensus 263 ~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 263 AHNNLT-LLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp TTSCCC-CCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred CCCCCC-ccChhHhccccCCCEEEcCCCCccCCCC
Confidence 888888 55543 3456778888898888765
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=3.8e-12 Score=136.62 Aligned_cols=116 Identities=22% Similarity=0.339 Sum_probs=100.4
Q ss_pred CcceeEeeC-----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCc
Q 007608 67 SWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135 (596)
Q Consensus 67 ~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N 135 (596)
.|..|.|.. .+++.|+|++|+|++..|..|.++++|++| +|++|.+++..|..|+++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L-~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEEL-ELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEE-ECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEE-ECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 578899974 268899999999997778899999999999 99999999888999999999999999999
Q ss_pred cCcCCCccccccCCCCcEEeCCCCcccccCCccc---cccccccccccccc
Q 007608 136 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHLI 183 (596)
Q Consensus 136 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l---~~l~~l~~~~n~~~ 183 (596)
++++..+..|+++++|++|+|++|++++..|..+ .+|+.|++++|.+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~ 141 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCC
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccc
Confidence 9994444468999999999999999997777655 46677888888764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.28 E-value=4.1e-12 Score=129.65 Aligned_cols=123 Identities=21% Similarity=0.341 Sum_probs=99.1
Q ss_pred CCCCCCCCCC-CCcceeEeeC-----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCC
Q 007608 56 DWNDHFVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGS 123 (596)
Q Consensus 56 ~w~~~~~~~c-~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~ 123 (596)
.|....+..| |.|..+.|+. .+++.|+|++|++++..|..|.++++|++| +|++|++++..|..|++
T Consensus 22 ~~~~~cp~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L-~L~~n~l~~~~~~~~~~ 100 (332)
T 2ft3_A 22 TYSAMCPFGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYAL-VLVNNKISKIHEKAFSP 100 (332)
T ss_dssp ---CCCCSSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEE-ECCSSCCCEECGGGSTT
T ss_pred cccCCCCCCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEE-ECCCCccCccCHhHhhC
Confidence 3443333444 5899999974 268899999999996667789999999999 99999999877899999
Q ss_pred CCcccEEEccCccCcCCCccccccCCCCcEEeCCCCcccccCCcc----ccccccccccccccc
Q 007608 124 MTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHLI 183 (596)
Q Consensus 124 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~----l~~l~~l~~~~n~~~ 183 (596)
+++|++|+|++|.++ .+|..+. ++|++|+|++|+++ .+|.. +.+|+.|++++|.+.
T Consensus 101 l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~ 160 (332)
T 2ft3_A 101 LRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160 (332)
T ss_dssp CTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCB
T ss_pred cCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccc
Confidence 999999999999999 8888776 89999999999999 56543 346677888888764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.28 E-value=3.1e-12 Score=132.23 Aligned_cols=105 Identities=23% Similarity=0.294 Sum_probs=77.9
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+|++..|..|.++++|+.| +|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 142 (361)
T 2xot_A 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYL-DLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEE-ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCEEECCCCcCCccChhhccCCCCCCEE-ECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence 467888888888885555678888888888 8888888855556678888888888888888866677788888888888
Q ss_pred CCCCcccccCCccc-------ccccccccccccc
Q 007608 156 LSSNNLTGRIPMQL-------FSVATFNFTGTHL 182 (596)
Q Consensus 156 l~~N~l~g~iP~~l-------~~l~~l~~~~n~~ 182 (596)
|++|+|+ .+|..+ .+|..|++++|.+
T Consensus 143 L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 143 LSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp CCSSCCC-SCCGGGTC----CTTCCEEECCSSCC
T ss_pred CCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCC
Confidence 8888888 566543 3556666666654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.27 E-value=6.2e-12 Score=124.53 Aligned_cols=105 Identities=25% Similarity=0.339 Sum_probs=74.8
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|.+++ + +.+.++++|++| +|++|++++..|..++++++|++|+|++|++++..|..++++++|++|+
T Consensus 63 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-I-SALKELTNLTYL-ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp TTCCEEECTTSCCCC-C-GGGTTCTTCCEE-ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCC-c-hhhcCCCCCCEE-ECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 367788888888774 3 367777888888 7888888865556677788888888888888755555677788888888
Q ss_pred CCCCcccccCCcc---ccccccccccccccc
Q 007608 156 LSSNNLTGRIPMQ---LFSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP~~---l~~l~~l~~~~n~~~ 183 (596)
|++|++++..|.. +.+|+.|++++|.+.
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 170 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcC
Confidence 8888887433322 345667777777654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.26 E-value=2.2e-12 Score=117.90 Aligned_cols=103 Identities=26% Similarity=0.290 Sum_probs=89.7
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCc--cccccCCCCcE
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP--ATWSQLSNLKH 153 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~ 153 (596)
.+|+.|+|++|.|++. ..+..+++|+.| +|++|++++.+|..+.++++|++|+|++|.|+ .+| ..+.++++|+.
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~l~~l~~L~~ 124 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKL-ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKS 124 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEE-EEESCCCCSCCCHHHHHCTTCCEEECBSSSCC-SSGGGGGGSSCSCCCE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEE-ECcCCcCchHHHHHHhhCCCCCEEeccCCccC-cchhHHHHhcCCCCCE
Confidence 5899999999999955 789999999999 99999999878988888999999999999999 555 78999999999
Q ss_pred EeCCCCcccccCCc----c---ccccccccccccccc
Q 007608 154 LDLSSNNLTGRIPM----Q---LFSVATFNFTGTHLI 183 (596)
Q Consensus 154 L~l~~N~l~g~iP~----~---l~~l~~l~~~~n~~~ 183 (596)
|+|++|+++ .+|. . +.+|..|++.+|...
T Consensus 125 L~l~~N~l~-~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 125 LDLFNCEVT-NLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp EECCSSGGG-TSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred EEeeCCcCc-chHHHHHHHHHhCccCcEecCCCCChh
Confidence 999999999 5554 3 346677888887653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.26 E-value=6.1e-12 Score=139.00 Aligned_cols=126 Identities=15% Similarity=0.208 Sum_probs=86.2
Q ss_pred CCCCCCCCCCCCCC----CcceeEeeC------------------CCEEEEEcCCCCCCcccCc-chhhhcccchhhccc
Q 007608 53 QFTDWNDHFVSPCF----SWSHVTCRN------------------GNVISLTLGSNGFSGKISP-SITKLKFLASFRELQ 109 (596)
Q Consensus 53 ~l~~w~~~~~~~c~----~w~gv~c~~------------------~~l~~L~l~~n~l~g~~p~-~~~~l~~L~~l~~l~ 109 (596)
.+++|.+. ..|| .|.++.|+. .+++.|++++|.+. .+|+ .+.++++|+.| +|+
T Consensus 8 ~l~~~~~~--~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L-~L~ 83 (597)
T 3oja_B 8 NVKPRQPE--YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELL-NLN 83 (597)
T ss_dssp ---CCCSE--ECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEES-EECTHHHHHCCCCSEE-ECT
T ss_pred cccCCCCC--CcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCC-CcCHHHHccCCCCcEE-ECC
Confidence 46788775 4554 376665531 25677778888777 4444 46777888888 788
Q ss_pred CccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCCCCcccccCCcc----ccccccccccccccc
Q 007608 110 DNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHLI 183 (596)
Q Consensus 110 ~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~----l~~l~~l~~~~n~~~ 183 (596)
+|.|++..|..|+++++|++|+|++|.|++..|..|+++++|++|+|++|+|+ .+|.. +.+|..|++++|.+.
T Consensus 84 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~ 160 (597)
T 3oja_B 84 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 160 (597)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCC
Confidence 88888666677888888888888888888666666778888888888888887 55543 235667777777654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=6.7e-12 Score=127.92 Aligned_cols=125 Identities=19% Similarity=0.266 Sum_probs=98.2
Q ss_pred CCCCCCCCCCC-CCcceeEeeC-----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccC
Q 007608 55 TDWNDHFVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLG 122 (596)
Q Consensus 55 ~~w~~~~~~~c-~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~ 122 (596)
..|....+..| |.|..+.|+. .+++.|+|++|++++..+..|.++++|++| +|++|++++..|..|+
T Consensus 19 ~~~~~~cp~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L-~L~~n~l~~~~~~~~~ 97 (330)
T 1xku_A 19 EPMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTL-ILINNKISKISPGAFA 97 (330)
T ss_dssp ---CCCCCTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE-ECCSSCCCCBCTTTTT
T ss_pred ccccCCCCCCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEE-ECCCCcCCeeCHHHhc
Confidence 35554444455 5899999964 368899999999996666689999999999 9999999977799999
Q ss_pred CCCcccEEEccCccCcCCCccccccCCCCcEEeCCCCcccccCCcc---ccccccccccccccc
Q 007608 123 SMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ---LFSVATFNFTGTHLI 183 (596)
Q Consensus 123 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~---l~~l~~l~~~~n~~~ 183 (596)
++++|++|+|++|.++ .+|..+. ++|++|++++|++++..|.. +.+|+.|++++|...
T Consensus 98 ~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 158 (330)
T 1xku_A 98 PLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158 (330)
T ss_dssp TCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC
T ss_pred CCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCC
Confidence 9999999999999999 8887765 78999999999999444433 346677888887653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.26 E-value=3.9e-12 Score=135.66 Aligned_cols=108 Identities=22% Similarity=0.353 Sum_probs=79.8
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+|+.|+|++|+|+ .+| .+..+++|+.| +|++|+|++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|
T Consensus 197 ~L~~L~L~~n~l~-~~~-~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 273 (452)
T 3zyi_A 197 NLKYLNLGMCNIK-DMP-NLTPLVGLEEL-EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL 273 (452)
T ss_dssp TCCEEECTTSCCS-SCC-CCTTCTTCCEE-ECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCccc-ccc-cccccccccEE-ECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEEC
Confidence 4666666666666 343 46677777777 77888887767777888888888888888888777777888888888888
Q ss_pred CCCcccccCCcc----ccccccccccccccccCCCC
Q 007608 157 SSNNLTGRIPMQ----LFSVATFNFTGTHLICGSSL 188 (596)
Q Consensus 157 ~~N~l~g~iP~~----l~~l~~l~~~~n~~~~~~~~ 188 (596)
++|+|+ .+|.. +.+|+.|++++|++.|.+.+
T Consensus 274 ~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 274 AHNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CSSCCS-CCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred CCCcCC-ccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 888888 55533 34567788888888887653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.26 E-value=6.6e-12 Score=125.59 Aligned_cols=106 Identities=27% Similarity=0.407 Sum_probs=52.0
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCcc-ccccCCCCcEEe
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~ 155 (596)
+++.|+|++|+|++..|..|.++++|+.| +|++|+|++..|..|..+++|+.|+|++|+|+ .+|. .|.++++|+.|+
T Consensus 101 ~L~~L~l~~N~l~~l~~~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~ 178 (290)
T 1p9a_G 101 ALTVLDVSFNRLTSLPLGALRGLGELQEL-YLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLL 178 (290)
T ss_dssp TCCEEECCSSCCCCCCSSTTTTCTTCCEE-ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS-CCCTTTTTTCTTCCEEE
T ss_pred CCCEEECCCCcCcccCHHHHcCCCCCCEE-ECCCCCCCccChhhcccccCCCEEECCCCcCC-ccCHHHhcCcCCCCEEE
Confidence 45555555555553333445555555555 55555555333334445555555555555555 3332 234455555555
Q ss_pred CCCCcccccCCccccc---cccccccccccccC
Q 007608 156 LSSNNLTGRIPMQLFS---VATFNFTGTHLICG 185 (596)
Q Consensus 156 l~~N~l~g~iP~~l~~---l~~l~~~~n~~~~~ 185 (596)
|++|+|+ .+|..++. ++.+.+.+|++.|.
T Consensus 179 L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 5555555 45544332 34444555555554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=5.2e-12 Score=125.23 Aligned_cols=106 Identities=20% Similarity=0.190 Sum_probs=90.2
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|++++..+..|.++++|+.| +|++|++++..|..|.++++|++|+|++|.+++..|..+.++++|++|++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L-~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVL-DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEE-ECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCcccccCHhHhccccCCcEE-ECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 68999999999996666689999999999 99999999766678999999999999999999777788999999999999
Q ss_pred CCCcccccCCccc---cccccccccccccc
Q 007608 157 SSNNLTGRIPMQL---FSVATFNFTGTHLI 183 (596)
Q Consensus 157 ~~N~l~g~iP~~l---~~l~~l~~~~n~~~ 183 (596)
++|++++..+..+ .+|+.|++++|.+.
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 137 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQ 137 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCC
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccc
Confidence 9999995444344 46677888888654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.25 E-value=3.4e-12 Score=119.96 Aligned_cols=105 Identities=20% Similarity=0.221 Sum_probs=80.2
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|+|++|.++ .++.+..+++|++| ++++|++++..|..++++++|++|+|++|++++..|..++++++|++|+
T Consensus 66 ~~L~~L~l~~n~~~--~~~~l~~l~~L~~L-~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 66 HNIKDLTINNIHAT--NYNPISGLSNLERL-RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp TTCSEEEEESCCCS--CCGGGTTCTTCCEE-EEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCEEEccCCCCC--cchhhhcCCCCCEE-EeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 36888888888665 33478888888888 8888888877888888888888888888888877788888888888888
Q ss_pred CCCCcccccCCc--cccccccccccccccc
Q 007608 156 LSSNNLTGRIPM--QLFSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP~--~l~~l~~l~~~~n~~~ 183 (596)
|++|++.+.+|. .+.+|+.|++++|...
T Consensus 143 L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~ 172 (197)
T 4ezg_A 143 LSYNGAITDIMPLKTLPELKSLNIQFDGVH 172 (197)
T ss_dssp CCSCTBCCCCGGGGGCSSCCEEECTTBCCC
T ss_pred ccCCCCccccHhhcCCCCCCEEECCCCCCc
Confidence 888873336762 2345667777777653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.24 E-value=8.2e-12 Score=119.53 Aligned_cols=111 Identities=22% Similarity=0.270 Sum_probs=97.3
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+|++..|..|.++++|++| +|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L-~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 134 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSL-VLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEE-ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEE-ECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence 489999999999998779999999999999 9999999944445578999999999999999988888999999999999
Q ss_pred CCCCcccccCCccc---cccccccccccccccCCC
Q 007608 156 LSSNNLTGRIPMQL---FSVATFNFTGTHLICGSS 187 (596)
Q Consensus 156 l~~N~l~g~iP~~l---~~l~~l~~~~n~~~~~~~ 187 (596)
|++|+|++..|..+ .+|..|++++|++.|.+.
T Consensus 135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 99999995444434 457788999999999764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=7.2e-12 Score=138.65 Aligned_cols=106 Identities=17% Similarity=0.219 Sum_probs=76.1
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|++++..+..|.++++|++| +|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 33 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L-~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 33 STKNIDLSFNPLKILKSYSFSNFSELQWL-DLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEE-ECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CcCEEECCCCCcCEeChhhccCCccCcEE-eCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 67778888888876666677788888888 78888877666777777888888888888777666777777777777777
Q ss_pred CCCcccccCCccc---cccccccccccccc
Q 007608 157 SSNNLTGRIPMQL---FSVATFNFTGTHLI 183 (596)
Q Consensus 157 ~~N~l~g~iP~~l---~~l~~l~~~~n~~~ 183 (596)
++|++++..|..+ .+|+.|++++|.+.
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 141 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIH 141 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCccc
Confidence 7777774333333 34556666666554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.5e-12 Score=146.73 Aligned_cols=105 Identities=24% Similarity=0.359 Sum_probs=94.8
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|.|+ .+|+.|++|++|+.| +|++|+|+ .+|..|++|++|++|+|++|.|+ .||..|++|++|+.|+
T Consensus 247 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L-~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~ 322 (727)
T 4b8c_D 247 DFLTRLYLNGNSLT-ELPAEIKNLSNLRVL-DLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLG 322 (727)
T ss_dssp CSCSCCBCTTSCCS-CCCGGGGGGTTCCEE-ECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEE
T ss_pred CCCCEEEeeCCcCc-ccChhhhCCCCCCEE-eCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEe
Confidence 47999999999999 999999999999999 99999999 89999999999999999999998 9999999999999999
Q ss_pred CCCCcccccCCccccccc----ccccccccccc
Q 007608 156 LSSNNLTGRIPMQLFSVA----TFNFTGTHLIC 184 (596)
Q Consensus 156 l~~N~l~g~iP~~l~~l~----~l~~~~n~~~~ 184 (596)
|++|+|+|.+|..+..+. .+++.+|.+..
T Consensus 323 L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~ 355 (727)
T 4b8c_D 323 VEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI 355 (727)
T ss_dssp CTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred CCCCccCCCChHHHhhcchhhhHHhhccCcccC
Confidence 999999999998775432 35567776643
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.9e-12 Score=142.63 Aligned_cols=106 Identities=23% Similarity=0.407 Sum_probs=96.3
Q ss_pred CCEEEEEcCCCCCCcc-----------------cCcchh--hhcccchhhcccCccccccCCcccCCCCcccEEEccCcc
Q 007608 76 GNVISLTLGSNGFSGK-----------------ISPSIT--KLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~-----------------~p~~~~--~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~ 136 (596)
.+++.|+|++|.|+|. +|+.++ ++++|++| +|++|++.|.+|..|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L-~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDV-EVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE-EEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEE-EecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 5899999999999986 999999 99999999 999999999999999999999999999998
Q ss_pred -CcC-CCccccccC------CCCcEEeCCCCcccccCCc--ccc---ccccccccccccc
Q 007608 137 -FSG-SIPATWSQL------SNLKHLDLSSNNLTGRIPM--QLF---SVATFNFTGTHLI 183 (596)
Q Consensus 137 -l~g-~~p~~~~~l------~~L~~L~l~~N~l~g~iP~--~l~---~l~~l~~~~n~~~ 183 (596)
++| .+|..++++ ++|++|+|++|+++ .+|. .+. +|+.|++++|.+.
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~ 343 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLE 343 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCE
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCc
Confidence 998 899998887 99999999999999 8998 554 5677788888765
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=6.7e-12 Score=137.69 Aligned_cols=108 Identities=20% Similarity=0.301 Sum_probs=51.6
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCcccc-ccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLS-GTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
+++.|+|++|.+.+.+|..+.++++|+.| +|++|+++ +.+|..+..+++|++|+|++|++++..|..+.++++|+.|+
T Consensus 422 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 500 (570)
T 2z63_A 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVL-KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500 (570)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEE-ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCEEeCcCCcccccchhhhhcCCcCcEE-ECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEe
Confidence 34444444444444444444445555555 45555544 34455555555555555555555544444555555555555
Q ss_pred CCCCcccccCCccc---cccccccccccccccC
Q 007608 156 LSSNNLTGRIPMQL---FSVATFNFTGTHLICG 185 (596)
Q Consensus 156 l~~N~l~g~iP~~l---~~l~~l~~~~n~~~~~ 185 (596)
|++|++++..|..+ .+|+.|++++|++.|.
T Consensus 501 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 501 MASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 55555553333222 2334444555555444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.3e-11 Score=113.69 Aligned_cols=101 Identities=20% Similarity=0.230 Sum_probs=84.9
Q ss_pred CEEEEEcCCCCCCcccCcchhhhc-ccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccc-cccCCCCcEE
Q 007608 77 NVISLTLGSNGFSGKISPSITKLK-FLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKHL 154 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~-~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L 154 (596)
+++.|+|++|+++ .+| .+..+. +|+.| +|++|.|++ + +.++++++|++|+|++|.|+ .+|+. ++++++|++|
T Consensus 20 ~L~~L~l~~n~l~-~i~-~~~~~~~~L~~L-~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 20 RDRELDLRGYKIP-VIE-NLGATLDQFDAI-DFSDNEIRK-L-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTEL 93 (176)
T ss_dssp SCEEEECTTSCCC-SCC-CGGGGTTCCSEE-ECCSSCCCE-E-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEE
T ss_pred CceEEEeeCCCCc-hhH-HhhhcCCCCCEE-ECCCCCCCc-c-cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEE
Confidence 7999999999999 565 466665 99999 999999995 4 68999999999999999999 55654 5999999999
Q ss_pred eCCCCcccccCCc--cc---ccccccccccccccc
Q 007608 155 DLSSNNLTGRIPM--QL---FSVATFNFTGTHLIC 184 (596)
Q Consensus 155 ~l~~N~l~g~iP~--~l---~~l~~l~~~~n~~~~ 184 (596)
+|++|+|+ .+|. .+ .+|..|++++|++..
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~ 127 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN 127 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC
Confidence 99999997 7886 44 456778899998753
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=1.2e-11 Score=135.21 Aligned_cols=87 Identities=25% Similarity=0.324 Sum_probs=81.7
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCC-ccccccCCCCcEE
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI-PATWSQLSNLKHL 154 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~-p~~~~~l~~L~~L 154 (596)
.+|+.|+|++|+|+ .+|..|++|++|+.| +|++|+|++ +| .|++|++|++|+|++|+|++.. |..+++|++|+.|
T Consensus 463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L-~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVL-QASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEE-ECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred ccCcEeecCccccc-ccchhhhcCCCCCEE-ECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 58999999999999 999999999999999 999999995 88 8999999999999999999776 9999999999999
Q ss_pred eCCCCcccccCC
Q 007608 155 DLSSNNLTGRIP 166 (596)
Q Consensus 155 ~l~~N~l~g~iP 166 (596)
+|++|+|++..|
T Consensus 539 ~L~~N~l~~~~~ 550 (567)
T 1dce_A 539 NLQGNSLCQEEG 550 (567)
T ss_dssp ECTTSGGGGSSS
T ss_pred EecCCcCCCCcc
Confidence 999999996544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.21 E-value=1e-11 Score=116.58 Aligned_cols=100 Identities=13% Similarity=0.220 Sum_probs=72.5
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|++++|+++ .+| .+..+++|+.| ++++|.++ .++.+.++++|++|+|++|.+++..|..++++++|++|+|
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L-~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDL-TINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEE-EEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEE-EccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 5777777777777 666 67777777777 77777665 3346777788888888888877667777777788888888
Q ss_pred CCCcccccCCcccc---ccccccccccc
Q 007608 157 SSNNLTGRIPMQLF---SVATFNFTGTH 181 (596)
Q Consensus 157 ~~N~l~g~iP~~l~---~l~~l~~~~n~ 181 (596)
++|++++..|..+. +|+.|++++|.
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 88887766665443 45666777776
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.20 E-value=4e-12 Score=113.58 Aligned_cols=88 Identities=30% Similarity=0.339 Sum_probs=79.3
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCC-CccccccCCCCcEE
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS-IPATWSQLSNLKHL 154 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~L 154 (596)
.+++.|+|++|.+++. +.++++++|+.| +|++|++++.+|..++++++|++|+|++|.+++. .|..++++++|++|
T Consensus 42 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L-~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L 118 (149)
T 2je0_A 42 EELEFLSTINVGLTSI--ANLPKLNKLKKL-ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118 (149)
T ss_dssp TTCCEEECTTSCCCCC--TTCCCCTTCCEE-ECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEE
T ss_pred CCCcEEECcCCCCCCc--hhhhcCCCCCEE-ECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEE
Confidence 5899999999999965 789999999999 9999999987999898999999999999999952 34889999999999
Q ss_pred eCCCCcccccCC
Q 007608 155 DLSSNNLTGRIP 166 (596)
Q Consensus 155 ~l~~N~l~g~iP 166 (596)
+|++|++++..+
T Consensus 119 ~l~~N~l~~~~~ 130 (149)
T 2je0_A 119 DLFNCEVTNLND 130 (149)
T ss_dssp ECTTCGGGGSTT
T ss_pred eCcCCcccchHH
Confidence 999999995443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=1.7e-11 Score=122.16 Aligned_cols=106 Identities=22% Similarity=0.304 Sum_probs=87.5
Q ss_pred CCEEEEEcCCCC-CCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEE
Q 007608 76 GNVISLTLGSNG-FSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 154 (596)
Q Consensus 76 ~~l~~L~l~~n~-l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 154 (596)
.+|+.|+|++|. +.+..|..+..+++|+.| +|++|++++..|..+.++++|++|+|++|++++..+..++++++|+.|
T Consensus 80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L-~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 158 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTL-HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158 (285)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEE-ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCEEeCCCCCCccccCHHHhcCCcCCCEE-ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEE
Confidence 478999999997 775557789999999999 999999997778889999999999999999995555568899999999
Q ss_pred eCCCCcccccCCc-cc---cccccccccccccc
Q 007608 155 DLSSNNLTGRIPM-QL---FSVATFNFTGTHLI 183 (596)
Q Consensus 155 ~l~~N~l~g~iP~-~l---~~l~~l~~~~n~~~ 183 (596)
+|++|+++ .+|. .+ .+|+.|++++|.+.
T Consensus 159 ~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 159 FLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp ECCSSCCC-EECTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCccc-ccCHHHhcCccccCEEECCCCccc
Confidence 99999999 4554 33 46777888888764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.1e-11 Score=133.12 Aligned_cols=109 Identities=22% Similarity=0.356 Sum_probs=96.1
Q ss_pred CEEEEEcCCCCCCcccC-cchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 77 NVISLTLGSNGFSGKIS-PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p-~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
+++.|+|++|+|+ .+| ..+.++++|+.| +|++|.+++..+..|.++++|+.|+|++|++++..|..|.++++|+.|+
T Consensus 225 ~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L-~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 302 (477)
T 2id5_A 225 NLTSLSITHCNLT-AVPYLAVRHLVYLRFL-NLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLN 302 (477)
T ss_dssp CCSEEEEESSCCC-SCCHHHHTTCTTCCEE-ECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEE
T ss_pred cccEEECcCCccc-ccCHHHhcCccccCee-ECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEE
Confidence 6889999999999 455 578999999999 9999999977778899999999999999999988899999999999999
Q ss_pred CCCCcccccCCcc----ccccccccccccccccCCCC
Q 007608 156 LSSNNLTGRIPMQ----LFSVATFNFTGTHLICGSSL 188 (596)
Q Consensus 156 l~~N~l~g~iP~~----l~~l~~l~~~~n~~~~~~~~ 188 (596)
|++|+|+ .+|.. +.+|+.|++++|++.|.+..
T Consensus 303 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~c~c~~ 338 (477)
T 2id5_A 303 VSGNQLT-TLEESVFHSVGNLETLILDSNPLACDCRL 338 (477)
T ss_dssp CCSSCCS-CCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred CCCCcCc-eeCHhHcCCCcccCEEEccCCCccCccch
Confidence 9999999 56643 34678899999999998653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=6.5e-12 Score=144.48 Aligned_cols=99 Identities=20% Similarity=0.163 Sum_probs=52.8
Q ss_pred CcceeEeeCCCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccC-CcccCCCCcccEEEccCccCcCCCcccc
Q 007608 67 SWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTL-PDFLGSMTHLQSLNLANNKFSGSIPATW 145 (596)
Q Consensus 67 ~w~gv~c~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 145 (596)
.|..|.+...+++.|+|++|.|++..|..|.++++|++| +|++|.+.+.+ |..|++|++|++|+|++|.+++..|..|
T Consensus 15 ~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~L-dLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~ 93 (844)
T 3j0a_A 15 NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLL-ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF 93 (844)
T ss_dssp CSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEE-EECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEE-eCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence 455555533466666666666665555555555555555 55555444444 4445555555555555555554445555
Q ss_pred ccCCCCcEEeCCCCcccccCC
Q 007608 146 SQLSNLKHLDLSSNNLTGRIP 166 (596)
Q Consensus 146 ~~l~~L~~L~l~~N~l~g~iP 166 (596)
+++++|++|+|++|++++.+|
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~ 114 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVL 114 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCS
T ss_pred cCCcccCEeeCcCCCCCcccc
Confidence 555555555555555554443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.19 E-value=8.9e-12 Score=130.10 Aligned_cols=102 Identities=20% Similarity=0.270 Sum_probs=76.4
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|++++. +.+..+++|+.| +|++|.+++..|..++++++|++|+|++|+++ .+|..+..+++|+.|+|
T Consensus 227 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L-~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L 302 (390)
T 3o6n_A 227 ELTILKLQHNNLTDT--AWLLNYPGLVEV-DLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 302 (390)
T ss_dssp SCCEEECCSSCCCCC--GGGGGCTTCSEE-ECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEEC
T ss_pred cccEEECCCCCCccc--HHHcCCCCccEE-ECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEEC
Confidence 677888888888753 567778888888 78888888777777888888888888888887 56777777788888888
Q ss_pred CCCcccccCCccc---cccccccccccccc
Q 007608 157 SSNNLTGRIPMQL---FSVATFNFTGTHLI 183 (596)
Q Consensus 157 ~~N~l~g~iP~~l---~~l~~l~~~~n~~~ 183 (596)
++|+++ .+|..+ .+|+.|++++|++.
T Consensus 303 ~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~ 331 (390)
T 3o6n_A 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIV 331 (390)
T ss_dssp CSSCCC-CCGGGHHHHTTCSEEECCSSCCC
T ss_pred CCCcce-ecCccccccCcCCEEECCCCccc
Confidence 888887 666544 45566777777653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=1.3e-11 Score=136.53 Aligned_cols=108 Identities=25% Similarity=0.306 Sum_probs=68.9
Q ss_pred CEEEEEcCCCCCCcc---cCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcE
Q 007608 77 NVISLTLGSNGFSGK---ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKH 153 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~---~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 153 (596)
+++.|+|++|.+++. .+..+..+++|+.| +|++|++++..|..|+++++|++|+|++|++++..|..+.++++| .
T Consensus 450 ~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L-~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~ 527 (606)
T 3t6q_A 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL-VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-Y 527 (606)
T ss_dssp TCCEEECTTCBCGGGEECSSCGGGGCTTCCEE-ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-E
T ss_pred CCCEEECCCCCCCccccccchhhccCCCccEE-ECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-E
Confidence 556666666666542 12346666666666 666666666666666777777777777777776666667777777 7
Q ss_pred EeCCCCcccccCCccc---cccccccccccccccCC
Q 007608 154 LDLSSNNLTGRIPMQL---FSVATFNFTGTHLICGS 186 (596)
Q Consensus 154 L~l~~N~l~g~iP~~l---~~l~~l~~~~n~~~~~~ 186 (596)
|+|++|++++..|..+ .+++.+++++|++.|.+
T Consensus 528 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 528 LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp EECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred EECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 7777777775444433 34566777777777754
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.19 E-value=8.4e-12 Score=137.89 Aligned_cols=101 Identities=20% Similarity=0.267 Sum_probs=68.4
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|.+++ ++.++.+++|+.| +|++|.+++.+|..|+++++|+.|+|++|.|+ .+|..++.+++|+.|+|
T Consensus 233 ~L~~L~L~~n~l~~--~~~l~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L 308 (597)
T 3oja_B 233 ELTILKLQHNNLTD--TAWLLNYPGLVEV-DLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 308 (597)
T ss_dssp CCCEEECCSSCCCC--CGGGGGCTTCSEE-ECCSSCCCEEESGGGTTCSSCCEEECTTSCCC-EEECSSSCCTTCCEEEC
T ss_pred CCCEEECCCCCCCC--ChhhccCCCCCEE-ECCCCccCCCCHHHhcCccCCCEEECCCCCCC-CCCcccccCCCCcEEEC
Confidence 56777777777765 3566777777777 77777777666777777777777777777777 46666666777777777
Q ss_pred CCCcccccCCccc---ccccccccccccc
Q 007608 157 SSNNLTGRIPMQL---FSVATFNFTGTHL 182 (596)
Q Consensus 157 ~~N~l~g~iP~~l---~~l~~l~~~~n~~ 182 (596)
++|+++ .+|..+ .+|..|++++|.+
T Consensus 309 s~N~l~-~i~~~~~~l~~L~~L~L~~N~l 336 (597)
T 3oja_B 309 SHNHLL-HVERNQPQFDRLENLYLDHNSI 336 (597)
T ss_dssp CSSCCC-CCGGGHHHHTTCSEEECCSSCC
T ss_pred CCCCCC-ccCcccccCCCCCEEECCCCCC
Confidence 777777 566543 3455566666655
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.19 E-value=7.7e-12 Score=115.20 Aligned_cols=100 Identities=17% Similarity=0.239 Sum_probs=86.3
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcc-cCCCCcccEEEccCccCcCCCcc--ccccCCCCcE
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDF-LGSMTHLQSLNLANNKFSGSIPA--TWSQLSNLKH 153 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~ 153 (596)
+++.|+|++|.|++ + +.+..+++|+.| +|++|+|++ +|+. ++.+++|++|+|++|.|+ .+|. .+.++++|+.
T Consensus 43 ~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L-~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~ 117 (176)
T 1a9n_A 43 QFDAIDFSDNEIRK-L-DGFPLLRRLKTL-LVNNNRICR-IGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTY 117 (176)
T ss_dssp CCSEEECCSSCCCE-E-CCCCCCSSCCEE-ECCSSCCCE-ECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred CCCEEECCCCCCCc-c-cccccCCCCCEE-ECCCCcccc-cCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCE
Confidence 79999999999995 4 689999999999 999999994 5654 599999999999999997 8887 8999999999
Q ss_pred EeCCCCcccccCCcc----c---ccccccccccccc
Q 007608 154 LDLSSNNLTGRIPMQ----L---FSVATFNFTGTHL 182 (596)
Q Consensus 154 L~l~~N~l~g~iP~~----l---~~l~~l~~~~n~~ 182 (596)
|+|++|.++ .+|.. + .+|..|++++|..
T Consensus 118 L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 118 LCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp EECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred EEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 999999999 78864 4 3556677777654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.18 E-value=4.7e-12 Score=144.31 Aligned_cols=106 Identities=25% Similarity=0.403 Sum_probs=96.8
Q ss_pred CCEEEEEcCCCCCCc-----------------ccCcchh--hhcccchhhcccCccccccCCcccCCCCcccEEEccCcc
Q 007608 76 GNVISLTLGSNGFSG-----------------KISPSIT--KLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g-----------------~~p~~~~--~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~ 136 (596)
.+|+.|+|++|+|+| .+|+.++ +|++|+.| +|++|++.|.+|..|++|++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L-~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV-ELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE-EEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEE-ECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 589999999999998 4999988 99999999 999999999999999999999999999998
Q ss_pred -CcC-CCccccccCC-------CCcEEeCCCCcccccCCc--ccc---ccccccccccccc
Q 007608 137 -FSG-SIPATWSQLS-------NLKHLDLSSNNLTGRIPM--QLF---SVATFNFTGTHLI 183 (596)
Q Consensus 137 -l~g-~~p~~~~~l~-------~L~~L~l~~N~l~g~iP~--~l~---~l~~l~~~~n~~~ 183 (596)
|+| .+|..+++++ +|+.|+|++|+|+ .+|. .+. +|..|++++|.+.
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~ 586 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR 586 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc
Confidence 998 8999888776 9999999999999 9998 554 5677889998765
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=2e-11 Score=124.37 Aligned_cols=102 Identities=17% Similarity=0.296 Sum_probs=64.3
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|++++|+++ .+|..+. ++|+.| ++++|++++..|..+.++++|++|+|++|.+++..|..+.++++|+.|+|
T Consensus 172 ~L~~L~l~~n~l~-~l~~~~~--~~L~~L-~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 247 (330)
T 1xku_A 172 KLSYIRIADTNIT-TIPQGLP--PSLTEL-HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247 (330)
T ss_dssp TCCEEECCSSCCC-SCCSSCC--TTCSEE-ECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred CcCEEECCCCccc-cCCcccc--ccCCEE-ECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEEC
Confidence 5666677776666 4555443 566666 66666666555666666666666666666666555556666666666666
Q ss_pred CCCcccccCCcccc---ccccccccccccc
Q 007608 157 SSNNLTGRIPMQLF---SVATFNFTGTHLI 183 (596)
Q Consensus 157 ~~N~l~g~iP~~l~---~l~~l~~~~n~~~ 183 (596)
++|+++ .+|..+. +|+.|++++|++.
T Consensus 248 ~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~ 276 (330)
T 1xku_A 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276 (330)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred CCCcCc-cCChhhccCCCcCEEECCCCcCC
Confidence 666666 6665543 3455566666553
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=9.1e-11 Score=115.30 Aligned_cols=145 Identities=16% Similarity=0.132 Sum_probs=112.0
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 347 (596)
...+.|+....++.|+.+.||++.. +++.+++|+...... .....+.+|+.+++.+. |..+.++++++.+.+..++|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 3445787778888888999999986 468999999864221 12345889999999885 67788899999888899999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC---------------------------------- 393 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------- 393 (596)
|||++|.++.+.+.. ......++.+++++|+.||+..
T Consensus 89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999998776321 1123467889999999999810
Q ss_pred ----------------------CCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 394 ----------------------NPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 394 ----------------------~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876666799999765
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.4e-11 Score=133.66 Aligned_cols=104 Identities=26% Similarity=0.333 Sum_probs=74.5
Q ss_pred CCEEEEEcCCCCCCc--ccCcchhhhcccchhhcccCccccccCCcc-cCCCCcccEEEccCccCcCCCccccccCCCCc
Q 007608 76 GNVISLTLGSNGFSG--KISPSITKLKFLASFRELQDNDLSGTLPDF-LGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 152 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g--~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 152 (596)
.+++.|+|++|++++ .+|..+..+++|+.| +|++|++++.+|.. +..+++|++|+|++|++++.+|..+. ++|+
T Consensus 348 ~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L-~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~ 424 (520)
T 2z7x_B 348 TELETLILQMNQLKELSKIAEMTTQMKSLQQL-DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIK 424 (520)
T ss_dssp SSCCEEECCSSCCCBHHHHHHHHTTCTTCCEE-ECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCC
T ss_pred CCCCEEEccCCccCccccchHHHhhCCCCCEE-ECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCC
Confidence 478888888888886 566778888888888 88888888767754 67777777777777777766666554 5677
Q ss_pred EEeCCCCcccccCCcccc---ccccccccccccc
Q 007608 153 HLDLSSNNLTGRIPMQLF---SVATFNFTGTHLI 183 (596)
Q Consensus 153 ~L~l~~N~l~g~iP~~l~---~l~~l~~~~n~~~ 183 (596)
.|+|++|+|+ .+|..++ +|+.|++++|.+.
T Consensus 425 ~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~ 457 (520)
T 2z7x_B 425 VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457 (520)
T ss_dssp EEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred EEECCCCccc-ccchhhhcCCCCCEEECCCCcCC
Confidence 7777777776 6666443 3455666666554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=1.3e-11 Score=136.70 Aligned_cols=116 Identities=17% Similarity=0.172 Sum_probs=99.6
Q ss_pred cceeEeeC-----------CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCcc
Q 007608 68 WSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136 (596)
Q Consensus 68 w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~ 136 (596)
+..+.|+. .+++.|+|++|.|++..|..|+++++|++| +|++|++++..|..|+++++|++|+|++|+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L-~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFL-DLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEE-ECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEE-ECCCCccceeChhhccCccccCeeeCCCCc
Confidence 55677854 378999999999997778899999999999 999999998889999999999999999999
Q ss_pred CcCCCccccccCCCCcEEeCCCCcccccCCccc---ccccccccccccccc
Q 007608 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHLIC 184 (596)
Q Consensus 137 l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l---~~l~~l~~~~n~~~~ 184 (596)
+++..|..|+++++|++|+|++|++++..|..+ .+|+.|++++|.+..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~ 143 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCC
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccc
Confidence 998889899999999999999999995434444 467788888887654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.18 E-value=6.6e-12 Score=136.76 Aligned_cols=114 Identities=25% Similarity=0.396 Sum_probs=91.4
Q ss_pred CCCCCCCCCCC----Cccee-EeeCCCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEE
Q 007608 56 DWNDHFVSPCF----SWSHV-TCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSL 130 (596)
Q Consensus 56 ~w~~~~~~~c~----~w~gv-~c~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L 130 (596)
+|..+ .++|. .|.|+ .|..++|+.|+|++|+|++ +|+.+. ++|+.| +|++|+|+ .+| ..+++|++|
T Consensus 35 ~W~~~-~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L-~Ls~N~l~-~ip---~~l~~L~~L 105 (571)
T 3cvr_A 35 KWEKQ-ALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVL-EITQNALI-SLP---ELPASLEYL 105 (571)
T ss_dssp HHHTT-CCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEE-ECCSSCCS-CCC---CCCTTCCEE
T ss_pred HHhcc-CCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEE-ECcCCCCc-ccc---cccCCCCEE
Confidence 56432 35663 59999 7887899999999999995 888764 789999 89999999 788 457899999
Q ss_pred EccCccCcCCCccccccCCCCcEEeCCCCcccccCCccccccccccccccccc
Q 007608 131 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLI 183 (596)
Q Consensus 131 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l~~l~~l~~~~n~~~ 183 (596)
+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|..+.+|..|++++|.+.
T Consensus 106 ~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~l~ 153 (571)
T 3cvr_A 106 DACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPELPALLEYINADNNQLT 153 (571)
T ss_dssp ECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS
T ss_pred EccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCCcCccccEEeCCCCccC
Confidence 999999985 887 665 88888888888885 7776667888888888764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=1e-11 Score=125.37 Aligned_cols=105 Identities=20% Similarity=0.296 Sum_probs=82.9
Q ss_pred CCEEEEEcCCCCCCcc--cC--cchhhhcccchhhcccCccccccCCc----ccCCCCcccEEEccCccCcCCCcccccc
Q 007608 76 GNVISLTLGSNGFSGK--IS--PSITKLKFLASFRELQDNDLSGTLPD----FLGSMTHLQSLNLANNKFSGSIPATWSQ 147 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~--~p--~~~~~l~~L~~l~~l~~n~l~g~~p~----~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 147 (596)
.+++.|+|++|++.+. ++ ..++.+++|++| +|++|+++ .+|. .++++++|++|||++|+|++.+|..++.
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L-~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 246 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNL-ALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPR 246 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSC-BCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSS
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEE-ECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHh
Confidence 4799999999998753 32 234788889999 89999987 4444 2577889999999999998777888777
Q ss_pred C---CCCcEEeCCCCcccccCCcccc-ccccccccccccc
Q 007608 148 L---SNLKHLDLSSNNLTGRIPMQLF-SVATFNFTGTHLI 183 (596)
Q Consensus 148 l---~~L~~L~l~~N~l~g~iP~~l~-~l~~l~~~~n~~~ 183 (596)
+ ++|++|+|++|+|+ .+|..+. +|+.|++++|.+.
T Consensus 247 ~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~ 285 (310)
T 4glp_A 247 CMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLN 285 (310)
T ss_dssp CCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCC
T ss_pred ccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCC
Confidence 7 58999999999998 7887654 7788888888775
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.8e-11 Score=116.51 Aligned_cols=109 Identities=28% Similarity=0.382 Sum_probs=95.1
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+|++..+..|..+++|+.| +|++|+|++..|..|..+++|++|+|++|+|+ .+|..+.++++|++|+
T Consensus 64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L-~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 64 INLKELYLGSNQLGALPVGVFDSLTQLTVL-DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEE-ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred cCCcEEECCCCCCCCcChhhcccCCCcCEE-ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 489999999999984444567999999999 99999999666667899999999999999999 9999999999999999
Q ss_pred CCCCcccccCCc-c---ccccccccccccccccCCC
Q 007608 156 LSSNNLTGRIPM-Q---LFSVATFNFTGTHLICGSS 187 (596)
Q Consensus 156 l~~N~l~g~iP~-~---l~~l~~l~~~~n~~~~~~~ 187 (596)
|++|+|+ .+|. . +.+|..|++.+|++.|.++
T Consensus 142 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 142 LDQNQLK-SIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCCCcCC-ccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9999999 5653 3 3467888999999998753
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=2.1e-11 Score=120.83 Aligned_cols=105 Identities=14% Similarity=0.236 Sum_probs=65.3
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|++++..+..|.++++|++| +|++|++++..|..|.++++|++|+|++|.+++..+..++++++|++|+|
T Consensus 53 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTL-ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TCSEEECTTCCCCEECTTTTTTCTTCCEE-ECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCcEEECCCCcCCccCHHHccCCcCCCEE-ECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 56667777776664444466666667766 67777766555566666666666666666666444445666666666666
Q ss_pred CCCcccc-cCCcccc---cccccccccccc
Q 007608 157 SSNNLTG-RIPMQLF---SVATFNFTGTHL 182 (596)
Q Consensus 157 ~~N~l~g-~iP~~l~---~l~~l~~~~n~~ 182 (596)
++|++++ .+|..+. +|+.|++++|.+
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l 161 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCC
Confidence 6666664 2455443 345555666644
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.9e-11 Score=112.58 Aligned_cols=90 Identities=21% Similarity=0.303 Sum_probs=78.6
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+|++..+..+..+++|+.| +|++|+|++..|..+.++++|++|+|++|+|++..+..+.++++|++|+
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 130 (177)
T 2o6r_A 52 TQLTKLSLSQNQIQSLPDGVFDKLTKLTIL-YLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEE-ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred ccccEEECCCCcceEeChhHccCCCccCEE-ECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEE
Confidence 479999999999996555568999999999 9999999976666789999999999999999944444578999999999
Q ss_pred CCCCcccccCC
Q 007608 156 LSSNNLTGRIP 166 (596)
Q Consensus 156 l~~N~l~g~iP 166 (596)
|++|.+++..|
T Consensus 131 l~~N~~~~~~~ 141 (177)
T 2o6r_A 131 LHTNPWDCSCP 141 (177)
T ss_dssp CCSSCBCCCHH
T ss_pred ecCCCeeccCc
Confidence 99999997665
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.7e-11 Score=134.46 Aligned_cols=103 Identities=23% Similarity=0.355 Sum_probs=62.5
Q ss_pred CCEEEEEcCCCCCCc--ccCcchhhhcccchhhcccCccccccCCcc-cCCCCcccEEEccCccCcCCCccccccCCCCc
Q 007608 76 GNVISLTLGSNGFSG--KISPSITKLKFLASFRELQDNDLSGTLPDF-LGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 152 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g--~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 152 (596)
.+++.|+|++|++++ .+|..+.++++|+.| +|++|++++.+|.. +..+++|++|+|++|++++.+|..+. ++|+
T Consensus 377 ~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L-~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~ 453 (562)
T 3a79_B 377 KRLQTLILQRNGLKNFFKVALMTKNMSSLETL-DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVK 453 (562)
T ss_dssp SSCCEEECCSSCCCBTTHHHHTTTTCTTCCEE-ECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCS
T ss_pred CCCCEEECCCCCcCCcccchhhhcCCCCCCEE-ECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCC
Confidence 367788888888875 334567778888888 78888887656653 55666666666666666555544433 4555
Q ss_pred EEeCCCCcccccCCcccc---cccccccccccc
Q 007608 153 HLDLSSNNLTGRIPMQLF---SVATFNFTGTHL 182 (596)
Q Consensus 153 ~L~l~~N~l~g~iP~~l~---~l~~l~~~~n~~ 182 (596)
.|+|++|+|+ .+|..++ +|+.|++++|.+
T Consensus 454 ~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l 485 (562)
T 3a79_B 454 VLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485 (562)
T ss_dssp EEECCSSCCC-CCCTTTTSSCCCSEEECCSSCC
T ss_pred EEECCCCcCc-ccChhhcCCCCCCEEECCCCCC
Confidence 5555555555 4554332 334444555544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=2.8e-11 Score=113.27 Aligned_cols=88 Identities=24% Similarity=0.296 Sum_probs=79.5
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|.|++..+..|.+|++|+.| +|++|+|++..|..|.++++|++|+|++|.|++..+..|.++++|+.|+
T Consensus 54 ~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L-~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (193)
T 2wfh_A 54 KHLTLIDLSNNRISTLSNQSFSNMTQLLTL-ILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLA 132 (193)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEE-ECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred cCCCEEECCCCcCCEeCHhHccCCCCCCEE-ECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEE
Confidence 589999999999997777789999999999 9999999977778899999999999999999944444699999999999
Q ss_pred CCCCccccc
Q 007608 156 LSSNNLTGR 164 (596)
Q Consensus 156 l~~N~l~g~ 164 (596)
|++|.+...
T Consensus 133 L~~N~~~C~ 141 (193)
T 2wfh_A 133 IGANPLYCD 141 (193)
T ss_dssp CCSSCEECS
T ss_pred eCCCCeecC
Confidence 999999854
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.9e-11 Score=124.70 Aligned_cols=101 Identities=20% Similarity=0.282 Sum_probs=49.1
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|++++|+++ .+|..+. ++|+.| ++++|++++..|..+.++++|++|+|++|++++..|..++.+++|+.|+|
T Consensus 173 ~L~~L~l~~n~l~-~l~~~~~--~~L~~L-~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 248 (332)
T 2ft3_A 173 KLNYLRISEAKLT-GIPKDLP--ETLNEL-HLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248 (332)
T ss_dssp CCSCCBCCSSBCS-SCCSSSC--SSCSCC-BCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEEC
T ss_pred ccCEEECcCCCCC-ccCcccc--CCCCEE-ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEEC
Confidence 3445555555555 2444332 445555 55555555444445555555555555555555433444555555555555
Q ss_pred CCCcccccCCcccc---cccccccccccc
Q 007608 157 SSNNLTGRIPMQLF---SVATFNFTGTHL 182 (596)
Q Consensus 157 ~~N~l~g~iP~~l~---~l~~l~~~~n~~ 182 (596)
++|+++ .+|..+. +|+.|++++|++
T Consensus 249 ~~N~l~-~lp~~l~~l~~L~~L~l~~N~l 276 (332)
T 2ft3_A 249 DNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276 (332)
T ss_dssp CSSCCC-BCCTTGGGCTTCCEEECCSSCC
T ss_pred CCCcCe-ecChhhhcCccCCEEECCCCCC
Confidence 555555 4554333 233444555444
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.17 E-value=2.3e-11 Score=126.95 Aligned_cols=105 Identities=16% Similarity=0.226 Sum_probs=90.3
Q ss_pred CCEEEEEcCCCCCCcccCcc-hhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEE
Q 007608 76 GNVISLTLGSNGFSGKISPS-ITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 154 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~-~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 154 (596)
.+++.|++++|.++ .+|+. +..+++|+.| +|++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|
T Consensus 45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L-~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELL-NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp CCCSEEEEESCEES-EECTHHHHHCCCCSEE-ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEecCCchh-hCChhHhcccccCcEE-ECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 36888999999998 67665 6889999999 999999997667799999999999999999997777789999999999
Q ss_pred eCCCCcccccCCcc----ccccccccccccccc
Q 007608 155 DLSSNNLTGRIPMQ----LFSVATFNFTGTHLI 183 (596)
Q Consensus 155 ~l~~N~l~g~iP~~----l~~l~~l~~~~n~~~ 183 (596)
+|++|+++ .+|.. +.+|+.|++++|.+.
T Consensus 123 ~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~ 154 (390)
T 3o6n_A 123 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 154 (390)
T ss_dssp ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCccC-cCCHHHhcCCCCCcEEECCCCccC
Confidence 99999999 77764 346788889988764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.16 E-value=2.4e-11 Score=122.39 Aligned_cols=108 Identities=19% Similarity=0.329 Sum_probs=83.9
Q ss_pred CCEEEEEcCCCCCCcccC-cchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcC-CCccccccCCCCcE
Q 007608 76 GNVISLTLGSNGFSGKIS-PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG-SIPATWSQLSNLKH 153 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p-~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~ 153 (596)
.+++.|+|++|++++..+ ..+..+++|+.| ++++|.+++..|..+.++++|++|+|++|.+++ .+|..+.++++|+.
T Consensus 101 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L-~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 179 (306)
T 2z66_A 101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL-DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179 (306)
T ss_dssp TTCCEEECTTSEEESSTTTTTTTTCTTCCEE-ECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred CCCCEEECCCCcccccccchhhhhccCCCEE-ECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCE
Confidence 478888888888885443 478888888888 888888887778888888888888888888886 47778888888888
Q ss_pred EeCCCCcccccCCcccc---cccccccccccccc
Q 007608 154 LDLSSNNLTGRIPMQLF---SVATFNFTGTHLIC 184 (596)
Q Consensus 154 L~l~~N~l~g~iP~~l~---~l~~l~~~~n~~~~ 184 (596)
|+|++|++++..|..+. +|+.|++++|.+..
T Consensus 180 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 213 (306)
T 2z66_A 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213 (306)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECTTSCCSB
T ss_pred EECCCCCcCCcCHHHhcCCCCCCEEECCCCccCc
Confidence 88888888866565543 56677788887643
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.16 E-value=1.7e-11 Score=118.76 Aligned_cols=103 Identities=15% Similarity=0.191 Sum_probs=87.4
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCcc-ccccCCcccCCCCcccEEEccC-ccCcCCCccccccCCCCcE
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDND-LSGTLPDFLGSMTHLQSLNLAN-NKFSGSIPATWSQLSNLKH 153 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~-l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~ 153 (596)
.+++.|+|++|++++..+..|.++++|+.| ++++|+ +++..|..|.++++|++|+|++ |+|++..|..|.++++|++
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L-~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRI-YVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEE-EEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEE-eCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 479999999999996555589999999999 999997 8855556899999999999999 9999555568999999999
Q ss_pred EeCCCCcccccCCc--cccccc---ccccccc
Q 007608 154 LDLSSNNLTGRIPM--QLFSVA---TFNFTGT 180 (596)
Q Consensus 154 L~l~~N~l~g~iP~--~l~~l~---~l~~~~n 180 (596)
|+|++|+++ .+|. .+.+++ .|++++|
T Consensus 110 L~l~~n~l~-~lp~~~~l~~L~~L~~L~l~~N 140 (239)
T 2xwt_C 110 LGIFNTGLK-MFPDLTKVYSTDIFFILEITDN 140 (239)
T ss_dssp EEEEEECCC-SCCCCTTCCBCCSEEEEEEESC
T ss_pred EeCCCCCCc-cccccccccccccccEEECCCC
Confidence 999999999 4886 334455 7788888
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=3.4e-11 Score=135.17 Aligned_cols=104 Identities=24% Similarity=0.332 Sum_probs=56.5
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCcc-ccccCCCCcEEe
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~ 155 (596)
+++.|+|++|++++..+..|.++++|++| +|++|++++..|..|+++++|++|+|++|.++ .+|. .|+++++|++|+
T Consensus 26 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L-~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 26 NITVLNLTHNQLRRLPAANFTRYSQLTSL-DVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TCSEEECCSSCCCCCCGGGGGGGTTCSEE-ECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEE
T ss_pred CCcEEECCCCCCCCcCHHHHhCCCcCcEE-ECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEE
Confidence 45566666666664444456666666666 56666666555555555666666666666555 3333 455555566666
Q ss_pred CCCCcccccCCccc---ccccccccccccc
Q 007608 156 LSSNNLTGRIPMQL---FSVATFNFTGTHL 182 (596)
Q Consensus 156 l~~N~l~g~iP~~l---~~l~~l~~~~n~~ 182 (596)
|++|++++..|..+ .+|+.|++++|.+
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 133 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGL 133 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcc
Confidence 66555553222332 2344455555543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.15 E-value=2.7e-11 Score=122.72 Aligned_cols=104 Identities=21% Similarity=0.180 Sum_probs=72.9
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccC-CCCcccEEEccCccCcCCCccccccCCCCcEE
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLG-SMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 154 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 154 (596)
.+++.|+|++|++++..|..++.+++|+.| +|++|.+++..|..+. .+++|++|+|++|.|+ .+|. ...+++|+.|
T Consensus 120 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~-~~~l~~L~~L 196 (317)
T 3o53_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYL-DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTL 196 (317)
T ss_dssp SSCEEEECCSSCCCSGGGBCTGGGSSEEEE-ECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC-EEEC-CCCCTTCCEE
T ss_pred CCCCEEECCCCCCCCccchhhhccCCCCEE-ECCCCCCCcccHHHHhhccCcCCEEECCCCcCc-cccc-ccccccCCEE
Confidence 367888888888886666678888888888 8888888866666663 6777777777777777 4443 3347777777
Q ss_pred eCCCCcccccCCcccc---ccccccccccccc
Q 007608 155 DLSSNNLTGRIPMQLF---SVATFNFTGTHLI 183 (596)
Q Consensus 155 ~l~~N~l~g~iP~~l~---~l~~l~~~~n~~~ 183 (596)
+|++|+++ .+|..+. +|+.|++++|.+.
T Consensus 197 ~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp ECCSSCCC-EECGGGGGGTTCSEEECTTSCCC
T ss_pred ECCCCcCC-cchhhhcccCcccEEECcCCccc
Confidence 77777777 4555443 4556667777654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.1e-11 Score=125.23 Aligned_cols=106 Identities=17% Similarity=0.210 Sum_probs=92.0
Q ss_pred CCEEEEEcCCCCCCcccCcch--hhhcccchhhcccCccccccCCcccCCC-----CcccEEEccCccCcCCCccccccC
Q 007608 76 GNVISLTLGSNGFSGKISPSI--TKLKFLASFRELQDNDLSGTLPDFLGSM-----THLQSLNLANNKFSGSIPATWSQL 148 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~--~~l~~L~~l~~l~~n~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~l 148 (596)
.+|+.|+|++|+++|.+|..+ ..+++|++| +|++|++++. |..++++ ++|++|+|++|++++..|..|+++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L-~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNIL-NLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEE-EEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEE-EccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 479999999999999999887 899999999 9999999966 8888887 999999999999997777899999
Q ss_pred CCCcEEeCCCCcccccC--C-----ccccccccccccccccc
Q 007608 149 SNLKHLDLSSNNLTGRI--P-----MQLFSVATFNFTGTHLI 183 (596)
Q Consensus 149 ~~L~~L~l~~N~l~g~i--P-----~~l~~l~~l~~~~n~~~ 183 (596)
++|++|+|++|+++|.+ | ..+.+|+.|++++|.+.
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 99999999999988763 2 34567788888888764
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.7e-11 Score=132.99 Aligned_cols=107 Identities=22% Similarity=0.254 Sum_probs=83.2
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccc--cCCcccCCCCcccEEEccCccCcCCCccc-cccCCCCc
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSG--TLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLK 152 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~ 152 (596)
.+++.|+|++|++++.+|..++++++|+.| +|++|++++ .+|..++++++|++|+|++|.+++.+|.. +..+++|+
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L-~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETL-ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEE-ECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEE-EccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 467788888888887777788888888888 788888875 56677888888888888888888667764 77778888
Q ss_pred EEeCCCCcccccCCccc-cccccccccccccc
Q 007608 153 HLDLSSNNLTGRIPMQL-FSVATFNFTGTHLI 183 (596)
Q Consensus 153 ~L~l~~N~l~g~iP~~l-~~l~~l~~~~n~~~ 183 (596)
.|+|++|++++.+|..+ .+|+.|++++|.+.
T Consensus 403 ~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434 (520)
T ss_dssp EEECCSSCCCGGGGGSCCTTCCEEECCSSCCC
T ss_pred EEECcCCCCCcchhhhhcccCCEEECCCCccc
Confidence 88888888877777776 47778888887664
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=3.4e-11 Score=121.55 Aligned_cols=105 Identities=19% Similarity=0.186 Sum_probs=87.1
Q ss_pred CEEEEEcCCCCCCcccCcch--hhhcccchhhcccCccccccCC----cccCCCCcccEEEccCccCcCCCccccccCCC
Q 007608 77 NVISLTLGSNGFSGKISPSI--TKLKFLASFRELQDNDLSGTLP----DFLGSMTHLQSLNLANNKFSGSIPATWSQLSN 150 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~--~~l~~L~~l~~l~~n~l~g~~p----~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 150 (596)
+++.|+|++|++++.+|..+ ..+++|+.| +|++|++++..| ..+..+++|++|+|++|++++..|..++++++
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L-~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSL-RLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSC-EEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEE-EeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 58999999999998888888 889999999 999999997666 45567899999999999998777788999999
Q ss_pred CcEEeCCCCccccc--C-----Ccccccccccccccccc
Q 007608 151 LKHLDLSSNNLTGR--I-----PMQLFSVATFNFTGTHL 182 (596)
Q Consensus 151 L~~L~l~~N~l~g~--i-----P~~l~~l~~l~~~~n~~ 182 (596)
|++|+|++|+++|. + +..+.+|+.|++++|.+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 209 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGM 209 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCC
Confidence 99999999998752 2 13455778888888865
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.12 E-value=4.7e-11 Score=130.94 Aligned_cols=104 Identities=20% Similarity=0.275 Sum_probs=90.2
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|+|++|.+++..|..|.++++|+.| +|++|+|++..|..|+++++|++|||++|+|+ .+|.. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVL-RLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEE-ECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEE-ECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 479999999999997777799999999999 99999999877899999999999999999999 88887 899999999
Q ss_pred CCCCcccc-cCCcccc---ccccccccccccc
Q 007608 156 LSSNNLTG-RIPMQLF---SVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g-~iP~~l~---~l~~l~~~~n~~~ 183 (596)
|++|++++ .+|..+. +|+.|++++|.+.
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~ 159 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCC
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCccc
Confidence 99999995 4455654 5667788888764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=5.4e-11 Score=129.92 Aligned_cols=60 Identities=22% Similarity=0.311 Sum_probs=28.8
Q ss_pred CEEEEEcCCCCCCcccC--cchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCc
Q 007608 77 NVISLTLGSNGFSGKIS--PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 138 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p--~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~ 138 (596)
+++.|+|++|+|++..+ ..+..+++|+.| ++++|+|+ .+|..++.+++|++|+|++|+|+
T Consensus 362 ~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L-~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~ 423 (549)
T 2z81_A 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSL-DISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423 (549)
T ss_dssp TCCEEECTTSCCCCHHHHHHHGGGCTTCCEE-ECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS
T ss_pred cCcEEEccCCcccccccchhhhhcCCCCCEE-ECCCCCCc-cCChhhcccccccEEECCCCCcc
Confidence 45555555555552211 234555555555 55555555 45554444444444444444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.10 E-value=5.2e-11 Score=122.15 Aligned_cols=109 Identities=22% Similarity=0.202 Sum_probs=85.4
Q ss_pred CCEEEEEcCC-CCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccc-cccCCCCcE
Q 007608 76 GNVISLTLGS-NGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKH 153 (596)
Q Consensus 76 ~~l~~L~l~~-n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~ 153 (596)
.+|+.|+|++ |.|++..|..|++|++|+.| +|++|+|+|..|..|++|++|++|||++|+|+ .+|.. +..++ |+.
T Consensus 31 ~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L-~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~~~-L~~ 107 (347)
T 2ifg_A 31 ENLTELYIENQQHLQHLELRDLRGLGELRNL-TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLS-LQE 107 (347)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEE-ECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCC-CCE
T ss_pred CCeeEEEccCCCCCCCcChhHhccccCCCEE-ECCCCccceeCHHHhcCCcCCCEEeCCCCccc-eeCHHHcccCC-ceE
Confidence 3799999996 99997666789999999999 99999999988889999999999999999999 55554 55555 999
Q ss_pred EeCCCCcccccCCc-ccc---ccccccccccccccCCC
Q 007608 154 LDLSSNNLTGRIPM-QLF---SVATFNFTGTHLICGSS 187 (596)
Q Consensus 154 L~l~~N~l~g~iP~-~l~---~l~~l~~~~n~~~~~~~ 187 (596)
|+|++|+|...-.. .|. ......+..+...|..+
T Consensus 108 l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~ 145 (347)
T 2ifg_A 108 LVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ 145 (347)
T ss_dssp EECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred EEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCC
Confidence 99999999843221 111 11233445566777654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.7e-10 Score=112.84 Aligned_cols=128 Identities=14% Similarity=0.042 Sum_probs=96.6
Q ss_pred eecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCC--ccceEeEEecCCeeEEEEEcccCCChhh
Q 007608 281 GQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGYCTTSSERILVYPFMQNLSVAY 358 (596)
Q Consensus 281 G~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~ 358 (596)
+.|..+.||++...+|..+++|..... ....+.+|+.+++.+.+.+ +.+++++....+..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 355569999998877888999987542 2245778999998886545 456888888777889999999998874
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 007608 359 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC--------------------------------------------- 393 (596)
Q Consensus 359 ~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------------- 393 (596)
... .+ ...++.++++.|..||+..
T Consensus 104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 2356778888888888642
Q ss_pred ----------CCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 394 ----------NPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 394 ----------~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887667799999875
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.07 E-value=1.8e-11 Score=125.97 Aligned_cols=61 Identities=23% Similarity=0.339 Sum_probs=34.0
Q ss_pred CEEEEEcCCCC-CCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCc
Q 007608 77 NVISLTLGSNG-FSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 138 (596)
Q Consensus 77 ~l~~L~l~~n~-l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~ 138 (596)
+++.|+|++|+ +.+..|..+.++++|+.| ++++|++++..|..++++++|++|+|++|.++
T Consensus 150 ~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L-~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEEL-EIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp TCCEEEEEESSSCCEECTTTTTTCCEEEEE-EEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred CCcEEECCCCccccccCHHHccCCCCCCEE-ECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 55666666653 443334456666666666 66666666555666655555555555555443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.07 E-value=1.1e-10 Score=128.13 Aligned_cols=104 Identities=14% Similarity=0.229 Sum_probs=47.6
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|++++..|..|.++++|++| +|++|++++..|..|+++++|++|+|++|++++..+..++++++|++|+|
T Consensus 53 ~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 131 (570)
T 2z63_A 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTL-ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (570)
T ss_dssp SCCEEECTTCCCCEECTTTTTTCTTCCEE-ECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEEC
T ss_pred CceEEECCCCcCCccCcccccCchhCCEE-eCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEec
Confidence 34444444444443333344444444444 44544444333344444555555555555544222223455555555555
Q ss_pred CCCcccc-cCCcccc---ccccccccccc
Q 007608 157 SSNNLTG-RIPMQLF---SVATFNFTGTH 181 (596)
Q Consensus 157 ~~N~l~g-~iP~~l~---~l~~l~~~~n~ 181 (596)
++|++++ .+|..+. +|+.|++++|.
T Consensus 132 ~~n~l~~~~lp~~~~~l~~L~~L~l~~n~ 160 (570)
T 2z63_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160 (570)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECTTSC
T ss_pred CCCccceecChhhhcccCCCCEEeCcCCc
Confidence 5555543 2444333 33444445444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=1.9e-10 Score=129.11 Aligned_cols=105 Identities=26% Similarity=0.289 Sum_probs=80.0
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCC-cccCCCCcccEEEccCccCcCCCccccccCCCCcEE
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLP-DFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 154 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 154 (596)
.+++.|+|++|.+++..|..|+++++|++| +|++|+++ .+| ..|+++++|++|+|++|++++..|..|+++++|++|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L-~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 126 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVL-NLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITL 126 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEE-ECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEE
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEE-ECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEE
Confidence 478888888888887777788888888888 88888888 455 468888888888888888885555678888888888
Q ss_pred eCCCCcccccCCccc---ccccccccccccc
Q 007608 155 DLSSNNLTGRIPMQL---FSVATFNFTGTHL 182 (596)
Q Consensus 155 ~l~~N~l~g~iP~~l---~~l~~l~~~~n~~ 182 (596)
+|++|++++..|..+ .+|+.|++++|.+
T Consensus 127 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 157 (680)
T 1ziw_A 127 DLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157 (680)
T ss_dssp ECCSSCCSCCCCCSSSCCTTCCEEECCSSCC
T ss_pred ECCCCcccccCchhhcccccCCEEEccCCcc
Confidence 888888886666544 3556667777754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.05 E-value=7.4e-11 Score=126.84 Aligned_cols=103 Identities=20% Similarity=0.157 Sum_probs=60.4
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcc-----------------cCCCCcccEEEccCccCcC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDF-----------------LGSMTHLQSLNLANNKFSG 139 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~-----------------~~~l~~L~~L~l~~N~l~g 139 (596)
+|+.|+|++|.+++.+| ++.+++|+.| +|++|.|++ +|.. ...+++|+.|+|++|.|++
T Consensus 59 ~L~~L~Ls~N~l~~~~~--l~~l~~L~~L-~Ls~N~l~~-l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~ 134 (487)
T 3oja_A 59 KLELLNLSSNVLYETLD--LESLSTLRTL-DLNNNYVQE-LLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (487)
T ss_dssp TCCEEECTTSCCEEEEE--CTTCTTCCEE-ECCSSEEEE-EEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCS
T ss_pred CCCEEEeeCCCCCCCcc--cccCCCCCEE-EecCCcCCC-CCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCC
Confidence 56666666666664443 5566666555 555555542 1110 0123455556666666665
Q ss_pred CCccccccCCCCcEEeCCCCcccccCCccc----cccccccccccccc
Q 007608 140 SIPATWSQLSNLKHLDLSSNNLTGRIPMQL----FSVATFNFTGTHLI 183 (596)
Q Consensus 140 ~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l----~~l~~l~~~~n~~~ 183 (596)
..|..++++++|+.|+|++|+|++.+|..+ .+|..|++++|.+.
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~ 182 (487)
T 3oja_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (487)
T ss_dssp GGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence 556667777777777777777776666544 34566667776653
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.05 E-value=2.5e-12 Score=121.01 Aligned_cols=104 Identities=22% Similarity=0.274 Sum_probs=88.3
Q ss_pred CCCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEE
Q 007608 75 NGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 154 (596)
Q Consensus 75 ~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 154 (596)
..+++.|+|++|++++ +| .+.++++|+.| +|++|+++ .+|..+..+++|++|+|++|+++ .+| .++++++|+.|
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L-~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L 120 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRIL-SLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVL 120 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEE-EEEEEEEC-SCSSHHHHHHHCSEEEEEEEECC-CHH-HHHHHHHSSEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEE-ECCCCCcc-cccchhhcCCcCCEEECcCCcCC-cCC-ccccCCCCCEE
Confidence 3589999999999995 77 89999999999 99999999 78988888899999999999999 467 68899999999
Q ss_pred eCCCCcccccCCc-----cccccccccccccccccC
Q 007608 155 DLSSNNLTGRIPM-----QLFSVATFNFTGTHLICG 185 (596)
Q Consensus 155 ~l~~N~l~g~iP~-----~l~~l~~l~~~~n~~~~~ 185 (596)
+|++|+++ .+|. .+.+|..|++++|++.+.
T Consensus 121 ~l~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 121 YMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp EESEEECC-CHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred ECCCCcCC-chhHHHHHhcCCCCCEEEecCCccccc
Confidence 99999998 4443 345677888999987654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.1e-09 Score=112.79 Aligned_cols=143 Identities=13% Similarity=0.164 Sum_probs=106.1
Q ss_pred cCceeeecCceEEEEEEeCCCcEEEEEEcc--ccCCcchHHHHHHHHHHHHhcC--CCCccceEeEEecC---CeeEEEE
Q 007608 276 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTS---SERILVY 348 (596)
Q Consensus 276 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~--~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~ 348 (596)
..+.++.|.++.||+....+ ..+++|+.. ..........+.+|+.+++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998754 678888765 3221223456788999999887 45678889888776 4579999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC----------------------------------- 393 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------- 393 (596)
||+++..+.+.. -..++...+..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999987764321 123678888899999999999999731
Q ss_pred --------------------CCCcEecCCCCCcEEEcCCCc--EEEeecccccc
Q 007608 394 --------------------NPKIIHRDLKAANILLDDNFE--AVLCDFGLAKL 425 (596)
Q Consensus 394 --------------------~~~ivH~dlkp~NIll~~~~~--~kl~DfGl~~~ 425 (596)
.+.++|+|+++.||+++.++. +.|.||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998864
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.02 E-value=2.7e-11 Score=133.54 Aligned_cols=115 Identities=23% Similarity=0.454 Sum_probs=80.5
Q ss_pred CCCCCCCCCCCCCCcceeE--------eeCCCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCC
Q 007608 54 FTDWNDHFVSPCFSWSHVT--------CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMT 125 (596)
Q Consensus 54 l~~w~~~~~~~c~~w~gv~--------c~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~ 125 (596)
.++|... .+||.|.|.. |...+++.|++++|+|+ .+|..+. ++|+.| +|++|+|+ .+|. .++
T Consensus 12 w~~W~~~--~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L-~L~~N~l~-~lp~---~l~ 81 (622)
T 3g06_A 12 WSAWRRA--APAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTL-VIPDNNLT-SLPA---LPP 81 (622)
T ss_dssp HHHHHHT--CCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEE-EECSCCCS-CCCC---CCT
T ss_pred HHHHHhc--CCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEE-EecCCCCC-CCCC---cCC
Confidence 3456543 4566886542 33346788888888888 7777665 678888 78888887 6776 567
Q ss_pred cccEEEccCccCcCCCccccccCCCCcEEeCCCCcccccCCccccccccccccccccc
Q 007608 126 HLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLI 183 (596)
Q Consensus 126 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l~~l~~l~~~~n~~~ 183 (596)
+|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|..+.+|..|++++|.+.
T Consensus 82 ~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~~l~~L~~L~L~~N~l~ 134 (622)
T 3g06_A 82 ELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPALPSGLCKLWIFGNQLT 134 (622)
T ss_dssp TCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCCCCTTCCEEECCSSCCS
T ss_pred CCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCCCCCCcCEEECCCCCCC
Confidence 7888888888887 6776 5677777777777777 56666666677777666543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.00 E-value=4.3e-10 Score=110.61 Aligned_cols=101 Identities=27% Similarity=0.389 Sum_probs=77.5
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+|++ +|+ +.++++|+.| +|++|+++ .+|.... ++|++|+|++|+++ .+| .++++++|+.|+
T Consensus 63 ~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L-~L~~N~l~-~l~~~~~--~~L~~L~L~~N~l~-~~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP-LKDLTKLEEL-SVNRNRLK-NLNGIPS--ACLSRLFLDNNELR-DTD-SLIHLKNLEILS 134 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCSSCCEE-ECCSSCCS-CCTTCCC--SSCCEEECCSSCCS-BSG-GGTTCTTCCEEE
T ss_pred CCCCEEECCCCccCC-Chh-hccCCCCCEE-ECCCCccC-CcCcccc--CcccEEEccCCccC-CCh-hhcCcccccEEE
Confidence 478899999999984 555 8889999999 89999998 4665443 88888888888888 455 588888888888
Q ss_pred CCCCcccccCCc--cccccccccccccccccC
Q 007608 156 LSSNNLTGRIPM--QLFSVATFNFTGTHLICG 185 (596)
Q Consensus 156 l~~N~l~g~iP~--~l~~l~~l~~~~n~~~~~ 185 (596)
|++|+++ .+|. .+.+|+.|++++|.+...
T Consensus 135 Ls~N~i~-~~~~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 135 IRNNKLK-SIVMLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CTTSCCC-BCGGGGGCTTCCEEECTTSCCCBC
T ss_pred CCCCcCC-CChHHccCCCCCEEECCCCcCcch
Confidence 8888888 4552 334567778888876543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.99 E-value=3.7e-10 Score=112.83 Aligned_cols=102 Identities=30% Similarity=0.427 Sum_probs=79.5
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|.+++ +| .+..+++|+.| +|++|++++ + +.+.++++|++|+|++|++++ + ..++++++|+.|+
T Consensus 90 ~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L-~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~ 162 (291)
T 1h6t_A 90 KNLGWLFLDENKVKD-LS-SLKDLKKLKSL-SLEHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLS 162 (291)
T ss_dssp TTCCEEECCSSCCCC-GG-GGTTCTTCCEE-ECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEE
T ss_pred CCCCEEECCCCcCCC-Ch-hhccCCCCCEE-ECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCc-c-hhhccCCCCCEEE
Confidence 478899999999984 44 48888999999 899999884 4 468888999999999999884 4 5788889999999
Q ss_pred CCCCcccccCC-cccccccccccccccccc
Q 007608 156 LSSNNLTGRIP-MQLFSVATFNFTGTHLIC 184 (596)
Q Consensus 156 l~~N~l~g~iP-~~l~~l~~l~~~~n~~~~ 184 (596)
|++|++++..| ..+.+|+.|++++|.+..
T Consensus 163 L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 163 LEDNQISDIVPLAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CCSSCCCCCGGGTTCTTCCEEECCSSCCCB
T ss_pred ccCCccccchhhcCCCccCEEECCCCcCCC
Confidence 99998885433 123456777888886643
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.99 E-value=5.4e-12 Score=118.63 Aligned_cols=102 Identities=20% Similarity=0.320 Sum_probs=87.1
Q ss_pred CEEEEEcCCCCCCcccCc------chhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCC
Q 007608 77 NVISLTLGSNGFSGKISP------SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSN 150 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~------~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 150 (596)
+++.++++.+.++|.+|+ .+..+++|+.| +|++|++++ +| .+.++++|++|+|++|.++ .+|..+..+++
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L-~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHL-ALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEE-ECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEE-ECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 455666677777777666 99999999999 999999995 88 9999999999999999999 89999999999
Q ss_pred CcEEeCCCCcccccCCc--cccccccccccccccc
Q 007608 151 LKHLDLSSNNLTGRIPM--QLFSVATFNFTGTHLI 183 (596)
Q Consensus 151 L~~L~l~~N~l~g~iP~--~l~~l~~l~~~~n~~~ 183 (596)
|+.|+|++|++++ +|. .+.+|..|++++|.+.
T Consensus 95 L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~i~ 128 (198)
T 1ds9_A 95 LEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp CSEEEEEEEECCC-HHHHHHHHHSSEEEESEEECC
T ss_pred CCEEECcCCcCCc-CCccccCCCCCEEECCCCcCC
Confidence 9999999999994 763 2346788889998764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.98 E-value=3.6e-10 Score=114.43 Aligned_cols=101 Identities=19% Similarity=0.166 Sum_probs=56.8
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCcccc-ccCCCCcEEe
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATW-SQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~L~ 155 (596)
+++.|++++|++++..+.. +++|+.| ++++|++++..|..++.+++|++|+|++|.+++..|..+ ..+++|++|+
T Consensus 100 ~L~~L~l~~n~l~~~~~~~---~~~L~~L-~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 175 (317)
T 3o53_A 100 SIETLHAANNNISRVSCSR---GQGKKNI-YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (317)
T ss_dssp TCCEEECCSSCCSEEEECC---CSSCEEE-ECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CcCEEECCCCccCCcCccc---cCCCCEE-ECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence 4555555555555333322 4556666 666666665555566666666666666666665445544 3566666666
Q ss_pred CCCCcccccCCcc--cccccccccccccc
Q 007608 156 LSSNNLTGRIPMQ--LFSVATFNFTGTHL 182 (596)
Q Consensus 156 l~~N~l~g~iP~~--l~~l~~l~~~~n~~ 182 (596)
|++|+++ .+|.. +.+|+.|++++|.+
T Consensus 176 L~~N~l~-~~~~~~~l~~L~~L~Ls~N~l 203 (317)
T 3o53_A 176 LQYNFIY-DVKGQVVFAKLKTLDLSSNKL 203 (317)
T ss_dssp CTTSCCC-EEECCCCCTTCCEEECCSSCC
T ss_pred CCCCcCc-ccccccccccCCEEECCCCcC
Confidence 6666666 33322 34555666666654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.98 E-value=4.2e-10 Score=113.41 Aligned_cols=102 Identities=22% Similarity=0.356 Sum_probs=82.8
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|+|++|++++ +|+ +..+++|+.| ++++|++++ +|. ++++++|++|+|++|+++ .+|. +.++++|+.|+
T Consensus 107 ~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L-~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~ 179 (308)
T 1h6u_A 107 QSIKTLDLTSTQITD-VTP-LAGLSNLQVL-YLDLNQITN-ISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLK 179 (308)
T ss_dssp TTCCEEECTTSCCCC-CGG-GTTCTTCCEE-ECCSSCCCC-CGG-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCC-chh-hcCCCCCCEE-ECCCCccCc-Ccc-ccCCCCccEEEccCCcCC-CChh-hcCCCCCCEEE
Confidence 478999999999985 554 8999999999 999999985 444 889999999999999998 5665 88999999999
Q ss_pred CCCCcccccCCc--cccccccccccccccccC
Q 007608 156 LSSNNLTGRIPM--QLFSVATFNFTGTHLICG 185 (596)
Q Consensus 156 l~~N~l~g~iP~--~l~~l~~l~~~~n~~~~~ 185 (596)
|++|+++ .+|. .+.+|+.|++++|.+...
T Consensus 180 l~~n~l~-~~~~l~~l~~L~~L~L~~N~l~~~ 210 (308)
T 1h6u_A 180 ADDNKIS-DISPLASLPNLIEVHLKNNQISDV 210 (308)
T ss_dssp CCSSCCC-CCGGGGGCTTCCEEECTTSCCCBC
T ss_pred CCCCccC-cChhhcCCCCCCEEEccCCccCcc
Confidence 9999998 4553 345677888888876543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.97 E-value=5.9e-10 Score=109.63 Aligned_cols=99 Identities=19% Similarity=0.296 Sum_probs=84.2
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|++++|+++ .+| .+..+++|+.| +|++|+|++ +|+ ++++++|++|+|++|+++ .+|.... ++|+.|+
T Consensus 41 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L-~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~-~l~~~~~--~~L~~L~ 112 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA-GMQFFTNLKEL-HLSHNQISD-LSP-LKDLTKLEELSVNRNRLK-NLNGIPS--ACLSRLF 112 (263)
T ss_dssp TTCSEEECTTSCCC-CCT-TGGGCTTCCEE-ECCSSCCCC-CGG-GTTCSSCCEEECCSSCCS-CCTTCCC--SSCCEEE
T ss_pred CcCcEEECcCCCcc-cch-HHhhCCCCCEE-ECCCCccCC-Chh-hccCCCCCEEECCCCccC-CcCcccc--CcccEEE
Confidence 48999999999998 677 79999999999 999999995 555 999999999999999999 5775433 9999999
Q ss_pred CCCCcccccCCc--cccccccccccccccc
Q 007608 156 LSSNNLTGRIPM--QLFSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP~--~l~~l~~l~~~~n~~~ 183 (596)
|++|+++ .+|. .+.+|+.|++++|.+.
T Consensus 113 L~~N~l~-~~~~l~~l~~L~~L~Ls~N~i~ 141 (263)
T 1xeu_A 113 LDNNELR-DTDSLIHLKNLEILSIRNNKLK 141 (263)
T ss_dssp CCSSCCS-BSGGGTTCTTCCEEECTTSCCC
T ss_pred ccCCccC-CChhhcCcccccEEECCCCcCC
Confidence 9999999 4653 3456788889998764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.96 E-value=1.4e-10 Score=123.53 Aligned_cols=101 Identities=19% Similarity=0.172 Sum_probs=66.9
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcc-------------cEEEccCccCcCCCc
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHL-------------QSLNLANNKFSGSIP 142 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L-------------~~L~l~~N~l~g~~p 142 (596)
.+++.|++++|+| |.+|++|++|++|++| ++++|+++|.+|.+++++++| ++|++++|.++ .+|
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L-~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp 87 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEY-YNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLP 87 (454)
T ss_dssp ------------------------CCHHHH-HHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhh-hccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCC
Confidence 4799999999999 7999999999999999 999999999999999999876 99999999999 566
Q ss_pred cccccCCCCcEEeCCCCcccccCCccccccccccccccccc
Q 007608 143 ATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLI 183 (596)
Q Consensus 143 ~~~~~l~~L~~L~l~~N~l~g~iP~~l~~l~~l~~~~n~~~ 183 (596)
.. .++|+.|+|++|++++ +|..+.+++.|++++|.+.
T Consensus 88 ~~---~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~ 124 (454)
T 1jl5_A 88 EL---PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLK 124 (454)
T ss_dssp SC---CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCS
T ss_pred CC---cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccC
Confidence 52 3688899999999985 8887778888888887654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.95 E-value=4.9e-10 Score=114.76 Aligned_cols=103 Identities=26% Similarity=0.391 Sum_probs=80.2
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|+|++|+++ .+++ +..+++|+.| ++++|.+++ + +.+..+++|++|+|++|.++ .+| .+..+++|+.|+
T Consensus 221 ~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L-~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~-~~~-~~~~l~~L~~L~ 293 (347)
T 4fmz_A 221 TRLNSLKIGNNKIT-DLSP-LANLSQLTWL-EIGTNQISD-I-NAVKDLTKLKMLNVGSNQIS-DIS-VLNNLSQLNSLF 293 (347)
T ss_dssp TTCCEEECCSSCCC-CCGG-GTTCTTCCEE-ECCSSCCCC-C-GGGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEEE
T ss_pred CcCCEEEccCCccC-CCcc-hhcCCCCCEE-ECCCCccCC-C-hhHhcCCCcCEEEccCCccC-CCh-hhcCCCCCCEEE
Confidence 47888999999888 4554 8888888888 888888884 4 46888888888888888888 454 578888888888
Q ss_pred CCCCcccccCCccc---cccccccccccccccC
Q 007608 156 LSSNNLTGRIPMQL---FSVATFNFTGTHLICG 185 (596)
Q Consensus 156 l~~N~l~g~iP~~l---~~l~~l~~~~n~~~~~ 185 (596)
|++|++++..|..+ .+|+.|++++|++...
T Consensus 294 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp CCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred CcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 88888886666544 4567778888876544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.95 E-value=7.7e-10 Score=111.49 Aligned_cols=100 Identities=23% Similarity=0.427 Sum_probs=73.2
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+++ .+++ +..+++|+.| +|++|++++ +| .+.++++|++|+|++|+++ .+|. +.++++|+.|+
T Consensus 63 ~~L~~L~L~~n~i~-~~~~-~~~l~~L~~L-~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 63 NNLIGLELKDNQIT-DLAP-LKNLTKITEL-ELSGNPLKN-VS-AIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLY 135 (308)
T ss_dssp TTCCEEECCSSCCC-CCGG-GTTCCSCCEE-ECCSCCCSC-CG-GGTTCTTCCEEECTTSCCC-CCGG-GTTCTTCCEEE
T ss_pred CCCCEEEccCCcCC-CChh-HccCCCCCEE-EccCCcCCC-ch-hhcCCCCCCEEECCCCCCC-Cchh-hcCCCCCCEEE
Confidence 47888888888887 4554 8888888888 888888874 44 6788888888888888887 4554 78888888888
Q ss_pred CCCCcccccCCc--cccccccccccccccc
Q 007608 156 LSSNNLTGRIPM--QLFSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP~--~l~~l~~l~~~~n~~~ 183 (596)
|++|+++ .+|. .+.+|+.|++++|.+.
T Consensus 136 l~~n~l~-~~~~l~~l~~L~~L~l~~n~l~ 164 (308)
T 1h6u_A 136 LDLNQIT-NISPLAGLTNLQYLSIGNAQVS 164 (308)
T ss_dssp CCSSCCC-CCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCccC-cCccccCCCCccEEEccCCcCC
Confidence 8888887 3443 3345667777777553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.95 E-value=8.6e-10 Score=110.18 Aligned_cols=100 Identities=30% Similarity=0.455 Sum_probs=79.2
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|++++ +++ +.++++|+.| +|++|++++ +|. ++++++|++|+|++|++++ + +.+.++++|+.|+
T Consensus 68 ~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L-~l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTD-IKP-LANLKNLGWL-FLDENKVKD-LSS-LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (291)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEE-ECCSSCCCC-GGG-GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCEEEccCCccCC-Ccc-cccCCCCCEE-ECCCCcCCC-Chh-hccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence 478899999999985 444 8889999999 899999884 554 8889999999999999984 5 4688899999999
Q ss_pred CCCCcccccCCc--cccccccccccccccc
Q 007608 156 LSSNNLTGRIPM--QLFSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP~--~l~~l~~l~~~~n~~~ 183 (596)
|++|++++ ++. .+.+|..|++++|.+.
T Consensus 141 l~~n~l~~-~~~l~~l~~L~~L~L~~N~l~ 169 (291)
T 1h6t_A 141 LGNNKITD-ITVLSRLTKLDTLSLEDNQIS 169 (291)
T ss_dssp CCSSCCCC-CGGGGGCTTCSEEECCSSCCC
T ss_pred ccCCcCCc-chhhccCCCCCEEEccCCccc
Confidence 99999884 442 3446677888888654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.93 E-value=7.6e-10 Score=120.48 Aligned_cols=95 Identities=23% Similarity=0.341 Sum_probs=75.6
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+|+ .+| ..+++|+.| +|++|+|++ +|. +++ +|++|+|++|+|++ +|. .+++|+.|+
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L-~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 146 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYL-DACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYIN 146 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEE-ECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEE-EccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEe
Confidence 36888888888888 777 457888888 888888885 887 665 88888888888885 777 678888888
Q ss_pred CCCCcccccCCcccccccccccccccccc
Q 007608 156 LSSNNLTGRIPMQLFSVATFNFTGTHLIC 184 (596)
Q Consensus 156 l~~N~l~g~iP~~l~~l~~l~~~~n~~~~ 184 (596)
|++|+|++ +|..+.+|..|++++|.+..
T Consensus 147 Ls~N~l~~-lp~~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 147 ADNNQLTM-LPELPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp CCSSCCSC-CCCCCTTCCEEECCSSCCSC
T ss_pred CCCCccCc-CCCcCCCcCEEECCCCCCCC
Confidence 88888884 88766778888888887543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.93 E-value=9.8e-10 Score=106.27 Aligned_cols=103 Identities=19% Similarity=0.201 Sum_probs=84.0
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccc---hhhcccCc-cccccCCcccCCCCccc-EEEccCccCcCCCccccccCCC
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLA---SFRELQDN-DLSGTLPDFLGSMTHLQ-SLNLANNKFSGSIPATWSQLSN 150 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~---~l~~l~~n-~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~ 150 (596)
.+++.|+|++|++++ +|. +..+++|+ .| ++++| ++++..+..|.++++|+ +|+|++|+++ .+|......++
T Consensus 105 ~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L-~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~ 180 (239)
T 2xwt_C 105 PLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFIL-EITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTK 180 (239)
T ss_dssp TTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEE-EEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCE
T ss_pred CCCCEEeCCCCCCcc-ccc-cccccccccccEE-ECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCC
Confidence 478999999999995 776 88888888 89 99999 99855556789999999 9999999999 88876555589
Q ss_pred CcEEeCCCCc-ccccCCc-cc----cccccccccccccc
Q 007608 151 LKHLDLSSNN-LTGRIPM-QL----FSVATFNFTGTHLI 183 (596)
Q Consensus 151 L~~L~l~~N~-l~g~iP~-~l----~~l~~l~~~~n~~~ 183 (596)
|+.|+|++|+ ++ .+|. .+ .+|+.|++++|++.
T Consensus 181 L~~L~L~~n~~l~-~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 181 LDAVYLNKNKYLT-VIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp EEEEECTTCTTCC-EECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCEEEcCCCCCcc-cCCHHHhhccccCCcEEECCCCccc
Confidence 9999999995 88 5553 33 46777888888775
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.1e-09 Score=120.50 Aligned_cols=101 Identities=31% Similarity=0.445 Sum_probs=67.2
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|.|++ +| .+..|++|+.| +|++|+|++ + +.+.+|++|+.|+|++|.|++ + ..++.|++|+.|+
T Consensus 87 ~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L-~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~ 159 (605)
T 1m9s_A 87 KNLGWLFLDENKIKD-LS-SLKDLKKLKSL-SLEHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLS 159 (605)
T ss_dssp TTCCEEECCSSCCCC-CT-TSTTCTTCCEE-ECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEE
T ss_pred CCCCEEECcCCCCCC-Ch-hhccCCCCCEE-EecCCCCCC-C-ccccCCCccCEEECCCCccCC-c-hhhcccCCCCEEE
Confidence 467778888887773 43 67777777777 777777774 3 347777777777777777773 3 4577777777777
Q ss_pred CCCCcccccCC-ccccccccccccccccc
Q 007608 156 LSSNNLTGRIP-MQLFSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP-~~l~~l~~l~~~~n~~~ 183 (596)
|++|+|++..| ..+.+|..|++++|.+.
T Consensus 160 Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 160 LEDNQISDIVPLAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp CCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred CcCCcCCCchhhccCCCCCEEECcCCCCC
Confidence 77777775444 12334556666666543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.90 E-value=6e-10 Score=114.44 Aligned_cols=100 Identities=20% Similarity=0.311 Sum_probs=83.0
Q ss_pred C-CCcceeEeeC-----------CCEEEEEcCCCCCCcccCc-chhhhcccchhhcccCccccccCCc-ccCCCCcccE-
Q 007608 65 C-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISP-SITKLKFLASFRELQDNDLSGTLPD-FLGSMTHLQS- 129 (596)
Q Consensus 65 c-~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~-~~~~l~~L~~l~~l~~n~l~g~~p~-~~~~l~~L~~- 129 (596)
| |+|..|.|++ .+++.|+|++|+|+ .||+ .|.+|++|+.| +|++|++.+.+|. .|.+|++|+.
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L-~Ls~N~i~~~i~~~~f~~L~~l~~~ 84 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKI-EISQNDVLEVIEADVFSNLPKLHEI 84 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEE-EEECCTTCCEECTTSBCSCTTCCEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEE-ECcCCCCCCccChhHhhcchhhhhh
Confidence 5 5899999975 26889999999999 6665 68999999999 9999999877874 5788988775
Q ss_pred EEccCccCcCCCccccccCCCCcEEeCCCCcccccCCc
Q 007608 130 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM 167 (596)
Q Consensus 130 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~ 167 (596)
+++++|+|++..|..|.++++|++|++++|+++ .+|.
T Consensus 85 l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~ 121 (350)
T 4ay9_X 85 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPD 121 (350)
T ss_dssp EEEEETTCCEECTTSBCCCTTCCEEEEEEECCS-SCCC
T ss_pred hcccCCcccccCchhhhhccccccccccccccc-cCCc
Confidence 677789999555778999999999999999999 4553
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.6e-09 Score=108.93 Aligned_cols=186 Identities=19% Similarity=0.202 Sum_probs=120.6
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCC--ccceEeEEecCC---eeEEEEEc
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKN--LLQLIGYCTTSS---ERILVYPF 350 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~e~ 350 (596)
.+.++.|.+..||++. ..+++|+... ......+.+|..+++.+. +.. +.+++......+ ..++||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4678999999999863 4688887542 234567889999998874 333 334555443333 34789999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ-------------------------------------- 392 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------- 392 (596)
++|.++...... .++..++..++.++++.++.||+.
T Consensus 98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999887653321 356677778888888888888851
Q ss_pred -----------------CCCCcEecCCCCCcEEEcC--CCcEEEeeccccccccccCcce--ecc-----------cccc
Q 007608 393 -----------------CNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVDAKLTHV--TTQ-----------IRGT 440 (596)
Q Consensus 393 -----------------~~~~ivH~dlkp~NIll~~--~~~~kl~DfGl~~~~~~~~~~~--~~~-----------~~gt 440 (596)
..+.++|+|++|.||++++ +..+.|+||+.+..-+....-. ... ....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1135799999999999998 5567899999886543211000 000 0000
Q ss_pred ccccC-cccccCCCCCcccccHHHHHHHHHHHhCCCCC
Q 007608 441 MGHIA-PEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 477 (596)
Q Consensus 441 ~~y~a-PE~~~~~~~~~~sDv~S~Gvil~elltg~~p~ 477 (596)
.++.. |+.... .....+.|++|.++|++.+|..++
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01111 222111 112358999999999999998765
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.86 E-value=2.7e-09 Score=117.32 Aligned_cols=102 Identities=30% Similarity=0.419 Sum_probs=87.0
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+|++ +++ +..|++|+.| +|++|+|++ +| .++.|++|+.|+|++|.|+ .+| .+.+|++|+.|+
T Consensus 65 ~~L~~L~Ls~N~l~~-~~~-l~~l~~L~~L-~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~-~l~-~l~~l~~L~~L~ 137 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTD-IKP-LTNLKNLGWL-FLDENKIKD-LS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLY 137 (605)
T ss_dssp TTCCEEECTTSCCCC-CGG-GGGCTTCCEE-ECCSSCCCC-CT-TSTTCTTCCEEECTTSCCC-CCG-GGGGCTTCSEEE
T ss_pred CCCCEEEeeCCCCCC-Chh-hccCCCCCEE-ECcCCCCCC-Ch-hhccCCCCCEEEecCCCCC-CCc-cccCCCccCEEE
Confidence 589999999999995 444 9999999999 999999994 55 7999999999999999999 454 699999999999
Q ss_pred CCCCcccccCCc--cccccccccccccccccC
Q 007608 156 LSSNNLTGRIPM--QLFSVATFNFTGTHLICG 185 (596)
Q Consensus 156 l~~N~l~g~iP~--~l~~l~~l~~~~n~~~~~ 185 (596)
|++|+|++ ++. .+.+|..|++++|.+...
T Consensus 138 Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 138 LGNNKITD-ITVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp CCSSCCCC-CGGGGSCTTCSEEECCSSCCCCC
T ss_pred CCCCccCC-chhhcccCCCCEEECcCCcCCCc
Confidence 99999995 442 345678889999976543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.85 E-value=2.9e-09 Score=113.24 Aligned_cols=96 Identities=21% Similarity=0.351 Sum_probs=53.6
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|++++ +| +++++++|++| ++++|++++ +|..+ .+|++|+|++|++++ +| .++++++|+.|++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L-~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKII-DVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEE-ECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEE-ECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 45555555555553 44 35555555555 555555553 45433 355555555565553 45 4566666666666
Q ss_pred CCCcccccCCcccccccccccccccc
Q 007608 157 SSNNLTGRIPMQLFSVATFNFTGTHL 182 (596)
Q Consensus 157 ~~N~l~g~iP~~l~~l~~l~~~~n~~ 182 (596)
++|+++ .+|....+++.|++++|.+
T Consensus 203 ~~N~l~-~l~~~~~~L~~L~l~~n~l 227 (454)
T 1jl5_A 203 DNNSLK-KLPDLPLSLESIVAGNNIL 227 (454)
T ss_dssp CSSCCS-SCCCCCTTCCEEECCSSCC
T ss_pred CCCcCC-cCCCCcCcccEEECcCCcC
Confidence 666666 3555555566666666544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.84 E-value=3.8e-09 Score=112.49 Aligned_cols=96 Identities=24% Similarity=0.304 Sum_probs=52.9
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+|+.|+|++|.+++ +| .++.+++|++| +|++|+|++ +| ++++++|++|+|++|.|++ +| ++++++|++|+|
T Consensus 43 ~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L-~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 43 TLTSLDCHNSSITD-MT-GIEKLTGLTKL-ICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNC 113 (457)
T ss_dssp TCCEEECCSSCCCC-CT-TGGGCTTCSEE-ECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCEEEccCCCccc-Ch-hhcccCCCCEE-EccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEEC
Confidence 55566666666663 33 45666666666 566666663 33 5566666666666666653 33 555666666666
Q ss_pred CCCcccccCC-cccccccccccccccc
Q 007608 157 SSNNLTGRIP-MQLFSVATFNFTGTHL 182 (596)
Q Consensus 157 ~~N~l~g~iP-~~l~~l~~l~~~~n~~ 182 (596)
++|++++ +| ..+.+|+.|++++|.+
T Consensus 114 ~~N~l~~-l~~~~l~~L~~L~l~~N~l 139 (457)
T 3bz5_A 114 DTNKLTK-LDVSQNPLLTYLNCARNTL 139 (457)
T ss_dssp CSSCCSC-CCCTTCTTCCEEECTTSCC
T ss_pred CCCcCCe-ecCCCCCcCCEEECCCCcc
Confidence 6666653 44 2233444555555544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.84 E-value=2.3e-09 Score=114.58 Aligned_cols=98 Identities=28% Similarity=0.437 Sum_probs=54.7
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|.+++ +++ +..+++|+.| +|++|++++..| ++.+++|+.|+|++|++++..| ++.+++|+.|++
T Consensus 266 ~L~~L~l~~n~l~~-~~~-~~~l~~L~~L-~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l 338 (466)
T 1o6v_A 266 KLTELKLGANQISN-ISP-LAGLTALTNL-ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338 (466)
T ss_dssp TCSEEECCSSCCCC-CGG-GTTCTTCSEE-ECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEEC
T ss_pred CCCEEECCCCccCc-ccc-ccCCCccCeE-EcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeEC
Confidence 56666666666663 333 6666666666 666666664322 5566666666666666664433 555666666666
Q ss_pred CCCcccccCCc--ccccccccccccccc
Q 007608 157 SSNNLTGRIPM--QLFSVATFNFTGTHL 182 (596)
Q Consensus 157 ~~N~l~g~iP~--~l~~l~~l~~~~n~~ 182 (596)
++|++++ +|. .+.+|+.|++++|++
T Consensus 339 ~~n~l~~-~~~l~~l~~L~~L~l~~n~l 365 (466)
T 1o6v_A 339 YNNKVSD-VSSLANLTNINWLSAGHNQI 365 (466)
T ss_dssp CSSCCCC-CGGGTTCTTCCEEECCSSCC
T ss_pred CCCccCC-chhhccCCCCCEEeCCCCcc
Confidence 6666653 221 123344455555544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.84 E-value=3.1e-10 Score=118.19 Aligned_cols=107 Identities=20% Similarity=0.337 Sum_probs=72.5
Q ss_pred CCEEEEEcCCCCCC-cccC---cchhhhcccchhhcccCcccc--c---cCCcccCCCCcccEEEccCccCc----CCCc
Q 007608 76 GNVISLTLGSNGFS-GKIS---PSITKLKFLASFRELQDNDLS--G---TLPDFLGSMTHLQSLNLANNKFS----GSIP 142 (596)
Q Consensus 76 ~~l~~L~l~~n~l~-g~~p---~~~~~l~~L~~l~~l~~n~l~--g---~~p~~~~~l~~L~~L~l~~N~l~----g~~p 142 (596)
.+|+.|+|++|+|+ +.+| ..+..+++|+.| +|++|+|+ | .+|..+.++++|++|+|++|.|+ +.+|
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L-~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~ 237 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV-KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEE-ECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEE-ECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHH
Confidence 46777777777776 4444 456677777777 77777776 3 34556777777777777777775 5677
Q ss_pred cccccCCCCcEEeCCCCccccc----CCcc-----ccccccccccccccc
Q 007608 143 ATWSQLSNLKHLDLSSNNLTGR----IPMQ-----LFSVATFNFTGTHLI 183 (596)
Q Consensus 143 ~~~~~l~~L~~L~l~~N~l~g~----iP~~-----l~~l~~l~~~~n~~~ 183 (596)
..+..+++|+.|+|++|+|++. +|.. +.+|..|++++|.+.
T Consensus 238 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~ 287 (386)
T 2ca6_A 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287 (386)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred HHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCC
Confidence 7777777777777777777754 4443 345666777777653
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.81 E-value=4.6e-09 Score=111.80 Aligned_cols=97 Identities=25% Similarity=0.279 Sum_probs=58.7
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|++++|...+.+ .++.+++|+.| ++++|++++ +| ++.+++|+.|+|++|++++ + .++++++|+.|+|
T Consensus 149 ~L~~L~l~~n~~~~~~--~~~~l~~L~~L-~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~-~--~l~~l~~L~~L~L 219 (457)
T 3bz5_A 149 QLTELDCHLNKKITKL--DVTPQTQLTTL-DCSFNKITE-LD--VSQNKLLNRLNCDTNNITK-L--DLNQNIQLTFLDC 219 (457)
T ss_dssp TCCEEECTTCSCCCCC--CCTTCTTCCEE-ECCSSCCCC-CC--CTTCTTCCEEECCSSCCSC-C--CCTTCTTCSEEEC
T ss_pred cCCEEECCCCCccccc--ccccCCcCCEE-ECCCCccce-ec--cccCCCCCEEECcCCcCCe-e--ccccCCCCCEEEC
Confidence 5666677766555555 35666666666 666666664 55 6666666666666666663 3 2666666666666
Q ss_pred CCCcccccCCc-cccccccccccccccc
Q 007608 157 SSNNLTGRIPM-QLFSVATFNFTGTHLI 183 (596)
Q Consensus 157 ~~N~l~g~iP~-~l~~l~~l~~~~n~~~ 183 (596)
++|+|++ +|. .+.+|+.|++++|.+.
T Consensus 220 s~N~l~~-ip~~~l~~L~~L~l~~N~l~ 246 (457)
T 3bz5_A 220 SSNKLTE-IDVTPLTQLTYFDCSVNPLT 246 (457)
T ss_dssp CSSCCSC-CCCTTCTTCSEEECCSSCCS
T ss_pred cCCcccc-cCccccCCCCEEEeeCCcCC
Confidence 6666664 551 2334555666666543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.80 E-value=7.1e-10 Score=115.44 Aligned_cols=106 Identities=24% Similarity=0.325 Sum_probs=73.3
Q ss_pred CCEEEEEcCCCCCCc----ccCcchhhh---------cccchhhcccCcccc-ccCC---cccCCCCcccEEEccCccCc
Q 007608 76 GNVISLTLGSNGFSG----KISPSITKL---------KFLASFRELQDNDLS-GTLP---DFLGSMTHLQSLNLANNKFS 138 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g----~~p~~~~~l---------~~L~~l~~l~~n~l~-g~~p---~~~~~l~~L~~L~l~~N~l~ 138 (596)
.+|+.|+|++|.|++ .++..+..+ ++|+.| +|++|+++ +.+| ..+.++++|++|+|++|+|+
T Consensus 122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L-~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI-ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEE-ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEE-ECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 577788888887752 355667666 778887 78888876 4555 46667778888888888776
Q ss_pred --C---CCccccccCCCCcEEeCCCCccc----ccCCccc---ccccccccccccc
Q 007608 139 --G---SIPATWSQLSNLKHLDLSSNNLT----GRIPMQL---FSVATFNFTGTHL 182 (596)
Q Consensus 139 --g---~~p~~~~~l~~L~~L~l~~N~l~----g~iP~~l---~~l~~l~~~~n~~ 182 (596)
| .+|..+.++++|+.|+|++|+|+ +.+|..+ .+|..|++++|.+
T Consensus 201 ~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i 256 (386)
T 2ca6_A 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 256 (386)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred HhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCC
Confidence 3 34446777788888888888875 4566544 3556677777764
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.79 E-value=5.1e-10 Score=114.01 Aligned_cols=112 Identities=21% Similarity=0.279 Sum_probs=66.7
Q ss_pred CCCCcceeEeeCCCEEEEEcCCCCCCcccCcchhhh--cccchhhcccCccccccCCcccCCCCcccEEEccCccCcCC-
Q 007608 64 PCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKL--KFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS- 140 (596)
Q Consensus 64 ~c~~w~gv~c~~~~l~~L~l~~n~l~g~~p~~~~~l--~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~- 140 (596)
-|..|.++.|+...++.|++++|.+. |..+..+ ++|+.| ++++|.+++.+|. +.++++|++|+|++|.+++.
T Consensus 35 vc~~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L-~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~ 109 (336)
T 2ast_B 35 VCKRWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAF-RCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST 109 (336)
T ss_dssp SCHHHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEE-ECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred HHHHHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEE-EcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence 34466666665445666666666655 3455555 666666 6666666644433 45566666666666666644
Q ss_pred CccccccCCCCcEEeCCCCcccccCCccc---ccccccccccc
Q 007608 141 IPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGT 180 (596)
Q Consensus 141 ~p~~~~~l~~L~~L~l~~N~l~g~iP~~l---~~l~~l~~~~n 180 (596)
+|..+.++++|++|+|++|++++.+|..+ .+|+.|++++|
T Consensus 110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~ 152 (336)
T 2ast_B 110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 152 (336)
T ss_dssp HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCC
Confidence 66666666666666666666665555433 24455555555
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.78 E-value=5.8e-09 Score=111.44 Aligned_cols=99 Identities=27% Similarity=0.442 Sum_probs=53.0
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|++++ + +.+..+++|+.| ++++|.+++..| +..+++|++|+|++|.+++ +|. +..+++|+.|+|
T Consensus 222 ~L~~L~l~~n~l~~-~-~~l~~l~~L~~L-~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L 294 (466)
T 1o6v_A 222 NLDELSLNGNQLKD-I-GTLASLTNLTDL-DLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLEL 294 (466)
T ss_dssp TCCEEECCSSCCCC-C-GGGGGCTTCSEE-ECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEEC
T ss_pred CCCEEECCCCCccc-c-hhhhcCCCCCEE-ECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEc
Confidence 56666666666653 3 245566666666 666666664333 5556666666666666653 333 555555666666
Q ss_pred CCCcccccCC-cccccccccccccccc
Q 007608 157 SSNNLTGRIP-MQLFSVATFNFTGTHL 182 (596)
Q Consensus 157 ~~N~l~g~iP-~~l~~l~~l~~~~n~~ 182 (596)
++|++++..| ..+.+|+.|++++|.+
T Consensus 295 ~~n~l~~~~~~~~l~~L~~L~L~~n~l 321 (466)
T 1o6v_A 295 NENQLEDISPISNLKNLTYLTLYFNNI 321 (466)
T ss_dssp CSSCCSCCGGGGGCTTCSEEECCSSCC
T ss_pred CCCcccCchhhcCCCCCCEEECcCCcC
Confidence 6655553222 1223444555555543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.76 E-value=1e-09 Score=113.30 Aligned_cols=105 Identities=24% Similarity=0.295 Sum_probs=61.0
Q ss_pred CEEEEEcCCCCCCcccC----cchhhhc-ccchhhcccCccccccCCcccCCC-----CcccEEEccCccCcCCCccccc
Q 007608 77 NVISLTLGSNGFSGKIS----PSITKLK-FLASFRELQDNDLSGTLPDFLGSM-----THLQSLNLANNKFSGSIPATWS 146 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p----~~~~~l~-~L~~l~~l~~n~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~ 146 (596)
+++.|+|++|.|++..+ ..+.+++ +|++| +|++|+|++..+..+..+ ++|++|+|++|.+++..+..++
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L-~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSL-NLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEE-ECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEE-ECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 46666666666664433 4455555 66666 666666665555555554 6666666666666655554433
Q ss_pred cC-----CCCcEEeCCCCcccccCCccc--------ccccccccccccc
Q 007608 147 QL-----SNLKHLDLSSNNLTGRIPMQL--------FSVATFNFTGTHL 182 (596)
Q Consensus 147 ~l-----~~L~~L~l~~N~l~g~iP~~l--------~~l~~l~~~~n~~ 182 (596)
.. ++|+.|+|++|+|++..+..+ .+|+.|++++|.+
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 150 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL 150 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcC
Confidence 32 666666666666663333222 2455666666644
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.76 E-value=7.6e-09 Score=105.80 Aligned_cols=100 Identities=22% Similarity=0.386 Sum_probs=77.8
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|++++|.+.+. ++ +..+++|+.| ++++|++++ +|. +..+++|++|+|++|.++ .+ +.+..+++|+.|+
T Consensus 199 ~~L~~L~l~~n~l~~~-~~-~~~~~~L~~L-~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~-~~-~~~~~l~~L~~L~ 271 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDI-TP-VANMTRLNSL-KIGNNKITD-LSP-LANLSQLTWLEIGTNQIS-DI-NAVKDLTKLKMLN 271 (347)
T ss_dssp TTCCEEECCSSCCCCC-GG-GGGCTTCCEE-ECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CC-GGGTTCTTCCEEE
T ss_pred CccceeecccCCCCCC-ch-hhcCCcCCEE-EccCCccCC-Ccc-hhcCCCCCEEECCCCccC-CC-hhHhcCCCcCEEE
Confidence 4788888999888844 33 8888888888 899998884 554 888889999999999888 45 4688888999999
Q ss_pred CCCCcccccCCc--cccccccccccccccc
Q 007608 156 LSSNNLTGRIPM--QLFSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP~--~l~~l~~l~~~~n~~~ 183 (596)
|++|+++ .+|. .+.+|+.|++++|.+.
T Consensus 272 l~~n~l~-~~~~~~~l~~L~~L~L~~n~l~ 300 (347)
T 4fmz_A 272 VGSNQIS-DISVLNNLSQLNSLFLNNNQLG 300 (347)
T ss_dssp CCSSCCC-CCGGGGGCTTCSEEECCSSCCC
T ss_pred ccCCccC-CChhhcCCCCCCEEECcCCcCC
Confidence 9999888 4552 3456777888888764
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.76 E-value=7e-09 Score=114.24 Aligned_cols=94 Identities=22% Similarity=0.340 Sum_probs=68.1
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+|+ .+|. .+++|+.| +|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|+.|+
T Consensus 61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L-~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~ 127 (622)
T 3g06_A 61 AHITTLVIPDNNLT-SLPA---LPPELRTL-EVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLW 127 (622)
T ss_dssp TTCSEEEECSCCCS-CCCC---CCTTCCEE-EECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEE
T ss_pred CCCcEEEecCCCCC-CCCC---cCCCCCEE-EcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEE
Confidence 36778888888887 6666 46777777 78888887 5776 6677888888888877 5665 556777777
Q ss_pred CCCCcccccCCccccccccccccccccc
Q 007608 156 LSSNNLTGRIPMQLFSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP~~l~~l~~l~~~~n~~~ 183 (596)
|++|+|+ .+|..+.+|..|++++|.+.
T Consensus 128 L~~N~l~-~lp~~l~~L~~L~Ls~N~l~ 154 (622)
T 3g06_A 128 IFGNQLT-SLPVLPPGLQELSVSDNQLA 154 (622)
T ss_dssp CCSSCCS-CCCCCCTTCCEEECCSSCCS
T ss_pred CCCCCCC-cCCCCCCCCCEEECcCCcCC
Confidence 7777777 57766667777777776554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.76 E-value=4.2e-10 Score=114.66 Aligned_cols=103 Identities=18% Similarity=0.198 Sum_probs=75.2
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCcccccc-CCcccCCCCcccEEEccCccCcCCCccccccCCCCcEE
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGT-LPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 154 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 154 (596)
.+++.|++++|.+.+..+. +.++++|++| +|++|.+++. +|..+.++++|++|+|++|.+++.+|..++++++|++|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L-~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHM-DLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEE-ECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEE-EccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence 4677888888888755443 5677888888 7888887765 77777788888888888888877777777788888888
Q ss_pred eCCCC-ccccc-CCcc---cccccccccccc
Q 007608 155 DLSSN-NLTGR-IPMQ---LFSVATFNFTGT 180 (596)
Q Consensus 155 ~l~~N-~l~g~-iP~~---l~~l~~l~~~~n 180 (596)
+|++| .+++. +|.. +.+|+.|++++|
T Consensus 148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 178 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWC 178 (336)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCC
Confidence 88888 57652 4442 345667777777
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.69 E-value=2.9e-09 Score=109.77 Aligned_cols=106 Identities=27% Similarity=0.341 Sum_probs=75.6
Q ss_pred CEEEEEcCCCCCCcccCcchhhh-----cccchhhcccCccccccCCcccCC----C-CcccEEEccCccCcCCCccccc
Q 007608 77 NVISLTLGSNGFSGKISPSITKL-----KFLASFRELQDNDLSGTLPDFLGS----M-THLQSLNLANNKFSGSIPATWS 146 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l-----~~L~~l~~l~~n~l~g~~p~~~~~----l-~~L~~L~l~~N~l~g~~p~~~~ 146 (596)
+|+.|+|++|+|++..+..+..+ ++|+.| +|++|++++..+..++. + ++|++|+|++|.|++..+..++
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L-~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~ 130 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSL-NLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFK 130 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEE-ECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEE-ECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHH
Confidence 68888888888887767777776 888888 88888888666654444 3 7888888888888855554443
Q ss_pred c-----CCCCcEEeCCCCcccccCCccc--------cccccccccccccc
Q 007608 147 Q-----LSNLKHLDLSSNNLTGRIPMQL--------FSVATFNFTGTHLI 183 (596)
Q Consensus 147 ~-----l~~L~~L~l~~N~l~g~iP~~l--------~~l~~l~~~~n~~~ 183 (596)
+ .++|++|+|++|++++.-+..+ .+|+.|++++|.+.
T Consensus 131 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~ 180 (362)
T 3goz_A 131 QAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180 (362)
T ss_dssp HHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence 3 2588888888888885333222 26777788877653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.51 E-value=9.6e-09 Score=109.30 Aligned_cols=107 Identities=17% Similarity=0.215 Sum_probs=84.3
Q ss_pred CCEEEEEcCCCCCCcccCcchhhh-----cccchhhcccCcccccc----CCcccCCCCcccEEEccCccCcCCCccccc
Q 007608 76 GNVISLTLGSNGFSGKISPSITKL-----KFLASFRELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGSIPATWS 146 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l-----~~L~~l~~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 146 (596)
.+++.|+|++|.+++..+..+... ++|+.| +|++|.+++. +|..+.++++|++|||++|.+++..+..+.
T Consensus 284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L-~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 362 (461)
T 1z7x_W 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESL-WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 362 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEE-ECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred CCcceEECCCCCCchHHHHHHHHHhccCCccceee-EcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHH
Confidence 579999999999876555556554 689999 8999999865 677778889999999999999866565555
Q ss_pred c-----CCCCcEEeCCCCcccc----cCCccc---cccccccccccccc
Q 007608 147 Q-----LSNLKHLDLSSNNLTG----RIPMQL---FSVATFNFTGTHLI 183 (596)
Q Consensus 147 ~-----l~~L~~L~l~~N~l~g----~iP~~l---~~l~~l~~~~n~~~ 183 (596)
+ .++|+.|+|++|++++ .+|..+ .+|+.|++++|++.
T Consensus 363 ~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 4 6789999999999986 677654 56778888888764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.50 E-value=2.1e-08 Score=97.87 Aligned_cols=66 Identities=23% Similarity=0.358 Sum_probs=38.3
Q ss_pred hhcccchhhcccCccccc--cCCcccCCCCcccEEEccCccCcCCCccccccCC--CCcEEeCCCCcccccCC
Q 007608 98 KLKFLASFRELQDNDLSG--TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLS--NLKHLDLSSNNLTGRIP 166 (596)
Q Consensus 98 ~l~~L~~l~~l~~n~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~--~L~~L~l~~N~l~g~iP 166 (596)
++++|+.| +|++|+|++ .+|..+..+++|+.|+|++|+|++. .++..+. +|+.|+|++|.+++.+|
T Consensus 168 ~l~~L~~L-~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 168 NIPELLSL-NLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HCTTCCEE-ECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hCCCCCEE-ECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 45566666 666666665 4455555666666666666666632 2333333 66666666666665555
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.1e-07 Score=97.44 Aligned_cols=105 Identities=15% Similarity=0.204 Sum_probs=83.6
Q ss_pred eEeeCCCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCC-cccCCCCcccEEEccCccCcCCCcc-ccccC
Q 007608 71 VTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLP-DFLGSMTHLQSLNLANNKFSGSIPA-TWSQL 148 (596)
Q Consensus 71 v~c~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l 148 (596)
-.|+.. .++.++++|+ .||..+ .++|+.| +|++|+|+ .|| ..|.+|++|++|+|++|++.+.+|. .|.++
T Consensus 7 C~C~~~---~v~C~~~~Lt-~iP~~l--~~~l~~L-~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L 78 (350)
T 4ay9_X 7 CHCSNR---VFLCQESKVT-EIPSDL--PRNAIEL-RFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL 78 (350)
T ss_dssp SEEETT---EEEEESTTCC-SCCTTC--CTTCSEE-EEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSC
T ss_pred cEeeCC---EEEecCCCCC-ccCcCc--CCCCCEE-EccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcc
Confidence 367653 5778999999 899877 3688999 99999999 666 5789999999999999999878876 57899
Q ss_pred CCCcE-EeCCCCcccccCCccc---cccccccccccccc
Q 007608 149 SNLKH-LDLSSNNLTGRIPMQL---FSVATFNFTGTHLI 183 (596)
Q Consensus 149 ~~L~~-L~l~~N~l~g~iP~~l---~~l~~l~~~~n~~~ 183 (596)
++|.. +++++|++++..|..+ .+|+.|++++|.+.
T Consensus 79 ~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~ 117 (350)
T 4ay9_X 79 PKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 117 (350)
T ss_dssp TTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCS
T ss_pred hhhhhhhcccCCcccccCchhhhhccccccccccccccc
Confidence 98775 6778899994445444 45677888888764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.46 E-value=9.2e-09 Score=109.47 Aligned_cols=106 Identities=19% Similarity=0.225 Sum_probs=59.5
Q ss_pred CCEEEEEcCCCCCCcccC----cch-hhhcccchhhcccCcccccc----CCcccCCCCcccEEEccCccCcCCCccccc
Q 007608 76 GNVISLTLGSNGFSGKIS----PSI-TKLKFLASFRELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGSIPATWS 146 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p----~~~-~~l~~L~~l~~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 146 (596)
.+++.|+|++|.+++.-. +.+ ..+++|+.| ++++|++++. +|..+.++++|++|+|++|.+++..+..+.
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L-~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 305 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL-WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 305 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEE-ECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEE-ECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHH
Confidence 466677777776654321 111 235666666 6777766643 566666666777777777766544333333
Q ss_pred cC-----CCCcEEeCCCCccccc----CCccc---ccccccccccccc
Q 007608 147 QL-----SNLKHLDLSSNNLTGR----IPMQL---FSVATFNFTGTHL 182 (596)
Q Consensus 147 ~l-----~~L~~L~l~~N~l~g~----iP~~l---~~l~~l~~~~n~~ 182 (596)
.. ++|+.|+|++|++++. +|..+ .+|+.|++++|.+
T Consensus 306 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i 353 (461)
T 1z7x_W 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL 353 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBC
T ss_pred HHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcc
Confidence 32 4666666666666643 23222 3455566666643
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.43 E-value=1.1e-07 Score=92.61 Aligned_cols=77 Identities=23% Similarity=0.338 Sum_probs=66.5
Q ss_pred CCEEEEEcCCCCCCc--ccCcchhhhcccchhhcccCccccccCCcccCCCC--cccEEEccCccCcCCCcc-------c
Q 007608 76 GNVISLTLGSNGFSG--KISPSITKLKFLASFRELQDNDLSGTLPDFLGSMT--HLQSLNLANNKFSGSIPA-------T 144 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g--~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~--~L~~L~l~~N~l~g~~p~-------~ 144 (596)
.+|+.|+|++|+|++ .+|..+..+++|+.| +|++|+|++. .++..++ +|++|+|++|.+++.+|. .
T Consensus 170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L-~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i 246 (267)
T 3rw6_A 170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL-NLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI 246 (267)
T ss_dssp TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEE-ECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred CCCCEEECCCCCCCCCccchhHHhhCCCCCEE-ECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence 589999999999998 667888999999999 9999999964 4455555 999999999999988873 3
Q ss_pred cccCCCCcEEe
Q 007608 145 WSQLSNLKHLD 155 (596)
Q Consensus 145 ~~~l~~L~~L~ 155 (596)
+..+++|+.||
T Consensus 247 l~~~P~L~~LD 257 (267)
T 3rw6_A 247 RERFPKLLRLD 257 (267)
T ss_dssp HHHCTTCCEES
T ss_pred HHHCcccCeEC
Confidence 77899999886
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.33 E-value=6e-08 Score=100.18 Aligned_cols=106 Identities=16% Similarity=0.128 Sum_probs=58.9
Q ss_pred CCEEEEEcCCCCCCcccCcch-hhhcccchhhcccCccccccCCccc-----CCCCcccEEEccCccCcC----CCcccc
Q 007608 76 GNVISLTLGSNGFSGKISPSI-TKLKFLASFRELQDNDLSGTLPDFL-----GSMTHLQSLNLANNKFSG----SIPATW 145 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~-~~l~~L~~l~~l~~n~l~g~~p~~~-----~~l~~L~~L~l~~N~l~g----~~p~~~ 145 (596)
.+|+.|+|++|.|+..-...+ ..+++|+.| +|++|+|+..-...+ ...++|++|+|++|.|+. .++..+
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L-~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L 179 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKL-GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGL 179 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEE-ECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHh-hcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHH
Confidence 367777777777754322222 345666777 777777664322222 234667777777776652 234445
Q ss_pred ccCCCCcEEeCCCCccccc----CCcc---cccccccccccccc
Q 007608 146 SQLSNLKHLDLSSNNLTGR----IPMQ---LFSVATFNFTGTHL 182 (596)
Q Consensus 146 ~~l~~L~~L~l~~N~l~g~----iP~~---l~~l~~l~~~~n~~ 182 (596)
..+++|++|+|++|+|+.. ++.. ..+|..|++++|.+
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i 223 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA 223 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCC
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCC
Confidence 5666677777777766531 1111 12455666666654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=7.2e-06 Score=82.13 Aligned_cols=136 Identities=19% Similarity=0.205 Sum_probs=93.2
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCC---CccceEeEEe-cCCeeEEEEEccc
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK---NLLQLIGYCT-TSSERILVYPFMQ 352 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~~ 352 (596)
.+.++.|....||+. |..+++|+-. .......+.+|.+++..+.+. .+.+++.++. ..+..++||+|++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456888888999988 5678888742 223456789999999998753 2556676664 4455789999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 007608 353 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ---------------------------------------- 392 (596)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------- 392 (596)
|.++...... .++......++.++++.|+.||+.
T Consensus 97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9887653211 123344444555555555555532
Q ss_pred -----------------CCCCcEecCCCCCcEEEcC---CCc-EEEeecccccc
Q 007608 393 -----------------CNPKIIHRDLKAANILLDD---NFE-AVLCDFGLAKL 425 (596)
Q Consensus 393 -----------------~~~~ivH~dlkp~NIll~~---~~~-~kl~DfGl~~~ 425 (596)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 355 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=6.6e-06 Score=80.61 Aligned_cols=136 Identities=14% Similarity=0.120 Sum_probs=96.0
Q ss_pred ceeeecCce-EEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCeeEEEEEcccCC
Q 007608 278 NIIGQGGFG-KVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 278 ~~lG~G~~g-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 354 (596)
+.+..|..| .||+.... ++..+++|+-.. .....+.+|...++.+. +-.+.++++++.+.+..++|||++++.
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 345556655 69988764 567789997542 24556888999988774 334668899999899999999999998
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 007608 355 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ------------------------------------------ 392 (596)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 392 (596)
++.+..... ......+..+++..|+.||..
T Consensus 106 ~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 106 TAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp EHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred cccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 776654321 112234555666666666632
Q ss_pred -------------CCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 393 -------------CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 393 -------------~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999887777999998753
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.19 E-value=2.6e-07 Score=95.40 Aligned_cols=85 Identities=18% Similarity=0.159 Sum_probs=42.3
Q ss_pred CEEEEEcCCCCCCcccCcchhhh-----cccchhhcccCccccccCCccc-CCCCcccEEEccCccCcCCCcccc-----
Q 007608 77 NVISLTLGSNGFSGKISPSITKL-----KFLASFRELQDNDLSGTLPDFL-GSMTHLQSLNLANNKFSGSIPATW----- 145 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l-----~~L~~l~~l~~n~l~g~~p~~~-~~l~~L~~L~l~~N~l~g~~p~~~----- 145 (596)
+++.|+|++|.|+..-...+..+ ++|+.| +|++|.|+..-...+ ..+++|+.|+|++|.|+..-...+
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L-~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEV-NLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEE-ECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEE-EecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 45566666666654333334433 456666 666666543222222 234556666666666653222222
Q ss_pred ccCCCCcEEeCCCCccc
Q 007608 146 SQLSNLKHLDLSSNNLT 162 (596)
Q Consensus 146 ~~l~~L~~L~l~~N~l~ 162 (596)
...++|+.|+|++|+|+
T Consensus 152 ~~~~~L~~L~Ls~n~l~ 168 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLT 168 (372)
T ss_dssp STTCCCCEEECCSSCCH
T ss_pred hcCCccceeeCCCCCCC
Confidence 13455666666666654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=9.8e-06 Score=82.93 Aligned_cols=82 Identities=6% Similarity=-0.040 Sum_probs=55.0
Q ss_pred Ccee-eecCceEEEEEEeC-------CCcEEEEEEccccC--CcchHHHHHHHHHHHHhcC-C--CCccceEeEEecC--
Q 007608 277 SNII-GQGGFGKVYKGVLS-------DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAI-H--KNLLQLIGYCTTS-- 341 (596)
Q Consensus 277 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~-H--~niv~l~~~~~~~-- 341 (596)
.+.| +.|....+|+.... ++..+++|+..... .......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999998764 26788888764321 0001235678888888774 2 3466788877655
Q ss_pred -CeeEEEEEcccCCChhh
Q 007608 342 -SERILVYPFMQNLSVAY 358 (596)
Q Consensus 342 -~~~~lv~e~~~~gsL~~ 358 (596)
+..++||||++|.++.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999876543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.94 E-value=7.7e-07 Score=82.19 Aligned_cols=105 Identities=18% Similarity=0.302 Sum_probs=74.1
Q ss_pred CCEEEEEcCCC-CCCcc----cCcchhhhcccchhhcccCccccc----cCCcccCCCCcccEEEccCccCcCC----Cc
Q 007608 76 GNVISLTLGSN-GFSGK----ISPSITKLKFLASFRELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSGS----IP 142 (596)
Q Consensus 76 ~~l~~L~l~~n-~l~g~----~p~~~~~l~~L~~l~~l~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p 142 (596)
.+++.|+|++| .|... +...+...++|++| +|++|.|.. .+...+...++|++|+|++|.|+.. +.
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L-~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKF-SIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEE-ECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEE-ECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 47889999998 88642 34455566888999 899999874 2445556668899999999998843 45
Q ss_pred cccccCCCCcEEeC--CCCcccccCCccc-------cccccccccccc
Q 007608 143 ATWSQLSNLKHLDL--SSNNLTGRIPMQL-------FSVATFNFTGTH 181 (596)
Q Consensus 143 ~~~~~l~~L~~L~l--~~N~l~g~iP~~l-------~~l~~l~~~~n~ 181 (596)
..+...++|++|+| ++|.|+..--..+ .+|+.|++++|.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~ 162 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 162 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCC
Confidence 66777888999999 7888874322111 245666666654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.0001 Score=74.59 Aligned_cols=141 Identities=18% Similarity=0.239 Sum_probs=78.8
Q ss_pred ceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC--CCCccceEe------EEecCCeeEEEEE
Q 007608 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--HKNLLQLIG------YCTTSSERILVYP 349 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~------~~~~~~~~~lv~e 349 (596)
+.|+.|..+.||++...+| .+++|+... . ...+..|..++..+. .-.+.+++. +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR--P---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS--C---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC--C---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4566677899999987555 588998754 1 233344555554443 112333332 1123566789999
Q ss_pred cccCCChh--------------hhhcccC-----CCC-----CCCCHHHHH-----------------------------
Q 007608 350 FMQNLSVA--------------YRLRDLK-----PGE-----KGLDWPTRK----------------------------- 376 (596)
Q Consensus 350 ~~~~gsL~--------------~~l~~~~-----~~~-----~~l~~~~~~----------------------------- 376 (596)
|++|.++. ..++... ... ..-.|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 1122111 000 112343211
Q ss_pred --HHHHHHHHHHHHHHh----------CCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 377 --RVAFGTAYGLEYLHE----------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 377 --~i~~~ia~~L~~LH~----------~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
.+...+..++.+|+. ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666663 123489999999999999888889999999764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.76 E-value=4.2e-06 Score=77.21 Aligned_cols=86 Identities=16% Similarity=0.190 Sum_probs=70.8
Q ss_pred CCEEEEEcCCCCCCcc----cCcchhhhcccchhhcccCcccccc----CCcccCCCCcccEEEc--cCccCcCC----C
Q 007608 76 GNVISLTLGSNGFSGK----ISPSITKLKFLASFRELQDNDLSGT----LPDFLGSMTHLQSLNL--ANNKFSGS----I 141 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~----~p~~~~~l~~L~~l~~l~~n~l~g~----~p~~~~~l~~L~~L~l--~~N~l~g~----~ 141 (596)
.+|+.|+|++|.|... +...+...+.|++| +|++|.|+.. +...+...++|++|+| ++|.|+.. +
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L-~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l 143 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSL-NVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 143 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEE-ECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEE-ECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHH
Confidence 5799999999999742 44556666899999 9999999853 5677888899999999 88999844 4
Q ss_pred ccccccCCCCcEEeCCCCccc
Q 007608 142 PATWSQLSNLKHLDLSSNNLT 162 (596)
Q Consensus 142 p~~~~~l~~L~~L~l~~N~l~ 162 (596)
...+...++|+.|+|++|.+.
T Consensus 144 ~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 144 ANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEeccCCCCC
Confidence 455667799999999999986
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.74 E-value=2e-05 Score=79.71 Aligned_cols=93 Identities=17% Similarity=0.259 Sum_probs=72.2
Q ss_pred CCEEEEEcCCCCCCcccCc-chhhhcccchhhcccCccccccCCcccCCCCccc-EEEccCccCcCCCc-cccccCCCCc
Q 007608 76 GNVISLTLGSNGFSGKISP-SITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQ-SLNLANNKFSGSIP-ATWSQLSNLK 152 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~-~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p-~~~~~l~~L~ 152 (596)
.+++.|+|++|+++ .||+ .|.++++|+.| +|.+| ++..-+..|.+|++|+ .|+|.+ .++ .|+ ..|.+|++|+
T Consensus 226 ~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l-~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~ 300 (329)
T 3sb4_A 226 PNLVSLDISKTNAT-TIPDFTFAQKKYLLKI-KLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLR 300 (329)
T ss_dssp TTCCEEECTTBCCC-EECTTTTTTCTTCCEE-ECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEE
T ss_pred CCCeEEECCCCCcc-eecHhhhhCCCCCCEE-ECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCC
Confidence 47889999998888 5655 68889999999 89888 7733346788899998 999988 777 554 6788999999
Q ss_pred EEeCCCCcccccCCc-ccccccc
Q 007608 153 HLDLSSNNLTGRIPM-QLFSVAT 174 (596)
Q Consensus 153 ~L~l~~N~l~g~iP~-~l~~l~~ 174 (596)
.|+|++|+++ .|+. .|.++..
T Consensus 301 ~l~l~~n~i~-~I~~~aF~~~~~ 322 (329)
T 3sb4_A 301 YVLATGDKIT-TLGDELFGNGVP 322 (329)
T ss_dssp EEEECSSCCC-EECTTTTCTTCC
T ss_pred EEEeCCCccC-ccchhhhcCCcc
Confidence 9999999988 6665 3444433
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00017 Score=74.84 Aligned_cols=76 Identities=14% Similarity=0.129 Sum_probs=49.0
Q ss_pred CceeeecCceEEEEEEeC-CCcEEEEEEccccCC------cchHHHHHHHHHHHHhcCC--CCc-cceEeEEecCCeeEE
Q 007608 277 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS------PGGEAAFQREVHLISVAIH--KNL-LQLIGYCTTSSERIL 346 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~~e~~~l~~l~H--~ni-v~l~~~~~~~~~~~l 346 (596)
.+.+|.|.++.||++... +++.++||....... ......+..|.+++..+.. +.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567899999999999854 568899997642211 1123456778888887642 333 345543 3455689
Q ss_pred EEEcccCC
Q 007608 347 VYPFMQNL 354 (596)
Q Consensus 347 v~e~~~~g 354 (596)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.65 E-value=5.8e-06 Score=90.64 Aligned_cols=88 Identities=14% Similarity=0.223 Sum_probs=49.8
Q ss_pred EEEEEcCCCC-CCc-ccCcchhhhcccchhhcccCcccccc----CCcccCCCCcccEEEccCccCc----CCCcccccc
Q 007608 78 VISLTLGSNG-FSG-KISPSITKLKFLASFRELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFS----GSIPATWSQ 147 (596)
Q Consensus 78 l~~L~l~~n~-l~g-~~p~~~~~l~~L~~l~~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~----g~~p~~~~~ 147 (596)
|+.|+|++|. ++. .++..+.++++|+.| +|++|.+++. ++..+.++++|++|+|++|.++ +.++..+.+
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L-~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTL-LMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEE-ECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEE-ECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 6677776665 110 122223356666666 6777666544 3334455666666666666665 334444556
Q ss_pred CCCCcEEeCCCCcccccCCc
Q 007608 148 LSNLKHLDLSSNNLTGRIPM 167 (596)
Q Consensus 148 l~~L~~L~l~~N~l~g~iP~ 167 (596)
+++|+.|+|++|.+++ +|.
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~ 237 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVG 237 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHH
T ss_pred CCCCcEEeccCccHHH-HHH
Confidence 6666666666666663 443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00039 Score=69.42 Aligned_cols=140 Identities=14% Similarity=0.194 Sum_probs=93.3
Q ss_pred cCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC---CCCccceEeEEecCCeeEEEEEccc
Q 007608 276 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTSSERILVYPFMQ 352 (596)
Q Consensus 276 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~ 352 (596)
..+.|+.|....+|+... ++..+++|+... .....|..|...|+.+. ...+.++++++...+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEG----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCc----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 356789999999999986 567888997643 23567889999888874 3567888988888888999999999
Q ss_pred CCChh--------h---hhcccCC-CC-----------------CCCCHHHHH---HHHH----------------HHHH
Q 007608 353 NLSVA--------Y---RLRDLKP-GE-----------------KGLDWPTRK---RVAF----------------GTAY 384 (596)
Q Consensus 353 ~gsL~--------~---~l~~~~~-~~-----------------~~l~~~~~~---~i~~----------------~ia~ 384 (596)
+..+. . .|+.... .. ..-+|.... ++.. .+..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87542 1 2332221 00 012565432 1111 1111
Q ss_pred H-HHHHHh-CCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 385 G-LEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 385 ~-L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
. ...|.. ...|.++|+|+.+.|++++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123322 2346899999999999999887 8898974
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.61 E-value=3.5e-06 Score=92.42 Aligned_cols=105 Identities=10% Similarity=0.066 Sum_probs=58.2
Q ss_pred CCEEEEEcCCCCCCcccCcchh-hhcccchhhccc--C----ccccc-----cCCcccCCCCcccEEEccCccCcCCCcc
Q 007608 76 GNVISLTLGSNGFSGKISPSIT-KLKFLASFRELQ--D----NDLSG-----TLPDFLGSMTHLQSLNLANNKFSGSIPA 143 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~-~l~~L~~l~~l~--~----n~l~g-----~~p~~~~~l~~L~~L~l~~N~l~g~~p~ 143 (596)
.+++.|.+..|++++.....+. .+++|+.| +|+ + |.+++ .++..+.++++|+.|+|++ .+++..+.
T Consensus 372 ~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L-~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 372 PKLESVLYFCRQMTNAALITIARNRPNMTRF-RLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp TTCCEEEEEESCCCHHHHHHHHHHCTTCCEE-EEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred hhHHHHHHhcCCcCHHHHHHHHhhCCCccee-EeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 3566777777777665555554 46677777 666 3 44541 1112244556666666655 45544444
Q ss_pred cccc-CCCCcEEeCCCCcccccCCcc----cccccccccccccc
Q 007608 144 TWSQ-LSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHL 182 (596)
Q Consensus 144 ~~~~-l~~L~~L~l~~N~l~g~iP~~----l~~l~~l~~~~n~~ 182 (596)
.++. +++|+.|+|++|.+++..+.. +.+|+.|++++|+.
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 4444 666666666666665443322 34555666666554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.60 E-value=2.4e-05 Score=85.70 Aligned_cols=102 Identities=13% Similarity=0.122 Sum_probs=54.9
Q ss_pred CEEEEEcCCCCCC----cccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCc---CCCccccccCC
Q 007608 77 NVISLTLGSNGFS----GKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS---GSIPATWSQLS 149 (596)
Q Consensus 77 ~l~~L~l~~n~l~----g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~---g~~p~~~~~l~ 149 (596)
+|+.|+|++|.++ +.++..+.++++|+.| ++++|.+.+ +|..+.++++|+.|+++.+... +..+..+..++
T Consensus 193 ~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L-~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~ 270 (592)
T 3ogk_B 193 SLEVLNFYMTEFAKISPKDLETIARNCRSLVSV-KVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPR 270 (592)
T ss_dssp CCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEE-ECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCT
T ss_pred CccEEEeeccCCCccCHHHHHHHHhhCCCCcEE-eccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccc
Confidence 4555555555554 2233334455555555 555555552 4444555555555555432211 23344566777
Q ss_pred CCcEEeCCCCcccccCCccc---cccccccccccc
Q 007608 150 NLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTH 181 (596)
Q Consensus 150 ~L~~L~l~~N~l~g~iP~~l---~~l~~l~~~~n~ 181 (596)
+|+.|+++++... .+|..+ .+|+.|++++|.
T Consensus 271 ~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~ 304 (592)
T 3ogk_B 271 KLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYAL 304 (592)
T ss_dssp TCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCC
T ss_pred cccccCccccchh-HHHHHHhhcCCCcEEecCCCc
Confidence 7888888776433 556443 366777777766
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.60 E-value=6.6e-06 Score=90.23 Aligned_cols=102 Identities=13% Similarity=0.141 Sum_probs=71.0
Q ss_pred CCEEEEEcCCCCCCcccCcchh-hhcccchhhcccCc-ccccc-CCcccCCCCcccEEEccCccCcCCCccccc----cC
Q 007608 76 GNVISLTLGSNGFSGKISPSIT-KLKFLASFRELQDN-DLSGT-LPDFLGSMTHLQSLNLANNKFSGSIPATWS----QL 148 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~-~l~~L~~l~~l~~n-~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~----~l 148 (596)
.+|+.|+|++|.+++..+..+. .+++|+.| +|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L-~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVL-VLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEE-EEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEE-eCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 4788888888888877666676 67888888 88887 55532 555555788888888888887765544443 56
Q ss_pred CCCcEEeCCCCcccccCC--------cccccccccccccc
Q 007608 149 SNLKHLDLSSNNLTGRIP--------MQLFSVATFNFTGT 180 (596)
Q Consensus 149 ~~L~~L~l~~N~l~g~iP--------~~l~~l~~l~~~~n 180 (596)
++|+.|+|++|. +.++ ..+.+|+.|++.+|
T Consensus 184 ~~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 184 TSLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp CCCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred CcCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 688888888886 1222 12356677777776
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.0007 Score=66.79 Aligned_cols=78 Identities=21% Similarity=0.255 Sum_probs=55.9
Q ss_pred CCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCC---CCccceEeEEecCCeeEEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH---KNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H---~niv~l~~~~~~~~~~~lv~e 349 (596)
.....+.+|.|..+.||+.+..||+.|++|+-... .......|..|...|+.+.- -.+.+++++. ..++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDD-APALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTT-CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCC-CcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 34446789999999999999999999999986532 22234568899999888742 2344555542 3478999
Q ss_pred cccCCC
Q 007608 350 FMQNLS 355 (596)
Q Consensus 350 ~~~~gs 355 (596)
|++.+.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 998764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.42 E-value=6.9e-05 Score=75.68 Aligned_cols=38 Identities=8% Similarity=0.083 Sum_probs=23.5
Q ss_pred hcccchhhcccCccccccCCcccCCCCcccEEEccCccCc
Q 007608 99 LKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 138 (596)
Q Consensus 99 l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~ 138 (596)
+++|+.| +|.+ +++..-+..|.+|++|+.|+|++|.++
T Consensus 100 ~~~L~~l-~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~ 137 (329)
T 3sb4_A 100 KQTLEKV-ILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP 137 (329)
T ss_dssp CTTCCC--CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC
T ss_pred cCCCcEE-ECCc-cccchhHHHhhcCcccceEEcCCCCcc
Confidence 6777777 6766 666222345667777777777777653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00099 Score=69.61 Aligned_cols=78 Identities=12% Similarity=0.046 Sum_probs=47.1
Q ss_pred CCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcceeccccccccccCcccccCC---CCCcccccHHHHHHHHHHH
Q 007608 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLELV 471 (596)
Q Consensus 395 ~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~Gvil~ell 471 (596)
+.++|+|+++.||+++.++ ++|+||+.+..-.....-...-..-...|.+|+..... ......++......+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4799999999999998876 99999998875432111000000002345666655321 1122345567777778777
Q ss_pred hC
Q 007608 472 TG 473 (596)
Q Consensus 472 tg 473 (596)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.27 E-value=3.7e-05 Score=78.63 Aligned_cols=54 Identities=17% Similarity=0.140 Sum_probs=24.6
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccC--CCCcccEEEcc
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLG--SMTHLQSLNLA 133 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~--~l~~L~~L~l~ 133 (596)
.+|+.|+|++|.-. .+++ + .+++|+.| +|..|.++...-..++ .+++|+.|+|+
T Consensus 172 P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L-~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL-SIGK-K-PRPNLKSL-EIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp TTCCEEEEECCBTC-BCCS-C-BCTTCSEE-EEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred CCCcEEEEeCCCCc-eecc-c-cCCCCcEE-EEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 46777777665211 2232 2 24555555 5555544422222222 45555555553
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00043 Score=59.48 Aligned_cols=52 Identities=21% Similarity=0.381 Sum_probs=32.2
Q ss_pred cccCcccc-ccCCcccCCCCcccEEEccCccCcCCCcc-ccccCCCCcEEeCCCCcc
Q 007608 107 ELQDNDLS-GTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNL 161 (596)
Q Consensus 107 ~l~~n~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l 161 (596)
+.++++|+ ..+|..+. ++|++|+|++|+|+ .||. .|..+++|+.|+|++|.+
T Consensus 14 ~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 14 DCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp ECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCC
T ss_pred EeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCe
Confidence 67777775 35665543 35777777777777 5554 456666666665555544
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.10 E-value=9e-05 Score=66.99 Aligned_cols=85 Identities=11% Similarity=0.113 Sum_probs=63.1
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCcc-ccccCCcccCCC----CcccEEEccCcc-CcCCCccccccCCC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDND-LSGTLPDFLGSM----THLQSLNLANNK-FSGSIPATWSQLSN 150 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~g~~p~~~~~l~~ 150 (596)
+|+.|||+++.++..=-..+..+++|+.| +|+++. |+..-=..++.+ ++|++|+|+++. ++..==..+.++++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L-~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKI-RLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEE-EEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEE-EeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 79999999998875433467889999999 999985 664333345554 479999999975 76332345788999
Q ss_pred CcEEeCCCCc-cc
Q 007608 151 LKHLDLSSNN-LT 162 (596)
Q Consensus 151 L~~L~l~~N~-l~ 162 (596)
|+.|+|++.. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999875 44
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00074 Score=57.98 Aligned_cols=55 Identities=22% Similarity=0.385 Sum_probs=24.3
Q ss_pred EEEccCccCc-CCCccccccCCCCcEEeCCCCcccccCCccc----cccccccccccccccCC
Q 007608 129 SLNLANNKFS-GSIPATWSQLSNLKHLDLSSNNLTGRIPMQL----FSVATFNFTGTHLICGS 186 (596)
Q Consensus 129 ~L~l~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l----~~l~~l~~~~n~~~~~~ 186 (596)
.+|.+++.|+ ..+|..+. .+|+.|+|++|+|+ .||... .+|..|++.+|++.|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~CdC 71 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWRCDC 71 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCBCSG
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCeeccC
Confidence 4445555543 23443221 23455555555555 444322 23344445555555543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.012 Score=58.53 Aligned_cols=159 Identities=13% Similarity=0.087 Sum_probs=86.4
Q ss_pred ccHHHHHHHhcCCCc-----CceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCC--ccce
Q 007608 262 FSCRELQLATDNFSE-----SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQL 334 (596)
Q Consensus 262 ~~~~el~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l 334 (596)
++.+++......|.. .+.|+.|....+|+....+| .+++|...... ....+..|+.++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 445555555555654 23466788899999987665 67888875421 1234556777766654222 2233
Q ss_pred EeE------EecCCeeEEEEEcccCCChhh--------------hhccc----CCCC-CC---CCHHHHHH---------
Q 007608 335 IGY------CTTSSERILVYPFMQNLSVAY--------------RLRDL----KPGE-KG---LDWPTRKR--------- 377 (596)
Q Consensus 335 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~~-~~---l~~~~~~~--------- 377 (596)
+.. ....+..+++++|++|..+.. .++.. .... .. ..|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 112355689999998764321 12211 1100 00 12332111
Q ss_pred ---HHHHHHHHHHHHHhC----CCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 378 ---VAFGTAYGLEYLHEQ----CNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 378 ---i~~~ia~~L~~LH~~----~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
+...+...+++++.. ....++|+|+.+.||+++++..+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455566532 13478999999999999987666899999775
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.91 E-value=9.8e-05 Score=75.50 Aligned_cols=106 Identities=19% Similarity=0.238 Sum_probs=75.5
Q ss_pred CCEEEEEcCCCCCCcccCcchh--hhcccchhhcccC--cccccc-----CCccc--CCCCcccEEEccCccCcCCCccc
Q 007608 76 GNVISLTLGSNGFSGKISPSIT--KLKFLASFRELQD--NDLSGT-----LPDFL--GSMTHLQSLNLANNKFSGSIPAT 144 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~--~l~~L~~l~~l~~--n~l~g~-----~p~~~--~~l~~L~~L~l~~N~l~g~~p~~ 144 (596)
.+|+.|+|..+.++...-..++ .+++|+.| +|+. |...|. +...+ ..+++|++|+|++|.+.+..+..
T Consensus 193 ~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L-~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKL-VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp TTCSEEEEECSBCCHHHHHHHHHSBCTTCCEE-EEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCcEEEEecCCCChHHHHHHHHccCCCCcEE-EEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 5899999999888754444555 68999999 8863 222221 11222 35899999999999998655544
Q ss_pred cc---cCCCCcEEeCCCCccccc----CCc---ccccccccccccccc
Q 007608 145 WS---QLSNLKHLDLSSNNLTGR----IPM---QLFSVATFNFTGTHL 182 (596)
Q Consensus 145 ~~---~l~~L~~L~l~~N~l~g~----iP~---~l~~l~~l~~~~n~~ 182 (596)
+. .+++|++|+|+.|.|++. ++. .+.+|..|++++|.+
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred HHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 44 588999999999999863 333 345678888888754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0027 Score=63.91 Aligned_cols=142 Identities=14% Similarity=0.048 Sum_probs=71.0
Q ss_pred ceeeecCceE-EEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCC--CCccceEeEEecCCeeEEEEEcccCC
Q 007608 278 NIIGQGGFGK-VYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 278 ~~lG~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g 354 (596)
+.|+.|+... +|+....++..+++|...... ...+..|+.++..+.. -.+.+++.+....+ +++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 4565555554 667765446778777643211 0223456666665532 23456666643333 7899998776
Q ss_pred Chhhhhcc---------------------cCCCC-CCCCHHHHH-------H-------------HHHHHHHHHHHHH--
Q 007608 355 SVAYRLRD---------------------LKPGE-KGLDWPTRK-------R-------------VAFGTAYGLEYLH-- 390 (596)
Q Consensus 355 sL~~~l~~---------------------~~~~~-~~l~~~~~~-------~-------------i~~~ia~~L~~LH-- 390 (596)
++.+++.. ..... ...+..... . ....+...+..+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 65443321 10000 011111000 0 0011112222221
Q ss_pred -hCCCCCcEecCCCCCcEEEcCC----CcEEEeecccccc
Q 007608 391 -EQCNPKIIHRDLKAANILLDDN----FEAVLCDFGLAKL 425 (596)
Q Consensus 391 -~~~~~~ivH~dlkp~NIll~~~----~~~kl~DfGl~~~ 425 (596)
....+.++|||+.+.||+++.+ ..+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123479999999999999874 6799999998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0034 Score=62.19 Aligned_cols=71 Identities=7% Similarity=0.015 Sum_probs=43.8
Q ss_pred CceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCc-cceEeEEecCCeeEEEEEcc-cCC
Q 007608 277 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILVYPFM-QNL 354 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~-~~g 354 (596)
.+.|+.|....+|+. ..+++|+....... .....+|+..++.+....+ .+++++ +.+..++++||+ ++-
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 678889999999998 56888876532111 1123467777776653333 355543 344457899999 554
Q ss_pred Ch
Q 007608 355 SV 356 (596)
Q Consensus 355 sL 356 (596)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 43
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0028 Score=66.32 Aligned_cols=73 Identities=15% Similarity=0.160 Sum_probs=49.2
Q ss_pred CceeeecCceEEEEEEeCC--------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCc-cceEeEEecCCeeEEE
Q 007608 277 SNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILV 347 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv 347 (596)
.+.|+.|-...+|++...+ +..+++|+.... .....+.+|..++..+...++ .++++.+.+ .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 4567888889999998753 578899987321 122456689888888754444 466665432 389
Q ss_pred EEcccCCCh
Q 007608 348 YPFMQNLSV 356 (596)
Q Consensus 348 ~e~~~~gsL 356 (596)
++|+++-++
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0081 Score=60.10 Aligned_cols=142 Identities=13% Similarity=0.115 Sum_probs=80.4
Q ss_pred ceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCC--ccceEeE-----EecCCeeEEEEEc
Q 007608 278 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGY-----CTTSSERILVYPF 350 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~-----~~~~~~~~lv~e~ 350 (596)
..++ |....||+....+|+.+++|...... .....+..|..++..+.... +.+++.. ....+..+++|+|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 4566 88889999887778789999875321 13456677888777664222 3344332 1123455789999
Q ss_pred ccCCChh-----------h---hhccc----CC-CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC
Q 007608 351 MQNLSVA-----------Y---RLRDL----KP-GEKGLDWPTR----KRV---------------AFGTAYGLEYLHEQ 392 (596)
Q Consensus 351 ~~~gsL~-----------~---~l~~~----~~-~~~~l~~~~~----~~i---------------~~~ia~~L~~LH~~ 392 (596)
++|.++. . .++.. .. .....++... ..+ ...+...++.+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9875432 0 11111 00 0111232211 001 11111223333221
Q ss_pred ----CCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 393 ----CNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 393 ----~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
....++|+|+++.||+++ + .+.|+||+.+.
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 234689999999999999 4 89999998775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0088 Score=61.05 Aligned_cols=73 Identities=11% Similarity=0.031 Sum_probs=42.8
Q ss_pred CceeeecCceEEEEEEeCC---------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCc-cceEeEEecCCeeEE
Q 007608 277 SNIIGQGGFGKVYKGVLSD---------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERIL 346 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~l 346 (596)
.+.++.|....+|+....+ +..+++|+..... ........|..++..+...++ .++++.. . -.+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 3456778888999998754 2688888764321 111123577888777753343 3565543 2 368
Q ss_pred EEEcccCCC
Q 007608 347 VYPFMQNLS 355 (596)
Q Consensus 347 v~e~~~~gs 355 (596)
||+|+++.+
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.30 E-value=0.016 Score=59.22 Aligned_cols=142 Identities=16% Similarity=0.199 Sum_probs=82.5
Q ss_pred CceeeecCceEEEEEEeC--------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCc-cceEeEEecCCeeEEE
Q 007608 277 SNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILV 347 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv 347 (596)
.+.+..|-...+|++... +++.+.+|+.... ......+.+|..+++.+.-.++ .++++++.+ .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 356667888899999874 2478999985321 1234566789999887753333 456666543 289
Q ss_pred EEcccCCChhhh-----------------hcccC-CCCCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 007608 348 YPFMQNLSVAYR-----------------LRDLK-PGEKGLD--WPTRKRVAFGTAY-------------------GLEY 388 (596)
Q Consensus 348 ~e~~~~gsL~~~-----------------l~~~~-~~~~~l~--~~~~~~i~~~ia~-------------------~L~~ 388 (596)
+||++|.++... ++... ....... |.+..++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999997654311 12111 1111222 4444555443321 2333
Q ss_pred HH----hC-CCCCcEecCCCCCcEEEcCC----CcEEEeeccccc
Q 007608 389 LH----EQ-CNPKIIHRDLKAANILLDDN----FEAVLCDFGLAK 424 (596)
Q Consensus 389 LH----~~-~~~~ivH~dlkp~NIll~~~----~~~kl~DfGl~~ 424 (596)
|. .. ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 32 21 12368999999999999876 689999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.27 E-value=0.027 Score=59.18 Aligned_cols=74 Identities=16% Similarity=0.121 Sum_probs=46.9
Q ss_pred CceeeecCceEEEEEEeCC-CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCc-cceEeEEecCCeeEEEEEcccCC
Q 007608 277 SNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILVYPFMQNL 354 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~g 354 (596)
.+.|+.|-...+|++...+ +..+++|+..... . ......+|..++..+...++ .++++.+. + ..|++|+++-
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 4567888889999998765 5788888764321 1 11112578888888865555 45666652 2 3599999875
Q ss_pred Ch
Q 007608 355 SV 356 (596)
Q Consensus 355 sL 356 (596)
++
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.94 E-value=0.04 Score=55.47 Aligned_cols=31 Identities=23% Similarity=0.369 Sum_probs=27.4
Q ss_pred CCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 395 PKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 395 ~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
..++|+|+.+.||++++++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4789999999999999888899999987754
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=95.68 E-value=0.0067 Score=62.81 Aligned_cols=61 Identities=10% Similarity=0.101 Sum_probs=30.2
Q ss_pred chhhhcccchhhcccCcccc-----ccCCcccCCCCcccEEEccCccCcCCCcc-ccccCCCCcEEeCCC
Q 007608 95 SITKLKFLASFRELQDNDLS-----GTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSS 158 (596)
Q Consensus 95 ~~~~l~~L~~l~~l~~n~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~ 158 (596)
.|.++++|+.+ ++.+|.+. ..-+..|.+|++|+.++|. |.++ .|+. .|.+|++|+.|+|.+
T Consensus 266 aF~~c~~L~~l-~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~L~~l~lp~ 332 (401)
T 4fdw_A 266 AFYYCPELAEV-TTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR-ILGQGLLGGNRKVTQLTIPA 332 (401)
T ss_dssp TTTTCTTCCEE-EEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC-EECTTTTTTCCSCCEEEECT
T ss_pred HhhCCCCCCEE-EeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE-EEhhhhhcCCCCccEEEECc
Confidence 45555555555 55555443 1222445555555555555 2344 3332 455555555555543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.67 E-value=0.044 Score=50.75 Aligned_cols=104 Identities=17% Similarity=0.102 Sum_probs=67.8
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcc
Q 007608 353 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 432 (596)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 432 (596)
..+|.+.|..+ +.+++..++|.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 32 ~vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 32 ALSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc--------
Confidence 34788888864 46899999999999999998776221111 1223456899999999988764 1110
Q ss_pred eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCC
Q 007608 433 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA 476 (596)
Q Consensus 433 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p 476 (596)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123456888763 4557888999999999999875544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=95.37 E-value=0.014 Score=60.41 Aligned_cols=84 Identities=15% Similarity=0.259 Sum_probs=65.7
Q ss_pred CEEEEEcCCCCCC----ccc-CcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCc-cccccCCC
Q 007608 77 NVISLTLGSNGFS----GKI-SPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP-ATWSQLSN 150 (596)
Q Consensus 77 ~l~~L~l~~n~l~----g~~-p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~ 150 (596)
+|+.|+|.+|.+. ..| +..|.++++|+.+ +|. |+++-.-...|.+|++|+.|+|.+| ++ .|+ ..|.++ +
T Consensus 272 ~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l-~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~aF~~~-~ 346 (401)
T 4fdw_A 272 ELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARF-EIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-QINFSAFNNT-G 346 (401)
T ss_dssp TCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEE-CCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-EECTTSSSSS-C
T ss_pred CCCEEEeCCccccCCcccEECHHHhhCCccCCeE-EeC-CceEEEhhhhhcCCCCccEEEECcc-cc-EEcHHhCCCC-C
Confidence 7888888887764 124 4578999999999 899 4577333478889999999999665 76 554 578999 9
Q ss_pred CcEEeCCCCcccccCC
Q 007608 151 LKHLDLSSNNLTGRIP 166 (596)
Q Consensus 151 L~~L~l~~N~l~g~iP 166 (596)
|+.|++++|.+. .++
T Consensus 347 L~~l~l~~n~~~-~l~ 361 (401)
T 4fdw_A 347 IKEVKVEGTTPP-QVF 361 (401)
T ss_dssp CCEEEECCSSCC-BCC
T ss_pred CCEEEEcCCCCc-ccc
Confidence 999999999887 454
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.11 E-value=0.0045 Score=55.76 Aligned_cols=79 Identities=10% Similarity=0.173 Sum_probs=55.8
Q ss_pred cccchhhcccCccccccCCcccCCCCcccEEEccCcc-CcCCCccccccC----CCCcEEeCCCCc-cccc----CCccc
Q 007608 100 KFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK-FSGSIPATWSQL----SNLKHLDLSSNN-LTGR----IPMQL 169 (596)
Q Consensus 100 ~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~g~----iP~~l 169 (596)
-+|+.| ||+++.++..=-..+.++++|+.|+|+++. ++..-=..++.+ ++|+.|+|+++. +|.. + ..+
T Consensus 61 ~~L~~L-DLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L-~~~ 138 (176)
T 3e4g_A 61 YKIQAI-DATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIAL-HHF 138 (176)
T ss_dssp CCEEEE-EEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHG-GGC
T ss_pred ceEeEE-eCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHH-hcC
Confidence 468999 999999885444567899999999999995 763322345554 479999999985 7631 1 124
Q ss_pred ccccccccccc
Q 007608 170 FSVATFNFTGT 180 (596)
Q Consensus 170 ~~l~~l~~~~n 180 (596)
.+|+.|++++.
T Consensus 139 ~~L~~L~L~~c 149 (176)
T 3e4g_A 139 RNLKYLFLSDL 149 (176)
T ss_dssp TTCCEEEEESC
T ss_pred CCCCEEECCCC
Confidence 45666666653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.76 E-value=0.0053 Score=56.40 Aligned_cols=84 Identities=12% Similarity=0.230 Sum_probs=53.4
Q ss_pred CCCEEEEEcCCC-CCCc----ccCcchhhhcccchhhcccCcccccc----CCcccCCCCcccEEEccCccCcCC----C
Q 007608 75 NGNVISLTLGSN-GFSG----KISPSITKLKFLASFRELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----I 141 (596)
Q Consensus 75 ~~~l~~L~l~~n-~l~g----~~p~~~~~l~~L~~l~~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~ 141 (596)
+..|+.|+|++| +|.. .+-..+..=+.|+.| +|++|+|... |-..+..=+.|+.|+|++|.|... |
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L-~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKF-SLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEE-ECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEE-EccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 346888888875 6642 133445555678888 8888888732 233344457788888888888732 2
Q ss_pred ccccccCCCCcEEeCCCC
Q 007608 142 PATWSQLSNLKHLDLSSN 159 (596)
Q Consensus 142 p~~~~~l~~L~~L~l~~N 159 (596)
-..+..-+.|+.|+|++|
T Consensus 119 a~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHTTTTCCCSEEECCCC
T ss_pred HHHHhhCCceeEEECCCC
Confidence 223444566888888765
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.62 E-value=0.017 Score=53.04 Aligned_cols=87 Identities=11% Similarity=0.125 Sum_probs=63.6
Q ss_pred CCCEEEEEcCCCCCCcc----cCcchhhhcccchhhcccCcccccc----CCcccCCCCcccEEEccCccC---cC----
Q 007608 75 NGNVISLTLGSNGFSGK----ISPSITKLKFLASFRELQDNDLSGT----LPDFLGSMTHLQSLNLANNKF---SG---- 139 (596)
Q Consensus 75 ~~~l~~L~l~~n~l~g~----~p~~~~~l~~L~~l~~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l---~g---- 139 (596)
+..|+.|+|++|+|... |...+..=+.|+.| +|++|+|... |-..+..=+.|+.|+|++|.. ..
T Consensus 69 N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L-~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~ 147 (197)
T 1pgv_A 69 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVL-NVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM 147 (197)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEE-ECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeE-ecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHH
Confidence 45899999999999743 33445566889999 9999999842 344556667899999997643 32
Q ss_pred CCccccccCCCCcEEeCCCCccc
Q 007608 140 SIPATWSQLSNLKHLDLSSNNLT 162 (596)
Q Consensus 140 ~~p~~~~~l~~L~~L~l~~N~l~ 162 (596)
.|-..+..-+.|+.|+|+.|.+.
T Consensus 148 ~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 148 DMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHhCCCcCeEeccCCCcc
Confidence 13344566688999999888654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.36 E-value=0.24 Score=51.35 Aligned_cols=142 Identities=11% Similarity=0.095 Sum_probs=83.0
Q ss_pred CceeeecCceEEEEEEeCC--------CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCc-cceEeEEecCCeeEEE
Q 007608 277 SNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILV 347 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv 347 (596)
.+.+..|-...+|+....+ +..+++|+.... .. ...+..+|..+++.+...++ .++++.+. -..|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 3566778889999998753 578999886432 11 11223578888877753333 45554332 3789
Q ss_pred EEcccCCChhh-----------------hhccc-------CC--CCCCCCHHHHHHHHHHH-------------------
Q 007608 348 YPFMQNLSVAY-----------------RLRDL-------KP--GEKGLDWPTRKRVAFGT------------------- 382 (596)
Q Consensus 348 ~e~~~~gsL~~-----------------~l~~~-------~~--~~~~l~~~~~~~i~~~i------------------- 382 (596)
++|+++.++.. .++.. .. ...+.-|.+..++..++
T Consensus 149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 228 (424)
T 3mes_A 149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI 228 (424)
T ss_dssp EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence 99999865321 01110 11 11222344444433222
Q ss_pred HHHHHHHHhC---------------------CCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 383 AYGLEYLHEQ---------------------CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 383 a~~L~~LH~~---------------------~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
...+.+|.+. ....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2223333211 1236899999999999 7888999999998753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=91.15 E-value=0.14 Score=52.47 Aligned_cols=65 Identities=18% Similarity=0.277 Sum_probs=37.1
Q ss_pred chhhhcccchhhcccCccccccC-CcccCCCCcccEEEccCccCcCCCc-cccccCCCCcEEeCCCCcccccCC
Q 007608 95 SITKLKFLASFRELQDNDLSGTL-PDFLGSMTHLQSLNLANNKFSGSIP-ATWSQLSNLKHLDLSSNNLTGRIP 166 (596)
Q Consensus 95 ~~~~l~~L~~l~~l~~n~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~iP 166 (596)
.+..+.+|+.+ .+.++ ++ .| ...|.++++|+.++|.++ ++ .|+ ..|.++++|+.++|..| ++ .|+
T Consensus 292 ~F~~~~~L~~i-~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~ 358 (394)
T 4fs7_A 292 TFYGCSSLTEV-KLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LR-KIG 358 (394)
T ss_dssp TTTTCTTCCEE-EECTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EEC
T ss_pred ccccccccccc-ccccc-cc-eechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-cc-Eeh
Confidence 45556666666 55443 44 33 345666677777776543 55 443 35666677777766655 44 444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=90.54 E-value=0.24 Score=50.74 Aligned_cols=98 Identities=15% Similarity=0.340 Sum_probs=64.7
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCC-cccCCCCcccEEEccCccCcCCCc-cccccCCCCcEE
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLP-DFLGSMTHLQSLNLANNKFSGSIP-ATWSQLSNLKHL 154 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L 154 (596)
.++.+.+.++..+ .-...|.+++.|+.+ .+. +.++ .|+ ..|.++++|+.++|..| ++ .|. ..|.++++|+.+
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i-~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i 339 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDI-EFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERI 339 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEE-ECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEE
T ss_pred cccEEecccccce-ecCcccccccccccc-cCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEE
Confidence 5666777655432 233467788888888 675 4555 454 56778888888888765 55 454 468888888888
Q ss_pred eCCCCcccccCCcc-cc---cccccccccccc
Q 007608 155 DLSSNNLTGRIPMQ-LF---SVATFNFTGTHL 182 (596)
Q Consensus 155 ~l~~N~l~g~iP~~-l~---~l~~l~~~~n~~ 182 (596)
.|..| ++ .|+.. |. +|+.+.+.+|..
T Consensus 340 ~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 340 AIPSS-VT-KIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp EECTT-CC-BCCGGGGTTCTTCCEEEESSCHH
T ss_pred EECcc-cC-EEhHhHhhCCCCCCEEEECCcee
Confidence 88654 66 66643 32 456667777643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=89.58 E-value=0.39 Score=49.09 Aligned_cols=68 Identities=19% Similarity=0.344 Sum_probs=48.5
Q ss_pred cchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCcc-ccccCCCCcEEeCCCCcccccCCc
Q 007608 94 PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPM 167 (596)
Q Consensus 94 ~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~iP~ 167 (596)
..|.++.+|+.+ .+.++..+ .-...|.++++|+.+.+. +.++ .|+. .|.++.+|+.++|..| ++ .|..
T Consensus 259 ~aF~~c~~L~~i-~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~ 327 (394)
T 4gt6_A 259 HAFDSCAYLASV-KMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILD 327 (394)
T ss_dssp TTTTTCSSCCEE-ECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECT
T ss_pred ceeeecccccEE-ecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehH
Confidence 357778888888 77665544 344677888999999986 5566 5654 5888899999998765 55 5553
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.94 E-value=3.2 Score=42.38 Aligned_cols=29 Identities=31% Similarity=0.520 Sum_probs=24.5
Q ss_pred cEecCCCCCcEEE------cCCCcEEEeecccccc
Q 007608 397 IIHRDLKAANILL------DDNFEAVLCDFGLAKL 425 (596)
Q Consensus 397 ivH~dlkp~NIll------~~~~~~kl~DfGl~~~ 425 (596)
++|+|+.+.||++ +++..+.++||-.+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4566799999998753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=87.99 E-value=0.49 Score=47.96 Aligned_cols=83 Identities=14% Similarity=0.270 Sum_probs=60.0
Q ss_pred CEEEEEcCCCCCCccc-CcchhhhcccchhhcccCccccccCC-cccCCCCcccEEEccCccCcCCCc-cccccCCCCcE
Q 007608 77 NVISLTLGSNGFSGKI-SPSITKLKFLASFRELQDNDLSGTLP-DFLGSMTHLQSLNLANNKFSGSIP-ATWSQLSNLKH 153 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~-p~~~~~l~~L~~l~~l~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~ 153 (596)
.++.+.+..+ ++ .| ...+.++.+|+.+ .+..+ +. .++ ..|.++++|+.+++.+|.++ .|+ ..|.++.+|+.
T Consensus 241 ~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i-~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~ 314 (379)
T 4h09_A 241 ALDEIAIPKN-VT-SIGSFLLQNCTALKTL-NFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSS 314 (379)
T ss_dssp SCCEEEECTT-CC-EECTTTTTTCTTCCEE-EECCC-CS-EECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCE
T ss_pred cceEEEcCCC-cc-EeCccccceeehhccc-ccccc-ce-eccccccccccccccccccccccc-eehhhhhcCCCCCCE
Confidence 5777777665 55 44 3467778888888 77544 55 344 56788999999999988888 665 46888999999
Q ss_pred EeCCCCcccccCCc
Q 007608 154 LDLSSNNLTGRIPM 167 (596)
Q Consensus 154 L~l~~N~l~g~iP~ 167 (596)
++|.+| ++ .|+.
T Consensus 315 i~lp~~-l~-~I~~ 326 (379)
T 4h09_A 315 VTLPTA-LK-TIQV 326 (379)
T ss_dssp EECCTT-CC-EECT
T ss_pred EEcCcc-cc-EEHH
Confidence 998755 55 5654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=87.78 E-value=0.64 Score=47.06 Aligned_cols=97 Identities=16% Similarity=0.251 Sum_probs=65.4
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCcc-ccccCCCCcEEe
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~ 155 (596)
++..+.+..+ +...-...+.++..|+.+ .+..+ ++..-...+.++.+|+.+.+..+ +. .++. .|.++++|+.++
T Consensus 218 ~l~~i~~~~~-~~~i~~~~f~~~~~L~~i-~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~ 292 (379)
T 4h09_A 218 NLKKITITSG-VTTLGDGAFYGMKALDEI-AIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVV 292 (379)
T ss_dssp SCSEEECCTT-CCEECTTTTTTCSSCCEE-EECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEE
T ss_pred ccceeeeccc-eeEEccccccCCccceEE-EcCCC-ccEeCccccceeehhcccccccc-ce-ecccccccccccccccc
Confidence 4666666544 442334467788888888 77665 55233466778999999999755 55 4554 688899999999
Q ss_pred CCCCcccccCCcc-cc---ccccccccc
Q 007608 156 LSSNNLTGRIPMQ-LF---SVATFNFTG 179 (596)
Q Consensus 156 l~~N~l~g~iP~~-l~---~l~~l~~~~ 179 (596)
+.+|.++ .|+.. |. +|+.+.+..
T Consensus 293 l~~~~i~-~I~~~aF~~c~~L~~i~lp~ 319 (379)
T 4h09_A 293 MDNSAIE-TLEPRVFMDCVKLSSVTLPT 319 (379)
T ss_dssp ECCTTCC-EECTTTTTTCTTCCEEECCT
T ss_pred ccccccc-eehhhhhcCCCCCCEEEcCc
Confidence 9998888 67643 33 355555543
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.01 E-value=1.7 Score=40.16 Aligned_cols=114 Identities=13% Similarity=0.144 Sum_probs=76.6
Q ss_pred CCCCccceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCcEecCCCCC
Q 007608 327 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE-YLHEQCNPKIIHRDLKAA 405 (596)
Q Consensus 327 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~dlkp~ 405 (596)
.||.. -...-.+.+...+.|+.-+++.-...++ .++...+++++..++.... +++. -+|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 3344466777777777765544334443 3678899999999888666 5554 478889999
Q ss_pred cEEEcCCCcEEEeeccccccccccCcceeccccccccccCcccccCCCCCccccc-HHHHHHHHHHHhCCCCCC
Q 007608 406 NILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV-FGYGITLLELVTGQRAID 478 (596)
Q Consensus 406 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv-~S~Gvil~elltg~~p~~ 478 (596)
|+++|.++.+++.-.|+-.. ++|.-. + ..|. -.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~------------------lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES------------------LPPDEW-----D-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTT------------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCccc------------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999987776432 233221 1 1222 356678888888776654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.86 E-value=1.3 Score=40.90 Aligned_cols=116 Identities=11% Similarity=0.076 Sum_probs=78.4
Q ss_pred CCCCccceEeEEecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCc
Q 007608 327 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 406 (596)
Q Consensus 327 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N 406 (596)
.||+.++. .+-.+.+...+.|+.-+.+.-...++ .++...+++++..|+....+++.. +|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 58888865 45556666666666554332222233 367889999999999888666544 788899999
Q ss_pred EEEcCCCcEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCC
Q 007608 407 ILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 478 (596)
Q Consensus 407 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~ 478 (596)
++++.++.+++.-.|+-..+ +|. ..+...=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999877764322 222 11111223357778889999887765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=80.44 E-value=0.82 Score=46.65 Aligned_cols=89 Identities=16% Similarity=0.214 Sum_probs=66.0
Q ss_pred CCEEEEEcCCCCCCcccC-cchhhhcccchhhcccCccccccC-CcccCCCCcccEEEccCccCcCCCc-cccccCCCCc
Q 007608 76 GNVISLTLGSNGFSGKIS-PSITKLKFLASFRELQDNDLSGTL-PDFLGSMTHLQSLNLANNKFSGSIP-ATWSQLSNLK 152 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p-~~~~~l~~L~~l~~l~~n~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~ 152 (596)
.+++.+.+.++ +. .|+ ..|.++++|+.+ +|.++ ++ .| ...|.++++|+.++|..| ++ .|+ ..|.++++|+
T Consensus 297 ~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i-~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~ 369 (394)
T 4fs7_A 297 SSLTEVKLLDS-VK-FIGEEAFESCTSLVSI-DLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLK 369 (394)
T ss_dssp TTCCEEEECTT-CC-EECTTTTTTCTTCCEE-CCCTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCC
T ss_pred ccccccccccc-cc-eechhhhcCCCCCCEE-EeCCc-cc-EEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCC
Confidence 36888888765 66 554 478899999999 88754 76 55 468899999999999887 77 565 4799999999
Q ss_pred EEeCCCCcccccCCccccccc
Q 007608 153 HLDLSSNNLTGRIPMQLFSVA 173 (596)
Q Consensus 153 ~L~l~~N~l~g~iP~~l~~l~ 173 (596)
.++|..| ++ .+...+.+..
T Consensus 370 ~i~lp~~-~~-~~~~~F~~c~ 388 (394)
T 4fs7_A 370 KVELPKR-LE-QYRYDFEDTT 388 (394)
T ss_dssp EEEEEGG-GG-GGGGGBCTTC
T ss_pred EEEECCC-CE-EhhheecCCC
Confidence 9999755 33 3333444433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 596 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 7e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-62
Identities = 74/282 (26%), Positives = 127/282 (45%), Gaps = 26/282 (9%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 330
+ IG G FG VYKG VAVK L +P AF+ EV ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
+L +GY T + + +V + + S+ + L ++ + +A TA G++YLH
Sbjct: 66 ILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLH 121
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYL 449
+ IIHRDLK+ NI L ++ + DFGLA + +H Q+ G++ +APE +
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 450 STGKS---SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506
S ++DV+ +GI L EL+TGQ ++ + + L+ +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS----NINNRDQIIFMVGRGYLSPDLSKV 234
Query: 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
S + M ++ C + ++RP Q++ ++
Sbjct: 235 --------RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 5e-62
Identities = 74/277 (26%), Positives = 126/277 (45%), Gaps = 24/277 (8%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
+ +G G FG+V+ G + +TKVAVK L+ AF E +L+ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRL 70
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 391
++L T ++ +M+N S+ L+ P L +A A G+ ++ E
Sbjct: 71 VRLYAVVT-QEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 451
+ IHRDL+AANIL+ D + DFGLA+L++ + + APE ++
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 452 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511
G + K+DV+ +GI L E+VT R E ++ ++ + R R ++ +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQNLERGYRMVRPDNCPEE-- 238
Query: 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ Q+ LC + PEDRP + +L+
Sbjct: 239 ----------LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 9e-61
Identities = 71/284 (25%), Positives = 123/284 (43%), Gaps = 28/284 (9%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
+ IG G FG V+ G + KVA+K +++ E F E ++ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKL 62
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGLEYLH 390
+QL G C + LV+ FM++ L D ++GL T + G+ YL
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 450
E C +IHRDL A N L+ +N + DFG+ + V +T + + +PE S
Sbjct: 119 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 451 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510
+ S K+DV+ +G+ + E+ + + +R E +++ I R +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVEDISTGFRLYKPRLASTH- 230
Query: 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAE 554
+ Q+ C + PEDRP +++++ L ++AE
Sbjct: 231 -----------VYQIMNHCWKERPEDRPAFSRLLRQL--AEIAE 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-60
Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 24/277 (8%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
++ +GQG FG+V+ G + T+VA+K L+ AF +E ++ H+ L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKL 74
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 391
+QL + +V +M S K L P +A A G+ Y+
Sbjct: 75 VQLYAVVSEE-PIYIVTEYMSKGS--LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 451
+HRDL+AANIL+ +N + DFGLA+L++ + + APE
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 452 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511
G+ + K+DV+ +GI L EL T R + E +LD + + R + +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPES-- 242
Query: 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + C + PE+RP + L+
Sbjct: 243 ----------LHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (505), Expect = 1e-59
Identities = 72/304 (23%), Positives = 126/304 (41%), Gaps = 39/304 (12%)
Query: 262 FSCRELQLATDNFSES---------NIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYY 308
F+ + A F++ +IG G FG+V G L K VA+K L+ Y
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 309 SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK 368
+ F E ++ H N++ L G T S+ +++ FM+N S+ LR +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDG 123
Query: 369 GLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428
+ G A G++YL + +HRDL A NIL++ N + DFGL++ ++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 429 KLTHVTT----QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 484
+ T + + APE + K + +DV+ YGI + E+++ + +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-YWDMTN 239
Query: 485 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 544
++ +++ I + R D + Q+ L C Q RP Q+V
Sbjct: 240 QD---VINAIEQDYRLPPPMDCPSA------------LHQLMLDCWQKDRNHRPKFGQIV 284
Query: 545 KMLQ 548
L
Sbjct: 285 NTLD 288
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (503), Expect = 2e-59
Identities = 71/310 (22%), Positives = 123/310 (39%), Gaps = 46/310 (14%)
Query: 266 ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 319
L+ +N IG+G FG+V++ T VAVK L++ S +A FQRE
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 320 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK--------------- 364
L++ + N+++L+G C L++ +M + LR +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 365 -----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 419
PG L + +A A G+ YL E+ K +HRDL N L+ +N + D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD 183
Query: 420 FGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 478
FGL++ + A + + PE + + + ++DV+ YG+ L E+ +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 479 FSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP 538
+ EE + + D N+ + + LC P DRP
Sbjct: 244 YGMAHEE----------------VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP 287
Query: 539 PMAQVVKMLQ 548
+ ++LQ
Sbjct: 288 SFCSIHRILQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-59
Identities = 65/327 (19%), Positives = 120/327 (36%), Gaps = 47/327 (14%)
Query: 267 LQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV 325
++L D+F + + +G G G V+K +A K + P RE+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 326 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 385
++ G + E + M S L + + +V+ G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGS----LDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445
L YL E+ KI+HRD+K +NIL++ E LCDFG++ + + GT +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMS 171
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505
PE L S ++D++ G++L+E+ G+ I +E E +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 506 IVDRNLNTYDSKEVETMVQVALL--------------------------CTQSTPEDRPP 539
R L++Y M LL C P +R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 540 MAQVVKMLQGEDLAERW---AEWEELE 563
+ Q+ + + ++ EE++
Sbjct: 292 LKQL--------MVHAFIKRSDAEEVD 310
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-59
Identities = 70/289 (24%), Positives = 128/289 (44%), Gaps = 29/289 (10%)
Query: 268 QLATDNFSESNIIGQGGFGKVYKGVLSDNT-----KVAVKRLQDYYSPGGEAAFQREVHL 322
++ + +IG G FG+VYKG+L ++ VA+K L+ Y+ F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 323 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 382
+ H N+++L G + +++ +M+N ++ LR+ + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGI 119
Query: 383 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGT 440
A G++YL N +HRDL A NIL++ N + DFGL++++ D + T+ T+ +
Sbjct: 120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 441 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500
+ APE +S K + +DV+ +GI + E++T + E ++ I R
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----VMKAINDGFRL 232
Query: 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549
D + Q+ + C Q RP A +V +L
Sbjct: 233 PTPMDCPSA------------IYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-58
Identities = 58/277 (20%), Positives = 108/277 (38%), Gaps = 24/277 (8%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
+ + +G G FG V G VA+K +++ E F E ++ H+ L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKL 61
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 391
+QL G CT ++ +M N + L L+ + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 451
+ +HRDL A N L++D + DFGL++ V + + + PE L
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 452 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 511
K S K+D++ +G+ + E+ + + + R E +HI + LR R + ++
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSE---TAEHIAQGLRLYRPHLASEK-- 229
Query: 512 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + C ++RP ++ +
Sbjct: 230 ----------VYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-57
Identities = 64/290 (22%), Positives = 121/290 (41%), Gaps = 29/290 (10%)
Query: 265 RELQLATDNFSESNI-IGQGGFGKVYKGVL---SDNTKVAVKRLQDYYSPGGEAAFQREV 320
++L L DN ++I +G G FG V +GV VA+K L+ RE
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 321 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 380
++ + +++LIG C +LV + L + + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLH 116
Query: 381 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIR 438
+ G++YL E+ +HRDL A N+LL + A + DFGL+K + D + +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 439 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 498
+ APE ++ K S ++DV+ YG+T+ E ++ + + +++ E ++ I +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPE---VMAFIEQGK 229
Query: 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
R + + + + C EDRP V + ++
Sbjct: 230 RMECPPECPPE------------LYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-56
Identities = 78/285 (27%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 273 NFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIH 328
+F+E +IG+G FG VY G L DN AVK L G + F E ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 329 KNLLQLIGYCT-TSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGL 386
N+L L+G C + ++V P+M++ LR+ E A G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGD----LRNFIRNETHNPTVKDLIGFGLQVAKGM 143
Query: 387 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTHVTTQIRGTMGH 443
+ K +HRDL A N +LD+ F + DFGLA+ + + H T + +
Sbjct: 144 ---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 444 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503
+A E L T K + K+DV+ +G+ L EL+T DV D LL+ RL
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-------PDVNTFDITVYLLQGRRL 253
Query: 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + +V L C E RP +++V +
Sbjct: 254 LQ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (480), Expect = 3e-56
Identities = 71/306 (23%), Positives = 134/306 (43%), Gaps = 26/306 (8%)
Query: 260 RRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQR 318
+ + ++ + + + +G G +G+VY+GV + VAVK L++ F +
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK 62
Query: 319 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 378
E ++ H NL+QL+G CT ++ FM ++ LR+ E + +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYM 120
Query: 379 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 438
A + +EYL + IHRDL A N L+ +N + DFGL++L+ +
Sbjct: 121 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 439 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 498
+ APE L+ K S K+DV+ +G+ L E+ T + + + + + K
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKDY 233
Query: 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAE 558
R +R ++ + ++ C Q P DRP A++ + E + + +
Sbjct: 234 RMERPEGCPEK------------VYELMRACWQWNPSDRPSFAEIHQAF--ETMFQESSI 279
Query: 559 WEELEE 564
+E+E+
Sbjct: 280 SDEVEK 285
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-56
Identities = 63/291 (21%), Positives = 114/291 (39%), Gaps = 30/291 (10%)
Query: 280 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 339
IG+G FG+V++G +VAVK + E++ + H+N+L I
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 340 ----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-- 393
T ++ LV + ++ S+ L + ++A TA GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 394 ---NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK---LTHVTTQIRGTMGHIAPE 447
P I HRDLK+ NIL+ N + D GLA D+ + GT ++APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 448 YLST------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE--EDVLLLDHIRKLLR 499
L +S ++ D++ G+ E+ + D++ D + +R
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 500 EDRLNDIVDRNL--NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + N+ + + M ++ C + R ++ K L
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 8e-56
Identities = 66/278 (23%), Positives = 108/278 (38%), Gaps = 30/278 (10%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 331
IG+G FG V G KVAVK +++ AF E +++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNL 62
Query: 332 LQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
+QL+G + +V +M S+ LR G L + + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 450
+HRDL A N+L+ ++ A + DFGL K + + + APE L
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALR 173
Query: 451 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510
K S K+DV+ +GI L E+ + R ++ ++ + K + D +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKGYKMDAPDGCPPA- 228
Query: 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ +V C RP Q+ + L+
Sbjct: 229 -----------VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-55
Identities = 67/301 (22%), Positives = 115/301 (38%), Gaps = 40/301 (13%)
Query: 272 DNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLIS- 324
+ S +G G FGKV + VAVK L+ A E+ ++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD--------------LKPGEKGL 370
+ H N++ L+G CT +++ + + LR ++ E L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 371 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430
D ++ A G+ +L + IHRDL A NILL +CDFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 431 TH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 489
+ V R + +APE + + ++DV+ YGI L EL + + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 490 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549
I++ R M + C + P RP Q+V++++
Sbjct: 257 FYKMIKEGFRML------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 550 E 550
+
Sbjct: 305 Q 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-55
Identities = 65/306 (21%), Positives = 117/306 (38%), Gaps = 45/306 (14%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTK------VAVKRLQDYYSPGGEAAFQREVHLIS- 324
+N ++G G FGKV +K VAVK L++ A E+ +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 325 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------------- 365
+ H+N++ L+G CT S L++ + + LR +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 366 GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425
L + A+ A G+E+L + +HRDL A N+L+ +CDFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 426 VDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 484
+ + +V R + +APE L G + K+DV+ YGI L E+ + + +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPV 272
Query: 485 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 544
+ + I+ + D+ + + + C RP +
Sbjct: 273 DAN--FYKLIQNGFKMDQPFYATEE------------IYIIMQSCWAFDSRKRPSFPNLT 318
Query: 545 KMLQGE 550
L +
Sbjct: 319 SFLGCQ 324
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-55
Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 37/293 (12%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLIS-VAI 327
++ ++IG+G FG+V K + + A+KR+++Y S F E+ ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE------------KGLDWPTR 375
H N++ L+G C L + + ++ LR + E L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 376 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 435
A A G++YL + + IHRDL A NIL+ +N+ A + DFGL++ + + T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 436 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495
R + +A E L+ + +DV+ YG+ L E+V+ E L + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLP 240
Query: 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ R ++ + D + + C + P +RP AQ++ L
Sbjct: 241 QGYRLEKPLNCDDE------------VYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-54
Identities = 55/280 (19%), Positives = 106/280 (37%), Gaps = 24/280 (8%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 329
+++ IG G +G+ K SD + K L + + EV+L+ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 330 NLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
N+++ + L V + + +A + + LD RV L+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 388 YLHEQ--CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445
H + ++HRDLK AN+ LD L DFGLA++++ T GT +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMS 182
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505
PE ++ +EK+D++ G L EL F+ ++E
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKE---------------LAGK 225
Query: 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
I + + + + ++ RP + ++++
Sbjct: 226 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 5e-54
Identities = 57/275 (20%), Positives = 107/275 (38%), Gaps = 31/275 (11%)
Query: 278 NIIGQGGFGKVYKGVLSD-NTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLI 335
IG+G F VYKG+ ++ +VA LQD + F+ E ++ H N+++
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 336 GYCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 391
++ + +LV M + + L+ K + + GL++LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGT----LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 392 QCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 450
+ P IIHRDLK NI + + D GLA L + GT +APE
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE 186
Query: 451 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510
K E DV+ +G+ +LE+ T + E + + + ++ + +
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
+ ++ C + ++R + ++
Sbjct: 242 V-----------KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-53
Identities = 56/277 (20%), Positives = 107/277 (38%), Gaps = 25/277 (9%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
+++ +G+G +G+V V VAVK + + ++E+ + + H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
+++ G+ + + L + + R+ + G+ P +R G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA-KLTHVTTQIRGTMGHIAPEYL 449
I HRD+K N+LLD+ + DFGLA + + ++ GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 450 STGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508
+ +E DV+ GI L ++ G+ D + D K + I
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKI-- 232
Query: 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
++ P R + + K
Sbjct: 233 -------DSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-53
Identities = 64/279 (22%), Positives = 109/279 (39%), Gaps = 30/279 (10%)
Query: 276 ESNIIGQGGFGKVYKGVLSD---NTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL 331
E +G G FG V KG VAVK L+ + P + E +++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 332 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 391
+++IG C S +LV + L + + + + G++YL E
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGP----LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 392 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYL 449
+HRDL A N+LL A + DFGL+K + A + Q + + APE +
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 450 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509
+ K S K+DV+ +G+ + E + + + ++ E + + K R
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSE---VTAMLEKGERMGCPAGCPRE 238
Query: 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
M + LC E+RP A V L+
Sbjct: 239 ------------MYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 3e-52
Identities = 63/277 (22%), Positives = 108/277 (38%), Gaps = 31/277 (11%)
Query: 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 328
++F +G+G FG VY +A+K L G E +REV + S H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
N+L+L GY ++ L+ + +V L+ L D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
H + ++IHRD+K N+LL E + DFG + + + GT+ ++ PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175
Query: 449 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508
+ EK D++ G+ E + G+ + + +E I ++ E D V
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYKRISRV--EFTFPDFVT 228
Query: 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
E + + P RP + +V++
Sbjct: 229 -----------EGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-51
Identities = 63/298 (21%), Positives = 128/298 (42%), Gaps = 32/298 (10%)
Query: 266 ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 319
E ++A + + S +GQG FG VY+GV T+VA+K + + S F E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 320 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG------LDWP 373
++ ++++L+G + +++ M + LR L+P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 374 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTH 432
++A A G+ YL+ K +HRDL A N ++ ++F + DFG+ + + +
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 433 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 492
+ + ++PE L G + +DV+ +G+ L E+ T + L E+ +L
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQ---VLR 246
Query: 493 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550
+ + D+ ++ D + ++ +C Q P+ RP +++ ++ E
Sbjct: 247 FVMEGGLLDKPDNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-50
Identities = 57/283 (20%), Positives = 116/283 (40%), Gaps = 29/283 (10%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVA 326
F + ++G G FG VYKG+ VA+K L++ SP E ++++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 327 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 386
+ ++ +L+G C TS+ +++ L ++ + + A G+
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 387 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA-KLTHVTTQIRGTMGHIA 445
YL ++ +++HRDL A N+L+ + DFGLAKL+ A + + + + +A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 446 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505
E + + ++DV+ YG+T+ EL+T + + E + + K R +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASE---ISSILEKGERLPQPPI 237
Query: 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + + C + RP +++
Sbjct: 238 CTID------------VYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 6e-50
Identities = 72/281 (25%), Positives = 101/281 (35%), Gaps = 34/281 (12%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAI 327
FS+ IG G FG VY + ++ VA+K++ S +EV +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
H N +Q G LV + + KP L V G GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 129
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 447
YLH +IHRD+KA NILL + L DFG A ++ GT +APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPE 181
Query: 448 YLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504
+ G+ K DV+ GIT +EL + L + L HI + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYHIAQNESPALQS 236
Query: 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
E C Q P+DRP ++K
Sbjct: 237 GHWS-----------EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-49
Identities = 73/286 (25%), Positives = 107/286 (37%), Gaps = 32/286 (11%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRL--QDYYSPGGEAAFQREVHLISV 325
+ +G G FG V +G + VAVK L P F REV+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 326 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAY 384
H+NL++L G T ++ V S L D +G T R A A
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH--VTTQIRGTMG 442
G+ YL + IHRDL A N+LL + DFGL + + H + +
Sbjct: 123 GMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 443 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502
APE L T S +D + +G+TL E+ T + + L + +L ++ R R
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQ--ILHKIDKEGERLPR 236
Query: 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
D + V + C PEDRP + L
Sbjct: 237 PEDCPQD------------IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-48
Identities = 54/282 (19%), Positives = 109/282 (38%), Gaps = 29/282 (10%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAI 327
+ IG+G FG V++G+ VA+K ++ S F +E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGL 386
H ++++LIG T + ++ LR K LD + A+ + L
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 387 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 446
YL + + +HRD+ A N+L+ N L DFGL++ ++ + ++ + + +AP
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 447 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506
E ++ + + +DV+ +G+ + E++ + ++ I R +
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENGERLPMPPNC 234
Query: 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
T+ + C P RP ++ L
Sbjct: 235 ------------PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-47
Identities = 63/281 (22%), Positives = 111/281 (39%), Gaps = 29/281 (10%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
D + +G G FGKVYK + A K + D S + E+ +++ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI-DTKSEEELEDYMVEIDILASCDHP 69
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N+++L+ + ++ F +V + +L+ + L + V T L YL
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYL 126
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H+ KIIHRDLKA NIL + + L DFG++ + + GT +APE +
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVV 182
Query: 450 STGKS-----SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504
S K DV+ GITL+E+ + L + K+ + +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMR------VLLKIAKSEPPT 234
Query: 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
S + ++ C + + R +Q+++
Sbjct: 235 LAQPSRW----SSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-47
Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 41/299 (13%)
Query: 272 DNFSESNIIGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLI 323
D +G+G FG+V + TKVAVK L+ + + E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 324 S-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------EKGL 370
+ HKN++ L+G CT ++ + ++ L+ +P E+ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 371 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430
A+ A G+EYL K IHRDL A N+L+ ++ + DFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 431 THVTTQ-IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 489
+ T R + +APE L + ++DV+ +G+ L E+ T + EE
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245
Query: 490 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
L +++ R D+ ++ + + + C + P RP Q+V+ L
Sbjct: 246 LFKLLKEGHRMDKPSNCTNE------------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 7e-47
Identities = 70/298 (23%), Positives = 123/298 (41%), Gaps = 39/298 (13%)
Query: 272 DNFSESNIIGQGGFGKVYKGV------LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV 325
D +G+G FG+V + + VAVK L++ + A E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 326 AIH-KNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKP------------GEKGLD 371
H N++ L+G CT + ++ F + +++ LR + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 372 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431
+F A G+E+L + K IHRDL A NILL + +CDFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 432 HV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 490
+V R + +APE + + ++DV+ +G+ L E+ + + V +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-------PGVKI 242
Query: 491 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+ + L+E D Y + E M Q L C P RP +++V+ L
Sbjct: 243 DEEFCRRLKEGTRMRAPD-----YTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-45
Identities = 52/276 (18%), Positives = 108/276 (39%), Gaps = 26/276 (9%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
++ IGQG G VY + ++ +VA++++ + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N++ + E +V ++ S+ + E +D V LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFL 132
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H ++IHRD+K+ NILL + L DFG + + + +T + GT +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 450 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509
+ K D++ GI +E++ G+ ++ + +L ++L
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL------ 242
Query: 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
S + C E R ++++
Sbjct: 243 ------SAIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 60/300 (20%), Positives = 107/300 (35%), Gaps = 34/300 (11%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 328
++F I+G+G F V L+ + + A+K L + RE ++S H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
++L + + +N L D + LEY
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPE 447
LH + IIHRDLK NILL+++ + DFG AK++ + GT +++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 448 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507
L+ + + +D++ G + +LV G + L+ I KL
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLIFQKIIKL---------- 225
Query: 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERW---AEWEELEE 564
+ + + +V+ R ++ G A + WE L +
Sbjct: 226 EYDFPEKFFPKARDLVE---KLLVLDATKRLGCEEMEGY--GPLKAHPFFESVTWENLHQ 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 155 bits (392), Expect = 8e-43
Identities = 56/277 (20%), Positives = 104/277 (37%), Gaps = 26/277 (9%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
D++ +G G FG V++ + A K + + ++E+ +SV H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPT 84
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
L+ L +E +++Y FM + ++ D + GL ++H
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH 141
Query: 391 EQCNPKIIHRDLKAANILL--DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
E +H DLK NI+ + E L DFGL +D K + T GT APE
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEV 196
Query: 449 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508
TD++ G+ L++G E D L +++ +D
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSP-----FGGENDDETLRNVKSCDWN------MD 245
Query: 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
+ + S++ + ++ + P R + Q ++
Sbjct: 246 DSAFSGISEDGKDFIR---KLLLADPNTRMTIHQALE 279
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 147 bits (372), Expect = 6e-41
Identities = 58/290 (20%), Positives = 110/290 (37%), Gaps = 39/290 (13%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--------QDYYSPGGEAAFQREVHL 322
+N+ I+G+G V + + + AVK + A +EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 323 IS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 381
+ V+ H N++QL T++ LV+ M+ + L + + L +++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRA 118
Query: 382 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 441
+ LH+ I+HRDLK NILLDD+ L DFG + +D ++ GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTP 173
Query: 442 GHIAPEYLSTG------KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495
++APE + ++ D++ G+ + L+ G + +L+L I
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQMLMLRMIM 228
Query: 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
+ + S V+ +V P+ R + +
Sbjct: 229 S--GNYQFGSPEWDDY----SDTVKDLVS---RFLVVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (374), Expect = 8e-41
Identities = 62/310 (20%), Positives = 125/310 (40%), Gaps = 29/310 (9%)
Query: 265 RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLI 323
++ + D + +++G G F +V VA+K + G E + + E+ ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 324 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 383
H N++ L + L+ + + R+ + R+ F
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVL 117
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 440
++YLH+ I+HRDLK N+L D++ + ++ DFGL+K+ D V + GT
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGT 172
Query: 441 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500
G++APE L+ S+ D + G+ L+ G +E D L + I K E
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----FYDENDAKLFEQILK--AE 225
Query: 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM--LQGEDLAERWAE 558
+ ++ S + ++ + PE R Q ++ + G+ ++
Sbjct: 226 YEFDSPYWDDI----SDSAKDFIR---HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIH 278
Query: 559 WEELEEVRQQ 568
E++++
Sbjct: 279 QSVSEQIKKN 288
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (377), Expect = 9e-41
Identities = 50/277 (18%), Positives = 99/277 (35%), Gaps = 26/277 (9%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
D + +G G FG V++ V + K + P + + E+ +++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPK 87
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
L+ L E +L+ F+ + R+ + GL+++H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH 144
Query: 391 EQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
E I+H D+K NI+ + + DFGLA ++ + T APE
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEI 199
Query: 449 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508
+ TD++ G+ L++G F+ ++ E + + ED + +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDEDAFSSV-- 255
Query: 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
S E + ++ Q P R + ++
Sbjct: 256 -------SPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 2e-40
Identities = 61/288 (21%), Positives = 116/288 (40%), Gaps = 23/288 (7%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 330
+ + IG+G +G VYK + A+K+++ + G + RE+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
+++L T +LV+ + + L E GL+ T K G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 450
++ +++HRDLK N+L++ E + DFGLA+ + T +I +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 451 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV--- 507
+ K S D++ G E+V G F + E + ++ + I ++
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPL--FPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 508 --DRNLNTYDSKEVETMVQ------VALL--CTQSTPEDRPPMAQVVK 545
D N Y+ E+ ++ + LL + P R Q ++
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 66/305 (21%), Positives = 115/305 (37%), Gaps = 36/305 (11%)
Query: 263 SCRELQLATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRL-QDYYSPGGEAAFQRE 319
CR A + IG+G +GKV+K + + VA+KR+ G + RE
Sbjct: 2 LCR----ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 57
Query: 320 VHL---ISVAIHKNLLQLIGYCTTSS--ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 374
V + + H N+++L CT S + +++ K E G+ T
Sbjct: 58 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 117
Query: 375 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 434
K + F GL++LH +++HRDLK NIL+ + + L DFGLA++ ++
Sbjct: 118 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 172
Query: 435 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 494
T + T+ + APE L + D++ G E+ + DV L I
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL-----FRGSSDVDQLGKI 227
Query: 495 RKLLR--------------EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 540
++ + + + + + E + L C P R
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
Query: 541 AQVVK 545
+
Sbjct: 288 YSALS 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 147 bits (371), Expect = 6e-40
Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 32/278 (11%)
Query: 272 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRL--QDYYSPGGEAAFQREVHLISV--- 325
++FS IIG+GGFG+VY +D A+K L + GE E ++S+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 326 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 385
++ + T + + M + Y L + A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 445
LE++H + +++RDLK ANILLD++ + D GLA K H + GT G++A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173
Query: 446 PEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504
PE L G + D F G L +L+ G + +++ ++ + + D
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF- 232
Query: 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 542
S E+ ++++ Q R
Sbjct: 233 -----------SPELRSLLE---GLLQRDVNRRLGCLG 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 1e-39
Identities = 58/287 (20%), Positives = 103/287 (35%), Gaps = 19/287 (6%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 329
+NF + IG+G +G VYK VA+K+++ D + G + RE+ L+ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N+++L+ T ++ LV+ F+ + G+ P K F GL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFC 118
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H ++HRDLK N+L++ L DFGLA+ + T ++ L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 450 STGKSSEKTDVFGYGITLLELVTGQRAID-----------FSRLEEEEDVLLLDHIRKLL 498
S D++ G E+VT + F L ++V+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 499 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
+ ++ + E + P R +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 143 bits (362), Expect = 2e-39
Identities = 57/284 (20%), Positives = 109/284 (38%), Gaps = 30/284 (10%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAI 327
+D + I+G GG +V+ L + VAVK L P F+RE +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 328 HKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 383
H ++ + + +V ++ +++ + P + V
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 441
L + H+ IIHRD+K ANI++ + DFG+A+ + V T + GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 442 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501
+++PE ++DV+ G L E++TG+ + + H+R+
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT----GDSPVSVAYQHVRE----- 229
Query: 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
+ I + S +++ +V PE+R A ++
Sbjct: 230 --DPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMR 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-39
Identities = 75/324 (23%), Positives = 124/324 (38%), Gaps = 41/324 (12%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAI- 327
++F ++G+G FGKV+ N A+K L E ++S+A
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
H L + T V ++ + Y ++ D A GL+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 447
+LH + I++RDLK NILLD + + DFG+ K T GT +IAPE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 173
Query: 448 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507
L K + D + +G+ L E++ GQ F +EEE L IR
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEE---LFHSIRM----------D 218
Query: 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM---LQGEDLAERWAEWEELEE 564
+ + KE + ++ PE R + ++ + + WEELE
Sbjct: 219 NPFYPRWLEKEAKDLLV---KLFVREPEKRLGVRGDIRQHPLFREIN-------WEELER 268
Query: 565 VRQQEVSLLPHQFAWGEDSSIDQE 588
++ + P + + S+ D+E
Sbjct: 269 -KEIDPPFRPKVKSPFDCSNFDKE 291
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (362), Expect = 4e-39
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 328
+F +G G FG+V+ + A+K L + E ++S+ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
++++ G + + ++ +++ L L + P K A LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
LH + II+RDLK NILLD N + DFG AK V VT + GT +IAPE
Sbjct: 120 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEV 172
Query: 449 LSTGKSSEKTDVFGYGITLLELVTGQR 475
+ST ++ D + +GI + E++ G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-39
Identities = 53/326 (16%), Positives = 118/326 (36%), Gaps = 36/326 (11%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
+ + + +G+G FG V++ V S K ++ + ++E+ ++++A H+N
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRN 62
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
+L L + E ++++ F+ L + R+ L+ L++LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLH 119
Query: 391 EQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
I H D++ NI+ + + +FG A+ + + + APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEV 174
Query: 449 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508
S TD++ G + L++G F ++ + + + E+ +I
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEAFKEI-- 230
Query: 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQ 568
S E V + R ++ L W + +++E V +
Sbjct: 231 -------SIEAMDFVD---RLLVKERKSRMTASEA--------LQHPWLK-QKIERVSTK 271
Query: 569 EVSLLPHQFAWGEDSSIDQEAIQLSN 594
+ L H+ + D + +
Sbjct: 272 VIRTLKHRRYYHTLIKKDLNMVVSAA 297
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 1e-38
Identities = 50/294 (17%), Positives = 93/294 (31%), Gaps = 32/294 (10%)
Query: 266 ELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS 324
EL++ + + IG G FG +Y G ++ +VA+K E +
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYK 57
Query: 325 VAIHKNLLQLIGYCTTSSER-ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 383
+ + I +C + ++V + + T +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMI 113
Query: 384 YGLEYLHEQCNPKIIHRDLKAANIL---LDDNFEAVLCDFGLAKLVDAKLTHV------T 434
+EY+H + IHRD+K N L + DFGLAK TH
Sbjct: 114 SRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 435 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 494
+ GT + + + S + D+ G L+ G + +
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
Query: 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548
+K+ L E T + C +D+P + + ++ +
Sbjct: 231 KKM-------STPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 53/295 (17%), Positives = 110/295 (37%), Gaps = 27/295 (9%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 329
++ + IG+G +G V + +VA+K++ + RE+ ++ H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N++ + + + ++ + L L + L + GL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYI 125
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIAPE 447
H ++HRDLK +N+LL+ + +CDFGLA++ D H T+ T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 448 YLSTG-KSSEKTDVFGYGITLLELVTGQ----------------RAIDFSRLEEEEDVLL 490
+ ++ D++ G L E+++ + + E+ ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 491 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
L LL N + L + ++ P R + Q +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (351), Expect = 9e-38
Identities = 44/288 (15%), Positives = 93/288 (32%), Gaps = 33/288 (11%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 338
IG+G FG +++G L +N +VA+K + E + + + Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 339 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 398
++ + S+ L + T A ++ +HE+ ++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 399 HRDLKAANILLDDNFEAV-----LCDFGLAKLVDAKLTHV------TTQIRGTMGHIAPE 447
+RD+K N L+ + DFG+ K +T + GT +++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 448 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507
+ S + D+ G + + G + L+ + + I + + L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSL--PWQGLKAATNKQKYERIGEKKQSTPL---- 237
Query: 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 555
R L +E + + P + + + ER
Sbjct: 238 -RELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLF--SKVLER 279
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 70/285 (24%), Positives = 108/285 (37%), Gaps = 24/285 (8%)
Query: 278 NIIGQGGFGKVYKGV-LSDNTKVAVKRL----QDYYSPGGEAAFQREVHLISVAIHKNLL 332
+ +G+G F VYK + N VA+K++ + G RE+ L+ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 333 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
L+ S LV+ FM+ +K L K T GLEYLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 393 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 452
I+HRDLK N+LLD+N L DFGLAK + T Q+ T + APE L
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 453 KS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL----------LDHIRKLLRED 501
+ D++ G L EL+ + ++ + + L
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546
L+ S + ++ + P R Q +KM
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 6e-37
Identities = 66/298 (22%), Positives = 107/298 (35%), Gaps = 39/298 (13%)
Query: 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 330
+++++ +IG G FG VY+ L VA+K++ + RE+ ++ H N
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCN 74
Query: 331 LLQLIGYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 384
+++L + +S E+ LV ++ R ++ L K +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 385 GLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 443
L Y+H I HRD+K N+LLD D LCDFG AK + + I
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYR 189
Query: 444 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503
+ DV+ G L EL+ GQ F + L I K+L
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVD---QLVEIIKVLGTPTR 244
Query: 504 NDIVDRNLNTYDSKEVETMVQ--------------VALL--CTQSTPEDRPPMAQVVK 545
I + N N + K + +AL + TP R +
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-36
Identities = 56/284 (19%), Positives = 97/284 (34%), Gaps = 33/284 (11%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISV 325
D + +G G F V K S + A K R + +REV ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 326 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 385
H N++ L ++ IL+ + L D ++ L G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 386 LEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLCDFGLAKLVDAKLTHVTTQIRGTM 441
+ YLH I H DLK NI+L D + DFGLA +D + I GT
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTP 180
Query: 442 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501
+APE ++ + D++ G+ L++G +E L ++ + E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVSAVNYEF 235
Query: 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
+ S + ++ P+ R + ++
Sbjct: 236 E------DEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 5e-36
Identities = 52/276 (18%), Positives = 103/276 (37%), Gaps = 32/276 (11%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIG 336
++G G GKV + K A+K LQD +REV L A ++++++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVD 72
Query: 337 YCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 392
++V + + R++ G++ + ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 393 CNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
I HRD+K N+L L DFG AK + + T T ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 450 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509
K + D++ G+ + L+ G + + ++ +R +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQYE--FPN 238
Query: 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
+ S+EV+ +++ ++ P R + + +
Sbjct: 239 PEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 1e-35
Identities = 56/277 (20%), Positives = 98/277 (35%), Gaps = 43/277 (15%)
Query: 279 IIGQGGFGKVYKGV-LSDNTKVAVKRL-----QDYYSPGGEAAFQREVHLIS--VAIHKN 330
++G GGFG VY G+ +SDN VA+K + D+ EV L+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 331 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 390
+++L+ + +L+ + + L D L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 391 EQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
++HRD+K NIL+D + E L DFG L+ V T GT + PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 181
Query: 450 STGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508
+ V+ GI L ++V G + V + + ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ-----HLIR 236
Query: 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
C P DRP ++
Sbjct: 237 W-------------------CLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 2e-34
Identities = 54/288 (18%), Positives = 103/288 (35%), Gaps = 21/288 (7%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 329
+ + IG+G +G V+K + VA+KR++ D G ++ RE+ L+ HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N+++L + + LV+ F + LD K F GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H + ++HRDLK N+L++ N E L +FGLA+ + + ++
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 450 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509
S D++ G EL R + +++ + + E +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 510 NLNTYDSKEVETMVQVALL------------CTQSTPEDRPPMAQVVK 545
+ Y T + + + P R + ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 6e-33
Identities = 45/207 (21%), Positives = 79/207 (38%), Gaps = 11/207 (5%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 328
++F ++G+G FGKV + A+K L + + A E ++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
L L T V + + + L T +R F A +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSA 117
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
L + +++RD+K N++LD + + DFGL K + GT ++APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 449 LSTGKSSEKTDVFGYGITLLELVTGQR 475
L D +G G+ + E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (313), Expect = 4e-32
Identities = 45/207 (21%), Positives = 75/207 (36%), Gaps = 14/207 (6%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 328
D F +G G FG+V A+K L Q E ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
L++L +S +V ++ + P + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAG----GEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
LH +I+RDLK N+L+D + DFG AK ++ T + GT +APE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEI 209
Query: 449 LSTGKSSEKTDVFGYGITLLELVTGQR 475
+ + ++ D + G+ + E+ G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 6e-32
Identities = 67/310 (21%), Positives = 109/310 (35%), Gaps = 39/310 (12%)
Query: 264 CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVH 321
C E+ + + IGQG FG+V+K KVA+K++ + G RE+
Sbjct: 6 CDEV----SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 322 LISVAIHKNLLQLIGYCTTSSERI--------LVYPFMQNLSVAYRLRDLKPGEKGLDWP 373
++ + H+N++ LI C T + LV+ F ++ L
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLS 117
Query: 374 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-- 431
KRV L L+ KI+HRD+KAAN+L+ + L DFGLA+
Sbjct: 118 EIKRVMQML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 432 -HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ------------RAI 477
+ T T+ + PE L + D++G G + E+ T I
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 478 DFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALL--CTQSTPE 535
+V +L + L R + V + L+ P
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 536 DRPPMAQVVK 545
R +
Sbjct: 295 QRIDSDDALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 8e-32
Identities = 51/289 (17%), Positives = 103/289 (35%), Gaps = 21/289 (7%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 329
+ + +G G +G V V KVA+K+L + + S RE+ L+ H+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N++ L+ T F + + L + + + GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 390 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 449
H HRDLK N+ ++++ E + DFGLA+ D+++ T + L
Sbjct: 138 HAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVIL 191
Query: 450 STGKSSEKTDVFGYGITLLELVTG-------------QRAIDFSRLEEEEDVLLLDHIRK 496
+ + ++ D++ G + E++TG + + + E V L
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 497 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545
L ++ ++ + + V + E R + +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 115 bits (289), Expect = 5e-29
Identities = 48/250 (19%), Positives = 97/250 (38%), Gaps = 22/250 (8%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHK 329
D++ +G+G + +V++ + +++N KV VK L P + +RE+ ++ +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGP 90
Query: 330 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 389
N++ L R F D K + L + + L+Y
Sbjct: 91 NIITLADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTLTDYDIRFYMYEILKALDYC 145
Query: 390 HEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE- 447
H I+HRD+K N+++D ++ + L D+GLA+ + + PE
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 448 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507
+ D++ G L ++ + ++ L I K+L + L D +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFF----HGHDNYDQLVRIAKVLGTEDLYDYI 256
Query: 508 DRNLNTYDSK 517
D+ D +
Sbjct: 257 DKYNIELDPR 266
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-27
Identities = 43/206 (20%), Positives = 85/206 (41%), Gaps = 8/206 (3%)
Query: 271 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIH 328
+ + + +G G +G V +VAVK+L + + S RE+ L+ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
+N++ L+ T + + + + L + + + GL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 448
+H HRDLK +N+ ++++ E + DFGLA+ D +T +
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 190
Query: 449 LSTGKSSEKTDVFGYGITLLELVTGQ 474
L+ ++ D++ G + EL+TG+
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 1e-27
Identities = 57/281 (20%), Positives = 97/281 (34%), Gaps = 31/281 (11%)
Query: 272 DNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRL---QDYYSPGGEAAFQREVHLIS 324
+NF ++G G +GKV+ A+K L + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 325 VAIHK-NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 383
L+ L T ++ L+ ++ + L + T V
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-------FTEHEVQIYVG 136
Query: 384 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 443
+ L II+RD+K NILLD N VL DFGL+K A T GT+ +
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 444 IAPEYLSTGKS--SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501
+AP+ + G S + D + G+ + EL+TG F+ E+ +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSEPP 254
Query: 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 542
++ S + ++Q P+ R
Sbjct: 255 YPQEM---------SALAKDLIQ---RLLMKDPKKRLGCGP 283
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (276), Expect = 4e-27
Identities = 48/235 (20%), Positives = 89/235 (37%), Gaps = 21/235 (8%)
Query: 280 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-----------VAI 327
+G G F V+ + +NT VA+K ++ A + E+ L+
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 328 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGL 386
++L+L+ + + + + L +K E K+++ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 387 EYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGHI 444
+Y+H +C IIH D+K N+L++ + L +A L +A T +
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 445 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 499
+PE L D++ + EL+TG F E DHI +++
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIE 249
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (274), Expect = 6e-27
Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 12/207 (5%)
Query: 272 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 329
+ IG G G V + VA+K+L + + + RE+ L+ HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 330 NLLQLIGYCTTSS--ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 387
N++ L+ T E + L A + ++ LD + + G++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133
Query: 388 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 447
+LH IHRDLK +NI++ + + DFGLA+ + + T T + APE
Sbjct: 134 HLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPE 188
Query: 448 YLSTGKSSEKTDVFGYGITLLELVTGQ 474
+ E D++ G + E+V +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.4 bits (213), Expect = 4e-20
Identities = 20/159 (12%), Positives = 42/159 (26%), Gaps = 20/159 (12%)
Query: 278 NIIGQGGFGKVYKGVLSDNTKVAVK---------RLQDYYSPGGEAAFQREVHLISVAIH 328
++G+G V+ + VK + G+ F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 329 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 388
+ L +L G + + + V +
Sbjct: 66 RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 389 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427
+ + I+H DL N+L+ + + DF + V
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVG 153
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.6 bits (166), Expect = 3e-13
Identities = 18/63 (28%), Positives = 28/63 (44%), Gaps = 1/63 (1%)
Query: 104 SFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTG 163
+ +L++N + GTLP L + L SLN++ N G IP L ++N
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLC 305
Query: 164 RIP 166
P
Sbjct: 306 GSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.9 bits (159), Expect = 3e-12
Identities = 24/71 (33%), Positives = 34/71 (47%), Gaps = 3/71 (4%)
Query: 124 MTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP--MQLFSVATFNFTGTH 181
+L L+L NN+ G++P +QL L L++S NNL G IP L +
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 182 LICGSSLEQPC 192
+CGS L C
Sbjct: 303 CLCGSPLP-AC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 38/143 (26%), Positives = 60/143 (41%), Gaps = 9/143 (6%)
Query: 36 EGEALIEVLKALNDTHGQFTDWNDHFVSPC-FSWSHVTCRNGN----VISLTLGSNGFSG 90
+ +AL+++ K L + + W C +W V C V +L L
Sbjct: 7 DKQALLQIKKDLGN-PTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 91 K--ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQL 148
I S+ L +L N+L G +P + +T L L + + SG+IP SQ+
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 149 SNLKHLDLSSNNLTGRIPMQLFS 171
L LD S N L+G +P + S
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISS 147
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.0 bits (157), Expect = 7e-12
Identities = 28/159 (17%), Positives = 54/159 (33%), Gaps = 13/159 (8%)
Query: 2 FGALHKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHF 61
+L L + + L+ E + + + T + N++
Sbjct: 237 LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN- 295
Query: 62 VSPCFSWSHVTCRNGNVISLTLGSNGFSGKIS-PSITKLKFLASFRELQDNDLSGTLPDF 120
N+ LTL N S S+TKL+ L +N +S
Sbjct: 296 ---QLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRL----FFANNKVSD--VSS 346
Query: 121 LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 159
L ++T++ L+ +N+ S P + L+ + L L+
Sbjct: 347 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 61.6 bits (148), Expect = 9e-11
Identities = 19/61 (31%), Positives = 31/61 (50%), Gaps = 4/61 (6%)
Query: 108 LQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM 167
L N++S P + S+T LQ L ANNK S ++ + L+N+ L N ++ P+
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL 369
Query: 168 Q 168
Sbjct: 370 A 370
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 5e-07
Identities = 35/138 (25%), Positives = 50/138 (36%), Gaps = 9/138 (6%)
Query: 57 WNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSI-TKLKFLASFRELQDNDLSG 115
S S V + N+ SL +N S I T L L L N L
Sbjct: 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDEL----SLNGNQLKD 233
Query: 116 TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATF 175
L S+T+L L+LANN+ S P S L+ L L L +N ++ P+ + T
Sbjct: 234 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTN 289
Query: 176 NFTGTHLICGSSLEQPCM 193
+ + S
Sbjct: 290 LELNENQLEDISPISNLK 307
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 3e-05
Identities = 13/82 (15%), Positives = 32/82 (39%), Gaps = 9/82 (10%)
Query: 77 NVISLTLGSNGFSGKISPS-ITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANN 135
+ LG + +S + + ++ L L + G + + +L +N +NN
Sbjct: 23 EKMKTVLGKTNVTDTVSQTDLDQVTTL-QADRLGIKSIDG-----VEYLNNLTQINFSNN 76
Query: 136 KFSGSIPATWSQLSNLKHLDLS 157
+ + P L+ L + ++
Sbjct: 77 QLTDITP--LKNLTKLVDILMN 96
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 4e-05
Identities = 13/63 (20%), Positives = 26/63 (41%), Gaps = 4/63 (6%)
Query: 106 RELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRI 165
L +++ T+ + + +L SI L+NL ++ S+N LT
Sbjct: 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGV-EYLNNLTQINFSNNQLTDIT 82
Query: 166 PMQ 168
P++
Sbjct: 83 PLK 85
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 33/146 (22%), Positives = 49/146 (33%), Gaps = 26/146 (17%)
Query: 66 FSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMT 125
S N+ L+L N ++ L L +L +N +S P L +T
Sbjct: 209 ISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDL-DLANNQISNLAP--LSGLT 263
Query: 126 HLQSLNLANNKFSGSIP--------------------ATWSQLSNLKHLDLSSNNLTGRI 165
L L L N+ S P + S L NL +L L NN++
Sbjct: 264 KLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS 323
Query: 166 PM-QLFSVATFNFTGTHLICGSSLEQ 190
P+ L + F + SSL
Sbjct: 324 PVSSLTKLQRLFFANNKVSDVSSLAN 349
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 23/102 (22%), Positives = 38/102 (37%), Gaps = 15/102 (14%)
Query: 63 SPCF-SWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFL 121
C V C + + + + P L +LQ+N ++
Sbjct: 6 FRCQCHLRVVQCSDLGLEKVPKD-------LPPDTALL-------DLQNNKITEIKDGDF 51
Query: 122 GSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTG 163
++ +L +L L NNK S P ++ L L+ L LS N L
Sbjct: 52 KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE 93
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 12/45 (26%), Positives = 18/45 (40%)
Query: 125 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 169
L+L NNK + + L NL L L +N ++ P
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 26/123 (21%), Positives = 50/123 (40%), Gaps = 4/123 (3%)
Query: 41 IEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLK 100
++ L Q +++ ++ V+ L SG + + +K
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 101 FLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNN 160
L S+ + D +++ T+P G L L+L NK + A+ L+NL L LS N+
Sbjct: 151 KL-SYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 161 LTG 163
++
Sbjct: 207 ISA 209
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.0 bits (92), Expect = 5e-04
Identities = 13/63 (20%), Positives = 20/63 (31%), Gaps = 3/63 (4%)
Query: 109 QDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 168
SG M L + +A+ + +IP +L L L N +T
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAAS 190
Query: 169 LFS 171
L
Sbjct: 191 LKG 193
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.6 bits (91), Expect = 7e-04
Identities = 32/183 (17%), Positives = 57/183 (31%), Gaps = 13/183 (7%)
Query: 10 PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWS 69
P + L + N R+ G + V++ + N F
Sbjct: 95 PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 154
Query: 70 HVTCRNG----------NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPD 119
++ L L N + + S+ L LA N +S
Sbjct: 155 IRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL-SFNSISAVDNG 213
Query: 120 FLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 179
L + HL+ L+L NNK +P + ++ + L +NN++ I F +N
Sbjct: 214 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA-IGSNDFCPPGYNTKK 271
Query: 180 THL 182
Sbjct: 272 ASY 274
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 1e-07
Identities = 13/70 (18%), Positives = 24/70 (34%), Gaps = 5/70 (7%)
Query: 107 ELQDNDLSGT-LPDFLGSMTHLQSLNLANNKFSG----SIPATWSQLSNLKHLDLSSNNL 161
++Q +LS + L + Q + L + + I + L L+L SN L
Sbjct: 8 DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL 67
Query: 162 TGRIPMQLFS 171
+
Sbjct: 68 GDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 4e-07
Identities = 19/131 (14%), Positives = 38/131 (29%), Gaps = 13/131 (9%)
Query: 48 NDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRE 107
+ + + + N G + + L+ L
Sbjct: 320 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL----W 375
Query: 108 LQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGSIPATWSQ-----LSNLKHLDLSS 158
L D D+S + L L + L+ L+L+NN + + L+ L L
Sbjct: 376 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYD 435
Query: 159 NNLTGRIPMQL 169
+ + +L
Sbjct: 436 IYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 3e-05
Identities = 15/97 (15%), Positives = 31/97 (31%), Gaps = 17/97 (17%)
Query: 77 NVISLTLGSNGFSGK----ISPSITKLKFLASFRELQDNDLSG----TLPDFLGSMTHLQ 128
++ SL + S + P + + + + L D L+ + L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVV----RLDDCGLTEARCKDISSALRVNPALA 58
Query: 129 SLNLANNKFSGSIP-----ATWSQLSNLKHLDLSSNN 160
LNL +N+ + ++ L L +
Sbjct: 59 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 3e-05
Identities = 17/60 (28%), Positives = 25/60 (41%), Gaps = 4/60 (6%)
Query: 123 SMTHLQSLNLANNKFSG----SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFT 178
+ L+ L LA+ S S+ AT +L+ LDLS+N L +QL
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 2e-04
Identities = 11/57 (19%), Positives = 19/57 (33%), Gaps = 1/57 (1%)
Query: 127 LQSLNLANNKFSGS-IPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 182
+QSL++ + S + L + + L LT + S N L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 2e-06
Identities = 14/70 (20%), Positives = 24/70 (34%), Gaps = 1/70 (1%)
Query: 92 ISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 151
+ P + L +N+L+ L + +L +L L N +IP + L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 152 KHLDLSSNNL 161
L N
Sbjct: 198 PFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 4e-05
Identities = 12/53 (22%), Positives = 18/53 (33%), Gaps = 3/53 (5%)
Query: 108 LQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNN 160
+L+ LP L L+L+ N AT + L L+L
Sbjct: 17 CDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 2e-06
Identities = 23/138 (16%), Positives = 39/138 (28%), Gaps = 5/138 (3%)
Query: 45 KALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLAS 104
L + P + N L + +S +I
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263
Query: 105 FRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR 164
N S + L+ LN++NNK +PA L+ L S N+L
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-E 318
Query: 165 IPMQLFSVATFNFTGTHL 182
+P ++ + L
Sbjct: 319 VPELPQNLKQLHVEYNPL 336
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 3e-06
Identities = 21/116 (18%), Positives = 35/116 (30%), Gaps = 13/116 (11%)
Query: 57 WNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGT 116
+ F+ + + S+ + L+ L + +N L
Sbjct: 244 QSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEEL----NVSNNKLI-E 298
Query: 117 LPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSV 172
LP L+ L + N + +P NLK L + N L P SV
Sbjct: 299 LPALPPR---LERLIASFNHLA-EVP---ELPQNLKQLHVEYNPLRE-FPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.002
Identities = 18/57 (31%), Positives = 28/57 (49%), Gaps = 8/57 (14%)
Query: 107 ELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTG 163
EL + LS +LP+ HL+SL + N + +P +LK L + +NNL
Sbjct: 44 ELNNLGLS-SLPELPP---HLESLVASCNSLT-ELP---ELPQSLKSLLVDNNNLKA 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.1 bits (84), Expect = 0.004
Identities = 15/60 (25%), Positives = 23/60 (38%), Gaps = 5/60 (8%)
Query: 125 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLIC 184
L L N S S+P +L+ L S N+LT +P S+ + +L
Sbjct: 38 RQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 6e-06
Identities = 16/48 (33%), Positives = 25/48 (52%), Gaps = 4/48 (8%)
Query: 110 DNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 157
DN +S P L S+ +L ++L NN+ S P + SNL + L+
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 13/51 (25%), Positives = 24/51 (47%), Gaps = 2/51 (3%)
Query: 118 PDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 168
L +++ L +L +NK S P + L NL + L +N ++ P+
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA 214
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 1e-05
Identities = 15/133 (11%), Positives = 33/133 (24%), Gaps = 2/133 (1%)
Query: 112 DLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 171
+L + + + L+L K I + L +D S N + L
Sbjct: 6 ELIEQAAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLR 63
Query: 172 VATFNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACR 231
+ IC + + L + + L+ +
Sbjct: 64 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123
Query: 232 YQKLRKLKHDVFF 244
+ + V +
Sbjct: 124 VTNKKHYRLYVIY 136
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.7 bits (96), Expect = 7e-05
Identities = 27/145 (18%), Positives = 45/145 (31%), Gaps = 2/145 (1%)
Query: 48 NDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRE 107
+ ++ L LG N + L L +
Sbjct: 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN- 108
Query: 108 LQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM 167
L DN +S +P + L SLNLA+N F+ + W L+ L+ P
Sbjct: 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPS 167
Query: 168 QLFSVATFNFTGTHLICGSSLEQPC 192
++ V + + C S + C
Sbjct: 168 KVRDVQIKDLPHSEFKCSSENSEGC 192
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (98), Expect = 8e-05
Identities = 23/116 (19%), Positives = 38/116 (32%), Gaps = 3/116 (2%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNL 132
GN+ L L N S + L L L N ++ P + L +L L
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL-LHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 133 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS--VATFNFTGTHLICGS 186
N S + L L++L L+ N + + F + + + C
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 0.002
Identities = 12/56 (21%), Positives = 22/56 (39%), Gaps = 4/56 (7%)
Query: 108 LQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTG 163
L DN LQ ++++ S+P +L+ L++N+L G
Sbjct: 232 LNDNPWVCD-CRARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 13/69 (18%), Positives = 22/69 (31%), Gaps = 11/69 (15%)
Query: 105 FRELQDNDLSGTLPDFLGSM------THLQSLNLANNKFSGSIP-----ATWSQLSNLKH 153
L D LS + LQ+L L N+ ++ +L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 154 LDLSSNNLT 162
L+L+ N +
Sbjct: 307 LELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 5e-04
Identities = 10/88 (11%), Positives = 24/88 (27%), Gaps = 8/88 (9%)
Query: 104 SFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG----SIPATWSQLSNLKHLDLSSN 159
+ D ++ L ++ + L+ N + + +L+ + S
Sbjct: 11 KLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69
Query: 160 ---NLTGRIPMQLFSVATFNFTGTHLIC 184
+ IP L + L
Sbjct: 70 FTGRVKDEIPEALRLLLQALLKCPKLHT 97
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 1e-04
Identities = 19/88 (21%), Positives = 31/88 (35%), Gaps = 5/88 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136
V L L N P++ L+ L + + D + ++ LQ L L NN+
Sbjct: 21 LVTHLDLSHNRLRALP-PALAALRCLEVLQASDNAL---ENVDGVANLPRLQELLLCNNR 76
Query: 137 F-SGSIPATWSQLSNLKHLDLSSNNLTG 163
+ L L+L N+L
Sbjct: 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.001
Identities = 15/70 (21%), Positives = 25/70 (35%), Gaps = 4/70 (5%)
Query: 128 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP--MQLFSVATFNFTGTHLICG 185
+ L+LA+ + + QL + HLDLS N L P L + + L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 186 SSLEQPCMSR 195
+ +
Sbjct: 59 DGVANLPRLQ 68
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.5 bits (81), Expect = 0.004
Identities = 17/85 (20%), Positives = 28/85 (32%), Gaps = 23/85 (27%)
Query: 108 LQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA---------------------TWS 146
L DL T+ L + + L+L++N+ PA +
Sbjct: 5 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 147 QLSNLKHLDLSSNNLTGRIPMQLFS 171
L L+ L L +N L +Q
Sbjct: 63 NLPRLQELLLCNNRLQQSAAIQPLV 87
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 2e-04
Identities = 15/38 (39%), Positives = 21/38 (55%), Gaps = 2/38 (5%)
Query: 121 LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSS 158
L +T LQ+L L+ N S + A + L NL L+L S
Sbjct: 174 LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 11/79 (13%), Positives = 25/79 (31%), Gaps = 4/79 (5%)
Query: 106 RELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRI 165
L+ ++ + + + + N+ L N+ L L+ N LT
Sbjct: 29 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIK 84
Query: 166 PMQLFSVATFNFTGTHLIC 184
P+ + F + +
Sbjct: 85 PLANLKNLGWLFLDENKVK 103
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 6e-04
Identities = 7/48 (14%), Positives = 15/48 (31%), Gaps = 3/48 (6%)
Query: 119 DFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166
D + L+++ + L L+ NL ++P
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 12/64 (18%), Positives = 26/64 (40%), Gaps = 5/64 (7%)
Query: 112 DLSGT--LPDFLGSMT--HLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM 167
DL+G PD G + + + + + +S ++H+DLS++ +
Sbjct: 6 DLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLH 64
Query: 168 QLFS 171
+ S
Sbjct: 65 GILS 68
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 596 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.62 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.32 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.29 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.29 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.27 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.17 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.16 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.07 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.99 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.89 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.71 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.71 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.65 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.61 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.58 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.55 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.52 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.48 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.21 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.19 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.14 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.1 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.92 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.83 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.61 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.61 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.43 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.33 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.77 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.61 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.22 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.08 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.38 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 93.44 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 93.0 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=408.15 Aligned_cols=260 Identities=29% Similarity=0.455 Sum_probs=204.9
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
+..++|+..+.||+|+||+||+|++++ .||||+++.. .+....+.|.+|++++.+++|||||++++++.+ +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 345789999999999999999998643 5999999743 345566889999999999999999999998754 568999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++... +..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999753 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCc-ceeccccccccccCcccccC---CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 428 AKLT-HVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 428 ~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
.... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+...+.. +.
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----~~~~~~~~----~~- 226 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGR----GY- 226 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHH----TS-
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH----HHHHHHhc----CC-
Confidence 4322 23345679999999999864 357999999999999999999999997533211 11111211 11
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+.+...+...+.++.+++.+||+.||++||||+||+++|+.
T Consensus 227 ---~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 227 ---LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp ---CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111112233445678899999999999999999999999974
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=405.35 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=200.1
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 351 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 351 (596)
++|+..+.||+|+||+||+|.+.+++.||||+++.. ....++|.+|++++++++||||++++|+|.+++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 578888999999999999999988999999999753 334678999999999999999999999999999999999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++|+|.+++... ...++|..+..++.|+|.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999998753 34689999999999999999999999 999999999999999999999999999987765444
Q ss_pred ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhC-CCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 432 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 432 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg-~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.......||+.|+|||++.+..++.++|||||||++|||+|+ ++|+..... ..+...+....+.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----~~~~~~i~~~~~~---------- 221 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDISTGFRL---------- 221 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----HHHHHHHHHTCCC----------
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHhcCCC----------
Confidence 444445689999999999999999999999999999999995 444443211 1122222221110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+...+.++.+++.+||+.||++||||+||+++|++
T Consensus 222 --~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 222 --YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1122334678899999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=409.14 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=209.8
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
+..++|+..+.||+|+||+||+|.+++++.||||+++.. ....+.|.+|++++++++|||||+++|++.+ +..++||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC--cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 345678889999999999999999988899999999743 3346789999999999999999999998754 5679999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++.... ...++|..+++++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 87 Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp ECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999999876432 23589999999999999999999999 999999999999999999999999999998765
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
..........||+.|+|||++.+..++.++|||||||++|||+||..|+..... .......+.. ..+
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~~~~~~i~~---~~~------ 228 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVIQNLER---GYR------ 228 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHT---TCC------
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----HHHHHHHHHh---cCC------
Confidence 544444556789999999999999999999999999999999997665542211 1112222221 110
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
+ ..+...+.++.+++.+||+.||++||||+||++.|++
T Consensus 229 ~---~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 229 M---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C---CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 0 1122344578899999999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=395.25 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=214.8
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
.++|+..+.||+|+||+||+|++++++.||||+++.. ....++|.+|+.++++++||||++++|+|.+++..++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 3689999999999999999999988999999999753 33467899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++|++..++... ...+++..+.+++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999987653 34689999999999999999999999 99999999999999999999999999998776554
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+...+.. ..+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----~~~~~i~~---~~~------- 219 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHIAQ---GLR------- 219 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHHHHHT---TCC-------
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-----HHHHHHHh---CCC-------
Confidence 444444668999999999999999999999999999999998 79999754321 12222221 111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...+...+.++.+++.+||+.||++|||++|+++.|.++
T Consensus 220 --~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 --LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 011223346788999999999999999999999999753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-51 Score=407.23 Aligned_cols=261 Identities=25% Similarity=0.359 Sum_probs=215.9
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 267 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 267 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
+++..++|+..+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|++++++++|||||++++++.+.+..+
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT--CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc--cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 3445677888999999999999999975 6889999998753 334678999999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 90 iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceee
Confidence 9999999999999997532 35789999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
.............|++.|+|||++.+..++.++|||||||++|||++|..|+..... ...+.+.+. .+..
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~~~~~~i~----~~~~-- 234 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLE----KDYR-- 234 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHHHHH----TTCC--
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----HHHHHHHHh----cCCC--
Confidence 766544444555689999999999999999999999999999999997776643221 111222221 1110
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...+...+.++.+++.+||+.||++|||++||++.|+..
T Consensus 235 ------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 235 ------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112233456788999999999999999999999999764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=399.09 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=203.0
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||+|+||+||+|+.. +|+.||||++.........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57888999999999999999975 78999999997544444456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999875 35699999999999999999999999 99999999999999999999999999998765432
Q ss_pred c-ceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 431 T-HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 431 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
. .......||+.|+|||++.+..+ +.++|||||||++|||+||+.||........ .... .. ......
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~~~-~~---~~~~~~---- 226 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSD-WK---EKKTYL---- 226 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH---HHHH-HH---TTCTTS----
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH---HHHH-Hh---cCCCCC----
Confidence 2 22345679999999999988776 5789999999999999999999975432111 1111 11 111000
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
......+.++.+++.+||+.||++|||++|+++
T Consensus 227 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011223456788999999999999999999854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-50 Score=405.60 Aligned_cols=255 Identities=27% Similarity=0.392 Sum_probs=200.1
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CC---cEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
++|+..+.||+|+||+||+|.++ ++ ..||||++.........+.|.+|++++++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45667789999999999999975 23 358999987666666678899999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++... ...++|.++..++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999988752 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcce----eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 428 AKLTHV----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 428 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
...... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||..... ..+...+.. ..+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----~~~~~~i~~---~~~ 251 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----QDVINAIEQ---DYR 251 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHT---TCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----HHHHHHHHc---CCC
Confidence 432221 122457899999999999999999999999999999998 8999875332 112222221 111
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+...+.++.+++.+||+.||++||||.||++.|++
T Consensus 252 ---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 252 ---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11223345678899999999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-51 Score=402.46 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=197.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEec--CCeeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv 347 (596)
++|+..+.||+|+||+||+|+.+ +|+.||+|++... .++...+.|.+|++++++++||||+++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999964 7899999998743 344456779999999999999999999999865 3457899
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC--NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
|||+++|+|.+++.........+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998754433567999999999999999999999862 12499999999999999999999999999987
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .+...+. .+...
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-----~~~~~i~----~~~~~- 232 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-----ELAGKIR----EGKFR- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHH----HTCCC-
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-----HHHHHHH----cCCCC-
Confidence 754322 233467999999999999999999999999999999999999999753321 1222221 11111
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
..+...+.++.+++.+||+.||++|||+.|+++
T Consensus 233 -------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112233457889999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-50 Score=398.64 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=203.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCC-----cEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
.+.|+..++||+|+||+||+|.++++ ..||||+++..........|.+|++++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35677889999999999999996532 4699999976666666778999999999999999999999999999999
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+||||+.++++.+.+... ...++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999887753 34699999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCc--ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 426 VDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 426 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
...... .......||+.|+|||++.+..++.++|||||||++|||+||..|+..... ...+...+.. +.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~----~~~~~~~i~~----~~- 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----NHEVMKAIND----GF- 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHT----TC-
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC----HHHHHHHHhc----cC-
Confidence 654322 222334689999999999999999999999999999999997666543221 1112222221 10
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
....+...+.++.+++.+||+.||++||+|.||+++|+.
T Consensus 231 -------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 231 -------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp -------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 111223345678899999999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-50 Score=393.56 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=206.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||+||+|+.+ +++.||+|++... ........+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57888999999999999999975 6899999998632 12334677899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999986 34689999999999999999999999 999999999999999999999999999986654
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+. ...
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~~i~---~~~------- 220 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----ETYKRIS---RVE------- 220 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHH---TTC-------
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-----HHHHHHH---cCC-------
Confidence 32 23456999999999999999999999999999999999999999754321 1111111 111
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. ..+...+.++.+++.+||+.||++|||++|+++
T Consensus 221 ~---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 F---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0 112233467888999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-50 Score=397.82 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=208.2
Q ss_pred cCCCcCce-eeecCceEEEEEEeC---CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 272 DNFSESNI-IGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 272 ~~f~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
++|...+. ||+|+||+||+|.++ ++..||||+++........+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45555664 999999999999864 4557999999866666667889999999999999999999999865 467999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999987642 34699999999999999999999999 99999999999999999999999999999775
Q ss_pred ccCcc--eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 428 AKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 428 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+. .+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-----~~~~~i~----~~~~- 230 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVMAFIE----QGKR- 230 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----HHHHHHH----TTCC-
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-----HHHHHHH----cCCC-
Confidence 54322 2233458999999999999999999999999999999998 89999753321 1222222 1111
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+...+.++.+++.+||+.||++||||.+|++.|+.
T Consensus 231 -------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 231 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11223345678899999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=408.36 Aligned_cols=269 Identities=22% Similarity=0.302 Sum_probs=209.0
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
+..++|+..+.||+|+||+||+|+.. +|+.||+|+++....+.....+.+|+.++++++|||||++++++.+.+..++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999964 78999999998655566677899999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++.+. ..+++..+..++.|++.||.|||+++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 83 mEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999999762 45899999999999999999999732 79999999999999999999999999998764
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHh-------cc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL-------RE 500 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~-------~~ 500 (596)
... .....||+.|+|||++.+.+++.++||||+||++|||+||+.||......+.............. ..
T Consensus 157 ~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CCc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 322 23457999999999999999999999999999999999999999764432111000000000000 00
Q ss_pred --------------Ccccc----cccCcCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 --------------DRLND----IVDRNLNTY-DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 --------------~~~~~----~~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+ +........ ....+.++.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000 000000000 01124578899999999999999999999763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=390.51 Aligned_cols=249 Identities=20% Similarity=0.297 Sum_probs=206.6
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4799999999999999999996 479999999987432 23457799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999998764 3589999999999999999999999 99999999999999999999999999998775433
Q ss_pred cceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... . .......... .
T Consensus 171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~---~~~~~~~~~~-~----- 235 (293)
T d1yhwa1 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----A---LYLIATNGTP-E----- 235 (293)
T ss_dssp C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----H---HHHHHHHCSC-C-----
T ss_pred c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-----H---HHHHHhCCCC-C-----
Confidence 2 2334569999999999999999999999999999999999999997533211 1 1111111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+ ..+.....++.+++.+||+.||++|||+.|+++
T Consensus 236 ~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 L-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp C-SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred C-CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 112233567889999999999999999999965
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=391.15 Aligned_cols=247 Identities=25% Similarity=0.344 Sum_probs=199.8
Q ss_pred ceeeecCceEEEEEEeC---CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEcccC
Q 007608 278 NIIGQGGFGKVYKGVLS---DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 353 (596)
Q Consensus 278 ~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 353 (596)
+.||+|+||+||+|.+. .++.||||+++.. .++...+.|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999864 3568999999743 334456789999999999999999999999865 457899999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCcce
Q 007608 354 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 433 (596)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 433 (596)
|+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999886 35699999999999999999999999 99999999999999999999999999998765443322
Q ss_pred --eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCcccccccCc
Q 007608 434 --TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 510 (596)
Q Consensus 434 --~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 510 (596)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+...+. .+..
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-----~~~~~i~----~~~~------- 228 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVTAMLE----KGER------- 228 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHH----TTCC-------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-----HHHHHHH----cCCC-------
Confidence 234568999999999999999999999999999999998 89999753321 1222222 1110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 511 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 511 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+...+.++.+++.+||+.||++|||++||+++|+.
T Consensus 229 -~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11223345678899999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=397.25 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=204.1
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
..++|++.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++.+++|||||+++|+|.+ +..++|||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 34678899999999999999999988889999999743 3345789999999999999999999999854 56899999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++|+|..++.... ...++|.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 y~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 92 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999998887532 24699999999999999999999999 9999999999999999999999999999877554
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccccC
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 509 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 509 (596)
.........||+.|+|||++.++.++.++|||||||++|||+||..|+..... .......+....+
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----~~~~~~~i~~~~~---------- 232 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYR---------- 232 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHTTCC----------
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----HHHHHHHHHhcCC----------
Confidence 43334445689999999999999999999999999999999997766553221 1122222221110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 510 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 510 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
...+...+.++.+++.+||+.||++||+|++|+++|++.
T Consensus 233 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 233 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred --CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 012233456788999999999999999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-49 Score=398.20 Aligned_cols=267 Identities=25% Similarity=0.392 Sum_probs=217.2
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeE
Q 007608 264 CRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 337 (596)
Q Consensus 264 ~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~ 337 (596)
+.+++...++|+..+.||+|+||+||+|+.+ +++.||||+++........+.|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3455667789999999999999999999863 4578999999866666667889999999999999999999999
Q ss_pred EecCCeeEEEEEcccCCChhhhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 007608 338 CTTSSERILVYPFMQNLSVAYRLRDLKP--------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 397 (596)
Q Consensus 338 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 397 (596)
|.+.+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. ++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999864221 123589999999999999999999999 99
Q ss_pred EecCCCCCcEEEcCCCcEEEeeccccccccccCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCC-C
Q 007608 398 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-R 475 (596)
Q Consensus 398 vH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~-~ 475 (596)
+||||||+|||++.++.+||+|||+++....... .......|++.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986644322 2333456889999999999999999999999999999999996 5
Q ss_pred CCCCccchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 476 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 476 p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
||..... ......+. .+.. ...+...+.++.+++.+||+.||++||||.||+++|+++
T Consensus 242 p~~~~~~-----~e~~~~v~----~~~~--------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAH-----EEVIYYVR----DGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCH-----HHHHHHHH----TTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCH-----HHHHHHHH----cCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 6654322 11222222 1111 112233445788999999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=400.39 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=208.6
Q ss_pred HHhcCCCcCceeeecCceEEEEEEeCC-C-----cEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecC
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVLSD-N-----TKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 341 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 341 (596)
+..++|+..+.||+|+||+||+|+... + ..||+|++...........|.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 345678889999999999999998642 2 369999987655555667899999999998 899999999999999
Q ss_pred CeeEEEEEcccCCChhhhhcccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKP-------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 402 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl 402 (596)
+..++||||+++|+|.++++.... ....+++..++.++.||+.||+|||++ +|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999975432 123589999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCc
Q 007608 403 KAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 480 (596)
Q Consensus 403 kp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~ 480 (596)
||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876554332 2334568999999999999999999999999999999998 89999753
Q ss_pred cchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 007608 481 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 548 (596)
Q Consensus 481 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 548 (596)
... ..+...+.. +. .. ..+...+.++.+++.+||+.||++|||++||+++|.
T Consensus 271 ~~~----~~~~~~~~~----~~-----~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVD----ANFYKLIQN----GF-----KM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCS----HHHHHHHHT----TC-----CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHH----HHHHHHHhc----CC-----CC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 321 112222221 11 00 112234567889999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=383.36 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=195.9
Q ss_pred CcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEec----CCeeEEEE
Q 007608 275 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERILVY 348 (596)
Q Consensus 275 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 348 (596)
+..+.||+|+||+||+|... +++.||+|++... ......+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999975 6889999998743 344456789999999999999999999999864 34578999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc-CCCcEEEeecccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DfGl~~~~~ 427 (596)
||+++|+|.+++.. ...+++..++.++.||++||+|||++ +++|+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999976 34689999999999999999999998 12399999999999996 57899999999998654
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.. ......||+.|+|||++.+ +++.++|||||||++|||+||+.||...... ..+...+. .+.....+
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~----~~~~~~i~----~~~~~~~~ 234 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVT----SGVKPASF 234 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHT----TTCCCGGG
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH----HHHHHHHH----cCCCCccc
Confidence 32 2234579999999999865 6999999999999999999999999743221 11111111 11111111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
+ .....++.+++.+||+.||++|||++|+++
T Consensus 235 ~-------~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 D-------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G-------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 112346788999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=390.03 Aligned_cols=251 Identities=25% Similarity=0.306 Sum_probs=205.2
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
+.|+..+.||+|+||+||+|+.. +++.||||++... .....+.|.+|++++++++|||||++++++.+.+..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 56888999999999999999964 7899999998643 344567889999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+++|+|.+++.+. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999987653 24699999999999999999999999 99999999999999999999999999997654321
Q ss_pred cceeccccccccccCccccc-----CCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccc
Q 007608 431 THVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 505 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 505 (596)
. ......||+.|+|||++. +..++.++|||||||++|||+||+.||...... .....+. .... .
T Consensus 165 ~-~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-----~~~~~i~---~~~~-~- 233 (288)
T d2jfla1 165 Q-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-----RVLLKIA---KSEP-P- 233 (288)
T ss_dssp H-HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----GHHHHHH---HSCC-C-
T ss_pred c-cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-----HHHHHHH---cCCC-C-
Confidence 1 223456999999999984 456899999999999999999999999754321 1111111 1110 0
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 506 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 506 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
....+...+.++.+++.+||+.||++|||++|+++
T Consensus 234 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 -----TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112334567889999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=390.91 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=199.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCC----CcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
..++|+..+.||+|+||+||+|++.. +..||||+++..........|.+|++++++++||||+++++++. .+..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 34678889999999999999998642 45699999876556666778999999999999999999999985 46789
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+||||+++|++.+++... ...+++..++.++.||++||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 84 iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999987652 34689999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 426 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 426 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
.............||+.|+|||++.+..++.++|||||||++|||+| |..||...... .+...+.. ...
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-----~~~~~i~~---~~~-- 227 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIEN---GER-- 227 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHT---TCC--
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-----HHHHHHHc---CCC--
Confidence 76544444455668999999999999999999999999999999998 88898754332 22222221 111
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+...+.++.+++.+||+.||++|||+.||++.|+.
T Consensus 228 -------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 228 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11223345678899999999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=389.33 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=204.5
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||+||+|+.. +|+.||||++... ......+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57899999999999999999974 7899999998632 12334577999999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999998876 34689999999999999999999999 999999999999999999999999999997754
Q ss_pred cCc-ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 429 KLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 429 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .+...+. ... .
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~~i~---~~~-~---- 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKII---KLE-Y---- 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHH---TTC-C----
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-----HHHHHHH---cCC-C----
Confidence 322 2334457999999999999999999999999999999999999999854321 1111111 111 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.++.....++.+++.+||+.||++|||++|+++
T Consensus 228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112233457889999999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-48 Score=391.73 Aligned_cols=253 Identities=22% Similarity=0.330 Sum_probs=192.2
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.+.|+..+.||+|+||+||+|+.. +++.||||++...........+.+|+.++++++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467899999999999999999975 6899999999754444455678899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc---CCCcEEEeeccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAKLV 426 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~DfGl~~~~ 426 (596)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++ +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999975 35699999999999999999999999 999999999999994 5789999999999876
Q ss_pred cccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+. .... .
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~~i~---~~~~--~- 227 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-----KLFEQIL---KAEY--E- 227 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHH---TTCC--C-
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHHh---ccCC--C-
Confidence 5432 223456999999999999999999999999999999999999999753321 1111111 1110 0
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.+. ......+.++.+++.+||+.||++|||++|++++
T Consensus 228 ~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FDS---PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCT---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCC---ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000 1122344678899999999999999999999884
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-47 Score=385.31 Aligned_cols=245 Identities=27% Similarity=0.349 Sum_probs=200.9
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCC--cchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.|+..+.||+|+||+||+|+.. +++.||||++..... ....+.|.+|++++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888999999999999999964 788999999874322 2334678999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++|++..++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999776654 35699999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcceeccccccccccCcccccC---CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 506 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 506 (596)
....||+.|+|||++.+ .+++.++|||||||++|||++|+.||...... +.+....... ....
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--------~~~~~i~~~~-~~~~ 234 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNE-SPAL 234 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSC-CCCC
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCC-CCCC
Confidence 23469999999999864 46899999999999999999999999743221 1111111111 1111
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.....+.++.+++.+||+.||++|||+.|+++
T Consensus 235 -------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11223457889999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=381.95 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=198.3
Q ss_pred hcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC-CeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-SERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e 349 (596)
.++|+..+.||+|+||.||+|.+ .|+.||||+++.. ...+.|.+|++++++++||||++++|+|.+. +..++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 35677789999999999999998 5789999999642 3457799999999999999999999998654 56799999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+++|+|.+++.... ...++|..+++++.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999997521 23589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
.....+++.|+|||++.+..++.++|||||||++|||+| |+.|+..... ..+...+.. +...
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----~~~~~~i~~----~~~~---- 219 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEK----GYKM---- 219 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHHHTT----TCCC----
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHc----CCCC----
Confidence 223357889999999999999999999999999999998 6777764322 123333321 1111
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
..+.....++.+++.+||+.||.+||||.|++++|+.+
T Consensus 220 ----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 220 ----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 12223346788999999999999999999999999763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=387.76 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=203.0
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCc----EEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 346 (596)
++|+..++||+|+||+||+|.+. +|+ +||+|+++...+....+.|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999964 444 58999987656666778899999999999999999999999865 5678
Q ss_pred EEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccc
Q 007608 347 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 426 (596)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~ 426 (596)
+++|+.+|+|.+.+... ...+++..+++++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 89999999999988753 35699999999999999999999999 9999999999999999999999999999977
Q ss_pred cccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCccc
Q 007608 427 DAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 504 (596)
Q Consensus 427 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 504 (596)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |..||+..... .+...+....+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-----~~~~~i~~~~~----- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEKGER----- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-----GHHHHHHHTCC-----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHcCCC-----
Confidence 544332 2333568999999999999999999999999999999999 78888754321 12222222110
Q ss_pred ccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 505 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 505 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
...+...+.++.+++.+||+.||++|||+.||++.|+.
T Consensus 232 -------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 232 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp -------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 11223345678899999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=379.59 Aligned_cols=252 Identities=22% Similarity=0.263 Sum_probs=205.9
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC-----CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 344 (596)
.++|+..+.||+|+||+||+|+. .+|+.||||++.... .....+.|.+|++++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999997 479999999986432 122467899999999999999999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC----cEEEeec
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF 420 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Df 420 (596)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999762 4699999999999999999999999 999999999999998776 4999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ ....+... .
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----~~~~i~~~--~ 232 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVSAV--N 232 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHTT--C
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-----HHHHHHhc--C
Confidence 9998765432 2234568999999999999999999999999999999999999998543211 11111110 0
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
...... .....+.++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YEFEDE-------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCCHH-------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCch-------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 01123456789999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=386.22 Aligned_cols=268 Identities=24% Similarity=0.356 Sum_probs=204.0
Q ss_pred cHHHHHHHhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceE
Q 007608 263 SCRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLI 335 (596)
Q Consensus 263 ~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~ 335 (596)
...++++..++|+..+.||+|+||.||+|... +++.||||+++........+.+.+|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34455556678999999999999999999853 34689999998666666677888898888877 689999999
Q ss_pred eEEecC-CeeEEEEEcccCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC
Q 007608 336 GYCTTS-SERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 402 (596)
Q Consensus 336 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl 402 (596)
+++... ...++||||+++|+|.++++.... ....+++..++.++.||++||+|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 998765 467999999999999999975321 124589999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCC-CCCCCc
Q 007608 403 KAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-RAIDFS 480 (596)
Q Consensus 403 kp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~-~p~~~~ 480 (596)
||+|||+++++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543332 234467999999999999999999999999999999999975 567543
Q ss_pred cchhhhhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 481 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 481 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
... ..+...+. .+... ..+...+.++.+++.+||+.||++|||+.||+++|++
T Consensus 241 ~~~----~~~~~~~~----~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 241 KID----EEFCRRLK----EGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp CCS----HHHHHHHH----HTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHH----HHHHHHHh----cCCCC--------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 221 11222222 11111 1122334578899999999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.2e-47 Score=386.80 Aligned_cols=253 Identities=22% Similarity=0.269 Sum_probs=207.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
-++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 358999999999999999999964 7899999998643 33446778999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc--CCCcEEEeecccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~DfGl~~~~~ 427 (596)
|+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++...
T Consensus 104 ~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 104 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred cCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 99999999998642 34699999999999999999999999 999999999999995 46789999999998775
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+.. .... .
T Consensus 178 ~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~~i~~---~~~~---~ 244 (350)
T d1koaa2 178 PKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-----ETLRNVKS---CDWN---M 244 (350)
T ss_dssp TTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH---TCCC---S
T ss_pred cccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHHHh---CCCC---C
Confidence 4332 23456899999999999999999999999999999999999999754321 11121211 1100 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
+. ......+.++.+++.+||+.||++|||++|++++
T Consensus 245 ~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DD---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CC---GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred Cc---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0111234578899999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=381.63 Aligned_cols=252 Identities=28% Similarity=0.399 Sum_probs=203.2
Q ss_pred CceeeecCceEEEEEEeCCC----cEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec-CCeeEEEEEcc
Q 007608 277 SNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILVYPFM 351 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~ 351 (596)
.++||+|+||+||+|++.++ ..||||+++........+.|.+|++++++++||||++++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999996432 36899999765566667889999999999999999999999875 46789999999
Q ss_pred cCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccCc
Q 007608 352 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 431 (596)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 431 (596)
++|+|.+++... ...+++..+++++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999988753 34578899999999999999999999 999999999999999999999999999987654322
Q ss_pred c---eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 432 H---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 432 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
. ......||+.|+|||++.+..++.++||||||+++|||+||+.|+..... .......+.. ..+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~----~~~~~~~i~~---g~~~----- 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDITVYLLQ---GRRL----- 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHT---TCCC-----
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC----HHHHHHHHHc---CCCC-----
Confidence 2 22335689999999999999999999999999999999998888764221 1112222221 1110
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
..+.....++.+++.+||+.||++||+|.||+++|+++
T Consensus 254 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11223345788999999999999999999999999753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=387.34 Aligned_cols=264 Identities=23% Similarity=0.362 Sum_probs=215.0
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEeC------CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEec
Q 007608 267 LQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 340 (596)
Q Consensus 267 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 340 (596)
+++..++|+..+.||+|+||+||+|.+. +++.||||+++..........|.+|++++++++||||++++++|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3445578888999999999999999863 3578999999865566666789999999999999999999999999
Q ss_pred CCeeEEEEEcccCCChhhhhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCc
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 414 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~ 414 (596)
.+..++||||+++|+|.+++.... .....+++..+.+++.|+|+||.|||+. +|+||||||+|||++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 999999999999999999886421 2234579999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccccCcce-eccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCC-CCCCCccchhhhhchHHH
Q 007608 415 AVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-RAIDFSRLEEEEDVLLLD 492 (596)
Q Consensus 415 ~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~-~p~~~~~~~~~~~~~l~~ 492 (596)
+||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||. .|+...... ....
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-----~~~~ 246 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----QVLR 246 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----HHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-----HHHH
Confidence 9999999998775543322 23345899999999999999999999999999999999985 566533221 1111
Q ss_pred HHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 493 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 493 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.+. . +. ....+...+..+.+++.+||+.+|++||||.||+++|++.
T Consensus 247 ~i~---~-~~--------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 247 FVM---E-GG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHH---T-TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHH---h-CC--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 121 1 11 1112233446799999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=383.27 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=203.5
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCc--EEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecCCeeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 347 (596)
++|+..++||+|+||+||+|+++ +|. .||||+++........+.|.+|++++.++ +||||++++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888899999999999999975 444 47888886555555667899999999998 799999999999999999999
Q ss_pred EEcccCCChhhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcE
Q 007608 348 YPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 415 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 415 (596)
|||+++|+|.++++... .....+++..+.+++.|||.||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997531 2245799999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCC-CCCCccchhhhhchHHHHH
Q 007608 416 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR-AIDFSRLEEEEDVLLLDHI 494 (596)
Q Consensus 416 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~-p~~~~~~~~~~~~~l~~~~ 494 (596)
||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||..... ..+...+
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-----~~~~~~i 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKL 239 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHG
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-----HHHHHHH
Confidence 9999999986543322 223458999999999999999999999999999999999765 5653221 1122211
Q ss_pred HHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 495 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 495 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
. .+.. ...+...+.++.+++.+||+.||++||||+||++.|+.
T Consensus 240 ~----~~~~--------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 240 P----QGYR--------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp G----GTCC--------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H----hcCC--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 1110 11223345678899999999999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-46 Score=383.47 Aligned_cols=253 Identities=19% Similarity=0.245 Sum_probs=207.8
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|+..+.||+|+||+||+|.. .+|+.||||+++... ......+.+|++++++++|||||++++++.+++..++|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35799999999999999999996 479999999987532 3345678899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc--CCCcEEEeecccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~DfGl~~~~~ 427 (596)
|+++|+|.+.+... ...+++..++.++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++...
T Consensus 107 ~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence 99999998877642 34699999999999999999999999 999999999999997 67899999999999876
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.... .....||+.|+|||++.+..++.++||||+||++|||+||+.||...... .....+.. .. .. +
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~---~~-~~--~ 247 (352)
T d1koba_ 181 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-----ETLQNVKR---CD-WE--F 247 (352)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHH---CC-CC--C
T ss_pred CCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh---CC-CC--C
Confidence 5322 33456899999999999999999999999999999999999999753321 12222211 11 00 0
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. ......+.++.+++.+||+.||.+|||+.|++++
T Consensus 248 ~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DE---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CS---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred Cc---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 1122334578899999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=381.15 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=206.9
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 347 (596)
.++|+..+.||+|+||.||+|+. .+|+.||||+++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999996 479999999986421 233467789999999999999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++.. ...++...++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999886 34688999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+...+.. ...
T Consensus 157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-----~~~~~i~~----~~~---- 222 (337)
T d1o6la_ 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILM----EEI---- 222 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH----CCC----
T ss_pred cCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-----HHHHHHhc----CCC----
Confidence 3322 233467999999999999999999999999999999999999999864321 12121111 110
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 545 (596)
.++...+.++.+++.+||++||++||+ ++|+++
T Consensus 223 -----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112234457788999999999999995 677755
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-46 Score=378.39 Aligned_cols=246 Identities=25% Similarity=0.311 Sum_probs=205.4
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||+||+|+.+ +|+.||||+++.. ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56888999999999999999964 7999999998632 12334577999999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+++|++...+.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999998886 34678899999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+. ... .
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~i~---~~~-~----- 218 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-----KTYEKIL---NAE-L----- 218 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHH---HCC-C-----
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-----HHHHHHH---cCC-C-----
Confidence 3 23457999999999999999999999999999999999999999754321 1111111 111 0
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM 546 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 546 (596)
..+...+.++.+++.+|++.||.+|| +++|++++
T Consensus 219 ----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11222345688899999999999996 88888763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=379.53 Aligned_cols=261 Identities=27% Similarity=0.377 Sum_probs=208.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEeCC--------CcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEec
Q 007608 270 ATDNFSESNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 340 (596)
Q Consensus 270 ~~~~f~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 340 (596)
..++|+..+.||+|+||.||+|+... +..||||+++..........+.+|...+.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 45678889999999999999998532 3479999998766666678899999999888 79999999999999
Q ss_pred CCeeEEEEEcccCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEE
Q 007608 341 SSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 408 (596)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl 408 (596)
++..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +|+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence 9999999999999999999975432 134689999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhh
Q 007608 409 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE 486 (596)
Q Consensus 409 l~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~ 486 (596)
++.++.+||+|||+++........ ......|++.|+|||.+.++.++.++|||||||++|||+| |..||......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--- 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence 999999999999999977554322 3344568999999999999999999999999999999998 68887643321
Q ss_pred hchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 487 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 487 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.+.+.+. .+... ..+...+.++.+++.+||+.||++|||+.||+++|+++
T Consensus 245 --~~~~~i~----~~~~~--------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 --ELFKLLK----EGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp --HHHHHHH----TTCCC--------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHH----cCCCC--------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1222222 11111 11222345788999999999999999999999999753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=378.19 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=213.4
Q ss_pred HHhcCCCcCceeeecCceEEEEEEe------CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEecC
Q 007608 269 LATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 341 (596)
Q Consensus 269 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 341 (596)
+..++|+..+.||+|+||.||+|++ .+++.||||+++..........|.+|+.++.++ +|||||+++++|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 4457888899999999999999985 346789999998655566677899999999999 699999999999999
Q ss_pred CeeEEEEEcccCCChhhhhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcE
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKP--------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 407 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI 407 (596)
+..++||||+++|+|.++++.... ....+++..+..++.||+.||+|||++ +++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 999999999999999999975432 234689999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeccccccccccCcc-eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhC-CCCCCCccchhh
Q 007608 408 LLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLEEE 485 (596)
Q Consensus 408 ll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg-~~p~~~~~~~~~ 485 (596)
+++.++.+|++|||.++........ ......||+.|+|||++.+..++.++|||||||++|||+|+ .+|+......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 9999999999999999977654332 33446789999999999999999999999999999999995 4445432221
Q ss_pred hhchHHHHHHHHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 486 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 486 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..+...+....+. ..+...+.++.+++.+||+.||++||||.||+++|++
T Consensus 255 --~~~~~~i~~~~~~------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 255 --SKFYKMIKEGFRM------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp --HHHHHHHHHTCCC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHHHhcCCCC------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1122222211110 1122345678999999999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-47 Score=373.92 Aligned_cols=255 Identities=29% Similarity=0.367 Sum_probs=196.7
Q ss_pred cCCCcCceeeecCceEEEEEEeC--CC--cEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS--DN--TKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 345 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 345 (596)
++|+..+.||+|+||+||+|++. ++ ..||||+++... .....+.|.+|++++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888899999999999999853 22 368999987432 33445789999999999999999999999975 4678
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
+||||+++|++.+.+... ...+++..++.++.|+|.||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999887753 24599999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCcce--eccccccccccCcccccCCCCCcccccHHHHHHHHHHHh-CCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 426 VDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 426 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
........ .....|+..|+|||++.+..++.++|||||||++|||+| |+.||...... .....+ .+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-----~~~~~i---~~~~~ 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHKI---DKEGE 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHH---HTSCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-----HHHHHH---HhCCC
Confidence 75543322 234557889999999999999999999999999999998 89999753321 122222 12211
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 503 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 503 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.. ..+...+.++.+++.+||+.||++||||.||++.|++
T Consensus 233 ~~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 RL--------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC--------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 10 1122334578899999999999999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=376.20 Aligned_cols=267 Identities=23% Similarity=0.301 Sum_probs=200.0
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC----eeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv 347 (596)
.+|...+.||+|+||+||+|++ +|+.||||+++.. ......+..|+..+.+++||||++++++|.+.+ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~--~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc--chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 3566678999999999999997 6899999998642 122222344555566789999999999997654 57899
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-----NPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
|||+++|+|.+++++ ..++|..+++++.|+|.||+|+|+.. .++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999986 35899999999999999999999731 24899999999999999999999999999
Q ss_pred cccccccCcc---eeccccccccccCcccccCCC------CCcccccHHHHHHHHHHHhCCCCCCCccchhhh------h
Q 007608 423 AKLVDAKLTH---VTTQIRGTMGHIAPEYLSTGK------SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE------D 487 (596)
Q Consensus 423 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~------~ 487 (596)
++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9877543322 223467999999999987542 577899999999999999998887542211110 0
Q ss_pred chHHHHHHHHhccCcccccccCcCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 007608 488 VLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 550 (596)
Q Consensus 488 ~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 550 (596)
.............+. .++.+.. ...+....+.+++.+||+.||++|||+.||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 011122222221111 2222222 1334667799999999999999999999999999753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-45 Score=367.44 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=201.0
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC--CcchHHHHHHHHHHHHhcCCCCccceEeEEecCC----e
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----E 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~ 343 (596)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... .......|.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 479999999997433 2334567999999999999999999999987654 3
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||+++++|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 7899999999999998876 34689999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccCc--ceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 424 KLVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 424 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~~~~~~ 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--------VAYQHVRED 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH--------HHHHHHhcC
Confidence 76543322 23344679999999999999999999999999999999999999997543211 111111111
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhcc
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-PMAQVVKMLQG 549 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~ 549 (596)
.... . ......+.++.+++.+|++.||++|| |++|+.+.|..
T Consensus 231 ~~~~---~---~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIPP---S---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCCG---G---GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCC---c---hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1100 0 01122346788899999999999999 89999887754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-45 Score=365.82 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=204.4
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCc--------chHHHHHHHHHHHHhcC-CCCccceEeEEecC
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSP--------GGEAAFQREVHLISVAI-HKNLLQLIGYCTTS 341 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--------~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~ 341 (596)
++|+..+.||+|+||+||+|+. .+|+.||||++...... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6788999999999999999996 47899999998643211 12346889999999997 99999999999999
Q ss_pred CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
+..++||||+++|+|.+++.. ...+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999976 34699999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeccccccccccCcccccC------CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHH
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 495 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~ 495 (596)
+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||+||+.||...... .....+.
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-----~~~~~i~ 228 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-----LMLRMIM 228 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-----HHHHHHH
Confidence 999775532 2334569999999999853 35788999999999999999999999854321 1111111
Q ss_pred HHhccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 496 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 496 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. +... ...+ .....+.++.+++.+||+.||++|||+.||+++
T Consensus 229 ~----~~~~-~~~~----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 S----GNYQ-FGSP----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp H----TCCC-CCTT----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred h----CCCC-CCCc----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 1110 0000 112344678899999999999999999998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-45 Score=378.15 Aligned_cols=245 Identities=21% Similarity=0.264 Sum_probs=204.9
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc--CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 348 (596)
++|+..+.||+|+||.||+|+.+ +|+.||||++... ......+.+.+|+++++.++||||+++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57899999999999999999974 7999999998632 12334567899999999999999999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 428 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~ 428 (596)
||+.+|+|..++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999999763 4689999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc
Q 007608 429 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 508 (596)
Q Consensus 429 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 508 (596)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+.. ...
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~i~~----~~~----- 255 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-----QIYEKIVS----GKV----- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH----CCC-----
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-----HHHHHHhc----CCC-----
Confidence 3 23456999999999999999999999999999999999999999753321 11111111 110
Q ss_pred CcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 007608 509 RNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVK 545 (596)
Q Consensus 509 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 545 (596)
..+.....++.+++.+||+.||.+|+ +++|+++
T Consensus 256 ----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11223345788999999999999994 8888865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=368.67 Aligned_cols=257 Identities=27% Similarity=0.261 Sum_probs=196.3
Q ss_pred cCceeeecCceEEEEEEeC-CCcEEEEEEccccCCc----chHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 276 ESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 276 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
..++||+|+||+||+|+.. +|+.||||+++..... .....+.+|++++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999964 6899999998643221 1234688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+.++++...... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 998877766543 35688899999999999999999999 99999999999999999999999999998765433
Q ss_pred cceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCccccccc-
Q 007608 431 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD- 508 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d- 508 (596)
.. .....||+.|+|||++.+. .++.++|||||||++|||+||+.||...... .....+.............+
T Consensus 155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-----~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-----DQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCCCTTTSSST
T ss_pred cc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-----HHHHHHHHhcCCCChhhccch
Confidence 22 2334689999999998755 5799999999999999999999999754321 12222222211111000000
Q ss_pred ---------CcCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 509 ---------RNLNTYD-----SKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 509 ---------~~l~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
......+ .....++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0001111 123467889999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-45 Score=380.18 Aligned_cols=250 Identities=24% Similarity=0.267 Sum_probs=198.9
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHH---HHHHHhcCCCCccceEeEEecCCee
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQRE---VHLISVAIHKNLLQLIGYCTTSSER 344 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e---~~~l~~l~H~niv~l~~~~~~~~~~ 344 (596)
-++|++.+.||+|+||.||+|+.. +|+.||||++.... .......+.+| +.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999965 79999999985321 11223334444 6667777899999999999999999
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999986 34688999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcc
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 503 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 503 (596)
...... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||....... .....+.. ....
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~-~~~~- 225 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMT-LTMA- 225 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHHS-SSCC-
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhc-ccCC-
Confidence 765432 234569999999999975 568999999999999999999999998543221 11111111 0000
Q ss_pred cccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 007608 504 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK 545 (596)
Q Consensus 504 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 545 (596)
...+...+.++.+++.+||+.||++||+ ++|+++
T Consensus 226 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 --------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0112233457889999999999999999 577765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=374.18 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=202.7
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC--CcchHHHHHHHHHHHH-hcCCCCccceEeEEecCCeeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTTSSERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lv 347 (596)
++|+..+.||+|+||+||+|+.. +++.||||+++... .......+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999975 78999999996321 2233456667777665 68999999999999999999999
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 427 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~ 427 (596)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999986 34588999999999999999999999 99999999999999999999999999998665
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCcccccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 507 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 507 (596)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .+...+. .+.
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-----~~~~~i~----~~~----- 219 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-----ELFHSIR----MDN----- 219 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHH----HCC-----
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHHH----cCC-----
Confidence 4322 233456999999999999999999999999999999999999999854321 1222121 111
Q ss_pred cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 007608 508 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA-QVVK 545 (596)
Q Consensus 508 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 545 (596)
+ .++...+.++.+++.+||+.||++||++. |+++
T Consensus 220 -~---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 -P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -C---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 11222345688999999999999999996 6643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=369.37 Aligned_cols=250 Identities=16% Similarity=0.237 Sum_probs=204.5
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
.++|++.+.||+|+||+||+|... +++.||||+++.. ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 367899999999999999999975 6889999999643 2345678899999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC--CCcEEEeecccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVD 427 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~DfGl~~~~~ 427 (596)
|+++|+|.+++... ...+++.++..++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999999752 23589999999999999999999999 9999999999999985 4589999999998765
Q ss_pred ccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc-cccc
Q 007608 428 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR-LNDI 506 (596)
Q Consensus 428 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~ 506 (596)
... ......+|+.|+|||...+..++.++||||+||++|||++|+.||...... .....+. .... ....
T Consensus 156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-----~~~~~i~---~~~~~~~~~ 225 (321)
T d1tkia_ 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENIM---NAEYTFDEE 225 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHH---HTCCCCCHH
T ss_pred cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH---hCCCCCChh
Confidence 432 223345899999999999999999999999999999999999999854321 1111111 1110 0000
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 507 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 507 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. ....+.++.+++.+|++.||++|||+.|+++
T Consensus 226 ~-------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 A-------FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H-------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h-------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0112456789999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=366.36 Aligned_cols=264 Identities=24% Similarity=0.304 Sum_probs=200.4
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
++|+..+.||+|+||+||+|+. .+|+.||||+++... .......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999996 579999999996432 23345789999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
|+.++.+...... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9986544433332 235699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc--Cccccc
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE--DRLNDI 506 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~ 506 (596)
.. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+ .+.......... ......
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----QLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTG
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH----HHHHHHHhcCCCchhhcccc
Confidence 22 233346899999999987665 5889999999999999999999998543211 111111111100 000000
Q ss_pred c---c--CcCCC---C-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 507 V---D--RNLNT---Y-----DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 507 ~---d--~~l~~---~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. + ..... . ......++.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 0 00000 0 11224678899999999999999999999764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=372.40 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=198.0
Q ss_pred hcCCCcC-ceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhc-CCCCccceEeEEec----CCe
Q 007608 271 TDNFSES-NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT----SSE 343 (596)
Q Consensus 271 ~~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~~ 343 (596)
.++|.+. ++||+|+||+||+|+. .+++.||||+++. ...+.+|++++.++ +||||+++++++.+ ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 3578776 4699999999999996 5789999999864 34577899987655 89999999998865 356
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC---CCcEEEeec
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDF 420 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Df 420 (596)
.++||||+++|+|.+++... +...+++.+++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 79999999999999999753 235699999999999999999999999 9999999999999985 567999999
Q ss_pred cccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 421 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 421 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+......
T Consensus 159 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-----~~~~~~~~i~~ 231 (335)
T d2ozaa1 159 GFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIRM 231 (335)
T ss_dssp TTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCS
T ss_pred ceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-----HHHHHHHHHhc
Confidence 99987654322 334569999999999999999999999999999999999999997432211 11111111000
Q ss_pred CcccccccCcCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 DRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 ~~~~~~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. ..... .....+.++.+++.+||+.||++|||+.|++++
T Consensus 232 ~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 232 GQ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CS------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 00010 112345678999999999999999999999883
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-44 Score=361.52 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=202.0
Q ss_pred cCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEEc
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 350 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 350 (596)
++|+..+.||+|+||+||+|+.++|+.||||+++... .......+.+|+.++++++||||+++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788999999999999999999999999999996432 333467899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 007608 351 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 430 (596)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 430 (596)
+.++.+...... ...++...+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 998777666554 35699999999999999999999999 99999999999999999999999999998765432
Q ss_pred cceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC---ccccc
Q 007608 431 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RLNDI 506 (596)
Q Consensus 431 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~~ 506 (596)
. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+ .+.. +....... .....
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~----~~~~-i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMR-IFRILGTPNSKNWPNV 228 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH-HHHHHCCCCTTTSTTG
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH----HHHH-HHHhhCCCChhhccch
Confidence 2 22334589999999998764 56899999999999999999999997543211 1111 11111110 00000
Q ss_pred -----ccCcCC--------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 507 -----VDRNLN--------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 507 -----~d~~l~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.+.... .........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 011223467889999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=361.39 Aligned_cols=241 Identities=22% Similarity=0.368 Sum_probs=195.6
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCc-----chHHHHHHHHHHHHhcC--CCCccceEeEEecCCe
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAI--HKNLLQLIGYCTTSSE 343 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~ 343 (596)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57889999999999999999964 7899999998642211 11234678999999986 9999999999999999
Q ss_pred eEEEEEcccC-CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-CCcEEEeecc
Q 007608 344 RILVYPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFG 421 (596)
Q Consensus 344 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfG 421 (596)
.++||||+.+ +++.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 577777765 34689999999999999999999999 9999999999999985 4799999999
Q ss_pred ccccccccCcceeccccccccccCcccccCCCC-CcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 422 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 422 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
+++..... ......||+.|+|||++.+.++ +.++|||||||++|||+||+.||..... +. +.
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------i~---~~ 219 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------II---RG 219 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HH---HC
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----------Hh---hc
Confidence 99865433 2234569999999999987765 5678999999999999999999974210 10 00
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
. .. .+...+.++.+++.+||+.||++|||++|++++
T Consensus 220 ~---~~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 Q---VF-------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C---CC-------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c---cC-------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 00 111224578889999999999999999999873
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=360.71 Aligned_cols=263 Identities=24% Similarity=0.334 Sum_probs=198.1
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CC-CcEEEEEEcccc-CCcchHHHHHHHHHHHHhc---CCCCccceEeEEec----
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SD-NTKVAVKRLQDY-YSPGGEAAFQREVHLISVA---IHKNLLQLIGYCTT---- 340 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~---- 340 (596)
.++|++.+.||+|+||+||+|+. ++ ++.||||+++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999996 34 567999998643 2223334566788777665 79999999998853
Q ss_pred -CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEee
Q 007608 341 -SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 419 (596)
Q Consensus 341 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 419 (596)
....++++||+.++++...... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 2457899999998876654443 235689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhc
Q 007608 420 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 499 (596)
Q Consensus 420 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~ 499 (596)
||+++...... ......||+.|+|||++.+.+++.++||||+||++|||+||+.||......+ ....+.....
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-----~~~~i~~~~~ 232 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLGKILDVIG 232 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHC
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-----HHHHHHHhhC
Confidence 99988654332 2334569999999999999999999999999999999999999998543211 1111211111
Q ss_pred cC---cccc-------c----ccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 500 ED---RLND-------I----VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 500 ~~---~~~~-------~----~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. .... . ...............+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000 0 0000111122334677889999999999999999999764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=351.34 Aligned_cols=263 Identities=24% Similarity=0.277 Sum_probs=196.9
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecC--------
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-------- 341 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-------- 341 (596)
++|+..+.||+|+||+||+|+. .+|+.||||++... ........+.+|++++++++|||++++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6788999999999999999996 47999999998633 3344567789999999999999999999988553
Q ss_pred CeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecc
Q 007608 342 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 421 (596)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG 421 (596)
...++||||+.++.+...... ...++...++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 457899999998776655443 35688899999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcc---eeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHH
Q 007608 422 LAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 497 (596)
Q Consensus 422 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~ 497 (596)
+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||...... .....+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-----~~~~~i~~~ 237 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALISQL 237 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-----HHHHHHHHh
Confidence 99866533221 22234689999999998765 6899999999999999999999999753321 111222221
Q ss_pred hcc---CcccccccCc---------CCCCC-HH------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 498 LRE---DRLNDIVDRN---------LNTYD-SK------EVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 498 ~~~---~~~~~~~d~~---------l~~~~-~~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
... .......... ..... .+ ....+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 111 1000100000 00001 11 13456789999999999999999999764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=356.16 Aligned_cols=263 Identities=19% Similarity=0.311 Sum_probs=198.7
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC----eeE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERI 345 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~ 345 (596)
+++|+..+.||+|+||+||+|+. .+|+.||||++.........+.+.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35788999999999999999996 5899999999975545555678999999999999999999999986653 345
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 425 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~ 425 (596)
++++|+.+|+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 66677789999999975 3589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcc--eeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 426 VDAKLTH--VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 426 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
....... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.. ...........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-----~~~~~~~~~~~ 233 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-----NHILGILGSPS 233 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----HHHHHHHCSCC
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH-----HHHhhhccCCC
Confidence 6543222 2234568999999999854 56789999999999999999999999754321111 11100000000
Q ss_pred cc-----------c--cccCcCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 503 LN-----------D--IVDRNLNTYD-----SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 503 ~~-----------~--~~d~~l~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.. . ...+.....+ .....++.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0 0000000011 1123468899999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=345.90 Aligned_cols=262 Identities=24% Similarity=0.283 Sum_probs=205.0
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 349 (596)
++|+..+.||+|+||+||+|+. .+++.||||+++... .......+.+|+.+++.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5788999999999999999996 478999999997433 33456789999999999999999999999999999999999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 429 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 429 (596)
++.++++..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999998887765 35688999999999999999999999 9999999999999999999999999999876544
Q ss_pred CcceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC---ccc-
Q 007608 430 LTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RLN- 504 (596)
Q Consensus 430 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~---~~~- 504 (596)
... .....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||....... .....+....... ...
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD----DQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH----HHHHHHHHHHCCCCTTTCTT
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH----HHHHHHHhhcCCCChhhhhh
Confidence 322 22334678999999987665 6899999999999999999999975432211 1111222111110 000
Q ss_pred --ccc----------cCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 505 --DIV----------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 505 --~~~----------d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
... ..............+.+++.+|++.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00011122234467788999999999999999999966
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=354.75 Aligned_cols=259 Identities=23% Similarity=0.322 Sum_probs=194.1
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEcccc-CCcchHHHHHHHHHHHHhcCCCCccceEeEEecCC------
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 342 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 342 (596)
.++|+..+.||+|+||+||+|... +|+.||||+++.. ......+.+.+|++++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 367889999999999999999964 7999999999743 33344567899999999999999999999997654
Q ss_pred eeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeeccc
Q 007608 343 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 422 (596)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl 422 (596)
..++||||+ +.+|....+. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 469999999 4577776654 4599999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeccccccccccCcccccCC-CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc-
Q 007608 423 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE- 500 (596)
Q Consensus 423 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~- 500 (596)
++..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||........ +..........
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~----~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ----LKEIMKVTGTPP 239 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCC
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH----HHHHHhccCCCc
Confidence 9876543 2345689999999998764 568999999999999999999999976432111 11110000000
Q ss_pred ----------------CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 501 ----------------DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 501 ----------------~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
....+.....+.........++.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000011111112234567889999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=352.66 Aligned_cols=263 Identities=22% Similarity=0.286 Sum_probs=192.7
Q ss_pred CCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEeEEecC------CeeE
Q 007608 273 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SERI 345 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~ 345 (596)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|++++++++||||+++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5777899999999999999975 799999999975321 234799999999999999999998543 2468
Q ss_pred EEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC-cEEEeeccccc
Q 007608 346 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAK 424 (596)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfGl~~ 424 (596)
+||||++++.+.. +.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~~~~-l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHHHH-HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccHHH-HHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 9999998764443 332222346799999999999999999999998 999999999999999765 89999999998
Q ss_pred cccccCcceeccccccccccCcccccC-CCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchH-------HHHHHH
Q 007608 425 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL-------LDHIRK 496 (596)
Q Consensus 425 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l-------~~~~~~ 496 (596)
....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+...... .+....
T Consensus 172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 7654322 233568999999998865 468999999999999999999999997543221110000 001111
Q ss_pred Hhcc---CcccccccCcC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 497 LLRE---DRLNDIVDRNL-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 497 ~~~~---~~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.... ........... .........++.+|+.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1000 00000000000 00122345578899999999999999999999763
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=352.48 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=202.6
Q ss_pred cCCCcCceeeecCceEEEEEEe----CCCcEEEEEEccccC---CcchHHHHHHHHHHHHhcCC-CCccceEeEEecCCe
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSE 343 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~ 343 (596)
++|+..+.||+|+||+||+|.. .+|+.||||+++... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999985 258899999986421 22335668899999999977 899999999999999
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++|+||+.+|+|.+++... ..++......++.|++.||.|+|+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999863 3567888999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeccccccccccCcccccCC--CCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccC
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 501 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 501 (596)
+..............|++.|+|||.+.+. .++.++|||||||++|||+||+.||......... ...........
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----~~i~~~~~~~~ 252 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKSE 252 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHHCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhcccCC
Confidence 87755444444456799999999999764 4688999999999999999999999764432211 11111111110
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 007608 502 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK 545 (596)
Q Consensus 502 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 545 (596)
...+.....++.+++.+|++.||++||| ++|+++
T Consensus 253 ----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0122344578889999999999999995 677754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-41 Score=342.22 Aligned_cols=258 Identities=17% Similarity=0.205 Sum_probs=195.1
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCccceEe-EEecCCeeEEEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG-YCTTSSERILVYP 349 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~-~~~~~~~~~lv~e 349 (596)
++|+..+.||+|+||.||+|+. .+|+.||||++.... ....+..|+++++.++|+|++..++ +..+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT---TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc---cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 5789999999999999999996 478999999886432 2345788999999998877665554 4567778889999
Q ss_pred cccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEc---CCCcEEEeeccccccc
Q 007608 350 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAKLV 426 (596)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~DfGl~~~~ 426 (596)
|+. +++...+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+++..
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLG-PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCC-CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcC-Cchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 995 5666555432 34689999999999999999999999 999999999999985 4557999999999977
Q ss_pred cccCcc------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhcc
Q 007608 427 DAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 500 (596)
Q Consensus 427 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~ 500 (596)
...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~~~~~~~~- 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMS- 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH-
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-HHHHhhcccCC-
Confidence 543221 2234579999999999999999999999999999999999999997543321111 11111111000
Q ss_pred CcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 501 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 501 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
..... .....+.++.+++..|++.+|++||++.++.+.|++
T Consensus 235 ~~~~~--------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 235 TPIEV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp SCHHH--------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred CChhH--------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00000 011234578899999999999999999999888875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-41 Score=344.87 Aligned_cols=258 Identities=19% Similarity=0.272 Sum_probs=196.1
Q ss_pred cCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecC--CeeEEE
Q 007608 272 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTS--SERILV 347 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lv 347 (596)
++|++.+.||+|+||+||+|+. .+|+.||||+++. ...+.+.+|++++.++. ||||+++++++... ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 5799999999999999999996 4789999999864 23567899999999995 99999999998744 458899
Q ss_pred EEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCC-cEEEeeccccccc
Q 007608 348 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLV 426 (596)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfGl~~~~ 426 (596)
|||+.+++|..... .++...++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 99999999876532 488999999999999999999999 999999999999998654 6999999999876
Q ss_pred cccCcceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHH---------HHHH
Q 007608 427 DAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD---------HIRK 496 (596)
Q Consensus 427 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~---------~~~~ 496 (596)
..... .....+|+.|+|||.+.+.. ++.++||||+||+++||++|+.||............... +...
T Consensus 181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 54322 23456899999999987654 799999999999999999999999754332111111111 1110
Q ss_pred Hhcc--CcccccccCc--------CCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 497 LLRE--DRLNDIVDRN--------LNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 497 ~~~~--~~~~~~~d~~--------l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
.... .......... ... .......++.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000000000 000 11223457889999999999999999999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-41 Score=337.79 Aligned_cols=259 Identities=15% Similarity=0.201 Sum_probs=202.7
Q ss_pred hcCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccCCcchHHHHHHHHHHHHhcCC-CCccceEeEEecCCeeEEEE
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSERILVY 348 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 348 (596)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+|++.+..+.| +|++.+++++......++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 357889999999999999999964 789999998864322 2346788899998875 89999999999999999999
Q ss_pred EcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcC-----CCcEEEeecccc
Q 007608 349 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-----NFEAVLCDFGLA 423 (596)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~DfGl~ 423 (596)
||+ +++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 81 e~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 998 68999888753 24689999999999999999999999 9999999999999974 568999999999
Q ss_pred ccccccCcc------eeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHH
Q 007608 424 KLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 497 (596)
Q Consensus 424 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~ 497 (596)
+........ ......||+.|+|||.+.+..++.++|||||||++|||+||+.||......... .....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~--~~~~~i~~~ 231 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QKYERIGEK 231 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH--HHHHHHHhc
Confidence 876533211 223456999999999999999999999999999999999999999754332111 111111111
Q ss_pred hccCcccccccCcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 007608 498 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 549 (596)
Q Consensus 498 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 549 (596)
.......++ ....+.++.+++..|+..+|++||+++.+.+.|++
T Consensus 232 ~~~~~~~~l--------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 232 KQSTPLREL--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHSCHHHH--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred cCCCChHHh--------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111111111 01123568888999999999999999998887764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=349.28 Aligned_cols=263 Identities=20% Similarity=0.270 Sum_probs=191.1
Q ss_pred cCCCcCceeeecCceEEEEEEeC-CCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC------Ce
Q 007608 272 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SE 343 (596)
Q Consensus 272 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~ 343 (596)
++|++.++||+|+||+||+|... +|+.||||++.... +......+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999965 69999999997433 334456789999999999999999999998643 57
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.++||||+.++.+. .+. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 89999999765544 333 2478999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHH------------
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL------------ 491 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~------------ 491 (596)
+...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||..............
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 8665432 22345689999999999999999999999999999999999999975432111100000
Q ss_pred --HHHHHHhccC------cccccccCcCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007608 492 --DHIRKLLRED------RLNDIVDRNLNT----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 546 (596)
Q Consensus 492 --~~~~~~~~~~------~~~~~~d~~l~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 546 (596)
.......... .....+...... .......++.+++.+|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 000011111111 123456788999999999999999999999654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=343.99 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=195.3
Q ss_pred hcCCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccC-CcchHHHHHHHHHHHHhcCCCCccceEeEEecC-----Ce
Q 007608 271 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE 343 (596)
Q Consensus 271 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 343 (596)
.++|+..+.||+|+||+||+|+. .+|+.||||++.... +....+.+.+|++++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999996 479999999997432 334456789999999999999999999998643 34
Q ss_pred eEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEEeecccc
Q 007608 344 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 423 (596)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~ 423 (596)
.+++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 5777888899999998864 3599999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeccccccccccCcccccCCC-CCcccccHHHHHHHHHHHhCCCCCCCccchhhhhchHHHHHHHHhccCc
Q 007608 424 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 502 (596)
Q Consensus 424 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 502 (596)
...... .....|++.|+|||...+.. ++.++|||||||++|||++|+.||...+.... ...+........
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-----~~~i~~~~~~~~ 239 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-----LKLILRLVGTPG 239 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHHHCCCC
T ss_pred cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhcCCCC
Confidence 765432 23346899999999877654 68999999999999999999999975432211 111111100000
Q ss_pred c-----------ccccc--CcCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007608 503 L-----------NDIVD--RNLNTY-----DSKEVETMVQVALLCTQSTPEDRPPMAQVVK 545 (596)
Q Consensus 503 ~-----------~~~~d--~~l~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 545 (596)
. ..... ...... ......++.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 00000 000000 0122456788999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-36 Score=310.48 Aligned_cols=263 Identities=20% Similarity=0.224 Sum_probs=188.3
Q ss_pred CCCcCceeeecCceEEEEEEe-CCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-----------CCCccceEeEEec
Q 007608 273 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----------HKNLLQLIGYCTT 340 (596)
Q Consensus 273 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~~ 340 (596)
+|++.++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+++++.+. |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 588899999999999999996 47999999999742 234567788998888775 5789999888754
Q ss_pred --CCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCcEEEcCCC----
Q 007608 341 --SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNF---- 413 (596)
Q Consensus 341 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~---- 413 (596)
....+++++++..+......... .....+++..++.++.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 34556677666555433332221 224568899999999999999999998 5 899999999999998654
Q ss_pred --cEEEeeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHHHHHHHhCCCCCCCccchhh--hhch
Q 007608 414 --EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE--EDVL 489 (596)
Q Consensus 414 --~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~--~~~~ 489 (596)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||........ ....
T Consensus 168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 3999999999865432 2345689999999999999999999999999999999999999975432111 0111
Q ss_pred HHHHHHHHh-------cc-Cccccccc---------C-----------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007608 490 LLDHIRKLL-------RE-DRLNDIVD---------R-----------NLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 541 (596)
Q Consensus 490 l~~~~~~~~-------~~-~~~~~~~d---------~-----------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 541 (596)
+...+...- .. ......++ . ...........++.+++.+|++.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 111111000 00 00000000 0 01123456778899999999999999999999
Q ss_pred HHHH
Q 007608 542 QVVK 545 (596)
Q Consensus 542 evl~ 545 (596)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9965
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.88 E-value=2.1e-23 Score=209.64 Aligned_cols=149 Identities=27% Similarity=0.499 Sum_probs=132.6
Q ss_pred CCChhHHHHHHHHHHhccCCCCCCCCCCCCCCCCCC--CcceeEeeC----CCEEEEEcCCCCCCc--ccCcchhhhccc
Q 007608 31 REPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCF--SWSHVTCRN----GNVISLTLGSNGFSG--KISPSITKLKFL 102 (596)
Q Consensus 31 ~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~--~w~gv~c~~----~~l~~L~l~~n~l~g--~~p~~~~~l~~L 102 (596)
.|.+.|++||++||+++.+|. .+++|..+ ++|| .|.||+|+. .+|+.|+|++|+++| .+|++|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~--~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT--SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCCC--CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 477899999999999998875 68999865 3454 699999975 279999999999998 589999999999
Q ss_pred chhhcccC-ccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCCCCcccccCCcccccc---cccccc
Q 007608 103 ASFRELQD-NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSV---ATFNFT 178 (596)
Q Consensus 103 ~~l~~l~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l~~l---~~l~~~ 178 (596)
++| +|++ |+++|.+|++|++|++|++|||++|+|.|..|..+.++.+|+.+++++|++.+.+|..+.++ ..++++
T Consensus 79 ~~L-~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~ 157 (313)
T d1ogqa_ 79 NFL-YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp SEE-EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred ccc-ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecc
Confidence 999 9986 89999999999999999999999999999999999999999999999999999999888765 456777
Q ss_pred ccccc
Q 007608 179 GTHLI 183 (596)
Q Consensus 179 ~n~~~ 183 (596)
+|.+.
T Consensus 158 ~n~l~ 162 (313)
T d1ogqa_ 158 GNRIS 162 (313)
T ss_dssp SSCCE
T ss_pred ccccc
Confidence 77654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.4e-22 Score=188.27 Aligned_cols=169 Identities=11% Similarity=0.056 Sum_probs=119.1
Q ss_pred CcCceeeecCceEEEEEEeCCCcEEEEEEccccCCc-----------------chHHHHHHHHHHHHhcCCCCccceEeE
Q 007608 275 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-----------------GGEAAFQREVHLISVAIHKNLLQLIGY 337 (596)
Q Consensus 275 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------------~~~~~~~~e~~~l~~l~H~niv~l~~~ 337 (596)
...+.||+|+||+||+|...+|+.||||+++..... .....+.+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 346899999999999999889999999987521110 012345668888999999999988765
Q ss_pred EecCCeeEEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCcEEEcCCCcEEE
Q 007608 338 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL 417 (596)
Q Consensus 338 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 417 (596)
. ..+++|||+++..+.. ++......++.|++.+++|||+. +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2479999998765432 22233567899999999999999 99999999999999976 5899
Q ss_pred eeccccccccccCcceeccccccccccCcccccCCCCCcccccHHHHHH
Q 007608 418 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGIT 466 (596)
Q Consensus 418 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvi 466 (596)
+|||++............. ..... -.+. ..+++..++|+||..--
T Consensus 144 iDFG~a~~~~~~~~~~~l~--rd~~~-~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILE--RDVRN-IITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHHHHHH--HHHHH-HHHH-HHHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHH--HHHHH-HHHH-HcCCCCCcccHHHHHHH
Confidence 9999997654321110000 00000 0111 13567889999996543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.62 E-value=2.3e-16 Score=145.84 Aligned_cols=123 Identities=24% Similarity=0.383 Sum_probs=105.4
Q ss_pred CCC-CCcceeEeeC-----------CCEEEEEcCCCCCCccc-CcchhhhcccchhhcccCccccccCCcccCCCCcccE
Q 007608 63 SPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKI-SPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQS 129 (596)
Q Consensus 63 ~~c-~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~-p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~ 129 (596)
..| |+|..|.|++ .+++.|+|++|+|++.+ +..|.++++|+.| +|++|.+.+..+..+..+++|++
T Consensus 4 ~~C~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L-~L~~N~i~~~~~~~~~~~~~L~~ 82 (192)
T d1w8aa_ 4 AMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKL-ELKRNQLTGIEPNAFEGASHIQE 82 (192)
T ss_dssp TTSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEE-ECCSSCCCCBCTTTTTTCTTCCE
T ss_pred CCCEEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeee-eccccccccccccccccccccce
Confidence 345 4899999974 27899999999998766 4568999999999 99999999888899999999999
Q ss_pred EEccCccCcCCCccccccCCCCcEEeCCCCcccccCCc-cc---cccccccccccccccCCC
Q 007608 130 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM-QL---FSVATFNFTGTHLICGSS 187 (596)
Q Consensus 130 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~-~l---~~l~~l~~~~n~~~~~~~ 187 (596)
|+|++|+|++..|..|.++++|++|+|++|+|+ .||+ .| .+|+.+++.+|++.|.+.
T Consensus 83 L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 83 LQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp EECCSCCCCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred eeeccccccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCcccccccccccccccccc
Confidence 999999999555667999999999999999999 5554 33 467889999999988753
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.52 E-value=3.1e-15 Score=149.16 Aligned_cols=113 Identities=31% Similarity=0.451 Sum_probs=100.5
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
....+++.++.+.|.+|..++.+++|+.| ++++|.++|.+| .++.+++|+.|+|++|+|+|.+|..|++|++|++|||
T Consensus 198 ~~~~l~l~~~~~~~~~~~~~~~~~~l~~l-~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~L 275 (313)
T d1ogqa_ 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKI-HLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275 (313)
T ss_dssp CCSEEECCSSEEEECCGGGCCTTSCCSEE-ECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEEC
T ss_pred ccccccccccccccccccccccccccccc-cccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEEC
Confidence 34468888888888888889999999999 999999997665 6999999999999999999999999999999999999
Q ss_pred CCCcccccCCcc--ccccccccccccccccCCCCCCCC
Q 007608 157 SSNNLTGRIPMQ--LFSVATFNFTGTHLICGSSLEQPC 192 (596)
Q Consensus 157 ~~N~l~g~iP~~--l~~l~~l~~~~n~~~~~~~~~~~c 192 (596)
++|+|+|.||.. +.+|..+++.||+.+||.|++ .|
T Consensus 276 s~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 276 SFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cCCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 999999999963 567788899999999998764 55
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=3.4e-14 Score=120.82 Aligned_cols=99 Identities=22% Similarity=0.377 Sum_probs=86.4
Q ss_pred EEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCCCC
Q 007608 80 SLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 159 (596)
Q Consensus 80 ~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 159 (596)
.|+|++|+|+ .++ .+.++++|++| ++++|+|+ .+|+.++.+++|++|++++|.|+ .+| .++++++|++|++++|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L-~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHL-DLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEE-ECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEE-ECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 6899999999 676 59999999999 99999999 79999999999999999999999 677 4999999999999999
Q ss_pred cccccCCc--cc---cccccccccccccccC
Q 007608 160 NLTGRIPM--QL---FSVATFNFTGTHLICG 185 (596)
Q Consensus 160 ~l~g~iP~--~l---~~l~~l~~~~n~~~~~ 185 (596)
+|+ .+|. .+ .+|..++++||+....
T Consensus 76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCC-SSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccC-CCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 999 5653 34 4567888999987643
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=3e-13 Score=119.81 Aligned_cols=108 Identities=18% Similarity=0.271 Sum_probs=88.6
Q ss_pred CcceeEeeCCCEEEEEcCCCCCCcccCcchhhhcccchhhcccCc-cccccCCcccCCCCcccEEEccCccCcCCCcccc
Q 007608 67 SWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDN-DLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATW 145 (596)
Q Consensus 67 ~w~gv~c~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 145 (596)
.+.++.|. ++++. .+|..+..+++|+.| ++++| .|+..-+..|.++++|+.|+|++|+|+..-|..|
T Consensus 9 ~~~~l~c~----------~~~~~-~~p~~l~~l~~l~~L-~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f 76 (156)
T d2ifga3 9 GSSGLRCT----------RDGAL-DSLHHLPGAENLTEL-YIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76 (156)
T ss_dssp SSSCEECC----------SSCCC-TTTTTSCSCSCCSEE-ECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGG
T ss_pred CCCeEEec----------CCCCc-cCcccccCccccCee-ecCCCccccccCchhhccccccCcceeeccccCCcccccc
Confidence 56666664 56666 678888889999999 89766 5884334679999999999999999995556779
Q ss_pred ccCCCCcEEeCCCCcccccCCcccc---ccccccccccccccCCC
Q 007608 146 SQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHLICGSS 187 (596)
Q Consensus 146 ~~l~~L~~L~l~~N~l~g~iP~~l~---~l~~l~~~~n~~~~~~~ 187 (596)
..+++|++|+|++|+|+ .+|...+ ++..|++++|++.|.+.
T Consensus 77 ~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C~ 120 (156)
T d2ifga3 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120 (156)
T ss_dssp GSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred cccccccceeccCCCCc-ccChhhhccccccccccCCCcccCCch
Confidence 99999999999999999 8887654 57789999999998764
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.32 E-value=1.3e-12 Score=120.17 Aligned_cols=111 Identities=20% Similarity=0.362 Sum_probs=92.8
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|++.+..+..+..+++|+.| +|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+
T Consensus 54 ~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L-~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~ 132 (192)
T d1w8aa_ 54 PHLVKLELKRNQLTGIEPNAFEGASHIQEL-QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEE-ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred ceEeeeecccccccccccccccccccccee-eeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccc
Confidence 489999999999998888899999999999 9999999966677899999999999999999966667799999999999
Q ss_pred CCCCcccccCCccc--cccccccccccccccCCC
Q 007608 156 LSSNNLTGRIPMQL--FSVATFNFTGTHLICGSS 187 (596)
Q Consensus 156 l~~N~l~g~iP~~l--~~l~~l~~~~n~~~~~~~ 187 (596)
|++|.+.+..+... ..+..+.+.+|...|..+
T Consensus 133 L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 133 LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence 99999985443222 134555666777777543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=1.3e-12 Score=116.34 Aligned_cols=101 Identities=20% Similarity=0.220 Sum_probs=86.8
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccc-cccCCCCcEEe
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKHLD 155 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~ 155 (596)
++++|+|++|+|+ .++..+..+++|+.| +|++|+|+ .++ .|..+++|++|+|++|+++ .+|+. +..+++|+.|+
T Consensus 19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L-~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENLGATLDQFDAI-DFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELI 93 (162)
T ss_dssp SCEEEECTTSCCC-SCCCGGGGTTCCSEE-ECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEE
T ss_pred cCcEEECCCCCCC-ccCccccccccCCEE-ECCCCCCC-ccC-CcccCcchhhhhccccccc-CCCccccccccccccce
Confidence 6899999999999 788777889999999 99999999 675 5899999999999999999 56554 67899999999
Q ss_pred CCCCcccccCCc-----cccccccccccccccc
Q 007608 156 LSSNNLTGRIPM-----QLFSVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP~-----~l~~l~~l~~~~n~~~ 183 (596)
|++|+++ .++. .+.+|..+++.+|++.
T Consensus 94 L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 94 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ecccccc-ccccccccccccccchhhcCCCccc
Confidence 9999998 5553 2356778889998764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=1.8e-12 Score=125.61 Aligned_cols=109 Identities=25% Similarity=0.335 Sum_probs=81.9
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|++++|.+.+..+..+..+.+|+.| ++++|.+++..|..+..+++|+.|++++|+|++..|..|..+++|++|+|
T Consensus 101 ~L~~L~l~~~~~~~~~~~~~~~l~~l~~L-~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~L 179 (266)
T d1p9ag_ 101 ALTVLDVSFNRLTSLPLGALRGLGELQEL-YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179 (266)
T ss_dssp TCCEEECCSSCCCCCCSSTTTTCTTCCEE-ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEEC
T ss_pred ccccccccccccceeeccccccccccccc-cccccccceeccccccccccchhcccccccccccCccccccccccceeec
Confidence 44555555555554444445555666666 66677777444556677899999999999999666677999999999999
Q ss_pred CCCcccccCCcccc---ccccccccccccccCCC
Q 007608 157 SSNNLTGRIPMQLF---SVATFNFTGTHLICGSS 187 (596)
Q Consensus 157 ~~N~l~g~iP~~l~---~l~~l~~~~n~~~~~~~ 187 (596)
++|+|+ .||..++ +|+.|+++||+|.|.+.
T Consensus 180 s~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp CSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred ccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 999999 9998766 45778899999999864
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.27 E-value=3.2e-12 Score=108.32 Aligned_cols=85 Identities=25% Similarity=0.348 Sum_probs=76.9
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCc--cccccCCCCcE
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP--ATWSQLSNLKH 153 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~ 153 (596)
.+++.|+|++|+|+ .+|+.++.+++|+.| ++++|.|+ .+| .++++++|++|++++|+|+ .+| ..++.+++|+.
T Consensus 20 ~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L-~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~ 94 (124)
T d1dcea3 20 LLVTHLDLSHNRLR-ALPPALAALRCLEVL-QASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVL 94 (124)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEE-ECCSSCCC-CCG-GGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCE
T ss_pred CCCCEEECCCCccC-cchhhhhhhhccccc-cccccccc-ccC-ccccccccCeEECCCCccC-CCCCchhhcCCCCCCE
Confidence 47999999999999 799999999999999 99999999 566 5999999999999999999 555 46899999999
Q ss_pred EeCCCCcccccCC
Q 007608 154 LDLSSNNLTGRIP 166 (596)
Q Consensus 154 L~l~~N~l~g~iP 166 (596)
|++++|+++ .++
T Consensus 95 L~l~~N~i~-~~~ 106 (124)
T d1dcea3 95 LNLQGNSLC-QEE 106 (124)
T ss_dssp EECTTSGGG-GSS
T ss_pred EECCCCcCC-cCc
Confidence 999999998 443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=1.4e-12 Score=127.76 Aligned_cols=111 Identities=20% Similarity=0.257 Sum_probs=95.9
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.+++++|+|++..+..|..+++|+.| ++++|+|++..|..|.++++|++|++++|++++..|..|.++++|++||
T Consensus 129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L-~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 129 AALQYLYLQDNALQALPDDTFRDLGNLTHL-FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEE-ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccchhhhccccccccChhHhccccchhhc-ccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 378899999999995556678899999999 9999999977778899999999999999999988899999999999999
Q ss_pred CCCCcccccCCccc---cccccccccccccccCCC
Q 007608 156 LSSNNLTGRIPMQL---FSVATFNFTGTHLICGSS 187 (596)
Q Consensus 156 l~~N~l~g~iP~~l---~~l~~l~~~~n~~~~~~~ 187 (596)
+++|++++..|..+ .+|+.+++++|++.|.+.
T Consensus 208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred ccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 99999995544444 457888999999999754
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=1.2e-11 Score=109.30 Aligned_cols=84 Identities=24% Similarity=0.253 Sum_probs=73.4
Q ss_pred CCEEEEEcCCCC-CCcccC-cchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcE
Q 007608 76 GNVISLTLGSNG-FSGKIS-PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKH 153 (596)
Q Consensus 76 ~~l~~L~l~~n~-l~g~~p-~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 153 (596)
.+++.|+|++|+ |+ .++ ..|.+|++|+.| +|++|+|+..-|..|..+++|++|+|++|+|+ .+|..+....+|+.
T Consensus 31 ~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L-~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~ 107 (156)
T d2ifga3 31 ENLTELYIENQQHLQ-HLELRDLRGLGELRNL-TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQE 107 (156)
T ss_dssp SCCSEEECCSCSSCC-EECGGGSCSCCCCSEE-ECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCE
T ss_pred cccCeeecCCCcccc-ccCchhhccccccCcc-eeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccc
Confidence 389999998764 88 555 579999999999 99999999655788999999999999999999 88887666668999
Q ss_pred EeCCCCccc
Q 007608 154 LDLSSNNLT 162 (596)
Q Consensus 154 L~l~~N~l~ 162 (596)
|+|++|.|.
T Consensus 108 L~L~~Np~~ 116 (156)
T d2ifga3 108 LVLSGNPLH 116 (156)
T ss_dssp EECCSSCCC
T ss_pred cccCCCccc
Confidence 999999985
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.16 E-value=1.4e-11 Score=121.50 Aligned_cols=107 Identities=22% Similarity=0.250 Sum_probs=91.4
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|++++|.+++..+..+.+++.++.| ++++|.+++..|..+.++++|++|+|++|+|+ .+|..|.++++|++|+
T Consensus 171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L-~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~ 248 (305)
T d1xkua_ 171 PSLTELHLDGNKITKVDAASLKGLNNLAKL-GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248 (305)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEE-ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CccCEEECCCCcCCCCChhHhhcccccccc-ccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence 368889999999998888889999999999 89999999777888899999999999999998 8898999999999999
Q ss_pred CCCCcccccCCccc----------cccccccccccccccC
Q 007608 156 LSSNNLTGRIPMQL----------FSVATFNFTGTHLICG 185 (596)
Q Consensus 156 l~~N~l~g~iP~~l----------~~l~~l~~~~n~~~~~ 185 (596)
|++|+|+ .|+... .++..|++.||++.+.
T Consensus 249 Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 249 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp CCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred CCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 9999998 776432 3467788899987653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.07 E-value=6.6e-11 Score=114.31 Aligned_cols=103 Identities=24% Similarity=0.278 Sum_probs=76.2
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|+|++..+..|.++++|++| +|++|+|+ .+|. ++.+++|++|+|++|+++ .+|..+.++++|+.|++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L-~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQL-NLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEE-ECTTSCCC-EEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccc-cccccccc-cccc-cccccccccccccccccc-ccccccccccccccccc
Confidence 67888888888885444578888888888 88888888 5664 577888888888888888 66777888888888888
Q ss_pred CCCcccccCCcc---ccccccccccccccc
Q 007608 157 SSNNLTGRIPMQ---LFSVATFNFTGTHLI 183 (596)
Q Consensus 157 ~~N~l~g~iP~~---l~~l~~l~~~~n~~~ 183 (596)
++|++.+..+.. +.++..|.+.+|.+.
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~ 137 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELK 137 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred cccccceeeccccccccccccccccccccc
Confidence 888887332222 345566677776543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.99 E-value=5.9e-11 Score=105.38 Aligned_cols=89 Identities=17% Similarity=0.226 Sum_probs=77.0
Q ss_pred eeCCCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcc-cCCCCcccEEEccCccCcCCCcc--ccccCC
Q 007608 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDF-LGSMTHLQSLNLANNKFSGSIPA--TWSQLS 149 (596)
Q Consensus 73 c~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~ 149 (596)
+...+++.|+|++|+|+ .++ .+..+++|+.| ++++|+++ .+|+. +..+++|+.|+|++|+|+ .++. .+..++
T Consensus 38 ~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L-~ls~N~i~-~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~ 112 (162)
T d1a9na_ 38 ATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTL-LVNNNRIC-RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLK 112 (162)
T ss_dssp GGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEE-ECCSSCCC-EECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCT
T ss_pred cccccCCEEECCCCCCC-ccC-CcccCcchhhh-hccccccc-CCCccccccccccccceecccccc-cccccccccccc
Confidence 44468999999999999 675 58999999999 99999999 56554 567999999999999999 6764 688999
Q ss_pred CCcEEeCCCCcccccCCc
Q 007608 150 NLKHLDLSSNNLTGRIPM 167 (596)
Q Consensus 150 ~L~~L~l~~N~l~g~iP~ 167 (596)
+|++|++++|.++ .+|.
T Consensus 113 ~L~~L~l~~N~i~-~~~~ 129 (162)
T d1a9na_ 113 SLTYLCILRNPVT-NKKH 129 (162)
T ss_dssp TCCEEECCSSGGG-GSTT
T ss_pred ccchhhcCCCccc-cccc
Confidence 9999999999998 6764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.95 E-value=7.7e-12 Score=115.23 Aligned_cols=102 Identities=24% Similarity=0.303 Sum_probs=87.6
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+|+ .++ .+..|++|+.| +|++|+|+ .+|..+..+++|+.|++++|+++ .++ .+.++++|+.|+
T Consensus 48 ~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L-~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~ 121 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS-SLSGMENLRIL-SLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTCCEEECSEEEES-CCC-CHHHHTTCCEE-ECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEE
T ss_pred cccceeECcccCCC-Ccc-cccCCccccCh-hhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccc
Confidence 58999999999999 676 59999999999 99999998 78877777889999999999999 665 488999999999
Q ss_pred CCCCcccccCCc-----ccccccccccccccccc
Q 007608 156 LSSNNLTGRIPM-----QLFSVATFNFTGTHLIC 184 (596)
Q Consensus 156 l~~N~l~g~iP~-----~l~~l~~l~~~~n~~~~ 184 (596)
|++|+|+ .++. .+.+|+.|+++||+..+
T Consensus 122 L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 122 MSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp ESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred cccchhc-cccccccccCCCccceeecCCCcccc
Confidence 9999998 5542 34567888999998754
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.92 E-value=7.3e-10 Score=108.92 Aligned_cols=105 Identities=24% Similarity=0.419 Sum_probs=73.2
Q ss_pred CCC-CCcceeEeeCCCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCC-cccCCCCcccEEEccCccCcCC
Q 007608 63 SPC-FSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLP-DFLGSMTHLQSLNLANNKFSGS 140 (596)
Q Consensus 63 ~~c-~~w~gv~c~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~ 140 (596)
..| |.|.+|.|++ ++|+ .+|+.+. ++|++| +|++|+|+ .+| ..|.++++|++|++++|.++..
T Consensus 6 ~~c~c~~~~~~C~~----------~~L~-~lP~~l~--~~l~~L-~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i 70 (305)
T d1xkua_ 6 FRCQCHLRVVQCSD----------LGLE-KVPKDLP--PDTALL-DLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKI 70 (305)
T ss_dssp TTCEEETTEEECTT----------SCCC-SCCCSCC--TTCCEE-ECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCB
T ss_pred CCCEecCCEEEecC----------CCCC-ccCCCCC--CCCCEE-ECcCCcCC-CcChhHhhcccccccccccccccccc
Confidence 455 5888888863 5566 6676653 567777 78888887 555 4677888888888888888855
Q ss_pred CccccccCCCCcEEeCCCCcccccCCcccc-ccccccccccccc
Q 007608 141 IPATWSQLSNLKHLDLSSNNLTGRIPMQLF-SVATFNFTGTHLI 183 (596)
Q Consensus 141 ~p~~~~~l~~L~~L~l~~N~l~g~iP~~l~-~l~~l~~~~n~~~ 183 (596)
.|..|.++++|++|++++|+++ .+|..+. .+..|.+..|.+.
T Consensus 71 ~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~~~l~~L~~~~n~l~ 113 (305)
T d1xkua_ 71 SPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEIT 113 (305)
T ss_dssp CTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSSCCC
T ss_pred chhhhhCCCccCEecccCCccC-cCccchhhhhhhhhccccchh
Confidence 5667788888888888888887 6765543 4556666666543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.89 E-value=8.6e-10 Score=107.31 Aligned_cols=107 Identities=23% Similarity=0.253 Sum_probs=84.7
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|+|++|.+.+..+..+..+.+|+.+ ++++|+|++..|..|..+++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l-~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYL-YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEE-ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEecCCcccccccccccchhcccchh-hhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 378888888888886666677788888888 8888888855566788888888999999888866667788888899999
Q ss_pred CCCCcccccCCcccc---ccccccccccccc
Q 007608 156 LSSNNLTGRIPMQLF---SVATFNFTGTHLI 183 (596)
Q Consensus 156 l~~N~l~g~iP~~l~---~l~~l~~~~n~~~ 183 (596)
+++|++++..|..+. ++..|++++|...
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~ 214 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred hhhccccccChhHhhhhhhcccccccccccc
Confidence 999988876676654 5567778877664
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.77 E-value=4.3e-09 Score=96.53 Aligned_cols=99 Identities=23% Similarity=0.399 Sum_probs=62.2
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|++++|+++ .++ .+..+++|++| ++++|+|++ +++ ++++++|++|++++|.+. .+|. ++++++|+.|++
T Consensus 41 ~l~~L~l~~~~i~-~l~-~l~~l~nL~~L-~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l 113 (199)
T d2omxa2 41 QVTTLQADRLGIK-SID-GVEYLNNLTQI-NFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTL 113 (199)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEE-ECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEEC
T ss_pred CCCEEECCCCCCC-Ccc-ccccCCCcCcC-ccccccccC-ccc-ccCCcccccccccccccc-cccc-cccccccccccc
Confidence 5667777777776 443 46667777777 777777763 333 677777777777777766 5553 667777777777
Q ss_pred CCCcccccCC-cccccccccccccccc
Q 007608 157 SSNNLTGRIP-MQLFSVATFNFTGTHL 182 (596)
Q Consensus 157 ~~N~l~g~iP-~~l~~l~~l~~~~n~~ 182 (596)
++|.+....+ ..+.++..|++++|..
T Consensus 114 ~~~~~~~~~~~~~l~~L~~L~l~~n~l 140 (199)
T d2omxa2 114 FNNQITDIDPLKNLTNLNRLELSSNTI 140 (199)
T ss_dssp CSSCCCCCGGGTTCTTCSEEECCSSCC
T ss_pred cccccccccccchhhhhHHhhhhhhhh
Confidence 7776663221 2234556666666644
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.73 E-value=6.7e-09 Score=96.05 Aligned_cols=100 Identities=28% Similarity=0.386 Sum_probs=69.4
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+|+.|+|++|+|++ ++ .++.|++|+.| ++++|+|+ .+| .+.++++|+.|++++|.+. .++ .+.++++|+.++
T Consensus 68 ~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L-~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~ 140 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTD-IK-PLANLKNLGWL-FLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLY 140 (210)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCTTCCEE-ECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEE
T ss_pred CCCCEEeCCCccccC-cc-ccccCcccccc-cccccccc-ccc-ccccccccccccccccccc-ccc-cccccccccccc
Confidence 478888999988884 54 36788888888 88888888 566 4788888888888888876 444 466666666666
Q ss_pred CCCCcccccCC-cccccccccccccccc
Q 007608 156 LSSNNLTGRIP-MQLFSVATFNFTGTHL 182 (596)
Q Consensus 156 l~~N~l~g~iP-~~l~~l~~l~~~~n~~ 182 (596)
+++|.+++..+ ..+.+|+.+++++|.+
T Consensus 141 ~~~n~l~~~~~~~~l~~L~~l~l~~n~l 168 (210)
T d1h6ta2 141 LGNNKITDITVLSRLTKLDTLSLEDNQI 168 (210)
T ss_dssp CCSSCCCCCGGGGGCTTCSEEECCSSCC
T ss_pred cccccccccccccccccccccccccccc
Confidence 66666663211 2234555566666644
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.71 E-value=8.7e-09 Score=95.26 Aligned_cols=98 Identities=19% Similarity=0.310 Sum_probs=80.5
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|++++|.++ .++ .+..+++|++| +|++|+|++ +| .+++|++|++|++++|+|+ .+| .+.++++|+.|++
T Consensus 47 ~L~~L~l~~~~i~-~l~-~l~~l~~L~~L-~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 47 SIDQIIANNSDIK-SVQ-GIQYLPNVTKL-FLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSL 119 (210)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEE-ECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEEC
T ss_pred CccEEECcCCCCC-Cch-hHhhCCCCCEE-eCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccc
Confidence 7889999999998 454 48899999999 999999995 55 4789999999999999999 677 5899999999999
Q ss_pred CCCcccccCCc--ccccccccccccccc
Q 007608 157 SSNNLTGRIPM--QLFSVATFNFTGTHL 182 (596)
Q Consensus 157 ~~N~l~g~iP~--~l~~l~~l~~~~n~~ 182 (596)
++|.++ .++. .+..+..+++.+|..
T Consensus 120 ~~~~~~-~~~~l~~l~~l~~l~~~~n~l 146 (210)
T d1h6ta2 120 EHNGIS-DINGLVHLPQLESLYLGNNKI 146 (210)
T ss_dssp TTSCCC-CCGGGGGCTTCCEEECCSSCC
T ss_pred cccccc-ccccccccccccccccccccc
Confidence 999988 5552 223455666666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.71 E-value=8.7e-09 Score=94.40 Aligned_cols=99 Identities=28% Similarity=0.523 Sum_probs=80.0
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|+|++|++++ +++ +.++++|+.| ++++|.+. .+| .+.++++|+.|++++|.+. .++ .+.++++|+.|+
T Consensus 62 ~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L-~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~-~~~-~~~~l~~L~~L~ 134 (199)
T d2omxa2 62 NNLTQINFSNNQLTD-ITP-LKNLTKLVDI-LMNNNQIA-DIT-PLANLTNLTGLTLFNNQIT-DID-PLKNLTNLNRLE 134 (199)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEE-ECCSSCCC-CCG-GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEE
T ss_pred CCcCcCccccccccC-ccc-ccCCcccccc-cccccccc-ccc-ccccccccccccccccccc-ccc-ccchhhhhHHhh
Confidence 589999999999995 444 8999999999 99999988 566 4889999999999999988 443 478899999999
Q ss_pred CCCCcccccCCc--ccccccccccccccc
Q 007608 156 LSSNNLTGRIPM--QLFSVATFNFTGTHL 182 (596)
Q Consensus 156 l~~N~l~g~iP~--~l~~l~~l~~~~n~~ 182 (596)
+++|+++ .+|. .+.++..|++.+|.+
T Consensus 135 l~~n~l~-~~~~l~~~~~L~~L~l~~n~l 162 (199)
T d2omxa2 135 LSSNTIS-DISALSGLTSLQQLNFSSNQV 162 (199)
T ss_dssp CCSSCCC-CCGGGTTCTTCSEEECCSSCC
T ss_pred hhhhhhc-ccccccccccccccccccccc
Confidence 9999988 5652 334667777777754
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.71 E-value=5.9e-09 Score=105.37 Aligned_cols=99 Identities=28% Similarity=0.427 Sum_probs=59.2
Q ss_pred CEEEEEcCCCCCCcccC--------------------cchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCcc
Q 007608 77 NVISLTLGSNGFSGKIS--------------------PSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNK 136 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p--------------------~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~ 136 (596)
+++.|++++|++++..+ ..+..+++++.| ++++|++++ ++ .+..+++|++|+|++|+
T Consensus 264 ~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L-~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~ 340 (384)
T d2omza2 264 KLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYL-TLYFNNISD-IS-PVSSLTKLQRLFFANNK 340 (384)
T ss_dssp TCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEE-ECCSSCCSC-CG-GGGGCTTCCEEECCSSC
T ss_pred cCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeE-ECCCCCCCC-Cc-ccccCCCCCEEECCCCC
Confidence 56677777766663221 235555666666 666776664 33 26666777777777777
Q ss_pred CcCCCccccccCCCCcEEeCCCCcccccCC-cccccccccccccc
Q 007608 137 FSGSIPATWSQLSNLKHLDLSSNNLTGRIP-MQLFSVATFNFTGT 180 (596)
Q Consensus 137 l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP-~~l~~l~~l~~~~n 180 (596)
|+ .+| .++++++|++|+|++|+|++-.| ..+.+|+.|++++|
T Consensus 341 l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 341 VS-DVS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CC-CCG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CC-CCh-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 76 454 46667777777777777774333 22334555666655
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.65 E-value=6.4e-10 Score=102.05 Aligned_cols=91 Identities=19% Similarity=0.306 Sum_probs=77.8
Q ss_pred CCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCCCCcccccCC
Q 007608 87 GFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166 (596)
Q Consensus 87 ~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP 166 (596)
.+. .+|.++..|++|+.| +|++|+|+ .++ .+.+|++|++|+|++|.|+ .+|..+..+++|+.|++++|+++ .++
T Consensus 36 ~i~-~l~~sl~~L~~L~~L-~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~ 109 (198)
T d1m9la_ 36 PIE-KMDATLSTLKACKHL-ALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS 109 (198)
T ss_dssp TCC-CCHHHHHHTTTCCEE-ECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH
T ss_pred chh-hhhhHHhccccccee-ECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc
Confidence 344 677899999999999 99999999 676 5999999999999999999 88877777889999999999999 565
Q ss_pred c--cccccccccccccccc
Q 007608 167 M--QLFSVATFNFTGTHLI 183 (596)
Q Consensus 167 ~--~l~~l~~l~~~~n~~~ 183 (596)
. .+.+|+.|++++|...
T Consensus 110 ~~~~l~~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 110 GIEKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp HHHHHHHSSEEEESEEECC
T ss_pred cccccccccccccccchhc
Confidence 3 3456788999998753
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.61 E-value=1.1e-08 Score=103.36 Aligned_cols=78 Identities=26% Similarity=0.381 Sum_probs=68.9
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|+|++|++++ ++ .+..+++|+.| ++++|+|+ .+| .+++|++|++|+|++|+|++ +|+ +.+|++|+.|+
T Consensus 307 ~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L-~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~-l~~-l~~l~~L~~L~ 379 (384)
T d2omza2 307 KNLTYLTLYFNNISD-IS-PVSSLTKLQRL-FFANNKVS-DVS-SLANLTNINWLSAGHNQISD-LTP-LANLTRITQLG 379 (384)
T ss_dssp TTCSEEECCSSCCSC-CG-GGGGCTTCCEE-ECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEE
T ss_pred cccCeEECCCCCCCC-Cc-ccccCCCCCEE-ECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCC-Chh-hccCCCCCEee
Confidence 478999999999996 44 38999999999 99999999 466 69999999999999999995 443 89999999999
Q ss_pred CCCCc
Q 007608 156 LSSNN 160 (596)
Q Consensus 156 l~~N~ 160 (596)
|++|.
T Consensus 380 L~~Na 384 (384)
T d2omza2 380 LNDQA 384 (384)
T ss_dssp CCCEE
T ss_pred CCCCc
Confidence 99983
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.58 E-value=2.7e-08 Score=93.01 Aligned_cols=65 Identities=25% Similarity=0.429 Sum_probs=43.0
Q ss_pred hhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeCCCCcccccCC
Q 007608 96 ITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 166 (596)
Q Consensus 96 ~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP 166 (596)
+.+.++|+.| ++++|.+++ ++ .++++++|++|||++|+++ .+|+ ++++++|++|+|++|+++ .+|
T Consensus 147 ~~~~~~L~~L-~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt-~i~ 211 (227)
T d1h6ua2 147 LAGLTNLQYL-SIGNAQVSD-LT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVS 211 (227)
T ss_dssp GGGCTTCCEE-ECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCC-BCG
T ss_pred hccccccccc-ccccccccc-ch-hhcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCcCC-CCc
Confidence 5566667777 677777663 22 2667777777777777776 4543 667777777777777777 454
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=1.8e-08 Score=95.04 Aligned_cols=95 Identities=20% Similarity=0.330 Sum_probs=68.7
Q ss_pred CCcceeEeeC-----------CCEEEEEcCCCCCCcccCc-chhhhcccchhhcccCccccccCC-cccCCCCcccEEEc
Q 007608 66 FSWSHVTCRN-----------GNVISLTLGSNGFSGKISP-SITKLKFLASFRELQDNDLSGTLP-DFLGSMTHLQSLNL 132 (596)
Q Consensus 66 ~~w~gv~c~~-----------~~l~~L~l~~n~l~g~~p~-~~~~l~~L~~l~~l~~n~l~g~~p-~~~~~l~~L~~L~l 132 (596)
|.+..|.|.. .+++.|+|++|+|+ .+|+ .|.++++|++| ++++|.+...+| ..|.+++++++|++
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L-~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKI-EISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEE-EEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhh-hhccccccceeeccccccccccccccc
Confidence 4777888864 25777888888887 4554 57778888888 788887775554 35677788888776
Q ss_pred cC-ccCcCCCccccccCCCCcEEeCCCCccc
Q 007608 133 AN-NKFSGSIPATWSQLSNLKHLDLSSNNLT 162 (596)
Q Consensus 133 ~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 162 (596)
.. |++....|..|.++++|+.|++++|+++
T Consensus 86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp ECCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred cccccccccccccccccccccccccchhhhc
Confidence 53 5676555666778888888888888776
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.52 E-value=3.7e-08 Score=97.88 Aligned_cols=92 Identities=24% Similarity=0.322 Sum_probs=51.6
Q ss_pred CEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEeC
Q 007608 77 NVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 156 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 156 (596)
+++.|+|++|+|+ .+|+. +++|++| +|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .++|++|+|
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L-~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESL-VASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEE-ECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEE-ECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 4566667776666 56653 3455666 66677666 666543 35566666666666 44421 134666666
Q ss_pred CCCcccccCCcc--cccccccccccccc
Q 007608 157 SSNNLTGRIPMQ--LFSVATFNFTGTHL 182 (596)
Q Consensus 157 ~~N~l~g~iP~~--l~~l~~l~~~~n~~ 182 (596)
++|+++ .+|.. +.+|+.|++.+|..
T Consensus 106 ~~n~l~-~lp~~~~l~~L~~L~l~~~~~ 132 (353)
T d1jl5a_ 106 SNNQLE-KLPELQNSSFLKIIDVDNNSL 132 (353)
T ss_dssp CSSCCS-SCCCCTTCTTCCEEECCSSCC
T ss_pred cccccc-cccchhhhccceeeccccccc
Confidence 666666 55531 23444555555443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.48 E-value=3.4e-08 Score=92.24 Aligned_cols=76 Identities=26% Similarity=0.425 Sum_probs=66.4
Q ss_pred CCEEEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCCccccccCCCCcEEe
Q 007608 76 GNVISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 155 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 155 (596)
.+++.|++++|.+.+. + .++++++|+.| +|++|+++ .+|+ ++++++|++|+|++|+|+ .+|+ ++++++|+.|+
T Consensus 151 ~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L-~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt-~i~~-l~~l~~L~~L~ 223 (227)
T d1h6ua2 151 TNLQYLSIGNAQVSDL-T-PLANLSKLTTL-KADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVT 223 (227)
T ss_dssp TTCCEEECCSSCCCCC-G-GGTTCTTCCEE-ECCSSCCC-CCGG-GGGCTTCCEEECTTSCCC-BCGG-GTTCTTCCEEE
T ss_pred cccccccccccccccc-h-hhcccccceec-ccCCCccC-CChh-hcCCCCCCEEECcCCcCC-CCcc-cccCCCCCEEE
Confidence 4799999999999843 3 48999999999 99999999 4654 899999999999999999 6764 89999999999
Q ss_pred CCC
Q 007608 156 LSS 158 (596)
Q Consensus 156 l~~ 158 (596)
|++
T Consensus 224 lsn 226 (227)
T d1h6ua2 224 LTN 226 (227)
T ss_dssp EEE
T ss_pred eeC
Confidence 974
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.21 E-value=7.2e-06 Score=77.53 Aligned_cols=148 Identities=17% Similarity=0.146 Sum_probs=96.5
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcC-CCCccceEeEEecCCee
Q 007608 266 ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSER 344 (596)
Q Consensus 266 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~ 344 (596)
++...-..|+..+..+.++.+.||+... +++.+.+|+..... ......+.+|...+..+. +-.+.+++.+....+..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 4444445665554444444578998875 56667888775322 112334677888877664 43456788888888889
Q ss_pred EEEEEcccCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 007608 345 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------------------------------- 393 (596)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------- 393 (596)
++||+++++.++.+..... .. ...++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 9999999988776543320 11 2234555555666666320
Q ss_pred -------------------------CCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 394 -------------------------NPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 394 -------------------------~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
.+.++|+|+.|.||+++++...-|.||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1137899999999999987667799999875
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.19 E-value=8.9e-07 Score=87.47 Aligned_cols=54 Identities=28% Similarity=0.350 Sum_probs=27.5
Q ss_pred CCcccEEEccCccCcCCCccccccCCCCcEEeCCCCcccccCCcccccccccccccccc
Q 007608 124 MTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 182 (596)
Q Consensus 124 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~iP~~l~~l~~l~~~~n~~ 182 (596)
+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|..+.+|+.|++++|++
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~~~~L~~L~L~~N~L 336 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELPQNLKQLHVEYNPL 336 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCC
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccccCCCCEEECcCCcC
Confidence 345555555555555 45432 344555555555555 4555444555555555544
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.14 E-value=5.4e-08 Score=85.74 Aligned_cols=66 Identities=24% Similarity=0.269 Sum_probs=34.8
Q ss_pred hhhhcccchhhcccCcccccc--CCcccCCCCcccEEEccCccCcCCCcc-ccccCCCCcEEeCCCCcccc
Q 007608 96 ITKLKFLASFRELQDNDLSGT--LPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 163 (596)
Q Consensus 96 ~~~l~~L~~l~~l~~n~l~g~--~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g 163 (596)
..++++|++| +|++|+|+.. ++..+..+++|+.|||++|.++ .+++ ......+|+.|+|++|.+++
T Consensus 61 ~~~~~~L~~L-~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 61 EENIPELLSL-NLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHHCTTCCCC-CCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HHhCCCCCEe-eCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCc
Confidence 3455566666 6666666521 2233445566666666666666 4443 22233455666666666653
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.10 E-value=8.4e-07 Score=83.16 Aligned_cols=99 Identities=14% Similarity=0.229 Sum_probs=79.0
Q ss_pred EEEEcCCCCCCcccCcchhhhcccchhhcccCccccccCC-cccCCCCcccEEEccCccCcCCCcc-ccccCCCCcEEeC
Q 007608 79 ISLTLGSNGFSGKISPSITKLKFLASFRELQDNDLSGTLP-DFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDL 156 (596)
Q Consensus 79 ~~L~l~~n~l~g~~p~~~~~l~~L~~l~~l~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l 156 (596)
+.++.++++++ .+|+.+. +++++| +|++|+|+ .+| ..|.++++|++|+|++|.+...+|. .|.++++++.|++
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L-~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIEL-RFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEE-EEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEE-ECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 36788899999 8998764 578999 99999999 565 4689999999999999999866655 6889999999998
Q ss_pred C-CCcccccCCcccc---cccccccccccc
Q 007608 157 S-SNNLTGRIPMQLF---SVATFNFTGTHL 182 (596)
Q Consensus 157 ~-~N~l~g~iP~~l~---~l~~l~~~~n~~ 182 (596)
. .|+++...|..+. +|+.+++.+|..
T Consensus 86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l 115 (242)
T d1xwdc1 86 EKANNLLYINPEAFQNLPNLQYLLISNTGI 115 (242)
T ss_dssp ECCTTCCEECTTSEECCTTCCEEEEESCCC
T ss_pred cccccccccccccccccccccccccchhhh
Confidence 6 4778755554444 567777887754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.98 E-value=5.7e-07 Score=78.96 Aligned_cols=85 Identities=22% Similarity=0.248 Sum_probs=57.8
Q ss_pred hhhhcccchhhcccCccccccCCcccCCCCcccEEEccCccCcCCC---ccccccCCCCcEEeCCCCcccccCCc----c
Q 007608 96 ITKLKFLASFRELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI---PATWSQLSNLKHLDLSSNNLTGRIPM----Q 168 (596)
Q Consensus 96 ~~~l~~L~~l~~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~---p~~~~~l~~L~~L~l~~N~l~g~iP~----~ 168 (596)
+..+..+..| ++.+|... .++..+.++++|++|||++|+|+ .+ +..+..+++|+.|||++|+++ .++. .
T Consensus 38 l~~~~~~~~l-~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~ 113 (162)
T d1koha1 38 LVAQNIDVVL-NRRSSMAA-TLRIIEENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIK 113 (162)
T ss_dssp TTTTTCCCCT-TSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHT
T ss_pred hhhccchhhc-chhhhHhh-hhHHHHHhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccc-cchhhhhhh
Confidence 4445555555 55555444 45555557888888888888888 44 345677888888888888888 6654 2
Q ss_pred cccccccccccccccc
Q 007608 169 LFSVATFNFTGTHLIC 184 (596)
Q Consensus 169 l~~l~~l~~~~n~~~~ 184 (596)
..++..|++.||+..+
T Consensus 114 ~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 114 GLKLEELWLDGNSLSD 129 (162)
T ss_dssp TCCCSSCCCTTSTTSS
T ss_pred ccccceeecCCCCcCc
Confidence 2356778888888754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.92 E-value=1.9e-05 Score=74.18 Aligned_cols=130 Identities=15% Similarity=0.059 Sum_probs=83.6
Q ss_pred eeeecCc-eEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCC--CCccceEeEEecCCeeEEEEEcccCCC
Q 007608 279 IIGQGGF-GKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSSERILVYPFMQNLS 355 (596)
Q Consensus 279 ~lG~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (596)
.+..|.. +.||+...+++..+++|..... ....+..|...++.+.. -.+.+++++..+.+..++||+|+++-+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3444543 6899999888888999976432 22346677777776643 335667888888888899999998765
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 007608 356 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--------------------------------------------- 390 (596)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------------------------------------------- 390 (596)
+.+.. .. ....+.++++.|+-||
T Consensus 93 ~~~~~---------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 93 LLSSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp TTTSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred ccccc---------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 43210 00 0111222233333333
Q ss_pred ------hCC----CCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 391 ------EQC----NPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 391 ------~~~----~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
... .+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 211 1237999999999999988667899999875
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.83 E-value=9e-07 Score=90.70 Aligned_cols=105 Identities=19% Similarity=0.271 Sum_probs=77.5
Q ss_pred CEEEEEcCCCCCCcc-cCcchhhhcccchhhcccCccccc----cCCcccCCCCcccEEEccCccCcCC----Cccccc-
Q 007608 77 NVISLTLGSNGFSGK-ISPSITKLKFLASFRELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSGS----IPATWS- 146 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~-~p~~~~~l~~L~~l~~l~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~- 146 (596)
+|+.||+++|++++. +..-+..+++|+.| +|++|.|+- .|+..+..+++|++|||++|.|+.. +...+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L-~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVV-RLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEE-EEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEE-EeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 689999999999853 24457788999999 999999872 4566678899999999999998621 222232
Q ss_pred cCCCCcEEeCCCCccccc----CCcc---cccccccccccccc
Q 007608 147 QLSNLKHLDLSSNNLTGR----IPMQ---LFSVATFNFTGTHL 182 (596)
Q Consensus 147 ~l~~L~~L~l~~N~l~g~----iP~~---l~~l~~l~~~~n~~ 182 (596)
...+|+.|+|++|+++.. ++.. ..+|+.|++++|..
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i 124 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL 124 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBC
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccc
Confidence 235799999999999743 3332 34677888888865
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.61 E-value=3.3e-06 Score=86.37 Aligned_cols=86 Identities=30% Similarity=0.359 Sum_probs=51.3
Q ss_pred CEEEEEcCCCCCCcccCcch----hhhcccchhhcccCccccc----cCCcccC-CCCcccEEEccCccCcC----CCcc
Q 007608 77 NVISLTLGSNGFSGKISPSI----TKLKFLASFRELQDNDLSG----TLPDFLG-SMTHLQSLNLANNKFSG----SIPA 143 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~~p~~~----~~l~~L~~l~~l~~n~l~g----~~p~~~~-~l~~L~~L~l~~N~l~g----~~p~ 143 (596)
.++.+++++|.++..-...+ ....+|+.| +|++|+|+. .++..+. ..+.|++|+|++|.|+. .++.
T Consensus 313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L-~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL-QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEE-ECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred ccccccccccchhhhhhhhcccccccccchhhh-heeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence 46666777766654322223 333467777 777777653 2343443 35567777777777762 2444
Q ss_pred ccccCCCCcEEeCCCCcccc
Q 007608 144 TWSQLSNLKHLDLSSNNLTG 163 (596)
Q Consensus 144 ~~~~l~~L~~L~l~~N~l~g 163 (596)
.+..+++|++|||++|+|+.
T Consensus 392 ~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 392 TLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHCCCCCEEECCSSSCCH
T ss_pred HHhcCCCCCEEECCCCcCCH
Confidence 56666777777777777764
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.61 E-value=3.9e-06 Score=83.06 Aligned_cols=85 Identities=24% Similarity=0.285 Sum_probs=43.5
Q ss_pred CEEEEEcCCCCCCcc-----cCcchhhhcccchhhcccCcccccc----CCcccCCCCcccEEEccCccCcCCCccc---
Q 007608 77 NVISLTLGSNGFSGK-----ISPSITKLKFLASFRELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGSIPAT--- 144 (596)
Q Consensus 77 ~l~~L~l~~n~l~g~-----~p~~~~~l~~L~~l~~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~--- 144 (596)
.++.|+|++|+++.. +...+..+++|+.| +|++|.++.. +...+..+++|++|+|++|.|++.-...
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L-~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVL-DLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEE-ECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhcccccccccccccccccchhhhhcchhhhccc-ccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 455666666665421 22334555566666 6666665421 3344555666666666666665321111
Q ss_pred -ccc--CCCCcEEeCCCCccc
Q 007608 145 -WSQ--LSNLKHLDLSSNNLT 162 (596)
Q Consensus 145 -~~~--l~~L~~L~l~~N~l~ 162 (596)
+.. .+.|++|+|++|+++
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCB
T ss_pred HhhhccCCCCCEEECCCCcCC
Confidence 222 244666666666654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.49 E-value=1.8e-05 Score=75.97 Aligned_cols=87 Identities=18% Similarity=0.325 Sum_probs=41.6
Q ss_pred CEEEEEcCCC-CCCc-ccCcchhhh-cccchhhcccCc--cccc-cCCcccCCCCcccEEEccCc-cCcCCCccccccCC
Q 007608 77 NVISLTLGSN-GFSG-KISPSITKL-KFLASFRELQDN--DLSG-TLPDFLGSMTHLQSLNLANN-KFSGSIPATWSQLS 149 (596)
Q Consensus 77 ~l~~L~l~~n-~l~g-~~p~~~~~l-~~L~~l~~l~~n--~l~g-~~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~ 149 (596)
+++.|+|+++ .++. .+...+..+ ++|+.| ++++. .++. .+..-+.++++|++|+|++| .+++..+..+++++
T Consensus 122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L-~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQL-NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEE-ECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred hccccccccccccccccchhhhcccccccchh-hhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 5666666663 3331 122223332 455555 55542 2221 12222334556666666553 35555555556666
Q ss_pred CCcEEeCCC-Cccccc
Q 007608 150 NLKHLDLSS-NNLTGR 164 (596)
Q Consensus 150 ~L~~L~l~~-N~l~g~ 164 (596)
+|++|+|++ +++++.
T Consensus 201 ~L~~L~L~~C~~i~~~ 216 (284)
T d2astb2 201 YLQHLSLSRCYDIIPE 216 (284)
T ss_dssp TCCEEECTTCTTCCGG
T ss_pred cCCEEECCCCCCCChH
Confidence 666666665 345443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.43 E-value=9.4e-06 Score=80.17 Aligned_cols=86 Identities=20% Similarity=0.320 Sum_probs=48.5
Q ss_pred CEEEEEcCCCCCCc----ccCcchhhhcccchhhcccCcccccc-----CCcccCCCCcccEEEccCccCcCC----Ccc
Q 007608 77 NVISLTLGSNGFSG----KISPSITKLKFLASFRELQDNDLSGT-----LPDFLGSMTHLQSLNLANNKFSGS----IPA 143 (596)
Q Consensus 77 ~l~~L~l~~n~l~g----~~p~~~~~l~~L~~l~~l~~n~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~ 143 (596)
.++.|++++|.++. .+...+...+.|+.| +|++|+++.. +...+..+++|+.|+|++|.++.. +..
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L-~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV-KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEE-ECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhccc-ccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 34555555555541 122334555666666 6777666521 334455666677777777766422 334
Q ss_pred ccccCCCCcEEeCCCCcccc
Q 007608 144 TWSQLSNLKHLDLSSNNLTG 163 (596)
Q Consensus 144 ~~~~l~~L~~L~l~~N~l~g 163 (596)
.+..+++|+.|+|++|+|++
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp HGGGCTTCCEEECTTCCCCH
T ss_pred cccccccchhhhhhcCccCc
Confidence 45666667777777776653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.33 E-value=0.00034 Score=69.97 Aligned_cols=77 Identities=14% Similarity=0.126 Sum_probs=46.8
Q ss_pred CceeeecCceEEEEEEeCC-CcEEEEEEcccc------CCcchHHHHHHHHHHHHhcC-C--CCccceEeEEecCCeeEE
Q 007608 277 SNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDY------YSPGGEAAFQREVHLISVAI-H--KNLLQLIGYCTTSSERIL 346 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~------~~~~~~~~~~~e~~~l~~l~-H--~niv~l~~~~~~~~~~~l 346 (596)
.+.||.|....||++...+ ++.++||.-... ..+........|.+.+..+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998654 678999854211 11112233456777776553 2 334555544 4556689
Q ss_pred EEEcccCCC
Q 007608 347 VYPFMQNLS 355 (596)
Q Consensus 347 v~e~~~~gs 355 (596)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.20 E-value=0.00013 Score=69.63 Aligned_cols=106 Identities=15% Similarity=0.198 Sum_probs=78.6
Q ss_pred CCEEEEEcCCC--CCCcc-cCcchhhhcccchhhcccCc-cccccCCcccCCCCcccEEEccC-ccCcCCCccccccCCC
Q 007608 76 GNVISLTLGSN--GFSGK-ISPSITKLKFLASFRELQDN-DLSGTLPDFLGSMTHLQSLNLAN-NKFSGSIPATWSQLSN 150 (596)
Q Consensus 76 ~~l~~L~l~~n--~l~g~-~p~~~~~l~~L~~l~~l~~n-~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~ 150 (596)
.+++.|+++++ .++.. +..-+.++++|+.| ++++| .+++..+..++++++|++|+|++ +.+++.-...++++++
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L-~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~ 226 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL-DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE-ECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTT
T ss_pred cccchhhhccccccccccccccccccccccccc-ccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCC
Confidence 47999999875 34422 33345678999999 99985 68888888999999999999999 5788777778999999
Q ss_pred CcEEeCCCCcccccCCcccccccccccccccc
Q 007608 151 LKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 182 (596)
Q Consensus 151 L~~L~l~~N~l~g~iP~~l~~l~~l~~~~n~~ 182 (596)
|+.|+++++--.+.++.-...++.|++..+++
T Consensus 227 L~~L~l~~~~~d~~l~~l~~~lp~L~i~~~~l 258 (284)
T d2astb2 227 LKTLQVFGIVPDGTLQLLKEALPHLQINCSHF 258 (284)
T ss_dssp CCEEECTTSSCTTCHHHHHHHSTTSEESCCCS
T ss_pred CCEEeeeCCCCHHHHHHHHHhCccccccCccC
Confidence 99999998832223332234566677655443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.77 E-value=0.0019 Score=62.52 Aligned_cols=136 Identities=14% Similarity=0.092 Sum_probs=76.7
Q ss_pred ceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCc--cceEe-----EEecCCeeEEEEEcccCCChh
Q 007608 285 FGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL--LQLIG-----YCTTSSERILVYPFMQNLSVA 357 (596)
Q Consensus 285 ~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~ 357 (596)
--.||++..++|+.+++|+.+... ...+++..|...+..+....+ +..+. .....+..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 468999999999999999875422 235667888888877653222 11111 123345678889998764321
Q ss_pred ------------------hhhcccCC-CCCCCCHHH-------------------HHHHHHHHHHHHHHHHh----CCCC
Q 007608 358 ------------------YRLRDLKP-GEKGLDWPT-------------------RKRVAFGTAYGLEYLHE----QCNP 395 (596)
Q Consensus 358 ------------------~~l~~~~~-~~~~l~~~~-------------------~~~i~~~ia~~L~~LH~----~~~~ 395 (596)
........ .....++.. +..+...+.+.++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 11111110 111122111 11112222223333322 2234
Q ss_pred CcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 396 KIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 396 ~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
+++|+|+.+.|||++++ ..+.||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC--ceEEechhcc
Confidence 78999999999999754 4589999876
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.61 E-value=0.00017 Score=62.82 Aligned_cols=86 Identities=12% Similarity=0.221 Sum_probs=59.0
Q ss_pred CCEEEEEcCCC-CCCcc----cCcchhhhcccchhhcccCcccccc----CCcccCCCCcccEEEccCccCcCC----Cc
Q 007608 76 GNVISLTLGSN-GFSGK----ISPSITKLKFLASFRELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----IP 142 (596)
Q Consensus 76 ~~l~~L~l~~n-~l~g~----~p~~~~~l~~L~~l~~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p 142 (596)
.++++|+|+++ .++.. +-..+...++|++| +|++|.+... +...+...+.|+.|+|++|.|+.. +-
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L-~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKF-SLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEE-ECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCcccee-eccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 36889999874 45422 22345566778888 8999888732 223445568899999999988733 22
Q ss_pred cccccCCCCcEEeCCCCccc
Q 007608 143 ATWSQLSNLKHLDLSSNNLT 162 (596)
Q Consensus 143 ~~~~~l~~L~~L~l~~N~l~ 162 (596)
..+...++|+.|+|++|.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSC
T ss_pred HHHHhCCcCCEEECCCCcCC
Confidence 34666678999999888766
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.22 E-value=0.02 Score=54.48 Aligned_cols=159 Identities=12% Similarity=0.058 Sum_probs=80.5
Q ss_pred ccHHHHHHHhcCCCcCcee-----eecCceEEEEEEeCCCcEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCc--cce
Q 007608 262 FSCRELQLATDNFSESNII-----GQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL--LQL 334 (596)
Q Consensus 262 ~~~~el~~~~~~f~~~~~l-----G~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~ni--v~l 334 (596)
.+.+|++....+|..++.. ..|---+.|+.+..+| .+++|+.....+. ++...|++++..+...++ ...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH---HHHHHHHHHHHhhhhcccccccc
Confidence 4567787778888775544 3555678899988665 4889987543222 334455666665542222 111
Q ss_pred Ee------EEecCCeeEEEEEcccCCChh--------------hhhcc----cCCC-CCCCCHH----------------
Q 007608 335 IG------YCTTSSERILVYPFMQNLSVA--------------YRLRD----LKPG-EKGLDWP---------------- 373 (596)
Q Consensus 335 ~~------~~~~~~~~~lv~e~~~~gsL~--------------~~l~~----~~~~-~~~l~~~---------------- 373 (596)
+. +.........++.+..+.... ..++. .... .......
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 10 112233455666666553211 01110 0000 0000000
Q ss_pred --HHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCcEEEcCCCcEEEeeccccc
Q 007608 374 --TRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 424 (596)
Q Consensus 374 --~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfGl~~ 424 (596)
.....+..+...+.-.+. ....+++|+|+.+.||+++++...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 001112222222222221 123379999999999999998777899999875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.08 E-value=0.00098 Score=57.77 Aligned_cols=87 Identities=13% Similarity=0.108 Sum_probs=65.2
Q ss_pred CCCEEEEEcCCCCCCcc----cCcchhhhcccchhhcccCcccccc----CCcccCCCCcccEEEccCccCcCC------
Q 007608 75 NGNVISLTLGSNGFSGK----ISPSITKLKFLASFRELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS------ 140 (596)
Q Consensus 75 ~~~l~~L~l~~n~l~g~----~p~~~~~l~~L~~l~~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~------ 140 (596)
+..|+.|+|++|.+... +...+...+.|+.| +|++|.|+.. +-..+..-++|++|+|++|.+...
T Consensus 43 n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L-~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~ 121 (167)
T d1pgva_ 43 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVL-NVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM 121 (167)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEE-ECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred CCccceeeccccccchhHHHHHhhhhhhcccccce-eeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHH
Confidence 35799999999999743 33445566889999 9999999842 334567789999999999987621
Q ss_pred -CccccccCCCCcEEeCCCCccc
Q 007608 141 -IPATWSQLSNLKHLDLSSNNLT 162 (596)
Q Consensus 141 -~p~~~~~l~~L~~L~l~~N~l~ 162 (596)
+...+..-++|+.|+++.+...
T Consensus 122 ~l~~~L~~n~sL~~l~l~~~~~~ 144 (167)
T d1pgva_ 122 DMMMAIEENESLLRVGISFASME 144 (167)
T ss_dssp HHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHhCCCccEeeCcCCCch
Confidence 3334556789999999887654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.38 E-value=0.039 Score=54.30 Aligned_cols=73 Identities=15% Similarity=0.162 Sum_probs=48.2
Q ss_pred CceeeecCceEEEEEEeCCC--------cEEEEEEccccCCcchHHHHHHHHHHHHhcCCCCcc-ceEeEEecCCeeEEE
Q 007608 277 SNIIGQGGFGKVYKGVLSDN--------TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL-QLIGYCTTSSERILV 347 (596)
Q Consensus 277 ~~~lG~G~~g~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~~~~~~~~~~~lv 347 (596)
.+.|+.|-.-.+|++..+++ ..|.+++... .. ......+|..+++.+.-.++. ++++++.+ .+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 45788888899999987543 4566666532 22 234566888888877533444 67776642 678
Q ss_pred EEcccCCCh
Q 007608 348 YPFMQNLSV 356 (596)
Q Consensus 348 ~e~~~~gsL 356 (596)
++|+++-++
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.44 E-value=0.006 Score=52.37 Aligned_cols=85 Identities=19% Similarity=0.291 Sum_probs=40.4
Q ss_pred CEEEEEcCC-CCCCcc----cCcchhhhcccchhhcccCcccccc----CCcccCCCCcccEEEccCccCcCC----Ccc
Q 007608 77 NVISLTLGS-NGFSGK----ISPSITKLKFLASFRELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----IPA 143 (596)
Q Consensus 77 ~l~~L~l~~-n~l~g~----~p~~~~~l~~L~~l~~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~ 143 (596)
.++.|+|++ +.++.. +-..+...++|+.| +|++|.++.. +-..+...++|+.|++++|.++.. +-.
T Consensus 18 ~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L-~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 18 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKF-SIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEE-ECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCee-eccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 455666655 334311 12233345556666 6666665432 222334455666666666665422 223
Q ss_pred ccccCCCCcEEeC--CCCccc
Q 007608 144 TWSQLSNLKHLDL--SSNNLT 162 (596)
Q Consensus 144 ~~~~l~~L~~L~l--~~N~l~ 162 (596)
.+...++|+.++| ++|.+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCccccEEeeccCCCcCc
Confidence 3455556654333 344443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.00 E-value=0.0068 Score=52.01 Aligned_cols=85 Identities=16% Similarity=0.194 Sum_probs=44.9
Q ss_pred CCEEEEEcCCCCCCcc----cCcchhhhcccchhhcccCcccccc----CCcccCCCCcccEEEc--cCccCcC----CC
Q 007608 76 GNVISLTLGSNGFSGK----ISPSITKLKFLASFRELQDNDLSGT----LPDFLGSMTHLQSLNL--ANNKFSG----SI 141 (596)
Q Consensus 76 ~~l~~L~l~~n~l~g~----~p~~~~~l~~L~~l~~l~~n~l~g~----~p~~~~~l~~L~~L~l--~~N~l~g----~~ 141 (596)
.+++.|+|++|.++.. +-..+...+.|+.| ++++|.++.. +-..+...++|+.++| ++|.+.. .+
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l-~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~L 124 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSL-NVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 124 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEE-ECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhh-hhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHH
Confidence 4566666666666532 22234445666666 6666665421 2344555566665444 3455532 23
Q ss_pred ccccccCCCCcEEeCCCCcc
Q 007608 142 PATWSQLSNLKHLDLSSNNL 161 (596)
Q Consensus 142 p~~~~~l~~L~~L~l~~N~l 161 (596)
...+...++|+.|+++.|..
T Consensus 125 a~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 125 ANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHhCCCcCEEeCcCCCC
Confidence 33455566666666665543
|